Citrus Sinensis ID: 041878
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 773 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SCT4 | 836 | Probably inactive leucine | yes | no | 0.978 | 0.904 | 0.686 | 0.0 | |
| C0LGP9 | 784 | Probable leucine-rich rep | no | no | 0.901 | 0.889 | 0.574 | 0.0 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.826 | 0.579 | 0.330 | 9e-90 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.822 | 0.533 | 0.332 | 2e-88 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.649 | 0.762 | 0.392 | 6e-88 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.838 | 0.541 | 0.344 | 1e-86 | |
| Q6XAT2 | 967 | LRR receptor-like serine/ | no | no | 0.783 | 0.626 | 0.333 | 1e-86 | |
| C0LGW6 | 966 | LRR receptor-like serine/ | no | no | 0.816 | 0.653 | 0.343 | 4e-86 | |
| Q42371 | 976 | LRR receptor-like serine/ | no | no | 0.742 | 0.588 | 0.336 | 4e-85 | |
| C0LGS2 | 1136 | Probable LRR receptor-lik | no | no | 0.820 | 0.558 | 0.305 | 1e-84 |
| >sp|Q9SCT4|IMK2_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase IMK2 OS=Arabidopsis thaliana GN=IMK2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 990 bits (2559), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 530/772 (68%), Positives = 624/772 (80%), Gaps = 16/772 (2%)
Query: 7 YLYPFHNYKHFFLYTHLFLCLVLAFTSQFVAG-----HSWDGVIVTQADYQSLRAIKHDL 61
Y PF Y+ F + L L F++Q VAG HSWDG++VTQA+YQ+L+AIKH+L
Sbjct: 5 YKNPFRIYEISFHFCASLLLCFLLFSAQAVAGGGGGGHSWDGIVVTQANYQALQAIKHEL 64
Query: 62 IDPHGFLRSWNDSGVGACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLS 121
ID G L+SWN+S GWAGIKC++GQV+AIQLPW+ LGG ISEKI QL +LRKLS
Sbjct: 65 IDFTGVLKSWNNSASSQVCSGWAGIKCLRGQVVAIQLPWKGLGGTISEKIGQLGSLRKLS 124
Query: 122 LHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPP 181
LH+N++AG VP SLG+L +LRGVYLFNNRLSGSIP S+GNCP LQ LDLS+N L GAIPP
Sbjct: 125 LHNNVIAGSVPRSLGYLKSLRGVYLFNNRLSGSIPVSLGNCPLLQNLDLSSNQLTGAIPP 184
Query: 182 SLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQ 241
SL STRLYRLNLS+NSL G +P+S+ R +L+ L LQHNNLSGS+P+ + N S+
Sbjct: 185 SLTESTRLYRLNLSFNSLSGPLPVSVARSYTLTFLDLQHNNLSGSIPDFFV----NGSHP 240
Query: 242 LQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIG 301
L+ LNLDHN +G +PVSL K LL+E+S+SHN++ G IP E G L LQ LD SYN+I
Sbjct: 241 LKTLNLDHNRFSGAVPVSLCKHSLLEEVSISHNQLSGSIPRECGGLPHLQSLDFSYNSIN 300
Query: 302 GSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISG 361
G+ P +F+N++SLVSLNLE+N L IP+ ++RL NLT LNLK N+ G IPETIGNISG
Sbjct: 301 GTIPDSFSNLSSLVSLNLESNHLKGPIPDAIDRLHNLTELNLKRNKINGPIPETIGNISG 360
Query: 362 INQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQLCG 421
I +LDLSEN+FTG I SL LA L+SFNVSYN LSG VPP+LSKKFNSSSF+GN+QLCG
Sbjct: 361 IKKLDLSENNFTGPIPLSLVHLAKLSSFNVSYNTLSGPVPPVLSKKFNSSSFLGNIQLCG 420
Query: 422 YSPSTACPS---LAPLSLPPPPVEAPKHHHHRKLSTKDIILIGVGALLAVLLILCCILLF 478
YS S CP+ PL+L P + P+ HHHRKLS KD+ILI +GALLA+LL+LCCILL
Sbjct: 421 YSSSNPCPAPDHHHPLTLSPTSSQEPRKHHHRKLSVKDVILIAIGALLAILLLLCCILLC 480
Query: 479 CLMRKRSASKEKNGKS-TAQKVVERAAPKAGTEVESGGEMGGKLVHFDGPFLFTADDLLC 537
CL++KR+A K+K+GK T++K V +A AGT +GGEMGGKLVHFDGPF+FTADDLLC
Sbjct: 481 CLIKKRAALKQKDGKDKTSEKTV--SAGVAGT-ASAGGEMGGKLVHFDGPFVFTADDLLC 537
Query: 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
ATAEIMGKSTYGTAYKATLEDG+EVAVKRLREKTTKG KEFE E A+GKI H NLLALR
Sbjct: 538 ATAEIMGKSTYGTAYKATLEDGNEVAVKRLREKTTKGVKEFEGEVTALGKIRHQNLLALR 597
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
AYYLGPKGEKLLVFD+M KGSL++FLHARGPET++ W TRM IA GI+RGL +LH ENM
Sbjct: 598 AYYLGPKGEKLLVFDYMSKGSLSAFLHARGPETLIPWETRMKIAKGISRGLAHLHSNENM 657
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTK 717
IH NLT+SN+LLDE+TN IAD+GLSRLMTAAA TNVIATAGTLGYRAPE SK+KNA+ K
Sbjct: 658 IHENLTASNILLDEQTNAHIADYGLSRLMTAAAATNVIATAGTLGYRAPEFSKIKNASAK 717
Query: 718 TDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEVFDLELMRD 769
TDVYSLG+IILELLTGKSPGEP NGMDLPQWVASIVKEEWTNEVFDLELMR+
Sbjct: 718 TDVYSLGIIILELLTGKSPGEPTNGMDLPQWVASIVKEEWTNEVFDLELMRE 769
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|C0LGP9|IMK3_ARATH Probable leucine-rich repeat receptor-like protein kinase IMK3 OS=Arabidopsis thaliana GN=IMK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 810 bits (2091), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/761 (57%), Positives = 513/761 (67%), Gaps = 64/761 (8%)
Query: 10 PFHNYKHFFLYTHLFLCLVLAFTSQFVAGHSWDGVIVTQADYQSLRAIKHDLIDPHGFLR 69
P + + FL HL +CL+ F + +WDGV++TQADYQ L+A+K +LIDP GFLR
Sbjct: 23 PKASLRSRFLL-HLIICLL--FFVPPCSSQAWDGVVITQADYQGLQAVKQELIDPRGFLR 79
Query: 70 SWNDSGVGACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAG 129
SWN SG ACSGGWAGIKC +GQVI IQLPW+ LGGRISEKI QL ALRKLSLHDN
Sbjct: 80 SWNGSGFSACSGGWAGIKCAQGQVIVIQLPWKSLGGRISEKIGQLQALRKLSLHDN---- 135
Query: 130 PVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRL 189
L GSIP S+G PNL+ + L N
Sbjct: 136 --------------------NLGGSIPMSLGLIPNLRGVQLFN----------------- 158
Query: 190 YRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDH 249
N L GSIP SL L L L +N LS +P N S +L LNL
Sbjct: 159 -------NRLTGSIPASLGVSHFLQTLDLSNNLLSEIIPPNLA-----DSSKLLRLNLSF 206
Query: 250 NLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLS-KLQKLDLSYNAIGGSFPVTF 308
N ++G IPVSL + LQ ++L HN + GPI D G S L+ L L +N++ G FP +
Sbjct: 207 NSLSGQIPVSLSRSSSLQFLALDHNNLSGPILDTWGSKSLNLRVLSLDHNSLSGPFPFSL 266
Query: 309 TNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLS 368
N+T L + +NR+ +P L +L L +++ N GHIPET+GNIS + LDLS
Sbjct: 267 CNLTQLQDFSFSHNRIRGTLPSELSKLTKLRKMDISGNSVSGHIPETLGNISSLIHLDLS 326
Query: 369 ENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQLCGYSPSTAC 428
+N TGEI S++ L +L FNVSYNNLSG VP LLS+KFNSSSFVGN LCGYS ST C
Sbjct: 327 QNKLTGEIPISISDLESLNFFNVSYNNLSGPVPTLLSQKFNSSSFVGNSLLCGYSVSTPC 386
Query: 429 PSLAPLSLPPPPVEAPKHHHHRKLSTKDIILIGVGALLAVLLILCCILLFCLMRKRSASK 488
P+L P P E + HR LSTKDIILI GALL V+LIL C+L CL+RK++
Sbjct: 387 PTL-----PSPSPEKERKPSHRNLSTKDIILIASGALLIVMLILVCVLC-CLLRKKANET 440
Query: 489 EKNGKSTAQKVVERAAPKAGTEVESGGEMGGKLVHFDGPFLFTADDLLCATAEIMGKSTY 548
+ G V K G E E+GGE GGKLVHFDGP FTADDLLCATAEIMGKSTY
Sbjct: 441 KAKGGEAGPGAVAAKTEKGG-EAEAGGETGGKLVHFDGPMAFTADDLLCATAEIMGKSTY 499
Query: 549 GTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608
GT YKATLEDGS+VAVKRLREK TK QKEFE E +G+I HPNLLALRAYYLGPKGEKL
Sbjct: 500 GTVYKATLEDGSQVAVKRLREKITKSQKEFENEINVLGRIRHPNLLALRAYYLGPKGEKL 559
Query: 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVL 668
+VFD+M +GSLA+FLHARGP+ +NW TRMS+ G+ARGL YLH N+IHGNLTSSNVL
Sbjct: 560 VVFDYMSRGSLATFLHARGPDVHINWPTRMSLIKGMARGLFYLHTHANIIHGNLTSSNVL 619
Query: 669 LDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIIL 728
LDE +I+D+GLSRLMTAAA ++VIATAG LGYRAPELSKLK ANTKTDVYSLGVIIL
Sbjct: 620 LDENITAKISDYGLSRLMTAAAGSSVIATAGALGYRAPELSKLKKANTKTDVYSLGVIIL 679
Query: 729 ELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEVFDLELMRD 769
ELLTGKSP E +NG+DLPQWVA+ VKEEWTNEVFDLEL+ D
Sbjct: 680 ELLTGKSPSEALNGVDLPQWVATAVKEEWTNEVFDLELLND 720
|
Can phosphorylate AGL24. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 332 bits (850), Expect = 9e-90, Method: Compositional matrix adjust.
Identities = 242/733 (33%), Positives = 359/733 (48%), Gaps = 94/733 (12%)
Query: 102 RLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGN 161
+L G I ++S L L KL L N L GP+P +L L + LF N LSG+IPP +G
Sbjct: 348 QLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGW 407
Query: 162 CPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHN 221
+L LD+S+N L G IP L + + LNL N+L G+IP +T +L L L N
Sbjct: 408 YSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARN 467
Query: 222 NLSGSVPNNW-------GVLAGNKSYQ------------LQFLNLDHNLIAGTIPVSLGK 262
NL G P+N + G ++ LQ L L N G +P +G
Sbjct: 468 NLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGM 527
Query: 263 LGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENN 322
L L +++S NK+ G +P E+ LQ+LD+ N G+ P ++ L L L NN
Sbjct: 528 LSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNN 587
Query: 323 RLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGIN-QLDLSENDFTGEISPSL- 380
L IP L L LT L + N F G IP +G+++G+ L+LS N TGEI P L
Sbjct: 588 NLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELS 647
Query: 381 --------------------ASLANLTS---FNVSYNNLSGSVPPLLSKKFNSSSFVGNL 417
+S ANL+S +N SYN+L+G +P L + + SSF+GN
Sbjct: 648 NLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP--LLRNISMSSFIGNE 705
Query: 418 QLCGYSPSTACPSLAPLSLPPPPVEAPKHHHHRKLSTKDIILIGVGALLAVLLILCCILL 477
LCG P C P + P P K II I + V L+L +++
Sbjct: 706 GLCG-PPLNQCIQTQPFA-PSQSTGKPGGMRSSK-----IIAITAAVIGGVSLMLIALIV 758
Query: 478 FCLMR--KRSASKEKNGKSTAQKVVERAAPKAGTEVESGGEMGGKLVHFDGPFLFTADDL 535
+ + R + AS ++G+ + + PK G FT DL
Sbjct: 759 YLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEG---------------------FTFQDL 797
Query: 536 LCATAE-----IMGKSTYGTAYKATLEDGSEVAVKRLREKTTKG-----QKEFEAEAAAI 585
+ AT ++G+ GT YKA L G +AVK+L G F AE +
Sbjct: 798 VAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTL 857
Query: 586 GKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIA 645
G I H N++ L + +G LL++++MPKGSL LH P ++W+ R IA+G A
Sbjct: 858 GNIRHRNIVKLHG-FCNHQGSNLLLYEYMPKGSLGEILH--DPSCNLDWSKRFKIALGAA 914
Query: 646 RGLNYLH--VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGY 703
+GL YLH + + H ++ S+N+LLD+K + DFGL++++ + ++ A AG+ GY
Sbjct: 915 QGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGY 974
Query: 704 RAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN-GMDLPQWVASIVKEE-WTNEV 761
APE + K+D+YS GV++LELLTGK+P +P++ G D+ WV S ++ + ++ V
Sbjct: 975 IAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGV 1034
Query: 762 FDLEL-MRDNTII 773
D L + D I+
Sbjct: 1035 LDARLTLEDERIV 1047
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (839), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 240/721 (33%), Positives = 357/721 (49%), Gaps = 85/721 (11%)
Query: 100 WRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI 159
+ RL G + +I +L++L L DN L G +P +G L +L + L N G IP +
Sbjct: 457 YNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKIPVEL 516
Query: 160 GNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIP------LSLTRLPSL 213
G+C +L TLDL +N L G IP + +L L LSYN+L GSIP +P L
Sbjct: 517 GDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDL 576
Query: 214 SVLA------LQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQ 267
S L L +N LSG +P G + L ++L +N ++G IP SL +L L
Sbjct: 577 SFLQHHGIFDLSYNRLSGPIPEELG-----ECLVLVEISLSNNHLSGEIPASLSRLTNLT 631
Query: 268 EISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNK 327
+ LS N + G IP E+G KLQ L+L+ N + G P +F + SLV LNL N+L
Sbjct: 632 ILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGP 691
Query: 328 IPEGLERLQNLTVLNL------------------------KNNQFKGHIPETIGNISGIN 363
+P L L+ LT ++L + N+F G IP +GN++ +
Sbjct: 692 VPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLE 751
Query: 364 QLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPL-LSKKFNSSSFVGNLQLCGY 422
LD+SEN +GEI + L NL N++ NNL G VP + + + + GN +LCG
Sbjct: 752 YLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGR 811
Query: 423 SPSTACPSLAPLSLPPPPVEAPKHHHHRKLSTKDIILIGVGALLAVLLILCCILLFCLMR 482
+ C +E K G+ L+ I+ + +F L R
Sbjct: 812 VVGSDC-----------KIEGTKLRSAW----------GIAGLMLGFTIIVFVFVFSL-R 849
Query: 483 KRSASKEKNGKSTAQKVVE---RAAPKAGTEVESGGE----MGGKLVHFDGPFL-FTADD 534
+ + +K + +++ E + SG + + F+ P L D
Sbjct: 850 RWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGD 909
Query: 535 LLCAT-----AEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH 589
++ AT I+G +GT YKA L VAVK+L E T+G +EF AE +GK+
Sbjct: 910 IVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVK 969
Query: 590 HPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHAR-GPETIVNWATRMSIAIGIARGL 648
HPNL++L Y + EKLLV+++M GSL +L + G +++W+ R+ IA+G ARGL
Sbjct: 970 HPNLVSLLGYCSFSE-EKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGL 1028
Query: 649 NYLH--VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAP 706
+LH ++IH ++ +SN+LLD P++ADFGL+RL++A + AGT GY P
Sbjct: 1029 AFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPP 1088
Query: 707 ELSKLKNANTKTDVYSLGVIILELLTGKSPGEP----MNGMDLPQWVASIVKEEWTNEVF 762
E + A TK DVYS GVI+LEL+TGK P P G +L W + + +V
Sbjct: 1089 EYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVI 1148
Query: 763 D 763
D
Sbjct: 1149 D 1149
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 325 bits (834), Expect = 6e-88, Method: Compositional matrix adjust.
Identities = 224/571 (39%), Positives = 319/571 (55%), Gaps = 69/571 (12%)
Query: 230 NW-GVLAGNKSYQLQFLNLDHNLIAGTIPV-SLGKLGLLQEISLSHNKIVGPIPDELGKL 287
NW GV + + L L + G IP SLG+L L+ +SL N++ G IP + L
Sbjct: 55 NWVGVECNSNQSSIHSLRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNL 114
Query: 288 SKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQ 347
+ L+ L L +N G FP +FT + +L+ L++ +N IP + L +LT L L NN
Sbjct: 115 THLRSLYLQHNEFSGEFPTSFTQLNNLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNG 174
Query: 348 FKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKK 407
F G++P S SL L FNVS NNL+GS+P LS +
Sbjct: 175 FSGNLP-----------------------SISLG----LVDFNVSNNNLNGSIPSSLS-R 206
Query: 408 FNSSSFVGNLQLCGYSPSTACPSLAPLSLPPPPVEAPKHHHHRKLSTKDIILIGVGALLA 467
F++ SF GN+ LCG P C S P P + P + K S A++A
Sbjct: 207 FSAESFTGNVDLCG-GPLKPCKSFFVSPSPSPSLINPSNRLSSKKSKLS-----KAAIVA 260
Query: 468 VLL-------ILCCILLFCLMRKRSASKEKNGKS-----TAQKVVERAAPKAGTEVESGG 515
+++ +L +LLF +RKR S E K A + V+ + ++ E G
Sbjct: 261 IIVASALVALLLLALLLFLCLRKRRGSNEARTKQPKPAGVATRNVDLPPGASSSKEEVTG 320
Query: 516 E---MGG-----KLVHFD-GPFLFTADDLLCATAEIMGKSTYGTAYKATLEDGSEVAVKR 566
MGG KLV + G + F +DLL A+AE++GK + GT+YKA LE+G+ V VKR
Sbjct: 321 TSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKR 380
Query: 567 LREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLH-A 625
L++ +KEFE + +GKI HPN++ LRAYY K EKLLVFDFMP GSL++ LH +
Sbjct: 381 LKD-VMASKKEFETQMEVVGKIKHPNVIPLRAYYYS-KDEKLLVFDFMPTGSLSALLHGS 438
Query: 626 RGP-ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSR 684
RG T ++W RM IAI ARGL +LHV ++HGN+ +SN+LL + ++D+GL++
Sbjct: 439 RGSGRTPLDWDNRMRIAITAARGLAHLHVSAKLVHGNIKASNILLHPNQDTCVSDYGLNQ 498
Query: 685 LMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM---N 741
L + ++ N +A GY APE+ + + K+DVYS GV++LELLTGKSP +
Sbjct: 499 LFSNSSPPNRLA-----GYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEE 553
Query: 742 GMDLPQWVASIVKEEWTNEVFDLELMRDNTI 772
G+DLP+WV S+V+EEWT EVFD+ELMR + I
Sbjct: 554 GIDLPRWVLSVVREEWTAEVFDVELMRYHNI 584
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (824), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 244/709 (34%), Positives = 361/709 (50%), Gaps = 61/709 (8%)
Query: 105 GRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPN 164
G+I +S L L L N L+G +P SLG L LR + L+ N L G IP +
Sbjct: 430 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKT 489
Query: 165 LQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLS 224
L+TL L N L G IP L+N T L ++LS N L G IP + RL +L++L L +N+ S
Sbjct: 490 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 549
Query: 225 GSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSL----GKL----------------G 264
G++P G L +L+L+ NL GTIP ++ GK+ G
Sbjct: 550 GNIPAELG-----DCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDG 604
Query: 265 LLQEISLSHN--KIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENN 322
+ +E + N + G ++L +LS +++ GG TF N S++ L++ N
Sbjct: 605 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYN 664
Query: 323 RLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLAS 382
L IP+ + + L +LNL +N G IP+ +G++ G+N LDLS N G I ++++
Sbjct: 665 MLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA 724
Query: 383 LANLTSFNVSYNNLSGSVPPLLS-KKFNSSSFVGNLQLCGYSPSTACPSLAPLSLPPPPV 441
L LT ++S NNLSG +P + + F + F+ N LCGY P C P
Sbjct: 725 LTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY-PLPRC----------DPS 773
Query: 442 EAPKHHHHRKLSTKDIILIGVGALLAVLLILCCILLFCLMRKRSASKEKNGKSTAQKVVE 501
A + HH++ + + + +L CI L+ + + + ++ + E
Sbjct: 774 NADGYAHHQRSHGRRPASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEMYAE 833
Query: 502 -------RAAPKAGTEVESGGE-MGGKLVHFDGPFL-FTADDLLCAT-----AEIMGKST 547
R A ++ E + L F+ P T DLL AT ++G
Sbjct: 834 GHGNSGDRTANNTNWKLTGVKEALSINLAAFEKPLRKLTFADLLQATNGFHNDSLIGSGG 893
Query: 548 YGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEK 607
+G YKA L+DGS VA+K+L + +G +EF AE IGKI H NL+ L Y E+
Sbjct: 894 FGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLG-YCKVGDER 952
Query: 608 LLVFDFMPKGSLASFLHARGPETI-VNWATRMSIAIGIARGLNYLH--VEENMIHGNLTS 664
LLV++FM GSL LH + +NW+TR IAIG ARGL +LH ++IH ++ S
Sbjct: 953 LLVYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKS 1012
Query: 665 SNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELSKLKNANTKTDVYSL 723
SNVLLDE R++DFG++RLM+A ++T AGT GY PE + +TK DVYS
Sbjct: 1013 SNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSY 1072
Query: 724 GVIILELLTGKSPGEPMNGMD--LPQWVASIVKEEWTNEVFDLELMRDN 770
GV++LELLTGK P + + D L WV K ++VFD ELM+++
Sbjct: 1073 GVVLLELLTGKRPTDSPDFGDNNLVGWVKQHAKLR-ISDVFDPELMKED 1120
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 321 bits (823), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 228/684 (33%), Positives = 341/684 (49%), Gaps = 78/684 (11%)
Query: 92 QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRL 151
QV + L +L GRI E I + AL L L DN L GP+P LG L +YL N+L
Sbjct: 265 QVATLSLQGNKLTGRIPEVIGLMQALAVLDLSDNELTGPIPPILGNLSFTGKLYLHGNKL 324
Query: 152 SGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLP 211
+G IPP +GN L L L++N L+G IPP L +L+ LNL+ N+L+G IP +++
Sbjct: 325 TGQIPPELGNMSRLSYLQLNDNELVGKIPPELGKLEQLFELNLANNNLVGLIPSNISSCA 384
Query: 212 SLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISL 271
+L+ + N LSG+VP L+F NL G L ++L
Sbjct: 385 ALNQFNVHGNFLSGAVP-------------LEFRNL----------------GSLTYLNL 415
Query: 272 SHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG 331
S N G IP ELG + L LDLS N GS P+T ++ L+ LNL N L +P
Sbjct: 416 SSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPAE 475
Query: 332 LERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNV 391
L+++ ++++ N G IP +G + IN L L+ N G+I L + +L + N+
Sbjct: 476 FGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLANLNI 535
Query: 392 SYNNLSGSVPPLLS-KKFNSSSFVGNLQLCGYSPSTAC-PSLAPLSLPPPPVEAPKHHHH 449
S+NNLSG +PP+ + +F+ +SF GN LCG + C PSL PK
Sbjct: 536 SFNNLSGIIPPMKNFTRFSPASFFGNPFLCGNWVGSICGPSL------------PKSQVF 583
Query: 450 RKLSTKDIILIGVGALLAVLLILCCILLFCLMRKRSASKEKNGKSTAQKVVERAAPKAGT 509
+++ + +L + ++C I + KS QK V + + K
Sbjct: 584 TRVAV-------ICMVLGFITLICMIFIAVY------------KSKQQKPVLKGSSK--- 621
Query: 510 EVESGGEMGGKLVHFDGPFLFTADDLLCATAE-----IMGKSTYGTAYKATLEDGSEVAV 564
+ G ++H D + T DD++ T I+G T YK T + +A+
Sbjct: 622 --QPEGSTKLVILHMDMA-IHTFDDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIAI 678
Query: 565 KRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLH 624
KR+ + +EFE E IG I H N+++L Y L P G LL +D+M GSL LH
Sbjct: 679 KRIYNQYPSNFREFETELETIGSIRHRNIVSLHGYALSPFG-NLLFYDYMENGSLWDLLH 737
Query: 625 ARGPETIVNWATRMSIAIGIARGLNYLH--VEENMIHGNLTSSNVLLDEKTNPRIADFGL 682
G + ++W TR+ IA+G A+GL YLH +IH ++ SSN+LLD R++DFG+
Sbjct: 738 GPGKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDGNFEARLSDFGI 797
Query: 683 SRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742
++ + A GT+GY PE ++ N K+D+YS G+++LELLTGK + N
Sbjct: 798 AKSIPATKTYASTYVLGTIGYIDPEYARTSRLNEKSDIYSFGIVLLELLTGKKAVD--NE 855
Query: 743 MDLPQWVASIVKEEWTNEVFDLEL 766
+L Q + S + E D E+
Sbjct: 856 ANLHQMILSKADDNTVMEAVDAEV 879
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 319 bits (818), Expect = 4e-86, Method: Compositional matrix adjust.
Identities = 236/687 (34%), Positives = 346/687 (50%), Gaps = 56/687 (8%)
Query: 88 CVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLF 147
C Q++ I + ++ G I I L + LSL N L G +P +G + L + L
Sbjct: 238 CTSFQILDIS--YNQITGEIPYNIGFLQ-VATLSLQGNRLTGRIPEVIGLMQALAVLDLS 294
Query: 148 NNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSL 207
+N L G IPP +GN L L N L G IP L N +RL L L+ N L+G+IP L
Sbjct: 295 DNELVGPIPPILGNLSFTGKLYLHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPEL 354
Query: 208 TRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQ 267
+L L L L +N L G +P+N A L N+ NL++G+IP++ LG L
Sbjct: 355 GKLEQLFELNLANNRLVGPIPSNISSCAA-----LNQFNVHGNLLSGSIPLAFRNLGSLT 409
Query: 268 EISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNK 327
++LS N G IP ELG + L KLDLS N GS P+T ++ L+ LNL N L +
Sbjct: 410 YLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQ 469
Query: 328 IPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLT 387
+P L+++ ++++ N G IP +G + +N L L+ N G+I L + L
Sbjct: 470 LPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLV 529
Query: 388 SFNVSYNNLSGSVPPLLS-KKFNSSSFVGNLQLCGYSPSTACPSLAPLSLPPPPVEAPKH 446
+ NVS+NNLSG VPP+ + +F +SFVGN LCG + C PL PK
Sbjct: 530 NLNVSFNNLSGIVPPMKNFSRFAPASFVGNPYLCGNWVGSIC---GPL---------PK- 576
Query: 447 HHHRKLSTKDIILIGVGALLAVLLILCCILLFCLMRKRSASKEKNGKSTAQKVVERAAPK 506
R S +I I +L V+ +LC I L KS QK + + + K
Sbjct: 577 --SRVFSRGALICI----VLGVITLLCMIFLAVY------------KSMQQKKILQGSSK 618
Query: 507 AGTEVESGGEMGGKLVHFDGPFLFTADDLLCATAE-----IMGKSTYGTAYKATLEDGSE 561
++ G ++H D + T DD++ T I+G T YK L+
Sbjct: 619 -----QAEGLTKLVILHMDMA-IHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRP 672
Query: 562 VAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLAS 621
+A+KRL + +EFE E IG I H N+++L Y L P G LL +D+M GSL
Sbjct: 673 IAIKRLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPTG-NLLFYDYMENGSLWD 731
Query: 622 FLHARGPETIVNWATRMSIAIGIARGLNYLH--VEENMIHGNLTSSNVLLDEKTNPRIAD 679
LH + ++W TR+ IA+G A+GL YLH +IH ++ SSN+LLDE ++D
Sbjct: 732 LLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSD 791
Query: 680 FGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739
FG+++ + A+ GT+GY PE ++ N K+D+YS G+++LELLTGK +
Sbjct: 792 FGIAKSIPASKTHASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGKKAVD- 850
Query: 740 MNGMDLPQWVASIVKEEWTNEVFDLEL 766
N +L Q + S + E D E+
Sbjct: 851 -NEANLHQLILSKADDNTVMEAVDPEV 876
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 316 bits (810), Expect = 4e-85, Method: Compositional matrix adjust.
Identities = 221/656 (33%), Positives = 330/656 (50%), Gaps = 82/656 (12%)
Query: 92 QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRL 151
QV + L +L G+I I + AL L L NLL+G +P LG L +YL +N+L
Sbjct: 260 QVATLSLQGNQLSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGNLTFTEKLYLHSNKL 319
Query: 152 SGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLP 211
+GSIPP +GN L L+L++N L G IPP L T L+ LN++ N L G IP L+
Sbjct: 320 TGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANNDLEGPIPDHLSSCT 379
Query: 212 SLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISL 271
+L+ L + N SG++P A K + +LNL N I G IPV L ++G L + L
Sbjct: 380 NLNSLNVHGNKFSGTIPR-----AFQKLESMTYLNLSSNNIKGPIPVELSRIGNLDTLDL 434
Query: 272 SHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG 331
S+NKI G IP LG L L K++LS N I G P F N+ S++ ++L NN + IPE
Sbjct: 435 SNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDISGPIPEE 494
Query: 332 LERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNV 391
L +LQN+ +L L+NN G++ SLA+ +LT NV
Sbjct: 495 LNQLQNIILLRLENNNLTGNVG-------------------------SLANCLSLTVLNV 529
Query: 392 SYNNLSGSVPPLLS-KKFNSSSFVGNLQLCGYSPSTACPSLAPLSLPPPPVEAPKHHHHR 450
S+NNL G +P + +F+ SF+GN LCG ++ C H R
Sbjct: 530 SHNNLVGDIPKNNNFSRFSPDSFIGNPGLCGSWLNSPC------------------HDSR 571
Query: 451 K-----LSTKDIILIGVGALLAVLLILCCILLFCLMRKRSASKEKNGKSTAQKVVERAAP 505
+ +S I+ I +G L+ +L++L R + +G + K V + P
Sbjct: 572 RTVRVSISRAAILGIAIGGLVILLMVL-----IAACRPHNPPPFLDG--SLDKPVTYSTP 624
Query: 506 KAGTEVESGGEMGGKLVHFDGPFLFTADDLLCATAE-----IMGKSTYGTAYKATLEDGS 560
K ++H + L +D++ T I+G T YK L++
Sbjct: 625 KL------------VILHMNMA-LHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCK 671
Query: 561 EVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLA 620
VA+KRL + K+FE E + I H NL++L+AY L G LL +D++ GSL
Sbjct: 672 PVAIKRLYSHNPQSMKQFETELEMLSSIKHRNLVSLQAYSLSHLGS-LLFYDYLENGSLW 730
Query: 621 SFLHARGPETIVNWATRMSIAIGIARGLNYLH--VEENMIHGNLTSSNVLLDEKTNPRIA 678
LH + ++W TR+ IA G A+GL YLH +IH ++ SSN+LLD+ R+
Sbjct: 731 DLLHGPTKKKTLDWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLT 790
Query: 679 DFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGK 734
DFG+++ + + + GT+GY PE ++ K+DVYS G+++LELLT +
Sbjct: 791 DFGIAKSLCVSKSHTSTYVMGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTRR 846
|
Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGS2|Y4361_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g36180 OS=Arabidopsis thaliana GN=At4g36180 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 315 bits (807), Expect = 1e-84, Method: Compositional matrix adjust.
Identities = 238/779 (30%), Positives = 360/779 (46%), Gaps = 145/779 (18%)
Query: 88 CVKG-QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYL 146
C G QV+ +Q R+ GR ++ + +L+ L + NL +G +P +G L L + L
Sbjct: 306 CRTGLQVLDLQ--ENRISGRFPLWLTNILSLKNLDVSGNLFSGEIPPDIGNLKRLEELKL 363
Query: 147 FNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPP------------------------S 182
NN L+G IP I C +L LD N+L G IP S
Sbjct: 364 ANNSLTGEIPVEIKQCGSLDVLDFEGNSLKGQIPEFLGYMKALKVLSLGRNSFSGYVPSS 423
Query: 183 LANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQL 242
+ N +L RLNL N+L GS P+ L L SLS L L N SG+VP + L+ L
Sbjct: 424 MVNLQQLERLNLGENNLNGSFPVELMALTSLSELDLSGNRFSGAVPVSISNLS-----NL 478
Query: 243 QFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGG 302
FLNL N +G IP S+G L L + LS + G +P EL L +Q + L N G
Sbjct: 479 SFLNLSGNGFSGEIPASVGNLFKLTALDLSKQNMSGEVPVELSGLPNVQVIALQGNNFSG 538
Query: 303 SFPVTFTNITSLVSLNLENNRLGNKIPEG------------------------LERLQNL 338
P F+++ SL +NL +N +IP+ + L
Sbjct: 539 VVPEGFSSLVSLRYVNLSSNSFSGEIPQTFGFLRLLVSLSLSDNHISGSIPPEIGNCSAL 598
Query: 339 TVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISP-------------------- 378
VL L++N+ GHIP + + + LDL +N+ +GEI P
Sbjct: 599 EVLELRSNRLMGHIPADLSRLPRLKVLDLGQNNLSGEIPPEISQSSSLNSLSLDHNHLSG 658
Query: 379 ----SLASLANLTSFNVSYNNLSGSVPPLL--------------------------SKKF 408
S + L+NLT ++S NNL+G +P L S+
Sbjct: 659 VIPGSFSGLSNLTKMDLSVNNLTGEIPASLALISSNLVYFNVSSNNLKGEIPASLGSRIN 718
Query: 409 NSSSFVGNLQLCGYSPSTACPSLAPLSLPPPPVEAPKHHHHRKLSTKDIILIGVGALLAV 468
N+S F GN +LCG + C S +K K I++I + A+ A
Sbjct: 719 NTSEFSGNTELCGKPLNRRCES--------------STAEGKKKKRKMILMIVMAAIGAF 764
Query: 469 LL-ILCCILLFCLMRKRSASKEKNGKSTAQKVVERAAPKAG--------TEVESGGEMGG 519
LL + CC ++ L++ R K+++ +T +K AG GE
Sbjct: 765 LLSLFCCFYVYTLLKWRKKLKQQS--TTGEKKRSPGRTSAGSRVRSSTSRSSTENGE--P 820
Query: 520 KLVHFDGPFLFTADDLLCATAE-----IMGKSTYGTAYKATLEDGSEVAVKRLREKTTKG 574
KLV F+ T + + AT + ++ ++ YG +KA DG ++++RL +
Sbjct: 821 KLVMFNNK--ITLAETIEATRQFDEENVLSRTRYGLLFKANYNDGMVLSIRRLPNGSLLN 878
Query: 575 QKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPET--IV 632
+ F+ EA +GK+ H N+ LR YY GP +LLV+D+MP G+L++ L + ++
Sbjct: 879 ENLFKKEAEVLGKVKHRNITVLRGYYAGPPDLRLLVYDYMPNGNLSTLLQEASHQDGHVL 938
Query: 633 NWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692
NW R IA+GIARGL +LH + NM+HG++ NVL D I+DFGL RL + +
Sbjct: 939 NWPMRHLIALGIARGLGFLH-QSNMVHGDIKPQNVLFDADFEAHISDFGLDRLTIRSPSR 997
Query: 693 NVIA--TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWV 749
+ + T GTLGY +PE + ++D+YS G+++LE+LTGK P D+ +WV
Sbjct: 998 SAVTANTIGTLGYVSPEATLSGEITRESDIYSFGIVLLEILTGKRPVMFTQDEDIVKWV 1056
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 773 | ||||||
| 224140493 | 826 | predicted protein [Populus trichocarpa] | 0.988 | 0.924 | 0.766 | 0.0 | |
| 255571471 | 811 | Systemin receptor SR160 precursor, putat | 0.950 | 0.906 | 0.775 | 0.0 | |
| 224091048 | 784 | predicted protein [Populus trichocarpa] | 0.940 | 0.927 | 0.770 | 0.0 | |
| 356495063 | 859 | PREDICTED: probably inactive leucine-ric | 0.965 | 0.868 | 0.724 | 0.0 | |
| 356506532 | 859 | PREDICTED: probably inactive leucine-ric | 0.959 | 0.863 | 0.722 | 0.0 | |
| 224109228 | 827 | predicted protein [Populus trichocarpa] | 0.979 | 0.915 | 0.708 | 0.0 | |
| 225448572 | 869 | PREDICTED: probable leucine-rich repeat | 0.978 | 0.869 | 0.694 | 0.0 | |
| 356553753 | 797 | PREDICTED: probably inactive leucine-ric | 0.935 | 0.907 | 0.678 | 0.0 | |
| 297816438 | 832 | hypothetical protein ARALYDRAFT_485528 [ | 0.968 | 0.900 | 0.693 | 0.0 | |
| 206584435 | 854 | RHG1 [Glycine max] | 0.946 | 0.857 | 0.687 | 0.0 |
| >gi|224140493|ref|XP_002323617.1| predicted protein [Populus trichocarpa] gi|222868247|gb|EEF05378.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1147 bits (2966), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 595/776 (76%), Positives = 660/776 (85%), Gaps = 12/776 (1%)
Query: 1 MENTYRYLYPFHNYKHFFLYTHLFLCLVLAFTSQFVAGHSWDGVIVTQADYQSLRAIKHD 60
MENT H+ FL HL L L L F QF + DGV VTQ+DY+SLRAIK++
Sbjct: 1 MENT------CHSRDKCFLCAHLCLFL-LVFLPQFASSQKGDGVAVTQSDYRSLRAIKNE 53
Query: 61 LIDPHGFLRSWNDSGVGACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKL 120
LID GFLRSWNDSG GACSG W GIKCVKGQVIAIQLPW+ LGGRISEKI QL ALRK+
Sbjct: 54 LIDFKGFLRSWNDSGYGACSGRWVGIKCVKGQVIAIQLPWKGLGGRISEKIGQLQALRKI 113
Query: 121 SLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIP 180
SLHDN+L G VP SLGFL NLRGVYLFNNRLSGSIPPS+GNCP LQ+LD+SNN+LIG IP
Sbjct: 114 SLHDNVLGGTVPSSLGFLRNLRGVYLFNNRLSGSIPPSLGNCPVLQSLDVSNNSLIGTIP 173
Query: 181 PSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSY 240
PSL NST+LYRLNLS+NSL+GSIP+ LT+ PSL LA+QHNNL+G +P++WG GN S
Sbjct: 174 PSLTNSTKLYRLNLSFNSLMGSIPVGLTQSPSLIFLAIQHNNLTGPIPDSWGS-KGNYSS 232
Query: 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAI 300
LQFL LDHN I+GTIPVSL KL LLQEISLSHN++ G IP E+G LS+LQKLD+S NA
Sbjct: 233 LLQFLTLDHNRISGTIPVSLSKLALLQEISLSHNQLSGAIPYEMGSLSRLQKLDISNNAF 292
Query: 301 GGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNIS 360
GS P +F+N+TSLVSLNLE NRL N+IPEG +RL NL++LNLKNNQFKG IP +IGNIS
Sbjct: 293 SGSIPFSFSNLTSLVSLNLEGNRLDNQIPEGFDRLHNLSMLNLKNNQFKGPIPASIGNIS 352
Query: 361 GINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQLC 420
INQLDL++N+F+GEI SLA LANLT FNVSYNNLSGSVP ++KKFNSSSFVGNLQLC
Sbjct: 353 SINQLDLAQNNFSGEIPASLARLANLTYFNVSYNNLSGSVPSSIAKKFNSSSFVGNLQLC 412
Query: 421 GYSPSTACPSLAPLSLPPPPVEAPKHHHHRKLSTKDIILIGVGALLAVLLILCCILLFCL 480
GYS ST CPS P LP P +PKHHH RKLSTKDIILI G LL VLL+LC ILL CL
Sbjct: 413 GYSISTPCPSPPPEILPAPTKGSPKHHH-RKLSTKDIILIAAGILLVVLLLLCSILLCCL 471
Query: 481 MRKRSASKEKNGKSTAQKVV---ERAAPKAGTEVESGGEMGGKLVHFDGPFLFTADDLLC 537
M+KRSASKEK+GK+T + + E+ AG EVESGGEMGGKLVHFDGPFLFTADDLLC
Sbjct: 472 MKKRSASKEKSGKTTTRGLPGKGEKTGAVAGPEVESGGEMGGKLVHFDGPFLFTADDLLC 531
Query: 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
ATAEIMGKSTYGTAYKATLEDG++VAVKRLREKTTKGQ+EFE EAAA+GKI HPNLLALR
Sbjct: 532 ATAEIMGKSTYGTAYKATLEDGNQVAVKRLREKTTKGQREFETEAAALGKIRHPNLLALR 591
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
AYYLGPKGEKLLVFD+M KGSLAS+LHARGPET VNW TRM+IAIG+ARGLN+LH +EN+
Sbjct: 592 AYYLGPKGEKLLVFDYMHKGSLASYLHARGPETTVNWPTRMNIAIGVARGLNHLHSQENI 651
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTK 717
IHGNLTSSNVLLDE+TN IADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNA+TK
Sbjct: 652 IHGNLTSSNVLLDEQTNAHIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNASTK 711
Query: 718 TDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEVFDLELMRDNTII 773
TDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEVFDLE+MRD I
Sbjct: 712 TDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEVFDLEIMRDAQTI 767
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255571471|ref|XP_002526683.1| Systemin receptor SR160 precursor, putative [Ricinus communis] gi|223533983|gb|EEF35705.1| Systemin receptor SR160 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1138 bits (2944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 572/738 (77%), Positives = 641/738 (86%), Gaps = 3/738 (0%)
Query: 33 SQFVAGHSWDGVIVTQADYQSLRAIKHDLIDPHGFLRSWNDSGVGACSGGWAGIKCVKGQ 92
+QF + WDGVIVTQ+DY++LRAIK++ ID G LRSWNDSG GACSGGW GIKCV+GQ
Sbjct: 19 AQFASCQRWDGVIVTQSDYKALRAIKNEFIDLKGHLRSWNDSGYGACSGGWVGIKCVQGQ 78
Query: 93 VIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLS 152
VIAIQLPW+ LGGRISE I QL ALRK+SLHDN+LAG +P SLGFL +LRGVYLFNNRLS
Sbjct: 79 VIAIQLPWKGLGGRISENIGQLQALRKISLHDNVLAGTIPLSLGFLSDLRGVYLFNNRLS 138
Query: 153 GSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPS 212
GSIPPSIGNCP LQ LD+SNN+L G IPP+LANSTRLYRLNLS+NSL GSIP SLTR PS
Sbjct: 139 GSIPPSIGNCPMLQGLDISNNSLTGIIPPTLANSTRLYRLNLSFNSLTGSIPSSLTRSPS 198
Query: 213 LSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLS 272
L+V ALQHNNLSGS+P++WG G+ SY+LQFL LDHNLI G IPVS KL LLQEISLS
Sbjct: 199 LTVFALQHNNLSGSIPDSWGE-TGDNSYKLQFLTLDHNLITGNIPVSFSKLSLLQEISLS 257
Query: 273 HNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGL 332
HN+I G IP ELGKLS LQKLD S N I GS P +F+N++SLVSLNLE+N L N+IPE
Sbjct: 258 HNQISGSIPTELGKLSSLQKLDFSNNIINGSMPPSFSNLSSLVSLNLESNGLENQIPEAF 317
Query: 333 ERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVS 392
E+L NL+VLNLKNNQFKG IP +IGNIS I+QLDL++N+FTGEI SLA L NL SFNVS
Sbjct: 318 EKLHNLSVLNLKNNQFKGLIPASIGNISSISQLDLAQNNFTGEIPASLAGLTNLASFNVS 377
Query: 393 YNNLSGSVPPLLSKKFNSSSFVGNLQLCGYSPSTACPSLAPLSLPPPPVEAPKHHHHRKL 452
YNNLSG+VP LLSK FNSSSFVGNLQLCGYS ST CPS P+ P P + P HHH+KL
Sbjct: 378 YNNLSGAVPALLSKNFNSSSFVGNLQLCGYSISTPCPSPPPVIQPSPTISGPPKHHHKKL 437
Query: 453 STKDIILIGVGALLAVLLILCCILLFCLMRKRSASKEKNGKSTAQKVVERAAPKAGTE-V 511
ST+DIILI VGALL +LL+LCCIL+ CLMR+R+AS +NGK+ A++ VE+ G V
Sbjct: 438 STRDIILIAVGALLGILLLLCCILICCLMRRRAAS-HQNGKTVARQAVEKTEKSGGAAAV 496
Query: 512 ESGGEMGGKLVHFDGPFLFTADDLLCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKT 571
ESGGEMGGKLVHFDGPF+FTADDLLCATAEIMGKSTYGTAYKATLEDG++VAVKRLREKT
Sbjct: 497 ESGGEMGGKLVHFDGPFVFTADDLLCATAEIMGKSTYGTAYKATLEDGNQVAVKRLREKT 556
Query: 572 TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETI 631
TKGQKEFE+EAA++GKI HPNLLALRAYYLGPKGEKLLVFD+MPKGSLASFLHARGPET
Sbjct: 557 TKGQKEFESEAASLGKIRHPNLLALRAYYLGPKGEKLLVFDYMPKGSLASFLHARGPETA 616
Query: 632 VNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691
+NW TRM+IAIGI RGL YLH EEN+IHGNLTSSN+LLDE+TN IAD+GLS+LMTAAAN
Sbjct: 617 INWPTRMNIAIGIGRGLTYLHTEENIIHGNLTSSNILLDEQTNAHIADYGLSKLMTAAAN 676
Query: 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVAS 751
TN+IATAG LGYRAPEL+KLKNANTKTDVYSLGVIILELLTGK+PGEP NGMDLPQWVAS
Sbjct: 677 TNIIATAGALGYRAPELAKLKNANTKTDVYSLGVIILELLTGKAPGEPTNGMDLPQWVAS 736
Query: 752 IVKEEWTNEVFDLELMRD 769
IVKEEWTNEVFDLELMRD
Sbjct: 737 IVKEEWTNEVFDLELMRD 754
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224091048|ref|XP_002309159.1| predicted protein [Populus trichocarpa] gi|222855135|gb|EEE92682.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1091 bits (2822), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 564/732 (77%), Positives = 628/732 (85%), Gaps = 5/732 (0%)
Query: 45 IVTQADYQSLRAIKHDLIDPHGFLRSWNDSGVGACSGGWAGIKCVKGQVIAIQLPWRRLG 104
+VT+ADYQ+LRAI+++L+D GFLRSWN SG GACSG WAGIKCVKGQVIAIQLPW+ LG
Sbjct: 1 MVTRADYQALRAIRNELVDFKGFLRSWNGSGYGACSGRWAGIKCVKGQVIAIQLPWKGLG 60
Query: 105 GRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPN 164
GRISEKI QL ALRK+SLHDN+L G VP SLG L NLRGVYLFNNRLSGSIPPSIGNCP
Sbjct: 61 GRISEKIGQLQALRKISLHDNVLGGTVPRSLGLLHNLRGVYLFNNRLSGSIPPSIGNCPV 120
Query: 165 LQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLS 224
L TLD+SNN+L GAIPPSLANSTRLYRLNLS+NSL+GSIP+SLT+ PSL VLALQHN LS
Sbjct: 121 LLTLDVSNNSLTGAIPPSLANSTRLYRLNLSFNSLMGSIPVSLTQSPSLIVLALQHNYLS 180
Query: 225 GSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDEL 284
GS+P+ WG GN SY LQFL LDHNLI+GTIPVSL KL LLQEISLSHNK+ G IP+E+
Sbjct: 181 GSIPDTWG-RKGNYSYHLQFLILDHNLISGTIPVSLNKLALLQEISLSHNKLSGAIPNEM 239
Query: 285 GKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLK 344
G LS+LQKLD S NA GS P + +N+TSL SLNLE NRL N+IP+G +RL NL+VLNLK
Sbjct: 240 GSLSRLQKLDFSNNAFNGSIPSSLSNLTSLASLNLEGNRLDNQIPDGFDRLHNLSVLNLK 299
Query: 345 NNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLL 404
NNQF G IP +IGNIS +NQLDL++N+F+GEI SL LA LT FNVSYNNLSGSVP L
Sbjct: 300 NNQFIGPIPASIGNISSVNQLDLAQNNFSGEIPASLVRLATLTYFNVSYNNLSGSVPSSL 359
Query: 405 SKKFNSSSFVGNLQLCGYSPSTACPSLAPLSLPPPPVEAPKHHHHRKLSTKDIILIGVGA 464
+KKFNSSSFVGNLQLCGYS ST C S P+ LP P E PK H RK STKDIILI G
Sbjct: 360 AKKFNSSSFVGNLQLCGYSFSTPCLSPPPIVLPTPTKEEPKRHR-RKFSTKDIILIAAGV 418
Query: 465 LLAVLLILCCILLFCLMRKRSASKEKNGKSTAQKV---VERAAPKAGTEVESGGEMGGKL 521
LLAVLL+LC ILL CLM+KRSASK K+GK+T + + E+ AG EVESGGEMGGKL
Sbjct: 419 LLAVLLLLCFILLCCLMKKRSASKGKHGKTTMRGLPGESEKTGAVAGPEVESGGEMGGKL 478
Query: 522 VHFDGPFLFTADDLLCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAE 581
VHFDG F+FTADDLLCATAEIMGKS+YGTAYKATLEDGS+VAVKRLREKTTKGQ EFE E
Sbjct: 479 VHFDGQFVFTADDLLCATAEIMGKSSYGTAYKATLEDGSQVAVKRLREKTTKGQMEFETE 538
Query: 582 AAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIA 641
AAA+GKI HPNLLALRAYYLGPKGEKLLVFD+MP GSLAS+LHARGPE V+W TRM+IA
Sbjct: 539 AAALGKIRHPNLLALRAYYLGPKGEKLLVFDYMPIGSLASYLHARGPEIAVDWPTRMNIA 598
Query: 642 IGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTL 701
IG+ARGLN+LH ++ +IHGNLTSSN+LLDE+TN IADFGLSRLMT ANT VI+T GTL
Sbjct: 599 IGVARGLNHLHTQQEIIHGNLTSSNILLDEQTNAHIADFGLSRLMTTTANTTVISTVGTL 658
Query: 702 GYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEV 761
GYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNE+
Sbjct: 659 GYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEI 718
Query: 762 FDLELMRDNTII 773
FDLEL+RD+ I
Sbjct: 719 FDLELVRDSQTI 730
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495063|ref|XP_003516400.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase IMK2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1065 bits (2753), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 543/750 (72%), Positives = 620/750 (82%), Gaps = 4/750 (0%)
Query: 24 FLCLVLAFTS--QFVAGHSWDGVIVTQADYQSLRAIKHDLIDPHGFLRSWNDSGVGACSG 81
F +LA TS Q V+GH WDGV+VTQAD+Q+LR IK++LID G L+SWNDSGVGACSG
Sbjct: 53 FFLFLLASTSTIQHVSGHLWDGVVVTQADFQALRVIKNELIDFKGVLKSWNDSGVGACSG 112
Query: 82 GWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNL 141
GWAGIKCV G+VIAIQLPWR LGGRISEKISQL +LRKLSLHDN L GPVP +LG LPNL
Sbjct: 113 GWAGIKCVNGEVIAIQLPWRGLGGRISEKISQLQSLRKLSLHDNALGGPVPLTLGLLPNL 172
Query: 142 RGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLG 201
RGVYLFNN+LSGSIPPS+GNCP LQ+LD+SNN+L G IP SLA STR++R+NLS+NSL G
Sbjct: 173 RGVYLFNNKLSGSIPPSLGNCPMLQSLDISNNSLSGKIPSSLARSTRIFRINLSFNSLSG 232
Query: 202 SIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLG 261
SIP SLT PSL++LALQHNNLSGS+P++WG K+ QLQ L LDHNL +GTIPVSLG
Sbjct: 233 SIPSSLTMSPSLTILALQHNNLSGSIPDSWGGTGKKKASQLQVLTLDHNLFSGTIPVSLG 292
Query: 262 KLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLEN 321
KL L+ +SLSHNKIVG IP ELG LS+LQ LDLS N I GS P +F+N++SLVSLNLE+
Sbjct: 293 KLAFLENVSLSHNKIVGAIPSELGALSRLQILDLSNNVINGSLPASFSNLSSLVSLNLES 352
Query: 322 NRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLA 381
N+L + IP+ L+RL NL+VLNLKNN+ G IP TIGNIS I+Q+DLSEN GEI SL
Sbjct: 353 NQLASHIPDSLDRLHNLSVLNLKNNKLDGQIPTTIGNISSISQIDLSENKLVGEIPDSLT 412
Query: 382 SLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQLCGYSPSTACPSLAPLSLPPPPV 441
L NL+SFNVSYNNLSG+VP LLSK+FN+SSFVGNL+LCG+ S C S P +LP
Sbjct: 413 KLTNLSSFNVSYNNLSGAVPSLLSKRFNASSFVGNLELCGFITSKPCSSPPPHNLPTQSP 472
Query: 442 EAPKHHHHRKLSTKDIILIGVGALLAVLLILCCILLFCLMRKRSASKEKNGKSTAQKVVE 501
AP HH KLSTKDIILI G LL VLL+LCC LL CL+R+R+AS K+ K+
Sbjct: 473 HAPSKPHHHKLSTKDIILIVAGILLLVLLVLCCFLLCCLIRRRAASSRKSSKTAKAAASA 532
Query: 502 RAAPKAGT--EVESGGEMGGKLVHFDGPFLFTADDLLCATAEIMGKSTYGTAYKATLEDG 559
R K + EVESGGE GGKLVHFDGPF+FTADDLLCATAEIMGKS +GTAYKATLEDG
Sbjct: 533 RGVEKGASAGEVESGGEAGGKLVHFDGPFVFTADDLLCATAEIMGKSAFGTAYKATLEDG 592
Query: 560 SEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSL 619
++VAVKRLREKTTKGQKEFE E AA+GKI HPNLLALRAYYLGPKGEKLLVFD+M KGSL
Sbjct: 593 NQVAVKRLREKTTKGQKEFETEVAALGKIRHPNLLALRAYYLGPKGEKLLVFDYMTKGSL 652
Query: 620 ASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIAD 679
ASFLHARGPE ++ W TRM IAIG+ RGL+YLH +EN++HGNLTSSN+LLDE+T I D
Sbjct: 653 ASFLHARGPEIVIEWPTRMKIAIGVTRGLSYLHNQENIVHGNLTSSNILLDEQTEAHITD 712
Query: 680 FGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739
FGLSRLMT +ANTN+IATAG+LGY APELSK K +TKTDVYSLGVI+LELLTGK PGEP
Sbjct: 713 FGLSRLMTTSANTNIIATAGSLGYNAPELSKTKKPSTKTDVYSLGVIMLELLTGKPPGEP 772
Query: 740 MNGMDLPQWVASIVKEEWTNEVFDLELMRD 769
NGMDLPQWVASIVKEEWTNEVFDLELMRD
Sbjct: 773 TNGMDLPQWVASIVKEEWTNEVFDLELMRD 802
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356506532|ref|XP_003522034.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase IMK2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1038 bits (2683), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 538/745 (72%), Positives = 617/745 (82%), Gaps = 3/745 (0%)
Query: 32 TSQFVAGHSWDGVIVTQADYQSLRAIKHDLIDPHGFLRSWNDSGVGACSGGWAGIKCVKG 91
T Q V+GH WDGV+VTQAD+Q+LRAIK+++ID G L+SWNDSGVGACSGGWAGIKCV G
Sbjct: 62 TIQHVSGHLWDGVVVTQADFQALRAIKNEIIDIRGVLKSWNDSGVGACSGGWAGIKCVNG 121
Query: 92 QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRL 151
+VIAIQLPWR LGGRISEKI QL +LRKLSLHDN L G VP++LG LPNLRGVYLFNN+L
Sbjct: 122 EVIAIQLPWRGLGGRISEKIGQLQSLRKLSLHDNALGGSVPFTLGLLPNLRGVYLFNNKL 181
Query: 152 SGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLP 211
SGSIPPS+GNCP LQ+LD+SNN+L G IPPSLA S+R++R+NLS+NSL GSIP SLT P
Sbjct: 182 SGSIPPSLGNCPMLQSLDISNNSLSGKIPPSLARSSRIFRINLSFNSLSGSIPSSLTMSP 241
Query: 212 SLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISL 271
SL++LALQHNNLSG +P++WG K+ QLQ L LDHNLI+GTIPVSLGKL LL+ +SL
Sbjct: 242 SLTILALQHNNLSGFIPDSWGGTGKKKASQLQVLTLDHNLISGTIPVSLGKLALLENVSL 301
Query: 272 SHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG 331
SHN+IVG IP ELG LS+LQ LDLS NAI GS P +F+N++SLVSLNLE+N+L N IP+
Sbjct: 302 SHNQIVGAIPSELGALSRLQILDLSNNAINGSLPASFSNLSSLVSLNLESNQLANHIPDS 361
Query: 332 LERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNV 391
++RL NL+VLNLKNN+ G IP ++GNIS I Q+D SEN GEI SL LA LTSFNV
Sbjct: 362 MDRLHNLSVLNLKNNKLDGQIPPSLGNISSIIQIDFSENKLVGEIPDSLTKLAKLTSFNV 421
Query: 392 SYNNLSGSVPPLLSKKFNSSSFVGNLQLCGYSPSTACPSLAPLSLPPPPVEAPKHHHHRK 451
SYNNLSG+VP LLSK+FN++SF GNL+LCG+ S C S AP +LP AP HHRK
Sbjct: 422 SYNNLSGTVPSLLSKRFNATSFEGNLELCGFISSKPCSSPAPHNLPAQSPHAPPKPHHRK 481
Query: 452 LSTKDIILIGVGALLAVLLILCCILLFCLMRKRSASKEKNGKSTAQKVVERAAPK---AG 508
LSTKDIILI G LL +LL+LCC LL CL+R+R+AS K+ K+ R K AG
Sbjct: 482 LSTKDIILIVAGILLLILLVLCCFLLCCLIRRRAASSRKSSKTAKAAASARGVEKGASAG 541
Query: 509 TEVESGGEMGGKLVHFDGPFLFTADDLLCATAEIMGKSTYGTAYKATLEDGSEVAVKRLR 568
EVESGGE GGKLVHFDGPF+FTADDLLCATAEIMGKS +GTAYKATLEDG++VAVKRLR
Sbjct: 542 GEVESGGEAGGKLVHFDGPFVFTADDLLCATAEIMGKSAFGTAYKATLEDGNQVAVKRLR 601
Query: 569 EKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGP 628
EKTTKGQKEFE E AA+GKI HPNLLALRAYYLGPKGEKLLVFD+M KGSLASFLHARGP
Sbjct: 602 EKTTKGQKEFETEVAALGKIRHPNLLALRAYYLGPKGEKLLVFDYMTKGSLASFLHARGP 661
Query: 629 ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688
E ++ W TRM IAIG+ GL+YLH +EN+IHGNLTSSN+LLDE+T I DFGLSRLMT
Sbjct: 662 EIVIEWPTRMKIAIGVTHGLSYLHSQENIIHGNLTSSNILLDEQTEAHITDFGLSRLMTT 721
Query: 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQW 748
+ANTN+IATAG+LGY APELSK K TKTDVYSLGVI+LELLTGK PGEP NGMDLPQW
Sbjct: 722 SANTNIIATAGSLGYNAPELSKTKKPTTKTDVYSLGVIMLELLTGKPPGEPTNGMDLPQW 781
Query: 749 VASIVKEEWTNEVFDLELMRDNTII 773
VASIVKEEWTNEVFDLELMRD I
Sbjct: 782 VASIVKEEWTNEVFDLELMRDAPAI 806
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224109228|ref|XP_002315129.1| predicted protein [Populus trichocarpa] gi|222864169|gb|EEF01300.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1037 bits (2682), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 540/762 (70%), Positives = 622/762 (81%), Gaps = 5/762 (0%)
Query: 17 FFLYTHLFLCLVLAFTS-QFVAGHSWDGVIVTQADYQSLRAIKHDLIDPHGFLRSWNDSG 75
F LYTH+FL L+L ++ Q V+ WDGVIVTQAD+Q+L+A KH+L+DP G LRSWNDSG
Sbjct: 8 FSLYTHIFLLLLLLISAFQPVSSQVWDGVIVTQADFQALQAFKHELVDPKGILRSWNDSG 67
Query: 76 VGACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSL 135
GACSGGW GIKC +GQVI IQLPW+ LGGRI+EKI QL LRKLSLHDN++ G +P L
Sbjct: 68 YGACSGGWIGIKCAQGQVIVIQLPWKGLGGRITEKIGQLQELRKLSLHDNVIGGSIPQEL 127
Query: 136 GFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLS 195
GFLPNLRGV LFNNRLSGSIPPS+G+CP LQTLDLSNN L G+IP SLANST+L+RLNLS
Sbjct: 128 GFLPNLRGVQLFNNRLSGSIPPSLGSCPLLQTLDLSNNLLTGSIPFSLANSTKLFRLNLS 187
Query: 196 YNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSY-QLQFLNLDHNLIAG 254
+NSL G IP+SLT SL L LQ+NNLSG++PN+WG ++ LQ L+L HN +G
Sbjct: 188 HNSLSGLIPVSLTSSSSLIFLDLQYNNLSGAIPNSWGATQKKSNFLPLQHLSLSHNFFSG 247
Query: 255 TIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSL 314
+IP SLGKL LQ+I +SHN+I G IP E+G LS+L+ LDLS NAI GS + +N++SL
Sbjct: 248 SIPASLGKLRELQDIYVSHNQINGAIPVEIGGLSRLRTLDLSNNAINGSLSDSLSNVSSL 307
Query: 315 VSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTG 374
V LNLENN L N+IPE + RL NL+VLNLK NQF GHIP TIGNIS + QLD+SEN +G
Sbjct: 308 VLLNLENNDLDNQIPEAIGRLHNLSVLNLKGNQFSGHIPATIGNISTLTQLDVSENKLSG 367
Query: 375 EISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQLCGYSPSTACPSLAPL 434
EI SLA L NL SFNVSYNNLSG VP LS+KFNSSSFVGN+QLCGYS + CPS AP
Sbjct: 368 EIPDSLADLNNLISFNVSYNNLSGPVPIPLSQKFNSSSFVGNIQLCGYSGTAPCPSHAPS 427
Query: 435 SLPPPPVEAPKHHHHRKLSTKDIILIGVGALLAVLLILCCILLFCLMRKRSASKEKNGKS 494
P P HHRKLSTKDIILI GALL V+LI+CCILL CL+RKR+ASK NG++
Sbjct: 428 PSVPVPPPEKPKKHHRKLSTKDIILIAAGALLVVMLIICCILLCCLIRKRAASKSNNGQA 487
Query: 495 TAQKVV---ERAAPKAGTEVESGGEMGGKLVHFDGPFLFTADDLLCATAEIMGKSTYGTA 551
T + E+ P A EVESGGE GGKLVHFDGP +FTADDLLCATAEIMGKSTYGT
Sbjct: 488 TTRAAAARGEKGVPPAAGEVESGGEAGGKLVHFDGPMVFTADDLLCATAEIMGKSTYGTV 547
Query: 552 YKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611
Y+ATLEDG++VAVKRLREK TKGQ+EFE+E +GKI HPNLLALRAYYLGPKGEKLLVF
Sbjct: 548 YRATLEDGNQVAVKRLREKITKGQREFESEVNVLGKIRHPNLLALRAYYLGPKGEKLLVF 607
Query: 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE 671
D++PKGSLA+FLHARGP+T+++W TRM IA G+ RGL YLH EN+IHGNLTSSNVLLDE
Sbjct: 608 DYIPKGSLATFLHARGPDTLIDWPTRMKIAQGMTRGLFYLHNNENIIHGNLTSSNVLLDE 667
Query: 672 KTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELL 731
+TN +IAD+GLSRLMTAAA+TNVIATA LGYRAPELSKLK ANTKTDVYSLGVIILELL
Sbjct: 668 RTNAKIADYGLSRLMTAAASTNVIATASVLGYRAPELSKLKKANTKTDVYSLGVIILELL 727
Query: 732 TGKSPGEPMNGMDLPQWVASIVKEEWTNEVFDLELMRDNTII 773
TGKSPGE MNG+DLPQWVASIVKEEWTNEVFDLELM+D +II
Sbjct: 728 TGKSPGEAMNGVDLPQWVASIVKEEWTNEVFDLELMKDASII 769
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225448572|ref|XP_002277929.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase IMK3-like isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1019 bits (2634), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 532/766 (69%), Positives = 621/766 (81%), Gaps = 10/766 (1%)
Query: 13 NYKHFFLYTHLFLCLVLAFTSQFVAGHSWDGVIVTQADYQSLRAIKHDLIDPHGFLRSWN 72
+Y F L+ L + +V Q V+ +WDGVIVT+AD+QSL+A KH+L+DP GFLRSWN
Sbjct: 54 HYARFLLFVQLIILVV-----QPVSSQAWDGVIVTEADFQSLQAFKHELVDPRGFLRSWN 108
Query: 73 DSGVGACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVP 132
DSG GACSGGW GIKC +GQVI IQLPW+ LGGRISEKI QL ALRKLSLHDN + G +P
Sbjct: 109 DSGYGACSGGWVGIKCAQGQVIVIQLPWKGLGGRISEKIGQLQALRKLSLHDNFIGGSIP 168
Query: 133 WSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRL 192
+LGFLPNLRGV LFNNR SGSIPPSIG+CP LQT+DLSNN+L G IP SL NST+ YRL
Sbjct: 169 SALGFLPNLRGVQLFNNRFSGSIPPSIGSCPLLQTVDLSNNSLSGTIPDSLFNSTKFYRL 228
Query: 193 NLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKS-YQLQFLNLDHNL 251
NLS+NS GSIP+SLTR SL+ LALQHNNLSG +PN+WGV KS ++LQ L LDHN
Sbjct: 229 NLSFNSFSGSIPVSLTRSSSLTFLALQHNNLSGPIPNSWGVGTQGKSLFRLQSLALDHNF 288
Query: 252 IAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNI 311
+G++P SLGKL LQ++SLSHN+I G IPDE+G+LS+L+ +D S NAI GS P++ +N+
Sbjct: 289 FSGSMPTSLGKLSELQKVSLSHNQITGAIPDEIGRLSRLKTVDFSSNAINGSLPISLSNL 348
Query: 312 TSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSEND 371
+SL+ LNLENN L ++IP+ E+LQNL+VLNL+ N+F G IP +IGN S + QLDLS+N+
Sbjct: 349 SSLLVLNLENNGLDSQIPDAFEKLQNLSVLNLRRNRFNGPIPGSIGNASALTQLDLSQNN 408
Query: 372 FTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQLCGYSPSTACPSL 431
TG+I S+A L NL SFNVSYNNLSGSVP LLS+KFNSS FVGNLQLCGY ST CPS
Sbjct: 409 LTGDIPSSIADLPNLNSFNVSYNNLSGSVPALLSQKFNSSCFVGNLQLCGYDASTPCPSE 468
Query: 432 APLSLPPPPVEAPKHHHHRKLSTKDIILIGVGALLAVLLILCCILLFCLMRKRSASKEKN 491
P + P P H RKLSTKDIILI GALL +LL++CCILL CL+RKR+ASK K+
Sbjct: 469 VPSQVVPAPSRGKPRSHGRKLSTKDIILIAAGALLIILLLVCCILLCCLIRKRAASKAKD 528
Query: 492 GKSTAQK----VVERAAPKAGTEVESGGEMGGKLVHFDGPFLFTADDLLCATAEIMGKST 547
G++T ++ E+ AP AG EVE+GGE GGKLVHFDGP +FTADDLLCATAEIMGKST
Sbjct: 529 GQATGRRPGAARAEKGAPSAGVEVEAGGEAGGKLVHFDGPMVFTADDLLCATAEIMGKST 588
Query: 548 YGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEK 607
YGT YKATLEDG+EVAVKRLREK TK Q+EFE E +GKI HPNLLALRAYYLGPKGEK
Sbjct: 589 YGTVYKATLEDGNEVAVKRLREKITKSQREFETEVNVLGKIRHPNLLALRAYYLGPKGEK 648
Query: 608 LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNV 667
LLVFD+MPKGSLA+FLHARGP+ ++W TRM IA G RGL +LH EN+IHGNLTSSN+
Sbjct: 649 LLVFDYMPKGSLAAFLHARGPDISIDWPTRMRIAQGTTRGLFHLHNNENIIHGNLTSSNL 708
Query: 668 LLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVII 727
LLDE +IADFGLSRLMT AAN+NVIATAG LGYRAPELSKLK A+TKTDVYSLGVII
Sbjct: 709 LLDENITAKIADFGLSRLMTTAANSNVIATAGALGYRAPELSKLKKASTKTDVYSLGVII 768
Query: 728 LELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEVFDLELMRDNTII 773
LELLTGKSPGE NG+DLPQWVASIVKEEWTNEVFDLELM+D + I
Sbjct: 769 LELLTGKSPGEATNGVDLPQWVASIVKEEWTNEVFDLELMKDASTI 814
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356553753|ref|XP_003545217.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase IMK2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1004 bits (2595), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 499/735 (67%), Positives = 589/735 (80%), Gaps = 12/735 (1%)
Query: 41 WDGVIVTQADYQSLRAIKHDLIDPHGFLRSWNDSGVGACSGGWAGIKCVKGQVIAIQLPW 100
WDGV+VTQ+++ +L+A K +L+DP GFLRSWNDSG GACSG W GIKC +GQVI IQLPW
Sbjct: 10 WDGVVVTQSNFLALQAFKQELVDPKGFLRSWNDSGYGACSGAWVGIKCAQGQVIVIQLPW 69
Query: 101 RRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIG 160
+ L G I+E+I QL LRKLSLHDN + G +P +LG L NLRGV LFNNR +G+IPPS+G
Sbjct: 70 KGLKGHITERIGQLRGLRKLSLHDNQIGGSIPSALGLLLNLRGVQLFNNRFTGTIPPSLG 129
Query: 161 NCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQH 220
+CP LQ+LDLSNN L G IP SL N+T+LY LNLS+NSL G +P SLT SL+ L+LQH
Sbjct: 130 SCPLLQSLDLSNNLLTGTIPMSLGNATKLYWLNLSFNSLSGPMPTSLT---SLTYLSLQH 186
Query: 221 NNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPI 280
NNLSGS+PN+WG N ++L+ L +DHNL++G+IP SLG L L EISLSHN+ G I
Sbjct: 187 NNLSGSIPNSWGGSLKNNFFRLRNLIIDHNLLSGSIPASLGGLSELTEISLSHNQFSGAI 246
Query: 281 PDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTV 340
P+E+G LS+L+ LD S NA+ GS P +N++SL LN+ENN LGN+IPE L RL NL+V
Sbjct: 247 PNEIGNLSRLKTLDFSNNALNGSLPAALSNVSSLTLLNVENNHLGNQIPEALGRLHNLSV 306
Query: 341 LNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSV 400
L L NQF GHIP+ IGNIS + QLDLS N+ +GEI + +L +L+ FNVS+NNLSG V
Sbjct: 307 LVLSRNQFSGHIPQNIGNISKLRQLDLSLNNLSGEIPVAFDNLRSLSFFNVSHNNLSGPV 366
Query: 401 PPLLSKKFNSSSFVGNLQLCGYSPSTACPSLAPLSLPPPPVEAPKHHHHRKLSTKDIILI 460
P LL++KFNSSSFVGN+QLCGYSPST CPSLAP PP E +H HH+KL TKDIILI
Sbjct: 367 PTLLAQKFNSSSFVGNIQLCGYSPSTTCPSLAPSGSPP---EISEHRHHKKLGTKDIILI 423
Query: 461 GVGALLAVLLILCCILLFCLMRKRSASKEKNGKSTAQKVV------ERAAPKAGTEVESG 514
G LL VL+ +CCILLFCL++KR++S + G++T + E+ P E E+G
Sbjct: 424 VAGVLLVVLVTICCILLFCLIKKRASSNAEGGQATGRASAAAAGRTEKGVPPVTGEAEAG 483
Query: 515 GEMGGKLVHFDGPFLFTADDLLCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKG 574
GE+GGKLVHFDGP FTADDLLCATAEIMGKSTYGT YKATLEDGS+ AVKRLREK TKG
Sbjct: 484 GEVGGKLVHFDGPLTFTADDLLCATAEIMGKSTYGTVYKATLEDGSQAAVKRLREKITKG 543
Query: 575 QKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNW 634
Q+EFE+E + IG+I HPNLLALRAYYLGPKGEKLLVFD+MP GSLASFLH+RGPET ++W
Sbjct: 544 QREFESEVSIIGRIRHPNLLALRAYYLGPKGEKLLVFDYMPNGSLASFLHSRGPETAIDW 603
Query: 635 ATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694
TRM IA G+A GL YLH EN+IHGNLTSSNVLLDE N +IADFGLSRLMT AAN+NV
Sbjct: 604 PTRMKIAQGMAHGLLYLHSRENIIHGNLTSSNVLLDENVNAKIADFGLSRLMTTAANSNV 663
Query: 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK 754
IATAG LGYRAPELSKLK ANTKTDVYSLGVI+LELLTGK PGE MNG+DLPQWVASIVK
Sbjct: 664 IATAGALGYRAPELSKLKKANTKTDVYSLGVILLELLTGKPPGEAMNGVDLPQWVASIVK 723
Query: 755 EEWTNEVFDLELMRD 769
EEWTNEVFD+ELMRD
Sbjct: 724 EEWTNEVFDVELMRD 738
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297816438|ref|XP_002876102.1| hypothetical protein ARALYDRAFT_485528 [Arabidopsis lyrata subsp. lyrata] gi|297321940|gb|EFH52361.1| hypothetical protein ARALYDRAFT_485528 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1002 bits (2591), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 533/769 (69%), Positives = 620/769 (80%), Gaps = 20/769 (2%)
Query: 10 PFHNYKHFFLYTHLFLCLVLAFTSQFVAG-----HSWDGVIVTQADYQSLRAIKHDLIDP 64
PF Y+ F + L L F+++ VAG HSWDG++VTQA+YQ+L+AIKH+LID
Sbjct: 8 PFRIYEISFHFCMSLLLCFLLFSARAVAGGGGGGHSWDGIVVTQANYQALQAIKHELIDF 67
Query: 65 HGFLRSWNDSGVGACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHD 124
G LRSWN+S GWAGIKC++GQV+AIQLPW+ LGG ISEKI QL +LRKLSLH+
Sbjct: 68 TGVLRSWNNSASSEVCSGWAGIKCLRGQVVAIQLPWKGLGGTISEKIGQLGSLRKLSLHN 127
Query: 125 NLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLA 184
N++AG VP SLG+L +LRGVYLFNNRLSGSIP S+GNCP LQ LDLS+N L G IP SLA
Sbjct: 128 NVIAGSVPRSLGYLKSLRGVYLFNNRLSGSIPASLGNCPLLQNLDLSSNQLTGIIPTSLA 187
Query: 185 NSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQF 244
STRLYRLNLS+NSL G +P+S+ R +L+ L LQHNNLSGS+PN N S+ L+
Sbjct: 188 ESTRLYRLNLSFNSLSGPLPVSVARAYTLTFLDLQHNNLSGSIPN----FLVNGSHPLKT 243
Query: 245 LNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSF 304
LNLDHNL +G IP+SL K GLL+E+SLSHN++ G IP E G L LQ LD SYN+I G+
Sbjct: 244 LNLDHNLFSGAIPLSLCKHGLLEEVSLSHNQLSGSIPRECGALPHLQSLDFSYNSINGTI 303
Query: 305 PVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQ 364
P +F+N++SLVSLNLE+N L IP+ ++RL N+T LN+K N+ G IPETIGNISGI Q
Sbjct: 304 PDSFSNLSSLVSLNLESNHLKGPIPDAIDRLHNMTELNIKRNKINGPIPETIGNISGIKQ 363
Query: 365 LDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQLCGYSP 424
LDLSEN+FTG I SL LANL+SFNVSYN LSG VPP+LSKKFNSSSFVGN+QLCGYS
Sbjct: 364 LDLSENNFTGPIPLSLVHLANLSSFNVSYNTLSGPVPPILSKKFNSSSFVGNIQLCGYSS 423
Query: 425 STACPSLAP---LSLPPPPVEAPKHHHHRKLSTKDIILIGVGALLAVLLILCCILLFCLM 481
S CPS P L+L P + P+ HH RKLS KDIILI +GALLA+LL+LCCILL CL+
Sbjct: 424 SKPCPSPKPHHPLTLSPTSSQEPRKHH-RKLSLKDIILIAIGALLAILLVLCCILLCCLI 482
Query: 482 RKRSASKEKNGKS-TAQKVVERAAPKAGTEVESGGEMGGKLVHFDGPFLFTADDLLCATA 540
+KR+A K+K+GK T++K V AA AG E MGGKLVHFDGPF+FTADDLLCATA
Sbjct: 483 KKRAALKQKDGKEKTSEKTVSAAAASAGGE------MGGKLVHFDGPFVFTADDLLCATA 536
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
EIMGKSTYGTAYKATLEDG+EVAVKRLREKTTKG KEFE E A+GKI H NLLALRAYY
Sbjct: 537 EIMGKSTYGTAYKATLEDGNEVAVKRLREKTTKGVKEFEGEVTALGKIRHQNLLALRAYY 596
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHG 660
LGPKGEKLLVFD+M KGSL++FLHARGPET++ W TRM IA GI+RGL +LH ENMIH
Sbjct: 597 LGPKGEKLLVFDYMSKGSLSAFLHARGPETLIPWETRMKIAKGISRGLAHLHSNENMIHE 656
Query: 661 NLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDV 720
NLT+SN+LLDE+TN IAD+GLSRLMTAAA TNVIATAGTLGYRAPE SK+KNA+TKTDV
Sbjct: 657 NLTASNILLDEQTNAHIADYGLSRLMTAAAATNVIATAGTLGYRAPEFSKIKNASTKTDV 716
Query: 721 YSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEVFDLELMRD 769
YSLG+IILELLTGKSPGEP NGMDLPQWVASIVKEEWTNEVFDLELMR+
Sbjct: 717 YSLGIIILELLTGKSPGEPTNGMDLPQWVASIVKEEWTNEVFDLELMRE 765
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|206584435|gb|ACI15359.1| RHG1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 999 bits (2583), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/740 (68%), Positives = 590/740 (79%), Gaps = 8/740 (1%)
Query: 41 WDGVIVTQADYQSLRAIKHDLIDPHGFLRSWNDSGVGACSGGWAGIKCVKGQVIAIQLPW 100
WDGV+VT ++ +L A K +L+DP GFLRSWNDSG GACSGGW GIKC +GQVI IQLPW
Sbjct: 66 WDGVVVTASNLLALEAFKQELVDPEGFLRSWNDSGYGACSGGWVGIKCAQGQVIVIQLPW 125
Query: 101 RRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIG 160
+ L GRI++KI QL LRKLSLHDN + G +P +LG LPNLRGV LFNNRL+GSIP S+G
Sbjct: 126 KGLRGRITDKIGQLQGLRKLSLHDNQIGGSIPSTLGLLPNLRGVQLFNNRLTGSIPLSLG 185
Query: 161 NCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQH 220
CP LQ+LDLSNN L GAIP SLANST+LY LNLS+NS G +P SLT SL+ L+LQ+
Sbjct: 186 FCPLLQSLDLSNNLLTGAIPYSLANSTKLYWLNLSFNSFSGPLPASLTHSFSLTFLSLQN 245
Query: 221 NNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPI 280
NNLSGS+PN+WG + N ++LQ L LDHN G +P SLG L L EISLSHNK G I
Sbjct: 246 NNLSGSLPNSWGGNSKNGFFRLQNLILDHNFFTGDVPASLGSLRELNEISLSHNKFSGAI 305
Query: 281 PDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTV 340
P+E+G LS+L+ LD+S NA+ G+ P T +N++SL LN ENN L N+IP+ L RL+NL+V
Sbjct: 306 PNEIGTLSRLKTLDISNNALNGNLPATLSNLSSLTLLNAENNLLDNQIPQSLGRLRNLSV 365
Query: 341 LNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSV 400
L L NQF GHIP +I NIS + QLDLS N+F+GEI S S +L FNVSYN+LSGSV
Sbjct: 366 LILSRNQFSGHIPSSIANISSLRQLDLSLNNFSGEIPVSFDSQRSLNLFNVSYNSLSGSV 425
Query: 401 PPLLSKKFNSSSFVGNLQLCGYSPSTACPSLAPLS--LPPPPVEAPKHHHHRKLSTKDII 458
PPLL+KKFNSSSFVGN+QLCGYSPST C S AP + PPP E KHHHHRKLSTKDII
Sbjct: 426 PPLLAKKFNSSSFVGNIQLCGYSPSTPCLSQAPSQGVIAPPP-EVSKHHHHRKLSTKDII 484
Query: 459 LIGVGALLAVLLILCCILLFCLMRKRSASKEKNGKST----AQKVVERAAPK-AGTEVES 513
LI G LL VL+ILCC+LLFCL+RKRS SK NG++T A E+ P AG +VE+
Sbjct: 485 LIVAGVLLVVLIILCCVLLFCLIRKRSTSKAGNGQATEGRAATMRTEKGVPPVAGGDVEA 544
Query: 514 GGEMGGKLVHFDGPFLFTADDLLCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTK 573
GGE GGKLVHFDGP FTADDLLCATAEIMGKSTYGT YKA LEDGS+VAVKRLREK TK
Sbjct: 545 GGEAGGKLVHFDGPMAFTADDLLCATAEIMGKSTYGTVYKAILEDGSQVAVKRLREKITK 604
Query: 574 GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVN 633
G +EFE+E + +GKI HPN+LALRAYYLGPKGEKLLVFD+M KGSLASFLH G ET ++
Sbjct: 605 GHREFESEVSVLGKIRHPNVLALRAYYLGPKGEKLLVFDYMSKGSLASFLHGGGTETFID 664
Query: 634 WATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693
W TRM IA +ARGL LH +EN+IHGNLTSSNVLLDE TN +IADFGLSRLM+ AAN+N
Sbjct: 665 WPTRMKIAQDLARGLFCLHSQENIIHGNLTSSNVLLDENTNAKIADFGLSRLMSTAANSN 724
Query: 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIV 753
VIATAG LGYRAPELSKLK ANTKTD+YSLGVI+LELLT KSPG PMNG+DLPQWVAS+V
Sbjct: 725 VIATAGALGYRAPELSKLKKANTKTDIYSLGVILLELLTRKSPGVPMNGLDLPQWVASVV 784
Query: 754 KEEWTNEVFDLELMRDNTII 773
KEEWTNEVFD +LMRD + +
Sbjct: 785 KEEWTNEVFDADLMRDASTV 804
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 773 | ||||||
| TAIR|locus:2098267 | 836 | IMK2 "inflorescence meristem r | 0.976 | 0.903 | 0.624 | 6.6e-248 | |
| TAIR|locus:2122239 | 1136 | AT4G36180 [Arabidopsis thalian | 0.446 | 0.303 | 0.373 | 1.9e-90 | |
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.333 | 0.392 | 0.481 | 1.5e-87 | |
| TAIR|locus:2093121 | 674 | TMKL1 "transmembrane kinase-li | 0.329 | 0.378 | 0.458 | 8.2e-85 | |
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.367 | 0.423 | 0.454 | 1.2e-83 | |
| TAIR|locus:2005629 | 1140 | AT1G75640 [Arabidopsis thalian | 0.435 | 0.295 | 0.355 | 7.5e-83 | |
| TAIR|locus:2088500 | 647 | RLK902 "receptor-like kinase 9 | 0.338 | 0.404 | 0.467 | 5.8e-80 | |
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.421 | 0.337 | 0.358 | 1.9e-79 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.478 | 0.296 | 0.346 | 3.8e-79 | |
| TAIR|locus:2182855 | 967 | ERL2 "ERECTA-like 2" [Arabidop | 0.421 | 0.337 | 0.343 | 6.6e-79 |
| TAIR|locus:2098267 IMK2 "inflorescence meristem receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2388 (845.7 bits), Expect = 6.6e-248, P = 6.6e-248
Identities = 483/773 (62%), Positives = 569/773 (73%)
Query: 7 YLYPFHNYK-HFFLYTHLFLCLVLAFTSQFVAG-----HSWDGVIVTQADYQSLRAIKHD 60
Y PF Y+ F L LC +L F++Q VAG HSWDG++VTQA+YQ+L+AIKH+
Sbjct: 5 YKNPFRIYEISFHFCASLLLCFLL-FSAQAVAGGGGGGHSWDGIVVTQANYQALQAIKHE 63
Query: 61 LIDPHGFLRSWNDSGVGACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKL 120
LID G L+SWN+S GWAGIKC++GQV+AIQLPW+ LGG ISEKI QL +LRKL
Sbjct: 64 LIDFTGVLKSWNNSASSQVCSGWAGIKCLRGQVVAIQLPWKGLGGTISEKIGQLGSLRKL 123
Query: 121 SLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIP 180
SLH+N++AG VP SLG+L +LRGVYLFNNRLSGSIP S+GNCP LQ LDLS+N L GAIP
Sbjct: 124 SLHNNVIAGSVPRSLGYLKSLRGVYLFNNRLSGSIPVSLGNCPLLQNLDLSSNQLTGAIP 183
Query: 181 PSLANSTXXXXXXXXXXXXXGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSY 240
PSL ST G +P+S+ R +L+ L LQHNNLSGS+P+ + N S+
Sbjct: 184 PSLTESTRLYRLNLSFNSLSGPLPVSVARSYTLTFLDLQHNNLSGSIPDFFV----NGSH 239
Query: 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAI 300
L+ LNLDHN +G +PVSL K LL+E+S+SHN++ G IP E G L LQ LD SYN+I
Sbjct: 240 PLKTLNLDHNRFSGAVPVSLCKHSLLEEVSISHNQLSGSIPRECGGLPHLQSLDFSYNSI 299
Query: 301 GGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNIS 360
G+ P +F+N++SLVSLNLE+N L IP+ ++RL NLT LNLK N+ G IPETIGNIS
Sbjct: 300 NGTIPDSFSNLSSLVSLNLESNHLKGPIPDAIDRLHNLTELNLKRNKINGPIPETIGNIS 359
Query: 361 GINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQLC 420
GI +LDLSEN+FTG I SL LA L+SFNVSYN LSG VPP+LSKKFNSSSF+GN+QLC
Sbjct: 360 GIKKLDLSENNFTGPIPLSLVHLAKLSSFNVSYNTLSGPVPPVLSKKFNSSSFLGNIQLC 419
Query: 421 GYXXXX---XXXXXXXXXXXXXXXXXXKHHHHRKLSTKDXXXXXXXXXXXXXXXXXXXXX 477
GY + HHHRKLS KD
Sbjct: 420 GYSSSNPCPAPDHHHPLTLSPTSSQEPRKHHHRKLSVKDVILIAIGALLAILLLLCCILL 479
Query: 478 FCLMRKRSASKEKNGKS-TAQKVVERAAPKAGTEVESGGEMGGKLVHFDGPFLFTADDLL 536
CL++KR+A K+K+GK T++K V +A AGT +GGEMGGKLVHFDGPF+FTADDLL
Sbjct: 480 CCLIKKRAALKQKDGKDKTSEKTV--SAGVAGT-ASAGGEMGGKLVHFDGPFVFTADDLL 536
Query: 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLAL 596
CATAEIMGKSTYGTAYKATLEDG+EVAVKRLREKTTKG KEFE E A+GKI H NLLAL
Sbjct: 537 CATAEIMGKSTYGTAYKATLEDGNEVAVKRLREKTTKGVKEFEGEVTALGKIRHQNLLAL 596
Query: 597 RAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
RAYYLGPKGEKLLVFD+M KGSL++FLHARGPET++ W TRM IA GI+RGL +LH EN
Sbjct: 597 RAYYLGPKGEKLLVFDYMSKGSLSAFLHARGPETLIPWETRMKIAKGISRGLAHLHSNEN 656
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKNANT 716
MIH NLT+SN+LLDE+TN IAD+GLSRLM LGYRAPE SK+KNA+
Sbjct: 657 MIHENLTASNILLDEQTNAHIADYGLSRLMTAAAATNVIATAGTLGYRAPEFSKIKNASA 716
Query: 717 KTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEVFDLELMRD 769
KTDVYSLG+IILELLTGKSPGEP NGMDLPQWVASIVKEEWTNEVFDLELMR+
Sbjct: 717 KTDVYSLGIIILELLTGKSPGEPTNGMDLPQWVASIVKEEWTNEVFDLELMRE 769
|
|
| TAIR|locus:2122239 AT4G36180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 534 (193.0 bits), Expect = 1.9e-90, Sum P(2) = 1.9e-90
Identities = 134/359 (37%), Positives = 190/359 (52%)
Query: 47 TQADYQSLRAIKHDLIDPHGFLRSWNDSGVGA-CSGGWAGIKCVKGQVIAIQLPWRRLGG 105
+QA+ +L A K +L DP G L SW+ S A C W G+ C +V I+LP +L G
Sbjct: 25 SQAEIDALTAFKLNLHDPLGALTSWDPSTPAAPCD--WRGVGCTNHRVTEIRLPRLQLSG 82
Query: 106 RISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNL 165
RIS++IS L LRKLSL N G +P SL + L V+L N LSG +PP++ N +L
Sbjct: 83 RISDRISGLRMLRKLSLRSNSFNGTIPTSLAYCTRLLSVFLQYNSLSGKLPPAMRNLTSL 142
Query: 166 QTLDLSNNALIGAIPPSLANSTXXXXXXXXXXXXXGSIPLSLTRLPSLSVLALQHNNLSG 225
+ +++ N L G IP L +S G IP L L L +L L +N L+G
Sbjct: 143 EVFNVAGNRLSGEIPVGLPSSLQFLDISSNTFS--GQIPSGLANLTQLQLLNLSYNQLTG 200
Query: 226 SVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELG 285
+P + G L LQ+L LD NL+ GT+P ++ L +S S N+I G IP G
Sbjct: 201 EIPASLGNLQS-----LQYLWLDFNLLQGTLPSAISNCSSLVHLSASENEIGGVIPAAYG 255
Query: 286 KLSKLQKLDLSYNAIGGSFPVT-FTNITSLVSLNLENNRLGNKI-PEGLERLQN-LTVLN 342
L KL+ L LS N G+ P + F N TSL + L N + + PE + L VL+
Sbjct: 256 ALPKLEVLSLSNNNFSGTVPFSLFCN-TSLTIVQLGFNAFSDIVRPETTANCRTGLQVLD 314
Query: 343 LKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVP 401
L+ N+ G P + NI + LD+S N F+GEI P + +L L ++ N+L+G +P
Sbjct: 315 LQENRISGRFPLWLTNILSLKNLDVSGNLFSGEIPPDIGNLKRLEELKLANNSLTGEIP 373
|
|
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 611 (220.1 bits), Expect = 1.5e-87, Sum P(2) = 1.5e-87
Identities = 131/272 (48%), Positives = 178/272 (65%)
Query: 508 GTEVESGGEMG-GKLVHFDGP-FLFTADDLLCATAEIMGKSTYGTAYKATLEDGSEVAVK 565
GT GGE KLV +G + F +DLL A+AE++GK + GT+YKA LE+G+ V VK
Sbjct: 320 GTSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVK 379
Query: 566 RLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLH- 624
RL++ +KEFE + +GKI HPN++ LRAYY K EKLLVFDFMP GSL++ LH
Sbjct: 380 RLKD-VMASKKEFETQMEVVGKIKHPNVIPLRAYYYS-KDEKLLVFDFMPTGSLSALLHG 437
Query: 625 ARGP-ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS 683
+RG T ++W RM IAI ARGL +LHV ++HGN+ +SN+LL + ++D+GL+
Sbjct: 438 SRGSGRTPLDWDNRMRIAITAARGLAHLHVSAKLVHGNIKASNILLHPNQDTCVSDYGLN 497
Query: 684 RLMXXXXXXXXXXXXXXLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM--- 740
+L GY APE+ + + K+DVYS GV++LELLTGKSP +
Sbjct: 498 QLFSNSSPPNRLA-----GYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGE 552
Query: 741 NGMDLPQWVASIVKEEWTNEVFDLELMRDNTI 772
G+DLP+WV S+V+EEWT EVFD+ELMR + I
Sbjct: 553 EGIDLPRWVLSVVREEWTAEVFDVELMRYHNI 584
|
|
| TAIR|locus:2093121 TMKL1 "transmembrane kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 565 (203.9 bits), Expect = 8.2e-85, Sum P(2) = 8.2e-85
Identities = 121/264 (45%), Positives = 164/264 (62%)
Query: 512 ESGGEMGGKLVHFDGPFLFTADDLLCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKT 571
+ GGE GKLV F G T DD+L AT ++M K++YGT YKA L DG +A++ LRE T
Sbjct: 350 KEGGE--GKLVVFQGGENLTLDDVLNATGQVMEKTSYGTVYKAKLSDGGNIALRLLREGT 407
Query: 572 TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGP-ET 630
K + +G+I H NL+ LRA+Y G +GEKLL++D++P SL LH P +
Sbjct: 408 CKDRSSCLPVIRQLGRIRHENLVPLRAFYQGKRGEKLLIYDYLPNISLHDLLHESKPRKP 467
Query: 631 IVNWATRMSIAIGIARGLNYLHV--EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMXX 688
+NWA R IA+GIARGL YLH E +IHGN+ S NVL+D+ R+ +FGL ++M
Sbjct: 468 ALNWARRHKIALGIARGLAYLHTGQEVPIIHGNIRSKNVLVDDFFFARLTEFGLDKIMVQ 527
Query: 689 XXXXXXXXXXXXLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP-MNG---MD 744
GY+APEL K+K N ++DVY+ G+++LE+L GK PG+ NG +D
Sbjct: 528 AVADEIVSQAKSDGYKAPELHKMKKCNPRSDVYAFGILLLEILMGKKPGKSGRNGNEFVD 587
Query: 745 LPQWVASIVKEEWTNEVFDLELMR 768
LP V + V EE T EVFDLE M+
Sbjct: 588 LPSLVKAAVLEETTMEVFDLEAMK 611
|
|
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 623 (224.4 bits), Expect = 1.2e-83, Sum P(2) = 1.2e-83
Identities = 140/308 (45%), Positives = 194/308 (62%)
Query: 478 FCLMRKRSASKEKNGKST-AQKVVERAAP-KAGTEVESGG--EMG--GKLVHFDGPFLFT 531
+C R+ + +K+K+ K +K+V + P T+ + ++G GK+V F+G F
Sbjct: 297 YCFWRQYAVNKKKHSKILEGEKIVYSSNPYPTSTQNNNNQNQQVGDKGKMVFFEGTRRFE 356
Query: 532 ADDLLCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHH 590
+DLL A+AE++GK +GTAYKA LEDG+EVAVKRL++ T G+KEFE + +G++ H
Sbjct: 357 LEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRH 416
Query: 591 PNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHA-RGP-ETIVNWATRMSIAIGIARGL 648
NL++L+AYY + EKLLV+D+MP GSL LH RGP T ++W TR+ IA G ARGL
Sbjct: 417 TNLVSLKAYYFA-REEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGL 475
Query: 649 NYLHVE---ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMXXXXXXXXXXXXXXLGYRA 705
++H + HG++ S+NVLLD N R++DFGLS GYRA
Sbjct: 476 AFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLSIFAPSQTVAKSN------GYRA 529
Query: 706 PELSKLKNANTKTDVYSLGVIILELLTGKSP-----GEPMNGMDLPQWVASIVKEEWTNE 760
PEL + K+DVYS GV++LE+LTGK P G +DLP+WV S+V+EEWT E
Sbjct: 530 PELIDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAVDLPRWVQSVVREEWTAE 589
Query: 761 VFDLELMR 768
VFDLELMR
Sbjct: 590 VFDLELMR 597
|
|
| TAIR|locus:2005629 AT1G75640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 504 (182.5 bits), Expect = 7.5e-83, Sum P(2) = 7.5e-83
Identities = 122/343 (35%), Positives = 178/343 (51%)
Query: 80 SGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLP 139
SG G + I L GRI + L+ L L+L++N L G +P + L
Sbjct: 399 SGQIPGFLSQLRSLTTISLGRNGFSGRIPSDLLSLYGLETLNLNENHLTGAIPSEITKLA 458
Query: 140 NLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTXXXXXXXXXXXX 199
NL + L NR SG +P ++G+ +L L++S L G IP S++
Sbjct: 459 NLTILNLSFNRFSGEVPSNVGDLKSLSVLNISGCGLTGRIPVSISGLMKLQVLDISKQRI 518
Query: 200 XGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVS 259
G +P+ L LP L V+AL +N L G VP + L L++LNL NL +G IP +
Sbjct: 519 SGQLPVELFGLPDLQVVALGNNLLGGVVPEGFSSLVS-----LKYLNLSSNLFSGHIPKN 573
Query: 260 LGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNL 319
G L LQ +SLSHN+I G IP E+G S L+ L+L N++ G PV + ++ L L+L
Sbjct: 574 YGFLKSLQVLSLSHNRISGTIPPEIGNCSSLEVLELGSNSLKGHIPVYVSKLSLLKKLDL 633
Query: 320 ENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPS 379
+N L IP+ + + +L L L +N G IPE++ ++ + LDLS N I S
Sbjct: 634 SHNSLTGSIPDQISKDSSLESLLLNSNSLSGRIPESLSRLTNLTALDLSSNRLNSTIPSS 693
Query: 380 LASLANLTSFNVSYNNLSGSVPPLLSKKF-NSSSFVGNLQLCG 421
L+ L L FN+S N+L G +P L+ +F N + FV N LCG
Sbjct: 694 LSRLRFLNYFNLSRNSLEGEIPEALAARFTNPTVFVKNPGLCG 736
|
|
| TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 579 (208.9 bits), Expect = 5.8e-80, Sum P(2) = 5.8e-80
Identities = 130/278 (46%), Positives = 178/278 (64%)
Query: 503 AAPKAGTEVESGGEMGGKLVHF-DGPFLFTADDLLCATAEIMGKSTYGTAYKATLEDGSE 561
+A KA EV S G KLV F + +F +DLL A+AE++GK T+GTAYKA L+ +
Sbjct: 333 SAVKA-VEVNSSGMK--KLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTL 389
Query: 562 VAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLAS 621
VAVKRL++ T +EF+ + +G + H NL+ LRAYY EKLLV+DFMP GSL++
Sbjct: 390 VAVKRLKD-VTMADREFKEKIEVVGAMDHENLVPLRAYYYSGD-EKLLVYDFMPMGSLSA 447
Query: 622 FLHA-RGP-ETIVNWATRMSIAIGIARGLNYLHVEENMI-HGNLTSSNVLLDEKTNPRIA 678
LH +G +NW R IA+G ARGL+YLH ++ + HGN+ SSN+LL + R++
Sbjct: 448 LLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDPLSSHGNVKSSNILLTNSHDARVS 507
Query: 679 DFGLSRLMXXXXXXXXXXXXXXLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGE 738
DFGL++L+ GYRAPE++ + + K DVYS GV++LELLTGK+P
Sbjct: 508 DFGLAQLVSASSTTPNRAT----GYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSN 563
Query: 739 P-MN--GMDLPQWVASIVKEEWTNEVFDLELMRDNTII 773
MN GMDL +WV S+ +EEW NEVFD ELM T++
Sbjct: 564 SVMNEEGMDLARWVHSVAREEWRNEVFDSELMSIETVV 601
|
|
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 480 (174.0 bits), Expect = 1.9e-79, Sum P(2) = 1.9e-79
Identities = 120/335 (35%), Positives = 172/335 (51%)
Query: 88 CVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLF 147
C Q++ I + ++ G I I L + LSL N L G +P +G + L + L
Sbjct: 238 CTSFQILDIS--YNQITGEIPYNIGFLQ-VATLSLQGNRLTGRIPEVIGLMQALAVLDLS 294
Query: 148 NNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTXXXXXXXXXXXXXGSIPLSL 207
+N L G IPP +GN L L N L G IP L N + G+IP L
Sbjct: 295 DNELVGPIPPILGNLSFTGKLYLHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPEL 354
Query: 208 TRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQ 267
+L L L L +N L G +P+N A QF N+ NL++G+IP++ LG L
Sbjct: 355 GKLEQLFELNLANNRLVGPIPSNISSCAALN----QF-NVHGNLLSGSIPLAFRNLGSLT 409
Query: 268 EISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNK 327
++LS N G IP ELG + L KLDLS N GS P+T ++ L+ LNL N L +
Sbjct: 410 YLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQ 469
Query: 328 IPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLT 387
+P L+++ ++++ N G IP +G + +N L L+ N G+I L + L
Sbjct: 470 LPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLV 529
Query: 388 SFNVSYNNLSGSVPPLLS-KKFNSSSFVGNLQLCG 421
+ NVS+NNLSG VPP+ + +F +SFVGN LCG
Sbjct: 530 NLNVSFNNLSGIVPPMKNFSRFAPASFVGNPYLCG 564
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 514 (186.0 bits), Expect = 3.8e-79, Sum P(2) = 3.8e-79
Identities = 134/387 (34%), Positives = 200/387 (51%)
Query: 25 LCLVLAFTSQFVAGHSWDGVIVTQADYQSLRAIKHDLI-DPHGF--LRSWNDSGVGACSG 81
L L+L F F +G G+I D Q+L +K L+ +P LR WN + CS
Sbjct: 4 LVLLLLFILCF-SGLGQPGII--NNDLQTLLEVKKSLVTNPQEDDPLRQWNSDNINYCS- 59
Query: 82 GWAGIKCVK-G--QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFL 138
W G+ C G +VIA+ L L G IS + L L L N L GP+P +L L
Sbjct: 60 -WTGVTCDNTGLFRVIALNLTGLGLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNL 118
Query: 139 PNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTXXXXXXXXXXX 198
+L ++LF+N+L+G IP +G+ N+++L + +N L+G IP +L N
Sbjct: 119 TSLESLFLFSNQLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCR 178
Query: 199 XXGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPV 258
G IP L RL + L LQ N L G +P GN S L N++ GTIP
Sbjct: 179 LTGPIPSQLGRLVRVQSLILQDNYLEGPIPAE----LGNCS-DLTVFTAAENMLNGTIPA 233
Query: 259 SLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLN 318
LG+L L+ ++L++N + G IP +LG++S+LQ L L N + G P + ++ +L +L+
Sbjct: 234 ELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLD 293
Query: 319 LENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETI-GNISGINQLDLSENDFTGEIS 377
L N L +IPE + L L L NN G +P++I N + + QL LS +GEI
Sbjct: 294 LSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIP 353
Query: 378 PSLASLANLTSFNVSYNNLSGSVPPLL 404
L+ +L ++S N+L+GS+P L
Sbjct: 354 VELSKCQSLKQLDLSNNSLAGSIPEAL 380
|
|
| TAIR|locus:2182855 ERL2 "ERECTA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 470 (170.5 bits), Expect = 6.6e-79, Sum P(2) = 6.6e-79
Identities = 115/335 (34%), Positives = 170/335 (50%)
Query: 88 CVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLF 147
C +++ + + ++ G I I L + LSL N L G +P +G + L + L
Sbjct: 240 CTSFEILDVS--YNQITGVIPYNIGFLQ-VATLSLQGNKLTGRIPEVIGLMQALAVLDLS 296
Query: 148 NNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTXXXXXXXXXXXXXGSIPLSL 207
+N L+G IPP +GN L L N L G IPP L N + G IP L
Sbjct: 297 DNELTGPIPPILGNLSFTGKLYLHGNKLTGQIPPELGNMSRLSYLQLNDNELVGKIPPEL 356
Query: 208 TRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQ 267
+L L L L +NNL G +P+N A QF N+ N ++G +P+ LG L
Sbjct: 357 GKLEQLFELNLANNNLVGLIPSNISSCAALN----QF-NVHGNFLSGAVPLEFRNLGSLT 411
Query: 268 EISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNK 327
++LS N G IP ELG + L LDLS N GS P+T ++ L+ LNL N L
Sbjct: 412 YLNLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGT 471
Query: 328 IPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLT 387
+P L+++ ++++ N G IP +G + IN L L+ N G+I L + +L
Sbjct: 472 LPAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLA 531
Query: 388 SFNVSYNNLSGSVPPLLS-KKFNSSSFVGNLQLCG 421
+ N+S+NNLSG +PP+ + +F+ +SF GN LCG
Sbjct: 532 NLNISFNNLSGIIPPMKNFTRFSPASFFGNPFLCG 566
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9SCT4 | IMK2_ARATH | No assigned EC number | 0.6865 | 0.9780 | 0.9043 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00161196 | hypothetical protein (826 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 773 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-79 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-61 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-39 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-20 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-17 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-15 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-15 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 8e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-09 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 5e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-06 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 9e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 8e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.003 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.003 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 274 bits (701), Expect = 2e-79
Identities = 204/671 (30%), Positives = 325/671 (48%), Gaps = 73/671 (10%)
Query: 92 QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRL 151
++I++ L L G I E + QL L L L N G +P +L LP L+ + L++N+
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344
Query: 152 SGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLP 211
SG IP ++G NL LDLS N L G IP L +S L++L L NSL G IP SL
Sbjct: 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR 404
Query: 212 SLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISL 271
SL + LQ N+ SG +P+ + K + FL++ +N + G I + LQ +SL
Sbjct: 405 SLRRVRLQDNSFSGELPSEF-----TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL 459
Query: 272 SHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG 331
+ NK G +PD G +L+ LDLS N G+ P +++ L+ L L N+L +IP+
Sbjct: 460 ARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDE 518
Query: 332 LERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNV 391
L + L L+L +NQ G IP + + ++QLDLS+N +GEI +L ++ +L N+
Sbjct: 519 LSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578
Query: 392 SYNNLSGSVPPLLS-KKFNSSSFVGNLQLCGYSPSTACPSLAPLSLPPPPVEAPKHHHHR 450
S+N+L GS+P + N+S+ GN+ LCG ++ LPP R
Sbjct: 579 SHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG--------LPPC---------KR 621
Query: 451 KLSTKDIILIGVGALLAVLLILCCILLFCLMRKRSASKEKNGKSTAQKVVERAAPKAGTE 510
T L A L++ F +R R+ + ++R + GT
Sbjct: 622 VRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLE-----------LKRVENEDGT- 669
Query: 511 VESGGEMGGKLVHFDGPFL--FTADDLLCATAE--IMGKSTYGTAYKA-TLEDGSEVAVK 565
+L FD T +D+L + E ++ + G +YK ++++G + VK
Sbjct: 670 --------WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVK 721
Query: 566 RLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHA 625
+ +E A +GK+ HPN++ L KG L+ +++ +L+ L
Sbjct: 722 ----EINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKG-AYLIHEYIEGKNLSEVLRN 776
Query: 626 RGPETIVNWATRMSIAIGIARGLNYLHV--EENMIHGNLTSSNVLLDEKTNPRIADFGLS 683
++W R IAIGIA+ L +LH ++ GNL+ +++D K P + L
Sbjct: 777 ------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829
Query: 684 RLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743
+ I++A Y APE + K+ K+D+Y G+I++ELLTGKSP + G+
Sbjct: 830 -GLLCTDTKCFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV 884
Query: 744 DLPQWVASIVK 754
SIV+
Sbjct: 885 H-----GSIVE 890
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 223 bits (569), Expect = 2e-61
Identities = 141/376 (37%), Positives = 195/376 (51%), Gaps = 32/376 (8%)
Query: 54 LRAIKHDLIDPHGFLRSWNDSGVGACSGGWAGIKCVK-GQVIAIQLPWRRLGGRISEKIS 112
L + K + DP +L +WN S C W GI C +V++I L + + G+IS I
Sbjct: 34 LLSFKSSINDPLKYLSNWNSS-ADVCL--WQGITCNNSSRVVSIDLSGKNISGKISSAIF 90
Query: 113 QLHALRKLSLHDNLLAGPVPWSL-----------------------GFLPNLRGVYLFNN 149
+L ++ ++L +N L+GP+P + G +PNL + L NN
Sbjct: 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNN 150
Query: 150 RLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTR 209
LSG IP IG+ +L+ LDL N L+G IP SL N T L L L+ N L+G IP L +
Sbjct: 151 MLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ 210
Query: 210 LPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEI 269
+ SL + L +NNLSG +P G L L L+L +N + G IP SLG L LQ +
Sbjct: 211 MKSLKWIYLGYNNLSGEIPYEIGGLT-----SLNHLDLVYNNLTGPIPSSLGNLKNLQYL 265
Query: 270 SLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIP 329
L NK+ GPIP + L KL LDLS N++ G P + +L L+L +N KIP
Sbjct: 266 FLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325
Query: 330 EGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSF 389
L L L VL L +N+F G IP+ +G + + LDLS N+ TGEI L S NL
Sbjct: 326 VALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL 385
Query: 390 NVSYNNLSGSVPPLLS 405
+ N+L G +P L
Sbjct: 386 ILFSNSLEGEIPKSLG 401
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 7e-40
Identities = 60/191 (31%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKE-FEAEAAAIGKIHHPNLLALRAYYL 601
G+ +GT Y A + G +VA+K ++++ + E E + K++HPN++ L +
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE 61
Query: 602 GPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGN 661
LV ++ GSL L + ++ + I + I GL YLH +IH +
Sbjct: 62 DEN-HLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLH-SNGIIHRD 117
Query: 662 LTSSNVLLDEKT-NPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKLKNANTKTD 719
L N+LLD ++ADFGLS+L+T+ + GT Y APE L + K+D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 720 VYSLGVIILEL 730
++SLGVI+ EL
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 66/223 (29%), Positives = 113/223 (50%), Gaps = 17/223 (7%)
Query: 541 EIMGKSTYGTAYKATLEDGS----EVAVKRLREKTTKGQ-KEFEAEAAAIGKIHHPNLLA 595
+ +G+ +G YK L+ EVAVK L+E ++ + K+F EA + K+ HPN++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPE------TIVNWATRMSIAIGIARGLN 649
L + LV ++M G L +L P + ++ +S AI IA+G+
Sbjct: 61 LLGVCTE-EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 650 YLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APE 707
YL + +H +L + N L+ E +I+DFGLSR + + T G L R APE
Sbjct: 120 YLA-SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV-YDDDYYRKKTGGKLPIRWMAPE 177
Query: 708 LSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
K +K+DV+S GV++ E+ T G +P ++ ++ +++
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL 220
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 6e-39
Identities = 74/202 (36%), Positives = 107/202 (52%), Gaps = 14/202 (6%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEA--EAAAIGKIHHPNLLALR 597
+G ++GT YKA G VAVK L++++ K +K+ A E + ++ HPN++ L
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
+ K LV ++ G L +L GP ++ IA+ I RGL YLH +
Sbjct: 65 DAF-EDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLH-SNGI 119
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT--AGTLGYRAPELSKLKN-A 714
IH +L N+LLDE +IADFGL++ + ++ T GT Y APE+ N
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLL---KSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 715 NTKTDVYSLGVIILELLTGKSP 736
K DV+SLGVI+ ELLTGK P
Sbjct: 177 GPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 65/201 (32%), Positives = 97/201 (48%), Gaps = 15/201 (7%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
E +G+ ++G Y A + G VA+K ++ +K K ++ E + K+ HPN++ L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVEE 655
+ KL LV ++ G L L RG E I L YLH +
Sbjct: 65 VFEDED--KLYLVMEYCEGGDLFDLLKKRGRLSEDEAR-----FYLRQILSALEYLH-SK 116
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNAN 715
++H +L N+LLDE + ++ADFGL+R + GT Y APE+ K
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKGYG 174
Query: 716 TKTDVYSLGVIILELLTGKSP 736
D++SLGVI+ ELLTGK P
Sbjct: 175 KAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 7e-38
Identities = 70/220 (31%), Positives = 115/220 (52%), Gaps = 14/220 (6%)
Query: 541 EIMGKSTYGTAYKATLEDGS-----EVAVKRLRE-KTTKGQKEFEAEAAAIGKIHHPNLL 594
+ +G+ +G YK TL+ EVAVK L+E + + +EF EA + K+ HPN++
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 595 ALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
L ++V ++MP G L +L P+ + + + +S A+ IARG+ YL
Sbjct: 65 KLLGVCTEE-EPLMIVMEYMPGGDLLDYLRKNRPKEL-SLSDLLSFALQIARGMEYLE-S 121
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLK 712
+N IH +L + N L+ E +I+DFGLSR + V G L R APE K
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV--KGGKLPIRWMAPESLKEG 179
Query: 713 NANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWVAS 751
+K+DV+S GV++ E+ T G+ P M+ ++ +++
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK 219
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 7e-38
Identities = 68/218 (31%), Positives = 112/218 (51%), Gaps = 15/218 (6%)
Query: 541 EIMGKSTYGTAYKATLEDGS-----EVAVKRLRE-KTTKGQKEFEAEAAAIGKIHHPNLL 594
+ +G+ +G YK L+ EVAVK L+E + + +EF EA + K+ HPN++
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 595 ALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
L +V ++M G L S+L P+ ++ + +S A+ IARG+ YL
Sbjct: 65 KLLGVCTEE-EPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE-S 120
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLK 712
+N IH +L + N L+ E +I+DFGLSR + G L R APE K
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK--RGGKLPIRWMAPESLKEG 178
Query: 713 NANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
+K+DV+S GV++ E+ T G+ P M+ ++ +++
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL 216
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 7e-37
Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 18/220 (8%)
Query: 541 EIMGKSTYGTAYKATLEDGSE-----VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLL 594
+ +G+ +G YK TL+ E VAVK L+E ++ ++ EF EA+ + K+ HPN++
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 595 ALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
L +V ++MP G L FL G + + + +A+ IA+G+ YL
Sbjct: 65 RLLGVCTQ-GEPLYIVTEYMPGGDLLDFLRKHGEK--LTLKDLLQMALQIAKGMEYLE-S 120
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLK 712
+N +H +L + N L+ E +I+DFGLSR + G L + APE LK
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRK-RGGGKLPIKWMAPES--LK 177
Query: 713 NA--NTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
+ +K+DV+S GV++ E+ T G+ P M+ ++ + +
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL 217
|
Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 5e-31
Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLA-LRAYYL 601
GK +G YKA G EVA+K ++ ++ + +++ E + K HPN++ +Y
Sbjct: 9 GKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL- 67
Query: 602 GPKGEKLLVFDFMPKGSLASFLHARG---PETIVNWATRMSIAIGIARGLNYLHVEENMI 658
K E +V +F GSL L + E+ + A + + +GL YLH +I
Sbjct: 68 -KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQI--AY---VCKELLKGLEYLH-SNGII 120
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKT 718
H ++ ++N+LL ++ DFGLS ++ N + GT + APE+ K + K
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYDYKA 178
Query: 719 DVYSLGVIILELLTGKSP 736
D++SLG+ +EL GK P
Sbjct: 179 DIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 21/207 (10%)
Query: 541 EIMGKSTYGTAYKATLED-GSEVAVK--RLREKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
E++G+ ++G+ Y A +D G +AVK L + + + E E + + HPN++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR-- 63
Query: 598 AYYLG----PKGEKLLVF-DFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNY 650
Y G + L +F +++ GSL+S L G PE ++ TR I GL Y
Sbjct: 64 --YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ-----ILEGLAY 116
Query: 651 LHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELS 709
LH ++H ++ +N+L+D ++ADFG ++ + + GT + APE+
Sbjct: 117 LH-SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSP 736
+ + D++SLG ++E+ TGK P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 64/221 (28%), Positives = 111/221 (50%), Gaps = 23/221 (10%)
Query: 542 IMGKSTYGTAYKAT-LEDGS----EVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLA 595
++G +GT YK + +G VA+K LRE+T+ K KE EA + + HP+++
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLH----ARGPETIVNWATRMSIAIGIARGLNYL 651
L L + L+ MP G L ++ G + ++NW + IA+G++YL
Sbjct: 74 LLGICLSSQ--VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYL 125
Query: 652 HVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELS 709
E+ ++H +L + NVL+ + +I DFGL++L+ A G + + A E
Sbjct: 126 E-EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK-EYHAEGGKVPIKWMALESI 183
Query: 710 KLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
+ K+DV+S GV + EL+T G P E + +++P +
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 8e-27
Identities = 55/206 (26%), Positives = 98/206 (47%), Gaps = 25/206 (12%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKR--LREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
GK ++G Y DG +K L + K +++ E + K++HPN++ +
Sbjct: 9 GKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESF 68
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGP-------ETIVNWATRMSIAIGIARGLNYLHV 653
KG+ +V ++ G L+ + + E I++W ++ +A L YLH
Sbjct: 69 EE-KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA------LKYLH- 120
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM---TAAANTNVIATAGTLGYRAPELSK 710
++H ++ N+ L ++ DFG+S+++ A T V GT Y +PEL +
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV----GTPYYLSPELCQ 176
Query: 711 LKNANTKTDVYSLGVIILELLTGKSP 736
K N K+D++SLG ++ EL T K P
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-26
Identities = 75/220 (34%), Positives = 115/220 (52%), Gaps = 6/220 (2%)
Query: 88 CVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLF 147
C G + + L L G I + + +LR++ L DN +G +P LP + + +
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 148 NNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSL 207
NN L G I + P+LQ L L+ N G +P S S RL L+LS N G++P L
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG-SKRLENLDLSRNQFSGAVPRKL 495
Query: 208 TRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQ 267
L L L L N LSG +P+ L+ K +L L+L HN ++G IP S ++ +L
Sbjct: 496 GSLSELMQLKLSENKLSGEIPDE---LSSCK--KLVSLDLSHNQLSGQIPASFSEMPVLS 550
Query: 268 EISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVT 307
++ LS N++ G IP LG + L ++++S+N + GS P T
Sbjct: 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 19/221 (8%)
Query: 544 GKSTYGTAYKATL-EDGSEVAVKRLREK-TTKGQKEFEAEAAAIGKIHHPNLLALR-AYY 600
G+ + G YK G A+K++ + +K+ E + P ++ A+Y
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVEENMI 658
+GE +V ++M GSLA L G PE ++ IA I +GL+YLH + ++I
Sbjct: 70 --KEGEISIVLEYMDGGSLADLLKKVGKIPEPVL-----AYIARQILKGLDYLHTKRHII 122
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAA---ANTNVIATAGTLGYRAPELSKLKNAN 715
H ++ SN+L++ K +IADFG+S+++ NT V GT+ Y +PE + ++ +
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV----GTVTYMSPERIQGESYS 178
Query: 716 TKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756
D++SLG+ +LE GK P P + + +I
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP 219
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 61/197 (30%), Positives = 107/197 (54%), Gaps = 10/197 (5%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
+GK +G G +VAVK L++ +T Q F AEA+ + + HPNL+ L
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVV 69
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHG 660
L +V ++M KGSL +L +RG ++ A ++ A+ + G+ YL E+N +H
Sbjct: 70 LQGNP-LYIVTEYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLE-EKNFVHR 126
Query: 661 NLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDV 720
+L + NVL+ E +++DFGL++ A+ + + + APE + K +TK+DV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182
Query: 721 YSLGVIILELLT-GKSP 736
+S G+++ E+ + G+ P
Sbjct: 183 WSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 107 bits (266), Expect = 7e-25
Identities = 67/234 (28%), Positives = 110/234 (47%), Gaps = 17/234 (7%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKE---FEAEAAAIGKI-HHPNLLAL 596
+G+ ++G Y A D VA+K L +K KE F E + + H PN++ L
Sbjct: 6 RKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 597 RAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
++ G LV +++ GSL L G + ++ + + I I L YLH +
Sbjct: 64 YDFFQDE-GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH-SKG 121
Query: 657 MIHGNLTSSNVLLDEKTN-PRIADFGLSRLMTAAANTNVIATA-----GTLGYRAPELSK 710
+IH ++ N+LLD ++ DFGL++L+ +T+ I GT GY APE+
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 711 LKN---ANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEV 761
+ A++ +D++SLG+ + ELLTG P E I+ E T +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
|
Length = 384 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 73/213 (34%), Positives = 110/213 (51%), Gaps = 21/213 (9%)
Query: 543 MGKSTYGTAYKATLED-GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYL 601
+G YG Y+ + VAVK L+E T + +EF EAA + +I HPNL+ L L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQL----L 68
Query: 602 GPKGEK---LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
G + ++ +FM G+L +L + VN + +A I+ + YL ++N I
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLE-KKNFI 126
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT---LGYRAPELSKLKNAN 715
H +L + N L+ E ++ADFGLSRLMT T A AG + + APE +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT---AHAGAKFPIKWTAPESLAYNKFS 183
Query: 716 TKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQ 747
K+DV++ GV++ E+ T G S P G+DL Q
Sbjct: 184 IKSDVWAFGVLLWEIATYGMS---PYPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 35/212 (16%)
Query: 541 EIMGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEAEAAAIG---------KIHH 590
+G+ TYG YKA + G VA+K++R + E E I K+ H
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMEN-------EKEGFPITAIREIKLLQKLRH 57
Query: 591 PNLLALRAYYLGP-KGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLN 649
PN++ L+ KG +VF++M L L + PE + + GL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQ 114
Query: 650 YLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMT---AAANTN-VIATAGTLGYRA 705
YLH ++H ++ SN+L++ ++ADFGL+R T +A TN VI TL YR
Sbjct: 115 YLH-SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI----TLWYRP 169
Query: 706 PELSKL---KNANTKTDVYSLGVIILELLTGK 734
PEL L + D++S+G I+ EL GK
Sbjct: 170 PEL--LLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-23
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 17/209 (8%)
Query: 541 EIMGKSTYGTAYKATLEDGSEV-AVKR--LREKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
+GK ++G +K + V A+K+ L + + ++E EA + K+ ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHA-RG---PETIVNWATRMSIAIGIARGLNYLHV 653
+L KG+ +V ++ G L L RG PE V W I I GL +LH
Sbjct: 66 ESFL-DKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV-W----RFFIQILLGLAHLH- 118
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELSKLK 712
+ ++H ++ S N+ LD N +I D G+++L++ NTN T GT Y +PEL + K
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYLSPELCEDK 176
Query: 713 NANTKTDVYSLGVIILELLTGKSPGEPMN 741
N K+DV++LGV++ E TGK P + N
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANN 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-22
Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 6/197 (3%)
Query: 543 MGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602
+G +G + + +VA+K +RE +++F EA + K+ HP L+ L
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCT- 69
Query: 603 PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNL 662
+ LVF+FM G L+ +L R + T + + + + G+ YL N+IH +L
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLE-SSNVIHRDL 126
Query: 663 TSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYS 722
+ N L+ E +++DFG++R + T+ T + + +PE+ ++K+DV+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 723 LGVIILELLT-GKSPGE 738
GV++ E+ + GK+P E
Sbjct: 187 FGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 62/206 (30%), Positives = 115/206 (55%), Gaps = 17/206 (8%)
Query: 543 MGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602
+G +G ++ ++ VA+K L+ Q++F+ E A+ ++ H +L++L A +
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFA--VC 71
Query: 603 PKGEKL-LVFDFMPKGSLASFLHARGPE-TIVNWATRMSIAIGIARGLNYLHVEENMIHG 660
GE + ++ + M KGSL +FL R PE ++ A+ + +A +A G+ YL E+N IH
Sbjct: 72 SVGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLE-EQNSIHR 128
Query: 661 NLTSSNVLLDEKTNPRIADFGLSRLMT----AAANTNVIATAGTLGYRAPELSKLKNANT 716
+L + N+L+ E ++ADFGL+RL+ +++ + + APE + +T
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-----PYKWTAPEAASHGTFST 183
Query: 717 KTDVYSLGVIILELLT-GKSPGEPMN 741
K+DV+S G+++ E+ T G+ P MN
Sbjct: 184 KSDVWSFGILLYEMFTYGQVPYPGMN 209
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 4e-22
Identities = 60/213 (28%), Positives = 110/213 (51%), Gaps = 20/213 (9%)
Query: 541 EIMGKSTYGTAYKA-TLEDGSEVAVKRLR-EKTTKGQ-KEFEAEAAAIGKIHHPNLLALR 597
+++G+ +G YK LE G VA+K++ EK + K E + + HPN++
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 598 AYYLGPKGEKLLVF-DFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVE 654
+ L + ++ GSL + G PE++V A + + +GL YLH E
Sbjct: 66 GSI--ETSDSLYIILEYAENGSLRQIIKKFGPFPESLV--AVYVY---QVLQGLAYLH-E 117
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLS-RLMTAAANTNVIATAGTLGYRAPELSKLKN 713
+ +IH ++ ++N+L + ++ADFG++ +L + + + GT + APE+ ++
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV--GTPYWMAPEVIEMSG 175
Query: 714 ANTKTDVYSLGVIILELLTGKSP---GEPMNGM 743
A+T +D++SLG ++ELLTG P PM +
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL 208
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 7/209 (3%)
Query: 543 MGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602
+G +G ++ + + VAVK L+ T K+F AEA + K+ HP L+ L Y +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQL--YAVC 70
Query: 603 PKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGN 661
E + +V + M GSL +L + + +A +A G+ YL +N IH +
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLIDMAAQVASGMAYLE-AQNYIHRD 128
Query: 662 LTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVY 721
L + NVL+ E ++ADFGL+R++ + + APE + + K+DV+
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 722 SLGVIILELLT-GKSPGEPMNGMDLPQWV 749
S G+++ E++T G+ P M ++ Q V
Sbjct: 189 SFGILLTEIVTYGRMPYPGMTNAEVLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 7e-22
Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 13/205 (6%)
Query: 543 MGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602
+G +G + T ++VAVK L+ T + F EA + K+ H L+ L Y +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQL--YAVC 70
Query: 603 PKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGN 661
+ E + +V ++M KGSL FL + G + + +A IA G+ YL N IH +
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKS-GEGKKLRLPQLVDMAAQIAEGMAYLE-SRNYIHRD 128
Query: 662 LTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT---LGYRAPELSKLKNANTKT 718
L + N+L+ E +IADFGL+RL+ + A G + + APE + K+
Sbjct: 129 LAARNILVGENLVCKIADFGLARLI---EDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 719 DVYSLGVIILELLT-GKSPGEPMNG 742
DV+S G+++ E++T G+ P M
Sbjct: 186 DVWSFGILLTEIVTYGRVPYPGMTN 210
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (239), Expect = 1e-21
Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 26/206 (12%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFEA----EAAAIGKIHHPNLL 594
E +G+ TYG YKA + G VA+K++R + +G + E + + ++ HPN++
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG---IPSTALREISLLKELKHPNIV 61
Query: 595 ALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
L + KL LVF++ L +L R ++ SI + RGL Y H
Sbjct: 62 KLLDVIHTER--KLYLVFEYCDM-DLKKYLDKRPGP--LSPNLIKSIMYQLLRGLAYCH- 115
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA--ANTNVIATAGTLGYRAPELSKL 711
++H +L N+L++ ++ADFGL+R T+ + TL YRAPE+ L
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV---TLWYRAPEI--L 170
Query: 712 ---KNANTKTDVYSLGVIILELLTGK 734
K+ +T D++S+G I E++TGK
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 56/239 (23%), Positives = 108/239 (45%), Gaps = 19/239 (7%)
Query: 543 MGKSTYGTAYKATLE-----DGSEVAVKRLREKTTKGQ-KEFEAEAAAIGKIHHPNLLAL 596
+G+ +G + G +VAVK L + +FE E + + H N++
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 597 RAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
+ P G L L+ +++P GSL +L + +N + + I +G++YL +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG-SQ 128
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLKN 713
IH +L + N+L++ + +I+DFGL++++ + + G APE +
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK 188
Query: 714 ANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWVASIVKEEWTNEVFDL-ELMRDN 770
++ +DV+S GV + EL T G P +++ I + V L EL+++
Sbjct: 189 FSSASDVWSFGVTLYELFTYGDPSQSPP-----AEFLRMIGIAQGQMIVTRLLELLKEG 242
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 63/235 (26%), Positives = 117/235 (49%), Gaps = 26/235 (11%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
+ +GK +G G++VAVK ++ T + F AEA+ + ++ H NL+ L
Sbjct: 12 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHG 660
+ KG +V ++M KGSL +L +RG +++ + ++ + + YL N +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE-ANNFVHR 126
Query: 661 NLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDV 720
+L + NVL+ E +++DFGL++ ++ +T + T APE + K +TK+DV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDV 182
Query: 721 YSLGVIILELLT-GKSP---------------GEPMNGMD-LPQWVASIVKEEWT 758
+S G+++ E+ + G+ P G M+ D P V ++K+ W
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWH 237
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 24/208 (11%)
Query: 541 EIMGKSTYGTAYKA-TLEDGSEVAVKR----LREKTTKGQ-KEFEAEAAAIGKIHHPNLL 594
E++G ++G+ Y+ L+DG AVK +T + K+ E E A + K+ HPN++
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 595 ALRAYYLGPK--GEKLLVF-DFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLN 649
YLG + + L +F + +P GSLA L G PE ++ TR I GL
Sbjct: 66 Q----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ-----ILLGLE 116
Query: 650 YLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELS 709
YLH + N +H ++ +N+L+D ++ADFG+++ + + + G+ + APE+
Sbjct: 117 YLH-DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK--SFKGSPYWMAPEVI 173
Query: 710 KLKNA-NTKTDVYSLGVIILELLTGKSP 736
+ D++SLG +LE+ TGK P
Sbjct: 174 AQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 543 MGKSTYGTAYKAT-LEDGSEVAVKR--LREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+G+ +G +KA E G VA+K+ LR + E A+ HP ++ L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARG---PETIVNWATRMSIAIGIARGLNYLHVEE 655
+ P G LV ++MP L+ L PE V RM + +G+ Y+H
Sbjct: 68 F--PHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRM-----LLKGVAYMH-AN 118
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNAN 715
++H +L +N+L+ +IADFGL+RL + T YRAPEL L A
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL--LYGAR 176
Query: 716 TKT---DVYSLGVIILELLTGKS--PGE 738
D++++G I ELL G PGE
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGSPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 8e-21
Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKE-FEAEAAAIGKIHHPNLLALRAY 599
E +GK +G YK L+ +EVAVK R K F EA + + HPN++ L
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL--- 57
Query: 600 YLGPKGEK---LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
+G +K +V + +P GSL +FL + V +MS + A G+ YL +N
Sbjct: 58 -IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMS--LDAAAGMEYLE-SKN 113
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSR-----LMTAAANTNVIATAGTLGYRAPELSKL 711
IH +L + N L+ E +I+DFG+SR + T + I T APE
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT----APEALNY 169
Query: 712 KNANTKTDVYSLGVIILELLT-GKSPGEPMN 741
+++DV+S G+++ E + G +P M+
Sbjct: 170 GRYTSESDVWSYGILLWETFSLGDTPYPGMS 200
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 68/239 (28%), Positives = 110/239 (46%), Gaps = 29/239 (12%)
Query: 543 MGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFEAEAAAIGKIHHPNLLAL-RAY 599
+G G K G +AVK +R E QK+ E + K + P ++ A+
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 600 YLGPKGEKLLVFDFMPKGSLASFL---HARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
Y G+ + ++M GSL L R PE I+ IA+ + +GL YLH +
Sbjct: 69 YN--NGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKHK 121
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA-AANTNVIATAGTLGYRAPELSKLKNAN 715
+IH ++ SN+L++ + ++ DFG+S + A T V GT Y APE + + +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV----GTSSYMAPERIQGNDYS 177
Query: 716 TKTDVYSLGVIILELLTGKSP-----GEPMNGMDLPQWVASIVKEE---WTNEVFDLEL 766
K+D++SLG+ ++EL TG+ P P +L Q IV E + F +
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ---YIVNEPPPRLPSGKFSPDF 233
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 20/213 (9%)
Query: 543 MGKSTYGTAYKAT--LEDGSE--VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLALR 597
+G +G+ K ++ G E VAVK L+++ K EF EA+ + ++ HP ++ L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGP---ETIVNWATRMSIAIGIARGLNYLHVE 654
G +LV + P G L +L R + A + +A G+ YL
Sbjct: 63 GVCKGEP--LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLE-S 113
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT--LGYRAPELSKLK 712
++ +H +L + NVLL + +I+DFG+SR + A ++ TAG L + APE
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 713 NANTKTDVYSLGVIILELLT-GKSPGEPMNGMD 744
++K+DV+S GV + E + G P M G +
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE 206
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 59/197 (29%), Positives = 107/197 (54%), Gaps = 12/197 (6%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
EI+G+ +G + G +VAVK ++ T + F E A + K+HH NL+ L
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHG 660
L +V + M KG+L +FL RG +V+ + ++ +A G+ YL + ++H
Sbjct: 69 L--HNGLYIVMELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLE-SKKLVHR 124
Query: 661 NLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDV 720
+L + N+L+ E +++DFGL+R+ + + + + T APE K K ++K+DV
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSDV 180
Query: 721 YSLGVIILELLT-GKSP 736
+S GV++ E+ + G++P
Sbjct: 181 WSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 57/214 (26%), Positives = 109/214 (50%), Gaps = 17/214 (7%)
Query: 541 EIMGKSTYGTAYKATLEDGSE----VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLA 595
+++G +G + L+ + VA+K L+ ++ Q+ +F EA+ +G+ HPN++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 596 LRAYYLGPKGEKLL-VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
L K ++ + ++M GSL FL R + + + GIA G+ YL E
Sbjct: 70 LEGVVT--KSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYLS-E 124
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAG---TLGYRAPELSKL 711
N +H +L + N+L++ +++DFGLSR + + T T G + + APE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT--YTTKGGKIPIRWTAPEAIAY 182
Query: 712 KNANTKTDVYSLGVIILELLT-GKSPGEPMNGMD 744
+ + +DV+S G+++ E+++ G+ P M+ D
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD 216
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 71/259 (27%), Positives = 116/259 (44%), Gaps = 48/259 (18%)
Query: 541 EIMGKSTYGTAYKATL------EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNL 593
E +G+ +G YK L + VA+K L+E K Q+EF EA + + HPN+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 594 LALRAYYLG--PKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATR------------- 637
+ L LG K + ++F+++ G L FL P + V +
Sbjct: 71 VCL----LGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 638 MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697
+ IAI IA G+ YL + +H +L + N L+ E +I+DFGLSR + +A V +
Sbjct: 127 LHIAIQIAAGMEYLS-SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 698 AGTLGYR--APELSKLKNANTKTDVYSLGVIILELLT-------GKSPGEPMNGM----- 743
+ L R PE T++D++S GV++ E+ + G S E + +
Sbjct: 186 S-LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL 244
Query: 744 -----DLPQWVASIVKEEW 757
D P V +++ E W
Sbjct: 245 LPCPEDCPARVYALMIECW 263
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 8e-20
Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 12/214 (5%)
Query: 541 EIMGKSTYGTAYKATL--EDGSEV--AVKRLREKTTKGQ-KEFEAEAAAIGKIHHPNLLA 595
++GK +G Y TL DG ++ AVK L T + ++F E + HPN+L+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
L L +G L+V +M G L +F+ R + + +A+G+ YL +
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFI--RSETHNPTVKDLIGFGLQVAKGMEYL-ASK 117
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT---LGYRAPELSKLK 712
+H +L + N +LDE ++ADFGL+R + +V G + + A E + +
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 713 NANTKTDVYSLGVIILELLT-GKSPGEPMNGMDL 745
TK+DV+S GV++ EL+T G P ++ D+
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI 211
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-19
Identities = 60/197 (30%), Positives = 86/197 (43%), Gaps = 37/197 (18%)
Query: 317 LNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEI 376
L L+N L IP + +L++L +NL N +G+IP ++G+I+ + LDLS N F G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 377 SPSLASLANLTSFNVSYNNLSGSVP------PLLSKKFNSSSFVGNLQLCGYSPSTACPS 430
SL L +L N++ N+LSG VP L FN F N LCG AC
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN---FTDNAGLCGIPGLRACGP 539
Query: 431 LAPLSLPPPPVEAPKHHHHRKLSTKDIILIGVGALLAVLLILCCILLFCLMRKRSASKEK 490
H + K I I G +A L ++ C + + K +
Sbjct: 540 ------------------HLSVGAK--IGIAFGVSVAFLFLVICAMCWW--------KRR 571
Query: 491 NGKSTAQKVVERAAPKA 507
AQ++ R AP A
Sbjct: 572 QNILRAQRIAAREAPYA 588
|
Length = 623 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 544 GKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEAAAIGKIHHPNLLALRAY 599
GK ++G +D ++ A+K L++K +KE E E + +I+HP ++ L
Sbjct: 2 GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA 61
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARGP---ETIVNWATRMSIAIGIARGLNYLHVEE 655
+ EKL LV ++ P G L S L G E +A + +A+ YLH
Sbjct: 62 FQTE--EKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALE------YLH-SL 112
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSR-LMTAAANTNVIATAGTLGYRAPELSKLKNA 714
+I+ +L N+LLD + ++ DFGL++ L + + TN GT Y APE+ K
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC--GTPEYLAPEVLLGKGY 170
Query: 715 NTKTDVYSLGVIILELLTGKSP 736
D +SLGV++ E+LTGK P
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 4e-19
Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 22/214 (10%)
Query: 541 EIMGKSTYGTAYKATLEDGSE-----VAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLL 594
+++G +GT YK E VA+K L E T K EF EA + + HP+L+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 595 ALRAYYLGPKGEKLLVFDFMPKGSLASFLHAR----GPETIVNWATRMSIAIGIARGLNY 650
L L P + LV MP G L ++H G + ++NW + IA+G+ Y
Sbjct: 73 RLLGVCLSPTIQ--LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMY 124
Query: 651 LHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA-AANTNVIATAGTLGYRAPELS 709
L E ++H +L + NVL+ + +I DFGL+RL+ N + + A E
Sbjct: 125 LE-ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743
+ ++DV+S GV I EL+T G+P +G+
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT--FGGKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 31/216 (14%)
Query: 541 EIMGKSTYGTAYKA-TLEDGSEVAVKRLR-EKTTKGQ---------KEFEAEAAAIGKIH 589
E++GK TYG Y A + G +AVK++ T G+ K +E + +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 590 HPNLLALRAYYLG--PKGEKLLVF-DFMPKGSLASFL--HARGPETIVNWATRMSIAIGI 644
H N++ YLG E L +F +++P GS+ S L + R E +V + T +
Sbjct: 67 HLNIVQ----YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ-----V 117
Query: 645 ARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA--GTLG 702
GL YLH + ++H +L + N+L+D +I+DFG+S+ + N + G++
Sbjct: 118 LEGLAYLH-SKGILHRDLKADNLLVDADGICKISDFGISK-KSDDIYDNDQNMSMQGSVF 175
Query: 703 YRAPEL--SKLKNANTKTDVYSLGVIILELLTGKSP 736
+ APE+ S + + K D++SLG ++LE+ G+ P
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 19/206 (9%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKE---FEA--EAAAIGKIHHPNLLALR 597
G+ TY YKA E G VA+K+++ K K+ F A E + ++ HPN++ L
Sbjct: 9 GEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLL 68
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
+ G K LVF+FM L + + ++ A S + RGL YLH +
Sbjct: 69 DVF-GHKSNINLVFEFME-TDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLH-SNWI 123
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTK 717
+H +L +N+L+ ++ADFGL+R + N + T YRAPEL L A
Sbjct: 124 LHRDLKPNNLLIASDGVLKLADFGLAR-SFGSPNRKMTHQVVTRWYRAPEL--LFGARHY 180
Query: 718 T---DVYSLGVIILELLTGKS--PGE 738
D++S+G I ELL PG+
Sbjct: 181 GVGVDMWSVGCIFAELLLRVPFLPGD 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 544 GKSTYGTAYKA-TLEDGSEVAVK--RLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
G T+G Y A L+ G +AVK R+++ K KE E + + HPNL+ + Y
Sbjct: 9 GGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV--KYYG 66
Query: 601 LGPKGEKLLVF-DFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVEENM 657
+ EK+ +F ++ G+L L E ++ + + GL YLH +
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI-----RVYTLQLLEGLAYLH-SHGI 120
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLM---TAAANTNVIATAGTLGYRAPEL---SKL 711
+H ++ +N+ LD ++ DFG + + T V + AGT Y APE+ K
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 712 KNANTKTDVYSLGVIILELLTGKSP 736
K D++SLG ++LE+ TGK P
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 64/235 (27%), Positives = 98/235 (41%), Gaps = 53/235 (22%)
Query: 543 MGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEAEAAAIG--------------- 586
+G+ TYG KA G VA+K++ K + + + +G
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKV--KIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 587 -KIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMS------ 639
+I H N++ L Y+ LV D M L +V+ R++
Sbjct: 75 NEIKHENIMGLVDVYV-EGDFINLVMDIM-ASDLKK---------VVDRKIRLTESQVKC 123
Query: 640 IAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSR-------------LM 686
I + I GLN LH + +H +L+ +N+ ++ K +IADFGL+R
Sbjct: 124 ILLQILNGLNVLH-KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 687 TAAANTNVIATAGTLGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKS--PGE 738
T + + TL YRAPEL + D++S+G I ELLTGK PGE
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237
|
Length = 335 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 68/218 (31%), Positives = 105/218 (48%), Gaps = 27/218 (12%)
Query: 542 IMGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
++GK TYG Y A L +A+K + E+ ++ + E A + H N++ Y
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ----Y 70
Query: 601 LGPKGEKLLVFDFM---PKGSLASFLHAR-GP----ETIVNWATRMSIAIGIARGLNYLH 652
LG E FM P GSL++ L ++ GP E + + T+ I GL YLH
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-----ILEGLKYLH 125
Query: 653 VEENMIHGNLTSSNVLLDEKTNP-RIADFGLSRLMTAAANTNVIATAGTLGYRAPEL--S 709
+ ++H ++ NVL++ + +I+DFG S+ + A N GTL Y APE+
Sbjct: 126 -DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVIDK 183
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSP----GEPMNGM 743
+ D++SLG I+E+ TGK P GEP M
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 61/222 (27%), Positives = 111/222 (50%), Gaps = 30/222 (13%)
Query: 542 IMGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKE---------FEAEAAAIGKIHHP 591
++G ++G+ Y G +AVK++ + + E A + ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 592 NLLALRAYYLGPK--GEKLLVF-DFMPKGSLASFLHARG--PETIVNWATRMSIAIGIAR 646
N++ YLG + L +F +++P GS+A+ L+ G ET+V R I +
Sbjct: 67 NIVQ----YLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ-----ILK 117
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSR-----LMTAAANTNVIATAGTL 701
GLNYLH +IH ++ +N+L+D K +I+DFG+S+ ++ N + G++
Sbjct: 118 GLNYLH-NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 702 GYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743
+ APE+ K + K D++SLG +++E+LTGK P +
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 64/214 (29%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
E +G+ +YG+ YKA E G VA+K + + +E E + + + P ++
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAI---GIARGLNYLHVEE 655
Y K L +V ++ GS++ + +T+ T IA +GL YLH
Sbjct: 67 YF--KNTDLWIVMEYCGAGSVSDIMKITN-KTL----TEEEIAAILYQTLKGLEYLH-SN 118
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMT---AAANTNVIATAGTLGYRAPELSKLK 712
IH ++ + N+LL+E+ ++ADFG+S +T A NT VI GT + APE+ +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VI---GTPFWMAPEVIQEI 174
Query: 713 NANTKTDVYSLGVIILELLTGKSPG---EPMNGM 743
N K D++SLG+ +E+ GK P PM +
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 541 EIMGKSTYGTAYKATLEDGSE-VAVKRLR-EKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
E++G Y A +E VA+KR+ EK E E A+ + +HPN++ +
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV--KY 64
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
Y G++L LV ++ GSL + + P ++ A ++ + +GL YLH
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH-SNGQ 123
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT-------AGTLGYRAPE-LS 709
IH ++ + N+LL E + +IADFG+S A+ T GT + APE +
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVS----ASLADGGDRTRKVRKTFVGTPCWMAPEVME 179
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSPG 737
++ + K D++S G+ +EL TG +P
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 61/232 (26%), Positives = 112/232 (48%), Gaps = 28/232 (12%)
Query: 542 IMGKSTYGTA--YKATLEDGSEVAVKR--LREKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
++GK +G A Y+ T ED S V K L + K +++ E + + HPN++A
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 598 AYYLGPKGEKLLV-FDFMPKGSLASFL-HARG---PETIVNWATRMSIAIGIARGLNYLH 652
+++ LL+ ++ G+L + +G E +V W I ++Y+H
Sbjct: 66 NHFM--DDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIH 118
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM---TAAANTNVIATAGTLGYRAPELS 709
+ ++H ++ + N+ L + ++ DFG+S+++ + A T V GT Y +PEL
Sbjct: 119 -KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV----GTPYYMSPELC 173
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEV 761
+ N K+D+++LG ++ ELLT K + N V IV+ +T V
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTPVV 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 13/153 (8%)
Query: 587 KIHHPNLLALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGP--ETIVNWATRMSIAIG 643
+++HP L+ L +Y E + LV D + G L L + E V +
Sbjct: 56 ELNHPFLVNL--WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-----WICE 108
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGY 703
I L YLH + +IH ++ N+LLDE+ + I DF ++ +T +T +T+GT GY
Sbjct: 109 IVLALEYLH-SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP--DTLTTSTSGTPGY 165
Query: 704 RAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
APE+ + + D +SLGV E L GK P
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 8e-18
Identities = 63/223 (28%), Positives = 107/223 (47%), Gaps = 41/223 (18%)
Query: 543 MGKSTYGTAYKATL------EDGSEVAVKRLREK-TTKGQKEFEAEAAAIGKIHHPNLLA 595
+G+ +G ++A E + VAVK L+E+ + Q +F+ EAA + + HPN++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 596 LRAYYLG--PKGEKL-LVFDFMPKGSLASFLHARGPETI-------------------VN 633
L LG G+ + L+F++M G L FL R P ++
Sbjct: 73 L----LGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 634 WATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA---- 689
++ IA +A G+ YL E +H +L + N L+ E +IADFGLSR + +A
Sbjct: 129 CTEQLCIAKQVAAGMAYLS-ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 690 ANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT 732
A+ N A + + PE T++DV++ GV++ E+ +
Sbjct: 188 ASEN---DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 1e-17
Identities = 62/213 (29%), Positives = 109/213 (51%), Gaps = 22/213 (10%)
Query: 543 MGKSTYGTAYKATL------EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLAL 596
+G+ +G + A +D VAVK L++ + +K+F EA + + H +++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV-- 70
Query: 597 RAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIV----NWATRMS------IAIGIA 645
+ Y + +G+ L +VF++M G L FL A GP+ ++ N ++ IA IA
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 646 RGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA-TAGTLGYR 704
G+ YL ++ +H +L + N L+ E +I DFG+SR + + V T + +
Sbjct: 131 AGMVYL-ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 705 APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
PE + T++DV+SLGV++ E+ T GK P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 6/195 (3%)
Query: 543 MGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602
+G+ +G + T + VA+K L+ T + F EA + K+ H L+ L Y +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAVV 70
Query: 603 PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNL 662
+ +V ++M KGSL FL + + +A IA G+ Y+ N +H +L
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDL 128
Query: 663 TSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYS 722
++N+L+ E ++ADFGL+RL+ T + + APE + K+DV+S
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 723 LGVIILELLT-GKSP 736
G+++ EL T G+ P
Sbjct: 189 FGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 67/226 (29%), Positives = 111/226 (49%), Gaps = 29/226 (12%)
Query: 542 IMGKSTYGTAYKATL----EDGSEVAVKRL--REKTTKGQKEFEAEAAAIGKIHHPNLLA 595
++GK +YG + +L DG + +K+L R + + +K E EA + ++ HPN++A
Sbjct: 7 VVGKGSYG---EVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHARG----PET-IVNWATRMSIAIGIARGLNY 650
R + G G +V F G L L + PE +V W + IA L Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW------FVQIAMALQY 117
Query: 651 LHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA--GTLGYRAPEL 708
LH E++++H +L + NV L ++ D G++R++ N +A+ GT Y +PEL
Sbjct: 118 LH-EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE---NQCDMASTLIGTPYYMSPEL 173
Query: 709 SKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK 754
K N K+DV++LG + E+ T K N D+ V I++
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLK---HAFNAKDMNSLVYRIIE 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 39/213 (18%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI------HHPNL 593
E +G+ G YKAT G EVA+K++R K KE I +I HPN+
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMR--LRKQNKE-----LIINEILIMKDCKHPNI 77
Query: 594 LA-LRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMS------IAIGIAR 646
+ +Y +G E +V ++M GSL + I RM+ + + +
Sbjct: 78 VDYYDSYLVG--DELWVVMEYMDGGSLT--------DIITQNFVRMNEPQIAYVCREVLQ 127
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA---NTNVIATAGTLGY 703
GL YLH +N+IH ++ S N+LL + + ++ADFG + +T N+ V GT +
Sbjct: 128 GLEYLH-SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV----GTPYW 182
Query: 704 RAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
APE+ K K+ K D++SLG++ +E+ G+ P
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 60/216 (27%), Positives = 113/216 (52%), Gaps = 16/216 (7%)
Query: 541 EIMGKSTYGTAYKATLEDGSE----VAVKRLREKTTKGQ-KEFEAEAAAIGKIHHPNLLA 595
E++G +G + L+ + VA+K L+ T+ Q ++F +EA+ +G+ HPN++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHAR-GPETIVNWATRMSIAIGIARGLNYLHVE 654
L + +++ +FM G+L SFL G T++ + GIA G+ YL E
Sbjct: 70 LEGV-VTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLS-E 124
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN--TNVIATAGTLGYR--APELSK 710
N +H +L + N+L++ +++DFGLSR + + T + G + R APE
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 711 LKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDL 745
+ + +DV+S G+++ E+++ G+ P M+ D+
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 220
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 36/217 (16%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRL---REKTTKGQKEFEA---EAAAIGKIHHPNL 593
+ +G + + Y+A ++ G+ +AVK++ R +++ ++ EA E + +++HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 594 LALRAYYLGPKGEKL---LVFDFMPKGSLASFLHARGP--ETIVNWATRMSIAIGIARGL 648
+ + LG E L ++M GS++ L G E ++ T + RGL
Sbjct: 66 IRM----LGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ-----LLRGL 116
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNP-RIADFGLSRLMTAAANTNVIATA--------G 699
+YLH E +IH ++ +N+L+D RIADFG AA A G
Sbjct: 117 SYLH-ENQIIHRDVKGANLLIDSTGQRLRIADFG-----AAARLAAKGTGAGEFQGQLLG 170
Query: 700 TLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
T+ + APE+ + + DV+S+G +I+E+ T K P
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 541 EIMGKSTYGTAYKATL------EDGSEVAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNL 593
+G+ +G + D VAVK L+E + +K+FE EA + H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 594 LALRAYYLGPKGEKLL-VFDFMPKGSLASFLHARGP-----------ETIVNWATRMSIA 641
+ Y + +G+ + VF++M G L FL + GP + + + IA
Sbjct: 71 VKF--YGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 642 IGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT- 700
+ IA G+ YL ++ +H +L + N L+ +I DFG+SR + T+ G
Sbjct: 129 VQIASGMVYL-ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT---TDYYRVGGHT 184
Query: 701 -LGYR--APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
L R PE + T++DV+S GV++ E+ T GK P
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 59/212 (27%), Positives = 109/212 (51%), Gaps = 11/212 (5%)
Query: 543 MGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602
+G +G + ++VA+K L++ + + F AEA + ++ HP L+ R Y +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLV--RLYAVV 70
Query: 603 PKGEKLLVFDFMPKGSLASFLHARGPETI-VNWATRMSIAIGIARGLNYLHVEENMIHGN 661
+ ++ ++M GSL FL + PE I + + +A IA G+ ++ +N IH +
Sbjct: 71 TQEPIYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIE-RKNYIHRD 127
Query: 662 LTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVY 721
L ++N+L+ E +IADFGL+RL+ T + + APE K+DV+
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 187
Query: 722 SLGVIILELLT-GKSPGEPMNGMDLPQWVASI 752
S G+++ E++T G+ P GM P+ + ++
Sbjct: 188 SFGILLTEIVTYGRI---PYPGMTNPEVIQNL 216
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 29/216 (13%)
Query: 541 EIMGKSTYGTAYKATL-----EDGSEVAVKRLREKTTKGQ-KEFEAEAAAIGKIHHPNLL 594
E +G+ +G YK L + VA+K L++ Q EF+ EA+ + ++HHPN++
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 595 ALRAYYLGPKGEK---LLVFDFMPKGSLASFLHARGPETIVNWATR-------------- 637
L LG ++ ++F+++ +G L FL R P + V ++
Sbjct: 71 CL----LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 638 MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA- 696
+ IAI IA G+ YL +H +L + N+L+ E+ + +I+D GLSR + +A V
Sbjct: 127 LHIAIQIAAGMEYL-SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT 732
+ + + PE ++ +D++S GV++ E+ +
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 67/218 (30%), Positives = 112/218 (51%), Gaps = 23/218 (10%)
Query: 543 MGKSTYGTAYKAT-LEDGSEVAVKR--LREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+GK +YG+ YK L D A+K L + K +++ E + ++HPN+++ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARG------PETIVNWATRMSIAIGIARGLNYLH 652
+L G KL +V ++ P G L+ + R PE + W I I + RGL LH
Sbjct: 68 FL--DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI-W----RIFIQLLRGLQALH 120
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA-AANTNVIATAGTLGYRAPELSKL 711
E+ ++H +L S+N+LL +I D G+S+++ A T + GT Y APE+ K
Sbjct: 121 -EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVWKG 175
Query: 712 KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWV 749
+ + K+D++SLG ++ E+ T P E + DL V
Sbjct: 176 RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV 213
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 543 MGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602
+G +G + + ++VAVK L+ T Q F EA + + H L+ R Y +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLV--RLYAVV 70
Query: 603 PKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGN 661
K E + ++ ++M KGSL FL + ++ + + IA G+ Y+ +N IH +
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE-RKNYIHRD 128
Query: 662 LTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVY 721
L ++NVL+ E +IADFGL+R++ T + + APE + K+DV+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 722 SLGVIILELLT-GKSPGEPMNGMDL 745
S G+++ E++T GK P M+ D+
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSNSDV 213
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 6/208 (2%)
Query: 543 MGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602
+G +G + T ++VAVK L+ T + F EA + K+ H L+ L Y +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQL--YAVV 70
Query: 603 PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNL 662
+ +V ++M KGSL FL G + + +A +A G+ Y+ N IH +L
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIE-RMNYIHRDL 128
Query: 663 TSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYS 722
S+N+L+ + +IADFGL+RL+ T + + APE + K+DV+S
Sbjct: 129 RSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 723 LGVIILELLT-GKSPGEPMNGMDLPQWV 749
G+++ EL+T G+ P MN ++ + V
Sbjct: 189 FGILLTELVTKGRVPYPGMNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 543 MGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEA--EAAAIGKIHHPNLLALRAY 599
+G+ TYG YKA G VA+K+++ + A E + +++HPN++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARG---PETIVNWATRMSIAIGIARGLNYLHVEEN 656
+ KG+ LVF+FM L + R PE+++ S + +GL + H
Sbjct: 67 F-RHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLI-----KSYLYQLLQGLAFCH-SHG 118
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA--AANTNVIATAGTLGYRAPE-LSKLKN 713
++H +L N+L++ + ++ADFGL+R + T+ + T YRAPE L K
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV---TRWYRAPELLLGDKG 175
Query: 714 ANTKTDVYSLGVIILELLTGKS--PGEPMNGMDLPQW 748
+T D++S+G I ELL+ + PG+ ++ Q
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKS----EIDQL 208
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 57/223 (25%), Positives = 113/223 (50%), Gaps = 24/223 (10%)
Query: 542 IMGKSTYGTAYKAT-LEDGSEVAVKRL--REKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
++G+ +G + D V +K++ + T + + E + + HPN++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARG-----PETIVNWATRMSIAIGIARGLNYLHV 653
+L K ++V ++ P G+LA ++ R +TI+++ ++ +A L+++H
Sbjct: 67 NFLEDK-ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHHVH- 118
Query: 654 EENMIHGNLTSSNVLLDEKTNP-RIADFGLSR-LMTAAANTNVIATAGTLGYRAPELSKL 711
+ ++H +L + N+LLD+ +I DFG+S+ L + + V+ GT Y +PEL +
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV---GTPCYISPELCEG 175
Query: 712 KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK 754
K N K+D+++LG ++ EL + K E N LP V I+
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAAN---LPALVLKIMS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 23/230 (10%)
Query: 542 IMGKSTYGTAYKATLED----GSE---VAVKRLRE-KTTKGQKEFEAEAAAIGKIHHPNL 593
+G +G Y+ T D GS VAVK LR+ T + +KEF EA + +HPN+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHA----RGPETIVNWATRMSIAIGIARGLN 649
+ L L + + ++ + M G L S+L R ++ + I + +A+G
Sbjct: 62 VKLLGVCLLNE-PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 650 YLHVEENMIHGNLTSSNVLLDEKTNPR-----IADFGLSRLMTAAANTNVIATAGTLGYR 704
YL + + IH +L + N L+ EK I DFGL+R + + G L R
Sbjct: 121 YLE-QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK-EGEGLLPVR 178
Query: 705 --APELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWVAS 751
APE T++DV+S GV++ E+LT G+ P +N ++ Q V +
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA 228
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 7e-17
Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 6/195 (3%)
Query: 543 MGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602
+G+ +G + T ++VA+K L+ T + F EA + K+ H L+ L Y +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPL--YAVV 70
Query: 603 PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNL 662
+ +V +FM KGSL FL G + + +A IA G+ Y+ N IH +L
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQIADGMAYIE-RMNYIHRDL 128
Query: 663 TSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYS 722
++N+L+ + +IADFGL+RL+ T + + APE + K+DV+S
Sbjct: 129 RAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 723 LGVIILELLT-GKSP 736
G+++ EL+T G+ P
Sbjct: 189 FGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 39/223 (17%)
Query: 541 EIMGKSTYGTAYKATL--EDGS--EVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLL 594
+I+G+ +G+ + L +DGS +VAVK ++ T +EF +EAA + HPN++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 595 AL-----RAYYLGPKGEKLLVFDFMPKGSLASFL-HARGPETIVNWATRMSI--AIGIAR 646
L A L + +++ FM G L SFL ++R + + + IA
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAP 706
G+ YL N IH +L + N +L E +ADFGLS+ + + YR
Sbjct: 125 GMEYLS-NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY-----------YRQG 172
Query: 707 ELSKL------------KNANTKTDVYSLGVIILELLT-GKSP 736
++K+ + +K+DV++ GV + E+ T G++P
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 8e-17
Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 32/216 (14%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRL--REKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
E +GK ++GT K DG + K + T K +++ +E + ++ HPN++
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR-- 63
Query: 598 AYY---LGPKGEKL-LVFDFMPKGSLASFL------HARGPETIVNWATRMSIAIGIARG 647
YY + + L +V ++ G LA + E + W I +
Sbjct: 64 -YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-W----RILTQLLLA 117
Query: 648 LNYLH----VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM---TAAANTNVIATAGT 700
L H ++H +L +N+ LD N ++ DFGL++++ ++ A T V GT
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV----GT 173
Query: 701 LGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
Y +PE + + K+D++SLG +I EL P
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 9/198 (4%)
Query: 543 MGKSTYGTAYKATLED-GSEVAVKRL---REKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
+GK +G ++ G A K+L R K KG++ E + K+ +++L A
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
Y K + LV M G L ++ G E A + A I GL +LH + ++
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLH-QRRIV 117
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKT 718
+ +L NVLLD+ N RI+D GL+ + AGT GY APE+ + + +
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK--GRAGTPGYMAPEVLQGEVYDFSV 175
Query: 719 DVYSLGVIILELLTGKSP 736
D ++LG + E++ G+SP
Sbjct: 176 DWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 542 IMGKSTYGTAYKATLEDGSE-VAVKRLREKTTKGQKEFEA--EAAAIGKIHHPNLLALRA 598
+G+ TYG Y+A E VA+K++R + + E + + HPN++ L+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLH---ARGPETIVNWATRMSIAIGIARGLNYLHVE 654
+G + + LV ++ + LAS L E+ V + + + RGL YLH E
Sbjct: 74 VVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVK-----CLMLQLLRGLQYLH-E 126
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKLKN 713
+IH +L SN+LL +K +IADFGL+R + TL YRAPE L
Sbjct: 127 NFIIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAKPMTPKVVTLWYRAPELLLGCTT 185
Query: 714 ANTKTDVYSLGVIILELLTGK 734
T D++++G I+ ELL K
Sbjct: 186 YTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 68/230 (29%), Positives = 110/230 (47%), Gaps = 33/230 (14%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSE----VAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLL 594
+++G +GT YK + +G + VA+K LRE T+ K KE EA + + +P++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 595 ALRAYYLGPKGEKLLVFDFMPKGSLASFLHAR----GPETIVNWATRMSIAIGIARGLNY 650
L L + L+ MP G L ++ G + ++NW + IA+G+NY
Sbjct: 73 RLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGMNY 124
Query: 651 LHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT--LGYRAPEL 708
L E ++H +L + NVL+ + +I DFGL++L+ A A G + + A E
Sbjct: 125 LE-ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-ADEKEYHAEGGKVPIKWMALES 182
Query: 709 SKLKNANTKTDVYSLGVIILELLT-GKSP--GEPM--------NGMDLPQ 747
+ ++DV+S GV + EL+T G P G P G LPQ
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 61/216 (28%), Positives = 106/216 (49%), Gaps = 25/216 (11%)
Query: 543 MGKSTYGTAYKAT------LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLAL 596
+G+ +G + A +D VAVK L++ T +K+F+ EA + + H +++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV-- 70
Query: 597 RAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIV-------------NWATRMSIAI 642
+ Y + G+ L +VF++M G L FL A GP+ ++ + + IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 643 GIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA-TAGTL 701
IA G+ YL ++ +H +L + N L+ +I DFG+SR + + V T +
Sbjct: 131 QIASGMVYL-ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 702 GYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
+ PE + T++DV+S GVI+ E+ T GK P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-16
Identities = 45/90 (50%), Positives = 57/90 (63%)
Query: 143 GVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGS 202
G+ L N L G IP I +LQ+++LS N++ G IPPSL + T L L+LSYNS GS
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 203 IPLSLTRLPSLSVLALQHNNLSGSVPNNWG 232
IP SL +L SL +L L N+LSG VP G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 23/219 (10%)
Query: 542 IMGKSTYGTAYKAT-LEDGSE----VAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLA 595
++G +GT YK + DG VA+K LRE T+ K KE EA + + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHAR----GPETIVNWATRMSIAIGIARGLNYL 651
L L + LV MP G L ++ G + ++NW + IA+G++YL
Sbjct: 74 LLGICLTSTVQ--LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYL 125
Query: 652 HVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKL 711
E ++H +L + NVL+ + +I DFGL+RL+ T A G + + L +
Sbjct: 126 E-EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD-IDETEYHADGGKVPIKWMALESI 183
Query: 712 --KNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQ 747
+ ++DV+S GV + EL+T G P + + ++P
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD 222
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 56/200 (28%), Positives = 103/200 (51%), Gaps = 19/200 (9%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLALRAY 599
E++GK +G +K TL+D + VAVK +E + K +F +EA + + HPN++ L
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57
Query: 600 YLGPKGEK---LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
+G ++ +V + +P G SFL + E + A+ A G+ YL +N
Sbjct: 58 -IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKF--ALDAAAGMAYLE-SKN 113
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAG----TLGYRAPELSKLK 712
IH +L + N L+ E +I+DFG+SR + + +++G + + APE
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR----QEDDGIYSSSGLKQIPIKWTAPEALNYG 169
Query: 713 NANTKTDVYSLGVIILELLT 732
++++DV+S G+++ E +
Sbjct: 170 RYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 54/189 (28%), Positives = 100/189 (52%), Gaps = 10/189 (5%)
Query: 562 VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLA 620
VA+K L+ T+ Q+ +F +EA+ +G+ HPN++ L K ++V ++M GSL
Sbjct: 35 VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK-PVMIVTEYMENGSLD 93
Query: 621 SFLHAR-GPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIAD 679
+FL G T++ + GIA G+ YL + +H +L + N+L++ +++D
Sbjct: 94 AFLRKHDGQFTVIQLVGMLR---GIASGMKYLS-DMGYVHRDLAARNILVNSNLVCKVSD 149
Query: 680 FGLSRLMTAAANTNVIATAGTLGYR--APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
FGLSR++ G + R APE + + +DV+S G+++ E+++ G+ P
Sbjct: 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
Query: 737 GEPMNGMDL 745
M+ D+
Sbjct: 210 YWEMSNQDV 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
E +GK ++G YKA VA+K + E+ ++ + E + + P +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEEN 656
+L KG KL ++ ++ GS L ET + + R + GL YLH EE
Sbjct: 67 SFL--KGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILRE-----VLLGLEYLH-EEG 118
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA---NTNVIATAGTLGYRAPELSKLKN 713
IH ++ ++N+LL E+ + ++ADFG+S +T+ NT V GT + APE+ K
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV----GTPFWMAPEVIKQSG 174
Query: 714 ANTKTDVYSLGVIILELLTGKSP 736
+ K D++SLG+ +EL G+ P
Sbjct: 175 YDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 53/198 (26%), Positives = 87/198 (43%), Gaps = 28/198 (14%)
Query: 562 VAVKRLR-EKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLA 620
VAVK L+ +K + +F EAA + + H NL+ L L ++V + P GSL
Sbjct: 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP--LMMVTELAPLGSLL 83
Query: 621 SFLHARGP-----ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNP 675
L T+ ++A + IA G+ YL + IH +L + N+LL
Sbjct: 84 DRLRKDALGHFLISTLCDYAVQ------IANGMRYLE-SKRFIHRDLAARNILLASDDKV 136
Query: 676 RIADFGLSRLM-------TAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIIL 728
+I DFGL R + + V + APE + + + +DV+ GV +
Sbjct: 137 KIGDFGLMRALPQNEDHYVMEEHLKV-----PFAWCAPESLRTRTFSHASDVWMFGVTLW 191
Query: 729 ELLT-GKSPGEPMNGMDL 745
E+ T G+ P ++G +
Sbjct: 192 EMFTYGEEPWAGLSGSQI 209
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 62/223 (27%), Positives = 100/223 (44%), Gaps = 35/223 (15%)
Query: 541 EIMGKSTYGTAYKATL-EDGSEVAVKRL-REKTTKGQKEFEA--EAAAIGKI-HHPNLLA 595
+I+G+ ++ T A E E A+K L + + K +K E + ++ HP ++
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 596 LRAYYLGPKGEKL-LVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLH 652
L YY E L V ++ P G L ++ G E + A I L YLH
Sbjct: 67 L--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF-----YAAEILLALEYLH 119
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA---AANTNVIATA----------- 698
+ +IH +L N+LLD+ + +I DFG ++++ + AT
Sbjct: 120 -SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 699 -----GTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
GT Y +PEL K A +D+++LG II ++LTGK P
Sbjct: 179 FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 50/180 (27%), Positives = 91/180 (50%), Gaps = 8/180 (4%)
Query: 561 EVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL-LVFDFMPKGSL 619
+VA+K +RE + +F EA + K+ HPNL+ L Y + K + +V ++M G L
Sbjct: 30 DVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQL--YGVCTKQRPIFIVTEYMANGCL 86
Query: 620 ASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIAD 679
++L R + + + + + + YL IH +L + N L+ E +++D
Sbjct: 87 LNYLRER--KGKLGTEWLLDMCSDVCEAMEYLE-SNGFIHRDLAARNCLVGEDNVVKVSD 143
Query: 680 FGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGE 738
FGL+R + T+ T + + PE+ ++K+DV+S GV++ E+ + GK P E
Sbjct: 144 FGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 58/244 (23%), Positives = 114/244 (46%), Gaps = 28/244 (11%)
Query: 541 EIMGKSTYGTAYKATLE----DGSEVAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLA 595
+++G +G ++ L+ VA+K L+ T+ Q+ +F +EA+ +G+ H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
L K +++ ++M G+L +L E M GIA G+ YL +
Sbjct: 71 LEGVVTKFK-PAMIITEYMENGALDKYLRDHDGEFSSYQLVGM--LRGIAAGMKYLS-DM 126
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLKN 713
N +H +L + N+L++ +++DFGLSR++ + G + R APE +
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 714 ANTKTDVYSLGVIILELLT-GKSPGEPMNG----------------MDLPQWVASIVKEE 756
+ +DV+S G+++ E+++ G+ P M+ MD P V ++ +
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQC 246
Query: 757 WTNE 760
W +
Sbjct: 247 WQQD 250
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 50/199 (25%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 544 GKSTYGTAYKATLEDGSEV-AVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
G +G ++ + A+K ++++ T Q+ +E + + +HP ++ L
Sbjct: 2 GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRT 61
Query: 600 YLGPKGEKLLVF--DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
+ K +K + ++ G L + L RG + R IA + YLH +
Sbjct: 62 F---KDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIA-CVVLAFEYLH-NRGI 114
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTK 717
I+ +L N+LLD ++ DFG ++ + + T GT Y APE+ K +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC--GTPEYVAPEIILNKGYDFS 172
Query: 718 TDVYSLGVIILELLTGKSP 736
D +SLG+++ ELLTG+ P
Sbjct: 173 VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 19/216 (8%)
Query: 540 AEIMGKSTYGTAYKATLED-GSEVAVKRL-----REKTTKGQKEFEAEAAAIGKIHHPNL 593
+++G+ +G Y D G E+AVK++ ++T+K E E + + H +
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 594 LALRAYYLGPKGEKLLVF-DFMPKGSLASFLHARGP--ETIVNWATRMSIAIGIARGLNY 650
+ P+ +KL +F ++MP GS+ L A G E + TR I +G++Y
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQ-----ILQGVSY 121
Query: 651 LHVEENMI-HGNLTSSNVLLDEKTNPRIADFGLS-RLMT-AAANTNVIATAGTLGYRAPE 707
LH NMI H ++ +N+L D N ++ DFG S R+ T + T + + GT + +PE
Sbjct: 122 LH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE 179
Query: 708 LSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743
+ + K DV+S+ ++E+LT K P M
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 28/217 (12%)
Query: 541 EIMGKSTYGTAYKA-TLEDGSEVAVKRLR-----EKTTKGQKEFEAEAAAIGKIHHPNLL 594
+++G+ +G Y ++ G E+AVK++ +T K E E + + H ++
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 595 ALRAYYLG--PKGEKLLVF-DFMPKGSLASFLHARGP--ETIVNWATRMSIAIGIARGLN 649
Y G E L +F ++MP GS+ L A G ET+ TR I G+
Sbjct: 68 Q----YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ-----ILEGVE 118
Query: 650 YLHVEENMI-HGNLTSSNVLLDEKTNPRIADFGLS-RLMTAAANTNVIATA-GTLGYRAP 706
YLH NMI H ++ +N+L D N ++ DFG S RL T ++ + + GT + +P
Sbjct: 119 YLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 707 ELSKLKNANTKTDVYSLGVIILELLTGKSPG---EPM 740
E+ + K DV+S+G ++E+LT K P E M
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM 213
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-16
Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 25/212 (11%)
Query: 540 AEIMGKSTYGTAYKA-TLEDGSEVAVKRLR-----EKTTKGQKEFEAEAAAIGKIHHPNL 593
+++G+ +G Y ++ G E+A K+++ +T+K E E + + H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 594 LALRAYY--LGPKGEKLLV--FDFMPKGSLASFLHARGP--ETIVNWATRMSIAIGIARG 647
+ YY L + EK L ++MP GS+ L A G E++ TR I G
Sbjct: 67 VQ---YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQ-----ILEG 118
Query: 648 LNYLHVEENMI-HGNLTSSNVLLDEKTNPRIADFGLS-RLMT-AAANTNVIATAGTLGYR 704
++YLH NMI H ++ +N+L D N ++ DFG S RL T + T + + GT +
Sbjct: 119 MSYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176
Query: 705 APELSKLKNANTKTDVYSLGVIILELLTGKSP 736
+PE+ + K DV+SLG ++E+LT K P
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 26/220 (11%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSE----VAVKRLREKTTKGQKEFEA---EAAAIGKIHHPN 592
+++G +GT +K + +G VA+K +++++ G++ F+ A+G + H
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAY 70
Query: 593 LLALRAYYLGPKGEKLLVFDFMPKGSLASFLHAR----GPETIVNWATRMSIAIGIARGL 648
++ L G + LV P GSL + P+ ++NW + IA+G+
Sbjct: 71 IVRLLGICPGASLQ--LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGM 122
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT-LGYRAPE 707
YL E M+H NL + N+LL + +IADFG++ L+ + T + + A E
Sbjct: 123 YYLE-EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 708 LSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQ 747
++DV+S GV + E+++ + EP GM +
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGA--EPYAGMRPHE 219
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 8e-16
Identities = 69/226 (30%), Positives = 113/226 (50%), Gaps = 34/226 (15%)
Query: 541 EIMGKSTYGTAYKATL-EDG--SEVAVKRLREKTTKG-QKEFEAEAAAIGKI-HHPNLLA 595
+++G+ +G KA + +DG + A+KR++E +K ++F E + K+ HHPN++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 596 LRAYYLGP---KGEKLLVFDFMPKGSLASFLH-ARGPETIVNWATR------------MS 639
L LG +G L ++ P G+L FL +R ET +A +
Sbjct: 73 L----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 640 IAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAG 699
A +ARG++YL ++ IH +L + N+L+ E +IADFGLSR V T G
Sbjct: 129 FAADVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 183
Query: 700 TLGYRAPELSKLKNA--NTKTDVYSLGVIILELLTGKSPGEPMNGM 743
L R + L + T +DV+S GV++ E+++ G P GM
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--LGGTPYCGM 227
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 542 IMGKSTYGTAYKATL--EDGS--EVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLA 595
++GK +G+ +A L EDGS +VAVK L+ ++ +EF EAA + + HPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 596 LRAYYLG--PKGE---KLLVFDFMPKGSLASFLHAR--GPETI-VNWATRMSIAIGIARG 647
L L KG +++ FM G L +FL G E + T + I IA G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 648 LNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE 707
+ YL +N IH +L + N +L+E +ADFGLS+ + + + A L +
Sbjct: 126 MEYLS-SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY-SGDYYRQGCASKLPVKWLA 183
Query: 708 LSKLKNA--NTKTDVYSLGVIILELLT-GKSP 736
L L + T +DV++ GV + E++T G++P
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 24/215 (11%)
Query: 543 MGKSTYGTAYKATL------EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLAL 596
+G+ +G + A +D VAVK L+E + +++F+ EA + + H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIV-- 70
Query: 597 RAYYLGPKGEKLL-VFDFMPKGSLASFLHARGPETIV------------NWATRMSIAIG 643
R Y + +G LL VF++M G L FL + GP+ + ++IA
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA-TAGTLG 702
IA G+ YL + +H +L + N L+ + +I DFG+SR + + V T +
Sbjct: 131 IASGMVYL-ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 703 YRAPELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
+ PE + T++D++S GV++ E+ T GK P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 75/258 (29%), Positives = 122/258 (47%), Gaps = 43/258 (16%)
Query: 541 EIMGKSTYGTAYKATLE-DGSEV--AVKRLREKTTKG-QKEFEAEAAAIGKI-HHPNLLA 595
+++G+ +G +A ++ DG ++ A+K L+E ++ ++F E + K+ HHPN++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 596 LRAYYLGP---KGEKLLVFDFMPKGSLASFLH-----------ARGPETIVNWATR--MS 639
L LG +G + ++ P G+L FL A+ T ++ +
Sbjct: 68 L----LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 640 IAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAG 699
A +A G+ YL E+ IH +L + NVL+ E +IADFGLSR V T G
Sbjct: 124 FASDVATGMQYLS-EKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMG 178
Query: 700 TLGYRAPELSKLKNA--NTKTDVYSLGVIILELLTGKSPGEPMNGM-------DLPQWVA 750
L R + L + TK+DV+S GV++ E+++ G P GM LPQ
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS--LGGTPYCGMTCAELYEKLPQGYR 236
Query: 751 SIVKEEWTNEVFDLELMR 768
+EV+ ELMR
Sbjct: 237 MEKPRNCDDEVY--ELMR 252
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-15
Identities = 76/271 (28%), Positives = 120/271 (44%), Gaps = 21/271 (7%)
Query: 152 SGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLP 211
S ++ N L +LDL+ N L I L T L L+L N++ IP + L
Sbjct: 82 SLDGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNIT-DIPPLIGLLK 139
Query: 212 S-LSVLALQHNNLSGSVPNNWGVLAGNKSY--QLQFLNLDHNLIAGTIPVSLGKLGLLQE 268
S L L L N + L L+ L+L N ++ +P L L L
Sbjct: 140 SNLKELDLSDNKIE--------SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNN 190
Query: 269 ISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKI 328
+ LS NKI +P E+ LS L++LDLS N+I + +N+ +L L L NN+L + +
Sbjct: 191 LDLSGNKI-SDLPPEIELLSALEELDLSNNSI-IELLSSLSNLKNLSGLELSNNKLED-L 247
Query: 329 PEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTS 388
PE + L NL L+L NNQ ++G+++ + +LDLS N + L +L L
Sbjct: 248 PESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNA--LPLIALLLLLL 303
Query: 389 FNVSYNNLSGSVPPLLSKKFNSSSFVGNLQL 419
+ L+ L ++ + +
Sbjct: 304 ELLLNLLLTLKALELKLNSILLNNNILSNGE 334
|
Length = 394 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 60/205 (29%), Positives = 106/205 (51%), Gaps = 22/205 (10%)
Query: 542 IMGKSTYGTAYKATLEDGSEV-AVKRLR-EKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
++G+ ++G A + + A+K +R K++ ++ EA + K+ HPN++A +
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLH-ARG---PE-TIVNWATRMSIAIGIARGLNYLHVE 654
+ G +V ++ G L + RG PE TI+ W +M + G+ ++H E
Sbjct: 67 FEA-DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIH-E 118
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMT---AAANTNVIATAGTLGYRAPELSKL 711
+ ++H ++ S N+ L + ++ DFG +RL+T A A T V GT Y PE+ +
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV----GTPYYVPPEIWEN 174
Query: 712 KNANTKTDVYSLGVIILELLTGKSP 736
N K+D++SLG I+ EL T K P
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-15
Identities = 44/103 (42%), Positives = 58/103 (56%), Gaps = 1/103 (0%)
Query: 245 LNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSF 304
L LD+ + G IP + KL LQ I+LS N I G IP LG ++ L+ LDLSYN+ GS
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 305 PVTFTNITSLVSLNLENNRLGNKIPEGL-ERLQNLTVLNLKNN 346
P + +TSL LNL N L ++P L RL + N +N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-15
Identities = 86/259 (33%), Positives = 129/259 (49%), Gaps = 16/259 (6%)
Query: 164 NLQTLDLSNNALIGA--IPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHN 221
L +LDL + + I + +L N L L+L+ N L +I L L +L+ L L +N
Sbjct: 68 RLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNN 126
Query: 222 NLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIP 281
N++ P L G L+ L+L N I ++P L L L+ + LS N + +P
Sbjct: 127 NITDIPP-----LIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSD-LP 179
Query: 282 DELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVL 341
L LS L LDLS N I P +++L L+L NN + ++ L L+NL+ L
Sbjct: 180 KLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI-IELLSSLSNLKNLSGL 237
Query: 342 NLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVP 401
L NN+ + +PE+IGN+S + LDLS N SL SL NL ++S N+LS +
Sbjct: 238 ELSNNKLED-LPESIGNLSNLETLDLSNN--QISSISSLGSLTNLRELDLSGNSLS-NAL 293
Query: 402 PLLSKKFNSSSFVGNLQLC 420
PL++ + NL L
Sbjct: 294 PLIALLLLLLELLLNLLLT 312
|
Length = 394 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 77/250 (30%), Positives = 116/250 (46%), Gaps = 48/250 (19%)
Query: 530 FTADDLLCATAEIMGKSTYGTAYKATLED-GSEVAVKRLREKTT-KGQKEFEAEAAAIGK 587
FTA+DL EI G+ +GT K + G+ +AVKR+R K QK + + +
Sbjct: 1 FTAEDLK-DLGEI-GRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR 58
Query: 588 IHH-PNLLALRAYY--LGPKGEKLLVFDFMPKGSLASF-------LHARGPETIVNWATR 637
P ++ +Y L +G+ + + M SL F L + PE I+
Sbjct: 59 SSDCPYIVK---FYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILG---- 110
Query: 638 MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS-RLMTAAANTNVIA 696
IA+ + LNYL E +IH ++ SN+LLD N ++ DFG+S +L+ + A T
Sbjct: 111 -KIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTR--- 166
Query: 697 TAGTLGYRAPEL---SKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIV 753
AG Y APE S + ++DV+SLG+ + E+ TGK P P+W
Sbjct: 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFP--------YPKW----- 213
Query: 754 KEEWTNEVFD 763
N VFD
Sbjct: 214 -----NSVFD 218
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 26/219 (11%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTK---GQKEFEA---EAAAIGKIHHPNLL 594
E++GK YGT Y G +AVK++ T+ +KE+E E + + H N++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 595 ALRAYYLGPKGEKLLV---FDFMPKGSLASFLHARGP--ETIVNWATRMSIAIGIARGLN 649
YLG + + +F+P GS++S L+ GP E + T+ I G+
Sbjct: 66 Q----YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQ-----ILDGVA 116
Query: 650 YLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA----NTNVIATA-GTLGYR 704
YLH ++H ++ +NV+L ++ DFG +R + ++N++ + GT +
Sbjct: 117 YLH-NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175
Query: 705 APELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743
APE+ K+D++S+G + E+ TGK P M+ +
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL 214
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 41/217 (18%)
Query: 543 MGKSTYGTAYKATL------EDGSEVAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLA 595
+G+ ++G Y+ E + VA+K + E + ++ EF EA+ + + + +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 596 LRAYYLGPKGEK-LLVFDFMPKGSLASFLHARGPET-------------IVNWATRMSIA 641
L + G+ L+V + M KG L S+L +R PE + A
Sbjct: 74 L--LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA------ 125
Query: 642 IGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV--IATAG 699
IA G+ YL + +H +L + N ++ E +I DFG++R + T+ G
Sbjct: 126 AEIADGMAYLA-AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIY---ETDYYRKGGKG 181
Query: 700 TLGYR--APELSKLKNA--NTKTDVYSLGVIILELLT 732
L R APE LK+ TK+DV+S GV++ E+ T
Sbjct: 182 LLPVRWMAPE--SLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 26/167 (15%)
Query: 604 KGEKLLVFDFMPKGSLASFLHARGP--ETIVNWATRMSIAIGIARGLNYLHVEENMIHGN 661
+ + +FM GSL GP I+ IA+ + GL YL+ ++H +
Sbjct: 75 ENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYNVHRIMHRD 129
Query: 662 LTSSNVLLDEKTNPRIADFGLS-RLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDV 720
+ SN+L++ + ++ DFG+S L+ + A+T V GT Y +PE + K+DV
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSGELINSIADTFV----GTSTYMSPERIQGGKYTVKSDV 185
Query: 721 YSLGVIILELLTGKSP-----------GEPMNGMDLPQWVASIVKEE 756
+SLG+ I+EL GK P +PM +DL Q IV+E
Sbjct: 186 WSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ---QIVQEP 229
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-15
Identities = 75/258 (29%), Positives = 123/258 (47%), Gaps = 43/258 (16%)
Query: 541 EIMGKSTYGTAYKATLE-DGSEV--AVKRLREKTTKG-QKEFEAEAAAIGKI-HHPNLLA 595
+++G+ +G KA ++ DG + A+KR++E +K ++F E + K+ HHPN++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 596 LRAYYLGP---KGEKLLVFDFMPKGSLASFLH-----------ARGPETIVNWATR--MS 639
L LG +G L ++ P G+L FL A T +++ +
Sbjct: 61 L----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 640 IAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAG 699
A +ARG++YL ++ IH +L + N+L+ E +IADFGLSR V T G
Sbjct: 117 FAADVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 171
Query: 700 TLGYRAPELSKLKNA--NTKTDVYSLGVIILELLTGKSPGEPMNGM-------DLPQWVA 750
L R + L + T +DV+S GV++ E+++ G P GM LPQ
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--LGGTPYCGMTCAELYEKLPQGYR 229
Query: 751 SIVKEEWTNEVFDLELMR 768
+EV+ +LMR
Sbjct: 230 LEKPLNCDDEVY--DLMR 245
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 4e-15
Identities = 63/210 (30%), Positives = 112/210 (53%), Gaps = 19/210 (9%)
Query: 541 EIMGKSTYGTAYKATLEDGSE--VAVKRLR-EKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
E +GK ++G +K +++ ++ VA+K + E+ ++ + E + + P +
Sbjct: 10 ERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 598 AYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
YL KG KL ++ +++ GS L A GP AT + I +GL+YLH E+
Sbjct: 69 GSYL--KGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLK---EILKGLDYLHSEKK 122
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA---NTNVIATAGTLGYRAPELSKLKN 713
IH ++ ++NVLL E+ + ++ADFG++ +T NT V GT + APE+ +
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIQQSA 177
Query: 714 ANTKTDVYSLGVIILELLTGKSPGEPMNGM 743
++K D++SLG+ +EL G+ P M+ M
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDMHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 19/216 (8%)
Query: 540 AEIMGKSTYGTAYKATLED-GSEVAVKRLR-----EKTTKGQKEFEAEAAAIGKIHHPNL 593
+++G+ +G Y D G E+AVK+++ +T+K E E + + H +
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 594 LALRAYYLGPKGEKLLVF-DFMPKGSLASFLHARGP--ETIVNWATRMSIAIGIARGLNY 650
+ P L +F + MP GS+ L + G E + TR I G++Y
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQ-----ILEGVSY 121
Query: 651 LHVEENMI-HGNLTSSNVLLDEKTNPRIADFGLS-RLMTAA-ANTNVIATAGTLGYRAPE 707
LH NMI H ++ +N+L D N ++ DFG S RL T + T + + GT + +PE
Sbjct: 122 LH--SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 708 LSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743
+ + K D++S+G ++E+LT K P M
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 57/211 (27%), Positives = 105/211 (49%), Gaps = 9/211 (4%)
Query: 543 MGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602
+G +G + AT ++VAVK ++ + + F AEA + + H L+ L A +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHA--VV 70
Query: 603 PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNL 662
K ++ +FM KGSL FL + + + IA G+ ++ + N IH +L
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIE-QRNYIHRDL 128
Query: 663 TSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYS 722
++N+L+ +IADFGL+R++ T + + APE + K+DV+S
Sbjct: 129 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 188
Query: 723 LGVIILELLT-GKSPGEPMNGMDLPQWVASI 752
G++++E++T G+ P GM P+ + ++
Sbjct: 189 FGILLMEIVTYGRI---PYPGMSNPEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 71/217 (32%), Positives = 106/217 (48%), Gaps = 48/217 (22%)
Query: 540 AEIMGKSTYGTAYKAT-LEDGSEVAVKR--------------LREKTTKGQKE-FEAEAA 583
AEI G+ YGT YKA L G VA+K+ LRE Q E FE
Sbjct: 5 AEI-GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE---- 59
Query: 584 AIGKIHHPNLLALRAYYLGPKGEK----LLVFDFMPKGSLASFLH---ARG--PETIVNW 634
HPN++ L GP+ ++ LVF+ + + LA++L G PETI +
Sbjct: 60 ------HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKD- 111
Query: 635 ATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMT-AAANTN 693
+ + RG+++LH ++H +L N+L+ +IADFGL+R+ + A T+
Sbjct: 112 -----LMRQLLRGVDFLH-SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS 165
Query: 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILEL 730
V+ TL YRAPE+ + T D++S+G I EL
Sbjct: 166 VVV---TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-14
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 36/223 (16%)
Query: 557 EDGSEVAVKRLREKTTKGQKE---FEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613
G EVA+K LR + + + F E A +++HPN++AL P G VF++
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL---D 670
+P +L L A G + + + + L H + ++H +L N+++
Sbjct: 61 VPGRTLREVLAADGA---LPAGETGRLMLQVLDALACAH-NQGIVHRDLKPQNIMVSQTG 116
Query: 671 EKTNPRIADFGLSRLMT---AAANTNVIATAGTLG---YRAPELSKLKNANTKTDVYSLG 724
+ + ++ DFG+ L+ A + T LG Y APE + + +D+Y+ G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 725 VIILELLTGK----------------SPGEPMNGMDLPQWVAS 751
+I LE LTG+ SP + + LP W+A
Sbjct: 177 LIFLECLTGQRVVQGASVAEILYQQLSPVD----VSLPPWIAG 215
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRL--REKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
E +GK ++G YK EV ++ E+ ++ + E + + P +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
YL KG KL ++ +++ GS L GP AT I I +GL+YLH E
Sbjct: 70 SYL--KGTKLWIIMEYLGGGSALDLLKP-GPLEETYIAT---ILREILKGLDYLHSERK- 122
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA---NTNVIATAGTLGYRAPELSKLKNA 714
IH ++ ++NVLL E+ + ++ADFG++ +T NT V GT + APE+ K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIKQSAY 178
Query: 715 NTKTDVYSLGVIILELLTGKSPGEPMNGM 743
+ K D++SLG+ +EL G+ P ++ M
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPM 207
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-14
Identities = 45/130 (34%), Positives = 65/130 (50%), Gaps = 6/130 (4%)
Query: 82 GWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNL 141
GW G CV Q PW + + + L L + L G +P + L +L
Sbjct: 391 GWNGDPCVPQQ-----HPWSGADCQFDSTKGKW-FIDGLGLDNQGLRGFIPNDISKLRHL 444
Query: 142 RGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLG 201
+ + L N + G+IPPS+G+ +L+ LDLS N+ G+IP SL T L LNL+ NSL G
Sbjct: 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG 504
Query: 202 SIPLSLTRLP 211
+P +L
Sbjct: 505 RVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 69/239 (28%), Positives = 115/239 (48%), Gaps = 15/239 (6%)
Query: 110 KISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLD 169
++ +L L L L +N + P NL+ + L +N++ S+P + N PNL+ LD
Sbjct: 111 ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLD 169
Query: 170 LSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229
LS N L +P L+N + L L+LS N + +P + L +L L L +N++ +
Sbjct: 170 LSFNDLS-DLPKLLSNLSNLNNLDLSGN-KISDLPPEIELLSALEELDLSNNSIIELLS- 226
Query: 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSK 289
L+ K+ L L L +N + +P S+G L L+ + LS+N+I LG L+
Sbjct: 227 ---SLSNLKN--LSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTN 278
Query: 290 LQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQF 348
L++LDLS N++ S + + L+ L N L L+ L N+ +N
Sbjct: 279 LRELDLSGNSL--SNALPLIALLLLLLELLLNLLL-TLKALELKLNSILLNNNILSNGE 334
|
Length = 394 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 73/216 (33%), Positives = 104/216 (48%), Gaps = 37/216 (17%)
Query: 542 IMGKSTYGTAYKATLED-GSEVAVKRLREKTTKGQKE-FEAEAAAIGKI----HHPNLLA 595
+G+ TYG YKA +D G VA+K++R +KE F A KI +H N++
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNHRNIVN 70
Query: 596 LRAY---------YLGPKGEKLLVFDFMPK---GSLASFLHARGPETIVNWATRMSIAIG 643
L+ + KG LVF++M G L S L + I S
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI------KSFMKQ 124
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN---TN-VIATAG 699
+ GLNY H ++N +H ++ SN+LL+ K ++ADFGL+RL + + TN VI
Sbjct: 125 LLEGLNYCH-KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI---- 179
Query: 700 TLGYRAPELSKLKNANTKT-DVYSLGVIILELLTGK 734
TL YR PEL + DV+S G I+ EL T K
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 50/195 (25%), Positives = 102/195 (52%), Gaps = 12/195 (6%)
Query: 561 EVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL-LVFDFMPKGSL 619
+VA+K ++E + + EF EA + K+ H L+ L Y + K + +V ++M G L
Sbjct: 30 DVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQL--YGVCTKQRPIYIVTEYMSNGCL 86
Query: 620 ASFL--HARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRI 677
++L H + + + + + + G+ YL ++ IH +L + N L+D++ ++
Sbjct: 87 LNYLREHGKRFQP----SQLLEMCKDVCEGMAYLESKQ-FIHRDLAARNCLVDDQGCVKV 141
Query: 678 ADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
+DFGLSR + T+ + + + + PE+ ++K+DV++ GV++ E+ + GK P
Sbjct: 142 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMP 201
Query: 737 GEPMNGMDLPQWVAS 751
E N + + V+
Sbjct: 202 YERFNNSETVEKVSQ 216
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 49/194 (25%), Positives = 90/194 (46%), Gaps = 21/194 (10%)
Query: 558 DGSEVAVKRLREKTTKGQK----EFEAEAAAIGKIHHPNLLALRAYYLG-----PKGEKL 608
+ EV ++ + K KG K E E + +I N+L + + + P+
Sbjct: 42 NNKEVIIRTFK-KFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL--S 98
Query: 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVL 668
L+ ++ +G L L E +++ T++ +AI +GL L+ N + NLTS + L
Sbjct: 99 LILEYCTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFL 155
Query: 669 LDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSK--LKNANTKTDVYSLGVI 726
+ E +I GL +++++ NV + Y + ++ K D+YSLGV+
Sbjct: 156 VTENYKLKIICHGLEKILSSPPFKNV----NFMVYFSYKMLNDIFSEYTIKDDIYSLGVV 211
Query: 727 ILELLTGKSPGEPM 740
+ E+ TGK P E +
Sbjct: 212 LWEIFTGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 44/137 (32%), Positives = 63/137 (45%), Gaps = 15/137 (10%)
Query: 609 LVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSN 666
LV +++P G LAS L G E + R+ IA I L YLH +IH +L N
Sbjct: 70 LVMEYLPGGDLASLLENVGSLDEDV----ARIYIA-EIVLALEYLH-SNGIIHRDLKPDN 123
Query: 667 VLLDEKTNPRIADFGLSR-------LMTAAANTNVIATAGTLGYRAPELSKLKNANTKTD 719
+L+D + ++ DFGLS+ + GT Y APE+ + + D
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVD 183
Query: 720 VYSLGVIILELLTGKSP 736
+SLG I+ E L G P
Sbjct: 184 WWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 62/203 (30%), Positives = 104/203 (51%), Gaps = 21/203 (10%)
Query: 544 GKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602
G TYG YKA + G VA+K ++ + + + E + + + HPN++A YL
Sbjct: 12 GSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL- 70
Query: 603 PKGEKL-LVFDFMPKGSLASFLHA-RGP--ETIVNWATRMSIAIGIARGLNYLHVEENMI 658
+ +KL +V ++ GSL RGP E + + R ++ +GL YLH E I
Sbjct: 71 -RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLH-ETGKI 123
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTA--AANTNVIATAGTLGYRAPEL---SKLKN 713
H ++ +N+LL E + ++ADFG+S +TA A + I GT + APE+ +
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI---GTPYWMAPEVAAVERKGG 180
Query: 714 ANTKTDVYSLGVIILELLTGKSP 736
+ K D+++LG+ +EL + P
Sbjct: 181 YDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 38/102 (37%), Positives = 59/102 (57%), Gaps = 8/102 (7%)
Query: 640 IAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS-RLMTAAANTNVIATA 698
IA+ I + L YLH + ++IH ++ SNVL++ ++ DFG+S L+ + A T A
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT---IDA 164
Query: 699 GTLGYRAPEL----SKLKNANTKTDVYSLGVIILELLTGKSP 736
G Y APE K + K+DV+SLG+ ++EL TG+ P
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 25/190 (13%)
Query: 559 GSEVAVKRLRE--KTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616
G VA+K++ + T K E + + H N+++L ++ P + V + +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94
Query: 617 GSLASFLHARGPET-IVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNP 675
L L +R E + + I RGL Y+H ++H +L SN+L++E +
Sbjct: 95 -DLHRLLTSRPLEKQFIQY-----FLYQILRGLKYVH-SAGVVHRDLKPSNILINENCDL 147
Query: 676 RIADFGLSRL----MTAAANTNVIATAGTLGYRAPELS-KLKNANTKTDVYSLGVIILEL 730
+I DFGL+R+ MT +T YRAPE+ + + + D++S G I E+
Sbjct: 148 KICDFGLARIQDPQMTGYVSTRY--------YRAPEIMLTWQKYDVEVDIWSAGCIFAEM 199
Query: 731 LTGKS--PGE 738
L GK PG+
Sbjct: 200 LEGKPLFPGK 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-14
Identities = 34/89 (38%), Positives = 52/89 (58%)
Query: 269 ISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKI 328
+ L + + G IP+++ KL LQ ++LS N+I G+ P + +ITSL L+L N I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 329 PEGLERLQNLTVLNLKNNQFKGHIPETIG 357
PE L +L +L +LNL N G +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 544 GKSTYGTAYKA---TLEDGSEVAVKRLREKTTKGQKE-FEA----EAAAIGKIHHPNLLA 595
G+ TYG YKA +DG E A+K+ K K Q E A + ++ H N+++
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKF--KGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 596 LRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETI-VNWATRMSIAIGIARGLNYLHV 653
L +L + + L+FD+ R + + + + S+ I G++YLH
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH- 125
Query: 654 EEN-MIHGNLTSSNVLL----DEKTNPRIADFGLSRLMTAA----ANTN--VIATAGTLG 702
N ++H +L +N+L+ E+ +I D GL+RL A A+ + V+ T+
Sbjct: 126 -SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV----TIW 180
Query: 703 YRAPELSKLKNANTKT---DVYSLGVIILELLT 732
YRAPEL L A T D++++G I ELLT
Sbjct: 181 YRAPEL--LLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 66/259 (25%), Positives = 117/259 (45%), Gaps = 46/259 (17%)
Query: 541 EIMGKSTYGTAYKATL------EDGSEVAVKRLREKTTKG-QKEFEAEAAAIGKIHHPNL 593
E +G+ +G YK L E VA+K L++K ++EF+ EA ++ HPN+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 594 LALRAYYLG--PKGEKL-LVFDFMPKGSLASFLHARGPETIVNW-------------ATR 637
+ L LG K + L ++F + L FL R P + V A
Sbjct: 71 VCL----LGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF 126
Query: 638 MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697
+ I IA G+ +L +++H +L + NVL+ +K N +I+D GL R + AA ++
Sbjct: 127 VHIVTQIAAGMEFLS-SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 698 AG-TLGYRAPELSKLKNANTKTDVYSLGVIILELLT-------GKSPGEPMNGM------ 743
+ + + +PE + +D++S GV++ E+ + G S + + +
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL 245
Query: 744 ----DLPQWVASIVKEEWT 758
D P WV +++ E W
Sbjct: 246 PCPDDCPAWVYTLMLECWN 264
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 68/243 (27%), Positives = 116/243 (47%), Gaps = 33/243 (13%)
Query: 540 AEIMGKSTYGTAYKA-TLEDGSE-VAVKRLREKTTKGQKEFEA--EAAAIGKIH---HPN 592
AEI G+ YG +KA L++G VA+KR+R +T + E A + + HPN
Sbjct: 7 AEI-GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 593 LLALRAYYLGPKGEK----LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGL 648
++ L + ++ LVF+ + + L ++L + PE V T + + RGL
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-KVPEPGVPTETIKDMMFQLLRGL 123
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPEL 708
++LH ++H +L N+L+ ++ADFGL+R+ + + TL YRAPE+
Sbjct: 124 DFLH-SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEV 180
Query: 709 SKLKNANTKTDVYSLGVIILE------LLTGKSP----GEPMNGMDLPQWVASIVKEEWT 758
+ T D++S+G I E L G S G+ ++ + LP +E+W
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG------EEDWP 234
Query: 759 NEV 761
+V
Sbjct: 235 RDV 237
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 8e-14
Identities = 39/98 (39%), Positives = 56/98 (57%), Gaps = 5/98 (5%)
Query: 168 LDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSV 227
L L N L G IP ++ L +NLS NS+ G+IP SL + SL VL L +N+ +GS+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 228 PNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGL 265
P + G L L+ LNL+ N ++G +P +LG L
Sbjct: 483 PESLGQLT-----SLRILNLNGNSLSGRVPAALGGRLL 515
|
Length = 623 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 66/208 (31%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 541 EIMGKSTYGTAYKA-TLEDGSEVAVKRLREKT-TKGQKEFEA-EAAAIGKIHHPNLLALR 597
E +G+ TYG YKA G VA+K++R T T+G E + + +++HPN++ L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 598 AYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
KL LVF+F+ + L F+ A I S + +GL + H
Sbjct: 66 DVIHTEN--KLYLVFEFLHQ-DLKKFMDASPLSGI-PLPLIKSYLFQLLQGLAFCH-SHR 120
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT---NVIATAGTLGYRAPE-LSKLK 712
++H +L N+L++ + ++ADFGL+R T V+ TL YRAPE L K
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEILLGCK 176
Query: 713 NANTKTDVYSLGVIILELLTGKS--PGE 738
+T D++SLG I E++T ++ PG+
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 52/203 (25%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 543 MGKSTYGTAYKAT---LED--GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
+GK +G+ L+D G VAVK+L+ T + ++FE E + + H N++ +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 598 A--YYLGPKGEKLLVFDFMPKGSLASFL----HARGPETIVNWATRMSIAIGIARGLNYL 651
Y G + +L V +++P GSL +L ++ +A++ I +G+ YL
Sbjct: 72 GVCYSAGRRNLRL-VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ------ICKGMEYL 124
Query: 652 HVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT--LGYRAPELS 709
+ +H +L + N+L++ + +I DFGL++++ + G + + APE
Sbjct: 125 G-SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 710 KLKNANTKTDVYSLGVIILELLT 732
+ +DV+S GV++ EL T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 41/114 (35%), Positives = 63/114 (55%), Gaps = 13/114 (11%)
Query: 628 PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS-RLM 686
PE I+ + + I + L+YL + +IH ++ SN+LLD N ++ DFG+S RL+
Sbjct: 112 PEDILG-----KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166
Query: 687 TAAANTNVIATAGTLGYRAPELSKLKNANTK----TDVYSLGVIILELLTGKSP 736
+ A T +AG Y APE + N K DV+SLG+ ++EL TG+ P
Sbjct: 167 DSKAKTR---SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 544 GKSTYGTAYKATLEDGSE-VAVKRLRE-KTTKGQKEFEA-EAAAIGKIHHPNLLALRAYY 600
G+ YG K + E VA+K+ +E + + K+ E + ++ H N++ L+ +
Sbjct: 10 GEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAF 69
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHAR----GPETIVNWATRMSIAIGIARGLNYLHVEEN 656
KG LVF+++ + +L L A P+ + S + + + Y H N
Sbjct: 70 RR-KGRLYLVFEYVER-TLLELLEASPGGLPPDAV------RSYIWQLLQAIAYCH-SHN 120
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKLKNAN 715
+IH ++ N+L+ E ++ DFG +R + A + + T YRAPE L N
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180
Query: 716 TKTDVYSLGVIILELLTGKS--PGE 738
DV+++G I+ ELL G+ PG+
Sbjct: 181 KPVDVWAIGCIMAELLDGEPLFPGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 543 MGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602
+G +G + +VA+K + E +++F EA + K+ HP L+ L Y +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQL--YGVC 68
Query: 603 PKGEKL-LVFDFMPKGSLASFLHAR----GPETIVNWATRMSIAIGIARGLNYLHVEENM 657
+ + L +V +FM G L ++L R + + +S+ + G+ YL +
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML------LSMCQDVCEGMEYLE-RNSF 121
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTK 717
IH +L + N L+ +++DFG++R + T+ + + PE+ ++K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 718 TDVYSLGVIILELLT-GKSPGE 738
+DV+S GV++ E+ T GK P E
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)
Query: 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLALRA 598
E +G+ +G + L D + VAVK RE K +F EA + + HPN++ L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL-- 58
Query: 599 YYLGPKGEK---LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
+G +K +V + + G +FL GP V +M A G+ YL +
Sbjct: 59 --IGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVE--NAAAGMEYLE-SK 113
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTL-----GYRAPELSK 710
+ IH +L + N L+ EK +I+DFG+SR V A+ G + + APE
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 711 LKNANTKTDVYSLGVIILELLT-GKSP 736
++++DV+S G+++ E + G P
Sbjct: 170 YGRYSSESDVWSFGILLWEAFSLGAVP 196
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 14/202 (6%)
Query: 543 MGKSTYG----TAYKATLEDGSEVAVKRLREKTTKGQKEFEA---EAAAIGKIHHPNLLA 595
+GK +G +AT G A K+L +K K +K +E E + K+H +++
Sbjct: 1 LGKGGFGEVSACQMRAT---GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS 57
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSI-AIGIARGLNYLHVE 654
L AY K + LV M G L ++ E R I GL +LH +
Sbjct: 58 L-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH-Q 115
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNA 714
+I+ +L NVLLD N RI+D GL+ + + AGT G+ APEL + +
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGTPGFMAPELLQGEEY 174
Query: 715 NTKTDVYSLGVIILELLTGKSP 736
+ D ++LGV + E++ + P
Sbjct: 175 DFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 24/222 (10%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKR--LREKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
+G+ G+ K L++ + + + QK+ E P ++
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLH------ARGPETIVNWATRMSIAIGIARGLNYL 651
+L + + ++ GSL S R E ++ IA + +GL+YL
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSYL 121
Query: 652 HVEENMIHGNLTSSNVLLDEKTNPRIADFGLS-RLMTAAANTNVIATAGTLGYRAPELSK 710
H +IH ++ SN+LL K ++ DFG+S L+ + A T GT Y APE +
Sbjct: 122 H-SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPERIQ 176
Query: 711 LKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASI 752
K + +DV+SLG+ +LE+ + P P + + I
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNRFPFPP----EGEPPLGPI 214
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 65/202 (32%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGK-IHHPNLLA 595
+++GK ++G A + DG AVK L++K K QK AE + K + HP L+
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 596 LRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
L +Y EKL V DF+ G L F H + + R A IA L YLH
Sbjct: 61 L--HYSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAA-EIASALGYLH-S 114
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNA 714
N+++ +L N+LLD + + + DFGL + A ++T GT Y APE+ + +
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT-TFCGTPEYLAPEVIRKQPY 173
Query: 715 NTKTDVYSLGVIILELLTGKSP 736
+ D + LG ++ E+L G P
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 51/198 (25%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLA-LRA 598
E +G+ GT + A + G EVA+K++ + ++ E + ++ +PN++ L +
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
+ +G E +V +++ GSL + ET ++ A ++ + L +LH + +I
Sbjct: 85 FLVG--DELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHANQ-VI 137
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKT 718
H ++ S NVLL + ++ DFG +T + GT + APE+ K K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAYGPKV 196
Query: 719 DVYSLGVIILELLTGKSP 736
D++SLG++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 52/187 (27%), Positives = 94/187 (50%), Gaps = 11/187 (5%)
Query: 561 EVAVKRLREKTTKG-QKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSL 619
+VA+K L+ + K + E EA + ++ +P ++ R + +LV + G L
Sbjct: 24 DVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV--RMIGVCEAEALMLVMEMASGGPL 81
Query: 620 ASFLHARGPE-TIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIA 678
FL + E T+ N M ++ G+ YL +N +H +L + NVLL + +I+
Sbjct: 82 NKFLSGKKDEITVSNVVELMH---QVSMGMKYLE-GKNFVHRDLAARNVLLVNQHYAKIS 137
Query: 679 DFGLSRLMTAAANTNVIATAGT--LGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKS 735
DFGLS+ + A + +AG L + APE + ++++DV+S G+ + E + G+
Sbjct: 138 DFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQK 197
Query: 736 PGEPMNG 742
P + M G
Sbjct: 198 PYKKMKG 204
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 58/205 (28%), Positives = 103/205 (50%), Gaps = 23/205 (11%)
Query: 541 EIMGKSTYGTAYKATLEDGSE-VAVKRLREKTTKGQKEFEAEAAAIGKI------HHPNL 593
E +G+ TY T YK E VA+K + +G + AI +I H N+
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG-----TPSTAIREISLMKELKHENI 60
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
+ L + + + +LVF++M K L ++ G ++ T S + +G+ + H
Sbjct: 61 VRLHDV-IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH- 117
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT---NVIATAGTLGYRAPE-LS 709
E ++H +L N+L++++ ++ADFGL+R NT V+ TL YRAP+ L
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----TLWYRAPDVLL 173
Query: 710 KLKNANTKTDVYSLGVIILELLTGK 734
+ +T D++S+G I+ E++TG+
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 62/225 (27%), Positives = 112/225 (49%), Gaps = 25/225 (11%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEA---EAAAIGKIHHPNLLALR 597
+ +G+ ++G Y A + SE V + + T KE EA E + K+ HPN++
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLH-ARG----PETIVNWATRMSIAIGIARGLNYLH 652
A G +V ++ G L ++ RG + I++W ++S+ GL ++H
Sbjct: 66 AS-FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIH 118
Query: 653 VEENMIHGNLTSSNVLLDEKTN-PRIADFGLSRLMTAAANTNVIA--TAGTLGYRAPELS 709
+ ++H ++ S N+ L + ++ DFG++R + ++ +A GT Y +PE+
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN---DSMELAYTCVGTPYYLSPEIC 174
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK 754
+ + N KTD++SLG ++ EL T K P E G +L Q V I +
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFE---GNNLHQLVLKICQ 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 76/247 (30%), Positives = 119/247 (48%), Gaps = 28/247 (11%)
Query: 529 LFTADD---LLCATAEIMGKSTYGTAYKATLEDGSE-VAVKRLR---EKTTKGQKEFEAE 581
LF DD + EI G ++G Y AT +E VAVK++ ++T + ++ E
Sbjct: 13 LFYKDDPEEIFVGLHEI-GHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKE 71
Query: 582 AAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHA-RGPETIVNWATRMSI 640
+ ++ HPN + + YL + LV ++ GS + L + P V A +I
Sbjct: 72 VKFLQQLKHPNTIEYKGCYL-KEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA---AI 126
Query: 641 AIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT 700
G +GL YLH NMIH ++ + N+LL E ++ADFG S ++ AN+ V GT
Sbjct: 127 THGALQGLAYLH-SHNMIHRDIKAGNILLTEPGQVKLADFG-SASKSSPANSFV----GT 180
Query: 701 LGYRAPELSKLKNA---NTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVA-----SI 752
+ APE+ + + K DV+SLG+ +EL K P MN M +A ++
Sbjct: 181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL 240
Query: 753 VKEEWTN 759
EWT+
Sbjct: 241 QSNEWTD 247
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 5e-13
Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 42/209 (20%)
Query: 547 TYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEA-------EAAAIGKIHHPNLLALRA 598
TYG Y+A + G VA+K+L K +KE E E + K+ HPN++ ++
Sbjct: 17 TYGVVYRARDKKTGEIVALKKL-----KMEKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFL-HARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
+G +K+ +V +++ + L S + + P + + + + G+ +LH +N
Sbjct: 72 VVVGSNLDKIYMVMEYV-EHDLKSLMETMKQPFLQ---SEVKCLMLQLLSGVAHLH--DN 125
Query: 657 MI-HGNLTSSNVLLDEKTNPRIADFGLSRL-------MTAAANTNVIATAGTLGYRAPEL 708
I H +L +SN+LL+ + +I DFGL+R T V+ TL YRAPEL
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT----QLVV----TLWYRAPEL 177
Query: 709 SKL---KNANTKTDVYSLGVIILELLTGK 734
L K +T D++S+G I ELLT K
Sbjct: 178 --LLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 69/233 (29%), Positives = 106/233 (45%), Gaps = 49/233 (21%)
Query: 539 TAEIMGKSTYGTAYKATL------EDGSEVAVKRLREKTT-KGQKEFEAEAA---AIGKI 588
+ +G+ +G KA + S VAVK L++ T K + +E IGK
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK- 74
Query: 589 HHPNLLALRAYYLG---PKGEKLLVFDFMPKGSLASFLHARGP--------------ETI 631
H N++ L LG +G +V ++ G+L FL AR P ET+
Sbjct: 75 -HKNIINL----LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 632 VNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691
+S A +ARG+ +L + IH +L + NVL+ E +IADFGL+R +
Sbjct: 130 TQKDL-VSFAYQVARGMEFL-ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR------D 181
Query: 692 TNVI-----ATAGTLGYR--APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
+ I T G L + APE + ++DV+S GV++ E+ T G SP
Sbjct: 182 IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 68/225 (30%), Positives = 109/225 (48%), Gaps = 21/225 (9%)
Query: 529 LFTADD--LLCATAEIMGKSTYGTAYKA-TLEDGSEVAVKRLR---EKTTKGQKEFEAEA 582
LF DD L + +G ++G Y A + + VA+K++ +++ + ++ E
Sbjct: 7 LFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 583 AAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHA-RGPETIVNWATRMSIA 641
+ K+ HPN + R YL + LV ++ GS + L + P V A ++
Sbjct: 67 RFLQKLRHPNTIQYRGCYL-REHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA---AVT 121
Query: 642 IGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTL 701
G +GL YLH NMIH ++ + N+LL E ++ DFG + +M A AN V GT
Sbjct: 122 HGALQGLAYLH-SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-APANXFV----GTP 175
Query: 702 GYRAPELSKLKNA---NTKTDVYSLGVIILELLTGKSPGEPMNGM 743
+ APE+ + + K DV+SLG+ +EL K P MN M
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 37/217 (17%)
Query: 541 EIMGKSTYGTAYKA-TLEDGSEVAVKRLR-EKTTKGQKEFEAEAAAIGKI------HHPN 592
E +G+ TYG YKA G VA+K++R E +G + AI +I +HPN
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG-----VPSTAIREISLLKELNHPN 59
Query: 593 LLALRAYYLGPKGEKL-LVFDFMP---KGSLASFLH-ARGPETIVNWATRMSIAIGIARG 647
++ L + KL LVF+F+ K + S P I ++ ++ +G
Sbjct: 60 IVRL--LDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQL------LQG 111
Query: 648 LNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT---NVIATAGTLGYR 704
+ Y H ++H +L N+L+D + ++ADFGL+R T V+ TL YR
Sbjct: 112 IAYCH-SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYR 166
Query: 705 APE-LSKLKNANTKTDVYSLGVIILELLTGKS--PGE 738
APE L + +T D++S+G I E++ + PG+
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 542 IMGKSTYGTA----YKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIG------KIHHP 591
++GK +G +AT G A K+L +K K +K EA A+ K++
Sbjct: 7 VLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRK---GEAMALNEKQILEKVNSR 60
Query: 592 NLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGP-----ETIVNWATRMSIAIGIAR 646
+++L AY K LV M G L ++ G E V +A ++
Sbjct: 61 FVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC------ 113
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAP 706
GL LH E +++ +L N+LLD+ + RI+D GL+ + + GT+GY AP
Sbjct: 114 GLEDLH-RERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAP 170
Query: 707 ELSKLKNANTKTDVYSLGVIILELLTGKSP 736
E+ K + D + LG +I E++ GKSP
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 73/247 (29%), Positives = 118/247 (47%), Gaps = 28/247 (11%)
Query: 529 LFTADD---LLCATAEIMGKSTYGTAYKATLEDGSEV-AVKRLR---EKTTKGQKEFEAE 581
LF +D L EI G ++G Y A +EV A+K++ +++ + ++ E
Sbjct: 17 LFFKEDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKE 75
Query: 582 AAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHA-RGPETIVNWATRMSI 640
+ +I HPN + + YL + LV ++ GS + L + P V A +I
Sbjct: 76 VKFLQRIKHPNSIEYKGCYL-REHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIA---AI 130
Query: 641 AIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT 700
G +GL YLH NMIH ++ + N+LL E ++ADFG S + + AN+ V GT
Sbjct: 131 THGALQGLAYLH-SHNMIHRDIKAGNILLTEPGQVKLADFG-SASIASPANSFV----GT 184
Query: 701 LGYRAPELSKLKNA---NTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVA-----SI 752
+ APE+ + + K DV+SLG+ +EL K P MN M +A ++
Sbjct: 185 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL 244
Query: 753 VKEEWTN 759
EW++
Sbjct: 245 QSNEWSD 251
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-13
Identities = 35/90 (38%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 216 LALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNK 275
L L + L G +PN+ L LQ +NL N I G IP SLG + L+ + LS+N
Sbjct: 423 LGLDNQGLRGFIPNDISKL-----RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS 477
Query: 276 IVGPIPDELGKLSKLQKLDLSYNAIGGSFP 305
G IP+ LG+L+ L+ L+L+ N++ G P
Sbjct: 478 FNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 9e-13
Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 20/200 (10%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEA-----EAAAIGKI-HHPNLLAL 596
G T+G+ Y A E G VA+K++++K +E E ++ K+ HPN++ L
Sbjct: 8 GDGTFGSVYLARNKETGELVAIKKMKKKFYS----WEECMNLREVKSLRKLNEHPNIVKL 63
Query: 597 RAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
+ + E VF++M +G+L + R + R SI I +GL ++H +
Sbjct: 64 KEVFR-ENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIH-KHG 119
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSR-LMTAAANTNVIATAGTLGYRAPE-LSKLKNA 714
H +L N+L+ +IADFGL+R + + T+ ++T YRAPE L + +
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR---WYRAPEILLRSTSY 176
Query: 715 NTKTDVYSLGVIILELLTGK 734
++ D+++LG I+ EL T +
Sbjct: 177 SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-12
Identities = 58/210 (27%), Positives = 103/210 (49%), Gaps = 15/210 (7%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRL--REKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
E +GK ++G +K +V ++ E+ ++ + E + + P +
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
YL K KL ++ +++ GS L GP AT I I +GL+YLH E+
Sbjct: 70 SYL--KDTKLWIIMEYLGGGSALDLLEP-GPLDETQIAT---ILREILKGLDYLHSEKK- 122
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT--AGTLGYRAPELSKLKNAN 715
IH ++ ++NVLL E ++ADFG++ +T +T + GT + APE+ K +
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLT---DTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 716 TKTDVYSLGVIILELLTGKSPGEPMNGMDL 745
+K D++SLG+ +EL G+ P ++ M +
Sbjct: 180 SKADIWSLGITAIELAKGEPPHSELHPMKV 209
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 541 EIMGKSTYGTAYKA-TLEDGSEVAVKRLR-EKTTKGQKEFEA-EAAAIGKIHHPNLLALR 597
E +G+ TYGT +KA E VA+KR+R + +G E + ++ H N++ L
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
K + LVF++ + L + + + ++ S + +GL + H N+
Sbjct: 66 DVLHSDK-KLTLVFEYCDQ-DLKKYFDSCNGD--IDPEIVKSFMFQLLKGLAFCH-SHNV 120
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKLKNANT 716
+H +L N+L+++ ++ADFGL+R A TL YR P+ L K +T
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYST 179
Query: 717 KTDVYSLGVIILELLTGKSPGEPMNGMD 744
D++S G I EL P P N +D
Sbjct: 180 SIDMWSAGCIFAELANAGRPLFPGNDVD 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 543 MGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYL 601
+G TYG YKA + G A+K ++ + + + E + H N++A YL
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 602 GPKGEKLLV-FDFMPKGSLASFLHARGP--ETIVNWATRMSIAIGIARGLNYLHVEENMI 658
+ +KL + +F GSL H GP E+ + + +R ++ +GL YLH + +
Sbjct: 77 --RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH-SKGKM 128
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTA--AANTNVIATAGTLGYRAPELSKLKNA-- 714
H ++ +N+LL + + ++ADFG+S +TA A + I GT + APE++ ++
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI---GTPYWMAPEVAAVERKGG 185
Query: 715 -NTKTDVYSLGVIILELLTGKSP 736
N D++++G+ +EL + P
Sbjct: 186 YNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 48/156 (30%), Positives = 76/156 (48%), Gaps = 22/156 (14%)
Query: 588 IHHPNLLALRAYYLGPKGEK---LLVFDFMPKGSLASFLHARGP--ETIVNWATRMSIAI 642
H N++A+R P + +V D M + L +H+ P E + +
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRY-----FLY 114
Query: 643 GIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN------TNVIA 696
+ RGL Y+H N+IH +L SN+L++E RI DFG++R ++++ T +A
Sbjct: 115 QLLRGLKYIH-SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 697 TAGTLGYRAPELS-KLKNANTKTDVYSLGVIILELL 731
T YRAPEL L T D++S+G I E+L
Sbjct: 174 ---TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGK-IHHPNLLA 595
+++GK ++G A + DGS AVK L++KT K Q AE + K + HP L+
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 596 LRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
L + EKL V D++ G L F H + + R A +A + YLH
Sbjct: 61 LHYSFQTA--EKLYFVLDYVNGGEL--FFHLQRERCFLEPRARF-YAAEVASAIGYLH-S 114
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNA 714
N+I+ +L N+LLD + + + DFGL + T GT Y APE+ + +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS-TFCGTPEYLAPEVLRKEPY 173
Query: 715 NTKTDVYSLGVIILELLTGKSP 736
+ D + LG ++ E+L G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 538 ATAEIMGKSTYGTAYKATLEDGSE--VAVKRLREKTTKGQKEFEAEAAAIGKI------- 588
A E +G +G YK ++ + +A+K + K+ +IG I
Sbjct: 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTII 62
Query: 589 ----HHPNLLALRAYYLGPKGEKL-LVFDFMPKGSLASFL------HARGPETIVNWATR 637
HPN++ +L + ++L +V D + L R E + W
Sbjct: 63 KEQLRHPNIVRYYKTFL--ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WN-- 117
Query: 638 MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697
I + + L YLH E+ ++H +LT +N++L E I DFGL++ + + +
Sbjct: 118 --IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSV 173
Query: 698 AGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
GT+ Y PE+ K + K DV++ G I+ ++ T + P
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 3e-12
Identities = 58/209 (27%), Positives = 88/209 (42%), Gaps = 31/209 (14%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEA-----EAAAIGKIHHPNLLALR 597
G YG A G +VA+K++ +A E + + H N++ L
Sbjct: 9 GSGAYGVVCSAVDKRTGRKVAIKKISNVF---DDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 598 AYYLGPKGEKL----LVFDFMPKGSLASFLHARGP--ETIVNWATRMSIAIGIARGLNYL 651
P E +V + M L + + P + + + I RGL YL
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-----FLYQILRGLKYL 119
Query: 652 HVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAG--TLGYRAPEL- 708
H N+IH +L SN+L++ + +I DFGL+R + + T T YRAPEL
Sbjct: 120 H-SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELL 178
Query: 709 ---SKLKNANTKTDVYSLGVIILELLTGK 734
S+ A D++S+G I ELLT K
Sbjct: 179 LSSSRYTKAI---DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 543 MGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEA-EAAAIGKIHHPNLLALRAYYL 601
+G+ TYG YKA +DG + L++ G E A + ++ HPN++AL+ +L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 602 GPKGEKL-LVFDFMP----------KGSLASFLHARGPETIVNWATRMSIAIGIARGLNY 650
K+ L+FD+ + S A+ + P ++V S+ I G++Y
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK-----SLLYQILDGIHY 123
Query: 651 LHVEENMIHGNLTSSNVLL----DEKTNPRIADFGLSRLMTAAAN--TNVIATAGTLGYR 704
LH ++H +L +N+L+ E+ +IAD G +RL + ++ T YR
Sbjct: 124 LHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 705 APELSKLKNANTKT-DVYSLGVIILELLTGK 734
APEL TK D++++G I ELLT +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 31/216 (14%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRA 598
E +GK TYG YK T +DGS AVK L + + +E EAE + + +HPN++
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKIL-DPISDVDEEIEAEYNILQSLPNHPNVVKFYG 86
Query: 599 -YYLGPK---GEKLLVFDFMPKGSLASFLHA------RGPETIVNWATRMSIAIGIARGL 648
+Y K G+ LV + GS+ + R E ++++ I G GL
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY-----ILYGALLGL 141
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA---ANTNVIATAGTLGYRA 705
+LH +IH ++ +N+LL + ++ DFG+S +T+ NT+V GT + A
Sbjct: 142 QHLH-NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV----GTPFWMA 196
Query: 706 PELSKLKNA-----NTKTDVYSLGVIILELLTGKSP 736
PE+ + + + DV+SLG+ +EL G P
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 43/144 (29%), Positives = 80/144 (55%), Gaps = 12/144 (8%)
Query: 605 GEKLLVFDFMPKGSLASFLHA--RGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNL 662
GE + + M GSL L R PE I+ ++I + RGL YL + ++H ++
Sbjct: 76 GEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLREKHQIMHRDV 130
Query: 663 TSSNVLLDEKTNPRIADFGLS-RLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVY 721
SN+L++ + ++ DFG+S +L+ + AN+ V GT Y +PE + + + ++D++
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSDIW 186
Query: 722 SLGVIILELLTGKSPGEPMNGMDL 745
S+G+ ++EL G+ P P + +L
Sbjct: 187 SMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 55/222 (24%), Positives = 101/222 (45%), Gaps = 30/222 (13%)
Query: 543 MGKSTYGTAYKAT-LEDGSEVAVKRL----------REKTTKGQKEFEAEAAAIGKIHHP 591
+GK + YKA L DG VA+K++ R+ K E + ++ HP
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-------EIDLLKQLDHP 62
Query: 592 NLLALRAYYLGPKGEKLLVFDFMPKGSLASFL-HARGPETIVNWATRMSIAIGIARGLNY 650
N++ A ++ E +V + G L+ + H + + ++ T + + L +
Sbjct: 63 NVIKYLASFI-ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 651 LHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM---TAAANTNVIATAGTLGYRAPE 707
+H + ++H ++ +NV + ++ D GL R T AA++ V GT Y +PE
Sbjct: 122 MH-SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV----GTPYYMSPE 176
Query: 708 LSKLKNANTKTDVYSLGVIILELLTGKSP--GEPMNGMDLPQ 747
N K+D++SLG ++ E+ +SP G+ MN L +
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 54/182 (29%), Positives = 89/182 (48%), Gaps = 17/182 (9%)
Query: 559 GSEVAVKRLREKTTKGQKE-FEAEAAAIGKIHHPNLLALRAYYLG---PKGEK--LLVFD 612
G VAVK L+ + + ++ E + ++H N++ Y G +G K L+ +
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK----YKGCCSEQGGKGLQLIME 88
Query: 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK 672
++P GSL +L P+ +N A + A I G+ YLH ++ IH +L + NVLLD
Sbjct: 89 YVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLH-SQHYIHRDLAARNVLLDND 143
Query: 673 TNPRIADFGLSRLMTAAANTNVIATAGT--LGYRAPELSKLKNANTKTDVYSLGVIILEL 730
+I DFGL++ + + G + + A E K + +DV+S GV + EL
Sbjct: 144 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203
Query: 731 LT 732
LT
Sbjct: 204 LT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 46/229 (20%)
Query: 538 ATAEIMGKSTYGTAYKATL-EDGS--EVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPN 592
A + +G+ +G+ + L +D S +VAVK ++ T ++F +EA + + HPN
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 593 LLAL---------RAYYLGPKGEKLLVFDFMPKGSLASFL-HARGPETIVNWATRMSIAI 642
++ L Y P +++ FM G L SFL ++R + T+M +
Sbjct: 62 VMRLIGVCLQTVESEGYPSP----VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117
Query: 643 --GIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT 700
IA G+ YL ++ IH +L + N +L+E N +ADFGLS+ +
Sbjct: 118 MTDIASGMEYLS-SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDY--------- 167
Query: 701 LGYRAPELSKL------------KNANTKTDVYSLGVIILELLT-GKSP 736
YR ++K+ + TK+DV+S GV + E+ T G++P
Sbjct: 168 --YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 50/197 (25%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 543 MGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYL 601
+G+ + G AT + G +VAVK++ + + ++ E + HH N++ + YL
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 602 GPKGEKL-LVFDFMPKGSLASFL-HARGPETIVNWATRMSIAIGIARGLNYLHVEENMIH 659
G++L +V +F+ G+L + H R E + ++ + + R L+YLH + +IH
Sbjct: 90 --VGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLH-NQGVIH 141
Query: 660 GNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTD 719
++ S ++LL +++DFG ++ + GT + APE+ T+ D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK-SLVGTPYWMAPEVISRLPYGTEVD 200
Query: 720 VYSLGVIILELLTGKSP 736
++SLG++++E++ G+ P
Sbjct: 201 IWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 32/217 (14%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRA 598
E++G+ TYG YKA + G VA+K + + ++E + E + K +HPN+
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYG 70
Query: 599 YYL-----GPKGEKLLVFDFMPKGS---LASFLHARG---PETIVNWATRMSIAIGIARG 647
++ G + LV + GS L L +G E + + R RG
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR-----ETLRG 125
Query: 648 LNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA---NTNVIATAGTLGYR 704
L YLH E +IH ++ N+LL + ++ DFG+S + + NT + GT +
Sbjct: 126 LAYLH-ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI----GTPYWM 180
Query: 705 APE--LSKLKNANT---KTDVYSLGVIILELLTGKSP 736
APE + + ++DV+SLG+ +EL GK P
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 40/128 (31%), Positives = 63/128 (49%), Gaps = 9/128 (7%)
Query: 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVL 668
LV +++ G AS + G +WA + IA + G+ LH + +IH ++ N+L
Sbjct: 74 LVMEYLNGGDCASLIKTLGGLPE-DWA-KQYIA-EVVLGVEDLH-QRGIIHRDIKPENLL 129
Query: 669 LDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIIL 728
+D+ + ++ DFGLSR N + GT Y APE + +D +SLG +I
Sbjct: 130 IDQTGHLKLTDFGLSRN--GLENKKFV---GTPDYLAPETILGVGDDKMSDWWSLGCVIF 184
Query: 729 ELLTGKSP 736
E L G P
Sbjct: 185 EFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 543 MGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYL 601
+G TYG YKA L G AVK ++ + + E + + H N++A YL
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 602 GPKGEKLLV-FDFMPKGSLASFLHARGP--ETIVNWATRMSIAIGIARGLNYLHVEENMI 658
EKL + ++ GSL H GP E + + R ++ +GL YLH + M
Sbjct: 77 SR--EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM- 128
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTA--AANTNVIATAGTLGYRAPELSKL-KNA- 714
H ++ +N+LL + + ++ADFG++ +TA A + I GT + APE++ + KN
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI---GTPYWMAPEVAAVEKNGG 185
Query: 715 -NTKTDVYSLGVIILELLTGKSP 736
N D++++G+ +EL + P
Sbjct: 186 YNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 542 IMGKSTYGTAY---KATLED-GSEVAVKRLREKTTKGQKEFEAEAAAIGKI------HHP 591
++G YG + K D G A+K L+ K T QK AE + P
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLK-KATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 592 NLLALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNY 650
L+ L +Y KL L+ D++ G L + L+ R E R+ IA I L++
Sbjct: 66 FLVTL--HYAFQTDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIA-EIVLALDH 120
Query: 651 LHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSK 710
LH + +I+ ++ N+LLD + + + DFGLS+ A + GT+ Y APE+ +
Sbjct: 121 LH-QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 711 LKNA--NTKTDVYSLGVIILELLTGKSP 736
+ + D +SLGV+ ELLTG SP
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 52/198 (26%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
E +G+ GT Y A + G EVA+K++ + ++ E + + HPN++
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
YL G++L +V +++ GSL + ET ++ ++ + L +LH + +I
Sbjct: 85 YL--VGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ-VI 137
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKT 718
H ++ S N+LL + ++ DFG +T + GT + APE+ K K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAYGPKV 196
Query: 719 DVYSLGVIILELLTGKSP 736
D++SLG++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 31/216 (14%)
Query: 543 MGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEA--EAAAIGKIHHPNLLAL--R 597
+G+ T+G YKA ++ G VA+K++ K A E + K+ HPN++ L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 598 AYYLGP-----KGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLH 652
A +G +V +M L+ L P + + + + G+NYLH
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYM-DHDLSGLLE--NPSVKLTESQIKCYMLQLLEGINYLH 132
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL-------------MTAAANTNVIATAG 699
E +++H ++ ++N+L+D + +IADFGL+R TN++ T
Sbjct: 133 -ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR- 190
Query: 700 TLGYRAPEL-SKLKNANTKTDVYSLGVIILELLTGK 734
YR PEL + T D++ +G + E+ T +
Sbjct: 191 --WYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 542 IMGKSTYGTAYKATLE-DGSEVAVKRL---REKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
++GK +G + G A KRL R K KG+ E + K++ ++ L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL- 65
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARG-----PETIVNWATRMSIAIGIARGLNYLH 652
AY K LV M G L ++ G E + +A I GL LH
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE------ILCGLEDLH 119
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLK 712
EN ++ +L N+LLD+ + RI+D GL+ + ++ GT+GY APE+ +
Sbjct: 120 -RENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQ 176
Query: 713 NANTKTDVYSLGVIILELLTGKSP 736
D + LG +I E++ G+SP
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 7e-12
Identities = 40/98 (40%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGY 703
I RGL Y+H +IH +L SN+ ++E +I DFGL+R T T +AT Y
Sbjct: 127 ILRGLKYIH-SAGIIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDEMTGYVATR---WY 181
Query: 704 RAPELSKLKNANTKT-DVYSLGVIILELLTGKS--PGE 738
RAPE+ +T D++S+G I+ ELLTGK+ PG
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 543 MGKSTYGTAYKATLED-GSEVAVKRLREKTTK---GQKEFEAEAAAIGKIHHPNLLALRA 598
+GK +G +++ G A K+L +K K G+K E + K++ P ++ L A
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGP-----ETIVNWATRMSIAIGIARGLNYLHV 653
Y K LV M G L ++ G E +++++ + I G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLH- 112
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKN 713
++++ ++ NVLLD++ N R++D GL+ + AGT GY APE+ K +
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTIT--QRAGTNGYMAPEILKEEP 170
Query: 714 ANTKTDVYSLGVIILELLTGKSP 736
+ D +++G I E++ G++P
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 9e-12
Identities = 51/198 (25%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 541 EIMGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLA-LRA 598
E +G+ GT Y A + G EVA+K++ + ++ E + + +PN++ L +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
Y +G E +V +++ GSL + ET ++ ++ + L++LH + +I
Sbjct: 85 YLVG--DELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSNQ-VI 137
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKT 718
H ++ S N+LL + ++ DFG +T + GT + APE+ K K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAYGPKV 196
Query: 719 DVYSLGVIILELLTGKSP 736
D++SLG++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 15/204 (7%)
Query: 541 EIMGKSTYGTAYKATLEDGS----EVAVKRLREKTTKGQKE-FEAEAAAIGKIHHPNLLA 595
+G+ +G Y+ VAVK + T+ +E F EA + + HP+++
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 596 LRAYYLGPKGEK--LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
L +G E +V + P G L S+L + A+ + + ++ L YL
Sbjct: 72 L----IGVITENPVWIVMELAPLGELRSYLQVNKYSLDL--ASLILYSYQLSTALAYLE- 124
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKN 713
+ +H ++ + NVL+ ++ DFGLSR + + + + APE +
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 714 ANTKTDVYSLGVIILELLT-GKSP 736
+ +DV+ GV + E+L G P
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 543 MGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQ-KEFEAEAAAIGKIHHPNLLALR-AY 599
+GK YG+ YK G +A+K +R + + + + E + K P ++ A+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPET-IVNWATRMSIAIGIARGLNYLHVEENMI 658
++ +G + ++M GSL L+A G T + I + +GL +L E N+I
Sbjct: 69 FI--EGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLS-RLMTAAANTNVIATAGTLGYRAPELSKLKNAN-- 715
H ++ +NVL++ ++ DFG+S L+ + A TN+ G Y APE K N
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERIKSGGPNQN 181
Query: 716 ----TKTDVYSLGVIILELLTGKSPGEP 739
++DV+SLG+ ILE+ G+ P P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPP 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 54/211 (25%), Positives = 101/211 (47%), Gaps = 30/211 (14%)
Query: 547 TYGTAYKATLEDGS-----EVAVKRLREKTTKGQKE-FEAEAAAIGKIHHPNLLALRAYY 600
T+G + L D EV VK +++ ++ Q E+ + + H N+L +
Sbjct: 18 TFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVC 77
Query: 601 LGPKGEKLLVFDFMPKGSLASFLH------ARGPETIVNWATR--MSIAIGIARGLNYLH 652
+ +++ +M G+L FL A P+ + +T+ + +AI IA G++YLH
Sbjct: 78 IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL---STQQLVHMAIQIACGMSYLH 134
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA------ANTNVIATAGTLGYRAP 706
+ +IH ++ + N ++DE+ +I D LSR + N N + + A
Sbjct: 135 -KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN-----RPVKWMAL 188
Query: 707 ELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
E K ++ +DV+S GV++ EL+T G++P
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 1e-11
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAY 599
E++G TYG YK ++A ++ + T ++E + E + K HH N+
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 600 YL--GPKG---EKLLVFDFMPKGSLASFL-HARGPETIVNWATRMSIAIGIARGLNYLHV 653
++ P G + LV +F GS+ + + +G W I I RGL++LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH- 128
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLS-RLMTAAANTNVIATAGTLGYRAPEL---- 708
+ +IH ++ NVLL E ++ DFG+S +L N GT + APE+
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYWMAPEVIACD 186
Query: 709 -SKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743
+ + K+D++SLG+ +E+ G P M+ M
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 57/217 (26%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQ-KEFEAEAAAIGKIHH---PNLLA 595
E++G+ YG Y+ + G VA+K + T + + E A + ++ PN+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 596 LRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGP--ETIVNWATRMSIAIGIARGLNYLH 652
YL KG +L ++ ++ GS+ + + A GP E ++ R + L Y+H
Sbjct: 67 YYGSYL--KGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLV-----ALKYIH 118
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKL 711
+ +IH ++ ++N+L+ N ++ DFG++ L+ ++ GT + APE +++
Sbjct: 119 -KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR-STFVGTPYWMAPEVITEG 176
Query: 712 KNANTKTDVYSLGVIILELLTGKSP---GEPMNGMDL 745
K +TK D++SLG+ I E+ TG P + M L
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML 213
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 542 IMGKSTYGTAYKAT-LEDGSEVAVKRLREKTT---KGQKEFEAEAAAIGK-IHHPNLLAL 596
++GK ++G A DG AVK L++K K QK AE + K + HP L+ L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 597 RAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
+ +KL V D++ G L F H + + R A IA L YLH
Sbjct: 62 HYSFQTA--DKLYFVLDYVNGGEL--FFHLQRERSFPEPRARF-YAAEIASALGYLH-SL 115
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNAN 715
N+I+ +L N+LLD + + + DFGL + + T GT Y APE+ + + +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS-TFCGTPEYLAPEVLRKQPYD 174
Query: 716 TKTDVYSLGVIILELLTGKSP 736
D + LG ++ E+L G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 41/146 (28%), Positives = 80/146 (54%), Gaps = 12/146 (8%)
Query: 605 GEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNL 662
GE + + M GSL L G PE I+ ++I + +GL YL + ++H ++
Sbjct: 76 GEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREKHKIMHRDV 130
Query: 663 TSSNVLLDEKTNPRIADFGLS-RLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVY 721
SN+L++ + ++ DFG+S +L+ + AN+ V GT Y +PE + + + ++D++
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSDIW 186
Query: 722 SLGVIILELLTGKSPGEPMNGMDLPQ 747
S+G+ ++E+ G+ P P + +L
Sbjct: 187 SMGLSLVEMAIGRYPIPPPDAKELEL 212
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 543 MGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEA-EAAAIGKIHHPNLLALRAYYL 601
+G+ TYG YKA +DG + L++ G E A + ++ HPN+++L+ +L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 602 GPKGEKL-LVFDFMP----------KGSLASFLHARGPETIVNWATRMSIAIGIARGLNY 650
K+ L+FD+ + S A+ + P +V S+ I G++Y
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK-----SLLYQILDGIHY 123
Query: 651 LHVEENMIHGNLTSSNVLL----DEKTNPRIADFGLSRLMTAAAN--TNVIATAGTLGYR 704
LH ++H +L +N+L+ E+ +IAD G +RL + ++ T YR
Sbjct: 124 LHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 705 APELSKLKNANTKT-DVYSLGVIILELLTGK 734
APEL TK D++++G I ELLT +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 55/216 (25%), Positives = 111/216 (51%), Gaps = 27/216 (12%)
Query: 543 MGKSTYGTAYKATL----EDGSEVAVKRLR--EKTTKGQKEFEAEAAAIGKIHHPNLLAL 596
+G+ ++G KA L EDG + +K + + + K ++E E A + + HPN++
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 597 RAYYLGPKGEKLLVFDFMPKGSLASFLHA-RG----PETIVNWATRMSIAIGIARGLNYL 651
+ + G +V D+ G L ++A RG + I++W ++ +A L ++
Sbjct: 65 QESF-EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHV 117
Query: 652 HVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA--GTLGYRAPELS 709
H + ++H ++ S N+ L + ++ DFG++R++ +T +A GT Y +PE+
Sbjct: 118 H-DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN---STVELARTCIGTPYYLSPEIC 173
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745
+ + N K+D+++LG ++ E+ T K E N +L
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 23/226 (10%)
Query: 529 LFTADD---LLCATAEIMGKSTYGTAYKATLEDGSE-VAVKRLR---EKTTKGQKEFEAE 581
LF+ DD L EI G ++G Y A +E VA+K++ +++ + ++ E
Sbjct: 7 LFSKDDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKE 65
Query: 582 AAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHA-RGPETIVNWATRMSI 640
+ ++ HPN + + YL + LV ++ GS + L + P V A +I
Sbjct: 66 VRFLQQLRHPNTIEYKGCYL-REHTAWLVMEYC-LGSASDILEVHKKPLQEVEIA---AI 120
Query: 641 AIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT 700
G +GL YLH IH ++ + N+LL E ++ADFG S + + AN+ V GT
Sbjct: 121 CHGALQGLAYLH-SHERIHRDIKAGNILLTEPGTVKLADFG-SASLVSPANSFV----GT 174
Query: 701 LGYRAPELSKLKNA---NTKTDVYSLGVIILELLTGKSPGEPMNGM 743
+ APE+ + + K DV+SLG+ +EL K P MN M
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 542 IMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIG------KIHHPNLL 594
++GK +G + G A K+L +K K +K E+ A+ K++ ++
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRK---GESMALNEKQILEKVNSRFVV 63
Query: 595 ALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
+L AY K LV M G L ++ G E + A I GL LH +
Sbjct: 64 SL-AYAYETKDALCLVLTLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLH-Q 120
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNA 714
E +++ +L N+LLD+ + RI+D GL+ + + GT+GY APE+ K +
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERY 178
Query: 715 NTKTDVYSLGVIILELLTGKSP 736
D ++LG ++ E++ G+SP
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 50/200 (25%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 543 MGKSTYGTAYKATLEDGSE-VAVKRL--REKTTKGQKE-FEAEAAAIGKIHHPNLLALRA 598
+G T+G + A+K + E Q++ E + ++ HP ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 599 YYLGPKGEKLL--VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
+ ++ L + +++P G L S+L G + +T + A I L YLH +
Sbjct: 67 -FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYLH-SKE 121
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANT 716
+++ +L N+LLD++ + ++ DFG ++ + T GT Y APE+ + K N
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT----LCGTPEYLAPEVIQSKGHNK 177
Query: 717 KTDVYSLGVIILELLTGKSP 736
D ++LG++I E+L G P
Sbjct: 178 AVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 50/198 (25%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLA-LRA 598
E +G+ GT Y A + G EVA++++ + ++ E + + +PN++ L +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
Y +G E +V +++ GSL + ET ++ ++ + L +LH + +I
Sbjct: 86 YLVG--DELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSNQ-VI 138
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKT 718
H ++ S N+LL + ++ DFG +T + GT + APE+ K K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAYGPKV 197
Query: 719 DVYSLGVIILELLTGKSP 736
D++SLG++ +E++ G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 53/188 (28%), Positives = 96/188 (51%), Gaps = 10/188 (5%)
Query: 562 VAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL-VFDFMPKGSL 619
VA+ LR + K ++ F AEA +G+ H N++ L +G ++ V ++M G+L
Sbjct: 36 VAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI--TRGNTMMIVTEYMSNGAL 93
Query: 620 ASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIAD 679
SFL R E + M + G+A G+ YL E +H L + VL++ +I+
Sbjct: 94 DSFL--RKHEGQLVAGQLMGMLPGLASGMKYL-SEMGYVHKGLAAHKVLVNSDLVCKISG 150
Query: 680 FG-LSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPG 737
F L + A T + + L + APE + + ++ +DV+S G+++ E+++ G+ P
Sbjct: 151 FRRLQEDKSEAIYTTMSGKSPVL-WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY 209
Query: 738 EPMNGMDL 745
M+G D+
Sbjct: 210 WDMSGQDV 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 18/216 (8%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAY 599
E++G TYG YK ++A ++ + T ++E + E + K HH N+
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 600 YL--GPKGEK---LLVFDFMPKGSLASFL-HARGPETIVNWATRMSIAIGIARGLNYLHV 653
++ P G LV +F GS+ + + +G +W I I RGL +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLHA 139
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLS-RLMTAAANTNVIATAGTLGYRAPELSKL- 711
+ +IH ++ NVLL E ++ DFG+S +L N GT + APE+
Sbjct: 140 HK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IGTPYWMAPEVIACD 196
Query: 712 KNANT----KTDVYSLGVIILELLTGKSPGEPMNGM 743
+N + ++D++SLG+ +E+ G P M+ M
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 18/209 (8%)
Query: 544 GKSTYGTAYKATLEDGS-EVAVKRLREKTTKGQKE-FEAEAAAIGKI-HHPNLLALRAYY 600
GK TAY + D +VAVK L+ ++E +E + + +H N++ L
Sbjct: 49 GKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNL---- 104
Query: 601 LGP---KGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
LG G L++ ++ G L +FL R E+ + +S + +A+G+ +L +N
Sbjct: 105 LGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQVAKGMAFL-ASKNC 162
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAG-TLGYRAPELSKLKNANT 716
IH +L + NVLL +I DFGL+R + +N V A + + APE S T
Sbjct: 163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE-SIFNCVYT 221
Query: 717 -KTDVYSLGVIILELLT-GKS--PGEPMN 741
++DV+S G+++ E+ + G + PG P++
Sbjct: 222 FESDVWSYGILLWEIFSLGSNPYPGMPVD 250
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 18/200 (9%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFEAEAAAIGKIHHPNLLAL-R 597
EI+G GT YKA L +AVK + + T + QK+ +E + K P ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
A+++ + + +FM GSL ++ + PE ++ IA+ + +GL YL +
Sbjct: 67 AFFV--ENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLW-SLKI 116
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSR-LMTAAANTNVIATAGTLGYRAPELSKLKNANT 716
+H ++ SN+L++ + ++ DFG+S L+ + A T V GT Y APE +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV----GTNAYMAPERISGEQYGI 172
Query: 717 KTDVYSLGVIILELLTGKSP 736
+DV+SLG+ +EL G+ P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 48/164 (29%), Positives = 80/164 (48%), Gaps = 21/164 (12%)
Query: 581 EAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSI 640
E + ++HPN++ + GE ++ +FM GSL I + +
Sbjct: 122 EIEILRDVNHPNVVKCHDMF-DHNGEIQVLLEFMDGGSLEG-------THIADEQFLADV 173
Query: 641 AIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA---ANTNVIAT 697
A I G+ YLH +++H ++ SN+L++ N +IADFG+SR++ N++V
Sbjct: 174 ARQILSGIAYLH-RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--- 229
Query: 698 AGTLGYRAPE-----LSKLKNANTKTDVYSLGVIILELLTGKSP 736
GT+ Y +PE L+ D++SLGV ILE G+ P
Sbjct: 230 -GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 38/221 (17%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFE--AEAAAIGK-------IHH 590
E++GK +YG A G +VA+K++ + FE ++A I + + H
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDV-------FEHVSDATRILREIKLLRLLRH 58
Query: 591 PNLLALRAYYLGPKGEKL----LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIAR 646
P+++ ++ L P + +VF+ M + L + A T + + + R
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFL---YQLLR 114
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT--AGTLGYR 704
L Y+H N+ H +L N+L + +I DFGL+R+ T + T T YR
Sbjct: 115 ALKYIHTA-NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 705 APEL-----SKLKNANTKTDVYSLGVIILELLTGKS--PGE 738
APEL SK A D++S+G I E+LTGK PG+
Sbjct: 174 APELCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGK 211
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 543 MGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFE---AEAAAIGKIHHPNLLAL-RA 598
+G +G YKA ++ +A ++ + TK ++E E E + HPN++ L A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 599 YYLGPKGEKLLVFDFMPKGSL-ASFLHARGP--ETIVNWATRMSIAIGIARGLNYLHVEE 655
+Y + ++ +F G++ A L P E + + ++ LNYLH E
Sbjct: 71 FYY--ENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-----EALNYLH-EN 122
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI----ATAGTLGYRAPEL--- 708
+IH +L + N+L + ++ADFG+S A NT I + GT + APE+
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 709 --SKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743
SK + + K DV+SLG+ ++E+ + P +N M
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM 214
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 18/219 (8%)
Query: 543 MGKSTYGTAYKA---TLEDGSEVAVKRLREKTTKG--QKEFEAEAAAIGKIHHPNLLALR 597
+G +GT K + VAVK L+ + E EA + ++ +P ++ +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM- 61
Query: 598 AYYLGP-KGEK-LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
+G + E +LV + G L FL T N + ++ G+ YL E
Sbjct: 62 ---IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNI---TELVHQVSMGMKYLE-ET 114
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT--LGYRAPELSKLKN 713
N +H +L + NVLL + +I+DFGLS+ + A N T G + + APE
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 714 ANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWVAS 751
++K+DV+S GV++ E + G+ P + M G ++ Q + S
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 543 MGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLAL-RAYY 600
+G +G YKA E G A K ++ ++ + ++F E + + HPN++ L AY+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARG---PETIVNWATRMSIAIGIARGLNYLHVEENM 657
K L+ +F G+L S + E + + R + LN+LH +
Sbjct: 73 YENKLWILI--EFCDGGALDSIMLELERGLTEPQIRYVCRQ-----MLEALNFLH-SHKV 124
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT----AGTLGYRAPEL----- 708
IH +L + N+LL + ++ADFG+S A N + + GT + APE+
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVS-----AKNKSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 709 SKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743
K + K D++SLG+ ++EL + P +N M
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM 214
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 9e-11
Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 14/157 (8%)
Query: 589 HHPNLLALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARG 647
HPN++ L + + LVF++M + LHA I+ + I + +
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLLKA 119
Query: 648 LNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA--AANTNVIAT--AGTLGY 703
L Y+H N+IH +L SN+LL+ ++ADFGL+R ++ N + T T Y
Sbjct: 120 LKYIH-SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 704 RAPE-LSKLKNANTKTDVYSLGVIILELLTGKS--PG 737
RAPE L D++S+G I+ E+L GK PG
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 49/206 (23%), Positives = 99/206 (48%), Gaps = 10/206 (4%)
Query: 543 MGKSTYGTAYKAT-LEDGSEVAVKRLR---EKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
+G+ + Y+AT L DG VA+K+++ K + + E + +++HPN++ A
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFL-HARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
++ E +V + G L+ + H + + ++ T + + L ++H +
Sbjct: 70 SFI-EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH-SRRV 127
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTK 717
+H ++ +NV + ++ D GL R ++ T + GT Y +PE N K
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 718 TDVYSLGVIILELLTGKSP--GEPMN 741
+D++SLG ++ E+ +SP G+ MN
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMN 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 541 EIMGKSTYGTAYKATLEDGSE-VAVKRLR-EKTTKGQKEFEA-EAAAIGKIHHPNLLALR 597
E +G+ TYG YKA +E +A+K++R E+ +G E + + ++ H N++ L+
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 598 AYYLGPKGEKLLVFDF----MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
K LVF++ + K +S A+ P I + ++ RG+ Y H
Sbjct: 68 DVVHSEK-RLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQI------LRGIAYCH- 119
Query: 654 EENMIHGNLTSSNVLLDEKTNP-RIADFGLSRLMTAAANT---NVIATAGTLGYRAPE-L 708
++H +L N+L+D +TN ++ADFGL+R T V+ TL YRAPE L
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPEIL 175
Query: 709 SKLKNANTKTDVYSLGVIILELLTGKS--PGE 738
++ +T D++S+G I E++ K PG+
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 43/140 (30%), Positives = 77/140 (55%), Gaps = 12/140 (8%)
Query: 605 GEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNL 662
GE + + M GSL L G PE I+ I+I + RGL YL + ++H ++
Sbjct: 72 GEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLREKHKIMHRDV 126
Query: 663 TSSNVLLDEKTNPRIADFGLS-RLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVY 721
SN+L++ + ++ DFG+S +L+ + AN+ V GT Y +PE + + ++D++
Sbjct: 127 KPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYTVQSDIW 182
Query: 722 SLGVIILELLTGKSPGEPMN 741
SLG+ ++E+ G+ P P +
Sbjct: 183 SLGLSLVEMAIGRYPIPPPD 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 58/217 (26%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 543 MGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLAL-RAYY 600
+G +G YKA E G+ A K + K+ + +++ E + +HP ++ L A+Y
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHA--RG---PETIVNWATRMSIAIGIARGLNYLHVEE 655
G+ ++ +F P G++ + + RG P+ V I + L YLH
Sbjct: 80 W--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------ICRQMLEALQYLH-SM 129
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI----ATAGTLGYRAPEL--- 708
+IH +L + NVLL + ++ADFG+S A N + + GT + APE+
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 709 SKLKNA--NTKTDVYSLGVIILELLTGKSPGEPMNGM 743
+K+ + K D++SLG+ ++E+ + P +N M
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 221
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 13/205 (6%)
Query: 541 EIMGKSTYGTAY---KATLED-GSEVAVKRLRE----KTTKGQKEFEAEAAAIGKIHHPN 592
+++G YG + K T D G A+K L++ + K + E + +
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 593 LLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLH 652
L Y + + L+ D++ G + + L+ R + R I L +LH
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSG-EIILALEHLH 122
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLK 712
+ +++ ++ N+LLD + + + DFGLS+ + + GT+ Y APE+ + K
Sbjct: 123 -KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 713 NANTK-TDVYSLGVIILELLTGKSP 736
+ K D +SLG++I ELLTG SP
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 61/210 (29%), Positives = 88/210 (41%), Gaps = 35/210 (16%)
Query: 544 GKSTYGTAYKATLEDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602
GK G A+ + V VK LR T Q F E +++HPN+L LG
Sbjct: 9 GKVLLGEAH--RGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC----LG 62
Query: 603 PKGEK---LLVFDFMPKGSLASFL-----HARG-PETIVNWATRMSIAIGIARGLNYLHV 653
E LLV +F P G L ++L + V RM A +A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQRM--ACEVASGLLWLH- 117
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT----LGYRAPELS 709
+ + IH +L N L + +I D+GL+ + T L + APEL
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLAL---EQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 710 -------KLKNANTKTDVYSLGVIILELLT 732
K+ K++++SLGV + EL T
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 63/205 (30%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 543 MGKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFEAEAAAIG--KIHHPNLLALRAY 599
+GK T+G Y+ +D + A+K L +K +KE A IG I LL +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEV---AHTIGERNILVRTLLDESPF 57
Query: 600 YLGPK------GEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
+G K + LV D+M G L F H + + IA + L +LH
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIA-ELVLALEHLH- 113
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLGYRAPE-LSKL 711
+ ++++ +L N+LLD + + DFGLS+ +T TN GT Y APE L
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF--CGTTEYLAPEVLLDE 171
Query: 712 KNANTKTDVYSLGVIILELLTGKSP 736
K D +SLGV++ E+ G SP
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 62/226 (27%), Positives = 107/226 (47%), Gaps = 34/226 (15%)
Query: 542 IMGKSTYGTAYKAT------LEDGSEVAVKRLREKTTKGQ-KEFEAEAAAIGKIHHPNLL 594
+G+ +G KAT + VAVK L+E + + ++ +E + +++HP+++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 595 ALRAYYLGPKGEKLLVFDFMPKGSLASFLHAR---GP------------------ETIVN 633
L G LL+ ++ GSL SFL GP E +
Sbjct: 67 KLYGA-CSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 634 WATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693
+S A I+RG+ YL E ++H +L + NVL+ E +I+DFGLSR + ++
Sbjct: 126 MGDLISFAWQISRGMQYL-AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY-EEDSY 183
Query: 694 VIATAGTL--GYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
V + G + + A E T++DV+S GV++ E++T G +P
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 28/208 (13%)
Query: 541 EIMGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEAE---AAAIGKI------HH 590
E +G+ TYG YK + G VA+K++R E E E + AI +I H
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIR-------LESEEEGVPSTAIREISLLKELQH 58
Query: 591 PNLLALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLN 649
PN++ L+ + +L L+F+F+ L +L + ++ S I +G+
Sbjct: 59 PNIVCLQDVLMQES--RLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 650 YLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL--MTAAANTNVIATAGTLGYRAPE 707
+ H ++H +L N+L+D K ++ADFGL+R + T+ + TL YRAPE
Sbjct: 116 FCH-SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV---TLWYRAPE 171
Query: 708 -LSKLKNANTKTDVYSLGVIILELLTGK 734
L +T D++S+G I E+ T K
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 15/183 (8%)
Query: 562 VAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL-LVFDFMPKGSL 619
VAVK LR TK + +F E + ++ +PN++ L + + L ++ ++M G L
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV--SDDPLCMITEYMENGDL 104
Query: 620 ASFLHARGPETI---------VNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLD 670
FL R E+ V+ A + +A+ IA G+ YL N +H +L + N L+
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL-ASLNFVHRDLATRNCLVG 163
Query: 671 EKTNPRIADFGLSRLMTAAANTNVIATAG-TLGYRAPELSKLKNANTKTDVYSLGVIILE 729
+IADFG+SR + + + A + + A E L T +DV++ GV + E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 730 LLT 732
+ T
Sbjct: 224 MFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 64/228 (28%), Positives = 92/228 (40%), Gaps = 54/228 (23%)
Query: 543 MGKSTYGTAYKATL----EDGSE--VAVKRLREKTTKGQKE--FEAEAAAIGKIHHPNLL 594
+G +G Y+ D E VAVK L E + Q E F EA + K +H N++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE-SCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 595 ALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMS----IAIGIARGLNY 650
L + + ++ + M G L SFL P + M A +A+G Y
Sbjct: 73 RLIGVSF-ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 651 LHVEEN-MIHGNLTSSNVLLDEKTNPR---IADFGLSRLMTAAANTNVIATAGTLGYRAP 706
L EEN IH ++ + N LL K R IADFG++R + YRA
Sbjct: 132 L--EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI----------------YRAS 173
Query: 707 ELSKLKNA-----------------NTKTDVYSLGVIILELLT-GKSP 736
K A +KTDV+S GV++ E+ + G P
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 4/94 (4%)
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLG 702
I GL +LH ++ +I+ +L NVLLD+ + +IADFG+ + M + GT
Sbjct: 105 IICGLQFLH-KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC--GTPD 161
Query: 703 YRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
Y APE+ K + N D +S GV++ E+L G+SP
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 49/189 (25%), Positives = 89/189 (47%), Gaps = 12/189 (6%)
Query: 559 GSEVAVKRLREKTTKGQ-KEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL-LVFDFMPK 616
G +VAVK L+ ++ + + E + ++H N++ + G + L+ +F+P
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 617 GSLASFLHARGPETI--VNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN 674
GSL +L P +N ++ A+ I +G++YL +H +L + NVL++ +
Sbjct: 93 GSLKEYL----PRNKNKINLKQQLKYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEHQ 147
Query: 675 PRIADFGLSRLMTAAANTNVIAT--AGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT 732
+I DFGL++ + + + + APE +DV+S GV + ELLT
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
Query: 733 -GKSPGEPM 740
S PM
Sbjct: 208 YCDSESSPM 216
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-10
Identities = 38/93 (40%), Positives = 57/93 (61%), Gaps = 4/93 (4%)
Query: 652 HVE-ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELS 709
HV ++MIH ++ S+N+LL ++ DFG S++ A + +V T GT Y APE+
Sbjct: 158 HVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW 217
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSP--GEPM 740
+ K + K D++SLGV++ ELLT K P GE M
Sbjct: 218 RRKPYSKKADMFSLGVLLYELLTLKRPFDGENM 250
|
Length = 496 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 39/97 (40%), Positives = 57/97 (58%), Gaps = 8/97 (8%)
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGY 703
I RGL Y+H ++IH +L SN+ ++E +I DFGL+R T T +AT Y
Sbjct: 129 ILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTGYVATR---WY 183
Query: 704 RAPELS-KLKNANTKTDVYSLGVIILELLTGKS--PG 737
RAPE+ + N D++S+G I+ ELLTG++ PG
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 40/101 (39%), Positives = 56/101 (55%), Gaps = 13/101 (12%)
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN--TNVIATAGTL 701
+ RGL Y+H N++H +L SN+LL+ + +I DFGL+R + + T + T
Sbjct: 117 LLRGLKYIH-SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR--- 172
Query: 702 GYRAPELSKLKNANTKT---DVYSLGVIILELLTGKS--PG 737
YRAPEL L N + T DV+S+G I ELL K PG
Sbjct: 173 WYRAPEL--LLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG 211
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 17/203 (8%)
Query: 543 MGKSTYGTAYK--ATLEDGSEVAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLALRAY 599
+G+ TY T YK + L D + VA+K +R + +G E + + + H N++ L
Sbjct: 14 LGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIH 659
+ + LVF+++ K L +L G +N + RGLNY H ++H
Sbjct: 73 -IHTEKSLTLVFEYLDK-DLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCH-RRKVLH 127
Query: 660 GNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT--NVIATAGTLGYRAPE-LSKLKNANT 716
+L N+L++E+ ++ADFGL+R + T N + TL YR P+ L + +T
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV---TLWYRPPDILLGSTDYST 184
Query: 717 KTDVYSLGVIILELLTGKS--PG 737
+ D++ +G I E+ TG+ PG
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 58/220 (26%), Positives = 107/220 (48%), Gaps = 15/220 (6%)
Query: 541 EIMGKSTYGTAY---KATLEDGSEV-AVKRLREKTTKGQKEFEA--EAAAIGKIHHPNLL 594
+++G+ ++G + K T D ++ A+K L++ T K + E + +++HP ++
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 595 ALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
L Y +G+ L+ DF+ G L + L E + +A L++LH
Sbjct: 62 KLH-YAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLH-S 116
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNA 714
+I+ +L N+LLDE+ + ++ DFGLS+ + + GT+ Y APE+ +
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 175
Query: 715 NTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK 754
D +S GV++ E+LTG P G D + + I+K
Sbjct: 176 TQSADWWSFGVLMFEMLTGSL---PFQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 541 EIMGKSTYGTAY----KATLEDGSEVAVKRLREKTTKGQKEFE---AEAAAIGKIHHPNL 593
+++GK T+G KAT G A+K L+++ + E E + HP L
Sbjct: 1 KLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
AL+ Y V ++ G L F H R A I L+YLH
Sbjct: 58 TALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA-EIVSALDYLHS 113
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKN 713
E+N+++ +L N++LD+ + +I DFGL + T + GT Y APE+ + +
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MKTFCGTPEYLAPEVLEDND 172
Query: 714 ANTKTDVYSLGVIILELLTGKSP 736
D + LGV++ E++ G+ P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 543 MGKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEAAAIGKIHHPNLLALRA 598
+GK ++G + D + A+K +R+ + E AE + +++ P ++ L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
+ P EKL LV F+ G L F H + R A + L LH + N+
Sbjct: 61 SFQSP--EKLYLVLAFINGGEL--FHHLQREGRFDLSRARFYTA-ELLCALENLH-KFNV 114
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLGYRAPELSKLKNANT 716
I+ +L N+LLD + + + DFGL +L M TN GT Y APEL
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF--CGTPEYLAPELLLGHGYTK 172
Query: 717 KTDVYSLGVIILELLTGKSP 736
D ++LGV++ E+LTG P
Sbjct: 173 AVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 21/211 (9%)
Query: 533 DDLLCATAEIMGKSTYGTAYKA--TLEDGSE----VAVKRLREKTTK---GQKEFE-AEA 582
DD L T + + Y TL GSE VA K + GQK EA
Sbjct: 49 DDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEA 108
Query: 583 AAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP--KGSLASFLHARGPETIVNWATRMSI 640
+ ++HP+++ ++ L +V +P L ++L R + + I
Sbjct: 109 MLLQNVNHPSVIRMKDT-LVSGAITCMV---LPHYSSDLYTYLTKR--SRPLPIDQALII 162
Query: 641 AIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT 700
I GL YLH + +IH ++ + N+ +++ I D G ++ A + AGT
Sbjct: 163 EKQILEGLRYLH-AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAF--LGLAGT 219
Query: 701 LGYRAPELSKLKNANTKTDVYSLGVIILELL 731
+ APE+ N+K D++S G+++ E+L
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 55/191 (28%), Positives = 89/191 (46%), Gaps = 32/191 (16%)
Query: 562 VAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLG--PKGEKL-LVFDFMPKG 617
VAVK LR + +++F E + ++ PN+ L LG L ++ ++M G
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL----LGVCTVDPPLCMIMEYMENG 104
Query: 618 SLASFLHARGPET--------IVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL 669
L FL ET ++++T + +A IA G+ YL N +H +L + N L+
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE-SLNFVHRDLATRNCLV 163
Query: 670 DEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAP--------ELSKLKNANTKTDVY 721
+ +IADFG+SR + ++ V RAP E L TK+DV+
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRV-------QGRAPLPIRWMAWESVLLGKFTTKSDVW 216
Query: 722 SLGVIILELLT 732
+ GV + E+LT
Sbjct: 217 AFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 541 EIMGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPNLLALRA 598
E +GK TYG +K ++GS+ AVK L + +E EAE + + HPN++
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 599 YYLGP---KGEKL-LVFDFMPKGSLASFLHA------RGPETIVNWATRMSIAIGIARGL 648
Y G++L LV + GS+ + R E I+ + ++ GL
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM-----GL 137
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA---ANTNVIATAGTLGYRA 705
+LHV + IH ++ +N+LL + ++ DFG+S +T+ NT+V GT + A
Sbjct: 138 QHLHVNKT-IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV----GTPFWMA 192
Query: 706 PELSKLKNA-----NTKTDVYSLGVIILELLTGKSP 736
PE+ + + + DV+SLG+ +EL G P
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 41/161 (25%), Positives = 66/161 (40%), Gaps = 42/161 (26%)
Query: 609 LVFDFMPKGSLASFLHARG--PETIVNW-ATRMSIAIGIARGLNYLHVEENM--IHGNLT 663
LV ++MP G L + L + PE + + +A+ + +H + IH ++
Sbjct: 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLAL------DSVH---KLGFIHRDIK 128
Query: 664 SSNVLLDEKTNPRIADFGLSRLM--------------------------TAAANTNVIA- 696
N+L+D + ++ADFGL + M V A
Sbjct: 129 PDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRAN 188
Query: 697 -TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
T GT Y APE+ + + D +SLGVI+ E+L G P
Sbjct: 189 STVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 36/99 (36%), Positives = 55/99 (55%), Gaps = 4/99 (4%)
Query: 641 AIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAG 699
A I GL +LH E +I+ +L NVLLD + + +IADFG+ + + T+ G
Sbjct: 102 AAEIVLGLQFLH-ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC--G 158
Query: 700 TLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGE 738
T Y APE+ + D ++LGV++ E+L G+SP E
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 35/221 (15%)
Query: 541 EIMGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEAE---AAAIGKIHHPNLLAL 596
E +G+ TYG YKA G VA+K+ R E + E A+ +I +L+
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTR-------LEMDEEGIPPTALREISLLQMLSE 59
Query: 597 RAYYL-----------GPKGEKLLVFDFMPKGSLASFL--HARGPETIVNWATRMSIAIG 643
Y + K LVF+++ L F+ + RGP + T S
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLD-EKTNPRIADFGLSRLMT--AAANTNVIATAGT 700
+ +G+ + H + ++H +L N+L+D +K +IAD GL R + + T+ I T
Sbjct: 119 LLKGVAHCH-KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV---T 174
Query: 701 LGYRAPE-LSKLKNANTKTDVYSLGVIILELLTGKS--PGE 738
L YRAPE L + +T D++S+G I E+ + PG+
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 38/96 (39%), Positives = 53/96 (55%), Gaps = 8/96 (8%)
Query: 646 RGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRA 705
RGL Y+H +IH +L SNV ++E RI DFGL+R A+ + T YRA
Sbjct: 129 RGLKYIH-SAGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVATRWYRA 183
Query: 706 PELS-KLKNANTKTDVYSLGVIILELLTGKS--PGE 738
PE+ + N D++S+G I+ ELL GK+ PG
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 20/188 (10%)
Query: 562 VAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLA 620
VAVK LR K + +F E + ++ PN++ L + + ++ ++M G L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-EDPLCMITEYMENGDLN 107
Query: 621 SFLHAR----------------GPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTS 664
FL + +++++ + +A+ IA G+ YL N +H +L +
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL-SSLNFVHRDLAT 166
Query: 665 SNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAG-TLGYRAPELSKLKNANTKTDVYSL 723
N L+ E +IADFG+SR + A + A + + A E + T +DV++
Sbjct: 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAF 226
Query: 724 GVIILELL 731
GV + E+L
Sbjct: 227 GVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 29/204 (14%)
Query: 560 SEVAVKRLR-EKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGP---KGEKLLVFDFM 614
++VAVK L+ + T K + +E + I H N++ L LG G ++ ++
Sbjct: 51 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINL----LGACTQDGPLYVIVEYA 106
Query: 615 PKGSLASFLHAR-------------GPETIVNWATRMSIAIGIARGLNYLHVEENMIHGN 661
KG+L +L AR PE +++ +S A +ARG+ YL + IH +
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL-ASKKCIHRD 165
Query: 662 LTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTL--GYRAPELSKLKNANTKTD 719
L + NVL+ E +IADFGL+R + + T G L + APE + ++D
Sbjct: 166 LAARNVLVTEDNVMKIADFGLARDI-HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224
Query: 720 VYSLGVIILELLT-GKS--PGEPM 740
V+S GV++ E+ T G S PG P+
Sbjct: 225 VWSFGVLLWEIFTLGGSPYPGVPV 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 9e-10
Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 14/103 (13%)
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN-----TNVIATA 698
I RGL Y+H N++H +L SN+LL+ + +I DFGL+R+ + T +AT
Sbjct: 115 ILRGLKYIH-SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 699 GTLGYRAPE--LSKLKNANTKTDVYSLGVIILELLTGKS--PG 737
YRAPE L+ K D++S+G I+ E+L+ + PG
Sbjct: 174 ---WYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPG 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 9e-10
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 541 EIMGKSTYGTAY----KATLEDGSEVAVKRLREKTTKGQKEFE---AEAAAIGKIHHPNL 593
+++GK T+G KA+ G A+K L+++ + E E+ + HP L
Sbjct: 1 KLLGKGTFGKVILVREKAS---GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
+L+ Y K V +++ G L F H TR A I L+YLH
Sbjct: 58 TSLK-YSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGA-EIVSALDYLH- 112
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLGYRAPELSKLK 712
+++ +L N++LD+ + +I DFGL + +T AA GT Y APE+ +
Sbjct: 113 SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC--GTPEYLAPEVLEDN 170
Query: 713 NANTKTDVYSLGVIILELLTGKSP 736
+ D + LGV++ E++ G+ P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 540 AEIMGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEA--EAAAIGKIH---HPNL 593
AEI G YGT YKA G VA+K +R +T + E A + ++ HPN+
Sbjct: 6 AEI-GVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNI 64
Query: 594 LALRAYYLGPKGEK----LLVFDFMPKGSLASFLHARGP-----ETIVNWATRMSIAIGI 644
+ L + ++ LVF+ + + L ++L P ETI + +
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF------ 117
Query: 645 ARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA-AANTNVIATAGTLGY 703
RGL++LH ++H +L N+L+ ++ADFGL+R+ + A T V+ T L Y
Sbjct: 118 LRGLDFLHAN-CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVT---LWY 173
Query: 704 RAPELSKLKNANTKTDVYSLGVIILELLTGK 734
RAPE+ T D++S+G I E+ K
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 52/198 (26%), Positives = 83/198 (41%), Gaps = 24/198 (12%)
Query: 554 ATLEDGSE----VAVKRLREKTTK-------GQKEFEAEAAAIGKIHHPNLL-ALRAYYL 601
++L GSE V K E+ K G K E + I H ++ + AY
Sbjct: 98 SSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRW 157
Query: 602 GPKGEKLLVFDFMP--KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIH 659
V MP K L +++ GP + ++I + L YLH +IH
Sbjct: 158 KS-----TVCMVMPKYKCDLFTYVDRSGPLPL---EQAITIQRRLLEALAYLH-GRGIIH 208
Query: 660 GNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKT 718
++ + N+ LDE N + DFG + + A +T +GTL +PEL L KT
Sbjct: 209 RDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKT 268
Query: 719 DVYSLGVIILELLTGKSP 736
D++S G+++ E+
Sbjct: 269 DIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 53/183 (28%), Positives = 90/183 (49%), Gaps = 16/183 (8%)
Query: 562 VAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL-LVFDFMPKGSL 619
VAVK LRE K + +F E + ++ PN++ L A + + L ++ ++M G L
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI--TSDPLCMITEYMENGDL 106
Query: 620 ASFLHARGPE--------TIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE 671
FL P+ ++++T + +A IA G+ YL N +H +L + N L+ +
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS-SLNFVHRDLATRNCLVGK 165
Query: 672 KTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLKNANTKTDVYSLGVIILE 729
+IADFG+SR + + + A L R + E L T +DV++ GV + E
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRA-VLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 730 LLT 732
+LT
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 541 EIMGKSTYGTAY---KATLEDGSEVAVKRLREKTTKGQKEFEAEAA-----AIGKIHHPN 592
+++G YG + K + D ++ ++ +K T QK E + I
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 593 LLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIG-IARGLNYL 651
L Y + L+ D++ G L + L R + I G I L +L
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK----EQEVQIYSGEIVLALEHL 121
Query: 652 HVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKL 711
H + +I+ ++ N+LLD + + DFGLS+ + GT+ Y AP++ +
Sbjct: 122 H-KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180
Query: 712 KNA--NTKTDVYSLGVIILELLTGKSP 736
+ + D +S+GV++ ELLTG SP
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 40/113 (35%), Positives = 60/113 (53%), Gaps = 7/113 (6%)
Query: 641 AIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAG 699
A I GL +LH + +++ +L N+LLD + +IADFG+ + M A T G
Sbjct: 102 AAEIICGLQFLH-SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC--G 158
Query: 700 TLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASI 752
T Y APE+ + NT D +S GV++ E+L G+S P +G D + SI
Sbjct: 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQS---PFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 542 IMGKSTYGTA----YKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIG------KIHHP 591
++GK +G +AT G A K+L +K K +K EA A+ K++
Sbjct: 7 VLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRK---GEAMALNEKRILEKVNSR 60
Query: 592 NLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARG-----PETIVNWATRMSIAIGIAR 646
+++L AY K LV M G L ++ G + + +A +
Sbjct: 61 FVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCC------ 113
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAP 706
GL L E +++ +L N+LLD++ + RI+D GL+ + V GT+GY AP
Sbjct: 114 GLEDLQ-RERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAP 170
Query: 707 ELSKLKNANTKTDVYSLGVIILELLTGKSP 736
E+ + D + LG +I E++ G+SP
Sbjct: 171 EVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 49/200 (24%), Positives = 100/200 (50%), Gaps = 18/200 (9%)
Query: 543 MGKSTYGTAYKATLED-GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYL 601
+G+ + G AT++ G VAVK++ + + ++ E + H N++ + YL
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 602 GPKGEKL-LVFDFMPKGSLASFL-HARGPETIVNWATRMSIAIGIARGLNYLHVEENMIH 659
G++L +V +F+ G+L + H R E + ++ + + + L+ LH + +IH
Sbjct: 88 --VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQ-GVIH 139
Query: 660 GNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV---IATAGTLGYRAPELSKLKNANT 716
++ S ++LL +++DFG A + V + GT + APEL
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFC----AQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195
Query: 717 KTDVYSLGVIILELLTGKSP 736
+ D++SLG++++E++ G+ P
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 37/201 (18%)
Query: 562 VAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGP---KGEKLLVFDFMPK 616
VAVK L++ T K + +E + I H N++ L LG G ++ ++ K
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL----LGACTQDGPLYVIVEYASK 105
Query: 617 GSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLT 663
G+L +L AR P + + + +S +ARG+ YL + IH +L
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL-ASQKCIHRDLA 164
Query: 664 SSNVLLDEKTNPRIADFGLSRLMTAAANTNVI-----ATAGTL--GYRAPELSKLKNANT 716
+ NVL+ E +IADFGL+R + N I T G L + APE +
Sbjct: 165 ARNVLVTENNVMKIADFGLAR------DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 218
Query: 717 KTDVYSLGVIILELLT-GKSP 736
++DV+S GV++ E+ T G SP
Sbjct: 219 QSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 61/198 (30%), Positives = 94/198 (47%), Gaps = 31/198 (15%)
Query: 562 VAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGP---KGEKLLVFDFMPK 616
VAVK L++ T K + +E + I H N++ L LG G ++ ++ K
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINL----LGACTQDGPLYVLVEYASK 102
Query: 617 GSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLT 663
G+L +L AR P E + + +S A +ARG+ YL + IH +L
Sbjct: 103 GNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL-ASQKCIHRDLA 161
Query: 664 SSNVLLDEKTNPRIADFGLSRLMTAAANTNVI--ATAGTL--GYRAPELSKLKNANTKTD 719
+ NVL+ E +IADFGL+R N + T G L + APE + ++D
Sbjct: 162 ARNVLVTEDNVMKIADFGLAR---DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 218
Query: 720 VYSLGVIILELLT-GKSP 736
V+S GV++ E+ T G SP
Sbjct: 219 VWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 6/158 (3%)
Query: 589 HHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGL 648
+HP L+ L + + + V +++ G L H + + R A I+ L
Sbjct: 54 NHPFLVGLHSCF-QTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSA-EISLAL 109
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPEL 708
NYLH E +I+ +L NVLLD + + ++ D+G+ + +T GT Y APE+
Sbjct: 110 NYLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEI 167
Query: 709 SKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLP 746
+ ++ D ++LGV++ E++ G+SP + + D P
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 31/226 (13%)
Query: 543 MGKSTYGTAY----KATLEDGSE--VAVKRLREKTTKGQK-EFEAEAAAIGKI--HHPNL 593
+G+ ++G Y K ++D E VA+K + E + ++ EF EA+ + + HH
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH--- 70
Query: 594 LALRAYYLGPKGE-KLLVFDFMPKGSLASFLHARGPETIVN-------WATRMSIAIGIA 645
+R + +G+ L++ + M +G L S+L + PE N + +A IA
Sbjct: 71 -VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 646 RGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT----L 701
G+ YL+ + +H +L + N ++ E +I DFG++R + T+ G +
Sbjct: 130 DGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY---ETDYYRKGGKGLLPV 185
Query: 702 GYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQ 747
+ +PE K T +DV+S GV++ E+ T +P GM Q
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--QPYQGMSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 47/200 (23%), Positives = 90/200 (45%), Gaps = 13/200 (6%)
Query: 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLAL 596
E +G ++G A + G A+K L+++ K + E + + ++ HP ++ +
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 597 RAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
+ + + +F+ G L F H R N + A + YLH ++
Sbjct: 84 MCSFQD-ENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHA-ELVLAFEYLH-SKD 138
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANT 716
+I+ +L N+LLD K + ++ DFG ++ + T GT Y APE+ + K
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT----LCGTPEYLAPEVIQSKGHGK 194
Query: 717 KTDVYSLGVIILELLTGKSP 736
D +++GV++ E + G P
Sbjct: 195 AVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 48/188 (25%), Positives = 96/188 (51%), Gaps = 27/188 (14%)
Query: 559 GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL-LVFDFMPKG 617
G +VAVK++ + + ++ E + HPN++ + + YL G++L +V +F+ G
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL--VGDELWVVMEFLEGG 101
Query: 618 SLASFLHARGPETIVNWATRMS------IAIGIARGLNYLHVEENMIHGNLTSSNVLLDE 671
+L IV TRM+ + + + + L++LH + +IH ++ S ++LL
Sbjct: 102 ALTD---------IVT-HTRMNEEQIATVCLAVLKALSFLH-AQGVIHRDIKSDSILLTS 150
Query: 672 KTNPRIADFGLSRLMTAAANTNVI---ATAGTLGYRAPELSKLKNANTKTDVYSLGVIIL 728
+++DFG A + V + GT + APE+ T+ D++SLG++++
Sbjct: 151 DGRVKLSDFGF----CAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVI 206
Query: 729 ELLTGKSP 736
E++ G+ P
Sbjct: 207 EMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 35/205 (17%)
Query: 557 EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLG---PKGEKLLVF 611
+ VAVK L++ T K + +E + I H N++ L LG +G ++
Sbjct: 42 DQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINL----LGVCTQEGPLYVIV 97
Query: 612 DFMPKGSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMI 658
++ KG+L FL AR P E +++ +S A +ARG+ YL I
Sbjct: 98 EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE-SRRCI 156
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSR------LMTAAANTNVIATAGTLGYRAPELSKLK 712
H +L + NVL+ E +IADFGL+R +N + + + APE +
Sbjct: 157 HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL-----PVKWMAPEALFDR 211
Query: 713 NANTKTDVYSLGVIILELLT-GKSP 736
++DV+S G+++ E+ T G SP
Sbjct: 212 VYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-09
Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 542 IMGKSTYGTAYKATLEDGSE-VAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
I+G ++G Y+A D SE VA+K++ + +E + ++H N++ L+ YY
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNREL----LIMKNLNHINIIFLKDYY 128
Query: 601 LGP---KGEKLL----VFDFMPKGSLASFLH-ARGPETIVNWATRMSIAIGIARGLNYLH 652
K EK + V +F+P+ H AR + + ++ + + R L Y+H
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL-YSYQLCRALAYIH 187
Query: 653 VEENMIHGNLTSSNVLLDEKTNP-RIADFGLSRLMTAAANTNVIATAGTLGYRAPELS-K 710
+ + H +L N+L+D T+ ++ DFG ++ + A + ++ + YRAPEL
Sbjct: 188 -SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRFYRAPELMLG 244
Query: 711 LKNANTKTDVYSLGVIILELLTG 733
N T D++SLG II E++ G
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 7e-09
Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 21/204 (10%)
Query: 541 EIMGKSTYGTAYKATLEDGSEV-AVKRL-REKTTKGQKEFE---AEAAAIGKIHHPNLLA 595
+ +G ++G + + A+K L + K K K+ E E + I HP L+
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK-LKQVEHVLNEKRILQSIRHPFLVN 65
Query: 596 LRAYYLGPKGEKL-LVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLH 652
L + L LV +++P G L S L G PE A A + L YLH
Sbjct: 66 LYGSFQDDS--NLYLVMEYVPGGELFSHLRKSGRFPE---PVA--RFYAAQVVLALEYLH 118
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLK 712
++++ +L N+LLD +I DFG ++ + T GT Y APE+ K
Sbjct: 119 -SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT----LCGTPEYLAPEIILSK 173
Query: 713 NANTKTDVYSLGVIILELLTGKSP 736
D ++LG++I E+L G P
Sbjct: 174 GYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 8e-09
Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 30/224 (13%)
Query: 543 MGKSTYGTAYKATLEDGSE-VAVKRLREKTTKGQKEF-----EAEAAAIGKIHHPNLLAL 596
+G+ YG + A +D E VA+KR+++ E E + K L+ L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK--SEWLVKL 66
Query: 597 RAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
Y E L L +++P G + L+ G + R +A ++ LH E
Sbjct: 67 --LYAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFE-AVDALH-EL 120
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNAN 715
IH +L N L+D + ++ DFGLS+ + AN+ V G+ Y APE+ + K +
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV----GSPDYMAPEVLRGKGYD 176
Query: 716 TKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTN 759
D +SLG ++ E L G P + S E W N
Sbjct: 177 FTVDYWSLGCMLYEFLCG-----------FPPFSGSTPNETWEN 209
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 541 EIMGKSTYGTAY----KATLEDGSEVAVKRLREKTTKGQKEFE---AEAAAIGKIHHPNL 593
+++GK T+G KAT G A+K LR++ + E E+ + HP L
Sbjct: 1 KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
AL+ Y V ++ G L F H R A I L YLH
Sbjct: 58 TALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA-EIVSALEYLH- 112
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLGYRAPELSKLK 712
++++ ++ N++LD+ + +I DFGL + ++ A GT Y APE+ +
Sbjct: 113 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC--GTPEYLAPEVLEDN 170
Query: 713 NANTKTDVYSLGVIILELLTGKSP 736
+ D + LGV++ E++ G+ P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRL--REKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
++G+ +YG K E G VA+K+ E +K E + ++ H NL+ L
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
+ K LVF+F+ L ++ + I RG+ + H N+
Sbjct: 67 EVFRRKK-RLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCH-SHNI 121
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA--ANTNVIATAGTLGYRAPEL----SKL 711
IH ++ N+L+ + ++ DFG +R + A T+ +AT YRAPEL +K
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR---WYRAPELLVGDTKY 178
Query: 712 KNANTKTDVYSLGVIILELLTGKS--PGE 738
A D++++G ++ E+LTG+ PG+
Sbjct: 179 GRA---VDIWAVGCLVTEMLTGEPLFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 52/205 (25%), Positives = 95/205 (46%), Gaps = 31/205 (15%)
Query: 543 MGKSTYGTAY-----KATLEDG----SEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNL 593
+GK ++GT Y KA E+ E+ V L T + EA + K+ HP +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV---QANQEAQLLSKLDHPAI 64
Query: 594 LALRAYYLGPKGEKLLVFDFMPKG-----SLASFLHARG--PET-IVNWATRMSIAIGIA 645
+ A +L + + + +G L H E + W ++ +
Sbjct: 65 VKFHASFL--ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----- 117
Query: 646 RGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRA 705
G++Y+H + ++H +L + N+ L + +I DFG+SRL+ + + T GT Y +
Sbjct: 118 -GVHYMH-QRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFT-GTPYYMS 173
Query: 706 PELSKLKNANTKTDVYSLGVIILEL 730
PE K + ++K+D++SLG I+ E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 48/212 (22%), Positives = 99/212 (46%), Gaps = 10/212 (4%)
Query: 543 MGKSTYGTAYKAT-LEDGSEVAVKRLR---EKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
+G+ + Y+AT L D VA+K+++ K +++ E + +++HPN++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFL-HARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
++ E +V + G L+ + + + + ++ T + + + ++H M
Sbjct: 70 SFI-EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVM 128
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTK 717
H ++ +NV + ++ D GL R ++ T + GT Y +PE N K
Sbjct: 129 -HRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 718 TDVYSLGVIILELLTGKSP--GEPMNGMDLPQ 747
+D++SLG ++ E+ +SP G+ MN L Q
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 68/260 (26%), Positives = 112/260 (43%), Gaps = 53/260 (20%)
Query: 542 IMGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEA--EAAAIGKIHHPNLLAL-- 596
+G+ T+G +KA + VA+K++ + K A E + + H N++ L
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 597 -----RAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIAR----- 646
Y KG LVF+F LA L N + +++ I +
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS--------NKNVKFTLSE-IKKVMKML 128
Query: 647 --GLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN------TNVIATA 698
GL Y+H ++H ++ ++N+L+ + ++ADFGL+R + + N TN +
Sbjct: 129 LNGLYYIH-RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-- 185
Query: 699 GTLGYRAPELSKL---KNANTKTDVYSLGVIILELLTGKSPGEPMNGMD-------LPQW 748
TL YR PEL L ++ D++ G I+ E+ T +SP M G + Q
Sbjct: 186 -TLWYRPPEL--LLGERDYGPPIDMWGAGCIMAEMWT-RSP--IMQGNTEQHQLTLISQL 239
Query: 749 VASIVKEEWTNEVFDLELMR 768
SI E W V LEL +
Sbjct: 240 CGSITPEVWPG-VDKLELFK 258
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 541 EIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEA---EAAAIGKIH-HPNLLA 595
++GK ++G A L E G AVK L++ + E E + HP L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 596 LRAYYLGPKGEKLL-VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
L Y ++L V +F+ G L H + R A I L +LH +
Sbjct: 61 L--YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARF-YAAEITSALMFLH-D 114
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA---GTLGYRAPELSKL 711
+ +I+ +L NVLLD + + ++ADFG M N T+ GT Y APE+ +
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFG----MCKEGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 712 KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745
D +++GV++ E+L G +P E N DL
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 49/163 (30%), Positives = 74/163 (45%), Gaps = 21/163 (12%)
Query: 589 HHPNLLALRAYY-LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARG 647
+PN + L YY + +L+ D++ G L L G ++ A I +
Sbjct: 67 DNPNFIKL--YYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQLVEA 121
Query: 648 LNYLHVEENMIHGNLTSSNVLLDE-KTNPRIADFGLSRLMTAAANTNVIATA----GTLG 702
LN LH N+IH ++ NVL D K + D+GL + +I T GTL
Sbjct: 122 LNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLCK---------IIGTPSCYDGTLD 171
Query: 703 YRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745
Y +PE K N + D +++GV+ ELLTGK P + +L
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL 214
|
Length = 267 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 541 EIMGKSTYGTAY----KATLEDGSEVAVKRLREKTTKGQKEFE---AEAAAIGKIHHPNL 593
+++GK T+G KAT G A+K L+++ + E E+ + HP L
Sbjct: 1 KLLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
AL+ Y V ++ G L F H R A I L YLH
Sbjct: 58 TALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA-EIVSALGYLH- 112
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLGYRAPELSKLK 712
++++ +L N++LD+ + +I DFGL + ++ A GT Y APE+ +
Sbjct: 113 SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYLAPEVLEDN 170
Query: 713 NANTKTDVYSLGVIILELLTGKSP 736
+ D + LGV++ E++ G+ P
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 40/215 (18%)
Query: 543 MGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-----------HH 590
+G+ +YG +K E G VA+K+ E + I KI H
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVE---------SEDDPVIKKIALREIRMLKQLKH 59
Query: 591 PNLLALRAYYLGPKGEKL-LVFDFMPKGSLASF-LHARG-PETIVNWATRMSIAIGIARG 647
PNL+ L + + KL LVF++ L + RG PE ++ I +
Sbjct: 60 PNLVNLIEVF--RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI-----KKIIWQTLQA 112
Query: 648 LNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA--AANTNVIATAGTLGYRA 705
+N+ H + N IH ++ N+L+ ++ ++ DFG +R++T T+ +AT YRA
Sbjct: 113 VNFCH-KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR---WYRA 168
Query: 706 PELSKLKNA-NTKTDVYSLGVIILELLTGKS--PG 737
PEL DV+++G + ELLTG+ PG
Sbjct: 169 PELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 56/198 (28%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEA--EAAAIGKIHHPNLLALR 597
E +G+ +Y T YK +G VA+K + KT +G F A EA+ + + H N++ L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLH 69
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
+ K VF++M LA ++ + P + + R+ + RGL Y+H +++
Sbjct: 70 DI-IHTKETLTFVFEYM-HTDLAQYM-IQHPGGLHPYNVRL-FMFQLLRGLAYIH-GQHI 124
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKLKNANT 716
+H +L N+L+ ++ADFGL+R + + T + TL YR P+ L + ++
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-YSSEVVTLWYRPPDVLLGATDYSS 183
Query: 717 KTDVYSLGVIILELLTGK 734
D++ G I +E+L G+
Sbjct: 184 ALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 542 IMGKSTYGTAYKATLED-GSEVAVKRLREKTTKGQKEFEAEA-------AAIGKIHHPNL 593
I+G+ +G Y D G A+K L +K K K+ E A + + P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLALNERIMLSLVSTGDCPFI 59
Query: 594 LALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLH 652
+ + + P +KL + D M G L L G + + A I GL ++H
Sbjct: 60 VCMTYAFHTP--DKLCFILDLMNGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMH 114
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKL 711
+++ +L +N+LLDE + RI+D GL+ + A+ GT GY APE L K
Sbjct: 115 -NRFVVYRDLKPANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 712 KNANTKTDVYSLGVIILELLTGKSP 736
++ D +SLG ++ +LL G SP
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 541 EIMGKSTYGTAYK--ATLEDGSEVAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLALR 597
E +G+ TY T +K + L + + VA+K +R + +G E + + + H N++ L
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
K L VF+++ K L ++ G I++ I RGL Y H +
Sbjct: 71 DIVHTDKSLTL-VFEYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCH-RRKV 125
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT--NVIATAGTLGYRAPE-LSKLKNA 714
+H +L N+L++E+ ++ADFGL+R + T N + TL YR P+ L
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV---TLWYRPPDVLLGSSEY 182
Query: 715 NTKTDVYSLGVIILELLTGKS--PG 737
+T+ D++ +G I E+ +G+ PG
Sbjct: 183 STQIDMWGVGCIFFEMASGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 16/193 (8%)
Query: 553 KATLEDGSEVAVKRLREKTTKGQKE---FEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609
KAT G A+K +++ Q+ FE E + + P + L+ Y K L
Sbjct: 23 KAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ-YAFQDKDNLYL 78
Query: 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL 669
V ++ P G L S L R + + +A + ++ +H + +H ++ NVL+
Sbjct: 79 VMEYQPGGDLLSLL-NRYEDQFDEDMAQFYLA-ELVLAIHSVH-QMGYVHRDIKPENVLI 135
Query: 670 DEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKT------DVYSL 723
D + ++ADFG + +TA N GT Y APE+ N + K D +SL
Sbjct: 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195
Query: 724 GVIILELLTGKSP 736
GVI E++ G+SP
Sbjct: 196 GVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 30/222 (13%)
Query: 543 MGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLALRAYY 600
+G+ TY T +K + + VA+K +R + +G E + + + H N++ L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI- 71
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAI---GIARGLNYLHVEENM 657
+ + LVF+++ L +L G N + ++ I + RGL+Y H + +
Sbjct: 72 IHTERCLTLVFEYL-DSDLKQYLDNCG-----NLMSMHNVKIFMFQLLRGLSYCH-KRKI 124
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT--NVIATAGTLGYRAPE-LSKLKNA 714
+H +L N+L++EK ++ADFGL+R + T N + TL YR P+ L
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV---TLWYRPPDVLLGSTEY 181
Query: 715 NTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756
+T D++ +G I+ E+ TG+ P + S VKEE
Sbjct: 182 STPIDMWGVGCILYEMATGR-----------PMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 542 IMGKSTYGTAYKATLEDGSE----VAVKRLREKT-TKGQKEF---EAEAAAIGKIHHPNL 593
++GK YG ++ G++ A+K L++ T + QK+ +AE + + HP +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARG---PETIVNWATRMSIAIGIARGLNY 650
+ L Y G+ L+ +++ G L L G +T + + +S+A+ +
Sbjct: 63 VDL-IYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE------H 115
Query: 651 LHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELS 709
LH ++ +I+ +L N+LLD + + ++ DFGL + + V T GT+ Y APE+
Sbjct: 116 LH-QQGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEIL 172
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSP 736
D +SLG ++ ++LTG P
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 11/201 (5%)
Query: 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKE----FEAEAAAIGKIHHPNLLA 595
+++GK ++G A + + AVK L++K +KE + + HP L+
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
L + + V D++ G L F H + + R A IA L YLH
Sbjct: 61 LH-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARF-YAAEIASALGYLH-SL 115
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNAN 715
N+++ +L N+LLD + + + DFGL + N GT Y APE+ + +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 716 TKTDVYSLGVIILELLTGKSP 736
D + LG ++ E+L G P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 34/94 (36%), Positives = 54/94 (57%), Gaps = 2/94 (2%)
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLG 702
I L+ +H M+H +L S+N+ L ++ DFG S+ + + + +V ++ GT
Sbjct: 178 IVLALDEVH-SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 703 YRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
Y APEL + K + K D++SLGVI+ ELLT P
Sbjct: 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 39/185 (21%), Positives = 82/185 (44%), Gaps = 35/185 (18%)
Query: 577 EFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWAT 636
F A+ + ++ H +L+ + Y + + E ++V +++ G L FLH ++W
Sbjct: 47 AFFETASLMSQLSHKHLV--KLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHW-- 102
Query: 637 RMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL-----DEKTNP--RIADFGLSRLMTAA 689
++ +A +A L+YL ++ ++HGN+ N+L+ +E P +++D G+
Sbjct: 103 KLDVAKQLASALHYLE-DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI----- 156
Query: 690 ANTNVIATAGTLGYR-------APELSK--LKNANTKTDVYSLGVIILELLTGKSPGEPM 740
T + R APE + + D +S G +LE+ + EP+
Sbjct: 157 -------TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE--EPL 207
Query: 741 NGMDL 745
+ +
Sbjct: 208 STLSS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 2/96 (2%)
Query: 641 AIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT 700
A I LN+LH E +I+ +L NVLLD + ++ D+G+ + +T GT
Sbjct: 102 AAEICIALNFLH-ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS-TFCGT 159
Query: 701 LGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
Y APE+ + + D ++LGV++ E++ G+SP
Sbjct: 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 2/92 (2%)
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGY 703
I RGL YLH ++H ++ N+L++ +I DFGL+R+ + ++ T Y
Sbjct: 112 ILRGLKYLH-SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 704 RAPE-LSKLKNANTKTDVYSLGVIILELLTGK 734
RAPE L ++ + D++S+G I ELL +
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 44/179 (24%), Positives = 89/179 (49%), Gaps = 9/179 (5%)
Query: 559 GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF-DFMPKG 617
G +VAVK + + + ++ E + H N++ + YL GE+L V +F+ G
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL--VGEELWVLMEFLQGG 103
Query: 618 SLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRI 677
+L + +T +N ++ + + L YLH + +IH ++ S ++LL ++
Sbjct: 104 ALTDIV----SQTRLNEEQIATVCESVLQALCYLH-SQGVIHRDIKSDSILLTLDGRVKL 158
Query: 678 ADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
+DFG ++ + GT + APE+ T+ D++SLG++++E++ G+ P
Sbjct: 159 SDFGFCAQISKDVPKRK-SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 19/201 (9%)
Query: 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEA--EAAAIGKIHHPNLLALR 597
E +G+ +Y T YK + +G VA+K +R + +G F A EA+ + + H N++ L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTP-FTAIREASLLKGLKHANIVLLH 69
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFL--HARG--PETIVNWATRMSIAIGIARGLNYLHV 653
+ K LVF+++ L ++ H G PE + + ++ RGL+Y+H
Sbjct: 70 DI-IHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQL------LRGLSYIH- 120
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKLK 712
+ ++H +L N+L+ + ++ADFGL+R + ++T TL YR P+ L
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGST 179
Query: 713 NANTKTDVYSLGVIILELLTG 733
+T D++ +G I +E++ G
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 37/133 (27%), Positives = 65/133 (48%), Gaps = 11/133 (8%)
Query: 609 LVFDFMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNV 667
+V ++MP G L + + PE WA + + +A L+ +H +IH ++ N+
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE---KWAKFYTAEVVLA--LDAIH-SMGLIHRDVKPDNM 173
Query: 668 LLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNAN----TKTDVYSL 723
LLD+ + ++ADFG M GT Y +PE+ K + + + D +S+
Sbjct: 174 LLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 724 GVIILELLTGKSP 736
GV + E+L G +P
Sbjct: 234 GVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 543 MGKSTYGTA-YKATLEDGSEVAVKRLREKTTKGQKEFEAEAA-----AIGKIHHPNLLAL 596
+G YGT G++VA+K+L Q E A+ A + + H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPF---QSELFAKRAYRELRLLKHMKHENVIGL 79
Query: 597 RAYY-----LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYL 651
+ L + LV FM H + E + + + + +GL Y+
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-----LVYQMLKGLKYI 134
Query: 652 HVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE--LS 709
H +IH +L N+ ++E +I DFGL+R ++ + T YRAPE L+
Sbjct: 135 HAA-GIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVVTRWYRAPEVILN 189
Query: 710 KLKNANTKTDVYSLGVIILELLTGK 734
+ T D++S+G I+ E+LTGK
Sbjct: 190 WMHYTQT-VDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 542 IMGKSTYGTAY----KATLEDGSE--VAVKRLRE-KTTKGQKEFEAEAAAIGKIHHPNLL 594
+G+ +G + K E+G E V VK L++ K Q EF E K+ H N++
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 595 ALRAYYLGPKGEK---LLVFDFMPKGSLASFLHARGPETIVNW------ATRMSIAIGIA 645
L LG E ++ ++ G L FL A + ++++ IA
Sbjct: 72 RL----LGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 646 RGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRA 705
G+++L +H +L + N L+ + +++ LS+ + + + L + A
Sbjct: 128 LGMDHLS-NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLA 186
Query: 706 PELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741
PE + + +TK+DV+S GV++ E+ T G+ P ++
Sbjct: 187 PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 33/93 (35%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 646 RGLNYLHVEENMIHGNLTSSNVLLD-EKTNPRIADFGLSRLMTAAANTNVIATAGTLG-- 702
RGL Y+H N++H +L +NV ++ E +I DFGL+R++ + + G +
Sbjct: 125 RGLKYIH-SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 703 YRAPELSKLKNANTKT-DVYSLGVIILELLTGK 734
YR+P L N TK D+++ G I E+LTGK
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 543 MGKSTYGTAYKATLED------GSEVAVKRLREKTTKGQK-EFEAEAAAIGKI--HHPNL 593
+G+ ++G Y+ D + VAVK + E + ++ EF EA+ + HH
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--- 70
Query: 594 LALRAYYLGPKGE-KLLVFDFMPKGSLASFLHARGPETIVNWAT-------RMSIAIGIA 645
+R + KG+ L+V + M G L S+L + PE N + +A IA
Sbjct: 71 -VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 646 RGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT----L 701
G+ YL+ ++ +H +L + N ++ +I DFG++R + T+ G +
Sbjct: 130 DGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIY---ETDYYRKGGKGLLPV 185
Query: 702 GYRAPELSKLKNANTKTDVYSLGVIILELLT 732
+ APE K T +D++S GV++ E+ +
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 50/207 (24%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 542 IMGKSTYGTAYKATLEDGSE-VAVKRLREKTTKGQKEFEA----EAAAIGKIHHPNLLAL 596
++G+ YG K ++ E VA+K+ K ++ +E + E + + N++ L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 597 RAYYLGPKGEKLLVFDFMPKGSLASFL-HARG--PETIVNWATRMSIAIGIARGLNYLHV 653
+ + +G+ LVF+++ K L G PE + ++ ++ AI ++ H
Sbjct: 66 KEAFR-RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAI------HWCHK 118
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKN 713
+ ++H ++ N+L+ ++ DFG +R ++ +N N T YR+PEL
Sbjct: 119 ND-IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 714 ANTKTDVYSLGVIILELLTGKS--PGE 738
D++S+G I+ EL G+ PGE
Sbjct: 178 YGKAVDMWSVGCILGELSDGQPLFPGE 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 13/99 (13%)
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN------TNVIAT 697
I GL Y+H N++H +L N+L++ +I DFGL+R + T +A
Sbjct: 114 ILCGLKYIH-SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA- 171
Query: 698 AGTLGYRAPELSKLKNAN-TKT-DVYSLGVIILELLTGK 734
T YRAPE+ L + TK DV+S+G I+ ELL K
Sbjct: 172 --TRWYRAPEI-MLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 63/195 (32%), Positives = 87/195 (44%), Gaps = 26/195 (13%)
Query: 560 SEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEK---LLVFDFMP 615
++V VK LR + + Q +F EA + H NLL LG E LLV +F P
Sbjct: 23 AQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC----LGQCTEVTPYLLVMEFCP 78
Query: 616 KGSLASFLHA-RGPETIV-NWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT 673
G L +L + R E + + T +A IA GL +LH + N IH +L N LL
Sbjct: 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-KNNFIHSDLALRNCLLTADL 137
Query: 674 NPRIADFGLSRLMTAAANTNVIATAGT----LGYRAPELSKLKNAN-------TKTDVYS 722
+I D+GLS + T L + APEL + N +++V+S
Sbjct: 138 TVKIGDYGLSHN---KYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWS 194
Query: 723 LGVIILELLT-GKSP 736
LGV I EL G P
Sbjct: 195 LGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 24/156 (15%)
Query: 590 HPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFL---------HARGPETIVNWATRMSI 640
HP L+ L + + V +F+ G L + HAR ++ +S+
Sbjct: 55 HPFLVGLHSCFQTE-SRLFFVIEFVSGGDLMFHMQRQRKLPEEHAR------FYSAEISL 107
Query: 641 AIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT 700
A LN+LH E +I+ +L NVLLD + + ++ D+G+ + +T GT
Sbjct: 108 A------LNFLH-ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS-TFCGT 159
Query: 701 LGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
Y APE+ + ++ D ++LGV++ E++ G+SP
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 9e-08
Identities = 60/224 (26%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 541 EIMGKSTYGTAYKATLEDGSEV-AVKRLREKT---------TKGQKEFEAEAAAIGKIHH 590
+++GK ++G A L+ EV A+K L++ T +K A AA H
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-----KH 55
Query: 591 PNLLALRAYYLGPKGEKLL-VFDFMPKGSLA-------SFLHARGPETIVNWATRMSIAI 642
P L AL + ++L V +++ G L F R +A +++A
Sbjct: 56 PFLTALHCCFQTK--DRLFFVMEYVNGGDLMFQIQRSRKFDEPRSR----FYAAEVTLA- 108
Query: 643 GIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT-AGTL 701
L +LH +I+ +L N+LLD + + ++ADFG+ + N T GT
Sbjct: 109 -----LMFLH-RHGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTP 160
Query: 702 GYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745
Y APE+ + D ++LGV++ E++ G+ P E N DL
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 44/133 (33%), Positives = 67/133 (50%), Gaps = 9/133 (6%)
Query: 606 EKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTS 664
+KL + D M G L L G + + A A I GL ++H +++ +L
Sbjct: 70 DKLSFILDLMNGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNR-FVVYRDLKP 125
Query: 665 SNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKLKNANTKTDVYSL 723
+N+LLDE + RI+D GL+ + A+ GT GY APE L K ++ D +SL
Sbjct: 126 ANILLDEHGHVRISDLGLA---CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSL 182
Query: 724 GVIILELLTGKSP 736
G ++ +LL G SP
Sbjct: 183 GCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 646 RGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRA 705
GL Y+H +IH +L N+ ++E +I DFGL+R A V+ T YRA
Sbjct: 128 CGLKYIH-SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRA 182
Query: 706 PE-LSKLKNANTKTDVYSLGVIILELLTGKS 735
PE + + N D++S+G I+ E+LTGK+
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 15/217 (6%)
Query: 536 LCATAEIMGKSTYGTAYKATLEDGSE-VAVKRLREKTTK------GQKEFEA-EAAAIGK 587
LCA A G G + T G+E A + KT + GQ+ A EA +
Sbjct: 81 LCAEARA-GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRA 139
Query: 588 IHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARG 647
I+HP+++ L+ + K L++ + K L +L A+ I + ++I + R
Sbjct: 140 INHPSIIQLKGTFTYNKFTCLILPRY--KTDLYCYLAAKRNIAICDI---LAIERSVLRA 194
Query: 648 LNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE 707
+ YLH E +IH ++ + N+ ++ + + DFG + AGT+ APE
Sbjct: 195 IQYLH-ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPE 253
Query: 708 LSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMD 744
L D++S G+++ E+ T +G+D
Sbjct: 254 LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLD 290
|
Length = 391 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 1e-07
Identities = 23/60 (38%), Positives = 33/60 (55%), Gaps = 2/60 (3%)
Query: 266 LQEISLSHNKIVGPIPDE-LGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRL 324
L+ + LS+N++ IPD L L+ LDLS N + P F+ + SL SL+L N L
Sbjct: 2 LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 17/162 (10%)
Query: 590 HPNLLALRAYYLGPKGEKLLVFD-FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGL 648
HPN++ + G L V FM GS S L PE + + A +I G RGL
Sbjct: 58 HPNIMTSWTVF--TTGSWLWVISPFMAYGSANSLLKTYFPEGM-SEALIGNILFGALRGL 114
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA--------GT 700
NYLH + IH N+ +S++L+ ++ GLS L + N
Sbjct: 115 NYLH-QNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSV 171
Query: 701 LGYRAPELSK--LKNANTKTDVYSLGVIILELLTGKSPGEPM 740
L + +PEL + L N K+D+YS+G+ EL TG+ P + M
Sbjct: 172 LPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 36/116 (31%), Positives = 60/116 (51%), Gaps = 7/116 (6%)
Query: 641 AIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAG 699
A IA GL +LH + +I+ +L NV+LD + + +IADFG+ + + T G
Sbjct: 107 AAEIAIGLFFLH-SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC--G 163
Query: 700 TLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKE 755
T Y APE+ + D ++ GV++ E+L G+ P +G D + SI++
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP---PFDGEDEDELFQSIMEH 216
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 25/210 (11%)
Query: 543 MGKSTYGTAYKATLEDGS--EVAVKRLREKTTKGQKEFE---AEAAAIGKIHHPNLLALR 597
+G ++G AT ++ VA+KR + QK+ + +E + I+HP + L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 598 AYYLGPKGEKLL--VFDFMPKGSLASFL--HARGPETIVNWATRMSIAIGIARGLNYLHV 653
+ K E L V +F+ G +FL + R P + + + I YL
Sbjct: 98 GSF---KDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI-----FEYLQ- 148
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKN 713
N+++ +L N+LLD+ ++ DFG ++++ +T GT Y APE+
Sbjct: 149 SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV----DTRTYTLCGTPEYIAPEILLNVG 204
Query: 714 ANTKTDVYSLGVIILELLTGKSP---GEPM 740
D ++LG+ I E+L G P EP+
Sbjct: 205 HGKAADWWTLGIFIYEILVGCPPFYANEPL 234
|
Length = 340 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 53/235 (22%), Positives = 95/235 (40%), Gaps = 45/235 (19%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKE----FEAEAAAIGKIHHPNLLAL 596
+++G+ +G +D V ++ K +KE AE + + +L +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDIL--VEADSLWVV 64
Query: 597 RAYY-LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
+ +Y K L+ +F+P G + + L + +T+ T+ IA + ++ +H +
Sbjct: 65 KMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVL-AIDSIH-QL 120
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN---------------------- 693
IH ++ N+LLD K + +++DFGL + A T
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 694 ------------VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
+T GT Y APE+ N D +SLGVI+ E+L G P
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 45/170 (26%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 591 PNLLALRAYYLGPKGEKLLVFDFMPKGSLASFL--HARGPETIVN-WATRMSIAIGIARG 647
PN++ L Y + + LV G L S + PE V WA M +A
Sbjct: 45 PNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------ 97
Query: 648 LNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE 707
L+ LH E ++ +L +N+LLD++ + ++ F + + + + Y APE
Sbjct: 98 LDALH-REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE 152
Query: 708 LSKLKNANTKTDVYSLGVIILELLTGKSPGE-------PMNGMDLPQWVA 750
+ + D +SLG I+ ELLTGK+ E +++P+WV+
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVS 202
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 36/115 (31%), Positives = 59/115 (51%), Gaps = 7/115 (6%)
Query: 641 AIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSR-LMTAAANTNVIATAG 699
A I+ GL +LH +I+ +L NV+LD + + +IADFG+ + M T G
Sbjct: 107 AAEISVGLFFLH-RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC--G 163
Query: 700 TLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK 754
T Y APE+ + D ++ GV++ E+L G+ P +G D + SI++
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP---PFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 2/90 (2%)
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAP 706
GL +LH + +I+ +L NV+LD + +IADFG+ + N GT Y AP
Sbjct: 108 GLQFLH-SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RASTFCGTPDYIAP 165
Query: 707 ELSKLKNANTKTDVYSLGVIILELLTGKSP 736
E+ + D +S GV++ E+L G+SP
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 8e-07
Identities = 40/111 (36%), Positives = 58/111 (52%), Gaps = 7/111 (6%)
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLGYRA 705
GL YLH E +++ +L N+LLD + +IADFGL + M T+ GT + A
Sbjct: 113 GLQYLH-ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTF--CGTPEFLA 169
Query: 706 PELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756
PE+ + D + LGV+I E+L G+S P G D + SIV +E
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGES---PFPGDDEEEVFDSIVNDE 217
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 37/133 (27%), Positives = 64/133 (48%), Gaps = 11/133 (8%)
Query: 609 LVFDFMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNV 667
+V ++MP G L + + PE WA + + +A L+ +H IH ++ N+
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE---KWARFYTAEVVLA--LDAIH-SMGFIHRDVKPDNM 173
Query: 668 LLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNAN----TKTDVYSL 723
LLD+ + ++ADFG M GT Y +PE+ K + + + D +S+
Sbjct: 174 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233
Query: 724 GVIILELLTGKSP 736
GV + E+L G +P
Sbjct: 234 GVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 39/135 (28%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 609 LVFDFMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENM--IHGNLTSS 665
+V ++MP G L + + PE WA + + +A L+ +H +M IH ++
Sbjct: 120 MVMEYMPGGDLVNLMSNYDIPE---KWARFYTAEVVLA--LDAIH---SMGFIHRDVKPD 171
Query: 666 NVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANT----KTDVY 721
N+LLD+ + ++ADFG M A GT Y +PE+ K + + + D +
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 722 SLGVIILELLTGKSP 736
S+GV + E+L G +P
Sbjct: 232 SVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 1e-06
Identities = 17/60 (28%), Positives = 28/60 (46%)
Query: 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAI 300
L+ L+L +N + + L L+ + LS N + P+ L L+ LDLS N +
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 38/115 (33%), Positives = 61/115 (53%), Gaps = 7/115 (6%)
Query: 641 AIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAG 699
A IA GL +LH + +I+ +L NV+LD + + +IADFG+ + M T G
Sbjct: 107 AAEIAIGLFFLH-SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC--G 163
Query: 700 TLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK 754
T Y APE+ + D ++ GV++ E+L G++P E G D + SI++
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE---GEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 2e-06
Identities = 19/60 (31%), Positives = 27/60 (45%)
Query: 289 KLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQF 348
L+ LDLS N + F + +L L+L N L + PE L +L L+L N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 54/242 (22%), Positives = 94/242 (38%), Gaps = 59/242 (24%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKE------------FEAEAAAIGKI 588
+++G+ +G +D + ++ K +KE EA+ A + K+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 589 HHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGL 648
Y K L+ +F+P G + + L + +T+ AT+ IA + +
Sbjct: 67 F---------YSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVL-AI 114
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN--------------- 693
+ +H + IH ++ N+LLD K + +++DFGL + A T
Sbjct: 115 DAIH-QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173
Query: 694 -------------------VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGK 734
+T GT Y APE+ N D +SLGVI+ E+L G
Sbjct: 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 735 SP 736
P
Sbjct: 234 PP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 22/199 (11%)
Query: 559 GSEVAVKRLR---EKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG-----EKLLV 610
G VAVK+L + T ++ + E + ++H N+++L + K + LV
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104
Query: 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAI-GIARGLNYLHVEENMIHGNLTSSNVLL 669
+ M +L +H RMS + + G+ +LH +IH +L SN+++
Sbjct: 105 MELM-DANLCQVIHMELDHE------RMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 156
Query: 670 DEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILE 729
+I DFGL+R TA N + T YRAPE+ D++S+G I+ E
Sbjct: 157 KSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
Query: 730 LLTGKSPGEPMNGMDLPQW 748
L+ G + + +D QW
Sbjct: 215 LVKGSVIFQGTDHID--QW 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 3e-06
Identities = 25/60 (41%), Positives = 32/60 (53%)
Query: 164 NLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNL 223
NL++LDLSNN L + L L+LS N+L P + + LPSL L L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 42/137 (30%), Positives = 62/137 (45%), Gaps = 16/137 (11%)
Query: 609 LVFDFMPKGSLASFLHA---RGPETIVN-WATRMSIAIGIARGLNYLHVEENMIHGNLTS 664
LV D+ G L + L R PE + + M +AI L+Y +H ++
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY-------VHRDIKP 130
Query: 665 SNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKLKNANTK----TD 719
NVLLD + R+ADFG M GT Y +PE L +++ K D
Sbjct: 131 DNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECD 190
Query: 720 VYSLGVIILELLTGKSP 736
+SLGV + E+L G++P
Sbjct: 191 WWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 3/101 (2%)
Query: 638 MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697
+S + +ARG+ +L IH +L + N+LL E +I DFGL+R + +
Sbjct: 176 ISYSFQVARGMEFL-ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 698 AG-TLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
A L + APE K T++DV+S GV++ E+ + G SP
Sbjct: 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 40/137 (29%), Positives = 62/137 (45%), Gaps = 16/137 (11%)
Query: 609 LVFDFMPKGSLASFLHA---RGPETIVN-WATRMSIAIGIARGLNYLHVEENMIHGNLTS 664
LV D+ G L + L R PE + + M IAI L+Y +H ++
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY-------VHRDIKP 130
Query: 665 SNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKLKNANTK----TD 719
N+L+D + R+ADFG + GT Y +PE L +++ K D
Sbjct: 131 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECD 190
Query: 720 VYSLGVIILELLTGKSP 736
+SLGV + E+L G++P
Sbjct: 191 WWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 49/221 (22%), Positives = 105/221 (47%), Gaps = 28/221 (12%)
Query: 541 EIMGKSTYGTAYKATLED--------GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPN 592
E +G+ T+ +K + +EV +K L + + F A+ + ++ H +
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 593 LLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLH 652
L+ + E ++V +++ GSL ++L ++W ++ +A +A L++L
Sbjct: 61 LVLNYGVCVCG-DESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE 117
Query: 653 VEENMIHGNLTSSNVLL----DEKT-NP---RIADFGLSRLMTAAANTNVIATAGTLGYR 704
++ + HGN+ + NVLL D KT NP +++D G+S +T ++ + +
Sbjct: 118 -DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILLE---RIPWV 171
Query: 705 APE-LSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMD 744
PE + +N + D +S G + E+ +G +P++ +D
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGD--KPLSALD 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 5e-06
Identities = 18/40 (45%), Positives = 20/40 (50%), Gaps = 3/40 (7%)
Query: 50 DYQSLRAIKHDL-IDPHGFLRSWNDSGVGACSGGWAGIKC 88
D +L A K L DP G L SWN S CS W G+ C
Sbjct: 4 DRDALLAFKSSLNGDPSGALSSWNPSSSDPCS--WTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 60/262 (22%), Positives = 105/262 (40%), Gaps = 67/262 (25%)
Query: 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKG-QKEFEAEAAAIGKI-HHPNLLA 595
A +++ S +G K++ VAVK L+E T K +E + I +H N++
Sbjct: 19 AFGKVVEASAFGIDKKSSCN---TVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVN 75
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHA----------RGPETIVN------------ 633
L P G +++ +F G+L++FL A + P+
Sbjct: 76 LLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDR 135
Query: 634 -------------------------------WATRMSI------AIGIARGLNYLHVEEN 656
W + +++ + +ARG+ +L
Sbjct: 136 RIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL-ASRK 194
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAG-TLGYRAPELSKLKNAN 715
IH +L + N+LL E +I DFGL+R + + +A L + APE K
Sbjct: 195 CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYT 254
Query: 716 TKTDVYSLGVIILELLT-GKSP 736
T++DV+S GV++ E+ + G SP
Sbjct: 255 TQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 66/274 (24%), Positives = 96/274 (35%), Gaps = 64/274 (23%)
Query: 163 PNLQTLDLSNNAL----IGAIPPSLANSTRLYRLNLSYNSL------LGSIPLSLTRLPS 212
LQ L L N L A+ +L L L LS N L S+ LT+
Sbjct: 23 LCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82
Query: 213 LSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGL------L 266
L L L N L L +S LQ L L++N + L K GL L
Sbjct: 83 LQELDLSDNALGPDGCGVLESLL--RSSSLQELKLNNNGLGDRGLRLLAK-GLKDLPPAL 139
Query: 267 QEISLSHNKIVG----PIPDELGKLSKLQKLDLSYNAIGGS-FPVT---FTNITSLVSLN 318
+++ L N++ G + L L++L+L+ N IG + +L L+
Sbjct: 140 EKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLD 199
Query: 319 LENNRLGNK----IPEGLERLQNLTVLNLKNN------------QFKGHIP--------- 353
L NN L ++ + E L L++L VLNL +N
Sbjct: 200 LNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSC 259
Query: 354 ------------ETIGNISGINQLDLSENDFTGE 375
E + + +LDL N F E
Sbjct: 260 NDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 541 EIMGKSTYGTAYKA-TLEDGSEVAVKRLREKTTKGQKEFEA--EAAAIGKIHHPNLLALR 597
+ +G+ +Y T YK + G VA+K +R + +G F A EA+ + + H N++ L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-FTAIREASLLKDLKHANIVTLH 69
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
+ K LVF+++ L ++ G ++ + RGL Y H + +
Sbjct: 70 DI-IHTKKTLTLVFEYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCH-QRRV 124
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT---NVIATAGTLGYRAPE-LSKLKN 713
+H +L N+L+ E+ ++ADFGL+R + + T V+ TL YR P+ L
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV----TLWYRPPDVLLGSTE 180
Query: 714 ANTKTDVYSLGVIILELLTGKS--PG 737
+T D++ +G I E+ TG+ PG
Sbjct: 181 YSTSLDMWGVGCIFYEMATGRPLFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 37/105 (35%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT--- 700
+A G+ +L +N +H +L + NVL+ E +I DFGL+R + ++N I+ T
Sbjct: 248 VANGMEFL-ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIM--RDSNYISKGSTFLP 304
Query: 701 LGYRAPELSKLKNA-NTKTDVYSLGVIILELLT-GKSPGE--PMN 741
L + APE S N T +DV+S G+++ E+ T G +P PMN
Sbjct: 305 LKWMAPE-SIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 30/206 (14%)
Query: 544 GKSTYGTAYKATLEDGSEVAVKRLR-EKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602
GK Y T + V VK L+ ++K Q EF + + HPN+L LG
Sbjct: 9 GKVLLSEIYTDT--GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC----LG 62
Query: 603 PKGEK---LLVFDFMPKGSLASFL-----HARGPETIVNWATRMSIAIGIARGLNYLHVE 654
E LLVF++ G L S+L H R + ++ RM A IA G+ ++H +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL--LQRM--ACEIAAGVTHMH-K 117
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGL--SRLMTAAANTNVIATAGTLGYRAPEL---- 708
N +H +L N L ++ D+G+ SR T L + APEL
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVGEF 176
Query: 709 --SKLKNANTK-TDVYSLGVIILELL 731
+ TK ++V++LGV + EL
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 33/102 (32%), Positives = 58/102 (56%), Gaps = 5/102 (4%)
Query: 638 MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697
+S + +A+G+++L +N IH +L + N+LL +I DFGL+R + +N V
Sbjct: 217 LSFSYQVAKGMSFL-ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275
Query: 698 AG-TLGYRAPELSKLKNANT-KTDVYSLGVIILELLT-GKSP 736
A + + APE S T ++DV+S G+++ E+ + G SP
Sbjct: 276 ARLPVKWMAPE-SIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 3/95 (3%)
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAG-TLG 702
+A+G+ +L IH +L + N+LL E +I DFGL+R + + A L
Sbjct: 188 VAKGMEFL-ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246
Query: 703 YRAPELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
+ APE + ++DV+S GV++ E+ + G SP
Sbjct: 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 38/210 (18%)
Query: 559 GSEVAVKRLREKTTKG---QKEFEAEAAAIGKIHHPNLLALRA--------YYLGP--KG 605
VA+K++RE ++ +K F EA + HP ++ + + YY P +G
Sbjct: 27 SRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG 86
Query: 606 EKL--LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLT 663
L L+ K SL+ L + T V +SI I + Y+H + ++H +L
Sbjct: 87 YTLKSLLKSVWQKESLSKELAEK---TSV--GAFLSIFHKICATIEYVH-SKGVLHRDLK 140
Query: 664 SSNVLLDEKTNPRIADFGLSRLMTA---------AANTNVIAT--------AGTLGYRAP 706
N+LL I D+G + N+ + GT Y AP
Sbjct: 141 PDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP 200
Query: 707 ELSKLKNANTKTDVYSLGVIILELLTGKSP 736
E A+ TD+Y+LGVI+ ++LT P
Sbjct: 201 ERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 3e-05
Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 2/61 (3%)
Query: 140 NLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNS 198
NL+ + L NNRL+ IP PNL+ LDLS N L P + + L L+LS N+
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 199 L 199
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 41/137 (29%), Positives = 63/137 (45%), Gaps = 16/137 (11%)
Query: 609 LVFDFMPKGSLASFLHA---RGPETIVN-WATRMSIAIGIARGLNYLHVEENMIHGNLTS 664
LV D+ G L + L R PE + + M +AI L Y +H ++
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY-------VHRDIKP 130
Query: 665 SNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKLKNAN----TKTD 719
NVLLD+ + R+ADFG + A GT Y +PE L +++ + D
Sbjct: 131 DNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECD 190
Query: 720 VYSLGVIILELLTGKSP 736
+SLGV + E+L G++P
Sbjct: 191 WWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 40/139 (28%), Positives = 71/139 (51%), Gaps = 18/139 (12%)
Query: 638 MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697
+S +ARG+ +L +N +H +L + NVLL + +I DFGL+R + ++N ++
Sbjct: 240 LSFTYQVARGMEFL-ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIM--HDSNYVSK 296
Query: 698 AGT---LGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIV 753
T + + APE S N T +DV+S G+++ E+ + G P GM + + +
Sbjct: 297 GSTFLPVKWMAPE-SIFDNLYTTLSDVWSYGILLWEIFS--LGGTPYPGMIVDSTFYNKI 353
Query: 754 K--------EEWTNEVFDL 764
K + T EV+D+
Sbjct: 354 KSGYRMAKPDHATQEVYDI 372
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 3/88 (3%)
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAP 706
G+ +LH +IH +L SN+++ +I DFGL+R TA + + T YRAP
Sbjct: 138 GIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 707 ELSKLKNANTKTDVYSLGVIILELLTGK 734
E+ D++S+G I+ E++ G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 5/96 (5%)
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAG-TLG 702
+A+G+++L +N IH ++ + NVLL + +I DFGL+R + +N V A +
Sbjct: 221 VAQGMDFL-ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVK 279
Query: 703 YRAPELSKLKNANT-KTDVYSLGVIILELLT-GKSP 736
+ APE S T ++DV+S G+++ E+ + GKSP
Sbjct: 280 WMAPE-SIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 3/88 (3%)
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAP 706
G+ +LH +IH +L SN+++ +I DFGL+R TA + + T YRAP
Sbjct: 130 GIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 186
Query: 707 ELSKLKNANTKTDVYSLGVIILELLTGK 734
E+ D++S+G I+ E++ G
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 47/219 (21%)
Query: 559 GSEVAVKRLR--EKTTKGQKE-FEAEAAAIGKIHHPNLLALRAYYLGPKGEKL-LVFDFM 614
G A+K+LR E K Q AE + + +P ++ L YY L L+ +++
Sbjct: 26 GHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL--YYSFQDENYLYLIMEYL 83
Query: 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN 674
P G + + L + +T TR IA I ++ +H + IH ++ N+LLD K +
Sbjct: 84 PGGDMMTLLMKK--DTFTEEETRFYIAETIL-AIDSIH-KLGYIHRDIKPDNLLLDAKGH 139
Query: 675 PRIADFGLS-------------RLMTAAANTNVIA------------------------T 697
+++DFGL L A + + T
Sbjct: 140 IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYST 199
Query: 698 AGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
GT Y APE+ N + D +SLGVI+ E+L G P
Sbjct: 200 VGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 3/88 (3%)
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAP 706
G+ +LH +IH +L SN+++ +I DFGL+R TA + + T YRAP
Sbjct: 131 GIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 187
Query: 707 ELSKLKNANTKTDVYSLGVIILELLTGK 734
E+ D++S+G I+ E++ K
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 2e-04
Identities = 21/65 (32%), Positives = 30/65 (46%), Gaps = 5/65 (7%)
Query: 188 RLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNL 247
L L+LS N L + LP+L VL L NNL+ + +G S L+ L+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSI---SPEAFSGLPS--LRSLDL 55
Query: 248 DHNLI 252
N +
Sbjct: 56 SGNNL 60
|
Length = 60 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 64/233 (27%), Positives = 101/233 (43%), Gaps = 29/233 (12%)
Query: 185 NSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQF 244
N T L L ++ IP +T L L +N L S+P N L GN ++
Sbjct: 179 NKTELRLKILGLTTIPACIPEQIT------TLILDNNELK-SLPEN---LQGN----IKT 224
Query: 245 LNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSF 304
L + N + +IP +L +QE+ LS N+I +P+ L S LQ LDL +N I
Sbjct: 225 LYANSNQLT-SIPATLPDT--IQEMELSINRIT-ELPERLP--SALQSLDLFHNKI-SCL 277
Query: 305 PVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQ 364
P L L++ +N + +P L +T LN+++N +PET+ G+
Sbjct: 278 PENLPE--ELRYLSVYDNSI-RTLPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKT 329
Query: 365 LDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNL 417
L+ EN T + L L L ++PP ++ S + + NL
Sbjct: 330 LEAGENALTSLPASLPPELQVLDVSKNQITVLPETLPPTITTLDVSRNALTNL 382
|
Length = 754 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 4e-04
Identities = 28/84 (33%), Positives = 48/84 (57%), Gaps = 4/84 (4%)
Query: 660 GNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPEL--SKLKNANTK 717
G +T+ L+ + +I DFGLS+ + + + + GT Y +PEL + K+ + K
Sbjct: 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH--SCVGTPYYWSPELLLHETKSYDDK 223
Query: 718 TDVYSLGVIILELLTGKSPGEPMN 741
+D+++LG II EL +GK+P N
Sbjct: 224 SDMWALGCIIYELCSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 40/148 (27%), Positives = 74/148 (50%), Gaps = 23/148 (15%)
Query: 606 EKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSS 665
E ++V +F+ G L L V W ++++A +A L+YL ++N++HGN+ +
Sbjct: 90 ENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLASALSYLE-DKNLVHGNVCAK 146
Query: 666 NVL-----LDEKTNP--RIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKLKNANTK 717
N+L L E T+P +++D G+S TA + + + + APE + + +T
Sbjct: 147 NILLARLGLAEGTSPFIKLSDPGVS--FTALSREERVE---RIPWIAPECVPGGNSLSTA 201
Query: 718 TDVYSLGVIILEL-------LTGKSPGE 738
D +S G +LE+ L ++P E
Sbjct: 202 ADKWSFGTTLLEICFDGEVPLKERTPSE 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 59/249 (23%), Positives = 98/249 (39%), Gaps = 57/249 (22%)
Query: 539 TAEIMGKSTYGTA-YKATLEDGSEVAVKRLR--EKTTKGQ-KEFEAEAAAIGKIHHPNLL 594
T +++GK +G + G A+K L E K Q +AE + + P ++
Sbjct: 5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVV 64
Query: 595 ALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
+L YY + L L+ +F+P G L + L +T TR +A + +H
Sbjct: 65 SL--YYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMA-ECVLAIEAVH- 118
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLS-------------RLMTAAANTNVI----- 695
+ IH ++ N+L+D + +++DFGLS +L+ +N N I
Sbjct: 119 KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178
Query: 696 ----------------------------ATAGTLGYRAPELSKLKNANTKTDVYSLGVII 727
+T GT Y APE+ + + D +SLG I+
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238
Query: 728 LELLTGKSP 736
E L G P
Sbjct: 239 FECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 8e-04
Identities = 17/37 (45%), Positives = 25/37 (67%), Gaps = 2/37 (5%)
Query: 139 PNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNAL 175
NL + L NN+++ +PP + N PNL+TLDLS N +
Sbjct: 1 TNLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKI 35
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 19/52 (36%), Positives = 28/52 (53%)
Query: 98 LPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNN 149
L + G I E + QL +LR L+L+ N L+G VP +LG R + F +
Sbjct: 473 LSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD 524
|
Length = 623 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 36/142 (25%), Positives = 62/142 (43%), Gaps = 18/142 (12%)
Query: 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVL 668
+V +++ G A+ L G + RM A + L YLH ++H +L N+L
Sbjct: 78 MVMEYVEGGDCATLLKNIGALPVD--MARMYFAETVL-ALEYLH-NYGIVHRDLKPDNLL 133
Query: 669 LDEKTNPRIADFGLSRLMTAAANTNVI--------------ATAGTLGYRAPELSKLKNA 714
+ + ++ DFGLS++ + TN+ GT Y APE+ +
Sbjct: 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193
Query: 715 NTKTDVYSLGVIILELLTGKSP 736
D +++G+I+ E L G P
Sbjct: 194 GKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 44/166 (26%), Positives = 65/166 (39%), Gaps = 40/166 (24%)
Query: 593 LLALRAYYLGPKGEKLLVFDFMPK--GSLASFLHARGPETIVNWATRMSIAIGIARGLNY 650
L+ ++ Y+ G +V MPK L ++ GP + I L+Y
Sbjct: 193 LMKIQRYFQNETGHMCIV---MPKYGPCLLDWIMKHGP---FSHRHLAQIIFQTGVALDY 246
Query: 651 LHVEENMIHGNLTSSNVLL---DEKTNP-------------RIADFG------LSRLMTA 688
H E +++H +L N+L+ D +P RI D G SR
Sbjct: 247 FHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSR---- 302
Query: 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGK 734
A T YR+PE+ TD++S+G II EL TGK
Sbjct: 303 ------TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 22/60 (36%), Positives = 33/60 (55%), Gaps = 2/60 (3%)
Query: 117 LRKLSLHDNLLAGPVPW-SLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNAL 175
L+ L L +N L +P + LPNL+ + L N L+ P + P+L++LDLS N L
Sbjct: 2 LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 22/60 (36%), Positives = 29/60 (48%)
Query: 313 SLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDF 372
+L SL+L NNRL + L NL VL+L N PE + + LDLS N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 51/240 (21%), Positives = 86/240 (35%), Gaps = 74/240 (30%)
Query: 556 LEDGSEVAVKRLREKTT---------KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGE 606
++ + A+K LR+K K +++ AEA N ++ YY +
Sbjct: 23 VDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA--------DNEWVVKLYYSFQDKD 74
Query: 607 KL-LVFDFMPKGSLASFLHARG--PETIVN-WATRMSIAIGIARGLNYLHVEENMIHGNL 662
L V D++P G + S L PE + + +++AI + + IH ++
Sbjct: 75 NLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF-------IHRDI 127
Query: 663 TSSNVLLDEKTNPRIADFGL---------------------------------------S 683
N+L+D + ++ DFGL
Sbjct: 128 KPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGD 187
Query: 684 RLMTAAANTN-------VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
RL T + GT Y APE+ K D +S+GVI+ E+L G+ P
Sbjct: 188 RLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 32/113 (28%), Positives = 58/113 (51%), Gaps = 16/113 (14%)
Query: 609 LVFDFMPKGSLASFLHARG---PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSS 665
LV +++ G + S LH G E V + + +++A L+YLH +IH +L
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALA------LDYLH-RHGIIHRDLKPD 133
Query: 666 NVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKT 718
N+L+ + + ++ DFGLS++ T N++ T P ++K KN ++T
Sbjct: 134 NMLISNEGHIKLTDFGLSKV-TLNRELNMMDILTT-----PSMAKPKNDYSRT 180
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 40/190 (21%), Positives = 83/190 (43%), Gaps = 21/190 (11%)
Query: 565 KRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV--FDFMPKGSLASF 622
KR++ ++ + E E A+G+++H N+L + ++ +DF L SF
Sbjct: 198 KRVK-AGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSF 252
Query: 623 LHARG---PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIAD 679
++ + + TR +I + + Y+H ++ +IH ++ N+ L+ + D
Sbjct: 253 MYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIH-DKKLIHRDIKLENIFLNCDGKIVLGD 310
Query: 680 FGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT------- 732
FG + GT+ +PE+ TD++S G+I+L++L+
Sbjct: 311 FGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370
Query: 733 --GKSPGEPM 740
G PG+ +
Sbjct: 371 DGGGKPGKQL 380
|
Length = 501 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 44/167 (26%), Positives = 65/167 (38%), Gaps = 44/167 (26%)
Query: 275 KIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSL---NLENNRLGNKI--- 328
+ + + L K LQ+LDLS NA+G ++ SL L NN LG++
Sbjct: 68 RGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRL 127
Query: 329 --------PEGLERLQ----------------------NLTVLNLKNNQFKG----HIPE 354
P LE+L +L LNL NN + E
Sbjct: 128 LAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE 187
Query: 355 TIGNISGINQLDLSENDFTGE----ISPSLASLANLTSFNVSYNNLS 397
+ + LDL+ N T E ++ +LASL +L N+ NNL+
Sbjct: 188 GLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 43/189 (22%), Positives = 78/189 (41%), Gaps = 21/189 (11%)
Query: 562 VAVKR--LREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGS- 618
VAVK+ L + + K + E ++ HPN+L ++ E +V M GS
Sbjct: 28 VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-DSELYVVSPLMAYGSC 86
Query: 619 ---LASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNP 675
L + PE + + + + L+Y+H + IH ++ +S++LL
Sbjct: 87 EDLLKTHFPEGLPELAIAFILK-----DVLNALDYIH-SKGFIHRSVKASHILLSGDGKV 140
Query: 676 RIADFGLSRLMTAAANTNV------IATAGTLGYRAPEL--SKLKNANTKTDVYSLGVII 727
++ S M ++ L + +PE+ L+ N K+D+YS+G+
Sbjct: 141 VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITA 200
Query: 728 LELLTGKSP 736
EL G P
Sbjct: 201 CELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 20/201 (9%)
Query: 552 YKATLEDGSEVAVKRLR-EKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLL 609
YK T G V V+R+ E T F + K+ +HPN++ RA ++ E +
Sbjct: 21 YKPT---GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWV 76
Query: 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL 669
V FM GS + + + A I G+ + L+Y+H +H ++ +S++L+
Sbjct: 77 VTSFMAYGSAKDLICTHFMDGMSELAIAY-ILQGVLKALDYIH-HMGYVHRSVKASHILI 134
Query: 670 DEKTNPRIADFGLSR---LMTAAANTNVIA-----TAGTLGYRAPEL--SKLKNANTKTD 719
+ ++ GL ++ V+ + L + +PE+ L+ + K+D
Sbjct: 135 --SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 192
Query: 720 VYSLGVIILELLTGKSPGEPM 740
+YS+G+ EL G P + M
Sbjct: 193 IYSVGITACELANGHVPFKDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 773 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.98 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.98 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.98 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.98 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.98 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.98 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.98 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.98 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.97 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.93 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.92 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.9 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.9 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.9 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.87 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.58 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.54 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.53 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.44 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.41 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.4 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.39 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.36 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.36 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.35 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.24 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.21 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.19 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.17 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.13 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.11 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.1 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.0 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.92 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.91 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.85 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.83 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.83 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.82 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.77 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.76 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.71 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.69 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.69 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.61 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.6 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.56 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-79 Score=746.83 Aligned_cols=663 Identities=32% Similarity=0.552 Sum_probs=381.1
Q ss_pred CHHHHHHHHHHHHhCCCCCCCcCCCCCCCCCCCCCCCcceEee-CCCEEEEEcCCCCcccccCccccCCCCCcEEEccCC
Q 041878 47 TQADYQSLRAIKHDLIDPHGFLRSWNDSGVGACSGGWAGIKCV-KGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDN 125 (773)
Q Consensus 47 ~~~~~~~L~~~k~~~~~~~~~l~sW~~~~~~~c~~~w~gv~c~-~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n 125 (773)
.++|++||++||+++.||.+.+.+|+. +.++|. |.||+|. .++|+.|+|++++++|.+++.+..+++|+.|+|++|
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c~--w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n 103 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNS-SADVCL--WQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNN 103 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCC-CCCCCc--CcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCC
Confidence 568999999999999999888999964 456665 9999995 579999999998888877777777777777777777
Q ss_pred cccccCCCCCC-CCCCCceEEcccC----------------------ccCCCCCCCCCCCCCCCEEEccCCCCCCC----
Q 041878 126 LLAGPVPWSLG-FLPNLRGVYLFNN----------------------RLSGSIPPSIGNCPNLQTLDLSNNALIGA---- 178 (773)
Q Consensus 126 ~l~~~~~~~l~-~l~~L~~L~L~~n----------------------~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~---- 178 (773)
++++.+|..+. .+++|++|+|++| .+++.+|..++++++|++|+|++|.+.+.
T Consensus 104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~ 183 (968)
T PLN00113 104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183 (968)
T ss_pred ccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChh
Confidence 66655554332 3333333333333 33333444444455555555555544444
Q ss_pred --------------------CccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCccccccc--
Q 041878 179 --------------------IPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAG-- 236 (773)
Q Consensus 179 --------------------~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-- 236 (773)
+|..++++++|++|+|++|++++.+|..+.++++|++|++++|++++.+|..++.+..
T Consensus 184 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 263 (968)
T PLN00113 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQ 263 (968)
T ss_pred hhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCC
Confidence 4444444555555555555555455555555555555555555555444433322110
Q ss_pred -----------------CcccccceeeccccccccccCcc------------------------CCCCCCccEEECCCCc
Q 041878 237 -----------------NKSYQLQFLNLDHNLIAGTIPVS------------------------LGKLGLLQEISLSHNK 275 (773)
Q Consensus 237 -----------------~~~~~L~~L~L~~n~l~~~~~~~------------------------l~~l~~L~~L~L~~N~ 275 (773)
..+.+|++|+|++|.+++.+|.. +..+++|+.|++++|+
T Consensus 264 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~ 343 (968)
T PLN00113 264 YLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343 (968)
T ss_pred EEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCC
Confidence 01123344444444433333333 3333333333333333
Q ss_pred ccCCCCCCcCcccccceecccccccc------------------------------------------------ccCccc
Q 041878 276 IVGPIPDELGKLSKLQKLDLSYNAIG------------------------------------------------GSFPVT 307 (773)
Q Consensus 276 l~~~~p~~l~~l~~L~~L~Ls~N~l~------------------------------------------------~~~~~~ 307 (773)
+.+.+|..++.+++|+.|++++|+++ +.+|..
T Consensus 344 l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~ 423 (968)
T PLN00113 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSE 423 (968)
T ss_pred CcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChh
Confidence 33333332222222333333222222 111111
Q ss_pred cccc-----------------------------------------------ccCceEEccCCCCCCCcchhhcccccccc
Q 041878 308 FTNI-----------------------------------------------TSLVSLNLENNRLGNKIPEGLERLQNLTV 340 (773)
Q Consensus 308 ~~~l-----------------------------------------------~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 340 (773)
+..+ ++|+.|++++|++++..|..+..+++|+.
T Consensus 424 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~ 503 (968)
T PLN00113 424 FTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQ 503 (968)
T ss_pred HhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCE
Confidence 1111 12333333344444444444555555666
Q ss_pred ccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCchhhh---------------
Q 041878 341 LNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLS--------------- 405 (773)
Q Consensus 341 L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~~~--------------- 405 (773)
|+|++|++.+.+|..+.++++|+.|+|++|.++|.+|..+..+++|+.|+|++|+++|.+|..+.
T Consensus 504 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l 583 (968)
T PLN00113 504 LKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583 (968)
T ss_pred EECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcc
Confidence 66666666666666666666666666666666665555555555555555555555555554431
Q ss_pred ----------ccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcCcCCccceEEeehhhHHHHHHHHHHH
Q 041878 406 ----------KKFNSSSFVGNLQLCGYSPSTACPSLAPLSLPPPPVEAPKHHHHRKLSTKDIILIGVGALLAVLLILCCI 475 (773)
Q Consensus 406 ----------~~~~~~~~~~n~~~c~~~~~~~c~s~~p~~~~~pp~~~~~~~~~~~~~~~~~i~i~~~~~~~~l~~~~~~ 475 (773)
..+...++.||+.+||.++... . |+... . ++ .....++++++++++++++++++
T Consensus 584 ~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~---~-------~~c~~----~-~~-~~~~~~~~~~~~~~~~~~~~~~~ 647 (968)
T PLN00113 584 HGSLPSTGAFLAINASAVAGNIDLCGGDTTSG---L-------PPCKR----V-RK-TPSWWFYITCTLGAFLVLALVAF 647 (968)
T ss_pred eeeCCCcchhcccChhhhcCCccccCCccccC---C-------CCCcc----c-cc-cceeeeehhHHHHHHHHHHHHHH
Confidence 2233344556666665432110 0 00000 0 01 11111222222222222222222
Q ss_pred HHHHhhhhccccccccCcchhhHHHhhcCCCCCcccccCCcCCCceeeecC--CcccChhHHH--HHhhcccccccceEE
Q 041878 476 LLFCLMRKRSASKEKNGKSTAQKVVERAAPKAGTEVESGGEMGGKLVHFDG--PFLFTADDLL--CATAEIMGKSTYGTA 551 (773)
Q Consensus 476 ~~~~~~rrr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~--~~~~~~lG~G~fg~V 551 (773)
.++++|+|+..+.+..+... + . .....++. ...+..+++. +...++||+|+||.|
T Consensus 648 -~~~~~~~~~~~~~~~~~~~~-----------~-------~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V 706 (968)
T PLN00113 648 -GFVFIRGRNNLELKRVENED-----------G-------T--WELQFFDSKVSKSITINDILSSLKEENVISRGKKGAS 706 (968)
T ss_pred -HHHHHHhhhccccccccccc-----------c-------c--ccccccccccchhhhHHHHHhhCCcccEEccCCCeeE
Confidence 22233333221111000000 0 0 00000110 0112233322 233568999999999
Q ss_pred EEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCCHHHHHhhcCCCC
Q 041878 552 YKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPET 630 (773)
Q Consensus 552 y~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~ 630 (773)
|+|.. .++..||||+++...... ..|++.+++++||||++++++|.. .+..++||||+++|+|.++++.
T Consensus 707 y~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~----- 776 (968)
T PLN00113 707 YKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRS-EKGAYLIHEYIEGKNLSEVLRN----- 776 (968)
T ss_pred EEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEc-CCCCEEEEeCCCCCcHHHHHhc-----
Confidence 99986 578999999986443221 346889999999999999999954 4588999999999999999963
Q ss_pred ccCHHHHHHHHHHHHHHHHHhcc--CCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeeccCccccccccc
Q 041878 631 IVNWATRMSIAIGIARGLNYLHV--EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPEL 708 (773)
Q Consensus 631 ~~~~~~~~~i~~~i~~al~yLH~--~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~ 708 (773)
++|.++.+++.||++|++|||. +.+|+||||||+||+++.++.+++. ||.+...... ....+|+.|||||+
T Consensus 777 -l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~ 849 (968)
T PLN00113 777 -LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPET 849 (968)
T ss_pred -CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCccc
Confidence 7899999999999999999993 3589999999999999999988875 6655433211 12257899999999
Q ss_pred cCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC--CCChHHHHHHHHHhhhcccccChhc
Q 041878 709 SKLKNANTKTDVYSLGVIILELLTGKSPGEPMN--GMDLPQWVASIVKEEWTNEVFDLEL 766 (773)
Q Consensus 709 ~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~ 766 (773)
+.+..++.++|||||||++|||+||+.||.... ...+.+|++....+....+++||.+
T Consensus 850 ~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 909 (968)
T PLN00113 850 RETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSI 909 (968)
T ss_pred ccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccc
Confidence 999999999999999999999999999996532 3457777776554443444455543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=379.63 Aligned_cols=238 Identities=41% Similarity=0.727 Sum_probs=205.1
Q ss_pred cccChhHHHHHh-----hcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEEC
Q 041878 528 FLFTADDLLCAT-----AEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602 (773)
Q Consensus 528 ~~~~~~~l~~~~-----~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 602 (773)
..|+++++..++ .++||+|+||.||+|.+.+|+.||||++........++|.+|+.++.+++|||+|+|+|||.+
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 468888988877 468999999999999999999999998876543215669999999999999999999999955
Q ss_pred CCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCC--CceecCCCCCCEEeCCCCCeEEeec
Q 041878 603 PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE--NMIHGNLTSSNVLLDEKTNPRIADF 680 (773)
Q Consensus 603 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~--~iiH~Dik~~NIll~~~~~~kl~Df 680 (773)
..++.++|||||++|+|.++++..... .++|.+|++|+.++|+||+|||+.. .||||||||+|||+|+++++||+||
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 443599999999999999999986533 6899999999999999999999544 5999999999999999999999999
Q ss_pred CCccccccccccceeec-cCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC---CCCChHHHHHHHHHhh
Q 041878 681 GLSRLMTAAANTNVIAT-AGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM---NGMDLPQWVASIVKEE 756 (773)
Q Consensus 681 G~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~---~~~~~~~~~~~~~~~~ 756 (773)
|+|+..... ....... .||.+|+|||+...+..+.|+|||||||++.|++||+.|.+.. ....+.+|+...+.+.
T Consensus 222 GLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 222 GLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred cCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 999655431 1111122 7999999999999999999999999999999999999988753 3445899999999998
Q ss_pred hcccccChhcc
Q 041878 757 WTNEVFDLELM 767 (773)
Q Consensus 757 ~~~~~~d~~~~ 767 (773)
...+++||.+.
T Consensus 301 ~~~eiiD~~l~ 311 (361)
T KOG1187|consen 301 KLREIVDPRLK 311 (361)
T ss_pred chhheeCCCcc
Confidence 88999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=355.85 Aligned_cols=200 Identities=29% Similarity=0.487 Sum_probs=175.6
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
..+.||+|+||+||+|+.+ ++..||||.+... ..+..+-+..|+.+++.++|||||++++++ ..++..|+|||||.
T Consensus 14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-~~~~~i~lVMEyC~ 92 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-EDDDFIYLVMEYCN 92 (429)
T ss_pred ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-ecCCeEEEEEEeCC
Confidence 3456999999999999864 6899999999766 455667789999999999999999999998 45569999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC------CCeEEeecCCccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK------TNPRIADFGLSRLMTAA 689 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~------~~~kl~DfG~a~~~~~~ 689 (773)
||+|.+|+++++. ++..++..++.|||.|+++|| +++||||||||+|||++.. -.+||+|||+|+.....
T Consensus 93 gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~-~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 93 GGDLSDYIRRRGR---LPEATARHFMQQLASALQFLH-ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred CCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH-HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 9999999998753 899999999999999999999 9999999999999999875 34899999999988743
Q ss_pred cccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCh
Q 041878 690 ANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~ 745 (773)
.- ....+|+|.|||||++..+.|+.|+|+||.|+++|||++|+.||...+..++
T Consensus 169 ~~--a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 169 SM--AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred hH--HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 32 2245799999999999999999999999999999999999999986554443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=356.71 Aligned_cols=202 Identities=37% Similarity=0.632 Sum_probs=176.1
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccCccc--HHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKG--QKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.+.+|+|+||+||+|.+.....||||++....... .++|.+|+.+|.+++|||||+++|+|..+....++||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 4556699999999999999855559999998654332 56999999999999999999999999665557899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCC-ceecCCCCCCEEeCCCC-CeEEeecCCccccccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN-MIHGNLTSSNVLLDEKT-NPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~-iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~~~~~ 693 (773)
+|+|.++++.. ....+++..+++++.|||+||.||| +.+ ||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH-~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~ 200 (362)
T KOG0192|consen 124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH-SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TS 200 (362)
T ss_pred CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh-cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-cc
Confidence 99999999885 3456999999999999999999999 888 99999999999999998 99999999998765432 22
Q ss_pred eeeccCccccccccccC--CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSK--LKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~--~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.+...||+.|||||++. ...|+.|+|||||||++|||+||+.||+....
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 33357999999999999 56999999999999999999999999998664
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=335.29 Aligned_cols=219 Identities=28% Similarity=0.426 Sum_probs=189.4
Q ss_pred ChhHHHHHhhcccccccceEEEEEEeC-CCCEEEEEEeccc-CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 531 TADDLLCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK-TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 531 ~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
..+++ ...+.||+|..|+|||+.++ +++.+|+|.+... .....+++.+|++++++.+||+||.+||.|..+..+..
T Consensus 77 ~~~dl--e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 77 SLSDL--ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred CHHHh--hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 34444 45678999999999999875 6788999999544 34457899999999999999999999999965543699
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
++||||++|+|.+++.+.+ .+++...-+++.+|++||.|||++++||||||||+|||++..|++||+|||.+..+..
T Consensus 155 I~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred eehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999999998753 3888999999999999999999669999999999999999999999999999987754
Q ss_pred ccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC--CCCChHHHHHHHHHhhh
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM--NGMDLPQWVASIVKEEW 757 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~--~~~~~~~~~~~~~~~~~ 757 (773)
. ......||..|||||.+.+..|+.++||||||+.++|+.+|+.||.+. +..++.+.+..|+.+..
T Consensus 232 S---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 232 S---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP 299 (364)
T ss_pred h---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC
Confidence 4 334567999999999999999999999999999999999999999874 34577888888877554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=353.27 Aligned_cols=225 Identities=28% Similarity=0.477 Sum_probs=192.2
Q ss_pred hhHHHHHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 532 ADDLLCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 532 ~~~l~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
.+.-.+...+.||+|.||.||+|.+.....||+|.++... -..++|.+|+++|++++|++||+++|+|. .++..+|||
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~-~~~piyIVt 280 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCT-KQEPIYIVT 280 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEe-cCCceEEEE
Confidence 3344456778999999999999999988899999998653 34688999999999999999999999994 444899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
|||+.|+|.+||+... ...+...+.+.++.|||+||+||+ ++++|||||.++||||+++..+||+|||+|+....+..
T Consensus 281 E~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLe-s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLE-SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred EecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHH-hCCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 9999999999999833 445888999999999999999999 99999999999999999999999999999996665555
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCChH----------------HHHHHHHH
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLP----------------QWVASIVK 754 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~~----------------~~~~~~~~ 754 (773)
+......-...|+|||.+....++.|+|||||||+||||+| |+.||..+...+.. ..+..+|.
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~ 438 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMK 438 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHH
Confidence 54444556779999999999999999999999999999999 99998886655443 34445777
Q ss_pred hhhccc
Q 041878 755 EEWTNE 760 (773)
Q Consensus 755 ~~~~~~ 760 (773)
.+|..+
T Consensus 439 ~CW~~~ 444 (468)
T KOG0197|consen 439 SCWHED 444 (468)
T ss_pred HHhhCC
Confidence 777543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=332.79 Aligned_cols=211 Identities=27% Similarity=0.438 Sum_probs=183.0
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+.+.++||+|+||.||.++. ++++.+|+|++++.. .++.+...+|..++.+++||.||+++-.++ ..+..|+|+|
T Consensus 27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ-t~~kLylVld 105 (357)
T KOG0598|consen 27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ-TEEKLYLVLD 105 (357)
T ss_pred eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc-cCCeEEEEEe
Confidence 35678999999999999975 468899999998653 335677889999999999999999998884 5559999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+.||.|..++++.+ .++...+.-++.+|+.||.||| ++||||||+||+|||+|++|+++|+|||+|+.......
T Consensus 106 ~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH-~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~- 180 (357)
T KOG0598|consen 106 YLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLH-SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD- 180 (357)
T ss_pred ccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHH-hCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC-
Confidence 999999999999864 3888888999999999999999 99999999999999999999999999999986544332
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhh
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 756 (773)
.+...+||+.|||||++.+..|+.++|-||+|+++|||++|.+||...+ ..++.+++.++.
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~---~~~~~~~I~~~k 241 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED---VKKMYDKILKGK 241 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc---HHHHHHHHhcCc
Confidence 2334689999999999999999999999999999999999999997665 456666776655
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=360.26 Aligned_cols=223 Identities=30% Similarity=0.502 Sum_probs=192.2
Q ss_pred HHhhcccccccceEEEEEEeC------CCCEEEEEEecccCcc-cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
+...+.||+|+||.||+|... +.+.||||.+++.... .+.+|++|+++++.++|||||+++|+| ..++..+|
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC-~~~~P~~M 566 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC-REGDPLCM 566 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-ccCCeeEE
Confidence 345678999999999999843 3457999999987666 788999999999999999999999999 55669999
Q ss_pred EEeecCCCCHHHHHhhcCCC-----------CccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEe
Q 041878 610 VFDFMPKGSLASFLHARGPE-----------TIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIA 678 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~-----------~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~ 678 (773)
|+|||..|||.+||+.+.+. ..++..+.+.||.|||.||+||- +..+|||||..+|+||+++..|||+
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs-~~~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS-SHHFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCcccccchhhhhceeccceEEEec
Confidence 99999999999999876431 22788899999999999999999 9999999999999999999999999
Q ss_pred ecCCcccccccccccee-eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCC------------
Q 041878 679 DFGLSRLMTAAANTNVI-ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMD------------ 744 (773)
Q Consensus 679 DfG~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~------------ 744 (773)
|||+++......++... ...-..+|||||.+..++|++++|||||||+|||+++ |+.||.+...++
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~ 725 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLS 725 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCccc
Confidence 99999988766665544 3345679999999999999999999999999999998 999999865544
Q ss_pred ----hHHHHHHHHHhhhcccc
Q 041878 745 ----LPQWVASIVKEEWTNEV 761 (773)
Q Consensus 745 ----~~~~~~~~~~~~~~~~~ 761 (773)
=+.+++++|.+.|-++.
T Consensus 726 ~Pe~CP~~vY~LM~~CW~~~P 746 (774)
T KOG1026|consen 726 CPENCPTEVYSLMLECWNENP 746 (774)
T ss_pred CCCCCCHHHHHHHHHHhhcCc
Confidence 35666778888885543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.35 Aligned_cols=206 Identities=26% Similarity=0.437 Sum_probs=182.4
Q ss_pred HHHHhhcccccccceEEEEEEe-CCCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 535 LLCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
.+|..+++||+|||..||+++. ..|+.||+|++.+. .....+.+.+||++.++++|||||+++++| ++.+..|+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-EDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-EDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-ecCCceEEE
Confidence 4456789999999999999997 78999999999764 334456789999999999999999999999 566699999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
.|+|+.++|.++++++ ..+++..+..+++||+.|+.||| +.+|||||||..|+++++++++||+|||+|.....+.
T Consensus 97 LELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH-~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLH-SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHH-hcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999999864 45899999999999999999999 9999999999999999999999999999999887553
Q ss_pred ccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChH
Q 041878 691 NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLP 746 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~ 746 (773)
. .....+|||.|+|||++....++..+||||+||+||.|+.|++||+..+-++..
T Consensus 173 E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety 227 (592)
T KOG0575|consen 173 E-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY 227 (592)
T ss_pred c-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH
Confidence 2 334568999999999999999999999999999999999999999876544433
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=318.10 Aligned_cols=217 Identities=22% Similarity=0.387 Sum_probs=183.9
Q ss_pred HHhhcccccccceEEEEEE-eCCCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEE-EECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAY-YLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~~~~lV~e 612 (773)
|.+.++||+|.||+||++. ..+|..||.|.+.-. +.+...+...|+.+|++++|||||+++++ +..+....++|||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE 100 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME 100 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence 5778999999999999997 578999999998732 34455678899999999999999999984 4344445899999
Q ss_pred ecCCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccC-CC--ceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 613 FMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVE-EN--MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~-~~--iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
|+..|+|...++... ..+.++...++++..|++.||..+|.. +. |+||||||.||+++++|.+|++|||+++....
T Consensus 101 ~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 101 LCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 999999999987653 355689999999999999999999931 33 88999999999999999999999999998865
Q ss_pred ccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhhh
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEW 757 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 757 (773)
... .....+|||.||+||.+.+..|++++||||+||++|||+.-..||.+. ...+..++|-+.++
T Consensus 181 ~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 181 KTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQGDY 245 (375)
T ss_pred hhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcCCC
Confidence 443 334567999999999999999999999999999999999999999876 45666666665554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=330.51 Aligned_cols=201 Identities=22% Similarity=0.410 Sum_probs=170.0
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcc-------cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTK-------GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
|.+.+.||+|+||.|-+|.. ++|+.||||++++.... ....+++|+++|++++||+||++++++ +.++..|
T Consensus 174 yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f-~~~ds~Y 252 (475)
T KOG0615|consen 174 YIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF-EVPDSSY 252 (475)
T ss_pred eEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-ecCCceE
Confidence 34578999999999999974 58999999999754211 234568999999999999999999999 5555889
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC---CCeEEeecCCccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK---TNPRIADFGLSRL 685 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~---~~~kl~DfG~a~~ 685 (773)
|||||++||+|.+.+-++.. +.....+.+++|++.|+.||| +.||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 253 mVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH-~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 253 MVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLH-SQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred EEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHH-HcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999987643 566677889999999999999 9999999999999999876 6699999999998
Q ss_pred cccccccceeeccCccccccccccCCCC---CCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 041878 686 MTAAANTNVIATAGTLGYRAPELSKLKN---ANTKTDVYSLGVIILELLTGKSPGEPMNGMD 744 (773)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~ 744 (773)
.. ....+...+|||.|.|||++.+.. +..++|+||+||++|-+++|.+||++.....
T Consensus 329 ~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 329 SG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred cc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 75 334455678999999999986654 3348899999999999999999999865443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=325.51 Aligned_cols=214 Identities=29% Similarity=0.440 Sum_probs=182.9
Q ss_pred HHHHHhhcccccccceEEEEEE-eCCCCEEEEEEecccCcc--cHHHHHHHHHHHHccCCCceEEeEEEEECC-CCeEEE
Q 041878 534 DLLCATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTK--GQKEFEAEAAAIGKIHHPNLLALRAYYLGP-KGEKLL 609 (773)
Q Consensus 534 ~l~~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~l 609 (773)
.-.|...++||+|.||.||+|+ ..+|+.||+|+++-...+ ...-..+||.+|+++.||||++|.+..... .+..||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3345667899999999999997 468999999999866533 344567899999999999999999999766 568999
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
|+|||+. ||.-++... .-.++..+++.+++|++.||+|+| .+||+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 196 VFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH-~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCH-SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHh-hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999965 888888764 345899999999999999999999 999999999999999999999999999999988877
Q ss_pred cccceeeccCccccccccccC-CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHH
Q 041878 690 ANTNVIATAGTLGYRAPELSK-LKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK 754 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 754 (773)
.....+..+-|.+|.|||++. ...|+.++|+||.||++.||++|++.|.+.++ .+++++|.+
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE---veQl~kIfk 334 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE---VEQLHKIFK 334 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH---HHHHHHHHH
Confidence 666666677899999999765 46799999999999999999999999877664 355555543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=303.02 Aligned_cols=209 Identities=25% Similarity=0.417 Sum_probs=182.6
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCccc---HHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKG---QKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+.+.||.|+||.|-+++.+ +|..+|+|+++...... .+...+|..+++++.||+++++++.+. +.+..+|||||
T Consensus 47 e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~-d~~~lymvmey 125 (355)
T KOG0616|consen 47 ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK-DNSNLYMVMEY 125 (355)
T ss_pred hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec-cCCeEEEEEec
Confidence 55688999999999999865 68889999998664333 445678999999999999999999994 55599999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
++||.|.+++++.++ ++...+..++.||+.|++||| +.+|++||+||+|||+|.+|.+||+|||.|+.... .
T Consensus 126 v~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH-~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~----r 197 (355)
T KOG0616|consen 126 VPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLH-SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG----R 197 (355)
T ss_pred cCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHH-hcCeeeccCChHHeeeccCCcEEEEeccceEEecC----c
Confidence 999999999998654 788999999999999999999 99999999999999999999999999999987643 3
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhhhc
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWT 758 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 758 (773)
+...+|||.|+|||.++...|+.++|-|||||++|||+.|..||...+..++.+ +|+..+..
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~---KI~~~~v~ 259 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE---KILEGKVK 259 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH---HHHhCccc
Confidence 556789999999999999999999999999999999999999999877654443 66655543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=327.79 Aligned_cols=204 Identities=26% Similarity=0.467 Sum_probs=177.9
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc---CcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK---TTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
+.+++.||+|+|++|++|+. ..++++|||++.+. ..+..+.+..|-.+|.+| .||.|++|+..|++. ...|+|+
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~-~sLYFvL 153 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE-ESLYFVL 153 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc-cceEEEE
Confidence 34678999999999999985 57899999999765 233456788899999999 799999999988554 4899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++|+|.+++++.+. ++......++.+|+.|++||| +.|||||||||+|||+|+||+++|+|||.|+.+.+...
T Consensus 154 e~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH-~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLH-SNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHH-hcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 99999999999998754 788888999999999999999 99999999999999999999999999999998864322
Q ss_pred c------------ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCh
Q 041878 692 T------------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745 (773)
Q Consensus 692 ~------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~ 745 (773)
. .....+||..|.+||++.....++.+|+|||||++|+|+.|.+||.+.++.-+
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli 295 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI 295 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH
Confidence 1 11346899999999999999999999999999999999999999988775443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=324.48 Aligned_cols=209 Identities=26% Similarity=0.463 Sum_probs=183.0
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|.+.+.||+|.||.||||+-+ +.+.||+|.+.+. ..++.+.+.+|++++++++|||||.++++| +...+.|+|+||
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-Et~~~~~vVte~ 82 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-ETSAHLWVVTEY 82 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-cccceEEEEehh
Confidence 566788999999999999854 6788999999764 344567799999999999999999999999 666699999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+.| +|..++...+ .+++.++..++.+++.||.||| +.+|+|||+||+|||++..+.+|++|||+|+.+... ...
T Consensus 83 a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLh-s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~v 156 (808)
T KOG0597|consen 83 AVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLH-SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSV 156 (808)
T ss_pred hhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH-hcCcccccCCcceeeecCCCceeechhhhhhhcccC-cee
Confidence 976 9999998754 4899999999999999999999 999999999999999999999999999999987653 233
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHh
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKE 755 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 755 (773)
.+...|||.|||||+..++.|+..+|+||+||++||+++|++||... .+.+.++.|..+
T Consensus 157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv~~I~~d 215 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLVKSILKD 215 (808)
T ss_pred eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHHHHHhcC
Confidence 34567999999999999999999999999999999999999998654 366666666654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=339.06 Aligned_cols=204 Identities=26% Similarity=0.504 Sum_probs=176.9
Q ss_pred HHhhcccccccceEEEEEEeC----CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE----DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
+.+.++||.|.||.||+|.++ ....||||.++.... +...+|..|+.+|.++.||||++|-|+. ......++|+
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-Tks~PvMIiT 709 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-TKSKPVMIIT 709 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-ecCceeEEEh
Confidence 346789999999999999875 234699999997654 4567899999999999999999999999 4455899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
|||++|+|..||+.+. ..+.+.+...++++||.||+||- +.+.|||||.++||||+.+-.+|++|||+++.+..+..
T Consensus 710 EyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLs-dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLS-DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHh-hcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 9999999999999875 44899999999999999999999 99999999999999999999999999999998865542
Q ss_pred ccee--eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCC
Q 041878 692 TNVI--ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMD 744 (773)
Q Consensus 692 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~ 744 (773)
...+ .-.-..+|.|||.+....++.++|||||||+|||+++ |+.||.++..+|
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd 842 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 842 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence 2222 2233569999999999999999999999999999887 999999876554
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=314.47 Aligned_cols=202 Identities=26% Similarity=0.504 Sum_probs=173.0
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCC-eEEEEEee
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG-EKLLVFDF 613 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~lV~e~ 613 (773)
.+...+.||+|+||+||++... +|...|||..........+.+++|+.+|++++|||||+.+|......+ .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 3566789999999999999865 489999999976543336678999999999999999999998644444 68899999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-CCCeEEeecCCcccccc--cc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE-KTNPRIADFGLSRLMTA--AA 690 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~--~~ 690 (773)
+++|+|.+++.+.+. .++...+.++.+||++||+||| ++|||||||||+|||++. ++.+||+|||+++.... ..
T Consensus 98 ~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylH-s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLH-SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred cCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH-hCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 999999999998753 4899999999999999999999 999999999999999999 79999999999987763 12
Q ss_pred ccceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 691 NTNVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
........||+.|||||++..+ ...+++||||+||++.||+||+.||...
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 2223356799999999999853 3446999999999999999999999864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=319.35 Aligned_cols=217 Identities=26% Similarity=0.408 Sum_probs=186.2
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccH-HHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQ-KEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
..++++||+|.||.|-++....+..||||.++....+.. .+|.+|+++|.+++||||++++|+|. .++..++|+|||+
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~-~DePicmI~EYmE 618 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV-QDDPLCMITEYME 618 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee-cCCchHHHHHHHh
Confidence 346799999999999999988889999999998766654 89999999999999999999999995 4458999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce-
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV- 694 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~- 694 (773)
+|+|.+|+.++.... ..-....+|+.||+.||+||. +..+|||||.++|+|+|.++++||+|||+++-+.+...+..
T Consensus 619 nGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLe-s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 619 NGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLE-SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred cCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHH-hhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 999999999986544 344566789999999999999 99999999999999999999999999999997765554433
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCCCChHHHHHHHHHhh
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT--GKSPGEPMNGMDLPQWVASIVKEE 756 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t--g~~P~~~~~~~~~~~~~~~~~~~~ 756 (773)
...+-..+|||||.+.-+.++.++|||+|||++||+++ .+.||+....++..+-.....+++
T Consensus 697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~ 760 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQ 760 (807)
T ss_pred cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCC
Confidence 23456779999999999999999999999999999876 788999887776665555444443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.45 Aligned_cols=190 Identities=29% Similarity=0.523 Sum_probs=168.8
Q ss_pred hhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCC
Q 041878 539 TAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
..+.||.|+.|.||+|++. ++.||||+++.-. +.+|+.|++++|+||+.+.|+| .....+|+|||||+.|-
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVC-tqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVC-TQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeee-cCCceeEEeeecccccc
Confidence 4578999999999999987 7899999985332 4589999999999999999999 45558999999999999
Q ss_pred HHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeecc
Q 041878 619 LASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA 698 (773)
Q Consensus 619 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 698 (773)
|.++|+... .+.......+..+||.||.||| ...|||||+|.=||||..+..+||+|||-++..... ...+.++
T Consensus 199 L~~VLka~~---~itp~llv~Wsk~IA~GM~YLH-~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa 272 (904)
T KOG4721|consen 199 LYEVLKAGR---PITPSLLVDWSKGIAGGMNYLH-LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA 272 (904)
T ss_pred HHHHHhccC---ccCHHHHHHHHHHhhhhhHHHH-HhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence 999999753 4777888899999999999999 999999999999999999999999999998876544 3445678
Q ss_pred CccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 699 GTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 699 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
||..|||||++...+.++|+||||||||||||+||+.||.+.+..
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss 317 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS 317 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh
Confidence 999999999999999999999999999999999999999885433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=297.96 Aligned_cols=201 Identities=23% Similarity=0.361 Sum_probs=169.0
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|....++|+|+||+||+++.+ +|+.||||++.+... .-.+-..+|++++++++|+|+|.++++| ..+...++|+||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-rrkrklhLVFE~ 82 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-RRKRKLHLVFEY 82 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-HhcceeEEEeee
Confidence 445578999999999999865 699999999976533 2234568999999999999999999999 556689999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
++. ++.+-+++.. ..++.....++++|++.|+.|+| +.++|||||||+|||++.++.+|++|||+|+.+..+.. .
T Consensus 83 ~dh-TvL~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cH-k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-~ 157 (396)
T KOG0593|consen 83 CDH-TVLHELERYP--NGVPSELVKKYLYQLLKAIHFCH-KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-N 157 (396)
T ss_pred cch-HHHHHHHhcc--CCCCHHHHHHHHHHHHHHhhhhh-hcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-h
Confidence 976 5555666653 23788889999999999999999 99999999999999999999999999999998874332 2
Q ss_pred eeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
.+..+.|.+|.|||.+.+ ..|+.++||||.||++.||++|.+.|.+.++-
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi 208 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI 208 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH
Confidence 233457899999998765 78999999999999999999999988766543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=323.13 Aligned_cols=196 Identities=26% Similarity=0.458 Sum_probs=177.1
Q ss_pred HHhhcccccccceEEEEEE-eCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|+..++||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||.++..|... ++.|+|||||+
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVMEym~ 353 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVMEYME 353 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEeecC
Confidence 4456789999999999997 567899999999887777778889999999999999999999988544 69999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.|.+.... +++.+...|++++++||+||| .+||+|||||.+|||++.+|.+||+|||+|..+...... ..
T Consensus 354 ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH-~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-R~ 427 (550)
T KOG0578|consen 354 GGSLTDVVTKTR----MTEGQIAAICREILQGLKFLH-ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-RS 427 (550)
T ss_pred CCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHH-hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-cc
Confidence 999999988653 789999999999999999999 999999999999999999999999999999887665542 33
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
...|||.|||||++....|++++||||+|++++||+.|++||-.
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 45799999999999999999999999999999999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=314.76 Aligned_cols=204 Identities=23% Similarity=0.355 Sum_probs=173.7
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCc---ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+.+.++||+|+||.||+|+- .+|..+|+|++++..- ...+.+..|-.+|....++.||+++..| .+.+..|||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-QD~~~LYLiME 221 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-QDKEYLYLIME 221 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-cCCCeeEEEEE
Confidence 35678999999999999975 4799999999986532 3345678899999999999999999998 45569999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc----
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA---- 688 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~---- 688 (773)
|+|||++..+|.+.+ .++...+..++.+.+-|++-+| +.|+|||||||+|+|||..|++||+|||++.-...
T Consensus 222 ylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH-~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 222 YLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIH-QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred ecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHH-HcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 999999999999864 4788888899999999999999 99999999999999999999999999999854321
Q ss_pred -------------------cccc----c-------------------eeeccCccccccccccCCCCCCcchhhHHHHHH
Q 041878 689 -------------------AANT----N-------------------VIATAGTLGYRAPELSKLKNANTKTDVYSLGVI 726 (773)
Q Consensus 689 -------------------~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~ 726 (773)
.... . ....+|||.|||||++.+..|+..+|.||+||+
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 0000 0 012359999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCCCh
Q 041878 727 ILELLTGKSPGEPMNGMDL 745 (773)
Q Consensus 727 l~el~tg~~P~~~~~~~~~ 745 (773)
||||+.|.+||...+..+.
T Consensus 378 myEmLvGyPPF~s~tp~~T 396 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQET 396 (550)
T ss_pred HHHHHhCCCCCCCCCHHHH
Confidence 9999999999987765443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.62 Aligned_cols=213 Identities=25% Similarity=0.457 Sum_probs=178.4
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc----Cc-ccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK----TT-KGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~l 609 (773)
|..++.||+|.||.|+.|.. .++..||+|.+... .. ...+.+.+|+.++++++ ||||+++++++... ...++
T Consensus 19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-~~~~i 97 (370)
T KOG0583|consen 19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-TKIYI 97 (370)
T ss_pred eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-CeEEE
Confidence 34578899999999999974 57899999977653 12 33566778999999999 99999999999544 47999
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC-CCeEEeecCCcccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK-TNPRIADFGLSRLMTA 688 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~~~ 688 (773)
||||+.+|+|.+++.+.++ +....+..+++|++.|++|+| ++||+||||||+|||++.+ +++||+|||++....
T Consensus 98 vmEy~~gGdL~~~i~~~g~---l~E~~ar~~F~Qlisav~y~H-~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIVNKGR---LKEDEARKYFRQLISAVAYCH-SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred EEEecCCccHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHH-hCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 9999999999999998543 667889999999999999999 9999999999999999999 999999999998774
Q ss_pred ccccceeeccCccccccccccCCCC-CC-cchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhhhc
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKN-AN-TKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWT 758 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 758 (773)
.........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+. .+.+...+++.+.++.
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---~~~~~l~~ki~~~~~~ 241 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD---SNVPNLYRKIRKGEFK 241 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC---ccHHHHHHHHhcCCcc
Confidence 2222334567999999999998877 75 789999999999999999999987 3344555556555554
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=304.38 Aligned_cols=190 Identities=32% Similarity=0.503 Sum_probs=156.6
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHH--ccCCCceEEeEEEEECC---CCeEEEEEe
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIG--KIHHPNLLALRAYYLGP---KGEKLLVFD 612 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~---~~~~~lV~e 612 (773)
...++||+|.||.||||++. ++.||||++... +...|+.|-++.+ .++|+||++++++-... ..+++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 44578999999999999987 599999999543 3456666666655 56899999999876321 237899999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccC--------CCceecCCCCCCEEeCCCCCeEEeecCCcc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE--------ENMIHGNLTSSNVLLDEKTNPRIADFGLSR 684 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~--------~~iiH~Dik~~NIll~~~~~~kl~DfG~a~ 684 (773)
|.+.|+|.+||..+. ++|....+++..+++||+|||++ .+|+|||||++||||.+|+++.|+|||+|.
T Consensus 289 fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999999864 89999999999999999999944 459999999999999999999999999999
Q ss_pred cccccccc-ceeeccCccccccccccCCCC------CCcchhhHHHHHHHHHHHcCCC
Q 041878 685 LMTAAANT-NVIATAGTLGYRAPELSKLKN------ANTKTDVYSLGVIILELLTGKS 735 (773)
Q Consensus 685 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~------~~~~~Dvws~Gv~l~el~tg~~ 735 (773)
.+...... .....+||.+|||||++.+.- .-.+.||||+|.|+|||++...
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~ 422 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT 422 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 88755433 233467999999999876432 2236899999999999998644
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=283.31 Aligned_cols=209 Identities=29% Similarity=0.439 Sum_probs=176.1
Q ss_pred HHHhhcccccccceEEEEEEe-CCCCEEEEEEecccCccc--HHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 536 LCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKG--QKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+|...+++|+|.||.||+|++ ++|+.||||+++....++ .....+||+.++.++|+||+.+++++ ...+..-+|+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-PHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-cCCCceEEEEE
Confidence 456678999999999999985 689999999998654332 34568899999999999999999999 77778999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
||+ .+|+..++.+ ...++..+.+.++.++++|++|+| ++.|+||||||.|+|++++|.+||+|||+|+...++...
T Consensus 82 fm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H-~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCH-SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred ecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHH-hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 996 5999999875 456889999999999999999999 999999999999999999999999999999988765433
Q ss_pred ceeeccCcccccccccc-CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHH
Q 041878 693 NVIATAGTLGYRAPELS-KLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIV 753 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~ 753 (773)
. ...+-|..|.|||.+ ....|+..+||||.||++.||+-|.+-|.+.++ .+++..+.
T Consensus 158 ~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD---idQL~~If 215 (318)
T KOG0659|consen 158 Q-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD---IDQLSKIF 215 (318)
T ss_pred c-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch---HHHHHHHH
Confidence 2 223578899999965 557799999999999999999999977765543 34444443
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=326.13 Aligned_cols=215 Identities=27% Similarity=0.445 Sum_probs=179.6
Q ss_pred cccChhHHHHHhhcccccccceEEEEEEeC--CC--CE-EEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEE
Q 041878 528 FLFTADDLLCATAEIMGKSTYGTAYKATLE--DG--SE-VAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAY 599 (773)
Q Consensus 528 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~--~g--~~-vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 599 (773)
+.+..+++.+. ++||+|+||.||+|.+. ++ .. ||||..+.. ......+|..|+++|+.++|||||+++|+
T Consensus 152 Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 152 WELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 55566665444 99999999999999864 23 23 899999852 35567889999999999999999999999
Q ss_pred EECCCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEee
Q 041878 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIAD 679 (773)
Q Consensus 600 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~D 679 (773)
+ ..+...++|||+|+||+|.++|+.... .++..++..++.++|+||+||| ++++|||||.++|+|++.++.+||+|
T Consensus 230 a-~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh-~k~~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 230 A-VLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLH-SKNCIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred E-cCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHH-HCCCcchhHhHHHheecCCCeEEeCc
Confidence 9 455589999999999999999998753 5899999999999999999999 99999999999999999999999999
Q ss_pred cCCccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCChHHHH
Q 041878 680 FGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749 (773)
Q Consensus 680 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~~~~~ 749 (773)
||+++.-...... .....-..+|+|||.+....|++++|||||||++||+++ |..||.+....+..+++
T Consensus 306 FGLs~~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI 375 (474)
T KOG0194|consen 306 FGLSRAGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI 375 (474)
T ss_pred cccccCCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH
Confidence 9998754311111 111134679999999999999999999999999999999 88899887765555544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=311.26 Aligned_cols=204 Identities=25% Similarity=0.383 Sum_probs=177.4
Q ss_pred HHHHHhhcccccccceEEEEEE-eCCCCEEEEEEecccCcc-cHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEE
Q 041878 534 DLLCATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTK-GQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 534 ~l~~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV 610 (773)
.-+|.+.++||.|.||.||+|+ ..+|..||||+++..-.. ++..-.+|++.+++++ |||||++.+++.+.....++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 3467888999999999999997 567999999999865333 3334578999999999 999999999997777799999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||| ..+|++.++.+ ++.++...++.|+.||.+||+|+| .+|+.|||+||+|||+.....+||+|||+|+.+.+..
T Consensus 89 fE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiH-k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIH-KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHH-hcCcccccCChhheEecccceeEecccccccccccCC
Confidence 9999 56999999887 567999999999999999999999 9999999999999999999999999999999876543
Q ss_pred ccceeeccCcccccccccc-CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 691 NTNVIATAGTLGYRAPELS-KLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
. .+..+.|.+|.|||++ ....|+.+.||||+||+++|+.+-++.|.+.++.
T Consensus 165 P--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~ 216 (538)
T KOG0661|consen 165 P--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI 216 (538)
T ss_pred C--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH
Confidence 3 3345579999999975 5677899999999999999999999999876653
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=298.94 Aligned_cols=214 Identities=26% Similarity=0.457 Sum_probs=187.1
Q ss_pred HHHHHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccH---HHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 534 DLLCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQ---KEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 534 ~l~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
.-+|.+.+.||+|.||.|-+|.. ..|+.||||.+++...+++ -.+.+||++|+.++||||+.++++| ++.+...+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-ENkdKIvi 130 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-ENKDKIVI 130 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-cCCceEEE
Confidence 34567788999999999999974 6899999999987655444 4578999999999999999999999 78889999
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||..+|.|+||+.+.+. ++...+..+++||+.|+.|+| ..+|+|||+|.+|||+|.++++||+|||++..+...
T Consensus 131 vMEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCH-knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCH-KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EEEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHh-hccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999999998654 889999999999999999999 999999999999999999999999999999876544
Q ss_pred cccceeeccCccccccccccCCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhhh
Q 041878 690 ANTNVIATAGTLGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEW 757 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 757 (773)
. ....++|+|-|.+||.+.+..| ++.+|-||+||++|.++.|..||++.+ ....+++|-++.|
T Consensus 207 k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lvrQIs~GaY 270 (668)
T KOG0611|consen 207 K--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLVRQISRGAY 270 (668)
T ss_pred c--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHHHHhhcccc
Confidence 3 2335689999999999998888 678999999999999999999997665 4555666666666
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.68 Aligned_cols=209 Identities=24% Similarity=0.407 Sum_probs=178.6
Q ss_pred ChhHHHHHhhcccccccceEEEEEE-eCCCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 531 TADDLLCATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 531 ~~~~l~~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
....-.|...++||.|..++||+|. ...++.||||++.-+.. .+.+.+.+|++.|+.++||||++++..|.. +...|
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-~~~LW 100 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-DSELW 100 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-cceeE
Confidence 3334445677899999999999997 46789999999975533 345889999999999999999999999954 44999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||.||.+|++.+.+....+.. +++..+..|.+++++||.||| .+|.||||||+.|||++.+|.+||+|||.+..+..
T Consensus 101 vVmpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH-~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLH-QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred EeehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHH-hcCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999999876544 888999999999999999999 99999999999999999999999999998766654
Q ss_pred ccccce----eeccCccccccccccC--CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 689 AANTNV----IATAGTLGYRAPELSK--LKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 689 ~~~~~~----~~~~gt~~y~aPE~~~--~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
.. .+. ....||+.|||||++. -..|+.|+||||||++..|+.+|..||.....+
T Consensus 179 ~G-~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm 238 (516)
T KOG0582|consen 179 SG-DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM 238 (516)
T ss_pred cC-ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH
Confidence 33 222 3347999999999843 356899999999999999999999999887644
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=340.64 Aligned_cols=226 Identities=29% Similarity=0.530 Sum_probs=189.4
Q ss_pred HHHhhcccccccceEEEEEEeC--CCC----EEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE--DGS----EVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~--~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
.....+.||+|+||.||+|... +|. .||||.++... ..+..+|.+|..+|++++||||++++|+|.. .+..+
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~~~ 771 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGPPL 771 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCCcE
Confidence 3445788999999999999864 343 49999998654 4457799999999999999999999999966 66899
Q ss_pred EEEeecCCCCHHHHHhhcCC----CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcc
Q 041878 609 LVFDFMPKGSLASFLHARGP----ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSR 684 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~ 684 (773)
+++|||++|+|..|+++.+. ...++....+.++.|||+|+.||+ ++++|||||.++|+|+++...+||+|||+|+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe-~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE-SKHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH-hCCCcCcchhhhheeecccCcEEEcccchhH
Confidence 99999999999999998732 345888999999999999999999 9999999999999999999999999999999
Q ss_pred ccccccccceeec-cCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCh----------------H
Q 041878 685 LMTAAANTNVIAT-AGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDL----------------P 746 (773)
Q Consensus 685 ~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~----------------~ 746 (773)
.+.....+..... .-..+|||||.+.++.++.|+|||||||++||++| |..||...+..+. +
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP 930 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCP 930 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCC
Confidence 7665554443333 44569999999999999999999999999999999 8899988554443 3
Q ss_pred HHHHHHHHhhhcccccC
Q 041878 747 QWVASIVKEEWTNEVFD 763 (773)
Q Consensus 747 ~~~~~~~~~~~~~~~~d 763 (773)
+-+.++|.+.|..+--|
T Consensus 931 ~~ly~lM~~CW~~~pe~ 947 (1025)
T KOG1095|consen 931 EKLYQLMLQCWKHDPED 947 (1025)
T ss_pred hHHHHHHHHHccCChhh
Confidence 44557788887655433
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.89 Aligned_cols=219 Identities=29% Similarity=0.489 Sum_probs=179.3
Q ss_pred HHHhhcccccccceEEEEEEeCCCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 536 LCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+...+.||+|.||+||+|.+. -.||||+++.... +..+.|..|+.++++=+|.||+-++|+|.. + ...+|+.+
T Consensus 393 ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~-p-~~AIiTqw 468 (678)
T KOG0193|consen 393 EVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN-P-PLAIITQW 468 (678)
T ss_pred Hhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC-C-ceeeeehh
Confidence 3456789999999999999975 3699999986543 345789999999999999999999999944 3 34999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc-cc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA-NT 692 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 692 (773)
|+|-+|+.+++... ..++..+...|++||++|+.||| .++|||||+|..||++.+++.|||+|||++..-..-. ..
T Consensus 469 CeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLH-AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~ 545 (678)
T KOG0193|consen 469 CEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLH-AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ 545 (678)
T ss_pred ccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhh-hhhhhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence 99999999998763 45888999999999999999999 9999999999999999999999999999987643221 11
Q ss_pred ceeeccCccccccccccCC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC--------------------hHHHH
Q 041878 693 NVIATAGTLGYRAPELSKL---KNANTKTDVYSLGVIILELLTGKSPGEPMNGMD--------------------LPQWV 749 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~--------------------~~~~~ 749 (773)
......|...|||||++.. .+|++.+||||||+|+|||+||..||...+.+. -++-+
T Consensus 546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~m 625 (678)
T KOG0193|consen 546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAM 625 (678)
T ss_pred ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHH
Confidence 1122347789999998864 458899999999999999999999998643332 24466
Q ss_pred HHHHHhhhcccc
Q 041878 750 ASIVKEEWTNEV 761 (773)
Q Consensus 750 ~~~~~~~~~~~~ 761 (773)
++++.++|..+.
T Consensus 626 k~Ll~~C~~~~~ 637 (678)
T KOG0193|consen 626 KRLLSDCWKFDR 637 (678)
T ss_pred HHHHHHHHhcCc
Confidence 677777775443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=318.73 Aligned_cols=210 Identities=25% Similarity=0.417 Sum_probs=176.7
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEEe
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e 612 (773)
...++||+|.||.|+++..+ +++.+|||++++.. .++.+....|.+++.... ||.+++++..++ .++..|.|||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ-T~~~l~fvme 449 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ-TKEHLFFVME 449 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc-cCCeEEEEEE
Confidence 45689999999999999875 57889999998763 344566777888887765 999999999884 5569999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+.||++..+.+ ...++...+.-++..|+.||+||| ++||||||||.+|||+|.+|++||+|||+++.--....
T Consensus 450 y~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH-~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~- 523 (694)
T KOG0694|consen 450 YVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLH-ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD- 523 (694)
T ss_pred ecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHH-hcCceeeecchhheEEcccCcEEecccccccccCCCCC-
Confidence 999999544333 234899999999999999999999 99999999999999999999999999999986543332
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhhh
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEW 757 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 757 (773)
.+...+|||.|||||++.++.|+.++|-|||||+||||+.|..||.+.+++++ ..+|+.++.
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~---FdsI~~d~~ 585 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV---FDSIVNDEV 585 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHhcCCC
Confidence 44567899999999999999999999999999999999999999998776543 334554444
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=281.56 Aligned_cols=208 Identities=26% Similarity=0.399 Sum_probs=178.9
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+.+++.||+|.||.||.|+. +++-.||+|++-+. ...-+.++.+|+++-+.++||||.++++++++.. ..|+++|
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~-riyLilE 102 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK-RIYLILE 102 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc-eeEEEEE
Confidence 36789999999999999985 46788999999654 2334678999999999999999999999996555 8999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|.++|.+...|++.. ...++......++.|+|.|+.|+| .++||||||||+|+|++.++..||+|||.+..-. ..
T Consensus 103 ya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h-~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~ 177 (281)
T KOG0580|consen 103 YAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCH-LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SN 177 (281)
T ss_pred ecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhc-cCCcccCCCCHHHhccCCCCCeeccCCCceeecC---CC
Confidence 999999999999643 334677778899999999999999 9999999999999999999999999999886533 22
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHH
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVA 750 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 750 (773)
.....+||..|.+||...+..++.++|+|++|++.||++.|..||+.....+..+.++
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~ 235 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR 235 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH
Confidence 3345679999999999999999999999999999999999999999877555544333
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.75 Aligned_cols=213 Identities=29% Similarity=0.450 Sum_probs=184.4
Q ss_pred HhhcccccccceEEEEEEe-CCCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
..++.||.|+.|.|-.|+. .+|+.+|||++..+. ......+++|+.+|+-+.||||+++++++ +.+.++|+|.||
T Consensus 15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-e~~~~lylvlEy 93 (786)
T KOG0588|consen 15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-ENKQHLYLVLEY 93 (786)
T ss_pred eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-ccCceEEEEEEe
Confidence 4578899999999999985 689999999997652 23356789999999999999999999999 667799999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++|.|.+++-++++ ++...+.++++||+.|+.|+| ..+|+|||+||+|+|+|.++++||+|||+|.......--
T Consensus 94 v~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH-~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL- 168 (786)
T KOG0588|consen 94 VPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCH-AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL- 168 (786)
T ss_pred cCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHh-hhcceeccCCchhhhhhcccCEeeeccceeecccCCccc-
Confidence 999999999998765 778888999999999999999 999999999999999999999999999999865443322
Q ss_pred eeeccCccccccccccCCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhhhccc
Q 041878 694 VIATAGTLGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNE 760 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 760 (773)
...+|+|.|.|||++.+..| +.++||||+||++|.++||++||+ ++++...+.++.++.|...
T Consensus 169 -eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV~~G~f~MP 232 (786)
T KOG0588|consen 169 -ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKVQRGVFEMP 232 (786)
T ss_pred -cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHHHcCcccCC
Confidence 23579999999999998887 568999999999999999999997 4457777777777776443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=287.88 Aligned_cols=203 Identities=29% Similarity=0.405 Sum_probs=173.1
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccH--HHHHHHHHHHHccCCCceEEeEEEEECC-CCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQ--KEFEAEAAAIGKIHHPNLLALRAYYLGP-KGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV~e 612 (773)
|...+.|++|.||.||+|+++ +++.||+|+++....+.. ---.+||.++.+++|||||.+-++.... -+..|+|||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 456789999999999999875 688999999986543322 2346899999999999999999988654 357999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
||+. +|.++++... +.+...+++.++.|+++|++||| ...|+|||+|++|+|+...|.+||+|||+|+.+..+..
T Consensus 158 ~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH-~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k- 232 (419)
T KOG0663|consen 158 YVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLH-DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK- 232 (419)
T ss_pred HHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHh-hceeEecccchhheeeccCCcEEecccchhhhhcCCcc-
Confidence 9965 9999998864 45888999999999999999999 99999999999999999999999999999998876633
Q ss_pred ceeeccCccccccccccC-CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSK-LKNANTKTDVYSLGVIILELLTGKSPGEPMNGMD 744 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~ 744 (773)
..+..+-|..|.|||.+. ...|++++|+||+||++.|++++++-|.+..+.+
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d 285 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID 285 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH
Confidence 334445689999999765 4679999999999999999999999988766543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=297.10 Aligned_cols=199 Identities=25% Similarity=0.431 Sum_probs=163.0
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCC----eEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG----EKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~~lV~ 611 (773)
+...+++|.|+||.||+|.. .+++.||||+...+.. .-.+|+++|+++.|||||++.-+|....+ ...+||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 34568999999999999985 4679999999864432 22568999999999999999888854432 234899
Q ss_pred eecCCCCHHHHHhhc-CCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC-CCeEEeecCCccccccc
Q 041878 612 DFMPKGSLASFLHAR-GPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK-TNPRIADFGLSRLMTAA 689 (773)
Q Consensus 612 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~~~~ 689 (773)
||||. +|.++++.. ...+.++...++-+..||.+|+.||| +.||+||||||+|+|+|.+ |.+||+|||.|+.+...
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh-~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH-SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH-hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 99975 899888753 12344677778889999999999999 7999999999999999987 88999999999988765
Q ss_pred cccceeeccCccccccccccC-CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSK-LKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
... .....|..|.|||.+. ...|+.+.||||.|||+.||+-|++-|.+.++.
T Consensus 180 epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~ 232 (364)
T KOG0658|consen 180 EPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV 232 (364)
T ss_pred CCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH
Confidence 443 3334688999999765 467999999999999999999999999875543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=298.00 Aligned_cols=200 Identities=28% Similarity=0.408 Sum_probs=164.1
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCc--------------ccHHHHHHHHHHHHccCCCceEEeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTT--------------KGQKEFEAEAAAIGKIHHPNLLALRAYYL 601 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 601 (773)
|.+.+.||+|.||.|-+|.. .+++.||||++.+... ...+...+||.+|++++|+|||+|+++..
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 55678899999999999985 4789999999964311 11357889999999999999999999985
Q ss_pred CCC-CeEEEEEeecCCCCHHHHHhhcCCCCc-cCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEee
Q 041878 602 GPK-GEKLLVFDFMPKGSLASFLHARGPETI-VNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIAD 679 (773)
Q Consensus 602 ~~~-~~~~lV~e~~~~g~L~~~l~~~~~~~~-~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~D 679 (773)
++. +..|||+|||..|.+... ..+.. ++..++++++++++.||+||| .+|||||||||+|+|++++|++||+|
T Consensus 179 DP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH-~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLH-YQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred CcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHH-hcCeeccccchhheEEcCCCcEEeec
Confidence 543 478999999998877432 22333 889999999999999999999 99999999999999999999999999
Q ss_pred cCCcccccccccc----ceeeccCccccccccccCCCC----CCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 680 FGLSRLMTAAANT----NVIATAGTLGYRAPELSKLKN----ANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 680 fG~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
||.+......... ......|||.|+|||.+.++. .+.+.||||+||+||.++.|+.||-+..
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 9998866322111 122467999999999876632 3668999999999999999999997643
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.37 Aligned_cols=200 Identities=24% Similarity=0.360 Sum_probs=170.0
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
...+.||+|+||+||+|... +++.||+|+++... ......+.+|+.++.+++|++|+++++.+. .....++||||
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~-~~~~~~lv~E~ 82 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ-DKLNLYLIMEF 82 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCeEEEEEcC
Confidence 45688999999999999864 68899999997532 223456788999999999999999999984 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc-
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT- 692 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~- 692 (773)
+++|+|.+++.+.. .+++..+..++.|++.||+||| +.||+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH-~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 83 LPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIH-QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 99999999998753 3788999999999999999999 999999999999999999999999999998754321100
Q ss_pred ---------------------------------ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 693 ---------------------------------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 693 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 01234699999999999989999999999999999999999999976
Q ss_pred CCC
Q 041878 740 MNG 742 (773)
Q Consensus 740 ~~~ 742 (773)
.+.
T Consensus 239 ~~~ 241 (363)
T cd05628 239 ETP 241 (363)
T ss_pred CCH
Confidence 543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=290.18 Aligned_cols=195 Identities=28% Similarity=0.446 Sum_probs=157.8
Q ss_pred hhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHH--HccCCCceEEeEEEEECCCC---eEEEEEee
Q 041878 539 TAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAI--GKIHHPNLLALRAYYLGPKG---EKLLVFDF 613 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l--~~l~h~niv~l~~~~~~~~~---~~~lV~e~ 613 (773)
..+.||+|.||.||+|.+. |+.||||++...+ +..+.+|.++. ..++|+||..+++.-..+.+ +.|||++|
T Consensus 215 L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdY 290 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDY 290 (513)
T ss_pred EEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeec
Confidence 4688999999999999997 8999999996554 44444555544 45799999999887654443 68999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccC-------CCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE-------ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~-------~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
.+.|||.|||.+.. ++....++++..+|.||++||.+ ..|.|||||+.||||..++.+.|+|+|+|...
T Consensus 291 He~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 291 HEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred ccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 99999999999843 78889999999999999999932 45999999999999999999999999999887
Q ss_pred cccccc---ceeeccCccccccccccCCCC----C--CcchhhHHHHHHHHHHHc----C------CCCCCCCC
Q 041878 687 TAAANT---NVIATAGTLGYRAPELSKLKN----A--NTKTDVYSLGVIILELLT----G------KSPGEPMN 741 (773)
Q Consensus 687 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--~~~~Dvws~Gv~l~el~t----g------~~P~~~~~ 741 (773)
...... ....++||.+|||||++...- + -..+||||||.|+||+.- | ..||.+.-
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 655322 234668999999999875421 1 236899999999999885 2 45777643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.93 Aligned_cols=206 Identities=27% Similarity=0.437 Sum_probs=170.7
Q ss_pred HHHHhhcccccccceEEEEEEe------CCCCEEEEEEecccCc-ccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCe
Q 041878 535 LLCATAEIMGKSTYGTAYKATL------EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGE 606 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 606 (773)
-++.+.++||+|+||.||+|.. .+++.||||+++.... .....+.+|+.+++++ +||||+++++++....+.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 3456789999999999999974 2356799999975432 3346789999999999 899999999998666667
Q ss_pred EEEEEeecCCCCHHHHHhhcCC----------------------------------------------------------
Q 041878 607 KLLVFDFMPKGSLASFLHARGP---------------------------------------------------------- 628 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 628 (773)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 8999999999999999975321
Q ss_pred -CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc-ceeeccCccccccc
Q 041878 629 -ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT-NVIATAGTLGYRAP 706 (773)
Q Consensus 629 -~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aP 706 (773)
...+++..+..++.||++||+||| +.||+||||||+||+++.++.+||+|||+++........ ......+++.|+||
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLA-SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHH-HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 123778888999999999999999 999999999999999999999999999999865432211 11223456789999
Q ss_pred cccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 707 ELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 707 E~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
|++.+..++.++|||||||++|||++ |..||....
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99988899999999999999999997 999997644
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=285.41 Aligned_cols=203 Identities=27% Similarity=0.399 Sum_probs=171.5
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcc--cHHHHHHHHHHHHccCCCc-eEEeEEEEECCCC-----eE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTK--GQKEFEAEAAAIGKIHHPN-LLALRAYYLGPKG-----EK 607 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~-----~~ 607 (773)
+...++||+|.||+||+|.. .+|+.||+|+++..... ......+|+.++++++|+| |+++++++..... ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 44557799999999999985 57899999999765432 3455688999999999999 9999999976553 78
Q ss_pred EEEEeecCCCCHHHHHhhcCCC-CccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 608 LLVFDFMPKGSLASFLHARGPE-TIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
++|+||++ -+|..++....+. ..++...++.+++||+.|++||| +++|+||||||+|||++++|.+||+|||+|+..
T Consensus 93 ~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H-~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 93 YLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH-SHGILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred EEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH-hCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 89999995 5999999887532 34677889999999999999999 999999999999999999999999999999966
Q ss_pred ccccccceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 687 TAAANTNVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.-+... .+..+.|..|.|||++.+. .|+...||||+||++.||++++.-|.+..+
T Consensus 171 ~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 171 SIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred cCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 533322 3345688999999987655 799999999999999999999999887665
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=299.82 Aligned_cols=201 Identities=26% Similarity=0.400 Sum_probs=170.9
Q ss_pred HhhcccccccceEEEEEEe-CCCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
...+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.++++++|++++++++++. ..+..++||||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-~~~~~~lv~e~ 81 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-TKDALCLVLTI 81 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-cCCeEEEEEEe
Confidence 3457899999999999986 578999999986542 223446788999999999999999999884 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++|+|.+++.... ...+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||++....... .
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH-~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQ-RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--T 157 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--e
Confidence 99999998886543 234788999999999999999999 9999999999999999999999999999987653222 1
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~ 207 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc
Confidence 22346899999999999999999999999999999999999999875543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=303.88 Aligned_cols=196 Identities=24% Similarity=0.390 Sum_probs=170.0
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++ ......++||||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~lv~e~ 82 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-HDQRFLYMLMEY 82 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-ccCCeEEEEEeC
Confidence 45688999999999999865 68999999986432 22345688999999999999999999888 445589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++|+|.++++... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--- 155 (291)
T cd05612 83 VPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLH-SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--- 155 (291)
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc---
Confidence 99999999998753 3788889999999999999999 9999999999999999999999999999987654321
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
....||+.|+|||.+.+..++.++||||+||++|||++|+.||...+.
T Consensus 156 -~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~ 203 (291)
T cd05612 156 -WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203 (291)
T ss_pred -ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 234589999999999988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=307.32 Aligned_cols=195 Identities=23% Similarity=0.366 Sum_probs=167.3
Q ss_pred cccccccceEEEEEEe-CCCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 541 EIMGKSTYGTAYKATL-EDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
++||+|+||.||+|.. .+|+.||+|+++... ......+.+|+.++++++||||+++++++. ..+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ-THDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-cCCEEEEEEeCCCC
Confidence 4699999999999986 478999999997542 223456788999999999999999999884 45589999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
|+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....... ....
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH-~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~ 154 (323)
T cd05571 80 GELFFHLSRER---VFSEDRARFYGAEIVSALGYLH-SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT 154 (323)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccc
Confidence 99999987643 4788999999999999999999 99999999999999999999999999999875332221 1223
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 458999999999998999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=300.19 Aligned_cols=230 Identities=24% Similarity=0.428 Sum_probs=195.0
Q ss_pred ccChhHHHHHhhcccccccceEEEEEEeC---CCC--EEEEEEeccc-CcccHHHHHHHHHHHHccCCCceEEeEEEEEC
Q 041878 529 LFTADDLLCATAEIMGKSTYGTAYKATLE---DGS--EVAVKRLREK-TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602 (773)
Q Consensus 529 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~---~g~--~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 602 (773)
.|+.+...+...++||+|.||.||+|.+. .|. .||||.-+.. ..++.+.|..|+.+|+.++|||||+++|+|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 45666666778899999999999999864 233 4889998874 44557789999999999999999999999953
Q ss_pred CCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCC
Q 041878 603 PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGL 682 (773)
Q Consensus 603 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~ 682 (773)
...|+|||.++.|.|+.|++.+. ..++..+...++.||..||.||| ++.+|||||.++|||+....-+|++|||+
T Consensus 463 --~P~WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLe-SkrfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 463 --QPMWIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLE-SKRFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred --cceeEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHH-hhchhhhhhhhhheeecCcceeeecccch
Confidence 37999999999999999999863 34888999999999999999999 99999999999999999999999999999
Q ss_pred ccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCC----------------h
Q 041878 683 SRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMD----------------L 745 (773)
Q Consensus 683 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~----------------~ 745 (773)
++.+..+..+......-...|||||.+...+++.++|||.|||.|||+++ |..||.+....| =
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nC 617 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNC 617 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCC
Confidence 99998777666555556779999999999999999999999999999987 999998843332 2
Q ss_pred HHHHHHHHHhhhcccccC
Q 041878 746 PQWVASIVKEEWTNEVFD 763 (773)
Q Consensus 746 ~~~~~~~~~~~~~~~~~d 763 (773)
+..+..++.+.|..|-.+
T Consensus 618 Pp~LYslmskcWayeP~k 635 (974)
T KOG4257|consen 618 PPALYSLMSKCWAYEPSK 635 (974)
T ss_pred ChHHHHHHHHHhccCccc
Confidence 455667888888655433
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=304.60 Aligned_cols=195 Identities=23% Similarity=0.375 Sum_probs=167.2
Q ss_pred cccccccceEEEEEEe-CCCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 541 EIMGKSTYGTAYKATL-EDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.||+|+||.||++.. .+|+.||+|+++... ......+.+|++++++++||||+++++++. ..+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-THDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-cCCEEEEEEeCCCC
Confidence 4699999999999986 468999999997542 233456778999999999999999999984 45589999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
|+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||++........ ....
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 154 (323)
T cd05595 80 GELFFHLSRER---VFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT 154 (323)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cccc
Confidence 99999887643 4788999999999999999999 99999999999999999999999999999875322221 1223
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 458999999999998999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=308.47 Aligned_cols=196 Identities=24% Similarity=0.356 Sum_probs=169.7
Q ss_pred HHhhcccccccceEEEEEEeCC--CCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLED--GSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~--g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
|.+.+.||+|+||.||+|.... +..||+|++.... ....+.+.+|+.+++.++||||+++++++. ..+..++||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~~lv~ 110 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-DESYLYLVL 110 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-eCCEEEEEE
Confidence 5567899999999999998543 3689999986432 233457889999999999999999999994 455899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++|+|.+++.+.. .+++..+..++.|++.||.||| +.||+||||||+|||++.++.+||+|||++......
T Consensus 111 Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 111 EFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQ-SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 9999999999998753 3788999999999999999999 999999999999999999999999999999765432
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE 232 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence 123468999999999988889999999999999999999999997654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=308.08 Aligned_cols=196 Identities=22% Similarity=0.406 Sum_probs=170.6
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|... +++.||+|.++... ....+.+.+|+.++++++||||+++++++. ..+..++|||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e 98 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-DENRVYFLLE 98 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-cCCEEEEEEc
Confidence 456789999999999999875 68899999997532 233467889999999999999999999985 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.... .++...+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 99 FVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLH-SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred CCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 999999999998753 3678888899999999999999 9999999999999999999999999999998654322
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 173 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 173 --FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred --ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 23468999999999998999999999999999999999999997644
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=311.46 Aligned_cols=200 Identities=21% Similarity=0.316 Sum_probs=169.6
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
.|.+.++||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++++. .+...++||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-~~~~~~lv~ 122 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ-DDKYLYMVM 122 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-cCCEEEEEE
Confidence 4566789999999999999865 5789999998642 2223456788999999999999999999984 555899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++|+|.+++... .++...+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++........
T Consensus 123 Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH-~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 123 EYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIH-SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred cCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 999999999999754 2678888999999999999999 99999999999999999999999999999987643332
Q ss_pred cceeeccCccccccccccCCC----CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLK----NANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.......||+.|+|||++... .++.++||||+||++|||++|+.||...+
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 223345699999999988654 37889999999999999999999997644
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=313.06 Aligned_cols=199 Identities=23% Similarity=0.338 Sum_probs=168.2
Q ss_pred HhhcccccccceEEEEEEe-CCCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
...+.||+|+||+||+|.. .+++.||+|++.... ......+.+|++++++++|+||+++++++. ..+..++||||
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-~~~~~~lv~E~ 82 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-DKDNLYFVMDY 82 (381)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-cCCEEEEEEec
Confidence 4567899999999999985 468899999997542 223457889999999999999999999995 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc--
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN-- 691 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-- 691 (773)
+++|+|.+++.+.. .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH-~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 83 IPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVH-KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 99999999998753 3788888899999999999999 99999999999999999999999999999754311000
Q ss_pred --------------------------------------------cceeeccCccccccccccCCCCCCcchhhHHHHHHH
Q 041878 692 --------------------------------------------TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVII 727 (773)
Q Consensus 692 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l 727 (773)
.......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 000123689999999999888999999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 041878 728 LELLTGKSPGEPMN 741 (773)
Q Consensus 728 ~el~tg~~P~~~~~ 741 (773)
|||+||+.||...+
T Consensus 239 ~elltG~~Pf~~~~ 252 (381)
T cd05626 239 FEMLVGQPPFLAPT 252 (381)
T ss_pred HHHHhCCCCCcCCC
Confidence 99999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.37 Aligned_cols=201 Identities=26% Similarity=0.468 Sum_probs=174.6
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|...+.||+|.||.||+|.+ ..++.||+|++.-... .+.++++.|+.++..++++||.++||.+.. +...|++|||+
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-g~~LwiiMey~ 93 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-GTKLWIIMEYC 93 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-cccHHHHHHHh
Confidence 34457899999999999985 4688999999986544 446889999999999999999999999954 44899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
.||++.+.++.... ++.....-+++++..|+.||| ..+.+|||||+.||++..+|.+|++|||.+..+.......
T Consensus 94 ~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH-~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 94 GGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLH-SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred cCcchhhhhccCCC---CccceeeeehHHHHHHhhhhh-hcceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 99999999987543 355566678899999999999 9999999999999999999999999999998776554443
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
...+|||.|||||++....|+.|+||||+|++.+||.+|.+|+...+.+
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm 217 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM 217 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc
Confidence 4567999999999999889999999999999999999999999885543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=277.32 Aligned_cols=206 Identities=28% Similarity=0.388 Sum_probs=174.1
Q ss_pred HHHhhcccccccceEEEEEE-eCCCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 536 LCATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
.|.+.++||+|.|+.||+.. ..+|+.+|+|.+... ...+.+++.+|+.+-+.++||||+++...+ ...+..|+|+|
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-~~~~~~ylvFe 90 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFD 90 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-cccceeEEEEe
Confidence 35677889999999999986 457899999888533 344678899999999999999999999888 56669999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC---CeEEeecCCccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT---NPRIADFGLSRLMTAA 689 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~---~~kl~DfG~a~~~~~~ 689 (773)
+|+|++|..-+-.+ ...++..+-..++||++||.|+| .++|||||+||+|+++-... .+|++|||+|....
T Consensus 91 ~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH-~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCH-SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred cccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHH-hcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999997544332 34677888889999999999999 99999999999999996443 48999999998876
Q ss_pred cccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHH
Q 041878 690 ANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQW 748 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~ 748 (773)
.......+.|||+|||||++...+|+..+|||+.||++|-++.|++||++.+...+.+.
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~ 223 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQ 223 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHH
Confidence 22334467899999999999999999999999999999999999999988665555553
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=296.56 Aligned_cols=205 Identities=22% Similarity=0.362 Sum_probs=172.5
Q ss_pred ccChhHHHHHhhcccccccceEEEEEEeCCCCEEEEEEecccCccc---HHHHHHHHHHHHccCCCceEEeEEEEEC--C
Q 041878 529 LFTADDLLCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKG---QKEFEAEAAAIGKIHHPNLLALRAYYLG--P 603 (773)
Q Consensus 529 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~--~ 603 (773)
.++.+++.......||+|++|.||+|.+ +|+.||||.++...... .+.+.+|+.++++++||||++++|++.. .
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 3455555545557899999999999998 58999999997653332 4678899999999999999999999865 2
Q ss_pred -CCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCC
Q 041878 604 -KGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGL 682 (773)
Q Consensus 604 -~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~ 682 (773)
....++||||+++|+|.+++... ..+++....+++.|++.|+.|||...+++||||||+||++++++.+||+|||+
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccch
Confidence 34678999999999999999864 34789999999999999999999435899999999999999999999999999
Q ss_pred ccccccccccceeeccCccccccccccCC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 683 SRLMTAAANTNVIATAGTLGYRAPELSKL--KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 683 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
++...... ....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 170 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 170 EKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred Hhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 87654322 12357889999999875 688999999999999999999999998654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=312.70 Aligned_cols=199 Identities=24% Similarity=0.391 Sum_probs=169.8
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+.++||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++|+||+++++++. ..+..++||||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-~~~~~~lv~E~ 82 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ-DENYLYLIMEY 82 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-cCCeEEEEECC
Confidence 45688999999999999864 68999999997532 233456788999999999999999999984 55589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc-
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT- 692 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~- 692 (773)
+++|+|.+++.... .++...+..++.||+.||+||| +.||+||||||+|||++.++.++|+|||++.........
T Consensus 83 ~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH-~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 83 LPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIH-KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 99999999998753 3788999999999999999999 999999999999999999999999999998754321100
Q ss_pred ------------------------------------ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCC
Q 041878 693 ------------------------------------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736 (773)
Q Consensus 693 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P 736 (773)
......||+.|+|||++....++.++|||||||++|||++|+.|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 00123589999999999989999999999999999999999999
Q ss_pred CCCCC
Q 041878 737 GEPMN 741 (773)
Q Consensus 737 ~~~~~ 741 (773)
|...+
T Consensus 239 f~~~~ 243 (364)
T cd05599 239 FCSDN 243 (364)
T ss_pred CCCCC
Confidence 97654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=302.29 Aligned_cols=193 Identities=25% Similarity=0.381 Sum_probs=166.3
Q ss_pred cccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCC
Q 041878 543 MGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 543 lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
||+|+||.||+|... +++.||+|.++.. .......+.+|+.++++++||||+++++++. ..+..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-SPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-cCCeEEEEEcCCCCCc
Confidence 699999999999865 5889999998653 2233466788999999999999999999884 5568999999999999
Q ss_pred HHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeecc
Q 041878 619 LASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA 698 (773)
Q Consensus 619 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 698 (773)
|.+++.+.. .+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++....... ......
T Consensus 80 L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~ 154 (312)
T cd05585 80 LFHHLQREG---RFDLSRARFYTAELLCALENLH-KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFC 154 (312)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-cccccc
Confidence 999998753 3788999999999999999999 99999999999999999999999999999875432221 222346
Q ss_pred CccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 699 GTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 699 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 8999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=303.97 Aligned_cols=195 Identities=24% Similarity=0.384 Sum_probs=167.5
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
++||+|+||.||++... +|+.||+|++.... ......+.+|++++++++||||+++++++. ..+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ-TKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-cCCEEEEEEeCCCC
Confidence 46899999999999864 68999999997542 234567888999999999999999999884 55589999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
|+|.+++.... .+++.++..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 80 g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~ 154 (328)
T cd05593 80 GELFFHLSRER---VFSEDRTRFYGAEIVSALDYLH-SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKT 154 (328)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cccc
Confidence 99999887643 4788999999999999999999 99999999999999999999999999999875432211 1223
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
..||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 468999999999998899999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=312.91 Aligned_cols=199 Identities=23% Similarity=0.353 Sum_probs=167.7
Q ss_pred HhhcccccccceEEEEEEe-CCCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+.++||+|+||.||++.. .+++.||||++.... ......+.+|++++++++||||+++++++. .....|+||||
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-~~~~~~lv~E~ 82 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-DAQYLYLIMEF 82 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-cCCeeEEEEeC
Confidence 4568899999999999985 478999999986432 223457888999999999999999999995 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc-
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT- 692 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~- 692 (773)
+++|+|.+++.... .++...+..++.|++.||+||| +.||+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH-~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 83 LPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVH-KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 99999999997643 3788888899999999999999 999999999999999999999999999998633210000
Q ss_pred ---------------------------------------------ceeeccCccccccccccCCCCCCcchhhHHHHHHH
Q 041878 693 ---------------------------------------------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVII 727 (773)
Q Consensus 693 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l 727 (773)
......||+.|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 00013589999999999989999999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 041878 728 LELLTGKSPGEPMN 741 (773)
Q Consensus 728 ~el~tg~~P~~~~~ 741 (773)
|||++|+.||...+
T Consensus 239 ~elltG~~Pf~~~~ 252 (377)
T cd05629 239 FECLIGWPPFCSEN 252 (377)
T ss_pred hhhhcCCCCCCCCC
Confidence 99999999997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=350.88 Aligned_cols=282 Identities=37% Similarity=0.571 Sum_probs=203.1
Q ss_pred CCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCC-CCCCCCEEEccCCCCCCCCccccccccccceee
Q 041878 115 HALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIG-NCPNLQTLDLSNNALIGAIPPSLANSTRLYRLN 193 (773)
Q Consensus 115 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 193 (773)
.+++.|+|++|++++.++..+..+++|++|+|++|++++.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 4789999999999999999999999999999999999999998765 888899999888888876664 3466777777
Q ss_pred cccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCC
Q 041878 194 LSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSH 273 (773)
Q Consensus 194 Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 273 (773)
|++|.+++.+|..+.++++|++|+|++|.+.+.+|..++.+. +|++|+|++|.+++.+|..++++++|+.|+|++
T Consensus 147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-----~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 221 (968)
T PLN00113 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLT-----SLEFLTLASNQLVGQIPRELGQMKSLKWIYLGY 221 (968)
T ss_pred CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCc-----CCCeeeccCCCCcCcCChHHcCcCCccEEECcC
Confidence 777777777777777777777777777777766776665544 566777777766666666666666666666666
Q ss_pred CcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccc
Q 041878 274 NKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIP 353 (773)
Q Consensus 274 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~ 353 (773)
|++++.+|..++++++|++|++++|.+++.+|..+.++++|+.|++++|++++.+|..+..+++|++|++++|.+.+.+|
T Consensus 222 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p 301 (968)
T PLN00113 222 NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301 (968)
T ss_pred CccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCC
Confidence 66666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCchh
Q 041878 354 ETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPL 403 (773)
Q Consensus 354 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~ 403 (773)
..+.++++|+.|++++|.+.+.+|..+..+++|+.|++++|.++|.+|..
T Consensus 302 ~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~ 351 (968)
T PLN00113 302 ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKN 351 (968)
T ss_pred hhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChH
Confidence 66666666666666666666666666666666666666666666555544
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=306.74 Aligned_cols=197 Identities=23% Similarity=0.367 Sum_probs=171.0
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|... +++.||+|+++... ......+..|++++++++||||+++++++. ..+..++|||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-~~~~~~lv~e 81 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-DDEYLYLAME 81 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-cCCEEEEEEe
Confidence 345688999999999999875 58899999997542 223457888999999999999999999984 5558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.... .+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALH-ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 999999999997653 3788889999999999999999 99999999999999999999999999999876543
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 12234589999999999988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=312.14 Aligned_cols=199 Identities=23% Similarity=0.343 Sum_probs=167.7
Q ss_pred HhhcccccccceEEEEEEe-CCCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
...++||+|+||+||+|.. .+++.||+|++.... ......+.+|+.++++++|+||+++++.+. ..+..++||||
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-~~~~~~lv~E~ 82 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-DKDNLYFVMDY 82 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-eCCEEEEEEeC
Confidence 4568899999999999986 468899999997542 223457889999999999999999999995 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc---
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA--- 690 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~--- 690 (773)
+++|+|.+++.+.. .++...+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH-~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 83 IPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVH-KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 99999999997653 3678888899999999999999 9999999999999999999999999999975321000
Q ss_pred -------------------------------------------ccceeeccCccccccccccCCCCCCcchhhHHHHHHH
Q 041878 691 -------------------------------------------NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVII 727 (773)
Q Consensus 691 -------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l 727 (773)
........||+.|+|||++.+..++.++||||+||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0001123589999999999989999999999999999
Q ss_pred HHHHcCCCCCCCCC
Q 041878 728 LELLTGKSPGEPMN 741 (773)
Q Consensus 728 ~el~tg~~P~~~~~ 741 (773)
|||++|+.||...+
T Consensus 239 ~elltG~~Pf~~~~ 252 (382)
T cd05625 239 YEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHhCCCCCCCCC
Confidence 99999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.84 Aligned_cols=195 Identities=28% Similarity=0.426 Sum_probs=163.6
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHc-cCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGK-IHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
++||+|+||.||+|... +++.||+|.++... ....+.+..|..++.. .+||||+++++++. ..+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ-TKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE-cCCEEEEEEcCCC
Confidence 46999999999999864 57899999997532 2233455667777664 47999999999984 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.... .++...+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 80 gg~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH-~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 80 GGDLMFHIQSSG---RFDEARARFYAAEIICGLQFLH-KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 999999987653 3788889999999999999999 9999999999999999999999999999987543222 2223
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 3468999999999998899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=299.91 Aligned_cols=205 Identities=31% Similarity=0.464 Sum_probs=180.2
Q ss_pred hhHHHHHhhcccccccceEEEEEEeCC-CCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 532 ADDLLCATAEIMGKSTYGTAYKATLED-GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 532 ~~~l~~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
.+.-.+...++||.|.||.||.|.|+. .-.||||.++++.. ..++|..|+.+|+.++|||+|+|+|+| ..+...|+|
T Consensus 264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVC-T~EpPFYIi 341 (1157)
T KOG4278|consen 264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVC-THEPPFYII 341 (1157)
T ss_pred ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhh-ccCCCeEEE
Confidence 333444567899999999999999874 56799999987654 478999999999999999999999999 555589999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
+|||.+|+|.+||++..+ ..++....+.++.||+.||+||. .+.+||||+.++|+||.++..+|++|||+++.+..+.
T Consensus 342 TEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLE-kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred EecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHH-HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 999999999999999864 44677777899999999999999 9999999999999999999999999999999998877
Q ss_pred ccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCC
Q 041878 691 NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPM 740 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~ 740 (773)
++......-...|.|||-+....++.|+|||+|||+|||+.| |-.||.+.
T Consensus 420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi 470 (1157)
T KOG4278|consen 420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI 470 (1157)
T ss_pred eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence 665555556779999999999999999999999999999998 77888763
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.71 Aligned_cols=200 Identities=21% Similarity=0.306 Sum_probs=168.6
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
.|.+.++||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++. .....++||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-~~~~~~lv~ 122 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-DDKYLYMVM 122 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCEEEEEE
Confidence 3566789999999999999864 68899999996432 223455788999999999999999999884 555899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++|+|.+++.+. .++...+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||++........
T Consensus 123 Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 123 EYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred cCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999998764 2677788889999999999999 99999999999999999999999999999987644332
Q ss_pred cceeeccCccccccccccCCC----CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLK----NANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.......||+.|+|||.+... .++.++|||||||++|||++|+.||...+
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 222345699999999987643 47889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=301.55 Aligned_cols=201 Identities=24% Similarity=0.389 Sum_probs=168.9
Q ss_pred HhhcccccccceEEEEEEe----CCCCEEEEEEecccC----cccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEE
Q 041878 538 ATAEIMGKSTYGTAYKATL----EDGSEVAVKRLREKT----TKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~ 608 (773)
.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+..|++++++++ |++|+++++++ ...+..+
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-~~~~~~~ 81 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-QTEAKLH 81 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-ecCCEEE
Confidence 4568899999999999975 357899999986432 223456788999999995 89999999888 4555899
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||+++|+|.+++.+.. .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++....
T Consensus 82 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLH-KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 9999999999999997643 3788999999999999999999 99999999999999999999999999999886544
Q ss_pred ccccceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
..........||+.|+|||++.+. .++.++|||||||++|||+||+.||......
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 213 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER 213 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC
Confidence 333333345689999999998765 4788999999999999999999999765443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.63 Aligned_cols=200 Identities=21% Similarity=0.311 Sum_probs=169.3
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
.|.+.+.||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++++. ..+..++||
T Consensus 44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-~~~~~~lv~ 122 (371)
T cd05622 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-DDRYLYMVM 122 (371)
T ss_pred hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-cCCEEEEEE
Confidence 4566789999999999999865 6789999998642 2223456788999999999999999999984 455899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++|+|.+++.... ++...+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 123 Ey~~gg~L~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 123 EYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred cCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHH-HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 9999999999987542 677888899999999999999 99999999999999999999999999999987654333
Q ss_pred cceeeccCccccccccccCCC----CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLK----NANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.......||+.|+|||++... .++.++||||+||++|||++|+.||...+
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 233345699999999988653 37889999999999999999999997644
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=308.00 Aligned_cols=214 Identities=28% Similarity=0.484 Sum_probs=182.9
Q ss_pred hHHHHHhhcccccccceEEEEEEe-CCCC----EEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCe
Q 041878 533 DDLLCATAEIMGKSTYGTAYKATL-EDGS----EVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGE 606 (773)
Q Consensus 533 ~~l~~~~~~~lG~G~fg~Vy~~~~-~~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 606 (773)
++......++||+|+||+||+|.+ ..|+ +||+|++.+.. .+...++.+|+..|.++.|||+++++|+|..+ .
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--~ 771 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS--T 771 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc--h
Confidence 455566778999999999999975 4454 58999987654 44567899999999999999999999999533 4
Q ss_pred EEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 607 KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
..+|++|||.|+|.||++.++ ..+-....+.+..|||+||.||| ++++|||||.++||||..-..+||+|||+++..
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe-~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLE-EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHH-hcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 789999999999999999874 34677888999999999999999 999999999999999999999999999999988
Q ss_pred cccccccee-eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCChHHHHHH
Q 041878 687 TAAANTNVI-ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWVAS 751 (773)
Q Consensus 687 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~~~~~~~ 751 (773)
..+...... ...-.+.|||-|.+....|+.++|||||||++||++| |..|+.+...+++++.+++
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ 915 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK 915 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc
Confidence 766543322 2234568999999999999999999999999999998 9999999888888776653
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=300.44 Aligned_cols=195 Identities=27% Similarity=0.450 Sum_probs=165.8
Q ss_pred cccccccceEEEEEEe----CCCCEEEEEEecccC----cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 541 EIMGKSTYGTAYKATL----EDGSEVAVKRLREKT----TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
++||+|+||.||++.. .+++.||+|.++... ......+..|+.++++++||||+++++++. .++..++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-TGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-cCCeEEEEEe
Confidence 5799999999999975 357889999997532 223456788999999999999999999984 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.+.. .++...+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 81 YLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLH-QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 999999999997653 3677888889999999999999 99999999999999999999999999999875432221
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 1223458999999999998889999999999999999999999997644
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=311.12 Aligned_cols=201 Identities=21% Similarity=0.324 Sum_probs=168.6
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++|+||+++++.+. ..+..++|||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-~~~~~~lv~E 81 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-DKDNLYFVMD 81 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-cCCEEEEEEe
Confidence 345688999999999999854 68999999986432 223456889999999999999999999995 4568999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc--
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA-- 690 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~-- 690 (773)
|+++|+|.+++.+.. .++...+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+|.......
T Consensus 82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVH-KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999997753 3678888889999999999999 9999999999999999999999999999975321000
Q ss_pred ----------------------------------------ccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHH
Q 041878 691 ----------------------------------------NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILEL 730 (773)
Q Consensus 691 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el 730 (773)
........||+.|||||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0001123689999999999999999999999999999999
Q ss_pred HcCCCCCCCCCC
Q 041878 731 LTGKSPGEPMNG 742 (773)
Q Consensus 731 ~tg~~P~~~~~~ 742 (773)
++|+.||...+.
T Consensus 238 l~G~~Pf~~~~~ 249 (376)
T cd05598 238 LVGQPPFLADTP 249 (376)
T ss_pred hhCCCCCCCCCH
Confidence 999999976543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=304.79 Aligned_cols=215 Identities=25% Similarity=0.412 Sum_probs=178.4
Q ss_pred hhcccccccceEEEEEE-eCCCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECC-----CCeEEEEE
Q 041878 539 TAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-----KGEKLLVF 611 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~~lV~ 611 (773)
..+.||+|+||.||+|+ -.+|+.||||.++.... ...+...+|+++|++++|+|||+++++-.+. .....+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 34679999999999998 45899999999987543 3456778999999999999999998875322 23567999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeC--CCCC--eEEeecCCccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLD--EKTN--PRIADFGLSRLMT 687 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~--~~~~--~kl~DfG~a~~~~ 687 (773)
|||.+|||+..+++-.....++..+.+.++.+++.||.||| +.|||||||||.||++- ++|. .||+|||.|+...
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr-En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~ 175 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR-ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD 175 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence 99999999999987655566899999999999999999999 99999999999999984 3343 7999999999876
Q ss_pred cccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC-ChHHHHHHHHHhh
Q 041878 688 AAANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNGM-DLPQWVASIVKEE 756 (773)
Q Consensus 688 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~-~~~~~~~~~~~~~ 756 (773)
... .....+||..|.+||+..+ +.|+..+|.|||||++||+.||..||.+..+. ...+.+..+..+.
T Consensus 176 d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk 244 (732)
T KOG4250|consen 176 DNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK 244 (732)
T ss_pred CCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence 554 5566789999999999985 88899999999999999999999999986543 3344444444433
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=290.99 Aligned_cols=203 Identities=25% Similarity=0.430 Sum_probs=169.8
Q ss_pred HHHhhcccccccceEEEEEEeC----CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE----DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
.+.+.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+..+++++||||+++++++. ..+..++|
T Consensus 6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv 84 (266)
T cd05064 6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-RGNTMMIV 84 (266)
T ss_pred HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-cCCCcEEE
Confidence 4567789999999999999753 356899999986533 33467899999999999999999999984 55689999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||+++|+|.+++.... ..+++.+++.++.|++.|++||| +.|++||||||+||+++.++.++++|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH-~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLS-EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH-HCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 99999999999998643 34789999999999999999999 9999999999999999999999999999876543222
Q ss_pred ccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 691 NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
........++..|+|||.+....++.++|||||||++||+++ |+.||...+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 111112235678999999988999999999999999999775 9999976543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=299.45 Aligned_cols=196 Identities=26% Similarity=0.396 Sum_probs=166.1
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
++||+|+||+||+|... +++.||+|+++... ......+..|..++..+ +||||+++++++. ..+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~-~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ-TPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE-cCCEEEEEEcCCC
Confidence 46999999999999865 68899999997532 23345677788888876 6999999999984 5558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.... .++...+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 80 ~g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH-~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (320)
T cd05590 80 GGDLMFHIQKSR---RFDEARARFYAAEITSALMFLH-DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTS 154 (320)
T ss_pred CchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-ccc
Confidence 999999987653 3788999999999999999999 99999999999999999999999999999875432221 122
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 201 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 34689999999999989999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=300.06 Aligned_cols=196 Identities=24% Similarity=0.382 Sum_probs=165.9
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
++||+|+||.||+|... +++.||+|+++... ......+..|.+++..+ +||||+++++++. ..+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-TKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-cCCeEEEEEeCCC
Confidence 46999999999999865 57899999997542 23345577788888866 7999999999994 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.... .+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||++........ ...
T Consensus 80 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (321)
T cd05591 80 GGDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLH-RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT 154 (321)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence 999999987653 3788889999999999999999 99999999999999999999999999999875432221 122
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 201 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH
Confidence 34589999999999988999999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.14 Aligned_cols=200 Identities=21% Similarity=0.309 Sum_probs=169.0
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||+||++... +++.||+|++... .....+.+.+|+.++..++|+||+++++++. ..+..++|||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~e 81 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-DENNLYLVMD 81 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-cCCeEEEEEe
Confidence 345688999999999999864 6899999999642 2223456888999999999999999999984 5568999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.+.. ..++...+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVH-QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH-hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999999999997642 34788889999999999999999 999999999999999999999999999998765543333
Q ss_pred ceeeccCccccccccccCC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKL-----KNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
......||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 3333468999999998763 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.23 Aligned_cols=200 Identities=23% Similarity=0.362 Sum_probs=169.8
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
...+.||+|+||.||++... +++.||+|+++... ......+.+|+.++.+++|++++++++.+. ..+..++||||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-~~~~~~lv~E~ 82 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-DKRNLYLIMEF 82 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-cCCEEEEEEeC
Confidence 44688999999999999864 68999999997432 233457888999999999999999999984 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc--
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN-- 691 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-- 691 (773)
+++|+|.+++.+.. .++...+..++.|++.||+||| +.||+||||||+|||++.++.++|+|||++........
T Consensus 83 ~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH-~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 83 LPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIH-QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred CCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 99999999997653 3788899999999999999999 99999999999999999999999999999875432110
Q ss_pred --------------------------------cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 692 --------------------------------TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 692 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 001134689999999999999999999999999999999999999976
Q ss_pred CCC
Q 041878 740 MNG 742 (773)
Q Consensus 740 ~~~ 742 (773)
.+.
T Consensus 239 ~~~ 241 (360)
T cd05627 239 ETP 241 (360)
T ss_pred CCH
Confidence 543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.08 Aligned_cols=201 Identities=20% Similarity=0.290 Sum_probs=169.4
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||++... +++.||+|.+... .......+.+|+.++..++|++|+++++++. ..+..|+|||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-~~~~~~lv~E 81 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ-DENYLYLVMD 81 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-cCCEEEEEEe
Confidence 345688999999999999865 6788999998642 1223455788999999999999999999984 4568999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.+.. ..+++..+..++.|++.||+||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 82 y~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH-~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIH-QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 999999999998642 24788889999999999999999 999999999999999999999999999999766543332
Q ss_pred ceeeccCccccccccccCC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKL-----KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||...+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 2233569999999998765 467889999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=304.40 Aligned_cols=329 Identities=25% Similarity=0.287 Sum_probs=274.2
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
|+++.|+|.+|.++..-.+.++-++.|+.||||.|.|+..--.+|..-.++++|+|++|+|+..--..|.++.+|.+|.|
T Consensus 125 ghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkL 204 (873)
T KOG4194|consen 125 GHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKL 204 (873)
T ss_pred cceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeec
Confidence 67888888888887666777888888888888888888666667777788888888888888777788888888888888
Q ss_pred cCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecccc
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN 250 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n 250 (773)
+.|+++...+..|.+|++|+.|+|..|+|.-.-...|.++++|+.|.|..|++...-...|..+. ++++|+|+.|
T Consensus 205 srNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~-----kme~l~L~~N 279 (873)
T KOG4194|consen 205 SRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLE-----KMEHLNLETN 279 (873)
T ss_pred ccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeec-----ccceeecccc
Confidence 88888866666677788888888888888755466788888888888888888755555555544 8999999999
Q ss_pred ccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcch
Q 041878 251 LIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPE 330 (773)
Q Consensus 251 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 330 (773)
+++.....++.+++.|+.|+||+|.|....++.+...++|++|+|++|+|+...+..|..+..|++|+|++|+++..-..
T Consensus 280 ~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~ 359 (873)
T KOG4194|consen 280 RLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEG 359 (873)
T ss_pred hhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhh
Confidence 99998899999999999999999999988899999999999999999999999999999999999999999999888888
Q ss_pred hhccccccccccccCccccccccc---ccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCchhhhc-
Q 041878 331 GLERLQNLTVLNLKNNQFKGHIPE---TIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSK- 406 (773)
Q Consensus 331 ~l~~l~~L~~L~ls~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~~~~- 406 (773)
.|..+.+|+.|||++|.++..+.+ .|.+|++|+.|+|.+|+|....-.+|.++..|+.|||.+|.+...-|..|..
T Consensus 360 af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m 439 (873)
T KOG4194|consen 360 AFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM 439 (873)
T ss_pred HHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc
Confidence 899999999999999999976654 4678999999999999999666689999999999999999998766655532
Q ss_pred cCCCCCCCCCCCCCCCCC
Q 041878 407 KFNSSSFVGNLQLCGYSP 424 (773)
Q Consensus 407 ~~~~~~~~~n~~~c~~~~ 424 (773)
.+....+....-+|+|.+
T Consensus 440 ~Lk~Lv~nSssflCDCql 457 (873)
T KOG4194|consen 440 ELKELVMNSSSFLCDCQL 457 (873)
T ss_pred hhhhhhhcccceEEeccH
Confidence 222233444455676654
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.48 Aligned_cols=196 Identities=24% Similarity=0.375 Sum_probs=166.4
Q ss_pred cccccccceEEEEEEe-CCCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 541 EIMGKSTYGTAYKATL-EDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.||+|+||.||++.. .+|+.||+|.++... ......+..|+++++.++||||+++++++. ..+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~-~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-THDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE-cCCEEEEEEeCCCC
Confidence 4689999999999985 478999999997542 223456778999999999999999999884 55589999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
|+|.+++.... .+++..+..++.||+.||+|||+..||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 80 ~~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (325)
T cd05594 80 GELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT 155 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccc
Confidence 99999887643 4789999999999999999999338999999999999999999999999999875432221 1223
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~ 200 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence 458999999999998999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=292.11 Aligned_cols=201 Identities=24% Similarity=0.407 Sum_probs=167.6
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.++||+|+||+||+|... +++.||+|.++... ......+.+|++++++++||||+++++++. ..+..++||||+
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~ 85 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-TERCLTLVFEYL 85 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc-CCCeEEEEEeCC
Confidence 455688999999999999864 68899999987543 223456788999999999999999999984 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
+ |+|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....... ..
T Consensus 86 ~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~ 160 (288)
T cd07871 86 D-SDLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCH-KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TY 160 (288)
T ss_pred C-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-cc
Confidence 7 59999887653 34688899999999999999999 99999999999999999999999999999876433221 11
Q ss_pred eeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
....+++.|+|||.+.+ ..++.++||||+||++|||+||+.||...+..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~ 210 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK 210 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 23457899999998764 56899999999999999999999999765543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=279.78 Aligned_cols=204 Identities=23% Similarity=0.336 Sum_probs=174.1
Q ss_pred HHhhcccccccceEEEEEEeCC-CCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLED-GSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+...+.||+|.-|+||++.+.+ +...|+|++.+.. .+...+.+.|.++|+.+.||.++.||+.+ +.....|+|||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-et~~~~cl~me 157 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-ETDKYSCLVME 157 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-eccceeEEEEe
Confidence 4567889999999999999764 5889999997653 34456788899999999999999999999 55559999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc----
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA---- 688 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~---- 688 (773)
||+||+|...++++. ...++...+..++.+|+-||+||| ..|||+||+||+||||.++|++.++||.++.....
T Consensus 158 yCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLH-mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLH-MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred cCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHH-hhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 999999999988764 566889999999999999999999 99999999999999999999999999998653210
Q ss_pred -----------------------------c-c---------------------ccceeeccCccccccccccCCCCCCcc
Q 041878 689 -----------------------------A-A---------------------NTNVIATAGTLGYRAPELSKLKNANTK 717 (773)
Q Consensus 689 -----------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 717 (773)
. . .......+||-.|+|||++.+...+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0 0 011123468889999999999999999
Q ss_pred hhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 718 TDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 718 ~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
+|-|+|||++|||+.|+.||.+.+.+
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~ 341 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNK 341 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCch
Confidence 99999999999999999999886543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=293.81 Aligned_cols=213 Identities=23% Similarity=0.393 Sum_probs=172.2
Q ss_pred HHhhcccccccceEEEEEEeCC-----------------CCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEE
Q 041878 537 CATAEIMGKSTYGTAYKATLED-----------------GSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRA 598 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~ 598 (773)
+.+.++||+|+||.||+|.+.+ +..||+|.+..... ....++.+|++++++++||||+++++
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 86 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG 86 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 4567889999999999997532 33699999976533 33567999999999999999999999
Q ss_pred EEECCCCeEEEEEeecCCCCHHHHHhhcCC----------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCC
Q 041878 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGP----------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNL 662 (773)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~----------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Di 662 (773)
++.. .+..++||||+++|+|.+++..... ...+++..+.+++.||+.||.||| +.||+||||
T Consensus 87 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~ivH~dl 164 (304)
T cd05096 87 VCVD-EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS-SLNFVHRDL 164 (304)
T ss_pred EEec-CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH-HCCccccCc
Confidence 9954 4578999999999999999865321 124678889999999999999999 999999999
Q ss_pred CCCCEEeCCCCCeEEeecCCccccccccccce-eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc--CCCCCCC
Q 041878 663 TSSNVLLDEKTNPRIADFGLSRLMTAAANTNV-IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT--GKSPGEP 739 (773)
Q Consensus 663 k~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t--g~~P~~~ 739 (773)
||+||+++.++.+||+|||+++.......... ....++..|+|||++....++.++|||||||++|||++ +..||..
T Consensus 165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred chhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 99999999999999999999976543322211 12345778999999888889999999999999999987 6678877
Q ss_pred CCCCChHHHHHH
Q 041878 740 MNGMDLPQWVAS 751 (773)
Q Consensus 740 ~~~~~~~~~~~~ 751 (773)
.+..+..+.+..
T Consensus 245 ~~~~~~~~~~~~ 256 (304)
T cd05096 245 LTDEQVIENAGE 256 (304)
T ss_pred CCHHHHHHHHHH
Confidence 655554444433
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=295.40 Aligned_cols=196 Identities=26% Similarity=0.415 Sum_probs=164.9
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHc-cCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGK-IHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
+.||+|+||.||+|... +++.||||.++... ......+..|..++.. .+||||+++++++. ..+..++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-TKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-eCCEEEEEEeCCC
Confidence 46899999999999865 57899999997542 2334556677888876 48999999999985 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.... .+++.++..++.|++.||.||| +.||+||||||+||+++.++.+||+|||++....... ....
T Consensus 80 ~g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH-~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05619 80 GGDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLH-SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC 154 (316)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence 999999997643 3788899999999999999999 9999999999999999999999999999987532221 1223
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE 201 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH
Confidence 34689999999999988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=298.12 Aligned_cols=199 Identities=24% Similarity=0.354 Sum_probs=166.6
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEe
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
.+.+.||+|+||.||+|... +++.||+|.++... ......+..|..++..+ +|++|+++++++ ...+..++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~~~~lv~E 81 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-QTMDRLYFVME 81 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-ecCCEEEEEEc
Confidence 45678999999999999865 57899999997542 22334566788888777 478899998888 45558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.... .+++.++..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~- 156 (323)
T cd05616 82 YVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLH-SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV- 156 (323)
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC-
Confidence 999999999987653 3788899999999999999999 99999999999999999999999999999875432221
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
......||+.|+|||++.+..++.++|||||||++|||+||+.||...+.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~ 206 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH
Confidence 12234689999999999999999999999999999999999999987554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=300.18 Aligned_cols=200 Identities=20% Similarity=0.299 Sum_probs=168.1
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+.++||+|+||.||++... +++.||+|.+.... ......+.+|+.++..++|++|+++++++. ..+..++||||
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~ey 82 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-DENNLYLVMDY 82 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-cCCEEEEEEec
Confidence 45688999999999999865 57789999986431 223345888999999999999999999884 55689999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++|+|.+++++.. ..+++..+..++.||+.|++||| +.+|+||||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH-~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 83 YVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVH-QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 99999999998642 23788889999999999999999 9999999999999999999999999999987654333323
Q ss_pred eeeccCccccccccccC-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSK-----LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 33456999999999875 3568899999999999999999999997643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=296.74 Aligned_cols=193 Identities=22% Similarity=0.409 Sum_probs=165.5
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
++||+|+||.||+|... +++.||+|+++... ......+..|..++.++ +||||+++++++. ..+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-TESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-cCCEEEEEEeCCC
Confidence 46899999999999864 68899999997542 22345678899999988 6999999999984 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.+.. .+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||+++....... ...
T Consensus 80 ~g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (329)
T cd05588 80 GGDLMFHMQRQR---KLPEEHARFYSAEISLALNFLH-ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TTS 154 (329)
T ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-ccc
Confidence 999999887643 3889999999999999999999 99999999999999999999999999999875322211 222
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
...||+.|+|||++.+..++.++||||+||++|||++|+.||+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 34689999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=288.08 Aligned_cols=196 Identities=27% Similarity=0.392 Sum_probs=166.5
Q ss_pred cccccceEEEEEEeC-CCCEEEEEEecccCcc---cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCC
Q 041878 543 MGKSTYGTAYKATLE-DGSEVAVKRLREKTTK---GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 543 lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
||+|+||+||++... +++.||+|.+...... ..+.+..|++++++++|+||+++.+++ ......++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-QTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-cCCCeEEEEEeCCCCCC
Confidence 699999999999864 7889999998654222 235677899999999999999999888 45568999999999999
Q ss_pred HHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeec
Q 041878 619 LASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697 (773)
Q Consensus 619 L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 697 (773)
|.+++.... ....+++..+..++.||+.||+||| +.+|+||||||+||+++.++.++|+|||.+........ .....
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 157 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH-QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGY 157 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccccc
Confidence 998886432 2345889999999999999999999 99999999999999999999999999999876543322 12234
Q ss_pred cCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 698 AGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 698 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 68999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=292.39 Aligned_cols=201 Identities=20% Similarity=0.357 Sum_probs=169.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|.+.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|++++++++|+||+++++++ ...+..++||||
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~ 81 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-RRRGKLYLVFEY 81 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-ecCCEEEEEEec
Confidence 455688999999999999875 67889999987542 22356788899999999999999999998 455689999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
++++.+..+.... ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++..........
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 82 VEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCH-KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 9987666544332 34788899999999999999999 9999999999999999999999999999998764333222
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~ 206 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE 206 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH
Confidence 2334689999999999888899999999999999999999999987553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=279.38 Aligned_cols=198 Identities=28% Similarity=0.445 Sum_probs=169.3
Q ss_pred hcccccccceEEEEEEe-CCCCEEEEEEecc--cCcccHHHHHHHHHHHHccCCCceEEeEEEEECC----CCeEEEEEe
Q 041878 540 AEIMGKSTYGTAYKATL-EDGSEVAVKRLRE--KTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP----KGEKLLVFD 612 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~~lV~e 612 (773)
.+.||+|+||.|+.|.. .+|+.||||++.. ......++..+|+++++.++|+||+.+..++..+ -.+.|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 47899999999999986 4789999999973 3445677889999999999999999999998652 237899999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc-c
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA-N 691 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~-~ 691 (773)
+| +.+|...++... .++.....-++.||++||.|+| +.+|+|||+||+|++++.+..+||+|||+|+...... .
T Consensus 107 lM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiH-SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIH-SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred HH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhh-cccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 99 669999998753 3788889999999999999999 9999999999999999999999999999999875431 1
Q ss_pred cceeeccCcccccccccc-CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELS-KLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
...+..+.|..|.|||++ ....|+.+.||||.||++.||++|+.-|.+.+.
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence 223445679999999965 557899999999999999999999999876553
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=296.32 Aligned_cols=198 Identities=23% Similarity=0.364 Sum_probs=166.4
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCC-ceEEeEEEEECCCCeEEEEEe
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHP-NLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~lV~e 612 (773)
.+.+.||+|+||.||+|... +++.||+|+++... ....+.+..|++++..+.|+ +|+++++++ ...+..|+|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~~~~lv~E 81 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-QTMDRLYFVME 81 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-EcCCEEEEEEc
Confidence 45688999999999999865 57899999997532 23455678899999999765 577888777 44558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||++....... .
T Consensus 82 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~ 156 (324)
T cd05587 82 YVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLH-SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-K 156 (324)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-C
Confidence 999999999987653 3788899999999999999999 9999999999999999999999999999986432221 1
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......||+.|+|||++.+..++.++||||+||++|||+||+.||...+
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 2234468999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=299.10 Aligned_cols=201 Identities=26% Similarity=0.429 Sum_probs=167.8
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCC----CeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK----GEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~l 609 (773)
|.+.++||+|+||.||+|... +|+.||||++... ......++.+|++++++++||||+++++++.... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 456788999999999999864 6899999998743 2234557889999999999999999999885432 24799
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||++ ++|.+++.+.. .+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 v~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 82 VFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIH-TANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 999995 68999887643 3789999999999999999999 999999999999999999999999999999765332
Q ss_pred ccc--ceeeccCccccccccccCC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 690 ANT--NVIATAGTLGYRAPELSKL--KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 690 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...+.
T Consensus 157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~ 213 (338)
T cd07859 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 213 (338)
T ss_pred cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh
Confidence 221 1123468999999998765 6789999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.38 Aligned_cols=200 Identities=25% Similarity=0.401 Sum_probs=172.6
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||+||+|... +|+.||+|+++... ......+.+|+++++.++|+||+++++++. ..+..++|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~e 81 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ-DEEHLYLVME 81 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee-cCCeEEEEEc
Confidence 345688999999999999865 78999999997542 234567889999999999999999999884 5558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc--
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA-- 690 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~-- 690 (773)
|+++++|.+++.+. ..++...+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH-~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 82 YMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVH-KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999999875 34788999999999999999999 8999999999999999999999999999988664432
Q ss_pred --------------------------ccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 691 --------------------------NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 691 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 011223468999999999998999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=295.39 Aligned_cols=196 Identities=27% Similarity=0.413 Sum_probs=164.9
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHc-cCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGK-IHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
++||+|+||.||+|... +|+.||+|.++... ......+..|..++.. .+||||+++++++. ..+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-TKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE-eCCEEEEEECCCC
Confidence 46999999999999865 68899999997542 2234556677777775 48999999999984 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++...... ....
T Consensus 80 ~g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05620 80 GGDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLH-SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS 154 (316)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence 999999987643 3788899999999999999999 9999999999999999999999999999987432211 1223
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~ 201 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE 201 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 45689999999999989999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=295.97 Aligned_cols=193 Identities=22% Similarity=0.408 Sum_probs=164.5
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
++||+|+||.||+|... +++.||+|+++... ......+..|+.++.++ +||||+++++++. ..+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-TESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-eCCEEEEEEeCCC
Confidence 46999999999999865 67899999997542 22345677888888776 7999999999984 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.... .+++..+..++.||+.|++||| +.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 80 ~~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (329)
T cd05618 80 GGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS 154 (329)
T ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccc
Confidence 999999887643 3788999999999999999999 99999999999999999999999999999875432221 122
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 34689999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=297.65 Aligned_cols=196 Identities=26% Similarity=0.413 Sum_probs=164.5
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHH---HccCCCceEEeEEEEECCCCeEEEEE
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAI---GKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
+.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++ ++++||||+++++++. ..+..++||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-~~~~~~lv~ 81 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-TEDHVCFVM 81 (324)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-cCCEEEEEE
Confidence 4578999999999999864 68999999997542 22345566676655 5678999999999984 555899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++|+|..++++. .+++..+..++.||+.|++||| +.||+||||||+||+++.++.+||+|||+++.......
T Consensus 82 E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH-~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05589 82 EYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLH-ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD 156 (324)
T ss_pred cCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH-hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC
Confidence 999999999888643 3789999999999999999999 99999999999999999999999999999875432221
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 157 -RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred -cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 1223468999999999998999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=298.77 Aligned_cols=195 Identities=29% Similarity=0.429 Sum_probs=163.4
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHH-HHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAA-AIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
++||+|+||.||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++++. ..+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-TTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-cCCEEEEEEcCCC
Confidence 46999999999999864 68999999996542 223345555654 467799999999999884 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++....... ...
T Consensus 80 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH-~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (325)
T cd05604 80 GGELFFHLQRER---SFPEPRARFYAAEIASALGYLH-SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTT 154 (325)
T ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Ccc
Confidence 999999887643 3788999999999999999999 99999999999999999999999999999875322211 122
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 3468999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=296.25 Aligned_cols=201 Identities=21% Similarity=0.359 Sum_probs=171.5
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.|.+.+.||+|+||.||++... +|..||+|.+..... ....++.+|++++++++||||+++++++. ..+..++||||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~ 84 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-SDGEISICMEH 84 (331)
T ss_pred cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-ECCEEEEEeec
Confidence 3456788999999999999865 688899999875432 33567999999999999999999999985 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++|+|.+++.... .+++..+..++.|++.|+.|||+..+|+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 158 (331)
T cd06649 85 MDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 158 (331)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc---
Confidence 99999999998753 378889999999999999999933579999999999999999999999999987653321
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 12345899999999999889999999999999999999999999765443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=288.74 Aligned_cols=203 Identities=27% Similarity=0.400 Sum_probs=171.8
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
++.++||+|+||+||++... +++.||+|++..... .....+.+|+.++++++|+||+++++.+ ..++..++||||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~ 81 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-ETKDALCLVLTL 81 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-cCCCeEEEEEec
Confidence 45688999999999999864 689999999965322 2234577899999999999999999988 445589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++|+|.+++.... ...+++..+..++.|++.|+.||| +.+++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 157 (285)
T cd05605 82 MNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLH-RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-- 157 (285)
T ss_pred cCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc--
Confidence 99999999887543 234789999999999999999999 99999999999999999999999999999876532221
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCh
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~ 745 (773)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||.+.+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~ 209 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK 209 (285)
T ss_pred cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH
Confidence 1234689999999999888899999999999999999999999987655433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=297.13 Aligned_cols=195 Identities=28% Similarity=0.419 Sum_probs=162.5
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHH-HHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAA-AIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
++||+|+||.||+|... +++.||+|++.... .....++..|.. +++.++||||+++++++. ..+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-TAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-cCCEEEEEEcCCC
Confidence 46999999999999864 68899999986432 222344555554 678899999999999884 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.+.. .++...+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....... ...
T Consensus 80 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH-~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (321)
T cd05603 80 GGELFFHLQRER---CFLEPRARFYAAEVASAIGYLH-SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTS 154 (321)
T ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-ccc
Confidence 999998887643 3678888899999999999999 99999999999999999999999999999875322221 122
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 3468999999999988899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.96 Aligned_cols=201 Identities=23% Similarity=0.353 Sum_probs=171.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||+||++... +|+.||+|+++... ....+.+.+|+.+++.++|+||+++++++. ..+..++|||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-~~~~~~lv~e 81 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ-DKDNLYLVME 81 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-cCCeEEEEEC
Confidence 345688999999999999864 68999999997542 234566889999999999999999999884 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.+.. ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH-~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVH-QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH-HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999999999998752 34788999999999999999999 999999999999999999999999999999876544333
Q ss_pred ceeeccCccccccccccC------CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSK------LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~------~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 333446899999999876 4567899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=284.07 Aligned_cols=201 Identities=24% Similarity=0.441 Sum_probs=171.2
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.+.+.||+|+||.||+|.+.++..+|+|.+... .....++..|++++++++||||+++++++ ...+..++||||+++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~iv~e~~~~ 83 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVC-TQQKPLYIVTEFMEN 83 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEE-ccCCCEEEEEEcCCC
Confidence 3456789999999999999888889999998643 33457889999999999999999999998 455689999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
|+|.++++... ..+++..++.++.|++.|++||| +.+|+||||||+||+++.++.+|++|||.++............
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 84 GCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLE-RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred CcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH-HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 99999987643 24789999999999999999999 9999999999999999999999999999987654332222222
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
..++..|+|||.+....++.++||||||+++|||++ |+.||...+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~ 207 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN 207 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 335668999999988889999999999999999999 8999976554
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=297.21 Aligned_cols=195 Identities=29% Similarity=0.423 Sum_probs=163.0
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHH-HHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAA-AIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
++||+|+||+||+|... +|+.||+|++.... .....++..|.. +++.++||||+++++++. ..+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-TADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-eCCEEEEEEcCCC
Confidence 46999999999999864 68999999996432 222344555544 567899999999999884 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++++.. .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||++....... ....
T Consensus 80 ~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (323)
T cd05575 80 GGELFFHLQRER---SFPEPRARFYAAEIASALGYLH-SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS 154 (323)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence 999999998643 3788889999999999999999 9999999999999999999999999999987532221 1222
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 3458999999999998999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=285.00 Aligned_cols=203 Identities=28% Similarity=0.456 Sum_probs=173.0
Q ss_pred HHHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 536 LCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+ ...+..++||||++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~ 84 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV-TKEEPIYIITEYMA 84 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEE-cCCCCcEEEEecCC
Confidence 456678999999999999998888899999986533 2357889999999999999999999988 45568899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|.++++... ...+++.+++.++.|++.|++||| +.+++||||||+||+++.++.++|+|||.+............
T Consensus 85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH-~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05072 85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIE-RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162 (261)
T ss_pred CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence 999999997653 234788899999999999999999 899999999999999999999999999999876543222222
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
...++..|+|||......++.++|||||||++|||+| |+.||.....
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 2345678999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=296.45 Aligned_cols=195 Identities=27% Similarity=0.400 Sum_probs=161.5
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHH-HHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEA-AAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
+.||+|+||+||+|... +++.||+|++.... ......+..|. .+++.++|+||+++++++. ..+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-TADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-cCCeEEEEEeCCC
Confidence 46999999999999865 57889999996432 12233444444 4567889999999999984 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.... .++......++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....... ...
T Consensus 80 ~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH-~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~ 154 (325)
T cd05602 80 GGELFYHLQRER---CFLEPRARFYAAEIASALGYLH-SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTS 154 (325)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Ccc
Confidence 999999997643 3677788889999999999999 99999999999999999999999999999875432211 223
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 3468999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=310.23 Aligned_cols=203 Identities=23% Similarity=0.297 Sum_probs=172.3
Q ss_pred HHhhcccccccceEEEEEEeC-C-CCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-D-GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.++++++||||+++++++. ..+..++||||+
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-~~~~~~lv~E~~ 147 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-SDDKLLLIMEYG 147 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-ECCEEEEEEECC
Confidence 456789999999999999753 3 6788999876555555567888999999999999999999995 456899999999
Q ss_pred CCCCHHHHHhhc-CCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc-
Q 041878 615 PKGSLASFLHAR-GPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT- 692 (773)
Q Consensus 615 ~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~- 692 (773)
++|+|.++++.. .....+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH-SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 999999988653 22334788899999999999999999 999999999999999999999999999999876433221
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~ 275 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275 (478)
T ss_pred cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1233468999999999998999999999999999999999999997643
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=294.85 Aligned_cols=225 Identities=28% Similarity=0.479 Sum_probs=189.0
Q ss_pred HHHHhhcccccccceEEEEEEeC--CCC--EEEEEEecccCcc-cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 535 LLCATAEIMGKSTYGTAYKATLE--DGS--EVAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~~--~g~--~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
..+...++||+|.||+|++|.|. +|+ .||||.++..... ...+|.+|+.+|.+|+|+|+++|||+..+ ....|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mM 187 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMM 187 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhH
Confidence 34566789999999999999875 344 5899999876554 56899999999999999999999999965 36889
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
|+|.++.|+|.+.|+. .....+-......++.|||.||.||. .+++||||+.++|+++-....+||+|||+.+.+...
T Consensus 188 V~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLe-skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLE-SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred HhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999999998 44556788889999999999999999 999999999999999999999999999999988765
Q ss_pred cccceee--ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCh----------------HHHHH
Q 041878 690 ANTNVIA--TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDL----------------PQWVA 750 (773)
Q Consensus 690 ~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~----------------~~~~~ 750 (773)
.....+. ..-...|+|||.+....++-++|||+|||++|||+| |+.||-+..+.++ .+-++
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 5443332 234568999999999999999999999999999999 8889988555443 34455
Q ss_pred HHHHhhhcccccC
Q 041878 751 SIVKEEWTNEVFD 763 (773)
Q Consensus 751 ~~~~~~~~~~~~d 763 (773)
.++++.|....-|
T Consensus 346 ~imk~cWah~paD 358 (1039)
T KOG0199|consen 346 QIMKNCWAHNPAD 358 (1039)
T ss_pred HHHHHhccCCccc
Confidence 6777777665444
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.71 Aligned_cols=193 Identities=22% Similarity=0.399 Sum_probs=165.2
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
++||+|+||.||+|... +++.||+|+++... ....+.+..|+.++.++ +|++|+++++++. ..+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-TTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-eCCEEEEEEeCCC
Confidence 46999999999999864 67899999997542 22345678899999888 5999999999884 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.... .+++..+..++.||+.|++||| +.||+||||||+||+++.++.+||+|||+++....... ...
T Consensus 80 ~~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (327)
T cd05617 80 GGDLMFHMQRQR---KLPEEHARFYAAEICIALNFLH-ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TTS 154 (327)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-cee
Confidence 999999887643 3889999999999999999999 99999999999999999999999999999875322211 223
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 35689999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=294.42 Aligned_cols=203 Identities=20% Similarity=0.376 Sum_probs=172.6
Q ss_pred HHHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 535 LLCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
-.|.+.++||+|+||.||++... ++..+|+|.+..... ....++.+|++++++++|+||+++++++.. .+..++|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICME 83 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-CCEEEEEEe
Confidence 34667889999999999999865 688899998875432 334678999999999999999999999954 558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.+.. .+++.....++.|++.|+.|||+..+|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc--
Confidence 999999999998653 378888899999999999999943579999999999999999999999999987553321
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMD 744 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~ 744 (773)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 209 (333)
T cd06650 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209 (333)
T ss_pred -cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 122358899999999998889999999999999999999999997655433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=275.48 Aligned_cols=201 Identities=23% Similarity=0.415 Sum_probs=176.0
Q ss_pred HHHHHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 534 DLLCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 534 ~l~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+..+.+.++||+|+||+||+|.. ..|+.||+|++. ...+..++..|+.+|+++..++||++||.|. ...+.|+|||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VP--V~sDLQEIIKEISIMQQC~S~yVVKYYGSYF-K~sDLWIVME 108 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVP--VDTDLQEIIKEISIMQQCKSKYVVKYYGSYF-KHSDLWIVME 108 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecC--ccchHHHHHHHHHHHHHcCCchhhhhhhhhc-cCCceEeehh
Confidence 44577889999999999999975 479999999985 3446788899999999999999999999995 4559999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
||.-|+..+.++.+. +.++......+++.-+.||+||| ...-||||||+.|||++.+|.+|++|||.|..+...-..
T Consensus 109 YCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH-~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 109 YCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLH-DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred hcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHH-HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 999999999998763 45888899999999999999999 888899999999999999999999999998766433221
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....|||.|||||++..-.|+.++||||+|++..||..|++||.+-.
T Consensus 186 -RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 186 -RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred -hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 223469999999999999999999999999999999999999998743
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.54 Aligned_cols=199 Identities=23% Similarity=0.357 Sum_probs=166.4
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEEe
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e 612 (773)
...++||+|+||.||+|... +|+.||+|+++... ....+.+..|..+++.+. |++|+++++++ ...+..++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-~~~~~~~lv~E 81 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-QTVDRLYFVME 81 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-ecCCEEEEEEc
Confidence 34578999999999999864 68899999997532 233456778888888886 46777888877 44558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.... .+++.++..++.||+.|++||| +.||+||||||+||+++.++.+||+|||+++.......
T Consensus 82 y~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH-~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~- 156 (323)
T cd05615 82 YVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLH-RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV- 156 (323)
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-
Confidence 999999999987653 3789999999999999999999 99999999999999999999999999999875432221
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 12234589999999999988999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=291.67 Aligned_cols=210 Identities=24% Similarity=0.432 Sum_probs=181.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc---cHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK---GQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~ 611 (773)
|.+.+.||+|.||.||++..+ +|+.+|+|.+.+.... +...+.+|+++|+++. |||||.+++++ +.....++||
T Consensus 37 Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-e~~~~~~lvm 115 (382)
T KOG0032|consen 37 YELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-EDPDSVYLVM 115 (382)
T ss_pred EEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-EcCCeEEEEE
Confidence 455688999999999999865 5999999999766443 3468999999999998 99999999999 5555999999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC----CCeEEeecCCccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK----TNPRIADFGLSRLMT 687 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~----~~~kl~DfG~a~~~~ 687 (773)
|++.||.|.+.+.+. .++...+..++.||+.|+.||| +.||+|||+||+|+|+... +.+|++|||++....
T Consensus 116 EL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH-~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 116 ELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLH-SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 999999999999876 2789999999999999999999 9999999999999999654 469999999999876
Q ss_pred cccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhhh
Q 041878 688 AAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEW 757 (773)
Q Consensus 688 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 757 (773)
. .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+........ ++...++
T Consensus 191 ~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---~i~~~~~ 255 (382)
T KOG0032|consen 191 P--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---AILRGDF 255 (382)
T ss_pred C--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---HHHcCCC
Confidence 6 334456689999999999999999999999999999999999999999877554433 4444444
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=288.04 Aligned_cols=204 Identities=27% Similarity=0.401 Sum_probs=167.0
Q ss_pred HHhhcccccccceEEEEEEeC--CCCEEEEEEecccCc--ccHHHHHHHHHHHHcc---CCCceEEeEEEEEC----CCC
Q 041878 537 CATAEIMGKSTYGTAYKATLE--DGSEVAVKRLREKTT--KGQKEFEAEAAAIGKI---HHPNLLALRAYYLG----PKG 605 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~--~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----~~~ 605 (773)
|.+.+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.+++++ +||||+++++++.. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 455688999999999999863 467899999875432 2234566777777765 69999999999852 234
Q ss_pred eEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccc
Q 041878 606 EKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL 685 (773)
Q Consensus 606 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~ 685 (773)
..++||||++ ++|.+++.... ...+++.++..++.||+.||.||| +.||+||||||+||+++.++.+||+|||+++.
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH-~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 6899999996 69999987653 234788999999999999999999 99999999999999999999999999999876
Q ss_pred cccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCh
Q 041878 686 MTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745 (773)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~ 745 (773)
.... .......||+.|+|||.+....++.++|||||||++|||++|+.||...+..+.
T Consensus 160 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~ 217 (290)
T cd07862 160 YSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 217 (290)
T ss_pred ccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 5433 122234589999999999888999999999999999999999999987654433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=292.79 Aligned_cols=195 Identities=28% Similarity=0.430 Sum_probs=165.8
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
+.||+|+||.||+|... +++.||+|+++... ......+..|+.+++.+ +||||+++++++. ..+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-TKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-cCCEEEEEEcCCC
Confidence 46999999999999865 57899999997542 23345677888888887 6999999999984 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.+.. .+++..+..++.||+.||.||| +.+|+||||||+||++++++.+||+|||+++....... ...
T Consensus 80 ~~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (318)
T cd05570 80 GGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLH-ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS 154 (318)
T ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence 999999987653 3789999999999999999999 99999999999999999999999999999875322211 122
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 3458999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=297.31 Aligned_cols=195 Identities=25% Similarity=0.446 Sum_probs=167.4
Q ss_pred cccccccceEEEEEEe----CCCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 541 EIMGKSTYGTAYKATL----EDGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
+.||+|+||.||++.. .+|+.||+|+++.... .....+..|++++++++||||+++++++. ..+..++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-TEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-cCCEEEEEEcCC
Confidence 5799999999999874 3578999999975432 23456778999999999999999999984 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++|+|.+++.+.. .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~ 155 (318)
T cd05582 81 RGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA 155 (318)
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence 9999999997643 3789999999999999999999 9999999999999999999999999999987654332 122
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 33468999999999988889999999999999999999999997644
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=297.58 Aligned_cols=206 Identities=24% Similarity=0.365 Sum_probs=169.0
Q ss_pred HHHHhhcccccccceEEEEEEeC------CCCEEEEEEecccC-cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCe
Q 041878 535 LLCATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGE 606 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 606 (773)
-.+.+.+.||+|+||.||+|... ++..||+|+++... ......+.+|+++++++ +|+||+++++++. ..+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~-~~~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT-HGGP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec-CCCC
Confidence 34667899999999999999742 33579999997543 23345688999999999 8999999999994 4558
Q ss_pred EEEEEeecCCCCHHHHHhhcCC----------------------------------------------------------
Q 041878 607 KLLVFDFMPKGSLASFLHARGP---------------------------------------------------------- 628 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 628 (773)
.++||||+++|+|.++++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999865321
Q ss_pred ---------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce-eecc
Q 041878 629 ---------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV-IATA 698 (773)
Q Consensus 629 ---------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~-~~~~ 698 (773)
...+++.++.+++.||+.||+||| ++||+||||||+|||+++++.+||+|||+++.......... ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~ 275 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA-SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH-HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence 123678889999999999999999 99999999999999999999999999999876543322111 1223
Q ss_pred CccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 699 GTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 699 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
+++.|||||++....++.++|||||||++|||++ |+.||.....
T Consensus 276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~ 320 (374)
T cd05106 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320 (374)
T ss_pred CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence 4568999999988899999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=282.32 Aligned_cols=194 Identities=26% Similarity=0.427 Sum_probs=165.2
Q ss_pred cccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCC
Q 041878 543 MGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 543 lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
||+|+||.||++... +|+.||+|.+..... .....+..|++++++++||||+++++++ ......++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-ESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-ecCCeEEEEEecCCCCC
Confidence 699999999999864 689999999864321 2234556799999999999999999988 45568999999999999
Q ss_pred HHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeecc
Q 041878 619 LASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA 698 (773)
Q Consensus 619 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 698 (773)
|.+++.... ...+++..+..++.||+.|++||| +.||+||||||+||+++.++.++|+|||++....... ......
T Consensus 80 L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 80 LKYHIYNVG-ERGLEMERVIHYSAQITCGILHLH-SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH-HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 998886643 234788999999999999999999 9999999999999999999999999999987654322 223346
Q ss_pred CccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 699 GTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 699 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
|++.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 8999999999988889999999999999999999999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=289.91 Aligned_cols=214 Identities=21% Similarity=0.371 Sum_probs=183.4
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|...+++|+|+||.++..+.+ +++.+++|.+.... .........|+.++++++|||||.+.+.+.......++||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 455789999999999998754 67899999997543 333446788999999999999999999996666559999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
++||++.+.+.+.. ...++......++.|++.|+.||| +..|+|||||+.||+++.++.+||+|||+|+.+..+...
T Consensus 86 ~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH-~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~- 162 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLH-ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL- 162 (426)
T ss_pred cCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH-hhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh-
Confidence 99999999998765 466899999999999999999999 999999999999999999999999999999998766522
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhh
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 756 (773)
.....|||.||+||.+.+.+|+.|+||||+||++|||++-+.+|...+ +...+.++++..
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~---m~~Li~ki~~~~ 222 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN---MSELILKINRGL 222 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc---hHHHHHHHhhcc
Confidence 224469999999999999999999999999999999999999987655 455555655544
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=296.56 Aligned_cols=204 Identities=25% Similarity=0.385 Sum_probs=168.8
Q ss_pred HHHhhcccccccceEEEEEEe------CCCCEEEEEEecccC-cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeE
Q 041878 536 LCATAEIMGKSTYGTAYKATL------EDGSEVAVKRLREKT-TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEK 607 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 607 (773)
.+.+.++||+|+||.||+|+. .++..||||+++... ....+.+.+|+++++.+ +||||+++++++ ...+..
T Consensus 36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-~~~~~~ 114 (375)
T cd05104 36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC-TVGGPT 114 (375)
T ss_pred HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-ccCCcc
Confidence 466789999999999999973 235689999997543 33456788999999999 899999999999 455589
Q ss_pred EEEEeecCCCCHHHHHhhcCC-----------------------------------------------------------
Q 041878 608 LLVFDFMPKGSLASFLHARGP----------------------------------------------------------- 628 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~----------------------------------------------------------- 628 (773)
++||||+++|+|.+++++...
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999999975321
Q ss_pred -------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc-e
Q 041878 629 -------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN-V 694 (773)
Q Consensus 629 -------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~ 694 (773)
...+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++......... .
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA-SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 124678889999999999999999 9999999999999999999999999999998664332211 1
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
....++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 12234568999999998999999999999999999998 888987643
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=289.01 Aligned_cols=198 Identities=24% Similarity=0.406 Sum_probs=165.6
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.+.||+|+||.||+|... +++.||||+++.... .....+.+|+.++++++||||+++++++. .....++||||+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~ 85 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-TKETLTLVFEYV 85 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-cCCeEEEEEECC
Confidence 455688999999999999875 689999999975432 23456788999999999999999999985 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
+ ++|.+++.... ..++...+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 86 ~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 160 (303)
T cd07869 86 H-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIH-QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-TY 160 (303)
T ss_pred C-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-cC
Confidence 5 68888887642 34788889999999999999999 99999999999999999999999999999875432221 12
Q ss_pred eeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 23457899999998754 56889999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=281.93 Aligned_cols=202 Identities=28% Similarity=0.471 Sum_probs=172.1
Q ss_pred HHHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 536 LCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.+.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++|+|++++++++ ...+..++||||++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~ 84 (261)
T cd05068 7 SIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVC-TLEEPIYIVTELMK 84 (261)
T ss_pred heeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEE-ecCCCeeeeeeccc
Confidence 355678999999999999998778899999987543 3467789999999999999999999988 45558899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|.+++.... ...+++..+..++.|++.|+.||| +.|++||||||+||++++++.++|+|||+++...........
T Consensus 85 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 162 (261)
T cd05068 85 YGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE-AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162 (261)
T ss_pred CCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccC
Confidence 999999997654 345789999999999999999999 999999999999999999999999999999876533222111
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
....+..|+|||...+..++.++||||||+++|||+| |+.||...+
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred CCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 2223457999999998899999999999999999999 999997654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=314.05 Aligned_cols=204 Identities=25% Similarity=0.322 Sum_probs=170.1
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.++||+|+||.||+|... +|+.||+|+++.... ...+++.+|++++++++||||+++++++. ..+..++|||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-d~~~lyLVME 82 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-DGDPVYYTMP 82 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-eCCEEEEEEE
Confidence 355689999999999999865 689999999975422 23467899999999999999999999984 4558999999
Q ss_pred ecCCCCHHHHHhhcCC--------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcc
Q 041878 613 FMPKGSLASFLHARGP--------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSR 684 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~ 684 (773)
|+++|+|.+++..... ....++..++.++.||++||+||| +.||+||||||+||+++.++.++|+|||+++
T Consensus 83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH-s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH-SKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH-HCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 9999999999875311 123567788999999999999999 9999999999999999999999999999998
Q ss_pred ccccccc-----------------cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 685 LMTAAAN-----------------TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 685 ~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
....... .......||+.|||||++.+..++.++|||||||++|||+||+.||...+.
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 6621110 001123589999999999999999999999999999999999999976443
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=298.36 Aligned_cols=191 Identities=20% Similarity=0.335 Sum_probs=163.9
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.+.||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++. .....++|+|++.
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~lv~e~~~ 166 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT-YNKFTCLILPRYK 166 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE-ECCeeEEEEecCC
Confidence 56678999999999999986 468899999753 235678999999999999999999984 4558899999995
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
++|.+++.... .+++..++.++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++...........
T Consensus 167 -~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH-~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 167 -TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLH-ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred -CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 78988887643 3788999999999999999999 899999999999999999999999999998754332222233
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
...||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 45699999999999989999999999999999999999988654
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=278.96 Aligned_cols=202 Identities=25% Similarity=0.441 Sum_probs=170.7
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+++.+.||+|+||.||+|.+.++..+|+|.+.... ....++.+|++++++++|+||+++++++ ...+..++||||+++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~e~~~~ 83 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVC-TKQRPIFIVTEYMAN 83 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEE-cCCCceEEEEecCCC
Confidence 56778899999999999998877889999986432 2356788899999999999999999998 455688999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.+++..... .+++..+..++.|++.|++||| +.+++||||||+||++++++.+||+|||.++............
T Consensus 84 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 84 GCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLE-SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH-HCCcccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 999999976532 4789999999999999999999 9999999999999999999999999999987654332222112
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGM 743 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~ 743 (773)
..++..|+|||......++.++||||||+++||+++ |+.||...+..
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 208 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS 208 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH
Confidence 224457999999988899999999999999999999 89999765433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=280.49 Aligned_cols=201 Identities=24% Similarity=0.455 Sum_probs=171.2
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.+.+.||+|+||+||+|...++..||+|.+.... ....++.+|+.++++++||||+++++++ ...+..++||||+++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~ 83 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVC-TKQRPIYIVTEYMSN 83 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEE-ccCCCcEEEEEcCCC
Confidence 34567899999999999998777789999987443 3457789999999999999999999998 455578999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
|+|.+++..... .+++.+++.++.||+.|++||| +.|++|+||||+||+++.++.+||+|||.++............
T Consensus 84 ~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 84 GCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLE-SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH-hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 999999976532 4789999999999999999999 9999999999999999999999999999987654433222222
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
..++..|+|||......++.++|||||||++|||++ |+.||...+.
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 207 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 335678999999988889999999999999999999 9999876543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=280.58 Aligned_cols=206 Identities=28% Similarity=0.466 Sum_probs=177.6
Q ss_pred HHHHHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 534 DLLCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 534 ~l~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
...|.+.++||.|+||.||+|...++..+|+|.+.........++..|+.++++++|+|++++++++. ..+..++||||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-VGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-cCCCeEEEEee
Confidence 34567789999999999999998889999999998766656778999999999999999999999984 45588999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++++|.++++... ...+++.++..++.||+.|++||| +.|++||||+|+||++++++.+||+|||.+..........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH-~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLE-EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 99999999998653 344789999999999999999999 9999999999999999999999999999997664332221
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGM 743 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~ 743 (773)
....++..|+|||......++.++||||||+++|+|++ |+.||...+..
T Consensus 162 -~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~ 211 (261)
T cd05148 162 -SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH 211 (261)
T ss_pred -cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 12335678999999988899999999999999999998 89999776543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=289.79 Aligned_cols=201 Identities=28% Similarity=0.470 Sum_probs=168.5
Q ss_pred HHHhhcccccccceEEEEEEeC-CCC----EEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGS----EVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
.|...+.||+|+||.||+|.+. +++ .||+|.++... ....+++.+|+.+++.++||||+++++++.. +..++
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~--~~~~~ 85 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQL 85 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC--CCcee
Confidence 4566789999999999999853 343 38999987543 3445688999999999999999999999953 35789
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
|+||+++|+|.+++.... ..+++...+.++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH-~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE-ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHH-hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 999999999999998753 34788889999999999999999 999999999999999999999999999999876543
Q ss_pred cccce-eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 690 ANTNV-IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 690 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
..... ....++..|+|||.+....++.++|||||||++||+++ |+.||....
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 32211 12234668999999998999999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-33 Score=296.09 Aligned_cols=200 Identities=26% Similarity=0.362 Sum_probs=171.1
Q ss_pred HHHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccC-CC-----ceEEeEEEEECCCCeEE
Q 041878 536 LCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HP-----NLLALRAYYLGPKGEKL 608 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~~ 608 (773)
+|.+.++||+|.||.|.+|.+ ++++.||||+++.... ...+-..|+.+|..++ |. |+|++++++ ..+++.|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-YFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-cccccee
Confidence 456789999999999999985 5699999999986543 3556678999999997 43 799999999 5666999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC--CeEEeecCCcccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT--NPRIADFGLSRLM 686 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~--~~kl~DfG~a~~~ 686 (773)
+|+|.+ .-+|.++++.+.. ..++......++.||+.||.+|| +.+|||+||||+|||+.+.+ .+||+|||.|...
T Consensus 265 iVfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~-~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLH-ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999999 5699999998753 44899999999999999999999 99999999999999998765 5999999999876
Q ss_pred ccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 041878 687 TAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMD 744 (773)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~ 744 (773)
..... ...-+..|.|||++.+.+|+.+.|||||||++.||++|.+.|.+.++.|
T Consensus 342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 54333 3346779999999999999999999999999999999988887766544
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=278.58 Aligned_cols=203 Identities=30% Similarity=0.471 Sum_probs=172.3
Q ss_pred HHHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 536 LCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.+.+.||+|+||.||+|...++..||+|.++.... ..+++.+|+.++++++|++++++++++ . ....++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~-~-~~~~~lv~e~~~ 83 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVV-S-EEPIYIVTEYMS 83 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEE-C-CCCcEEEEEecC
Confidence 4567789999999999999988888999999975433 456799999999999999999999987 3 346899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|.++++... ...+++.++..++.|++.|++||| +.+++||||||+||++++++.++|+|||.+............
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIE-RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 999999997643 234789999999999999999999 999999999999999999999999999999766443322222
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGM 743 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~ 743 (773)
...++..|+|||......++.++||||||+++|||++ |+.||...+..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 2235668999999888889999999999999999999 89999765443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=292.08 Aligned_cols=195 Identities=27% Similarity=0.459 Sum_probs=161.4
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
+...++||+|+||.||+|... +++.||||++..... .....+.+|++++++++|+||+++++++ ...+..++||||+
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~ 154 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-DHNGEIQVLLEFM 154 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-ccCCeEEEEEecC
Confidence 345688999999999999864 689999999965432 3356789999999999999999999998 5556899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++|+|.+.. ..+...+..++.||+.||+||| +.||+||||||+|||+++++.+||+|||+++....... ..
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 225 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLH-RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PC 225 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cc
Confidence 999986432 2456677889999999999999 99999999999999999999999999999986543221 12
Q ss_pred eeccCccccccccccCC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKL-----KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....||..|+|||.+.. ...+.++|||||||++|||++|+.||....
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 277 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 23468999999998743 234568999999999999999999997433
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=284.90 Aligned_cols=199 Identities=36% Similarity=0.622 Sum_probs=164.7
Q ss_pred hcccccccceEEEEEEeC-----CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 540 AEIMGKSTYGTAYKATLE-----DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+.||.|.||.||+|.+. .+..|+||.++.... ...++|.+|++.+++++||||++++|++. ..+..++|+||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-~~~~~~lv~e~ 82 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-ENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-SSSSEEEEEE-
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-ccccccccccc
Confidence 468999999999999876 256799999976433 34788999999999999999999999997 44579999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc-
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT- 692 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~- 692 (773)
+++|+|.++++... ...+++.++..++.||++||.||| +.+++|+||+++||++++++.+||+|||++.........
T Consensus 83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh-~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLH-SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHH-HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccc-cccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999862 244899999999999999999999 899999999999999999999999999999876322211
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
..........|+|||.+....++.++||||||+++||+++ |+.||...+
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~ 210 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD 210 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 1122346779999999988889999999999999999999 789987653
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=282.40 Aligned_cols=206 Identities=27% Similarity=0.456 Sum_probs=172.8
Q ss_pred HHHhhcccccccceEEEEEEeCC------CCEEEEEEecccCcc-cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLED------GSEVAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
.+.+.+.||+|+||.||+|...+ +..||||.++..... ..+.+.+|++++++++|+|++++++++.. ....+
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 84 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE-GDPPI 84 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-CCCeE
Confidence 35667899999999999998632 478999999765444 45789999999999999999999999954 46899
Q ss_pred EEEeecCCCCHHHHHhhcCC-----------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEE
Q 041878 609 LVFDFMPKGSLASFLHARGP-----------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRI 677 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl 677 (773)
+||||+++++|.++++..+. ...+++.++..++.|++.|++||| +.|++||||||+||+++.++.+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH-~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA-SQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh-hCCeeccccccceEEEcCCCeEEE
Confidence 99999999999999986532 234788899999999999999999 999999999999999999999999
Q ss_pred eecCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 041878 678 ADFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGM 743 (773)
Q Consensus 678 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~ 743 (773)
+|||++......... ......+++.|+|||.+....+++++|||||||++|||++ |+.||...+..
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~ 231 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999998765332211 1122345778999999999999999999999999999998 99998765443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=296.17 Aligned_cols=200 Identities=24% Similarity=0.356 Sum_probs=167.1
Q ss_pred HhhcccccccceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCC----CeEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK----GEKLLV 610 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~lV 610 (773)
...++||+|+||.||+|.. .+|+.||+|++.... ....+++.+|+.+++.++|+||+++++++.... ...++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 4568899999999999986 478999999986532 234567889999999999999999999985433 268999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
+||++ ++|.+++... ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH-~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~ 157 (372)
T cd07853 83 TELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLH-SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE 157 (372)
T ss_pred eeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence 99996 6888887653 34789999999999999999999 9999999999999999999999999999998654333
Q ss_pred ccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 691 NTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 210 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH
Confidence 322333457889999998876 4578999999999999999999999987554
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=277.91 Aligned_cols=202 Identities=27% Similarity=0.470 Sum_probs=172.7
Q ss_pred HHHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 536 LCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.+.++||+|+||.||+|...+++.||+|.+..... ...++.+|+.++++++|+|++++++++ . .+..++||||++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~-~~~~~~v~e~~~ 83 (260)
T cd05067 7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV-T-QEPIYIITEYME 83 (260)
T ss_pred HceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEE-c-cCCcEEEEEcCC
Confidence 4566789999999999999988899999999875433 457889999999999999999999887 3 347899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|.+++.... ...+++.++..++.|++.|++||| +.|++||||||+||+++.++.++++|||.+............
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH-~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05067 84 NGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIE-RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE 161 (260)
T ss_pred CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHh-cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccccc
Confidence 999999987643 345789999999999999999999 999999999999999999999999999998766533222222
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
...++..|+|||.+....++.++||||||+++||+++ |+.||...+.
T Consensus 162 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 162 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred CCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 3345678999999988889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-33 Score=293.71 Aligned_cols=210 Identities=24% Similarity=0.438 Sum_probs=172.3
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEec--cc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCC-eEEEEEe
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLR--EK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG-EKLLVFD 612 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~--~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~~lV~e 612 (773)
..++||+|+|-+||+|.+. +|..||.-.++ .. .....++|..|+.+|+.|+|+||++++.++.+... ..-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3568999999999999864 68888864443 22 23345789999999999999999999999866543 5679999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCceecCCCCCCEEeCCC-CCeEEeecCCcccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV-EENMIHGNLTSSNVLLDEK-TNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~-~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~~~~~ 690 (773)
.+..|+|+.|+.+.+. ++....+.+++||++||.|||+ +.+|||||||-+||+|+.+ |.|||+|+|+|.......
T Consensus 124 L~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred cccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999998754 7888999999999999999993 3779999999999999865 789999999999876543
Q ss_pred ccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhhh
Q 041878 691 NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEW 757 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 757 (773)
.. ...|||.|||||+.. ..|++.+||||||+.|+||+|+.+||..-. ...|..++.+.+.+
T Consensus 201 ak---svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 201 AK---SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYKKVTSGIK 261 (632)
T ss_pred cc---eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHHHHHcCCC
Confidence 32 256999999999887 889999999999999999999999997532 23444445544443
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=278.27 Aligned_cols=201 Identities=28% Similarity=0.454 Sum_probs=170.6
Q ss_pred HHHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 536 LCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
+|.+.++||+|+||+||+|.+.++..||+|.++.... ..+++.+|++++++++|+||+++++.+ . ....++||||++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~-~-~~~~~lv~e~~~ 83 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVV-S-EEPIYIVTEYMS 83 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEE-C-CCCcEEEEEcCC
Confidence 4567789999999999999987777899999975332 456789999999999999999999887 3 346799999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++++.. ...+++..+..++.|++.||+||| +.+++||||||+||++++++.++|+|||.+............
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH-~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~ 161 (262)
T cd05071 84 KGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 161 (262)
T ss_pred CCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHH-HCCccccccCcccEEEcCCCcEEeccCCceeecccccccccc
Confidence 999999998643 234789999999999999999999 999999999999999999999999999999766443322222
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
...++..|+|||...+..++.++||||||+++||++| |+.||....
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 3346678999999988899999999999999999999 888887654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=281.73 Aligned_cols=199 Identities=28% Similarity=0.414 Sum_probs=169.1
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
..++||+|+||+||+|... +++.||+|.+..... .....+.+|++++++++|++++++.+++ ...+..++||||+
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-~~~~~~~lv~e~~ 82 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-ETKDALCLVLTIM 82 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-ecCCEEEEEEEec
Confidence 4578999999999999864 688999999865422 2234578899999999999999999888 4556899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++++|.+++.... ...+++..+..++.|++.|+.||| +.+|+||||||+||++++++.++|+|||++........ .
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH-~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~ 158 (285)
T cd05632 83 NGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLH-RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--I 158 (285)
T ss_pred cCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc--c
Confidence 9999998887643 234899999999999999999999 99999999999999999999999999999876532221 1
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
....|++.|+|||.+.+..++.++|+||+||++|||++|+.||.....
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~ 206 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 234589999999999888999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=304.24 Aligned_cols=205 Identities=25% Similarity=0.336 Sum_probs=171.2
Q ss_pred HHHhhcccccccceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCC-------
Q 041878 536 LCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG------- 605 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------- 605 (773)
+|.+.++||+|+||+||+|.. .+|+.||||.+.... ......+.+|+..+..++|+|++++.+.+.....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 345678999999999999985 478999999986542 3345678899999999999999998877643221
Q ss_pred eEEEEEeecCCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcc
Q 041878 606 EKLLVFDFMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSR 684 (773)
Q Consensus 606 ~~~lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~ 684 (773)
..++||||+++|+|.+++.... ....++...+..++.|++.||.||| +.+|+||||||+|||++.++.+||+|||+++
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH-~~~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH-SKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 3679999999999999997642 2345888999999999999999999 9999999999999999999999999999998
Q ss_pred cccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 685 LMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 685 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~ 249 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 65433221 1223468999999999999999999999999999999999999997543
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=302.51 Aligned_cols=212 Identities=21% Similarity=0.333 Sum_probs=176.7
Q ss_pred cccChhHHHHHhhcccccccceEEEEEEeCCC-CEEEEEEecccCcccHHHHHHHHHHHHccC-CCceEEeEE-EEECC-
Q 041878 528 FLFTADDLLCATAEIMGKSTYGTAYKATLEDG-SEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPNLLALRA-YYLGP- 603 (773)
Q Consensus 528 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~g-~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~~- 603 (773)
..++....++++.++|.+|||+.||.|.+..+ ..||+|++-..+..+...+.+||++|++|+ |+|||.+++ .....
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 34555666778889999999999999997665 999999998777777888999999999998 999999998 33221
Q ss_pred --C--CeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCceecCCCCCCEEeCCCCCeEEe
Q 041878 604 --K--GEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV-EENMIHGNLTSSNVLLDEKTNPRIA 678 (773)
Q Consensus 604 --~--~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~-~~~iiH~Dik~~NIll~~~~~~kl~ 678 (773)
. -+.+|.||||++|.|.|++..+.... ++..++++|+.|+++|+.+||. ..+|||||||.+|||++.+++.|||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 1 26789999999999999998764333 8999999999999999999992 2459999999999999999999999
Q ss_pred ecCCcccccccc-c-c------ceeeccCcccccccccc---CCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 679 DFGLSRLMTAAA-N-T------NVIATAGTLGYRAPELS---KLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 679 DfG~a~~~~~~~-~-~------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
|||.|.-..... . . .......|+.|.|||.+ .+...++|+||||+||+||-++....||+..
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 999987543222 1 1 11234579999999964 6788999999999999999999999999874
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=279.08 Aligned_cols=201 Identities=32% Similarity=0.489 Sum_probs=170.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
+.+.+.||+|+||.||+|.+. .++.||+|.+... .....++.+|++++++++|+|++++++++. ..+..++||||++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~ 85 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-REPPFYIITEFMT 85 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEc-CCCCcEEEEEeCC
Confidence 455688999999999999865 5889999998743 334667899999999999999999999984 4558899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|.+++.... ...+++..++.++.|++.|++||| +.|++||||||+||++++++.+||+|||.+............
T Consensus 86 ~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 86 YGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred CCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH-hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 999999997653 244789999999999999999999 999999999999999999999999999999876543322222
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
...++..|+|||.+.+..++.++|||||||++|||++ |..||...+
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 2234668999999988899999999999999999998 999986544
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=280.41 Aligned_cols=198 Identities=27% Similarity=0.431 Sum_probs=168.5
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccCcc---cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK---GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
..++||+|+||.||++... +++.||+|.+...... ....+..|+.++++++|++++++++.+. ..+..++||||+
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-~~~~~~lv~e~~ 82 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-TKDALCLVLTLM 82 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-cCCEEEEEEEec
Confidence 4578999999999999864 6889999998654222 2345778999999999999999999984 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++++|.+++.... ...++..++..++.|++.|+.||| +.+|+||||||+||+++.++.++|+|||++........ .
T Consensus 83 ~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH-~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~ 158 (285)
T cd05630 83 NGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLH-QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--I 158 (285)
T ss_pred CCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--c
Confidence 9999999986543 234788999999999999999999 99999999999999999999999999999876533221 1
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....|++.|+|||.+.+..++.++||||+||++|||++|+.||....
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 23468999999999998899999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=265.68 Aligned_cols=204 Identities=25% Similarity=0.430 Sum_probs=174.5
Q ss_pred hhHHHHHhhcccccccceEEEEEE-eCCCCEEEEEEecccCcccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEE
Q 041878 532 ADDLLCATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 532 ~~~l~~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~l 609 (773)
+.++..-+.+.||+|+++.|-.+. +.+|.++|||++.+...+...++.+|++++...+ |+||+.+++++ ++++..|+
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-Edd~~FYL 153 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-EDDTRFYL 153 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-cccceEEE
Confidence 345555678999999999998885 7889999999999888888899999999999996 99999999999 66669999
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC---eEEeecCCcccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN---PRIADFGLSRLM 686 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~---~kl~DfG~a~~~ 686 (773)
|||-|.||+|..+++++ +.++...+-++.++|+.||.||| .+||.|||+||+|||-.+-.. +||+||.+..-+
T Consensus 154 VfEKm~GGplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH-~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKR---KHFNEREASRVVKDIASALDFLH-TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred EEecccCchHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHh-hcCcccccCCccceeecCCCCcCceeeecccccccc
Confidence 99999999999999875 44888999999999999999999 999999999999999976554 899999887654
Q ss_pred ccc------cccceeeccCcccccccccc-----CCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 687 TAA------ANTNVIATAGTLGYRAPELS-----KLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 687 ~~~------~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
.-. ........+|+..|||||+. ....|+.++|.||+||++|-|++|.+||.+.
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 321 12223345788899999964 2346899999999999999999999999884
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=293.20 Aligned_cols=210 Identities=24% Similarity=0.345 Sum_probs=171.5
Q ss_pred ccChhHHHHHhhcccccccceEEEEEEeC------CCCEEEEEEecccCc-ccHHHHHHHHHHHHccC-CCceEEeEEEE
Q 041878 529 LFTADDLLCATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIH-HPNLLALRAYY 600 (773)
Q Consensus 529 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 600 (773)
.++.+.-.+.+.++||+|+||.||+|+.. .+..||||+++.... ...+.+.+|+++++++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34444555677899999999999999852 234699999975433 23467899999999996 99999999999
Q ss_pred ECCCCeEEEEEeecCCCCHHHHHhhcCC----------------------------------------------------
Q 041878 601 LGPKGEKLLVFDFMPKGSLASFLHARGP---------------------------------------------------- 628 (773)
Q Consensus 601 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~---------------------------------------------------- 628 (773)
...+..++||||+++|+|.++++....
T Consensus 111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (400)
T cd05105 111 -TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV 189 (400)
T ss_pred -ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence 455689999999999999999875310
Q ss_pred -----------------------------------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCE
Q 041878 629 -----------------------------------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNV 667 (773)
Q Consensus 629 -----------------------------------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NI 667 (773)
...+++..+..++.||+.|++||| +.+|+||||||+||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivH~dikp~Ni 268 (400)
T cd05105 190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA-SKNCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChHhE
Confidence 123677888999999999999999 99999999999999
Q ss_pred EeCCCCCeEEeecCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCC
Q 041878 668 LLDEKTNPRIADFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPM 740 (773)
Q Consensus 668 ll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~ 740 (773)
+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 9999999999999998865432221 1122346788999999988899999999999999999997 99998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=281.33 Aligned_cols=209 Identities=28% Similarity=0.503 Sum_probs=172.4
Q ss_pred HHhhcccccccceEEEEEEeCC------CCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLED------GSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
+.+.+.||+|+||.||+|.... ...||+|.++.... ....++.+|++.+++++||||+++++++. ..+..++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-~~~~~~~ 85 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-KEQPTCM 85 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-CCCceEE
Confidence 3557889999999999998642 25799999875433 33567899999999999999999999984 4558899
Q ss_pred EEeecCCCCHHHHHhhcCCC-------------CccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeE
Q 041878 610 VFDFMPKGSLASFLHARGPE-------------TIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPR 676 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~-------------~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~k 676 (773)
+|||+++++|.+++...... ..+++.....++.|++.|+.||| +.+++||||||+||++++++.++
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH-~~~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS-SHHFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccccceEEEcCCCcEE
Confidence 99999999999999765321 34788899999999999999999 99999999999999999999999
Q ss_pred EeecCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCChHH
Q 041878 677 IADFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQ 747 (773)
Q Consensus 677 l~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~~~ 747 (773)
|+|||++......... ......+++.|+|||.+....++.++|||||||++|||++ |..||.+....++.+
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999998765433221 1223346788999999988889999999999999999998 999998765544433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=287.51 Aligned_cols=205 Identities=27% Similarity=0.421 Sum_probs=170.8
Q ss_pred HHHhhcccccccceEEEEEEeC------CCCEEEEEEecccCc-ccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEK 607 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 607 (773)
+|.+.++||+|+||.||+|... +++.||+|+++.... ...+.+..|+++++++ +|+||+++++++.......
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 5677899999999999999632 357899999975432 2345678899999999 7999999999987666788
Q ss_pred EEEEeecCCCCHHHHHhhcCC----------------------------------------------------------C
Q 041878 608 LLVFDFMPKGSLASFLHARGP----------------------------------------------------------E 629 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~----------------------------------------------------------~ 629 (773)
++|+||+++++|.+++..... .
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 999999999999999865321 1
Q ss_pred CccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc-ceeeccCccccccccc
Q 041878 630 TIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT-NVIATAGTLGYRAPEL 708 (773)
Q Consensus 630 ~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~ 708 (773)
..+++..+..++.||+.|++||| +.||+||||||+|||++.++.++|+|||+++.+...... ......++..|+|||+
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH-~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLA-SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 25789999999999999999999 999999999999999999999999999999876433221 1222345678999999
Q ss_pred cCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 709 SKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 709 ~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
+.+..++.++|||||||++|||++ |..||....
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999999998 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=280.94 Aligned_cols=203 Identities=27% Similarity=0.508 Sum_probs=168.4
Q ss_pred HhhcccccccceEEEEEEe-----CCCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATL-----EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
++.+.||+|+||+||+|.. .++..||+|.++.... ....++.+|++++++++|+||+++++++. .....++||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~ 86 (283)
T cd05090 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-QEQPVCMLF 86 (283)
T ss_pred eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-cCCceEEEE
Confidence 4568899999999999974 2467899999975433 33467899999999999999999999984 455889999
Q ss_pred eecCCCCHHHHHhhcCC--------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEE
Q 041878 612 DFMPKGSLASFLHARGP--------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRI 677 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl 677 (773)
||+++++|.+++..... ...+++.+...++.|++.|++||| +++++||||||+||++++++.+|+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~i~H~dlkp~nili~~~~~~kl 165 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS-SHFFVHKDLAARNILIGEQLHVKI 165 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH-hcCeehhccccceEEEcCCCcEEe
Confidence 99999999999864321 234788889999999999999999 999999999999999999999999
Q ss_pred eecCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 678 ADFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 678 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
+|||+++........ ......++..|+|||...+..++.++|||||||++|||++ |..||...+.
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05090 166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232 (283)
T ss_pred ccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999765433211 1122335678999999988889999999999999999998 9999876543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-34 Score=295.78 Aligned_cols=304 Identities=25% Similarity=0.272 Sum_probs=200.0
Q ss_pred CEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCC------
Q 041878 92 QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNL------ 165 (773)
Q Consensus 92 ~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L------ 165 (773)
.+..||+++|.++..-+..+.++++|+.++|..|.++ .+|.......+|+.|+|.+|.|+..-.+.++.++.|
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 3456777777766555555666666666666666665 455444444455555555555554444444444444
Q ss_pred ------------------CEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeecccccccccc
Q 041878 166 ------------------QTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSV 227 (773)
Q Consensus 166 ------------------~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 227 (773)
++|+|++|+|+......|..+.+|.+|.|+.|+++...+..|.+++.|+.|+|..|++.-.
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv- 236 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV- 236 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee-
Confidence 4455555554444444444455555555555555544444444555555555555554411
Q ss_pred CCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCccc
Q 041878 228 PNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVT 307 (773)
Q Consensus 228 p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~ 307 (773)
..+.+..+.+|+.|.|..|.+....-..|..+.++++|+|..|++...-..++.++++|+.|+||+|.|...-++.
T Consensus 237 ----e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~ 312 (873)
T KOG4194|consen 237 ----EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDS 312 (873)
T ss_pred ----hhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecch
Confidence 1222233446666666666666666666777777888888888887766777888888888888888888777788
Q ss_pred ccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCc---hhhccC
Q 041878 308 FTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISP---SLASLA 384 (773)
Q Consensus 308 ~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~ 384 (773)
+.-.++|++|+|++|+|+...+..|..+..|++|+|++|++...-...|..+++|++|||++|.|+..+.+ .|..|+
T Consensus 313 WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~ 392 (873)
T KOG4194|consen 313 WSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLP 392 (873)
T ss_pred hhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccch
Confidence 88888888888888888888888888888888888888888876667778888888888888888876554 366778
Q ss_pred ccCEEEeecccCCCCCch
Q 041878 385 NLTSFNVSYNNLSGSVPP 402 (773)
Q Consensus 385 ~L~~L~ls~N~l~g~~p~ 402 (773)
+|+.|+|.+|+|. .||.
T Consensus 393 ~LrkL~l~gNqlk-~I~k 409 (873)
T KOG4194|consen 393 SLRKLRLTGNQLK-SIPK 409 (873)
T ss_pred hhhheeecCceee-ecch
Confidence 8888888888886 3554
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=279.11 Aligned_cols=205 Identities=23% Similarity=0.396 Sum_probs=168.6
Q ss_pred HHHhhcccccccceEEEEEEeC------CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
.+++.+.||+|+||.||+|.+. .+..||+|++.... .....++.+|+.++++++|+||+++++++ ...+..+
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-~~~~~~~ 85 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-SQGQPTL 85 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-cCCCCeE
Confidence 4567789999999999999753 35679999986433 23345788999999999999999999998 5556899
Q ss_pred EEEeecCCCCHHHHHhhcCC-------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecC
Q 041878 609 LVFDFMPKGSLASFLHARGP-------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFG 681 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG 681 (773)
+||||+++|+|.++++.... ....++.++..++.|++.|+.||| +.+++||||||+||++++++.++++|||
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~vH~dlkp~Nil~~~~~~~~l~dfg 164 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFG 164 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCcchheEEEcCCCCEEECCCC
Confidence 99999999999999976432 123578889999999999999999 8999999999999999999999999999
Q ss_pred Cccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 682 LSRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 682 ~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
+++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred CccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 987654322211 112245778999999988889999999999999999999 7889876543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=290.87 Aligned_cols=196 Identities=24% Similarity=0.332 Sum_probs=164.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCC-----CeEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-----GEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~~ 608 (773)
|.+.+.||+|+||.||++... +|..||+|++... .......+.+|+.+++.++||||+++++++.... ...+
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 102 (359)
T cd07876 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY 102 (359)
T ss_pred eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence 456789999999999999864 6899999999643 2234567889999999999999999999985433 2479
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||+++ ++.+.++. .++...+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 103 lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH-~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 103 LVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred EEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 99999965 67666643 2677888899999999999999 99999999999999999999999999999875432
Q ss_pred ccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 176 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 176 NF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred Cc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1223458999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=273.79 Aligned_cols=197 Identities=28% Similarity=0.481 Sum_probs=167.1
Q ss_pred cccccccceEEEEEEeCCCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCCH
Q 041878 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSL 619 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~L 619 (773)
++||+|+||.||+|...+++.||+|.++.... .....+.+|++++++++||||+++++++. ..+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-QRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-cCCccEEEEECCCCCcH
Confidence 46999999999999988899999999876543 23457889999999999999999999984 45588999999999999
Q ss_pred HHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeeccC
Q 041878 620 ASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAG 699 (773)
Q Consensus 620 ~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~g 699 (773)
.+++.... ..+++..+..++.|++.|+.|+| +.|++||||||+||+++.++.+|++|||++...............+
T Consensus 80 ~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH-~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 80 LSFLRKKK--DELKTKQLVKFALDAAAGMAYLE-SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 99987643 34789999999999999999999 9999999999999999999999999999987543322221122234
Q ss_pred ccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 700 TLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 700 t~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
++.|+|||+.....++.++||||||+++||+++ |..||....
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~ 199 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence 668999999988889999999999999999998 999987643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-33 Score=287.78 Aligned_cols=196 Identities=28% Similarity=0.448 Sum_probs=166.8
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.-.+-||.|+||.||-|.+ .+.+.||||++.-. ..+.+.++..|+.++++++|||+|.+.|+|... ...|+|||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-~TaWLVME 106 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-HTAWLVME 106 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-chHHHHHH
Confidence 34456799999999999985 46788999999643 344578999999999999999999999999544 37899999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|| -|+-.|++.-.. +.+....+..|..+.+.||+||| +.+.||||||+.|||+++.|.||++|||.|....+..
T Consensus 107 YC-lGSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLH-S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn-- 180 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH-SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN-- 180 (948)
T ss_pred HH-hccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHH-HhhHHhhhccccceEecCCCeeeeccccchhhcCchh--
Confidence 99 568888776653 33667778889999999999999 9999999999999999999999999999998765443
Q ss_pred ceeeccCccccccccccC---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSK---LKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.++|||.|||||++. .+.|+-++||||+|++..|+...++|.-.++.
T Consensus 181 ---sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA 230 (948)
T KOG0577|consen 181 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 230 (948)
T ss_pred ---cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH
Confidence 356999999999874 56799999999999999999999999766543
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=298.12 Aligned_cols=198 Identities=24% Similarity=0.395 Sum_probs=160.8
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECC-------CCeEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-------KGEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------~~~~~ 608 (773)
|.+.++||+|+||.||+|... +++.||||++.... ....+|+.++++++|+||+++++++... ....+
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~ 143 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEE
Confidence 556789999999999999864 68899999885432 2345799999999999999998886432 12466
Q ss_pred EEEeecCCCCHHHHHhhc-CCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC-CeEEeecCCcccc
Q 041878 609 LVFDFMPKGSLASFLHAR-GPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT-NPRIADFGLSRLM 686 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~ 686 (773)
+||||++ +++.+++... .....+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+|+..
T Consensus 144 lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH-~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 144 VVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH-SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 8999997 4787776543 22345889999999999999999999 99999999999999999765 6999999999866
Q ss_pred ccccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 687 TAAANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.
T Consensus 222 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 222 LAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred cCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 43222 223458999999998765 4689999999999999999999999987554
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=259.85 Aligned_cols=207 Identities=26% Similarity=0.370 Sum_probs=176.2
Q ss_pred hhHHHHHhhcccccccceEEEEEE-eCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECC----CCe
Q 041878 532 ADDLLCATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP----KGE 606 (773)
Q Consensus 532 ~~~l~~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~ 606 (773)
.++.+|.+.+.+|+|||+-||.++ ..++..+|+|++.....++.+...+|++..++++||||++++++.... ...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 455667888999999999999998 678899999999888777888999999999999999999998876432 336
Q ss_pred EEEEEeecCCCCHHHHHhhcCC-CCccCHHHHHHHHHHHHHHHHHhccCCC--ceecCCCCCCEEeCCCCCeEEeecCCc
Q 041878 607 KLLVFDFMPKGSLASFLHARGP-ETIVNWATRMSIAIGIARGLNYLHVEEN--MIHGNLTSSNVLLDEKTNPRIADFGLS 683 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~yLH~~~~--iiH~Dik~~NIll~~~~~~kl~DfG~a 683 (773)
.|++++|...|+|.+.+++... ...++..+.+.|+.+|++||++|| +.. .+||||||.||++.+.+.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH-~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH-EKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh-ccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999987643 447999999999999999999999 765 999999999999999999999999998
Q ss_pred cccccccc--------cceeeccCccccccccccC---CCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 684 RLMTAAAN--------TNVIATAGTLGYRAPELSK---LKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 684 ~~~~~~~~--------~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
....-... ++......|..|.|||.+. +...++++||||+||++|+|+.|..||+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 76532211 1122334788999999874 45678999999999999999999999986
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=300.99 Aligned_cols=201 Identities=23% Similarity=0.331 Sum_probs=163.9
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCC------CceEEeEEEEECCCCeEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHH------PNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~~~~~~ 608 (773)
+|.+.++||+|+||+||+|... .++.||||+++... ....++..|++++++++| .+++++++++.......+
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 3566789999999999999864 57889999996432 224456667777777754 458899999876666889
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC---------------
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT--------------- 673 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~--------------- 673 (773)
+|||++ +++|.+++.+.. .+++..+..++.||+.||+|||.+.|||||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred EEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 999998 778999887653 3788999999999999999999336999999999999998765
Q ss_pred -CeEEeecCCccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCh
Q 041878 674 -NPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745 (773)
Q Consensus 674 -~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~ 745 (773)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.
T Consensus 285 ~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 285 CRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred ceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 499999998754321 12245689999999999999999999999999999999999999987654433
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=274.93 Aligned_cols=201 Identities=29% Similarity=0.461 Sum_probs=169.8
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.+.+.||+|++|.||+|.+.++..+|+|.+.... ...+.+.+|++++++++|+|++++++++ . .+..++||||+++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~-~~~~~~v~e~~~~ 84 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVV-S-EEPIYIVTEFMGK 84 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEE-c-CCCcEEEEEcCCC
Confidence 45668899999999999998877789999886433 3456788999999999999999999887 3 3468899999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.++++... ...+++..+..++.|++.|+.||| +.|++||||||+||++++++.++|+|||.+.............
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05069 85 GSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE-RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred CCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHH-hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence 99999997643 234789999999999999999999 9999999999999999999999999999997654332222222
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
..++..|+|||......++.++|||||||++|||+| |+.||.....
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 209 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 335678999999988889999999999999999999 8999876543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=283.73 Aligned_cols=203 Identities=25% Similarity=0.411 Sum_probs=167.7
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++|+||+++++++. .++..++||||+
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~ 86 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-TDKSLTLVFEYL 86 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-eCCeEEEEEeCC
Confidence 345688999999999999865 678899999875432 23456788999999999999999999985 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++ +|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||.+......... .
T Consensus 87 ~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH-~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~ 161 (309)
T cd07872 87 DK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCH-RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT-Y 161 (309)
T ss_pred CC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc-c
Confidence 74 8888887643 34788889999999999999999 999999999999999999999999999998754332211 1
Q ss_pred eeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCh
Q 041878 695 IATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~ 745 (773)
....+++.|+|||.+.+ ..++.++||||+||++|||+||+.||...+..+.
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 213 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 22357889999998754 5688999999999999999999999987654443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=280.23 Aligned_cols=203 Identities=28% Similarity=0.479 Sum_probs=170.8
Q ss_pred HHhhcccccccceEEEEEEeC------CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
+.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+|++++++++. ..+..++|
T Consensus 7 ~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv 85 (288)
T cd05093 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-EGDPLIMV 85 (288)
T ss_pred eeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCccEEE
Confidence 456788999999999999742 34568999997666556678999999999999999999999995 45589999
Q ss_pred EeecCCCCHHHHHhhcCC----------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeec
Q 041878 611 FDFMPKGSLASFLHARGP----------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADF 680 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~----------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~Df 680 (773)
|||+++++|.+++..... ...+++.+++.++.|++.||+||| +.|++||||||+||++++++.++|+||
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH-~~~i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA-SQHFVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccCcceEEEccCCcEEeccC
Confidence 999999999999976431 234899999999999999999999 999999999999999999999999999
Q ss_pred CCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 681 GLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 681 G~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
|++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 998765432211 1112335678999999998899999999999999999998 899987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=273.79 Aligned_cols=195 Identities=25% Similarity=0.459 Sum_probs=163.2
Q ss_pred cccccceEEEEEEeC---CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCC
Q 041878 543 MGKSTYGTAYKATLE---DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 543 lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
||+|+||.||+|.+. ++..||+|++..... ...+++.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~--~~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE--AEALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc--CCCeEEEEEeCCCCC
Confidence 899999999999753 355799999976533 23467899999999999999999999883 347899999999999
Q ss_pred HHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce--ee
Q 041878 619 LASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV--IA 696 (773)
Q Consensus 619 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~--~~ 696 (773)
|.+++.... ..+++..+++++.|++.|+.||| +.|++||||||+||+++.++.+||+|||.+........... ..
T Consensus 81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLE-GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH-hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 999987542 34789999999999999999999 99999999999999999999999999999876543322111 11
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
..+++.|+|||.+....++.++|||||||++||+++ |..||.....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 204 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 223578999999988889999999999999999996 9999976543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=291.17 Aligned_cols=193 Identities=25% Similarity=0.362 Sum_probs=159.0
Q ss_pred cccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHHHHcc---CCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 543 MGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGKI---HHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 543 lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
||+|+||+||+|... +++.||||++..... .....+..|..++.+. .||||+++++++. .....++||||++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~-~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ-TDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe-cCCeEEEEEcCCC
Confidence 699999999999864 689999999864321 1223445566676655 6999999999884 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.... .++...+..++.||++||+||| +.||+||||||+|||++.++.++|+|||++........ ...
T Consensus 80 ~g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH-~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~ 154 (330)
T cd05586 80 GGELFWHLQKEG---RFSEDRAKFYIAELVLALEHLH-KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTN 154 (330)
T ss_pred CChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Ccc
Confidence 999999987643 3788999999999999999999 99999999999999999999999999999875432221 122
Q ss_pred eccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...||+.|+|||++.+. .++.++||||+||++|||++|+.||...+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 34589999999988654 58999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=275.03 Aligned_cols=202 Identities=30% Similarity=0.470 Sum_probs=172.5
Q ss_pred HHHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 536 LCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.+.++||+|+||.||+|..+++..||||.+.... ...+++.+|+.++++++|+|++++++++. .....++||||++
T Consensus 7 ~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~~ 84 (261)
T cd05034 7 SLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS-EEEPIYIVTEYMS 84 (261)
T ss_pred heeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee-cCCceEEEEeccC
Confidence 456678999999999999998888899999987543 34678999999999999999999999984 4458899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|.+++.... ...+++.++..++.|++.|+.||| +.+++|+||||+||++++++.++++|||.+............
T Consensus 85 ~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh-~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (261)
T cd05034 85 KGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLE-SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE 162 (261)
T ss_pred CCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhh
Confidence 999999998753 234789999999999999999999 999999999999999999999999999998766433222222
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
....+..|+|||...+..++.++||||+||++||+++ |+.||...+
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 209 (261)
T cd05034 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209 (261)
T ss_pred ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 2234568999999988889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=279.66 Aligned_cols=208 Identities=23% Similarity=0.376 Sum_probs=174.3
Q ss_pred HHHhhcccccccceEEEEEEeCC-----CCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLED-----GSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
.|.+.++||+|+||.||+|...+ +..||+|++.... ......+.+|+.++++++|+|++++++++.......++
T Consensus 7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 86 (280)
T cd05043 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFV 86 (280)
T ss_pred heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEE
Confidence 45567899999999999998765 6789999987543 33456788999999999999999999998766678899
Q ss_pred EEeecCCCCHHHHHhhcCCC-----CccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcc
Q 041878 610 VFDFMPKGSLASFLHARGPE-----TIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSR 684 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~ 684 (773)
++||+++++|.+++...... ..+++.++..++.|++.|++||| +.+++||||||+||++++++.+||+|||+++
T Consensus 87 ~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~i~H~di~p~nil~~~~~~~kl~d~g~~~ 165 (280)
T cd05043 87 LYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-KRGVIHKDIAARNCVIDEELQVKITDNALSR 165 (280)
T ss_pred EEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence 99999999999999765322 45889999999999999999999 9999999999999999999999999999998
Q ss_pred ccccccccce-eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCC
Q 041878 685 LMTAAANTNV-IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMD 744 (773)
Q Consensus 685 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~ 744 (773)
.+........ ....++..|+|||+.....++.++|||||||++||+++ |+.||...+..+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 227 (280)
T cd05043 166 DLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227 (280)
T ss_pred cccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH
Confidence 6543322111 12235668999999988889999999999999999999 999997654433
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=278.04 Aligned_cols=203 Identities=24% Similarity=0.408 Sum_probs=166.7
Q ss_pred HHhhcccccccceEEEEEEeC-CCC----EEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGS----EVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
+.+.+.||+|+||+||+|.+. +++ .||+|.+..... ....++..|+..++++.||||+++++++. ....++|
T Consensus 9 ~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~~~~~~i 86 (279)
T cd05111 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--GASLQLV 86 (279)
T ss_pred ceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC--CCccEEE
Confidence 345688999999999999864 454 477888754332 23467788888999999999999999873 3357889
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
+||+++|+|.+++.... ..+++..+..++.||+.|++||| +.+++||||||+||++++++.+||+|||.++......
T Consensus 87 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH-~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 87 TQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLE-EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH-HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 99999999999997643 34789999999999999999999 9999999999999999999999999999998654322
Q ss_pred cc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCC
Q 041878 691 NT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMD 744 (773)
Q Consensus 691 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~ 744 (773)
.. ......++..|+|||.+....++.++|||||||++||+++ |+.||.+.....
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~ 219 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 21 1123346778999999988899999999999999999998 999997765433
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=273.52 Aligned_cols=197 Identities=27% Similarity=0.533 Sum_probs=168.7
Q ss_pred HHHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 536 LCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.+.+.||+|+||.||++... |..||+|..+... ..+.+.+|+.++++++|+|++++++++....+..++|+||++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 3456788999999999999765 7889999986432 356789999999999999999999987666667899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|.++++... ...+++..++.++.|++.|++||| +.|++||||||+||++++++.+|++|||++........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---- 157 (256)
T cd05082 84 KGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE-ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD---- 157 (256)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH-hCCEeccccchheEEEcCCCcEEecCCccceeccccCC----
Confidence 999999998654 234788999999999999999999 99999999999999999999999999999875433221
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
...++..|+|||+.....++.++|||||||++|||++ |+.||...+
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~ 204 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence 2234568999999988899999999999999999997 999987544
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=275.11 Aligned_cols=201 Identities=26% Similarity=0.504 Sum_probs=169.3
Q ss_pred HHhhcccccccceEEEEEEeCC----CCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLED----GSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
+...+.||+|+||+||+|.+.. ...||||.++.... ....+|.+|+.++++++|+||+++++++. ..+..++||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~iv~ 84 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-KSRPVMIIT 84 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-cCCceEEEE
Confidence 4567899999999999998642 45799999875433 34567899999999999999999999984 455889999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++++|.+++.... ..+++.++.+++.|++.|++||| +.+|+||||||+||++++++.++++|||++........
T Consensus 85 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh-~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 85 EYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLS-EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 9999999999997653 25789999999999999999999 99999999999999999999999999999987652221
Q ss_pred c-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 692 T-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 692 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
. ......+++.|+|||......++.++||||||+++|||++ |..||....
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 1 1112234678999999988899999999999999999998 999986544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=273.64 Aligned_cols=199 Identities=24% Similarity=0.432 Sum_probs=168.6
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCc-----ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTT-----KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
+...+.||+|++|.||+|.. .+++.||+|.+..... .....+.+|++++++++||||+++++++. ..+..++|
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v 82 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-DDETLSIF 82 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-cCCeEEEE
Confidence 34578999999999999986 4689999999864321 12356888999999999999999999995 45599999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
+||+++++|.+++.... .++...+..++.|++.|+.||| +.|++||||+|+||++++++.++|+|||+++......
T Consensus 83 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 83 MEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLH-SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999987653 3788888999999999999999 9999999999999999999999999999987654322
Q ss_pred ccce--eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 691 NTNV--IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 691 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
.... ....++..|+|||.+.+..++.++||||+|+++|||++|+.||...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 1111 2335778999999999888999999999999999999999998654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=279.38 Aligned_cols=203 Identities=28% Similarity=0.464 Sum_probs=171.3
Q ss_pred HhhcccccccceEEEEEEeC------CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
...+.||+|+||.||+|... ++..+|+|.++.......+.+.+|++.+++++|+||+++++++. ..+..++||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~ 86 (291)
T cd05094 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-DGDPLIMVF 86 (291)
T ss_pred EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-cCCceEEEE
Confidence 44578999999999999742 34568999997666666678999999999999999999999994 555899999
Q ss_pred eecCCCCHHHHHhhcCC-------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEe
Q 041878 612 DFMPKGSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIA 678 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~ 678 (773)
||+++++|.+++..... ...+++..++.++.||+.|++||| ++||+||||||+||+++.++.++|+
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccCcceEEEccCCcEEEC
Confidence 99999999999976532 234789999999999999999999 9999999999999999999999999
Q ss_pred ecCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 679 DFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 679 DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
|||++......... ......++..|+|||.+....++.++|||||||++|||+| |+.||...+.
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99998765433221 1123346788999999988899999999999999999999 9999866443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=282.17 Aligned_cols=198 Identities=26% Similarity=0.425 Sum_probs=161.4
Q ss_pred hcccccccceEEEEEEeC---CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECC-CCeEEEEEeecC
Q 041878 540 AEIMGKSTYGTAYKATLE---DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-KGEKLLVFDFMP 615 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV~e~~~ 615 (773)
+++||+|+||+||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++... ....++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999864 46789999986442 235578899999999999999999988543 346789999995
Q ss_pred CCCHHHHHhhcC------CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe----CCCCCeEEeecCCccc
Q 041878 616 KGSLASFLHARG------PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL----DEKTNPRIADFGLSRL 685 (773)
Q Consensus 616 ~g~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll----~~~~~~kl~DfG~a~~ 685 (773)
++|.+++.... ....++...+..++.||+.||+||| +.||+||||||+|||+ +..+.+||+|||+++.
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH-hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 58888876432 1234788899999999999999999 9999999999999999 4567899999999987
Q ss_pred ccccccc--ceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 686 MTAAANT--NVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 686 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 6433221 2223468999999998866 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=276.74 Aligned_cols=209 Identities=25% Similarity=0.379 Sum_probs=180.4
Q ss_pred hhcccccccceEEEEEEe-CCCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 539 TAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.-++||+|+||.||-++. .+|+.+|.|++.+.. .+.+.....|-+++.+++.+.||.+--+| ..++..++|+..|
T Consensus 189 ~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-eTkd~LClVLtlM 267 (591)
T KOG0986|consen 189 VYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-ETKDALCLVLTLM 267 (591)
T ss_pred eeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-cCCCceEEEEEee
Confidence 457899999999999875 479999999986543 23455677899999999999999986666 6777999999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
.||+|.-++.+.+. ..++...+..++.+|+.||++|| ..+||+||+||+|||+|+.|+++|+|+|+|..+.... ..
T Consensus 268 NGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH-~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~--~~ 343 (591)
T KOG0986|consen 268 NGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLH-RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK--PI 343 (591)
T ss_pred cCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHH-hcceeeccCChhheeeccCCCeEeeccceEEecCCCC--cc
Confidence 99999999988764 45899999999999999999999 9999999999999999999999999999998876443 33
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASI 752 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~ 752 (773)
...+||.+|||||++.++.|+...|-||+||++|||+.|+.||.....++-.+-+.+.
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr 401 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRR 401 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHH
Confidence 4557999999999999999999999999999999999999999886666555445443
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=291.57 Aligned_cols=206 Identities=22% Similarity=0.295 Sum_probs=170.5
Q ss_pred HHHhhcccccccceEEEEEEeC---CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 536 LCATAEIMGKSTYGTAYKATLE---DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+|.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++. .....++|||
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~-~~~~~~lv~e 166 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYR-WKSTVCMVMP 166 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEe-eCCEEEEEeh
Confidence 3566789999999999999753 3578999988543 23467999999999999999999884 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
++. ++|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||++.++.++|+|||++.........
T Consensus 167 ~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH-~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 167 KYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLH-GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred hcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 995 6898888543 34899999999999999999999 999999999999999999999999999998765443222
Q ss_pred -ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 041878 693 -NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASI 752 (773)
Q Consensus 693 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~ 752 (773)
......||+.|+|||++....++.++|||||||++|||++|+.||.+.......+.++.+
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i 302 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSI 302 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHH
Confidence 222456899999999999899999999999999999999999999876554443444333
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=274.23 Aligned_cols=201 Identities=27% Similarity=0.467 Sum_probs=170.7
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.+.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|++++++++|+|++++++++.. ...++||||+++
T Consensus 8 ~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~~~~ 84 (260)
T cd05073 8 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEFMAK 84 (260)
T ss_pred eeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEEeCCC
Confidence 45678999999999999998888889999886432 235678899999999999999999998854 578999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.+++.... ....++.+++.++.|++.|+.||| +.|++||||+|+||+++.++.+||+|||.+.............
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH-~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 162 (260)
T cd05073 85 GSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162 (260)
T ss_pred CcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHH-hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence 99999998643 234788899999999999999999 8999999999999999999999999999987654332222222
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
..++..|+|||++....++.++|+|||||++||++| |+.||...+.
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 345678999999988889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=274.23 Aligned_cols=199 Identities=24% Similarity=0.380 Sum_probs=169.2
Q ss_pred HHHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 536 LCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.|.+.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++|+|++++++++. ..+..++||||+
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-~~~~~~iv~e~~ 88 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-SREKLWICMEYC 88 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-eCCEEEEEEeCC
Confidence 356678999999999999986 468899999997655555667889999999999999999999985 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++++|.++++... .++...+..++.|++.|++||| +.+|+||||+|+||+++.++.++|+|||++........ ..
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 163 (267)
T cd06646 89 GGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLH-SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KR 163 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-cc
Confidence 9999999987643 3788999999999999999999 99999999999999999999999999999886543221 12
Q ss_pred eeccCccccccccccC---CCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSK---LKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
....+++.|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 2345788999999874 445788999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=264.99 Aligned_cols=205 Identities=23% Similarity=0.356 Sum_probs=174.6
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHH---HHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKE---FEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+...++||+|.||.|.+++- .+|+.+|+|++++.......+ -..|-++++..+||.+..+--.+ ...+..|+|||
T Consensus 170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-Qt~drlCFVMe 248 (516)
T KOG0690|consen 170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-QTQDRLCFVME 248 (516)
T ss_pred hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-ccCceEEEEEE
Confidence 34568999999999999985 478999999998875544444 34588999999999999887666 45568999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|..||.|.-++.+. +.++......+...|+.||.||| +++||+||+|.+|.|+|.+|++||+|||+++.--....
T Consensus 249 yanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLH-s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~- 323 (516)
T KOG0690|consen 249 YANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLH-SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD- 323 (516)
T ss_pred EccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhh-hCCeeeeechhhhheeccCCceEeeecccchhcccccc-
Confidence 99999999888874 45788888889999999999999 89999999999999999999999999999985433322
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHH
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQ 747 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~ 747 (773)
.+...+|||.|+|||++....|+.++|-|.+||+||||++|+.||...+.+.+-+
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFe 378 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFE 378 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHH
Confidence 2345789999999999999999999999999999999999999998876654433
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=275.67 Aligned_cols=203 Identities=27% Similarity=0.420 Sum_probs=165.9
Q ss_pred HhhcccccccceEEEEEEeCC-CC--EEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCC-----CeE
Q 041878 538 ATAEIMGKSTYGTAYKATLED-GS--EVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-----GEK 607 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~-g~--~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 607 (773)
+++++||+|+||.||+|.+.+ +. .||+|.++... ....+.+.+|++++++++|+||+++++++.... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 356789999999999998754 33 58999886542 334567889999999999999999999874321 246
Q ss_pred EEEEeecCCCCHHHHHhhcC---CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcc
Q 041878 608 LLVFDFMPKGSLASFLHARG---PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSR 684 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~ 684 (773)
++|+||+++|+|.+++.... ....+++.....++.|++.|++||| +++|+||||||+||++++++.+||+|||+++
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS-SKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH-HCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 89999999999999875332 2344789999999999999999999 8999999999999999999999999999998
Q ss_pred ccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 685 LMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 685 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
......... .....+++.|+|||......++.++|||||||++|||++ |+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 219 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 764332211 112235678999999998999999999999999999999 889987643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=289.42 Aligned_cols=196 Identities=21% Similarity=0.309 Sum_probs=165.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCC-----CeEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-----GEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~~ 608 (773)
|.+.+.||+|+||.||+|... .++.||||++.... ......+.+|+.+++.++||||+++++++.... ...+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence 556789999999999999864 68899999997532 334567888999999999999999999874332 3579
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||++ ++|.+++... +++..+..++.|++.||+||| ++||+||||||+||+++.++.+||+|||+++....
T Consensus 106 lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 106 IVMELMD-ANLCQVIQME-----LDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred EEEeCCC-CCHHHHHHhc-----CCHHHHHHHHHHHHHHHHHHh-hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 9999996 4787777542 678888999999999999999 99999999999999999999999999999976543
Q ss_pred ccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 179 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 179 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred CC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 22 1223458999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=285.19 Aligned_cols=205 Identities=25% Similarity=0.431 Sum_probs=169.2
Q ss_pred HHHhhcccccccceEEEEEEe------CCCCEEEEEEecccCc-ccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeE
Q 041878 536 LCATAEIMGKSTYGTAYKATL------EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEK 607 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 607 (773)
+|.+.++||+|+||.||+|.+ .+++.||||+++.... .....+.+|+.++.++ +|+||+++++++.......
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 87 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCce
Confidence 567889999999999999973 3467899999975433 2345688999999999 6899999999986666678
Q ss_pred EEEEeecCCCCHHHHHhhcCC-----------------------------------------------------------
Q 041878 608 LLVFDFMPKGSLASFLHARGP----------------------------------------------------------- 628 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~----------------------------------------------------------- 628 (773)
++||||+++|+|.++++....
T Consensus 88 ~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (343)
T cd05103 88 MVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAE 167 (343)
T ss_pred EEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhh
Confidence 999999999999999875321
Q ss_pred -----CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc-cceeeccCccc
Q 041878 629 -----ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN-TNVIATAGTLG 702 (773)
Q Consensus 629 -----~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~ 702 (773)
...+++.++..++.||+.|++||| +.+|+||||||+||+++.++.+||+|||++........ .......+++.
T Consensus 168 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 168 QEDLYKKVLTLEDLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhhhccCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 123678888999999999999999 99999999999999999999999999999876533221 11112235678
Q ss_pred cccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 703 YRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 703 y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 999999988899999999999999999997 999986543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=272.13 Aligned_cols=200 Identities=28% Similarity=0.442 Sum_probs=172.0
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
...+.||+|++|.||+|... +++.||+|.+... ......++.+|++++++++|||++++++++. ..+..++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~ 81 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-DKGKLNIVMEYA 81 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-cCCEEEEEEEeC
Confidence 34578999999999999864 6899999998643 3445678899999999999999999999984 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++++|.++++... ...+++..+..++.|++.|+.||| +.|++||||+|+||+++.++.++|+|||++......... .
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH-~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-~ 158 (256)
T cd08529 82 ENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLH-SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-A 158 (256)
T ss_pred CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch-h
Confidence 9999999998753 345788999999999999999999 999999999999999999999999999998866543222 1
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....+++.|+|||+..+..++.++|||||||++|||++|+.||...+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 23357889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=272.37 Aligned_cols=196 Identities=27% Similarity=0.435 Sum_probs=164.5
Q ss_pred ccccccceEEEEEEe---CCCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 542 IMGKSTYGTAYKATL---EDGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 542 ~lG~G~fg~Vy~~~~---~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
.||+|+||.||+|.+ .++..+|+|+++.... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEEecCCC
Confidence 589999999999975 3578899999864432 23567899999999999999999999883 3367899999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc--e
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN--V 694 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~--~ 694 (773)
|+|.+++.... .+++..+..++.|++.|++||| ++||+||||||+||+++.++.+||+|||.+.......... .
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH-~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 80 GPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLE-ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 99999997643 4788999999999999999999 9999999999999999999999999999998764433211 1
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGM 743 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~ 743 (773)
....++..|+|||.+....++.++|||||||++|||++ |+.||...+..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 205 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN 205 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 12234578999999988889999999999999999998 99999865443
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=285.03 Aligned_cols=206 Identities=24% Similarity=0.381 Sum_probs=169.0
Q ss_pred hHHHHHhhcccccccceEEEEEEeC------CCCEEEEEEecccCcc-cHHHHHHHHHHHHccC-CCceEEeEEEEECCC
Q 041878 533 DDLLCATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTTK-GQKEFEAEAAAIGKIH-HPNLLALRAYYLGPK 604 (773)
Q Consensus 533 ~~l~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 604 (773)
..-.+.+.++||+|+||.||+|.+. .+..||+|+++..... ....+..|++++.++. ||||+++++++.. .
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-~ 113 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-G 113 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc-C
Confidence 3334567899999999999999853 3467999999754332 2346889999999997 9999999999954 4
Q ss_pred CeEEEEEeecCCCCHHHHHhhcCC--------------------------------------------------------
Q 041878 605 GEKLLVFDFMPKGSLASFLHARGP-------------------------------------------------------- 628 (773)
Q Consensus 605 ~~~~lV~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 628 (773)
+..++|+||+++|+|.+++++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 589999999999999999976421
Q ss_pred ---------------------------------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe
Q 041878 629 ---------------------------------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL 669 (773)
Q Consensus 629 ---------------------------------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll 669 (773)
...+++.....++.||+.||+||| +.+++||||||+||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrdlkp~NiLl 272 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA-SKNCVHRDLAARNVLI 272 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh-cCCcCcccCCcceEEE
Confidence 123677788899999999999999 9999999999999999
Q ss_pred CCCCCeEEeecCCccccccccc-cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCC
Q 041878 670 DEKTNPRIADFGLSRLMTAAAN-TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPM 740 (773)
Q Consensus 670 ~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~ 740 (773)
++++.+|++|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |+.||...
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999986533221 11222346789999999988889999999999999999998 89998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=272.79 Aligned_cols=199 Identities=27% Similarity=0.433 Sum_probs=170.2
Q ss_pred cccccccceEEEEEEeCC--CC--EEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLED--GS--EVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~--g~--~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
++||+|++|.||+|.+.+ ++ .||+|.+..... ...+++..|++++++++|+||+++++++.. ...++|+||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence 468999999999998643 33 699999987655 556789999999999999999999999855 68899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc--
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN-- 693 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~-- 693 (773)
+++|.+++..... ..+++.....++.|++.||+||| +.+++||||+|+||+++.++.+||+|||.++.........
T Consensus 79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLE-SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHH-hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999987643 45799999999999999999999 9999999999999999999999999999998765432211
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGM 743 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~ 743 (773)
.....++..|+|||......++.++|||||||++|||++ |+.||...+..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 207 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS 207 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 112346778999999988899999999999999999999 99999755433
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=271.39 Aligned_cols=197 Identities=26% Similarity=0.458 Sum_probs=165.0
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
+.||+|+||.||+|... +++.||+|...... ......+.+|++++++++|+||+++++++. .....++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-QKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCCeEEEEeeccCCc
Confidence 46999999999999864 78999999886543 334567899999999999999999999984 4558899999999999
Q ss_pred HHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce-eec
Q 041878 619 LASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV-IAT 697 (773)
Q Consensus 619 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~-~~~ 697 (773)
|.+++.+.. ..+++.+++.++.|++.||.||| +.+|+||||||+||+++.++.+|++|||.+........... ...
T Consensus 80 L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRTEG--PRLKVKELIQMVENAAAGMEYLE-SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH-hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 999997643 34789999999999999999999 99999999999999999999999999999876442211111 111
Q ss_pred cCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 698 AGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 698 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
..+..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 23457999999988889999999999999999998 888987544
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=275.90 Aligned_cols=208 Identities=25% Similarity=0.393 Sum_probs=171.9
Q ss_pred HHHHHhhcccccccceEEEEEEeCC------CCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCe
Q 041878 534 DLLCATAEIMGKSTYGTAYKATLED------GSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGE 606 (773)
Q Consensus 534 ~l~~~~~~~lG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 606 (773)
...+.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++|+|++++++++. ....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-TGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-CCCC
Confidence 3345667899999999999998642 3679999986543 233457889999999999999999999984 4568
Q ss_pred EEEEEeecCCCCHHHHHhhcCC-------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEee
Q 041878 607 KLLVFDFMPKGSLASFLHARGP-------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIAD 679 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~D 679 (773)
.++||||+++|+|.+++..... ...+++..+..++.|++.|+.||| +.+|+||||||+||+++.++.+||+|
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA-AKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccChheEEEcCCCCEEECC
Confidence 9999999999999999976432 123688899999999999999999 99999999999999999999999999
Q ss_pred cCCccccccccc-cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 041878 680 FGLSRLMTAAAN-TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGM 743 (773)
Q Consensus 680 fG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~ 743 (773)
||+++....... .......++..|+|||.+....++.++|||||||++||++| |..||...+..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 228 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE 228 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH
Confidence 999876543322 11223346789999999988889999999999999999998 99998765433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=277.03 Aligned_cols=203 Identities=27% Similarity=0.456 Sum_probs=170.6
Q ss_pred HHhhcccccccceEEEEEEeC------CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
+...++||+|+||.||++... ++..+|+|.+.........++.+|++++++++|+||+++++++. ..+..++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv 85 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-EGRPLLMV 85 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-cCCceEEE
Confidence 345788999999999999632 35679999988766666778999999999999999999999984 45578999
Q ss_pred EeecCCCCHHHHHhhcCC------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEe
Q 041878 611 FDFMPKGSLASFLHARGP------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIA 678 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~ 678 (773)
|||+++++|.+++..... ...+++.+++.++.|++.|++||| +.|++||||||+||++++++.+||+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA-SLHFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH-HCCeecccccHhhEEEcCCCCEEEC
Confidence 999999999999986532 134788999999999999999999 9999999999999999999999999
Q ss_pred ecCCccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 679 DFGLSRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 679 DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
|||++.......... .....+++.|+|||...+..++.++|||||||++|||++ |+.||....
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 229 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS 229 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence 999987554322111 112235678999999988899999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=258.27 Aligned_cols=194 Identities=29% Similarity=0.501 Sum_probs=164.9
Q ss_pred hhcccccccceEEEEEEe-CCCCEEEEEEecccCc----cc----HHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEE
Q 041878 539 TAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTT----KG----QKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~----~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~ 608 (773)
..+.+|.|..++|.++.. ++|.+.|+|++..... +. .+.-..|+.+++++. ||+|+.+.++| ..+...+
T Consensus 21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-es~sF~F 99 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-ESDAFVF 99 (411)
T ss_pred hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-cCcchhh
Confidence 457899999999988865 4788999999853321 11 234456899999985 99999999999 5566899
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+|+|.|+.|.|.|++...- .++.....+|++|+.+|++||| .+.|||||+||+|||+|+++++||+|||.|..+.+
T Consensus 100 lVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylH-a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLH-ARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHH-HhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 9999999999999998753 3788889999999999999999 99999999999999999999999999999998765
Q ss_pred ccccceeeccCccccccccccC------CCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSK------LKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
... ....+|||+|+|||.+. ...|+..+|+||+||+||.++.|.+||.-
T Consensus 176 Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH 230 (411)
T KOG0599|consen 176 GEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH 230 (411)
T ss_pred chh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence 543 33567999999999764 34678899999999999999999999865
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=276.36 Aligned_cols=206 Identities=29% Similarity=0.484 Sum_probs=169.6
Q ss_pred HHhhcccccccceEEEEEEe-CCCC----EEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGS----EVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~----~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
+...++||+|+||+||+|.+ .+|+ .||+|.++.... ....++.+|+.+++.+.|+||+++++++.. ...+++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~l~ 86 (279)
T cd05109 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--STVQLV 86 (279)
T ss_pred eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--CCcEEE
Confidence 45568999999999999985 3454 489999875433 345678899999999999999999999853 357899
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
+||+++|+|.++++... ..+++..++.++.||+.||+||| +.+|+||||||+||++++++.+||+|||+++......
T Consensus 87 ~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH-~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~ 163 (279)
T cd05109 87 TQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLE-EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163 (279)
T ss_pred EEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence 99999999999997642 34789999999999999999999 9999999999999999999999999999998764332
Q ss_pred ccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCChHH
Q 041878 691 NTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQ 747 (773)
Q Consensus 691 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~~~ 747 (773)
... .....+++.|+|||...+..++.++|||||||++||+++ |..||......++.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 222 (279)
T cd05109 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD 222 (279)
T ss_pred ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 211 112235678999999988899999999999999999998 999987655433333
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=287.99 Aligned_cols=196 Identities=22% Similarity=0.295 Sum_probs=164.7
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCC-----CeEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-----GEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~~ 608 (773)
|...+.||+|+||.||++... .++.||||++.... ......+.+|+.+++.++||||+++++++.... ...+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 98 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY 98 (355)
T ss_pred eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence 456789999999999999864 68899999997542 233467788999999999999999999885432 2578
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||+++ ++.+.+.. .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 99 lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH-~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 99 LVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred EEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 99999964 67776654 2678888999999999999999 99999999999999999999999999999976533
Q ss_pred ccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. ......+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 172 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 172 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred cc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 1223458999999999998899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=278.13 Aligned_cols=199 Identities=24% Similarity=0.415 Sum_probs=171.9
Q ss_pred HHHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 536 LCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
+|...+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|+|++++++.+.. ....++||||+
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-~~~~~lv~e~~ 99 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYL 99 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-CCEEEEeeccc
Confidence 345668899999999999985 4688999999987666666788999999999999999999999854 55899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++++|.+++.+. .+++.++..++.|++.|+.||| +.||+||||||+||+++.++.++|+|||.+........ ..
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH-~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~ 173 (296)
T cd06654 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (296)
T ss_pred CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-cc
Confidence 999999998653 2688899999999999999999 99999999999999999999999999999876543221 12
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....+++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 23458889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=273.86 Aligned_cols=198 Identities=27% Similarity=0.414 Sum_probs=159.6
Q ss_pred ccccccceEEEEEEeCC---CCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 542 IMGKSTYGTAYKATLED---GSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 542 ~lG~G~fg~Vy~~~~~~---g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
.||+|+||.||+|...+ ...+|+|.+..... .....+.+|+..++.++|+||+++++.+. .....++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-ESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCceEEEEEeCCCC
Confidence 58999999999997543 34688888764432 33567889999999999999999999984 556899999999999
Q ss_pred CHHHHHhhcCC--CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc-ce
Q 041878 618 SLASFLHARGP--ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT-NV 694 (773)
Q Consensus 618 ~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~ 694 (773)
+|.+++..... ....++.....++.||+.|++||| +.+|+||||||+||++++++.+||+|||++......... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH-hcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 99999987532 223467788899999999999999 999999999999999999999999999998754332211 11
Q ss_pred eeccCccccccccccC-------CCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSK-------LKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~-------~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
....+++.|+|||+.. ...++.++|||||||++|||++ |..||....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 2234567899999863 3456889999999999999999 788887654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=270.45 Aligned_cols=192 Identities=22% Similarity=0.388 Sum_probs=159.6
Q ss_pred cccccccceEEEEEEeCC-------------CCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeE
Q 041878 541 EIMGKSTYGTAYKATLED-------------GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEK 607 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~-------------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 607 (773)
+.||+|+||.||+|...+ ...||+|.+..........+.+|+.++++++||||+++++++. .+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-RDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCCC
Confidence 468999999999998532 2258999987665555668889999999999999999999985 44578
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC-------eEEeec
Q 041878 608 LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN-------PRIADF 680 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~-------~kl~Df 680 (773)
++||||+++|+|..++.... ..+++..+..++.||+.|++||| +++|+||||||+|||++.++. ++++||
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLE-DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhh-hCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 99999999999999887643 34788999999999999999999 999999999999999987664 899999
Q ss_pred CCccccccccccceeeccCccccccccccC-CCCCCcchhhHHHHHHHHHHH-cCCCCCCCCC
Q 041878 681 GLSRLMTAAANTNVIATAGTLGYRAPELSK-LKNANTKTDVYSLGVIILELL-TGKSPGEPMN 741 (773)
Q Consensus 681 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~-tg~~P~~~~~ 741 (773)
|.+....... ...++..|+|||.+. ...++.++|||||||++|||+ +|+.||....
T Consensus 157 g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 157 GIPITVLSRQ-----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCCccccCcc-----cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9986543221 234778899999876 467899999999999999997 6888886543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=273.85 Aligned_cols=204 Identities=26% Similarity=0.427 Sum_probs=167.6
Q ss_pred HhhcccccccceEEEEEEeCC----CCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCC-----e
Q 041878 538 ATAEIMGKSTYGTAYKATLED----GSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG-----E 606 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~ 606 (773)
.+.+.||+|+||.||+|.... +..||+|.++... ......+.+|+..+++++|+||+++++++..... .
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 356789999999999998642 3679999987542 2334678999999999999999999998854332 3
Q ss_pred EEEEEeecCCCCHHHHHhhcC---CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCc
Q 041878 607 KLLVFDFMPKGSLASFLHARG---PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS 683 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a 683 (773)
.++|+||+++|+|.+++.... ....+++..+..++.|++.||+||| +.+++||||||+||++++++.+||+|||.+
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH-~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS-NRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH-hCCeeccccchheEEECCCCeEEECCccce
Confidence 689999999999999986542 2345889999999999999999999 899999999999999999999999999999
Q ss_pred cccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 684 RLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 684 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
+......... ......+..|+|||......++.++|||||||++|||++ |..||...+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN 221 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH
Confidence 8764433221 112234678999999988899999999999999999999 8899876543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=275.58 Aligned_cols=203 Identities=26% Similarity=0.422 Sum_probs=167.9
Q ss_pred HHhhcccccccceEEEEEEeC------CCCEEEEEEecccCcc-cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
+.+.+.||+|+||.||+|... ++..||+|+++..... ....+.+|+.++++++||||+++++++. ..+..++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-~~~~~~~ 85 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-KEQPLSM 85 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCCceEE
Confidence 566788999999999999853 2467999999755432 2456889999999999999999999994 4557899
Q ss_pred EEeecCCCCHHHHHhhcC-------------CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeE
Q 041878 610 VFDFMPKGSLASFLHARG-------------PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPR 676 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~k 676 (773)
++||+++++|.+++.... ....+++..+..++.|++.||+||| +.||+||||||+||++++++.+|
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH-~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS-SHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH-HcCccccccchhheEecCCCceE
Confidence 999999999999985321 1234788889999999999999999 99999999999999999999999
Q ss_pred EeecCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 677 IADFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 677 l~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
|+|||+++........ ......+++.|+|||.+....++.++||||+||++|||++ |..||.+..
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 231 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 231 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999998865433221 1122345779999999988889999999999999999998 888887644
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=275.75 Aligned_cols=205 Identities=25% Similarity=0.425 Sum_probs=170.4
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc-CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK-TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
+++.+.||+|+||.||++... ++..||+|.++.. ......++.+|+.++++++|+||+++++.+. ..+..++||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~e~~ 81 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-IEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-cCCeEEEEEeec
Confidence 466789999999999999875 7899999988754 2333567889999999999999999999884 456899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++++|.++++.......+++..+..++.|++.|+.|||++.+|+||||||+||+++.++.++|+|||.+........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--- 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA--- 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc---
Confidence 99999999876533345899999999999999999999446999999999999999999999999999876532211
Q ss_pred eeccCccccccccccCCC------CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCh
Q 041878 695 IATAGTLGYRAPELSKLK------NANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~ 745 (773)
....+++.|+|||.+.+. .++.++|||||||++|||++|+.||........
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 215 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI 215 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH
Confidence 123478899999987543 357899999999999999999999976544333
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=273.53 Aligned_cols=202 Identities=22% Similarity=0.401 Sum_probs=168.9
Q ss_pred HHHhhcccccccceEEEEEEeCC----CCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLED----GSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
.+...++||+|+||.||+|.+.+ ...||+|...... ....+.+.+|+.+++++.|+|++++++++.. +..++|
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~lv 84 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVWIV 84 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcEEE
Confidence 35567899999999999998643 2468999887654 3445689999999999999999999998843 367899
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||+++|+|.+++.+.. ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.++++|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH-~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLE-SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 99999999999997643 24789999999999999999999 9999999999999999999999999999987664432
Q ss_pred ccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 691 NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
........+++.|+|||.+....++.++||||||+++||+++ |..||.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 222222234568999999888889999999999999999986 9999976553
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=276.25 Aligned_cols=201 Identities=27% Similarity=0.391 Sum_probs=164.9
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc--cHHHHHHHHHHHHcc---CCCceEEeEEEEECC----CCe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK--GQKEFEAEAAAIGKI---HHPNLLALRAYYLGP----KGE 606 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~----~~~ 606 (773)
|.+.+.||+|+||+||+|... +++.||+|.++..... ....+.+|+++++++ +||||+++++++... ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 345678999999999999865 6889999998754322 234566777777665 699999999988542 235
Q ss_pred EEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 607 KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
.++||||++ ++|.+++.... ...+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 789999997 58999887653 234789999999999999999999 999999999999999999999999999998765
Q ss_pred ccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 687 TAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
..... .....+|+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~ 212 (288)
T cd07863 159 SCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212 (288)
T ss_pred cCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence 43221 1234578899999999888899999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=278.52 Aligned_cols=210 Identities=26% Similarity=0.425 Sum_probs=172.3
Q ss_pred cChhHHHHHhhcccccccceEEEEEEeC--------CCCEEEEEEecccC-cccHHHHHHHHHHHHcc-CCCceEEeEEE
Q 041878 530 FTADDLLCATAEIMGKSTYGTAYKATLE--------DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKI-HHPNLLALRAY 599 (773)
Q Consensus 530 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 599 (773)
+....-.+.+.+.||+|+||.||+|... ++..||+|.++... .....++.+|+.+++.+ +||||++++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 3444555677899999999999999741 24579999987543 33456789999999999 79999999999
Q ss_pred EECCCCeEEEEEeecCCCCHHHHHhhcCC-------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCC
Q 041878 600 YLGPKGEKLLVFDFMPKGSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSN 666 (773)
Q Consensus 600 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~N 666 (773)
+. .....++||||+++|+|.+++..... ...+++.++..++.||+.|++||| +.|++||||||+|
T Consensus 90 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH-~~givH~dlkp~N 167 (304)
T cd05101 90 CT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA-SQKCIHRDLAARN 167 (304)
T ss_pred Ee-cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH-HCCeeecccccce
Confidence 84 45588999999999999999986421 235788899999999999999999 9999999999999
Q ss_pred EEeCCCCCeEEeecCCccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 667 VLLDEKTNPRIADFGLSRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 667 Ill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
|+++.++.+||+|||.++......... .....+++.|+|||++.+..++.++||||||+++||+++ |..||...+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999998764332221 122345678999999988889999999999999999998 788886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=278.10 Aligned_cols=202 Identities=28% Similarity=0.482 Sum_probs=165.1
Q ss_pred HHhhcccccccceEEEEEEeCC-CC--EEEEEEecccC-cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLED-GS--EVAVKRLREKT-TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~-g~--~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
+.+.++||+|+||.||+|..++ +. .+|+|.++... ....+.+.+|+++++++ +||||+++++++ ...+..++|+
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-~~~~~~~lv~ 82 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-ENRGYLYIAI 82 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-ccCCcceEEE
Confidence 3456789999999999998753 33 47888887532 33456789999999999 799999999998 4455899999
Q ss_pred eecCCCCHHHHHhhcCC-------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEe
Q 041878 612 DFMPKGSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIA 678 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~ 678 (773)
||+++++|.+++++... ...+++..+..++.|++.|++||| +.||+||||||+||++++++.+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH-~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS-EKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCcCCcceEEECCCCeEEEC
Confidence 99999999999976421 134788899999999999999999 9999999999999999999999999
Q ss_pred ecCCccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 679 DFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 679 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
|||++........ ......+..|+|||......++.++|||||||++|||++ |..||.....
T Consensus 162 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 162 DFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred CcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999864322111 111123557999999988889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=278.08 Aligned_cols=199 Identities=22% Similarity=0.379 Sum_probs=169.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.+.||+|+||.||++... ++..+|+|.++.... ....++.+|++++++++||||+++++++. ..+..++||||+
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~ey~ 81 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-SDGEISICMEHM 81 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-eCCEEEEEeecc
Confidence 345688999999999999864 678899999875432 23456889999999999999999999995 456899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++++|.++++... .+++..+..++.|++.||.|||+..+++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--- 155 (308)
T cd06615 82 DGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--- 155 (308)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccccc---
Confidence 9999999998753 3788889999999999999999436999999999999999999999999999875533211
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
....+++.|+|||...+..++.++|||||||++|||++|+.||...+.
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 203 (308)
T cd06615 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA 203 (308)
T ss_pred ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch
Confidence 234578899999998888899999999999999999999999875443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=271.48 Aligned_cols=199 Identities=29% Similarity=0.386 Sum_probs=161.4
Q ss_pred cccccccceEEEEEEeCC---CCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 541 EIMGKSTYGTAYKATLED---GSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~---g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.++++++||||+++++++ ......++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC-TEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-cCCCCcEEEEECCCC
Confidence 358999999999998643 45799999875432 3445788999999999999999999998 445578999999999
Q ss_pred CCHHHHHhhcCC--CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc-
Q 041878 617 GSLASFLHARGP--ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN- 693 (773)
Q Consensus 617 g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~- 693 (773)
|+|.++++.... ....++..+..++.|++.|++||| +.+++||||||+||+++.++.+|++|||.+..........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH-HCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999976432 224567788889999999999999 9999999999999999999999999999987543322111
Q ss_pred eeeccCccccccccccCCC-------CCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLK-------NANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~-------~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
.....++..|+|||++... .++.++||||||+++|||++ |+.||....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 214 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS 214 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 1123467889999987532 35789999999999999996 999997644
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=274.72 Aligned_cols=200 Identities=24% Similarity=0.448 Sum_probs=168.0
Q ss_pred HHHhhcccccccceEEEEEEe-----CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECC-CCeEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATL-----EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-KGEKLL 609 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~l 609 (773)
.+.+.+.||+|+||+||++.. .++..||+|.+........+.+.+|++++++++||||+++++++... ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 455678999999999999974 35789999999776666677899999999999999999999987543 346889
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
|+||+++++|.+++.+.. ..+++..+..++.|++.||+||| +.||+||||||+||++++++.+||+|||++......
T Consensus 85 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH-~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLG-SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred EEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 999999999999997643 24789999999999999999999 999999999999999999999999999999876443
Q ss_pred ccccee--eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 041878 690 ANTNVI--ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGE 738 (773)
Q Consensus 690 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~ 738 (773)
...... ...++..|+|||...+..++.++|||||||++|||++|..|+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 222111 1123446999999988889999999999999999999877754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=286.22 Aligned_cols=197 Identities=28% Similarity=0.440 Sum_probs=168.0
Q ss_pred ccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCCHH
Q 041878 542 IMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLA 620 (773)
Q Consensus 542 ~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~L~ 620 (773)
+||+|.||+||-|++. +...+|||-+.+........+.+||...+.++|+|||+++|.+ ..++..-+.||.+|||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-SENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-CCCCeEEEEeecCCCCcHH
Confidence 6999999999999865 4567999999888777788899999999999999999999998 6666888999999999999
Q ss_pred HHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-CCCeEEeecCCccccccccccceeeccC
Q 041878 621 SFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE-KTNPRIADFGLSRLMTAAANTNVIATAG 699 (773)
Q Consensus 621 ~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~g 699 (773)
+.++..-..-.-...+.-.+.+||++||.||| +..|||||||-+||||+. .|.+||+|||-++.+..-.. -+-..-|
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH-en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETFTG 738 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH-ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETFTG 738 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhh-hcceeeccccCCcEEEeeccceEEecccccchhhccCCc-ccccccc
Confidence 99987632222356677788999999999999 999999999999999974 57899999999887653322 2234459
Q ss_pred ccccccccccCCC--CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 700 TLGYRAPELSKLK--NANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 700 t~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
|..|||||++..+ .|+.++|||||||++.||.||++||....
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg 782 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG 782 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence 9999999998654 58899999999999999999999997643
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.78 Aligned_cols=205 Identities=22% Similarity=0.374 Sum_probs=167.3
Q ss_pred HHHHhhcccccccceEEEEEEeC------CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeE
Q 041878 535 LLCATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEK 607 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 607 (773)
-+|.+.++||+|+||.||+|..+ .+..||+|.+..... ....++.+|+.++++++|+||+++++++. ..+..
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~ 84 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS-KGQPT 84 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCCc
Confidence 35667889999999999999643 245799999864432 23456788999999999999999999984 44588
Q ss_pred EEEEeecCCCCHHHHHhhcCC-------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeec
Q 041878 608 LLVFDFMPKGSLASFLHARGP-------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADF 680 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~Df 680 (773)
++||||+++|+|.++++.... ....++.....++.|++.|+.||| +++|+||||||+||++++++.++++||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dikp~nili~~~~~~~L~Df 163 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN-AKKFVHRDLAARNCMVAHDFTVKIGDF 163 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcCCCCChheEEEcCCCcEEECcC
Confidence 999999999999999976421 123466788899999999999999 999999999999999999999999999
Q ss_pred CCccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 681 GLSRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 681 G~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
|+++......... .....++..|+|||...+..++.++|||||||++|||++ |..||....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~ 226 (288)
T cd05061 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226 (288)
T ss_pred CccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9987654322211 112235678999999988899999999999999999998 788986644
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=278.95 Aligned_cols=205 Identities=28% Similarity=0.423 Sum_probs=168.9
Q ss_pred HHHHhhcccccccceEEEEEEeC--------CCCEEEEEEecccC-cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCC
Q 041878 535 LLCATAEIMGKSTYGTAYKATLE--------DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPK 604 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 604 (773)
-.+.+.+.||+|+||.||+|... ++..+|+|.++... .....++.+|+++++++ +|+||+++++++. ..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-QD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-cC
Confidence 45677899999999999999752 23569999997543 33456788899999999 7999999999994 45
Q ss_pred CeEEEEEeecCCCCHHHHHhhcCC-------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC
Q 041878 605 GEKLLVFDFMPKGSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE 671 (773)
Q Consensus 605 ~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~ 671 (773)
+..++||||+++|+|.+++....+ ...+++.+++.++.|++.||+||| +.|++||||||+||+++.
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH-~~gi~H~dlkp~Nill~~ 175 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTE 175 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH-HCCcccccccHHheEEcC
Confidence 589999999999999999986532 234789999999999999999999 999999999999999999
Q ss_pred CCCeEEeecCCccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 672 KTNPRIADFGLSRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 672 ~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
++.+||+|||.++......... .....+++.|+|||...+..++.++|||||||++|||++ |..||...+
T Consensus 176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 9999999999987654322111 112224568999999988889999999999999999998 888986544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=272.03 Aligned_cols=200 Identities=24% Similarity=0.386 Sum_probs=169.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.+.||+|+||.||+|... ++..+|+|.+........+.+.+|+++++.++|+|++++++++.. .+..++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-CCEEEEEEEecC
Confidence 567788999999999999865 577889999876655556788999999999999999999999854 458999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|.+++.+.. ..+++..+..++.|++.||.||| +.|++||||||+||+++.++.+|++|||++....... ....
T Consensus 86 ~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH-~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 161 (282)
T cd06643 86 GGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLH-ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD 161 (282)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence 999999886532 34789999999999999999999 9999999999999999999999999999987543221 1222
Q ss_pred eccCccccccccccC-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSK-----LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...+++.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 345889999999873 4557889999999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=271.19 Aligned_cols=200 Identities=25% Similarity=0.399 Sum_probs=170.7
Q ss_pred HHHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 536 LCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.|.+.+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++|||++++++.+. ..+..++|+||+
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-~~~~~~lv~e~~ 88 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-RRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-eCCEEEEEEecc
Confidence 467778999999999999986 468899999997665555567889999999999999999999985 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++++|.+++.... .++..+...++.|++.|+.||| +.|++|+||||+||+++.++.++|+|||.+....... ...
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 163 (267)
T cd06645 89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLH-SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKR 163 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-ccc
Confidence 9999999987653 3788999999999999999999 9999999999999999999999999999987654322 112
Q ss_pred eeccCccccccccccC---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSK---LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....|++.|+|||.+. ...++.++||||+||++|||++|+.||....
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 2346899999999874 4568889999999999999999999986543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=268.89 Aligned_cols=197 Identities=30% Similarity=0.502 Sum_probs=165.5
Q ss_pred cccccccceEEEEEEeC--C--CCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE--D--GSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~--~--g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
++||+|+||.||+|.+. + +..||+|.+..... ...+++.+|+++++++.|+|++++++++. ....++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEeCC
Confidence 46999999999999753 2 26899999975543 34567899999999999999999999873 336899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.... .+++..+..++.|++.|++||| +.+++||||||+||+++.++.+||+|||.++...........
T Consensus 79 ~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh-~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 79 LGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLE-SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHh-hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 999999998754 4789999999999999999999 999999999999999999999999999998866433322111
Q ss_pred --eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 041878 696 --ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGM 743 (773)
Q Consensus 696 --~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~ 743 (773)
...++..|+|||......++.++|||||||++|||++ |..||...+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~ 205 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA 205 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 1123467999999988899999999999999999998 99999765543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=269.70 Aligned_cols=200 Identities=31% Similarity=0.531 Sum_probs=171.7
Q ss_pred cccccccceEEEEEEeCC----CCEEEEEEecccCccc-HHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLED----GSEVAVKRLREKTTKG-QKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
++||+|+||.||+|.... +..||+|.++...... .+++.+|++.+++++|+|++++++++.. ....++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence 469999999999998653 7889999998654433 6788999999999999999999999954 668999999999
Q ss_pred CCCHHHHHhhcCC------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 616 KGSLASFLHARGP------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 616 ~g~L~~~l~~~~~------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
+++|.++++.... ...+++..+..++.|++.|++||| +.+++||||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA-SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH-cCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999987521 245899999999999999999999 999999999999999999999999999999876543
Q ss_pred cc-cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 690 AN-TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 690 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
.. .......+++.|+|||......++.++||||+|+++|||++ |..||.....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 31 11223457889999999888889999999999999999999 6999987643
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=275.55 Aligned_cols=199 Identities=24% Similarity=0.408 Sum_probs=172.6
Q ss_pred HHHHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 535 LLCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
..|.+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++|+|++++++++. ..+..++||||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~lv~e~ 97 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-VGDELWVVMEY 97 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEeecc
Confidence 3456778999999999999985 578999999997665555677889999999999999999999994 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++++|.+++.+. .+++.++..++.|++.|+.||| +.|++||||||+||+++.++.++|+|||.+.........
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH-~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~- 171 (297)
T cd06656 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLH-SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 171 (297)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-
Confidence 9999999998653 3688899999999999999999 999999999999999999999999999998765433221
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
.....+++.|+|||...+..++.++|||||||++|++++|+.||...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~ 218 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 12335788999999998888999999999999999999999999653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=278.27 Aligned_cols=197 Identities=27% Similarity=0.429 Sum_probs=160.4
Q ss_pred hcccccccceEEEEEEeC---CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECC-CCeEEEEEeecC
Q 041878 540 AEIMGKSTYGTAYKATLE---DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-KGEKLLVFDFMP 615 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV~e~~~ 615 (773)
+.+||+|+||.||+|... ++..||+|.+.... ....+.+|++++++++||||+++++++... ....++|+||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 467999999999999864 45789999986443 235678899999999999999999988543 446789999996
Q ss_pred CCCHHHHHhhcC------CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe----CCCCCeEEeecCCccc
Q 041878 616 KGSLASFLHARG------PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL----DEKTNPRIADFGLSRL 685 (773)
Q Consensus 616 ~g~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll----~~~~~~kl~DfG~a~~ 685 (773)
++|.+++.... ....+++..+..++.||+.||.||| +.+|+||||||+||++ +.++.+||+|||+++.
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH-hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 58888775321 1234788899999999999999999 9999999999999999 5667899999999987
Q ss_pred ccccccc--ceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 686 MTAAANT--NVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 686 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
....... ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 6443221 1223457899999998865 45789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=271.63 Aligned_cols=197 Identities=25% Similarity=0.404 Sum_probs=165.6
Q ss_pred HhhcccccccceEEEEEEe-----CCCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCC-CeEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATL-----EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-GEKLLV 610 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~lV 610 (773)
...+.||+|+||+||++.. .+++.||+|.++.... .....+.+|++++++++||||+++++++.... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5568899999999988653 3578899999975533 34567889999999999999999999885543 367899
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||+++++|.+++... .+++.++..++.|++.|+.||| +.+|+||||||+||++++++.++|+|||+++......
T Consensus 87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH-~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLH-SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHH-HCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 9999999999999764 2799999999999999999999 9999999999999999999999999999988664332
Q ss_pred ccce--eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 691 NTNV--IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 691 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
.... ....++..|+|||......++.++||||||+++|||+||+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 2111 112345679999999888899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=270.78 Aligned_cols=197 Identities=28% Similarity=0.483 Sum_probs=161.6
Q ss_pred cccccccceEEEEEEeC----CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE----DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++.++|||++++++++...++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 23579999986433 33456788999999999999999999988666667899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc---
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT--- 692 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~--- 692 (773)
+|+|.+++.+.. ...++..+..++.||+.|+.||| +.+++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLA-SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 999999997653 23577788899999999999999 899999999999999999999999999998765432211
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcC-CCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTG-KSPGEPM 740 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg-~~P~~~~ 740 (773)
......+++.|+|||......++.++|||||||++|||++| ..||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 206 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 206 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 11122356789999999888899999999999999999995 5566543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=277.75 Aligned_cols=208 Identities=27% Similarity=0.422 Sum_probs=170.0
Q ss_pred hHHHHHhhcccccccceEEEEEEeC--------CCCEEEEEEecccC-cccHHHHHHHHHHHHcc-CCCceEEeEEEEEC
Q 041878 533 DDLLCATAEIMGKSTYGTAYKATLE--------DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLG 602 (773)
Q Consensus 533 ~~l~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 602 (773)
...++.+.++||+|+||.||+|... ....||+|.++... .....++..|+++++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 88 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT- 88 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc-
Confidence 3445667899999999999999742 24568999987543 23456788999999999 6999999999984
Q ss_pred CCCeEEEEEeecCCCCHHHHHhhcCC-------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe
Q 041878 603 PKGEKLLVFDFMPKGSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL 669 (773)
Q Consensus 603 ~~~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll 669 (773)
..+..++||||+++|+|.+++..... ...+++.++.+++.|++.|+.||| +.|++||||||+||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH-~~gi~H~dlkp~Nill 167 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE-SRRCIHRDLAARNVLV 167 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH-HCCeeeccccceeEEE
Confidence 45588999999999999999976421 235889999999999999999999 9999999999999999
Q ss_pred CCCCCeEEeecCCccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 670 DEKTNPRIADFGLSRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 670 ~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
+.++.+||+|||.++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...+.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999998654322111 112224567999999988889999999999999999999 8899876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=277.96 Aligned_cols=202 Identities=28% Similarity=0.509 Sum_probs=165.9
Q ss_pred HHhhcccccccceEEEEEEeC-CCC--EEEEEEecccC-cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGS--EVAVKRLREKT-TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~--~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
+.+.+.||+|+||.||+|.+. ++. .+|+|.++... .....++.+|++++.++ +|+||+++++++ ...+..++||
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-~~~~~~~lv~ 87 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-EHRGYLYLAI 87 (303)
T ss_pred ceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-CCCCCceEEE
Confidence 355688999999999999864 454 45788776433 23456788999999999 899999999998 5556899999
Q ss_pred eecCCCCHHHHHhhcCC-------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEe
Q 041878 612 DFMPKGSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIA 678 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~ 678 (773)
||+++++|.+++++... ...+++.+++.++.|++.|++||| +.|++||||||+||+++.++.+||+
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH-hCCccccccchheEEecCCCcEEeC
Confidence 99999999999976531 124788999999999999999999 9999999999999999999999999
Q ss_pred ecCCccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 679 DFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 679 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
|||++....... .......+..|+|||.+....++.++|||||||++|||+| |..||...+.
T Consensus 167 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 229 (303)
T cd05088 167 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 229 (303)
T ss_pred ccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh
Confidence 999986432111 1112234668999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=272.31 Aligned_cols=201 Identities=24% Similarity=0.398 Sum_probs=171.7
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.|.+.+.||+|+||.||+|... ++..||+|.++.......+.+..|++++++++|+|++++++++. .+...++||||+
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~ 84 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-YENKLWILIEFC 84 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-cCCeEEEEeecc
Confidence 3677888999999999999864 68899999997666556678999999999999999999999985 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++++|.+++.... ..+++..+..++.|++.|+.||| +.+|+||||+|+||+++.++.++|+|||.+........ ..
T Consensus 85 ~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh-~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~ 160 (280)
T cd06611 85 DGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLH-SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-KR 160 (280)
T ss_pred CCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-cc
Confidence 9999999987653 34788999999999999999999 99999999999999999999999999998765433221 12
Q ss_pred eeccCccccccccccC-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSK-----LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||...+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC
Confidence 2345888999999864 3457789999999999999999999997654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=275.62 Aligned_cols=203 Identities=29% Similarity=0.427 Sum_probs=167.5
Q ss_pred HhhcccccccceEEEEEEeC------CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
.+.+.||+|+||.||+|... ....+|+|.+..... ....++.+|+.++++++||||+++++.+. ..+..++|
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv 81 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-QDGPLLLI 81 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-cCCCcEEE
Confidence 45688999999999999753 235688998875432 33567889999999999999999999984 55588999
Q ss_pred EeecCCCCHHHHHhhcC---------------------CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe
Q 041878 611 FDFMPKGSLASFLHARG---------------------PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL 669 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll 669 (773)
+||+++++|.+++.... ....+++.++..++.|++.|++||| +.+++||||||+||++
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~ivH~dikp~nill 160 (290)
T cd05045 82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA-EMKLVHRDLAARNVLV 160 (290)
T ss_pred EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH-HCCeehhhhhhheEEE
Confidence 99999999999986531 1234788999999999999999999 9999999999999999
Q ss_pred CCCCCeEEeecCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 670 DEKTNPRIADFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 670 ~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+...
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999998765433221 1122345678999999888889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=270.45 Aligned_cols=199 Identities=24% Similarity=0.423 Sum_probs=166.6
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC-----cccHHHHHHHHHHHHccCCCceEEeEEEEECCC-CeEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-----TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-GEKLLV 610 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~lV 610 (773)
.+.++||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+||+++++++.... ...++|
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 45688999999999999864 58999999885321 122357888999999999999999999875443 467899
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||+++++|.+++.+.. .++......++.|++.||+||| +.+++|+||||+||+++.++.++|+|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 85 MEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLH-SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 99999999999997653 3678888999999999999999 9999999999999999999999999999987654321
Q ss_pred c--cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 691 N--TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 691 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
. .......++..|+|||...+..++.++|||||||++||+++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 1 1122335788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=271.80 Aligned_cols=203 Identities=25% Similarity=0.485 Sum_probs=169.0
Q ss_pred HHhhcccccccceEEEEEEeC-C---CCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-D---GSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~---g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
+.+.+.||+|+||.||+|... + +..+|+|.++... ....+.+.+|+.++++++||||+++++++. ..+..++||
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~ 84 (267)
T cd05066 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-KSKPVMIVT 84 (267)
T ss_pred eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCccEEEE
Confidence 456789999999999999853 2 3379999987543 334568899999999999999999999984 556899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++++|.+++.... ..+++.++..++.|++.|+.||| +.+++||||||+||+++.++.++++|||.+........
T Consensus 85 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH-~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd05066 85 EYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 161 (267)
T ss_pred EcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence 9999999999998653 34788999999999999999999 99999999999999999999999999999987654322
Q ss_pred ccee--eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 041878 692 TNVI--ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGM 743 (773)
Q Consensus 692 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~ 743 (773)
.... ...++..|+|||.+....++.++||||||+++||+++ |+.||......
T Consensus 162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~ 216 (267)
T cd05066 162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216 (267)
T ss_pred eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence 1111 1123568999999998889999999999999999886 99999765543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=272.48 Aligned_cols=205 Identities=27% Similarity=0.526 Sum_probs=168.8
Q ss_pred HHhhcccccccceEEEEEEeC-CC---CEEEEEEeccc-CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DG---SEVAVKRLREK-TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g---~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
+.+.+.||+|+||.||+|... ++ ..||||.++.. ......+|..|+.++++++||||+++++++ ...+..++||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-~~~~~~~lv~ 84 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-TKSRPVMIIT 84 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-CCCCceEEEE
Confidence 346788999999999999864 33 36999999754 333456899999999999999999999998 4556889999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++++|.+++.... ..+++.+++.++.|++.|+.||| +.|++||||||+||+++.++.+|++|||.+........
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH-~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLS-EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 9999999999997653 34789999999999999999999 99999999999999999999999999999876543222
Q ss_pred cce-e-ecc--CccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCh
Q 041878 692 TNV-I-ATA--GTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDL 745 (773)
Q Consensus 692 ~~~-~-~~~--gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~ 745 (773)
... . ... .+..|+|||.+....++.++|||||||++||+++ |..||...+..+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~ 220 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 220 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH
Confidence 111 1 111 2457999999998899999999999999999886 9999976554333
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=272.97 Aligned_cols=204 Identities=26% Similarity=0.423 Sum_probs=167.5
Q ss_pred HHhhcccccccceEEEEEEeCC------CCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLED------GSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
+.+.+.||+|+||.||+|.+.+ +..||+|....... .....+..|+.++++++|+||+++++++. ..+..++
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~l 86 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF-ERLPRFI 86 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-cCCCcEE
Confidence 4567889999999999998653 56789998865433 33567899999999999999999999884 4457899
Q ss_pred EEeecCCCCHHHHHhhcCC----CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC---CeEEeecCC
Q 041878 610 VFDFMPKGSLASFLHARGP----ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT---NPRIADFGL 682 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~---~~kl~DfG~ 682 (773)
||||+++++|.+++.+... ...+++.++..++.||+.|++||| +.+++||||||+||+++.++ .+|++|||+
T Consensus 87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE-ENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccchheEEEeccCCCcceEeccCcc
Confidence 9999999999999987532 235889999999999999999999 89999999999999998765 589999999
Q ss_pred ccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 683 SRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 683 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||...+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~ 227 (277)
T cd05036 166 ARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227 (277)
T ss_pred ccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 98763322111 112223568999999988899999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=273.88 Aligned_cols=196 Identities=32% Similarity=0.533 Sum_probs=168.5
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHH--HHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQK--EFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
..+.||+|+||+||++... +++.||+|.+......... ...+|+.++++++|+||+++++++.. ....++||||++
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~~~ 81 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEEET
T ss_pred EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-cccccccccccc
Confidence 4688999999999999875 5668999999876544332 34569999999999999999999954 558899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|.+++... ..+++..+..++.|+++||.||| +.+++||||||+||++++++.++|+|||.+... ........
T Consensus 82 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh-~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~~ 156 (260)
T PF00069_consen 82 GGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLH-SKGIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENFN 156 (260)
T ss_dssp TEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHH-HTTEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEBS
T ss_pred ccccccccccc---ccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccc-cccccccc
Confidence 99999999843 33789999999999999999999 899999999999999999999999999998754 11222333
Q ss_pred eccCccccccccccC-CCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSK-LKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
...+++.|+|||... ...++.++||||+|+++|+|++|+.||...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 456899999999988 888999999999999999999999999876
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=268.90 Aligned_cols=200 Identities=27% Similarity=0.514 Sum_probs=169.5
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+++.+.||+|+||.||+|.+.++..+|+|.+..... ...++.+|++++++++|||++++++++ ......++||||+++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~~v~e~~~~ 83 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVC-TERSPICLVFEFMEH 83 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEE-ccCCceEEEEEcCCC
Confidence 345688999999999999887788999999864432 356789999999999999999999998 455588999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.+++.... ..+++..+..++.|++.|++||| +.+++||||||+||+++.++.++|+|||.+.............
T Consensus 84 ~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH-~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 84 GCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLE-SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred CcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH-HCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 99999997643 23788999999999999999999 9999999999999999999999999999987654332221222
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
..++.+|+|||...+..++.++||||||+++|||++ |+.||....
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 235678999999988889999999999999999998 999987544
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=280.73 Aligned_cols=204 Identities=26% Similarity=0.428 Sum_probs=174.0
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcc--cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTK--GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|.+...||+|.|+.|.+|.. .++..||+|.+++..-. ....+.+|+++|+.++|||||+++.+.. .+...|+||||
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~-t~~~lylV~ey 136 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE-TEATLYLVMEY 136 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee-ecceeEEEEEe
Confidence 34568899999999999985 47999999999765322 2345889999999999999999999994 45599999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+.+|.+++++.+++.. ....+..+..|+++|++|+| ++.|||||||++|||++.++++||+|||++..+.... .
T Consensus 137 a~~ge~~~yl~~~gr~---~e~~ar~~F~q~vsaveYcH-~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~--~ 210 (596)
T KOG0586|consen 137 ASGGELFDYLVKHGRM---KEKEARAKFRQIVSAVEYCH-SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL--M 210 (596)
T ss_pred ccCchhHHHHHhcccc---hhhhhhhhhHHHHHHHHHHh-hcceeccccchhhcccccccceeeeccccceeecccc--c
Confidence 9999999999998653 33667788999999999999 9999999999999999999999999999998876332 2
Q ss_pred eeeccCccccccccccCCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCChHH
Q 041878 694 VIATAGTLGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQ 747 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~ 747 (773)
....+|++.|.|||++.+..| ++.+|+||+|+++|-++.|.+||++.+-.++.+
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~ 265 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP 265 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc
Confidence 334679999999999987776 679999999999999999999999866555433
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=271.92 Aligned_cols=200 Identities=24% Similarity=0.391 Sum_probs=169.7
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|++.++||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++|+|++++++.+. ..+..++||||++
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~ 92 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-WDGKLWIMIEFCP 92 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-eCCeEEEEEecCC
Confidence 567788999999999999865 58899999998766666778899999999999999999999985 4458999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|..++.+.. ..+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||.+....... ....
T Consensus 93 ~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~ 168 (292)
T cd06644 93 GGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLH-SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRRD 168 (292)
T ss_pred CCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh-cCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-cccc
Confidence 999998876543 34789999999999999999999 8999999999999999999999999999887543221 1122
Q ss_pred eccCccccccccccC-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSK-----LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...+++.|+|||.+. ...++.++|||||||++|||++|+.||...+
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 345788999999874 3457889999999999999999999987643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=269.89 Aligned_cols=201 Identities=20% Similarity=0.369 Sum_probs=169.1
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.++||+|+||.||+|... +++.||||.+.... .....++.+|++++++++|||++++++++.. .+..++|+|
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 82 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-DNELNIVLE 82 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-CCeEEEEEE
Confidence 345688999999999999864 78999999886432 2334578899999999999999999999854 458899999
Q ss_pred ecCCCCHHHHHhhcCC-CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 613 FMPKGSLASFLHARGP-ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
|+++|+|.+++..... ...++...+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH-SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh-hCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 9999999998865322 344788899999999999999999 99999999999999999999999999999876543321
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
. .....+++.|+|||...+..++.++||||||+++|||++|+.||...
T Consensus 162 ~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 162 A-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred H-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 1 12235788999999998888999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=300.59 Aligned_cols=211 Identities=23% Similarity=0.299 Sum_probs=183.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.++||+|+||.|..++.+ +++.||+|++.+. ...+...|..|-.+|.--+.+=|+.++-.|. ++.+.|+|||
T Consensus 77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ-D~~~LYlVMd 155 (1317)
T KOG0612|consen 77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ-DERYLYLVMD 155 (1317)
T ss_pred hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc-CccceEEEEe
Confidence 567899999999999999864 6888999999874 2334567889999999888888999988884 4459999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
||+||+|..++.... .++..-+..++..|+-||.-+| +.|+|||||||+|||+|..|++|++|||.|-.+..++..
T Consensus 156 Y~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH-~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 156 YMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLH-SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred cccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHH-hccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 999999999999875 4777778889999999999999 999999999999999999999999999999999888777
Q ss_pred ceeeccCccccccccccC----C-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHh
Q 041878 693 NVIATAGTLGYRAPELSK----L-KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKE 755 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 755 (773)
.....+|||.|++||++. + +.|++.+|-||+||++|||+.|..||.... +.+...+||..
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads---lveTY~KIm~h 296 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS---LVETYGKIMNH 296 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH---HHHHHHHHhch
Confidence 777889999999999763 2 679999999999999999999999997644 56666677655
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=270.76 Aligned_cols=197 Identities=29% Similarity=0.529 Sum_probs=162.2
Q ss_pred cccccccceEEEEEEeC-CCC--EEEEEEecccC-cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE-DGS--EVAVKRLREKT-TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~--~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
++||+|+||.||+|.+. ++. .+|+|.++... ......+.+|+++++++ +||||+++++++. ..+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-HRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-cCCCceEEEEeCC
Confidence 46899999999999875 343 46888887543 33456788999999999 7999999999994 4557899999999
Q ss_pred CCCHHHHHhhcCC-------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCC
Q 041878 616 KGSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGL 682 (773)
Q Consensus 616 ~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~ 682 (773)
+|+|.+++..... ...+++.++..++.|++.|++||| +.|++||||||+||++++++.+|++|||+
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH-~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999976421 234788999999999999999999 99999999999999999999999999999
Q ss_pred ccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 683 SRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 683 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
+....... .......+..|+|||++....++.++|||||||++|||++ |..||...+
T Consensus 159 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 216 (270)
T cd05047 159 SRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216 (270)
T ss_pred ccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence 86322111 1111224567999999988889999999999999999997 999996544
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=276.12 Aligned_cols=205 Identities=29% Similarity=0.441 Sum_probs=170.1
Q ss_pred HHHHhhcccccccceEEEEEEeC------CCCEEEEEEecccC-cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCe
Q 041878 535 LLCATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGE 606 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 606 (773)
-.+.+.+.||+|+||.||++... ....+|+|.+.... .....++.+|+++++++ +|+||+++++++ ...+.
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-~~~~~ 90 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC-TQEGP 90 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-cCCCC
Confidence 34567789999999999999853 23579999987542 23445788999999999 799999999998 45558
Q ss_pred EEEEEeecCCCCHHHHHhhcC-------------CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC
Q 041878 607 KLLVFDFMPKGSLASFLHARG-------------PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT 673 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~ 673 (773)
.++||||+++|+|.+++++.. ....+++..++.++.|++.|++||| +.+|+||||||+||+++.++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA-SKKCIHRDLAARNVLVTEDH 169 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH-HCCccccccceeeEEEcCCC
Confidence 999999999999999997542 2345889999999999999999999 99999999999999999999
Q ss_pred CeEEeecCCccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 674 NPRIADFGLSRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 674 ~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
.+|++|||.++......... .....++..|+|||......++.++|||||||++||+++ |..||....
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 99999999998765432211 112234668999999988899999999999999999997 999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=271.26 Aligned_cols=198 Identities=26% Similarity=0.425 Sum_probs=171.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|...+.||.|++|.||+|... +++.||+|.+.... ......+.+|++++++++|+|++++++++... ...++|+||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~ 81 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-SKLWIIMEYC 81 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-CeEEEEEEee
Confidence 456688999999999999865 68899999987543 33456788999999999999999999998544 5899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++++|.+++... .+++..+..++.|++.|+.||| +.+++||||+|+||++++++.++++|||+++....... ..
T Consensus 82 ~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh-~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (274)
T cd06609 82 GGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH-EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KR 155 (274)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-cc
Confidence 999999998864 4789999999999999999999 99999999999999999999999999999987654322 22
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....+++.|+|||...+..++.++|||||||++|||+||+.||...+
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 23457889999999988889999999999999999999999997544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=287.49 Aligned_cols=319 Identities=30% Similarity=0.412 Sum_probs=254.7
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccC-CCCCCCCCCCCCCCEEE
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLS-GSIPPSIGNCPNLQTLD 169 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~ 169 (773)
.+++-|.|....+. .+|+.++.|.+|++|.+++|++. .+...+..|+.|+.+++..|++. .-||+.+.++..|+.||
T Consensus 32 t~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lD 109 (1255)
T KOG0444|consen 32 TQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILD 109 (1255)
T ss_pred hheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeee
Confidence 46777777776665 78888999999999999999887 45667888888888888888876 34788888888899999
Q ss_pred ccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccc
Q 041878 170 LSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDH 249 (773)
Q Consensus 170 Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~ 249 (773)
||+|++. ..|..+...+++..|+||+|+|..+....+.++..|-.|||++|++. .+|+.+..+. .|++|.|++
T Consensus 110 LShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~-----~LqtL~Ls~ 182 (1255)
T KOG0444|consen 110 LSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLS-----MLQTLKLSN 182 (1255)
T ss_pred cchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHh-----hhhhhhcCC
Confidence 9999887 77888888888888888888888443444568888888888888887 5555554443 456666666
Q ss_pred cccc-------------------------cccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccC
Q 041878 250 NLIA-------------------------GTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSF 304 (773)
Q Consensus 250 n~l~-------------------------~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 304 (773)
|.+. ..+|.++..+.+|..+|+|.|++. .+|+.+.++.+|+.|+||+|+|+ .+
T Consensus 183 NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL 260 (1255)
T KOG0444|consen 183 NPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-EL 260 (1255)
T ss_pred ChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-ee
Confidence 6442 356777888888999999999998 78999999999999999999998 56
Q ss_pred cccccccccCceEEccCCCCCCCcchhhccccccccccccCccccc-ccccccCCCCcCceeecCCccCccCCCchhhcc
Q 041878 305 PVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKG-HIPETIGNISGINQLDLSENDFTGEISPSLASL 383 (773)
Q Consensus 305 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 383 (773)
....+...+|++|+||.|+++ .+|..++++++|+.|.+.+|+++- -+|+.++++.+|+.+..++|.+. .+|..++.+
T Consensus 261 ~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC 338 (1255)
T KOG0444|consen 261 NMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRC 338 (1255)
T ss_pred eccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhh
Confidence 666777788999999999994 789999999999999999999873 48999999999999999999988 889999999
Q ss_pred CccCEEEeecccCCCCCchhh--hccCCCCCCCCCCCCCCCC
Q 041878 384 ANLTSFNVSYNNLSGSVPPLL--SKKFNSSSFVGNLQLCGYS 423 (773)
Q Consensus 384 ~~L~~L~ls~N~l~g~~p~~~--~~~~~~~~~~~n~~~c~~~ 423 (773)
..|+.|.|+.|+|- .+|..+ ...+....+-.|+.+--+|
T Consensus 339 ~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 339 VKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred HHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 99999999999986 356543 2334445566777775444
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=269.42 Aligned_cols=199 Identities=26% Similarity=0.454 Sum_probs=169.3
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccCc------ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTT------KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
.+.+.||+|+||.||+|...+++.+|+|.++.... .....+.+|++++++++|+||+++++++.. .+..++|+
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~ 81 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-DNTISIFM 81 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-CCeEEEEE
Confidence 45688999999999999988899999999864321 123568899999999999999999999954 56899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc-
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA- 690 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~- 690 (773)
||+++++|.+++.+.. .+++..+..++.|++.|++||| +.+|+|+||+|+||++++++.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 82 EFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLH-NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 9999999999997653 3688888999999999999999 9999999999999999999999999999987653211
Q ss_pred ----ccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 691 ----NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 691 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
........++..|+|||...+..++.++||||+||++||+++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 111123357889999999998889999999999999999999999997644
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=272.47 Aligned_cols=207 Identities=29% Similarity=0.499 Sum_probs=171.6
Q ss_pred HHHHhhcccccccceEEEEEEeC-CCC----EEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 535 LLCATAEIMGKSTYGTAYKATLE-DGS----EVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
..+.+.+.||+|+||.||+|... +|. .||+|....... ....++.+|+..+++++|+|++++++++.. +..+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceE
Confidence 34566789999999999999864 333 589998875543 345678899999999999999999999965 5889
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+|+||+++|+|.+++.... ..+++..+..++.||+.|++||| +.+++||||||+||+++.++.+||+|||.++....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH-~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLE-EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH-hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999998753 23789999999999999999999 89999999999999999999999999999987653
Q ss_pred ccccce-eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCChH
Q 041878 689 AANTNV-IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLP 746 (773)
Q Consensus 689 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~~ 746 (773)
...... ....++..|+|||.+....++.++|+||||+++||+++ |+.||...+.+++.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 221 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP 221 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 322211 11223568999999988889999999999999999998 99999876544433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=271.25 Aligned_cols=192 Identities=23% Similarity=0.341 Sum_probs=157.5
Q ss_pred ccccccceEEEEEEeCC-------------------------CCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEe
Q 041878 542 IMGKSTYGTAYKATLED-------------------------GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLAL 596 (773)
Q Consensus 542 ~lG~G~fg~Vy~~~~~~-------------------------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l 596 (773)
.||+|+||.||+|.... ...||+|.+.........++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 13489999875544445678889999999999999999
Q ss_pred EEEEECCCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC---
Q 041878 597 RAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT--- 673 (773)
Q Consensus 597 ~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~--- 673 (773)
++++.. ....++||||+++|+|..++.+.. ..+++..+..++.||++||+||| +++|+||||||+||+++..+
T Consensus 82 ~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH-~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVR-GSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLE-DKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEe-CCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-cCCccCCCCCcccEEEeccCccc
Confidence 999954 458899999999999999987642 34788899999999999999999 99999999999999998654
Q ss_pred ----CeEEeecCCccccccccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHH-cCCCCCCCCCC
Q 041878 674 ----NPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELL-TGKSPGEPMNG 742 (773)
Q Consensus 674 ----~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~-tg~~P~~~~~~ 742 (773)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||.....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 3799999987543221 12346788999998765 56899999999999999984 79999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=272.78 Aligned_cols=201 Identities=23% Similarity=0.404 Sum_probs=168.6
Q ss_pred HHHHHhhcccccccceEEEEEEe-----CCCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECC-CCe
Q 041878 534 DLLCATAEIMGKSTYGTAYKATL-----EDGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-KGE 606 (773)
Q Consensus 534 ~l~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~ 606 (773)
...+++.+.||+|+||.||++.+ .++..||+|.++... .....++.+|++++++++|+|++++++++... ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 34567788999999999999974 357889999987553 33346789999999999999999999998654 346
Q ss_pred EEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 607 KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
.++||||+++++|.+++.+.. ..+++..+..++.|++.||+||| +.|++||||||+||+++.++.++|+|||+++..
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH-~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH-HCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 889999999999999997653 24789999999999999999999 999999999999999999999999999998866
Q ss_pred ccccccc--eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCC
Q 041878 687 TAAANTN--VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPG 737 (773)
Q Consensus 687 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~ 737 (773)
....... .....++..|+|||...+..++.++|||||||++||++|++.|+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 4332211 11234567899999988888999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=267.35 Aligned_cols=196 Identities=30% Similarity=0.579 Sum_probs=170.0
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.+.+.||.|+||.||+|... |+.||+|.++.... ..+++.+|+.++++++|+|++++++++.. ....++||||+++
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~ 84 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTEYMAK 84 (256)
T ss_pred ccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEEecCC
Confidence 456788999999999999875 88999999976544 56788999999999999999999999854 6689999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.+++..... ..+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++|+|||.++....... .
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh-~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~----~ 158 (256)
T cd05039 85 GSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLE-EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD----S 158 (256)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH-hCCccchhcccceEEEeCCCCEEEcccccccccccccc----c
Confidence 999999987542 35899999999999999999999 99999999999999999999999999999886632211 2
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
...+..|+|||.+....++.++||||||+++||+++ |+.||...+
T Consensus 159 ~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 204 (256)
T cd05039 159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred CCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 234568999999988889999999999999999997 999987654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=279.75 Aligned_cols=211 Identities=27% Similarity=0.420 Sum_probs=172.7
Q ss_pred ccChhHHHHHhhcccccccceEEEEEEeC--------CCCEEEEEEecccC-cccHHHHHHHHHHHHcc-CCCceEEeEE
Q 041878 529 LFTADDLLCATAEIMGKSTYGTAYKATLE--------DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKI-HHPNLLALRA 598 (773)
Q Consensus 529 ~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~ 598 (773)
.++....++.+.+.||+|+||.||+|... .+..||+|.++... .....++.+|+++++++ +|+||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 34555666788899999999999999742 12368999887543 23456889999999999 7999999999
Q ss_pred EEECCCCeEEEEEeecCCCCHHHHHhhcC-------------CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCC
Q 041878 599 YYLGPKGEKLLVFDFMPKGSLASFLHARG-------------PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSS 665 (773)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~ 665 (773)
++. ..+..++|+||+++|+|.+++.+.. +...+++.+++.++.|++.|+.||| +.|++||||||+
T Consensus 86 ~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~givH~dlkp~ 163 (334)
T cd05100 86 ACT-QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA-SQKCIHRDLAAR 163 (334)
T ss_pred EEc-cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH-HCCeeccccccc
Confidence 994 5558999999999999999997642 2345788999999999999999999 999999999999
Q ss_pred CEEeCCCCCeEEeecCCccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 666 NVLLDEKTNPRIADFGLSRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 666 NIll~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
||+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...+
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999987654322111 112234567999999998899999999999999999998 888986644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=282.66 Aligned_cols=196 Identities=27% Similarity=0.378 Sum_probs=164.5
Q ss_pred HHHhhcccccccceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCC-----CeE
Q 041878 536 LCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-----GEK 607 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 607 (773)
+|...+.||+|+||.||+|.. .+++.||||++.... ......+.+|++++++++|+||+++++++.... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 356678999999999999985 468899999986532 223456778999999999999999998874321 356
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccc
Q 041878 608 LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMT 687 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 687 (773)
++++|++ +++|.+++... .++...+..++.||+.||+||| +.||+||||||+||++++++.+||+|||+++...
T Consensus 96 ~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 96 YLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred EEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH-HCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 8999998 78998887642 3788999999999999999999 9999999999999999999999999999988654
Q ss_pred cccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 688 AAANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 688 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...+
T Consensus 170 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 170 DE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred CC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 32 223458999999998866 568999999999999999999999997654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=271.61 Aligned_cols=190 Identities=27% Similarity=0.402 Sum_probs=163.8
Q ss_pred HhhcccccccceEEEEEEe-CCCCEEEEEEeccc-CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK-TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
...++||+|+||.||+|.. .+++.||+|.+... ......++.+|++++++++|||++++++++.. .+..++||||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~ 82 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-ENRISICTEFMD 82 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-CCEEEEEEecCC
Confidence 4567899999999999985 57889999998654 23345678899999999999999999999954 458899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|..+. .+++..+..++.|++.|+.||| +.||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 83 ~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~ 151 (279)
T cd06619 83 GGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW-SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AK 151 (279)
T ss_pred CCChHHhh-------cCCHHHHHHHHHHHHHHHHHHH-HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---cc
Confidence 99996542 2577888899999999999999 9999999999999999999999999999987654322 12
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
...++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 34588999999999988999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=270.37 Aligned_cols=202 Identities=22% Similarity=0.382 Sum_probs=173.2
Q ss_pred HHhhcccccccceEEEEEE-eCCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|...+.||+|.|.+|-+|+ .-+|..||||++.+.. .-....+..|++.|+-++|||||++|++. +.....|+|.|.
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-DTQTKlyLiLEL 98 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-DTQTKLYLILEL 98 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-cccceEEEEEEe
Confidence 3456789999999999997 4589999999997643 23345788899999999999999999998 667799999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-CCCeEEeecCCcccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE-KTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~~~~~ 692 (773)
=++|+|++|+-.+. ..+......+++.||+.|+.|+| +..|||||+||+||.+-+ -|-+|++|||++..+.+...
T Consensus 99 GD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCH-qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k- 174 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCH-QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK- 174 (864)
T ss_pred cCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHh-hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch-
Confidence 99999999998874 34788889999999999999999 999999999999988754 57799999999987765543
Q ss_pred ceeeccCccccccccccCCCCCC-cchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNAN-TKTDVYSLGVIILELLTGKSPGEPMNGMD 744 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Dvws~Gv~l~el~tg~~P~~~~~~~~ 744 (773)
....+|+..|-|||.+.+..|+ +++||||+||++|-+++|+.||+..++.+
T Consensus 175 -L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE 226 (864)
T KOG4717|consen 175 -LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE 226 (864)
T ss_pred -hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence 3345799999999999988886 58999999999999999999999855443
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=269.12 Aligned_cols=201 Identities=26% Similarity=0.420 Sum_probs=167.9
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEECC-----CCeEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGP-----KGEKL 608 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~~~~~ 608 (773)
.|.+.+.||+|+||.||+|... +++.||+|.+.... ....++..|+.+++++ +|+|++++++++... ....+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 3556788999999999999864 67889999986543 3456788999999998 699999999998643 23578
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||+++++|.+++.... ...+++..+..++.|++.|++||| +.+|+||||||+||++++++.++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH-~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLH-QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 9999999999999988643 334788999999999999999999 89999999999999999999999999999876533
Q ss_pred ccccceeeccCccccccccccC-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSK-----LKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
.. .......|++.|+|||++. ...++.++|||||||++|||++|+.||...
T Consensus 164 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~ 219 (272)
T cd06637 164 TV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219 (272)
T ss_pred cc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 22 1223345889999999875 346788999999999999999999999653
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=270.97 Aligned_cols=203 Identities=22% Similarity=0.379 Sum_probs=169.1
Q ss_pred HHhhcccccccceEEEEEEeC------CCCEEEEEEecccCcc-cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
+...+.||+|+||.||+|+.+ +.+.||+|.+...... ...++.+|++++++++|+|++++++++ ...+..++
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~l 85 (275)
T cd05046 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-REAEPHYM 85 (275)
T ss_pred ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-CCCCcceE
Confidence 345678999999999999853 2467999988654433 356799999999999999999999998 45568899
Q ss_pred EEeecCCCCHHHHHhhcCCC------CccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCc
Q 041878 610 VFDFMPKGSLASFLHARGPE------TIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS 683 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a 683 (773)
||||+++|+|.++++..... ..+++..+..++.|++.|++||| +.+|+||||||+||+++.++.++++|||.+
T Consensus 86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH-~~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS-NARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh-hcCcccCcCccceEEEeCCCcEEEcccccc
Confidence 99999999999999865422 25899999999999999999999 999999999999999999999999999998
Q ss_pred cccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 684 RLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
...............+++.|+|||.+.+..++.++||||||+++||+++ |..||....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~ 223 (275)
T cd05046 165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223 (275)
T ss_pred cccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc
Confidence 7543332222223346778999999888888999999999999999999 888986543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=266.79 Aligned_cols=202 Identities=27% Similarity=0.448 Sum_probs=170.9
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|.+.+.||+|++|.||++... +++.||+|.+.... ....+.+.+|++++++++|+|++++++.+.......++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 345688999999999999864 57889999986432 234567889999999999999999998875455568999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++++|.+++.... ...+++.++..++.|++.|++||| +.|++||||+|+||+++.++.++|+|||++........ .
T Consensus 82 ~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH-~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 158 (257)
T cd08223 82 CEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLH-EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-M 158 (257)
T ss_pred cCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC-c
Confidence 99999999998643 334789999999999999999999 99999999999999999999999999999876643322 1
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....+++.|+|||...+..++.++||||+|+++||+++|+.||...+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 223357889999999998999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=275.35 Aligned_cols=200 Identities=26% Similarity=0.423 Sum_probs=166.3
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++|+||+++++++. ..+..++||||+
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-~~~~~~lv~e~~ 86 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-TEKSLTLVFEYL 86 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-cCCeEEEEEecc
Confidence 345688999999999999865 67899999987443 233456788999999999999999999994 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
+ ++|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+||++++++.++|+|||++......... .
T Consensus 87 ~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH-~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-~ 161 (301)
T cd07873 87 D-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCH-RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-Y 161 (301)
T ss_pred c-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-c
Confidence 7 69999887653 34788899999999999999999 999999999999999999999999999998764332211 1
Q ss_pred eeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
....+++.|+|||.+.+ ..++.++||||+||++|||+||+.||...+.
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~ 210 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 22346889999998754 4578899999999999999999999976654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=268.22 Aligned_cols=198 Identities=27% Similarity=0.418 Sum_probs=165.5
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCCH
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSL 619 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~L 619 (773)
.+||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++. ..+..++|+||+++++|
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-ENGFFKIFMEQVPGGSL 92 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-cCCEEEEEEecCCCCCH
Confidence 57999999999999854 67889999987666666778999999999999999999999984 45589999999999999
Q ss_pred HHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-CCCeEEeecCCccccccccccceeecc
Q 041878 620 ASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE-KTNPRIADFGLSRLMTAAANTNVIATA 698 (773)
Q Consensus 620 ~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~ 698 (773)
.++++........+...+..++.||+.|++||| +.+|+||||||+||+++. ++.++|+|||.+........ ......
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 170 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH-DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFT 170 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-ccccCC
Confidence 999986532212377888899999999999999 999999999999999986 67899999999876532221 122234
Q ss_pred CccccccccccCCC--CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 699 GTLGYRAPELSKLK--NANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 699 gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
+++.|+|||.+... .++.++||||||+++|||++|+.||....
T Consensus 171 ~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 171 GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred CCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 78899999987654 37889999999999999999999997543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=269.67 Aligned_cols=198 Identities=27% Similarity=0.481 Sum_probs=167.7
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc---------cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeE
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK---------GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEK 607 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 607 (773)
.+.+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|+.++++++||||+++++++. ..+..
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~ 81 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL-DADHL 81 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-eCCcc
Confidence 45678999999999999864 6889999988654322 1256888999999999999999999984 45588
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccc
Q 041878 608 LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMT 687 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 687 (773)
++|+||+++++|.+++.+.. .++...+..++.|++.|++||| +.|++||||+|+||++++++.++|+|||.++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH-~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLH-NRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHH-hcCcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999998753 3788889999999999999999 9999999999999999999999999999988765
Q ss_pred ccccc-----ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 688 AAANT-----NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 688 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
..... ......+++.|+|||.+.+..++.++||||+||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 32111 111234788999999998888999999999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=271.76 Aligned_cols=200 Identities=27% Similarity=0.413 Sum_probs=167.6
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
...+.||+|++|.||+|... +++.||+|+++... ....+.+.+|+.++++++|||++++++++. .++..++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~ 81 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-QESRLYLIFEFL 81 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-eCCeEEEEEecC
Confidence 44678999999999999864 68999999986442 223467889999999999999999999995 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
+ ++|.++++.......+++..+..++.||+.||+||| +.+++||||+|+||+++.++.++|+|||++........ ..
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH-SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-VY 158 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc-cc
Confidence 7 689998876554456899999999999999999999 99999999999999999999999999999875533221 11
Q ss_pred eeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....+++.|+|||.+.+ ..++.++|||||||++|||+||+.||....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 23356889999998754 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=270.20 Aligned_cols=200 Identities=25% Similarity=0.345 Sum_probs=171.6
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+.+.+.||+|+||+||++... +|+.||+|++.... ....+++.+|+++++.++||||+++++++... +..++||||
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~ 84 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-NNICMCMEF 84 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-CEEEEEEec
Confidence 4667789999999999999864 68899999886543 33467899999999999999999999999544 689999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++++|.+++...+ .+++..+..++.+++.|+.|||+..+++||||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~-- 159 (284)
T cd06620 85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA-- 159 (284)
T ss_pred CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc--
Confidence 99999999987643 3788999999999999999999447899999999999999999999999999865432211
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
....++..|+|||++.+..++.++|||||||++||++||+.||.....
T Consensus 160 -~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 160 -DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred -CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 134588999999999888899999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=267.52 Aligned_cols=190 Identities=24% Similarity=0.415 Sum_probs=160.9
Q ss_pred cccccccceEEEEEEeCCCC-----------EEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 541 EIMGKSTYGTAYKATLEDGS-----------EVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~-----------~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
+.||+|+||.||+|.+.+.. .|++|.+...... ...+.+|+.++++++|+||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR--DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec--CCcEE
Confidence 46899999999999875432 5788887654433 6788999999999999999999999865 57899
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC-------CeEEeecCC
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT-------NPRIADFGL 682 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~-------~~kl~DfG~ 682 (773)
||||+++|+|.+++..... .+++..++.++.||+.||+||| +.+|+||||||+||+++.++ .+|++|||.
T Consensus 78 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLE-DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHh-hCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 9999999999999987542 4788999999999999999999 99999999999999999888 799999999
Q ss_pred ccccccccccceeeccCccccccccccCCC--CCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 683 SRLMTAAANTNVIATAGTLGYRAPELSKLK--NANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 683 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
+...... ....++..|+|||++... .++.++|||||||++||+++ |..||...+
T Consensus 155 a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 155 PITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred ccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 8765431 123466789999998766 78999999999999999999 577876653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=273.61 Aligned_cols=195 Identities=26% Similarity=0.399 Sum_probs=169.5
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++. .....++||||
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~ 82 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-DDSNLYLVMEY 82 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-cCCeEEEEEec
Confidence 45688999999999999865 68999999986432 233567889999999999999999999984 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++++|.++++... .++...+..++.|++.||.||| +.|++||||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH-~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 83 VPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLH-SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 99999999998753 4788999999999999999999 899999999999999999999999999998765433
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....+++.|+|||.+....++.++||||||+++|||++|+.||...+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 223458899999999888888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=273.52 Aligned_cols=211 Identities=25% Similarity=0.380 Sum_probs=170.1
Q ss_pred HHHHhhcccccccceEEEEEEeCC---------------CCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEE
Q 041878 535 LLCATAEIMGKSTYGTAYKATLED---------------GSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRA 598 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~~~---------------g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~ 598 (773)
-+|.+.+.||+|+||.||++.... ...||+|.++.... ....++.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 345667889999999999987532 12489999976533 33457899999999999999999999
Q ss_pred EEECCCCeEEEEEeecCCCCHHHHHhhcCC---------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe
Q 041878 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGP---------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL 669 (773)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll 669 (773)
++. ..+..++||||+++++|.+++..... ...+++..++.++.|++.|++||| +.+++||||||+||++
T Consensus 85 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~i~H~dlkp~Nill 162 (295)
T cd05097 85 VCV-SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA-SLNFVHRDLATRNCLV 162 (295)
T ss_pred EEc-CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH-hcCeeccccChhhEEE
Confidence 994 55589999999999999999975421 123688899999999999999999 9999999999999999
Q ss_pred CCCCCeEEeecCCccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCCCChH
Q 041878 670 DEKTNPRIADFGLSRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT--GKSPGEPMNGMDLP 746 (773)
Q Consensus 670 ~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t--g~~P~~~~~~~~~~ 746 (773)
++++.+||+|||++.......... .....+++.|+|||......++.++|||||||++|||++ |..||.....++..
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~ 242 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHH
Confidence 999999999999987654332211 112234678999999988889999999999999999998 67788765544443
Q ss_pred H
Q 041878 747 Q 747 (773)
Q Consensus 747 ~ 747 (773)
+
T Consensus 243 ~ 243 (295)
T cd05097 243 E 243 (295)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=267.96 Aligned_cols=200 Identities=24% Similarity=0.436 Sum_probs=168.2
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC-----cccHHHHHHHHHHHHccCCCceEEeEEEEECC-CCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT-----TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-KGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~l 609 (773)
|...++||+|+||.||+|.. .++..||+|++.... .+....+.+|+.++++++|+||+++++++... ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 34568899999999999986 468999999886432 12345688899999999999999999988543 356789
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
++||+++++|.+++.... .+++.....++.|++.|++||| +.+|+||||+|+||+++.++.++|+|||++......
T Consensus 84 ~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH-~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 84 FMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLH-SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 999999999999998653 3788888999999999999999 999999999999999999999999999998765432
Q ss_pred cc--cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 690 AN--TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 690 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
.. .......++..|+|||.+.+..++.++||||+||++||+++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 11 1112234788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=264.92 Aligned_cols=197 Identities=29% Similarity=0.495 Sum_probs=166.7
Q ss_pred cccccccceEEEEEEeCCCCEEEEEEecccCcc-cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCCH
Q 041878 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSL 619 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~L 619 (773)
++||+|+||.||++.+.+++.||+|.+...... ....+..|++++++++|+||+++++++. .....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-QKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-cCCCeEEEEEcCCCCcH
Confidence 469999999999999877999999998765443 4568899999999999999999999984 45589999999999999
Q ss_pred HHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce-eecc
Q 041878 620 ASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV-IATA 698 (773)
Q Consensus 620 ~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~-~~~~ 698 (773)
.+++.... ..+++..+..++.+++.|++||| +.+++||||+|+||+++.++.++|+|||.+........... ....
T Consensus 80 ~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH-~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 80 LTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLE-SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 99997643 24788899999999999999999 99999999999999999999999999999876542221111 1122
Q ss_pred CccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 699 GTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 699 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
.+..|+|||.+.+..++.++|+|||||++|||+| |..||....
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 3567999999988889999999999999999999 888887644
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=268.38 Aligned_cols=202 Identities=24% Similarity=0.499 Sum_probs=167.6
Q ss_pred HHhhcccccccceEEEEEEeC-CCC---EEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGS---EVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~---~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
+...+.||+|+||.||+|... ++. .+|+|.++... .....++..|++++++++|+|++++++++ ...+..++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~ 85 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV-TKFKPAMIIT 85 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-ccCCCcEEEE
Confidence 455688999999999999864 333 69999987543 33356788999999999999999999998 4555889999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++++|.+++.... ..+++.++..++.|++.|++||| +.+++||||||+||+++.++.+|++|||++........
T Consensus 86 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 162 (268)
T cd05063 86 EYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLS-DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162 (268)
T ss_pred EcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence 9999999999997643 34789999999999999999999 99999999999999999999999999999876643222
Q ss_pred ccee--eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 692 TNVI--ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 692 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
.... ....++.|+|||++....++.++|||||||++||+++ |+.||...+.
T Consensus 163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~ 216 (268)
T cd05063 163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN 216 (268)
T ss_pred cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence 1111 1123457999999988889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=273.38 Aligned_cols=198 Identities=25% Similarity=0.433 Sum_probs=171.8
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|...+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+..+++++|+|++++++++. .....++|+||++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~ 99 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-VGDELFVVMEYLA 99 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-cCceEEEEEEecC
Confidence 44567899999999999985 578999999997665556678899999999999999999999985 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|.+++... .+++.++..++.|++.|++||| +.|++||||||+||+++.++.+||+|||++......... ..
T Consensus 100 ~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH-~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~ 173 (296)
T cd06655 100 GGSLTDVVTET----CMDEAQIAAVCRECLQALEFLH-ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RS 173 (296)
T ss_pred CCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CC
Confidence 99999988753 3789999999999999999999 999999999999999999999999999998765433221 12
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...+++.|+|||.+.+..++.++|||||||++||+++|+.||...+
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3357889999999988889999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=275.50 Aligned_cols=196 Identities=24% Similarity=0.430 Sum_probs=169.0
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
....||+|+||.||++... ++..||||.+........+.+.+|+..+++++|+|++++++.+. ..+..++||||++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-~~~~~~lv~e~~~~~ 104 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-VGDELWVVMEFLEGG 104 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-cCCeEEEEEeCCCCC
Confidence 3567999999999999864 68899999987655555677899999999999999999999884 455899999999999
Q ss_pred CHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeec
Q 041878 618 SLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697 (773)
Q Consensus 618 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 697 (773)
+|.+++... .+++..+..++.||+.|+.||| +.+|+||||||+||++++++.++|+|||++........ .....
T Consensus 105 ~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~ 178 (292)
T cd06658 105 ALTDIVTHT----RMNEEQIATVCLSVLRALSYLH-NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSL 178 (292)
T ss_pred cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCcee
Confidence 999988542 3788899999999999999999 99999999999999999999999999999875533221 12234
Q ss_pred cCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 698 AGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 698 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.+++.|+|||...+..++.++|||||||++|||++|+.||...+
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 58889999999988889999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=273.61 Aligned_cols=204 Identities=26% Similarity=0.460 Sum_probs=171.7
Q ss_pred hcccccccceEEEEEEe-CCCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 540 AEIMGKSTYGTAYKATL-EDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
.++||.|.||+||-|.. ++|+.||||++.+. ..+.+.++.+|+++++.++||.||.+...| +..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-ETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-cCCceEEEEehhhcc
Confidence 68899999999999985 58999999999764 445678899999999999999999998888 666799999999955
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC---CeEEeecCCccccccccccc
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT---NPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~---~~kl~DfG~a~~~~~~~~~~ 693 (773)
+..+.+-... ...++....+.++.||+.||.||| .++|+|+|+||+|||+.+.. .+||+|||.|+++......
T Consensus 648 -DMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH-~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR- 723 (888)
T KOG4236|consen 648 -DMLEMILSSE-KGRLPERITKFLVTQILVALRYLH-FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR- 723 (888)
T ss_pred -hHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhh-hcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh-
Confidence 5544443332 234788888889999999999999 99999999999999997654 4999999999998654332
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHH
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVAS 751 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~ 751 (773)
...+|||.|+|||++..+.|...-|+||.||++|--++|..||. .++|+.++++.
T Consensus 724 -rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQN 778 (888)
T KOG4236|consen 724 -RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQN 778 (888)
T ss_pred -hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhc
Confidence 34569999999999999999999999999999999999999995 45566665553
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=270.44 Aligned_cols=199 Identities=26% Similarity=0.442 Sum_probs=169.8
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++. .....++||||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~ 83 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-KGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-cCCceEEEEEc
Confidence 3566788999999999999864 57889999987443 334567899999999999999999999984 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++++|.+++... .+++..+..++.|+++|+.||| +.+++|+||+|+||++++++.++++|||++........ .
T Consensus 84 ~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH-~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 84 LGGGSALDLLKPG----PLEETYIATILREILKGLDYLH-SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred cCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHh-cCCeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 9999999988653 3788899999999999999999 99999999999999999999999999999876543221 1
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 122357889999999998889999999999999999999999987543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=299.42 Aligned_cols=201 Identities=21% Similarity=0.366 Sum_probs=165.0
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECC-CCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-KGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV~e 612 (773)
|.+.+.||+|+||+||+|... ++..||+|.+... .......+..|+.++++++||||+++++++... ....|+|||
T Consensus 15 YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVME 94 (1021)
T PTZ00266 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILME 94 (1021)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEe
Confidence 456789999999999999865 5778999988643 233456789999999999999999999988543 346899999
Q ss_pred ecCCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccC-------CCceecCCCCCCEEeCCC------------
Q 041878 613 FMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVE-------ENMIHGNLTSSNVLLDEK------------ 672 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~-------~~iiH~Dik~~NIll~~~------------ 672 (773)
|+++|+|.+++.... ....+++..++.|+.||+.||.||| + .+||||||||+|||++.+
T Consensus 95 Y~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLH-s~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~ 173 (1021)
T PTZ00266 95 FCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH-NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173 (1021)
T ss_pred CCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-hcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence 999999999997642 2345899999999999999999999 5 459999999999999642
Q ss_pred -----CCeEEeecCCccccccccccceeeccCccccccccccCC--CCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 673 -----TNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKL--KNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 673 -----~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
..+||+|||++........ .....||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 174 n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 174 NLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3489999999976543221 123468999999998753 45889999999999999999999999754
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=272.91 Aligned_cols=207 Identities=24% Similarity=0.364 Sum_probs=171.1
Q ss_pred hhHHHHHhhcccccccceEEEEEEeC------CCCEEEEEEecccC-cccHHHHHHHHHHHHcc-CCCceEEeEEEEECC
Q 041878 532 ADDLLCATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGP 603 (773)
Q Consensus 532 ~~~l~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 603 (773)
.....+...+.||+|+||.||+|... ++..||+|.++... ....+.+.+|+++++++ +|+||+++++++. .
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-~ 110 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT-I 110 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe-c
Confidence 34445677899999999999999742 34579999987543 23346789999999999 7999999999985 4
Q ss_pred CCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCc
Q 041878 604 KGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS 683 (773)
Q Consensus 604 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a 683 (773)
.+..++||||+++|+|.+++++.. ...+++.++..++.|++.|++||| +.+|+|+||||+||+++.++.++++|||++
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH-~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH-HCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 458999999999999999997643 233799999999999999999999 999999999999999999999999999998
Q ss_pred cccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 684 RLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 684 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
+......... .....++..|+|||.+....++.++||||+||++|||++ |+.||....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~ 248 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCC
Confidence 8654332211 112235678999999988889999999999999999998 999987654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=267.43 Aligned_cols=200 Identities=24% Similarity=0.431 Sum_probs=170.3
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEeccc-CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK-TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.++||+|+||.||++... +++.+|+|.++.. .....+.+..|+.++++++|+|++++++.+. ..+..++||||++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~ 81 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-ADGHLYIVMEYCD 81 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-ECCEEEEEEeeCC
Confidence 45688999999999999864 6889999998643 2334567888999999999999999999984 5568999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|.+++.... ...++....+.++.|++.|+.||| +.||+|+||||+||++++++.++++|||.+......... ..
T Consensus 82 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH-~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 158 (255)
T cd08219 82 GGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIH-EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-AC 158 (255)
T ss_pred CCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc-cc
Confidence 999999887542 334788889999999999999999 999999999999999999999999999998765433221 12
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...+++.|+|||+..+..++.++|+||||+++|+|++|+.||...+
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 3458889999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=267.64 Aligned_cols=200 Identities=25% Similarity=0.439 Sum_probs=168.0
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc-----CcccHHHHHHHHHHHHccCCCceEEeEEEEECCC-CeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK-----TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-GEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~l 609 (773)
|.+.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|++++++++|+||+++++++.... ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 45678999999999999986 46899999987532 1223457889999999999999999999885543 46789
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
|+||+++++|.+++.+.. .+++.....++.|++.|+.||| +.|++|+||||+||+++.++.++|+|||.++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH-~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLH-SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 999999999999997653 2678888999999999999999 999999999999999999999999999999865432
Q ss_pred cc--cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 690 AN--TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 690 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
.. .......++..|+|||...+..++.++|+|||||++||+++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 11 1112345788999999998888999999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=276.54 Aligned_cols=199 Identities=21% Similarity=0.320 Sum_probs=163.4
Q ss_pred hcccccc--cceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 540 AEIMGKS--TYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 540 ~~~lG~G--~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.++||+| +||+||++.. .+|+.||+|++.... ......+.+|+++++.++||||+++++++.. ++..++||||+
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~~ 81 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSFM 81 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCEEEEEEecc
Confidence 4679999 7899999986 478999999997543 2234567889999999999999999999954 45899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc--
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT-- 692 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 692 (773)
++|+|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+||+++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH-~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIH-HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 99999999976432 23789999999999999999999 999999999999999999999999999865443211110
Q ss_pred ----ceeeccCccccccccccCC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 ----NVIATAGTLGYRAPELSKL--KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......++..|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 0112246678999999865 468999999999999999999999997644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=267.05 Aligned_cols=197 Identities=27% Similarity=0.466 Sum_probs=168.9
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC-----cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-----TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
...+.||+|++|.||+|... +++.||+|.+.... .+..+.+.+|++++++++|+|++++++++. .....++|+
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~lv~ 81 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-EEDNLYIFL 81 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-cCCeEEEEE
Confidence 34578999999999999875 78999999986543 224567899999999999999999999884 455899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++++|.+++.+.. .+++..+..++.|++.|++||| +.|++|+||+|+||+++.++.+||+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 82 ELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLH-DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 9999999999998753 3788899999999999999999 9999999999999999999999999999987654332
Q ss_pred cceeeccCccccccccccCCCC-CCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKN-ANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......+++.|+|||.+.... ++.++|+|||||++||+++|+.||....
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 122345788999999887766 8999999999999999999999997654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=287.66 Aligned_cols=191 Identities=23% Similarity=0.308 Sum_probs=161.9
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.+.||+|+||.||+|... .++.||||... ...+.+|++++++++|+||+++++++. ..+..++|||++
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~-~~~~~~lv~e~~- 242 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRV-VGGLTCLVLPKY- 242 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEE-ECCEEEEEEEcc-
Confidence 556788999999999999865 57889999642 234568999999999999999999984 455889999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc-ce
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT-NV 694 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~ 694 (773)
.++|.+++.... ..+++.+++.++.||+.||.||| +.||+||||||+|||++.++.+||+|||+++........ ..
T Consensus 243 ~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH-~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 243 RSDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIH-GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 479998887642 24899999999999999999999 999999999999999999999999999999865432221 11
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGE 738 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~ 738 (773)
....||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 23468999999999998999999999999999999999887654
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=272.24 Aligned_cols=206 Identities=25% Similarity=0.398 Sum_probs=170.1
Q ss_pred HHHhhcccccccceEEEEEEeCC-----------------CCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeE
Q 041878 536 LCATAEIMGKSTYGTAYKATLED-----------------GSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALR 597 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~ 597 (773)
.+.+.+.||+|+||.||+|...+ +..||+|.+..... ...+++.+|++++++++|+|+++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 34567899999999999997542 24589999875543 3456789999999999999999999
Q ss_pred EEEECCCCeEEEEEeecCCCCHHHHHhhcCC--------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe
Q 041878 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGP--------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL 669 (773)
Q Consensus 598 ~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll 669 (773)
+++. ..+..++|+||+++++|.+++.+... ...+++..++.++.|++.|++||| +.+++||||||+||++
T Consensus 86 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH-~~~i~H~dlkp~Nili 163 (296)
T cd05051 86 GVCT-VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE-SLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEe-cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH-HcCccccccchhceee
Confidence 9994 44689999999999999999977531 125789999999999999999999 9999999999999999
Q ss_pred CCCCCeEEeecCCccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCCC
Q 041878 670 DEKTNPRIADFGLSRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT--GKSPGEPMNGM 743 (773)
Q Consensus 670 ~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t--g~~P~~~~~~~ 743 (773)
+.++.++++|||.++......... .....+++.|+|||......++.++|||||||++|||++ |..||...+..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999987654332211 123346778999999888889999999999999999998 77788665433
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=265.63 Aligned_cols=201 Identities=22% Similarity=0.385 Sum_probs=170.6
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|++++++++++.. .+..++|||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e 82 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-NNELNIVLE 82 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEEEEe
Confidence 345688999999999999876 7899999988642 22335678999999999999999999999954 458899999
Q ss_pred ecCCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 613 FMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
|+++++|.+++.... ....+++.++..++.|++.|+.||| +.|++||||+|+||+++.++.++++|||.+........
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH-SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH-hCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999999987542 2345789999999999999999999 99999999999999999999999999999876543221
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
. .....+++.|+|||...+..++.++|||||||++|||++|+.||...
T Consensus 162 ~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 162 A-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred c-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 1 12335788999999998888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=271.81 Aligned_cols=208 Identities=25% Similarity=0.423 Sum_probs=169.3
Q ss_pred HHhhcccccccceEEEEEEeC-----------------CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-----------------DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRA 598 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-----------------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~ 598 (773)
|++.++||+|+||.||++... ++..||+|.++.... ....++.+|++++++++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 566788999999999998532 234689999975433 33568999999999999999999999
Q ss_pred EEECCCCeEEEEEeecCCCCHHHHHhhcCC--------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeC
Q 041878 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGP--------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLD 670 (773)
Q Consensus 599 ~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~ 670 (773)
++.. .+..++||||+++++|.+++..... ...+++.+...++.|++.|++||| +.|++||||||+||+++
T Consensus 87 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH-~~~i~H~dlkp~Nili~ 164 (296)
T cd05095 87 VCIT-SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS-SLNFVHRDLATRNCLVG 164 (296)
T ss_pred EEec-CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH-HCCeecccCChheEEEc
Confidence 9854 4578999999999999999986532 124678889999999999999999 99999999999999999
Q ss_pred CCCCeEEeecCCccccccccccce-eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc--CCCCCCCCCCCChH
Q 041878 671 EKTNPRIADFGLSRLMTAAANTNV-IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT--GKSPGEPMNGMDLP 746 (773)
Q Consensus 671 ~~~~~kl~DfG~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t--g~~P~~~~~~~~~~ 746 (773)
.++.++++|||+++.......... ....+++.|+|||......++.++|||||||++|||++ |..||...+..+..
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243 (296)
T ss_pred CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 999999999999876543322111 12234678999998888889999999999999999998 77898765544433
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=273.64 Aligned_cols=194 Identities=22% Similarity=0.391 Sum_probs=167.7
Q ss_pred hcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCC
Q 041878 540 AEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
...||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|||++++++++. ..+..++|+||+++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-VGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-eCCeEEEEEecCCCCC
Confidence 357999999999999864 68999999997655555677889999999999999999999884 4558999999999999
Q ss_pred HHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeecc
Q 041878 619 LASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA 698 (773)
Q Consensus 619 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 698 (773)
|.+++... .+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++........ ......
T Consensus 105 L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH-~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~ 178 (297)
T cd06659 105 LTDIVSQT----RLNEEQIATVCESVLQALCYLH-SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLV 178 (297)
T ss_pred HHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccccee
Confidence 99987652 3788999999999999999999 99999999999999999999999999999875543221 122345
Q ss_pred CccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 699 GTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 699 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
+++.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 220 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSD 220 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 889999999998888999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=264.43 Aligned_cols=197 Identities=26% Similarity=0.460 Sum_probs=171.1
Q ss_pred HHhhcccccccceEEEEEEeCC-CCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLED-GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|...++||+|+||.||+|...+ ++.+|+|.+..... .+++.+|++++++++|+|++++++++.. ....++++||++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~ 81 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK-NTDLWIVMEYCG 81 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec-CCcEEEEEecCC
Confidence 4567889999999999998764 78999999865433 6789999999999999999999999954 468999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|.+++.... ..+++..+..++.|++.|+.||| +.+++||||+|+||+++.++.++|+|||++........ ...
T Consensus 82 ~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh-~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (256)
T cd06612 82 AGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLH-SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRN 157 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccc
Confidence 999999997643 34789999999999999999999 99999999999999999999999999999887654321 222
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
...++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~ 202 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 334788999999998889999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=268.80 Aligned_cols=201 Identities=21% Similarity=0.386 Sum_probs=170.4
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|.. .+++.+|||.+.... .....++.+|+++++.++|+|++++++++.. .+..++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~e 82 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIVLE 82 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-CCeEEEEEE
Confidence 45668899999999999985 578999999886432 2234678899999999999999999999854 458899999
Q ss_pred ecCCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 613 FMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
|+++++|.+++.... ....+++.+++.++.||+.|+.||| +.|++|+||+|+||+++.++.++++|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH-SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 999999999987532 2345789999999999999999999 99999999999999999999999999999876543222
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
. .....++..|+|||...+..++.++||||||+++|||++|..||...
T Consensus 162 ~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 162 A-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred c-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 1 12335888999999998888999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=264.79 Aligned_cols=201 Identities=22% Similarity=0.387 Sum_probs=171.7
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|...++||+|+||.||.+.. .+++.+++|.+... ......++.+|++++++++|+||+++++++. ..+..++||||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~~~~e~ 80 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-DDNTLLIEMEY 80 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-cCCeEEEEEEe
Confidence 44568899999999999975 46889999998644 2344567889999999999999999999995 45689999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++++|.+++.+.. ...+++.++..++.|++.|+.||| +.+++||||+|+||++++++.+||+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIH-KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 99999999998653 345789999999999999999999 89999999999999999999999999999876644332 1
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....+++.|+|||...+..++.++||||||+++|||++|+.||...+
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence 223458899999999888888999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=265.45 Aligned_cols=201 Identities=33% Similarity=0.537 Sum_probs=170.5
Q ss_pred hhcccccccceEEEEEEeCC-----CCEEEEEEecccCcc-cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 539 TAEIMGKSTYGTAYKATLED-----GSEVAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+.+.||+|+||.||++...+ +..||+|.++..... ..+.+..|+.++++++|+||+++++++.. .+..++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~i~e 81 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-EEPLMIVME 81 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCeeEEEEe
Confidence 45789999999999998653 378999999765443 56789999999999999999999999954 468999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++++|.+++..... ..+++.++..++.|++.|++||| +.+++||||+|+||++++++.++++|||.+.........
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh-~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLE-SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHh-cCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999999986532 22799999999999999999999 999999999999999999999999999999876544222
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
......+++.|+|||......++.++||||+|+++|||++ |+.||...+.
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~ 210 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN 210 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 2212336789999999988889999999999999999998 7888876443
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=269.85 Aligned_cols=201 Identities=25% Similarity=0.384 Sum_probs=167.7
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++|+|++++++++. .....++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~~v~e~ 81 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-RKRKLHLVFEY 81 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-eCCEEEEEEec
Confidence 345678999999999999875 68999999986442 223466889999999999999999999985 44588999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
++++.|..+..... .+++..+..++.|++.||+||| +.+++||||||+||+++.++.++|+|||++........ .
T Consensus 82 ~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~ 156 (286)
T cd07847 82 CDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCH-KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D 156 (286)
T ss_pred cCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHH-HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence 99988887765432 3789999999999999999999 89999999999999999999999999999987644321 1
Q ss_pred eeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~ 207 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV 207 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 122346789999998765 56789999999999999999999999865543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=270.26 Aligned_cols=201 Identities=25% Similarity=0.353 Sum_probs=170.4
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++|+|++++++++. .....++|+||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~~v~e~ 80 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-HGSGFVLVMEY 80 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-cCCeeEEEecc
Confidence 345688999999999999864 68999999997554 334568899999999999999999999984 45588999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+ +++|.+++.... ..+++.++..++.||+.||+||| +.+++|+||||+||+++.++.++++|||.+..........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMH-ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 999999987653 34889999999999999999999 9999999999999999999999999999988765443222
Q ss_pred eeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.....++..|+|||.+.+. .++.++||||+|+++|||++|..||.....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 206 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND 206 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH
Confidence 3344688999999987544 468999999999999999999888866543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=266.77 Aligned_cols=198 Identities=23% Similarity=0.368 Sum_probs=157.4
Q ss_pred ccccccceEEEEEEeCCC---CEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 542 IMGKSTYGTAYKATLEDG---SEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 542 ~lG~G~fg~Vy~~~~~~g---~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
.||+|+||.||+|...++ ..+++|.++... ....+.+.+|+.+++.++||||+++++.+. .....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-EAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-CCCccEEEEecCCCC
Confidence 589999999999975433 346677765433 334678999999999999999999999995 455889999999999
Q ss_pred CHHHHHhhcCC-CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc-ccee
Q 041878 618 SLASFLHARGP-ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN-TNVI 695 (773)
Q Consensus 618 ~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~ 695 (773)
+|.+++++... ....+......++.||+.||+||| +.+++||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH-~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH-KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH-HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 99999986532 234567778899999999999999 99999999999999999999999999999764322111 1112
Q ss_pred eccCccccccccccCC-------CCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKL-------KNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~-------~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
...++..|+|||+... ..++.++|||||||++|||++ |..||...+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 3457889999998743 345789999999999999997 566876543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=266.43 Aligned_cols=199 Identities=26% Similarity=0.442 Sum_probs=170.2
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.|...+.||.|+||.||+|... +++.||+|.+.... ......+.+|+++++++.|+|++++++++.. ....++||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWIIMEY 83 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEec
Confidence 3556688999999999999865 58899999987543 3445678999999999999999999999854 5589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++++|.+++... .++..+...++.|++.|++||| +.+++|+||+|+||+++.++.++++|||++........ .
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh-~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLH-SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH-hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence 9999999998753 3678888999999999999999 99999999999999999999999999999876543221 1
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....++..|+|||.+.+..++.++|+|||||++|||+||..||...+
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 223357889999999988889999999999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=265.82 Aligned_cols=205 Identities=24% Similarity=0.414 Sum_probs=170.7
Q ss_pred HhhcccccccceEEEEEEe-CCCCEEEEEEecccCc------ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTT------KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
...+.||+|++|.||+|.. .+++.||+|.+..... ...+++.+|++++++++|+|++++++++ ...+..++|
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~~v 81 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-CEDSHFNLF 81 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-ccCCeEEEE
Confidence 4567899999999999985 5789999999864321 1246788999999999999999999998 455589999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC-CeEEeecCCccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT-NPRIADFGLSRLMTAA 689 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~ 689 (773)
+||+++++|.+++.+.. .+++..+..++.|++.|+.||| +.|++||||+|+||+++.++ .++|+|||.+......
T Consensus 82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH-~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 82 VEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLH-ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 99999999999998653 3788899999999999999999 99999999999999998876 5999999998776543
Q ss_pred ccc---ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHH
Q 041878 690 ANT---NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQ 747 (773)
Q Consensus 690 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~ 747 (773)
... ......++..|+|||.+.+..++.++||||+|+++||+++|+.||...+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 218 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA 218 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH
Confidence 211 1122357889999999988889999999999999999999999997654433333
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=272.92 Aligned_cols=200 Identities=31% Similarity=0.519 Sum_probs=165.3
Q ss_pred HHhhcccccccceEEEEEEeC-CCC----EEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGS----EVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
+...+.||+|+||.||+|.+. +|. .||+|.+..... ....++.+|+.++++++||||+++++++.. . ..++|
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~-~~~~v 86 (303)
T cd05110 9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-P-TIQLV 86 (303)
T ss_pred ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-C-Cceee
Confidence 456688999999999999853 444 478898865433 234478899999999999999999999853 2 56799
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
+||+++|+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++......
T Consensus 87 ~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH-~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~ 163 (303)
T cd05110 87 TQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLE-ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163 (303)
T ss_pred ehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHh-hcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence 99999999999987653 24788899999999999999999 9999999999999999999999999999998664332
Q ss_pred cc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 691 NT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 691 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
.. ......++..|+|||.+.+..++.++|||||||++||+++ |+.||....
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~ 216 (303)
T cd05110 164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216 (303)
T ss_pred cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 21 1112335678999999988889999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=264.63 Aligned_cols=199 Identities=27% Similarity=0.430 Sum_probs=171.0
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
.+.+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++|||++++++++. .....+++|||+++
T Consensus 6 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~l~~e~~~~ 84 (262)
T cd06613 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL-RRDKLWIVMEYCGG 84 (262)
T ss_pred EEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE-eCCEEEEEEeCCCC
Confidence 45678999999999999864 57889999998665556788999999999999999999999884 45589999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.+++.... ..++..++..++.|++.|+.||| +.+++||||+|+||++++++.++|+|||.+........ ....
T Consensus 85 ~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh-~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~ 160 (262)
T cd06613 85 GSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLH-ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRKS 160 (262)
T ss_pred CcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-cccc
Confidence 99999987652 34788999999999999999999 99999999999999999999999999999876543221 1223
Q ss_pred ccCccccccccccCCC---CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLK---NANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~---~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
..++..|+|||.+... .++.++||||||+++|||+||+.||...+
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 4578899999998766 78999999999999999999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=270.34 Aligned_cols=204 Identities=29% Similarity=0.468 Sum_probs=168.3
Q ss_pred HHHhhcccccccceEEEEEEeC------CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
.+...+.||+|+||.||+|... ++..||+|.+..... ....++.+|+.++++++|||++++++++. .....+
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-~~~~~~ 84 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-VGKPMC 84 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-CCCccE
Confidence 3456788999999999999853 467899999875433 33567899999999999999999999984 455789
Q ss_pred EEEeecCCCCHHHHHhhcCC-------------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe
Q 041878 609 LVFDFMPKGSLASFLHARGP-------------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL 669 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~-------------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll 669 (773)
+||||+++|+|.+++..... ...+++..++.++.|++.||+||| +.+++||||||+||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH-~~~i~H~dl~p~nil~ 163 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS-ERKFVHRDLATRNCLV 163 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH-hCCeecccccHhheEe
Confidence 99999999999999975321 123678889999999999999999 9999999999999999
Q ss_pred CCCCCeEEeecCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 670 DEKTNPRIADFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 670 ~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
+.++.++++|||.+......... .......++.|+|||...+..++.++|||||||++|||++ |..||.+..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999998765432211 1112234668999999988899999999999999999997 888986544
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=270.57 Aligned_cols=199 Identities=21% Similarity=0.339 Sum_probs=166.5
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+.+.||+|+||.||++... +++.||+|.+..... .....+.+|+++++.++|+||+++++.+. .++..++||||
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~e~ 82 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-TKRHLCMVMEY 82 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-cCCEEEEEEec
Confidence 44578999999999999864 578999999875432 23457889999999999999999999884 55588999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc-
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT- 692 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~- 692 (773)
+++++|.+++.... .+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++++|||+++........
T Consensus 83 ~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 83 VEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLH-NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 99999999997753 3788889999999999999999 999999999999999999999999999988642111000
Q ss_pred -------------ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 -------------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......++..|+|||.+....++.++|+|||||++||+++|+.||.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~ 220 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0012346789999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=277.15 Aligned_cols=189 Identities=22% Similarity=0.368 Sum_probs=159.2
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.|.+.+.||+|+||.||+|... +++.||+|..... ....|+.++++++|+||+++++++.. ....++|+||+
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~ 139 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS-GAITCMVLPHY 139 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe-CCeeEEEEEcc
Confidence 3667889999999999999865 5678999975432 23468999999999999999999854 45889999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
.++|.+++.... ..+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+|||.++...... ..
T Consensus 140 -~~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~ 213 (357)
T PHA03209 140 -SSDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLH-AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AF 213 (357)
T ss_pred -CCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--cc
Confidence 468998887643 34789999999999999999999 9999999999999999999999999999987533221 12
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPG 737 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~ 737 (773)
....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 2345899999999999899999999999999999999865554
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=272.61 Aligned_cols=201 Identities=25% Similarity=0.374 Sum_probs=169.6
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc---cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK---GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
...+.||+|++|.||+|... +++.||+|.+...... ..+.+..|++++++++|+||+++++.+ ......++||||
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~e~ 82 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-QTETYLCLVMDY 82 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-ecCCEEEEEEEe
Confidence 45678999999999999865 5899999999754322 446788999999999999999999998 455589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc-
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT- 692 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~- 692 (773)
+++++|.+++.... ...+++..+..++.|++.||+||| +.|++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 83 CPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLH-LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred cCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHH-HCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999987542 345788999999999999999999 999999999999999999999999999998754322110
Q ss_pred ---------------------------ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 ---------------------------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......|+..|+|||...+..++.++||||||+++|||++|+.||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 0112357889999999988889999999999999999999999997554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=265.21 Aligned_cols=195 Identities=28% Similarity=0.416 Sum_probs=165.7
Q ss_pred cccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCC
Q 041878 543 MGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 543 lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
||+|+||+||++... +|+.||+|.+.... ......+..|++++++++|||++++++++. ..+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-TKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-cCCeEEEEEecCCCCc
Confidence 689999999999754 68999999986432 223456678999999999999999999884 4558999999999999
Q ss_pred HHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeecc
Q 041878 619 LASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA 698 (773)
Q Consensus 619 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 698 (773)
|.+++..... ..+++..+..++.|++.|+.||| +.|++||||+|+||++++++.++|+|||.+....... ......
T Consensus 80 L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH-~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 80 LKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLH-QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 9999987542 34789999999999999999999 9999999999999999999999999999987654321 122335
Q ss_pred CccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 699 GTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 699 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
++..|+|||...+..++.++||||+||++|+|++|+.||.....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 78899999998888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=257.13 Aligned_cols=222 Identities=26% Similarity=0.393 Sum_probs=174.2
Q ss_pred cccChhHHHHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHcc-CCCceEEeEEEEECCC
Q 041878 528 FLFTADDLLCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPK 604 (773)
Q Consensus 528 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 604 (773)
+.|+.+++ +-...||.|+||+|+|...+ .|+..|||+++.... ++++++..|.++..+- +.||||+++|++ ..+
T Consensus 59 ~~F~~~~L--qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~-F~E 135 (361)
T KOG1006|consen 59 HTFTSDNL--QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL-FSE 135 (361)
T ss_pred cccccchH--HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh-hcC
Confidence 34555544 34467999999999999764 799999999987654 6678899998876655 589999999999 566
Q ss_pred CeEEEEEeecCCCCHHHHHhhc--CCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCC
Q 041878 605 GEKLLVFDFMPKGSLASFLHAR--GPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGL 682 (773)
Q Consensus 605 ~~~~lV~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~ 682 (773)
+..|+.||.| ..++..+-..- -....+++.-.-.|....++||.||..+..||||||||+|||++..|.+|++|||.
T Consensus 136 GdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 136 GDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred CceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccc
Confidence 7999999999 45665443321 12334677777778888999999999788999999999999999999999999999
Q ss_pred ccccccccccceeeccCccccccccccCC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhhh
Q 041878 683 SRLMTAAANTNVIATAGTLGYRAPELSKL--KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEW 757 (773)
Q Consensus 683 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 757 (773)
+..+.... ..+...|...|||||.+.. ..|+.++||||+|++|+|+.||..||..++. .-+++..+..+.+
T Consensus 215 cGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdp 287 (361)
T KOG1006|consen 215 CGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDP 287 (361)
T ss_pred hHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCC
Confidence 87664332 2234468889999998743 3589999999999999999999999988765 5566666655554
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=264.46 Aligned_cols=194 Identities=26% Similarity=0.402 Sum_probs=157.6
Q ss_pred ccccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHHHHc---cCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 542 IMGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGK---IHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 542 ~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
+||+|+||.||++... +++.||+|.+..... .....+.+|..+++. .+|++++.+++++. ..+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-TPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-cCCeEEEEEecC
Confidence 4899999999999864 688999998865422 112334445444433 46999999998884 445889999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++|+|.+++.... .+++..+..++.|++.|++||| +.+|+||||||+||++++++.++++|||++....... .
T Consensus 80 ~~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH-~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 80 NGGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMH-NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 9999999987653 3899999999999999999999 9999999999999999999999999999987543221 1
Q ss_pred eeccCccccccccccC-CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSK-LKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
....|++.|+|||... +..++.++||||+||++|||++|+.||......
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 202 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc
Confidence 2235899999999876 456889999999999999999999999765433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=264.11 Aligned_cols=204 Identities=26% Similarity=0.434 Sum_probs=173.4
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.+.||.|+||+||+|... ++..+|+|++.... ......+.+|++.++.++|+|++++++.+. .....++|+||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~iv~e~~ 81 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-VGDELWLVMPYL 81 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-eCCEEEEEEecc
Confidence 345688999999999999854 67899999986543 335678999999999999999999999884 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc--
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT-- 692 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 692 (773)
++++|.++++.......+++.....++.|++.|++||| +.|++||||+|+||++++++.++|+|||.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh-~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH-SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 99999999987644455889999999999999999999 999999999999999999999999999998776544322
Q ss_pred -ceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 693 -NVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 693 -~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
......++..|+|||.+... .++.++|+|||||++|||++|+.||...+.
T Consensus 161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 11233578899999988766 789999999999999999999999976543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=248.14 Aligned_cols=199 Identities=25% Similarity=0.427 Sum_probs=163.9
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
......||.|..|.||++... .|...|||.+.... .+..+++...+.++.+.+ .|.||+.+|+|..+. ..++.||.
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-dV~IcMel 172 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-DVFICMEL 172 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-hHHHHHHH
Confidence 355678999999999999865 58899999997654 345678888888887765 899999999996655 78888999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
| ...+..++.+.. ..+++...-++...++.||.||.+..||||||+||+|||+|+.|++|++|||.+..+......
T Consensus 173 M-s~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh- 248 (391)
T KOG0983|consen 173 M-STCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH- 248 (391)
T ss_pred H-HHHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccc-
Confidence 8 345556665542 347777777889999999999997889999999999999999999999999999877544332
Q ss_pred eeeccCccccccccccC---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSK---LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
+...|.+.|||||.+. ...|+.++||||||+.++|+.||..||.+.+
T Consensus 249 -trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 249 -TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred -ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 2345899999999874 4578999999999999999999999998743
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=269.56 Aligned_cols=199 Identities=25% Similarity=0.421 Sum_probs=171.2
Q ss_pred HHHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 536 LCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
+|.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++|||++++++++.. .+..++|+||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~ 98 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-GDELWVVMEYL 98 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-CCcEEEEEecC
Confidence 455678899999999999985 4688999999876555556778999999999999999999999854 45899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++++|.+++.+. .+++..+..++.|++.|+.||| +.|++||||+|+||+++.++.++|+|||++......... .
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH-~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-~ 172 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 172 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH-hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-c
Confidence 999999998753 2678889999999999999999 999999999999999999999999999988765433221 1
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....+++.|+|||......++.++|||||||++||+++|+.||...+
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22357889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=264.26 Aligned_cols=199 Identities=26% Similarity=0.436 Sum_probs=170.4
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc--cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK--GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|+..+.||+|+||.||+|... +++.||+|.++..... ....+.+|++++++++|+||+++++++ ...+..++|+||
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-~~~~~~~lv~e~ 80 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-VHREKVYIFMEY 80 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-ecCCEEEEEEec
Confidence 455688999999999999864 7899999999765443 567899999999999999999999988 455689999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++++|.+++.... .+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.+||+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh-~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLH-SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999998643 3678889999999999999999 9999999999999999999999999999988765433221
Q ss_pred ee---eccCccccccccccCCCC---CCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 694 VI---ATAGTLGYRAPELSKLKN---ANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 694 ~~---~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
.. ...+++.|+|||.+.... ++.++||||||+++||+++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 11 245788999999987665 889999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-30 Score=266.32 Aligned_cols=197 Identities=24% Similarity=0.451 Sum_probs=167.9
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc-CcccHHHHHHHHHHHHccC---CCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK-TTKGQKEFEAEAAAIGKIH---HPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~lV~ 611 (773)
|...+.||+|+||.||+|.. .+++.||+|.++.. ......++.+|+.++++++ |||++++++++. .....++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-~~~~~~lv~ 81 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-KGPRLWIIM 81 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-eCCEEEEEE
Confidence 44567899999999999986 57899999998754 3344567889999999997 999999999984 455899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++++|.++++.. .+++.....++.|++.|+.||| +.||+||||+|+||+++.++.++++|||.+........
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh-~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIH-KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHH-hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999998653 4789999999999999999999 99999999999999999999999999999887654332
Q ss_pred cceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
. .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 157 K-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred c-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 223458889999998765 45688999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=266.41 Aligned_cols=198 Identities=25% Similarity=0.396 Sum_probs=165.6
Q ss_pred HhhcccccccceEEEEEEe----CCCCEEEEEEecccC----cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEE
Q 041878 538 ATAEIMGKSTYGTAYKATL----EDGSEVAVKRLREKT----TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 608 (773)
.+.+.||+|+||.||+|.. .+|..||+|+++... ....+.+.+|+++++++ +|++|+++++.+. .....+
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~ 81 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-TDTKLH 81 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee-cCCeEE
Confidence 4567899999999999985 368899999997532 22346788899999999 5899999998884 455889
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||+++++|.+++.... .+++.....++.|++.||.||| +.|++||||+|+||+++.++.+||+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH-~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 82 LILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLH-KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 9999999999999998653 3678888899999999999999 99999999999999999999999999999876544
Q ss_pred ccccceeeccCccccccccccCC--CCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKL--KNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
..........|+..|+|||.... ..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 33222233458889999998765 34678999999999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=266.09 Aligned_cols=200 Identities=25% Similarity=0.374 Sum_probs=172.8
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++.+ ......++|+|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e 80 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-QDEENMYLVVD 80 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-cCCCeEEEEEe
Confidence 345688999999999999875 68999999997543 23457889999999999999999999988 45568999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++++|.+++... ..++...+..++.|+++|+.||| +.+++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLH-SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999875 24788899999999999999999 9999999999999999999999999999987654332
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
......++..|+|||......++.++|+||+|+++|+|++|+.||...+..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 205 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT 205 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc
Confidence 223345888999999998888999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=261.07 Aligned_cols=198 Identities=27% Similarity=0.457 Sum_probs=172.5
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.+.||+|++|.||+|... +++.||+|++..... ....++.+|+..+++++|+|++++++++. .....++||||++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~ 82 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-KEGEISIVLEYMD 82 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-cCCeEEEEEEecC
Confidence 45688999999999999876 589999999876544 44678999999999999999999999984 4468999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccC-CCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE-ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~-~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
+++|.+++... ..++...+..++.|+++|++||| + .+++||||+|+||+++.++.++|+|||.+..........
T Consensus 83 ~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh-~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~- 157 (264)
T cd06623 83 GGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLH-TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC- 157 (264)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHh-ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-
Confidence 99999999875 34788999999999999999999 7 999999999999999999999999999988765433221
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....++..|+|||......++.++||||||+++|||+||+.||....
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 12347889999999988889999999999999999999999997764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=263.64 Aligned_cols=200 Identities=24% Similarity=0.436 Sum_probs=166.3
Q ss_pred HhhcccccccceEEEEEEeCC--CCEEEEEEecccC----------cccHHHHHHHHHHHHc-cCCCceEEeEEEEECCC
Q 041878 538 ATAEIMGKSTYGTAYKATLED--GSEVAVKRLREKT----------TKGQKEFEAEAAAIGK-IHHPNLLALRAYYLGPK 604 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~--g~~vAvK~l~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~ 604 (773)
.+.+.||+|+||.||+|.... ++.+|+|.+.... .....++..|+.++.+ ++|+|++++++++. ..
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-~~ 81 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-EN 81 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-cC
Confidence 456789999999999999764 6889999885321 1223456778888875 79999999999994 55
Q ss_pred CeEEEEEeecCCCCHHHHHhhc-CCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCc
Q 041878 605 GEKLLVFDFMPKGSLASFLHAR-GPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS 683 (773)
Q Consensus 605 ~~~~lV~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a 683 (773)
+..++||||+++++|.+++... .....+++..++.++.|++.|+.|||+..+++||||+|+||+++.++.++|+|||.+
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccce
Confidence 6899999999999999988653 223458889999999999999999994478999999999999999999999999998
Q ss_pred cccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 684 RLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
....... ......++..|+|||...+..++.++||||||+++|||++|+.||...
T Consensus 162 ~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 162 KQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred eeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 8654432 223445888999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=266.11 Aligned_cols=199 Identities=30% Similarity=0.494 Sum_probs=164.5
Q ss_pred cccccccceEEEEEEeCC-------CCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 541 EIMGKSTYGTAYKATLED-------GSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~-------g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+.||+|+||.||+|+..+ ++.+|+|.+.... .....++.+|++++++++||||+++++++. ..+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-LNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-CCCCeEEEEe
Confidence 368999999999998642 2579999886543 234667899999999999999999999984 4558999999
Q ss_pred ecCCCCHHHHHhhcC----CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC-----CeEEeecCCc
Q 041878 613 FMPKGSLASFLHARG----PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT-----NPRIADFGLS 683 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~-----~~kl~DfG~a 683 (773)
|+++++|.+++++.. ....+++.+++.++.|++.|++||| +.+++|+||||+||+++.++ .++++|||++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE-QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH-hCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999997642 1234788999999999999999999 99999999999999999887 8999999998
Q ss_pred ccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 684 RLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 684 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
......... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~ 218 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC
Confidence 765432211 1122345678999999998899999999999999999998 999986543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=267.39 Aligned_cols=191 Identities=22% Similarity=0.399 Sum_probs=159.1
Q ss_pred cccccccceEEEEEEeCC--------CCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 541 EIMGKSTYGTAYKATLED--------GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++|||++++++++.. .+..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-GDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-CCCcEEEEe
Confidence 469999999999997532 23488888866555556788999999999999999999999954 447899999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC--------eEEeecCCcc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN--------PRIADFGLSR 684 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~--------~kl~DfG~a~ 684 (773)
|+++|+|.++++.... .+++..++.++.||+.|++||| ++||+||||||+||+++.++. ++++|||.+.
T Consensus 80 ~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH-~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 80 YVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLE-DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred cCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999999987532 4788999999999999999999 999999999999999988765 5999999886
Q ss_pred ccccccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCC-CCCCCC
Q 041878 685 LMTAAANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGK-SPGEPM 740 (773)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~-~P~~~~ 740 (773)
..... ....+++.|+|||++.+ ..++.++|||||||++|||++|. .||...
T Consensus 157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~ 209 (258)
T cd05078 157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL 209 (258)
T ss_pred ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc
Confidence 54322 12347889999999876 45789999999999999999985 565543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=261.38 Aligned_cols=192 Identities=23% Similarity=0.404 Sum_probs=166.8
Q ss_pred cccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCC
Q 041878 543 MGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 543 lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
||.|++|.||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++++++. .+...++|+||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-DKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-cCCccEEEEecCCCCc
Confidence 699999999999875 588999999865432 34567999999999999999999999884 4558999999999999
Q ss_pred HHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeecc
Q 041878 619 LASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA 698 (773)
Q Consensus 619 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 698 (773)
|.+++.+.. .++...+..++.||+.|++||| +.+++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 80 L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH-~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 80 LWTILRDRG---LFDEYTARFYIACVVLAFEYLH-NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 999998753 3788899999999999999999 8999999999999999999999999999988765432 122345
Q ss_pred CccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 699 GTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 699 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
+++.|+|||.+....++.++|+||+|+++|||++|..||....
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 7889999999888889999999999999999999999997655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=262.56 Aligned_cols=195 Identities=30% Similarity=0.562 Sum_probs=165.5
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+++.+.||+|+||.||++.. .++.||+|..+... ....+.+|+.++++++|+|++++++++.. +..++||||+++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~v~e~~~~ 82 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH--NGLYIVMELMSK 82 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC--CCcEEEEECCCC
Confidence 46678999999999999975 57889999986432 34678899999999999999999999843 357999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.+++.... ...+++.++..++.|++.|+.||| +.|++||||||+||+++.++.+||+|||.+....... ..
T Consensus 83 ~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH-~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----~~ 156 (254)
T cd05083 83 GNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLE-SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----DN 156 (254)
T ss_pred CCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccCcceEEEcCCCcEEECCCccceeccccC----CC
Confidence 99999998654 234788999999999999999999 9999999999999999999999999999987543221 11
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
...+..|+|||.+.+..++.++|||||||++|||++ |+.||...+.
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 203 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH
Confidence 224568999999988899999999999999999997 9999876543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=264.85 Aligned_cols=196 Identities=23% Similarity=0.426 Sum_probs=168.9
Q ss_pred HhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 538 ATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
...++||+|++|.||++.. .+++.+|+|++........+.+.+|+.++++++|+|++++++++. ..+..++|+||+++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-~~~~~~~v~e~~~~ 100 (285)
T cd06648 22 DNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-VGDELWVVMEFLEG 100 (285)
T ss_pred hcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-cCCeEEEEEeccCC
Confidence 3457899999999999985 478899999987655555667889999999999999999999885 45589999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.+++... .+++..+..++.|++.|++||| +.|++||||+|+||+++.++.++++|||.+........ ....
T Consensus 101 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 174 (285)
T cd06648 101 GALTDIVTHT----RMNEEQIATVCLAVLKALSFLH-AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKS 174 (285)
T ss_pred CCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccc
Confidence 9999998762 3788899999999999999999 99999999999999999999999999998775543222 1223
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
..|++.|+|||...+..++.++|||||||++|||++|+.||...
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~ 218 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence 45889999999998888999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=263.10 Aligned_cols=192 Identities=27% Similarity=0.421 Sum_probs=156.9
Q ss_pred ccccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHH---HHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 542 IMGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAA---AIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 542 ~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
+||+|+||.||+|... +++.||+|.+..... .....+..|.. .++...|++++++.+++. ..+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-TPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-cCCEEEEEEecC
Confidence 4899999999999864 688999999865422 11223344433 344457999999998884 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++|+|.+++.... .+++..+..++.|++.|+.||| +.+|+||||||+||+++.++.++|+|||++........
T Consensus 80 ~g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--- 152 (278)
T cd05606 80 NGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMH-NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (278)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence 9999999887643 4899999999999999999999 89999999999999999999999999999875532221
Q ss_pred eeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....|+..|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 223589999999998644 68999999999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-29 Score=262.26 Aligned_cols=198 Identities=25% Similarity=0.440 Sum_probs=169.0
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
+...+.||+|+||.||+|.. .++..||+|...... ......+.+|+..+++++|+|++++++++. .....++||||+
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~ 84 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-KDTKLWIIMEYL 84 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-eCCeEEEEEEeC
Confidence 45678899999999999986 468899999986443 233567889999999999999999999995 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++++|.+++... .+++.....++.|++.|+.||| +.|++|+||+|+||+++.++.++++|||++........ ..
T Consensus 85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06641 85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLH-SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHc-cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-hh
Confidence 999999998753 3788999999999999999999 99999999999999999999999999999876543221 12
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....++..|+|||......++.++|+|||||++|||++|..||....
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 23357889999999988888999999999999999999999997644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=264.29 Aligned_cols=198 Identities=26% Similarity=0.452 Sum_probs=165.4
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcc----------cHHHHHHHHHHHHccCCCceEEeEEEEECCCC
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTK----------GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG 605 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 605 (773)
|...+.||+|+||.||+|.. .+|+.||+|.++..... ..+.+.+|+.++++++|+|++++++++ ...+
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 81 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE-TTEE 81 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe-ccCC
Confidence 34567899999999999975 46899999988532110 124678899999999999999999998 4556
Q ss_pred eEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccc
Q 041878 606 EKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL 685 (773)
Q Consensus 606 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~ 685 (773)
..++||||+++++|.+++++.. .+++..+..++.||+.|+.||| +.+++||||+|+||+++.++.++++|||.+..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLH-SKGILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHh-hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 8999999999999999998753 4788889999999999999999 89999999999999999999999999999876
Q ss_pred ccccccc-ceeeccCccccccccccCCCC--CCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 686 MTAAANT-NVIATAGTLGYRAPELSKLKN--ANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 686 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
....... ......++..|+|||...... ++.++|+||+|+++||+++|..||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 5432211 122345788999999876654 78899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=267.29 Aligned_cols=197 Identities=26% Similarity=0.384 Sum_probs=163.3
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|...+.||+|+||.||+|... +|+.||+|+++... ......+.+|++++++++|+|++++++++. .....++|+||
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~ 80 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-SDKKLTLVFEY 80 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-cCCceEEEEec
Confidence 345678999999999999864 68999999986432 223456788999999999999999999984 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
++ ++|.+++.... ..+++..+..++.||++||.||| +.+++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH-~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~- 155 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCH-SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC- 155 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence 96 58888877542 34789999999999999999999 999999999999999999999999999998765432211
Q ss_pred eeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
.....+++.|+|||.+.+. .++.++|||||||++|||+||+.|+..
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 1233578899999987654 478999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=235.64 Aligned_cols=212 Identities=25% Similarity=0.387 Sum_probs=168.5
Q ss_pred HhhcccccccceEEEEEEe-CCCCEEEEEEeccc-CcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK-TTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
...+-||+|++|.|=+.++ .+|+..|+|+++.. ..+.+++..+|+.+..+. ..|.+|.++|.+ ..++..|+.||.|
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-~regdvwIcME~M 127 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-FREGDVWICMELM 127 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh-hccccEEEeHHHh
Confidence 4456799999999987764 68999999999765 344567788888877664 689999999988 5566999999999
Q ss_pred CCCCHHHHHhhc-CCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 615 PKGSLASFLHAR-GPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 615 ~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
..+|..+-++- .....+++...-+|+..|+.||.|||+...+||||+||+|||++.+|++|++|||.+..+...-..
T Consensus 128 -~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk- 205 (282)
T KOG0984|consen 128 -DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK- 205 (282)
T ss_pred -hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH-
Confidence 45776654432 334568888888999999999999997789999999999999999999999999998776543222
Q ss_pred eeeccCccccccccccC----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHh
Q 041878 694 VIATAGTLGYRAPELSK----LKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKE 755 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~----~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 755 (773)
+...|...|||||.+. ...|+-++||||+|+.++||.+++.||+.... .-++++++..+
T Consensus 206 -t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t--pF~qLkqvVee 268 (282)
T KOG0984|consen 206 -TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT--PFQQLKQVVEE 268 (282)
T ss_pred -HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC--HHHHHHHHhcC
Confidence 2235888999999763 34789999999999999999999999976432 34555555543
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-30 Score=268.98 Aligned_cols=198 Identities=24% Similarity=0.390 Sum_probs=166.0
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc--cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK--GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.+.++||+|+||.||+|..+ +++.||+|++...... ..+.+.+|++++++++|+||+++++++ ...+..++|+||+
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~ 82 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-RRKKRLYLVFEFV 82 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-ccCCeEEEEEecC
Confidence 45688999999999999875 5899999998654322 356788999999999999999999999 4566899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++++|.++..... .+++.+++.++.||+.|+.||| +.+++||||+|+||++++++.++++|||++....... ...
T Consensus 83 ~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH-~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (286)
T cd07846 83 DHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCH-SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVY 157 (286)
T ss_pred CccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-ccc
Confidence 9998888765432 3789999999999999999999 8999999999999999999999999999987654332 122
Q ss_pred eeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....++..|+|||...+ ..++.++|||||||++|||++|+.||....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 23347889999998764 457889999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=264.74 Aligned_cols=201 Identities=27% Similarity=0.460 Sum_probs=168.7
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
...++||+|++|.||+|+.. +|+.||||.++.... .....+.+|+.++++++|+|++++++++.. .+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 81 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-ENKLMLVFEYMD 81 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-CCcEEEEEecCC
Confidence 45688999999999999975 688999999975533 235667789999999999999999999954 458899999997
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+ +|.+++........+++..+..++.||+.|++||| +.+++||||+|+||++++++.++++|||.+......... ..
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~ 158 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH-ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FS 158 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc-cc
Confidence 4 89998877654556899999999999999999999 999999999999999999999999999998765432211 12
Q ss_pred eccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
...+++.|+|||.+.+ ..++.++|||||||++||+++|+.||...+.
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 206 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 2346889999998755 4578899999999999999999999986554
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=266.42 Aligned_cols=196 Identities=22% Similarity=0.398 Sum_probs=168.7
Q ss_pred hhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 539 TAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
...+||+|+||.||++.. .+++.||+|++..........+.+|+.++++++|+|++++++++. ..+..++||||++++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~ 102 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-VGDELWVVMEFLEGG 102 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-eCCEEEEEEecCCCC
Confidence 346799999999999986 478999999987655556678999999999999999999999985 455899999999999
Q ss_pred CHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeec
Q 041878 618 SLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697 (773)
Q Consensus 618 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 697 (773)
+|.+++... .+++.....++.|++.|++||| +.|++||||+|+||++++++.++|+|||.+........ .....
T Consensus 103 ~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH-~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 103 ALTDIVTHT----RMNEEQIAAVCLAVLKALSVLH-AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 999987543 3688899999999999999999 89999999999999999999999999998875543221 12234
Q ss_pred cCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 698 AGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 698 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.+++.|+|||...+..++.++|+||+|+++|||++|..||...+
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 57889999999888889999999999999999999999987644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=266.52 Aligned_cols=198 Identities=25% Similarity=0.419 Sum_probs=164.4
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
...+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+||+++++++. .....++||||++
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~ 86 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-TKKTLTLVFEYLD 86 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-cCCeEEEEEecCC
Confidence 45688999999999999865 689999999875432 22345678999999999999999999984 5558999999997
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
++|.+++.+.. ..+++.....++.|++.||.||| +.+|+||||||+||+++.++.+||+|||+++........ ..
T Consensus 87 -~~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH-~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~ 161 (291)
T cd07844 87 -TDLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCH-QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT-YS 161 (291)
T ss_pred -CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH-hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc-cc
Confidence 49999987653 24788999999999999999999 999999999999999999999999999998754322111 11
Q ss_pred eccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...++..|+|||.+.+ ..++.++||||+||++|||++|+.||....
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 2246789999998764 558899999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=262.05 Aligned_cols=196 Identities=27% Similarity=0.443 Sum_probs=170.0
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
...+.||+|++|.||++... +++.||+|.+.... .....++.+|++++++++||||+++++++.. ....++|+||++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 82 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-NGDISICMEYMD 82 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-CCEEEEEEEecC
Confidence 45678999999999999875 68899999987653 3345678999999999999999999999854 468999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccC-CCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE-ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~-~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
+++|.+++.... ..++......++.|++.|++||| + .+++||||||+||++++++.++|+|||.+..........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH-~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~- 158 (265)
T cd06605 83 GGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLH-EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT- 158 (265)
T ss_pred CCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHc-CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc-
Confidence 999999998753 44788889999999999999999 7 999999999999999999999999999987654332211
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
..++..|+|||...+..++.++||||||+++|+|++|+.||...
T Consensus 159 --~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 159 --FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred --ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 45788999999998889999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=288.36 Aligned_cols=201 Identities=17% Similarity=0.272 Sum_probs=156.4
Q ss_pred HHHhhcccccccceEEEEEEeCC--CCEEEEEEe--------------c---ccCcccHHHHHHHHHHHHccCCCceEEe
Q 041878 536 LCATAEIMGKSTYGTAYKATLED--GSEVAVKRL--------------R---EKTTKGQKEFEAEAAAIGKIHHPNLLAL 596 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~--g~~vAvK~l--------------~---~~~~~~~~~~~~E~~~l~~l~h~niv~l 596 (773)
.|.+.+.||+|+||+||++..+. +..+++|.+ . .........+.+|+.++++++|+||+++
T Consensus 149 ~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 228 (501)
T PHA03210 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKI 228 (501)
T ss_pred ccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcE
Confidence 35677899999999999987532 222222211 0 0112234568899999999999999999
Q ss_pred EEEEECCCCeEEEEEeecCCCCHHHHHhhcCC--CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC
Q 041878 597 RAYYLGPKGEKLLVFDFMPKGSLASFLHARGP--ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN 674 (773)
Q Consensus 597 ~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~ 674 (773)
++++. ..+..++|+|++. +++.+++..... ...........++.||+.||+||| +.|||||||||+|||++.++.
T Consensus 229 ~~~~~-~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH-~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 229 EEILR-SEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH-DKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred eEEEE-ECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCCC
Confidence 99995 4558899999994 678877754321 112345567789999999999999 999999999999999999999
Q ss_pred eEEeecCCccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 675 PRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 675 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
+||+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 99999999987654433333345689999999999999999999999999999999998865443
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=276.01 Aligned_cols=201 Identities=23% Similarity=0.398 Sum_probs=171.5
Q ss_pred HHhhcccccccceEEEEEEeCC-CCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLED-GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
+.+..-||.|+||.||+|..++ +-..|.|++........+++.-||++|..+.||+||++++.| ...+..|++.|||+
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ay-y~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAY-YFENKLWILIEFCG 112 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHH-hccCceEEEEeecC
Confidence 4566679999999999998664 344578888777777788999999999999999999999988 44558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
||-....+-+-+ ..+...++.-+++|++.||.||| +..|||||+|+.|||+.-+|.++++|||.+....... ....
T Consensus 113 GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LH-s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qkRD 188 (1187)
T KOG0579|consen 113 GGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLH-SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QKRD 188 (1187)
T ss_pred CchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHh-hcchhhhhccccceEEEecCcEeeecccccccchhHH-hhhc
Confidence 999998887653 45889999999999999999999 9999999999999999999999999999876443222 2233
Q ss_pred eccCcccccccccc-----CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELS-----KLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 696 ~~~gt~~y~aPE~~-----~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.+.|||+|||||+. ...+|+.++||||||+++.||..+.+|....+.
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp 240 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP 240 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence 56799999999964 567899999999999999999999999876554
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=260.45 Aligned_cols=200 Identities=24% Similarity=0.453 Sum_probs=169.0
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|...+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|++++++++|+|++++++.+ ...+..++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~lv~e~ 80 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-LEDKALMIVMEY 80 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-ecCCEEEEEEec
Confidence 34567899999999999986 468899999986542 33456789999999999999999999988 455689999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC-CeEEeecCCcccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT-NPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~~~~ 692 (773)
+++++|.+++.... ...+++..+..++.|++.|++||| +.+++||||+|+||++++++ .+|++|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVH-TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence 99999999998653 234788999999999999999999 99999999999999998654 5799999998866433221
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....++..|+|||......++.++||||||+++|+|++|+.||...+
T Consensus 159 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 159 --YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred --cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 22357889999999988888999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=267.92 Aligned_cols=199 Identities=28% Similarity=0.398 Sum_probs=167.1
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc-----cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK-----GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
...+.||+|+||.||+|... +|+.||||.++..... ....+..|++++++++|+||+++++++.. ....++||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~ 81 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINLVF 81 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEEEE
Confidence 44578999999999999864 6899999999765432 24557789999999999999999999955 56899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+ +++|.+++.... ..+++..+..++.||++||.||| +.|++||||+|+||+++.++.++|+|||+++.......
T Consensus 82 e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLH-SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999 899999998653 24899999999999999999999 99999999999999999999999999999987654321
Q ss_pred cceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
......+++.|+|||.+.+ ..++.++|||||||++|||++|..||...+.
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 158 -KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred -cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence 1122346788999998754 5678999999999999999999888876544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=264.41 Aligned_cols=202 Identities=27% Similarity=0.389 Sum_probs=166.3
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEEC----CCCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLG----PKGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~~lV 610 (773)
|.+.+.||+|+||.||+|... +++.+|+|.+.... ....++.+|+.+++++ +|+||+++++++.. ..+..++|
T Consensus 20 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred eeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 456688999999999999864 67899999886432 2346788899999999 69999999998742 23468999
Q ss_pred EeecCCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 611 FDFMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
|||+++++|.+++.... ....+++..+..++.|++.|+.||| +.+++||||||+||+++.++.++++|||++......
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 177 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH-VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH-hCCccccCCCHHhEEECCCCCEEEccCCceeecccC
Confidence 99999999999886532 2345788899999999999999999 999999999999999999999999999998765432
Q ss_pred cccceeeccCccccccccccC-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSK-----LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. ......|++.|+|||.+. ...++.++||||+||++|||++|+.||...+
T Consensus 178 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~ 233 (286)
T cd06638 178 RL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233 (286)
T ss_pred CC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc
Confidence 21 122335889999999874 3457889999999999999999999987643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=265.26 Aligned_cols=198 Identities=25% Similarity=0.394 Sum_probs=162.8
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|++++++++|+||+++++++. ..+..++|+||++
T Consensus 8 ~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~~lv~e~~~ 86 (291)
T cd07870 8 LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-TKETLTFVFEYMH 86 (291)
T ss_pred EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-cCCeEEEEEeccc
Confidence 45678999999999999864 688999999865433 23456788999999999999999999985 4558999999995
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++.+++.... ..+++..+..++.||+.||.||| +.+|+||||||+||+++.++.++|+|||+++........ ..
T Consensus 87 -~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~ 161 (291)
T cd07870 87 -TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIH-GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-YS 161 (291)
T ss_pred -CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-CC
Confidence 78877776542 23677888899999999999999 899999999999999999999999999998754332211 12
Q ss_pred eccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 2346889999998765 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=266.91 Aligned_cols=201 Identities=25% Similarity=0.399 Sum_probs=168.7
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|.+.++||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++|+||+++++++.. .+..++||||
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e~ 81 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVFEY 81 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEEec
Confidence 345688999999999999865 58899999987532 2335778999999999999999999999954 5589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
++++.+..+.... ..+++..+..++.||+.|+.||| +.+++||||+|+||++++++.+||+|||.+..........
T Consensus 82 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 82 VERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCH-SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9987666655442 23788999999999999999999 9999999999999999999999999999988765543322
Q ss_pred eeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 207 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD 207 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2334578899999998877 889999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=260.48 Aligned_cols=200 Identities=23% Similarity=0.439 Sum_probs=169.8
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|++.+.||+|+||.||++.. .+|+.||+|.+... .....+++.+|+.++++++|+||+++++++ ...+..++|+||
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~e~ 80 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-EENGNLYIVMDY 80 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-cCCCeEEEEEec
Confidence 45568899999999999985 46889999998643 233456889999999999999999999998 555689999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++++|.+++.... ...+++.++..++.|++.|+.||| +.+++|+||+|+||+++.++.++++|||.+.........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~- 157 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVH-DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL- 157 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-
Confidence 99999999987643 234688899999999999999999 899999999999999999999999999998765432211
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
.....+++.|+|||+..+..++.++|||||||++||+++|+.||...
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 11234788999999998888999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=263.61 Aligned_cols=201 Identities=26% Similarity=0.423 Sum_probs=166.0
Q ss_pred HHHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEECC-----CCeEE
Q 041878 536 LCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGP-----KGEKL 608 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~~~~~ 608 (773)
.+.+.++||+|+||.||+|.. .+++.||+|.+.... ....++..|+.+++++ +|+|++++++++... ....+
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 345668899999999999986 468899999985433 3346788899999998 699999999998532 34789
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||+++|+|.+++.... ...+++..+..++.||+.|+.||| +.+|+||||+|+||++++++.++|+|||.+.....
T Consensus 96 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH-~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLH-AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 9999999999999987643 234678888999999999999999 99999999999999999999999999999875532
Q ss_pred ccccceeeccCccccccccccC-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSK-----LKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
... ......+++.|+|||.+. ...++.++|||||||++|||++|+.||...
T Consensus 174 ~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 174 TVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred ccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 221 112345888999999875 356788999999999999999999999654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=262.96 Aligned_cols=194 Identities=26% Similarity=0.430 Sum_probs=166.6
Q ss_pred cccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCC
Q 041878 543 MGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 543 lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
||+|+||.||++... +|+.+|+|.+..... ...+.+.+|++++++++|+|++++++.+ ......++|+||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-QGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-ecCcEEEEEEecCCCCc
Confidence 689999999999976 589999999865433 3456788999999999999999999888 45568999999999999
Q ss_pred HHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc-------
Q 041878 619 LASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN------- 691 (773)
Q Consensus 619 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~------- 691 (773)
|.+++.+.. .+++..+..++.||+.||+||| +.+++||||+|+||++++++.++|+|||++........
T Consensus 80 L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH-~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 80 LASLLENVG---SLDEDVARIYIAEIVLALEYLH-SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 999998754 4789999999999999999999 99999999999999999999999999999876543321
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.......++..|+|||......++.++||||||+++||+++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 12223457889999999888889999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=263.70 Aligned_cols=202 Identities=30% Similarity=0.442 Sum_probs=166.5
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCC----CeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPK----GEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----~~~~lV 610 (773)
|.+.+.||+|+||.||++.. .+++.+|+|.+.... ....++.+|+.+++++ +|||++++++++...+ +..++|
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 34567899999999999986 468899999986432 2356778899999999 7999999999986433 358999
Q ss_pred EeecCCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 611 FDFMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
+||+++++|.++++... ....+++..++.++.|++.|++||| +.+++||||||+||+++.++.+||+|||.+......
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 181 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH-NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEEcCCCCEEEeecccchhcccc
Confidence 99999999999887532 2345789999999999999999999 999999999999999999999999999998765432
Q ss_pred cccceeeccCccccccccccCCC-----CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSKLK-----NANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
... .....++..|+|||.+... .++.++|||||||++|||++|+.||...+
T Consensus 182 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~ 237 (291)
T cd06639 182 RLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237 (291)
T ss_pred ccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc
Confidence 211 1233578899999987543 36889999999999999999999997654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=263.61 Aligned_cols=202 Identities=26% Similarity=0.378 Sum_probs=168.3
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCC-CeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-GEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~lV~e 612 (773)
|...+.||+|+||.||+|... +++.+|+|.++.... .....+.+|+.++++++||||+++++++.... ...++|||
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 556788999999999999875 688999999975432 22346778999999999999999999885542 68999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|++ ++|.+++.... ..+++..+..++.||+.||+||| +.+++||||||+||+++.++.++|+|||.+........
T Consensus 87 ~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH-~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 161 (293)
T cd07843 87 YVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLH-DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK- 161 (293)
T ss_pred hcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc-
Confidence 997 59999987653 24789999999999999999999 99999999999999999999999999999887654321
Q ss_pred ceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
......+++.|+|||.+.+. .++.++|+||+|+++|||++|+.||...+..
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~ 213 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 12233478899999987654 4688999999999999999999999865543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=263.04 Aligned_cols=203 Identities=29% Similarity=0.456 Sum_probs=164.9
Q ss_pred hhcccccccceEEEEEEeC----CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCC-----eE
Q 041878 539 TAEIMGKSTYGTAYKATLE----DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG-----EK 607 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~ 607 (773)
+.++||+|+||.||+|.+. +++.||||.+.... ....+++.+|++++++++|||++++++++..... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4578999999999999753 36789999987542 3345678899999999999999999998854321 24
Q ss_pred EEEEeecCCCCHHHHHhhcC---CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcc
Q 041878 608 LLVFDFMPKGSLASFLHARG---PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSR 684 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~ 684 (773)
++++||+++|+|.+++.... ....+++.....++.||+.|++||| +.+|+||||||+||+++.++.+|++|||.++
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~nili~~~~~~kl~dfg~~~ 161 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS-SKNFIHRDLAARNCMLNENMTVCVADFGLSK 161 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeecccchhhEEEcCCCCEEECcccccc
Confidence 78999999999998875432 1224788899999999999999999 9999999999999999999999999999988
Q ss_pred cccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 685 LMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 685 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
........ ......+++.|++||......++.++|||||||++|||++ |+.||...+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05074 162 KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN 221 (273)
T ss_pred cccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH
Confidence 65432211 1112235678999999988889999999999999999999 8899876543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-30 Score=249.92 Aligned_cols=202 Identities=23% Similarity=0.345 Sum_probs=168.5
Q ss_pred hcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEEC---CCCeEEEEEeec
Q 041878 540 AEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLG---PKGEKLLVFDFM 614 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---~~~~~~lV~e~~ 614 (773)
.++||-|-.|.|..+.. .+|+.+|+|++... ....+|++..-.. .|||||+++++|.. ......+|||.|
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 37899999999998875 47899999999533 2335677765444 59999999999832 234677999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC---CCeEEeecCCccccccccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK---TNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~---~~~kl~DfG~a~~~~~~~~ 691 (773)
+||.|.+.++.++ .+.+++.++-.|++||..|+.||| +..|.||||||+|+|.... -.+|++|||+|+.... .
T Consensus 142 eGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH-~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~--~ 217 (400)
T KOG0604|consen 142 EGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLH-SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE--P 217 (400)
T ss_pred cchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHH-hcchhhccCChhheeeecCCCCcceEecccccccccCC--C
Confidence 9999999999876 456899999999999999999999 9999999999999999754 4589999999986543 2
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHH
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVA 750 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 750 (773)
......+.||.|.|||++....|+..+|+||+||+||-|++|.+||..+.+..+..-++
T Consensus 218 ~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk 276 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276 (400)
T ss_pred ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHH
Confidence 33345578999999999999999999999999999999999999999988776554444
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=262.49 Aligned_cols=198 Identities=29% Similarity=0.475 Sum_probs=171.4
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
...+.||+|++|.||+|... +++.||+|++..... ..+.+.+|++.+++++|+|++++++++... ...++|+||+++
T Consensus 22 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~ 99 (286)
T cd06614 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG-DELWVVMEYMDG 99 (286)
T ss_pred hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-CEEEEEEeccCC
Confidence 45578999999999999876 688999999975544 567788999999999999999999998554 589999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.+++.... ..+++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 100 ~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH-~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~ 175 (286)
T cd06614 100 GSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLH-SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNS 175 (286)
T ss_pred CcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhcc
Confidence 99999998764 35899999999999999999999 89999999999999999999999999998875543321 1122
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
..+++.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 347889999999988889999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=290.14 Aligned_cols=209 Identities=26% Similarity=0.411 Sum_probs=174.7
Q ss_pred ChhHHHHHhhcccccccceEEEEEEeC----C----CCEEEEEEecccCc-ccHHHHHHHHHHHHccC-CCceEEeEEEE
Q 041878 531 TADDLLCATAEIMGKSTYGTAYKATLE----D----GSEVAVKRLREKTT-KGQKEFEAEAAAIGKIH-HPNLLALRAYY 600 (773)
Q Consensus 531 ~~~~l~~~~~~~lG~G~fg~Vy~~~~~----~----g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~ 600 (773)
+.++-...+.+.+|+|+||.|++|... . ...||||.++.... .+.+.+..|+++|+.+. |+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 333333356679999999999999742 1 34699999986543 45678999999999984 99999999999
Q ss_pred ECCCCeEEEEEeecCCCCHHHHHhhcC-----------CC--CccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCE
Q 041878 601 LGPKGEKLLVFDFMPKGSLASFLHARG-----------PE--TIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNV 667 (773)
Q Consensus 601 ~~~~~~~~lV~e~~~~g~L~~~l~~~~-----------~~--~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NI 667 (773)
.. ++..++|+||++.|+|.++++.++ .. ..++....+.++.|||.|++||+ +.++||||+.++||
T Consensus 372 t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~-~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 372 TQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA-SVPCVHRDLAARNV 449 (609)
T ss_pred cc-CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh-hCCccchhhhhhhE
Confidence 54 779999999999999999998875 01 23788899999999999999999 99999999999999
Q ss_pred EeCCCCCeEEeecCCccccccccccceeecc--CccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 668 LLDEKTNPRIADFGLSRLMTAAANTNVIATA--GTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 668 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
|+.++..+||+|||+|+.......+...... -..+|||||.+....|+.++|||||||++||++| |..||.+..
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999977665554433222 2457999999999999999999999999999999 888987633
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=260.62 Aligned_cols=203 Identities=23% Similarity=0.357 Sum_probs=166.9
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc---cHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEe
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK---GQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
....+||+|+||.|.+|.-+ +.+.+|||++++.... +.+--..|-++|.-. +-|.++++...+ ..-+..|.|||
T Consensus 352 nFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-QTmDRLyFVME 430 (683)
T KOG0696|consen 352 NFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-QTMDRLYFVME 430 (683)
T ss_pred ceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-hhhhheeeEEE
Confidence 34678999999999999755 4567999999876432 222334466666554 467888888777 45558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+.||+|--.++.-++ +....+..++.+||-||-+|| ++|||+||+|.+|||+|.+|++||+|||+++.---+. .
T Consensus 431 yvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh-~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~-~ 505 (683)
T KOG0696|consen 431 YVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLH-SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG-V 505 (683)
T ss_pred EecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhh-cCCeeeeeccccceEeccCCceEeeecccccccccCC-c
Confidence 9999999998988664 556777889999999999999 9999999999999999999999999999997533222 2
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChH
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLP 746 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~ 746 (773)
.+...+|||.|+|||.+..++|+.++|-|||||++|||+.|..||++.+++++-
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF 559 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 559 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 334568999999999999999999999999999999999999999887765543
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=263.64 Aligned_cols=200 Identities=28% Similarity=0.438 Sum_probs=168.9
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECC-CCeEEEEEeec
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-KGEKLLVFDFM 614 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV~e~~ 614 (773)
+.+.||+|+||.||+|... +++.+|+|++.... ......+.+|++++++++|+|++++++++... .+..++|+||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 4578999999999999865 58899999998653 33456788999999999999999999999655 26899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
+ ++|.+++.... ..+++..++.++.||+.|++||| +.+++|+||+|+||++++++.++|+|||.+...........
T Consensus 83 ~-~~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH-~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 83 D-HDLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLH-SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred c-ccHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 7 48988887642 35889999999999999999999 89999999999999999999999999999987655432223
Q ss_pred eeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||+..+.
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 33456889999997654 4678999999999999999999999976654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=255.29 Aligned_cols=197 Identities=29% Similarity=0.506 Sum_probs=172.9
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
...+.||+|++|.||++... +++.+++|++.........++.+|++.+++++|++++++++++.. ....++++||+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~ 81 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-KDELWIVMEFCSG 81 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEecCCC
Confidence 34578999999999999875 688999999977655567889999999999999999999999854 4689999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.+++.... ..+++..+..++.|++.|+.||| +.+++||||+|+||++++++.++|+|||.+........ ...
T Consensus 82 ~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh-~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 156 (253)
T cd05122 82 GSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLH-SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNT 156 (253)
T ss_pred CcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhh-cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccc
Confidence 99999988753 34799999999999999999999 89999999999999999999999999999887654432 223
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
..++..|+|||......++.++||||||+++|+|++|+.||...
T Consensus 157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 45788999999998888999999999999999999999998765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=225.83 Aligned_cols=208 Identities=27% Similarity=0.401 Sum_probs=169.2
Q ss_pred HhhcccccccceEEEEEE-eCCCCEEEEEEecccCcc--cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTK--GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
...++||+|.+|+||+|+ ..+++.||+|+.+-.... ......+|+-+++.++|+|||+++++.+.++ ..-+|+|||
T Consensus 5 dkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdk-kltlvfe~c 83 (292)
T KOG0662|consen 5 DKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-KLTLVFEFC 83 (292)
T ss_pred HHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc-eeEEeHHHh
Confidence 445889999999999998 456889999998755332 3466789999999999999999999985544 788999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
..+|..+..... ..++...+..++.|+++|+.++| +..+.|||+||+|.+++.+|++|++|||+++...-+... .
T Consensus 84 -dqdlkkyfdsln--g~~d~~~~rsfmlqllrgl~fch-shnvlhrdlkpqnllin~ngelkladfglarafgipvrc-y 158 (292)
T KOG0662|consen 84 -DQDLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCH-SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-Y 158 (292)
T ss_pred -hHHHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhh-hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-e
Confidence 458988887653 34788899999999999999999 999999999999999999999999999999977654322 1
Q ss_pred eeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCC-CCCCCCCChHHHHHHHHH
Q 041878 695 IATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSP-GEPMNGMDLPQWVASIVK 754 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P-~~~~~~~~~~~~~~~~~~ 754 (773)
...+-|..|.+|.++.+ .-|+...|+||.||++.|+.....| |.+. +..++++++.+
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~---dvddqlkrif~ 217 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN---DVDDQLKRIFR 217 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC---cHHHHHHHHHH
Confidence 23346889999998655 5689999999999999999985555 5444 44555555543
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=262.20 Aligned_cols=197 Identities=27% Similarity=0.462 Sum_probs=160.8
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHH-HHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAA-IGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.+.+.||+|+||.||+|... +|+.||+|+++... ...+.++..|+.. ++..+|+|++++++++. ..+..++||||+
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-~~~~~~lv~e~~ 82 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-REGDVWICMEVM 82 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-cCCcEEEEhhhh
Confidence 45678999999999999865 68999999987543 2334556666664 56678999999999995 455899999999
Q ss_pred CCCCHHHHHhhc-CCCCccCHHHHHHHHHHHHHHHHHhccCC-CceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 615 PKGSLASFLHAR-GPETIVNWATRMSIAIGIARGLNYLHVEE-NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 615 ~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~al~yLH~~~-~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
+ |+|.++++.. .....+++..+..++.||+.|++||| +. +++||||||+||+++.++.+||+|||.+........
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA- 159 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc-
Confidence 6 6898888653 22346899999999999999999999 65 999999999999999999999999999876533211
Q ss_pred ceeeccCccccccccccCC----CCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKL----KNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~----~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
.....++..|+|||.+.. ..++.++|+|||||++|||++|+.||..
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 160 -KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred -cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 122357889999998754 4568899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-31 Score=300.50 Aligned_cols=198 Identities=28% Similarity=0.452 Sum_probs=167.7
Q ss_pred hhcccccccceEEEEEE-eCCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 539 TAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.+||.|.||.||.|. ..+|...|+|-++-.. .+..+.+.+|+.++..++|||+|+++|+- ..++..++-||||+
T Consensus 1239 rg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVE-vHRekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVE-VHREKVYIFMEYCE 1317 (1509)
T ss_pred cccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCcee-ecHHHHHHHHHHhc
Confidence 46789999999999997 5678999999887543 33456788999999999999999999987 45668899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc---c
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN---T 692 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~---~ 692 (773)
+|+|.+.++..+ ..+......+..|++.|+.||| +.|||||||||.||+++.+|.+|++|||.|..+..... .
T Consensus 1318 ~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH-~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1318 GGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLH-EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred cCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHH-hcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 999999987643 2455666678899999999999 99999999999999999999999999999988765421 1
Q ss_pred ceeeccCccccccccccCCC---CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLK---NANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~---~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....+||+.|||||++.+. ....+.||||+|||+.||+||+.||...+
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence 22355799999999998653 46678999999999999999999998755
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=263.26 Aligned_cols=201 Identities=23% Similarity=0.454 Sum_probs=169.1
Q ss_pred HHhhcccccccceEEEEEEeC-----CCCEEEEEEecccCcc-cHHHHHHHHHHHHccCCCceEEeEEEEECC-CCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-----DGSEVAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGP-KGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~l 609 (773)
+...+.||+|+||.||+|.+. ++..||||.++..... ...++.+|++.+++++|+|++++++++... ....++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 345688999999999999853 3678999999765443 467899999999999999999999988542 346899
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||+++++|.+++..... .+++..+..++.|++.||+||| +.|++||||||+||+++.++.++++|||.+......
T Consensus 86 v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLG-SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred EEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 9999999999999987532 4889999999999999999999 999999999999999999999999999999876533
Q ss_pred cccce--eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 690 ANTNV--IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 690 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
..... ....++..|+|||......++.++||||||+++|||+||+.|+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 22111 1223456799999998888999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=263.05 Aligned_cols=194 Identities=27% Similarity=0.431 Sum_probs=163.4
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|...+.||+|+||.||+|... +++.||+|.+..... ....++.+|++++++++|||++++++++.. .+..++|+|
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 95 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-EHTAWLVME 95 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-CCeEEEEHH
Confidence 556788999999999999864 689999999864322 234578899999999999999999999954 458899999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|++ |++.+++.... ..+++..+..++.|++.|+.||| +.+|+||||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH-~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~-- 169 (307)
T cd06607 96 YCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLH-SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-- 169 (307)
T ss_pred hhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCcccEEECCCCCEEEeecCcceecCCCC--
Confidence 996 67877776543 24789999999999999999999 9999999999999999999999999999987543221
Q ss_pred ceeeccCccccccccccC---CCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSK---LKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
...+++.|+|||.+. ...++.++||||||+++|||+||+.||...
T Consensus 170 ---~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 170 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred ---CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 234788999999873 456888999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=265.91 Aligned_cols=201 Identities=31% Similarity=0.447 Sum_probs=166.1
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc--cHHHHHHHHHHHHccCCCceEEeEEEEECCC-CeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK--GQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-GEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|... +|+.||+|.++..... ....+.+|+.++++++|+|++++++++.... +..++|||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 345688999999999999864 6899999998754322 2345678999999999999999999986543 46899999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|++ ++|.+++.... ..+++.++..++.||+.|++||| +.|++||||||+||+++.++.+||+|||.+........
T Consensus 89 ~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~- 163 (309)
T cd07845 89 YCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLH-ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK- 163 (309)
T ss_pred cCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC-
Confidence 996 58988887642 34789999999999999999999 99999999999999999999999999999887654321
Q ss_pred ceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+.
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1222345778999998754 5678999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=263.16 Aligned_cols=195 Identities=29% Similarity=0.450 Sum_probs=163.6
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+...+.||+|+||.||+|.. .++..||+|.+.... .+...++..|++++++++|+|++++++++.. ....++|||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 105 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-EHTAWLVME 105 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCeEEEEEe
Confidence 55678899999999999986 468899999986432 2234578889999999999999999999954 458899999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|++ |++.+.+.... ..+++.++..++.|++.|+.||| +.+|+||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH-~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 106 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH-SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 996 58888776542 34789999999999999999999 999999999999999999999999999988654322
Q ss_pred ceeeccCccccccccccC---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSK---LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....+++.|+|||.+. .+.++.++|||||||++|||++|+.||...+
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 228 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 2235788999999873 4568899999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-31 Score=269.22 Aligned_cols=203 Identities=23% Similarity=0.352 Sum_probs=176.8
Q ss_pred hhcccccccceEEEEEEeCCCC-EEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 539 TAEIMGKSTYGTAYKATLEDGS-EVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~~g~-~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
....||-|+||.|=++..+... .+|+|.+++. .++.++.+..|-++|...+.|.||++|..|.+. ...|+.||-|
T Consensus 424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~-kyvYmLmEaC 502 (732)
T KOG0614|consen 424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS-KYVYMLMEAC 502 (732)
T ss_pred hhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc-hhhhhhHHhh
Confidence 3456999999999999876444 3788888765 445567788899999999999999999988544 4899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
-||.++..++.++. ++..+...++..+++|++||| .+|||+||+||+|.++|.+|-+||.|||.|+.+..... +
T Consensus 503 lGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH-~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K--T 576 (732)
T KOG0614|consen 503 LGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLH-RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK--T 576 (732)
T ss_pred cCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHH-hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc--e
Confidence 99999999998654 666777888999999999999 99999999999999999999999999999998876554 4
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHH
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQW 748 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~ 748 (773)
...+|||.|.|||.+.....+.++|.||+|+++||+++|.+||++.+.+..++.
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ 630 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL 630 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 567899999999999999999999999999999999999999999877664443
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=256.38 Aligned_cols=186 Identities=25% Similarity=0.378 Sum_probs=154.9
Q ss_pred cccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeecCCCCHH
Q 041878 543 MGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFMPKGSLA 620 (773)
Q Consensus 543 lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~~g~L~ 620 (773)
+|+|+||.||++.. .++..+|+|.+........ |+.....+ +|+|++++++.+.. .+..++||||+++++|.
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~-~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT-LKGHVLIMDYIKDGDLF 97 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec-CCeeEEEEEcCCCCcHH
Confidence 59999999999985 4688899999865422211 22222222 69999999999954 45899999999999999
Q ss_pred HHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC-CeEEeecCCccccccccccceeeccC
Q 041878 621 SFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT-NPRIADFGLSRLMTAAANTNVIATAG 699 (773)
Q Consensus 621 ~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~g 699 (773)
+++.+.. .+++.++..++.||+.|+.||| +.|++||||+|+||+++.++ .++|+|||.+....... ...+
T Consensus 98 ~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~ 168 (267)
T PHA03390 98 DLLKKEG---KLSEAEVKKIIRQLVEALNDLH-KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----CYDG 168 (267)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----cCCC
Confidence 9998753 4899999999999999999999 99999999999999999998 99999999987654322 2347
Q ss_pred ccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 700 TLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 700 t~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
+..|+|||++.+..++.++||||+|+++|||++|+.||.....+
T Consensus 169 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 212 (267)
T PHA03390 169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE 212 (267)
T ss_pred CCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc
Confidence 88999999998888999999999999999999999999865433
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=258.30 Aligned_cols=203 Identities=23% Similarity=0.383 Sum_probs=170.5
Q ss_pred HhhcccccccceEEEEEEe-CCCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECC-CCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-KGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV~e~ 613 (773)
.+.+.||.|+||.||++.. .+++.||+|.+... .....+++..|++++++++|+|++++++++... ....+++|||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 3457899999999999985 46889999998643 233456788999999999999999999987543 3467899999
Q ss_pred cCCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhc----cCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 614 MPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLH----VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 614 ~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH----~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+++++|.+++.+.. ....+++..++.++.||+.|+.||| .+.+++||||+|+||+++.++.+|++|||++.....
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~ 162 (265)
T cd08217 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162 (265)
T ss_pred ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence 99999999997642 2345889999999999999999999 246799999999999999999999999999887654
Q ss_pred ccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.... .....+++.|+|||.+....++.++||||||+++|+|++|+.||...+
T Consensus 163 ~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 163 DSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred Cccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 3321 223458899999999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=262.63 Aligned_cols=199 Identities=28% Similarity=0.424 Sum_probs=165.5
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
...+.||.|++|.||+|... +|+.||||+++... ......+.+|++++++++||||+++++++ ...+..++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e~~ 81 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-HTENKLYLVFEFL 81 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-ccCCcEEEEeecc
Confidence 34578999999999999864 68999999987543 22345788999999999999999999998 4556899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
+ ++|.+++.... ...+++..+..++.|++.|++||| +.+++||||+|+||+++.++.+|++|||.+........ ..
T Consensus 82 ~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh-~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (284)
T cd07860 82 H-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCH-SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY 157 (284)
T ss_pred c-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-cc
Confidence 5 68999887643 244789999999999999999999 99999999999999999999999999999876543221 12
Q ss_pred eeccCccccccccccCCCC-CCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKN-ANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....+++.|+|||...+.. ++.++|||||||++|||+||+.||...+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2234678999999876544 6889999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=271.39 Aligned_cols=196 Identities=22% Similarity=0.337 Sum_probs=165.3
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCC-----CeEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-----GEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~~ 608 (773)
|...+.||+|+||.||+|... +|+.||+|.+... ......++.+|+.++++++|+||+++++++.... ...+
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence 456788999999999999864 7899999998643 2233456778999999999999999999885432 2569
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||++ ++|.+.+... ++...+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.++....
T Consensus 98 lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH-~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 98 LVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred EEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 9999995 5888887643 678888999999999999999 89999999999999999999999999999986543
Q ss_pred ccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+
T Consensus 171 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 171 SFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred CCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 221 223357889999999998999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=263.39 Aligned_cols=203 Identities=29% Similarity=0.406 Sum_probs=166.7
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCC--------
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-------- 604 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 604 (773)
.|.+.+.||+|+||.||+|..+ +|+.||+|.++... ......+.+|++++++++|||++++++++....
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~ 87 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKD 87 (302)
T ss_pred hhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcccc
Confidence 3566789999999999999875 58899999997543 223456788999999999999999999885433
Q ss_pred -CeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCc
Q 041878 605 -GEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS 683 (773)
Q Consensus 605 -~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a 683 (773)
+..++|+||+++ ++.+.+... ...+++..+..++.||+.||+||| +.||+||||||+||++++++.+||+|||.+
T Consensus 88 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH-~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 88 KGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCH-KKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred CCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 368999999975 777777654 234789999999999999999999 999999999999999999999999999998
Q ss_pred cccccccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 684 RLMTAAANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~ 223 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 8765433222222345778999997754 4578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=266.99 Aligned_cols=205 Identities=26% Similarity=0.406 Sum_probs=167.4
Q ss_pred HHhhcccccccceEEEEEEeC---CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCC-CeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE---DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-GEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~l 609 (773)
|.+.++||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.... ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 345678999999999999864 47899999997633 333467788999999999999999999996542 57899
Q ss_pred EEeecCCCCHHHHHhhcCC--CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC----CCCeEEeecCCc
Q 041878 610 VFDFMPKGSLASFLHARGP--ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE----KTNPRIADFGLS 683 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~----~~~~kl~DfG~a 683 (773)
||||+++ ++.+++..... ...++...+..++.||+.|++||| +.+|+||||||+||+++. ++.+||+|||++
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH-SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH-hCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999964 77777754432 225788899999999999999999 999999999999999999 899999999998
Q ss_pred cccccccc--cceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 684 RLMTAAAN--TNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 684 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
........ .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 86643322 11123357889999998765 45789999999999999999999999875543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=256.61 Aligned_cols=192 Identities=26% Similarity=0.362 Sum_probs=159.4
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHHH-HccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAI-GKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
+.||+|+||.||+|... +|+.||+|.+..... .....+..|..++ ...+|+|++++++++. ..+..++|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-SKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-cCCeEEEEEeccC
Confidence 46899999999999864 689999999865322 1223344454444 4558999999999994 5568999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|.++++... .++...+..++.|++.||.||| +.+++||||+|+||++++++.++|+|||++..... ..
T Consensus 81 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 81 GGDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLH-QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 999999998753 3788889999999999999999 89999999999999999999999999998875432 12
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
...+++.|+|||...+..++.++||||+|+++|||++|..||...+.
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 198 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 23478899999998888889999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=259.11 Aligned_cols=198 Identities=25% Similarity=0.353 Sum_probs=168.2
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECC-CCeEEEEEeecC
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-KGEKLLVFDFMP 615 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV~e~~~ 615 (773)
..+.||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++|+||+++++++... ....++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 84 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence 4578999999999999874 678999999875433 3456789999999999999999999988544 346899999999
Q ss_pred CCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 616 KGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 616 ~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
+++|.+++.... ....++......++.||+.||.||| +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH-~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--- 160 (287)
T cd06621 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH-SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA--- 160 (287)
T ss_pred CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEecCCeEEEeecccccccccccc---
Confidence 999999876532 2344788889999999999999999 99999999999999999999999999999875543221
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
....++..|+|||...+..++.++||||+||++|||++|+.||...
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1234678999999998889999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=260.95 Aligned_cols=205 Identities=23% Similarity=0.319 Sum_probs=165.9
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccC-CCceEEeEEEEECCC-CeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPK-GEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~~lV~e~ 613 (773)
.+.+.||+|+||.||+|... +++.||+|+++... ........+|+.+++++. |+|++++++++.... +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 34678999999999999864 68899999987542 223344567899999886 999999999986542 578999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
++ +++.+++.... ..+++.++..++.|++.||+||| +.+++||||+|+||+++. +.+||+|||.++........
T Consensus 82 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH-~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 82 MD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMH-RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred CC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH-HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence 96 58888887642 34799999999999999999999 999999999999999999 99999999999866433221
Q ss_pred eeeccCccccccccccC-CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHH
Q 041878 694 VIATAGTLGYRAPELSK-LKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWV 749 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~ 749 (773)
....+++.|+|||... ...++.++||||+||++|||++|+.||...+..+...+.
T Consensus 156 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~ 211 (282)
T cd07831 156 -TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI 211 (282)
T ss_pred -CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH
Confidence 2234788999999754 456788999999999999999999999876654443333
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=249.20 Aligned_cols=202 Identities=27% Similarity=0.402 Sum_probs=166.4
Q ss_pred HHhhcccccccceEEEEEEeC---C--CCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE---D--GSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~---~--g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
|.....||+|.||.||+|.-. + ...+|+|+++.... .-.....+|+..++.++|||++.+..++...+...++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 455678999999999999633 2 23689999975522 2234568899999999999999999999776778999
Q ss_pred EEeecCCCCHHHHHhhc--CCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC----CCeEEeecCCc
Q 041878 610 VFDFMPKGSLASFLHAR--GPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK----TNPRIADFGLS 683 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~----~~~kl~DfG~a 683 (773)
++||.+. +|...++-+ ...+.++...++.|+.||+.|+.||| +.=|+|||+||.|||+..+ |.|||+|||++
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH-~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH-SNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh-hhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 9999976 888887644 23456888899999999999999999 8889999999999999888 88999999999
Q ss_pred cccccccccc--eeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 684 RLMTAAANTN--VIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 684 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
+.+..+-..- ....+-|..|.|||.+.+ ..|+++.||||.||++.||+|-++-|.+.
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9887654322 223346889999997765 56899999999999999999999988873
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-29 Score=260.48 Aligned_cols=199 Identities=27% Similarity=0.424 Sum_probs=161.9
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
...++||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++. .++..+++|||+
T Consensus 7 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-~~~~~~~~~e~~ 85 (288)
T cd06616 7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-REGDCWICMELM 85 (288)
T ss_pred HHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-cCCcEEEEEecc
Confidence 34578999999999999864 68999999987543 234567889999999996 999999999884 455889999998
Q ss_pred CCCCHHHHHhhc--CCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 615 PKGSLASFLHAR--GPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 615 ~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
+ +++.++.... .....+++..+..++.|++.|++|||++.+++||||||+||+++.++.++|+|||++.........
T Consensus 86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 164 (288)
T cd06616 86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164 (288)
T ss_pred c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence 5 4665543321 112458889999999999999999994569999999999999999999999999998765432211
Q ss_pred ceeeccCccccccccccCCC---CCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLK---NANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~---~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
....+++.|+|||.+... .++.++|||||||++|||++|+.||...
T Consensus 165 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 165 --TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred --ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 223578899999988765 6899999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=261.21 Aligned_cols=201 Identities=16% Similarity=0.199 Sum_probs=152.0
Q ss_pred HHHhhcccccccceEEEEEEeCC----CCEEEEEEecccCccc--H---------HHHHHHHHHHHccCCCceEEeEEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLED----GSEVAVKRLREKTTKG--Q---------KEFEAEAAAIGKIHHPNLLALRAYY 600 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~~--~---------~~~~~E~~~l~~l~h~niv~l~~~~ 600 (773)
+|.+.++||+|+||.||+|...+ +..+|+|......... + .....+...+..+.|++++++++++
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 35667899999999999998654 3456666543222111 1 1122233455667899999999876
Q ss_pred ECCCC---eEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEE
Q 041878 601 LGPKG---EKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRI 677 (773)
Q Consensus 601 ~~~~~---~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl 677 (773)
..... ..++++|++. .++.+.+.... ..++..+..++.|++.|++||| +.+|+||||||+|||++.++.++|
T Consensus 93 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH-~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 93 SFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIH-EHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCcEEE
Confidence 43332 3467888774 46777666532 2467778899999999999999 999999999999999999999999
Q ss_pred eecCCccccccccc------cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 678 ADFGLSRLMTAAAN------TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 678 ~DfG~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
+|||+|+....... .......||+.|+|||+..+..++.++|||||||++|||++|+.||....
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999986642211 11123459999999999999999999999999999999999999998763
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=269.93 Aligned_cols=199 Identities=24% Similarity=0.402 Sum_probs=163.7
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCC----CeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK----GEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~lV 610 (773)
|.+.++||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.++++++|+||+++++++.... ...++|
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 45678999999999999985 478999999986432 223456788999999999999999998875432 357999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
+||++ +++.+++... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH-~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 87 QELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred ehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 99996 5888777643 3788999999999999999999 9999999999999999999999999999987654322
Q ss_pred ccc--eeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 691 NTN--VIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 691 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
... .....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~ 214 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD 214 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 211 122357889999998654 568899999999999999999999997644
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=253.51 Aligned_cols=199 Identities=24% Similarity=0.444 Sum_probs=171.9
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|...+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+|++++++++.. .+..++||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~ 80 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-SDSLYIILEY 80 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEEEEEEec
Confidence 345688999999999999865 678999999976543 345688999999999999999999999854 4589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++++|.+++.+. ..+++..+..++.|++.|+.||| +.|++||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLH-EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999999875 34789999999999999999999 999999999999999999999999999999876543321
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||...+
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 223457889999999887788999999999999999999999987543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=266.20 Aligned_cols=200 Identities=27% Similarity=0.416 Sum_probs=166.0
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCC-CeEEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPK-GEKLLV 610 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-~~~~lV 610 (773)
.|.+.+.||+|+||.||+|.+. +++.+|+|++... .......+.+|+.+++++ +|+||+++++++.... ...++|
T Consensus 8 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 3567789999999999999865 6889999988543 223345677899999999 9999999999985443 367999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||++ ++|.+++... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||.+.......
T Consensus 88 ~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH-~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 88 FEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIH-SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred ecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 99997 5999888764 4788889999999999999999 9999999999999999999999999999988664432
Q ss_pred cc----ceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 691 NT----NVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 691 ~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. ......+++.|+|||.+.. ..++.++||||||+++|||+||+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1223357889999997654 567889999999999999999999997544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=257.52 Aligned_cols=203 Identities=27% Similarity=0.446 Sum_probs=168.3
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCC-----CeEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPK-----GEKL 608 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----~~~~ 608 (773)
+|.+.+.||+|++|.||+|... +++.+|+|.+..... ..+++.+|+.+++++ .|+||+++++++.... ...+
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 3456789999999999999874 678899999875443 456789999999999 6999999999986433 3579
Q ss_pred EEEeecCCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccc
Q 041878 609 LVFDFMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMT 687 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 687 (773)
+||||+++++|.++++... ....+++..+..++.|++.|+.||| +.+++||||+|+||++++++.++++|||.+....
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH-~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~ 164 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH-ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh-cCCcccCCCCHHHEEEccCCeEEECCCccceecc
Confidence 9999999999999987642 2345789999999999999999999 9999999999999999999999999999987654
Q ss_pred cccccceeeccCccccccccccCC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 688 AAANTNVIATAGTLGYRAPELSKL-----KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 688 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.... ......+++.|+|||.+.. ..++.++|||||||++|||++|+.||....
T Consensus 165 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 222 (275)
T cd06608 165 STLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222 (275)
T ss_pred cchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence 3221 1223457889999997643 356789999999999999999999997543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=259.73 Aligned_cols=198 Identities=26% Similarity=0.400 Sum_probs=165.3
Q ss_pred HhhcccccccceEEEEEEe----CCCCEEEEEEecccC----cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEE
Q 041878 538 ATAEIMGKSTYGTAYKATL----EDGSEVAVKRLREKT----TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 608 (773)
.+.+.||+|++|.||++.. .+++.||||.++... ....+.+..|++++.++ +|+|++++++.+ ......+
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-~~~~~~~ 81 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-QTDTKLH 81 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-ecCCEEE
Confidence 4567899999999999974 357889999987432 22345688999999999 599999999888 4555889
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||+++|+|.+++.... .+++.....++.|+++||.||| +.+++||||+|+||+++.++.++++|||+++....
T Consensus 82 lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH-~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 82 LILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLH-QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 9999999999999987643 3788889999999999999999 99999999999999999999999999999876544
Q ss_pred ccccceeeccCccccccccccCCCC--CCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKN--ANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
..........++..|+|||...+.. .+.++||||||+++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 3322222345788999999886654 788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=264.85 Aligned_cols=199 Identities=29% Similarity=0.383 Sum_probs=163.9
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccCccc--------------HHHHHHHHHHHHccCCCceEEeEEEEECC
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKG--------------QKEFEAEAAAIGKIHHPNLLALRAYYLGP 603 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 603 (773)
..+.||+|+||+||+|... +++.||||.++...... ...+.+|++++++++|+||+++++++. .
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~ 91 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYV-E 91 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEe-c
Confidence 4577999999999999864 68999999986542221 125778999999999999999999984 4
Q ss_pred CCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCc
Q 041878 604 KGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS 683 (773)
Q Consensus 604 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a 683 (773)
.+..++||||++ |+|.+++.... .++......++.|++.|++||| +.|++||||+|+||+++.++.++++|||.+
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH-~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLH-KWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeecccccHHHeEECCCCCEEECCccce
Confidence 558999999996 69999987643 3788999999999999999999 999999999999999999999999999998
Q ss_pred ccccccc-------------ccceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 684 RLMTAAA-------------NTNVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 684 ~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
....... ........+++.|+|||.+.+. .++.++||||+||++|||++|+.||...+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 7654111 1111123467889999987654 4688999999999999999999999876543
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=256.32 Aligned_cols=200 Identities=25% Similarity=0.458 Sum_probs=168.7
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
...+.||+|+||.||+|... +|..||+|.+.... ....+.+.+|++++++++|+|++++++.+ ...+..++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-~~~~~~~lv~e~~ 81 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-QENGRLFIVMEYC 81 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-ccCCeEEEEEecC
Confidence 45678999999999999865 58899999986532 23456788999999999999999999988 4556899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC-eEEeecCCccccccccccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN-PRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~-~kl~DfG~a~~~~~~~~~~ 693 (773)
++++|.+++.+... ..+++..+..++.|++.|+.||| +.+++|+||+|+||++++++. +|++|||.+........ .
T Consensus 82 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh-~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~ 158 (257)
T cd08225 82 DGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIH-DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-L 158 (257)
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-c
Confidence 99999999976432 34789999999999999999999 899999999999999998864 69999999876643221 1
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....|++.|+|||......++.++||||||+++|||++|+.||...+
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 222358889999999888889999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=259.13 Aligned_cols=199 Identities=25% Similarity=0.383 Sum_probs=162.3
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
...+.||+|++|+||+|... +|+.||+|.+..... ...+.+.+|++++++++|+|++++++++. .....++||||+
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~ 83 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-SEKRLYLVFEYL 83 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-cCCeEEEEEecc
Confidence 45678999999999999865 688999999865422 23467888999999999999999999995 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-CCCeEEeecCCccccccccccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE-KTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+ +++.+++..... ...++.....++.||+.||+||| +++++||||+|+||+++. ++.+||+|||++........ .
T Consensus 84 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH-~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~-~ 159 (294)
T PLN00009 84 D-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCH-SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR-T 159 (294)
T ss_pred c-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-c
Confidence 6 588888765432 23577888899999999999999 999999999999999985 45689999999976533211 1
Q ss_pred eeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....+++.|+|||.+.+ ..++.++||||+||++|||+||+.||...+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 122346889999998765 457899999999999999999999997654
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=257.79 Aligned_cols=206 Identities=20% Similarity=0.321 Sum_probs=170.1
Q ss_pred cccChhHHHHHhhcccccccceEEEEEEeCCCCEEEEEEeccc--CcccHHHHHHHHHHHHccC-CCceEEeEEEEECCC
Q 041878 528 FLFTADDLLCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPK 604 (773)
Q Consensus 528 ~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 604 (773)
.++..++-.|.+.++||+||.+.||++...+.+.+|+|++... +.....-|..|+..|.+++ |.+||++++|-.. +
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d 432 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-D 432 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-C
Confidence 3455667778889999999999999999888889999887543 4444677999999999996 9999999998854 6
Q ss_pred CeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcc
Q 041878 605 GEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSR 684 (773)
Q Consensus 605 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~ 684 (773)
+..||||||= ..+|..+|+..... ...| .++.+..|++.|+.++| +.||||.|+||.|+|+-. |.+||+|||.|.
T Consensus 433 ~~lYmvmE~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH-~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~ 507 (677)
T KOG0596|consen 433 GYLYMVMECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIH-QHGIVHSDLKPANFLLVK-GRLKLIDFGIAN 507 (677)
T ss_pred ceEEEEeecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHH-HhceeecCCCcccEEEEe-eeEEeeeechhc
Confidence 6999999976 56999999886532 2334 67789999999999999 999999999999999954 679999999999
Q ss_pred ccccccccce-eeccCccccccccccCCCC-----------CCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 685 LMTAAANTNV-IATAGTLGYRAPELSKLKN-----------ANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 685 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~-----------~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
.+..+...-. ...+||+.|||||.+.... .++++||||+||++|+|+.|+.||..
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 8865543322 2457999999999875433 45789999999999999999999865
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=257.88 Aligned_cols=198 Identities=27% Similarity=0.417 Sum_probs=165.1
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
+.+.||.|++|.||+|... +|+.||+|++.... ......+.+|++++++++|+|++++++++. ..+..++||||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-~~~~~~iv~e~~~ 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-SENKLYLVFEFLD 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-cCCeEEEEEeccC
Confidence 4578999999999999864 79999999987543 223456888999999999999999999984 4568999999995
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
++|.+++..... ..+++..+..++.|+++||+||| +.+++||||+|+||+++.++.++|+|||.+......... ..
T Consensus 82 -~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH-~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~ 157 (283)
T cd07835 82 -LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCH-SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-YT 157 (283)
T ss_pred -cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-cC
Confidence 699999876542 34799999999999999999999 899999999999999999999999999998765332211 11
Q ss_pred eccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...+++.|+|||++.+. .++.++||||||+++|||++|+.||...+
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 204 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 22467899999987554 57889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-28 Score=250.48 Aligned_cols=200 Identities=24% Similarity=0.432 Sum_probs=173.1
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCC-CeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-GEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~lV~e~ 613 (773)
...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++.+++++|+|++++++.+.... ...++|+||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 34578999999999999875 789999999875543 44678899999999999999999999985442 588999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc-
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT- 692 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~- 692 (773)
+++++|.+++.+.. .+++..+..++.|+++|++||| +.+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 83 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh-~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 83 VSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLH-SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc
Confidence 99999999998754 5899999999999999999999 899999999999999999999999999998876544321
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......++..|+|||......++.++||||||+++|++++|..||...+
T Consensus 159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223457889999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=259.17 Aligned_cols=202 Identities=25% Similarity=0.327 Sum_probs=163.8
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc--ccHHHHHHHHHHHHccC-CCceEEeEEEEECCCC----eEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKG----EKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----~~~ 608 (773)
|.+.+.||+|+||.||+|... +++.||+|..+.... .....+.+|+.++++++ |+||+++++++..... ..+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 345678999999999999864 689999998865432 23467888999999995 6999999998854332 379
Q ss_pred EEEeecCCCCHHHHHhhcCC--CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-CCCeEEeecCCccc
Q 041878 609 LVFDFMPKGSLASFLHARGP--ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE-KTNPRIADFGLSRL 685 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~ 685 (773)
+||||+++ +|.+++..... ...+++..+..++.||+.||.||| +.+|+||||+|+||+++. ++.+||+|||.+..
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH-KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 99999985 89888876432 245799999999999999999999 999999999999999998 88999999999876
Q ss_pred cccccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 686 MTAAANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....... .....+++.|+|||.+.+ ..++.++||||||+++|||++|..||...+
T Consensus 161 ~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 216 (295)
T cd07837 161 FSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS 216 (295)
T ss_pred cCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 5332211 122346789999998754 457899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=260.42 Aligned_cols=203 Identities=23% Similarity=0.343 Sum_probs=165.1
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCC-------Ce
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-------GE 606 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------~~ 606 (773)
|...++||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++.... ..
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 456788999999999999864 689999998864422 22345678999999999999999999985432 24
Q ss_pred EEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 607 KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
.++||||++ ++|.+++.... ..+++.++..++.||+.|++||| +.|++|+||||+||+++.++.+||+|||.+...
T Consensus 94 ~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH-~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 94 FYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIH-RNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred EEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 699999996 58888887542 34789999999999999999999 899999999999999999999999999999866
Q ss_pred cccccc---ceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 687 TAAANT---NVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 687 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
...... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~ 230 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ 230 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 433221 11233577899999987554 4788999999999999999999999765543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=261.22 Aligned_cols=200 Identities=22% Similarity=0.301 Sum_probs=162.5
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+++.+|.|+++.||++.. +++.||||+++.. .....+.+..|++++++++|+||+++++++. ..+..+++|||++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-~~~~~~~~~e~~~ 82 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-VDSELYVVSPLMA 82 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-cCCeEEEEEeccC
Confidence 3455566666666666654 6899999998754 3445678999999999999999999999884 4558899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc---
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT--- 692 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~--- 692 (773)
+|+|.+++.+... ..++......++.|++.||+||| +.+|+||||||+||+++.++.+|++|||.+.........
T Consensus 83 ~~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH-~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 83 YGSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIH-SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999999986532 34788888999999999999999 999999999999999999999999999988755322110
Q ss_pred ---ceeeccCccccccccccCC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 ---NVIATAGTLGYRAPELSKL--KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......++..|+|||.+.. ..++.++|||||||++|||++|+.||...+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1112346778999998765 458899999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=266.55 Aligned_cols=201 Identities=26% Similarity=0.370 Sum_probs=170.6
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCC----CeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK----GEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~l 609 (773)
|.+.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++.... ...++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 455688999999999999865 58999999997643 344578899999999999999999999985543 36899
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||++ ++|.+++.+.. .+++..+..++.|++.||+||| +.||+||||||+||+++.++.++|+|||.+......
T Consensus 82 v~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH-~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 82 VTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLH-SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred Eecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 999997 58988887643 4889999999999999999999 999999999999999999999999999999876544
Q ss_pred cc--cceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 690 AN--TNVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 690 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.. .......+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||...+.
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~ 212 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH
Confidence 31 112233578899999998877 789999999999999999999999977654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=265.84 Aligned_cols=199 Identities=26% Similarity=0.408 Sum_probs=165.4
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCC----CeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK----GEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~l 609 (773)
|.+.+.||+|+||+||+|.. .+++.||||.+... ......++.+|+.++++++|+||+++++++.... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 45567899999999999985 46899999998753 2333556788999999999999999999875432 35799
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
|+||+. ++|.+++.... .++...+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH-~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 87 VYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIH-SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred EEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 999995 78998887643 3788999999999999999999 999999999999999999999999999998865433
Q ss_pred cccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
. .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...+
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 162 G-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred c-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 2 11223357889999998754 468899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=258.41 Aligned_cols=196 Identities=29% Similarity=0.455 Sum_probs=163.6
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
.+...+.||+|+||.||+|... +++.||+|.+... ......++.+|++++++++|+|++++++++.. ....++||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 94 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLVM 94 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCeeEEEE
Confidence 4566788999999999999864 6788999998642 22334578889999999999999999999854 45889999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+. |++.+++.... ..+++.++..++.|++.|+.||| +.+++||||+|+||+++.++.++++|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH-~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH-SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 9996 68888776542 33788899999999999999999 999999999999999999999999999998765322
Q ss_pred cceeeccCccccccccccC---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSK---LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....+++.|+|||.+. ...++.++|||||||++|||++|+.||...+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 1234788999999864 3567889999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=253.61 Aligned_cols=200 Identities=27% Similarity=0.451 Sum_probs=170.7
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.+.++||+|+||.||++... +++.+|+|.+.... .....++.+|++++++++|+||+++++++.. ....++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~ 81 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-GNKLCIVMEYA 81 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-CCEEEEEehhc
Confidence 45678999999999999754 68899999987532 3345677889999999999999999998844 46899999999
Q ss_pred CCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 615 PKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 615 ~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
++++|.+++.+.. ....+++..++.++.|++.|++||| +.|++||||+|+||++++++.+|++|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh-~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~--- 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH-EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--- 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC---
Confidence 9999999987632 2345788999999999999999999 9999999999999999999999999999998765441
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.....+++.|+|||...+..++.++|+||+|+++||+++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 206 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206 (256)
T ss_pred cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1223578899999999888899999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=251.50 Aligned_cols=201 Identities=24% Similarity=0.428 Sum_probs=172.4
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.+.+.||.|+||.||++... +++.||+|++..... ....++.+|++++++++|+|++++++.+.. .+..++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~~~~lv~e~~ 81 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-KGKLCIVMEYA 81 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-CCEEEEEEEec
Confidence 45678999999999999865 688999999975533 456678999999999999999999998854 46899999999
Q ss_pred CCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 615 PKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 615 ~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
++++|.+++.+.. ....+++..+..++.+++.|+.||| +.|++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~ 159 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH-SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-DL 159 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH-hCCEecccCChHHeEEcCCCcEEECCccceeecccCc-ce
Confidence 9999999998752 1345899999999999999999999 8999999999999999999999999999987654432 12
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....+++.|+|||......++.++||||+|+++|+|++|+.||...+
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 223457889999999888889999999999999999999999986654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-28 Score=256.91 Aligned_cols=195 Identities=29% Similarity=0.437 Sum_probs=162.7
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+...+.||+|+||+||+|... +|+.||+|.+..... .....+.+|++++++++|+|++++++++.. ....++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-EHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEEe
Confidence 444577999999999999864 688999999864322 233568889999999999999999999954 458999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|++ |++.+++.... ..+++.++..++.||+.|+.||| +.|++||||+|+||+++.++.++|+|||++.....
T Consensus 102 ~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH-~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 102 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH-SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred cCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 995 68888876543 34789999999999999999999 99999999999999999999999999998864322
Q ss_pred ceeeccCccccccccccC---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSK---LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....++..|+|||++. ...++.++|||||||++|||++|..||...+
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12345788999999874 4568889999999999999999999986643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=265.24 Aligned_cols=201 Identities=27% Similarity=0.405 Sum_probs=166.1
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECC---CCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP---KGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~~~lV 610 (773)
|.+.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++|+||+++++++... ....++|
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 445678999999999999864 68999999987542 23356778899999999999999999887432 2468999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||++ ++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||++++++.+||+|||.+.......
T Consensus 87 ~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 87 MDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIH-SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred Eehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 99995 68999887543 3789999999999999999999 8999999999999999999999999999987654332
Q ss_pred ccc---eeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 691 NTN---VIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 691 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||...+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 217 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh
Confidence 211 123357889999998755 5688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=261.22 Aligned_cols=198 Identities=25% Similarity=0.345 Sum_probs=160.6
Q ss_pred cccccc--cceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKS--TYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G--~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
+.||+| +||+||++.. .+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.. .+..++|+||++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-GSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-CCceEEEEeccc
Confidence 346666 9999999986 479999999987543 2234678899999999999999999999954 558899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc--
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN-- 693 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~-- 693 (773)
++++.+++.+... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH-~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 83 YGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLH-QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999999987542 34788999999999999999999 9999999999999999999999999998654332211110
Q ss_pred ----eeeccCccccccccccCCC--CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 ----VIATAGTLGYRAPELSKLK--NANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ----~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....++..|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 0012245679999998653 47899999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=263.06 Aligned_cols=194 Identities=27% Similarity=0.408 Sum_probs=161.4
Q ss_pred HhhcccccccceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCC-----CeEEE
Q 041878 538 ATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-----GEKLL 609 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~~l 609 (773)
...+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.++++++|+||+++++++.... ...++
T Consensus 20 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 99 (345)
T cd07877 20 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 99 (345)
T ss_pred EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEE
Confidence 4567899999999999985 578999999997532 223466888999999999999999999885322 34678
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
+++++ +++|.++++.. .+++..+..++.|+++|++||| +.||+||||||+||++++++.+||+|||++......
T Consensus 100 v~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~ 173 (345)
T cd07877 100 VTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173 (345)
T ss_pred Eehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCChHHEEEcCCCCEEEeccccccccccc
Confidence 88887 78998887643 3788999999999999999999 999999999999999999999999999998754322
Q ss_pred cccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....+++.|+|||...+ ..++.++|||||||++|||++|+.||...+
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 174 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred ----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 123357889999998765 568889999999999999999999996544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-31 Score=275.14 Aligned_cols=292 Identities=29% Similarity=0.389 Sum_probs=251.2
Q ss_pred EEEEEcCCCCcc-cccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCC-CCCCCCCCCEEEc
Q 041878 93 VIAIQLPWRRLG-GRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPP-SIGNCPNLQTLDL 170 (773)
Q Consensus 93 v~~l~l~~~~l~-~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L 170 (773)
+.+++++.|++- .-||+.+..|..|+.||||+|+++ +.|..+..-+++-.|+||+|+|. .||. -|.+|..|-+|||
T Consensus 80 LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDL 157 (1255)
T KOG0444|consen 80 LRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDL 157 (1255)
T ss_pred hHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhcc
Confidence 445666677664 457888889999999999999998 78888888899999999999998 4554 4578889999999
Q ss_pred cCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccc-cccCCcccccccCcccccceeeccc
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLS-GSVPNNWGVLAGNKSYQLQFLNLDH 249 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~~~~~~L~~L~L~~ 249 (773)
|+|++. .+|+.+..+..|++|+|++|.+.-.--..+..+++|++|++++.+-+ ..+|..+..+. +|..++++.
T Consensus 158 S~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~-----NL~dvDlS~ 231 (1255)
T KOG0444|consen 158 SNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLH-----NLRDVDLSE 231 (1255)
T ss_pred ccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhh-----hhhhccccc
Confidence 999987 78888888999999999999876433344556777888888877644 45777776665 899999999
Q ss_pred cccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCC-c
Q 041878 250 NLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNK-I 328 (773)
Q Consensus 250 n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~ 328 (773)
|.+. ..|..+.++.+|+.|+||+|+|+ .+....+...+|++|+||.|+++ .+|+.+..+++|+.|++.+|+++-. +
T Consensus 232 N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGi 308 (1255)
T KOG0444|consen 232 NNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGI 308 (1255)
T ss_pred cCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCC
Confidence 9999 78999999999999999999999 45556777889999999999999 8999999999999999999999754 7
Q ss_pred chhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCC
Q 041878 329 PEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLS 397 (773)
Q Consensus 329 ~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~ 397 (773)
|..++++.+|+++..++|.+. ..|+.++.+..|+.|.|++|++. .+|.++.-++.|+.|||..|+--
T Consensus 309 PSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 309 PSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred ccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 999999999999999999998 89999999999999999999998 79999999999999999999854
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=256.83 Aligned_cols=200 Identities=28% Similarity=0.487 Sum_probs=170.8
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~ 611 (773)
|...+.||+|+||.||+|... +|+.||+|++... .....+.+.+|++++++++ |+||+++++++ ...+..++||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-~~~~~~~lv~ 81 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-QDEENLYFVL 81 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-cCCceEEEEE
Confidence 345678999999999999865 7899999998653 2233567889999999999 99999999988 4556899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++++|.+++.+.. .+++..+..++.|++.|+.||| +.|++|+||+|+||+++.++.++++|||++........
T Consensus 82 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh-~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 82 EYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLH-SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999999999998753 4899999999999999999999 99999999999999999999999999999886643321
Q ss_pred -------------------cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 -------------------TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.......++..|+|||......++.++||||+|+++||+++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 11123357889999999888889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=254.06 Aligned_cols=199 Identities=28% Similarity=0.419 Sum_probs=163.8
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccCcc--cHHHHHHHHHHHHcc---CCCceEEeEEEEECCCC----eEE
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK--GQKEFEAEAAAIGKI---HHPNLLALRAYYLGPKG----EKL 608 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----~~~ 608 (773)
+.+.||+|+||.||+|..+ +++.||+|.++..... ....+.+|+.+++++ +|+|++++++++..... ..+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 4578999999999999976 4899999999744322 234566777777665 59999999999965432 389
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
++|||++ ++|.+++..... ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 83 l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH-~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 83 LVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLH-SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred EEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 9999996 589998876532 34899999999999999999999 89999999999999999999999999999877643
Q ss_pred ccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.... ....++..|+|||.+....++.++|||||||++|||++|+.||.....
T Consensus 160 ~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~ 211 (287)
T cd07838 160 EMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE 211 (287)
T ss_pred Cccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence 3221 223468899999999888899999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-28 Score=258.65 Aligned_cols=195 Identities=26% Similarity=0.433 Sum_probs=164.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|.+.++||+|+||.||+|... +++.||+|++... .....+.+..|++++++++|||++++++++.......++|+||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 456789999999999999854 7899999988643 2233567888999999999999999999986666688999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+ +++|.++++.. .++......++.|++.|++||| +.+|+||||+|+||++++++.++|+|||.+......
T Consensus 92 ~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH-~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~---- 161 (328)
T cd07856 92 L-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVH-SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ---- 161 (328)
T ss_pred h-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEeECCCCCEEeCccccccccCCC----
Confidence 9 56898888643 2677788889999999999999 999999999999999999999999999998754322
Q ss_pred eeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 122346889999998755 568999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=256.05 Aligned_cols=198 Identities=28% Similarity=0.415 Sum_probs=167.4
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccCcc--cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK--GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
+.+.||+|++|.||+|... +++.+|+|.+...... ....+..|++++++++|+|++++++++. .++..++|+||++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~e~~~ 81 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-HKGDLYLVFEFMD 81 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-cCCCEEEEEeccC
Confidence 4577999999999999864 6889999998754332 4567888999999999999999999984 4568999999997
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+ ++.+++.... ..+++.++..++.|++.|+.||| +.+|+|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 82 ~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~ 156 (283)
T cd05118 82 T-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCH-SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYT 156 (283)
T ss_pred C-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHH-HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cccc
Confidence 5 8888887643 34789999999999999999999 9999999999999999999999999999987665433 1122
Q ss_pred eccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
...++..|+|||...+. .++.++||||+|+++|+|+||+.||...+.
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 204 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 23478899999988766 789999999999999999999999976553
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=249.62 Aligned_cols=193 Identities=28% Similarity=0.440 Sum_probs=166.6
Q ss_pred cccccceEEEEEEeC-CCCEEEEEEecccCcc---cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCC
Q 041878 543 MGKSTYGTAYKATLE-DGSEVAVKRLREKTTK---GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 543 lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
||+|+||.||++... +++.+|+|.+...... ....+..|++++++++|+|++++++.+ ......++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-QTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-ecCCeeEEEEecCCCCc
Confidence 699999999999865 5899999998755332 345788999999999999999999888 45568999999999999
Q ss_pred HHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeecc
Q 041878 619 LASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA 698 (773)
Q Consensus 619 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 698 (773)
|.+++.... .+++.....++.|++.|+.||| +.+++|+||+|+||+++.++.++|+|||.+........ ......
T Consensus 80 L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh-~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (250)
T cd05123 80 LFSHLSKEG---RFSEERARFYAAEIVLALEYLH-SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFC 154 (250)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCCc
Confidence 999998753 3788999999999999999999 89999999999999999999999999999876543321 122345
Q ss_pred CccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 699 GTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 699 gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
++..|+|||...+...+.++|+||||+++||+++|+.||...+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 7889999999988888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=259.87 Aligned_cols=203 Identities=24% Similarity=0.384 Sum_probs=163.9
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc--cHHHHHHHHHHHHccCCCceEEeEEEEECCCC-------e
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK--GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG-------E 606 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-------~ 606 (773)
|.+.++||+|+||.||+|... +++.||+|++...... ....+.+|++++++++|+||+++++++..... .
T Consensus 10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 89 (311)
T cd07866 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS 89 (311)
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence 455688999999999999864 6899999998654322 23467889999999999999999988754332 4
Q ss_pred EEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 607 KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
.++|+||+++ ++.+.+... ...+++..+..++.|+++||+||| +.||+||||||+||++++++.++|+|||++...
T Consensus 90 ~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH-~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 90 VYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLH-ENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred EEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 7899999964 777777653 234899999999999999999999 999999999999999999999999999998765
Q ss_pred ccccccc----------eeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 687 TAAANTN----------VIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 687 ~~~~~~~----------~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
....... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~ 233 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 4322111 112246788999998754 45889999999999999999999999765543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-28 Score=256.04 Aligned_cols=197 Identities=25% Similarity=0.451 Sum_probs=161.4
Q ss_pred HHhhcccccccceEEEEEEeCC-CCEEEEEEecccCc-ccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLED-GSEVAVKRLREKTT-KGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
+.+.+.||+|+||.||+|...+ ++.||||.++.... ....++..|+.++.+.. |+||+++++++.. ....++||||
T Consensus 17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~ 95 (296)
T cd06618 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-DSDVFICMEL 95 (296)
T ss_pred heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-CCeEEEEeec
Confidence 4667899999999999999764 89999999975432 23456677887777765 9999999999954 5589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
++ +++.+++.... ..+++..+..++.||+.|++|||+..||+||||+|+||++++++.+||+|||.+.........
T Consensus 96 ~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~- 171 (296)
T cd06618 96 MS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171 (296)
T ss_pred cC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc-
Confidence 85 57877776532 257889999999999999999994369999999999999999999999999998765432221
Q ss_pred eeeccCccccccccccCCCC----CCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKN----ANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~----~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
....+++.|+|||.+.... ++.++||||||+++|||++|+.||..
T Consensus 172 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 172 -TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred -cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 2234778999999886554 78899999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=255.24 Aligned_cols=198 Identities=27% Similarity=0.417 Sum_probs=165.6
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEEeecC
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
+.+.||+|++|+||+|... +++.||+|++..... .......+|+..+++++ |+|++++++++.. .+..++||||+
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~- 80 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEYM- 80 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEecC-
Confidence 4578999999999999975 578899999875432 23345567999999999 9999999999854 66899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.... ...+++..+..++.|++.|+.||| +.+++|+||+|+||++++++.++|+|||.+......... .
T Consensus 81 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh-~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~ 156 (283)
T cd07830 81 EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIH-KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--T 156 (283)
T ss_pred CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc--C
Confidence 889999887754 234799999999999999999999 999999999999999999999999999998765433221 2
Q ss_pred eccCccccccccccC-CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSK-LKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
...++..|+|||.+. ...++.++|+||||+++|||++|+.||.....
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~ 204 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE 204 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh
Confidence 234788999999774 45578999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=245.76 Aligned_cols=210 Identities=21% Similarity=0.356 Sum_probs=174.3
Q ss_pred hhcccccccceEEEEEEeC------CCCEEEEEEecccCcc-cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 539 TAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
...++-+|.||.||+|.+. +.+.|-||.++....+ ....+..|.-.+..+.|||+.++.+++.+..+..+++|
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 4567899999999999653 3456778888765433 34567788888889999999999999988888899999
Q ss_pred eecCCCCHHHHHhhc-----CCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 612 DFMPKGSLASFLHAR-----GPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 612 e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
.++.-|+|..+++.. ...+.++..+...++.|++.|++||| ..||||.||.++|++||+.-++||+|=.+++.+
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh-~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH-NHGVIHKDIAARNCVIDDQLQVKLTDSALSRDL 446 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH-hcCcccchhhhhcceehhheeEEeccchhcccc
Confidence 999999999999833 22345677788899999999999999 999999999999999999999999999999987
Q ss_pred cccccccee-eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCChHHHH
Q 041878 687 TAAANTNVI-ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749 (773)
Q Consensus 687 ~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~~~~~ 749 (773)
.+....-.. ..-....||+||.+....|+.++|||||||+||||+| |+.||...++.++..++
T Consensus 447 FP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 447 FPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred CcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 665443222 1224669999999999999999999999999999998 99999887765554443
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=263.49 Aligned_cols=199 Identities=24% Similarity=0.334 Sum_probs=163.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCC-----------
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK----------- 604 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----------- 604 (773)
|...+.||.|+||.||+|... +|+.||+|.+........+.+.+|++++++++||||+++++++....
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence 456788999999999999864 68999999997666666778899999999999999999998764332
Q ss_pred --CeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-CCCeEEeecC
Q 041878 605 --GEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE-KTNPRIADFG 681 (773)
Q Consensus 605 --~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~-~~~~kl~DfG 681 (773)
...++||||++ ++|.+++... .+++.....++.||+.|+.||| +.||+||||||+||+++. ++.+|++|||
T Consensus 87 ~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH-~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 87 ELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIH-SANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 24689999997 5898887643 3788999999999999999999 999999999999999985 4568999999
Q ss_pred Ccccccccccc--ceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 682 LSRLMTAAANT--NVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 682 ~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.+......... ......++..|+|||.+.. ..++.++|||||||++|||++|+.||...+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 98765332111 1122347889999997644 567889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-29 Score=279.24 Aligned_cols=191 Identities=26% Similarity=0.476 Sum_probs=153.5
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCC------------
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK------------ 604 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------------ 604 (773)
..++||+||||.||+++.+ ||+.||||++.... ......+.+|+.++++++|||||+++..+.+..
T Consensus 483 EL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~ 562 (1351)
T KOG1035|consen 483 ELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASD 562 (1351)
T ss_pred HHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccc
Confidence 4478999999999999865 89999999997553 334567889999999999999999874432100
Q ss_pred --------------------------------------------------------------------------------
Q 041878 605 -------------------------------------------------------------------------------- 604 (773)
Q Consensus 605 -------------------------------------------------------------------------------- 604 (773)
T Consensus 563 ~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~ 642 (1351)
T KOG1035|consen 563 SESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVIL 642 (1351)
T ss_pred hhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcccc
Confidence
Q ss_pred --------------------------CeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCce
Q 041878 605 --------------------------GEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658 (773)
Q Consensus 605 --------------------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~ii 658 (773)
...|+-||||+...++++++++-... .....++++++|++||.|+| +.|||
T Consensus 643 d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH-~~giI 719 (1351)
T KOG1035|consen 643 DDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH-DQGII 719 (1351)
T ss_pred CcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH-hCcee
Confidence 01367888998888888887753221 34567899999999999999 99999
Q ss_pred ecCCCCCCEEeCCCCCeEEeecCCccccc-----------------cccccceeeccCccccccccccCCC---CCCcch
Q 041878 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMT-----------------AAANTNVIATAGTLGYRAPELSKLK---NANTKT 718 (773)
Q Consensus 659 H~Dik~~NIll~~~~~~kl~DfG~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~ 718 (773)
||||||.||++|+++.|||+|||+|.... .......+..+||.-|+|||++.+. .|+.|+
T Consensus 720 HRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~Ki 799 (1351)
T KOG1035|consen 720 HRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKI 799 (1351)
T ss_pred eccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchh
Confidence 99999999999999999999999998721 0111133456799999999988654 499999
Q ss_pred hhHHHHHHHHHHHc
Q 041878 719 DVYSLGVIILELLT 732 (773)
Q Consensus 719 Dvws~Gv~l~el~t 732 (773)
|+||+||+++||+.
T Consensus 800 DmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 800 DMYSLGIVLFEMLY 813 (1351)
T ss_pred hhHHHHHHHHHHhc
Confidence 99999999999986
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=260.79 Aligned_cols=195 Identities=26% Similarity=0.375 Sum_probs=163.0
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCC-----CeEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-----GEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~~ 608 (773)
|.+.+.||+|+||.||+|.. .+|+.||||++.... ......+.+|++++++++|+||+++++++.... ...+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence 44568899999999999975 478999999986432 223456889999999999999999999885433 2468
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||+ +++|.+++... .+++..+..++.||+.|++||| +.||+||||||+||+++.++.++++|||.+.....
T Consensus 97 lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH-~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 97 LVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIH-AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred EEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 999999 77998887642 3789999999999999999999 99999999999999999999999999999876533
Q ss_pred ccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. ....+++.|+|||.+.. ..++.++|+||+||++|++++|+.||...+
T Consensus 171 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 171 EM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred Cc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 22347889999998765 458889999999999999999999997654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=258.89 Aligned_cols=199 Identities=25% Similarity=0.317 Sum_probs=162.4
Q ss_pred HhhcccccccceEEEEEEeC-C--CCEEEEEEecccC--cccHHHHHHHHHHHHcc-CCCceEEeEEEEECC---CCeEE
Q 041878 538 ATAEIMGKSTYGTAYKATLE-D--GSEVAVKRLREKT--TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGP---KGEKL 608 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~--g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~---~~~~~ 608 (773)
.+.+.||+|+||.||++... . +..||+|++.... ....+.+.+|+.+++++ .|+||+++++.+... ....+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 45678999999999999864 3 7789999986432 22356778899999999 499999999875322 23578
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+++||++ ++|.+++.... .+++..++.++.||+.||+||| +.|++||||||+||+++.++.+||+|||.++....
T Consensus 83 ~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH-~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 83 LYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIH-SANVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 8999985 68999887543 4789999999999999999999 99999999999999999999999999999986543
Q ss_pred cccc---ceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 689 AANT---NVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 689 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.... ......|++.|+|||...+ ..++.++||||+||++|++++|+.||...+
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 2221 1123458899999998755 568999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=253.88 Aligned_cols=198 Identities=29% Similarity=0.425 Sum_probs=167.1
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
..+.||+|++|.||+|... +++.||+|.+.... ....+.+..|+.++++++|+|++++++++. ..+..++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~~v~e~~~ 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-TERKLYLVFEYCD 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-cCCceEEEecCcC
Confidence 3467999999999999865 58999999997653 334567888999999999999999999984 4468999999997
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
++|.+++.+.. ..+++..+..++.|++.|++||| +.||+||||+|+||++++++.++|+|||.+........ ...
T Consensus 82 -~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (282)
T cd07829 82 -MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCH-SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYT 156 (282)
T ss_pred -cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccC
Confidence 59999998753 34889999999999999999999 89999999999999999999999999999876543321 112
Q ss_pred eccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
...++..|+|||.+... .++.++|||||||++||+++|+.||...+.
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 204 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE 204 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence 23356789999988666 789999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=260.22 Aligned_cols=194 Identities=26% Similarity=0.386 Sum_probs=160.1
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCC-----CeEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-----GEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~~ 608 (773)
|...+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|++++++++|+||+++++++.... ...+
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence 34568899999999999986 468999999986532 223456889999999999999999999885432 2468
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+|+||++ .++.++.. ..+++..+..++.|++.||+||| +.+++||||||+||+++.++.+|++|||+++....
T Consensus 97 lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH-~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 97 LVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIH-SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred EEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 9999996 47776653 23788899999999999999999 99999999999999999999999999999876432
Q ss_pred ccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. ....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+
T Consensus 170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 170 EM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 22346889999998765 468899999999999999999999997644
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=256.47 Aligned_cols=201 Identities=21% Similarity=0.348 Sum_probs=167.0
Q ss_pred hhcccccccceEEEEEE-eCCCCEEEEEEecccCc---ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 539 TAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
..+.||-|+||.|.++. .++...+|+|.+++.+. .....+..|..+|.....+=||+||-.| .+++..|+||||+
T Consensus 633 kik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-QDkdnLYFVMdYI 711 (1034)
T KOG0608|consen 633 KIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-QDKDNLYFVMDYI 711 (1034)
T ss_pred EEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-ccCCceEEEEecc
Confidence 35779999999999996 45567799999976543 2234567899999999999999999888 5666999999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc------
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA------ 688 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~------ 688 (773)
+||++-++|-+.+ .+++..+..++.++..|+++.| ..|+|||||||+|||||.+|++||+|||+|.-+.-
T Consensus 712 PGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVH-kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 712 PGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVH-KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred CCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHH-hccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 9999999998754 4777888889999999999999 99999999999999999999999999999864310
Q ss_pred --cccc-------------------------------c--eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcC
Q 041878 689 --AANT-------------------------------N--VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTG 733 (773)
Q Consensus 689 --~~~~-------------------------------~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg 733 (773)
...+ . ....+||+.|+|||++....|+..+|-||.||+||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 0000 0 0023599999999999999999999999999999999999
Q ss_pred CCCCCCCCCCC
Q 041878 734 KSPGEPMNGMD 744 (773)
Q Consensus 734 ~~P~~~~~~~~ 744 (773)
+.||......+
T Consensus 868 ~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 868 QPPFLADTPGE 878 (1034)
T ss_pred CCCccCCCCCc
Confidence 99998755443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-28 Score=264.55 Aligned_cols=202 Identities=19% Similarity=0.295 Sum_probs=152.4
Q ss_pred HHhhcccccccceEEEEEEe-----------------CCCCEEEEEEecccCcccHH--------------HHHHHHHHH
Q 041878 537 CATAEIMGKSTYGTAYKATL-----------------EDGSEVAVKRLREKTTKGQK--------------EFEAEAAAI 585 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-----------------~~g~~vAvK~l~~~~~~~~~--------------~~~~E~~~l 585 (773)
|.+.++||+|+||+||+|.+ .+++.||||+++.......+ ....|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 45678999999999999963 23567999998754332222 234477788
Q ss_pred HccCCCce-----EEeEEEEECC-------CCeEEEEEeecCCCCHHHHHhhcCC---------------------CCcc
Q 041878 586 GKIHHPNL-----LALRAYYLGP-------KGEKLLVFDFMPKGSLASFLHARGP---------------------ETIV 632 (773)
Q Consensus 586 ~~l~h~ni-----v~l~~~~~~~-------~~~~~lV~e~~~~g~L~~~l~~~~~---------------------~~~~ 632 (773)
.+++|.++ ++++++|... ++..++||||+++++|.++++.... ....
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 88876654 6677777432 3468999999999999999875311 1234
Q ss_pred CHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeeccCccccccccccCCC
Q 041878 633 NWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLK 712 (773)
Q Consensus 633 ~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 712 (773)
++..+..++.|++.|+.||| +.+|+||||||+||+++.++.+||+|||++...............+|+.|+|||.+...
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH-~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLH-RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP 385 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHH-HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence 67788899999999999999 99999999999999999999999999999976543322222223458899999986533
Q ss_pred C--------------------C--CcchhhHHHHHHHHHHHcCCC-CCCC
Q 041878 713 N--------------------A--NTKTDVYSLGVIILELLTGKS-PGEP 739 (773)
Q Consensus 713 ~--------------------~--~~~~Dvws~Gv~l~el~tg~~-P~~~ 739 (773)
. | ..+.||||+||+++||++|.. ||..
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 2 1 124799999999999999986 7654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=247.66 Aligned_cols=202 Identities=26% Similarity=0.363 Sum_probs=166.8
Q ss_pred HHHhhcccccccceEEEEEEe-CCCCEEEEEEeccc---Ccc----cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeE
Q 041878 536 LCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK---TTK----GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEK 607 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 607 (773)
+|-...+||+|+|+.||+|.+ ...+.||||+-... ..+ -.+...+|..+.+.+.||-||++|+++.-+.+..
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 455678999999999999974 56778999976422 111 1245678999999999999999999997777789
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCceecCCCCCCEEeCC---CCCeEEeecCCc
Q 041878 608 LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV-EENMIHGNLTSSNVLLDE---KTNPRIADFGLS 683 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~-~~~iiH~Dik~~NIll~~---~~~~kl~DfG~a 683 (773)
|-|.|||+|.+|.-|++.+. .++...+..|+.||+.||.||.+ ..+|||-|+||.|||+-+ -|.+||+|||++
T Consensus 544 CTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred eeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 99999999999999998864 47889999999999999999983 367999999999999954 367999999999
Q ss_pred cccccccccc------eeeccCccccccccccCC----CCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 684 RLMTAAANTN------VIATAGTLGYRAPELSKL----KNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 684 ~~~~~~~~~~------~~~~~gt~~y~aPE~~~~----~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
+.+..+.... +....||.+|++||++.- ...+.|+||||.||++|+++.|+.||...
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 9997665431 224469999999997643 34677999999999999999999999753
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=236.70 Aligned_cols=196 Identities=21% Similarity=0.392 Sum_probs=167.8
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEe
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
....+||+|+|..|..+.+. +.+.+|+|++++.. .++..=.+.|-.+..+. +||.+|-+..++ ..+...++|.|
T Consensus 253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-qtesrlffvie 331 (593)
T KOG0695|consen 253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-QTESRLFFVIE 331 (593)
T ss_pred eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-cccceEEEEEE
Confidence 34688999999999999864 67889999998653 23334456676666655 699999998888 45558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|++||+|--++++.++ ++...+..+...|.-||.||| ++|||+||+|.+|+|+|..|++|++|+|+++.-..+...
T Consensus 332 yv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh-~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~ 407 (593)
T KOG0695|consen 332 YVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLH-ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT 407 (593)
T ss_pred EecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHh-hcCeeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence 9999999888887543 788888999999999999999 999999999999999999999999999999865544433
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
+...+|||.|+|||.+.+..|+..+|-|++||+|+||+.|+.||+.
T Consensus 408 -tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 408 -TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred -cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 3456899999999999999999999999999999999999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=242.47 Aligned_cols=180 Identities=24% Similarity=0.303 Sum_probs=151.5
Q ss_pred ccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCCHHHHHh
Q 041878 546 STYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLH 624 (773)
Q Consensus 546 G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~L~~~l~ 624 (773)
|.+|.||++... +++.||+|++.... .+..|...+....|||++++++++. .....++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV-SEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee-cCCeEEEEEecCCCCCHHHHHH
Confidence 889999999864 68899999996543 2334555555667999999999984 4568999999999999999987
Q ss_pred hcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeeccCccccc
Q 041878 625 ARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR 704 (773)
Q Consensus 625 ~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~ 704 (773)
+.. .+++..+..++.|++.|++||| +.||+||||||+||+++.++.++++|||.+....... ....++..|+
T Consensus 78 ~~~---~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~ 149 (237)
T cd05576 78 KFL---NIPEECVKRWAAEMVVALDALH-REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYC 149 (237)
T ss_pred Hhc---CCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcccc
Confidence 653 3789999999999999999999 9999999999999999999999999999876554321 1233567899
Q ss_pred cccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 705 APELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 705 aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
|||......++.++||||+|+++|||++|+.|+..
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 99999888899999999999999999999988654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=275.80 Aligned_cols=142 Identities=23% Similarity=0.408 Sum_probs=124.8
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+.++||+|+||.||+|.+. +++.||||+++.... .....+..|+.+++.++|+||+++++++. .....++||||
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~~lVmEy 85 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-SANNVYLVMEY 85 (669)
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-ECCEEEEEEeC
Confidence 45688999999999999865 689999999975432 22467889999999999999999998884 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSR 684 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~ 684 (773)
+++++|.+++.... .+++..++.++.||+.||+||| ..+||||||||+|||++.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH-~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLH-RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999997643 3778889999999999999999 8999999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=247.19 Aligned_cols=199 Identities=24% Similarity=0.394 Sum_probs=162.1
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc-----CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK-----TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
|.+.++||+|+||.||++... .+..+++|.++.. ......++..|+.++++++|||++++++++. ..+..++|
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv 80 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-ERDAFCII 80 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-cCCceEEE
Confidence 445688999999999999864 3455666665432 1223446778999999999999999999884 45578999
Q ss_pred EeecCCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 611 FDFMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
+||+++++|.+++.... ....+++..++.++.|++.|+.||| +.|++|+||+|+||+++. +.++++|||.+......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH-HcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 99999999999887532 2345899999999999999999999 999999999999999975 56999999998766433
Q ss_pred cccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
... .....+++.|+|||......++.++|+||||+++|++++|..||..
T Consensus 159 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 159 CDL-ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred ccc-ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 221 1233578899999998888889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-29 Score=240.71 Aligned_cols=198 Identities=25% Similarity=0.362 Sum_probs=166.5
Q ss_pred hcccccccceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCC----CeEEEEEe
Q 041878 540 AEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK----GEKLLVFD 612 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~lV~e 612 (773)
.+.||.|+||+||-+++ ++|+.||.|++...- -...+.+.+|++++...+|.|+...+++...+. .+.|+|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 46799999999999986 489999999986432 234578899999999999999999998885543 25678889
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
.| ..+|...+-. .+.++...++-+..||++||.||| +.+|.||||||.|.|++.+..+||+|||+++....+...
T Consensus 138 Lm-QSDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLH-sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 138 LM-QSDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLH-TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HH-Hhhhhheecc---CCCCCcchhhhhHHHHHhhhHHHh-hcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 88 4577766654 445788888999999999999999 999999999999999999999999999999987766655
Q ss_pred ceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.++..+-|..|.|||.+.+ ..|+.+.||||.||++.|++..+..|...+.
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence 5555567889999997755 5689999999999999999999999876654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=255.46 Aligned_cols=190 Identities=24% Similarity=0.374 Sum_probs=158.4
Q ss_pred hcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 540 AEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
...+|.|+|++|-++.. .+++..+||++.+. ..+-.+|+.++.+. +|+|++++.+.+ ....+.|+|||.+.++
T Consensus 327 ~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~-~~~~~~~~v~e~l~g~ 401 (612)
T KOG0603|consen 327 REELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVY-EDGKEIYLVMELLDGG 401 (612)
T ss_pred ccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeeccee-cCCceeeeeehhcccc
Confidence 34599999999988875 46888999999765 22334567666655 599999999999 4555999999999999
Q ss_pred CHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe-CCCCCeEEeecCCccccccccccceee
Q 041878 618 SLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL-DEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 618 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll-~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
-+.+.+..... .. ..+..|+.+|+.|+.||| ++||||||+||+|||+ ++.++++|+|||.++..... ...
T Consensus 402 ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH-~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~t 472 (612)
T KOG0603|consen 402 ELLRRIRSKPE---FC-SEASQWAAELVSAVDYLH-EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CDT 472 (612)
T ss_pred HHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHH-hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh----hcc
Confidence 88877766432 23 566779999999999999 8999999999999999 68999999999999876554 233
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
.+-|..|.|||+.....|++++|+||+|++||+|++|+.||......
T Consensus 473 p~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 473 PALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred cchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 45688999999999999999999999999999999999999876554
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-29 Score=234.63 Aligned_cols=210 Identities=24% Similarity=0.386 Sum_probs=167.3
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc--cHHHHHHHHHHHHccCCCceEEeEEEEECC-------CCe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK--GQKEFEAEAAAIGKIHHPNLLALRAYYLGP-------KGE 606 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------~~~ 606 (773)
|....+||+|.||.||+|+.+ .|+.||+|+.-....+ ......+|++++..++|+|++.+++.|... +..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 444578999999999999854 5788998876433222 234557899999999999999999888432 234
Q ss_pred EEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 607 KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
.|+||++|+. +|.-.+... ...++..++.++++++..||.|+| ...|+|||+||.|+||+.++.+||+|||+++..
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iH-r~kilHRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIH-RNKILHRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHH-HhhHHhhcccHhhEEEcCCceEEeeccccccce
Confidence 7999999965 888888764 345888999999999999999999 999999999999999999999999999999766
Q ss_pred cccccc---ceeeccCccccccccccC-CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHH
Q 041878 687 TAAANT---NVIATAGTLGYRAPELSK-LKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVA 750 (773)
Q Consensus 687 ~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 750 (773)
....+. ..+-++-|..|.+||.+. ...|+++.|||+.||++.||+||.+-+.+.....-...+.
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 543321 222344588999999764 5679999999999999999999999988766554333333
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=256.85 Aligned_cols=195 Identities=27% Similarity=0.402 Sum_probs=162.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCC-----eEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG-----EKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~~ 608 (773)
|...+.||+|++|.||+|... +++.||+|++.... ......+.+|+.++++++|+|++++++++..... ..+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 345688999999999999875 67899999986432 2234667889999999999999999887743331 389
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+|+||+ +++|.+++... .+++..+..++.|++.|++||| +.||+||||+|+||+++.++.++|+|||.+.....
T Consensus 97 lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH-~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 97 LVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIH-SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred EEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 999999 67999988752 3789999999999999999999 99999999999999999999999999999876543
Q ss_pred ccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
. .....++..|+|||.... ..++.++||||+||++||+++|+.||...+
T Consensus 171 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 171 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred c----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 122357889999998754 467889999999999999999999997544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=257.99 Aligned_cols=201 Identities=27% Similarity=0.443 Sum_probs=171.0
Q ss_pred HhhcccccccceEEEEEE-eCCCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEEC----CCCeEEEEE
Q 041878 538 ATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLG----PKGEKLLVF 611 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~~~lV~ 611 (773)
.+.++||.|.+|.||+++ .++++.+|+|+.....+ ..++++.|.++++.. .|||++.++|++.. ..+..|+||
T Consensus 22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVM 100 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVM 100 (953)
T ss_pred EEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEe
Confidence 456889999999999998 45788999999875544 366778899999887 49999999999853 346899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
|||.+|+..|+++... ...+.|....-|++.++.|+.+|| ...++|||||-.|||++.++.+|+.|||.+........
T Consensus 101 EfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH-~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g 178 (953)
T KOG0587|consen 101 EFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLH-NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG 178 (953)
T ss_pred eccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHh-hcceeeecccCceEEEeccCcEEEeeeeeeeeeecccc
Confidence 9999999999998765 566899999999999999999999 99999999999999999999999999999887654332
Q ss_pred cceeeccCccccccccccCC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKL-----KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
......|||.|||||++.. ..|+.++|+||+|++..||-.|.+|+-++..
T Consensus 179 -rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 179 -RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred -cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 2234569999999998743 3577899999999999999999999877543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=234.69 Aligned_cols=197 Identities=30% Similarity=0.465 Sum_probs=169.0
Q ss_pred hhcccccccceEEEEEEeCC-CCEEEEEEecccCcc-cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 539 TAEIMGKSTYGTAYKATLED-GSEVAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
..+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++. .....++++||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-~~~~~~~v~e~~~~ 81 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-DPEPLYLVMEYCEG 81 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-cCCceEEEEeccCC
Confidence 45789999999999998764 899999999866554 5778999999999999999999999984 44589999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.+++...... +++.....++.+++.++.||| +.+++|+||+|+||+++.++.++|+|||.+.............
T Consensus 82 ~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh-~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 82 GDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLH-SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 9999999875321 688899999999999999999 8899999999999999999999999999988765442111223
Q ss_pred ccCcccccccccc-CCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 697 TAGTLGYRAPELS-KLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 697 ~~gt~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
..++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 3477889999988 667788899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-28 Score=251.47 Aligned_cols=194 Identities=19% Similarity=0.345 Sum_probs=165.0
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--------cccHHHHHHHHHHHHccC---CCceEEeEEEEECCC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--------TKGQKEFEAEAAAIGKIH---HPNLLALRAYYLGPK 604 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 604 (773)
|.+.+.+|+|+||.|+.|.++ +...|+||.+.+.. ..+.-.+-.||++|..++ |+||++++.++ ++.
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF-Edd 641 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF-EDD 641 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee-ecC
Confidence 566789999999999999976 45679999886542 111223567999999998 99999999999 667
Q ss_pred CeEEEEEeecC-CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCc
Q 041878 605 GEKLLVFDFMP-KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS 683 (773)
Q Consensus 605 ~~~~lV~e~~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a 683 (773)
+.+|++||-.. +-+|.+++..+.. +++..+.-|.+||+.|+++|| +.||||||||-+|+.++.+|-+||+|||.|
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh-~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLH-DQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhcccccc-ccCceecccccccEEEecCCeEEEeeccch
Confidence 79999999774 4489999987643 788999999999999999999 999999999999999999999999999998
Q ss_pred cccccccccceeeccCccccccccccCCCCC-CcchhhHHHHHHHHHHHcCCCCCC
Q 041878 684 RLMTAAANTNVIATAGTLGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKSPGE 738 (773)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~P~~ 738 (773)
...+.. +....+||..|.|||++.+..| +...||||+|+++|.++..+.||.
T Consensus 718 a~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 766543 2335679999999999998887 667999999999999999999985
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-28 Score=242.83 Aligned_cols=210 Identities=21% Similarity=0.339 Sum_probs=172.3
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCC--Cc----eEEeEEEEECCCCeEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHH--PN----LLALRAYYLGPKGEKL 608 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h--~n----iv~l~~~~~~~~~~~~ 608 (773)
+|.+...+|+|.||.|.++.+. .+..||||+++.... -.+...-|+++++++.+ |+ ++.+.+++ +..+..+
T Consensus 90 Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-dyrghiC 167 (415)
T KOG0671|consen 90 RYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWF-DYRGHIC 167 (415)
T ss_pred ceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-hccCceE
Confidence 5667889999999999999764 478899999975433 34555779999999943 22 77777888 7778999
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-----------------
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE----------------- 671 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~----------------- 671 (773)
+|+|.+ |-++.+++.++. ...++..++..++.|++++++||| +.+++|-|+||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh-~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLH-DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred EEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHH-hcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 999999 669999999865 455888999999999999999999 999999999999999942
Q ss_pred ---CCCeEEeecCCccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHH
Q 041878 672 ---KTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQW 748 (773)
Q Consensus 672 ---~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~ 748 (773)
+..+|++|||.|....... ...+.|..|.|||++.+-.++.++||||+||+|+|+.||...|...+..+-...
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM 320 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAM 320 (415)
T ss_pred cCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence 2358999999998654333 234578899999999999999999999999999999999999988665554455
Q ss_pred HHHHHH
Q 041878 749 VASIVK 754 (773)
Q Consensus 749 ~~~~~~ 754 (773)
+.++++
T Consensus 321 MerIlG 326 (415)
T KOG0671|consen 321 MERILG 326 (415)
T ss_pred HHHhhC
Confidence 555554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-27 Score=219.07 Aligned_cols=204 Identities=18% Similarity=0.356 Sum_probs=168.0
Q ss_pred HHHhhcccccccceEEEEEE-eCCCCEEEEEEecccCcccHHHHHHHHHHHHccC-CCceEEeEEEEECCCC-eEEEEEe
Q 041878 536 LCATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKG-EKLLVFD 612 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-~~~lV~e 612 (773)
.|++.+++|+|.++.||.|. ..+.+.++||+++.. ..+.+.+|+.+++.++ ||||+.++++..++.. ...+|+|
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 46778999999999999997 567889999999754 3567889999999998 9999999999976654 4569999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC-CeEEeecCCccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT-NPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~~~ 691 (773)
|+.+.+....-.. ++......++.+++.||.|+| +.||.|||+||.|+|+|... .++++|.|+|.+..+...
T Consensus 116 ~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCH-S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 116 YVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCH-SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred hhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHH-hcCcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 9999888766543 566677889999999999999 99999999999999999765 599999999998876654
Q ss_pred cceeeccCccccccccccC-CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHH
Q 041878 692 TNVIATAGTLGYRAPELSK-LKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIV 753 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~ 753 (773)
.. .++.+..|--||.+. .+.|+.+-|+|||||++.+|+..+.||- .+.+-.+++.++.
T Consensus 189 Yn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF--hG~dN~DQLVkIa 247 (338)
T KOG0668|consen 189 YN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF--HGHDNYDQLVKIA 247 (338)
T ss_pred ee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc--CCCCCHHHHHHHH
Confidence 43 344677899999764 4678999999999999999999999984 4444444444443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=263.12 Aligned_cols=197 Identities=19% Similarity=0.251 Sum_probs=137.8
Q ss_pred HHhhcccccccceEEEEEEeC-C----CCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEE----E-ECCCCe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-D----GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY----Y-LGPKGE 606 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~----g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~----~-~~~~~~ 606 (773)
|...++||+|+||.||+|.+. + +..||+|++...... +....| .++...+.++..++.. . ......
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCc
Confidence 456789999999999999875 4 689999998643221 111111 1111122222222111 1 134457
Q ss_pred EEEEEeecCCCCHHHHHhhcCCC-----------------CccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe
Q 041878 607 KLLVFDFMPKGSLASFLHARGPE-----------------TIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL 669 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~~-----------------~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll 669 (773)
.++||||+++++|.++++..... .......+..++.||+.||+||| +.+|+||||||+|||+
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH-~~gIiHRDLKP~NILl 288 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH-STGIVHRDVKPQNIIF 288 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH-HCCEEeCcCCHHHEEE
Confidence 89999999999999998754210 00112345679999999999999 9999999999999999
Q ss_pred CC-CCCeEEeecCCccccccccccceeeccCccccccccccCCC----------------------CCCcchhhHHHHHH
Q 041878 670 DE-KTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLK----------------------NANTKTDVYSLGVI 726 (773)
Q Consensus 670 ~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dvws~Gv~ 726 (773)
+. ++.+||+|||+|+..............+++.|||||.+... .++.++||||+||+
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi 368 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 368 (566)
T ss_pred eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence 86 57899999999986644333333345689999999964322 23456799999999
Q ss_pred HHHHHcCCCCCC
Q 041878 727 ILELLTGKSPGE 738 (773)
Q Consensus 727 l~el~tg~~P~~ 738 (773)
+|||+++..|++
T Consensus 369 L~el~~~~~~~~ 380 (566)
T PLN03225 369 FLQMAFPNLRSD 380 (566)
T ss_pred HHHHHhCcCCCc
Confidence 999999887754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-26 Score=231.47 Aligned_cols=186 Identities=33% Similarity=0.525 Sum_probs=163.4
Q ss_pred cceEEEEEEeC-CCCEEEEEEecccCccc-HHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCCHHHHHh
Q 041878 547 TYGTAYKATLE-DGSEVAVKRLREKTTKG-QKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLH 624 (773)
Q Consensus 547 ~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~L~~~l~ 624 (773)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++. .....++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-DEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-eCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999976 58999999997665544 688999999999999999999999984 4458999999999999999998
Q ss_pred hcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeeccCccccc
Q 041878 625 ARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR 704 (773)
Q Consensus 625 ~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~ 704 (773)
.... +++..+..++.+++.++.||| +.+++|+||+|+||++++++.++++|||.+....... ......++..|+
T Consensus 80 ~~~~---~~~~~~~~~~~~l~~~l~~lh-~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 80 KRGR---LSEDEARFYARQILSALEYLH-SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred hccC---CCHHHHHHHHHHHHHHHHHHH-HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 7543 788999999999999999999 8999999999999999999999999999988765432 222345788999
Q ss_pred cccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 705 APELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 705 aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
|||......++.++||||+|+++|++++|..||..
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999888899999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=251.25 Aligned_cols=197 Identities=27% Similarity=0.424 Sum_probs=158.3
Q ss_pred HHhhcccccccceE-EEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGT-AYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~-Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
+...+++|.|+.|+ ||+|.++ |+.||||++-.. ...-.++|++.++.- .|||||++++.- ..+...|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E-~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSE-QDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeec-cCCceEEEEehHh
Confidence 34567899999986 7999986 889999998432 234557899999887 499999998765 4556899999999
Q ss_pred CCCCHHHHHhhcCCCCc-cCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC---CC--CeEEeecCCcccccc
Q 041878 615 PKGSLASFLHARGPETI-VNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE---KT--NPRIADFGLSRLMTA 688 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~-~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~---~~--~~kl~DfG~a~~~~~ 688 (773)
..+|.+++.....+.. ........+..|++.|+++|| +.+|||||+||.||||+. ++ .++|+|||+++.+..
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH-sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH-SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH-hcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 5699999988521111 111344678999999999999 899999999999999976 34 589999999998875
Q ss_pred ccccc--eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcC-CCCCCCC
Q 041878 689 AANTN--VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTG-KSPGEPM 740 (773)
Q Consensus 689 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg-~~P~~~~ 740 (773)
..... .....||-+|+|||++....-+.++||||+||++|++++| ..||.+.
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~ 718 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS 718 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch
Confidence 54332 2344689999999999988888899999999999999996 8899763
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-28 Score=244.86 Aligned_cols=288 Identities=27% Similarity=0.376 Sum_probs=202.4
Q ss_pred ccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCC-CCCCCCEEEccCCCCCCCCccc
Q 041878 104 GGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIG-NCPNLQTLDLSNNALIGAIPPS 182 (773)
Q Consensus 104 ~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~ 182 (773)
-+++|+.++.+.+|..|+|..|.|. .+| .|..++.|++|.++.|+|. .+|.... ++++|.+|||.+|+++ ..|+.
T Consensus 195 L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde 270 (565)
T KOG0472|consen 195 LETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDE 270 (565)
T ss_pred hhcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchH
Confidence 3577777888888888888888777 455 7777888888888888877 5565554 8888899999999988 78888
Q ss_pred cccccccceeecccccccccCCccccCCCccceeeccccccccccCC--------------------cc-----c-----
Q 041878 183 LANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN--------------------NW-----G----- 232 (773)
Q Consensus 183 l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~--------------------~~-----~----- 232 (773)
+..+++|.+||+|+|.|+ ..|..++++ .|+.|.+.+|.+...-.+ .+ +
T Consensus 271 ~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~ 348 (565)
T KOG0472|consen 271 ICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAM 348 (565)
T ss_pred HHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccC
Confidence 888888999999999888 677888888 888888888876411000 00 0
Q ss_pred ------ccccCcccccceeeccccccccccCccCCCCC--CccEEECCCCccc-----------------------CCCC
Q 041878 233 ------VLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLG--LLQEISLSHNKIV-----------------------GPIP 281 (773)
Q Consensus 233 ------~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~--~L~~L~L~~N~l~-----------------------~~~p 281 (773)
.-......+.+.|+++.-+++.+....|.... -...++++.|++. +.+|
T Consensus 349 t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~ 428 (565)
T KOG0472|consen 349 TLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVP 428 (565)
T ss_pred CCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccch
Confidence 00000111344555555444422222221111 1334444444443 3556
Q ss_pred CCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCc
Q 041878 282 DELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISG 361 (773)
Q Consensus 282 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~ 361 (773)
..++.+++|..|+|++|-+. .+|..++.+..|+.|+++.|++ ...|..+-.+..|+.+-.++|++....|..+.+|.+
T Consensus 429 ~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrF-r~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~n 506 (565)
T KOG0472|consen 429 LELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRF-RMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRN 506 (565)
T ss_pred HHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccccccc-ccchHHHhhHHHHHHHHhccccccccChHHhhhhhh
Confidence 66677777777777777776 6677777777777778877777 467777777777777777777877666666899999
Q ss_pred CceeecCCccCccCCCchhhccCccCEEEeecccCCCCCch
Q 041878 362 INQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402 (773)
Q Consensus 362 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~ 402 (773)
|..|||.+|.+. .+|+.+++|++|+.|++++|+|. .|+
T Consensus 507 L~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr 544 (565)
T KOG0472|consen 507 LTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPR 544 (565)
T ss_pred cceeccCCCchh-hCChhhccccceeEEEecCCccC--CCH
Confidence 999999999998 88999999999999999999998 454
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=239.61 Aligned_cols=225 Identities=23% Similarity=0.286 Sum_probs=182.9
Q ss_pred HHHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccC------CCceEEeEEEEECCCCeE
Q 041878 535 LLCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH------HPNLLALRAYYLGPKGEK 607 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~~~ 607 (773)
-+|.+....|+|-|++|.+|.+. .|..||||++..... -.+.=..|+++|++|+ .-|+++++..| ....+.
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-~hknHL 509 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-KHKNHL 509 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-hhccee
Confidence 34666677899999999999865 588999999975432 2445577999999996 34788888887 567799
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC-eEEeecCCcccc
Q 041878 608 LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN-PRIADFGLSRLM 686 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~-~kl~DfG~a~~~ 686 (773)
|||+|.+ ..+|.+++...+....+....+..++.|+.-||..|. .+||+|.||||+||||++... +||||||.|...
T Consensus 510 ClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK-~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 510 CLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK-KCGVLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred EEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH-hcCeeecccCccceEeccCcceeeeccCcccccc
Confidence 9999998 5799999999887777888899999999999999999 999999999999999998755 799999999876
Q ss_pred ccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHH---------HHHhhh
Q 041878 687 TAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVAS---------IVKEEW 757 (773)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~---------~~~~~~ 757 (773)
.....++ ..-+..|.|||++.+-.|+...|+||.||+|||+.||+..|.+....++....-. +-+..+
T Consensus 588 ~eneitP---YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF 664 (752)
T KOG0670|consen 588 SENEITP---YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQF 664 (752)
T ss_pred ccccccH---HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcch
Confidence 5443332 2235579999999999999999999999999999999999998776666555432 344455
Q ss_pred cccccChhc
Q 041878 758 TNEVFDLEL 766 (773)
Q Consensus 758 ~~~~~d~~~ 766 (773)
....||..+
T Consensus 665 ~dqHFD~d~ 673 (752)
T KOG0670|consen 665 KDQHFDQDL 673 (752)
T ss_pred hhhhccccc
Confidence 556666553
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=226.67 Aligned_cols=134 Identities=19% Similarity=0.217 Sum_probs=111.6
Q ss_pred HHHHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccC-----C---CceEEeEEEEEC--
Q 041878 534 DLLCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-----H---PNLLALRAYYLG-- 602 (773)
Q Consensus 534 ~l~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 602 (773)
.-+|.+.++||.|.|++||++.+. +.+.||+|+.+.... -.+....||.+|++++ | .+||+|++.|.-
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 345667899999999999999864 567899999976533 3455677999999985 2 369999998842
Q ss_pred -CCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeC
Q 041878 603 -PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLD 670 (773)
Q Consensus 603 -~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~ 670 (773)
+..+.+||+|++ |.+|..++.... .+-++...+++|++||+.||.|||.+.||||.||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 234789999999 789999998875 345899999999999999999999889999999999999993
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=219.60 Aligned_cols=202 Identities=24% Similarity=0.339 Sum_probs=164.9
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCC-----CeEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-----GEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~~ 608 (773)
|.-...+|.|+- .|..|.+. .+++||+|+.... .....++..+|..++..++|+|+++++.++...+ .+.|
T Consensus 19 y~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y 97 (369)
T KOG0665|consen 19 YVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVY 97 (369)
T ss_pred eeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHH
Confidence 344467888887 66666543 5889999988644 2334677889999999999999999999995443 2578
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+|||+| .++|...++-. ++..+...+..|+..|++||| +.||+|||+||+||++..+..+||.|||+|+.-..
T Consensus 98 ~v~e~m-~~nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lh-s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 98 LVMELM-DANLCQVILME-----LDHETISYILYQMLCGIKHLH-SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HHHHhh-hhHHHHHHHHh-----cchHHHHHHHHHHHHHHHHHH-hcceeecccCcccceecchhheeeccchhhcccCc
Confidence 999999 57999888732 678888999999999999999 99999999999999999999999999999986443
Q ss_pred ccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHH
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVA 750 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 750 (773)
. ...+..+.|..|.|||++.+..|.+.+||||.||++.||++|+.-|.+.+ .+-||-+
T Consensus 171 ~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d--~idQ~~k 228 (369)
T KOG0665|consen 171 D--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD--HIDQWNK 228 (369)
T ss_pred c--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch--HHHHHHH
Confidence 3 33445567889999999988889999999999999999999999986432 2445544
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=213.81 Aligned_cols=199 Identities=23% Similarity=0.384 Sum_probs=157.1
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEee
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.|.+.+.+|+|.||.+-++..+ ..+.+++|.+..... ..++|.+|..---.+ .|.||+.-|++.....+.+++++||
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 3678899999999999999865 567899998865433 478899887654444 3899998887766667788899999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeC-CC-CCeEEeecCCccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLD-EK-TNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~-~~-~~~kl~DfG~a~~~~~~~~ 691 (773)
+|.|+|.+-+...+ +-+...++++.|+++|+.|+| ++.+||||||.+||||- .+ ..+|++|||.++......
T Consensus 104 aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMH-sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV- 177 (378)
T KOG1345|consen 104 APRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMH-SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV- 177 (378)
T ss_pred CccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhh-ccchhhcccccceEEEecCCccEEEeeecccccccCcee-
Confidence 99999988776654 556677899999999999999 99999999999999993 33 369999999987543221
Q ss_pred cceeeccCccccccccccCC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKL-----KNANTKTDVYSLGVIILELLTGKSPGEPMNGMD 744 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~ 744 (773)
.....+..|.+||.... -...+.+|+|.||+++|.++||+.||.....++
T Consensus 178 ---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d 232 (378)
T KOG1345|consen 178 ---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD 232 (378)
T ss_pred ---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC
Confidence 11224557999996532 235778999999999999999999998755444
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=245.17 Aligned_cols=269 Identities=27% Similarity=0.360 Sum_probs=216.5
Q ss_pred EeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCC
Q 041878 87 KCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQ 166 (773)
Q Consensus 87 ~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 166 (773)
.|....-..|+|+.++++ .+|+.+. ++|+.|+|++|+|+. +|. .+++|++|+|++|+|+ .+|.. .++|+
T Consensus 197 ~Cl~~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~ 265 (788)
T PRK15387 197 ACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL---PPGLL 265 (788)
T ss_pred HHhcCCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc---ccccc
Confidence 354344557899999998 6888776 489999999999994 564 3689999999999999 56653 47899
Q ss_pred EEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceee
Q 041878 167 TLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLN 246 (773)
Q Consensus 167 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~ 246 (773)
.|+|++|.++ .+|..+ ++|+.|+|++|+++ .+|. ..++|+.|+|++|++++ +|... .+|+.|+
T Consensus 266 ~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~lp--------~~L~~L~ 328 (788)
T PRK15387 266 ELSIFSNPLT-HLPALP---SGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLAS-LPALP--------SELCKLW 328 (788)
T ss_pred eeeccCCchh-hhhhch---hhcCEEECcCCccc-cccc---cccccceeECCCCcccc-CCCCc--------ccccccc
Confidence 9999999998 555533 57889999999998 4554 34789999999999995 45321 2688999
Q ss_pred ccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCC
Q 041878 247 LDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGN 326 (773)
Q Consensus 247 L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 326 (773)
+++|.+++ +|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++
T Consensus 329 Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~ 396 (788)
T PRK15387 329 AYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS 396 (788)
T ss_pred cccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC
Confidence 99999985 4432 2579999999999995 5653 3578899999999994 6653 3579999999999985
Q ss_pred CcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCchhh
Q 041878 327 KIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLL 404 (773)
Q Consensus 327 ~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~~ 404 (773)
+|.. .++|+.|++++|+|++ +|.. ..+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|+|.+|..+
T Consensus 397 -LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 397 -LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred -CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 4443 3679999999999984 6754 347889999999999 789999999999999999999999998876
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-27 Score=239.39 Aligned_cols=261 Identities=31% Similarity=0.467 Sum_probs=145.5
Q ss_pred EEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCC
Q 041878 95 AIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNA 174 (773)
Q Consensus 95 ~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 174 (773)
.+.++.|.+. .+.+.+.+|..|..|++++|.+. ..|.+++.+..++.|+.++|+++ .+|+.++.+.+|+.|+.++|.
T Consensus 49 ~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~ 125 (565)
T KOG0472|consen 49 KLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNE 125 (565)
T ss_pred hhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccccc
Confidence 3444444444 33344555555555555555555 44555555555555555555555 555555555555555555555
Q ss_pred CCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecccccccc
Q 041878 175 LIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAG 254 (773)
Q Consensus 175 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~ 254 (773)
+. .+|+.++.+..|..|+..+|+++ ..|..+.++.+|..|++.+|+++ .
T Consensus 126 ~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-----------------------------~ 174 (565)
T KOG0472|consen 126 LK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-----------------------------A 174 (565)
T ss_pred ee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh-----------------------------h
Confidence 55 44555555555555555555555 44444555555555555555555 3
Q ss_pred ccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhcc
Q 041878 255 TIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLER 334 (773)
Q Consensus 255 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~ 334 (773)
..|..+. |+.|++||...|-++ .+|..++.+.+|+.|+|..|+|. .+| .|.++..|++|+++.|+|.-...+....
T Consensus 175 l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~ 250 (565)
T KOG0472|consen 175 LPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKH 250 (565)
T ss_pred CCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcc
Confidence 3333333 555555555555555 45555565666666666666655 444 5555566666666666653222223335
Q ss_pred ccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccC
Q 041878 335 LQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNL 396 (773)
Q Consensus 335 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l 396 (773)
+++|.+|||.+|+++ +.|..+..+++|+.||+|+|.++ ..|.+++++ .|+.|-+.+|++
T Consensus 251 L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 251 LNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPL 309 (565)
T ss_pred cccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCch
Confidence 666666666666666 55666666666666666666666 456666666 666777777665
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-23 Score=205.10 Aligned_cols=197 Identities=31% Similarity=0.542 Sum_probs=163.8
Q ss_pred cccccceEEEEEEeCC-CCEEEEEEecccCcc-cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCCHH
Q 041878 543 MGKSTYGTAYKATLED-GSEVAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLA 620 (773)
Q Consensus 543 lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~L~ 620 (773)
||+|++|.||++...+ ++.+++|++...... ....+.+|++.+++++|++++++++++. .....++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-DENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-cCCeEEEEEecCCCCcHH
Confidence 6899999999998754 899999999755432 3578999999999999999999999994 446899999999999999
Q ss_pred HHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-CCCeEEeecCCccccccccccceeeccC
Q 041878 621 SFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE-KTNPRIADFGLSRLMTAAANTNVIATAG 699 (773)
Q Consensus 621 ~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~g 699 (773)
+++.... ..+++..+..++.+++++++||| +.+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 80 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh-~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 80 DLLKENE--GKLSEDEILRILLQILEGLEYLH-SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 9998652 34788999999999999999999 889999999999999999 89999999999876644321 1223447
Q ss_pred ccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhh
Q 041878 700 TLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756 (773)
Q Consensus 700 t~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 756 (773)
...|++||..... .++.+.|+|++|++++++ ..+.+.+.+.+...
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------~~~~~~l~~~l~~~ 201 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------PELKDLIRKMLQKD 201 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------HHHHHHHHHHhhCC
Confidence 7899999988776 888999999999999999 34555555555433
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-25 Score=234.10 Aligned_cols=194 Identities=27% Similarity=0.438 Sum_probs=169.2
Q ss_pred HhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 538 ATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
.....+|.|.+|.|||+++ ..++..|+|+++.....+..-++.|+-+++..+|+||+.++|.| -..+..|+.|||+.+
T Consensus 18 ellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsy-lr~dklwicMEycgg 96 (829)
T KOG0576|consen 18 ELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSY-LRRDKLWICMEYCGG 96 (829)
T ss_pred hheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhh-hhhcCcEEEEEecCC
Confidence 3457899999999999985 47899999999988888888889999999999999999999999 455589999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
|+|++.-+..++ ++..+...+.+...+|++||| +.|-+|||||-.||++++.|.+|++|||.+..+..... ....
T Consensus 97 gslQdiy~~Tgp---lselqiayvcRetl~gl~ylh-s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-Krks 171 (829)
T KOG0576|consen 97 GSLQDIYHVTGP---LSELQIAYVCRETLQGLKYLH-SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-KRKS 171 (829)
T ss_pred Ccccceeeeccc---chhHHHHHHHhhhhccchhhh-cCCcccccccccceeecccCceeecccCchhhhhhhhh-hhhc
Confidence 999998877654 777888889999999999999 99999999999999999999999999999876654332 2234
Q ss_pred ccCcccccccccc---CCCCCCcchhhHHHHHHHHHHHcCCCCC
Q 041878 697 TAGTLGYRAPELS---KLKNANTKTDVYSLGVIILELLTGKSPG 737 (773)
Q Consensus 697 ~~gt~~y~aPE~~---~~~~~~~~~Dvws~Gv~l~el~tg~~P~ 737 (773)
+.|||.|||||+. ..+.|...+|||+.|+...|+-.-..|-
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 5799999999964 5678999999999999999998877773
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=238.13 Aligned_cols=344 Identities=22% Similarity=0.320 Sum_probs=251.4
Q ss_pred cCCcchHHHHHHHHHHHHHHHhhhhhccccCCCcccCHHHHHHHHHHHHhCCCCCCCcCC----CCCCCCCCCCCC----
Q 041878 11 FHNYKHFFLYTHLFLCLVLAFTSQFVAGHSWDGVIVTQADYQSLRAIKHDLIDPHGFLRS----WNDSGVGACSGG---- 82 (773)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~k~~~~~~~~~l~s----W~~~~~~~c~~~---- 82 (773)
+.++|-||-.+|=.=.+=.....+ ......+++|.+.++++...+..| +++.+ |+. .+++|.-.
T Consensus 31 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~p-~~~~~~~~~~~~-~~~fc~~~~~~~ 102 (754)
T PRK15370 31 WNKISAFFSSEHQVEAQNCIAYLC------HPPETASPEEIKSKFECLRMLAFP-AYADNIQYSRGG-ADQYCILSENSQ 102 (754)
T ss_pred HHHHHHHhccchHHHHHHHHHHHh------CCCCCCCHHHHHHHHHHHHHhcCC-chhhccccccCC-CCcccccCCcch
Confidence 455666665555443332222222 112345789999999999999877 66666 965 67888531
Q ss_pred ----------CcceEeeCCCEEEEEcCCCCcccc--------------------cC--------ccc-----cCCCCCcE
Q 041878 83 ----------WAGIKCVKGQVIAIQLPWRRLGGR--------------------IS--------EKI-----SQLHALRK 119 (773)
Q Consensus 83 ----------w~gv~c~~~~v~~l~l~~~~l~~~--------------------i~--------~~l-----~~l~~L~~ 119 (773)
-..|.|..+.||.+..-+...... -+ ..+ .-..+...
T Consensus 103 ~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~~~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~ 182 (754)
T PRK15370 103 EILSIVFNTEGYTVEGGGKSVTYTRVTESEQASSASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTE 182 (754)
T ss_pred hhheeeecCCceEEecCCCcccccccccccccccCCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceE
Confidence 124889888888877654211100 00 000 01135788
Q ss_pred EEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccc
Q 041878 120 LSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSL 199 (773)
Q Consensus 120 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l 199 (773)
|+|+++.++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|.|+ .+|..+. ++|+.|+|++|++
T Consensus 183 L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L 253 (754)
T PRK15370 183 LRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRI 253 (754)
T ss_pred EEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCcc
Confidence 999999998 4676653 58999999999999 5676654 58999999999998 5676654 4799999999999
Q ss_pred cccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCC
Q 041878 200 LGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGP 279 (773)
Q Consensus 200 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 279 (773)
. .+|..+. ++|+.|++++|+++ .+|..+. .+|+.|+|++|.+++ +|..+. ++|+.|++++|+++.
T Consensus 254 ~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~-------~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~- 318 (754)
T PRK15370 254 T-ELPERLP--SALQSLDLFHNKIS-CLPENLP-------EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA- 318 (754)
T ss_pred C-cCChhHh--CCCCEEECcCCccC-ccccccC-------CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-
Confidence 8 6676654 58999999999998 5676543 279999999999995 444433 479999999999995
Q ss_pred CCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCC
Q 041878 280 IPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNI 359 (773)
Q Consensus 280 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l 359 (773)
+|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+.
T Consensus 319 LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~-- 387 (754)
T PRK15370 319 LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP-- 387 (754)
T ss_pred CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--
Confidence 565443 689999999999985 666553 79999999999997 4565553 68999999999999 5666554
Q ss_pred CcCceeecCCccCccCCCchhh----ccCccCEEEeecccCCC
Q 041878 360 SGINQLDLSENDFTGEISPSLA----SLANLTSFNVSYNNLSG 398 (773)
Q Consensus 360 ~~L~~L~L~~N~l~~~~~~~~~----~l~~L~~L~ls~N~l~g 398 (773)
.+|+.|++++|+|+ .+|..+. .++++..|+|.+|+|+.
T Consensus 388 ~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 388 AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH
Confidence 47999999999998 5665543 34788999999999974
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-25 Score=245.37 Aligned_cols=173 Identities=29% Similarity=0.426 Sum_probs=122.2
Q ss_pred ccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCc--------------------------Ccccccceec
Q 041878 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDEL--------------------------GKLSKLQKLD 294 (773)
Q Consensus 241 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l--------------------------~~l~~L~~L~ 294 (773)
+|++|.+..|.++ -+|.....+++|++|+|..|+|.. .|+.+ ...+.|+.|+
T Consensus 288 ~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Ly 365 (1081)
T KOG0618|consen 288 SLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELY 365 (1081)
T ss_pred hHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccc-cchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHH
Confidence 4444444444444 445566667788888888888763 22211 0124577778
Q ss_pred cccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCcc
Q 041878 295 LSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTG 374 (773)
Q Consensus 295 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (773)
+.+|.|++..-..+.+.++|+.|+|++|+|.......+.++..|+.|+||+|+|+ .+|..+.+++.|++|...+|++.
T Consensus 366 lanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~- 443 (1081)
T KOG0618|consen 366 LANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL- 443 (1081)
T ss_pred HhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-
Confidence 8888888777777778888888888888887666677888888888888888888 77788888888888888888887
Q ss_pred CCCchhhccCccCEEEeecccCCC-CCchhhh-ccCCCCCCCCCCC
Q 041878 375 EISPSLASLANLTSFNVSYNNLSG-SVPPLLS-KKFNSSSFVGNLQ 418 (773)
Q Consensus 375 ~~~~~~~~l~~L~~L~ls~N~l~g-~~p~~~~-~~~~~~~~~~n~~ 418 (773)
..| .+..+++|+.+|||.|+|+- .+|.... .++....+.||.+
T Consensus 444 ~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 444 SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 555 78888888888888888863 3343332 3444556667765
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-25 Score=220.25 Aligned_cols=301 Identities=22% Similarity=0.243 Sum_probs=214.7
Q ss_pred CCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccC-CCCCCCCccccccccccceeec
Q 041878 116 ALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSN-NALIGAIPPSLANSTRLYRLNL 194 (773)
Q Consensus 116 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~~l~~l~~L~~L~L 194 (773)
.-..++|..|.|+.+.|.+|+.+++|+.||||+|+|+.+-|++|..+++|..|-+-+ |+|+..-...|++|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 445677777888877777788888888888888888877778888887776665554 7777555556777788888888
Q ss_pred ccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecccccc------------ccccCccCCC
Q 041878 195 SYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLI------------AGTIPVSLGK 262 (773)
Q Consensus 195 s~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l------------~~~~~~~l~~ 262 (773)
.-|++.-.....|..+++|..|.+.+|.+...--..|..+. .++.+.+..|.+ ....|..++.
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~-----~i~tlhlA~np~icdCnL~wla~~~a~~~ietsg 222 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLA-----AIKTLHLAQNPFICDCNLPWLADDLAMNPIETSG 222 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchh-----ccchHhhhcCccccccccchhhhHHhhchhhccc
Confidence 88877777777777788888888888877633222333333 677777777762 2233444455
Q ss_pred CCCccEEECCCCcccCCCCCCcCcc-cccceeccccccccccCc-ccccccccCceEEccCCCCCCCcchhhcccccccc
Q 041878 263 LGLLQEISLSHNKIVGPIPDELGKL-SKLQKLDLSYNAIGGSFP-VTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTV 340 (773)
Q Consensus 263 l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 340 (773)
+.-..-..+.++++....+..|... ..+..--.+.+...+..| ..|..+++|+.|+|++|+++++-+.+|.++..++.
T Consensus 223 arc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~e 302 (498)
T KOG4237|consen 223 ARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQE 302 (498)
T ss_pred ceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhh
Confidence 4444455555555554434333322 122211222232333444 56899999999999999999999999999999999
Q ss_pred ccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCch-hhhccCCCCCCCCCCCC
Q 041878 341 LNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP-LLSKKFNSSSFVGNLQL 419 (773)
Q Consensus 341 L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~-~~~~~~~~~~~~~n~~~ 419 (773)
|.|..|+|...-...|.++.+|+.|+|++|+|+...|.+|..+.+|.+|+|-.|+|.+.+.- ++..++....-.||+.
T Consensus 303 L~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~- 381 (498)
T KOG4237|consen 303 LYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPR- 381 (498)
T ss_pred hhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCC-
Confidence 99999999977778899999999999999999999999999999999999999999887753 3444555445556654
Q ss_pred CCC
Q 041878 420 CGY 422 (773)
Q Consensus 420 c~~ 422 (773)
|+.
T Consensus 382 Cq~ 384 (498)
T KOG4237|consen 382 CQS 384 (498)
T ss_pred CCC
Confidence 443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=213.98 Aligned_cols=193 Identities=22% Similarity=0.373 Sum_probs=159.6
Q ss_pred HHhhcccccccceEEEEEEeC----CCCEEEEEEecccCcccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE----DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~ 611 (773)
+...++||+|.|++||++++. .++.||+|.+.... ....+.+|+++|..+. +.||+++.+++ ..++...+|+
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~-rnnd~v~ivl 114 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCF-RNNDQVAIVL 114 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhh-ccCCeeEEEe
Confidence 456789999999999999854 46789999996543 3566899999999996 89999999888 5667999999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC-CCeEEeecCCcccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK-TNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~~~~~ 690 (773)
||++.....++... ++......+++.+..||.++| ..|||||||||+|++.+.. +.-.|.|||+|.......
T Consensus 115 p~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h-~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 115 PYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLH-KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred cccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhh-ccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 99999999998875 567888999999999999999 9999999999999999865 457899999987221000
Q ss_pred ----------------------------------cc---------ceeeccCcccccccccc-CCCCCCcchhhHHHHHH
Q 041878 691 ----------------------------------NT---------NVIATAGTLGYRAPELS-KLKNANTKTDVYSLGVI 726 (773)
Q Consensus 691 ----------------------------------~~---------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dvws~Gv~ 726 (773)
.. ......||++|.|||++ ..+..++++||||.||+
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 00 01123599999999976 45678999999999999
Q ss_pred HHHHHcCCCCCCC
Q 041878 727 ILELLTGKSPGEP 739 (773)
Q Consensus 727 l~el~tg~~P~~~ 739 (773)
+..++++++||-.
T Consensus 268 ~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 268 LLSLLSRRYPFFK 280 (418)
T ss_pred eehhhcccccccc
Confidence 9999999999865
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=214.05 Aligned_cols=215 Identities=20% Similarity=0.244 Sum_probs=171.1
Q ss_pred HHHhhcccccccceEEEEEEeCCC--CEEEEEEecccCcccHHHHHHHHHHHHccCC----CceEEeEEEEECCCCeEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLEDG--SEVAVKRLREKTTKGQKEFEAEAAAIGKIHH----PNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~g--~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~~~~~~~~~l 609 (773)
.+.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.. +++..++..........++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 456788999999999999986543 4788888876544333377888999888873 5788887776435558899
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC-----CCeEEeecCCcc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK-----TNPRIADFGLSR 684 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~-----~~~kl~DfG~a~ 684 (773)
||+.+ |.+|.++..... ...++..+..+|+.|++.+|+++| +.|++||||||.|++++.. ..+.+.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH-~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH-SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH-hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 99999 889999887665 566899999999999999999999 9999999999999999865 358999999998
Q ss_pred --ccccccc-----c-c-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHH
Q 041878 685 --LMTAAAN-----T-N-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIV 753 (773)
Q Consensus 685 --~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~ 753 (773)
....... . . .....||.+|+++++..+...+++.|+||++.++.|+..|..||.........+.+.+..
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 3221111 1 1 123569999999999999999999999999999999999999997765444344444333
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=214.79 Aligned_cols=160 Identities=15% Similarity=0.177 Sum_probs=123.0
Q ss_pred HHhhcccccccceEEEEEEeC--CCCEEEEEEecccC-----cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE--DGSEVAVKRLREKT-----TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~--~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
|...++||+|+||+||+|... +++.||||++.... ......|.+|++++++++|+|+++.+..+ +..++
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~L 95 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGL 95 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEE
Confidence 456788999999999999864 57778999875331 12345689999999999999998533222 35799
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCC-CCCCEEeCCCCCeEEeecCCcccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNL-TSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Di-k~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
||||+++++|.. ... . . ...++.|+++||.||| +.||+|||| ||+|||++.++.+||+|||+|+....
T Consensus 96 VmE~~~G~~L~~-~~~---~---~---~~~~~~~i~~aL~~lH-~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 96 VRGWTEGVPLHL-ARP---H---G---DPAWFRSAHRALRDLH-RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred EEEccCCCCHHH-hCc---c---c---hHHHHHHHHHHHHHHH-HCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 999999999963 211 1 1 1457889999999999 999999999 99999999999999999999997654
Q ss_pred cccc-------ceeeccCccccccccccCC
Q 041878 689 AANT-------NVIATAGTLGYRAPELSKL 711 (773)
Q Consensus 689 ~~~~-------~~~~~~gt~~y~aPE~~~~ 711 (773)
.... ......+++.|+|||.+..
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 3211 1124457888999997643
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-24 Score=216.37 Aligned_cols=234 Identities=25% Similarity=0.245 Sum_probs=185.3
Q ss_pred CEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEccc-CccCCCCCCCCCCCCCCCEEEc
Q 041878 92 QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFN-NRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 92 ~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L 170 (773)
..++|+|..|.++...+.+|+.+++|++|||++|+|+.+-|++|.++++|..|-+.+ |+|+...-..|++|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 578999999999988888999999999999999999999999999999998887766 9999777788999999999999
Q ss_pred cCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccc------------cccCCcccc-----
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLS------------GSVPNNWGV----- 233 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~------------~~~p~~~~~----- 233 (773)
.-|.+.-.....|..+++|..|.|..|.+.......|..+.+++.+++..|.+- ...|..++.
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 999999888889999999999999999998555558899999999999988731 011111111
Q ss_pred ----------------------------------------cccCcccccceeeccccccccccCccCCCCCCccEEECCC
Q 041878 234 ----------------------------------------LAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSH 273 (773)
Q Consensus 234 ----------------------------------------l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~ 273 (773)
..+..+++|+.|+|++|.|+++.+.+|..+.++++|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 0012344677777777777777777777777777777777
Q ss_pred CcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCC
Q 041878 274 NKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLG 325 (773)
Q Consensus 274 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 325 (773)
|++...-...|.+++.|+.|+|.+|+|+...|..|..+.+|.+|+|-.|.+.
T Consensus 308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 7776555566777777777777777777777777777777777777776653
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-22 Score=229.44 Aligned_cols=272 Identities=26% Similarity=0.430 Sum_probs=213.7
Q ss_pred eEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCC
Q 041878 86 IKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNL 165 (773)
Q Consensus 86 v~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 165 (773)
..|.....+.++|++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. ++|
T Consensus 173 ~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L 243 (754)
T PRK15370 173 RDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTI 243 (754)
T ss_pred HhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccc
Confidence 4576677899999999888 4666554 58999999999999 5666554 69999999999999 5676553 589
Q ss_pred CEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCccccccee
Q 041878 166 QTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFL 245 (773)
Q Consensus 166 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L 245 (773)
+.|+|++|.+. .+|..+. ++|++|+|++|+|+ .+|..+. ++|+.|++++|++++ +|..+. .+|+.|
T Consensus 244 ~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp-------~sL~~L 309 (754)
T PRK15370 244 QEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP-------SGITHL 309 (754)
T ss_pred cEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch-------hhHHHH
Confidence 99999999998 7787765 58999999999999 5676554 589999999999994 555432 279999
Q ss_pred eccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCC
Q 041878 246 NLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLG 325 (773)
Q Consensus 246 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 325 (773)
++++|.++. +|..+ .++|+.|++++|.+++ +|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+
T Consensus 310 ~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt 380 (754)
T PRK15370 310 NVQSNSLTA-LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT 380 (754)
T ss_pred HhcCCcccc-CCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC
Confidence 999999995 44433 2689999999999995 676664 69999999999998 5676553 68999999999998
Q ss_pred CCcchhhccccccccccccCccccccccc----ccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCC
Q 041878 326 NKIPEGLERLQNLTVLNLKNNQFKGHIPE----TIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSV 400 (773)
Q Consensus 326 ~~~~~~l~~l~~L~~L~ls~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~ 400 (773)
. +|..+. ..|+.|++++|+|+ .+|. .++.++++..|+|.+|+++. ..+.+|+.| ++.+.+.|..
T Consensus 381 ~-LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~ 448 (754)
T PRK15370 381 N-LPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPR 448 (754)
T ss_pred C-CCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCc
Confidence 5 555553 37999999999998 4454 34556889999999999983 344555555 4556666543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-24 Score=233.63 Aligned_cols=270 Identities=30% Similarity=0.398 Sum_probs=219.1
Q ss_pred CCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeec
Q 041878 115 HALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNL 194 (773)
Q Consensus 115 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 194 (773)
++|+.|+.++|.++...+ -..-.+|+++++++|+++ .+|+.++.+.+|+.|+..+|+|+ .+|..+..+++|+.|.+
T Consensus 219 ~~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~ 294 (1081)
T KOG0618|consen 219 PSLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSA 294 (1081)
T ss_pred cchheeeeccCcceeecc--ccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHh
Confidence 355566666666652222 223457999999999999 66799999999999999999996 88999999999999999
Q ss_pred ccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCC
Q 041878 195 SYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHN 274 (773)
Q Consensus 195 s~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N 274 (773)
.+|.+. .+|..+..+++|++|+|..|+|. .+|+.+-... ..+|+.|+.+.|.+.......=..++.|+.|++.+|
T Consensus 295 ~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~---~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN 369 (1081)
T KOG0618|consen 295 AYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVL---NASLNTLNVSSNKLSTLPSYEENNHAALQELYLANN 369 (1081)
T ss_pred hhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhh---hHHHHHHhhhhccccccccccchhhHHHHHHHHhcC
Confidence 999998 78888899999999999999998 5565443322 125788888888887554333334678999999999
Q ss_pred cccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCccccccccc
Q 041878 275 KIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPE 354 (773)
Q Consensus 275 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~ 354 (773)
.+++..-..+.+.++|+.|+|++|+|.......+.+++.|++|+||+|+++ .+|..+..+..|++|...+|++. ..|
T Consensus 370 ~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP- 446 (1081)
T KOG0618|consen 370 HLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP- 446 (1081)
T ss_pred cccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-
Confidence 999877677888999999999999998665667889999999999999995 67799999999999999999998 667
Q ss_pred ccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccC
Q 041878 355 TIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNL 396 (773)
Q Consensus 355 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l 396 (773)
.+..+++|+.+|+|.|+|+...-.....-++|++|||++|..
T Consensus 447 e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 447 ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 889999999999999999865544444448999999999985
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=237.49 Aligned_cols=289 Identities=25% Similarity=0.295 Sum_probs=190.0
Q ss_pred EEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccC
Q 041878 93 VIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSN 172 (773)
Q Consensus 93 v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 172 (773)
++.|++.++.+. .+|..+ ...+|+.|+|++|.+. .++..+..+++|+.|+|++|.....+|. ++.+++|++|+|++
T Consensus 591 Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSD 666 (1153)
T ss_pred cEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecC
Confidence 444444444332 444444 3566667777776665 4566666677777777766554445553 66667777777776
Q ss_pred CCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecccccc
Q 041878 173 NALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLI 252 (773)
Q Consensus 173 N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l 252 (773)
|.....+|..+.++++|+.|++++|.....+|..+ ++++|+.|+|++|.....+|.. ..+|++|+|++|.+
T Consensus 667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~--------~~nL~~L~L~~n~i 737 (1153)
T PLN03210 667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI--------STNISWLDLDETAI 737 (1153)
T ss_pred CCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc--------cCCcCeeecCCCcc
Confidence 65555666667777777777777654444555544 5667777777766544444432 12567777777776
Q ss_pred ccccCccCCCCCCccEEECCCCccc-------CCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCC
Q 041878 253 AGTIPVSLGKLGLLQEISLSHNKIV-------GPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLG 325 (773)
Q Consensus 253 ~~~~~~~l~~l~~L~~L~L~~N~l~-------~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 325 (773)
+ .+|..+ .+++|+.|++.++... ...+..+...++|+.|+|++|...+.+|..++++++|+.|+|++|...
T Consensus 738 ~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L 815 (1153)
T PLN03210 738 E-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINL 815 (1153)
T ss_pred c-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCc
Confidence 5 334433 4566666666653321 111112223468899999999887788999999999999999988755
Q ss_pred CCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeec-ccCCCCCch
Q 041878 326 NKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSY-NNLSGSVPP 402 (773)
Q Consensus 326 ~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~-N~l~g~~p~ 402 (773)
+.+|..+ .+++|+.|++++|.....+|.. ..+|+.|+|++|.+. .+|..+..+++|+.|+|++ |+|.+ +|.
T Consensus 816 ~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~-l~~ 887 (1153)
T PLN03210 816 ETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQR-VSL 887 (1153)
T ss_pred CeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCc-cCc
Confidence 6677665 7889999999998765555543 367889999999998 6888899999999999988 55554 554
|
syringae 6; Provisional |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-22 Score=187.93 Aligned_cols=213 Identities=19% Similarity=0.289 Sum_probs=170.2
Q ss_pred HHhhcccccccceEEEEEE-eCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCC-ceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHP-NLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.++||.|+||.+|.|. ..+|..||||.-+.... ..++..|..+.+.+++- .|..+..+. .++....+|||.+
T Consensus 17 y~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~-~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 17 YKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYG-TEKDYNVLVMDLL 93 (341)
T ss_pred eEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhc-cccccceeeeecc
Confidence 3457899999999999997 67899999999865543 35667788888888763 444444443 6666889999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC---CCeEEeecCCccccccccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK---TNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~---~~~kl~DfG~a~~~~~~~~ 691 (773)
|-+|++.+.-.. +.++..+++-++.|++.-++|+| .+++|||||||+|+|..-+ ..+.++|||+|+.+.+...
T Consensus 94 -GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH-~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 94 -GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVH-LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred -CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHH-hhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 789999887653 34788999999999999999999 9999999999999999754 4588999999998754322
Q ss_pred c------ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhh
Q 041878 692 T------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756 (773)
Q Consensus 692 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 756 (773)
. +.....||.+|.+-....+...+.+.|+-|+|.++...--|..||.+.....-.|...+|....
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 1 1223458999999888888888899999999999999999999999987766666666665443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=222.42 Aligned_cols=247 Identities=25% Similarity=0.351 Sum_probs=198.7
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
.+++.|++.+|+++. +|. .+++|++|+|++|+|+. +|.. .++|+.|+|++|.++ .+|.. .++|+.|+|
T Consensus 222 ~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~-~Lp~l---p~~L~~L~L 289 (788)
T PRK15387 222 AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLT-HLPAL---PSGLCKLWI 289 (788)
T ss_pred cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCc---ccccceeeccCCchh-hhhhc---hhhcCEEEC
Confidence 367889999999984 554 35899999999999994 5643 478999999999998 55553 367999999
Q ss_pred cCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecccc
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN 250 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n 250 (773)
++|.++ .+|.. +++|+.|+|++|+|++ +|.. ..+|+.|++++|++++ +|.. . .+|++|+|++|
T Consensus 290 s~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~l----p----~~Lq~LdLS~N 352 (788)
T PRK15387 290 FGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LPTL----P----SGLQELSVSDN 352 (788)
T ss_pred cCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc-cccc----c----cccceEecCCC
Confidence 999998 56653 4789999999999985 4442 2468889999999984 5541 1 27999999999
Q ss_pred ccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcch
Q 041878 251 LIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPE 330 (773)
Q Consensus 251 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 330 (773)
+|++ +|.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +|.. .++|+.|++++|+++. +|.
T Consensus 353 ~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~ 419 (788)
T PRK15387 353 QLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPM 419 (788)
T ss_pred ccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCc
Confidence 9995 4433 3578899999999995 6654 3579999999999994 5543 3689999999999975 564
Q ss_pred hhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhcc
Q 041878 331 GLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASL 383 (773)
Q Consensus 331 ~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 383 (773)
. ..+|+.|++++|+|+ .+|..++++++|+.|+|++|+|++.++..+..+
T Consensus 420 l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 420 L---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred c---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 3 357899999999999 789999999999999999999999988877554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=189.58 Aligned_cols=211 Identities=18% Similarity=0.259 Sum_probs=171.4
Q ss_pred HHHHhhcccccccceEEEEEE-eCCCCEEEEEEecccCcccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEEe
Q 041878 535 LLCATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e 612 (773)
..|+++++||+|.||+++.|+ +-+++.||||.-... .+..++..|.+..+.+. .+.|..++-+- ...-.-.||+|
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFG-qeG~~NiLVid 104 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFG-QEGKYNILVID 104 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeec-cccchhhhhhh
Confidence 356789999999999999997 568999999986433 34567788888888886 57777765333 33336679999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC-----CeEEeecCCccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT-----NPRIADFGLSRLMT 687 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~-----~~kl~DfG~a~~~~ 687 (773)
.+ |-+|+|++.-.+ +.++..++..+|.|+..-++|+| ++..|.|||||+|+||..-+ .+.++|||+|+.+.
T Consensus 105 LL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH-~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVH-EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHH-hcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 99 789999988774 34899999999999999999999 99999999999999997543 48999999999886
Q ss_pred cccccc------eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 041878 688 AAANTN------VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASI 752 (773)
Q Consensus 688 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~ 752 (773)
.+.... .....||.+||+-....+.+.+.+.|+-|+|-++...+-|.+||.+......-+...+|
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 554322 22345999999999999999999999999999999999999999997665554544444
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.84 E-value=4e-20 Score=227.19 Aligned_cols=278 Identities=23% Similarity=0.253 Sum_probs=192.9
Q ss_pred cCccccCCC-CCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCcccccc
Q 041878 107 ISEKISQLH-ALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLAN 185 (773)
Q Consensus 107 i~~~l~~l~-~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~ 185 (773)
+|..+..++ .|+.|++.++.+. .+|..+ .+.+|++|+|++|++. .+|..+..+++|++|+|++|.....+| .++.
T Consensus 580 lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~ 655 (1153)
T PLN03210 580 LPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSM 655 (1153)
T ss_pred cCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-cccc
Confidence 444444443 4666666666554 455555 3567777777777776 566667777777777777765444555 3667
Q ss_pred ccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCC
Q 041878 186 STRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGL 265 (773)
Q Consensus 186 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~ 265 (773)
+++|++|+|++|.....+|..+.++++|+.|++++|..-..+|..+ .+.+|+.|++++|...+..|.. .++
T Consensus 656 l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i------~l~sL~~L~Lsgc~~L~~~p~~---~~n 726 (1153)
T PLN03210 656 ATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI------NLKSLYRLNLSGCSRLKSFPDI---STN 726 (1153)
T ss_pred CCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC------CCCCCCEEeCCCCCCccccccc---cCC
Confidence 7777777777776556777777777777777777765444555443 2336777777777655444432 346
Q ss_pred ccEEECCCCcccCCCCCCcCcccccceecccccccc-------ccCcccccccccCceEEccCCCCCCCcchhhcccccc
Q 041878 266 LQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIG-------GSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNL 338 (773)
Q Consensus 266 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 338 (773)
|++|++++|.+. .+|..+ .+++|++|++.++... ...+..+...++|+.|+|++|.....+|..++.+++|
T Consensus 727 L~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L 804 (1153)
T PLN03210 727 ISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKL 804 (1153)
T ss_pred cCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCC
Confidence 777777777776 455544 4667777777664321 1122223345789999999999888999999999999
Q ss_pred ccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCchhh
Q 041878 339 TVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLL 404 (773)
Q Consensus 339 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~~ 404 (773)
+.|++++|...+.+|..+ ++++|+.|+|++|.....+|.. ..+|+.|+|++|.++ .+|..+
T Consensus 805 ~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si 865 (1153)
T PLN03210 805 EHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWI 865 (1153)
T ss_pred CEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHH
Confidence 999999987666788776 7999999999998766566653 368999999999998 577654
|
syringae 6; Provisional |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.4e-21 Score=187.10 Aligned_cols=168 Identities=14% Similarity=0.245 Sum_probs=130.1
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHH---------HHHHHHHHHccCCCceEEeEEEEECC----
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKE---------FEAEAAAIGKIHHPNLLALRAYYLGP---- 603 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l~~~~~~~---- 603 (773)
|.+.+++|.|+||.||++.. ++..+|+|.+.+.....+.. +++|++.+.++.|++|.....++...
T Consensus 33 y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~ 111 (232)
T PRK10359 33 IKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKT 111 (232)
T ss_pred eEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccc
Confidence 45678999999999999766 57789999997654433332 68999999999999999998876433
Q ss_pred ---CCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeec
Q 041878 604 ---KGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADF 680 (773)
Q Consensus 604 ---~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~Df 680 (773)
.+..++||||++|.+|.++.. .+. ....+++.++..+| +.|++|||++|+||+++.++ ++++||
T Consensus 112 ~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH-~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 112 LRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLH-QHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHH-HcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 235789999999999988732 222 24568999999999 99999999999999999988 999999
Q ss_pred CCccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHH
Q 041878 681 GLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELL 731 (773)
Q Consensus 681 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~ 731 (773)
|............ .......|+.++|+||||+.+.-..
T Consensus 179 g~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 9876543221111 1334455778999999999977543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-21 Score=230.26 Aligned_cols=148 Identities=20% Similarity=0.239 Sum_probs=112.3
Q ss_pred cCC-CceEEeEEEEECC------CCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceec
Q 041878 588 IHH-PNLLALRAYYLGP------KGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHG 660 (773)
Q Consensus 588 l~h-~niv~l~~~~~~~------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~ 660 (773)
++| +||.++++++... .+..+.++||+ +++|.+++... ...+++.+++.++.||++||+||| ++||+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH-~~gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAH-SQGIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHH-hCCeeec
Confidence 345 5777777766211 12466788988 66999999753 344899999999999999999999 9999999
Q ss_pred CCCCCCEEeCC-------------------CCCeEEeecCCcccccccc---------------ccceeeccCccccccc
Q 041878 661 NLTSSNVLLDE-------------------KTNPRIADFGLSRLMTAAA---------------NTNVIATAGTLGYRAP 706 (773)
Q Consensus 661 Dik~~NIll~~-------------------~~~~kl~DfG~a~~~~~~~---------------~~~~~~~~gt~~y~aP 706 (773)
||||+|||++. ++.+|++|||+++...... ........||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999954 4456677777665421100 0001123578899999
Q ss_pred cccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 707 ELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 707 E~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
|++.+..|+.++|||||||++|||++|..|+..
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 999999999999999999999999999988753
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=182.11 Aligned_cols=140 Identities=16% Similarity=0.186 Sum_probs=107.7
Q ss_pred hcccccccceEEEEEEeCCCCEEEEEEecccCcc--c-------HH-----------------HHHHHHHHHHccCCCce
Q 041878 540 AEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTK--G-------QK-----------------EFEAEAAAIGKIHHPNL 593 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~--~-------~~-----------------~~~~E~~~l~~l~h~ni 593 (773)
.+.||+|+||.||+|...+|+.||||+++..... . .. ....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999999754211 1 11 22349999999987776
Q ss_pred EEeEEEEECCCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHh-ccCCCceecCCCCCCEEeCCC
Q 041878 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYL-HVEENMIHGNLTSSNVLLDEK 672 (773)
Q Consensus 594 v~l~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yL-H~~~~iiH~Dik~~NIll~~~ 672 (773)
.....+. . . ..++||||++++++....... ..++......++.|++.+|.|+ | +.||+||||||+||+++ +
T Consensus 82 ~~p~~~~-~-~-~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H-~~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPIL-L-K-SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQ-DCRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEE-e-c-CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEE-C
Confidence 3322222 1 1 348999999988776543322 2478888999999999999999 6 89999999999999998 4
Q ss_pred CCeEEeecCCccccc
Q 041878 673 TNPRIADFGLSRLMT 687 (773)
Q Consensus 673 ~~~kl~DfG~a~~~~ 687 (773)
+.++++|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=8e-20 Score=175.09 Aligned_cols=186 Identities=15% Similarity=0.118 Sum_probs=141.4
Q ss_pred hhcccccccceEEEEEEeCCCCEEEEEEecccCcc----cHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEEee
Q 041878 539 TAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTK----GQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
+...|++|+||+||.+.. ++.+++.+.+.....- ....+.+|+++|+++. |+++++++++. ..+++|||
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~~~lvmey 79 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----GRHLDRSY 79 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----CEEEEEee
Confidence 457899999999998765 6788888887654331 1235889999999996 47888888762 57999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCC-CCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNL-TSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Di-k~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
++|.+|...... . ...++.|++++++++| +.||+|||| ||+|||++.++.++|+|||+|.........
T Consensus 80 I~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH-~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 80 LAGAAMYQRPPR---------G-DLAYFRAARRLLQQLH-RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred ecCccHHhhhhh---------h-hHHHHHHHHHHHHHHH-HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 999998654321 0 1346789999999999 999999999 799999999999999999999855433210
Q ss_pred ----c--------eeeccCccccccccccCC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 ----N--------VIATAGTLGYRAPELSKL--KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ----~--------~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
. ......++.|++|+...- ..--.+.+-++-|.-+|.++|++.|+...+
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 112346888999985332 222356788999999999999999976543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-19 Score=189.66 Aligned_cols=201 Identities=30% Similarity=0.506 Sum_probs=167.6
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccCcc---cHHHHHHHHHHHHccCCC-ceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTK---GQKEFEAEAAAIGKIHHP-NLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~~lV~e~ 613 (773)
...+.||.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +++++...+ ......++++||
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~ 79 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-QDEGSLYLVMEY 79 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-ecCCEEEEEEec
Confidence 34578999999999999876 88999999765443 367899999999999988 799999998 444467999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC-CeEEeecCCcccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT-NPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~~~~ 692 (773)
+.++++.+++........++......++.|++.++.|+| +.+++|||+||+||+++..+ .++++|||.+.........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H-~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH-SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999977765431124788889999999999999999 99999999999999999998 6999999998855443322
Q ss_pred -----ceeeccCccccccccccCC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 693 -----NVIATAGTLGYRAPELSKL---KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 693 -----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
......++..|+|||.... ..+....|+||+|++++++++|..||.....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 2345579999999999887 5788899999999999999999999766543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-21 Score=182.28 Aligned_cols=194 Identities=26% Similarity=0.444 Sum_probs=155.7
Q ss_pred hcccccccceEEEEEEeCCCCEEEEEEecc--cCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 540 AEIMGKSTYGTAYKATLEDGSEVAVKRLRE--KTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
..+|.+...|..|+|+++. ..+++|++.- .......+|.+|.-.++-..||||.+++|.|..+ ....++..|||.|
T Consensus 195 ~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-pnlv~isq~mp~g 272 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-PNLVIISQYMPFG 272 (448)
T ss_pred hhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-CCceEeeeeccch
Confidence 4578899999999999984 4455566643 3344457899999999999999999999999555 4889999999999
Q ss_pred CHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceec-CCCCCCEEeCCCCCeEEe--ecCCccccccccccce
Q 041878 618 SLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHG-NLTSSNVLLDEKTNPRIA--DFGLSRLMTAAANTNV 694 (773)
Q Consensus 618 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~-Dik~~NIll~~~~~~kl~--DfG~a~~~~~~~~~~~ 694 (773)
+|+..+++.. .-.++..++.+++.+||+|++|||+-.+++-| -+.+..+++|++.+++|+ |--++ ...
T Consensus 273 slynvlhe~t-~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs--------fqe 343 (448)
T KOG0195|consen 273 SLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS--------FQE 343 (448)
T ss_pred HHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee--------eec
Confidence 9999999864 34578889999999999999999955666655 789999999999998875 22221 112
Q ss_pred eeccCccccccccccCCCCCC---cchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNAN---TKTDVYSLGVIILELLTGKSPGEPMNGMD 744 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~---~~~Dvws~Gv~l~el~tg~~P~~~~~~~~ 744 (773)
..+...|.||+||.++..+.+ .++|+|||++++||+.|.+.||.+...++
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme 396 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME 396 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh
Confidence 234467899999998876654 47999999999999999999999866554
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-22 Score=213.47 Aligned_cols=276 Identities=28% Similarity=0.333 Sum_probs=154.0
Q ss_pred EEcCCCCcc-cccCccccCCCCCcEEEccCCcccc----cCCCCCCCCCCCceEEcccCccCC------CCCCCCCCCCC
Q 041878 96 IQLPWRRLG-GRISEKISQLHALRKLSLHDNLLAG----PVPWSLGFLPNLRGVYLFNNRLSG------SIPPSIGNCPN 164 (773)
Q Consensus 96 l~l~~~~l~-~~i~~~l~~l~~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~n~l~~------~~p~~l~~l~~ 164 (773)
|+|..+.++ +.....+..++.|+.|+++++.+++ .++..+...++|++|+++++.+.+ .++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 566666666 3445555667778888888887743 245556667777888887777662 23345566777
Q ss_pred CCEEEccCCCCCCCCccccccccc---cceeecccccccc----cCCccccCC-CccceeeccccccccccCCccccccc
Q 041878 165 LQTLDLSNNALIGAIPPSLANSTR---LYRLNLSYNSLLG----SIPLSLTRL-PSLSVLALQHNNLSGSVPNNWGVLAG 236 (773)
Q Consensus 165 L~~L~Ls~N~l~~~~~~~l~~l~~---L~~L~Ls~N~l~~----~~~~~l~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~ 236 (773)
|++|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++.....
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~------ 156 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEA------ 156 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHH------
Confidence 777777777776555555555444 7777777776652 222334444 56666666666655322111
Q ss_pred CcccccceeeccccccccccCccCCCCCCccEEECCCCcccCC----CCCCcCcccccceecccccccccc----Ccccc
Q 041878 237 NKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGP----IPDELGKLSKLQKLDLSYNAIGGS----FPVTF 308 (773)
Q Consensus 237 ~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~~~~~ 308 (773)
++..+..+++|++|++++|.+++. ++..+..+++|++|+|++|.+++. ++..+
T Consensus 157 -------------------~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~ 217 (319)
T cd00116 157 -------------------LAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETL 217 (319)
T ss_pred -------------------HHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHh
Confidence 122333444555556655555531 122233344566666666655432 22334
Q ss_pred cccccCceEEccCCCCCCCcchhhcc-----ccccccccccCccccc----ccccccCCCCcCceeecCCccCccC----
Q 041878 309 TNITSLVSLNLENNRLGNKIPEGLER-----LQNLTVLNLKNNQFKG----HIPETIGNISGINQLDLSENDFTGE---- 375 (773)
Q Consensus 309 ~~l~~L~~L~Ls~N~l~~~~~~~l~~-----l~~L~~L~ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~---- 375 (773)
..+++|++|++++|.+++.....+.. .+.|+.|++++|.++. .+...+..+++|+.+++++|.++..
T Consensus 218 ~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~ 297 (319)
T cd00116 218 ASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQL 297 (319)
T ss_pred cccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHH
Confidence 45566666666666665533333322 2566666666666651 2334444556677777777777644
Q ss_pred CCchhhcc-CccCEEEeecccC
Q 041878 376 ISPSLASL-ANLTSFNVSYNNL 396 (773)
Q Consensus 376 ~~~~~~~l-~~L~~L~ls~N~l 396 (773)
....+... +.|+.|++.+|+|
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 298 LAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHHhhcCCchhhcccCCCCC
Confidence 22223333 4666677666653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-19 Score=174.53 Aligned_cols=140 Identities=18% Similarity=0.252 Sum_probs=109.3
Q ss_pred hcccccccceEEEEEEeCCCCEEEEEEecccCcc--c------------------------HHHHHHHHHHHHccCCCce
Q 041878 540 AEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTK--G------------------------QKEFEAEAAAIGKIHHPNL 593 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 593 (773)
...||+|+||.||+|...+|+.||||+++..... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999999778999999999754211 0 1124578999999999887
Q ss_pred EEeEEEEECCCCeEEEEEeecCCCCHHHH-HhhcCCCCccCHHHHHHHHHHHHHHHHHhccC-CCceecCCCCCCEEeCC
Q 041878 594 LALRAYYLGPKGEKLLVFDFMPKGSLASF-LHARGPETIVNWATRMSIAIGIARGLNYLHVE-ENMIHGNLTSSNVLLDE 671 (773)
Q Consensus 594 v~l~~~~~~~~~~~~lV~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~-~~iiH~Dik~~NIll~~ 671 (773)
.....+... ..++||||++++++... +.. ..++......++.|++.++.|+| + .||+||||||+||+++
T Consensus 82 ~~p~~~~~~---~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH-~~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK---KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLY-QEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec---CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHH-HhCCEecCCCChhhEEEE-
Confidence 433333321 34899999998865433 332 23567788999999999999999 6 9999999999999999
Q ss_pred CCCeEEeecCCcccccc
Q 041878 672 KTNPRIADFGLSRLMTA 688 (773)
Q Consensus 672 ~~~~kl~DfG~a~~~~~ 688 (773)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999986643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=4e-19 Score=172.13 Aligned_cols=107 Identities=27% Similarity=0.319 Sum_probs=94.1
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
|+|.++++.+. ..+++.++..++.||+.||+||| +.+ ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH-~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELH-RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH-hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence 68999998643 34899999999999999999999 666 999999999999999 99987654322
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
..||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 25889999999999999999999999999999999999999754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.1e-18 Score=167.21 Aligned_cols=137 Identities=18% Similarity=0.261 Sum_probs=106.7
Q ss_pred hcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHcc-----CCCceEEeEEEEECCCC--eEE-EEE
Q 041878 540 AEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-----HHPNLLALRAYYLGPKG--EKL-LVF 611 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~~--~~~-lV~ 611 (773)
.++||+|+||.||. .-.++.. +||++........+++.+|+.+++.+ .||||++++|++.++.+ ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 47899999999996 3233444 79988765555667899999999999 57999999999976643 333 789
Q ss_pred ee--cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHH-HHhccCCCceecCCCCCCEEeCCC----CCeEEee-cCCc
Q 041878 612 DF--MPKGSLASFLHARGPETIVNWATRMSIAIGIARGL-NYLHVEENMIHGNLTSSNVLLDEK----TNPRIAD-FGLS 683 (773)
Q Consensus 612 e~--~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al-~yLH~~~~iiH~Dik~~NIll~~~----~~~kl~D-fG~a 683 (773)
|| +++|+|.+++.+.. ++.. ..++.+++.++ +||| +.+|+||||||+|||++.. ..++|+| ||..
T Consensus 85 e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh-~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 85 DFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLL-DNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred cCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 99 55799999997632 4444 35677888887 9999 9999999999999999743 3799999 5554
Q ss_pred cc
Q 041878 684 RL 685 (773)
Q Consensus 684 ~~ 685 (773)
..
T Consensus 158 ~~ 159 (210)
T PRK10345 158 TF 159 (210)
T ss_pred ce
Confidence 43
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-20 Score=168.23 Aligned_cols=185 Identities=29% Similarity=0.542 Sum_probs=123.4
Q ss_pred cccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCC
Q 041878 185 NSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLG 264 (773)
Q Consensus 185 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~ 264 (773)
++.+++.|.||+|+++ .+|..++.+.+|+.|++.+|+++ .+|..++.++
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie------------------------------~lp~~issl~ 79 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE------------------------------ELPTSISSLP 79 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh------------------------------hcChhhhhch
Confidence 4444555555555555 44444555555555555555544 4455666666
Q ss_pred CccEEECCCCcccCCCCCCcCcccccceeccccccccc-cCcccccccccCceEEccCCCCCCCcchhhccccccccccc
Q 041878 265 LLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGG-SFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNL 343 (773)
Q Consensus 265 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l 343 (773)
.|+.|+++-|++. .+|..|+.++.|+.|||++|++.. .+|..|-.++.|+.|+|++|.+ ..+|..++.+++|+.|.+
T Consensus 80 klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndf-e~lp~dvg~lt~lqil~l 157 (264)
T KOG0617|consen 80 KLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDF-EILPPDVGKLTNLQILSL 157 (264)
T ss_pred hhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCc-ccCChhhhhhcceeEEee
Confidence 6777777777666 567777777777777777777654 5666777777777777777777 466777777777778878
Q ss_pred cCcccccccccccCCCCcCceeecCCccCccCCCchhhccC---ccCEEEeecccCCCCCchhh
Q 041878 344 KNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLA---NLTSFNVSYNNLSGSVPPLL 404 (773)
Q Consensus 344 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~---~L~~L~ls~N~l~g~~p~~~ 404 (773)
.+|.+. .+|..++.+.+|++|++.+|+++ .+|+.++++. +-+.+.+..|+|...|...+
T Consensus 158 rdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pIaeQf 219 (264)
T KOG0617|consen 158 RDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPIAEQF 219 (264)
T ss_pred ccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCChHHHHH
Confidence 777777 67888888888888888888888 6777776653 23456677788766655443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-20 Score=200.12 Aligned_cols=262 Identities=27% Similarity=0.311 Sum_probs=165.5
Q ss_pred EEEccCCccc-ccCCCCCCCCCCCceEEcccCccCCC----CCCCCCCCCCCCEEEccCCCCCCCCccccccccccceee
Q 041878 119 KLSLHDNLLA-GPVPWSLGFLPNLRGVYLFNNRLSGS----IPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLN 193 (773)
Q Consensus 119 ~L~L~~n~l~-~~~~~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 193 (773)
.|+|.++.++ +.....+..+.+|+.|+|+++.++.. ++..+...++|++|+++++.+.+ .+..+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~---------- 70 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGL---------- 70 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHH----------
Confidence 4566666665 23344455566677777777666432 44445555666666666666542 01000
Q ss_pred cccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecccccccc----ccCccCCCC-CCccE
Q 041878 194 LSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAG----TIPVSLGKL-GLLQE 268 (773)
Q Consensus 194 Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~----~~~~~l~~l-~~L~~ 268 (773)
..++..+..+++|+.|++++|.+.+..+..+..+... ++|++|++++|.+++ .+...+..+ ++|+.
T Consensus 71 -------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~--~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~ 141 (319)
T cd00116 71 -------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRS--SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEK 141 (319)
T ss_pred -------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhcc--CcccEEEeeCCccchHHHHHHHHHHHhCCCCceE
Confidence 0112233334444444444444443333333322211 235555555555542 223345556 78999
Q ss_pred EECCCCcccCC----CCCCcCcccccceecccccccccc----CcccccccccCceEEccCCCCCCCcc----hhhcccc
Q 041878 269 ISLSHNKIVGP----IPDELGKLSKLQKLDLSYNAIGGS----FPVTFTNITSLVSLNLENNRLGNKIP----EGLERLQ 336 (773)
Q Consensus 269 L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~----~~l~~l~ 336 (773)
|++++|.+++. ++..+..+.+|++|+|++|.+++. ++..+..+++|++|++++|.+++... ..+..++
T Consensus 142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~ 221 (319)
T cd00116 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK 221 (319)
T ss_pred EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC
Confidence 99999998843 344566778999999999999853 33445566799999999999986543 4566788
Q ss_pred ccccccccCcccccccccccC-----CCCcCceeecCCccCcc----CCCchhhccCccCEEEeecccCCCCC
Q 041878 337 NLTVLNLKNNQFKGHIPETIG-----NISGINQLDLSENDFTG----EISPSLASLANLTSFNVSYNNLSGSV 400 (773)
Q Consensus 337 ~L~~L~ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~ls~N~l~g~~ 400 (773)
+|++|++++|.+++.....+. ..+.|++|++++|.++. .+...+..+++|+.+++++|.++..-
T Consensus 222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~ 294 (319)
T cd00116 222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEG 294 (319)
T ss_pred CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHH
Confidence 999999999999864333332 24799999999999972 34455666789999999999998653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.2e-20 Score=164.92 Aligned_cols=121 Identities=22% Similarity=0.413 Sum_probs=76.4
Q ss_pred CccCCCCCCccEEECCCCcccC-CCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccc
Q 041878 257 PVSLGKLGLLQEISLSHNKIVG-PIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERL 335 (773)
Q Consensus 257 ~~~l~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l 335 (773)
|..|+.++.|+.|||.+|++.. .+|..|..+..|+.|+|++|.+. .+|..++++++|+.|.+.+|.+ -..|..++.+
T Consensus 95 prgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndl-l~lpkeig~l 172 (264)
T KOG0617|consen 95 PRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDL-LSLPKEIGDL 172 (264)
T ss_pred ccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCch-hhCcHHHHHH
Confidence 3344444445555555554432 35566666666666666666666 6666677777777777777766 3567777777
Q ss_pred cccccccccCcccccccccccCCCCc---CceeecCCccCccCCCchh
Q 041878 336 QNLTVLNLKNNQFKGHIPETIGNISG---INQLDLSENDFTGEISPSL 380 (773)
Q Consensus 336 ~~L~~L~ls~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~~~~~~~ 380 (773)
+.|++|++.+|+++ .+|+.++++.- =+.+.+.+|+....|...|
T Consensus 173 t~lrelhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~pIaeQf 219 (264)
T KOG0617|consen 173 TRLRELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWVNPIAEQF 219 (264)
T ss_pred HHHHHHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCCChHHHHH
Confidence 77888888888877 66766665532 2356677777765555443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.2e-19 Score=190.12 Aligned_cols=186 Identities=27% Similarity=0.418 Sum_probs=153.4
Q ss_pred ccccccceEEEEEE----eCCCCEEEEEEecccCcc--cHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEEeec
Q 041878 542 IMGKSTYGTAYKAT----LEDGSEVAVKRLREKTTK--GQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 542 ~lG~G~fg~Vy~~~----~~~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
++|+|+||.|+++. ...|.-+|+|.+++.... .......|..++..++ ||.++++...+ ..++..+++.+|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-qt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-QTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-ccccchhHhhhhc
Confidence 47999999998874 234677899988765322 1224556788888887 99999997776 5666899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
.+|.+...+.... .++......+...++-|++++| +.+|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 80 rgg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh-~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEV---MFDELDVAFYLAELALALDHLH-KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred ccchhhhccccCC---chHHHHHHHHHHHHHHHHhhcc-hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 9999988776543 3566667778889999999999 999999999999999999999999999998865433322
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
+||..|||||++. ....++|-||||++++||+||..||..
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 7899999999988 677899999999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=9e-18 Score=167.81 Aligned_cols=135 Identities=19% Similarity=0.392 Sum_probs=111.4
Q ss_pred cccccccceEEEEEEeCCCCEEEEEEecccCcc--------cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTK--------GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+.||+|++|.||+|.. +|..|++|+....... ....+.+|+.++..++|+++.....++.. .+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-PENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-CCCCEEEEE
Confidence 5799999999999987 6788999987643321 12457889999999999987766556533 347789999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
|++|++|.+++.... . .+..++.+++.++.++| +.+++|||++|+||+++ ++.++++|||.+...
T Consensus 80 ~~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH-~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 80 YIEGEPLKDLINSNG------M-EELELSREIGRLVGKLH-SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred EeCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHH-hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 999999999986532 1 77889999999999999 99999999999999999 788999999998753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=166.85 Aligned_cols=142 Identities=20% Similarity=0.207 Sum_probs=110.0
Q ss_pred HHHhhcccccccceEEEEEE--eCCCCEEEEEEecccCcc------------------------cHHHHHHHHHHHHccC
Q 041878 536 LCATAEIMGKSTYGTAYKAT--LEDGSEVAVKRLREKTTK------------------------GQKEFEAEAAAIGKIH 589 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~--~~~g~~vAvK~l~~~~~~------------------------~~~~~~~E~~~l~~l~ 589 (773)
.+++.+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|++.++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35678899999999999998 568999999998753210 0123578999999997
Q ss_pred CC--ceEEeEEEEECCCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCC-ceecCCCCCC
Q 041878 590 HP--NLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN-MIHGNLTSSN 666 (773)
Q Consensus 590 h~--niv~l~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~-iiH~Dik~~N 666 (773)
+. .+.+.+++. ..++||||++++++........ .....+...++.||+.+++||| +.| |+||||||+|
T Consensus 109 ~~~i~~p~~~~~~-----~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH-~~g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAWR-----RNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLY-KEGELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEec-----CceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHH-hcCCEEeCCCChhh
Confidence 63 344444421 3589999999988876543222 2445566789999999999999 898 9999999999
Q ss_pred EEeCCCCCeEEeecCCccccc
Q 041878 667 VLLDEKTNPRIADFGLSRLMT 687 (773)
Q Consensus 667 Ill~~~~~~kl~DfG~a~~~~ 687 (773)
|+++ ++.++++|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8889999999987543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-18 Score=196.72 Aligned_cols=197 Identities=22% Similarity=0.344 Sum_probs=152.5
Q ss_pred hhcccccccceEEEEEEe-CCCCEEEEEEeccc--Cccc----HHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 539 TAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK--TTKG----QKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
..+++|.|++|.|+.+.. ......+.|..... .... ...+..|..+-.+++|+|++..+..+.... ...-+|
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-~~~~~m 400 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-GILQSM 400 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-cchhhh
Confidence 457899999998877763 33444444443211 1111 122666888888899999987766663333 333449
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++ +|..++.+.. .+....+..+.+|+..|++|+| +.||.|||+|++|+++..++.+||+|||.+....-+..
T Consensus 401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h-~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLH-SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHH-hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 9999988752 3677788889999999999999 99999999999999999999999999999877654432
Q ss_pred ---cceeeccCccccccccccCCCCCCc-chhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 ---TNVIATAGTLGYRAPELSKLKNANT-KTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ---~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.......|+..|+|||.+....|++ ..||||.|+++..|.+|+.||....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 3344567899999999999999977 5899999999999999999998643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.2e-17 Score=167.10 Aligned_cols=196 Identities=22% Similarity=0.362 Sum_probs=129.1
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCC-----------CceEEeEEEEEC-
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHH-----------PNLLALRAYYLG- 602 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h-----------~niv~l~~~~~~- 602 (773)
.++.||.|+++.||.+++. +|+++|||++.... ....+++.+|.-....+.+ .-++++--.-..
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 3578999999999999975 58999999886443 2235667777655544322 222222111111
Q ss_pred --------CC-C-----eEEEEEeecCCCCHHHHHhh---cCC-CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCC
Q 041878 603 --------PK-G-----EKLLVFDFMPKGSLASFLHA---RGP-ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTS 664 (773)
Q Consensus 603 --------~~-~-----~~~lV~e~~~~g~L~~~l~~---~~~-~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~ 664 (773)
.+ + ..+++|+-+ .++|.+++.. ... ........++.+..|+++.+++|| ..|++|+||+|
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh-~~GlVHgdi~~ 173 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH-SYGLVHGDIKP 173 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH-HTTEEEST-SG
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh-hcceEecccce
Confidence 11 1 235788877 5688877653 221 223455667788899999999999 99999999999
Q ss_pred CCEEeCCCCCeEEeecCCccccccccccceeeccCccccccccccCC--------CCCCcchhhHHHHHHHHHHHcCCCC
Q 041878 665 SNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKL--------KNANTKTDVYSLGVIILELLTGKSP 736 (773)
Q Consensus 665 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dvws~Gv~l~el~tg~~P 736 (773)
+|++++.+|.++|+||+........... ...+..|.+||.... -.++.+.|.|++|+++|.|++|+.|
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP 249 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP 249 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred eeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence 9999999999999999877654432221 234578999996533 2478899999999999999999999
Q ss_pred CCCC
Q 041878 737 GEPM 740 (773)
Q Consensus 737 ~~~~ 740 (773)
|...
T Consensus 250 f~~~ 253 (288)
T PF14531_consen 250 FGLS 253 (288)
T ss_dssp TCCC
T ss_pred CCCC
Confidence 9863
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.4e-17 Score=191.07 Aligned_cols=198 Identities=21% Similarity=0.293 Sum_probs=155.7
Q ss_pred ChhHHHHHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccC---CCceEEeEEEEECCCCeE
Q 041878 531 TADDLLCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH---HPNLLALRAYYLGPKGEK 607 (773)
Q Consensus 531 ~~~~l~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~ 607 (773)
......+.+.+.||+|+||.||+|...+|+.||+|+-+.....+ |.--.+++.||+ -+.|..+...+. ..+..
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~-~~~~S 769 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHV-FQNAS 769 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHc-cCCcc
Confidence 33344455678899999999999998889999999987665442 222233444444 223344433332 33477
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-------CCCeEEeec
Q 041878 608 LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE-------KTNPRIADF 680 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~-------~~~~kl~Df 680 (773)
++|+||.+.|+|.+++.. .+.+++...+.++.|+++-++.|| ..+|||+||||+|+|+.. ...++|+||
T Consensus 770 ~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH-~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLH-AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHH-hcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 899999999999999983 456899999999999999999999 999999999999999953 234899999
Q ss_pred CCcccccccc-ccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCC
Q 041878 681 GLSRLMTAAA-NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736 (773)
Q Consensus 681 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P 736 (773)
|.+-.+.--. .+......+|-.+-.+|...+..++..+|.|.++-+++-|+.|++-
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9988775332 2345566788899999999999999999999999999999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.5e-17 Score=159.59 Aligned_cols=137 Identities=18% Similarity=0.192 Sum_probs=107.6
Q ss_pred HHHhhcccccccceEEEEEEeCCCCEEEEEEecccCcc----------------------cHHHHHHHHHHHHccCCCc-
Q 041878 536 LCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTK----------------------GQKEFEAEAAAIGKIHHPN- 592 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~----------------------~~~~~~~E~~~l~~l~h~n- 592 (773)
.+.+.+.||+|+||.||++...+|+.||||++...... ....+..|+..+.++.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 35667899999999999999888999999987543210 1123677899999998874
Q ss_pred -eEEeEEEEECCCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC
Q 041878 593 -LLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE 671 (773)
Q Consensus 593 -iv~l~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~ 671 (773)
+...++. ...++||||+++++|.+.... .....++.+++.++.++| +.||+||||+|+||++++
T Consensus 96 ~v~~~~~~-----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh-~~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 96 PVPKPIDW-----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAY-KHGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCCceeec-----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHH-HCCCCcCCCCcccEEEcC
Confidence 4444332 256899999999998765431 234568889999999999 899999999999999999
Q ss_pred CCCeEEeecCCccccc
Q 041878 672 KTNPRIADFGLSRLMT 687 (773)
Q Consensus 672 ~~~~kl~DfG~a~~~~ 687 (773)
++.++|+|||.+....
T Consensus 161 ~~~~~liDfg~~~~~~ 176 (198)
T cd05144 161 DEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcEEEEECCccccCC
Confidence 9999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=157.71 Aligned_cols=131 Identities=19% Similarity=0.360 Sum_probs=104.1
Q ss_pred ccccccceEEEEEEeCCCCEEEEEEecccCcc--------cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 542 IMGKSTYGTAYKATLEDGSEVAVKRLREKTTK--------GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 542 ~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.||+|+||.||+|.+ +|..|++|........ ...++.+|+++++.++|+++.....++. .....++||||
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-DPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-ECCCCEEEEEE
Confidence 489999999999985 5788999986543211 1256778999999999876543333332 23356899999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
++|++|.+++..... .++.+++.++.++| +.|++|||++|+||+++ ++.++++|||.+...
T Consensus 79 ~~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH-~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND----------ELLREIGRLVGKLH-KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH----------HHHHHHHHHHHHHH-HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999988765310 78899999999999 99999999999999999 789999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-16 Score=182.92 Aligned_cols=136 Identities=31% Similarity=0.510 Sum_probs=95.8
Q ss_pred ccCHHHHHHHHHHHHhCCCCCCCcCCCCCCCCCCCC---CCCcceEeeC------CCEEEEEcCCCCcccccCccccCCC
Q 041878 45 IVTQADYQSLRAIKHDLIDPHGFLRSWNDSGVGACS---GGWAGIKCVK------GQVIAIQLPWRRLGGRISEKISQLH 115 (773)
Q Consensus 45 ~~~~~~~~~L~~~k~~~~~~~~~l~sW~~~~~~~c~---~~w~gv~c~~------~~v~~l~l~~~~l~~~i~~~l~~l~ 115 (773)
.+.++|.+||+++|.++.+|.. .+|+. ++|+ +.|.||.|.. ..|+.|+|++++++|.+|+.+++++
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~ 442 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLR 442 (623)
T ss_pred ccCchHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCC
Confidence 4567899999999999977632 58953 4563 2599999952 1366777777777777777777777
Q ss_pred CCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCcccccc
Q 041878 116 ALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLAN 185 (773)
Q Consensus 116 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~ 185 (773)
+|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|+.++++++|++|+|++|.++|.+|..+..
T Consensus 443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~ 512 (623)
T PLN03150 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512 (623)
T ss_pred CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhh
Confidence 7777777777777667766677777777777777776666666666666666666666666666666544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.9e-16 Score=175.52 Aligned_cols=133 Identities=19% Similarity=0.308 Sum_probs=106.2
Q ss_pred hhcccccccceEEEEEEeCCCCEEEEEEe-ccc-Cc------ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 539 TAEIMGKSTYGTAYKATLEDGSEVAVKRL-REK-TT------KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l-~~~-~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
..++||+|+||+||+|.+.+.. +++|+. ... .. ...+.+.+|++++++++|++++....++.. ....++|
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv 414 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-PEEKTIV 414 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe-CCCCEEE
Confidence 4688999999999999876443 444432 211 11 113568899999999999998877666643 3467899
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
|||+++++|.+++. ....++.++++++.||| +.+++||||||+||++ +++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH-~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLH-KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHH-hCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999998885 24678999999999999 9999999999999999 6778999999999764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=6.1e-17 Score=181.84 Aligned_cols=195 Identities=22% Similarity=0.299 Sum_probs=144.0
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccC-cccHHHHHH---HHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKT-TKGQKEFEA---EAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+...+.||.+.|=.|.+|+++.|. |+||++-+.. .-....|.+ |++ ...++|||++++.-+- .....-|||-+
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-~t~kAAylvRq 101 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-VTDKAAYLVRQ 101 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-HhhHHHHHHHH
Confidence 445678999999999999988777 8899886544 333344443 444 4556899999886654 33336788888
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc--cccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM--TAAA 690 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~--~~~~ 690 (773)
|+ ..+|+|.+..+. .+...+.+=|+.|++.|+..+| ..||+|||||.+||||+..+=+.|+||-.=+.. ..+.
T Consensus 102 yv-khnLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH-~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YV-KHNLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCH-KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HH-hhhhhhhhccch---HHHHHHHHHHHHHHHHHHHHHH-HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 88 569999887643 3666777889999999999999 999999999999999999998999999753322 1111
Q ss_pred cccee----eccCccccccccccCC----------CC-CCcchhhHHHHHHHHHHHc-CCCCCCC
Q 041878 691 NTNVI----ATAGTLGYRAPELSKL----------KN-ANTKTDVYSLGVIILELLT-GKSPGEP 739 (773)
Q Consensus 691 ~~~~~----~~~gt~~y~aPE~~~~----------~~-~~~~~Dvws~Gv~l~el~t-g~~P~~~ 739 (773)
..... .......|+|||.+.. .. .+++.||||.||++.|+++ |++||+-
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L 241 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL 241 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH
Confidence 11111 1123347999997533 11 5678999999999999997 6777764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.5e-15 Score=147.05 Aligned_cols=137 Identities=20% Similarity=0.239 Sum_probs=98.6
Q ss_pred hcccccccceEEEEEEeCCCCEEEEEEecccCcc--cHHH----------------------HHHHHHHHHccCCCc--e
Q 041878 540 AEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTK--GQKE----------------------FEAEAAAIGKIHHPN--L 593 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 593 (773)
.+.||+|+||+||+|...+|+.||||+++..... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999998653221 1111 135666666665443 3
Q ss_pred EEeEEEEECCCCeEEEEEeecCCCCHHH-HHhhcCCCCccCHHHHHHHHHHHHHHHHHhccC-CCceecCCCCCCEEeCC
Q 041878 594 LALRAYYLGPKGEKLLVFDFMPKGSLAS-FLHARGPETIVNWATRMSIAIGIARGLNYLHVE-ENMIHGNLTSSNVLLDE 671 (773)
Q Consensus 594 v~l~~~~~~~~~~~~lV~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~-~~iiH~Dik~~NIll~~ 671 (773)
.+.++.. ..++||||++++.+.. .+.... .. .....++.+++.++.++| . .+|+||||||+||+++
T Consensus 82 ~~~~~~~-----~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh-~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDLN-----RHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLY-REAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEecC-----CCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHh-hccCcCcCCCChhhEEEE-
Confidence 3443322 4689999999954431 121111 01 456788999999999999 6 9999999999999999
Q ss_pred CCCeEEeecCCcccccc
Q 041878 672 KTNPRIADFGLSRLMTA 688 (773)
Q Consensus 672 ~~~~kl~DfG~a~~~~~ 688 (773)
++.++++|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 88999999999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.6e-14 Score=145.96 Aligned_cols=139 Identities=17% Similarity=0.211 Sum_probs=107.7
Q ss_pred Hhhcccc-cccceEEEEEEeCCCCEEEEEEecccC-------------cccHHHHHHHHHHHHccCCCce--EEeEEEEE
Q 041878 538 ATAEIMG-KSTYGTAYKATLEDGSEVAVKRLREKT-------------TKGQKEFEAEAAAIGKIHHPNL--LALRAYYL 601 (773)
Q Consensus 538 ~~~~~lG-~G~fg~Vy~~~~~~g~~vAvK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~ 601 (773)
....+|| .|+.|+||.+... +..++||++.... ......+.+|++++.+++|+++ ++.+++..
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~ 112 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV 112 (239)
T ss_pred hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence 4467898 8999999999875 7789999885321 1223567889999999998874 66666653
Q ss_pred CCCCe---EEEEEeecCC-CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEE
Q 041878 602 GPKGE---KLLVFDFMPK-GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRI 677 (773)
Q Consensus 602 ~~~~~---~~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl 677 (773)
..... .++|+||+++ .+|.+++... .++.. .+.+|+.++.+|| +.||+||||||+|||++.++.++|
T Consensus 113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH-~~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 113 VRHGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFH-DAGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred eecCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHH-HCCCCCCCCCchhEEEcCCCCEEE
Confidence 33322 3599999997 6999888653 13332 3568999999999 999999999999999999999999
Q ss_pred eecCCcccc
Q 041878 678 ADFGLSRLM 686 (773)
Q Consensus 678 ~DfG~a~~~ 686 (773)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988754
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.3e-15 Score=169.92 Aligned_cols=117 Identities=38% Similarity=0.629 Sum_probs=104.8
Q ss_pred cCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEee
Q 041878 313 SLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVS 392 (773)
Q Consensus 313 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls 392 (773)
.++.|+|++|.+++.+|..++.+++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCchhhhcc---CCCCCCCCCCCCCCCCCCCCCC
Q 041878 393 YNNLSGSVPPLLSKK---FNSSSFVGNLQLCGYSPSTACP 429 (773)
Q Consensus 393 ~N~l~g~~p~~~~~~---~~~~~~~~n~~~c~~~~~~~c~ 429 (773)
+|+++|.+|..+... .....+.+|+.+|+.|....|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 999999999876432 2344678999999876544553
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.9e-16 Score=164.41 Aligned_cols=123 Identities=27% Similarity=0.440 Sum_probs=110.0
Q ss_pred eEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccc
Q 041878 606 EKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL 685 (773)
Q Consensus 606 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~ 685 (773)
..++.|+++...+|.+|+.++......++...+.++.|++.|++| ++.+|||+||.||+...+..+||.|||+...
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccchhhhhhhhhheee
Confidence 578999999999999999877666667889999999999999999 8999999999999999999999999999877
Q ss_pred ccccc-----ccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc
Q 041878 686 MTAAA-----NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT 732 (773)
Q Consensus 686 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t 732 (773)
+.... ....+...||..||+||.+.++.|+.++||||+|++++|++.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 65444 233445679999999999999999999999999999999998
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.4e-14 Score=133.56 Aligned_cols=132 Identities=18% Similarity=0.214 Sum_probs=109.4
Q ss_pred hcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCC--CceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 540 AEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHH--PNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
.+.||+|.++.||++...+ ..+++|....... ..++..|+..++.++| ..+++++++. ...+..++++||++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-ESDGWSYLLMEWIEGE 78 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-CCCCccEEEEEecCCe
Confidence 3679999999999999754 7899999865433 5678999999999987 4888888877 4446899999999887
Q ss_pred CHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccC--CCceecCCCCCCEEeCCCCCeEEeecCCccc
Q 041878 618 SLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE--ENMIHGNLTSSNVLLDEKTNPRIADFGLSRL 685 (773)
Q Consensus 618 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~--~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~ 685 (773)
.+..+ +......++.+++++++++|.. .+++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 4456677889999999999932 4799999999999999988999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.4e-14 Score=156.09 Aligned_cols=153 Identities=27% Similarity=0.446 Sum_probs=125.3
Q ss_pred HHccCCCceEEeEEEEECCCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCC
Q 041878 585 IGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTS 664 (773)
Q Consensus 585 l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~ 664 (773)
|+.+.|.|+.+++|.+... ...+.|.+|++.|+|.|.+... ...+++.-...++++|+.||+|+|.+....|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecc
Confidence 3567899999999999766 6899999999999999999874 455899999999999999999999555559999999
Q ss_pred CCEEeCCCCCeEEeecCCccccccc-cccceeeccCccccccccccCCC-------CCCcchhhHHHHHHHHHHHcCCCC
Q 041878 665 SNVLLDEKTNPRIADFGLSRLMTAA-ANTNVIATAGTLGYRAPELSKLK-------NANTKTDVYSLGVIILELLTGKSP 736 (773)
Q Consensus 665 ~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dvws~Gv~l~el~tg~~P 736 (773)
+|+++|....+|++|||+....... ............-|.|||.+... ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998776431 11111111234579999987653 146679999999999999999999
Q ss_pred CCCC
Q 041878 737 GEPM 740 (773)
Q Consensus 737 ~~~~ 740 (773)
|...
T Consensus 158 ~~~~ 161 (484)
T KOG1023|consen 158 FDLR 161 (484)
T ss_pred cccc
Confidence 9873
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.1e-15 Score=166.00 Aligned_cols=172 Identities=24% Similarity=0.409 Sum_probs=122.6
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
+.+.+.|..|++|.||.++++ ..++.|+| +.+... +. +||..+ .+..++|
T Consensus 85 f~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----il-----------Rnilt~-------a~npfvv----- 135 (1205)
T KOG0606|consen 85 FNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----IL-----------RNILTF-------AGNPFVV----- 135 (1205)
T ss_pred cceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hh-----------hccccc-------cCCccee-----
Confidence 456789999999999999875 45677874 322211 11 111111 1122333
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc----
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN---- 691 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~---- 691 (773)
|+-...+...++ ++. +.+.+++|+| +.||+|||+||+|.+|..-|++|++|||+++...-...
T Consensus 136 -gDc~tllk~~g~---lPv--------dmvla~Eylh-~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 -GDCATLLKNIGP---LPV--------DMVLAVEYLH-SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred -chhhhhcccCCC---Ccc--------hhhHHhHhhc-cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhh
Confidence 555555555332 222 1278899999 99999999999999999999999999999876421100
Q ss_pred --------cc--eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHH
Q 041878 692 --------TN--VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVA 750 (773)
Q Consensus 692 --------~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 750 (773)
.. ....+|||.|.|||++..+.|+..+|-|++|+++||.+-|+.||.+...+++...+.
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi 271 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 271 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh
Confidence 00 113369999999999999999999999999999999999999998887665544433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.4e-14 Score=142.69 Aligned_cols=147 Identities=21% Similarity=0.355 Sum_probs=110.5
Q ss_pred CCCceEEeEEEEECC--------------------------CCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHH
Q 041878 589 HHPNLLALRAYYLGP--------------------------KGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAI 642 (773)
Q Consensus 589 ~h~niv~l~~~~~~~--------------------------~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~ 642 (773)
+|||||++.++|.+. +...|+||...+ .+|++++..+. .+...+.-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 599999998877431 124689999884 59999998753 46667777899
Q ss_pred HHHHHHHHhccCCCceecCCCCCCEEeC--CCCC--eEEeecCCcccccc-----ccccceeeccCccccccccccCCCC
Q 041878 643 GIARGLNYLHVEENMIHGNLTSSNVLLD--EKTN--PRIADFGLSRLMTA-----AANTNVIATAGTLGYRAPELSKLKN 713 (773)
Q Consensus 643 ~i~~al~yLH~~~~iiH~Dik~~NIll~--~~~~--~kl~DfG~a~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~ 713 (773)
|+++|+.||| .+||.|||+|++|||+. +|+. +.|+|||.+-.-+. +........-|...-||||+....+
T Consensus 349 QlLEav~hL~-~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 349 QLLEAVTHLH-KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHH-HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999999 99999999999999994 4433 68899997643221 1111122334666789999875432
Q ss_pred ------CCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 714 ------ANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 714 ------~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.-.|+|.|+.|-+.||+++...||....
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG 461 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG 461 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccc
Confidence 1348999999999999999999998833
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-13 Score=151.20 Aligned_cols=142 Identities=22% Similarity=0.326 Sum_probs=104.5
Q ss_pred cccccccceEEEEEEeCCCCEEEEEEecccCccc----------------------------------------HHHHHH
Q 041878 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKG----------------------------------------QKEFEA 580 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~----------------------------------------~~~~~~ 580 (773)
+.||.|++|.||+|++.+|+.||||+.+....+. +-+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999999999999999986532110 113555
Q ss_pred HHHHHHccC----CCceEEeEEEEECCCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHH-HHHHhccCC
Q 041878 581 EAAAIGKIH----HPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIAR-GLNYLHVEE 655 (773)
Q Consensus 581 E~~~l~~l~----h~niv~l~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~-al~yLH~~~ 655 (773)
|++.+.+++ |.+-+.+-.++....+..++||||++|++|.++....... . .+..++.+++. .+.++| ..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~-~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVL-RD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHH-hC
Confidence 666666653 3333444444544455789999999999998876542111 1 23456666666 478889 89
Q ss_pred CceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 656 ~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
|++|+|++|.||++++++.++++|||++..+..
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.4e-15 Score=154.27 Aligned_cols=194 Identities=26% Similarity=0.441 Sum_probs=131.8
Q ss_pred CCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccc
Q 041878 162 CPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQ 241 (773)
Q Consensus 162 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~ 241 (773)
+..-...||+.|++. .+|..+..+..|+.|.|+.|.+. .+|..+.++..|++|+|+.|+++ .+|..++.++
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp------ 144 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP------ 144 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc------
Confidence 344456677777776 67777777777888888888877 77788888888888888888887 6676666655
Q ss_pred cceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccC
Q 041878 242 LQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLEN 321 (773)
Q Consensus 242 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 321 (773)
|+.|.+++|+++ .+|..++.+..|..||.+.|++. .+|..++.+.+|+.|.+..|++. .+|..+. .-.|..||+|.
T Consensus 145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfSc 220 (722)
T KOG0532|consen 145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSC 220 (722)
T ss_pred ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeeccc
Confidence 777777777776 55666666677777777777776 46666777777777777777776 4555555 33566777777
Q ss_pred CCCCCCcchhhccccccccccccCcccccccccccC---CCCcCceeecCCc
Q 041878 322 NRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIG---NISGINQLDLSEN 370 (773)
Q Consensus 322 N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~---~l~~L~~L~L~~N 370 (773)
|+++ .+|-.|.+|..|++|-|.+|.|+ ..|..+. ...=-++|+..-+
T Consensus 221 Nkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 221 NKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred Ccee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 7773 56666666777777777777666 3344332 2222345555544
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.7e-13 Score=149.13 Aligned_cols=198 Identities=37% Similarity=0.520 Sum_probs=101.5
Q ss_pred EEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCC-CCCEEEccCCCCCCCCccccccccccceeecccc
Q 041878 119 KLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCP-NLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197 (773)
Q Consensus 119 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N 197 (773)
.|+++.|.+... ...+..++.++.|++.+|.++ .+|.....++ +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 355555554321 223334455666666666666 5555555553 6666666666665 44445556666666666666
Q ss_pred cccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCccc
Q 041878 198 SLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIV 277 (773)
Q Consensus 198 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~ 277 (773)
+++ .+|.....+++|+.|++++|+++ .+|...... ..|++|.+++|.+. ..+..+..+.++..|.+.+|++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~-----~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~ 245 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELL-----SALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE 245 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhh-----hhhhhhhhcCCcce-ecchhhhhcccccccccCCceee
Confidence 665 44444445556666666666655 333322111 13555555555322 23344455555555555555555
Q ss_pred CCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcch
Q 041878 278 GPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPE 330 (773)
Q Consensus 278 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 330 (773)
. ++..++.++.+++|++++|.++...+ ++.+.+++.|++++|.++...+.
T Consensus 246 ~-~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 246 D-LPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred e-ccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence 2 24445555555555555555553222 55555555555555555544443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.40 E-value=9.9e-15 Score=153.74 Aligned_cols=191 Identities=34% Similarity=0.501 Sum_probs=102.8
Q ss_pred ceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeecccc
Q 041878 142 RGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHN 221 (773)
Q Consensus 142 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N 221 (773)
...||+.|++. .+|..+..+..|+.|.|..|.+. .+|..++++..|.+|+|+.|+++ ..|..++.|+ |+.|-+++|
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNN 153 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNN 153 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecC
Confidence 33444444444 44444444444444444444443 44444444444444444444444 3344444333 444444444
Q ss_pred ccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceecccccccc
Q 041878 222 NLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIG 301 (773)
Q Consensus 222 ~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 301 (773)
+++ .+|..++.+. +|..|+.+.|.+. .+|..++.+.+|+.|.+..|++. .+|.++..+ .|..||+|+|+++
T Consensus 154 kl~-~lp~~ig~~~-----tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 154 KLT-SLPEEIGLLP-----TLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred ccc-cCCcccccch-----hHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence 444 4444444222 4555555555554 44555666667777777777776 455566633 5777777777777
Q ss_pred ccCcccccccccCceEEccCCCCCCCcchhhcc---ccccccccccCcc
Q 041878 302 GSFPVTFTNITSLVSLNLENNRLGNKIPEGLER---LQNLTVLNLKNNQ 347 (773)
Q Consensus 302 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~---l~~L~~L~ls~N~ 347 (773)
.+|..|.+|+.|++|-|.+|.+. ..|..++. ..=.++|+..-++
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 67777777777777777777774 33444332 2334566665553
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=5.5e-14 Score=159.09 Aligned_cols=200 Identities=26% Similarity=0.361 Sum_probs=157.2
Q ss_pred hhcccccccceEEEEEEeC--CCCEEEEEEecccC--cccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEEee
Q 041878 539 TAEIMGKSTYGTAYKATLE--DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~--~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
..+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+-+.+. |+|++.+++.. ...+..+++.||
T Consensus 24 ~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 24 LSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-SSPRSYLLSLSY 102 (601)
T ss_pred ccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-CCCcccccccCc
Confidence 4456999999999777643 34457777775443 223445556777777777 99999999988 566689999999
Q ss_pred cCCCCHHHHH-hhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC-CeEEeecCCcccccc-cc
Q 041878 614 MPKGSLASFL-HARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT-NPRIADFGLSRLMTA-AA 690 (773)
Q Consensus 614 ~~~g~L~~~l-~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~-~~ 690 (773)
.+++++.+.+ .... ...+......+..|+..++.|+|...++.||||||+|.+++..+ ..+++|||+|..... ..
T Consensus 103 s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g 180 (601)
T KOG0590|consen 103 SDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG 180 (601)
T ss_pred ccccccccccccCCc--cCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence 9999998877 3321 12444556778999999999999778999999999999999999 999999999988765 22
Q ss_pred -ccceeeccC-ccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 691 -NTNVIATAG-TLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 691 -~~~~~~~~g-t~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
........| ++.|+|||...+ ....+..|+||.|+++.-+++|..|+....
T Consensus 181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 233345578 999999998877 456788999999999999999999987643
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.3e-14 Score=144.83 Aligned_cols=90 Identities=20% Similarity=0.307 Sum_probs=48.8
Q ss_pred ccccccCceEEccCCCCCCCc----chhhccccccccccccCccccccccccc-----CCCCcCceeecCCccCccC---
Q 041878 308 FTNITSLVSLNLENNRLGNKI----PEGLERLQNLTVLNLKNNQFKGHIPETI-----GNISGINQLDLSENDFTGE--- 375 (773)
Q Consensus 308 ~~~l~~L~~L~Ls~N~l~~~~----~~~l~~l~~L~~L~ls~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~--- 375 (773)
|..+++|+.|||.+|.++... ...+..+++|+.|++++|.+.......+ ...|+|+.|.|.+|.++..
T Consensus 209 l~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~ 288 (382)
T KOG1909|consen 209 LEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAAL 288 (382)
T ss_pred HHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHH
Confidence 344455555555555554332 2234445555555555555554322222 2356677777777776632
Q ss_pred -CCchhhccCccCEEEeecccCC
Q 041878 376 -ISPSLASLANLTSFNVSYNNLS 397 (773)
Q Consensus 376 -~~~~~~~l~~L~~L~ls~N~l~ 397 (773)
+...+...+.|..|+|++|++.
T Consensus 289 ~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 289 ALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHHHHhcchhhHHhcCCccccc
Confidence 2233445677888888888883
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.6e-13 Score=145.59 Aligned_cols=213 Identities=31% Similarity=0.466 Sum_probs=169.2
Q ss_pred CcceEeeCCCEE---EEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCC-CCceEEcccCccCCCCCCC
Q 041878 83 WAGIKCVKGQVI---AIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLP-NLRGVYLFNNRLSGSIPPS 158 (773)
Q Consensus 83 w~gv~c~~~~v~---~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~L~~n~l~~~~p~~ 158 (773)
+.+..+...... .+++..+.+...+ ..+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..
T Consensus 82 ~l~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~ 158 (394)
T COG4886 82 SLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSP 158 (394)
T ss_pred cccccccccCCCCCceeeccccccccCc-hhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhh
Confidence 344444443444 4666666654333 34556689999999999999 6777888885 9999999999999 77778
Q ss_pred CCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCc
Q 041878 159 IGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNK 238 (773)
Q Consensus 159 l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~ 238 (773)
++.+++|+.|++++|+++ .+|...+.+++|+.|++++|++. .+|........|++|.+++|++. ..+..+..+.
T Consensus 159 ~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~--- 232 (394)
T COG4886 159 LRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLK--- 232 (394)
T ss_pred hhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcc---
Confidence 999999999999999998 77777778999999999999998 67776666777999999999644 3344444433
Q ss_pred ccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCccccc
Q 041878 239 SYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFT 309 (773)
Q Consensus 239 ~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 309 (773)
++..|.+.+|++... +..++.+++|+.|++++|+++.. +. ++.+.+|+.|++++|.+....+....
T Consensus 233 --~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 233 --NLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred --cccccccCCceeeec-cchhccccccceecccccccccc-cc-ccccCccCEEeccCccccccchhhhc
Confidence 788888999998843 67888999999999999999954 33 89999999999999999977665544
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.7e-14 Score=142.57 Aligned_cols=239 Identities=22% Similarity=0.282 Sum_probs=133.7
Q ss_pred CCCCCCCCceEEcccCccCC----CCCCCCCCCCCCCEEEccCCCCCC----CCccc-------cccccccceeeccccc
Q 041878 134 SLGFLPNLRGVYLFNNRLSG----SIPPSIGNCPNLQTLDLSNNALIG----AIPPS-------LANSTRLYRLNLSYNS 198 (773)
Q Consensus 134 ~l~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~----~~~~~-------l~~l~~L~~L~Ls~N~ 198 (773)
.+.....++.|+|++|.|.. .+...+++.++|+..++|+= ++| .+|++ +...++|++||||.|-
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 45566778888888888863 24455667778888888853 333 33443 2345677777777777
Q ss_pred ccccCCcc----ccCCCccceeeccccccccccCCcccc----c----ccCcccccceeeccccccccc----cCccCCC
Q 041878 199 LLGSIPLS----LTRLPSLSVLALQHNNLSGSVPNNWGV----L----AGNKSYQLQFLNLDHNLIAGT----IPVSLGK 262 (773)
Q Consensus 199 l~~~~~~~----l~~l~~L~~L~L~~N~l~~~~p~~~~~----l----~~~~~~~L~~L~L~~n~l~~~----~~~~l~~ 262 (773)
|....+.. +.++.+|++|.|.+|.+.-.--..++. + .....++|+++...+|++... +...|..
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~ 183 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQS 183 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHh
Confidence 76444333 345667777777777665111111110 0 001223566666666666532 2223444
Q ss_pred CCCccEEECCCCcccCC----CCCCcCcccccceeccccccccc----cCcccccccccCceEEccCCCCCCCcchhhc-
Q 041878 263 LGLLQEISLSHNKIVGP----IPDELGKLSKLQKLDLSYNAIGG----SFPVTFTNITSLVSLNLENNRLGNKIPEGLE- 333 (773)
Q Consensus 263 l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~- 333 (773)
.+.|+.+.+..|.+... +...|..+++|+.|||.+|-|+. .+...+..+++|++|++++|.+.......+.
T Consensus 184 ~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~ 263 (382)
T KOG1909|consen 184 HPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVD 263 (382)
T ss_pred ccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHH
Confidence 55666666666666421 12345556666666666666653 2233455556666666666666655443332
Q ss_pred ----cccccccccccCccccc----ccccccCCCCcCceeecCCccCc
Q 041878 334 ----RLQNLTVLNLKNNQFKG----HIPETIGNISGINQLDLSENDFT 373 (773)
Q Consensus 334 ----~l~~L~~L~ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~ 373 (773)
..++|++|.|.+|.++. .+...+...+.|+.|+|++|++.
T Consensus 264 al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 264 ALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 24566666666666652 22233444666666666666663
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.3e-11 Score=136.87 Aligned_cols=140 Identities=19% Similarity=0.282 Sum_probs=96.6
Q ss_pred cccccccceEEEEEEeCC-CCEEEEEEecccCcc----------------------------------------cHHHHH
Q 041878 541 EIMGKSTYGTAYKATLED-GSEVAVKRLREKTTK----------------------------------------GQKEFE 579 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~----------------------------------------~~~~~~ 579 (773)
+.||.|++|.||+|++++ |+.||||+.+....+ .+-++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999887 999999999743110 012345
Q ss_pred HHHHHHHccC----CCceEEeEEEEECCCCeEEEEEeecCCCCHHHH--HhhcCCCCccCHHHHHHHHHHHHH-HHHHhc
Q 041878 580 AEAAAIGKIH----HPNLLALRAYYLGPKGEKLLVFDFMPKGSLASF--LHARGPETIVNWATRMSIAIGIAR-GLNYLH 652 (773)
Q Consensus 580 ~E~~~l~~l~----h~niv~l~~~~~~~~~~~~lV~e~~~~g~L~~~--l~~~~~~~~~~~~~~~~i~~~i~~-al~yLH 652 (773)
+|+..+.+++ +...+.+-.++.+-.+..++||||++|+++.++ +.+.+ .+.. .++...+. -+..+.
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g----~d~~---~la~~~v~~~~~Qif 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG----TDMK---LLAERGVEVFFTQVF 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC----CCHH---HHHHHHHHHHHHHHH
Confidence 5666555553 444555555565555678999999999999874 33222 1111 12222222 133344
Q ss_pred cCCCceecCCCCCCEEeCCCC----CeEEeecCCcccccc
Q 041878 653 VEENMIHGNLTSSNVLLDEKT----NPRIADFGLSRLMTA 688 (773)
Q Consensus 653 ~~~~iiH~Dik~~NIll~~~~----~~kl~DfG~a~~~~~ 688 (773)
..|++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 278 -~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 68999999999999999988 899999999887654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=2e-11 Score=117.24 Aligned_cols=126 Identities=17% Similarity=0.157 Sum_probs=94.7
Q ss_pred cccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceE-EeEEEEECCCCeEEEEEeecCCCCH
Q 041878 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLL-ALRAYYLGPKGEKLLVFDFMPKGSL 619 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~~lV~e~~~~g~L 619 (773)
+.++.|.++.||+++.. +..|++|....... ....+..|+.+++.+.+..++ +++.+. . +..++||||+++.++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-P--ETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-C--CCCeEEEEecCCCcc
Confidence 56899999999999865 78899999864432 234567899999988765544 444433 2 245899999999887
Q ss_pred HHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCC-----ceecCCCCCCEEeCCCCCeEEeecCCcc
Q 041878 620 ASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN-----MIHGNLTSSNVLLDEKTNPRIADFGLSR 684 (773)
Q Consensus 620 ~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~-----iiH~Dik~~NIll~~~~~~kl~DfG~a~ 684 (773)
.+. . . ....++.+++++++.|| ..+ ++|+|++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~--~------~---~~~~~~~~l~~~l~~LH-~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE--D------F---SDPENLEKIAKLLKKLH-SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc--c------c---cCHHHHHHHHHHHHHHh-CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 543 0 0 11235678999999999 666 59999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=6.7e-11 Score=128.75 Aligned_cols=168 Identities=20% Similarity=0.263 Sum_probs=125.9
Q ss_pred eCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCCHHHHHhhcCCCCccCHH
Q 041878 556 LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWA 635 (773)
Q Consensus 556 ~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~ 635 (773)
..++.+|.|...+...........+-++.++.++||+|++++..+ +..+..|+|+|.+ -.|..++.+.+ -.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-e~~~~~ylvTErV--~Pl~~~lk~l~------~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-EEEGTLYLVTERV--RPLETVLKELG------KE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-cccCceEEEeecc--ccHHHHHHHhH------HH
Confidence 457889999888765553345567788999999999999999988 5556899999998 48888888754 23
Q ss_pred HHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeeccCccccccccccCCCCCC
Q 041878 636 TRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNAN 715 (773)
Q Consensus 636 ~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 715 (773)
...-.++||+.||.|||++++++|++|.-+.|+|++.|+.||++|..+........ ......---.|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 34456889999999999789999999999999999999999999998764432221 000001111455666443222
Q ss_pred cchhhHHHHHHHHHHHcCCC
Q 041878 716 TKTDVYSLGVIILELLTGKS 735 (773)
Q Consensus 716 ~~~Dvws~Gv~l~el~tg~~ 735 (773)
-..|.|-|||++||++.|..
T Consensus 182 ~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred cchhhhhHHHHHHHHhCccc
Confidence 35799999999999999933
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.3e-12 Score=134.20 Aligned_cols=215 Identities=28% Similarity=0.304 Sum_probs=114.6
Q ss_pred cCccccCCCCCcEEEccCCcccccCC-CCCCCCCCCceEEcccCccCC--CCCCCCCCCCCCCEEEccCCCCCCCCcccc
Q 041878 107 ISEKISQLHALRKLSLHDNLLAGPVP-WSLGFLPNLRGVYLFNNRLSG--SIPPSIGNCPNLQTLDLSNNALIGAIPPSL 183 (773)
Q Consensus 107 i~~~l~~l~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l 183 (773)
+...-+++.+|+...|.+..+..... .....|++++.|||+.|-|.. .+-.....||+|+.|+|+.|.+........
T Consensus 113 i~akQsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~ 192 (505)
T KOG3207|consen 113 IAAKQSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNT 192 (505)
T ss_pred HHHHhhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccc
Confidence 33444567777777777776652211 355667777777777776652 222334567777777777777763322222
Q ss_pred -ccccccceeecccccccc-cCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCC
Q 041878 184 -ANSTRLYRLNLSYNSLLG-SIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLG 261 (773)
Q Consensus 184 -~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~ 261 (773)
..+++|+.|.|+.|.|+. .+...+..+|+|+.|+|..|... ........
T Consensus 193 ~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~-----------------------------~~~~~~~~ 243 (505)
T KOG3207|consen 193 TLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEII-----------------------------LIKATSTK 243 (505)
T ss_pred hhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhccccc-----------------------------ceecchhh
Confidence 245667777777777763 22333445666666776666421 11112222
Q ss_pred CCCCccEEECCCCcccCCC-CCCcCcccccceecccccccccc-Cccc-----ccccccCceEEccCCCCCCC-cchhhc
Q 041878 262 KLGLLQEISLSHNKIVGPI-PDELGKLSKLQKLDLSYNAIGGS-FPVT-----FTNITSLVSLNLENNRLGNK-IPEGLE 333 (773)
Q Consensus 262 ~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~-~~~~-----~~~l~~L~~L~Ls~N~l~~~-~~~~l~ 333 (773)
.+..|++|||++|++-... -...+.++.|+.|+++.|.+... .|+. ...+++|++|+++.|++..- --..+.
T Consensus 244 i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~ 323 (505)
T KOG3207|consen 244 ILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLR 323 (505)
T ss_pred hhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhh
Confidence 3334445555555443211 12334445555555555555431 1221 23456666666666666322 123445
Q ss_pred cccccccccccCccccc
Q 041878 334 RLQNLTVLNLKNNQFKG 350 (773)
Q Consensus 334 ~l~~L~~L~ls~N~l~~ 350 (773)
.+++|+.|.+..|.++.
T Consensus 324 ~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 324 TLENLKHLRITLNYLNK 340 (505)
T ss_pred ccchhhhhhcccccccc
Confidence 56667777777777663
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.19 E-value=5e-12 Score=123.38 Aligned_cols=133 Identities=27% Similarity=0.323 Sum_probs=79.0
Q ss_pred CCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccc
Q 041878 262 KLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVL 341 (773)
Q Consensus 262 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 341 (773)
....|++|||++|.|+ .+.++..-+++++.|++|+|.|+.. ..+..+++|+.||||+|.++ .+..+=.++.|.+.|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 3445566666666655 3444455556666666666666522 12555666666666666663 223333445566666
Q ss_pred cccCcccccccccccCCCCcCceeecCCccCccCC-CchhhccCccCEEEeecccCCCCC
Q 041878 342 NLKNNQFKGHIPETIGNISGINQLDLSENDFTGEI-SPSLASLANLTSFNVSYNNLSGSV 400 (773)
Q Consensus 342 ~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~ls~N~l~g~~ 400 (773)
.|++|.+. ....++++-+|..||+++|+|.... ...+++++-|+.|.|.+|++.+.+
T Consensus 358 ~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 358 KLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred ehhhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 66666664 2244566667777777777776422 245677777888888888887654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.18 E-value=6.4e-12 Score=122.65 Aligned_cols=130 Identities=31% Similarity=0.415 Sum_probs=87.9
Q ss_pred ccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEcc
Q 041878 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLE 320 (773)
Q Consensus 241 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 320 (773)
.|+.|+|++|.|+ .+..+..-++.++.|++++|.+... +.+..+++|+.||||+|.++ .+-.+-..+-+++.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 4566666666665 3344455566677777777777632 23666777777777777776 344444556677777777
Q ss_pred CCCCCCCcchhhccccccccccccCcccccc-cccccCCCCcCceeecCCccCccCC
Q 041878 321 NNRLGNKIPEGLERLQNLTVLNLKNNQFKGH-IPETIGNISGINQLDLSENDFTGEI 376 (773)
Q Consensus 321 ~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~ 376 (773)
.|.|. .-..+.++-+|..||+++|+|... --..++++|-|+.|.|.+|++.+..
T Consensus 361 ~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 361 QNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 77773 234566677788888888888742 2356899999999999999999643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.4e-10 Score=110.18 Aligned_cols=137 Identities=15% Similarity=0.165 Sum_probs=97.8
Q ss_pred cccccccceEEEEEEeCC-------CCEEEEEEecccC------------c---------cc-HHHHH----HHHHHHHc
Q 041878 541 EIMGKSTYGTAYKATLED-------GSEVAVKRLREKT------------T---------KG-QKEFE----AEAAAIGK 587 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~-------g~~vAvK~l~~~~------------~---------~~-~~~~~----~E~~~l~~ 587 (773)
..||.|.-+.||.|...+ +..+|||+.+... . .. .+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 4789999874321 0 00 12233 79999999
Q ss_pred cCC--CceEEeEEEEECCCCeEEEEEeecCCCCHHH-HHhhcCCCCccCHHHHHHHHHHHHHHHHHh-ccCCCceecCCC
Q 041878 588 IHH--PNLLALRAYYLGPKGEKLLVFDFMPKGSLAS-FLHARGPETIVNWATRMSIAIGIARGLNYL-HVEENMIHGNLT 663 (773)
Q Consensus 588 l~h--~niv~l~~~~~~~~~~~~lV~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~i~~~i~~al~yL-H~~~~iiH~Dik 663 (773)
+.. -++...+++ ...++||||+.++.+.. .++. ..++..+...+..+++.++.++ | ..|+||||++
T Consensus 83 l~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H-~~glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYK-ECNLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHH-hCCeecCCCC
Confidence 864 355555543 26789999997654422 2222 1234455667889999999999 7 8999999999
Q ss_pred CCCEEeCCCCCeEEeecCCcccccc
Q 041878 664 SSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 664 ~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+.||+++ ++.+.++|||.+.....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999997 46799999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.8e-12 Score=131.71 Aligned_cols=161 Identities=24% Similarity=0.186 Sum_probs=84.4
Q ss_pred CCCCCCEEEccCCCCCCCCc--cccccccccceeecccccccc--cCCccccCCCccceeeccccccccccCCccccccc
Q 041878 161 NCPNLQTLDLSNNALIGAIP--PSLANSTRLYRLNLSYNSLLG--SIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAG 236 (773)
Q Consensus 161 ~l~~L~~L~Ls~N~l~~~~~--~~l~~l~~L~~L~Ls~N~l~~--~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 236 (773)
++++|+...|.+.... ..+ .....+++++.||||.|-+.. .+......+|+|+.|+|+.|++.........
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~---- 193 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTT---- 193 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccch----
Confidence 3444555555554443 111 133345555555555555442 1223344566666666666665522221111
Q ss_pred Ccccccceeeccccccccc-cCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccC-cccccccccC
Q 041878 237 NKSYQLQFLNLDHNLIAGT-IPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSF-PVTFTNITSL 314 (773)
Q Consensus 237 ~~~~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L 314 (773)
..++.|+.|.|+.|+++.. +...+..+++|+.|+|..|.....-......++.|+.|||++|++-... -...+.++.|
T Consensus 194 ~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L 273 (505)
T KOG3207|consen 194 LLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGL 273 (505)
T ss_pred hhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccch
Confidence 1223677777777777632 2223445677888888887532222333444567777777777765322 1344556666
Q ss_pred ceEEccCCCCCC
Q 041878 315 VSLNLENNRLGN 326 (773)
Q Consensus 315 ~~L~Ls~N~l~~ 326 (773)
+.|+++.+.+..
T Consensus 274 ~~Lnls~tgi~s 285 (505)
T KOG3207|consen 274 NQLNLSSTGIAS 285 (505)
T ss_pred hhhhccccCcch
Confidence 666666666654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.2e-11 Score=136.41 Aligned_cols=249 Identities=30% Similarity=0.357 Sum_probs=126.7
Q ss_pred CCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCcccccccccccee
Q 041878 113 QLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRL 192 (773)
Q Consensus 113 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 192 (773)
.+..++.+++..|.+.. +-..+..+++|+.|++.+|+|. .+...+..+++|++|+|++|.|+.. ..+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhhh
Confidence 45555666666666663 3334666677777777777776 3333356667777777777776643 334555556666
Q ss_pred ecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECC
Q 041878 193 NLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLS 272 (773)
Q Consensus 193 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 272 (773)
++++|.|+. ...+..+++|+.+++++|++...-+. . +..+.+|+.++++
T Consensus 146 ~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~----------------------------~-~~~~~~l~~l~l~ 194 (414)
T KOG0531|consen 146 NLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIEND----------------------------E-LSELISLEELDLG 194 (414)
T ss_pred eeccCcchh--ccCCccchhhhcccCCcchhhhhhhh----------------------------h-hhhccchHHHhcc
Confidence 666666652 12233355666666666665522220 1 2334444444455
Q ss_pred CCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCccccccc
Q 041878 273 HNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHI 352 (773)
Q Consensus 273 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~ 352 (773)
+|.+... ..+..+..+..+++..|.++..-+........|+.+++++|++.. .+..+..+.++..|++.+|++...
T Consensus 195 ~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~- 270 (414)
T KOG0531|consen 195 GNSIREI--EGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNL- 270 (414)
T ss_pred CCchhcc--cchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCcccc-ccccccccccccccchhhcccccc-
Confidence 5444421 223333334444555554442211111000025555555555532 224444555566666666665522
Q ss_pred ccccCCCCcCceeecCCccCccC---CCch-hhccCccCEEEeecccCCCCCc
Q 041878 353 PETIGNISGINQLDLSENDFTGE---ISPS-LASLANLTSFNVSYNNLSGSVP 401 (773)
Q Consensus 353 ~~~~~~l~~L~~L~L~~N~l~~~---~~~~-~~~l~~L~~L~ls~N~l~g~~p 401 (773)
..+...+.+..+.+..|.+... .... ....+.++.+++.+|+.....+
T Consensus 271 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 271 -EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred -ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 2233445555566666655421 1111 3445667777777777766554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.2e-11 Score=113.05 Aligned_cols=109 Identities=34% Similarity=0.421 Sum_probs=39.2
Q ss_pred ccCCCCCcEEEccCCcccccCCCCCC-CCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCcccc-ccccc
Q 041878 111 ISQLHALRKLSLHDNLLAGPVPWSLG-FLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSL-ANSTR 188 (773)
Q Consensus 111 l~~l~~L~~L~L~~n~l~~~~~~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l-~~l~~ 188 (773)
+.+...+++|+|++|.|+. + +.++ .+.+|+.|+|++|.|+.. +.+..+++|++|+|++|.|+. +.+.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred ccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCc
Confidence 4455678889999998884 3 2455 578889999999998843 357788889999999999884 44444 46888
Q ss_pred cceeeccccccccc-CCccccCCCccceeeccccccc
Q 041878 189 LYRLNLSYNSLLGS-IPLSLTRLPSLSVLALQHNNLS 224 (773)
Q Consensus 189 L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~ 224 (773)
|++|+|++|+|... .-..+..+++|+.|+|.+|.++
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 99999999988742 2245667788888888888876
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1e-11 Score=136.77 Aligned_cols=241 Identities=27% Similarity=0.306 Sum_probs=159.3
Q ss_pred CCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecc
Q 041878 116 ALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLS 195 (773)
Q Consensus 116 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls 195 (773)
.++.++...+.+.+.--. ...+..++.+++..|.+.. +-..+..+++|+.|++.+|.|. .+...+..+++|++|+|+
T Consensus 50 ~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls 126 (414)
T KOG0531|consen 50 DLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLS 126 (414)
T ss_pred hhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecc
Confidence 444455554443321111 1456677777777787773 3445677778888888888877 333336667777777777
Q ss_pred cccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCc
Q 041878 196 YNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNK 275 (773)
Q Consensus 196 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~ 275 (773)
+|.|+... .+..++.|+.|++++|.++ . ...+..++.|+.+++++|+
T Consensus 127 ~N~I~~i~--~l~~l~~L~~L~l~~N~i~-----------------------------~--~~~~~~l~~L~~l~l~~n~ 173 (414)
T KOG0531|consen 127 FNKITKLE--GLSTLTLLKELNLSGNLIS-----------------------------D--ISGLESLKSLKLLDLSYNR 173 (414)
T ss_pred cccccccc--chhhccchhhheeccCcch-----------------------------h--ccCCccchhhhcccCCcch
Confidence 77776432 2334444556666666554 2 1234447889999999999
Q ss_pred ccCCCC-CCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCccccccccc
Q 041878 276 IVGPIP-DELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPE 354 (773)
Q Consensus 276 l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~ 354 (773)
+...-+ . ...+.+++.+++++|.+... ..+..+..+..+++.+|.++..-+........|+.+++++|++. ..+.
T Consensus 174 i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~-~~~~ 249 (414)
T KOG0531|consen 174 IVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRIS-RSPE 249 (414)
T ss_pred hhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCccc-cccc
Confidence 985433 2 57788999999999999743 33445566666799999986543322211114899999999998 4447
Q ss_pred ccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCC
Q 041878 355 TIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSG 398 (773)
Q Consensus 355 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g 398 (773)
.+..+..+..|++.+|++...- .+.....+..+.+..|.+..
T Consensus 250 ~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~ 291 (414)
T KOG0531|consen 250 GLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLAL 291 (414)
T ss_pred cccccccccccchhhccccccc--cccccchHHHhccCcchhcc
Confidence 7888999999999999998532 23345667778888888763
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=8.4e-11 Score=111.02 Aligned_cols=122 Identities=30% Similarity=0.376 Sum_probs=34.3
Q ss_pred CccEEECCCCcccCCCCCCcC-cccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccc
Q 041878 265 LLQEISLSHNKIVGPIPDELG-KLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNL 343 (773)
Q Consensus 265 ~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l 343 (773)
++++|+|.+|+|+. + +.++ .+.+|+.|+|++|.|+.. ..+..++.|++|++++|+|+...+.....+++|+.|++
T Consensus 20 ~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L 95 (175)
T PF14580_consen 20 KLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYL 95 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EEE-
T ss_pred cccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEEC
Confidence 34455555555542 2 1233 344555555555555522 13444555555555555554332211123555555555
Q ss_pred cCcccccc-cccccCCCCcCceeecCCccCccCCC---chhhccCccCEEE
Q 041878 344 KNNQFKGH-IPETIGNISGINQLDLSENDFTGEIS---PSLASLANLTSFN 390 (773)
Q Consensus 344 s~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~ 390 (773)
++|+|... .-..+..+++|+.|+|.+|+++..-- ..+..+++|+.||
T Consensus 96 ~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 96 SNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred cCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 55555432 12344566677777777777663311 1244567777765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.1e-10 Score=124.01 Aligned_cols=203 Identities=23% Similarity=0.269 Sum_probs=154.6
Q ss_pred cChhHHHHHhhccccc--ccceEEEEEEe---CCCCEEEEEEecccCc--ccHHHHHHHHHHHHccC-CCceEEeEEEEE
Q 041878 530 FTADDLLCATAEIMGK--STYGTAYKATL---EDGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIH-HPNLLALRAYYL 601 (773)
Q Consensus 530 ~~~~~l~~~~~~~lG~--G~fg~Vy~~~~---~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 601 (773)
++..+..+.+.+-+|. |.+|.||.+.. .++..+|+|+-+.... .....=.+|+...++++ |++.++.+..+
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~- 187 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW- 187 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-
Confidence 3444455556778999 99999999975 4678899998543322 33333455777667775 99999977666
Q ss_pred CCCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHH----HHHHhccCCCceecCCCCCCEEeCCC-CCeE
Q 041878 602 GPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIAR----GLNYLHVEENMIHGNLTSSNVLLDEK-TNPR 676 (773)
Q Consensus 602 ~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~----al~yLH~~~~iiH~Dik~~NIll~~~-~~~k 676 (773)
...+..++-+|++ +.++.++-+... ..++....+....+..+ |+.++| +..++|-|+||.||+...+ ..++
T Consensus 188 e~~~~lfiqtE~~-~~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~h-s~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 188 EGSGILFIQTELC-GESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLH-SNNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred ccCCcceeeeccc-cchhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccC-CCcccccccchhheecccccceee
Confidence 5666889999998 578888877643 23555667777888888 999999 9999999999999999999 8899
Q ss_pred EeecCCccccccccccce---ee-ccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 041878 677 IADFGLSRLMTAAANTNV---IA-TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGE 738 (773)
Q Consensus 677 l~DfG~a~~~~~~~~~~~---~~-~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~ 738 (773)
++|||+...+........ .. ..|...|++||... ..++.+.|+||+|.+..|..+|..+..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence 999999887765542211 12 25778899999766 778899999999999999998766543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.6e-09 Score=109.06 Aligned_cols=141 Identities=18% Similarity=0.240 Sum_probs=103.3
Q ss_pred cccccccceEEEEEEeCCCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCC--ceEEeEEEEECCC--CeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHP--NLLALRAYYLGPK--GEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~--~~~~lV~e~~~ 615 (773)
+.++.|..+.||++...+|+.+++|....... ....++..|+++++.+++. .+.+++.+..... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999999865432 2356788999999999764 3566666653221 25689999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhcc------------------------------------------
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV------------------------------------------ 653 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~------------------------------------------ 653 (773)
|.++.+.+.. ..++..++..++.++++++.+||+
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888765421 124555666667777777777762
Q ss_pred -------------CCCceecCCCCCCEEeCC--CCCeEEeecCCccc
Q 041878 654 -------------EENMIHGNLTSSNVLLDE--KTNPRIADFGLSRL 685 (773)
Q Consensus 654 -------------~~~iiH~Dik~~NIll~~--~~~~kl~DfG~a~~ 685 (773)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 56689999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.8e-09 Score=97.23 Aligned_cols=129 Identities=21% Similarity=0.342 Sum_probs=94.0
Q ss_pred cccccccceEEEEEEeCCCCEEEEEEecccC-cc-------cHHHHHHHHHHHHccCCCc--eEEeEEEEECCCCeEEEE
Q 041878 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKT-TK-------GQKEFEAEAAAIGKIHHPN--LLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~-~~-------~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~lV 610 (773)
..+++|+-+.+|.+.+. |..+++|.-.... .. ....-.+|+.++.+++--. +..++.+ .+....++
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv---D~~~~~I~ 77 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV---DPDNGLIV 77 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE---cCCCCEEE
Confidence 35789999999999775 4446666443221 11 1234567899998886432 2333332 23467899
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL 685 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~ 685 (773)
|||++|-.|.+.+... +..++..+-.-+.-|| ..||||+|+.++||.+..++ +.++|||++..
T Consensus 78 me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH-~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 78 MEYIEGELLKDALEEA----------RPDLLREVGRLVGKLH-KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHH-hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999999888764 1346667777788899 99999999999999998776 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=8.6e-09 Score=94.91 Aligned_cols=142 Identities=22% Similarity=0.366 Sum_probs=99.6
Q ss_pred cccccccceEEEEEEeCCCCEEEEEEec-ccCcc-------cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 541 EIMGKSTYGTAYKATLEDGSEVAVKRLR-EKTTK-------GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~-~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
.++-||+-+.|+++.+. |+.+.||.-- +.... ..++...|++.+.+++--.|.--.-++.+.. .-.++||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~-~~~i~ME 90 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY-GGQIYME 90 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-CCeEEEE
Confidence 56889999999999876 7777777442 22111 1345677999999886322221111222222 4578899
Q ss_pred ecCC-CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC---eEEeecCCcccc
Q 041878 613 FMPK-GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN---PRIADFGLSRLM 686 (773)
Q Consensus 613 ~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~---~kl~DfG~a~~~ 686 (773)
|+++ -++.+++.........+.. ...++.+|-+.+.-|| ..++||+|+..+||++..++. +.++|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~-~~~~~~~iG~~igklH-~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEG-LAELARRIGELIGKLH-DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcccchh-HHHHHHHHHHHHHHhh-hCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9976 4888888876544333332 2578889999999999 999999999999999977664 589999998654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.5e-10 Score=130.69 Aligned_cols=272 Identities=22% Similarity=0.295 Sum_probs=140.1
Q ss_pred CCCcEEEccCCcccccCCCCCCCCCCCceEEcccCc--cCCCCCCCCCCCCCCCEEEccCCCCCCCCcccccccccccee
Q 041878 115 HALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNR--LSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRL 192 (773)
Q Consensus 115 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~--l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 192 (773)
...+...+.+|.+. .++... .+++|++|-+..|. +....+..|..++.|++|||++|.=.+.+|..++.+-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 45555666555554 222222 23356666666664 343333345556666666666655555666666666666666
Q ss_pred ecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecccccc--ccccCccCCCCCCccEEE
Q 041878 193 NLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLI--AGTIPVSLGKLGLLQEIS 270 (773)
Q Consensus 193 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l--~~~~~~~l~~l~~L~~L~ 270 (773)
+|++..+. .+|..+.++..|.+|++..+.-...+|.....+. +|++|.+..... +...-..+.++.+|+.+.
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~-----~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls 674 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQ-----SLRVLRLPRSALSNDKLLLKELENLEHLENLS 674 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcc-----cccEEEeeccccccchhhHHhhhcccchhhhe
Confidence 66666665 5666666666666666665554433333333232 566666655431 112223334455555555
Q ss_pred CCCCcccCCCCCCcCcccccc----eeccccccccccCcccccccccCceEEccCCCCCCCcchhhcc------cccccc
Q 041878 271 LSHNKIVGPIPDELGKLSKLQ----KLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLER------LQNLTV 340 (773)
Q Consensus 271 L~~N~l~~~~p~~l~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~------l~~L~~ 340 (773)
...... .+-..+..+..|. .+.+.++... ..+..+..+.+|+.|.+.++.++......... ++++..
T Consensus 675 ~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~ 751 (889)
T KOG4658|consen 675 ITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSK 751 (889)
T ss_pred eecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHH
Confidence 533332 1111222233332 3333333322 44556677788888888888876443332222 223333
Q ss_pred ccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCC
Q 041878 341 LNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSG 398 (773)
Q Consensus 341 L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g 398 (773)
+...++..- ..+.+.--.++|+.|++.++.....+.+....+..++.+-+..+.+.|
T Consensus 752 ~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~ 808 (889)
T KOG4658|consen 752 VSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEG 808 (889)
T ss_pred HHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEeccccccc
Confidence 333332221 222333345777888887777666666666666666665555555554
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.9e-09 Score=100.81 Aligned_cols=126 Identities=22% Similarity=0.309 Sum_probs=83.1
Q ss_pred EEEEEEeCCCCEEEEEEecccCc---------------------c-----cHHHHHHHHHHHHccCCC--ceEEeEEEEE
Q 041878 550 TAYKATLEDGSEVAVKRLREKTT---------------------K-----GQKEFEAEAAAIGKIHHP--NLLALRAYYL 601 (773)
Q Consensus 550 ~Vy~~~~~~g~~vAvK~l~~~~~---------------------~-----~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 601 (773)
.||.|...+|..+|||..+.... . ......+|.+.|.++... ++.+.+.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999988899999998743210 0 023466799999999866 566666543
Q ss_pred CCCCeEEEEEeecC--CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHH-hccCCCceecCCCCCCEEeCCCCCeEEe
Q 041878 602 GPKGEKLLVFDFMP--KGSLASFLHARGPETIVNWATRMSIAIGIARGLNY-LHVEENMIHGNLTSSNVLLDEKTNPRIA 678 (773)
Q Consensus 602 ~~~~~~~lV~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~y-LH~~~~iiH~Dik~~NIll~~~~~~kl~ 678 (773)
...+||||++ |..+..+.... ++......++.+++..+.. +| ..|++|+|+++.||+++++ .+.++
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~-~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLH-KAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHH-CTTEEESS-STTSEEEETT-CEEE-
T ss_pred ----CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHH-hcCceecCCChhhEEeecc-eEEEE
Confidence 4589999998 65555443322 1122335567777776655 46 9999999999999999988 89999
Q ss_pred ecCCccccc
Q 041878 679 DFGLSRLMT 687 (773)
Q Consensus 679 DfG~a~~~~ 687 (773)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999886544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=3.2e-10 Score=133.22 Aligned_cols=253 Identities=26% Similarity=0.245 Sum_probs=135.8
Q ss_pred CCCcEEEccCCc--ccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCcccccccccccee
Q 041878 115 HALRKLSLHDNL--LAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRL 192 (773)
Q Consensus 115 ~~L~~L~L~~n~--l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 192 (773)
+.|++|-+.+|. +.....+.|..++.|+.|||++|.=-+.+|..++.|-+|++|+|++..+. .+|..+.++++|.+|
T Consensus 545 ~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L 623 (889)
T KOG4658|consen 545 PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL 623 (889)
T ss_pred CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence 467777777775 44344445777888888888877766678888888888888888888877 778888888888888
Q ss_pred ecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCcc----E
Q 041878 193 NLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQ----E 268 (773)
Q Consensus 193 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~----~ 268 (773)
++..+.-...+|.....+++|++|.+..-.... ....++.+ ..+..|+.+....... .+-..+..++.|. .
T Consensus 624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~-~~~~l~el--~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~ 698 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILLELQSLRVLRLPRSALSN-DKLLLKEL--ENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQS 698 (889)
T ss_pred ccccccccccccchhhhcccccEEEeecccccc-chhhHHhh--hcccchhhheeecchh--HhHhhhhhhHHHHHHhHh
Confidence 888777655566666678888888776554210 00111111 1112333333322222 0001112222221 2
Q ss_pred EECCCCcccCCCCCCcCcccccceeccccccccccCcccccc------cccCceEEccCCCCCCCcchhhcccccccccc
Q 041878 269 ISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTN------ITSLVSLNLENNRLGNKIPEGLERLQNLTVLN 342 (773)
Q Consensus 269 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~------l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 342 (773)
+.+.++... ..+..+..+.+|+.|.+.++.+.......... ++++..+.+.++.. -..+.+..-.++|+.|+
T Consensus 699 l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~-~r~l~~~~f~~~L~~l~ 776 (889)
T KOG4658|consen 699 LSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHM-LRDLTWLLFAPHLTSLS 776 (889)
T ss_pred hhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcccc-ccccchhhccCcccEEE
Confidence 222222222 23344555666666666666654322222111 11222222222211 11222333446677777
Q ss_pred ccCcccccccccccCCCCcCceeecCCccCccC
Q 041878 343 LKNNQFKGHIPETIGNISGINQLDLSENDFTGE 375 (773)
Q Consensus 343 ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 375 (773)
+..+.....+.+....+..++.+-+..+.+.+.
T Consensus 777 l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 777 LVSCRLLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred EecccccccCCCHHHHhhhcccEEecccccccc
Confidence 776666655555555555565555555555544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=5.7e-08 Score=99.28 Aligned_cols=143 Identities=13% Similarity=0.099 Sum_probs=99.5
Q ss_pred hcccccccceEEEEEEeCCCCEEEEEEecccCcc-----------cHHHHHHHHHHHHccCCCc--eEEeEEEEECC---
Q 041878 540 AEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTK-----------GQKEFEAEAAAIGKIHHPN--LLALRAYYLGP--- 603 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~--- 603 (773)
++++-......|++..+ +|+.+.||+.....-. ....+.+|...+.++.... +...+++....
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34555555555777766 4778999977433211 1124778888888875322 22333333221
Q ss_pred -CCeEEEEEeecCCC-CHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-------CCC
Q 041878 604 -KGEKLLVFDFMPKG-SLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE-------KTN 674 (773)
Q Consensus 604 -~~~~~lV~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~-------~~~ 674 (773)
....++|+|++++. +|.+++.... ....+...+..++.+++..+.-|| +.||+|+|++++|||++. +..
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH-~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMH-AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH-HCcCccCCCChhhEEEeccccCCCCCce
Confidence 23578999999886 8999986432 122455667789999999999999 999999999999999985 467
Q ss_pred eEEeecCCccc
Q 041878 675 PRIADFGLSRL 685 (773)
Q Consensus 675 ~kl~DfG~a~~ 685 (773)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 89999998864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.5e-09 Score=105.32 Aligned_cols=153 Identities=22% Similarity=0.385 Sum_probs=113.3
Q ss_pred HHHccCCCceEEeEEEEECC----CCeEEEEEeecCCCCHHHHHhhcCC-CCccCHHHHHHHHHHHHHHHHHhcc-CCCc
Q 041878 584 AIGKIHHPNLLALRAYYLGP----KGEKLLVFDFMPKGSLASFLHARGP-ETIVNWATRMSIAIGIARGLNYLHV-EENM 657 (773)
Q Consensus 584 ~l~~l~h~niv~l~~~~~~~----~~~~~lV~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~yLH~-~~~i 657 (773)
-+-.+-|.|+++++.|+.+. .....+++|||+.|++..+|++... ...+......+++.||..||.|||+ +..|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34445699999998888443 2356789999999999999987643 2346667778999999999999993 3679
Q ss_pred eecCCCCCCEEeCCCCCeEEeecCCccccc---cccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCC
Q 041878 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMT---AAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGK 734 (773)
Q Consensus 658 iH~Dik~~NIll~~~~~~kl~DfG~a~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~ 734 (773)
+|+++.-+-|++..++-+|+.----..... ...........+-++|.|||.-.....+.++|||+||....||.-|+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 999999999999999988875211111000 00011111223677999999887777888999999999999999877
Q ss_pred CC
Q 041878 735 SP 736 (773)
Q Consensus 735 ~P 736 (773)
.-
T Consensus 280 iq 281 (458)
T KOG1266|consen 280 IQ 281 (458)
T ss_pred ec
Confidence 63
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=5.9e-11 Score=128.71 Aligned_cols=127 Identities=28% Similarity=0.310 Sum_probs=55.4
Q ss_pred ccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccC
Q 041878 266 LQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKN 345 (773)
Q Consensus 266 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~ 345 (773)
|...+.+.|.++ .+..++.-++.|+.|||++|+++... .+..+++|++|||+.|.+....--...++. |+.|.+++
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrn 241 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRN 241 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecc
Confidence 334444444444 23333444444444444444444221 344444444444444444322111122222 55555555
Q ss_pred cccccccccccCCCCcCceeecCCccCccCCC-chhhccCccCEEEeecccCCC
Q 041878 346 NQFKGHIPETIGNISGINQLDLSENDFTGEIS-PSLASLANLTSFNVSYNNLSG 398 (773)
Q Consensus 346 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~ls~N~l~g 398 (773)
|.++. ...+.++.+|+.|||+.|-|.+.-- ..+..+..|+.|+|.+|++.+
T Consensus 242 N~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 242 NALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred cHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 55542 1234455555555555555543211 122334455555555555543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.1e-10 Score=111.12 Aligned_cols=215 Identities=26% Similarity=0.296 Sum_probs=114.4
Q ss_pred cCCCCCcEEEccCCcccccC-CCCC-CCCCCCceEEcccCccCC--CCCCCCCCCCCCCEEEccCCCCCCCCcccccccc
Q 041878 112 SQLHALRKLSLHDNLLAGPV-PWSL-GFLPNLRGVYLFNNRLSG--SIPPSIGNCPNLQTLDLSNNALIGAIPPSLANST 187 (773)
Q Consensus 112 ~~l~~L~~L~L~~n~l~~~~-~~~l-~~l~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 187 (773)
+.+..++.|.|.++.|..+. ...| ..++.++.|||.+|.|+. .|-..+.++|.|++|+|+.|++...|...-..+.
T Consensus 42 ~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~ 121 (418)
T KOG2982|consen 42 SSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLK 121 (418)
T ss_pred ccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCccccc
Confidence 33445556666666654221 1112 235677778888887773 2333456778888888888887754432224566
Q ss_pred ccceeeccccccccc-CCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCc
Q 041878 188 RLYRLNLSYNSLLGS-IPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLL 266 (773)
Q Consensus 188 ~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L 266 (773)
+|++|.|.+..+.-. ....+..+|.++.|+++.|.+ +.+++..|.++...+ .+
T Consensus 122 nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~-------------------rq~n~Dd~c~e~~s~-------~v 175 (418)
T KOG2982|consen 122 NLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL-------------------RQLNLDDNCIEDWST-------EV 175 (418)
T ss_pred ceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchh-------------------hhhccccccccccch-------hh
Confidence 777777777776532 233455667777777777643 333344443332111 11
Q ss_pred cEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcc-hhhccccccccccccC
Q 041878 267 QEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIP-EGLERLQNLTVLNLKN 345 (773)
Q Consensus 267 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~ls~ 345 (773)
++ +..++.+..+.++-|++... ++++..+.+..|.+...-. .....++.+..|+|+.
T Consensus 176 ~t---------------lh~~~c~~~~w~~~~~l~r~-------Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~ 233 (418)
T KOG2982|consen 176 LT---------------LHQLPCLEQLWLNKNKLSRI-------FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGA 233 (418)
T ss_pred hh---------------hhcCCcHHHHHHHHHhHHhh-------cccchheeeecCcccchhhcccCCCCCcchhhhhcc
Confidence 11 11222333334444444422 3456666666666644322 2344455556666666
Q ss_pred cccccc-cccccCCCCcCceeecCCccCcc
Q 041878 346 NQFKGH-IPETIGNISGINQLDLSENDFTG 374 (773)
Q Consensus 346 N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~ 374 (773)
|+|... --..+.++++|..|.+++|++..
T Consensus 234 ~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 234 NNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred cccccHHHHHHHcCCchhheeeccCCcccc
Confidence 666532 22345566666666666666653
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.6e-09 Score=82.10 Aligned_cols=61 Identities=44% Similarity=0.546 Sum_probs=38.4
Q ss_pred CCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCC
Q 041878 115 HALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNAL 175 (773)
Q Consensus 115 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 175 (773)
++|++|+|++|+|+...+..|..+++|++|+|++|+++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566666666666655555666666666666666666655555666666666666666653
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.6e-09 Score=82.10 Aligned_cols=61 Identities=48% Similarity=0.630 Sum_probs=35.3
Q ss_pred CCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccc
Q 041878 139 PNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSL 199 (773)
Q Consensus 139 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l 199 (773)
|+|++|+|++|+|+...+..|.++++|++|++++|.++...+..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3556666666666644445556666666666666666544455555566666666555543
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.77 E-value=6.7e-08 Score=102.30 Aligned_cols=169 Identities=24% Similarity=0.353 Sum_probs=128.2
Q ss_pred eEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEEC---CCCeEEEEEeecCC-CCHHHHH
Q 041878 549 GTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG---PKGEKLLVFDFMPK-GSLASFL 623 (773)
Q Consensus 549 g~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~~~lV~e~~~~-g~L~~~l 623 (773)
.+.|+++. .||..|++|+++............-+++++++.|.|+|++.+++.. .....++||+|.|+ ++|.++-
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 56899974 5899999999954433333334556889999999999999998863 23468899999997 4777765
Q ss_pred hhcCC------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 624 HARGP------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 624 ~~~~~------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
-...+ ....++...+.++.|+..||.++| +.|...+-+.+++|+++.+.+++|+..|.......+..
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH-ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~ 448 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH-SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT 448 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH-hcCceeecccHhHeEeeCcceEEEecccceeeecCCCC
Confidence 43321 223577889999999999999999 99999999999999999999999998887655443321
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P 736 (773)
|-+ .--.+-|.=.+|.++..+.||..-
T Consensus 449 ---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 449 ---------------EPL---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred ---------------cch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 001 112357889999999999999653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.76 E-value=3.2e-09 Score=115.05 Aligned_cols=189 Identities=17% Similarity=0.211 Sum_probs=137.9
Q ss_pred hhcccccccceEEEEEEe--CCCCEEEEEEecccCcccHHHH--HHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEee
Q 041878 539 TAEIMGKSTYGTAYKATL--EDGSEVAVKRLREKTTKGQKEF--EAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~--~~g~~vAvK~l~~~~~~~~~~~--~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
....||.|.|+.|++... .++..+++|.+.........++ ..|+.+...+ .|.++++.+..+ .+-+..++--||
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-SQLRQGYIPLEF 347 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc-cccccccCchhh
Confidence 457899999999999864 4678899998876533322222 3455555555 488888776655 333466788999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC-CCeEEeecCCcccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK-TNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~~~~~~~ 692 (773)
++++++.....- ...++...++++..|++.++.++| ++.++|+|+||+||++..+ +..++.|||.+..+.-.
T Consensus 348 ~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~-s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~--- 420 (524)
T KOG0601|consen 348 CEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIH-SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS--- 420 (524)
T ss_pred hcCcchhhhhHH---HHhcCcchhhhhHHHHHhcccccc-chhhhcccccccceeeccchhhhhcccccccccccee---
Confidence 999988765522 234666778899999999999999 9999999999999999886 77899999988642211
Q ss_pred ceeeccCccccc--cccccCCCCCCcchhhHHHHHHHHHHHcCCCC
Q 041878 693 NVIATAGTLGYR--APELSKLKNANTKTDVYSLGVIILELLTGKSP 736 (773)
Q Consensus 693 ~~~~~~gt~~y~--aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P 736 (773)
.......-+++ +|+......+..+.|++|||.-+.|..+|..-
T Consensus 421 -~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 421 -SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred -cccccccccccccchhhccccccccccccccccccccccccCccc
Confidence 11111233444 55566667788899999999999999998753
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.71 E-value=7.8e-10 Score=106.94 Aligned_cols=252 Identities=19% Similarity=0.215 Sum_probs=113.7
Q ss_pred CCEEEEEcCCCCcccc----cCccccCCCCCcEEEccCCcc---cccC-------CCCCCCCCCCceEEcccCccCCCCC
Q 041878 91 GQVIAIQLPWRRLGGR----ISEKISQLHALRKLSLHDNLL---AGPV-------PWSLGFLPNLRGVYLFNNRLSGSIP 156 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~----i~~~l~~l~~L~~L~L~~n~l---~~~~-------~~~l~~l~~L~~L~L~~n~l~~~~p 156 (773)
..++.++|++|.++.. +...+.+-.+|+..++++-.. ...+ .+++-.||+|+..+||.|.|....|
T Consensus 30 d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~~ 109 (388)
T COG5238 30 DELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEFP 109 (388)
T ss_pred cceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCcccc
Confidence 3456667777666532 333444555666666554211 1111 1233344555555555555543333
Q ss_pred CC----CCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCccc
Q 041878 157 PS----IGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWG 232 (773)
Q Consensus 157 ~~----l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 232 (773)
+. +++-..|++|.|++|.+......-+++ .|.+ |..| .-..+-|.|+++....|++.. .|....
T Consensus 110 e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigk--al~~--la~n-------KKaa~kp~Le~vicgrNRlen-gs~~~~ 177 (388)
T COG5238 110 EELGDLISSSTDLVHLKLNNNGLGPIAGGRIGK--ALFH--LAYN-------KKAADKPKLEVVICGRNRLEN-GSKELS 177 (388)
T ss_pred hHHHHHHhcCCCceeEEeecCCCCccchhHHHH--HHHH--HHHH-------hhhccCCCceEEEeccchhcc-CcHHHH
Confidence 32 233344444444444443111111110 0000 0011 112344567777777777652 221111
Q ss_pred ccccCcccccceeeccccccccc-----cCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCccc
Q 041878 233 VLAGNKSYQLQFLNLDHNLIAGT-----IPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVT 307 (773)
Q Consensus 233 ~l~~~~~~~L~~L~L~~n~l~~~-----~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~ 307 (773)
.........|+.+.+..|.|.-. ....+..+.+|+.|||.+|-++-.-.. .+...
T Consensus 178 a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~--------------------~La~a 237 (388)
T COG5238 178 AALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSR--------------------YLADA 237 (388)
T ss_pred HHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHH--------------------HHHHH
Confidence 11111112455666666655411 111222344555555555555421000 11222
Q ss_pred ccccccCceEEccCCCCCCCcchhhc------cccccccccccCcccccccccc-------cCCCCcCceeecCCccCcc
Q 041878 308 FTNITSLVSLNLENNRLGNKIPEGLE------RLQNLTVLNLKNNQFKGHIPET-------IGNISGINQLDLSENDFTG 374 (773)
Q Consensus 308 ~~~l~~L~~L~Ls~N~l~~~~~~~l~------~l~~L~~L~ls~N~l~~~~~~~-------~~~l~~L~~L~L~~N~l~~ 374 (773)
+...+.|++|.+.+|-++.....++- ..++|..|-..+|...+.+... -.++|-|..|.+.+|++..
T Consensus 238 l~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~E 317 (388)
T COG5238 238 LCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIKE 317 (388)
T ss_pred hcccchhhhccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcchh
Confidence 33344455555555555544433221 2456677777777665533222 1367788888888888873
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.9e-10 Score=123.44 Aligned_cols=127 Identities=33% Similarity=0.414 Sum_probs=82.6
Q ss_pred ccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEcc
Q 041878 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLE 320 (773)
Q Consensus 241 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 320 (773)
+|.+.+.+.|.+. ..-.++.-++.|+.|+|++|+++.. +.+..+++|++|||++|.|+...--....+. |..|.|+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 4555566666665 3344555666777777777777743 3677777777888888777733222333333 7777888
Q ss_pred CCCCCCCcchhhccccccccccccCccccccc-ccccCCCCcCceeecCCccCc
Q 041878 321 NNRLGNKIPEGLERLQNLTVLNLKNNQFKGHI-PETIGNISGINQLDLSENDFT 373 (773)
Q Consensus 321 ~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~ 373 (773)
+|.++.. ..+.++.+|+.||+++|-|.+.- ...++.+..|+.|+|.+|++-
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 8777432 34667777788888888777532 233556777888888888875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.5e-09 Score=119.52 Aligned_cols=200 Identities=20% Similarity=0.227 Sum_probs=137.1
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
+.+-+-.|.++.++.+.-. .|...+.|...... ..+.+....+-.+.-..++|.+++...-+ ......++|++|.
T Consensus 808 i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-~~rsP~~L~~~~~ 886 (1205)
T KOG0606|consen 808 ITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-PCRSPLPLVGHYL 886 (1205)
T ss_pred ecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-CCCCCcchhhHHh
Confidence 3457888999999887632 34444444443221 11122222232322223455555443332 3456789999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccc-c-----
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMT-A----- 688 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~-~----- 688 (773)
.+++|...++..+. .+..-.......++.+.+||| ...+.|||++|.|.+...+++.+++|||...... .
T Consensus 887 ~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~-s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 887 NGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLH-SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred ccCCchhhhhcCCC---cccccccchhHHHHhhhhccc-cchhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 99999999988653 222233445667889999999 7779999999999999999999999998322110 0
Q ss_pred ---------------c----cc-----cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 689 ---------------A----AN-----TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 689 ---------------~----~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
. .. .......+|+.|.+||...+......+|.|+.|++++|.++|..||.....+
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0 00 0012335899999999999999999999999999999999999999775544
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=8.6e-08 Score=98.86 Aligned_cols=194 Identities=19% Similarity=0.259 Sum_probs=128.1
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEE-----EECCCCe-EEEE
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAY-----YLGPKGE-KLLV 610 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-----~~~~~~~-~~lV 610 (773)
..+..||+|+.+.+|-.-- -+..|| |+........+.+. +..|.+. .||-+-.-+.+ +...++. ..+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e-~~d~VA-KIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE-VRDQVA-KIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch-hhchhh-eeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3457799999999986531 122344 66655444333332 2333333 35533221111 1112222 5677
Q ss_pred EeecCCC-CHHHHHh---hcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 611 FDFMPKG-SLASFLH---ARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 611 ~e~~~~g-~L~~~l~---~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
|..+++. ...++.. ++......+|.-.+++++.++.+.+-|| ..|.+-+|+.++|+|+++++.+.+.|-..-..-
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH-~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH-EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH-hcCCcccccCccceeeecCceEEEEcccceeec
Confidence 8877664 2333332 2223345789999999999999999999 999999999999999999999999876532221
Q ss_pred ccccccceeeccCcccccccccc-----CCCCCCcchhhHHHHHHHHHHHcC-CCCCCC
Q 041878 687 TAAANTNVIATAGTLGYRAPELS-----KLKNANTKTDVYSLGVIILELLTG-KSPGEP 739 (773)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dvws~Gv~l~el~tg-~~P~~~ 739 (773)
.........+|...|.+||.- .+-..+...|-|.+||++++++.| +.||++
T Consensus 168 --~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 168 --ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred --cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 222233345688999999953 345567789999999999999886 999987
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.4e-07 Score=92.91 Aligned_cols=136 Identities=18% Similarity=0.187 Sum_probs=96.8
Q ss_pred HHHhhcccccccceEEEEEEeCCCCEEEEEEecccC----------------------cccHHHHHHHHHHHHccCCC--
Q 041878 536 LCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKT----------------------TKGQKEFEAEAAAIGKIHHP-- 591 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~----------------------~~~~~~~~~E~~~l~~l~h~-- 591 (773)
..++++.||.|.-+.||.|..+.|.++|||.=+... .-.....++|.++|.++.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999999999999999432110 01123456799999988755
Q ss_pred ceEEeEEEEECCCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC
Q 041878 592 NLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE 671 (773)
Q Consensus 592 niv~l~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~ 671 (773)
.|.+-+++- ...+||||++|-.|...-- +....-.++..|++-+.-.- ..|+||+|+++=||++++
T Consensus 172 ~VP~P~~~n-----RHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~-~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAWN-----RHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAY-RRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCccccc-----cceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHH-HcCccccCCchheEEEec
Confidence 555544433 6789999999876654321 11222334444555554444 689999999999999999
Q ss_pred CCCeEEeecCCccc
Q 041878 672 KTNPRIADFGLSRL 685 (773)
Q Consensus 672 ~~~~kl~DfG~a~~ 685 (773)
+|.+.++||=.+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999986654
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.5e-09 Score=105.01 Aligned_cols=186 Identities=22% Similarity=0.216 Sum_probs=108.0
Q ss_pred CCEEEEEcCCCCcc---cc-------cCccccCCCCCcEEEccCCcccccCCCCC----CCCCCCceEEcccCccCCC--
Q 041878 91 GQVIAIQLPWRRLG---GR-------ISEKISQLHALRKLSLHDNLLAGPVPWSL----GFLPNLRGVYLFNNRLSGS-- 154 (773)
Q Consensus 91 ~~v~~l~l~~~~l~---~~-------i~~~l~~l~~L~~L~L~~n~l~~~~~~~l----~~l~~L~~L~L~~n~l~~~-- 154 (773)
..+..++++.-..+ .. +.+.+..+++|+..+||+|.|....|+.+ +.-+.|++|.|++|.+.-.
T Consensus 58 ~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG 137 (388)
T COG5238 58 RNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAG 137 (388)
T ss_pred cceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccch
Confidence 45666666653222 12 23567789999999999999987766654 4568899999999988621
Q ss_pred --CCC---------CCCCCCCCCEEEccCCCCCCCCccc-----cccccccceeeccccccccc-----CCccccCCCcc
Q 041878 155 --IPP---------SIGNCPNLQTLDLSNNALIGAIPPS-----LANSTRLYRLNLSYNSLLGS-----IPLSLTRLPSL 213 (773)
Q Consensus 155 --~p~---------~l~~l~~L~~L~Ls~N~l~~~~~~~-----l~~l~~L~~L~Ls~N~l~~~-----~~~~l~~l~~L 213 (773)
|-. -.++-|.|++.+...|++.. .+.. |..-..|+.+.+..|.|... +...+..+.+|
T Consensus 138 ~rigkal~~la~nKKaa~kp~Le~vicgrNRlen-gs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~L 216 (388)
T COG5238 138 GRIGKALFHLAYNKKAADKPKLEVVICGRNRLEN-GSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSL 216 (388)
T ss_pred hHHHHHHHHHHHHhhhccCCCceEEEeccchhcc-CcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcc
Confidence 211 12344778888888888763 2222 12224677777777776632 11123345566
Q ss_pred ceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCc------Ccc
Q 041878 214 SVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDEL------GKL 287 (773)
Q Consensus 214 ~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l------~~l 287 (773)
+.|||.+|-++-.... .+...+...+.|++|.+.+|-++..-..++ ...
T Consensus 217 evLDlqDNtft~~gS~-------------------------~La~al~~W~~lrEL~lnDClls~~G~~~v~~~f~e~~~ 271 (388)
T COG5238 217 EVLDLQDNTFTLEGSR-------------------------YLADALCEWNLLRELRLNDCLLSNEGVKSVLRRFNEKFV 271 (388)
T ss_pred eeeeccccchhhhhHH-------------------------HHHHHhcccchhhhccccchhhccccHHHHHHHhhhhcC
Confidence 6666666666521111 122334455556666666666653322211 113
Q ss_pred cccceeccccccccc
Q 041878 288 SKLQKLDLSYNAIGG 302 (773)
Q Consensus 288 ~~L~~L~Ls~N~l~~ 302 (773)
++|..|-..+|...+
T Consensus 272 p~l~~L~~~Yne~~~ 286 (388)
T COG5238 272 PNLMPLPGDYNERRG 286 (388)
T ss_pred CCccccccchhhhcC
Confidence 455666666665543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.1e-07 Score=102.99 Aligned_cols=140 Identities=20% Similarity=0.343 Sum_probs=98.2
Q ss_pred cccccccceEEEEEEeCCCCEEEEEEecccCcc----------------------------------------cHHHHHH
Q 041878 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTK----------------------------------------GQKEFEA 580 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~----------------------------------------~~~~~~~ 580 (773)
+.|+.++-|.||+|++++|+.||||+.+..-.+ .+-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 678899999999999999999999988543110 1123455
Q ss_pred HHHHHHccC----CCceEEeEEEEECCCCeEEEEEeecCCCCHHHH--HhhcCCCCccCHHHHHHHHHHHHHH-HHHhcc
Q 041878 581 EAAAIGKIH----HPNLLALRAYYLGPKGEKLLVFDFMPKGSLASF--LHARGPETIVNWATRMSIAIGIARG-LNYLHV 653 (773)
Q Consensus 581 E~~~l~~l~----h~niv~l~~~~~~~~~~~~lV~e~~~~g~L~~~--l~~~~~~~~~~~~~~~~i~~~i~~a-l~yLH~ 653 (773)
|+.-+.+++ ...-+.+=.+|.+-.+...++|||++|-.+.+. ++..+ .+ +..++..++++ +..+=
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g----~d---~k~ia~~~~~~f~~q~~- 282 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG----ID---RKELAELLVRAFLRQLL- 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC----CC---HHHHHHHHHHHHHHHHH-
Confidence 666666653 222334445554555688999999999988877 34432 23 23344444444 22333
Q ss_pred CCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 654 ~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
..|+.|.|.+|.||+++.++.+.+.|||+...+..
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 57999999999999999999999999999877654
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.60 E-value=9.6e-09 Score=100.82 Aligned_cols=191 Identities=23% Similarity=0.218 Sum_probs=120.3
Q ss_pred CCCCCcEEEccCCcccc--cCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCC-CCcccccccccc
Q 041878 113 QLHALRKLSLHDNLLAG--PVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIG-AIPPSLANSTRL 189 (773)
Q Consensus 113 ~l~~L~~L~L~~n~l~~--~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L 189 (773)
..++++.|||.+|.|+. ++-..+.++|.|+.|+|+.|.+...|-..-..+++|++|-|.+..+.- .....+..+|.+
T Consensus 69 ~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v 148 (418)
T KOG2982|consen 69 SVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV 148 (418)
T ss_pred HhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence 46789999999999974 455567789999999999999986554433567899999999988873 234567789999
Q ss_pred ceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEE
Q 041878 190 YRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEI 269 (773)
Q Consensus 190 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 269 (773)
+.|++|.|.+. .+++..|-.+..-|. ...+. ..+.+..++++-|++.. -++++..+
T Consensus 149 telHmS~N~~r--------------q~n~Dd~c~e~~s~~-v~tlh--~~~c~~~~w~~~~~l~r-------~Fpnv~sv 204 (418)
T KOG2982|consen 149 TELHMSDNSLR--------------QLNLDDNCIEDWSTE-VLTLH--QLPCLEQLWLNKNKLSR-------IFPNVNSV 204 (418)
T ss_pred hhhhhccchhh--------------hhccccccccccchh-hhhhh--cCCcHHHHHHHHHhHHh-------hcccchhe
Confidence 99999999543 244444444321110 00000 00112223333333332 23556677
Q ss_pred ECCCCcccCC-CCCCcCcccccceecccccccccc-CcccccccccCceEEccCCCCCCC
Q 041878 270 SLSHNKIVGP-IPDELGKLSKLQKLDLSYNAIGGS-FPVTFTNITSLVSLNLENNRLGNK 327 (773)
Q Consensus 270 ~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~ 327 (773)
-+..|.+... ....+..++.+..|+|+.|+|..- .-+.+.++++|..|.+++|.+.+.
T Consensus 205 ~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~ 264 (418)
T KOG2982|consen 205 FVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDP 264 (418)
T ss_pred eeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccccc
Confidence 7777766532 223344455666777887777642 224566677777777777777543
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.56 E-value=8.9e-08 Score=67.90 Aligned_cols=40 Identities=48% Similarity=0.911 Sum_probs=30.0
Q ss_pred HHHHHHHHHHHHhCC-CCCCCcCCCCCCC-CCCCCCCCcceEee
Q 041878 48 QADYQSLRAIKHDLI-DPHGFLRSWNDSG-VGACSGGWAGIKCV 89 (773)
Q Consensus 48 ~~~~~~L~~~k~~~~-~~~~~l~sW~~~~-~~~c~~~w~gv~c~ 89 (773)
++|++||++||.++. ||.+.+.+|+... .++|. |.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~--W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCS--WSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCC--STTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCee--eccEEeC
Confidence 579999999999999 5778999997643 67777 9999994
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 773 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-34 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-34 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-34 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-09 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-34 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-25 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-24 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 9e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-12 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 6e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-08 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 4e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 5e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 1e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-07 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 9e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 9e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-06 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-06 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-06 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 1e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-05 | ||
| 2z64_A | 599 | Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Comp | 1e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-05 | ||
| 3vq1_A | 606 | Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLE | 2e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-04 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 1e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-04 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 2e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-04 | ||
| 2ft3_A | 332 | Crystal Structure Of The Biglycan Dimer Core Protei | 2e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-04 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-04 | ||
| 3rg1_A | 612 | Crystal Structure Of The Rp105MD-1 Complex Length = | 4e-04 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 4e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-04 | ||
| 3oja_B | 597 | Crystal Structure Of Lrim1APL1C COMPLEX Length = 59 | 4e-04 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 4e-04 | ||
| 3o6n_A | 390 | Crystal Structure Of Apl1 Leucine-Rich Repeat Domai | 4e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-04 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 4e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-04 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 5e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-04 | ||
| 1ziw_A | 680 | Human Toll-Like Receptor 3 Extracellular Domain Str | 7e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-04 | ||
| 3ulu_A | 694 | Structure Of Quaternary Complex Of Human Tlr3ecd Wi | 7e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-04 | ||
| 2a0z_A | 705 | The Molecular Structure Of Toll-like Receptor 3 Lig | 8e-04 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 8e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2Z64|A Chain A, Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Complex Length = 599 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VQ1|A Chain A, Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLEX Length = 606 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein Length = 332 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3OJA|B Chain B, Crystal Structure Of Lrim1APL1C COMPLEX Length = 597 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|3O6N|A Chain A, Crystal Structure Of Apl1 Leucine-Rich Repeat Domain Length = 390 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 314 bits (806), Expect = 8e-96
Identities = 113/352 (32%), Positives = 165/352 (46%), Gaps = 16/352 (4%)
Query: 102 RLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGN 161
L G I + L LR L L N+L G +P L ++ L + L N L+G IP + N
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 162 CPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHN 221
C NL + LSNN L G IP + L L LS NS G+IP L SL L L N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548
Query: 222 NLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHN--KIVGP 279
+G++P + N IAG V + G+ +E + N + G
Sbjct: 549 LFNGTIPAAMFKQ---------SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGI 599
Query: 280 IPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLT 339
++L +LS +++ GG TF N S++ L++ N L IP+ + + L
Sbjct: 600 RSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLF 659
Query: 340 VLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGS 399
+LNL +N G IP+ +G++ G+N LDLS N G I ++++L LT ++S NNLSG
Sbjct: 660 ILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGP 719
Query: 400 VPPLLS-KKFNSSSFVGNLQLCGYSPSTACPSLAPLSLPPPPVEAPKHHHHR 450
+P + + F + F+ N LCGY PS + HHHH
Sbjct: 720 IPEMGQFETFPPAKFLNNPGLCGYPLPRCDPS----NADGYAHHQRSHHHHH 767
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = 1e-90
Identities = 111/327 (33%), Positives = 157/327 (48%), Gaps = 11/327 (3%)
Query: 102 RLGGRISEKISQLHALRKLSLHDNLLAGPVPWSL-GFLPNLRGVYLFNNRLSGSIPPSIG 160
+ G I L +L+ LSL +N G +P L G L G+ L N G++PP G
Sbjct: 258 QFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315
Query: 161 NCPNLQTLDLSNNALIGAIPP-SLANSTRLYRLNLSYNSLLGSIPLSLTRL-PSLSVLAL 218
+C L++L LS+N G +P +L L L+LS+N G +P SLT L SL L L
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 219 QHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVG 278
NN SG + N N LQ L L +N G IP +L L + LS N + G
Sbjct: 376 SSNNFSGPILPNLC---QNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSG 432
Query: 279 PIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNL 338
IP LG LSKL+ L L N + G P + +L +L L+ N L +IP GL NL
Sbjct: 433 TIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNL 492
Query: 339 TVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSG 398
++L NN+ G IP+ IG + + L LS N F+G I L +L +++ N +G
Sbjct: 493 NWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 399 SVPPLLSKKFNSSSFVGNLQLCGYSPS 425
++P + F S + + G
Sbjct: 553 TIPAAM---FKQSGKIAANFIAGKRYV 576
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 2e-83
Identities = 107/345 (31%), Positives = 162/345 (46%), Gaps = 19/345 (5%)
Query: 102 RLGGRISEKIS-QLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPP-SI 159
+ G I + +S L L L N G VP G L + L +N SG +P ++
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339
Query: 160 GNCPNLQTLDLSNNALIGAIPPSLAN-STRLYRLNLSYNSLLGSIPLSL--TRLPSLSVL 216
L+ LDLS N G +P SL N S L L+LS N+ G I +L +L L
Sbjct: 340 LKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 399
Query: 217 ALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKI 276
LQ+N +G +P + +L L+L N ++GTIP SLG L L+++ L N +
Sbjct: 400 YLQNNGFTGKIPPTLSNCS-----ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNML 454
Query: 277 VGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQ 336
G IP EL + L+ L L +N + G P +N T+L ++L NNRL +IP+ + RL+
Sbjct: 455 EGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLE 514
Query: 337 NLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNL 396
NL +L L NN F G+IP +G+ + LDL+ N F G I ++ S ++ N +
Sbjct: 515 NLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFI 570
Query: 397 SGSVPPLLSKKFNSSSFVG---NLQLCGYSPST--ACPSLAPLSL 436
+G + G L+ G + P ++
Sbjct: 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNI 615
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 7e-83
Identities = 95/314 (30%), Positives = 149/314 (47%), Gaps = 15/314 (4%)
Query: 98 LPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPP 157
+ ++ G + +S+ L L + N + +P LG L+ + + N+LSG
Sbjct: 185 ISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSR 241
Query: 158 SIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLT-RLPSLSVL 216
+I C L+ L++S+N +G IPP L L+L+ N G IP L+ +L+ L
Sbjct: 242 AISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGL 299
Query: 217 ALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPV-SLGKLGLLQEISLSHNK 275
L N+ G+VP +G + L+ L L N +G +P+ +L K+ L+ + LS N+
Sbjct: 300 DLSGNHFYGAVPPFFGSCS-----LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354
Query: 276 IVGPIPDELGKLS-KLQKLDLSYNAIGGSFPVTFTNI--TSLVSLNLENNRLGNKIPEGL 332
G +P+ L LS L LDLS N G +L L L+NN KIP L
Sbjct: 355 FSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
Query: 333 ERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVS 392
L L+L N G IP ++G++S + L L N GEI L + L + +
Sbjct: 415 SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILD 474
Query: 393 YNNLSGSVPPLLSK 406
+N+L+G +P LS
Sbjct: 475 FNDLTGEIPSGLSN 488
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 1e-81
Identities = 106/357 (29%), Positives = 161/357 (45%), Gaps = 37/357 (10%)
Query: 50 DYQSLRAIKHDLIDPHGFLRSWNDSGVGACSGGWAGIKCVKGQVIAIQLPWRRLGGRISE 109
+ L + K L D L W+ S C+ + G+ C +V +I L + L
Sbjct: 13 EIHQLISFKDVLPDK-NLLPDWS-SNKNPCT--FDGVTCRDDKVTSIDLSSKPLNVGF-- 66
Query: 110 KISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLD 169
V SL L L ++L N+ ++GS+ +L +LD
Sbjct: 67 -------------------SAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLD 106
Query: 170 LSNNALIGAIPP--SLANSTRLYRLNLSYNSLLGSIPLS-LTRLPSLSVLALQHNNLSGS 226
LS N+L G + SL + + L LN+S N+L +S +L SL VL L N++SG+
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 227 VPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGK 286
W + G L+ L + N I+G + + + L+ + +S N IP LG
Sbjct: 167 NVVGWVLSDGCGE--LKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGD 221
Query: 287 LSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNN 346
S LQ LD+S N + G F + T L LN+ +N+ IP L++L L+L N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAEN 279
Query: 347 QFKGHIPETI-GNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402
+F G IP+ + G + LDLS N F G + P S + L S +S NN SG +P
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 9e-55
Identities = 72/254 (28%), Positives = 113/254 (44%), Gaps = 16/254 (6%)
Query: 164 NLQTLDLSNNAL---IGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQH 220
+ ++DLS+ L A+ SL + T L L LS + + GS+ SL+ L L
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSR 109
Query: 221 NNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLG-KLGLLQEISLSHNKIVGP 279
N+LSG V + G+ S L+FLN+ N + VS G KL L+ + LS N I G
Sbjct: 110 NSLSGPVTTLTSL--GSCS-GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 280 IPDEL---GKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQ 336
+L+ L +S N I G + +L L++ +N IP L
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCS 223
Query: 337 NLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNL 396
L L++ N+ G I + + L++S N F G I P L +L +++ N
Sbjct: 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKF 281
Query: 397 SGSVPPLLSKKFNS 410
+G +P LS ++
Sbjct: 282 TGEIPDFLSGACDT 295
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-33
Identities = 39/143 (27%), Positives = 67/143 (46%)
Query: 88 CVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLF 147
+ G SE++++L ++ + G + ++ + +
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640
Query: 148 NNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSL 207
N LSG IP IG+ P L L+L +N + G+IP + + L L+LS N L G IP ++
Sbjct: 641 YNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM 700
Query: 208 TRLPSLSVLALQHNNLSGSVPNN 230
+ L L+ + L +NNLSG +P
Sbjct: 701 SALTMLTEIDLSNNNLSGPIPEM 723
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-15
Identities = 28/104 (26%), Positives = 42/104 (40%), Gaps = 6/104 (5%)
Query: 312 TSLVSLNLENNRL---GNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLS 368
+ S++L + L + + L L L L L N+ G + + + LDLS
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLS 108
Query: 369 ENDFTGEISP--SLASLANLTSFNVSYNNLSGSVPPLLSKKFNS 410
N +G ++ SL S + L NVS N L K NS
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNS 152
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 2e-90
Identities = 105/384 (27%), Positives = 157/384 (40%), Gaps = 83/384 (21%)
Query: 50 DYQSLRAIKHDLIDPHGFLRSWNDSGVGACSGGWAGIKCVKGQVIAIQLPWRRLGGRISE 109
D Q+L IK DL +P L SW + C+ W G+ C +
Sbjct: 7 DKQALLQIKKDLGNP-TTLSSWLPT-TDCCNRTWLGVLC--------------------D 44
Query: 110 KISQLHALRKLSLHDNLLAG--PVPWSLGFLPNLRGVYLFN-NRLSGSIPPSIGNCPNLQ 166
+Q + + L L L P+P SL LP L +Y+ N L G IPP+I L
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 167 TLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGS 226
L +++ + GAIP L+ L L+ SYN+L G++P S++ LP+L + N +SG+
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164
Query: 227 VPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKL-GLLQEISLSHNKIVGPIPDELG 285
IP S G L +++S N++ G IP
Sbjct: 165 -----------------------------IPDSYGSFSKLFTSMTISRNRLTGKIPPTFA 195
Query: 286 KLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKN 345
L+ L +DLS N + G +N ++L
Sbjct: 196 NLN-LAFVDLSRNMLEGD------------------------ASVLFGSDKNTQKIHLAK 230
Query: 346 NQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLS 405
N + + +G +N LDL N G + L L L S NVS+NNL G +P +
Sbjct: 231 NSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289
Query: 406 -KKFNSSSFVGNLQLCGYSPSTAC 428
++F+ S++ N LCG SP AC
Sbjct: 290 LQRFDVSAYANNKCLCG-SPLPAC 312
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 5e-71
Identities = 97/260 (37%), Positives = 146/260 (56%), Gaps = 17/260 (6%)
Query: 522 VHFDGPFLFTADDLLCAT-----AEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKG-Q 575
VH F+ +L A+ I+G+ +G YK L DG+ VAVKRL+E+ T+G +
Sbjct: 12 VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGE 71
Query: 576 KEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIV-NW 634
+F+ E I H NLL LR + + P E+LLV+ +M GS+AS L R +W
Sbjct: 72 LQFQTEVEMISMAVHRNLLRLRGFCMTPT-ERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 635 ATRMSIAIGIARGLNYLHVEEN--MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692
R IA+G ARGL YLH + +IH ++ ++N+LLDE+ + DFGL++LM +T
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDT 189
Query: 693 NVI-ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP---GEPMNGMD--LP 746
+V A GT+G+ APE ++ KTDV+ GV++LEL+TG+ N D L
Sbjct: 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 747 QWVASIVKEEWTNEVFDLEL 766
WV ++KE+ + D++L
Sbjct: 250 DWVKGLLKEKKLEALVDVDL 269
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 9e-66
Identities = 80/244 (32%), Positives = 126/244 (51%), Gaps = 12/244 (4%)
Query: 530 FTADDLLCAT-----AEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAA 584
DL AT ++G +G YK L DG++VA+KR ++++G +EFE E
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 585 IGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIV-NWATRMSIAIG 643
+ HP+L++L + + E +L++ +M G+L L+ T+ +W R+ I IG
Sbjct: 89 LSFCRHPHLVSLIGFCD-ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI-ATAGTLG 702
ARGL+YLH +IH ++ S N+LLDE P+I DFG+S+ T T++ GTLG
Sbjct: 148 AARGLHYLH-TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLG 206
Query: 703 YRAPELSKLKNANTKTDVYSLGVIILELLTGKSP---GEPMNGMDLPQWVASIVKEEWTN 759
Y PE K+DVYS GV++ E+L +S P ++L +W
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 760 EVFD 763
++ D
Sbjct: 267 QIVD 270
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 1e-64
Identities = 62/362 (17%), Positives = 122/362 (33%), Gaps = 32/362 (8%)
Query: 96 IQLPWRRLGGRISEKISQLHALRKLSLHDN-LLAGPVPWSLGFLPNLRGVYLFNNRLSGS 154
I + + ++ + + N L PV SL + L + N+L G
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG- 344
Query: 155 IPPSIGNCPNLQTLDLSNNALIGAIPPSL-ANSTRLYRLNLSYNSLLGSIP--LSLTRLP 211
P+ G+ L +L+L+ N + IP + + ++ L+ ++N L IP +
Sbjct: 345 KLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVS 402
Query: 212 SLSVLALQHNNLSGSVPNNWGVLAGN--KSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEI 269
+S + +N + N+ L K + +NL +N I+ L I
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSI 462
Query: 270 SLSHNKIVG-------PIPDELGKLSKLQKLDLSYNAIGGSFP-VTFTNITSLVSLNLEN 321
+L N + + L +DL +N + T + LV ++L
Sbjct: 463 NLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSY 522
Query: 322 NRLGNKIPEGLERLQNLTVLNLKN------NQFKGHIPETIGNISGINQLDLSENDFTGE 375
N +K P L ++N N+ PE I + QL + ND
Sbjct: 523 NSF-SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK- 580
Query: 376 ISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQLCGYSPSTACPSLAPLS 435
++ + N++ ++ N + + + + Y + L
Sbjct: 581 VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEA-----GMYMLFYDKTQDIRGCDALD 633
Query: 436 LP 437
+
Sbjct: 634 IK 635
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 7e-61
Identities = 63/342 (18%), Positives = 118/342 (34%), Gaps = 42/342 (12%)
Query: 98 LPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRL------ 151
+ + K L L + +++ +P L LP ++ + + NR
Sbjct: 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL 291
Query: 152 --SGSIPPSIGNCPNLQTLDLSNNALI-GAIPPSLANSTRLYRLNLSYNSLLGSIPLSLT 208
+Q + + N L + SL +L L YN L G +P +
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFG 350
Query: 209 RLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIP--VSLGKLGLL 266
L+ L L +N ++ N + Q++ L+ HN + IP + ++
Sbjct: 351 SEIKLASLNLAYNQITEIPAN-----FCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVM 404
Query: 267 QEISLSHNKIVG-------PIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNL 319
I S+N+I P+ K + ++LS N I F+ + L S+NL
Sbjct: 405 SAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINL 464
Query: 320 ENNRL-------GNKIPEGLERLQNLTVLNLKNNQFKGHIPETI--GNISGINQLDLSEN 370
N L E + LT ++L+ N+ + + + + +DLS N
Sbjct: 465 MGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYN 523
Query: 371 DFTGEISPSLASLANLTSF------NVSYNNLSGSVPPLLSK 406
F+ + + L F + N P ++
Sbjct: 524 SFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITL 564
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-60
Identities = 54/334 (16%), Positives = 119/334 (35%), Gaps = 38/334 (11%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALI 176
L K ++ + + S + +N ++ + ++ L+ + N+ +
Sbjct: 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFV 219
Query: 177 G-------------------AIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLA 217
N L + + L +P L LP + ++
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279
Query: 218 LQHNNLSG--SVPNNWGVLAG-NKSYQLQFLNLDHN-LIAGTIPVSLGKLGLLQEISLSH 273
+ N + ++W LA ++Q + + +N L + SL K+ L + +
Sbjct: 280 VACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLY 339
Query: 274 NKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLE 333
N++ G +P G KL L+L+YN I + +L+ +N+L IP +
Sbjct: 340 NQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL-KYIPNIFD 397
Query: 334 --RLQNLTVLNLKNNQFKG-------HIPETIGNISGINQLDLSENDFTGEISPSLASLA 384
+ ++ ++ N+ + T ++ ++LS N + ++ +
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457
Query: 385 NLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQ 418
L+S N+ N L+ +P K N + N
Sbjct: 458 PLSSINLMGNMLTE-IPKNSLKDENEN--FKNTY 488
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-59
Identities = 49/352 (13%), Positives = 119/352 (33%), Gaps = 29/352 (8%)
Query: 70 SWNDSGVGACSGGWAGIKC-VKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLA 128
+WN + G G+ G+V + L GR+ + I QL L L+L +
Sbjct: 59 NWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK 118
Query: 129 GP----VPWSLGFLPNLRGVYLFNNRLSGSIPPSIG--NCPNLQTLDLSNNALIGAIPPS 182
P + + + + +L ++++ +I S
Sbjct: 119 VNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS 178
Query: 183 LANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQL 242
+ + ++ N+ + + ++ RL L + ++
Sbjct: 179 SRITLKDTQIGQLSNN-ITFVSKAVMRLTKLRQFYMGNSPFVAENICE----------AW 227
Query: 243 QFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAI-- 300
+ N ++ T + L L ++ + + + +P L L ++Q ++++ N
Sbjct: 228 ENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287
Query: 301 ------GGSFPVTFTNITSLVSLNLENNRLGN-KIPEGLERLQNLTVLNLKNNQFKGHIP 353
+ + + N L + L++++ L +L NQ +G +P
Sbjct: 288 GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
Query: 354 ETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLS 405
G+ + L+L+ N T + + + + ++N L +P +
Sbjct: 348 A-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFD 397
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 29/172 (16%), Positives = 58/172 (33%), Gaps = 7/172 (4%)
Query: 246 NLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGG--- 302
N + ++ VSL G + +SL G +PD +G+L++L+ L L +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 303 -SFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQ--NLTVLNLKNNQFKGHIPETIGNI 359
P + S + R +L + ++ + I ++
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
Query: 360 SGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSS 411
Q+ N+ T +S ++ L L F + + + NS
Sbjct: 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE 233
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 17/138 (12%), Positives = 43/138 (31%), Gaps = 6/138 (4%)
Query: 303 SFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGI 362
S T + + N E + G + L +T L+L+ G +P+ IG ++ +
Sbjct: 48 SQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTEL 107
Query: 363 NQLDLSENDFTG----EISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQ 418
L L + +++ + + + + S +
Sbjct: 108 EVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPR--EDFSDLIKDC 165
Query: 419 LCGYSPSTACPSLAPLSL 436
+ + + ++L
Sbjct: 166 INSDPQQKSIKKSSRITL 183
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 7e-64
Identities = 75/249 (30%), Positives = 115/249 (46%), Gaps = 31/249 (12%)
Query: 530 FTADDLLCAT-----------AEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTK----G 574
F+ +L T MG+ +G YK + + + VAVK+L
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 575 QKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNW 634
+++F+ E + K H NL+ L + + LV+ +MP GSL L ++W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGD-DLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 635 ATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694
R IA G A G+N+LH E + IH ++ S+N+LLDE +I+DFGL+R A T +
Sbjct: 133 HMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 695 -IATAGTLGYRAPE-----LSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG-MDLPQ 747
GT Y APE ++ K+D+YS GV++LE++TG + L
Sbjct: 192 TSRIVGTTAYMAPEALRGEIT------PKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245
Query: 748 WVASIVKEE 756
I EE
Sbjct: 246 IKEEIEDEE 254
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 217 bits (553), Expect = 7e-60
Identities = 57/339 (16%), Positives = 109/339 (32%), Gaps = 30/339 (8%)
Query: 105 GRISEKISQLHALRKLSLHDNLLAG-PVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCP 163
R+++ ++ + N L P SL + L + +N++ + G
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNV 595
Query: 164 NLQTLDLSNNALIGAIPPSL-ANSTRLYRLNLSYNSLLGSIP--LSLTRLPSLSVLALQH 220
L L L N + IP A + ++ L S+N L IP + + + + +
Sbjct: 596 KLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSY 653
Query: 221 NNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKI---- 276
N + N + K + L +N I + I LS+N +
Sbjct: 654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIP 713
Query: 277 ---VGPIPDELGKLSKLQKLDLSYNAIGG-SFPVTFTNITSLVSLNLENNRLGNKIPEGL 332
+ P L +DL +N + S T + L ++++ N + P
Sbjct: 714 ENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCF-SSFPTQP 772
Query: 333 ERLQNLTVLNL------KNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANL 386
L + + N+ P I + QL + ND ++ L L
Sbjct: 773 LNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQL 829
Query: 387 TSFNVSYNNLS----GSVPPLLSKKFNSSSFVGNLQLCG 421
+++ N SV P + + + G
Sbjct: 830 YILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRG 868
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 187 bits (475), Expect = 1e-49
Identities = 67/385 (17%), Positives = 127/385 (32%), Gaps = 44/385 (11%)
Query: 50 DYQSLRAIKHDL-----------IDPHGFLRSWNDSGVGACSGGWAGIKCVK-GQVIAIQ 97
DY++L+AI L I+ +WN + G G+ G+V +
Sbjct: 270 DYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLS 329
Query: 98 LPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPP 157
L GR+ + I QL L+ LS + +R+
Sbjct: 330 LAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKK 389
Query: 158 -SIGNCPNLQTLDLSNNAL-----IGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLP 211
+ L DL +A+ + I S + ++ N + I ++ RL
Sbjct: 390 MFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTN-RITFISKAIQRLT 448
Query: 212 SLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISL 271
L ++ ++ + N + + N D+ +S L L ++ L
Sbjct: 449 KLQIIYFANSPFTYD----------NIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498
Query: 272 SHNKIVGPIPDELGKLSKLQKLDLSYNAIGG---------SFPVTFTNITSLVSLNLENN 322
+ + +PD L L +LQ L+++ N + + N
Sbjct: 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYN 558
Query: 323 RLGN-KIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSL- 380
L L+++ L +L+ +N+ + H+ G + L L N EI
Sbjct: 559 NLEEFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIE-EIPEDFC 615
Query: 381 ASLANLTSFNVSYNNLSGSVPPLLS 405
A + S+N L +P + +
Sbjct: 616 AFTDQVEGLGFSHNKLK-YIPNIFN 639
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 4e-33
Identities = 36/275 (13%), Positives = 76/275 (27%), Gaps = 40/275 (14%)
Query: 149 NRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLT 208
+ + N + L L+ G +P ++ T L L+ +S S L
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 209 RLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLI-----AGTIPVSLGKL 263
+ + + + + + + +L +L + I I
Sbjct: 369 EELTPDMSEERKHRIRMHYKK----MFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRIS 424
Query: 264 GLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNR 323
+I N+I I + +L+KLQ + + + N + +
Sbjct: 425 LKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAK 478
Query: 324 LGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASL 383
L++LT + L N +P+ + + L
Sbjct: 479 QYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD------------------------L 514
Query: 384 ANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQ 418
L S N++ N L + +
Sbjct: 515 PELQSLNIACNRGIS-AAQLKADWTRLADDEDTGP 548
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-23
Identities = 36/191 (18%), Positives = 67/191 (35%), Gaps = 27/191 (14%)
Query: 102 RLGGRISEKISQLHALRKLSLHDNLL-------AGPVPWSLGFLPNLRGVYLFNNRLSGS 154
+ +E + + + L +NL+ P + L + L N+L+ S
Sbjct: 684 EIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-S 742
Query: 155 IPPSI--GNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSY------NSLLGSIPLS 206
+ P L +D+S N P NS++L + + N +L P
Sbjct: 743 LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801
Query: 207 LTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN-LIAGTIPVSLGKLGL 265
+T PSL L + N++ V + QL L++ N I+ + +
Sbjct: 802 ITTCPSLIQLQIGSNDIR-KVDEKL-------TPQLYILDIADNPNISIDVTSVCPYIEA 853
Query: 266 LQEISLSHNKI 276
L ++K
Sbjct: 854 GM-YVLLYDKT 863
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 9e-13
Identities = 22/201 (10%), Positives = 59/201 (29%), Gaps = 3/201 (1%)
Query: 224 SGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDE 283
+ SV + NK + + + A I + + + + + +
Sbjct: 236 TQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINN 295
Query: 284 LGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNL 343
+ + G V N + L+L ++P+ + +L L VL+
Sbjct: 296 TIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSF 354
Query: 344 KNNQFKGHIPETIGNISGINQLDLSENDFTGEISP-SLASLANLTSFNVSYNNLSGSVPP 402
+ + + ++ L L ++ + ++ P
Sbjct: 355 GTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN-RNPE 413
Query: 403 LLSKKFNSSSFVGNLQLCGYS 423
+ K +S + + Q+ +
Sbjct: 414 MKPIKKDSRISLKDTQIGNLT 434
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 8e-60
Identities = 63/314 (20%), Positives = 118/314 (37%), Gaps = 17/314 (5%)
Query: 107 ISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQ 166
+ ++ L L + N ++ P LP L+ + L +N LS + C NL
Sbjct: 41 PAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLT 100
Query: 167 TLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGS 226
L L +N++ L L+LS+N L + + +L +L L L +N +
Sbjct: 101 ELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160
Query: 227 VPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELG- 285
+ + L+ L L N I P +G L + L++ ++ + ++L
Sbjct: 161 KSEELDIF---ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217
Query: 286 --KLSKLQKLDLSYNAIGGSFPVTFTN--ITSLVSLNLENNRLGNKIPEGLERLQNLTVL 341
+ ++ L LS + + + TF T+L L+L N L + L L
Sbjct: 218 ELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYF 277
Query: 342 NLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISP---------SLASLANLTSFNVS 392
L+ N + ++ + + L+L + IS S L L N+
Sbjct: 278 FLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNME 337
Query: 393 YNNLSGSVPPLLSK 406
N++ G + +
Sbjct: 338 DNDIPGIKSNMFTG 351
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 3e-59
Identities = 67/322 (20%), Positives = 118/322 (36%), Gaps = 19/322 (5%)
Query: 102 RLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGN 161
L + + L +L L N + NL + L +N LS + +
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 162 CPNLQTLDLSNNALIGAIPPSLA--NSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQ 219
NLQ L LSNN + L ++ L +L LS N + P + L L L
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203
Query: 220 HNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGL--LQEISLSHNKIV 277
+ L S+ + N S ++ L+L ++ ++ T + L L + LS+N +
Sbjct: 204 NVQLGPSLTEKLCLELANTS--IRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN 261
Query: 278 GPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENN---------RLGNKI 328
D L +L+ L YN I F + + ++ LNL+ + L
Sbjct: 262 VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321
Query: 329 PEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLA----SLA 384
+ L+ L LN+++N G + + L LS + + + + +
Sbjct: 322 DFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381
Query: 385 NLTSFNVSYNNLSGSVPPLLSK 406
L N++ N +S S
Sbjct: 382 PLHILNLTKNKISKIESDAFSW 403
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-58
Identities = 73/310 (23%), Positives = 117/310 (37%), Gaps = 12/310 (3%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALI 176
+ L+L N L + L + + N +S P P L+ L+L +N L
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 177 GAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAG 236
+ A T L L+L NS+ + +L L L HN LS + G
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL---GTQVQ 143
Query: 237 NKSYQLQFLNLDHNLIAGTIPVSLGKLGL--LQEISLSHNKIVGPIPDELGKLSKLQKLD 294
++ LQ L L +N I L L+++ LS N+I P + +L L
Sbjct: 144 LEN--LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLF 201
Query: 295 LSYNAIGGSFPVTFT---NITSLVSLNLENNRLGNKIPEGLERLQ--NLTVLNLKNNQFK 349
L+ +G S TS+ +L+L N++L L+ NLT+L+L N
Sbjct: 202 LNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN 261
Query: 350 GHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFN 409
++ + + L N+ S SL L N+ N+ + S+ K +
Sbjct: 262 VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321
Query: 410 SSSFVGNLQL 419
SF L
Sbjct: 322 DFSFQWLKCL 331
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 6e-58
Identities = 75/374 (20%), Positives = 128/374 (34%), Gaps = 27/374 (7%)
Query: 98 LPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPP 157
+ L L L L++ DN + G L NL+ + L N+ S
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371
Query: 158 SIG----NCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLS-LTRLPS 212
+ L L+L+ N + + + L L+L N + + L +
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 213 LSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAG--TIPVSLGKLGLLQEIS 270
+ + L +N N++ ++ LQ L L + + P L L +
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALV-----PSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD 486
Query: 271 LSHNKIVGPIPDELGKLSKLQKLDLSYN--------AIGGSFPVTFTNITSLVSLNLENN 322
LS+N I D L L KL+ LDL +N A G ++ L LNLE+N
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN 546
Query: 323 RLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLA- 381
E + L L +++L N N + L+L +N T
Sbjct: 547 GFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGP 606
Query: 382 SLANLTSFNVSYNNLSGSVPPL------LSKKFNSSSFVGNLQLCGYSPSTACPSLAPLS 435
+ NLT ++ +N + + +++ + + + LC P +
Sbjct: 607 AFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFD 666
Query: 436 LPPPPVEAPKHHHH 449
A HHHH
Sbjct: 667 TSSCKDSAHHHHHH 680
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 1e-56
Identities = 80/297 (26%), Positives = 116/297 (39%), Gaps = 15/297 (5%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALI 176
L VP L N+ + L +N+L + L +LD+ N +
Sbjct: 6 HEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 177 GAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAG 236
P L LNL +N L + +L+ L L N++ N +
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK- 121
Query: 237 NKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELG--KLSKLQKLD 294
L L+L HN ++ T + +L LQE+ LS+NKI +EL S L+KL+
Sbjct: 122 ----NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE 177
Query: 295 LSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGL---ERLQNLTVLNLKNNQFKGH 351
LS N I P F I L L L N +LG + E L ++ L+L N+Q
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237
Query: 352 IPETIGNISGIN--QLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSK 406
T + N LDLS N+ + S A L L F + YNN+ L
Sbjct: 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHG 294
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 7e-46
Identities = 59/247 (23%), Positives = 97/247 (39%), Gaps = 13/247 (5%)
Query: 164 NLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNL 223
+ + D S+ L +P L + LNL++N L + TR L+ L + N +
Sbjct: 5 SHEVADCSHLKL-TQVPDDLPTNIT--VLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 224 SGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDE 283
S P L L+ LNL HN ++ + L E+ L N I +
Sbjct: 62 SKLEPELCQKL-----PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNP 116
Query: 284 LGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQN--LTVL 341
K L LDLS+N + + T + +L L L NN++ E L+ N L L
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176
Query: 342 NLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLA---SLANLTSFNVSYNNLSG 398
L +NQ K P I + L L+ ++ L + ++ + ++S + LS
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236
Query: 399 SVPPLLS 405
+
Sbjct: 237 TSNTTFL 243
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-29
Identities = 39/171 (22%), Positives = 65/171 (38%), Gaps = 3/171 (1%)
Query: 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAI 300
+ + H + +P L + ++L+HN++ + S+L LD+ +N I
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 301 GGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNIS 360
P + L LNL++N L + NLT L+L +N +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 361 GINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSS 411
+ LDLS N + + L NL +S N + L NSS
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS 172
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-13
Identities = 22/94 (23%), Positives = 37/94 (39%), Gaps = 3/94 (3%)
Query: 312 TSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSEND 371
S + + +L ++P+ L N+TVLNL +NQ + S + LD+ N
Sbjct: 4 VSHEVADCSHLKL-TQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 372 FTGEISPSLASLANLTSFNVSYNNLSGSVPPLLS 405
+ L L N+ +N LS +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFA 94
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-55
Identities = 68/303 (22%), Positives = 112/303 (36%), Gaps = 16/303 (5%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
S + L L + L L L G S + P+L+ LDL
Sbjct: 300 FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDL 354
Query: 171 SNNAL--IGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVP 228
S N L G S +T L L+LS+N ++ + + L L L QH+NL
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSE 413
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPI-PDELGKL 287
V ++ L +L++ H L L+ + ++ N PD +L
Sbjct: 414 F--SVFLSLRN--LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469
Query: 288 SKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQ 347
L LDLS + P F +++SL LN+ +N + + L +L VL+ N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 348 FKGHIPETIGNI-SGINQLDLSENDFTG--EISPSLASLANLTSFNVSYNNLSGSVPPLL 404
+ + + S + L+L++NDF E L + + V + + P
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
Query: 405 SKK 407
Sbjct: 590 QGM 592
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-52
Identities = 67/310 (21%), Positives = 112/310 (36%), Gaps = 23/310 (7%)
Query: 111 ISQLHALRKLSLHDN------LLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPN 164
S L L L++ + + L N+ L + +
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFG 305
Query: 165 LQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLS 224
Q L+L N L + L++ S G S LPSL L L N LS
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLK-----RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360
Query: 225 --GSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPD 282
G + L++L+L N + T+ + L L+ + H+ +
Sbjct: 361 FKGCCSQSDFGTT-----SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEF 414
Query: 283 E-LGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRL-GNKIPEGLERLQNLTV 340
L L LD+S+ +F F ++SL L + N N +P+ L+NLT
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474
Query: 341 LNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSV 400
L+L Q + P ++S + L++S N+F + L +L + S N++ S
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 534
Query: 401 PPLLSKKFNS 410
L +S
Sbjct: 535 KQELQHFPSS 544
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 4e-51
Identities = 61/335 (18%), Positives = 104/335 (31%), Gaps = 25/335 (7%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALI 176
+ L L N L +S P L+ + L + + + +L TL L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 177 GAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNL-SGSVPNNWGVLA 235
+ + + L +L +L + L +L L + HN + S +P + L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 236 GNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQ----EISLSHNKIVGPIPDELGKLSKLQ 291
L+ L+L N I L L + + LS N + I K +L
Sbjct: 150 -----NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLH 203
Query: 292 KLDLSYNAIGGSFP-VTFTNITSLVSLNLENNRLGNK------IPEGLERLQNLTVLNL- 343
KL L N + + L L N+ LE L NLT+
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 344 --KNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVP 401
+ + I + ++ ++ L + + P
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQ-FP 320
Query: 402 PLLSKKFNSSSFVGNLQLCGYSPSTACPSLAPLSL 436
L K +F + + PSL L L
Sbjct: 321 TLKLKSLKRLTF-TSNKGGNAFSEVDLPSLEFLDL 354
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-50
Identities = 61/291 (20%), Positives = 103/291 (35%), Gaps = 14/291 (4%)
Query: 109 EKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLS--GSIPPSIGNCPNLQ 166
+ L L G +S LP+L + L N LS G S +L+
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 167 TLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLS-LTRLPSLSVLALQHNNLSG 225
LDLS N +I + + +L L+ +++L S L +L L + H +
Sbjct: 377 YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 226 SVPNNWGVLAGNKSYQLQFLNLDHNLIAGTI-PVSLGKLGLLQEISLSHNKIVGPIPDEL 284
+ + L+ L+ L + N P +L L + LS ++ P
Sbjct: 436 AFNGIFNGLS-----SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490
Query: 285 GKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERL-QNLTVLNL 343
LS LQ L++S+N + + SL L+ N + + L+ +L LNL
Sbjct: 491 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 550
Query: 344 KNNQFKGHIPET--IGNISGINQLDLSENDFTGEISPSLASLANLTSFNVS 392
N F + I QL + + + S N++
Sbjct: 551 TQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-49
Identities = 54/308 (17%), Positives = 100/308 (32%), Gaps = 15/308 (4%)
Query: 102 RLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGN 161
L S L+ L L + + L +L + L N + +
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
Query: 162 CPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLG-SIPLSLTRLPSLSVLALQH 220
+LQ L L + + L LN+++N + +P + L +L L L
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 221 NNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPI 280
N + + VL L+L N + P + ++ L +++L +N +
Sbjct: 159 NKIQSIYCTDLRVLH-QMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNV 216
Query: 281 PDE-LGKLSKLQKLDLSYNAIGGSF---PVTFTNITSLVSLNLENNRL------GNKIPE 330
+ L+ L+ L + + L +L +E RL + I +
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276
Query: 331 GLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFN 390
L N++ +L + + G L+L F + L SL LT +
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTS 334
Query: 391 VSYNNLSG 398
N
Sbjct: 335 NKGGNAFS 342
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-48
Identities = 67/286 (23%), Positives = 109/286 (38%), Gaps = 23/286 (8%)
Query: 131 VPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLY 190
+P +L + + + L N L S + P LQ LDLS + + + + L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 191 RLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN 250
L L+ N + + + L SL L NL+ + K+ L+ LN+ HN
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF---PIGHLKT--LKELNVAHN 134
Query: 251 LIAGT-IPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQ----KLDLSYNAIGGSFP 305
LI +P L L+ + LS NKI +L L ++ LDLS N + P
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194
Query: 306 VTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQFKGHI---PETIGNISG 361
F I L L L NN + + ++ L L V L +F+ + G
Sbjct: 195 GAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG 253
Query: 362 INQLDLSEND------FTGEISPSLASLANLTSFNVSYNNLSGSVP 401
+ L + E + +I L N++SF++ +
Sbjct: 254 LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 6e-43
Identities = 56/249 (22%), Positives = 95/249 (38%), Gaps = 16/249 (6%)
Query: 157 PSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVL 216
P + PN+ + N IP +L ST+ L+LS+N L S P L VL
Sbjct: 2 PCVEVVPNITYQCMELN--FYKIPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVL 57
Query: 217 ALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKI 276
L + + L+ L L L N I + L LQ++ +
Sbjct: 58 DLSRCEIQTIEDGAYQSLS-----HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
Query: 277 VGPIPDELGKLSKLQKLDLSYNAI-GGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERL 335
+G L L++L++++N I P F+N+T+L L+L +N++ + L L
Sbjct: 113 ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172
Query: 336 QNLTV----LNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISP-SLASLANLTSFN 390
+ + L+L N P I +++L L N + + + LA L
Sbjct: 173 HQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHR 231
Query: 391 VSYNNLSGS 399
+
Sbjct: 232 LVLGEFRNE 240
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-41
Identities = 50/268 (18%), Positives = 93/268 (34%), Gaps = 34/268 (12%)
Query: 105 GRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPN 164
G S+ +L+ L L N + + +
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVIT-------------------------MSSNFLGLEQ 397
Query: 165 LQTLDLSNNALIGAIPPS-LANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNL 223
L+ LD ++ L S + L L++S+ + L SL VL + N+
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457
Query: 224 SGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDE 283
+ + ++ L FL+L + P + L LQ +++SHN
Sbjct: 458 QENFL--PDIFTELRN--LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
Query: 284 LGKLSKLQKLDLSYNAIGGSFPVTFTNI-TSLVSLNLENNRL-GN-KIPEGLERLQNLTV 340
L+ LQ LD S N I S + +SL LNL N + L+ +++
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQ 573
Query: 341 LNLKNNQFKGHIPETIGNISGINQLDLS 368
L ++ + + P + + L+++
Sbjct: 574 LLVEVERMECATPSDKQGMP-VLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 27/123 (21%), Positives = 47/123 (38%), Gaps = 2/123 (1%)
Query: 280 IPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLT 339
IPD L + LDLS+N + +F + L L+L + + L +L+
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 340 VLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGS 399
L L N + +S + +L E + + + L L NV++N +
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139
Query: 400 VPP 402
P
Sbjct: 140 KLP 142
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-15
Identities = 17/94 (18%), Positives = 34/94 (36%)
Query: 312 TSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSEND 371
S +L+L N L + L VL+L + + ++S ++ L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 372 FTGEISPSLASLANLTSFNVSYNNLSGSVPPLLS 405
+ + L++L NL+ +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-54
Identities = 68/276 (24%), Positives = 114/276 (41%), Gaps = 35/276 (12%)
Query: 517 MGGKLVHFDGPFLFTADDLLCAT-----AEIMGKSTYGTAYKATLEDGSEVAVKRLREKT 571
MG H ++L + E+ + +G +KA L VAVK +
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD 59
Query: 572 TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG---EKLLVFDFMPKGSLASFLHARGP 628
+ + E E ++ + H N+L + L+ F KGSL+ FL A
Sbjct: 60 KQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-- 116
Query: 629 ETIVNWATRMSIAIGIARGLNYLHVEE---------NMIHGNLTSSNVLLDEKTNPRIAD 679
+V+W IA +ARGL YLH + + H ++ S NVLL IAD
Sbjct: 117 --VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174
Query: 680 FGLSRLMTAAANT-NVIATAGTLGYRAPE-----LSKLKNANTKTDVYSLGVIILELLTG 733
FGL+ A + + GT Y APE ++ ++A + D+Y++G+++ EL +
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 734 KSPGEPMNGMDLPQWVASIVKEEWTNEVFDLELMRD 769
+ + + + EE + LE M++
Sbjct: 235 CTAADGPVDEYMLPF------EEEIGQHPSLEDMQE 264
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 1e-53
Identities = 61/299 (20%), Positives = 112/299 (37%), Gaps = 12/299 (4%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQ--TL 168
+ L L L N ++ L+ + NN + + + +L
Sbjct: 125 LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSL 184
Query: 169 DLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIP--LSLTRLPSLSVLALQHNNLSGS 226
+L+ N I I P +S LN L I L + + SL + + +
Sbjct: 185 NLNGN-DIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDI 243
Query: 227 VPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGK 286
P V G ++ +NL + + LQE+ L+ + +P L
Sbjct: 244 SPA---VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVG 299
Query: 287 LSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKN 345
LS L+KL LS N ++ +N SL L+++ N ++ G LE L+NL L+L +
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSH 359
Query: 346 NQFK--GHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402
+ + + N+S + L+LS N+ + + L ++++ L
Sbjct: 360 DDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 8e-52
Identities = 66/275 (24%), Positives = 108/275 (39%), Gaps = 11/275 (4%)
Query: 106 RISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPP-SIGNCPN 164
+ + L L+KL L N S P+L + + N + + N N
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351
Query: 165 LQTLDLSNNAL--IGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNN 222
L+ LDLS++ + L N + L LNLSYN L + P L +L L
Sbjct: 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR 411
Query: 223 LSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPI-- 280
L L+ LNL H+L+ + L LQ ++L N
Sbjct: 412 LKVKDAQ--SPFQNLHL--LKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQ 467
Query: 281 -PDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLT 339
+ L L +L+ L LS+ + FT++ + ++L +NRL + E L L+ +
Sbjct: 468 KTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI- 526
Query: 340 VLNLKNNQFKGHIPETIGNISGINQLDLSENDFTG 374
LNL +N +P + +S ++L +N
Sbjct: 527 YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-51
Identities = 64/302 (21%), Positives = 114/302 (37%), Gaps = 10/302 (3%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALI 176
+ ++L + + L+ + L LS +P + L+ L LS N
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFE 314
Query: 177 GAIPPSLANSTRLYRLNLSYNSLLGSI-PLSLTRLPSLSVLALQHNNLSGSVPNNWGVLA 235
S +N L L++ N+ + L L +L L L H+++ S N L
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN-LQLR 373
Query: 236 GNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDE-LGKLSKLQKLD 294
LQ LNL +N + + L+ + L+ ++ L L+ L+
Sbjct: 374 NLSH--LQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431
Query: 295 LSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKI---PEGLERLQNLTVLNLKNNQFKGH 351
LS++ + S F + +L LNL+ N L+ L L +L L
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 352 IPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSS 411
++ +N +DLS N T +L+ L + N++ N++S +P LL
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQR 550
Query: 412 SF 413
+
Sbjct: 551 TI 552
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 3e-50
Identities = 54/296 (18%), Positives = 91/296 (30%), Gaps = 9/296 (3%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
S+L L L L + + L + L N L ++ L+ L
Sbjct: 53 FSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112
Query: 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNN 230
+ L N L L L N + L VL Q+N + +
Sbjct: 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172
Query: 231 WGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELG--KLS 288
L + LNL+ N I I + Q ++ + + I L +
Sbjct: 173 MSSL---QQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228
Query: 289 KLQKLDLSYNAIGGSFPVTFTNI--TSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNN 346
L P F + S+ S+NL+ + N L L+L
Sbjct: 229 SLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTAT 288
Query: 347 QFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402
+P + +S + +L LS N F S ++ +LT ++ N +
Sbjct: 289 HLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 2e-49
Identities = 63/307 (20%), Positives = 106/307 (34%), Gaps = 18/307 (5%)
Query: 107 ISEKISQLHALRKLSLHDNLLAGPVPWSLGF--LPNLRGVYLFNNRLSGSIPPSIGNCP- 163
I + L+ + L + +L + P
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 164 -NLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNN 222
++++++L + + + L L+L+ L +P L L +L L L N
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANK 312
Query: 223 LSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTI-PVSLGKLGLLQEISLSHNKI--VGP 279
+ L L++ N + L L L+E+ LSH+ I
Sbjct: 313 FENLCQISASNFP-----SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDC 367
Query: 280 IPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNL 338
+L LS LQ L+LSYN F L L+L RL K + + L L
Sbjct: 368 CNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL 427
Query: 339 TVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEI---SPSLASLANLTSFNVSYNN 395
VLNL ++ + + + L+L N F + SL +L L +S+ +
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487
Query: 396 LSGSVPP 402
LS S+
Sbjct: 488 LS-SIDQ 493
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-44
Identities = 52/295 (17%), Positives = 106/295 (35%), Gaps = 16/295 (5%)
Query: 118 RKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIG 177
+ + + L +P +L + + N L + NL LDL+ +
Sbjct: 15 KTYNCENLGLNE-IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 178 AIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGN 237
+ + RL L L+ N L+ +L+ +L L +S L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF---IPLHNQ 128
Query: 238 KSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQ--KLDL 295
K+ L+ L L N I+ L+ + +N I +++ L + L+L
Sbjct: 129 KT--LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNL 186
Query: 296 SYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLE--RLQNLTVLNLKNNQFKGHIP 353
+ N I + SLN + I +GL+ +Q+L + ++ + P
Sbjct: 187 NGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP 245
Query: 354 ETIGNISGIN--QLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSK 406
+ ++ ++L ++ F S + + L +++ +LS +P L
Sbjct: 246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVG 299
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-30
Identities = 43/221 (19%), Positives = 74/221 (33%), Gaps = 28/221 (12%)
Query: 105 GRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCP 163
+ ++ L L+ L+L N + P L + L RL S N
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425
Query: 164 NLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNL 223
L+ L+LS++ L + L LNL N L +L
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG--------- 476
Query: 224 SGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDE 283
+L+ L L ++ + L ++ + LSHN++ +
Sbjct: 477 -----------------RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519
Query: 284 LGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRL 324
L L + L+L+ N I P ++ ++NL N L
Sbjct: 520 LSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-27
Identities = 32/200 (16%), Positives = 63/200 (31%), Gaps = 11/200 (5%)
Query: 215 VLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHN 274
++ L+ +P L + + L N++ + +L L + L+
Sbjct: 16 TYNCENLGLN-EIPGT---LPNS----TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRC 67
Query: 275 KIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLER 334
+I D +L L L+ N + + +L L + + L
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN 127
Query: 335 LQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLT--SFNVS 392
+ L L L +N + LD N ++SL T S N++
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLN 187
Query: 393 YNNLSGSVPPLLSKKFNSSS 412
N+++ + P S
Sbjct: 188 GNDIA-GIEPGAFDSAVFQS 206
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 49/227 (21%), Positives = 75/227 (33%), Gaps = 14/227 (6%)
Query: 102 RLGGRISEKISQLHALRKLSLHDNLLAGPVPWS-LGFLPNLRGVYLFNNRLSGSIPPSIG 160
+E + L L L L S L L+ + L ++ L S
Sbjct: 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446
Query: 161 NCPNLQTLDLSNNALIGAI---PPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLA 217
P LQ L+L N SL RL L LS+ L + T L ++ +
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD 506
Query: 218 LQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIV 277
L HN L+ S L + +LNL N I+ +P L L + I+L N +
Sbjct: 507 LSHNRLTSSSIEALSHL------KGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLD 560
Query: 278 GPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRL 324
L+ + + + N L + L + L
Sbjct: 561 CTC--SNIYF--LEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTL 603
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 4e-52
Identities = 59/216 (27%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
E++G+ +G KA +VA+K++ ++ + K F E + +++HPN++ L
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE--NMI 658
L P LV ++ GSL + LH P A MS + ++G+ YLH + +I
Sbjct: 71 LNPV---CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 659 HGNLTSSNVLLDEK-TNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTK 717
H +L N+LL T +I DFG + + T++ G+ + APE+ + N + K
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 718 TDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIV 753
DV+S G+I+ E++T + +P + + P +
Sbjct: 184 CDVFSWGIILWEVITRR---KPFDEIGGPAFRIMWA 216
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 8e-52
Identities = 74/213 (34%), Positives = 118/213 (55%), Gaps = 6/213 (2%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRA 598
E +G ++GT ++A GS+VAVK L E+ + EF E A + ++ HPN++
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
P +V +++ +GSL LH G ++ R+S+A +A+G+NYLH I
Sbjct: 102 AVTQP-PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 659 -HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTK 717
H NL S N+L+D+K ++ DFGLSRL + ++ + AGT + APE+ + + +N K
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK-SAAGTPEWMAPEVLRDEPSNEK 219
Query: 718 TDVYSLGVIILELLTGKSPGEPMNGMDLPQWVA 750
+DVYS GVI+ EL T + P +N + V
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLNPAQVVAAVG 252
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 3e-51
Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 15/217 (6%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLR--EKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
+ ++ G +K G+++ VK L+ + +T+ ++F E + HPN+L +
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
P L+ +MP GSL + LH G +V+ + + A+ +ARG+ +LH E +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 658 I-HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPEL--SKLKNA 714
I L S +V++DE RI+ + + + APE K ++
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM------YAPAWVAPEALQKKPEDT 187
Query: 715 NT-KTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVA 750
N D++S V++ EL+T + P ++ M++ VA
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA 224
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-49
Identities = 74/225 (32%), Positives = 111/225 (49%), Gaps = 25/225 (11%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLR----EKTTKGQKEFEAEAAAIGKIHHPNLLAL 596
EI+G +G Y+A G EVAVK R E ++ + EA + HPN++AL
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 597 RAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE- 654
R L L LV +F G L L + + ++ A+ IARG+NYLH E
Sbjct: 72 RGVCLKE--PNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEA 125
Query: 655 -ENMIHGNLTSSNVLLDEKTNPR--------IADFGLSRLMTAAANTNVIATAGTLGYRA 705
+IH +L SSN+L+ +K I DFGL+R T ++ AG + A
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAGAYAWMA 182
Query: 706 PELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVA 750
PE+ + + +DV+S GV++ ELLTG+ P ++G+ + VA
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA 227
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-48
Identities = 74/295 (25%), Positives = 131/295 (44%), Gaps = 25/295 (8%)
Query: 109 EKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTL 168
+ I L L L+L+ N + P L L L +Y+ N+++ ++ N NL+ L
Sbjct: 60 QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLREL 115
Query: 169 DLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVP 228
L+ + + LAN T++Y LNL N L + L+ + L+ L + + + P
Sbjct: 116 YLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP 172
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLS 288
+A L L+L++N I P L L L + N+I P + ++
Sbjct: 173 -----IANLT--DLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMT 221
Query: 289 KLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQF 348
+L L + N I P N++ L L + N++ + ++ L L +LN+ +NQ
Sbjct: 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI 277
Query: 349 KGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPL 403
+ N+S +N L L+ N E + L NLT+ +S N+++ + PL
Sbjct: 278 SD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT-DIRPL 329
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 9e-43
Identities = 70/260 (26%), Positives = 114/260 (43%), Gaps = 22/260 (8%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
+ L LR+L L+++ ++ P L L + + L N S + N L L +
Sbjct: 106 LQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTV 162
Query: 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNN 230
+ + + P +AN T LY L+L+YN + PL+ L SL N ++ P
Sbjct: 163 TESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLA--SLTSLHYFTAYVNQITDITP-- 216
Query: 231 WGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKL 290
+A L L + +N I P L L L + + N+I + + L+KL
Sbjct: 217 ---VANMTR--LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKL 267
Query: 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKG 350
+ L++ N I S N++ L SL L NN+LGN+ E + L NLT L L N
Sbjct: 268 KMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
Query: 351 HIPETIGNISGINQLDLSEN 370
P + ++S ++ D +
Sbjct: 326 IRP--LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-38
Identities = 58/287 (20%), Positives = 108/287 (37%), Gaps = 27/287 (9%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALI 176
L+ + P L L ++ + ++ L ++ +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE-KV 56
Query: 177 GAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAG 236
+I + T L LNL+ N + PLS L L+ L + N ++ + L
Sbjct: 57 ASIQG-IEYLTNLEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKITD--ISALQNLT- 110
Query: 237 NKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLS 296
L+ L L+ + I+ P L L + ++L N + L ++ L L ++
Sbjct: 111 ----NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVT 163
Query: 297 YNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETI 356
+ + P N+T L SL+L N++ + L L +L NQ P +
Sbjct: 164 ESKVKDVTP--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--V 217
Query: 357 GNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPL 403
N++ +N L + N T LA+L+ LT + N +S + +
Sbjct: 218 ANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQIS-DINAV 261
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-33
Identities = 47/216 (21%), Positives = 90/216 (41%), Gaps = 19/216 (8%)
Query: 109 EKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTL 168
+S + L L++ ++ + P + L +L + L N++ P + + +L
Sbjct: 149 SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYF 204
Query: 169 DLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVP 228
N + P +AN TRL L + N + PL+ L L+ L + N +S +
Sbjct: 205 TAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLA--NLSQLTWLEIGTNQIS-DIN 259
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLS 288
+ +L+ LN+ N I + L L L + L++N++ + +G L+
Sbjct: 260 A----VKDLT--KLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLT 311
Query: 289 KLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRL 324
L L LS N I P +++ + S + N +
Sbjct: 312 NLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 24/114 (21%), Positives = 45/114 (39%), Gaps = 6/114 (5%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
++ L L L + N ++ + L L+ + + +N++S + N L +L L
Sbjct: 239 LANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFL 294
Query: 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLS 224
+NN L + T L L LS N + PL+ L + + +
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDSADFANQVIK 346
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 8e-48
Identities = 68/345 (19%), Positives = 119/345 (34%), Gaps = 31/345 (8%)
Query: 107 ISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQ 166
I E + + + D+ L + N++ + L N LS + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 167 TLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGS 226
L+LS+N L L + + L L+L+ N + L PS+ L +NN+S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113
Query: 227 VPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVG-PIPDELG 285
V + G + + L +N I + G +Q + L N+I +
Sbjct: 114 VSCSRGQ-------GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
Query: 286 KLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKN 345
L+ L+L YN I L +L+L +N+L + + +T ++L+N
Sbjct: 167 SSDTLEHLNLQYNFI-YDVK-GQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRN 223
Query: 346 NQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSG-SVPPLL 404
N+ I + + + DL N F + N V+ + +
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE 281
Query: 405 SKKFNSSSFVGNLQLCGYSPSTACPSLAPLSLPPPPVEAPKHHHH 449
+ G C P+ L L HHHH
Sbjct: 282 ECTVPTLGHYGAY-CCEDLPAPFADRLIALG--------HHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 55/271 (20%), Positives = 101/271 (37%), Gaps = 22/271 (8%)
Query: 154 SIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSL 213
+I N + +++++L A+ ++ + L+LS N L L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 214 SVLALQHNNLSGSVPNNWGV-------LAGNK------SYQLQFLNLDHNLIAGTIPVSL 260
+L L N L + + L N ++ L+ +N I+ + S
Sbjct: 61 ELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 261 GKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGG-SFPVTFTNITSLVSLNL 319
G+ + I L++NKI + G S++Q LDL N I +F + +L LNL
Sbjct: 119 GQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 320 ENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPS 379
+ N + + + L L+L +N+ + + +G+ + L N I +
Sbjct: 177 QYNFI-YDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 380 LASLANLTSFNVSYNNLSGSVPPLLSKKFNS 410
L NL F++ N K
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 16/115 (13%), Positives = 30/115 (26%), Gaps = 2/115 (1%)
Query: 106 RISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNL 165
+ + + +SL +N L + +L F NL L N N
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQ 262
Query: 166 QTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQH 220
+ ++ + + T + RL +L H
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHHH 317
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-47
Identities = 57/231 (24%), Positives = 111/231 (48%), Gaps = 26/231 (11%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQ-------KEFEAEAAAIGKIHHPN 592
+ +GK +G +K ++D S VA+K L ++G+ +EF+ E + ++HPN
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 593 LLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLH 652
++ L P +V +F+P G L L + + W+ ++ + + IA G+ Y+
Sbjct: 85 IVKLYGLMHNPP---RMVMEFVPCGDLYHRLLDKAHP--IKWSVKLRLMLDIALGIEYMQ 139
Query: 653 VEEN-MIHGNLTSSNVLLDEK-----TNPRIADFGLSRLMTAAANTNVIATAGTLGYRAP 706
+ ++H +L S N+ L ++ADFGLS+ +V G + AP
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV----HSVSGLLGNFQWMAP 195
Query: 707 EL--SKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKE 755
E ++ ++ K D YS +I+ +LTG+ P + + + +++ I +E
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMIREE 245
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-47
Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 13/210 (6%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRA 598
+ +G ++GT YK +VAVK L T + + F+ E + K H N+L
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
Y P+ +V + SL LH ET + IA ARG++YLH +++I
Sbjct: 88 YSTAPQ--LAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLH-AKSII 142
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI-ATAGTLGYRAPELSKLKNAN-- 715
H +L S+N+ L E +I DFGL+ + + ++ +G++ + APE+ +++++N
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 716 -TKTDVYSLGVIILELLTGKSPGEPMNGMD 744
++DVY+ G+++ EL+TG+ P +N D
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRD 232
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-47
Identities = 59/294 (20%), Positives = 102/294 (34%), Gaps = 17/294 (5%)
Query: 108 SEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQT 167
K L + +SL + + + + + +L P + P L++
Sbjct: 278 IVKFHCLANVSAMSLAGVSIKYLE--DVPKHFKWQSLSIIRCQLK-QFPTL--DLPFLKS 332
Query: 168 LDLSNNALIGAIPPSLANSTRLYRLNLSYNSL--LGSIPLSLTRLPSLSVLALQHNNLSG 225
L L+ N I L L+LS N+L G S SL L L N
Sbjct: 333 LTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI- 389
Query: 226 SVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVS-LGKLGLLQEISLSHNKIVGPIPDEL 284
+ N+ L +LQ L+ H+ + S L L + +S+
Sbjct: 390 IMSANFMGLE-----ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIF 444
Query: 285 GKLSKLQKLDLSYN-AIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNL 343
L+ L L ++ N + F N T+L L+L +L + L L +LN+
Sbjct: 445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504
Query: 344 KNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLS 397
+N + ++ LD S N +L FN++ N+++
Sbjct: 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-46
Identities = 62/291 (21%), Positives = 100/291 (34%), Gaps = 13/291 (4%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALI 176
+ + L L N+ + L + + Q+L + +
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRC-QL 319
Query: 177 GAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAG 236
P + L L L+ N SI LPSLS L L N LS S +
Sbjct: 320 KQFPT--LDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGC---CSYSD 372
Query: 237 NKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIP-DELGKLSKLQKLDL 295
+ L+ L+L N + + L LQ + H+ + L KL LD+
Sbjct: 373 LGTNSLRHLDLSFNGA-IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDI 431
Query: 296 SYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQFKGHIPE 354
SY F F +TSL +L + N + NLT L+L Q +
Sbjct: 432 SYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
Query: 355 TIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLS 405
+ + L++S N+ S L +L++ + S+N + S L
Sbjct: 492 VFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQH 542
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-43
Identities = 55/311 (17%), Positives = 99/311 (31%), Gaps = 25/311 (8%)
Query: 111 ISQLHALRKLSLHDNLLAG------PVPWSLGFLPNLRG--VYLFNNRLSGSIPPSIGNC 162
+ L L L P + L ++ L
Sbjct: 225 LQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCL 284
Query: 163 PNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNN 222
N+ + L+ ++ + + L++ L LP L L L N
Sbjct: 285 ANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNK 339
Query: 223 LSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGL--LQEISLSHNKIVGPI 280
S S L +L+L N ++ + S LG L+ + LS N + +
Sbjct: 340 GSIS-------FKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-M 391
Query: 281 PDELGKLSKLQKLDLSYNAIGGSFPV-TFTNITSLVSLNLENNRLGNKIPEGLERLQNLT 339
L +LQ LD ++ + F ++ L+ L++ L +L
Sbjct: 392 SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN 451
Query: 340 VLNLKNNQFKGHIP-ETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSG 398
L + N FK + N + + LDLS+ +L L N+S+NNL
Sbjct: 452 TLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511
Query: 399 SVPPLLSKKFN 409
++ ++
Sbjct: 512 LDSSHYNQLYS 522
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-41
Identities = 77/331 (23%), Positives = 120/331 (36%), Gaps = 25/331 (7%)
Query: 120 LSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAI 179
D L+ VP + + + + L N L S N LQ LDLS +
Sbjct: 16 YQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE 72
Query: 180 PPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKS 239
+ L L L+ N + P S + L SL L L+ G L
Sbjct: 73 DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLI---- 128
Query: 240 YQLQFLNLDHNLIAG-TIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKL----QKLD 294
L+ LN+ HN I +P L L + LS+N I ++L L + LD
Sbjct: 129 -TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLD 187
Query: 295 LSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQFKGHIP 353
+S N I F I L L L N + I + L+ L L V L +FK
Sbjct: 188 MSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERN 246
Query: 354 ETIGNIS--------GINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLS 405
I S I++ L+ + + LAN+++ +++ ++ + +
Sbjct: 247 LEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPK 305
Query: 406 KKFNSSSFVGNLQLCGYSPSTACPSLAPLSL 436
S + QL + P+ P L L+L
Sbjct: 306 HFKWQSLSIIRCQLKQF-PTLDLPFLKSLTL 335
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 7e-41
Identities = 48/296 (16%), Positives = 87/296 (29%), Gaps = 22/296 (7%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALI 176
+ + L N L +S L+ + L + + +L L L+ N +
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 177 GAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAG 236
P S + T L L L + +L +L L + HN + +
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLP--AYFSN 151
Query: 237 NKSYQLQFLNLDHNLIAGTIPVSLGKLG----LLQEISLSHNKIVGPIPDELGKLSKLQK 292
+ L ++L +N I L L + + +S N I I D+ + KL +
Sbjct: 152 LTN--LVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHE 208
Query: 293 LDLSYNAIGGS-FPVTFTNITSLVSLNLENNR---------LGNKIPEGLERLQNLTVLN 342
L L N + N+ L L I EGL +
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDE-FR 267
Query: 343 LKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSG 398
L ++ ++ + L+ + S ++ L
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ 321
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-40
Identities = 63/327 (19%), Positives = 95/327 (29%), Gaps = 35/327 (10%)
Query: 111 ISQLHALRKLSLHDNLLAG-PVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNL---- 165
I QL L+KL++ N + +P L NL V L N + +
Sbjct: 124 IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVN 183
Query: 166 QTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIP-LSLTRLPSLSVLALQHNNLS 224
+LD+S N I I +L+ L L N +I L L L V L
Sbjct: 184 LSLDMSLNP-IDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFK 242
Query: 225 GSVPNNW---GVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIP 281
++ G + L + V L + +SL+ I
Sbjct: 243 DERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED 302
Query: 282 D-------------------ELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENN 322
L L+ L L+ N S + SL L+L N
Sbjct: 303 VPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRN 360
Query: 323 RLGNKIPEGLERLQ--NLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPS- 379
L L +L L+L N + + + LD + S
Sbjct: 361 ALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSA 419
Query: 380 LASLANLTSFNVSYNNLSGSVPPLLSK 406
SL L ++SY N +
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLG 446
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-40
Identities = 62/315 (19%), Positives = 112/315 (35%), Gaps = 27/315 (8%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
LH L L L N + P S L +L + +L+ IG L+ L++
Sbjct: 76 WHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135
Query: 171 SNNALIGA-IPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLS----VLALQHNNLSG 225
++N + +P +N T L ++LSYN + L L L + N +
Sbjct: 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID- 194
Query: 226 SVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIP-------VSLGKLGLLQEISLSHNKIVG 278
+ + + +L L L N + I L L+ +
Sbjct: 195 FIQDQAF-----QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249
Query: 279 PIPDELGKLSKLQK--LDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQ 336
P + L + L+Y V F + ++ +++L + K E + +
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHF 307
Query: 337 NLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNL 396
L++ Q K P ++ + L L+ N + IS +L +L+ ++S N L
Sbjct: 308 KWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNAL 362
Query: 397 SGSVPPLLSKKFNSS 411
S S S +S
Sbjct: 363 SFSGCCSYSDLGTNS 377
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-39
Identities = 57/223 (25%), Positives = 87/223 (39%), Gaps = 8/223 (3%)
Query: 105 GRISEKISQLHALRKLSLHDNLLA--GPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNC 162
G IS K L +L L L N L+ G +S +LR + L N + +
Sbjct: 340 GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGL 398
Query: 163 PNLQTLDLSNNALIGAIPPS-LANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHN 221
LQ LD ++ L S + +L L++SY + L SL+ L + N
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
Query: 222 NLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIP 281
+ + V A + L FL+L + L LQ +++SHN ++
Sbjct: 459 SFKDNTL--SNVFANTTN--LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514
Query: 282 DELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRL 324
+L L LD S+N I S + SL NL NN +
Sbjct: 515 SHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-38
Identities = 61/273 (22%), Positives = 102/273 (37%), Gaps = 19/273 (6%)
Query: 153 GSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPS 212
GS+ P I PN+ T + L +P + +ST+ ++LS+N L S +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKL-SKVPDDIPSSTK--NIDLSFNPLKILKSYSFSNFSE 57
Query: 213 LSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLS 272
L L L + G L L L N I P S L L+ +
Sbjct: 58 LQWLDLSRCEIETIED---KAWHGLHH--LSNLILTGNPIQSFSPGSFSGLTSLENLVAV 112
Query: 273 HNKIVGPIPDELGKLSKLQKLDLSYNAIGG-SFPVTFTNITSLVSLNLENNRLGNKIPEG 331
K+ +G+L L+KL++++N I P F+N+T+LV ++L N +
Sbjct: 113 ETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND 172
Query: 332 LERLQNLT----VLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISP-SLASLANL 386
L+ L+ L++ N + I +++L L N + I L +LA L
Sbjct: 173 LQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGL 231
Query: 387 TSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQL 419
+ + F S G +
Sbjct: 232 HVHRLILGEFKDERN---LEIFEPSIMEGLCDV 261
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-18
Identities = 23/124 (18%), Positives = 41/124 (33%), Gaps = 1/124 (0%)
Query: 102 RLGGRISEKISQLHALRKLSLHDN-LLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIG 160
L +L L + N + NL + L +L
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494
Query: 161 NCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQH 220
LQ L++S+N L+ L L+ S+N + S + SL+ L +
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
Query: 221 NNLS 224
N+++
Sbjct: 555 NSVA 558
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-46
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 541 EIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
E++GK +G A K T E G + +K L + Q+ F E + + HPN+L
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF--- 72
Query: 600 YLG--PKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
+G K ++L + +++ G+L + + + W+ R+S A IA G+ YLH N
Sbjct: 73 -IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLH-SMN 128
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMT-------------AAANTNVIATAGTLGY 703
+IH +L S N L+ E N +ADFGL+RLM G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 704 RAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741
APE+ ++ + K DV+S G+++ E++ +
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYL 226
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-45
Identities = 51/225 (22%), Positives = 92/225 (40%), Gaps = 25/225 (11%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
E +GK YG ++ + G VAVK + K E E + H N+L A
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEK-SWFRETELYNTVMLRHENILGFIASD 71
Query: 601 LGPKGEK---LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE-- 655
+ + L+ + GSL +L ++ + + I + IA GL +LH+E
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 656 -----NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT---AGTLGYRAPE 707
+ H +L S N+L+ + IAD GL+ + + + N + GT Y APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 708 L------SKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLP 746
+ ++ + D+++ G+++ E+ + P
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-45
Identities = 58/315 (18%), Positives = 108/315 (34%), Gaps = 22/315 (6%)
Query: 107 ISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQ 166
I E + + + D+ L + N++ + L N LS + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 167 TLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGS 226
L+LS+N L L + + L L+L+ N + L PS+ L +NN+S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113
Query: 227 VPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVG-PIPDELG 285
V + G + + L +N I + G +Q + L N+I +
Sbjct: 114 VSCSRGQ-------GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166
Query: 286 KLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKN 345
L+ L+L YN I L +L+L +N+L + + +T ++L+N
Sbjct: 167 SSDTLEHLNLQYNFI-YDVK-GQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRN 223
Query: 346 NQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLS 405
N+ I + + + DL N F + +
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLTGQNE 280
Query: 406 KKFNSSSFVGNLQLC 420
++ + C
Sbjct: 281 EECTVPTLGHYGAYC 295
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 6e-40
Identities = 56/280 (20%), Positives = 102/280 (36%), Gaps = 22/280 (7%)
Query: 154 SIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSL 213
+I N + +++++L A+ ++ + L+LS N L L L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 214 SVLALQHNNLSGSVPNNWGV-------LAGNK------SYQLQFLNLDHNLIAGTIPVSL 260
+L L N L + + L N ++ L+ +N I+ VS
Sbjct: 61 ELLNLSSNVLY-ETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISR---VSC 116
Query: 261 GKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGG-SFPVTFTNITSLVSLNL 319
+ + I L++NKI + G S++Q LDL N I +F + +L LNL
Sbjct: 117 SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 320 ENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPS 379
+ N + + + L L+L +N+ + + +G+ + L N I +
Sbjct: 177 QYNFI-YDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 380 LASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQL 419
L NL F++ N K V +
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-30
Identities = 32/311 (10%), Positives = 81/311 (26%), Gaps = 29/311 (9%)
Query: 111 ISQLHALRKLSLHDNLLAG-PVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLD 169
++ L L N + L + L N + + + L+TLD
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLD 197
Query: 170 LSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229
LS+N + + P ++ + ++L N L I +L +L L+ N
Sbjct: 198 LSSNK-LAFMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLR 255
Query: 230 NWGV------------------LAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISL 271
++ + + +L L+
Sbjct: 256 DFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEH 315
Query: 272 SHNKI----VGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNK 327
+ + E ++ +++D + ++L + L +
Sbjct: 316 ALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQ 375
Query: 328 IPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPS-LASLANL 386
+ G L + + + S + L + +
Sbjct: 376 VSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAI 434
Query: 387 TSFNVSYNNLS 397
+++ + +
Sbjct: 435 RDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 6e-20
Identities = 29/284 (10%), Positives = 70/284 (24%), Gaps = 5/284 (1%)
Query: 106 RISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNL 165
+ + + +SL +N L + +L F NL L N N
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQ 262
Query: 166 QTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSG 225
+ ++ + + T + RL +L + G
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQG 322
Query: 226 SVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELG 285
S N++ + + ++ I + + + + +
Sbjct: 323 SETERLECERENQA-RQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRR 381
Query: 286 KLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNK-IPEGLERLQNLTVLNLK 344
++L + L L R + + + + ++
Sbjct: 382 AHAELDGTLQQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMY 440
Query: 345 NNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTS 388
++ E + DL+ + + NL S
Sbjct: 441 QHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNLAS 484
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-45
Identities = 63/235 (26%), Positives = 96/235 (40%), Gaps = 35/235 (14%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
E++G+ YG YK +L D VAVK + E + + H N+
Sbjct: 19 ELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN-EKNIYRVPLMEHDNIARFIVGD 76
Query: 601 LGPKG----EKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
E LLV ++ P GSL +L +W + +A + RGL YLH E
Sbjct: 77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 657 --------MIHGNLTSSNVLLDEKTNPRIADFGLSRLM-------TAAANTNVIATAGTL 701
+ H +L S NVL+ I+DFGLS + + I+ GT+
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192
Query: 702 GYRAPE-------LSKLKNANTKTDVYSLGVIILELLTGKS---PGEPMNGMDLP 746
Y APE L ++A + D+Y+LG+I E+ + PGE + +
Sbjct: 193 RYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-45
Identities = 58/248 (23%), Positives = 92/248 (37%), Gaps = 32/248 (12%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
+ +GK YG + G +VAVK T + E E + H N+L A
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT-TEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 601 LGPKGEK---LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE-- 655
+ G L+ D+ GSL +L + ++ + + +A GL +LH E
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 656 -----NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT---AGTLGYRAPE 707
+ H +L S N+L+ + IAD GL+ + N I GT Y PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 708 L------SKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEV 761
+ + D+YS G+I+ E+ G + LP +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY-------HDLVPSD 269
Query: 762 FDLELMRD 769
E MR+
Sbjct: 270 PSYEDMRE 277
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 25/225 (11%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
E +GK +G ++ G EVAVK + EAE + H N+L A
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 601 LGPKGEK---LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE-- 655
G LV D+ GSL +L+ V + +A+ A GL +LH+E
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 656 -----NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT---AGTLGYRAPE 707
+ H +L S N+L+ + IAD GL+ +A +T IA GT Y APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 708 L------SKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLP 746
+ K + + D+Y++G++ E+ S G LP
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-44
Identities = 49/219 (22%), Positives = 87/219 (39%), Gaps = 24/219 (10%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRA 598
E++GK +G Y EVA++ + + K F+ E A + H N++
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
+ P L ++ +L S + + +++ IA I +G+ YLH + +
Sbjct: 97 ACMSP--PHLAIITSLCKGRTLYSVVR--DAKIVLDVNKTRQIAQEIVKGMGYLH-AKGI 151
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA----NTNVIATAGTLGYRAPELSKLKN 713
+H +L S NV D I DFGL + + G L + APE+ + +
Sbjct: 152 LHKDLKSKNVFYDNGK-VVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 714 A---------NTKTDVYSLGVIILELLTGKSPGEPMNGM 743
+ +DV++LG I EL + P +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE 249
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-43
Identities = 75/288 (26%), Positives = 126/288 (43%), Gaps = 27/288 (9%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
++ L L +L + N ++ L L NL + NN++S P +G NL L L
Sbjct: 173 LANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSL 228
Query: 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNN 230
+ N L +LA+ T L L+L+ N + PLS L L+ L L N +S P
Sbjct: 229 NGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNISP-- 282
Query: 231 WGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKL 290
LAG L L L+ N + P + L L ++L N I P + L+KL
Sbjct: 283 ---LAGLT--ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKL 333
Query: 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKG 350
Q+L N + S + N+T++ L+ +N++ + P L L +T L L + +
Sbjct: 334 QRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389
Query: 351 HIPETIGNISGINQLDLSENDFTGEISPS-LASLANLTSFNVSYNNLS 397
N+S + +N I+P+ ++ + T ++++N S
Sbjct: 390 APVNYKANVS---IPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-41
Identities = 74/312 (23%), Positives = 117/312 (37%), Gaps = 44/312 (14%)
Query: 109 EKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTL 168
+ L K L + V L + + + + NL +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73
Query: 169 DLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVP 228
+ SNN L P L N T+L + ++ N + PL+ L +L+ L L +N ++ P
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLA--NLTNLTGLTLFNNQITDIDP 129
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVS-------------------LGKLGLLQEI 269
L L L L N I+ +S L L L+ +
Sbjct: 130 -----LKNLT--NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERL 182
Query: 270 SLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIP 329
+S NK+ L KL+ L+ L + N I P +T+L L+L N+L +
Sbjct: 183 DISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--I 236
Query: 330 EGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSF 389
L L NLT L+L NNQ P + ++ + +L L N + LA L LT+
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNL 292
Query: 390 NVSYNNLSGSVP 401
++ N L P
Sbjct: 293 ELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-35
Identities = 64/266 (24%), Positives = 103/266 (38%), Gaps = 22/266 (8%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
+ L L +LSL+ N L L L NL + L NN++S P + L L L
Sbjct: 217 LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 272
Query: 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNN 230
N + LA T L L L+ N L P+S L +L+ L L NN+S P
Sbjct: 273 GANQISN--ISPLAGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISP-- 326
Query: 231 WGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKL 290
++ +LQ L +N + + SL L + +S HN+I P L L+++
Sbjct: 327 ---VSSLT--KLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRI 377
Query: 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKG 350
+L L+ A + N++ ++ L P + + T ++ N
Sbjct: 378 TQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITWNLPSY 435
Query: 351 HIPETIGNISGINQLDLSENDFTGEI 376
E S + F+G +
Sbjct: 436 -TNEVSYTFSQPVTIGKGTTTFSGTV 460
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-42
Identities = 77/311 (24%), Positives = 122/311 (39%), Gaps = 27/311 (8%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDL 170
+ H ++KL + N + P +P L + L N LS S+P I N P L TL +
Sbjct: 90 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSM 148
Query: 171 SNNALIGAIPPS-LANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229
SNN + I +T L L LS N L + LSL +PSL + +N LS ++
Sbjct: 149 SNN-NLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS-TLAI 203
Query: 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSK 289
++ L+ HN I + + L + L HN + L
Sbjct: 204 P---------IAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT--AWLLNYPG 249
Query: 290 LQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFK 349
L ++DLSYN + F + L L + NNRL + + + L VL+L +N
Sbjct: 250 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL 308
Query: 350 GHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFN 409
H+ + L L N + S + L + +S+N+ + L +
Sbjct: 309 -HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDCNSLRALFRNVA 364
Query: 410 SSSFVGNLQLC 420
+ Q C
Sbjct: 365 RPAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-40
Identities = 60/304 (19%), Positives = 111/304 (36%), Gaps = 36/304 (11%)
Query: 114 LHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSN 172
L+ + ++ ++ + L + + L + ++ I +Q L +
Sbjct: 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 102
Query: 173 NALIGAIPPS-LANSTRLYRLNLSYNSLLGSIPLSL-TRLPSLSVLALQHNNLSGSVPNN 230
N I +PP N L L L N L S+P + P L+ L++ +NNL +
Sbjct: 103 N-AIRYLPPHVFQNVPLLTVLVLERND-LSSLPRGIFHNTPKLTTLSMSNNNLE-RIE-- 157
Query: 231 WGVLAGNKSYQLQFLNLDHNLIAGTIPV----SLGKLGL-------------LQEISLSH 273
S LQ L L N + + + SL + ++E+ SH
Sbjct: 158 DDTFQATTS--LQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASH 214
Query: 274 NKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLE 333
N I + + +L L L +N + + N LV ++L N L +
Sbjct: 215 NSINV-VRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFV 269
Query: 334 RLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSY 393
++Q L L + NN+ + I + LDLS N + + L + + +
Sbjct: 270 KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDH 327
Query: 394 NNLS 397
N++
Sbjct: 328 NSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-35
Identities = 57/290 (19%), Positives = 118/290 (40%), Gaps = 24/290 (8%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLD 169
+ + + + L N + V N+ + +P ++ + ++ L+
Sbjct: 17 LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLN 75
Query: 170 LSNNALIGAIPP-SLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVP 228
L++ I I + A + + +L + +N++ P +P L+VL L+ N+LS S+P
Sbjct: 76 LNDLQ-IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLP 133
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLS 288
G+ L L++ +N + + LQ + LS N++ + L +
Sbjct: 134 R--GIFHNTPK--LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--LSLIP 186
Query: 289 KLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQF 348
L ++SYN + T ++ L+ +N + N + + LT+L L++N
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGPV--NVELTILKLQHNNL 238
Query: 349 KGHIPETIGNISGINQLDLSENDFTGEISP-SLASLANLTSFNVSYNNLS 397
+ N G+ ++DLS N+ +I + L +S N L
Sbjct: 239 T-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 50/278 (17%), Positives = 97/278 (34%), Gaps = 24/278 (8%)
Query: 123 HDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPS 182
+ +L + V++ N + + N+ + +P +
Sbjct: 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNS-TMRKLPAA 63
Query: 183 -LANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQ 241
L + ++ LNL+ + + ++ L + N + +P V
Sbjct: 64 LLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPP--HVFQNVPL-- 118
Query: 242 LQFLNLDHNLIAGTIPVSL-GKLGLLQEISLSHNKIVGPIPDE-LGKLSKLQKLDLSYNA 299
L L L+ N ++ ++P + L +S+S+N + I D+ + LQ L LS N
Sbjct: 119 LTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNR 176
Query: 300 IGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNI 359
+ V + I SL N+ N L L + L+ +N +
Sbjct: 177 LTH---VDLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSIN-VVRG--PVN 225
Query: 360 SGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLS 397
+ L L N+ T + L + L ++SYN L
Sbjct: 226 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE 261
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 40/232 (17%), Positives = 87/232 (37%), Gaps = 16/232 (6%)
Query: 172 NNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNW 231
I +L Y +++ + L + ++ +++ + +P
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPA-- 62
Query: 232 GVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQ 291
+L + Q++ LNL+ I + +Q++ + N I P + L
Sbjct: 63 ALLDSFR--QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 120
Query: 292 KLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQFKG 350
L L N + F N L +L++ NN L +I + + +L L L +N+
Sbjct: 121 VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT- 178
Query: 351 HIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402
H+ + I + ++S N + +LA + + S+N+++ V
Sbjct: 179 HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG 222
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 47/169 (27%), Positives = 70/169 (41%), Gaps = 17/169 (10%)
Query: 109 EKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTL 168
++ A+ +L N + L + L +N L+ + N P L +
Sbjct: 199 STLAIPIAVEELDASHNSINVV---RGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEV 253
Query: 169 DLSNNALIGAIPP-SLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSV 227
DLS N + I RL RL +S N L ++ L +P+L VL L HN+L V
Sbjct: 254 DLSYNE-LEKIMYHPFVKMQRLERLYISNNR-LVALNLYGQPIPTLKVLDLSHNHLL-HV 310
Query: 228 PNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKI 276
N +L+ L LDHN I T+ L L+ ++LSHN
Sbjct: 311 ERNQPQF-----DRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 15/69 (21%), Positives = 27/69 (39%), Gaps = 4/69 (5%)
Query: 107 ISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQ 166
++ + L+ L L N L V + L +YL +N + ++ L+
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLK 342
Query: 167 TLDLSNNAL 175
L LS+N
Sbjct: 343 NLTLSHNDW 351
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-42
Identities = 51/303 (16%), Positives = 99/303 (32%), Gaps = 29/303 (9%)
Query: 106 RISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNC--P 163
+ L ++ D W N + L + + + P
Sbjct: 24 ALRPYHDVLSQWQRHYNADRNRWHS-AWRQANSNNPQIETRTGRALK-ATADLLEDATQP 81
Query: 164 NLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNL 223
L+L + L P + L + + L +P ++ + L L L N L
Sbjct: 82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNPL 139
Query: 224 SGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDE 283
++P + L +L+ L++ +P L E
Sbjct: 140 R-ALPASIASLN-----RLRELSIRACPELTELPEPLASTDA---------------SGE 178
Query: 284 LGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNL 343
L LQ L L + I S P + N+ +L SL + N+ L + + + L L L+L
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKLEELDL 236
Query: 344 KNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPL 403
+ + P G + + +L L + + + L L ++ +P L
Sbjct: 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296
Query: 404 LSK 406
+++
Sbjct: 297 IAQ 299
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 37/259 (14%), Positives = 84/259 (32%), Gaps = 22/259 (8%)
Query: 153 GSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPS 212
GS + + L + + L+ R Y + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNN 57
Query: 213 LSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLS 272
+ L + + L L + P +L LQ +++
Sbjct: 58 PQIETRTGRALK-ATADLLEDA---TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTID 112
Query: 273 HNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNL-ENNRLGN----- 326
++ +PD + + + L+ L L+ N + + P + ++ L L++ L
Sbjct: 113 AAGLME-LPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPL 170
Query: 327 ---KIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASL 383
+ L NL L L+ + +P +I N+ + L + + + + P++ L
Sbjct: 171 ASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHL 228
Query: 384 ANLTSFNVSYNNLSGSVPP 402
L ++ + PP
Sbjct: 229 PKLEELDLRGCTALRNYPP 247
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 44/282 (15%), Positives = 91/282 (32%), Gaps = 26/282 (9%)
Query: 132 PWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYR 191
+Y + + D + ANS +
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNP-Q 59
Query: 192 LNLSYNSLLGSIPLSLTRL--PSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDH 249
+ L + L P L L+ L P+ L+ LQ + +D
Sbjct: 60 IETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLS-----HLQHMTIDA 113
Query: 250 NLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYN--------AIG 301
+ +P ++ + L+ ++L+ N + +P + L++L++L + +
Sbjct: 114 AGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLA 171
Query: 302 -GSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNIS 360
+ +L SL LE + +P + LQNL L ++N+ + I ++
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLP 229
Query: 361 GINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402
+ +LDL P A L + + ++P
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPL 271
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 25/122 (20%), Positives = 55/122 (45%), Gaps = 2/122 (1%)
Query: 109 EKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTL 168
I+ L L+ L + ++ L+ + ++ LP L + L + PP G L+ L
Sbjct: 200 ASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258
Query: 169 DLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVP 228
L + + + +P + T+L +L+L L +P + +LP+ ++ + +L +
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV-PPHLQAQLD 317
Query: 229 NN 230
+
Sbjct: 318 QH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 19/104 (18%), Positives = 34/104 (32%), Gaps = 2/104 (1%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFN-NRLSGSIPPSIGNCPNLQTLD 169
I L L +L L P G L+ + L + + L ++P I L+ LD
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLD 283
Query: 170 LSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSL 213
L + +P +A + + + P+
Sbjct: 284 LRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 157 bits (397), Expect = 2e-40
Identities = 78/313 (24%), Positives = 121/313 (38%), Gaps = 27/313 (8%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDL 170
+ H ++KL + N + P +P L + L N LS S+P I N P L TL +
Sbjct: 96 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSM 154
Query: 171 SNNALIGAIPPS-LANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229
SNN + I +T L L LS N L + LSL +PSL + +N LS ++
Sbjct: 155 SNNN-LERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS-TLAI 209
Query: 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSK 289
++ L+ HN I V L + L HN + L
Sbjct: 210 P---------IAVEELDASHNSINV---VRGPVNVELTILKLQHNNLTDT--AWLLNYPG 255
Query: 290 LQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFK 349
L ++DLSYN + F + L L + NNRL + + + L VL+L +N
Sbjct: 256 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL 314
Query: 350 GHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFN 409
H+ + L L N + S + L + +S+N+ + L +
Sbjct: 315 -HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDCNSLRALFRNVA 370
Query: 410 SSSFVGNLQLCGY 422
+ Q C
Sbjct: 371 RPAVDDADQHCKI 383
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-38
Identities = 60/304 (19%), Positives = 111/304 (36%), Gaps = 36/304 (11%)
Query: 114 LHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSN 172
L+ + ++ ++ + L + + L + ++ I +Q L +
Sbjct: 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 108
Query: 173 NALIGAIPPS-LANSTRLYRLNLSYNSLLGSIPLSL-TRLPSLSVLALQHNNLSGSVPNN 230
N I +PP N L L L N L S+P + P L+ L++ +NNL +
Sbjct: 109 N-AIRYLPPHVFQNVPLLTVLVLERND-LSSLPRGIFHNTPKLTTLSMSNNNLE-RIE-- 163
Query: 231 WGVLAGNKSYQLQFLNLDHNLIAGTIPV----SLGKLGL-------------LQEISLSH 273
S LQ L L N + + + SL + ++E+ SH
Sbjct: 164 DDTFQATTS--LQNLQLSSNRLT-HVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASH 220
Query: 274 NKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLE 333
N I + + +L L L +N + + N LV ++L N L +
Sbjct: 221 NSINV-VRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFV 275
Query: 334 RLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSY 393
++Q L L + NN+ + I + LDLS N + + L + + +
Sbjct: 276 KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDH 333
Query: 394 NNLS 397
N++
Sbjct: 334 NSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-34
Identities = 58/294 (19%), Positives = 119/294 (40%), Gaps = 24/294 (8%)
Query: 107 ISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNL 165
I + + + + L N + V N+ + +P ++ + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 166 QTLDLSNNALIGAIPP-SLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLS 224
+ L+L++ I I + A + + +L + +N++ P +P L+VL L+ N+LS
Sbjct: 78 ELLNLNDLQ-IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 225 GSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDEL 284
S+P G+ L L++ +N + + LQ + LS N++ + L
Sbjct: 137 -SLPR--GIFHNTPK--LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--L 188
Query: 285 GKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLK 344
+ L ++SYN + T ++ L+ +N + N + + LT+L L+
Sbjct: 189 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGPV--NVELTILKLQ 240
Query: 345 NNQFKGHIPETIGNISGINQLDLSENDFTGEISP-SLASLANLTSFNVSYNNLS 397
+N + N G+ ++DLS N+ +I + L +S N L
Sbjct: 241 HNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 7e-27
Identities = 42/235 (17%), Positives = 89/235 (37%), Gaps = 18/235 (7%)
Query: 170 LSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229
I +L Y +++ + L + ++ +++ + +P
Sbjct: 10 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPA 68
Query: 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSK 289
+L + Q++ LNL+ I + +Q++ + N I P +
Sbjct: 69 --ALLDSFR--QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPL 124
Query: 290 LQKLDLSYNAIGGSFPV-TFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQ 347
L L L N + S P F N L +L++ NN L +I + + +L L L +N+
Sbjct: 125 LTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNR 182
Query: 348 FKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402
H+ + I + ++S N + +LA + + S+N+++ V
Sbjct: 183 LT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG 228
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-26
Identities = 43/244 (17%), Positives = 77/244 (31%), Gaps = 16/244 (6%)
Query: 154 SIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSL 213
I ++ + + + +++ L +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 214 SVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSH 273
+L L + + A + +Q L + N I P + LL + L
Sbjct: 78 ELLNLNDLQIE-EIDTY--AFAYAHT--IQKLYMGFNAIRYLPPHVFQNVPLLTVLVLER 132
Query: 274 NKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLE 333
N + KL L +S N + TF TSL +L L +NRL + L
Sbjct: 133 NDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-THVDLSL- 190
Query: 334 RLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSY 393
+ +L N+ N T+ + +LD S N + + LT + +
Sbjct: 191 -IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQH 241
Query: 394 NNLS 397
NNL+
Sbjct: 242 NNLT 245
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 5e-22
Identities = 43/214 (20%), Positives = 78/214 (36%), Gaps = 6/214 (2%)
Query: 193 NLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLI 252
YN ++ + + + + ++ +
Sbjct: 4 QQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM 63
Query: 253 AGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNIT 312
L ++ ++L+ +I +QKL + +NAI P F N+
Sbjct: 64 RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 123
Query: 313 SLVSLNLENNRLGNKIPEGL-ERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSEND 371
L L LE N L + +P G+ LT L++ NN + +T + + L LS N
Sbjct: 124 LLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 182
Query: 372 FTGEISPSLASLANLTSFNVSYNNLSGSVPPLLS 405
T + SL + +L NVSYN LS ++ ++
Sbjct: 183 LT-HVDLSL--IPSLFHANVSYNLLS-TLAIPIA 212
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 1e-19
Identities = 57/279 (20%), Positives = 95/279 (34%), Gaps = 29/279 (10%)
Query: 109 EKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTL 168
++ A+ +L N + V L + L +N L+ + N P L +
Sbjct: 205 STLAIPIAVEELDASHNSINV-VR--GPVNVELTILKLQHNNLTD--TAWLLNYPGLVEV 259
Query: 169 DLSNNALIGAIPP-SLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSV 227
DLS N + I RL RL +S N L ++ L +P+L VL L HN+L V
Sbjct: 260 DLSYNE-LEKIMYHPFVKMQRLERLYISNNR-LVALNLYGQPIPTLKVLDLSHNHLL-HV 316
Query: 228 PNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKL 287
N +L+ L LDHN I T+ L L+ ++LSHN L
Sbjct: 317 ERNQPQF-----DRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--F 366
Query: 288 SKLQKLDLSYNAIGGSFPVTFTN----------ITSLVSLNLENNRLGNKIPEGLERLQN 337
+ + + + + + + K+ R
Sbjct: 367 RNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSA 426
Query: 338 LTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEI 376
+N + + + G QL+ N+ E+
Sbjct: 427 TDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEV 465
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 38/305 (12%), Positives = 85/305 (27%), Gaps = 16/305 (5%)
Query: 107 ISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQ 166
++ + L+ L L N L V + L +YL +N + ++ L+
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLK 348
Query: 167 TLDLSNNAL----IGAIPPSLAN-STRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHN 221
L LS+N + A+ ++A + + + L LQ+
Sbjct: 349 NLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYI 408
Query: 222 NLSGSV--PNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGP 279
L+ V +L H + G L E++ ++
Sbjct: 409 ALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQL 468
Query: 280 IPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLT 339
+++ + LQ L + + + L + N++ + E + L
Sbjct: 469 TNEQIQQEQLLQGLHAEIDTNLRRYRLPK---DGLARSSDNLNKVFTHLKE--RQAFKLR 523
Query: 340 VLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGS 399
+ + ET L+ ++ + + +
Sbjct: 524 ETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVKQLEAKKNR 583
Query: 400 VPPLL 404
P
Sbjct: 584 NPDTR 588
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 6e-39
Identities = 66/292 (22%), Positives = 118/292 (40%), Gaps = 18/292 (6%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNAL 175
R L L N + P+L + L N +S ++ P N NL+TL L +N
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSN-R 91
Query: 176 IGAIPP-SLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVL 234
+ IP + L +L++S N ++ + L +L L + N+L + +
Sbjct: 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISH--RAF 148
Query: 235 AGNKSYQLQFLNLDHNLIAGTIPV-SLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKL 293
+G S L+ L L+ + +IP +L L L + L H I +L +L+ L
Sbjct: 149 SGLNS--LEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVL 205
Query: 294 DLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQFKGHI 352
++S+ + +L SL++ + L +P + L L LNL N I
Sbjct: 206 EISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYNPIS-TI 263
Query: 353 PETI-GNISGINQLDLSENDFTGEISP-SLASLANLTSFNVSYNNLSGSVPP 402
++ + + ++ L + P + L L NVS N L+ ++
Sbjct: 264 EGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEE 313
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-38
Identities = 71/291 (24%), Positives = 118/291 (40%), Gaps = 15/291 (5%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDL 170
+ L +L L++N+++ P + L NLR + L +NRL IP + NL LD+
Sbjct: 53 ASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDI 111
Query: 171 SNNALIGAIPP-SLANSTRLYRLNLSYNSLLGSIP-LSLTRLPSLSVLALQHNNLSGSVP 228
S N I + + L L + N L I + + L SL L L+ NL+ S+P
Sbjct: 112 SEN-KIVILLDYMFQDLYNLKSLEVGDND-LVYISHRAFSGLNSLEQLTLEKCNLT-SIP 168
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLS 288
L+ L L L H I S +L L+ + +SH + +
Sbjct: 169 TEA--LSHLHG--LIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGL 224
Query: 289 KLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQ 347
L L +++ + + ++ L LNL N + I L L L + L Q
Sbjct: 225 NLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIST-IEGSMLHELLRLQEIQLVGGQ 283
Query: 348 FKGHIPETIGNISGINQLDLSENDFTGEISPSL-ASLANLTSFNVSYNNLS 397
P ++ + L++S N T + S+ S+ NL + + N L+
Sbjct: 284 LAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-35
Identities = 60/274 (21%), Positives = 107/274 (39%), Gaps = 20/274 (7%)
Query: 136 GFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNALIGAIPP-SLANSTRLYRLN 193
G R + L NR+ ++ + P+L+ L+L+ N + A+ P + N L L
Sbjct: 29 GIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENI-VSAVEPGAFNNLFNLRTLG 86
Query: 194 LSYNSLLGSIP-LSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLI 252
L N L IP T L +L+ L + N + + + + L+ L + N +
Sbjct: 87 LRSNR-LKLIPLGVFTGLSNLTKLDISENKIV-ILLD--YMFQDLY--NLKSLEVGDNDL 140
Query: 253 AGTIPV-SLGKLGLLQEISLSHNKIVGPIPDE-LGKLSKLQKLDLSYNAIGGSFPVTFTN 310
I + L L++++L + IP E L L L L L + I +F
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNINAIRDYSFKR 198
Query: 311 ITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPE-TIGNISGINQLDLSE 369
+ L L + + + + NLT L++ + +P + ++ + L+LS
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSY 257
Query: 370 NDFTGEISP-SLASLANLTSFNVSYNNLSGSVPP 402
N + I L L L + L+ V P
Sbjct: 258 NPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEP 289
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-32
Identities = 58/248 (23%), Positives = 97/248 (39%), Gaps = 12/248 (4%)
Query: 157 PSIGNC-PNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSV 215
P C + + + A+P + TR L+L N + P L
Sbjct: 4 PPRCECSAQDRAVLCHRKRFV-AVPEGIPTETR--LLDLGKNRIKTLNQDEFASFPHLEE 60
Query: 216 LALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNK 275
L L N +S +V G + L+ L L N + L L ++ +S NK
Sbjct: 61 LELNENIVS-AVEP--GAFNNLFN--LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENK 115
Query: 276 IVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LER 334
IV + L L+ L++ N + F+ + SL L LE L IP L
Sbjct: 116 IVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL-TSIPTEALSH 174
Query: 335 LQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYN 394
L L VL L++ + + + L++S + ++P+ NLTS ++++
Sbjct: 175 LHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234
Query: 395 NLSGSVPP 402
NL+ +VP
Sbjct: 235 NLT-AVPY 241
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 28/122 (22%), Positives = 48/122 (39%), Gaps = 6/122 (4%)
Query: 106 RISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPN 164
++ L LS+ L ++ L LR + L N +S +I S+
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLR 273
Query: 165 LQTLDLSNNALIGAIPP-SLANSTRLYRLNLSYNSLLGSIPLSL-TRLPSLSVLALQHNN 222
LQ + L + + P + L LN+S N L ++ S+ + +L L L N
Sbjct: 274 LQEIQLVGGQ-LAVVEPYAFRGLNYLRVLNVSGNQ-LTTLEESVFHSVGNLETLILDSNP 331
Query: 223 LS 224
L+
Sbjct: 332 LA 333
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 58/244 (23%), Positives = 102/244 (41%), Gaps = 15/244 (6%)
Query: 136 GFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNAL--IGAIPPSLANSTRLYRL 192
G + + L +N+L S+P + L L LS+N L G S +T L L
Sbjct: 25 GIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYL 83
Query: 193 NLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLI 252
+LS+N ++ ++ + L L L QH+NL + + V ++ L +L++ H
Sbjct: 84 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMS-EFSVFLSLRN--LIYLDISHTHT 138
Query: 253 AGTIPVSLGKLGLLQEISLSHNKIVGPIPDE-LGKLSKLQKLDLSYNAIGGSFPVTFTNI 311
L L+ + ++ N + +L L LDLS + P F ++
Sbjct: 139 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 198
Query: 312 TSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQFKGHIPETI--GNISGINQLDLS 368
+SL LN+ +N + + L +L VL+ N + S + L+L+
Sbjct: 199 SSLQVLNMSHNNF-FSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLT 256
Query: 369 ENDF 372
+NDF
Sbjct: 257 QNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 57/238 (23%), Positives = 90/238 (37%), Gaps = 13/238 (5%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLS--GSIPPSIGNCPNLQTLDLSNNA 174
+L L N L L L + L +N LS G S +L+ LDLS N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 175 LIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSL-TRLPSLSVLALQHNNLSGSVPNNWGV 233
+I + + +L L+ +++L S+ L +L L + H + N G+
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFN--GI 145
Query: 234 LAGNKSYQLQFLNLDHNLIAGTI-PVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQK 292
G S L+ L + N P +L L + LS ++ P LS LQ
Sbjct: 146 FNGLSS--LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 203
Query: 293 LDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGL--ERLQNLTVLNLKNNQF 348
L++S+N + + SL L+ N + + +L LNL N F
Sbjct: 204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT-SKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 52/217 (23%), Positives = 83/217 (38%), Gaps = 9/217 (4%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGF--LPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLD 169
+L L KLSL N L+ S +L+ + L N + ++ + L+ LD
Sbjct: 49 DKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD 107
Query: 170 LSNNALIGAIPPSL-ANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVP 228
++ L S+ + L L++S+ + L SL VL + N+ +
Sbjct: 108 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 167
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLS 288
+ L FL+L + P + L LQ +++SHN L+
Sbjct: 168 --PDIFTE--LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 223
Query: 289 KLQKLDLSYNAIGGSFPVTFTNI-TSLVSLNLENNRL 324
LQ LD S N I S + +SL LNL N
Sbjct: 224 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 61/261 (23%), Positives = 108/261 (41%), Gaps = 18/261 (6%)
Query: 144 VYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPS-LANSTRLYRLNLSYNSL--L 200
+ + L+ S+P I + L+L +N + ++P T+L +L+LS N L
Sbjct: 12 IRCNSKGLT-SVPTGIP--SSATRLELESN-KLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 201 GSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSL 260
G S SL L L N + ++ +N+ L QL+ L+ H+ + S+
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLE-----QLEHLDFQHSNLKQMSEFSV 121
Query: 261 -GKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSF-PVTFTNITSLVSLN 318
L L + +SH LS L+ L ++ N+ +F P FT + +L L+
Sbjct: 122 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181
Query: 319 LENNRLGNKIPEG-LERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEIS 377
L +L + L +L VLN+ +N F ++ + LD S N
Sbjct: 182 LSQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 240
Query: 378 PSLASL-ANLTSFNVSYNNLS 397
L ++L N++ N+ +
Sbjct: 241 QELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 38/177 (21%), Positives = 59/177 (33%), Gaps = 14/177 (7%)
Query: 106 RISEKISQLHALRKLSLHDNLLAGPVPWSL-GFLPNLRGVYLFNNRLSGSIPPSI-GNCP 163
+S L L L + L +S+ L NL + + + I
Sbjct: 92 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLS 150
Query: 164 NLQTLDLSNNALIGAIPP-SLANSTRLYRLNLSYNSLLGSIP-LSLTRLPSLSVLALQHN 221
+L+ L ++ N+ P L L+LS L + + L SL VL + HN
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ-LEQLSPTAFNSLSSLQVLNMSHN 209
Query: 222 NLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSL--GKLGLLQEISLSHNKI 276
N S+ S LQ L+ N I T L ++L+ N
Sbjct: 210 NFF-SLDT--FPYKCLNS--LQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 36/194 (18%), Positives = 66/194 (34%), Gaps = 36/194 (18%)
Query: 212 SLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISL 271
S + + L+ SVP L L+ N + KL L ++SL
Sbjct: 8 SGTEIRCNSKGLT-SVP-------TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSL 59
Query: 272 SHNKI--VGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIP 329
S N + G + L+ LDLS+N + + F + L L+ +++ L
Sbjct: 60 SSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE 118
Query: 330 EGL-ERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTS 388
+ L+NL L++ + + F G L++L
Sbjct: 119 FSVFLSLRNLIYLDISHTHTR----------------VAFNGIFNG--------LSSLEV 154
Query: 389 FNVSYNNLSGSVPP 402
++ N+ + P
Sbjct: 155 LKMAGNSFQENFLP 168
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-35
Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 15/241 (6%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171
S + L L + L L L +N+ + S + P+L+ LDLS
Sbjct: 301 SYNFGWQHLELVNCKFGQFPTLKLKSLKRL---TFTSNKGGNA--FSEVDLPSLEFLDLS 355
Query: 172 NNAL--IGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229
N L G S +T L L+LS+N ++ ++ + L L L QH+NL +
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSE 413
Query: 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDE-LGKLS 288
V ++ L +L++ H L L+ + ++ N + +L
Sbjct: 414 F-SVFLSLRN--LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 289 KLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQ 347
L LDLS + P F +++SL LN+ +N+L +P+G +RL +L + L N
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL-KSVPDGIFDRLTSLQKIWLHTNP 529
Query: 348 F 348
+
Sbjct: 530 W 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-34
Identities = 59/266 (22%), Positives = 104/266 (39%), Gaps = 19/266 (7%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171
+ L + SL + +S + + + L N + P +L+ L +
Sbjct: 279 NCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFG-QFPT--LKLKSLKRLTFT 333
Query: 172 NNALIGAIPPSLANSTRLYRLNLSYNSL--LGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229
+N A S + L L+LS N L G S SL L L N + ++ +
Sbjct: 334 SNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSS 390
Query: 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPVS-LGKLGLLQEISLSHNKIVGPIPDELGKLS 288
N+ L QL+ L+ H+ + S L L + +SH LS
Sbjct: 391 NFLGLE-----QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 289 KLQKLDLSYNAIGGSF-PVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNN 346
L+ L ++ N+ +F P FT + +L L+L +L ++ L +L VLN+ +N
Sbjct: 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMASN 504
Query: 347 QFKGHIPETIGNISGINQLDLSENDF 372
Q K ++ + ++ L N +
Sbjct: 505 QLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-33
Identities = 65/298 (21%), Positives = 106/298 (35%), Gaps = 21/298 (7%)
Query: 111 ISQLHALRKLSLHDNLLAG------PVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPN 164
S L L L++ + LA + L N+ L + + + N
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-G 305
Query: 165 LQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLS 224
Q L+L N L + L RL + N + S LPSL L L N LS
Sbjct: 306 WQHLELVNCKFGQFPTLKLKS---LKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLS 360
Query: 225 GSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDE- 283
G S L++L+L N + T+ + L L+ + H+ + + +
Sbjct: 361 -FKGCCSQSDFGTTS--LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFS 415
Query: 284 -LGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVL 341
L L LD+S+ +F F ++SL L + N L+NLT L
Sbjct: 416 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 475
Query: 342 NLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGS 399
+L Q + P ++S + L+++ N L +L + N S
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-33
Identities = 59/339 (17%), Positives = 110/339 (32%), Gaps = 41/339 (12%)
Query: 106 RISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGV----YLFNNRLSGSIPPSIGN 161
++ E S L L L L N + L L + + L N ++ I P
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK 198
Query: 162 CPNLQTLDLSNNALIGAIPP-SLANSTRLYRLNLSYNSLLGSIPLS------LTRLPSLS 214
L L L NN + + L L L L L +L+
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258
Query: 215 VLALQHNNLSGSVPN-----------NWGVLAGNK---------SYQLQFLNLDHNLIAG 254
+ + L + + + L ++ Q L L +
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ 318
Query: 255 TIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIG--GSFPVTFTNIT 312
KL L+ ++ + NK + L L+ LDLS N + G + T
Sbjct: 319 ---FPTLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373
Query: 313 SLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETI-GNISGINQLDLSEND 371
SL L+L N + + L+ L L+ +++ K ++ ++ + LD+S
Sbjct: 374 SLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432
Query: 372 FTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNS 410
+ L++L ++ N+ + P + + +
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-32
Identities = 73/313 (23%), Positives = 119/313 (38%), Gaps = 23/313 (7%)
Query: 139 PNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNS 198
+ + + L N L S + P LQ LDLS + + + + L L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 199 LLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIA-GTIP 257
+ + + L SL L NL+ S+ N + K+ L+ LN+ HNLI +P
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLA-SLEN--FPIGHLKT--LKELNVAHNLIQSFKLP 142
Query: 258 VSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQ----KLDLSYNAIGGSFPVTFTNITS 313
L L+ + LS NKI +L L ++ LDLS N + P F I
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-R 201
Query: 314 LVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQFKGHIPET---IGNISGINQLDLSE 369
L L L NN + + ++ L L V L +F+ + G+ L + E
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261
Query: 370 ND------FTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQLCGYS 423
+ +I L N++SF++ + V + N + +
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQF- 319
Query: 424 PSTACPSLAPLSL 436
P+ SL L+
Sbjct: 320 PTLKLKSLKRLTF 332
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-32
Identities = 63/335 (18%), Positives = 105/335 (31%), Gaps = 25/335 (7%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALI 176
+ L L N L +S P L+ + L + + + +L TL L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 177 GAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNL-SGSVPNNWGVLA 235
+ + + L +L +L + L +L L + HN + S +P + L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 236 GNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQ----EISLSHNKIVGPIPDELGKLSKLQ 291
L+ L+L N I L L + + LS N + I K +L
Sbjct: 150 -----NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLH 203
Query: 292 KLDLSYNAIGGS-FPVTFTNITSLVSLNLENNRLGN-----KIPEG-LERLQNLTVLNL- 343
KL L N + + L L N K + LE L NLT+
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 344 --KNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVP 401
+ + I + ++ ++ L + + P
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFG-QFP 320
Query: 402 PLLSKKFNSSSFVGNLQLCGYSPSTACPSLAPLSL 436
L K +F N + PSL L L
Sbjct: 321 TLKLKSLKRLTFTSN-KGGNAFSEVDLPSLEFLDL 354
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-31
Identities = 59/339 (17%), Positives = 107/339 (31%), Gaps = 43/339 (12%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171
L+ L L + + L +L + L N + + +LQ L
Sbjct: 49 FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 172 NNALIGAIPPSLANSTRLYRLNLSYNSLL-GSIPLSLTRLPSLSVLALQHNNLSGSVPNN 230
L + + L LN+++N + +P + L +L L L N + +
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
Query: 231 WGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDE-LGKLSK 289
VL L+L N + I K L +++L +N + + L+
Sbjct: 169 LRVL-HQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAG 226
Query: 290 LQKLDLSYNAIGGSFPVTFTN---ITSLVSLNLENNRL------GNKIPEGLERLQNLTV 340
L+ L + + + L +L +E RL + I + L N++
Sbjct: 227 LEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSS 286
Query: 341 LNLKNNQFKGHIPETIGNIS---------GINQ-----------LDLSENDFTGEISPSL 380
+L + + + + N Q L + N + S
Sbjct: 287 FSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN--AFSE 343
Query: 381 ASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQL 419
L +L ++S N LS K S S G L
Sbjct: 344 VDLPSLEFLDLSRNGLS-------FKGCCSQSDFGTTSL 375
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 43/190 (22%), Positives = 71/190 (37%), Gaps = 14/190 (7%)
Query: 218 LQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIV 277
N +P+N L + + L+L N + S LQ + LS +I
Sbjct: 14 CMELNFY-KIPDN---LPFS----TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 278 GPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQN 337
LS L L L+ N I F+ ++SL L L + + L+
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 338 LTVLNLKNNQFK-GHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSF----NVS 392
L LN+ +N + +PE N++ + LDLS N L L + ++S
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 393 YNNLSGSVPP 402
N ++ + P
Sbjct: 186 LNPMN-FIQP 194
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 35/195 (17%), Positives = 67/195 (34%), Gaps = 30/195 (15%)
Query: 105 GRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPN 164
G S+ +L+ L L N + ++ +
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-------------------------TMSSNFLGLEQ 397
Query: 165 LQTLDLSNNALIGAIPPS-LANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNL 223
L+ LD ++ L S + L L++S+ + L SL VL + N+
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457
Query: 224 SGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDE 283
+ + + L FL+L + P + L LQ ++++ N++
Sbjct: 458 QENFLPD----IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGI 513
Query: 284 LGKLSKLQKLDLSYN 298
+L+ LQK+ L N
Sbjct: 514 FDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 21/96 (21%), Positives = 36/96 (37%), Gaps = 3/96 (3%)
Query: 112 SQLHALRKLSLHDNLLAGPVPW-SLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLD 169
+ L +L L + N L NL + L +L + P+ + +LQ L+
Sbjct: 442 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLN 500
Query: 170 LSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPL 205
+++N L T L ++ L N S P
Sbjct: 501 MASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-35
Identities = 63/300 (21%), Positives = 112/300 (37%), Gaps = 47/300 (15%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALI 176
+ L + DN L +P LR + + N+L+ S+P L L
Sbjct: 63 ITTLVIPDNNLTS-LPALPP---ELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL- 116
Query: 177 GAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAG 236
P + L +L + N L S+P+ P L L++ N L+ S+P
Sbjct: 117 ---PALPSG---LCKLWIFGNQ-LTSLPVL---PPGLQELSVSDNQLA-SLPALPS---- 161
Query: 237 NKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLS 296
+L L +N + ++P+ LQE+S+S N++ +P +L KL +
Sbjct: 162 ----ELCKLWAYNNQLT-SLPMLPSG---LQELSVSDNQLAS-LPTLPSELYKLWAYNNR 212
Query: 297 YNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETI 356
++ + L L + NRL + +P L L + N+ +P
Sbjct: 213 LTSLPAL-------PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP 260
Query: 357 GNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGN 416
+ L + N T + SL L++ T+ N+ N LS ++ S+
Sbjct: 261 SGLL---SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSG 315
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-30
Identities = 58/279 (20%), Positives = 98/279 (35%), Gaps = 59/279 (21%)
Query: 148 NNRLSGSIPPSIGNC--PNLQTLDLSNNALIGAIPPSLANS------------------T 187
+R ++ + C L++ + L +P L
Sbjct: 23 ESRGRAAVVQKMRACLNNGNAVLNVGESGL-TTLPDCLPAHITTLVIPDNNLTSLPALPP 81
Query: 188 RLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNL 247
L L +S N L S+P+ L LS+ + +L L L +
Sbjct: 82 ELRTLEVSGNQ-LTSLPVLPPGLLELSIFSNPLTHLPALPSG------------LCKLWI 128
Query: 248 DHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVT 307
N + ++PV LQE+S+S N++ +P +L KL N + S P
Sbjct: 129 FGNQLT-SLPVLPPG---LQELSVSDNQLAS-LPALPS---ELCKLWAYNNQL-TSLP-- 177
Query: 308 FTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDL 367
+ L L++ +N+L +P L L N + +P + +L +
Sbjct: 178 -MLPSGLQELSVSDNQL-ASLPTLPSELYKLWAYNNRLTS----LPALPSGLK---ELIV 228
Query: 368 SENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSK 406
S N T + + L L VS N L+ S+P L S
Sbjct: 229 SGNRLT-SLPVLPSELKEL---MVSGNRLT-SLPMLPSG 262
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 5e-27
Identities = 57/325 (17%), Positives = 115/325 (35%), Gaps = 35/325 (10%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171
L++LS+ DN LA +P L L + +NN+L+ S+P LQ L +S
Sbjct: 138 VLPPGLQELSVSDNQLAS-LPALPSELCKL---WAYNNQLT-SLPMLPSG---LQELSVS 189
Query: 172 NNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNW 231
+N L ++P + +L+ N SL L L + N L+ S+P
Sbjct: 190 DNQLA-SLPTLPSELYKLWAYNNRLTSLPALPS-------GLKELIVSGNRLT-SLPVLP 240
Query: 232 GVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQ 291
+L+ L + N + ++P+ L +S+ N++ +P+ L LS
Sbjct: 241 S--------ELKELMVSGNRLT-SLPMLPSGL---LSLSVYRNQLTR-LPESLIHLSSET 287
Query: 292 KLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGH 351
++L N + T + + S + + G + L+L +
Sbjct: 288 TVNLEGNPLS---ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWL-- 342
Query: 352 IPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSS 411
+P G + ++ + + + + T + + L++
Sbjct: 343 VPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQISSWLAQLAEDE 402
Query: 412 SFVGNLQLCGYSPSTACPSLAPLSL 436
+ N +++C L
Sbjct: 403 ALRANTFAMATEATSSCEDRVTFFL 427
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-35
Identities = 67/321 (20%), Positives = 116/321 (36%), Gaps = 48/321 (14%)
Query: 107 ISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGN----- 161
I+ + L++ H + L +P + + Y + + PP G
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 162 --------CPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSL 213
L+L+N L ++P + L L S NS L +P L SL
Sbjct: 62 VSRLRDCLDRQAHELELNNLGL-SSLPELPPH---LESLVASCNS-LTELPELPQSLKSL 116
Query: 214 SVLALQHNNLSGSVPNNWGVL--AGNK---------SYQLQFLNLDHNLIAGTIPVSLGK 262
V LS +P L + N+ S L+ +++D+N + +P
Sbjct: 117 LVDNNNLKALS-DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS 174
Query: 263 LGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENN 322
L+ I+ +N++ EL L L + N++ SL S+ NN
Sbjct: 175 ---LEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKLPD----LPLSLESIVAGNN 225
Query: 323 RLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLAS 382
L + L+ L LT + NN K +P+ ++ L++ +N T ++ S
Sbjct: 226 IL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE---ALNVRDNYLT-DLPELPQS 278
Query: 383 LANLTSFNVSYNNLSGSVPPL 403
L L ++ LS P L
Sbjct: 279 LTFLDVSENIFSGLSELPPNL 299
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-35
Identities = 64/293 (21%), Positives = 112/293 (38%), Gaps = 49/293 (16%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
+ L L + +N L +P +L + NN L P + N P L T+
Sbjct: 191 LQNLPFLTAIYADNNSLKK-LPDLPL---SLESIVAGNNILE--ELPELQNLPFLTTIYA 244
Query: 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNN 230
NN L+ +P + L LN+ N L +P L L V + LS PN
Sbjct: 245 DNN-LLKTLPDLPPS---LEALNVRDNY-LTDLPELPQSLTFLDVSENIFSGLSELPPN- 298
Query: 231 WGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKL 290
L +LN N I ++ L+E+++S+NK++ +P +L
Sbjct: 299 -----------LYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLIE-LPALPP---RL 339
Query: 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKG 350
++L S+N + P +L L++E N L + P+ E +++L + +
Sbjct: 340 ERLIASFNHL-AEVP---ELPQNLKQLHVEYNPL-REFPDIPESVEDLRMNSHLA----- 389
Query: 351 HIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPL 403
+PE N+ QL + N E S+ +L ++ +
Sbjct: 390 EVPELPQNLK---QLHVETNPLR-EFPDIPESVEDL---RMNSERVV-DPYEF 434
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-33
Identities = 58/282 (20%), Positives = 103/282 (36%), Gaps = 46/282 (16%)
Query: 138 LPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLAN------------ 185
L+ ++ L+ +P N + + + PP
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 186 -STRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQF 244
+ + L L+ L S+P P L L N+L+ +P L L
Sbjct: 69 LDRQAHELELNNLG-LSSLPEL---PPHLESLVASCNSLT-ELPELPQSLK-----SLLV 118
Query: 245 LNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSF 304
N + ++ P LL+ + +S+N++ +P EL S L+ +D+ N++
Sbjct: 119 DNNNLKALSDLPP-------LLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSL-KKL 168
Query: 305 PVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQ 364
P SL + NN+L ++PE L+ L LT + NN K +P+ ++
Sbjct: 169 P---DLPPSLEFIAAGNNQL-EELPE-LQNLPFLTAIYADNNSLK-KLPDLPLSLE---S 219
Query: 365 LDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSK 406
+ N P L +L LT+ N L ++P L
Sbjct: 220 IVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPS 258
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-26
Identities = 49/272 (18%), Positives = 95/272 (34%), Gaps = 56/272 (20%)
Query: 106 RISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNL 165
+ + +L + +N+L L LP L +Y NN L ++P + L
Sbjct: 206 SLKKLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPS---L 259
Query: 166 QTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRL--------------P 211
+ L++ +N L +P + T L ++ L +P +L L P
Sbjct: 260 EALNVRDNYLT-DLPELPQSLTFLDVSENIFSGL-SELPPNLYYLNASSNEIRSLCDLPP 317
Query: 212 SLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISL 271
SL L + +N L +P +L+ L N +A +P L +++ +
Sbjct: 318 SLEELNVSNNKLI-ELPALPP--------RLERLIASFNHLA-EVPELPQNL---KQLHV 364
Query: 272 SHNKIVGPIPDELGKL----------------SKLQKLDLSYNAIGGSFPVTFTNITSLV 315
+N + PD + L++L + N + FP S+
Sbjct: 365 EYNPLRE-FPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFP---DIPESVE 419
Query: 316 SLNLENNRLGNKIPEGLERLQNLTVLNLKNNQ 347
L + + R+ + E L +++
Sbjct: 420 DLRMNSERVVDPYEFAHETTDKLEDDVFEHHH 451
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 43/247 (17%), Positives = 84/247 (34%), Gaps = 60/247 (24%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNC-------- 162
+ L L + +NLL +P P+L + + +N L+ +P +
Sbjct: 233 LQNLPFLTTIYADNNLLKT-LP---DLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSEN 287
Query: 163 ---------PNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSL 213
PNL L+ S+N I ++ + L LN+S N L+ +P P L
Sbjct: 288 IFSGLSELPPNLYYLNASSNE-IRSLCDLPPS---LEELNVSNNKLI-ELPALP---PRL 339
Query: 214 SVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGL-------- 265
L N+L+ VP L+ L++++N + P +
Sbjct: 340 ERLIASFNHLA-EVPELPQ--------NLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLA 389
Query: 266 --------LQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSL 317
L+++ + N + PD + + L ++ + + L
Sbjct: 390 EVPELPQNLKQLHVETNPLRE-FPDIPESV---EDLRMNSERVVDPYEFAHETTDKLEDD 445
Query: 318 NLENNRL 324
E++
Sbjct: 446 VFEHHHH 452
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 21/129 (16%), Positives = 40/129 (31%), Gaps = 25/129 (19%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGN---------- 161
+ L +L N LA VP NL+ +++ N L P +
Sbjct: 334 ALPPRLERLIASFNHLAE-VPELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRMNSHL 388
Query: 162 ------CPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSV 215
NL+ L + N L P + + L ++ ++ + L
Sbjct: 389 AEVPELPQNLKQLHVETNPLR-EFPDIPES---VEDLRMNSERVVDPYEFAHETTDKLED 444
Query: 216 LALQHNNLS 224
+H++
Sbjct: 445 DVFEHHHHH 453
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-35
Identities = 65/324 (20%), Positives = 117/324 (36%), Gaps = 40/324 (12%)
Query: 111 ISQLHALRKLSLHDNLLAG-PVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGN--CPNLQT 167
L AL +L L N + + S G L +L+ + +N++ + L
Sbjct: 119 FRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSF 178
Query: 168 LDLSNNALIGAIPPSLANS------TRLYRLNLSYNSLL------------GSIPLSLTR 209
L+ N+L + L L++S N S SL
Sbjct: 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLIL 238
Query: 210 LPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEI 269
+ +N+ N AG ++ L+L H + L L+ +
Sbjct: 239 AHHIMGAGFGFHNIK-DPDQN--TFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVL 295
Query: 270 SLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIP 329
+L++NKI + L LQ L+LSYN +G + F + + ++L+ N +
Sbjct: 296 NLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQD 355
Query: 330 EGLERLQNLTVLNLKNNQFK-----GHIPE------TIGNISGI----NQLDLSENDFTG 374
+ + L+ L L+L++N IP+ + + I N + LSEN
Sbjct: 356 QTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLEN 415
Query: 375 -EISPSLASLANLTSFNVSYNNLS 397
+I L + +L ++ N S
Sbjct: 416 LDILYFLLRVPHLQILILNQNRFS 439
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-34
Identities = 63/311 (20%), Positives = 111/311 (35%), Gaps = 29/311 (9%)
Query: 112 SQLHALRKLSLHDNLLAGPV-PWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLD 169
L L+ L L + + LPNLR + L ++++ + P +L L
Sbjct: 45 PFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELR 103
Query: 170 LSNNALIGAIPPS--LANSTRLYRLNLSYNSLLG-SIPLSLTRLPSLSVLALQHNNLSGS 226
L L A+ N L RL+LS N + + S +L SL + N +
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163
Query: 227 VPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLG------LLQEISLSHNKIVGPI 280
L + L F +L N + + V GK +L+ + +S N I
Sbjct: 164 CE---HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDI 220
Query: 281 PD------------ELGKLSKLQKLDLSYNAIGGSFPVTFTNI--TSLVSLNLENNRLGN 326
L + ++ I TF + +S+ L+L + + +
Sbjct: 221 TGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS 280
Query: 327 KIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANL 386
E L++L VLNL N+ E + + L+LS N S + L +
Sbjct: 281 LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKV 340
Query: 387 TSFNVSYNNLS 397
++ N+++
Sbjct: 341 AYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-31
Identities = 62/284 (21%), Positives = 95/284 (33%), Gaps = 27/284 (9%)
Query: 138 LPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPP-SLANSTRLYRLNLSY 196
L + L N + S LQ L+L + I + N L L+L
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 197 NSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAG-T 255
+ + P + L L L L LS +V + G K+ L L+L N I
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKD-GYFRNLKA--LTRLDLSKNQIRSLY 139
Query: 256 IPVSLGKLGLLQEISLSHNKIVGPIPDELGKLS--KLQKLDLSYNAIGGSFPVTFTNI-- 311
+ S GKL L+ I S N+I EL L L L+ N++ V +
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 312 ----TSLVSLNLENNRLGNKIP------------EGLERLQNLTVLNLKNNQFKGHIPET 355
L L++ N I L ++ + K T
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259
Query: 356 IGNI--SGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLS 397
+ S + LDLS S +L +L N++YN ++
Sbjct: 260 FAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-30
Identities = 72/379 (18%), Positives = 132/379 (34%), Gaps = 51/379 (13%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171
L L+ L+L NLL + LP + + L N ++ + LQTLDL
Sbjct: 311 YGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLR 370
Query: 172 NNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNW 231
+NAL ++ + + LS N L+ ++L + +++ L N L +
Sbjct: 371 DNALT-----TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLEN--LDIL 419
Query: 232 GVLAGNKSYQLQFLNLDHNLIAGTIPVSL-GKLGLLQEISLSHNKIVGPI-----PDELG 285
L LQ L L+ N + + L+++ L N + D
Sbjct: 420 YFLLRVPH--LQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFE 477
Query: 286 KLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKN 345
LS LQ L L++N + P F+++T+L L+L +NRL + NL +L++
Sbjct: 478 GLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL-TVLSHND-LPANLEILDISR 535
Query: 346 NQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLS 405
NQ +P+ +L+ ++++N
Sbjct: 536 NQLL---------------------------APNPDVFVSLSVLDITHNKFICECEL--- 565
Query: 406 KKFNSSSFVGNLQLCGYSPSTACPSLAPLSLPPPPVEAPKHHHHRKLSTKDIILIGVGAL 465
F + N+ + G C S + + ++ + +
Sbjct: 566 STFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCT 625
Query: 466 LAVLLILCCILLFCLMRKR 484
+ + L L IL R
Sbjct: 626 VTLTLFLMTILTVTKFRGF 644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 7e-15
Identities = 30/155 (19%), Positives = 58/155 (37%), Gaps = 7/155 (4%)
Query: 287 LSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKN 345
L+ ++L LS+N I +F + L L L + I + L NL +L+L +
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 346 NQFKGHIPETIGNISGINQLDLSENDFTGEISPS--LASLANLTSFNVSYNNLSGSVPPL 403
++ P+ + + +L L + + +L LT ++S N + S+
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR-SLYL- 140
Query: 404 LSKKFNSSSFVGNLQLCGYSPSTACP-SLAPLSLP 437
F + + ++ C L PL
Sbjct: 141 -HPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGK 174
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 28/96 (29%), Positives = 43/96 (44%), Gaps = 5/96 (5%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
L L+ L L+ N L P L LRG+ L +NRL+ + + NL+ LD+
Sbjct: 476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDI 533
Query: 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLS 206
S N + A P L L++++N + LS
Sbjct: 534 SRNQ-LLAPNPD--VFVSLSVLDITHNKFICECELS 566
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVK--RLREKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
+G+ ++ T YK E EVA + R+ T ++ F+ EA + + HPN++
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 598 AYYL-GPKGEKLLVF--DFMPKGSLASFLHARGP---ETIVNWATRMSIAIGIARGLNYL 651
+ KG+K +V + M G+L ++L + + +W + I +GL +L
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ------ILKGLQFL 145
Query: 652 HVEENM-IHGNLTSSNVLLDEKT-NPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELS 709
H IH +L N+ + T + +I D GL+ L A+ VI GT + APE+
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---GTPEFMAPEMY 202
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743
+ + + DVY+ G+ +LE+ T + P
Sbjct: 203 E-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA 235
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-33
Identities = 59/314 (18%), Positives = 117/314 (37%), Gaps = 23/314 (7%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
+ L +L +L + L SL + ++ + L + + + +++ L+L
Sbjct: 144 FAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLEL 203
Query: 171 SNNALIG---AIPPSLANSTRLYRLNLSYNSL-------LGSIPLSLTRLPSLSVLALQH 220
+ L + P S+ + +L + L L + + L +
Sbjct: 204 RDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTL 263
Query: 221 NNLSGSVPNNWGVLAGNKSYQ---LQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIV 277
N L P+ V++ + ++ L++ + + L ++ I++ ++K+
Sbjct: 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF 323
Query: 278 GPIPDELGKLSKLQKLDLSYNAIGGSFPVT---FTNITSLVSLNLENNRLGN--KIPEGL 332
L L+ LDLS N + + SL +L L N L + K E L
Sbjct: 324 LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL 383
Query: 333 ERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVS 392
L+NLT L++ N F +P++ + L+LS + + L +VS
Sbjct: 384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVS 439
Query: 393 YNNLSGSVPPLLSK 406
NNL S L +
Sbjct: 440 NNNLD-SFSLFLPR 452
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-33
Identities = 58/347 (16%), Positives = 110/347 (31%), Gaps = 33/347 (9%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNAL 175
++ L L N + L NL+ + L ++R++ +I + +L+ LDLS+N L
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHL 86
Query: 176 IGAIPPSLANSTRLYRLNLSYNSLLG-SIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVL 234
+ L LNL N + L +L L + + +
Sbjct: 87 SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR--IDF 144
Query: 235 AGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLD 294
AG S L L + + SL + + ++L ++ + LS ++ L+
Sbjct: 145 AGLTS--LNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202
Query: 295 LSYNAIGGSFPVTFTNITSLVSLNLENNRLGN----------KIPEGLERLQNLTVLNLK 344
L + + R K+ + L + +
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCT 262
Query: 345 NNQFKGHIPETIGNISG--------INQLDLSENDFTGEISPSLASLANLTSFNVSYNNL 396
N P +S I +L + + ++S + L + V + +
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 397 SGSVPPLLSKKFN-------SSSFVGNLQLCGYSPSTACPSLAPLSL 436
VP S+ S + + L + A PSL L L
Sbjct: 323 F-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-31
Identities = 61/339 (17%), Positives = 112/339 (33%), Gaps = 63/339 (18%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSG----------------- 153
+ + + L+LH + A + L ++R + L + L+
Sbjct: 168 LKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227
Query: 154 -----------------SIPPSIGNCPNLQTLDLSNNALIGAIPPSLA--------NSTR 188
+ I ++ D + N L P +
Sbjct: 228 LAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287
Query: 189 LYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLD 248
+ RL++ L + + L + + ++++ + VP KS L+FL+L
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPC--SFSQHLKS--LEFLDLS 342
Query: 249 HNLIAGTI---PVSLGKLGLLQEISLSHNKI--VGPIPDELGKLSKLQKLDLSYNAIGGS 303
NL+ G LQ + LS N + + + L L L LD+S N
Sbjct: 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-P 401
Query: 304 FPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGIN 363
P + + LNL + + + + Q L VL++ NN + +
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGI-RVVKTCI--PQTLEVLDVSNNNLD-SFSL---FLPRLQ 454
Query: 364 QLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402
+L +S N + P + L +S N L SVP
Sbjct: 455 ELYISRNKLK-TL-PDASLFPVLLVMKISRNQLK-SVPD 490
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-31
Identities = 55/309 (17%), Positives = 106/309 (34%), Gaps = 28/309 (9%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSG-SIPPSIGNCPNLQTLDL 170
L +L L L DN L+ G L +L+ + L N + N NLQTL +
Sbjct: 71 YSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRI 130
Query: 171 SNNALIGAIPP-SLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229
N I A T L L + SL SL + + L L + + +
Sbjct: 131 GNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEI 190
Query: 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGP---------- 279
+ +++L L +A L + + +
Sbjct: 191 -----FADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 280 IPDELGKLSKLQKLDLSYNAIGGSFPVTFTNI--------TSLVSLNLENNRLGNKIPEG 331
+ + +LS+++ D + N +G P + ++ L++ L +
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305
Query: 332 LERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPS---LASLANLTS 388
L+ + + ++N++ ++ + LDLSEN E + + +L +
Sbjct: 306 YSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQT 365
Query: 389 FNVSYNNLS 397
+S N+L
Sbjct: 366 LVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-31
Identities = 59/326 (18%), Positives = 102/326 (31%), Gaps = 50/326 (15%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171
L ++R L L D LA L + R S S L L
Sbjct: 193 DILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILE 252
Query: 172 NNAL---------IGAIPPSLANS---------TRLYRLNLSYNSLLGSIPLSLTRLPSL 213
+ + +G PS ++ + RL++ L + + L +
Sbjct: 253 LSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKV 312
Query: 214 SVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTI---PVSLGKLGLLQEIS 270
+ ++++ + VP KS L+FL+L NL+ G LQ +
Sbjct: 313 KRITVENSKVF-LVPC--SFSQHLKS--LEFLDLSENLMVEEYLKNSACKGAWPSLQTLV 367
Query: 271 LSHNKI--VGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRL---- 324
LS N + + + L L L LD+S N P + + LNL + +
Sbjct: 368 LSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVK 426
Query: 325 -------------GNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSEND 371
N + L L L + N+ K +P+ + + +S N
Sbjct: 427 TCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQ 484
Query: 372 FTGEISPS-LASLANLTSFNVSYNNL 396
+ L +L + N
Sbjct: 485 LK-SVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-30
Identities = 48/262 (18%), Positives = 94/262 (35%), Gaps = 12/262 (4%)
Query: 161 NCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQH 220
+C D + + +IP L + + L+LS+N + L +L VL L+
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 221 NNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVG-P 279
+ ++ ++ S L+ L+L N ++ G L L+ ++L N
Sbjct: 60 SRIN-TIEG--DAFYSLGS--LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLG 114
Query: 280 IPDELGKLSKLQKLDLS-YNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNL 338
+ L+ LQ L + + F +TSL L ++ L N + L+ ++++
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI 174
Query: 339 TVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSG 398
L L ++ + +S + L+L + + L + G
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK--KLAFRG 232
Query: 399 SVPPLLSKKFNSSSFVGNLQLC 420
SV S L+L
Sbjct: 233 SVLTDESFNELLKLLRYILELS 254
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-16
Identities = 42/189 (22%), Positives = 67/189 (35%), Gaps = 32/189 (16%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGF---LPNLRGVYLFNNRLSGSIPPSIG---NCPNL 165
L +L L L +NL+ + P+L+ + L N L S+ + NL
Sbjct: 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNL 389
Query: 166 QTLDLSNNALIGAIPPSLANSTRLYRLNLSYN---SLLGSIPLSLT-------------- 208
+LD+S N +P S ++ LNLS + IP +L
Sbjct: 390 TSLDISRN-TFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSL 448
Query: 209 RLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQE 268
LP L L + N L ++P+ L + + N + +L LQ+
Sbjct: 449 FLPRLQELYISRNKLK-TLPDAS------LFPVLLVMKISRNQLKSVPDGIFDRLTSLQK 501
Query: 269 ISLSHNKIV 277
I L N
Sbjct: 502 IWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 17/72 (23%), Positives = 28/72 (38%), Gaps = 4/72 (5%)
Query: 106 RISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPN 164
+ L L++L + N L +P P L + + N+L S+P I +
Sbjct: 442 NLDSFSLFLPRLQELYISRNKLKT-LP-DASLFPVLLVMKISRNQLK-SVPDGIFDRLTS 498
Query: 165 LQTLDLSNNALI 176
LQ + L N
Sbjct: 499 LQKIWLHTNPWD 510
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 55/246 (22%), Positives = 96/246 (39%), Gaps = 24/246 (9%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDL 170
+ L L +L L N L +P L+ + + N ++ + S+ + ++L
Sbjct: 97 APLVKLERLYLSKNQLKE-LP--EKMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVEL 152
Query: 171 SNNAL-IGAIPP-SLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVP 228
N L I + +L + ++ ++ +IP L PSL+ L L N ++ V
Sbjct: 153 GTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKIT-KVD 208
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLS 288
L G + L L L N I+ SL L+E+ L++NK+V +P L
Sbjct: 209 A--ASLKGLNN--LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHK 263
Query: 289 KLQKLDLSYNAI----GGSF--PVTFTNITSLVSLNLENNRLGN-KIPEGL-ERLQNLTV 340
+Q + L N I F P T S ++L +N + +I +
Sbjct: 264 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 323
Query: 341 LNLKNN 346
+ L N
Sbjct: 324 VQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 71/299 (23%), Positives = 116/299 (38%), Gaps = 32/299 (10%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPP-SIGNCPNLQTLDLSNNAL 175
LR + D L VP P+ + L NN+++ I N NL TL L NN
Sbjct: 33 LRVVQCSDLGLEK-VP--KDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNK- 87
Query: 176 IGAIPP-SLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVL 234
I I P + A +L RL LS N L +P + +L L + N ++ V V
Sbjct: 88 ISKISPGAFAPLVKLERLYLSKNQ-LKELPEKM--PKTLQELRVHENEIT-KVRK--SVF 141
Query: 235 AGNKSYQLQFLNLDHNLI-AGTIPV-SLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQK 292
G Q+ + L N + + I + + L I ++ I IP L L +
Sbjct: 142 NGLN--QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTE 196
Query: 293 LDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQFKGH 351
L L N I + + +L L L N + + + G L +L L+L NN+
Sbjct: 197 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSI-SAVDNGSLANTPHLRELHLNNNKLV-K 254
Query: 352 IPETIGNISGINQLDLSENDFTGEISPS-------LASLANLTSFNVSYNNLS-GSVPP 402
+P + + I + L N+ + I + A+ + ++ N + + P
Sbjct: 255 VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 312
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 56/271 (20%), Positives = 99/271 (36%), Gaps = 26/271 (9%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171
L L L L +N ++ P + L L +YL N+L +P + LQ L +
Sbjct: 73 KNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVH 129
Query: 172 NNALIGAIPP-SLANSTRLYRLNLSYNSLLGSI--PLSLTRLPSLSVLALQHNNLSGSVP 228
N I + ++ + L N L S + + LS + + N++ ++P
Sbjct: 130 EN-EITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIP 187
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLS 288
G+ L L+LD N I SL L L ++ LS N I L
Sbjct: 188 Q--GLPPS-----LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 240
Query: 289 KLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-------LERLQNLTVL 341
L++L L+ N + P + + + L NN + + I + + + +
Sbjct: 241 HLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNI-SAIGSNDFCPPGYNTKKASYSGV 298
Query: 342 NLKNNQFKGHI--PETIGNISGINQLDLSEN 370
+L +N + P T + + L
Sbjct: 299 SLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 21/218 (9%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRL-SGSIPPSI-GNCPNLQTLDLSNNA 174
L++L +H+N + L + V L N L S I L + +++
Sbjct: 123 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 182
Query: 175 LIGAIPPSLANSTRLYRLNLSYNSLLGSIP-LSLTRLPSLSVLALQHNNLSGSVPNNWGV 233
I IP L L L+L N + + SL L +L+ L L N++S +V N G
Sbjct: 183 -ITTIPQGL--PPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSIS-AVDN--GS 235
Query: 234 LAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKI------VGPIPDELGKL 287
LA L+ L+L++N + +P L +Q + L +N I P K
Sbjct: 236 LANTPH--LRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 292
Query: 288 SKLQKLDLSYNAIGGSF--PVTFTNITSLVSLNLENNR 323
+ + L N + P TF + ++ L N +
Sbjct: 293 ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 32/166 (19%), Positives = 61/166 (36%), Gaps = 9/166 (5%)
Query: 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAI 300
L+ + + +P L + L +NKI + L L L L N I
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 301 GGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNIS 360
P F + L L L N+L ++PE + + L L + N+ ++
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQL-KELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145
Query: 361 GINQLDLSENDFT-GEISP-SLASLANLTSFNVSYNNLSGSVPPLL 404
+ ++L N I + + L+ ++ N++ ++P L
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL 190
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 15/76 (19%), Positives = 28/76 (36%), Gaps = 8/76 (10%)
Query: 106 RISEKISQLHALRKLSLHDNLL------AGPVPWSLGFLPNLRGVYLFNNRLS-GSIPPS 158
++ ++ ++ + LH+N + P + GV LF+N + I PS
Sbjct: 254 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313
Query: 159 IGNC-PNLQTLDLSNN 173
C + L N
Sbjct: 314 TFRCVYVRAAVQLGNY 329
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 14/218 (6%)
Query: 136 GFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNALIGAIPP-SLANSTRLYRLN 193
G + ++L NR+S +P + C NL L L +N + I + L +L+
Sbjct: 29 GIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNV-LARIDAAAFTGLALLEQLD 86
Query: 194 LSYNSLLGSIPLS-LTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLI 252
LS N+ L S+ + L L L L L + G+ G + LQ+L L N +
Sbjct: 87 LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGP--GLFRGLAA--LQYLYLQDNAL 141
Query: 253 AGTIPV-SLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNI 311
+P + LG L + L N+I L L +L L N + P F ++
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 312 TSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQF 348
L++L L N L +P L L+ L L L +N +
Sbjct: 201 GRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 13/233 (5%)
Query: 167 TLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGS 226
T L A+P + +++ R+ L N + S +L++L L N L+
Sbjct: 15 TTSCPQQGLQ-AVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-R 70
Query: 227 VPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVS-LGKLGLLQEISLSHNKIVGPIPDELG 285
+ G L+ L+L N ++ + LG L + L + P
Sbjct: 71 IDA--AAFTGLAL--LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFR 126
Query: 286 KLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLK 344
L+ LQ L L NA+ TF ++ +L L L NR+ + +PE L +L L L
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLH 185
Query: 345 NNQFKGHIPETIGNISGINQLDLSENDFTGEISPS-LASLANLTSFNVSYNNL 396
N+ P ++ + L L N+ + + LA L L ++ N
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 48/214 (22%), Positives = 73/214 (34%), Gaps = 34/214 (15%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDL 170
L L LH N+LA I + L+ LDL
Sbjct: 53 RACRNLTILWLHSNVLA-------------------------RIDAAAFTGLALLEQLDL 87
Query: 171 SNNALIGAIPPS-LANSTRLYRLNLSYNSLLGSIPL-SLTRLPSLSVLALQHNNLSGSVP 228
S+NA + ++ P+ RL+ L+L L + L +L L LQ N L ++P
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCG-LQELGPGLFRGLAALQYLYLQDNALQ-ALP 145
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLS 288
+ L L L N I+ + L L + L N++ P L
Sbjct: 146 D--DTFRDLG--NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 289 KLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENN 322
+L L L N + + +L L L +N
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 31/140 (22%), Positives = 49/140 (35%), Gaps = 6/140 (4%)
Query: 266 LQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLG 325
Q I L N+I L L L N + FT + L L+L +N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 326 NKIPEG-LERLQNLTVLNLKNNQFKGHIPETI-GNISGINQLDLSENDFTGEISP-SLAS 382
+ L L L+L + + + ++ + L L +N + +
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRD 151
Query: 383 LANLTSFNVSYNNLSGSVPP 402
L NLT + N +S SVP
Sbjct: 152 LGNLTHLFLHGNRIS-SVPE 170
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 51/227 (22%), Positives = 104/227 (45%), Gaps = 26/227 (11%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVK--RLREKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
+ +G+ ++G A EDG + +K + ++K ++E E A + + HPN++ R
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 598 AYYLGPKGEKL-LVFDFMPKGSLASFLHARG----PETIVNWATRMSIAIGIARGLNYLH 652
+ + L +V D+ G L ++A+ E + + + I L ++H
Sbjct: 90 ESFE--ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-----LDWFVQICLALKHVH 142
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM---TAAANTNVIATAGTLGYRAPELS 709
+ ++H ++ S N+ L + ++ DFG++R++ A + GT Y +PE+
Sbjct: 143 -DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI----GTPYYLSPEIC 197
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756
+ K N K+D+++LG ++ EL T K + V I+
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKH---AFEAGSMKNLVLKIISGS 241
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
E++G +G +KA DG +KR++ ++ E E A+ K+ H N++
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 600 YLG--------------PKGEKL-LVFDFMPKGSLASFLHARG----PETIVNWATRMSI 640
+ G K + L + +F KG+L ++ R + + + +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA-----LEL 127
Query: 641 AIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM--TAAANTNVIATA 698
I +G++Y+H + +I+ +L SN+ L + +I DFGL + +
Sbjct: 128 FEQITKGVDYIH-SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK---- 182
Query: 699 GTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743
GTL Y +PE ++ + D+Y+LG+I+ ELL +
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF 227
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-31
Identities = 55/308 (17%), Positives = 114/308 (37%), Gaps = 38/308 (12%)
Query: 107 ISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQ 166
+ + N + + + L LS S+P ++ P +
Sbjct: 29 YFSAWDKWEKQALPGENRNEAVSLLK--ECLINQFSELQLNRLNLS-SLPDNLP--PQIT 83
Query: 167 TLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGS 226
L+++ NALI ++P A+ L L+ N L ++P SL L + +N L+
Sbjct: 84 VLEITQNALI-SLPELPAS---LEYLDACDNRL-STLP---ELPASLKHLDVDNNQLT-M 134
Query: 227 VPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGK 286
+P L+++N D+N + +P L + +S+ +N++ +P+
Sbjct: 135 LPELPA--------LLEYINADNNQL-TMLPELPTSL---EVLSVRNNQLTF-LPELPES 181
Query: 287 LSKLQKLDLSYNAIGGSFPVTFTNITSL----VSLNLENNRLGNKIPEGLERLQNLTVLN 342
L + LD+S N + S P + NR+ + IPE + L +
Sbjct: 182 L---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTII 236
Query: 343 LKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402
L++N I E++ + Q D +S + + + +
Sbjct: 237 LEDNPLSSRIRESLSQQT--AQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQS 294
Query: 403 LLSKKFNS 410
+S+ +++
Sbjct: 295 DVSQIWHA 302
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 7e-30
Identities = 57/288 (19%), Positives = 105/288 (36%), Gaps = 41/288 (14%)
Query: 146 LFNNRLSGSIPPSIGNCP----NLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLG 201
F N +S + + N + + L N L L+ +L
Sbjct: 17 SFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ--FSELQLNRLNL-S 72
Query: 202 SIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLG 261
S+P +L P ++VL + N L S+P L++L+ N ++ T+P
Sbjct: 73 SLPDNL--PPQITVLEITQNALI-SLPELPA--------SLEYLDACDNRLS-TLPELPA 120
Query: 262 KLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLEN 321
L + + + +N++ +P+ L + ++ N + P TSL L++ N
Sbjct: 121 SL---KHLDVDNNQLTM-LPELPALL---EYINADNNQLT-MLP---ELPTSLEVLSVRN 169
Query: 322 NRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNI----SGINQLDLSENDFTGEIS 377
N+L +PE E +L L++ N + +P EN T I
Sbjct: 170 NQL-TFLPELPE---SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIP 223
Query: 378 PSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQLCGYSPS 425
++ SL + + N LS + LS++ + G S
Sbjct: 224 ENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 1e-21
Identities = 43/232 (18%), Positives = 85/232 (36%), Gaps = 36/232 (15%)
Query: 192 LNLSYNSL---LGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLD 248
N YN++ + + ++ N + Q L L+
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN-------QFSELQLN 67
Query: 249 HNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTF 308
++ ++P +L + + ++ N ++ +P+ L+ LD N + + P
Sbjct: 68 RLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPA---SLEYLDACDNRL-STLP--- 116
Query: 309 TNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLS 368
SL L+++NN+L +PE L +N NNQ +PE ++ L +
Sbjct: 117 ELPASLKHLDVDNNQL-TMLPEL---PALLEYINADNNQLT-MLPELPTSLE---VLSVR 168
Query: 369 ENDFTGEISPSL-ASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQL 419
N T L +L + +VS N L S+P + + +S +
Sbjct: 169 NNQLT-----FLPELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRC 214
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 29/129 (22%), Positives = 44/129 (34%), Gaps = 8/129 (6%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGV----YLFNNRLSGSIPPSIGNCPNLQT 167
+L L + NLL +P + NR++ IP +I + T
Sbjct: 177 ELPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCT 234
Query: 168 LDLSNNALIGAIPPSLANSTRL--YRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSG 225
+ L +N L I SL+ T Y Y S+ +L R + +V A N
Sbjct: 235 IILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQS 294
Query: 226 SVPNNWGVL 234
V W
Sbjct: 295 DVSQIWHAF 303
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+ +G+ + L DG A+KR+ + ++E + EA +HPN+L L AY
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 600 YLGPKGEK---LLVFDFMPKGSLASFLHARG------PETIVNWATRMSIAIGIARGLNY 650
L +G K L+ F +G+L + + E + + + +GI RGL
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI-----LWLLLGICRGLEA 149
Query: 651 LHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM--------TAAANTNVIATAGTLG 702
+H + H +L +N+LL ++ P + D G A + A T+
Sbjct: 150 IH-AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 703 YRAPELSKLK---NANTKTDVYSLGVIILELLTGKSP 736
YRAPEL ++ + +TDV+SLG ++ ++ G+ P
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 57/246 (23%), Positives = 94/246 (38%), Gaps = 23/246 (9%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDL 170
S L L+KL + N L +P +L +L + + +NR+ +P + N+ +++
Sbjct: 99 SPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEM 154
Query: 171 SNNAL-IGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229
N L P + +L L +S L IP L +L+ L L HN + ++
Sbjct: 155 GGNPLENSGFEPGAFDGLKLNYLRISEAKL-TGIPKDL--PETLNELHLDHNKIQ-AIEL 210
Query: 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSK 289
L L L L HN I SL L L+E+ L +NK+ +P L L
Sbjct: 211 --EDLLRYSK--LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKL 265
Query: 290 LQKLDLSYNAI----GGSFP--VTFTNITSLVSLNLENNRLGNK-IPEGL-ERLQNLTVL 341
LQ + L N I F ++L NN + + + + +
Sbjct: 266 LQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAI 325
Query: 342 NLKNNQ 347
N +
Sbjct: 326 QFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 66/277 (23%), Positives = 111/277 (40%), Gaps = 30/277 (10%)
Query: 139 PNLRGVYLFNNRLSGSIPP-SIGNCPNLQTLDLSNNALIGAIPP-SLANSTRLYRLNLSY 196
P+ + L NN +S + +L L L NN I I + + +L +L +S
Sbjct: 54 PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNK-ISKIHEKAFSPLRKLQKLYISK 111
Query: 197 NSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTI 256
N L IP +L SL L + N + VP GV +G ++ + + + N +
Sbjct: 112 NHL-VEIPPNL--PSSLVELRIHDNRIR-KVPK--GVFSGLRN--MNCIEMGGNPLE-NS 162
Query: 257 PVSLGKL-GL-LQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSL 314
G GL L + +S K+ G IP +L L +L L +N I + L
Sbjct: 163 GFEPGAFDGLKLNYLRISEAKLTG-IPKDL--PETLNELHLDHNKIQAIELEDLLRYSKL 219
Query: 315 VSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFT 373
L L +N++ I G L L L L+L NN+ +P + ++ + + L N+ T
Sbjct: 220 YRLGLGHNQIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
Query: 374 GEISPS-------LASLANLTSFNVSYNNLS-GSVPP 402
++ + A ++ N + V P
Sbjct: 278 -KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-31
Identities = 54/271 (19%), Positives = 95/271 (35%), Gaps = 27/271 (9%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171
L L L L +N ++ + L L+ +Y+ N L IPP++ +L L +
Sbjct: 75 KGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIH 131
Query: 172 NNALIGAIPP-SLANSTRLYRLNLSYNSL-LGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229
+N I +P + + + + N L L+ L + L+ +P
Sbjct: 132 DN-RIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK 189
Query: 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPV-SLGKLGLLQEISLSHNKIVGPIPDELGKLS 288
+ L L+LDHN I I + L + L + L HN+I L L
Sbjct: 190 --DLPET-----LNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLP 241
Query: 289 KLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-------LERLQNLTVL 341
L++L L N + P ++ L + L N + K+ + +
Sbjct: 242 TLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNI-TKVGVNDFCPVGFGVKRAYYNGI 299
Query: 342 NLKNNQFKGHI--PETIGNISGINQLDLSEN 370
+L NN P T ++ +
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 31/165 (18%), Positives = 56/165 (33%), Gaps = 8/165 (4%)
Query: 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAI 300
L+ + + +P + + L +N I D+ L L L L N I
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISPD--TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 301 GGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNIS 360
F+ + L L + N L +IP L +L L + +N+ + +
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHL-VEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 361 GINQLDLSENDFT-GEISPSLASLANLTSFNVSYNNLSGSVPPLL 404
+N +++ N P L +S L+ +P L
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL 191
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 14/76 (18%), Positives = 25/76 (32%), Gaps = 8/76 (10%)
Query: 106 RISEKISQLHALRKLSLHDNLL------AGPVPWSLGFLPNLRGVYLFNNRLS-GSIPPS 158
R+ + L L+ + LH N + G+ LFNN + + P+
Sbjct: 255 RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPA 314
Query: 159 IGNC-PNLQTLDLSNN 173
C + + N
Sbjct: 315 TFRCVTDRLAIQFGNY 330
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 54/232 (23%), Positives = 104/232 (44%), Gaps = 31/232 (13%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR---EKTTKGQKEFEAEAAAIGKIHHPNLLAL 596
+ +G+ + Y+A L DG VA+K+++ K + + E + +++HPN++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 597 RAYYLGPKGEKL-LVFDFMPKGSLASFLHARG------PETIVNWATRMSIAIGIARGLN 649
A ++ + +L +V + G L+ + PE V + + L
Sbjct: 98 YASFI--EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV-----WKYFVQLCSALE 150
Query: 650 YLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM---TAAANTNVIATAGTLGYRAP 706
++H ++H ++ +NV + ++ D GL R T AA++ V GT Y +P
Sbjct: 151 HMH-SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV----GTPYYMSP 205
Query: 707 ELSKLKNANTKTDVYSLGVIILELLTGKSP--GEPMNGMDLPQWVASIVKEE 756
E N K+D++SLG ++ E+ +SP G+ MN L I + +
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL---CKKIEQCD 254
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 52/205 (25%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 541 EIMGKSTYGTAYKATL-----EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLA 595
+GK +G+ G+ VAVK+L+ Q++F+ E + +H ++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 596 LRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
R GP + L LV +++P G L FL ++ + + + I +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR--LDASRLLLYSSQICKGMEYLG-S 145
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLK 712
+H +L + N+L++ + + +IADFGL++L+ + V+ G APE
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 713 NANTKTDVYSLGVIILELLT-GKSP 736
+ ++DV+S GV++ EL T
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 31/225 (13%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
++G+ +G KA D A+K++R T + +E + ++H ++ A
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 600 YLGP-----------KGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARG 647
+L K L + ++ G+L +H+ + R + I
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR--LFRQILEA 128
Query: 648 LNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA--------- 698
L+Y+H + +IH +L N+ +DE N +I DFGL++ + + + + +
Sbjct: 129 LSYIH-SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 699 ----GTLGYRAPE-LSKLKNANTKTDVYSLGVIILELLTGKSPGE 738
GT Y A E L + N K D+YSLG+I E++ S G
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM 232
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 541 EIMGKSTYGTAYKATLEDGSE-----VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLL 594
+++G +GT YK E VA+K LRE T+ E EA + + +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 595 ALRAYYLG--PKGEKLLVFDFMPKGSLASFLHAR----GPETIVNWATRMSIAIGIARGL 648
L LG L+ MP G L ++ G + ++NW IA+G+
Sbjct: 81 RL----LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGM 130
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--AP 706
NYL + ++H +L + NVL+ + +I DFGL++L+ A A G + + A
Sbjct: 131 NYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YHAEGGKVPIKWMAL 188
Query: 707 ELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
E + ++DV+S GV + EL+T G P + + ++ +
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 29/233 (12%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVK--RLREKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
+G +YG K DG + K T ++ +E + ++ HPN++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 598 AYYLGPKGEKL-LVFDFMPKGSLASFLHARG------PETIVNWATRMSIAIGIARGLNY 650
+ L +V ++ G LAS + E V + + + L
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-----LRVMTQLTLALKE 126
Query: 651 LH----VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM---TAAANTNVIATAGTLGY 703
H ++H +L +NV LD K N ++ DFGL+R++ T+ A T V GT Y
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV----GTPYY 182
Query: 704 RAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756
+PE + N K+D++SLG ++ EL P + I + +
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMP---PFTAFSQKELAGKIREGK 232
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 43/248 (17%), Positives = 85/248 (34%), Gaps = 22/248 (8%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDL 170
+ L+ L L N + S L +L + L N LS ++ S +L L+L
Sbjct: 73 QRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNL 131
Query: 171 SNNALIGAIPPS--LANSTRLYRLNLSYNSLLGSIPL-SLTRLPSLSVLALQHNNLSGSV 227
N + + ++ T+L L + I L L L + ++L S
Sbjct: 132 LGN-PYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SY 189
Query: 228 PNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGP-------- 279
L + + L L + + + ++ + L +
Sbjct: 190 EP--KSLKSIQ--NVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG 245
Query: 280 IPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNL 338
+ L K + + ++ ++ I+ L+ L N+L +P+G +RL +L
Sbjct: 246 ETNSLIKKFTFRNVKITDESL-FQVMKLLNQISGLLELEFSRNQL-KSVPDGIFDRLTSL 303
Query: 339 TVLNLKNN 346
+ L N
Sbjct: 304 QKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 59/278 (21%), Positives = 104/278 (37%), Gaps = 26/278 (9%)
Query: 138 LPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPS-LANSTRLYRLNLSY 196
+ L+ SIP + +++LDLSNN I I S L L L L+
Sbjct: 30 CDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNN-RITYISNSDLQRCVNLQALVLTS 85
Query: 197 NSLLGSIPL-SLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGT 255
N + +I S + L SL L L +N LS ++ + S L FLNL N
Sbjct: 86 N-GINTIEEDSFSSLGSLEHLDLSYNYLS-NLSS--SWFKPLSS--LTFLNLLGNPYKTL 139
Query: 256 IPVSL-GKLGLLQEISLSHNKIVGPIPDE-LGKLSKLQKLDLSYNAIGGSFPVTFTNITS 313
SL L LQ + + + I + L+ L++L++ + + P + +I +
Sbjct: 140 GETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQN 199
Query: 314 LVSLNLENNRLGNKIPEGL-ERLQNLTVLNLKNNQFKGHIPETIGNIS--------GINQ 364
+ L L + + E + ++ L L++ +
Sbjct: 200 VSHLILHMKQH-ILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN 258
Query: 365 LDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402
+ +++ ++ L ++ L S N L SVP
Sbjct: 259 VKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPD 294
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 21/121 (17%), Positives = 41/121 (33%), Gaps = 11/121 (9%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSG----SIPP----SIGNCP 163
+ + L LH + + ++ + L + L + S+
Sbjct: 195 KSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKF 254
Query: 164 NLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLS-LTRLPSLSVLALQHNN 222
+ + +++ +L + L + L L S N L S+P RL SL + L N
Sbjct: 255 TFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQ-LKSVPDGIFDRLTSLQKIWLHTNP 312
Query: 223 L 223
Sbjct: 313 W 313
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 60/261 (22%), Positives = 102/261 (39%), Gaps = 19/261 (7%)
Query: 115 HALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNN 173
+ K+ L+ VP G N R + L N + I + +L+ L L N
Sbjct: 54 NQFSKVVCTRRGLSE-VP--QGIPSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRN 109
Query: 174 ALIGAIPP-SLANSTRLYRLNLSYNSLLGSIPL-SLTRLPSLSVLALQHNNLSGSVPNNW 231
I I + L L L N L IP + L L L L++N + S+P+
Sbjct: 110 -SIRQIEVGAFNGLASLNTLELFDNW-LTVIPSGAFEYLSKLRELWLRNNPIE-SIPS-- 164
Query: 232 GVLAGNKSYQLQFLNLDH-NLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKL 290
L L+L + + L L+ ++L I +P+ L L L
Sbjct: 165 YAFNRVP--SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPN-LTPLVGL 220
Query: 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQFK 349
++L++S N P +F ++SL L + N+++ + I + L +L LNL +N
Sbjct: 221 EELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV-SLIERNAFDGLASLVELNLAHNNLS 279
Query: 350 GHIPETIGNISGINQLDLSEN 370
+ + + +L L N
Sbjct: 280 SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 57/264 (21%), Positives = 97/264 (36%), Gaps = 21/264 (7%)
Query: 139 PNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPP-SLANSTRLYRLNLSYN 197
V LS +P I N + L+L N I I + + L L L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMEN-NIQMIQADTFRHLHHLEVLQLGRN 109
Query: 198 SLLGSIPL-SLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTI 256
+ I + + L SL+ L L N L+ +P+ G L+ L L +N I +I
Sbjct: 110 -SIRQIEVGAFNGLASLNTLELFDNWLT-VIPS--GAFEYLSK--LRELWLRNNPIE-SI 162
Query: 257 PV-SLGKLGLLQEISLSH-NKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSL 314
P + ++ L + L K+ L L+ L+L I T + L
Sbjct: 163 PSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI--KDMPNLTPLVGL 220
Query: 315 VSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFT 373
L + N +I G L +L L + N+Q ++ + +L+L+ N+ +
Sbjct: 221 EELEMSGNHF-PEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279
Query: 374 GEISPS-LASLANLTSFNVSYNNL 396
+ L L ++ +N
Sbjct: 280 -SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 63/239 (26%), Positives = 94/239 (39%), Gaps = 34/239 (14%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDL 170
LH L L L N + + L +L + LF+N L+ IP L+ L L
Sbjct: 96 RHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWL 154
Query: 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNN 230
NN I +IP + R+PSL L L +
Sbjct: 155 RNNP-IESIPSY-----------------------AFNRVPSLMRLDLGELKKLEYISE- 189
Query: 231 WGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKL 290
G G + L++LNL I +P +L L L+E+ +S N P LS L
Sbjct: 190 -GAFEGLFN--LKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSL 244
Query: 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQF 348
+KL + + + F + SLV LNL +N L + +P L+ L L+L +N +
Sbjct: 245 KKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL-SSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 62/276 (22%), Positives = 106/276 (38%), Gaps = 23/276 (8%)
Query: 137 FLPNLRGVYLFNNRLSGSIPPSIGNCP-------NLQTLDLSNNALIGAIPPSLANSTRL 189
F+ V++ ++ + NCP + + L +P + +
Sbjct: 21 FVYLTAQVWILCAAIAAAASAGPQNCPSVCSCSNQFSKVVCTRRGLS-EVPQGI--PSNT 77
Query: 190 YRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDH 249
LNL N++ + L L VL L N++ + G G S L L L
Sbjct: 78 RYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEV--GAFNGLAS--LNTLELFD 132
Query: 250 NLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDE-LGKLSKLQKLDLS-YNAIGGSFPVT 307
N + + L L+E+ L +N I IP ++ L +LDL +
Sbjct: 133 NWLTVIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGA 191
Query: 308 FTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDL 367
F + +L LNL + +P L L L L + N F P + +S + +L +
Sbjct: 192 FEGLFNLKYLNLGMCNI-KDMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWV 249
Query: 368 SENDFTGEISP-SLASLANLTSFNVSYNNLSGSVPP 402
+ + I + LA+L N+++NNLS S+P
Sbjct: 250 MNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPH 283
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-30
Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 10/212 (4%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
+G+ +G + T + VA+K L+ T + F EA + K+ H L+ L Y
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQL--YA 246
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHG 660
+ + +V ++M KGSL FL + + + +A IA G+ Y+ N +H
Sbjct: 247 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE-RMNYVHR 304
Query: 661 NLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLKNANTKT 718
+L ++N+L+ E ++ADFGL+RL+ N + APE + K+
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 719 DVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
DV+S G+++ EL T G+ P M ++ V
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 541 EIMGKSTYGTAYKATLEDGSE----VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLA 595
E++G+ +G Y TL D AVK L T G+ +F E + HPN+L+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
L L +G L+V +M G L +F+ V + + +A+G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLA-SK 147
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR------APELS 709
+H +L + N +LDEK ++ADFGL+R M + + G + A E
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 710 KLKNANTKTDVYSLGVIILELLT-GKSP 736
+ + TK+DV+S GV++ EL+T G P
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-30
Identities = 55/240 (22%), Positives = 98/240 (40%), Gaps = 16/240 (6%)
Query: 136 GFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNALIGAIPP-SLANSTRLYRLN 193
G N R + L N++ I + + +L+ L LS N I I + L L
Sbjct: 61 GISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRN-HIRTIEIGAFNGLANLNTLE 118
Query: 194 LSYNSLLGSIPL-SLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDH-NL 251
L N L +IP + L L L L++N + + + L+ L+L
Sbjct: 119 LFDNR-LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIP-----SLRRLDLGELKR 172
Query: 252 IAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNI 311
++ + L L+ ++L+ + IP+ L L KL +LDLS N + P +F +
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLSAIRPGSFQGL 230
Query: 312 TSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSEN 370
L L + +++ I + LQ+L +NL +N + + + ++ L N
Sbjct: 231 MHLQKLWMIQSQI-QVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 65/237 (27%), Positives = 93/237 (39%), Gaps = 34/237 (14%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDL 170
L L L L N + + L NL + LF+NRL+ +IP L+ L L
Sbjct: 85 KHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWL 143
Query: 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNN 230
NN I +IP + R+PSL L L +
Sbjct: 144 RNNP-IESIPSY-----------------------AFNRIPSLRRLDLGELKRLSYISE- 178
Query: 231 WGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKL 290
G G + L++LNL + IP +L L L E+ LS N + P L L
Sbjct: 179 -GAFEGLSN--LRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHL 233
Query: 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNN 346
QKL + + I F N+ SLV +NL +N L +P L +L ++L +N
Sbjct: 234 QKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL-TLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-29
Identities = 62/264 (23%), Positives = 108/264 (40%), Gaps = 21/264 (7%)
Query: 139 PNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPP-SLANSTRLYRLNLSYN 197
V L +P I N + L+L N I I S + L L LS N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQ-IQIIKVNSFKHLRHLEILQLSRN 98
Query: 198 SLLGSIPL-SLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTI 256
+ +I + + L +L+ L L N L+ ++PN G L+ L L +N I +I
Sbjct: 99 -HIRTIEIGAFNGLANLNTLELFDNRLT-TIPN--GAFVYLSK--LKELWLRNNPIE-SI 151
Query: 257 PVSL-GKLGLLQEISLSHNKIVGPIPDE-LGKLSKLQKLDLSYNAIGGSFPVTFTNITSL 314
P ++ L+ + L K + I + LS L+ L+L+ + P T + L
Sbjct: 152 PSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKL 209
Query: 315 VSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFT 373
L+L N L + I G + L +L L + +Q + N+ + +++L+ N+ T
Sbjct: 210 DELDLSGNHL-SAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
Query: 374 GEISPS-LASLANLTSFNVSYNNL 396
+ L +L ++ +N
Sbjct: 269 -LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 51/195 (26%), Positives = 80/195 (41%), Gaps = 16/195 (8%)
Query: 211 PSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEIS 270
S + NL VP+ S + LNL N I S L L+ +
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI-------STNTRLLNLHENQIQIIKVNSFKHLRHLEILQ 94
Query: 271 LSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPE 330
LS N I L+ L L+L N + F ++ L L L NN + + IP
Sbjct: 95 LSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES-IPS 153
Query: 331 GL-ERLQNLTVLNL-KNNQFKGHIPETI-GNISGINQLDLSENDFTGEISPSLASLANLT 387
R+ +L L+L + + +I E +S + L+L+ + EI P+L L L
Sbjct: 154 YAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EI-PNLTPLIKLD 210
Query: 388 SFNVSYNNLSGSVPP 402
++S N+LS ++ P
Sbjct: 211 ELDLSGNHLS-AIRP 224
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 43/141 (30%), Positives = 62/141 (43%), Gaps = 6/141 (4%)
Query: 266 LQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLG 325
+ ++L N+I + L L+ L LS N I F + +L +L L +NRL
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL- 124
Query: 326 NKIPEG-LERLQNLTVLNLKNNQFKGHIPE-TIGNISGINQLDLSENDFTGEISP-SLAS 382
IP G L L L L+NN + IP I + +LDL E IS +
Sbjct: 125 TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
Query: 383 LANLTSFNVSYNNLSGSVPPL 403
L+NL N++ NL +P L
Sbjct: 184 LSNLRYLNLAMCNLR-EIPNL 203
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 35/113 (30%), Positives = 50/113 (44%), Gaps = 8/113 (7%)
Query: 114 LHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPP-SIGNCPNLQTLDLSN 172
L LR L+L L +P +L L L + L N LS +I P S +LQ L +
Sbjct: 184 LSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQ 240
Query: 173 NALIGAIPP-SLANSTRLYRLNLSYNSLLGSIPLS-LTRLPSLSVLALQHNNL 223
+ I I + N L +NL++N+ L +P T L L + L HN
Sbjct: 241 SQ-IQVIERNAFDNLQSLVEINLAHNN-LTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 21/90 (23%), Positives = 42/90 (46%), Gaps = 4/90 (4%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPP-SIGNCPNLQTLDL 170
+ L L +L L N L+ P S L +L+ +++ +++ I + N +L ++L
Sbjct: 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINL 262
Query: 171 SNNALIGAIPPS-LANSTRLYRLNLSYNSL 199
++N L +P L R++L +N
Sbjct: 263 AHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-30
Identities = 66/216 (30%), Positives = 108/216 (50%), Gaps = 16/216 (7%)
Query: 541 EIMGKSTYGTAYKATLEDGS-EVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+G YG Y+ + S VAVK L+E T + +EF EAA + +I HPNL+ L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQL--- 281
Query: 600 YLG---PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
LG + ++ +FM G+L +L + + + + +A I+ + YL ++N
Sbjct: 282 -LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLE-KKN 338
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLKNA 714
IH NL + N L+ E ++ADFGLSRLMT +T + APE
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 715 NTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
+ K+DV++ GV++ E+ T G SP ++ + + +
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 432
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 51/233 (21%), Positives = 96/233 (41%), Gaps = 27/233 (11%)
Query: 541 EIMGKSTYGTAYKATLE-----DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLA 595
+ +GK +G+ + G VAVK+L+ T + ++FE E + + H N++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 596 LRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
+ L L+ +++P GSL +L ++ + I +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLG-T 132
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLK 712
+ IH +L + N+L++ + +I DFGL++++ + G APE
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 713 NANTKTDVYSLGVIILELLT----------------GKSPGEPMNGMDLPQWV 749
+ +DV+S GV++ EL T G M L + +
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 51/233 (21%), Positives = 96/233 (41%), Gaps = 27/233 (11%)
Query: 541 EIMGKSTYGTAYKATLE-----DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLA 595
+ +GK +G+ + G VAVK+L+ T + ++FE E + + H N++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 596 LRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
+ L L+ +++P GSL +L ++ + I +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLG-T 163
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLK 712
+ IH +L + N+L++ + +I DFGL++++ + G APE
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223
Query: 713 NANTKTDVYSLGVIILELLT----------------GKSPGEPMNGMDLPQWV 749
+ +DV+S GV++ EL T G M L + +
Sbjct: 224 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 16/204 (7%)
Query: 541 EIMGKSTYGTAYKATLEDGS-EVAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLALRA 598
E +G+ +G + L + VAVK RE K +F EA + + HPN++ L
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL-- 177
Query: 599 YYLG--PKGE-KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
+G + + +V + + G +FL G + T + + A G+ YL +
Sbjct: 178 --IGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYLE-SK 232
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLKN 713
IH +L + N L+ EK +I+DFG+SR + + APE
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA-ASGGLRQVPVKWTAPEALNYGR 291
Query: 714 ANTKTDVYSLGVIILELLT-GKSP 736
++++DV+S G+++ E + G SP
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP 315
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-29
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 14/214 (6%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
+G+ +G + T + VA+K L+ T + F EA + K+ H L+ L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQL---- 327
Query: 601 LG--PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
+ +V ++M KGSL FL + + + +A IA G+ Y+ N +
Sbjct: 328 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE-RMNYV 385
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLKNANT 716
H +L ++N+L+ E ++ADFGL+RL+ N + APE +
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIE--DNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 717 KTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
K+DV+S G+++ EL T G+ P M ++ V
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 60/224 (26%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 541 EIMGKSTYGTAYKATLEDGSE-----VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLL 594
+++G +GT YK E VA+K LRE T+ E EA + + +P++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 595 ALRAYYLG--PKGEKLLVFDFMPKGSLASFLHAR----GPETIVNWATRMSIAIGIARGL 648
L LG L+ MP G L ++ G + ++NW IA+G+
Sbjct: 81 RL----LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV------QIAKGM 130
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--AP 706
NYL + ++H +L + NVL+ + +I DFGL++L+ A A G + + A
Sbjct: 131 NYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE-YHAEGGKVPIKWMAL 188
Query: 707 ELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
E + ++DV+S GV + EL+T G P + + ++ +
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 56/282 (19%), Positives = 104/282 (36%), Gaps = 33/282 (11%)
Query: 116 ALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNAL 175
+ S L L + N+ ++ + I L L ++N
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNN- 75
Query: 176 IGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLA 235
I + L+ +T L L N L L +T L L+ L N L+ L
Sbjct: 76 ITTLD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLTK--------LD 122
Query: 236 GNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDL 295
+++ L +LN N + + + L E+ NK + + + ++L LD
Sbjct: 123 VSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDC 177
Query: 296 SYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPET 355
S+N I + + L LN + N + K+ L + LT L+ +N+ I
Sbjct: 178 SFNKITE---LDVSQNKLLNRLNCDTNNI-TKLD--LNQNIQLTFLDCSSNKLT-EID-- 228
Query: 356 IGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLS 397
+ ++ + D S N T +++L+ LT+ + +L
Sbjct: 229 VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-29
Identities = 55/286 (19%), Positives = 99/286 (34%), Gaps = 36/286 (12%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
QL L L H++ + + L L + +N ++ ++ + NL L
Sbjct: 38 EEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLAC 92
Query: 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNN 230
+N L + + T+L LN N L L +++ P L+ L N L+
Sbjct: 93 DSNKL-TNLD--VTPLTKLTYLNCDTNKL---TKLDVSQNPLLTYLNCARNTLT------ 140
Query: 231 WGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKL 290
+ + + QL L+ N + + L + S NKI ++ + L
Sbjct: 141 --EIDVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLL 193
Query: 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKG 350
+L+ N I + L L+ +N+L +I + L LT + N
Sbjct: 194 NRLNCDTNNITK---LDLNQNIQLTFLDCSSNKL-TEID--VTPLTQLTYFDCSVNPLT- 246
Query: 351 HIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNL 396
+ + +S + L + D EI L L F
Sbjct: 247 ELD--VSTLSKLTTLHCIQTDLL-EI--DLTHNTQLIYFQAEGCRK 287
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-28
Identities = 46/287 (16%), Positives = 92/287 (32%), Gaps = 35/287 (12%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
+SQ L L+ N L + L + N+ + + L TLD
Sbjct: 123 VSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDC 177
Query: 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNN 230
S N + ++ + L RLN N++ L L + L+ L N L+ +
Sbjct: 178 SFNKITEL---DVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID-- 228
Query: 231 WGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKL 290
+ L + + N + + VS L L + ++ I L ++L
Sbjct: 229 ---VTPLTQ--LTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLLE-ID--LTHNTQL 277
Query: 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKG 350
+ T+ T L L+ + + ++ L + L L L N +
Sbjct: 278 IYFQAEGCRK--IKELDVTHNTQLYLLDCQAAGI-TELD--LSQNPKLVYLYLNNTELT- 331
Query: 351 HIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLS 397
+ + + + + L + S+ + L + +
Sbjct: 332 ELD--VSHNTKLKSLSCVNAHIQ-DF-SSVGKIPALNNNFEAEGQTI 374
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 49/303 (16%), Positives = 99/303 (32%), Gaps = 34/303 (11%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
+S L +L H N + + L + N+++ + + L L+
Sbjct: 144 VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNC 198
Query: 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNN 230
N + L + +L L+ S N L I ++ L L+ N L+
Sbjct: 199 DTNNITK---LDLNQNIQLTFLDCSSNKLT-EIDVT--PLTQLTYFDCSVNPLT------ 246
Query: 231 WGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKL 290
L + +L L+ + I ++ L + + + ++ ++L
Sbjct: 247 --ELDVSTLSKLTTLHCIQTDLL-EIDLT--HNTQLIYFQAEGCRKIKEL--DVTHNTQL 299
Query: 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKG 350
LD I + + LV L L N L ++ + L L+ N +
Sbjct: 300 YLLDCQAAGIT---ELDLSQNPKLVYLYLNNTEL-TELD--VSHNTKLKSLSCVNAHIQD 353
Query: 351 HIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNS 410
+G I +N +E + + +LT VS + L P+ + +
Sbjct: 354 -FSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLT-IAVSPDLLDQFGNPMNIEPGDG 409
Query: 411 SSF 413
+
Sbjct: 410 GVY 412
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 52/259 (20%), Positives = 100/259 (38%), Gaps = 30/259 (11%)
Query: 139 PNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNS 198
N + + S L +LD N++ I + + T L +L + N+
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSS-ITDMTG-IEKLTGLTKLICTSNN 75
Query: 199 LLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPV 258
+ ++ LS + +L+ LA N L+ L +L +LN D N + +
Sbjct: 76 -ITTLDLS--QNTNLTYLACDSNKLTN--------LDVTPLTKLTYLNCDTNKLT---KL 121
Query: 259 SLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLN 318
+ + LL ++ + N + ++ ++L +LD N + T T L +L+
Sbjct: 122 DVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLD 176
Query: 319 LENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISP 378
N++ ++ + + + L LN N + + + LD S N T
Sbjct: 177 CSFNKI-TELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT---EI 227
Query: 379 SLASLANLTSFNVSYNNLS 397
+ L LT F+ S N L+
Sbjct: 228 DVTPLTQLTYFDCSVNPLT 246
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 55/306 (17%), Positives = 98/306 (32%), Gaps = 59/306 (19%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
+SQ L +L+ N + L L + +N+L+ I + L D
Sbjct: 187 VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDC 240
Query: 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNN 230
S N + + S ++L L+ LL + LT L +
Sbjct: 241 SVN-PLTELDVS--TLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCR-------- 286
Query: 231 WGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKL 290
+++ L++ HN L + I +L + KL
Sbjct: 287 ----------KIKELDVTHNT-------------QLYLLDCQAAGIT---ELDLSQNPKL 320
Query: 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKG 350
L L+ + V ++ T L SL+ N + + ++ L Q
Sbjct: 321 VYLYLNNTEL-TELDV--SHNTKLKSLSCVNAHI-QDFSS-VGKIPALNNNFEAEGQTIT 375
Query: 351 HIPETIGNIS-----GINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLS 405
ET+ N S + LD N I P + + + +++ NLS P ++
Sbjct: 376 MPKETLTNNSLTIAVSPDLLDQFGNPMN--IEPGDGGVYDQATNTITWENLSTD-NPAVT 432
Query: 406 KKFNSS 411
F S
Sbjct: 433 YTFTSE 438
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 14/212 (6%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
+ +GK +G G++VAVK ++ T + F AEA+ + ++ H NL+ L
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHG 660
+ KG +V ++M KGSL +L +RG + + ++ + + YL N +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE-GNNFVHR 313
Query: 661 NLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLKNANTKT 718
+L + NVL+ E +++DFGL++ + G L + APE + K +TK+
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFSTKS 367
Query: 719 DVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
DV+S G+++ E+ + G+ P + D+ V
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 399
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 59/224 (26%), Positives = 109/224 (48%), Gaps = 13/224 (5%)
Query: 533 DDLLCATAEIMGKSTYGTAYKATLEDGSE---VAVKRLREKTTKGQK-EFEAEAAAIGKI 588
D+LL A E+ G +G+ + + VA+K L++ T K E EA + ++
Sbjct: 9 DNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 67
Query: 589 HHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGL 648
+P ++ L +LV + G L FL + E + + + ++ G+
Sbjct: 68 DNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 123
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--AP 706
YL E+N +H +L + NVLL + +I+DFGLS+ + A + +AG + AP
Sbjct: 124 KYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 182
Query: 707 ELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
E + ++++DV+S GV + E L+ G+ P + M G ++ ++
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 3e-29
Identities = 54/291 (18%), Positives = 89/291 (30%), Gaps = 17/291 (5%)
Query: 121 SLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIP 180
S + L A V G + + I +L+ L + + I
Sbjct: 26 SAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRIL 85
Query: 181 PSLA---NSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNW-GVLAG 236
+ L L L + G+ P L + L N+S + + W L
Sbjct: 86 FGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQ 145
Query: 237 NKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDE----LGKLSKLQK 292
L+ L++ + L + LS N +G K LQ
Sbjct: 146 WLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQV 205
Query: 293 LDLSYN---AIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGL-ERLQNLTVLNLKNNQF 348
L L G L L+L +N L + + L LNL
Sbjct: 206 LALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL 265
Query: 349 KGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGS 399
K +P+ + + ++ LDLS N +PS L + + ++ N S
Sbjct: 266 K-QVPKGLP--AKLSVLDLSYNRLDR--NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 50/217 (23%), Positives = 78/217 (35%), Gaps = 32/217 (14%)
Query: 113 QLHALRKLSLHDNLLAGPVPWSLGF----LPNLRGVYLFNNRLSGSIPPSIGNCPNLQTL 168
L L+L + A W P L+ + + + P L TL
Sbjct: 119 TGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178
Query: 169 DLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVP 228
DLS+N +G A L + P+L VLAL++ + +
Sbjct: 179 DLSDNPELGERGLISA--------------------LCPLKFPTLQVLALRNAGME-TPS 217
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSL-GKLGLLQEISLSHNKIVGPIPDELGKL 287
LA + QLQ L+L HN + L ++LS + +P L
Sbjct: 218 GVCSALAAARV-QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--P 273
Query: 288 SKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRL 324
+KL LDLSYN + P + + +L+L+ N
Sbjct: 274 AKLSVLDLSYNRL-DRNPS-PDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 50/257 (19%), Positives = 76/257 (29%), Gaps = 31/257 (12%)
Query: 160 GNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRL---PSLSVL 216
G L + + S L RL + + I R+ L L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 217 ALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLG-----LLQEISL 271
L++ ++G+ P G L LNL + A L +L L+ +S+
Sbjct: 101 TLENLEVTGTAPPPLLEATGP---DLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSI 156
Query: 272 SHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG 331
+ + +++ L LDLS N G + P
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC-----------------PLK 199
Query: 332 LERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLAS-LANLTSFN 390
LQ L + N G + LDLS N + L S N
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259
Query: 391 VSYNNLSGSVPPLLSKK 407
+S+ L VP L K
Sbjct: 260 LSFTGLK-QVPKGLPAK 275
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 33/192 (17%), Positives = 59/192 (30%), Gaps = 26/192 (13%)
Query: 233 VLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKL---SK 289
+ G +S + +D G + L L + +++ +I I ++ S
Sbjct: 38 LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSL-KRLTVRAARIPSRILFGALRVLGISG 96
Query: 290 LQKLDLSYNAIGGSFPVTFTNIT--SLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQ 347
LQ+L L + G+ P T L LNL N L LQ LK
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW-ATRDAWLAELQQWLKPGLKV-- 153
Query: 348 FKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKK 407
L +++ + L++ ++S N G + +
Sbjct: 154 -----------------LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC 196
Query: 408 FNSSSFVGNLQL 419
+ L L
Sbjct: 197 PLKFPTLQVLAL 208
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 18/221 (8%)
Query: 541 EIMGKSTYGTAYKATLEDGSE----VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLA 595
++GK +G Y D ++ A+K L T Q F E + ++HPN+LA
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
L L P+G ++ +M G L F+ + V +S + +ARG+ YL E+
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYLA-EQ 143
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR------APELS 709
+H +L + N +LDE ++ADFGL+R + + + R A E
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDI---LDREYYSVQQHRHARLPVKWTALESL 200
Query: 710 KLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
+ TK+DV+S GV++ ELLT G P ++ DL ++
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 52/215 (24%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
+ +G +G + + +VA+K +RE +++F EA + K+ HP L+ L
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQL---- 68
Query: 601 LG---PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
G + LV +FM G L+ +L + T + + + + G+ YL E +
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLE-EACV 125
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLKNAN 715
IH +L + N L+ E +++DFG++R + + +T + +PE+ +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 716 TKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
+K+DV+S GV++ E+ + GK P E + ++ + +
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 15/219 (6%)
Query: 541 EIMGKSTYGTAYKATLEDGS----EVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNL 593
E +G ++G + + S VAVK L+ + +F E A+ + H NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
+ L L P +V + P GSL L ++ T A+ +A G+ YL
Sbjct: 84 IRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYLE- 138
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKL 711
+ IH +L + N+LL + +I DFGL R + + V+ + + APE K
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 712 KNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
+ + +D + GV + E+ T G+ P +NG + +
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 13/211 (6%)
Query: 541 EIMGKSTYGTAYKATLE-----DGSEVAVKRLRE-KTTKGQKEFEAEAAAIGKIHHPNLL 594
+G+ +G + G +VAVK L+ + + E + ++H N++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 595 ALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
+ G + L+ +F+P GSL +L + +N ++ A+ I +G++YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK--INLKQQLKYAVQICKGMDYLG- 143
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKL 711
+H +L + NVL++ + +I DFGL++ + + APE
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ 203
Query: 712 KNANTKTDVYSLGVIILELLT-GKSPGEPMN 741
+DV+S GV + ELLT S PM
Sbjct: 204 SKFYIASDVWSFGVTLHELLTYCDSDSSPMA 234
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 48/216 (22%), Positives = 102/216 (47%), Gaps = 18/216 (8%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
+ +G +G + +VAVK ++E + + EF EA + K+ HP L+
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKF---- 68
Query: 601 LG--PKGE-KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
G K +V +++ G L ++L + G + + + + + G+ +L
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFLE-SHQF 125
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT-LGYR--APELSKLKNA 714
IH +L + N L+D +++DFG++R + + +++ GT + APE+
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVL---DDQYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 715 NTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
++K+DV++ G+++ E+ + GK P + ++ V
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV 218
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 18/220 (8%)
Query: 541 EIMGKSTYGTAYKATLEDGSE----VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLA 595
+I+G G L + VA+K L+ T+ Q+ +F +EA+ +G+ HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 596 LRAYYLG--PKGE-KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLH 652
L G +G ++V ++M GSL +FL + + + G+ G+ YL
Sbjct: 115 L----EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYLS 168
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSK 710
+ +H +L + NVL+D +++DFGLSR++ + T G + R APE
Sbjct: 169 -DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 711 LKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
+ ++ +DV+S GV++ E+L G+ P M D+ V
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 27/224 (12%)
Query: 541 EIMGKSTYGTAYKATLEDGSE-----VAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLL 594
+++G +GT +K E V +K + +K+ + + AIG + H +++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 595 ALRAYYLG--PKGEKLLVFDFMPKGSLASFLHAR----GPETIVNWATRMSIAIGIARGL 648
L LG P LV ++P GSL + GP+ ++NW IA+G+
Sbjct: 79 RL----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV------QIAKGM 128
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--AP 706
YL E M+H NL + NVLL + ++ADFG++ L+ + ++ + + A
Sbjct: 129 YYLE-EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP-PDDKQLLYSEAKTPIKWMAL 186
Query: 707 ELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
E ++DV+S GV + EL+T G P + ++P +
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 48/216 (22%), Positives = 90/216 (41%), Gaps = 25/216 (11%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
+ +G+ +G ++A D A+KR+R +++ E A+ K+ HP ++
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 599 YYL--------GPKGEKLLVF---DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARG 647
+L P K+ ++ K +L +++ R + + I + IA
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 648 LNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM---TAAANTNVIATA------ 698
+ +LH + ++H +L SN+ ++ DFGL M A
Sbjct: 131 VEFLH-SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 699 --GTLGYRAPELSKLKNANTKTDVYSLGVIILELLT 732
GT Y +PE + + K D++SLG+I+ ELL
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-28
Identities = 55/212 (25%), Positives = 103/212 (48%), Gaps = 10/212 (4%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
+ +G +G + AT ++VAVK ++ + + F AEA + + H L+ L A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHG 660
K ++ +FM KGSL FL + + + IA G+ ++ + N IH
Sbjct: 253 T--KEPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIE-QRNYIHR 308
Query: 661 NLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLKNANTKT 718
+L ++N+L+ +IADFGL+R++ N + APE + K+
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 719 DVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
DV+S G++++E++T G+ P M+ ++ + +
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 12/205 (5%)
Query: 541 EIMGKSTYGTAYKATLEDGSE----VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLA 595
E++G+ +G Y TL D AVK L T G+ +F E + HPN+L+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
L L +G L+V +M G L +F+ V + + +A+G+ +L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLA-SK 211
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT-LGYR--APELSKLK 712
+H +L + N +LDEK ++ADFGL+R M +V G L + A E + +
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 713 NANTKTDVYSLGVIILELLT-GKSP 736
TK+DV+S GV++ EL+T G P
Sbjct: 272 KFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 56/219 (25%), Positives = 111/219 (50%), Gaps = 15/219 (6%)
Query: 541 EIMGKSTYGTAYKATLEDGSE-----VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLL 594
+++G +G YK L+ S VA+K L+ T+ Q+ +F EA +G+ H N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 595 ALRAYYLGPKGE-KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
L K + +++ ++M G+L FL + E + + + GIA G+ YL
Sbjct: 110 RLEGVIS--KYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYLA- 164
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKL 711
N +H +L + N+L++ +++DFGLSR++ + G + R APE
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 712 KNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
+ + +DV+S G+++ E++T G+ P ++ ++ + +
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 58/212 (27%), Positives = 106/212 (50%), Gaps = 14/212 (6%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
+ +GK +G G++VAVK ++ T + F AEA+ + ++ H NL+ L
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHG 660
+ KG +V ++M KGSL +L +RG + + ++ + + YL N +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYLE-GNNFVHR 141
Query: 661 NLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLKNANTKT 718
+L + NVL+ E +++DFGL++ + G L + APE + K +TK+
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 719 DVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
DV+S G+++ E+ + G+ P + D+ V
Sbjct: 196 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 69/295 (23%), Positives = 117/295 (39%), Gaps = 30/295 (10%)
Query: 109 EKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTL 168
+ L + LS + + +L NL G+ L +N+++ + P + N + L
Sbjct: 35 VTQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDNQIT-DLAP-LKNLTKITEL 90
Query: 169 DLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVP 228
+LS N + + +A + L+L+ + PL+ L +L VL L N ++
Sbjct: 91 ELSGN-PLKNVSA-IAGLQSIKTLDLTSTQITDVTPLA--GLSNLQVLYLDLNQIT---- 142
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLS 288
N LAG LQ+L++ + ++ P L L L + NKI P L L
Sbjct: 143 -NISPLAGLT--NLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP--LASLP 195
Query: 289 KLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLN-LKNNQ 347
L ++ L N I P N ++L + L N + N+ NL V N +K
Sbjct: 196 NLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV---FYNNNLVVPNVVKGPS 250
Query: 348 FKGHIPETIGNISGINQLDLSEN--DFTGEISPSLASLANLTSFNVSYNNLSGSV 400
P TI + +L+ N F +S + + V + SG+V
Sbjct: 251 GAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVPF---SGTV 302
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 60/266 (22%), Positives = 101/266 (37%), Gaps = 26/266 (9%)
Query: 138 LPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197
L N + + ++ + + + TL + I + L L L N
Sbjct: 18 LANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGT-GVTTIEG-VQYLNNLIGLELKDN 73
Query: 198 SLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIP 257
+ + L L ++ L L N L +V +AG + ++ L+L I P
Sbjct: 74 Q-ITDLA-PLKNLTKITELELSGNPLK-NVSA----IAGLQ--SIKTLDLTSTQITDVTP 124
Query: 258 VSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSL 317
L L LQ + L N+I P L L+ LQ L + + P N++ L +L
Sbjct: 125 --LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL 178
Query: 318 NLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEIS 377
++N++ + I L L NL ++LKNNQ P + N S + + L+ T +
Sbjct: 179 KADDNKI-SDIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT---N 231
Query: 378 PSLASLANLTSFNVSYNNLSGSVPPL 403
+ NL NV + P
Sbjct: 232 QPVFYNNNLVVPNVVKGPSGAPIAPA 257
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 50/266 (18%), Positives = 105/266 (39%), Gaps = 24/266 (9%)
Query: 161 NCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQH 220
N + + + + A+ + L+ + +I + L +L L L+
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGT-GVTTIE-GVQYLNNLIGLELKD 72
Query: 221 NNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPI 280
N ++ + L ++ L L N + ++ L ++ + L+ +I
Sbjct: 73 NQIT-DLAP----LKNLT--KITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVT 123
Query: 281 PDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTV 340
P L LS LQ L L N I P +T+L L++ N ++ + + L L LT
Sbjct: 124 P--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV-SDL-TPLANLSKLTT 177
Query: 341 LNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSV 400
L +N+ I + ++ + ++ L N + ++SP LA+ +NL ++ ++ +
Sbjct: 178 LKADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTIT-NQ 232
Query: 401 PPLLSKKFNSSSFVGNLQLCGYSPST 426
P + + V +P+T
Sbjct: 233 PVFYNNNLVVPNVVKGPSGAPIAPAT 258
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 54/234 (23%), Positives = 96/234 (41%), Gaps = 23/234 (9%)
Query: 170 LSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229
++ I I P ++ +++ ++ + L ++ L+ ++ ++
Sbjct: 3 ITQPTAINVIFP-DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG 58
Query: 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSK 289
+ L L L N I P L L + E+ LS N + + L
Sbjct: 59 ----VQYLN--NLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK--NVSAIAGLQS 108
Query: 290 LQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFK 349
++ LDL+ I P +++L L L+ N++ N L L NL L++ N Q
Sbjct: 109 IKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVS 164
Query: 350 GHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPL 403
P + N+S + L +N + +ISP LASL NL ++ N +S V PL
Sbjct: 165 DLTP--LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVSPL 213
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 44/216 (20%), Positives = 96/216 (44%), Gaps = 18/216 (8%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
+ +G +G +VA+K ++E + + EF EA + + H L+ L
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQL---- 84
Query: 601 LG--PKGE-KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
G K ++ ++M G L ++L + + + + YL +
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLE-SKQF 141
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT-LGYR--APELSKLKNA 714
+H +L + N L++++ +++DFGLSR + + ++ G+ R PE+
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 715 NTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
++K+D+++ GV++ E+ + GK P E + + +
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-28
Identities = 65/262 (24%), Positives = 98/262 (37%), Gaps = 23/262 (8%)
Query: 109 EKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTL 168
K +L + V L ++ + N+ + S+ I PN+ L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 70
Query: 169 DLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVP 228
L+ N + I P L N L L L N + + SL L L L+L+HN +S +
Sbjct: 71 FLNGN-KLTDIKP-LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DIN 125
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLS 288
L QL+ L L +N I T L +L L +SL N+I I L L+
Sbjct: 126 G----LVHLP--QLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISD-IVP-LAGLT 175
Query: 289 KLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQF 348
KLQ L LS N I S + +L L L + NK L + +
Sbjct: 176 KLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
Query: 349 KGHIPETIGNISGINQLDLSEN 370
PE I + + ++ +
Sbjct: 234 --VTPEIISDDGDYEKPNVKWH 253
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 104 bits (259), Expect = 3e-23
Identities = 54/245 (22%), Positives = 90/245 (36%), Gaps = 23/245 (9%)
Query: 165 LQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLS 224
+ + I I P + NL S+ ++ + L S+ + ++++
Sbjct: 1 MGETITVSTP-IKQIFP-DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 56
Query: 225 GSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDEL 284
SV + + L L+ N + P L L L + L NKI L
Sbjct: 57 -SVQG----IQYLP--NVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSS--L 105
Query: 285 GKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLK 344
L KL+ L L +N I ++ L SL L NN++ L RL L L+L+
Sbjct: 106 KDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLE 161
Query: 345 NNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLL 404
+NQ I + ++ + L LS+N + ++ LA L NL +
Sbjct: 162 DNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQ 217
Query: 405 SKKFN 409
S
Sbjct: 218 SNLVV 222
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.2 bits (223), Expect = 7e-19
Identities = 41/213 (19%), Positives = 83/213 (38%), Gaps = 13/213 (6%)
Query: 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAI 300
+ NL + + +L + +I +++ I + L + KL L+ N +
Sbjct: 22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--SVQGIQYLPNVTKLFLNGNKL 77
Query: 301 GGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNIS 360
P TN+ +L L L+ N++ + L+ L+ L L+L++N I + ++
Sbjct: 78 TDIKP--LTNLKNLGWLFLDENKI-KDL-SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLP 131
Query: 361 GINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQLC 420
+ L L N T +I+ L+ L L + ++ N +S + PL + ++ +
Sbjct: 132 QLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHIS 188
Query: 421 GYSPSTACPSLAPLSLPPPPVEAPKHHHHRKLS 453
+L L L +H L
Sbjct: 189 DLRALAGLKNLDVLELFSQECLNKPINHQSNLV 221
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 50/236 (21%), Positives = 94/236 (39%), Gaps = 45/236 (19%)
Query: 541 EIMGKSTYGTAYKATLEDGS--------EVAVKRLREKTTKGQKEFEAEAAAIGKIHHPN 592
E +G+ T+ +K + EV +K L + + F A+ + K+ H +
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 593 LLALRAYYLG---PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLN 649
L+ G E +LV +F+ GSL ++L + W + A +A ++
Sbjct: 74 LVLN----YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV--AKQLAAAMH 127
Query: 650 YLHVEENMIHGNLTSSNVLLDEKTNPR--------IADFGLSRLMTAAANTNVIATAGTL 701
+L E +IHGN+ + N+LL + + + ++D G+S +
Sbjct: 128 FLE-ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-----------LPKD 175
Query: 702 GYR------APE-LSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
+ PE + KN N TD +S G + E+ + G P ++ Q+
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 60/229 (26%), Positives = 91/229 (39%), Gaps = 22/229 (9%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR--EKTTKGQKEFEAEAAAIGKI-HHPNLLAL 596
+G +YG +K EDG AVKR + K + AE + K+ HP + L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 597 RAYYLGPKGEKL-LVFDFMPKGSLASFLHARG---PETIVNWATRMSIAIGIARGLNYLH 652
+ +G L L + SL A G PE V L +LH
Sbjct: 123 EQAWE--EGGILYLQTELC-GPSLQQHCEAWGASLPEAQV-----WGYLRDTLLALAHLH 174
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLK 712
+ ++H ++ +N+ L + ++ DFGL + A V G Y APEL +
Sbjct: 175 -SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ--EGDPRYMAPELLQ-G 230
Query: 713 NANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEV 761
+ T DV+SLG+ ILE+ P G Q + E+T +
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL--PHGGEGWQQLRQGYLPPEFTAGL 277
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 55/213 (25%), Positives = 106/213 (49%), Gaps = 14/213 (6%)
Query: 541 EIMGKSTYGTAYKATLEDGSE----VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLA 595
+++G +G L+ S+ VA+K L+ T+ Q+ +F EA+ +G+ HPN++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 596 LRAYYLGPKGE-KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
L K + ++V ++M GSL SFL + + + GIA G+ YL +
Sbjct: 111 LEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYLS-D 165
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLK 712
+H +L + N+L++ +++DFGL R++ G + R +PE +
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 713 NANTKTDVYSLGVIILELLT-GKSPGEPMNGMD 744
+ +DV+S G+++ E+++ G+ P M+ D
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 65/216 (30%), Positives = 108/216 (50%), Gaps = 16/216 (7%)
Query: 541 EIMGKSTYGTAYKATLEDGS-EVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+G YG Y+ + S VAVK L+E T + +EF EAA + +I HPNL+ L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQL--- 74
Query: 600 YLG--PKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
LG + ++ +FM G+L +L + + + + +A I+ + YL ++N
Sbjct: 75 -LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLE-KKN 131
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLKNA 714
IH +L + N L+ E ++ADFGLSRLMT +T + APE
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 715 NTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
+ K+DV++ GV++ E+ T G SP ++ + + +
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-28
Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 27/219 (12%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
++GK TYG Y L + +A+K + E+ ++ + E A + H N++
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83
Query: 600 YLG--PKGEKLLVF-DFMPKGSLASFLHARG-----PETIVNWATRMSIAIGIARGLNYL 651
YLG + + +F + +P GSL++ L ++ E + + T+ I GL YL
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYL 138
Query: 652 HVEENMIHGNLTSSNVLLDEKT-NPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE--L 708
H + ++H ++ NVL++ + +I+DFG S+ + A N GTL Y APE
Sbjct: 139 H-DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIID 196
Query: 709 SKLKNANTKTDVYSLGVIILELLTGKSP----GEPMNGM 743
+ D++SLG I+E+ TGK P GEP M
Sbjct: 197 KGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-27
Identities = 60/224 (26%), Positives = 109/224 (48%), Gaps = 13/224 (5%)
Query: 533 DDLLCATAEIMGKSTYGTAYKATLEDGSE---VAVKRLREKTTKGQK-EFEAEAAAIGKI 588
D+LL A E+ G +G+ + + VA+K L++ T K E EA + ++
Sbjct: 335 DNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393
Query: 589 HHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGL 648
+P ++ L +LV + G L FL + E + + + ++ G+
Sbjct: 394 DNPYIVRLIGVCQAE--ALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 449
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--AP 706
YL E+N +H NL + NVLL + +I+DFGLS+ + A + +AG + AP
Sbjct: 450 KYLE-EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 508
Query: 707 ELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
E + ++++DV+S GV + E L+ G+ P + M G ++ ++
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
E +G +G + ++VAVK L++ + F AEA + ++ H L+ L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRL---- 73
Query: 601 LG--PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
+ ++ ++M GSL FL + + +A IA G+ ++ E N I
Sbjct: 74 YAVVTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE-ERNYI 131
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLKNANT 716
H +L ++N+L+ + + +IADFGL+RL+ N + APE
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 717 KTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
K+DV+S G+++ E++T G+ P M ++ Q +
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL 223
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 15/212 (7%)
Query: 541 EIMGKSTYGTAYKATLED-----GSEVAVKRLRE-KTTKGQKEFEAEAAAIGKIHHPNLL 594
+G+ +G + G VAVK L+ + + ++ E + ++H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 595 ALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
+ L LV +++P GSL +L + A + A I G+ YLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLH- 151
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKL 711
++ IH +L + NVLLD +I DFGL++ + + G APE K
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 211
Query: 712 KNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742
+DV+S GV + ELLT S P
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK 243
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 45/218 (20%), Positives = 90/218 (41%), Gaps = 17/218 (7%)
Query: 541 EIMGKSTYGTAYKATLEDGSE----VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLA 595
+G+ +G ++ VA+K + T+ + +F EA + + HP+++
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
L ++ + G L SFL R + + + A ++ L YL +
Sbjct: 81 LIGVITENP--VWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLE-SK 135
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTL---GYRAPELSKLK 712
+H ++ + NVL+ ++ DFGLSR M ++ + + APE +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAPESINFR 192
Query: 713 NANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
+ +DV+ GV + E+L G P + + D+ +
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 544 GKSTYGTAYKATLEDGS---EVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRA 598
G +GT K + VAVK L+ + + E AEA + ++ +P ++ +
Sbjct: 26 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
+LV + G L +L V + + ++ G+ YL E N +
Sbjct: 86 ICEAES--WMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE-ESNFV 139
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKLKNANT 716
H +L + NVLL + +I+DFGLS+ + A N T G + APE ++
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199
Query: 717 KTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
K+DV+S GV++ E + G+ P M G ++ +
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 73/311 (23%), Positives = 116/311 (37%), Gaps = 51/311 (16%)
Query: 109 EKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTL 168
K +L + V L ++ + N+ + S+ I PN+ L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73
Query: 169 DLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVP 228
L+ N + I P LAN L L L N + + SL L L L+L+HN +S +
Sbjct: 74 FLNGN-KLTDIKP-LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DIN 128
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLS 288
L QL+ L L +N I T L +L L +SL N+I +P L L+
Sbjct: 129 G----LVHLP--QLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLT 178
Query: 289 KLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQF 348
KLQ L LS N +I+ L L L+NL VL L + +
Sbjct: 179 KLQNLYLSKN-----------HISDL---------------RALAGLKNLDVLELFSQEC 212
Query: 349 KGHIPETIGNISGINQLDLSENDFTGEISPSLAS-LANLTSFNVSYNNLSGSVPPLLSKK 407
N+ N + ++ ++P + S + NV ++ + +S
Sbjct: 213 LNKPINHQSNLVVPNTVKNTDGSL---VTPEIISDDGDYEKPNVKWHLPEFT--NEVSFI 267
Query: 408 FNSSSFVGNLQ 418
F +G +
Sbjct: 268 FYQPVTIGKAK 278
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 49/220 (22%), Positives = 97/220 (44%), Gaps = 21/220 (9%)
Query: 541 EIMGKSTYGTAYKATLEDGSE----VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLA 595
I+G+ +G Y+ + VAVK ++ T K +F +EA + + HP+++
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 596 LRAYYLG--PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
L +G + ++ + P G L +L + T + ++ I + + YL
Sbjct: 78 L----IGIIEEEPTWIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAMAYLE- 130
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGT-LGYR--APELSK 710
N +H ++ N+L+ ++ DFGLSR + + + + T L + +PE
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTRLPIKWMSPESIN 187
Query: 711 LKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
+ T +DV+ V + E+L+ GK P + D+ +
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 47/214 (21%), Positives = 88/214 (41%), Gaps = 26/214 (12%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+G+ ++G ++ + G + AVK++R + + + E A + P ++
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVP---- 114
Query: 600 YLG--PKGEKLLVF-DFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVE 654
G +G + +F + + GSL + G PE + GL YLH
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ-----ALEGLEYLH-T 168
Query: 655 ENMIHGNLTSSNVLLDEKTNP-RIADFGLSRLMTAAANTNVIATA----GTLGYRAPELS 709
++HG++ + NVLL + + DFG + + + T GT + APE+
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743
K + K D++S ++L +L G P
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 262
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 31/221 (14%)
Query: 541 EIMGKSTYGTAYKATL------EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLL 594
+G+ +G + A +D VAVK L++ T +K+F+ EA + + H +++
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 595 ALRAYYLG--PKGE-KLLVFDFMPKGSLASFLHARGPETIVNWATR-------------M 638
G G+ ++VF++M G L FL A GP+ ++ + +
Sbjct: 81 KF----YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 639 SIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA 698
IA IA G+ YL ++ +H +L + N L+ +I DFG+SR + + + +
Sbjct: 137 HIASQIASGMVYLA-SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVY-STDYYRVGGH 194
Query: 699 GTLGYR--APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
L R PE + T++DV+S GVI+ E+ T GK P
Sbjct: 195 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-26
Identities = 51/219 (23%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 541 EIMGKSTYGTAYKATLEDGSE----VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLLA 595
+G+ +G ++ VA+K + T+ + +F EA + + HP+++
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 596 LRAYYLG--PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
L +G + ++ + G L SFL R ++ A+ + A ++ L YL
Sbjct: 456 L----IGVITENPVWIIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTALAYLE- 508
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR--APELSKL 711
+ +H ++ + NVL+ ++ DFGLSR M +T A+ G L + APE
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINF 566
Query: 712 KNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749
+ + +DV+ GV + E+L G P + + D+ +
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-26
Identities = 73/318 (22%), Positives = 108/318 (33%), Gaps = 32/318 (10%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRL-SGSIPPSI-GNCPNLQTLD 169
L +L L L N + L NL + L L + + +L+ L
Sbjct: 76 RGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLV 135
Query: 170 LSNNALIGAIPPSLA--NSTRLYRLNLSYNSLLGSIPLSLTRLPS--LSVLALQHNNLSG 225
L +N I I P+ N R + L+L++N + L ++L L L
Sbjct: 136 LRDNN-IKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQD 194
Query: 226 SVPNN-WGVLAGN--KSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEI------------- 269
GN K+ + L+L N ++ +I
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS 254
Query: 270 SLSHNKIVGPIPDELGKL--SKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNK 327
S H P L S ++ DLS + I F++ T L L L N + NK
Sbjct: 255 SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEI-NK 313
Query: 328 IPEG-LERLQNLTVLNLKNNQFKGHIPETI-GNISGINQLDLSENDFTGEISP-SLASLA 384
I + L +L LNL N I + N+ + LDLS N + S L
Sbjct: 314 IDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLP 371
Query: 385 NLTSFNVSYNNLSGSVPP 402
NL + N L SVP
Sbjct: 372 NLKELALDTNQLK-SVPD 388
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 53/337 (15%), Positives = 107/337 (31%), Gaps = 55/337 (16%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNAL 175
+ + L N +A S L +L+ + + I + +L L L N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 176 IGAIPPS-LANSTRLYRLNLSYNSLLGSI--PLSLTRLPSLSVLALQHNNLSGSVP---- 228
+ L L L+ +L G++ L SL +L L+ NN+ P
Sbjct: 92 -LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFF 150
Query: 229 -------------NNW-----GVLAGNKSYQLQFLNLDHN--------LIAGTIPVSLGK 262
N L + L L + + K
Sbjct: 151 LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 263 LGLLQEISLSHNKIVGPIP---DELGKLSKLQKL----------DLSYNAIGGSFPVTFT 309
+ + LS N + + +K+Q L + TF
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270
Query: 310 NI--TSLVSLNLENNRLGNKIPEGL-ERLQNLTVLNLKNNQFKGHIPETI-GNISGINQL 365
+ + + + +L +++ + + + +L L L N+ I + ++ + +L
Sbjct: 271 GLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKL 328
Query: 366 DLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402
+LS+N S +L L ++SYN++ ++
Sbjct: 329 NLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGD 364
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-25
Identities = 66/313 (21%), Positives = 111/313 (35%), Gaps = 33/313 (10%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGF--LPNLRGVYLFNNRLSGSIPPSI--GNCPNLQT 167
+ L L L+L L G V F L +L + L +N + I P+ N
Sbjct: 100 NGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHV 158
Query: 168 LDLSNNALIGAIPPSL---ANSTRLYRLNLSYNSLL--------GSIPLSLTRLPSLSVL 216
LDL+ N + +I L LS +L + + S++ L
Sbjct: 159 LDLTFNK-VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTL 217
Query: 217 ALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKL------GL----L 266
L N S+ + Q L+ +N+ + + GL +
Sbjct: 218 DLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGV 277
Query: 267 QEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGN 326
+ LS +KI + + L++L L+ N I F +T L+ LNL N LG+
Sbjct: 278 KTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGS 337
Query: 327 KIPEGL-ERLQNLTVLNLKNNQFKGHIPE-TIGNISGINQLDLSENDFTGEISPS-LASL 383
I + E L L VL+L N + + + + + + +L L N + L
Sbjct: 338 -IDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRL 394
Query: 384 ANLTSFNVSYNNL 396
+L + N
Sbjct: 395 TSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 52/295 (17%), Positives = 95/295 (32%), Gaps = 39/295 (13%)
Query: 139 PNLRGVYLFNNRLSGSIPP-SIGNCPNLQTLDLSNNALIGAIPP-SLANSTRLYRLNLSY 196
++ V L N ++ + S +LQ L + I + + L L L Y
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 197 NSLLGSIPLS-LTRLPSLSVLALQHNNL-SGSVPNNWGVLAGNKSYQLQFLNLDHNLIAG 254
N L + L +L VL L NL + S L+ L L N I
Sbjct: 89 NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSG--NFFKPLTS--LEMLVLRDNNIKK 143
Query: 255 TIPVSL-GKLGLLQEISLSHNKIVGPIPDELGKLSKL----------QKLDLSYNAIGGS 303
P S + + L+ NK+ ++L D++ +G
Sbjct: 144 IQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWE 203
Query: 304 FPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVL-------------NLKNNQFKG 350
TS+ +L+L N + + T + + + FK
Sbjct: 204 KCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKD 263
Query: 351 HIPETIGNI--SGINQLDLSENDFTGEISPSL-ASLANLTSFNVSYNNLSGSVPP 402
T + SG+ DLS++ + S+ + +L ++ N ++ +
Sbjct: 264 PDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDD 316
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 51/255 (20%), Positives = 86/255 (33%), Gaps = 44/255 (17%)
Query: 97 QLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIP 156
+ LG + ++ L L N + F + G + + LS S
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAK--RFFDAIAGTKIQSLILSNSYN 251
Query: 157 PSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSL-TRLPSLSV 215
D N G + +LS + + ++ S+ + L
Sbjct: 252 MGSSFGHT-NFKDPDNFTFKGLEASGVK------TCDLSKSK-IFALLKSVFSHFTDLEQ 303
Query: 216 LALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNK 275
L L N ++ + + G L LNL N + G+I
Sbjct: 304 LTLAQNEIN-KIDD--NAFWGLT--HLLKLNLSQNFL-GSID------------------ 339
Query: 276 IVGPIPDELGKLSKLQKLDLSYNAIGGSFPV-TFTNITSLVSLNLENNRLGNKIPEG-LE 333
L KL+ LDLSYN I + +F + +L L L+ N+L +P+G +
Sbjct: 340 -----SRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQL-KSVPDGIFD 392
Query: 334 RLQNLTVLNLKNNQF 348
RL +L + L N +
Sbjct: 393 RLTSLQKIWLHTNPW 407
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 541 EIMGKSTYGTAYKATLEDGSE------VAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLL 594
+G+ +G + A + VAVK L+E + +++F+ EA + + H +++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 595 ALRAYYLG--PKGE-KLLVFDFMPKGSLASFLHARGPETIVNWATR------------MS 639
G +G L+VF++M G L FL + GP+ + ++
Sbjct: 107 RF----FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 640 IAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAG 699
+A +A G+ YL + +H +L + N L+ + +I DFG+SR + + + +
Sbjct: 163 VASQVAAGMVYLA-GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-YSTDYYRVGGRT 220
Query: 700 TLGYR--APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
L R PE + T++DV+S GV++ E+ T GK P
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-26
Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 15/216 (6%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKE-FEAEAAAIGKIHHPNLLALRA 598
E +G +G + + G +VA+K+ R++ + +E + E + K++HPN+++ R
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 599 YY-----LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
L P LL ++ G L +L+ + ++ I+ L YLH
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH- 138
Query: 654 EENMIHGNLTSSNVLLDEKTNPR---IADFGLSRLMTAAANTNVIATA-GTLGYRAPELS 709
E +IH +L N++L I D G ++ + + GTL Y APEL
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---QGELCTEFVGTLQYLAPELL 195
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745
+ K D +S G + E +TG P P
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 46/249 (18%), Positives = 96/249 (38%), Gaps = 21/249 (8%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRL-REKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
+I+G+ ++ + G A+K + E + K++H N++ L A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
L+ +F P GSL + L + + + + + G+N+L E +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-ENGI 133
Query: 658 IHGNLTSSNVLL----DEKTNPRIADFGLSRLMTAAANTNVIATA-GTLGYRAPEL---- 708
+H N+ N++ D ++ ++ DFG +R + + + GT Y P++
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVSLYGTEEYLHPDMYERA 190
Query: 709 ----SKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL-PQWVASIVKEEWTNEVFD 763
K D++S+GV TG P P G + + I+ + + +
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 764 LELMRDNTI 772
++ + I
Sbjct: 251 VQKAENGPI 259
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 25/216 (11%)
Query: 541 EIMGKSTYGTAYKATLEDGSE----VAVKRLREKTTKGQ--KEFEAEAAAIGKIHHPNLL 594
++GK +G+ +A L+ VAVK L+ +EF EAA + + HP++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 595 AL-----RAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATR---MSIAIGIAR 646
L R+ G +++ FM G L +FL A + + IA
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR-- 704
G+ YL N IH +L + N +L E +ADFGLSR + + G
Sbjct: 149 GMEYLS-SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI----YSGDYYRQGCASKLPV 203
Query: 705 ---APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
A E +DV++ GV + E++T G++P
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 45/193 (23%), Positives = 99/193 (51%), Gaps = 11/193 (5%)
Query: 549 GTAYKAT-LEDGSEVAVKRLREKTTKGQ---KEFEAEAAAIGKIHHPNLLALRAYYLGPK 604
T Y A +VA+K + + + K FE E ++ H N++++ + +
Sbjct: 25 STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM--IDVDEE 82
Query: 605 GEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLT 663
+ LV +++ +L+ ++ + GP ++ T ++ I G+ + H + ++H ++
Sbjct: 83 DDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH-DMRIVHRDIK 138
Query: 664 SSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSL 723
N+L+D +I DFG+++ ++ + T GT+ Y +PE +K + + TD+YS+
Sbjct: 139 PQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSI 198
Query: 724 GVIILELLTGKSP 736
G+++ E+L G+ P
Sbjct: 199 GIVLYEMLVGEPP 211
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 541 EIMGKSTYGTAYKATLEDGSE----VAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLL 594
+I+G+ +G+ + L+ VAVK ++ + + +EF +EAA + HPN++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 595 ALRAYYLG--------PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATR---MSIAIG 643
L LG + +++ FM G L ++L ET + +
Sbjct: 100 RL----LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGY 703
IA G+ YL N +H +L + N +L + +ADFGLS+ + + + +
Sbjct: 156 IALGMEYLS-NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI-YSGDYYRQGRIAKMPV 213
Query: 704 R--APELSKLKNA-NTKTDVYSLGVIILELLT-GKSP 736
+ A E S +K+DV++ GV + E+ T G +P
Sbjct: 214 KWIAIE-SLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 38/225 (16%)
Query: 541 EIMGKSTYGTAYKATLEDGSE------VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNL 593
E +G+ +G YK L + VA+K L++K + EF EA ++ HPN+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 594 LALRAYYLG--PKGE-KLLVFDFMPKGSLASFLHARGPETIVNWATR------------- 637
+ L LG K + ++F + G L FL R P + V
Sbjct: 75 VCL----LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 638 MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697
+ + IA G+ YL +++H +L + NVL+ +K N +I+D GL R +
Sbjct: 131 VHLVAQIAAGMEYLS-SHHVVHKDLATRNVLVYDKLNVKISDLGLFREV----YAADYYK 185
Query: 698 AGTLGY---R--APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
R APE + +D++S GV++ E+ + G P
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 26/216 (12%)
Query: 541 EIMGKSTYGTAYKATLEDGSE------VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNL 593
+G+ ++G Y+ + + VA+K + E + ++ EF EA+ + + + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 594 LALRAYYLG---PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATR-------MSIAIG 643
+ L LG L++ + M +G L S+L + P N + +A
Sbjct: 91 VRL----LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 146
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGY 703
IA G+ YL+ +H +L + N ++ E +I DFG++R + + G L
Sbjct: 147 IADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPV 204
Query: 704 R--APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
R +PE K T +DV+S GV++ E+ T + P
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 55/251 (21%), Positives = 109/251 (43%), Gaps = 19/251 (7%)
Query: 516 EMGGKLVHFDGPFLFTADDLLCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLR-EKTTK 573
+ L DD +G G +K + G +A K + E
Sbjct: 16 RLEAFLTQKQKVGELKDDDFE--KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA 73
Query: 574 GQKEFEAEAAAIGKIHHPNLLA-LRAYYLGPKGEKLLVFDFMPKGSLASFLHARG--PET 630
+ + E + + + P ++ A+Y GE + + M GSL L G PE
Sbjct: 74 IRNQIIRELQVLHECNSPYIVGFYGAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQ 131
Query: 631 IVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA- 689
I+ ++I + +GL YL + ++H ++ SN+L++ + ++ DFG+S + +
Sbjct: 132 IL-----GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186
Query: 690 ANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWV 749
AN+ V GT Y +PE + + + ++D++S+G+ ++E+ G+ P P + +L
Sbjct: 187 ANSFV----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 750 ASIVKEEWTNE 760
V+ +
Sbjct: 243 GCQVEGDAAET 253
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 549 GTAYKATLED---GSEVAVKRLREKTTKG---QKEFEAEAAAIGKIHHPNLLALRAYYLG 602
G Y+A ED VA+K + E + + + EA G++ P+++ + + G
Sbjct: 48 GDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI--HDFG 103
Query: 603 PKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGN 661
+L + + LA+ L +GP + ++I I L+ H H +
Sbjct: 104 EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAH-AAGATHRD 159
Query: 662 LTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVY 721
+ N+L+ + DFG++ T T + T GTL Y APE +A + D+Y
Sbjct: 160 VKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIY 219
Query: 722 SLGVIILELLTGKSP--GEPM 740
+L ++ E LTG P G+ +
Sbjct: 220 ALTCVLYECLTGSPPYQGDQL 240
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 26/216 (12%)
Query: 541 EIMGKSTYGTAYKATL------EDGSEVAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNL 593
+G +G Y+ + +VAVK L E ++ + +F EA I K +H N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 594 LALRAYYLG--PKGE-KLLVFDFMPKGSLASFLHARGPETIVNWATRM----SIAIGIAR 646
+ +G + + ++ + M G L SFL P + M +A IA
Sbjct: 96 VRC----IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPR---IADFGLSRLMTAAANTNVIATAGTLGY 703
G YL E + IH ++ + N LL R I DFG++R + A+ L
Sbjct: 152 GCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRASYYRKGGCAMLPV 209
Query: 704 R--APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
+ PE +KTD +S GV++ E+ + G P
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 33/213 (15%), Positives = 73/213 (34%), Gaps = 22/213 (10%)
Query: 544 GKSTYGTAYKAT------LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
G+ + Y+AT ++ + +K + + +
Sbjct: 74 GEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFY 133
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVEE 655
+ +L +LV + G+L + ++ PE ++ +S A+ + + +H +
Sbjct: 134 SAHLFQN-GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH-DC 191
Query: 656 NMIHGNLTSSNVLL-----------DEKTNPRIADFGLSRLMTAAANTNVIATA-GTLGY 703
+IHG++ N +L D + D G S M + T G+
Sbjct: 192 EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGF 251
Query: 704 RAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
+ E+ K N + D + + + +L G
Sbjct: 252 QCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 57/233 (24%), Positives = 94/233 (40%), Gaps = 20/233 (8%)
Query: 148 NNRLSGSIPPSIGNCP-NLQTLDLSNNALIGAIPP-SLANSTRLYRLNLSYNSLLGSIPL 205
IP ++ P + + LDLS N + + S + L L+LS + +I
Sbjct: 16 ELNFY-KIPDNL---PFSTKNLDLSFN-PLRHLGSYSFFSFPELQVLDLSRCEI-QTIED 69
Query: 206 SL-TRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLG 264
L LS L L N + S+ A + LQ L +A +G L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQ-SLALG----AFSGLSSLQKLVAVETNLASLENFPIGHLK 124
Query: 265 LLQEISLSHNKI-VGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSL----VSLNL 319
L+E++++HN I +P+ L+ L+ LDLS N I + + + +SL+L
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 320 ENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDF 372
N + N I G + L L L NQ K ++ + ++ L N +
Sbjct: 185 SLNPM-NFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 236
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-23
Identities = 62/221 (28%), Positives = 93/221 (42%), Gaps = 21/221 (9%)
Query: 136 GFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNALIGAIPPSL-ANSTRLYRLN 193
+ + + L N L + + P LQ LDLS I I + + L L
Sbjct: 25 NLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLI 82
Query: 194 LSYNSLLGSIPLSL-TRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLI 252
L+ N + S+ L + L SL L NL+ S+ N L+ LN+ HNLI
Sbjct: 83 LTGN-PIQSLALGAFSGLSSLQKLVAVETNLA-SLENF----PIGHLKTLKELNVAHNLI 136
Query: 253 AGTIPVS--LGKLGLLQEISLSHNKIVGPIPDELGKLSKLQ----KLDLSYNAIGGSFPV 306
+ + L L+ + LS NKI +L L ++ LDLS N + P
Sbjct: 137 Q-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195
Query: 307 TFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNN 346
F I L L L+ N+L + +P+G +RL +L + L N
Sbjct: 196 AFKEI-RLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 48/214 (22%), Positives = 82/214 (38%), Gaps = 17/214 (7%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNAL 175
+ L L N L +S P L+ + L + +I + +L TL L+ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN-P 87
Query: 176 IGAIPPSL-ANSTRLYRLNLSYNSLLGSIP-LSLTRLPSLSVLALQHNNLSGSVPNNWGV 233
I ++ + + L +L +L S+ + L +L L + HN + S
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLP-EY 144
Query: 234 LAGNKSYQLQFLNLDHNLIAGTIPV----SLGKL-GLLQEISLSHNKIVGPIPDELGKLS 288
+ L+ L+L N I +I L ++ L + LS N + I K
Sbjct: 145 FSN--LTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEI 200
Query: 289 KLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENN 322
+L++L L N + F +TSL + L N
Sbjct: 201 RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 63/250 (25%), Positives = 97/250 (38%), Gaps = 38/250 (15%)
Query: 157 PSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVL 216
P + PN T IP +L ST+ L+LS+N L S P L VL
Sbjct: 2 PCVEVVPN-ITYQCMELNFY-KIPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVL 57
Query: 217 ALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSL-GKLGLLQEISLSHNK 275
L + ++ + G L L L N I ++ + L LQ++
Sbjct: 58 DLSRCEIQ-TIED--GAYQSLS--HLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETN 111
Query: 276 IVGPIPDELGKLSKLQKLDLSYNAIGGSFPV--TFTNITSLVSLNLENNRLGNKIPEG-L 332
+ +G L L++L++++N I SF + F+N+T+L L+L +N++ + I L
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDL 169
Query: 333 ERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVS 392
L + +LNL LDLS N I P L +
Sbjct: 170 RVLHQMPLLNL--------------------SLDLSLNPMN-FIQPGAFKEIRLKELALD 208
Query: 393 YNNLSGSVPP 402
N L SVP
Sbjct: 209 TNQLK-SVPD 217
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 41/170 (24%), Positives = 70/170 (41%), Gaps = 15/170 (8%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDL 170
L L L L N + + L +L+ + L+ S+ G+ L+ L++
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNV 131
Query: 171 SNNALIGAIPPSL-ANSTRLYRLNLSYNSLLGSIPL----SLTRLPSLSV-LALQHNNLS 224
++N + P +N T L L+LS N + SI L ++P L++ L L N ++
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNK-IQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 225 GSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHN 274
+ G +L+ L LD N + +L LQ+I L N
Sbjct: 191 -FIQP--GAFKE---IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 16/211 (7%)
Query: 138 LPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197
+ + V L+ ++PP + + L LS N L +L TRL +LNL
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 198 SLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIP 257
L + + LP L L L HN L S+P + L L++ N + ++P
Sbjct: 66 E-LTKLQVD-GTLPVLGTLDLSHNQLQ-SLP---LLGQTLP--ALTVLDVSFNRLT-SLP 116
Query: 258 VSL-GKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPV-TFTNITSLV 315
+ LG LQE+ L N++ P L KL+KL L+ N + P + +L
Sbjct: 117 LGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL-TELPAGLLNGLENLD 175
Query: 316 SLNLENNRLGNKIPEGLERLQNLTVLNLKNN 346
+L L+ N L IP+G L L N
Sbjct: 176 TLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 52/184 (28%), Positives = 77/184 (41%), Gaps = 13/184 (7%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALI 176
L L +NLL +L L + L L+ + G P L TLDLS+N L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQL- 89
Query: 177 GAIPPSLANSTRLYRLNLSYNSLLGSIPLSL-TRLPSLSVLALQHNNLSGSVPNNWGVLA 235
++P L L++S+N L S+PL L L L L+ N L ++P G+L
Sbjct: 90 QSLPLLGQTLPALTVLDVSFNR-LTSLPLGALRGLGELQELYLKGNELK-TLPP--GLLT 145
Query: 236 GNKSYQLQFLNLDHNLIAGTIPVSL-GKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLD 294
+ +L+ L+L +N + +P L L L + L N + IP L
Sbjct: 146 --PTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAF 201
Query: 295 LSYN 298
L N
Sbjct: 202 LHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 9e-20
Identities = 52/236 (22%), Positives = 79/236 (33%), Gaps = 40/236 (16%)
Query: 161 NCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQH 220
+ ++ L A+PP L T L+LS N L +L L+ L L
Sbjct: 8 KVASHLEVNCDKRNL-TALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 221 NNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPI 280
L+ + V G L +L + LSHN++ +
Sbjct: 65 AELT------------------------------KLQVD-GTLPVLGTLDLSHNQLQS-L 92
Query: 281 PDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGL-ERLQNLT 339
P L L LD+S+N + + L L L+ N L +P GL L
Sbjct: 93 PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLE 151
Query: 340 VLNLKNNQFKGHIPETI-GNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYN 394
L+L NN +P + + ++ L L EN I L + N
Sbjct: 152 KLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 48/166 (28%), Positives = 66/166 (39%), Gaps = 15/166 (9%)
Query: 112 SQLHALRKLSLHDNLLAG-PVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
L +L+L L V + LP L + L +N+L S+P P L LD+
Sbjct: 52 MPYTRLTQLNLDRAELTKLQVDGT---LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107
Query: 171 SNNALIGAIPPSL-ANSTRLYRLNLSYNSLLGSIPLSL-TRLPSLSVLALQHNNLSGSVP 228
S N + ++P L L L N L ++P L T P L L+L +NNL+ +P
Sbjct: 108 SFNR-LTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELP 164
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHN 274
N L L L N + TIP LL L N
Sbjct: 165 AG----LLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 29/114 (25%), Positives = 43/114 (37%), Gaps = 6/114 (5%)
Query: 290 LQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFK 349
L LS N + T T L LNL+ L + L L L+L +NQ +
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ 90
Query: 350 GHIPETIGNISGINQLDLSENDFTGEISPSL-ASLANLTSFNVSYNNLSGSVPP 402
+P + + LD+S N T + L L + N L ++PP
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPP 141
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 35/117 (29%), Positives = 47/117 (40%), Gaps = 5/117 (4%)
Query: 107 ISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNL 165
+ L AL L + N L +L L L+ +YL N L ++PP + P L
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKL 150
Query: 166 QTLDLSNNALIGAIPPSL-ANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHN 221
+ L L+NN L +P L L L L NS L +IP L L N
Sbjct: 151 EKLSLANNNL-TELPAGLLNGLENLDTLLLQENS-LYTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 26/117 (22%), Positives = 46/117 (39%), Gaps = 9/117 (7%)
Query: 287 LSKLQKLDLSYNAIGGSFPVTFTNI-TSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKN 345
++ +++ + + P ++ L+L N L L LT LNL
Sbjct: 9 VASHLEVNCDKRNLT-ALP---PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 346 NQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402
+ + G + + LDLS N + +L LT +VS+N L+ S+P
Sbjct: 65 AELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL 117
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 45/249 (18%), Positives = 95/249 (38%), Gaps = 21/249 (8%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRL-REKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
+I+G+ ++ + G A+K + E + K++H N++ L A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
L+ +F P GSL + L + + + + + G+N+L E +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-ENGI 133
Query: 658 IHGNLTSSNVLL----DEKTNPRIADFGLSRLMTAAANTNVIATA-GTLGYRAPEL---- 708
+H N+ N++ D ++ ++ DFG +R + + + GT Y P++
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE---DDEQFVSLYGTEEYLHPDMYERA 190
Query: 709 ----SKLKNANTKTDVYSLGVIILELLTGKSPGEPMN-GMDLPQWVASIVKEEWTNEVFD 763
K D++S+GV TG P P + + I+ + + +
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 764 LELMRDNTI 772
++ + I
Sbjct: 251 VQKAENGPI 259
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 43/208 (20%), Positives = 85/208 (40%), Gaps = 22/208 (10%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKR--LREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
G T A G V V+R L + + + E +HPN++ RA +
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 601 LGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAI---GIARGLNYLHVEEN 656
+ +L +V FM GS + + + ++IA G+ + L+Y+H
Sbjct: 96 I--ADNELWVVTSFMAYGSAKDLICTHFMDGM----NELAIAYILQGVLKALDYIH-HMG 148
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA------AANTNVIATAGTLGYRAPEL-- 708
+H ++ +S++L+ ++ + M + + + L + +PE+
Sbjct: 149 YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208
Query: 709 SKLKNANTKTDVYSLGVIILELLTGKSP 736
L+ + K+D+YS+G+ EL G P
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 26/216 (12%)
Query: 541 EIMGKSTYGTAYKATL------EDGSEVAVKRLREK-TTKGQKEFEAEAAAIGKIHHPNL 593
+G +G Y+ + +VAVK L E + + + +F EA I K +H N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 594 LALRAYYLG--PKGE-KLLVFDFMPKGSLASFLHARGPETIVNWATRM----SIAIGIAR 646
+ +G + + ++ + M G L SFL P + M +A IA
Sbjct: 137 VRC----IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPR---IADFGLSRLMTAAANTNVIATAGTLGY 703
G YL E + IH ++ + N LL R I DFG++R + A L
Sbjct: 193 GCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-YRAGYYRKGGCAMLPV 250
Query: 704 R--APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
+ PE +KTD +S GV++ E+ + G P
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 62/220 (28%), Positives = 101/220 (45%), Gaps = 33/220 (15%)
Query: 541 EIMGKSTYGTAYKATLEDGSE---VAVKRLREKTTKGQK-EFEAEAAAIGKI-HHPNLLA 595
+++G+ +G KA ++ A+KR++E +K +F E + K+ HHPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 596 LRAYYLG---PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATR-------------MS 639
L LG +G L ++ P G+L FL +
Sbjct: 91 L----LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 640 IAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAG 699
A +ARG++YL ++ IH +L + N+L+ E +IADFGLSR V T G
Sbjct: 147 FAADVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 201
Query: 700 TLGYR--APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
L R A E T +DV+S GV++ E+++ G +P
Sbjct: 202 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
E++G A +VA+KR+ EK E E A+ + HHPN+++
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWA--TRMSIAI---GIARGLNYLH 652
++ ++L LV + GS+ + + +IA + GL YLH
Sbjct: 81 SFV--VKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT----AGTLGYRAPE- 707
+ IH ++ + N+LL E + +IADFG+S + + GT + APE
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 708 LSKLKNANTKTDVYSLGVIILELLTGKSP 736
+ +++ + K D++S G+ +EL TG +P
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-24
Identities = 42/221 (19%), Positives = 89/221 (40%), Gaps = 29/221 (13%)
Query: 549 GTAYKA--TLEDGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAY--YLGP 603
G Y A +G V +K L + Q AE + ++ HP+++ + + +
Sbjct: 94 GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153
Query: 604 KGEKL--LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGN 661
G+ + +V +++ SL + P A ++ + I L+YLH +++ +
Sbjct: 154 HGDPVGYIVMEYVGGQSLKRSKGQKLP-----VAEAIAYLLEILPALSYLH-SIGLVYND 207
Query: 662 LTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVY 721
L N++L E ++ D G + + + GT G++APE+ + TD+Y
Sbjct: 208 LKPENIMLTE-EQLKLIDLGAVSRINS---FGYLY--GTPGFQAPEIVRTG-PTVATDIY 260
Query: 722 SLGVIILELLTGKSP--GEPMNGM-------DLPQWVASIV 753
++G + L G ++G+ ++
Sbjct: 261 TVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLL 301
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 36/220 (16%), Positives = 79/220 (35%), Gaps = 35/220 (15%)
Query: 544 GKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIG----------------- 586
+ + +D A+K+ + + +++F
Sbjct: 40 NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 587 KIHHPNLLALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMS------ 639
I + L ++ +++++M S+ F N+ +
Sbjct: 99 DIKNEYCLTCEGIITNYD--EVYIIYEYMENDSILKFDEYFFVLD-KNYTCFIPIQVIKC 155
Query: 640 IAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA- 698
I + +Y+H E+N+ H ++ SN+L+D+ +++DFG S M I +
Sbjct: 156 IIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV----DKKIKGSR 211
Query: 699 GTLGYRAPEL--SKLKNANTKTDVYSLGVIILELLTGKSP 736
GT + PE ++ K D++SLG+ + + P
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 32/230 (13%), Positives = 60/230 (26%), Gaps = 45/230 (19%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRLR---EKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+ +E + A+K E + + A ++ + R
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 600 Y-------------------LGPKGEKLLVFDF---MP--KGSLASFLHA-------RGP 628
L P + V ++ MP L RG
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD 190
Query: 629 ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688
E I + + R L + ++HG+ T N+ + + D
Sbjct: 191 EGI---LALHILTAQLIRLAANLQ-SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---- 242
Query: 689 AANTNVIATAGTLGYRAPELSKLKNA--NTKTDVYSLGVIILELLTGKSP 736
T A++ + Y E A + + LG+ I + P
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 53/222 (23%), Positives = 95/222 (42%), Gaps = 35/222 (15%)
Query: 544 GKSTYGTAYKATL------EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLA 595
G +G +AT + VAVK L+ ++ +E + + +H N++
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 596 LRAYYLG---PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATR--------------- 637
L LG G L++ ++ G L +FL + I + +
Sbjct: 92 L----LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 638 MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697
+S + +A+G+ +L +N IH +L + N+LL +I DFGL+R + + V+
Sbjct: 148 LSFSYQVAKGMAFL-ASKNCIHRDLAARNILLTHGRITKICDFGLARDI-KNDSNYVVKG 205
Query: 698 AGTLGYR--APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
L + APE ++DV+S G+ + EL + G SP
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 29/205 (14%)
Query: 549 GTAYKAT-LEDGSEVAVKRLREKTTKGQ---KEFEAEAAAIGKIHHPNLLA--------- 595
+ A L D +VAVK LR + F EA ++HP ++A
Sbjct: 26 SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85
Query: 596 --LRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
Y+ V +++ +L +H GP + + + + LN+ H
Sbjct: 86 PAGPLPYI--------VMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH- 133
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA--GTLGYRAPELSKL 711
+ +IH ++ +N+++ ++ DFG++R + + N+ A GT Y +PE ++
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 712 KNANTKTDVYSLGVIILELLTGKSP 736
+ + ++DVYSLG ++ E+LTG+ P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 41/218 (18%), Positives = 78/218 (35%), Gaps = 16/218 (7%)
Query: 136 GFLPNLRGVYLFNNRLSGSIPP-SIGNCPNLQTLDLSNNALIGAIPP-SLANSTRLYRLN 193
P+ + + L L +IP + N PN+ + +S + + + S N +++ +
Sbjct: 28 SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86
Query: 194 LSYNSLLGSIPLS-LTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLI 252
+ L I L LP L L + + L P+ V + L + N
Sbjct: 87 IRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKV---YSTDIFFILEITDNPY 142
Query: 253 AGTIPVSL--GKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPV-TFT 309
+IPV+ G + L +N + +KL + L+ N F
Sbjct: 143 MTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFG 201
Query: 310 NITS-LVSLNLENNRLGNKIPEGLERLQNLTVLNLKNN 346
+ S L++ + +P L++L L +N
Sbjct: 202 GVYSGPSLLDVSQTSV-TALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 38/212 (17%), Positives = 73/212 (34%), Gaps = 13/212 (6%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNAL 175
+ L L + L + LPN+ +Y+ + + N + +++ N
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 176 IGAIPPS-LANSTRLYRLNLSYNSLLGSIP--LSLTRLPSLSVLALQHNNLSGSVPNNWG 232
+ I P L L L + L P + +L + N S+P N
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTG-LKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN-- 149
Query: 233 VLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDEL--GKLSKL 290
G + + L L +N ++ L + L+ NK + I + G S
Sbjct: 150 AFQGLCN-ETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 291 QKLDLSYNAIGGSFPV-TFTNITSLVSLNLEN 321
LD+S ++ + P ++ L++ N
Sbjct: 208 SLLDVSQTSV-TALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 43/242 (17%), Positives = 84/242 (34%), Gaps = 41/242 (16%)
Query: 157 PSIGNCPNLQTLDLSNNALIGAIPP-SLANSTRLYRLNLSYNSLLGSIPL-SLTRLPSLS 214
PS+ P+ QTL L + IP + +N + R+ +S + L + S L ++
Sbjct: 27 PSLP--PSTQTLKLIETH-LRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVT 83
Query: 215 VLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIP--VSLGKLGLLQEISLS 272
+ +++ + L L+FL + + + P + + + ++
Sbjct: 84 HIEIRNTRNLTYIDP--DALKELP--LLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEIT 138
Query: 273 HNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITS-LVSLNLENNRLGNKIPEG 331
N + IP F + + ++L L NN +
Sbjct: 139 DNPYMTSIPVN-----------------------AFQGLCNETLTLKLYNNGF-TSVQGY 174
Query: 332 LERLQNLTVLNLKNNQFKGHIPETI--GNISGINQLDLSENDFTGEISP-SLASLANLTS 388
L + L N++ I + G SG + LD+S+ T + L L L +
Sbjct: 175 AFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIA 233
Query: 389 FN 390
N
Sbjct: 234 RN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 29/168 (17%), Positives = 55/168 (32%), Gaps = 10/168 (5%)
Query: 242 LQFLNLDHNLIAGTIPV-SLGKLGLLQEISLSHNKIVGPIPDEL-GKLSKLQKLDLSYNA 299
Q L L + TIP + L + I +S + + + LSK+ +++
Sbjct: 33 TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 300 IGGSFPV-TFTNITSLVSLNLENNRLGNKIPEG--LERLQNLTVLNLKNNQFKGHIPETI 356
+ L L + N L P+ + +L + +N + IP
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 357 --GNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402
G + L L N FT + + L + ++ N +
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDK 197
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 32/170 (18%), Positives = 57/170 (33%), Gaps = 16/170 (9%)
Query: 112 SQLHALRKLSLHDN-LLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPP--SIGNCPNLQTL 168
L + + + + L P +L LP L+ + +FN L P + + L
Sbjct: 77 YNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFIL 135
Query: 169 DLSNNALIGAIPP----SLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLS 224
++++N + +IP L N T L L N S+ L + L N
Sbjct: 136 EITDNPYMTSIPVNAFQGLCNETL--TLKLYNNG-FTSVQGYAFNGTKLDAVYLNKNKYL 192
Query: 225 GSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPV-SLGKLGLLQEISLSH 273
+ + G S L++ + +P L L L +
Sbjct: 193 TVIDKD--AFGGVYS-GPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 32/145 (22%), Positives = 56/145 (38%), Gaps = 12/145 (8%)
Query: 112 SQLHALRKLSLHDNLLAG-PVPWSLGFLPNLRGVYLFNNRLSGSIPPSI--GNCPNLQTL 168
+L L+ L + + L P + + + +N SIP + G C TL
Sbjct: 102 KELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161
Query: 169 DLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIP-LSLTRLPS-LSVLALQHNNLSGS 226
L NN ++ N T+L + L+ N L I + + S S+L + +++ +
Sbjct: 162 KLYNNG-FTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-A 219
Query: 227 VPNNWGVLAGNKSYQLQFLNLDHNL 251
+P+ L K L N L
Sbjct: 220 LPS--KGLEHLKE--LIARNT-WTL 239
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 22/112 (19%), Positives = 40/112 (35%), Gaps = 7/112 (6%)
Query: 110 KISQLHALRKLSLHDNLLAGPVPWSL--GFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQT 167
K+ L + DN +P + G + L+NN + S+ N L
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDA 183
Query: 168 LDLSNNALIGAIPP-SLAN-STRLYRLNLSYNSLLGSIP-LSLTRLPSLSVL 216
+ L+ N + I + + L++S S+ ++P L L L
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIAR 234
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 35/139 (25%), Positives = 56/139 (40%), Gaps = 12/139 (8%)
Query: 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL 669
K +L +++ R + I I IA + +LH + ++H +L SN+
Sbjct: 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH-SKGLMHRDLKPSNIFF 197
Query: 670 DEKTNPRIADFGLSRLMTAAANTNVIATA-----------GTLGYRAPELSKLKNANTKT 718
++ DFGL M + T GT Y +PE N + K
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 719 DVYSLGVIILELLTGKSPG 737
D++SLG+I+ ELL S
Sbjct: 258 DIFSLGLILFELLYSFSTQ 276
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-23
Identities = 49/309 (15%), Positives = 97/309 (31%), Gaps = 27/309 (8%)
Query: 113 QLHALRKLSLHDNLLAGPVPWSLGF--LPNLRGVYLFNNRLSGSIPPS--IGNCPNLQTL 168
L L L N L + NL+ + L N ++P GN L+ L
Sbjct: 67 FNQELEYLDLSHNKL-----VKISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFL 120
Query: 169 DLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVP 228
LS L + +A+ L + + L + +L +
Sbjct: 121 GLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEG--LQDFNTESLHIVFPTNKEF 178
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAG------TIPVSLGKLGLLQEISLSHNKIVGPIPD 282
+ ++ L+ N+ L +I L L ++L++ +
Sbjct: 179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFI 238
Query: 283 ELGKL---SKLQKLDLSYNAIGG-----SFPVTFTNITSLVSLNLENNRLGNKIPEGLER 334
+ +L + + +S + G F + T++ +L + ++ G E
Sbjct: 239 RILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEI 298
Query: 335 LQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYN 394
N+ + N + + IS LD S N T + + L L + + N
Sbjct: 299 FSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN 358
Query: 395 NLSGSVPPL 403
L + +
Sbjct: 359 QLK-ELSKI 366
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 6e-22
Identities = 50/271 (18%), Positives = 93/271 (34%), Gaps = 9/271 (3%)
Query: 135 LGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNL 194
+ + F + L+ + L ++ + N+ I L T ++ ++
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIR--ILQLVWHTTVWYFSI 254
Query: 195 SYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAG 254
S L G + S+ AL + + V + N +
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314
Query: 255 TIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVT--FTNIT 312
+ K+ + S+N + + + G L++L+ L L N + + T +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374
Query: 313 SLVSLNLENNRLGNKIPEGL-ERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSEND 371
SL L++ N + +G ++L LN+ +N I + I LDL N
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNK 432
Query: 372 FTGEISPSLASLANLTSFNVSYNNLSGSVPP 402
I + L L NV+ N L SVP
Sbjct: 433 IK-SIPKQVVKLEALQELNVASNQLK-SVPD 461
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 7e-22
Identities = 49/240 (20%), Positives = 82/240 (34%), Gaps = 35/240 (14%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171
+ L AL + ++ P + N+ + LD S
Sbjct: 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332
Query: 172 NNALIGAIPPSLANSTRLYRLNLSYNSL--LGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229
NN L + + + T L L L N L L I T++ SL L + N++S
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEK- 391
Query: 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSK 289
L +++S N + I L +
Sbjct: 392 ---------------------------KGDCSWTKSLLSLNMSSNILTDTIFRCL--PPR 422
Query: 290 LQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQF 348
++ LDL N I S P + +L LN+ +N+L +P+G +RL +L + L N +
Sbjct: 423 IKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQL-KSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-21
Identities = 45/276 (16%), Positives = 102/276 (36%), Gaps = 23/276 (8%)
Query: 110 KISQLHALRKLSLHDNLLAGPVPWSLG---FLPNLRGVYLFNNRLSGSIPPSIGNCPN-- 164
K+ L L+L++ + + + + N +L G + +
Sbjct: 215 KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTS 274
Query: 165 ---LQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHN 221
L + ++ + + N + + L +++ L +N
Sbjct: 275 LKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334
Query: 222 NLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLG---KLGLLQEISLSHNKIVG 278
L+ +V N G L +L+ L L N + + ++ LQ++ +S N +
Sbjct: 335 LLTDTVFENCGHLT-----ELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSY 388
Query: 279 PIPDEL-GKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQN 337
L L++S N + + + L+L +N++ IP+ + +L+
Sbjct: 389 DEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKI-KSIPKQVVKLEA 445
Query: 338 LTVLNLKNNQFKGHIPETI-GNISGINQLDLSENDF 372
L LN+ +NQ K +P+ I ++ + ++ L N +
Sbjct: 446 LQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-21
Identities = 50/316 (15%), Positives = 103/316 (32%), Gaps = 25/316 (7%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171
+ L+ L L L + L + + + P + T L
Sbjct: 112 GNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTESLH 169
Query: 172 NNALIGAIPPSLANSTRLYRLNLSYNSL-----------LGSIPLSLTRLPSLSVLALQH 220
+ + + NL +++ SI L P LS L L +
Sbjct: 170 IVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNN 229
Query: 221 NNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAG-----TIPVSLGKLGLLQEISLSHNK 275
+ + L + + + + ++ + + G S L L + +
Sbjct: 230 IETTWNSFIRILQLVWHTT--VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV 287
Query: 276 IVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERL 335
P S + + + + + + I+ + L+ NN L + + E L
Sbjct: 288 FGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347
Query: 336 QNLTVLNLKNNQFKGHIPETIG---NISGINQLDLSENDFTGEISPSL-ASLANLTSFNV 391
L L L+ NQ K + + + + QLD+S+N + + + +L S N+
Sbjct: 348 TELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNM 406
Query: 392 SYNNLSGSVPPLLSKK 407
S N L+ ++ L +
Sbjct: 407 SSNILTDTIFRCLPPR 422
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 49/325 (15%), Positives = 107/325 (32%), Gaps = 45/325 (13%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNAL 175
L++ N ++ + L LR + + +NR+ + S+ L+ LDLS+N L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKL 81
Query: 176 IGAIPPSLANSTRLYRLNLSYNSLLGSIPLS--LTRLPSLSVLALQHNNLSGSV------ 227
+ L L+LS+N+ ++P+ + L L L +L S
Sbjct: 82 VKISCHPT---VNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 228 ----------------PNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISL 271
+ L + L + + + VS+ + L+ ++
Sbjct: 138 LNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 272 SHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNI---------TSLVSLNLENN 322
L L+KLQ N + T+ + T++ ++ N
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNV 257
Query: 323 RLGNKIPEGL-----ERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEIS 377
+L ++ L+ L++ + ++ F S +N + + +
Sbjct: 258 KLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHM 317
Query: 378 PSLASLANLTSFNVSYNNLSGSVPP 402
+ ++ + S N L+
Sbjct: 318 LCPSKISPFLHLDFSNNLLT-DTVF 341
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 4e-16
Identities = 44/265 (16%), Positives = 87/265 (32%), Gaps = 26/265 (9%)
Query: 148 NNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSL 207
N L +P + L++S N + + + ++L L +S+N +
Sbjct: 9 KNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVF 65
Query: 208 TRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVS--LGKLGL 265
L L L HN L + + V L+ L+L N +P+ G +
Sbjct: 66 KFNQELEYLDLSHNKLV-KISCHPTV-------NLKHLDLSFNAFD-ALPICKEFGNMSQ 116
Query: 266 LQEISLSHNKIVGPIPDELGKLSKLQ-KLDLSYNAIGGSFPVTFTNI--TSLVSLNLENN 322
L+ + LS + + L+ + L L P + SL + N
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK 176
Query: 323 RLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQ------LDLSENDFTGEI 376
+ ++ + NL + N+K + ++ + L L+ + T
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236
Query: 377 SPSL---ASLANLTSFNVSYNNLSG 398
+ + F++S L G
Sbjct: 237 FIRILQLVWHTTVWYFSISNVKLQG 261
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 33/228 (14%), Positives = 73/228 (32%), Gaps = 9/228 (3%)
Query: 242 LQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIG 301
LN+ N I+ + L L+ + +SHN+I +L+ LDLS+N +
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 302 GSFPVTFTNITSLVSLNLENNRLGNKIPEG--LERLQNLTVLNLKNNQFKGHIPETIGNI 359
++ +L L+L N + +P + L L L + I ++
Sbjct: 83 K---ISCHPTVNLKHLDLSFNAF-DALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138
Query: 360 SGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLS-GSVPPLLSKKFNSSSFVGNLQ 418
+ L + + + P L + + ++ + +L + + +
Sbjct: 139 NISKVLLVLGETYGEKEDPE--GLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196
Query: 419 LCGYSPSTACPSLAPLSLPPPPVEAPKHHHHRKLSTKDIILIGVGALL 466
+ C + + + T I + L+
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLV 244
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 5e-13
Identities = 38/146 (26%), Positives = 61/146 (41%), Gaps = 11/146 (7%)
Query: 108 SEKISQLHALRKLSLHDNLLAGPVPWSLGF--LPNLRGVYLFNNRLSGSIPPSIGNCP-N 164
E L L L L N L + + +L+ + + N +S + +
Sbjct: 341 FENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400
Query: 165 LQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLS 224
L +L++S+N L I L R+ L+L N + SIP + +L +L L + N L
Sbjct: 401 LLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK 457
Query: 225 GSVPNNWGVLAGNKSYQLQFLNLDHN 250
SVP+ G+ S LQ + L N
Sbjct: 458 -SVPD--GIFDRLTS--LQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 33/160 (20%), Positives = 57/160 (35%), Gaps = 9/160 (5%)
Query: 280 IPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNL 338
+P +L K L++S N I + +++ L L + +NR+ + + Q L
Sbjct: 15 VPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRI-QYLDISVFKFNQEL 71
Query: 339 TVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTG-EISPSLASLANLTSFNVSYNNL- 396
L+L +N+ I + LDLS N F I +++ L +S +L
Sbjct: 72 EYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 397 SGSVPPLLSKKFNSSSFVGNLQLCGYSPSTACPSLAPLSL 436
SV P+ + V SL
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESL 168
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 30/120 (25%), Positives = 58/120 (48%), Gaps = 6/120 (5%)
Query: 106 RISEKISQLHALRKLSLHDNLLAGPVPWSL-GFLPNLRGVYLFNNRLSGSIPPSIGNCPN 164
+I+E +Q+ +L++L + N ++ + +L + + +N L+ +I + P
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PR 422
Query: 165 LQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPL-SLTRLPSLSVLALQHNNL 223
++ LDL +N + +IP + L LN++ N L S+P RL SL + L N
Sbjct: 423 IKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQ-LKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 40/227 (17%)
Query: 541 EIMGKSTYGTAYKATL------EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPN 592
+ +G+ +G +A VAVK L+E T + +E + I HH N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 593 LLALRAYYLG----PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATR----------- 637
++ L LG P G +++ +F G+L+++L ++ E +
Sbjct: 93 VVNL----LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 638 --MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695
+ + +A+G+ +L IH +L + N+LL EK +I DFGL+R + +
Sbjct: 149 HLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDI----YKDPD 203
Query: 696 ATAGTLGYR-----APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
APE + ++DV+S GV++ E+ + G SP
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 5e-23
Identities = 41/296 (13%), Positives = 89/296 (30%), Gaps = 54/296 (18%)
Query: 493 KSTAQKVVERAAPKAGTEVESGGEMGGKLVHFDGPFLFTADDLLCATAEIMGKSTYGTAY 552
+S A +V + G E+G + P +L G+
Sbjct: 49 QSAADSLVSTSLWNTGQPFRVESELGER------PRTLVRGTVL-------GQEDPYAYL 95
Query: 553 KAT-LEDGSEVAVKRLR---EKTTKGQKEFEAEAAAIGKI-------------------- 588
+AT E G V + K+ + E + +
Sbjct: 96 EATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155
Query: 589 -----HHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFL-----HARGPETIVNWATRM 638
++ +R + +L +F H+ +++V+ A R+
Sbjct: 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA-RL 214
Query: 639 SIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA 698
+ + + R L LH ++H L +++LD++ + F A+A + +
Sbjct: 215 QLTLQVIRLLASLH-HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGF 273
Query: 699 GTLGYRAPELSKLKNANTK-----TDVYSLGVIILELLTGKSPGEPMNGMDLPQWV 749
A + + D ++LG+ I + P + +W+
Sbjct: 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI 329
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 51/228 (22%), Positives = 99/228 (43%), Gaps = 33/228 (14%)
Query: 541 EIMGKSTYGTAYKATL------EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPN 592
+ +G +G +AT + +VAVK L+ ++ +E + + H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 593 LLALRAYYLG---PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATR-----------M 638
++ L LG G L++ ++ G L +FL + + A +
Sbjct: 112 IVNL----LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 639 SIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA 698
+ +A+G+ +L +N IH ++ + NVLL +I DFGL+R + + ++
Sbjct: 168 HFSSQVAQGMAFLA-SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI-MNDSNYIVKGN 225
Query: 699 GTLGYR--APELSKLKNANTKTDVYSLGVIILELLT-GKSP--GEPMN 741
L + APE ++DV+S G+++ E+ + G +P G +N
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-23
Identities = 41/216 (18%), Positives = 82/216 (37%), Gaps = 37/216 (17%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKR-LREKTTKGQKEFEAEAAAIGKI-----HHPNLL 594
+++G GT + D +VAVKR L E + +E + + HPN++
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQ--------LLRESDEHPNVI 81
Query: 595 ALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARG---PETIVNWATRMSIAIGIARGLNY 650
+ + + +L ++ + +++ GL +
Sbjct: 82 RYFCTEKDR--QFQYIAIELCA-ATLQEYVEQKDFAHLGLEP-----ITLLQQTTSGLAH 133
Query: 651 LHVEENMIHGNLTSSNVLLDEKTN-----PRIADFGLSRLMTA--AANTNVIATAGTLGY 703
LH N++H +L N+L+ I+DFGL + + + + GT G+
Sbjct: 134 LH-SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 704 RAPEL---SKLKNANTKTDVYSLGVIILELLTGKSP 736
APE+ +N D++S G + +++ S
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 64/234 (27%), Positives = 108/234 (46%), Gaps = 29/234 (12%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
E +GK ++G +K VA+K + E+ ++ + E + + P +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARG-PETIVNWATRMSIAI---GIARGLNYLHV 653
YL K KL ++ +++ GS L ET IA I +GL+YLH
Sbjct: 88 SYL--KDTKLWIIMEYLGGGSALDLLEPGPLDETQ--------IATILREILKGLDYLH- 136
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA---ANTNVIATAGTLGYRAPELSK 710
E IH ++ ++NVLL E ++ADFG++ +T NT V GT + APE+ K
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIK 192
Query: 711 LKNANTKTDVYSLGVIILELLTGKSP---GEPMNGMDL-PQWVASIVKEEWTNE 760
++K D++SLG+ +EL G+ P PM + L P+ ++ ++
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP 246
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 8e-23
Identities = 45/239 (18%), Positives = 93/239 (38%), Gaps = 17/239 (7%)
Query: 136 GFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNALIGAIPPS-LANSTRLYRLN 193
N + +L I +L+ +++S N ++ I +N +L+ +
Sbjct: 27 DLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR 85
Query: 194 LSYNSLLGSIPLS-LTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLI 252
+ + L I LP+L L + + + +P+ + S Q L++ N+
Sbjct: 86 IEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPD----VHKIHSLQKVLLDIQDNIN 140
Query: 253 AGTIP--VSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLS-YNAIGGSFPVTFT 309
TI +G + L+ N I I + ++L +L+LS N + F
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199
Query: 310 NITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLS 368
+ V L++ R+ + GLE L+ L + N + +P T+ + + + L+
Sbjct: 200 GASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLT 254
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 3e-20
Identities = 48/218 (22%), Positives = 76/218 (34%), Gaps = 17/218 (7%)
Query: 112 SQLHALRKLSLHDN-LLAGPVPWSLGFLPNLRGVYLFN-NRLSGSIPPSI-GNCPNLQTL 168
S L K+ + N +L LP L + + N L I P N PNLQ L
Sbjct: 51 SGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYL 109
Query: 169 DLSNNALIGAIPP-SLANSTRLYRLNLSYNSLLGSIP-LSLTRLPSLSV-LALQHNNLSG 225
+SN I +P +S + L++ N + +I S L SV L L N +
Sbjct: 110 LISNTG-IKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ- 167
Query: 226 SVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELG 285
+ N+ A N + + D+N + + +S +I L
Sbjct: 168 EIHNS----AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE 223
Query: 286 KLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNR 323
L KL+ P T + +L+ +L
Sbjct: 224 NLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 7e-18
Identities = 45/251 (17%), Positives = 83/251 (33%), Gaps = 15/251 (5%)
Query: 192 LNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNL 251
+ + IP L + L L + G +G L+ + + N
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQK--GAFSGFG--DLEKIEISQND 65
Query: 252 IAGTIPVS-LGKLGLLQEISLSH-NKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFT 309
+ I L L EI + N ++ P+ L LQ L +S I V
Sbjct: 66 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 125
Query: 310 NITSLVSLNLENNRLGNKIPEG-LERLQ-NLTVLNLKNNQFKGHIPETIGNISGINQLDL 367
+ V L++++N + I L +L L N + I + N + +++L+L
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNL 184
Query: 368 SENDFTGEISP-SLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQLCGYSPST 426
S+N+ E+ + ++S + S+P + L
Sbjct: 185 SDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKLPTLE 243
Query: 427 ACPSLAPLSLP 437
+L SL
Sbjct: 244 KLVALMEASLT 254
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 8e-23
Identities = 47/219 (21%), Positives = 87/219 (39%), Gaps = 23/219 (10%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRA 598
++ + + Y+A + G E A+KRL + + E + K+ HPN++ +
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 599 YY------LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLH 652
+ L+ + KG L FL ++ T + I R + ++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 653 -VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMT-----------AAANTNVIATAGT 700
+ +IH +L N+LL + ++ DFG + ++ A I T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 701 LGYRAPELSKLKN---ANTKTDVYSLGVIILELLTGKSP 736
YR PE+ L + K D+++LG I+ L + P
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 9e-23
Identities = 59/258 (22%), Positives = 110/258 (42%), Gaps = 30/258 (11%)
Query: 513 SGGEMGGKLVHFDGPFLFTADDLLCATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLR-EK 570
S G+ G L + +DL MG T G +K + G +AVK++R
Sbjct: 5 SSGKQTGYLTIGGQRYQAEINDL--ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG 62
Query: 571 TTKGQKEFEAEAAAIGK-IHHPNLLALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARG- 627
+ K + + K P ++ ++ + + + M + +G
Sbjct: 63 NKEENKRILMDLDVVLKSHDCPYIVQCFGTFI--TNTDVFIAMELMGTCAEKLKKRMQGP 120
Query: 628 -PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686
PE I+ + + I + L YL + +IH ++ SN+LLDE+ ++ DFG+S +
Sbjct: 121 IPERIL-----GKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175
Query: 687 TA--AANTNVIATAGTLGYRAPELSKLKNA-----NTKTDVYSLGVIILELLTGKSPGEP 739
A + +AG Y APE + + + DV+SLG+ ++EL TG+ P +
Sbjct: 176 VDDKAKDR----SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231
Query: 740 MNG-MDLPQWVASIVKEE 756
++ + +++EE
Sbjct: 232 CKTDFEV---LTKVLQEE 246
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 58/245 (23%), Positives = 102/245 (41%), Gaps = 32/245 (13%)
Query: 528 FLFTADDLLCATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFEAEAAAI 585
ADDL +G+ YG K + G +AVKR+R ++ QK +
Sbjct: 2 MEVKADDL--EPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS 59
Query: 586 GK-IHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFL------HARGPETIVNWATRM 638
+ + P + G+ + + M SL F PE I+
Sbjct: 60 MRTVDCPFTVTFYGALFRE-GDVWICMELMD-TSLDKFYKQVIDKGQTIPEDIL-----G 112
Query: 639 SIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA--AANTNVIA 696
IA+ I + L +LH + ++IH ++ SNVL++ ++ DFG+S + A + +
Sbjct: 113 KIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-- 170
Query: 697 TAGTLGYRAPE-LSKLKNANT---KTDVYSLGVIILELLTGKSPGEPMNG-MDLPQWVAS 751
G Y APE ++ N K+D++SLG+ ++EL + P + +
Sbjct: 171 --GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ---LKQ 225
Query: 752 IVKEE 756
+V+E
Sbjct: 226 VVEEP 230
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 29/232 (12%)
Query: 528 FLFTADDLLCATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFEAEAAAI 585
+ FTA+DL +G+ YG+ K G +AVKR+R K QK+ + +
Sbjct: 17 WDFTAEDL--KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 586 GK-IHHPNLLALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARG-------PETIVNWAT 636
+ P ++ + + + M S F PE I+
Sbjct: 75 MRSSDCPYIVQFYGALF--REGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEIL---- 127
Query: 637 RMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS-RLMTAAANTNVI 695
I + + LN+L +IH ++ SN+LLD N ++ DFG+S +L+ + A T
Sbjct: 128 -GKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR-- 184
Query: 696 ATAGTLGYRAPE----LSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743
AG Y APE + + + ++DV+SLG+ + EL TG+ P N +
Sbjct: 185 -DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 43/213 (20%), Positives = 84/213 (39%), Gaps = 25/213 (11%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKR--LREKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
+ +G ++ E A+K L E + + E A + K+ + +R
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 599 Y-YLGPKGEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVEE 655
Y Y +V + L S+L + S + ++ +H +
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWER-----KSYWKNMLEAVHTIH-QH 127
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELSKLKNA 714
++H +L +N L+ + ++ DFG++ M + V + GT+ Y PE K ++
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 715 -----------NTKTDVYSLGVIILELLTGKSP 736
+ K+DV+SLG I+ + GK+P
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 40/230 (17%)
Query: 541 EIMGKSTYGTAYKATLEDGSE------VAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNL 593
+G+ +G ++A VAVK L+E+ + Q +F+ EAA + + +PN+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 594 LALRAYYLG--PKGE-KLLVFDFMPKGSLASFLHARGPETIVNWATR------------- 637
+ L LG G+ L+F++M G L FL + P T+ + +
Sbjct: 113 VKL----LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 638 --------MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689
+ IA +A G+ YL E +H +L + N L+ E +IADFGLSR + +
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLS-ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI-YS 226
Query: 690 ANTNVIATAGTLGYR--APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
A+ + R PE T++DV++ GV++ E+ + G P
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 40/230 (17%)
Query: 541 EIMGKSTYGTAYKATL------EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNL 593
+ +G+ +G KAT + VAVK L+E + ++ +E + +++HP++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 594 LALRAYYLG---PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATR------------- 637
+ L G G LL+ ++ GSL FL +
Sbjct: 89 IKL----YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 638 --------MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689
+S A I++G+ YL E ++H +L + N+L+ E +I+DFGLSR +
Sbjct: 145 RALTMGDLISFAWQISQGMQYLA-EMKLVHRDLAARNILVAEGRKMKISDFGLSRDV-YE 202
Query: 690 ANTNVIATAGTLGYR--APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
++ V + G + + A E T++DV+S GV++ E++T G +P
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-22
Identities = 47/205 (22%), Positives = 88/205 (42%), Gaps = 21/205 (10%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
E +G +G ++ G K + + + E + + ++HHP L+ L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMS--IAIGIAR----GLNYLHV 653
+ E +L+ +F+ G L F + I +MS I R GL ++H
Sbjct: 117 FEDKY-EMVLILEFLSGGEL--F------DRIAAEDYKMSEAEVINYMRQACEGLKHMH- 166
Query: 654 EENMIHGNLTSSNVLLDEKTNPRI--ADFGLSRLMTAAANTNVIATAGTLGYRAPELSKL 711
E +++H ++ N++ + K + DFGL+ + V T + APE+
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDR 224
Query: 712 KNANTKTDVYSLGVIILELLTGKSP 736
+ TD++++GV+ LL+G SP
Sbjct: 225 EPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 3e-22
Identities = 40/212 (18%), Positives = 82/212 (38%), Gaps = 23/212 (10%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKR--LREKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
+ +G ++ E A+K L E + + E A + K+ + +R
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVEEN 656
Y + + + L S+L + S + ++ +H +
Sbjct: 122 YDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWER-----KSYWKNMLEAVHTIH-QHG 175
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELSKLKNAN 715
++H +L +N L+ + ++ DFG++ M + V + G + Y PE K +++
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 716 -----------TKTDVYSLGVIILELLTGKSP 736
K+DV+SLG I+ + GK+P
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 43/213 (20%), Positives = 84/213 (39%), Gaps = 25/213 (11%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKR--LREKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
+ +G ++ E A+K L E + + E A + K+ + +R
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 599 Y-YLGPKGEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVEE 655
Y Y +V + L S+L + S + ++ +H +
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWER-----KSYWKNMLEAVHTIH-QH 146
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELSKLKNA 714
++H +L +N L+ + ++ DFG++ M + V + GT+ Y PE K ++
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 715 -----------NTKTDVYSLGVIILELLTGKSP 736
+ K+DV+SLG I+ + GK+P
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 53/217 (24%), Positives = 103/217 (47%), Gaps = 36/217 (16%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEA-EAAAIGKIHHPNLLALRAY 599
+++G ++G ++A L + EVA+K++ + K F+ E + + HPN++ L+A+
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAF 100
Query: 600 YLGPKGEKL-----LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIG------IARGL 648
+ +K LV +++P+ ++ M + + + R L
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLK-----QTMPMLLIKLYMYQLLRSL 154
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNP-RIADFGLSR-LMTAAANTNVIATAGTLGYRAP 706
Y+H + H ++ N+LLD + ++ DFG ++ L+ N + I + YRAP
Sbjct: 155 AYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICS---RYYRAP 210
Query: 707 ELSKL---KNANTKTDVYSLGVIILELLTGKS--PGE 738
EL + N T D++S G ++ EL+ G+ PGE
Sbjct: 211 EL--IFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-22
Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 35/225 (15%)
Query: 541 EIMGKSTYGTAYKATL--------EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HH 590
+ +G+ +G A ++ VAVK L++ T K + +E + I H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 591 PNLLALRAYYLG---PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATR---------- 637
N++ L LG G ++ ++ KG+L +L AR P +
Sbjct: 147 KNIINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 638 ---MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694
+S +ARG+ YL + IH +L + NVL+ E +IADFGL+R + +
Sbjct: 203 KDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYK 260
Query: 695 IATAGTLGYR--APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
T G L + APE + ++DV+S GV++ E+ T G SP
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 5e-22
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
E +G +G ++ T G+ A K + ++ E + + HP L+ L
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMS--IAIGIAR----GLNYLHV 653
+ E +++++FM G L F E + + +MS A+ R GL ++H
Sbjct: 223 FEDDN-EMVMIYEFMSGGEL--F------EKVADEHNKMSEDEAVEYMRQVCKGLCHMH- 272
Query: 654 EENMIHGNLTSSNVLLDEKTNPRI--ADFGLSRLMTAAANTNVIATAGTLGYRAPELSKL 711
E N +H +L N++ K + + DFGL+ + + V GT + APE+++
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEG 330
Query: 712 KNANTKTDVYSLGVIILELLTGKSP 736
K TD++S+GV+ LL+G SP
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 41/225 (18%)
Query: 544 GKSTYGTAYKATL--------EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNL 593
G+ +G A ++ VAVK L++ T K + +E + I H N+
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 594 LALRAYYLG---PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATR------------- 637
+ L LG G ++ ++ KG+L +L AR P +
Sbjct: 104 INL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 638 MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697
+S +ARG+ YL + IH +L + NVL+ E +IADFGL+R + N
Sbjct: 160 VSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI----NNIDYYK 214
Query: 698 AGTLGYR-----APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
T G APE + ++DV+S GV++ E+ T G SP
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 47/217 (21%), Positives = 92/217 (42%), Gaps = 29/217 (13%)
Query: 541 EIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+ G+ T+GT G VA+K++ + +E + + +HHPN++ L++Y
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSY 87
Query: 600 YLGPKGEKL------LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIG------IARG 647
+ +V +++P +L + + R
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQ-----VAPPPILIKVFLFQLIRS 141
Query: 648 LNYLHVE-ENMIHGNLTSSNVLLDEKTNP-RIADFGLSR-LMTAAANTNVIATAGTLGYR 704
+ LH+ N+ H ++ NVL++E ++ DFG ++ L + N I + YR
Sbjct: 142 IGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS---RYYR 198
Query: 705 APEL-SKLKNANTKTDVYSLGVIILELLTGKS--PGE 738
APEL ++ T D++S+G I E++ G+ G+
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 41/225 (18%)
Query: 544 GKSTYGTAYKATL--------EDGSEVAVKRLREKTTKGQK-EFEAEAAAIGKI-HHPNL 593
G+ +G A ++VAVK L+ T+ + +E + I H N+
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137
Query: 594 LALRAYYLG---PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATR------------- 637
+ L LG G ++ ++ KG+L +L AR P +
Sbjct: 138 INL----LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 638 MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697
+S A +ARG+ YL + IH +L + NVL+ E +IADFGL+R + +
Sbjct: 194 VSCAYQVARGMEYL-ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYK 248
Query: 698 AGTLGYR-----APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
T G APE + ++DV+S GV++ E+ T G SP
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 52/270 (19%), Positives = 91/270 (33%), Gaps = 29/270 (10%)
Query: 109 EKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTL 168
L K +L + V L ++ N+ + S+ + NL+ L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68
Query: 169 DLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVP 228
LS+N I + P L + T+L L+++ N L + LS L L +N L
Sbjct: 69 HLSHNQ-ISDLSP-LKDLTKLEELSVNRNRLKNLNGIPS---ACLSRLFLDNNELR-DTD 122
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLS 288
+ L K L+ L++ +N + V LG L L+ + L N+I L +L
Sbjct: 123 S----LIHLK--NLEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEITNT--GGLTRLK 172
Query: 289 KLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKI-PEGLERLQNLTVLNLKNNQ 347
K+ +DL+ L N + G I P + + +
Sbjct: 173 KVNWIDLTGQKCVNE---PVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWEL 229
Query: 348 FKGHIPETIGNISGINQLDLSENDFTGEIS 377
P +S ++ +
Sbjct: 230 -----PVYTDEVSYKFSEYINVGETEAIFD 254
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 44/194 (22%), Positives = 82/194 (42%), Gaps = 26/194 (13%)
Query: 207 LTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLL 266
L + L +++ V +Q N D++ I ++ + L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS-----QKELS--GVQNFNGDNSNIQ-SLA-GMQFFTNL 65
Query: 267 QEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLG- 325
+E+ LSHN+I P L L+KL++L ++ N + N+ + S L L
Sbjct: 66 KELHLSHNQISDLSP--LKDLTKLEELSVNRNRL--------KNLNGIPSACLSRLFLDN 115
Query: 326 NKIP--EGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASL 383
N++ + L L+NL +L+++NN+ K I +G +S + LDL N+ T L L
Sbjct: 116 NELRDTDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT-NTGG-LTRL 171
Query: 384 ANLTSFNVSYNNLS 397
+ +++
Sbjct: 172 KKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 30/149 (20%), Positives = 58/149 (38%), Gaps = 22/149 (14%)
Query: 260 LGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNL 319
L + +L + + +LS +Q + + I T+L L+L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHL 70
Query: 320 ENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGIN-----QLDLSENDFTG 374
+N++ + + L+ L L L++ N+ + N++GI +L L N+
Sbjct: 71 SHNQI-SDL-SPLKDLTKLEELSVNRNR--------LKNLNGIPSACLSRLFLDNNELR- 119
Query: 375 EISPSLASLANLTSFNVSYNNLSGSVPPL 403
+ L L NL ++ N L S+ L
Sbjct: 120 DTDS-LIHLKNLEILSIRNNKLK-SIVML 146
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 19/158 (12%), Positives = 57/158 (36%), Gaps = 7/158 (4%)
Query: 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAI 300
L ++ L + + + ++++++++ P + LS L++L + +
Sbjct: 45 SLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDV 100
Query: 301 GGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNIS 360
+ +TSL L++ ++ + I + L + ++L N I + +
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLP 159
Query: 361 GINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSG 398
+ L++ + + + L + G
Sbjct: 160 ELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-20
Identities = 29/144 (20%), Positives = 58/144 (40%), Gaps = 10/144 (6%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
I H ++ L++++ P + L NL + + ++ P++ +L LD+
Sbjct: 62 IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNN 230
S++A +I + ++ ++LSYN + I L LP L L +Q + +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG-- 176
Query: 231 WGVLAGNKSYQLQFLNLDHNLIAG 254
+ +L L I G
Sbjct: 177 ---IEDFP--KLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 32/209 (15%), Positives = 65/209 (31%), Gaps = 36/209 (17%)
Query: 139 PNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNS 198
+ S + + +L + L+N + + + + + L ++
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANI-NVTDLTG-IEYAHNIKDLTINNIH 77
Query: 199 LLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPV 258
P+S LS L+ L + +
Sbjct: 78 ATNYNPIS---------------GLS----------------NLERLRIMGKDVTSDKIP 106
Query: 259 SLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLN 318
+L L L + +SH+ I ++ L K+ +DLSYN + L SLN
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLN 165
Query: 319 LENNRLGNKIPEGLERLQNLTVLNLKNNQ 347
++ + + + G+E L L +
Sbjct: 166 IQFDGVHD--YRGIEDFPKLNQLYAFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-15
Identities = 36/175 (20%), Positives = 68/175 (38%), Gaps = 11/175 (6%)
Query: 264 GLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNR 323
G ++ L ++ IPD L ++ +T + SL + L N
Sbjct: 1 GAAEQTGLKASQDNVNIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANIN 55
Query: 324 LGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASL 383
+ + G+E N+ L + N I +S + +L + D T + P+L+ L
Sbjct: 56 V-TDL-TGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGL 111
Query: 384 ANLTSFNVSYNNLSGSVPPLLS--KKFNSSSFVGNLQLCGYSPSTACPSLAPLSL 436
+LT ++S++ S+ ++ K NS N + P P L L++
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNI 166
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 15/89 (16%), Positives = 34/89 (38%), Gaps = 3/89 (3%)
Query: 109 EKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTL 168
+S L +L L + + + + LP + + L N I P + P L++L
Sbjct: 106 PNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSL 164
Query: 169 DLSNNALIGAIPPSLANSTRLYRLNLSYN 197
++ + + + + +L +L
Sbjct: 165 NIQFDG-VHDYRG-IEDFPKLNQLYAFSQ 191
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 51/230 (22%), Positives = 100/230 (43%), Gaps = 40/230 (17%)
Query: 541 EIMGKSTYGTAYKATL------EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPN 592
+++G +G AT +VAVK L+EK ++ +E + ++ H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 593 LLALRAYYLG---PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATR------------ 637
++ L LG G L+F++ G L ++L ++ + +
Sbjct: 111 IVNL----LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 638 --------MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689
+ A +A+G+ +L ++ +H +L + NVL+ +I DFGL+R + +
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFL-EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI-MS 224
Query: 690 ANTNVIATAGTLGYR--APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
+ V+ L + APE K+DV+S G+++ E+ + G +P
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 36/234 (15%), Positives = 85/234 (36%), Gaps = 44/234 (18%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKR--LREKTTKGQKEFEAEAAAIGKI-HHPNLLAL 596
E +G +G+ +K DG A+KR + ++ E A + H +++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 597 RAYYLGPKGEKLLVF-DFMPKGSLASFLHARG------PETIVNWATRMSIAIGIARGLN 649
+ + + + +L+ ++ GSLA + E + + + + RGL
Sbjct: 77 FSAWA--EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL-----KDLLLQVGRGLR 129
Query: 650 YLHVEENMIHGNLTSSNVLLDEKTNP-------------------RIADFGLSRLMTAAA 690
Y+H +++H ++ SN+ + + P +I D G +++
Sbjct: 130 YIH-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP- 187
Query: 691 NTNVIATAGTLGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKSPGEPMNGM 743
G + A E+ + K D+++L + ++ + +
Sbjct: 188 QVEE----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 51/205 (24%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
EI+G +G +K G ++A K ++ + K ++E + E + + ++ H NL+ L
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMS--IAIGIAR----GLNYLHV 653
+ + +LV +++ G L F + I++ + ++ I + G+ ++H
Sbjct: 155 FESKN-DIVLVMEYVDGGEL--F------DRIIDESYNLTELDTILFMKQICEGIRHMH- 204
Query: 654 EENMIHGNLTSSNVLLDEKTNPRI--ADFGLSRLMTAAANTNVIATAGTLGYRAPELSKL 711
+ ++H +L N+L + +I DFGL+R V GT + APE+
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--GTPEFLAPEVVNY 262
Query: 712 KNANTKTDVYSLGVIILELLTGKSP 736
+ TD++S+GVI LL+G SP
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 3e-21
Identities = 51/353 (14%), Positives = 107/353 (30%), Gaps = 79/353 (22%)
Query: 446 HHHHRKLSTKDIILIGVGALLAVLLILCCILLFCLMRKRSASKEKNGK---STAQKVVER 502
HHHH +++ G G ++ L R A+ + S A +V
Sbjct: 3 HHHHHSSGRENLYFQGPGDVVIEEL---------FNRIPQANVRTTSEYMQSAADSLVST 53
Query: 503 AAPKAGTEVESGGEMGGKLVHFD-GPFLFTADDLLCATAEIMGKSTYGTAYKAT-LEDGS 560
+ G E+G + G L G+ +AT E G
Sbjct: 54 SLWNTGQPFRVESELGERPRTLVRGTVL--------------GQEDPYAYLEATDQETGE 99
Query: 561 EVAVK---RLREKTTKGQKEFEAEAAAIGKI-------------------------HHPN 592
V + K+ + E + +
Sbjct: 100 SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 159
Query: 593 LLALRAYYLGPKGEKLLVFDFMPKGSLASFL-----HARGPETIVNWATRMSIAIGIARG 647
++ +R + +L +F H+ +++V+ A R+ + + + R
Sbjct: 160 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA-RLQLTLQVIRL 218
Query: 648 LNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE 707
L LH ++H L +++LD++ + F + + ++ + G+ PE
Sbjct: 219 LASLH-HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGFEPPE 272
Query: 708 L-----------SKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWV 749
L + D ++LG++I + P + +W+
Sbjct: 273 LEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI 325
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 28/207 (13%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
E +G+ +YG+ YKA E G VA+K++ +E E + + + P+++
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMS---IAI---GIARGLNYLH 652
Y K L +V ++ GS++ + R ++ IA +GL YLH
Sbjct: 93 YF--KNTDLWIVMEYCGAGSVSDIIRLRN--------KTLTEDEIATILQSTLKGLEYLH 142
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA---ANTNVIATAGTLGYRAPELS 709
IH ++ + N+LL+ + + ++ADFG++ +T NT + GT + APE+
Sbjct: 143 -FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI----GTPFWMAPEVI 197
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSP 736
+ N D++SLG+ +E+ GK P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 27/228 (11%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAY 599
GK +G Y A + +A+K L + + + E + HPN+L L Y
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
+ ++ L+ ++ P G++ L T I +A L+Y H + +I
Sbjct: 78 FHDAT--RVYLILEYAPLGTVYRELQKLSKFD--EQRTATYIT-ELANALSYCH-SKRVI 131
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA-GTLGYRAPELSKLKNANTK 717
H ++ N+LL +IADFG S A ++ GTL Y PE+ + + + K
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWS----VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEK 187
Query: 718 TDVYSLGVIILELLTGKSPGEPMNGMDL-----------PQWVASIVK 754
D++SLGV+ E L GK P E + P +V +
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 235
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-20
Identities = 52/315 (16%), Positives = 105/315 (33%), Gaps = 52/315 (16%)
Query: 117 LRKLSLHDNLL-AGPVPWSLGFLPNLRGVYLFNNRLS----GSIPPSIGNCPNLQTLDLS 171
++ L + L L L + V L + L+ I ++ P L L+L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 172 NNALIGAIPPSLA-----NSTRLYRLNLSYNSL----LGSIPLSLTRLPSLSVLALQHNN 222
+N L + S ++ +L+L L G + +L LP+L L L N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 223 LSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPD 282
L + + +L+ L L++ ++ L + L
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV-------LRAKP------- 170
Query: 283 ELGKLSKLQKLDLSYNAIGGS-----FPVTFTNITSLVSLNLENNRLGNK----IPEGLE 333
++L +S N I + + L +L LE+ + + + +
Sbjct: 171 ------DFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 224
Query: 334 RLQNLTVLNLKNNQFKG----HIPETIGNISGINQ-LDLSENDFTGE----ISPSLASLA 384
+L L L +N+ + + + S + L + E T + + L +
Sbjct: 225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE 284
Query: 385 NLTSFNVSYNNLSGS 399
+L +++ N L
Sbjct: 285 SLKELSLAGNELGDE 299
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-20
Identities = 67/343 (19%), Positives = 114/343 (33%), Gaps = 54/343 (15%)
Query: 106 RISEKISQLHALRKLSLHDNLL----AGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGN 161
R +E + L + + L D L + +L P L + L +N L +
Sbjct: 19 RWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQ 78
Query: 162 C-----PNLQTLDLSNNAL----IGAIPPSLANSTRLYRLNLSYNSL--LGSIPLS---L 207
+Q L L N L G + +L L L+LS N L G L L
Sbjct: 79 GLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLL 138
Query: 208 TRLPSLSVLALQHNNLS-GSVPNNWGVLAGNKSYQLQFLNLDHN--------LIAGTIPV 258
L L L++ +LS S VL + L + +N ++ +
Sbjct: 139 DPQCRLEKLQLEYCSLSAASCEPLASVLRAKPD--FKELTVSNNDINEAGVRVLCQGLKD 196
Query: 259 SLGKLGLLQEISLSHNKI----VGPIPDELGKLSKLQKLDLSYNAIGGS-----FPVTFT 309
S +L + + L + + + + L++L L N +G P
Sbjct: 197 SPCQL---EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLH 253
Query: 310 NITSLVSLNLENNRLGNK----IPEGLERLQNLTVLNLKNNQFKG----HIPETIGNI-S 360
+ L +L + + K + L ++L L+L N+ + ET+
Sbjct: 254 PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGC 313
Query: 361 GINQLDLSENDFTGE----ISPSLASLANLTSFNVSYNNLSGS 399
+ L + FT S LA L +S N L +
Sbjct: 314 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-20
Identities = 61/329 (18%), Positives = 113/329 (34%), Gaps = 52/329 (15%)
Query: 117 LRKLSLHDNLLAGPVPWS-----LGFLPNLRGVYLFNNRLSGSIPPSIG-----NCPNLQ 166
++KLSL + L L LP L+ ++L +N L + + L+
Sbjct: 87 IQKLSLQNCCL-TGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145
Query: 167 TLDLSNNAL----IGAIPPSLANSTRLYRLNLSYNSL----LGSIPLSLTRLP-SLSVLA 217
L L +L + L L +S N + + + L P L L
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205
Query: 218 LQHNNLSGSVPNNWGVLAG--NKSYQLQFLNLDHNLIAGTIPVSLGKLGL-----LQEIS 270
L+ ++ +N L G L+ L L N + L L L+ +
Sbjct: 206 LESCGVT---SDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262
Query: 271 LSHNKI----VGPIPDELGKLSKLQKLDLSYNAIGGS-----FPVTFTNITSLVSLNLEN 321
+ I G + L L++L L+ N +G L SL +++
Sbjct: 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 322
Query: 322 NRLGNK----IPEGLERLQNLTVLNLKNNQFKG----HIPETIGNI-SGINQLDLSENDF 372
L + + L L + NN+ + + + +G S + L L++ D
Sbjct: 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382
Query: 373 TGE----ISPSLASLANLTSFNVSYNNLS 397
+ ++ +L + +L ++S N L
Sbjct: 383 SDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 51/274 (18%), Positives = 94/274 (34%), Gaps = 48/274 (17%)
Query: 164 NLQTLDLSNNAL----IGAIPPSLANSTRLYRLNLSYNSL----LGSIPLSLTRLPSLSV 215
++Q+LD+ L + P L + L L I +L P+L+
Sbjct: 4 DIQSLDIQCEELSDARWAELLPLLQQCQ---VVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 216 LALQHNNLSGSVPNNWGVLA-----GNKSYQLQFLNLDHNLI----AGTIPVSLGKLGLL 266
L L+ N L GV S ++Q L+L + + G + +L L L
Sbjct: 61 LNLRSNELGDV-----GVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTL 115
Query: 267 QEISLSHNKIVGPIPDELGKL-----SKLQKLDLSYNAIG----GSFPVTFTNITSLVSL 317
QE+ LS N + L + +L+KL L Y ++ L
Sbjct: 116 QELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKEL 175
Query: 318 NLENNRLGNK----IPEGLERLQ-NLTVLNLKNNQFK----GHIPETIGNISGINQLDLS 368
+ NN + + +GL+ L L L++ + + + + + +L L
Sbjct: 176 TVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALG 235
Query: 369 ENDFTGE----ISPSL-ASLANLTSFNVSYNNLS 397
N + P L + L + + ++
Sbjct: 236 SNKLGDVGMAELCPGLLHPSSRLRTLWIWECGIT 269
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-16
Identities = 58/325 (17%), Positives = 110/325 (33%), Gaps = 55/325 (16%)
Query: 107 ISEKISQLH-ALRKLSLHDNLL----AGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIG- 160
+ E + L KL L L P+ L P+ + + + NN ++ + +
Sbjct: 133 LCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQ 192
Query: 161 ----NCPNLQTLDLSNNAL----IGAIPPSLANSTRLYRLNLSYNSLL--GSIPLSLTRL 210
+ L+ L L + + + +A+ L L L N L G L L
Sbjct: 193 GLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLL 252
Query: 211 ---PSLSVLALQHNNLSGSVPNNWG------VLAGNKSYQLQFLNLDHNLI----AGTIP 257
L L + ++ G VL +S L+ L+L N + A +
Sbjct: 253 HPSSRLRTLWIWECGITAK-----GCGDLCRVLRAKES--LKELSLAGNELGDEGARLLC 305
Query: 258 VSLGKLGL-LQEISLSHNKI----VGPIPDELGKLSKLQKLDLSYNAIGGS-----FPVT 307
+L + G L+ + + L + L +L +S N + +
Sbjct: 306 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGL 365
Query: 308 FTNITSLVSLNLENNRLGNK----IPEGLERLQNLTVLNLKNNQFKG----HIPETI-GN 358
+ L L L + + + + L +L L+L NN + E++
Sbjct: 366 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 425
Query: 359 ISGINQLDLSENDFTGEISPSLASL 383
+ QL L + ++ E+ L +L
Sbjct: 426 GCLLEQLVLYDIYWSEEMEDRLQAL 450
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-12
Identities = 49/268 (18%), Positives = 91/268 (33%), Gaps = 49/268 (18%)
Query: 117 LRKLSLHDNLL----AGPVPWSLGFLPNLRGVYLFNNRLSGS-----IPPSIGNCPNLQT 167
L L L + + + +LR + L +N+L P + L+T
Sbjct: 201 LEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRT 260
Query: 168 LDLSNNAL----IGAIPPSLANSTRLYRLNLSYNSL--LGSIPLS---LTRLPSLSVLAL 218
L + + G + L L L+L+ N L G+ L L L L +
Sbjct: 261 LWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320
Query: 219 QHNNLSGSVPNNWG------VLAGNKSYQLQFLNLDHNLI--AGTIPVSLG---KLGLLQ 267
+ + + VLA N+ L L + +N + AG + G +L+
Sbjct: 321 KSCSFT-----AACCSHFSSVLAQNRF--LLELQISNNRLEDAGVRELCQGLGQPGSVLR 373
Query: 268 EISLSHNKI----VGPIPDELGKLSKLQKLDLSYNAIGGSFPVTF-----TNITSLVSLN 318
+ L+ + + L L++LDLS N +G + + L L
Sbjct: 374 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 433
Query: 319 LENNRLGNK----IPEGLERLQNLTVLN 342
L + + + + +L V++
Sbjct: 434 LYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 36/173 (20%), Positives = 60/173 (34%), Gaps = 29/173 (16%)
Query: 266 LQEISLSHNKIVGPIPDELGK-LSKLQKLDLSYNAIG----GSFPVTFTNITSLVSLNLE 320
+Q + + ++ EL L + Q + L + +L LNL
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 321 NNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGE----I 376
+N LG+ G+ + L+ K I +L L TG +
Sbjct: 65 SNELGD---VGVHCVLQG----LQTPSCK------------IQKLSLQNCCLTGAGCGVL 105
Query: 377 SPSLASLANLTSFNVSYNNLSGSVPPLLSKKF-NSSSFVGNLQLCGYSPSTAC 428
S +L +L L ++S N L + LL + + + LQL S S A
Sbjct: 106 SSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS 158
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 15/96 (15%), Positives = 33/96 (34%), Gaps = 10/96 (10%)
Query: 312 TSLVSLNLENNRLGNK-IPEGLERLQNLTVLNLKNNQFK----GHIPETIGNISGINQLD 366
+ SL+++ L + E L LQ V+ L + I + + +L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 367 LSENDFTGE----ISPSLASL-ANLTSFNVSYNNLS 397
L N+ + L + + ++ L+
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 98
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 39/219 (17%)
Query: 541 EIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEA-EAAAIGKIHHPNLLALRA 598
+++G ++G Y+A L + G VA+K++ + K F+ E + K+ H N++ LR
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLR- 113
Query: 599 YYLGPKGEKL------LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIG------IAR 646
Y+ GEK LV D++P+ ++ + + + R
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-----QTLPVIYVKLYMYQLFR 167
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNP-RIADFGLSR-LMTAAANTNVIATAGTLGYR 704
L Y+H + H ++ N+LLD T ++ DFG ++ L+ N + I + YR
Sbjct: 168 SLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS---RYYR 223
Query: 705 APELSKL---KNANTKTDVYSLGVIILELLTGKS--PGE 738
APEL + + + DV+S G ++ ELL G+ PG+
Sbjct: 224 APEL--IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 260
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 544 GKSTYGTAYKA---TLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI------HHPNLL 594
G+ TYG YKA +D + A+K++ +A +I HPN++
Sbjct: 30 GRGTYGHVYKAKRKDGKDDKDYALKQIEG--------TGISMSACREIALLRELKHPNVI 81
Query: 595 ALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRM------SIAIGIARG 647
+L+ +L K+ L+FD+ L + ++ S+ I G
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 648 LNYLHVEENMIHGNLTSSNVLLDEKTNPR----IADFGLSRLMTAAAN--TNVIATAGTL 701
++YLH ++H +L +N+L+ + R IAD G +RL + ++ T
Sbjct: 141 IHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 702 GYRAPELSKL---KNANTKTDVYSLGVIILELLTGK 734
YRAPEL L ++ D++++G I ELLT +
Sbjct: 200 WYRAPEL--LLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 3e-20
Identities = 50/190 (26%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 144 VYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPP--SLANSTRLYRLNLSYNSLLG 201
+ +L ++P S+ LDLS+N + + + T L+ L LS+N L
Sbjct: 23 LSCSKQQLP-NVPQSLP--SYTALLDLSHNN-LSRLRAEWTPTRLTNLHSLLLSHNHL-N 77
Query: 202 SIP-LSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSL 260
I + +P+L L L N+L ++ + + + L+ L L +N I +
Sbjct: 78 FISSEAFVPVPNLRYLDLSSNHLH-TLD--EFLFSDLQ--ALEVLLLYNNHIVVVDRNAF 132
Query: 261 GKLGLLQEISLSHNKIVGPIPDE----LGKLSKLQKLDLSYNAIGGSFPVTFTNITSLV- 315
+ LQ++ LS N+I P E KL KL LDLS N + + + V
Sbjct: 133 EDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK 191
Query: 316 -SLNLENNRL 324
L L NN L
Sbjct: 192 NGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 7e-19
Identities = 49/226 (21%), Positives = 80/226 (35%), Gaps = 45/226 (19%)
Query: 157 PSIGNCP-----NLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLP 211
S+ +CP L S L +P SL + T L+LS+N+L +RL
Sbjct: 7 RSVVSCPANCLCASNILSCSKQQLP-NVPQSLPSYTA--LLDLSHNNL--------SRLR 55
Query: 212 SLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPV-SLGKLGLLQEIS 270
+ L+ L L L HN + I + + L+ +
Sbjct: 56 AEWTPT----RLT----------------NLHSLLLSHNHLN-FISSEAFVPVPNLRYLD 94
Query: 271 LSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPE 330
LS N + L L+ L L N I F ++ L L L N++ ++ P
Sbjct: 95 LSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI-SRFPV 153
Query: 331 G----LERLQNLTVLNLKNNQFKGHIPETIGNISGINQ--LDLSEN 370
+L L +L+L +N+ K + + + L L N
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 4e-16
Identities = 39/165 (23%), Positives = 63/165 (38%), Gaps = 13/165 (7%)
Query: 117 LRKLSLHDNLLAG-PVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNA 174
L L N L+ W+ L NL + L +N L+ I PNL+ LDLS+N
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN- 98
Query: 175 LIGAIPP-SLANSTRLYRLNLSYNSLLGSIPL-SLTRLPSLSVLALQHNNLSGSVPNNWG 232
+ + ++ L L L N + + + + L L L N +S P
Sbjct: 99 HLHTLDEFLFSDLQALEVLLLYNN-HIVVVDRNAFEDMAQLQKLYLSQNQIS-RFP--VE 154
Query: 233 VLAGNKSY-QLQFLNLDHNLIAGTIPVSLGKLGLLQE--ISLSHN 274
++ +L L+L N + L KL + + L +N
Sbjct: 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 39/162 (24%), Positives = 61/162 (37%), Gaps = 12/162 (7%)
Query: 242 LQFLNLDHNLIAGTIP-VSLGKLGLLQEISLSHNKIVGPIPDE-LGKLSKLQKLDLSYNA 299
L+L HN ++ + +L L + LSHN + I E + L+ LDLS N
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNH 99
Query: 300 IGGSFPV-TFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQFKGHIPE--- 354
+ + F+++ +L L L NN + + E + L L L NQ P
Sbjct: 100 LH-TLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELI 156
Query: 355 -TIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNN 395
+ + LDLS N L L + +N
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 37/145 (25%), Positives = 60/145 (41%), Gaps = 12/145 (8%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDL 170
++L L L L N L + +PNLR + L +N L ++ + + L+ L L
Sbjct: 61 TRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 171 SNNALIGAIPP-SLANSTRLYRLNLSYNSLLGSIP----LSLTRLPSLSVLALQHNNLSG 225
NN I + + + +L +L LS N + P +LP L +L L N L
Sbjct: 120 YNN-HIVVVDRNAFEDMAQLQKLYLSQNQ-ISRFPVELIKDGNKLPKLMLLDLSSNKLK- 176
Query: 226 SVPNNWGVLAGNKSYQLQFLNLDHN 250
+P L ++ L L +N
Sbjct: 177 KLPL--TDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 30/116 (25%), Positives = 46/116 (39%), Gaps = 6/116 (5%)
Query: 290 LQKLDLSYNAIGGSFP-VTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQ 347
LDLS+N + T T +T+L SL L +N L N I + NL L+L +N
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNH 99
Query: 348 FKGHIPETIGNISGINQLDLSENDFTGEISP-SLASLANLTSFNVSYNNLSGSVPP 402
++ + L L N + + +A L +S N +S P
Sbjct: 100 LHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 59/213 (27%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 140 NLRGVYLFNNRLSGSIPPSIGNCP-NLQTLDLSNNALIGAIPPS-LANSTRLYRLNLSYN 197
N V + +L+ +IP +I P + + LDL +N + ++P T+L L L+ N
Sbjct: 17 NKNSVDCSSKKLT-AIPSNI---PADTKKLDLQSNK-LSSLPSKAFHRLTKLRLLYLNDN 71
Query: 198 SLLGSIPLSL-TRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTI 256
L ++P + L +L L + N L ++P ++ L L LD N + ++
Sbjct: 72 KL-QTLPAGIFKELKNLETLWVTDNKLQ-ALPIG----VFDQLVNLAELRLDRNQLK-SL 124
Query: 257 PVSL-GKLGLLQEISLSHNKIVGPIPDEL-GKLSKLQKLDLSYNAIGGSFPVTFTNITSL 314
P + L L +SL +N++ +P + KL+ L++L L N + F +T L
Sbjct: 125 PPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTEL 183
Query: 315 VSLNLENNRLGNKIPEGL-ERLQNLTVLNLKNN 346
+L L+NN+L +PEG + L+ L +L L+ N
Sbjct: 184 KTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 62/251 (24%), Positives = 100/251 (39%), Gaps = 40/251 (15%)
Query: 148 NNRLSGSIPPSIGNC-PNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLS 206
N L + +C N ++D S+ L AIP ++ T+ +L+L N L +
Sbjct: 1 NEAL-CKKDGGVCSCNNNKNSVDCSSKKLT-AIPSNIPADTK--KLDLQSNKLSSLPSKA 56
Query: 207 LTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLL 266
RL L +L L N L ++P G+ K L+ L + N + +P
Sbjct: 57 FHRLTKLRLLYLNDNKLQ-TLPA--GIFKELK--NLETLWVTDNKLQ-ALP--------- 101
Query: 267 QEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPV-TFTNITSLVSLNLENNRLG 325
+L L +L L N + S P F ++T L L+L N L
Sbjct: 102 --------------IGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ 146
Query: 326 NKIPEGL-ERLQNLTVLNLKNNQFKGHIPETI-GNISGINQLDLSENDFTGEISPSLASL 383
+ +P+G+ ++L +L L L NNQ K +PE ++ + L L N + SL
Sbjct: 147 S-LPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSL 204
Query: 384 ANLTSFNVSYN 394
L + N
Sbjct: 205 EKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 11/166 (6%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCP-NLQTLDL 170
+L LR L L+DN L L NL +++ +N+L ++P + + NL L L
Sbjct: 58 HRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116
Query: 171 SNNALIGAIPPSL-ANSTRLYRLNLSYNSLLGSIPLSL-TRLPSLSVLALQHNNLSGSVP 228
N + ++PP + + T+L L+L YN L S+P + +L SL L L +N L VP
Sbjct: 117 DRNQ-LKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVP 173
Query: 229 NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHN 274
A +K +L+ L LD+N + + L L+ + L N
Sbjct: 174 EG----AFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 33/116 (28%), Positives = 56/116 (48%), Gaps = 7/116 (6%)
Query: 290 LQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGL-ERLQNLTVLNLKNNQF 348
+KLDL N + F +T L L L +N+L +P G+ + L+NL L + +N+
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKL 97
Query: 349 KGHIPETI-GNISGINQLDLSENDFTGEISPSL-ASLANLTSFNVSYNNLSGSVPP 402
+ +P + + + +L L N + P + SL LT ++ YN L S+P
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPK 150
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+G +G YKA E G+ A K + K+ + +++ E + HP ++ L
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAI---GIARGLNYLHVEE 655
Y KL ++ +F P G++ + + T I + + LN+LH +
Sbjct: 85 YY--HDGKLWIMIEFCPGGAVDAIMLELD-----RGLTEPQIQVVCRQMLEALNFLH-SK 136
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA---ANTNVIATAGTLGYRAPELSKLK 712
+IH +L + NVL+ + + R+ADFG+S ++ + GT + APE+ +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI----GTPYWMAPEVVMCE 192
Query: 713 NA-----NTKTDVYSLGVIILELLTGKSPGEPMNGM 743
+ K D++SLG+ ++E+ + P +N M
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 228
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 59/235 (25%), Positives = 99/235 (42%), Gaps = 41/235 (17%)
Query: 544 GKSTYGTAYKA-TLEDGSEVAVKRL-REKTTKG--QKEFEAEAAAIGKIHHPNLLALRAY 599
GK +G Y A ++ +A+K L + + K + + E + HPN+L + Y
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY 82
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVEEN 656
+ K ++ L+ +F P+G L L G E + + +A L+Y H E
Sbjct: 83 FHDRK--RIYLMLEFAPRGELYKELQKHGRFDE----QRSATFME-ELADALHYCH-ERK 134
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLS------RLMTAAANTNVIATAGTLGYRAPELSK 710
+IH ++ N+L+ K +IADFG S R T GTL Y PE+ +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT---------MCGTLDYLPPEMIE 185
Query: 711 LKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL-----------PQWVASIVK 754
K + K D++ GV+ E L G P + + + P +++ K
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSK 240
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 28/207 (13%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
E +G+ GT Y A + G EVA++++ + ++ E + + +PN++
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMS---IAI---GIARGLNYLH 652
YL G++L +V +++ GSL + T M IA + L +LH
Sbjct: 86 YL--VGDELWVVMEYLAGGSLTDVVTE----------TCMDEGQIAAVCRECLQALEFLH 133
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA---ANTNVIATAGTLGYRAPELS 709
+IH ++ S N+LL + ++ DFG +T +T V GT + APE+
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVV 188
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSP 736
K K D++SLG++ +E++ G+ P
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 48/207 (23%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+G+ + G A G +VAVK + + + ++ E + H N++ +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMS---IAI---GIARGLNYLH 652
YL GE+L ++ +F+ G+L + R++ IA + + L YLH
Sbjct: 111 YL--VGEELWVLMEFLQGGALTDIVSQ----------VRLNEEQIATVCEAVLQALAYLH 158
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA---NTNVIATAGTLGYRAPELS 709
+ +IH ++ S ++LL +++DFG ++ + V GT + APE+
Sbjct: 159 -AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV----GTPYWMAPEVI 213
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSP 736
T+ D++SLG++++E++ G+ P
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 9e-20
Identities = 47/305 (15%), Positives = 93/305 (30%), Gaps = 23/305 (7%)
Query: 113 QLHALRKLSLHDNLLAGPVPWSLGF--LPNLRGVYLFNNRLSGSIPPS--IGNCPNLQTL 168
L L + N L ++ + +LR + L N +P GN L L
Sbjct: 98 FNQDLEYLDVSHNRL-----QNISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFL 151
Query: 169 DLSNNALIGAIPPSLAN-STRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSV 227
LS +A+ L+L + G SL + + + H N SV
Sbjct: 152 GLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSV 211
Query: 228 PNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPD----- 282
N + QL + L+ + ++++ I
Sbjct: 212 QVN-MSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF 270
Query: 283 ELGKLSKLQKLDLSYNAIGG-----SFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQN 337
+ ++ L++ I F + T + SL+ +++N
Sbjct: 271 QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE 330
Query: 338 LTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLS 397
+ + L + + S L+ ++N FT + ++L L + + N L
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
Query: 398 GSVPP 402
+
Sbjct: 391 -NFFK 394
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 5e-18
Identities = 64/322 (19%), Positives = 114/322 (35%), Gaps = 42/322 (13%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNAL 175
+ LSL N ++ + FL LR + L +NR+ S+ + +L+ LD+S+N L
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL 112
Query: 176 IGAIPPSLANSTRLYRLNLSYNSLLGSIPLS--LTRLPSLSVLALQHN------------ 221
I L L+LS+N +P+ L L+ L L
Sbjct: 113 -QNISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAH 168
Query: 222 ---------NLSGSVPNNW-GVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISL 271
+S + L + L + ++L + + +S+ LG LQ ++
Sbjct: 169 LHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228
Query: 272 SHNKI----VGPIPDELGKLSKLQKLDLSYNAIGGSFPV---TFTNITSLVSLNLENNRL 324
N + EL + L + L + V F + LN+ N +
Sbjct: 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTI 288
Query: 325 GNKIPEGLER-----LQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPS 379
+I L++L + ++KN F + +N LS +D
Sbjct: 289 TERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVC 348
Query: 380 LASLANLTSFNVSYNNLSGSVP 401
S ++ T N + N + SV
Sbjct: 349 PPSPSSFTFLNFTQNVFTDSVF 370
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 7e-18
Identities = 56/334 (16%), Positives = 106/334 (31%), Gaps = 42/334 (12%)
Query: 114 LHALRKLSLHDNLLAG-PVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQT--LDL 170
+ +LR L L N PV G L L + L + + +L LDL
Sbjct: 120 MASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDL 178
Query: 171 SNNALIGAIPPSLAN-STRLYRLNLSYNSLLGSI-PLSLTRLPSLSVLALQHNNLSGSVP 228
+ + G SL +T + L NSL +S+ L L + ++ N+ +
Sbjct: 179 VSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRL 238
Query: 229 NN--WGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELG- 285
+ G + +++ ++ +++ + I I E
Sbjct: 239 MTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFT 298
Query: 286 ----------------------------KLSKLQKLDLSYNAIGGSFPVTFTNITSLVSL 317
+++ LS + V + +S L
Sbjct: 299 YSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFL 358
Query: 318 NLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFT---- 373
N N + + +G L+ L L L+ N K + + ++ L+ +
Sbjct: 359 NFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNS 417
Query: 374 GEISPSLASLANLTSFNVSYNNLSGSVPPLLSKK 407
+ A ++ N+S N L+GSV L K
Sbjct: 418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK 451
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-17
Identities = 48/270 (17%), Positives = 93/270 (34%), Gaps = 38/270 (14%)
Query: 110 KISQLHALRKLSLHDNLLAGPVPW-----SLGFLPNLRGVYLFNNRLSGSIPPSIGNCPN 164
+ + L++++ + + S L +L ++ N S
Sbjct: 271 QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE 330
Query: 165 LQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLS 224
+ LS + + + LN + N S+ + L L L LQ N L
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
Query: 225 GSVPNNWGVLAGNKSYQLQFLNLDHN-LIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDE 283
+ + S L+ L++ N L + + + ++LS N + G +
Sbjct: 391 -NFFKVALMTKNMSS--LETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRC 447
Query: 284 LGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNL 343
L K++ LDL N I S+ P+ + LQ L LN+
Sbjct: 448 L--PPKVKVLDLHNN-----------RIMSI--------------PKDVTHLQALQELNV 480
Query: 344 KNNQFKGHIPE-TIGNISGINQLDLSENDF 372
+NQ K +P+ ++ + + L +N +
Sbjct: 481 ASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 1e-16
Identities = 47/302 (15%), Positives = 93/302 (30%), Gaps = 18/302 (5%)
Query: 113 QLHALRKLSLHDNLLAGPVPWSLGFLPNL--RGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170
L + ++L + V S+ L +L + L + + L++
Sbjct: 195 NTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNV 254
Query: 171 SNNALIGAIPP-----SLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSG 225
+ + + LN+ ++ I ++ +L ++
Sbjct: 255 TLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKN 314
Query: 226 SVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELG 285
V + ++ L + V ++ + N +
Sbjct: 315 QVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCS 374
Query: 286 KLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGL-----ERLQNLTV 340
L +LQ L L N + +F ++ SL + L N + +++ V
Sbjct: 375 TLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSL-NSLNSHAYDRTCAWAESILV 432
Query: 341 LNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSV 400
LNL +N G + + + LDL N I + L L NV+ N L SV
Sbjct: 433 LNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SV 488
Query: 401 PP 402
P
Sbjct: 489 PD 490
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 2e-16
Identities = 58/251 (23%), Positives = 100/251 (39%), Gaps = 14/251 (5%)
Query: 162 CPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHN 221
+D SN L +P L T+ L+LS NS+ ++ L L VL L HN
Sbjct: 30 NELESMVDYSNRNLT-HVPKDLPPRTK--ALSLSQNSISELRMPDISFLSELRVLRLSHN 86
Query: 222 NLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKI-VGPI 280
+ S+ V N+ L++L++ HN + +S + L+ + LS N V P+
Sbjct: 87 RIR-SLDF--HVFLFNQ--DLEYLDVSHNRLQN---ISCCPMASLRHLDLSFNDFDVLPV 138
Query: 281 PDELGKLSKLQKLDLSYNAIGGSFPVTFTNI-TSLVSLNLENNRLGNKIPEGLERLQNLT 339
E G L+KL L LS + ++ S + L+L + + E L+ N T
Sbjct: 139 CKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTT 197
Query: 340 VLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGS 399
VL+L + + +++ + L LS E L + + + + N++
Sbjct: 198 VLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQ 257
Query: 400 VPPLLSKKFNS 410
K
Sbjct: 258 HIETTWKCSVK 268
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 47/224 (20%), Positives = 87/224 (38%), Gaps = 34/224 (15%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKR-LREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+I+G + GT G VAVKR L + E + + HPN++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTES---DDHPNVIRYYCS 77
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAI--GIARGLNYLHVEE 655
+ + + +L + ++ E + I++ IA G+ +LH
Sbjct: 78 ETTDR-FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-SL 134
Query: 656 NMIHGNLTSSNVLLDEKTNPR-------------IADFGLSRLMT---AAANTNVIATAG 699
+IH +L N+L+ + I+DFGL + + ++ TN+ +G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 700 TLGYRAPEL-------SKLKNANTKTDVYSLGVIILELLTGKSP 736
T G+RAPEL + D++S+G + +L+
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 22/209 (10%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVK-----RLREKTTKGQKE-FEAEAAAIGKIHHPNL 593
E +G + K G E A K + R +E E E + + ++ HPN+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYL 651
+ L Y + +L+ + + G L FL + E + I G+NYL
Sbjct: 78 ITLHDVYENRT-DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ-----ILDGVNYL 131
Query: 652 HVEENMIHGNLTSSNVLLDEKTNP----RIADFGLSRLMTAAANTNVIATAGTLGYRAPE 707
H + + H +L N++L +K P ++ DFGL+ + I GT + APE
Sbjct: 132 H-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPE 188
Query: 708 LSKLKNANTKTDVYSLGVIILELLTGKSP 736
+ + + D++S+GVI LL+G SP
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQK------EFEAEAAAIGKIHHPNL 593
E +G + K G E A K ++++ ++ + E E E + + ++ H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYL 651
+ L Y + +L+ + + G L FL + E + I G+NYL
Sbjct: 78 ITLHDVYENRT-DVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ-----ILDGVNYL 131
Query: 652 HVEENMIHGNLTSSNVLLDEKTNP----RIADFGLSRLMTAAANTNVIATAGTLGYRAPE 707
H + + H +L N++L +K P ++ DFGL+ + I GT + APE
Sbjct: 132 H-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF--GTPEFVAPE 188
Query: 708 LSKLKNANTKTDVYSLGVIILELLTGKSP 736
+ + + D++S+GVI LL+G SP
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRL-REKTTKG--QKEFEAEAAAIGKIHHPNLLALRAY 599
GK ++ Y+A + G EVA+K + ++ K + + E ++ HP++L L Y
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARG---PETIVNWATRMSIAIGIARGLNYLHVEE 655
+ + LV + G + +L R E R + I G+ YLH
Sbjct: 80 FEDSN--YVYLVLEMCHNGEMNRYLKNRVKPFSE----NEARHFMH-QIITGMLYLH-SH 131
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLS--------RLMTAAANTNVIATAGTLGYRAPE 707
++H +LT SN+LL N +IADFGL+ + T GT Y +PE
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT---------LCGTPNYISPE 182
Query: 708 LSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745
++ ++DV+SLG + LL G+ P + +
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT 220
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 28/221 (12%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRA 598
E++G TYG YK ++ G A+K + + ++E + E + K HH N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYG 88
Query: 599 YYL----GPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAI---GIARGLNY 650
++ ++L LV +F GS+ + T+ IA I RGL++
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL----KEEWIAYICREILRGLSH 144
Query: 651 LHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA---ANTNVIATAGTLGYRAPE 707
LH + +IH ++ NVLL E ++ DFG+S + NT + GT + APE
Sbjct: 145 LH-QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI----GTPYWMAPE 199
Query: 708 LSKLKNA-----NTKTDVYSLGVIILELLTGKSPGEPMNGM 743
+ + K+D++SLG+ +E+ G P M+ M
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 39/202 (19%), Positives = 85/202 (42%), Gaps = 16/202 (7%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
E +G+ +G ++ K ++ Q + E + + H N+L L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARGP---ETIVNWATRMSIAIGIARGLNYLHVEEN 656
+ + E +++F+F+ + ++ E + + L +LH N
Sbjct: 70 FESME-ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ-----VCEALQFLH-SHN 122
Query: 657 MIHGNLTSSNVLLDEKTNP--RIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNA 714
+ H ++ N++ + + +I +FG +R + N ++ Y APE+ +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVV 180
Query: 715 NTKTDVYSLGVIILELLTGKSP 736
+T TD++SLG ++ LL+G +P
Sbjct: 181 STATDMWSLGTLVYVLLSGINP 202
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-19
Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALR 597
+ +G YG E A+K +R+ +T + E A + + HPN++ L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVEE 655
++ + LV + G L + R E I + G+ YLH +
Sbjct: 103 DFFEDKR-NYYLVMECYKGGELFDEIIHRMKFNEVDA-----AVIIKQVLSGVTYLH-KH 155
Query: 656 NMIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLK 712
N++H +L N+LL ++ +I DFGLS + + GT Y APE+ + K
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKERLGTAYYIAPEVLR-K 212
Query: 713 NANTKTDVYSLGVIILELLTGKSP 736
+ K DV+S+GVI+ LL G P
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPP 236
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 7e-19
Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFEAEAA-------AIGKIHHP 591
+G YGT YKA G VA+K +R G + HP
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 592 NLLALRAYYLGPKGEKL----LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARG 647
N++ L + ++ LVF+ + + L ++L P + T + RG
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKA-PPPGLPAETIKDLMRQFLRG 132
Query: 648 LNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN-TNVIATAGTLGYRAP 706
L++LH ++H +L N+L+ ++ADFGL+R+ + T V+ TL YRAP
Sbjct: 133 LDFLH-ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV---TLWYRAP 188
Query: 707 ELSKLKNA--NTKTDVYSLGVIILELLTGK 734
E+ L + T D++S+G I E+ K
Sbjct: 189 EV--LLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 7e-19
Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 22/209 (10%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVK-----RLREKTTKGQKE-FEAEAAAIGKIHHPNL 593
E +G + K G E A K RL +E E E + +I HPN+
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYL 651
+ L + + +L+ + + G L FL + E + I G++YL
Sbjct: 71 ITLHDIFENKT-DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ-----ILDGVHYL 124
Query: 652 HVEENMIHGNLTSSNVLLDEKTNP----RIADFGLSRLMTAAANTNVIATAGTLGYRAPE 707
H + + H +L N++L +K P ++ DFG++ + A I GT + APE
Sbjct: 125 H-SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--GTPEFVAPE 181
Query: 708 LSKLKNANTKTDVYSLGVIILELLTGKSP 736
+ + + D++S+GVI LL+G SP
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKE---FEA--EAAAIGKIHHPNLLA 595
E +G+ TYG YKA G VA+KR+R + E A E + + ++HHPN+++
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 596 LRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
L + L LVF+FM K L L T + + + RG+ + H +
Sbjct: 84 LIDVIHSER--CLTLVFEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCH-Q 137
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT---NVIATAGTLGYRAPELSKL 711
++H +L N+L++ ++ADFGL+R + V+ TL YRAP++ L
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPDV--L 191
Query: 712 ---KNANTKTDVYSLGVIILELLTGK 734
K +T D++S+G I E++TGK
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 8e-19
Identities = 51/246 (20%), Positives = 89/246 (36%), Gaps = 52/246 (21%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVK-----RLREKTTKGQKEFEAEAAAIGKIHHPNLL 594
+G+ +YG A + + A+K ++R+ K + + E + K+HHPN+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIA 91
Query: 595 ALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIG----------- 643
L Y + LV + G L L+ ++ A +
Sbjct: 92 RLYEVYEDEQ-YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 644 --------------------------IARGLNYLHVEENMIHGNLTSSNVLL--DEKTNP 675
I L+YLH + + H ++ N L ++
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH-NQGICHRDIKPENFLFSTNKSFEI 209
Query: 676 RIADFGLSRLMTAAANTNVIA---TAGTLGYRAPEL--SKLKNANTKTDVYSLGVIILEL 730
++ DFGLS+ N AGT + APE+ + ++ K D +S GV++ L
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 731 LTGKSP 736
L G P
Sbjct: 270 LMGAVP 275
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 8e-19
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 31/208 (14%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEA-------EAAAIGKIHHPNL 593
E +G+ TYG YKA G A+K++R +KE E E + + ++ H N+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRL-----EKEDEGIPSTTIREISILKELKHSNI 62
Query: 594 LALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLH 652
+ L K +L LVF+ + + L L + T S + + G+ Y H
Sbjct: 63 VKLYDVIHTKK--RLVLVFEHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH 117
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT---NVIATAGTLGYRAPELS 709
+ ++H +L N+L++ + +IADFGL+R ++ TL YRAP++
Sbjct: 118 -DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDV- 171
Query: 710 KL---KNANTKTDVYSLGVIILELLTGK 734
L K +T D++S+G I E++ G
Sbjct: 172 -LMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 9e-19
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEA---EAAAIGKIHHPNLLAL 596
++GK ++G G E AVK + ++ K + + E+ E + ++ HPN++ L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 597 RAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
++ LV + G L + +R + V+ A I + G+ Y+H +
Sbjct: 92 YEFFEDKG-YFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYMH-KNK 146
Query: 657 MIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKN 713
++H +L N+LL + N RI DFGLS A + + GT Y APE+
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAYYIAPEVLH-GT 203
Query: 714 ANTKTDVYSLGVIILELLTGKSP 736
+ K DV+S GVI+ LL+G P
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPP 226
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEA--EAAAIGKIHHPNLLALR 597
+G+ +YG +K + G VA+K+ E + A E + ++ HPNL+ L
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
K LVF++ ++ L V SI + +N+ H + N
Sbjct: 69 EV-FRRKRRLHLVFEYCDH-TVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCH-KHNC 123
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN--TNVIATAGTLGYRAPELSKL---K 712
IH ++ N+L+ + + ++ DFG +RL+T ++ + +A T YR+PEL L
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA---TRWYRSPEL--LVGDT 178
Query: 713 NANTKTDVYSLGVIILELLTGKS--PGE 738
DV+++G + ELL+G PG+
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGK 206
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 18/207 (8%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEA--EAAAIGKIHHPNLLALR 597
++G+ +YG K + G VA+K+ E + A E + ++ H NL+ L
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 598 AYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
K + LVF+F+ ++ L +++ I G+ + H N
Sbjct: 91 EVCKKKK--RWYLVFEFVDH-TILDDLELFP--NGLDYQVVQKYLFQIINGIGFCH-SHN 144
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN--TNVIATAGTLGYRAPE-LSKLKN 713
+IH ++ N+L+ + ++ DFG +R + A + +A T YRAPE L
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA---TRWYRAPELLVGDVK 201
Query: 714 ANTKTDVYSLGVIILELLTGKS--PGE 738
DV+++G ++ E+ G+ PG+
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGD 228
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 547 TYGTAYKAT-LEDGSEVAVKRLREKTTKGQKE---FEA--EAAAIGKIHHPNLLALRAYY 600
+ T YKA VA+K+++ K+ A E + ++ HPN++ L +
Sbjct: 22 QFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF 81
Query: 601 LGPKGEKL-LVFDFMPKGSLASFLHARG----PETIVNWATRMSIAIGIARGLNYLHVEE 655
+ LVFDFM L + P I + M +GL YLH +
Sbjct: 82 GH--KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAY-MLM-----TLQGLEYLH-QH 131
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT---NVIATAGTLGYRAPELSKL- 711
++H +L +N+LLDE ++ADFGL++ + V+ T YRAPEL L
Sbjct: 132 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV----TRWYRAPEL--LF 185
Query: 712 --KNANTKTDVYSLGVIILELLTGKS--PGE 738
+ D++++G I+ ELL PG+
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGD 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 48/223 (21%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEA-----AAIGKI------ 588
+G+ T+G +KA + G +VA+K++ E E A+ +I
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVL---------MENEKEGFPITALREIKILQLL 73
Query: 589 HHPNLLAL------RAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIA 641
H N++ L +A + LVFDF LA L + +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVM 130
Query: 642 IGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN------TN-V 694
+ GL Y+H ++H ++ ++NVL+ ++ADFGL+R + A N TN V
Sbjct: 131 QMLLNGLYYIH-RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 695 IATAGTLGYRAPELSKL---KNANTKTDVYSLGVIILELLTGK 734
+ TL YR PEL L ++ D++ G I+ E+ T
Sbjct: 190 V----TLWYRPPEL--LLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 49/214 (22%), Positives = 86/214 (40%), Gaps = 29/214 (13%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRL--------REKTTKGQKEFEAEAAAIGKIHHP 591
+ +G G A + +VA++ + + E E + K++HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 592 NLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLN 649
++ ++ ++ +V + M G L + E + + +
Sbjct: 201 CIIKIKNFFDAED--YYIVLELMEGGELFDKVVGNKRLKEA----TCK-LYFYQMLLAVQ 253
Query: 650 YLHVEENMIHGNLTSSNVLLDEKTNP---RIADFGLSRLMTAAANTNVIATA-GTLGYRA 705
YLH E +IH +L NVLL + +I DFG S+++ T+++ T GT Y A
Sbjct: 254 YLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGTPTYLA 309
Query: 706 PEL---SKLKNANTKTDVYSLGVIILELLTGKSP 736
PE+ N D +SLGVI+ L+G P
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKG------QKEFEAEAAAIGKIHHPNL 593
E +G + K G + A K ++++ TK +++ E E + + +I HPN+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYL 651
+ L Y + +L+ + + G L FL + E + I G+ YL
Sbjct: 77 ITLHEVYENKT-DVILILELVAGGELFDFLAEKESLTEEEATEFLKQ-----ILNGVYYL 130
Query: 652 HVEENMIHGNLTSSNVLLDEKTNP----RIADFGLSRLMTAAANTNVIATAGTLGYRAPE 707
H + H +L N++L ++ P +I DFGL+ + I GT + APE
Sbjct: 131 H-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPE 187
Query: 708 LSKLKNANTKTDVYSLGVIILELLTGKSP 736
+ + + D++S+GVI LL+G SP
Sbjct: 188 IVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFEA----EAAAIGKIHHPNLL 594
E +G+ TYGT +KA E VA+KR+R + +G + E + ++ H N++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG---VPSSALREICLLKELKHKNIV 64
Query: 595 ALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
L K KL LVF+F + L + + ++ S + +GL + H
Sbjct: 65 RLHDVLHSDK--KLTLVFEFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH- 118
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT---NVIATAGTLGYRAPELSK 710
N++H +L N+L++ ++A+FGL+R V+ TL YR P++
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TLWYRPPDV-- 172
Query: 711 L---KNANTKTDVYSLGVIILELLTGKSP 736
L K +T D++S G I EL P
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 47/212 (22%), Positives = 80/212 (37%), Gaps = 40/212 (18%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRL-REKTTK-GQKE-FEAEAAAIGKIHHPNLLALRAY 599
GK + ++ + + A K + + K Q+E E + + H +++ +
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMS------IAIGIARGLNYLH 652
+ + +V + + SL R ++ I G YLH
Sbjct: 84 FEDND--FVFVVLELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLH 132
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLS--------RLMTAAANTNVIATAGTLGYR 704
+IH +L N+ L+E +I DFGL+ R GT Y
Sbjct: 133 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---------LCGTPNYI 182
Query: 705 APELSKLKNANTKTDVYSLGVIILELLTGKSP 736
APE+ K + + DV+S+G I+ LL GK P
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-18
Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 542 IMGKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEAAAIGKIHHPNLLALR 597
++GK +G + ++ A K+L +K K +K E + K++ +++L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 598 AYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
Y + L LV M G L ++ G A I GL LH E
Sbjct: 251 YAYETK--DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA-EICCGLEDLH-RER 306
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANT 716
+++ +L N+LLD+ + RI+D GL+ + GT+GY APE+ K +
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRVGTVGYMAPEVVKNERYTF 364
Query: 717 KTDVYSLGVIILELLTGKSP 736
D ++LG ++ E++ G+SP
Sbjct: 365 SPDWWALGCLLYEMIAGQSP 384
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 45/214 (21%), Positives = 78/214 (36%), Gaps = 44/214 (20%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVK-----RLREKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
GK + ++ + + A K L + + + E + + H +++
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVGFH 107
Query: 598 AYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMS------IAIGIARGLNY 650
++ + +V + + SL R ++ I G Y
Sbjct: 108 GFFEDND--FVFVVLELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQY 156
Query: 651 LHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS--------RLMTAAANTNVIATAGTLG 702
LH +IH +L N+ L+E +I DFGL+ R GT
Sbjct: 157 LH-RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---------LCGTPN 206
Query: 703 YRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
Y APE+ K + + DV+S+G I+ LL GK P
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRL---REKTTKGQKEFEAEAAAIGKIHHPNLLAL 596
+G ++G Y A + + VA+K++ +++ + ++ E + K+ HPN +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 597 RAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAI---GIARGLNYLH 652
R YL + LV ++ GS + L + + + IA G +GL YLH
Sbjct: 120 RGCYL--REHTAWLVMEYCL-GSASDLLEVH-KKPL----QEVEIAAVTHGALQGLAYLH 171
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPEL---S 709
NMIH ++ + N+LL E ++ DFG + +M AN+ V GT + APE+
Sbjct: 172 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-PANSFV----GTPYWMAPEVILAM 225
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSP 736
+ K DV+SLG+ +EL K P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 49/204 (24%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+++G G + G + A+K L + K ++E + A G P+++ +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLL-YDSPKARQEVDHHWQASG---GPHIVCILDV 90
Query: 600 Y---LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
Y K L++ + M G L S + RG + I I + +LH N
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA-EIMRDIGTAIQFLH-SHN 148
Query: 657 MIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANTNVIATA-GTLGYRAPELSKLK 712
+ H ++ N+L ++ ++ DFG ++ T N + T T Y APE+ +
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT----QNALQTPCYTPYYVAPEVLGPE 204
Query: 713 NANTKTDVYSLGVIILELLTGKSP 736
+ D++SLGVI+ LL G P
Sbjct: 205 KYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 31/208 (14%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI------HHPNL 593
+ +G+ TY T YK + VA+K +R + +G A AI ++ H N+
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG-----APCTAIREVSLLKDLKHANI 62
Query: 594 LALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLH 652
+ L K L LVF+++ K L +L G I+N + RGL Y H
Sbjct: 63 VTLHDIIHTEK--SLTLVFEYLDK-DLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCH 117
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT---NVIATAGTLGYRAPELS 709
+ ++H +L N+L++E+ ++ADFGL+R + T V+ TL YR P++
Sbjct: 118 -RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV----TLWYRPPDI- 171
Query: 710 KL---KNANTKTDVYSLGVIILELLTGK 734
L + +T+ D++ +G I E+ TG+
Sbjct: 172 -LLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 52/328 (15%), Positives = 108/328 (32%), Gaps = 63/328 (19%)
Query: 107 ISEKISQLHALRKLSLHDNLL----AGPVPWSLGFLPNLRGVYLFNNRLS---------- 152
+ + + +++++ L N + A + ++ +L +
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 153 GSIPPSIGNCPNLQTLDLSNNAL----IGAIPPSLANSTRLYRLNLSYNSL--LGSIPLS 206
+ ++ CP L T+ LS+NA + L+ T L L L N L ++
Sbjct: 84 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 143
Query: 207 LTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLI----AGTIPVSLGK 262
ALQ ++ N L+ + N + +
Sbjct: 144 ---------RALQELAVNKKAKNA---------PPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 263 LGLLQEISLSHNKI-----VGPIPDELGKLSKLQKLDLSYNAIGG----SFPVTFTNITS 313
LL + + N I + + L +L+ LDL N + + + +
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245
Query: 314 LVSLNLENNRLGNK----IPEGLERLQN--LTVLNLKNNQFKG----HIPETIG-NISGI 362
L L L + L + + + +L+N L L L+ N+ + + I + +
Sbjct: 246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 305
Query: 363 NQLDLSENDFTGEISPSLASLANLTSFN 390
L+L+ N F E + + + S
Sbjct: 306 LFLELNGNRF-SEEDDVVDEIREVFSTR 332
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 7e-18
Identities = 44/282 (15%), Positives = 97/282 (34%), Gaps = 49/282 (17%)
Query: 165 LQTLDLSNNAL----IGAIPPSLANSTRLYRLNLSYNSL--LGSIPLS--LTRLPSLSVL 216
++ L +A+ ++ L + + LS N++ + LS + L +
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 217 ALQHN---NLSGSVPNNWGVLAG--NKSYQLQFLNLDHNLI----AGTIPVSLGKLGLLQ 267
+ +P +L K +L + L N + L K L+
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 268 EISLSHNKI-------------VGPIPDELGKLSKLQKLDLSYNAIGG----SFPVTFTN 310
+ L +N + + + L+ + N + + TF +
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 311 ITSLVSLNLENNRLGNK-----IPEGLERLQNLTVLNLKNNQF--KG--HIPETIGNISG 361
L ++ + N + + + EGL Q L VL+L++N F G + + +
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245
Query: 362 INQLDLSENDFTGE----ISPSLASLAN--LTSFNVSYNNLS 397
+ +L L++ + + + + L N L + + YN +
Sbjct: 246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 15/106 (14%), Positives = 35/106 (33%), Gaps = 20/106 (18%)
Query: 311 ITSLVSLNLENNRLGNK----IPEGLERLQNLTVLNLKNNQF--KG--HIPETIGNISGI 362
S+ +L+ + + + + L ++ + L N + + E I + +
Sbjct: 3 RFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 62
Query: 363 NQLDLSENDFTGE-----------ISPSLASLANLTSFNVSYNNLS 397
+ S+ FTG + +L L + +S N
Sbjct: 63 EIAEFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 107
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 38/214 (17%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEA-------EAAAIGKIHHPN 592
+G+ TYG YKA VA+KR+R + E E E + + ++ H N
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRL-----EHEEEGVPGTAIREVSLLKELQHRN 94
Query: 593 LLALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYL 651
++ L++ +L L+F++ L ++ ++ S + G+N+
Sbjct: 95 IIELKSVIHHNH--RLHLIFEYAEN-DLKKYMDKNPDVSM---RVIKSFLYQLINGVNFC 148
Query: 652 HVEENMIHGNLTSSNVLLDEKTNPR-----IADFGLSRLMTAAANT---NVIATAGTLGY 703
H +H +L N+LL I DFGL+R +I TL Y
Sbjct: 149 H-SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII----TLWY 203
Query: 704 RAPELSKL---KNANTKTDVYSLGVIILELLTGK 734
R PE+ L ++ +T D++S+ I E+L
Sbjct: 204 RPPEI--LLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
E++G + + G A+K +++ E E A + KI H N++ L
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVEENM 657
Y LV + G L + RG E + + + + YLH E +
Sbjct: 75 YESTT-HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ-----VLSAVKYLH-ENGI 127
Query: 658 IHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELSKLKN 713
+H +L N+L +E + I DFGLS++ +++T GT GY APE+ K
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACGTPGYVAPEVLAQKP 183
Query: 714 ANTKTDVYSLGVIILELLTGKSP 736
+ D +S+GVI LL G P
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPP 206
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 60/215 (27%), Positives = 90/215 (41%), Gaps = 29/215 (13%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR-------------EKTTKGQKEFEAEAAAIG 586
+G YG SE A+K ++ + K +E E + +
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 587 KIHHPNLLALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIA 645
+ HPN++ L + K LV +F G L + R + A +I I
Sbjct: 102 SLDHPNIIKLFDVFEDKK--YFYLVTEFYEGGELFEQIINRHKFDECDAA---NIMKQIL 156
Query: 646 RGLNYLHVEENMIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANTNVIAT-AGTL 701
G+ YLH + N++H ++ N+LL + N +I DFGLS + + GT
Sbjct: 157 SGICYLH-KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS---KDYKLRDRLGTA 212
Query: 702 GYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736
Y APE+ K K N K DV+S GVI+ LL G P
Sbjct: 213 YYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 40/215 (18%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAE----AAAIGKI------H 589
E +G TY T YK G VA+K ++ ++E + AI +I
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVK---------LDSEEGTPSTAIREISLMKELK 61
Query: 590 HPNLLALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRM---SIAIGIA 645
H N++ L KL LVF+FM L ++ +R +
Sbjct: 62 HENIVRLYDVIHTEN--KLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 646 RGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT---NVIATAGTLG 702
+GL + H E ++H +L N+L++++ ++ DFGL+R NT V+ TL
Sbjct: 119 QGLAFCH-ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV----TLW 173
Query: 703 YRAPELSKL---KNANTKTDVYSLGVIILELLTGK 734
YRAP++ L + +T D++S G I+ E++TGK
Sbjct: 174 YRAPDV--LMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 12/201 (5%)
Query: 542 IMGKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEAAAIGKIHHPNLLALR 597
I+G+ ++ T A S A+K L ++ + + E + ++ HP + L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL- 95
Query: 598 AYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
Y+ EKL + G L + R + TR A I L YLH +
Sbjct: 96 -YFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDETCTRFYTA-EIVSALEYLH-GKG 150
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELSKLKNAN 715
+IH +L N+LL+E + +I DFG +++++ + + GT Y +PEL K+A
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 210
Query: 716 TKTDVYSLGVIILELLTGKSP 736
+D+++LG II +L+ G P
Sbjct: 211 KSSDLWALGCIIYQLVAGLPP 231
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRL--REKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
++GK ++G K E AVK + K E + K+ HPN++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
+V + G L + R + + A I + G+ Y+H + N+
Sbjct: 88 EILEDSS-SFYIVGELYTGGELFDEIIKRKRFSEHDAA---RIIKQVFSGITYMH-KHNI 142
Query: 658 IHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELSKLKN 713
+H +L N+LL ++ + +I DFGLS + GT Y APE+ +
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYYIAPEVLR-GT 198
Query: 714 ANTKTDVYSLGVIILELLTGKSP 736
+ K DV+S GVI+ LL+G P
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP 221
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALR 597
E +GK + + G E A K + K + + ++ E EA K+ HPN++ L
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
LVFD + G L + AR + + + + I + Y H +
Sbjct: 72 DSIQEES-FHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ---ILESIAYCH-SNGI 126
Query: 658 IHGNLTSSNVLLDEKTNP---RIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELSKLKN 713
+H NL N+LL K ++ADFGL+ + ++ AGT GY +PE+ K
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 714 ANTKTDVYSLGVIILELLTGKSP 736
+ D+++ GVI+ LL G P
Sbjct: 184 YSKPVDIWACGVILYILLVGYPP 206
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 56/225 (24%), Positives = 95/225 (42%), Gaps = 20/225 (8%)
Query: 542 IMGKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEA---AAIGKIHHPNLL 594
I+G+ +G Y D ++ A+K L +K K ++ E + + P ++
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 595 ALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
+ + P +KL + D M G L H R A I GL ++H
Sbjct: 256 CMSYAFHTP--DKLSFILDLMNGGDL--HYHLSQHGVFSEADMRFYAA-EIILGLEHMH- 309
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLS-RLMTAAANTNVIATAGTLGYRAPELSKLK 712
+++ +L +N+LLDE + RI+D GL+ + +V GT GY APE+ +
Sbjct: 310 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKG 365
Query: 713 NANTKT-DVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756
A + D +SLG ++ +LL G SP D + +
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 25/212 (11%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVK-----RLREKTTKGQKEFEAEAAAIGKIHHPNLL 594
E++GK + + E G + AVK + ++ + EA+ + HP+++
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 595 ALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMS------IAIGIARGL 648
L Y G +VF+FM L + R + S I L
Sbjct: 90 ELLETYSS-DGMLYMVFEFMDGADLCFEIVKRA-----DAGFVYSEAVASHYMRQILEAL 143
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNP---RIADFGLSRLMTAAANTNVIAT-AGTLGYR 704
Y H + N+IH ++ VLL K N ++ FG++ + + V GT +
Sbjct: 144 RYCH-DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE--SGLVAGGRVGTPHFM 200
Query: 705 APELSKLKNANTKTDVYSLGVIILELLTGKSP 736
APE+ K + DV+ GVI+ LL+G P
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 24/209 (11%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVK--RLREKTTKGQKEFEAEAAAIGKI-HHPNLLAL 596
+ +G+ + + G E A K + R + + E E A + P ++ L
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 597 RAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMS--IAIGIAR----GLNY 650
Y E +L+ ++ G + S E +S I + + G+ Y
Sbjct: 95 HEVYENTS-EIILILEYAAGGEIFSLCLPELAE-------MVSENDVIRLIKQILEGVYY 146
Query: 651 LHVEENMIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE 707
LH + N++H +L N+LL + +I DFG+SR + A I GT Y APE
Sbjct: 147 LH-QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLAPE 203
Query: 708 LSKLKNANTKTDVYSLGVIILELLTGKSP 736
+ T TD++++G+I LLT SP
Sbjct: 204 ILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 41/201 (20%), Positives = 79/201 (39%), Gaps = 14/201 (6%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+G+ ++G A A K++ + + F+ E + + HPN++ L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIH 659
+ + LV + G L + + + A M + + Y H + N+ H
Sbjct: 75 FEDNT-DIYLVMELCTGGELFERVVHKRVFRESDAARIMKD---VLSAVAYCH-KLNVAH 129
Query: 660 GNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELSKLKNAN 715
+L N L + ++ DFGL+ ++ T GT Y +P++ +
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFK---PGKMMRTKVGTPYYVSPQVLE-GLYG 185
Query: 716 TKTDVYSLGVIILELLTGKSP 736
+ D +S GV++ LL G P
Sbjct: 186 PECDEWSAGVMMYVLLCGYPP 206
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 84.4 bits (208), Expect = 4e-17
Identities = 54/316 (17%), Positives = 93/316 (29%), Gaps = 40/316 (12%)
Query: 83 WAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLR 142
G + + + WR GR L L SL+D L + +
Sbjct: 270 RMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQK 329
Query: 143 GVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGS 202
L +R L +LS + L + L L L +
Sbjct: 330 ECVLLKDRPE-CWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLT 387
Query: 203 IPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGK 262
I L + L L S L + +L+ + V +
Sbjct: 388 IILLMRALDPLLYEKETLQYFST--------LKAVDPMRAAYLDDLRSKFLLENSVLKME 439
Query: 263 LGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENN 322
++ + L+H + + L +L + LDLS+N +
Sbjct: 440 YADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRL---------------------- 475
Query: 323 RLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTG-EISPSLA 381
+P L L+ L VL +N + ++ + N+ + +L L N L
Sbjct: 476 ---RALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLV 530
Query: 382 SLANLTSFNVSYNNLS 397
S L N+ N+L
Sbjct: 531 SCPRLVLLNLQGNSLC 546
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 4e-17
Identities = 56/252 (22%), Positives = 106/252 (42%), Gaps = 19/252 (7%)
Query: 493 KSTAQKVVERAAPKAGTEVESGGEMGGKLVHFDGPFLFTADD--LLCATAEIMGKSTYGT 550
++ ++G+ ++ G ++ T ++ L +++GK T+G
Sbjct: 108 DGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYL----KLLGKGTFGK 163
Query: 551 AYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEAAAIGKIHHPNLLALRAYYLGPKGE 606
+ A+K L+++ + E E + HP L AL+ + +
Sbjct: 164 VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH--D 221
Query: 607 KL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSS 665
+L V ++ G L F H R A I L+YLH E+N+++ +L
Sbjct: 222 RLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGA-EIVSALDYLHSEKNVVYRDLKLE 278
Query: 666 NVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLG 724
N++LD+ + +I DFGL + + A GT Y APE+ + + D + LG
Sbjct: 279 NLMLDKDGHIKITDFGLCKEGIKDGATMKTF--CGTPEYLAPEVLEDNDYGRAVDWWGLG 336
Query: 725 VIILELLTGKSP 736
V++ E++ G+ P
Sbjct: 337 VVMYEMMCGRLP 348
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 56/236 (23%), Positives = 97/236 (41%), Gaps = 24/236 (10%)
Query: 544 GKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEAAAIGKIHHPNLLALRAY 599
GK ++G D ++ A+K + ++ + E E + + HP L+ L
Sbjct: 24 GKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW-- 81
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIA-IGIARGLNYLHVEENM 657
Y E + +V D + G L H + ++ I + +A L+YL + +
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKLFICELVMA--LDYLQ-NQRI 136
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE--LSKLKNAN 715
IH ++ N+LLDE + I DF ++ ++ + AGT Y APE S+
Sbjct: 137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM--AGTKPYMAPEMFSSRKGAGY 194
Query: 716 TKT-DVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE------WTNEVFDL 764
+ D +SLGV ELL G+ P + + V + W+ E+ L
Sbjct: 195 SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSL 250
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 47/202 (23%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
E +G +Y + E AVK + + +E + HPN++ L+
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPNIITLKDV 84
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIH 659
Y K +V + M G L + + + + + I + + YLH + ++H
Sbjct: 85 YDDGK-YVYVVTELMKGGELLDKILRQKFFSEREASAVLFT---ITKTVEYLH-AQGVVH 139
Query: 660 GNLTSSNVLLDEKTNP----RIADFGLSRLMTAAANTNVIATA-GTLGYRAPELSKLKNA 714
+L SN+L +++ RI DFG ++ + A ++ T T + APE+ + +
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRA--ENGLLMTPCYTANFVAPEVLERQGY 197
Query: 715 NTKTDVYSLGVIILELLTGKSP 736
+ D++SLGV++ +LTG +P
Sbjct: 198 DAACDIWSLGVLLYTMLTGYTP 219
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 7e-17
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 542 IMGKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEAAAIGKIHHPNLLALR 597
++G+ +G + ++ ++ A K+L +K K +K ++ E + K+H +++L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 598 AYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSI---------AIGIARG 647
+ L LV M G + H I N I G
Sbjct: 252 YAFETK--TDLCLVMTIMNGGDI--RYH------IYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 648 LNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS-RLMTAAANTNVIATAGTLGYRAP 706
L +LH + N+I+ +L NVLLD+ N RI+D GL+ L T AGT G+ AP
Sbjct: 302 LEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--GYAGTPGFMAP 358
Query: 707 ELSKLKNANTKTDVYSLGVIILELLTGKSP 736
EL + + D ++LGV + E++ + P
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 9e-17
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 36/215 (16%)
Query: 541 EIMGKSTYGTAYKA--TLEDGSEVAVKRLR-EKTTKGQ-----------KEFEAEAAAIG 586
+G+ YG +KA G VA+KR+R + +G + E
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF----- 71
Query: 587 KIHHPNLLALRAYYLGPKGEKL----LVFDFMPKGSLASFLHARGPETIVNWATRMSIAI 642
HPN++ L + ++ LVF+ + + L ++L PE V T +
Sbjct: 72 --EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKV-PEPGVPTETIKDMMF 127
Query: 643 GIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN-TNVIATAGTL 701
+ RGL++LH ++H +L N+L+ ++ADFGL+R+ + T+V+ TL
Sbjct: 128 QLLRGLDFLH-SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV---TL 183
Query: 702 GYRAPELSKLKNA--NTKTDVYSLGVIILELLTGK 734
YRAPE+ L + T D++S+G I E+ K
Sbjct: 184 WYRAPEV--LLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 48/230 (20%), Positives = 88/230 (38%), Gaps = 49/230 (21%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVK-----RLREKTTKGQKEFEAEAAAIG----------- 586
GK +YG A D + A+K +L + ++
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 587 ----------KIHHPNLLALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWA 635
K+ HPN++ L P + L +VF+ + +G + +
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV--M-------EVPT-L 131
Query: 636 TRMSIAIG------IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689
+S + +G+ YLH + +IH ++ SN+L+ E + +IADFG+S
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLH-YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-G 189
Query: 690 ANTNVIATAGTLGYRAPELSKLKNAN---TKTDVYSLGVIILELLTGKSP 736
++ + T GT + APE DV+++GV + + G+ P
Sbjct: 190 SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 29/206 (14%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEA---EAAAIGKIHHPNLLALRAY 599
GK + A + G EVA+K + +KT + E + ++HPN++ L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKII-DKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMS------IAIGIARGLNYLH 652
K L L+ ++ G + +L A G RM I + Y H
Sbjct: 83 IETEK--TLYLIMEYASGGEVFDYLVAHG---------RMKEKEARSKFRQIVSAVQYCH 131
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA-GTLGYRAPELSKL 711
++ ++H +L + N+LLD N +IADFG S T + G Y APEL +
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT---VGGKLDAFCGAPPYAAPELFQG 187
Query: 712 KN-ANTKTDVYSLGVIILELLTGKSP 736
K + DV+SLGVI+ L++G P
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 54/239 (22%), Positives = 97/239 (40%), Gaps = 22/239 (9%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRA 598
+++G+ + L E AVK + ++ + E + + H N+L L
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
++ LVF+ M GS+ S +H R + + + +A L++LH + +
Sbjct: 79 FFEEED-RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD---VASALDFLH-NKGIA 133
Query: 659 HGNLTSSNVLLDEKTNP---RIADFGLSRLMTAAANTNVIAT------AGTLGYRAPELS 709
H +L N+L + +I DF L + + + I+T G+ Y APE+
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 710 KLKNANTKT-----DVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEVFD 763
+ + D++SLGVI+ LL+G P G D W N +F+
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD-CGWDRGEACPACQNMLFE 251
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 29/211 (13%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKE-FEAEAAAIGKIHHPNLLALRA 598
+G +G + G E +K + + ++ E EAE + + HPN++ +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRM---------SIAIGIARGLN 649
+ +V + G L E IV+ R + + L
Sbjct: 88 VFEDYH-NMYIVMETCEGGEL--L------ERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 650 YLHVEENMIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRA 705
Y H ++++H +L N+L + +I DFGL+ L + AGT Y A
Sbjct: 139 YFH-SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK---SDEHSTNAAGTALYMA 194
Query: 706 PELSKLKNANTKTDVYSLGVIILELLTGKSP 736
PE+ K ++ K D++S GV++ LLTG P
Sbjct: 195 PEVFK-RDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+G+ Y+ A+K L K T +K E + ++ HPN++ L+
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVEENM 657
+ P E LV + + G L + +G E A + I + YLH E +
Sbjct: 117 FETPT-EISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ-----ILEAVAYLH-ENGI 169
Query: 658 IHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELSKLKN 713
+H +L N+L +IADFGLS+++ + ++ T GT GY APE+ +
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVE---HQVLMKTVCGTPGYCAPEILRGCA 226
Query: 714 ANTKTDVYSLGVIILELLTGKSP 736
+ D++S+G+I LL G P
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEP 249
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 16/203 (7%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALR 597
++GK ++G K E AVK + + K E + K+ HPN++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
+V + G L + R + + A + + G+ Y+H + N+
Sbjct: 88 EILEDSS-SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ---VFSGITYMH-KHNI 142
Query: 658 IHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELSKLKN 713
+H +L N+LL ++ + +I DFGLS + GT Y APE+ +
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYYIAPEVLR-GT 198
Query: 714 ANTKTDVYSLGVIILELLTGKSP 736
+ K DV+S GVI+ LL+G P
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP 221
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALR 597
E +GK + + G E A K + K + + ++ E EA K+ HPN++ L
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
LVFD + G L + AR + + + + I + Y H +
Sbjct: 95 DSIQEE-SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ---ILESIAYCH-SNGI 149
Query: 658 IHGNLTSSNVLLDEKTNP---RIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELSKLKN 713
+H NL N+LL K ++ADFGL+ + ++ AGT GY +PE+ K
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAWHGFAGTPGYLSPEVLKKDP 206
Query: 714 ANTKTDVYSLGVIILELLTGKSP 736
+ D+++ GVI+ LL G P
Sbjct: 207 YSKPVDIWACGVILYILLVGYPP 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 5e-16
Identities = 47/206 (22%), Positives = 82/206 (39%), Gaps = 27/206 (13%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRL-REKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYL 601
G+ YG A VAVK + ++ + + E ++H N++ +
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 602 GPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIAR--------GLNYLH 652
L ++ G L + M A+ G+ YLH
Sbjct: 76 EGN--IQYLFLEYCSGGELFDRIEPDI---------GMPEPD--AQRFFHQLMAGVVYLH 122
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA-GTLGYRAPE-LSK 710
+ H ++ N+LLDE+ N +I+DFGL+ + ++ GTL Y APE L +
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 711 LKNANTKTDVYSLGVIILELLTGKSP 736
+ DV+S G+++ +L G+ P
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 56/216 (25%), Positives = 82/216 (37%), Gaps = 30/216 (13%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIG-----KI-----H 589
EI+G+ + E AVK + E + I
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 590 HPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARG 647
HPN++ L+ Y LVFD M KG L +L + E TR I +
Sbjct: 83 HPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLTEKVTLSEK----ETR-KIMRALLEV 136
Query: 648 LNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA-GTLGYRAP 706
+ LH + N++H +L N+LLD+ N ++ DFG S + + GT Y AP
Sbjct: 137 ICALH-KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD---PGEKLREVCGTPSYLAP 192
Query: 707 E------LSKLKNANTKTDVYSLGVIILELLTGKSP 736
E + D++S GVI+ LL G P
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 6e-16
Identities = 51/203 (25%), Positives = 85/203 (41%), Gaps = 14/203 (6%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKE--FEAEAAAIGKIHHPNLLALR 597
E +GK + + + G E A + K + E EA + HPN++ L
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
+G L+FD + G L + AR + + + + I + + H + +
Sbjct: 77 DSISE-EGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ---ILEAVLHCH-QMGV 131
Query: 658 IHGNLTSSNVLLDEKTNP---RIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELSKLKN 713
+H NL N+LL K ++ADFGL+ + AGT GY +PE+ +
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 714 ANTKTDVYSLGVIILELLTGKSP 736
D+++ GVI+ LL G P
Sbjct: 190 YGKPVDLWACGVILYILLVGYPP 212
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 47/217 (21%), Positives = 91/217 (41%), Gaps = 24/217 (11%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEA----EAAAIGKIHHPNLLALRA 598
G+ +YG + E AVK L++K + EA E + ++ H N++ L
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIG------IARGLNYL 651
+ +K+ +V ++ G +++ R + + GL YL
Sbjct: 74 VLYNEEKQKMYMVMEYCVCGMQEML------DSVPE--KRFPVCQAHGYFCQLIDGLEYL 125
Query: 652 HVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA-GTLGYRAPE-LS 709
H + ++H ++ N+LL +I+ G++ + A + T+ G+ ++ PE +
Sbjct: 126 H-SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 710 KLKN-ANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745
L + K D++S GV + + TG P E N L
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL 221
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 35/152 (23%), Positives = 62/152 (40%), Gaps = 15/152 (9%)
Query: 205 LSLTRLPS-----LSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPV- 258
L ++P + L L +N + G+ QL+ +N +N I I
Sbjct: 21 QKLNKIPEHIPQYTAELRLNNNEFTVLEAT--GIFKKLP--QLRKINFSNNKIT-DIEEG 75
Query: 259 SLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPV-TFTNITSLVSL 317
+ + EI L+ N++ L L+ L L N I +F ++S+ L
Sbjct: 76 AFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLL 134
Query: 318 NLENNRLGNKIPEG-LERLQNLTVLNLKNNQF 348
+L +N++ + G + L +L+ LNL N F
Sbjct: 135 SLYDNQITT-VAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 29/132 (21%), Positives = 57/132 (43%), Gaps = 7/132 (5%)
Query: 243 QFLNLDHNLIAGTIPVSL-GKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIG 301
L L++N + KL L++I+ S+NKI S + ++ L+ N +
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 302 GSFPV-TFTNITSLVSLNLENNRLGNKIPEGL-ERLQNLTVLNLKNNQFKGHIPE-TIGN 358
+ F + SL +L L +NR+ + L ++ +L+L +NQ +
Sbjct: 95 -NVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDT 151
Query: 359 ISGINQLDLSEN 370
+ ++ L+L N
Sbjct: 152 LHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 31/137 (22%), Positives = 53/137 (38%), Gaps = 12/137 (8%)
Query: 118 RKLSLHDNLLAGPVPWSL-GFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNAL 175
+L L++N + LP LR + NN+++ I + + L++N L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93
Query: 176 IGAIPPSL-ANSTRLYRLNLSYNSLLGSIPL-SLTRLPSLSVLALQHNNLSGSVPNNWGV 233
+ + L L L N + + S L S+ +L+L N ++ +V G
Sbjct: 94 E-NVQHKMFKGLESLKTLMLRSNR-ITCVGNDSFIGLSSVRLLSLYDNQIT-TVAP--GA 148
Query: 234 LAGNKSYQLQFLNLDHN 250
S L LNL N
Sbjct: 149 FDTLHS--LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 19/89 (21%), Positives = 38/89 (42%), Gaps = 8/89 (8%)
Query: 113 QLHALRKLSLHDNLLAGPVPWSLGF--LPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLD 169
+ ++ L N L V + F L +L+ + L +NR++ + +++ L
Sbjct: 79 GASGVNEILLTSNRLEN-VQHKM-FKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLS 135
Query: 170 LSNNALIGAIPPSLANS-TRLYRLNLSYN 197
L +N + + P ++ L LNL N
Sbjct: 136 LYDNQI-TTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 16/63 (25%), Positives = 31/63 (49%), Gaps = 2/63 (3%)
Query: 114 LHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSN 172
L +L+ L L N + S L ++R + L++N+++ ++ P +L TL+L
Sbjct: 104 LESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLA 162
Query: 173 NAL 175
N
Sbjct: 163 NPF 165
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 51/213 (23%), Positives = 86/213 (40%), Gaps = 28/213 (13%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKE--FEAEAAA---------IGKIH 589
+ +YG +G VA+KR+ + G+ + H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 590 HPNLLALRAYYLGPKGEKL----LVFDFMPKGSLASFLHA--RGPETIVNWATRMSIAIG 643
HPN+L LR ++ + + LV + M + L +++
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN-TNVIATAGTLG 702
I GL+ LH E ++H +L N+LL + + I DF L+R TA AN T+ +
Sbjct: 143 ILLGLHVLH-EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT---HRW 198
Query: 703 YRAPE-LSKLKNANTKTDVYSLGVIILELLTGK 734
YRAPE + + K D++S G ++ E+ K
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 37/218 (16%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRL--------REKTTKGQKEFEAEAAAIGKIHHP 591
+ +G G A + +VA+K + + E E + K++HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 592 NLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMS------IAIGIA 645
++ ++ ++ +V + M G L F + +V R+ +
Sbjct: 76 CIIKIKNFFDAED--YYIVLELMEGGEL--F------DKVVG-NKRLKEATCKLYFYQML 124
Query: 646 RGLNYLHVEENMIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANTNVIATA-GTL 701
+ YLH E +IH +L NVLL +E +I DFG S+++ T+++ T GT
Sbjct: 125 LAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG---ETSLMRTLCGTP 180
Query: 702 GYRAPEL---SKLKNANTKTDVYSLGVIILELLTGKSP 736
Y APE+ N D +SLGVI+ L+G P
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 45/207 (21%), Positives = 88/207 (42%), Gaps = 16/207 (7%)
Query: 536 LCATAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNL 593
L + +G+ ++ K + AVK + + + + E A+ HPN+
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNI 68
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
+ L + LV + + G L + + + + M + ++++H
Sbjct: 69 VKLHEVFHDQL-HTFLVMELLNGGELFERIKKKKHFSETEASYIMRK---LVSAVSHMH- 123
Query: 654 EENMIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANTNVIATA-GTLGYRAPELS 709
+ ++H +L N+L ++ +I DFG +RL + + T TL Y APEL
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPELL 181
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSP 736
+ D++SLGVI+ +L+G+ P
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 42/247 (17%), Positives = 94/247 (38%), Gaps = 63/247 (25%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+ +G ++G + +E G A+K++ + +E + + + H N++ L Y
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDI----MKVLDHVNIIKLVDY 68
Query: 600 YLGPKGEKL-------------------------------------LVFDFMPKGSLASF 622
+ E+ ++ +++P +L
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKV 127
Query: 623 LHARGPETIVNWATRMSIAIG------IARGLNYLHVEENMIHGNLTSSNVLLDEKTNP- 675
L + + + + + + R + ++H + H ++ N+L++ K N
Sbjct: 128 LK-----SFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDNTL 181
Query: 676 RIADFGLSR-LMTAAANTNVIATAGTLGYRAPELS-KLKNANTKTDVYSLGVIILELLTG 733
++ DFG ++ L+ + + I + YRAPEL D++S+G + EL+ G
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICS---RFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238
Query: 734 KS--PGE 738
K GE
Sbjct: 239 KPLFSGE 245
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 48/207 (23%), Positives = 82/207 (39%), Gaps = 29/207 (14%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRL-REKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYL 601
G+ YG A VAVK + ++ + + E ++H N++ +
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 602 GPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIAR--------GLNYLH 652
L ++ G L + M A+ G+ YLH
Sbjct: 76 EGN--IQYLFLEYCSGGELFDRIEPDI---------GMPEPD--AQRFFHQLMAGVVYLH 122
Query: 653 VEENMI-HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA-GTLGYRAPE-LS 709
I H ++ N+LLDE+ N +I+DFGL+ + ++ GTL Y APE L
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSP 736
+ + DV+S G+++ +L G+ P
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 48/208 (23%), Positives = 85/208 (40%), Gaps = 25/208 (12%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+++G G + + A+K L + K ++E E A P+++ +
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREVELHWRASQ---CPHIVRIVDV 123
Query: 600 Y---LGPKGEKLLVFDFMPKGSLASFLHARGP----ETIVNWATRMSIAIGIARGLNYLH 652
Y + L+V + + G L S + RG E + + I + YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS-----IGEAIQYLH 178
Query: 653 VEENMIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPEL 708
N+ H ++ N+L ++ DFG ++ T+ N + T T Y APE+
Sbjct: 179 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEV 234
Query: 709 SKLKNANTKTDVYSLGVIILELLTGKSP 736
+ + D++SLGVI+ LL G P
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 45/221 (20%), Positives = 83/221 (37%), Gaps = 46/221 (20%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI----------H 589
+G +G + A E EV VK + +K K ++ E +GK+
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFI-KKE-KVLEDCWIEDPKLGKVTLEIAILSRVE 87
Query: 590 HPNLLAL-------RAYYL-----GPKGEKLLVFDF-MPKGSLASFLHARGPETIVNWAT 636
H N++ + + L G + +F F L L A
Sbjct: 88 HANIIKVLDIFENQGFFQLVMEKHGSGLD---LFAFIDRHPRLDEPL-AS---------- 133
Query: 637 RMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696
I + + YL +++IH ++ N+++ E ++ DFG + +
Sbjct: 134 --YIFRQLVSAVGYLR-LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-- 188
Query: 697 TAGTLGYRAPE-LSKLKNANTKTDVYSLGVIILELLTGKSP 736
GT+ Y APE L + +++SLGV + L+ ++P
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 7e-15
Identities = 55/215 (25%), Positives = 86/215 (40%), Gaps = 29/215 (13%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGK---------IHH 590
+++G+ + G E AVK + + E E + H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 591 PNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGL 648
P+++ L Y LVFD M KG L +L + E TR SI + +
Sbjct: 160 PHIITLIDSYESSS-FMFLVFDLMRKGELFDYLTEKVALSEK----ETR-SIMRSLLEAV 213
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA-GTLGYRAPE 707
++LH N++H +L N+LLD+ R++DFG S + + GT GY APE
Sbjct: 214 SFLH-ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE---PGEKLRELCGTPGYLAPE 269
Query: 708 ------LSKLKNANTKTDVYSLGVIILELLTGKSP 736
+ D+++ GVI+ LL G P
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR---EKTTKGQKEFEAEAAAIGKIHHPNLLAL 596
+G YG+ A G +VA+K+L + ++ + E + + H N++ L
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGL 88
Query: 597 RAYYLGPKGEKL-----LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYL 651
+ + LV FM L + + E + + + + +GL Y+
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY-----LVYQMLKGLKYI 142
Query: 652 HVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSK 710
H ++H +L N+ ++E +I DFGL+R A T + T YRAPE +
Sbjct: 143 H-SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYVV---TRWYRAPEVILS 197
Query: 711 LKNANTKTDVYSLGVIILELLTGKS--PG 737
+ N D++S+G I+ E+LTGK+ G
Sbjct: 198 WMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRL-REKTTKG--QKEFEAEAAAIGKIHHPNLLALRAY 599
G T+G G +VAVK L R+K + + E + HP+++ L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL--- 76
Query: 600 Y--LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIG------IARGLNYL 651
Y + + +V +++ G L ++ G R+ I ++Y
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHG---------RVEEMEARRLFQQILSAVDYC 127
Query: 652 HVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA-GTLGYRAPE-LS 709
H ++H +L NVLLD N +IADFGLS +M+ + + T+ G+ Y APE +S
Sbjct: 128 H-RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRTSCGSPNYAAPEVIS 183
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745
A + D++S GVI+ LL G P + + L
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL 219
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 54/211 (25%), Positives = 88/211 (41%), Gaps = 31/211 (14%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR--EKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
+G+ YG A + VA+K++ E T Q+ E + + H N++ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 91
Query: 598 AYYLGPKGEKL----LVFDFMP-------KGSLASFLHARGPETIVNWATRMSIAIGIAR 646
P E++ +V D M K S H I R
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC------------YFLYQILR 139
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA--GTLGYR 704
GL Y+H N++H +L SN+LL+ + +I DFGL+R+ + T T YR
Sbjct: 140 GLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 198
Query: 705 APE-LSKLKNANTKTDVYSLGVIILELLTGK 734
APE + K D++S+G I+ E+L+ +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 35/149 (23%), Positives = 64/149 (42%), Gaps = 12/149 (8%)
Query: 206 SLTRLPS-----LSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPV-S 259
LT +P+ ++ + L+ N + +P G + K +L+ ++L +N I+ + +
Sbjct: 22 GLTEIPTNLPETITEIRLEQNTIK-VIPP--GAFSPYK--KLRRIDLSNNQIS-ELAPDA 75
Query: 260 LGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNL 319
L L + L NKI L LQ L L+ N I F ++ +L L+L
Sbjct: 76 FQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSL 135
Query: 320 ENNRLGNKIPEGLERLQNLTVLNLKNNQF 348
+N+L L+ + ++L N F
Sbjct: 136 YDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 36/130 (27%), Positives = 56/130 (43%), Gaps = 4/130 (3%)
Query: 243 QFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGG 302
+ L+ N I P + L+ I LS+N+I PD L L L L N I
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 303 SFPV-TFTNITSLVSLNLENNRLGNKIPEGL-ERLQNLTVLNLKNNQFKGHIPETIGNIS 360
P F + SL L L N++ N + + L NL +L+L +N+ + T +
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 361 GINQLDLSEN 370
I + L++N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 31/136 (22%), Positives = 60/136 (44%), Gaps = 11/136 (8%)
Query: 118 RKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNALI 176
++ L N + P + LR + L NN++S + P +L +L L N +
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI- 92
Query: 177 GAIPPSL-ANSTRLYRLNLSYNSLLGSIPL-SLTRLPSLSVLALQHNNLSGSVPNNWGVL 234
+P SL L L L+ N + + + + L +L++L+L N L ++ G
Sbjct: 93 TELPKSLFEGLFSLQLLLLNANK-INCLRVDAFQDLHNLNLLSLYDNKLQ-TIAK--GTF 148
Query: 235 AGNKSYQLQFLNLDHN 250
+ ++ +Q ++L N
Sbjct: 149 SPLRA--IQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 25/112 (22%), Positives = 51/112 (45%), Gaps = 4/112 (3%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDL 170
S LR++ L +N ++ P + L +L + L+ N+++ +P S+ +LQ L L
Sbjct: 53 SPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLL 111
Query: 171 SNNALIGAIPP-SLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHN 221
+ N + + + + L L+L N L + + L ++ + L N
Sbjct: 112 NANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 17/64 (26%), Positives = 30/64 (46%), Gaps = 2/64 (3%)
Query: 114 LHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSN 172
L +L+ L L+ N + + L NL + L++N+L +I +QT+ L+
Sbjct: 103 LFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQ 161
Query: 173 NALI 176
N I
Sbjct: 162 NPFI 165
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 45/203 (22%), Positives = 86/203 (42%), Gaps = 19/203 (9%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR---EKTTKGQKEFEAEAAAIGKIHHPNLLAL 596
+ +G G A VA+K+L + T ++ + E + ++H N+++L
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 597 R-----AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYL 651
L + LV + M +L + +++ + + G+ +L
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSY-----LLYQMLCGIKHL 180
Query: 652 HVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKL 711
H +IH +L SN+++ +I DFGL+R TA + + T YRAPE+
Sbjct: 181 H-SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILG 237
Query: 712 KNANTKTDVYSLGVIILELLTGK 734
D++S+G I+ E++ K
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHK 260
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 44/207 (21%), Positives = 81/207 (39%), Gaps = 17/207 (8%)
Query: 542 IMGKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKE---FEAEAAAIGKIHHPNLLALR 597
++G+ + ++ +V A+K + + + E F E + + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL- 126
Query: 598 AYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
++ L LV ++ G L + L G A R +A I ++ +H
Sbjct: 127 -HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLA-EIVMAIDSVH-RLG 182
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANT 716
+H ++ N+LLD + R+ADFG + A + GT Y +PE+ +
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242
Query: 717 KTDVY-------SLGVIILELLTGKSP 736
T Y +LGV E+ G++P
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 52/285 (18%), Positives = 90/285 (31%), Gaps = 55/285 (19%)
Query: 161 NCPNLQTLDLSNNALIGAIPPSLA-----NSTRLYRLNLSYNSL-----------LGSIP 204
+ +LDLS N L L + LNLS NSL L +IP
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79
Query: 205 LSLTRLPSLSVLALQHNNLS-GSVPNNWGVLAGNKSYQLQFLNLDHNLI--AGTIPVSLG 261
++T L L N LS S LA + L+L N +
Sbjct: 80 ANVTS------LNLSGNFLSYKSSDELVKTLAAIPF-TITVLDLGWNDFSSKSSSEFKQA 132
Query: 262 KLGL---LQEISLSHNKI----VGPIPDELGKL-SKLQKLDLSYNAIGGSFPVTF----- 308
L + ++L N + + L + + + L+L N +
Sbjct: 133 FSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLA 192
Query: 309 TNITSLVSLNLENNRLGNK----IPEGLERLQN-LTVLNLKNNQFKGHIPETIGNISGIN 363
+ S+ SL+L N LG K + + N + LNL N G E + +
Sbjct: 193 SIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSL 252
Query: 364 Q----LDLSENDFTG-------EISPSLASLANLTSFNVSYNNLS 397
+ + L + + + ++ + + + +
Sbjct: 253 KHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 36/151 (23%), Positives = 60/151 (39%), Gaps = 24/151 (15%)
Query: 271 LSHNKIVGP----IPDELGKLSKLQKLDLSYNAIGGS-----FPVTFTNITSLVSLNLEN 321
+++ + P + + + LDLS N + S+ SLNL
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 322 NRLGNK----IPEGLERL-QNLTVLNLKNNQFKGHIPETIGNI-----SGINQLDLSEND 371
N LG K + + L + N+T LNL N + + I LDL ND
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 372 FTGE----ISPSLASL-ANLTSFNVSYNNLS 397
F+ + + ++L A++TS N+ N+L
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 45/259 (17%), Positives = 82/259 (31%), Gaps = 66/259 (25%)
Query: 140 NLRGVYLFNNRLSGS----IPPSIGNCP-NLQTLDLSNNAL----IGAIPPSLAN-STRL 189
+ + L N S + N P ++ +L+L N L + LA +
Sbjct: 110 TITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANV 169
Query: 190 YRLNLSYNSL-----------LGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWG------ 232
LNL N+L L SIP S+T L +LS N G
Sbjct: 170 NSLNLRGNNLASKNCAELAKFLASIPASVTSL-----------DLSA---NLLGLKSYAE 215
Query: 233 ---VLAGNKSYQLQFLNLDHNLI----AGTIPVSLGKLGLLQEISLSHNKIVGPIPDE-- 283
+ + + + LNL N + + + L LQ + L ++ + ++
Sbjct: 216 LAYIFSSIPN-HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCK 274
Query: 284 -----LGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQN- 337
+ K+ +D + I S + +N+ +S + L N+ ++ Q
Sbjct: 275 ALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTN 334
Query: 338 ---------LTVLNLKNNQ 347
L
Sbjct: 335 IEDLNIPDELRESIQTCKP 353
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 50/199 (25%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 544 GKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEAAAIGKIHHPNLLALRAY 599
GK T+G + A+K LR++ + E E+ + HP L AL+
Sbjct: 14 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 73
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
+ ++L V ++ G L F H R A I L YLH +++
Sbjct: 74 FQTH--DRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGA-EIVSALEYLH-SRDVV 127
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLGYRAPELSKLKNANTK 717
+ ++ N++LD+ + +I DFGL + ++ A GT Y APE+ + +
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYLAPEVLEDNDYGRA 185
Query: 718 TDVYSLGVIILELLTGKSP 736
D + LGV++ E++ G+ P
Sbjct: 186 VDWWGLGVVMYEMMCGRLP 204
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 47/211 (22%), Positives = 89/211 (42%), Gaps = 25/211 (11%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR---EKTTKGQKEFEAEAAAIGKIHHPNLLAL 596
+ +G G A VA+K+L + T ++ + E + ++H N++ L
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 89
Query: 597 RAYYLGPKGEKL-----LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYL 651
+ K + +V + M +L + +++ + + G+ +L
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSY-----LLYQMLCGIKHL 143
Query: 652 HVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT--AGTLGYRAPELS 709
H +IH +L SN+++ +I DFGL+R A T+ + T T YRAPE+
Sbjct: 144 H-SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVVTRYYRAPEVI 198
Query: 710 KLKNANTKTDVYSLGVIILELLTGKS--PGE 738
D++S+G I+ E++ G PG
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 47/198 (23%), Positives = 83/198 (41%), Gaps = 15/198 (7%)
Query: 544 GKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEAAAIGKIHHPNLLALRAY 599
G ++G ++ A+K L ++ K+ E E + ++ P L+ L
Sbjct: 50 GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS 109
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
+ L +V +++ G + F H R R A I YLH ++I
Sbjct: 110 FKDNS--NLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAA-QIVLTFEYLH-SLDLI 163
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKT 718
+ +L N+L+D++ ++ DFG ++ + T GT APE+ K N
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEIILSKGYNKAV 219
Query: 719 DVYSLGVIILELLTGKSP 736
D ++LGV+I E+ G P
Sbjct: 220 DWWALGVLIYEMAAGYPP 237
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 54/216 (25%), Positives = 80/216 (37%), Gaps = 32/216 (14%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602
G +G A VAVK + E+ + + E + HPN++ + L
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 603 PKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIAR--------GLNYLHV 653
P L ++ ++ G L + G R S AR G++Y H
Sbjct: 88 PT--HLAIIMEYASGGELYERICNAG---------RFSEDE--ARFFFQQLLSGVSYCH- 133
Query: 654 EENMIHGNLTSSNVLLDEKTNPR--IADFGLSRLMTAAANTNVIATA-GTLGYRAPE-LS 709
+ H +L N LLD PR I DFG S+ + + GT Y APE L
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---LHSQPKSTVGTPAYIAPEVLL 190
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745
+ + DV+S GV + +L G P E
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD 226
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 48/218 (22%), Positives = 83/218 (38%), Gaps = 38/218 (17%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR--EKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
++G+ YG AT G VA+K++ +K + E + H N++ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIF 75
Query: 598 AYYLGPKGEKL----LVFDFMP-------KGSLASFLHARGPETIVNWATRMSIAIGIAR 646
E ++ + M + S H + R
Sbjct: 76 NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ------------YFIYQTLR 123
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLG---- 702
+ LH N+IH +L SN+L++ + ++ DFGL+R++ +A N T G
Sbjct: 124 AVKVLH-GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 703 -----YRAPE-LSKLKNANTKTDVYSLGVIILELLTGK 734
YRAPE + + DV+S G I+ EL +
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 46/214 (21%), Positives = 90/214 (42%), Gaps = 26/214 (12%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREK---TTKGQKEF-------EAEAAAIGKIH 589
+G + T + A + + + VA+K +R T + E +A+ +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 590 HPNLLALRA--YYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIAR 646
++L L + GP G + +VF+ + +L + + I + I+ +
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK-QISKQLLL 142
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNP------RIADFGLSRLMTAAANTNVIATAGT 700
GL+Y+H +IH ++ NVL++ +P +IAD G + + + + T
Sbjct: 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW----YDEHYTNSIQT 198
Query: 701 LGYRAPELSKLKNANTKTDVYSLGVIILELLTGK 734
YR+PE+ D++S +I EL+TG
Sbjct: 199 REYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR---EKTTKGQKEFEAEAAAIGKIHHPNLLAL 596
+G YG+ A + G VAVK+L + ++ + E + + H N++ L
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 93
Query: 597 RAYYLGPKGEKL-----LVFDFMP-------KGSLASFLHARGPETIVNWATRMSIAIGI 644
+ + + LV M K + H + + I
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ------------FLIYQI 141
Query: 645 ARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYR 704
RGL Y+H ++IH +L SN+ ++E +I DFGL+R TA T +A T YR
Sbjct: 142 LRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGYVA---TRWYR 196
Query: 705 APE-LSKLKNANTKTDVYSLGVIILELLTGKS--PG 737
APE + + N D++S+G I+ ELLTG++ PG
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 26/207 (12%)
Query: 154 SIPPSIGNCP-NLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSL--LGSIPLSLTRL 210
P + +L ++ + + ++ + + + + I L
Sbjct: 12 IFPD---DAFAETIKANLKKKSV--TDAVTQNELNSIDQIIANNSDIKSVQGIQ----YL 62
Query: 211 PSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSL-GKLGLLQEI 269
P++ LAL N L + L + L +L L N + ++P + KL L+E+
Sbjct: 63 PNVRYLALGGNKLH-----DISAL--KELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKEL 114
Query: 270 SLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPV-TFTNITSLVSLNLENNRLGNKI 328
L N++ KL+ L L+L++N + S P F +T+L L+L N+L +
Sbjct: 115 VLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL-QSL 172
Query: 329 PEGL-ERLQNLTVLNLKNNQFKGHIPE 354
PEG+ ++L L L L NQ K +P+
Sbjct: 173 PEGVFDKLTQLKDLRLYQNQLKS-VPD 198
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 44/189 (23%), Positives = 81/189 (42%), Gaps = 24/189 (12%)
Query: 166 QTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSG 225
+T+ +S P T + NL S+ + L S+ + ++++
Sbjct: 1 ETITVSTPIK-QIFPDDAFAETI--KANLKKKSV-TDAV-TQNELNSIDQIIANNSDIK- 54
Query: 226 SVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLG---KLGLLQEISLSHNKIVGPIPD 282
SV +++L L N + + +L L + L+ N++
Sbjct: 55 SVQ------GIQYLPNVRYLALGGNKLH-----DISALKELTNLTYLILTGNQLQSLPNG 103
Query: 283 ELGKLSKLQKLDLSYNAIGGSFPV-TFTNITSLVSLNLENNRLGNKIPEGL-ERLQNLTV 340
KL+ L++L L N + S P F +T+L LNL +N+L +P+G+ ++L NLT
Sbjct: 104 VFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQL-QSLPKGVFDKLTNLTE 161
Query: 341 LNLKNNQFK 349
L+L NQ +
Sbjct: 162 LDLSYNQLQ 170
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVK---RLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
G T+G G +VAVK R + ++ + E + HP+++ L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL--- 81
Query: 600 Y--LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIG------IARGLNYL 651
Y + + +V +++ G L ++ G R+ I G++Y
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNG---------RLDEKESRRLFQQILSGVDYC 132
Query: 652 HVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA-GTLGYRAPE-LS 709
H ++H +L NVLLD N +IADFGLS +M+ + + T+ G+ Y APE +S
Sbjct: 133 H-RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRTSCGSPNYAAPEVIS 188
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSP 736
A + D++S GVI+ LL G P
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 44/205 (21%), Positives = 82/205 (40%), Gaps = 29/205 (14%)
Query: 543 MGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFEAEAAAIGKI-----HHPNLLA 595
+G+ Y ++A + + +V VK L+ K K ++E KI PN++
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREI--------KILENLRGGPNIIT 95
Query: 596 LRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
L P LVF+ + I I + L+Y H
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI------RFYMYEILKALDYCH-S 148
Query: 655 ENMIHGNLTSSNVLLDEKT-NPRIADFGLSRLMTAAANTNV-IATAGTLGYRAPE-LSKL 711
++H ++ NV++D + R+ D+GL+ NV +A+ ++ PE L
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS---RYFKGPELLVDY 205
Query: 712 KNANTKTDVYSLGVIILELLTGKSP 736
+ + D++SLG ++ ++ K P
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 43/213 (20%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRL-REKTTKG--QKEFEAEAAAIGKIHHPNLLALRAY 599
G+ ++G AT + +VA+K + R+ K E E + + + HP+++ L Y
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL--Y 75
Query: 600 --------------YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIA 645
Y G GE +FD++ + R E + I
Sbjct: 76 DVITTPTDIVMVIEYAG--GE---LFDYIVE-------KKRMTEDEGRRFFQQIIC---- 119
Query: 646 RGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA-GTLGYR 704
+ Y H ++H +L N+LLD+ N +IADFGLS +MT + N + T+ G+ Y
Sbjct: 120 -AIEYCH-RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT---DGNFLKTSCGSPNYA 174
Query: 705 APE-LSKLKNANTKTDVYSLGVIILELLTGKSP 736
APE ++ A + DV+S G+++ +L G+ P
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR---EKTTKGQKEFEAEAAAIGKIHHPNLLAL 596
+ +G YG A G++VA+K+L + ++ + E + + H N++ L
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGL 89
Query: 597 RAYYLGPKGEKL-----LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYL 651
+ + LV FM L + + + + +GL Y+
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE----KLGEDRIQFLVYQMLKGLRYI 144
Query: 652 HVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSK 710
H +IH +L N+ ++E +I DFGL+R + V+ T YRAPE +
Sbjct: 145 H-AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV----TRWYRAPEVILN 199
Query: 711 LKNANTKTDVYSLGVIILELLTGK 734
D++S+G I+ E++TGK
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 48/219 (21%), Positives = 83/219 (37%), Gaps = 39/219 (17%)
Query: 157 PSIGNC---PNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSL 213
++ C + +D +L ++P + T +L+L L + L L
Sbjct: 5 ETVTGCTCNEGKKEVDCQGKSLD-SVPSGIPADTE--KLDLQSTGLATLSDATFRGLTKL 61
Query: 214 SVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSH 273
+ L L +N L ++ + +L L L +N +A ++P+
Sbjct: 62 TWLNLDYNQLQ-TLSAG----VFDDLTELGTLGLANNQLA-SLPLG-------------- 101
Query: 274 NKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPV-TFTNITSLVSLNLENNRLGNKIPEGL 332
+ D L++L KL L N + S P F +T L L L N+L IP G
Sbjct: 102 ------VFD---HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGA 150
Query: 333 -ERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSEN 370
++L NL L+L NQ + + + + L N
Sbjct: 151 FDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 49/160 (30%), Positives = 72/160 (45%), Gaps = 11/160 (6%)
Query: 118 RKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCP-NLQTLDLSNNALI 176
KL L LA + L L + L N+L ++ + + L TL L+NN L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQL- 95
Query: 177 GAIPPSLANS-TRLYRLNLSYNSLLGSIPLSL-TRLPSLSVLALQHNNLSGSVPNNWGVL 234
++P + + T+L +L L N L S+P + RL L L L N L S+P G
Sbjct: 96 ASLPLGVFDHLTQLDKLYLGGNQ-LKSLPSGVFDRLTKLKELRLNTNQLQ-SIPA--GAF 151
Query: 235 AGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHN 274
+K LQ L+L N + + +LG LQ I+L N
Sbjct: 152 --DKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 51/173 (29%), Positives = 79/173 (45%), Gaps = 15/173 (8%)
Query: 154 SIPPSIGNCP-NLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSL-TRLP 211
S+P I P + + LDL + L + T+L LNL YN L ++ + L
Sbjct: 28 SVPSGI---PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLT 83
Query: 212 SLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSL-GKLGLLQEIS 270
L L L +N L+ S+P GV + QL L L N + ++P + +L L+E+
Sbjct: 84 ELGTLGLANNQLA-SLPL--GVF--DHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELR 137
Query: 271 LSHNKIVGPIPDEL-GKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENN 322
L+ N++ IP KL+ LQ L LS N + F + L ++ L N
Sbjct: 138 LNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 31/115 (26%), Positives = 52/115 (45%), Gaps = 7/115 (6%)
Query: 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGL-ERLQNLTVLNLKNNQFK 349
+KLDL + TF +T L LNL+ N+L + G+ + L L L L NNQ
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 350 GHIPETI-GNISGINQLDLSENDFTGEISPSL-ASLANLTSFNVSYNNLSGSVPP 402
+P + +++ +++L L N + + L L ++ N L S+P
Sbjct: 97 S-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPA 148
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 42/218 (19%), Positives = 86/218 (39%), Gaps = 44/218 (20%)
Query: 543 MGKSTYGTAYKAT-LEDGSEVAVKRL-REKTTKGQKEFEA-----EAAAIGKIHH--PNL 593
+G +G+ Y + D VA+K + +++ + + E + K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 594 LAL-------RAYYL-----GPKGEKLLVFDFM-PKGSLASFLHARGPETIVNWATRMSI 640
+ L ++ L P + +FDF+ +G+L L AR S
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEEL-AR------------SF 154
Query: 641 AIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT-NPRIADFGLSRLMTAAANTNVIATAG 699
+ + + H ++H ++ N+L+D ++ DFG L+ +T G
Sbjct: 155 FWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDG 210
Query: 700 TLGYRAPE-LSKLKNANTKTDVYSLGVIILELLTGKSP 736
T Y PE + + V+SLG+++ +++ G P
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 48/200 (24%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 544 GKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEAAAIGKI-HHPNLLALRA 598
G+ +Y L+ + A+K ++++ ++ + E + +HP L+ L +
Sbjct: 18 GRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 77
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
+ +L V +++ G L H + + R A I+ LNYLH E +
Sbjct: 78 CFQTE--SRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAE-ISLALNYLH-ERGI 131
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLGYRAPELSKLKNANT 716
I+ +L NVLLD + + ++ D+G+ + + T+ GT Y APE+ + ++
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF--CGTPNYIAPEILRGEDYGF 189
Query: 717 KTDVYSLGVIILELLTGKSP 736
D ++LGV++ E++ G+SP
Sbjct: 190 SVDWWALGVLMFEMMAGRSP 209
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 8e-13
Identities = 30/135 (22%), Positives = 48/135 (35%), Gaps = 7/135 (5%)
Query: 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAI 300
+ + L+L I I L I S N+I + L +L+ L ++ N I
Sbjct: 20 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRI 76
Query: 301 GGSFPVTFTNITSLVSLNLENNRLGN-KIPEGLERLQNLTVLNLKNN---QFKGHIPETI 356
+ L L L NN L + L L++LT L + N K + I
Sbjct: 77 CRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVI 136
Query: 357 GNISGINQLDLSEND 371
+ + LD +
Sbjct: 137 YKVPQVRVLDFQKVK 151
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 6e-09
Identities = 28/117 (23%), Positives = 46/117 (39%), Gaps = 8/117 (6%)
Query: 108 SEKISQLHALRKLSLHDNLLAGPVPWSLG-FLPNLRGVYLFNNRLSGSIPPSIGNCPNLQ 166
+ + + R+L L + PV +LG L + +N + + L+
Sbjct: 12 AAQYTNAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLK 67
Query: 167 TLDLSNNALIGAIPPSLANSTRLYRLNLSYNSL--LGSIPLSLTRLPSLSVLALQHN 221
TL ++NN + L L L+ NSL LG + L L SL+ L + N
Sbjct: 68 TLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 25/116 (21%), Positives = 41/116 (35%), Gaps = 7/116 (6%)
Query: 138 LPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197
R + L ++ I +D S+N I + RL L ++ N
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN-EIRKLDG-FPLLRRLKTLLVNNN 74
Query: 198 SLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIA 253
+ LP L+ L L +N+L + LA KS L +L + N +
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKS--LTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 26/147 (17%), Positives = 48/147 (32%), Gaps = 22/147 (14%)
Query: 157 PSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLS-LTRLPSLSV 215
N + LDL I I A + ++ S N + L L L
Sbjct: 13 AQYTNAVRDRELDLRGY-KIPVIENLGATLDQFDAIDFSDNEI---RKLDGFPLLRRLKT 68
Query: 216 LALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVS-LGKLGLLQEISLSHN 274
L + +N + + L L L +N + + L L L + + N
Sbjct: 69 LLVNNNRIC-RIGEGL----DQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
Query: 275 KIVGPIPDE-------LGKLSKLQKLD 294
P+ ++ + K+ +++ LD
Sbjct: 124 ----PVTNKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 32/132 (24%), Positives = 50/132 (37%), Gaps = 30/132 (22%)
Query: 103 LGGRISEKISQLHA----LRKLSLHDNL---LAGPVPWSLGFLPNLRGVYLFNNRLSGSI 155
L G I L A + DN L G L L+ + + NNR+
Sbjct: 26 LRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDG-----FPLLRRLKTLLVNNNRICRIG 80
Query: 156 PPSIGNCPNLQTLDLSNNAL--IGAIPPSLANSTRLYRLNLSYNSLLGSIPLS------- 206
P+L L L+NN+L +G + P LA+ L L + N P++
Sbjct: 81 EGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRN------PVTNKKHYRL 133
Query: 207 --LTRLPSLSVL 216
+ ++P + VL
Sbjct: 134 YVIYKVPQVRVL 145
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 27/153 (17%), Positives = 42/153 (27%), Gaps = 53/153 (34%)
Query: 245 LNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSF 304
+ L LI +E+ L KI I + L + +D S N
Sbjct: 2 VKLTAELIE-QAA-QYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDN------ 52
Query: 305 PVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQ 364
I L +G L+ L L + NN I I +
Sbjct: 53 -----EIRKL---------------DGFPLLRRLKTLLVNNN-----------RICRIGE 81
Query: 365 LDLSENDFTGEISPSLASLANLTSFNVSYNNLS 397
+L +LT ++ N+L
Sbjct: 82 GLDQ-------------ALPDLTELILTNNSLV 101
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 46/207 (22%), Positives = 84/207 (40%), Gaps = 19/207 (9%)
Query: 542 IMGKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKE---FEAEAAAIGKIHHPNLLALR 597
++G+ +G L++ +V A+K L + + E F E + + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139
Query: 598 AYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIV--NWATRMSIAIGIARGLNYLHVE 654
+Y L LV D+ G L E + A R +A + ++ +H +
Sbjct: 140 -HYAFQDDNNLYLVMDYYVGGDL--LTLLSKFEDRLPEEMA-RFYLA-EMVIAIDSVH-Q 193
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNA 714
+ +H ++ N+L+D + R+ADFG + GT Y +PE+ +
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 715 NTKT-----DVYSLGVIILELLTGKSP 736
D +SLGV + E+L G++P
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 48/202 (23%), Positives = 96/202 (47%), Gaps = 19/202 (9%)
Query: 544 GKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEAAAIGKI-HHPNLLALRA 598
G+ +Y L+ + A++ ++++ ++ + E + +HP L+ L +
Sbjct: 61 GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 120
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVEE 655
+ +L V +++ G L + + PE R A I+ LNYLH E
Sbjct: 121 CFQTE--SRLFFVIEYVNGGDLMFHMQRQRKLPEE----HARFYSAE-ISLALNYLH-ER 172
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLGYRAPELSKLKNA 714
+I+ +L NVLLD + + ++ D+G+ + + T+ GT Y APE+ + ++
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF--CGTPNYIAPEILRGEDY 230
Query: 715 NTKTDVYSLGVIILELLTGKSP 736
D ++LGV++ E++ G+SP
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSP 252
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 48/198 (24%), Positives = 90/198 (45%), Gaps = 15/198 (7%)
Query: 544 GKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEAAAIGKIHHPNLLALRAY 599
G ++G + A+K L+++ K+ E E + + HP ++ +
Sbjct: 15 GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGT 74
Query: 600 YLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
+ +++ ++ D++ G L F R + N + A + L YLH +++I
Sbjct: 75 FQDA--QQIFMIMDYIEGGEL--FSLLRKSQRFPNPVAKFYAA-EVCLALEYLH-SKDII 128
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKT 718
+ +L N+LLD+ + +I DFG ++ + T GT Y APE+ K N
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGTPDYIAPEVVSTKPYNKSI 184
Query: 719 DVYSLGVIILELLTGKSP 736
D +S G++I E+L G +P
Sbjct: 185 DWWSFGILIYEMLAGYTP 202
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 2e-12
Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 15/202 (7%)
Query: 542 IMGKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEAAAIGKI-HHPNLLAL 596
++GK ++G + + E+ AVK L++ + E E + P L L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 597 RAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
+ + ++L V +++ G L H + A IA GL +L +
Sbjct: 408 HSCFQTM--DRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQ-SK 461
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLGYRAPELSKLKNA 714
+I+ +L NV+LD + + +IADFG+ + + T GT Y APE+ +
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF--CGTPDYIAPEIIAYQPY 519
Query: 715 NTKTDVYSLGVIILELLTGKSP 736
D ++ GV++ E+L G++P
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAP 541
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 544 GKSTYGTAY---KATLEDGSEV-AVKRLREKTTKGQKEFE--AEAAAIGKIHHPNLLALR 597
G+ ++G + K + D ++ A+K L++ T K + E + +++HP ++ L
Sbjct: 33 GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL- 91
Query: 598 AYYLGPKGEKL-LVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVE 654
+Y KL L+ DF+ G L + L E + +A +A L++LH
Sbjct: 92 -HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE----DVKFYLA-ELALALDHLH-S 144
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLGYRAPELSKLKN 713
+I+ +L N+LLDE+ + ++ DFGLS+ + GT+ Y APE+ +
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF--CGTVEYMAPEVVNRRG 202
Query: 714 ANTKTDVYSLGVIILELLTGKSP 736
D +S GV++ E+LTG P
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLP 225
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 47/241 (19%), Positives = 85/241 (35%), Gaps = 55/241 (22%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAA------IGKI----H 589
++G +YG +A + VA+K++ + FE I I +
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREI-AILNRLN 110
Query: 590 HPNLLALRAYYLGPKGEKL----LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIA 645
H +++ + + EK +V + T ++ +
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTE---LHIKTLLYNLL 166
Query: 646 RGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAG------ 699
G+ Y+H ++H +L +N L+++ + ++ DFGL+R + N N
Sbjct: 167 VGVKYVH-SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 700 --------------------TLGYRAPELSKLKNANTKT-DVYSLGVIILELLTGKSPGE 738
T YRAPEL L+ T+ DV+S+G I ELL
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 739 P 739
Sbjct: 286 A 286
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 542 IMGKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKE---FEAEAAAIGKIHHPNLLALR 597
++G+ +G + +V A+K L + + + F E + + P ++ L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 134
Query: 598 AYYLGPKGEKL-LVFDFMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEE 655
+Y L +V ++MP G L + + PE WA R A + L+ +H
Sbjct: 135 -FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KWA-RFYTA-EVVLALDAIH-SM 187
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNAN 715
IH ++ N+LLD+ + ++ADFG M GT Y +PE+ K + +
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 716 TK----TDVYSLGVIILELLTGKSP 736
D +S+GV + E+L G +P
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-12
Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 4/115 (3%)
Query: 234 LAGNKSYQLQFLNLDHNLI-AGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQK 292
L ++ L LD++ G + + L+ +S + + I + L KL+KL+K
Sbjct: 11 LRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IAN-LPKLNKLKK 68
Query: 293 LDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGN-KIPEGLERLQNLTVLNLKNN 346
L+LS N + G V +L LNL N++ + E L++L+NL L+L N
Sbjct: 69 LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-09
Identities = 24/115 (20%), Positives = 51/115 (44%), Gaps = 7/115 (6%)
Query: 140 NLRGVYLFNNRLS-GSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNS 198
+++ + L N+R + G + L+ L N + +I +L +L +L LS N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV-GLTSIA-NLPKLNKLKKLELSDNR 75
Query: 199 LLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIA 253
+ G + + + P+L+ L L N + + L ++ L+ L+L + +
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLEN--LKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 32/126 (25%), Positives = 48/126 (38%), Gaps = 26/126 (20%)
Query: 105 GRISEKISQLHALRKLSLHDNLL---AGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGN 161
G++ + L LS + L A L L L+ + L +NR+SG +
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGLTSIAN-----LPKLNKLKKLELSDNRVSGGLEVLAEK 86
Query: 162 CPNLQTLDLSNNAL--IGAIPPSLANSTRLYRLNLSYNSLLGSIPLS---------LTRL 210
CPNL L+LS N + + I P L L L+L ++ L
Sbjct: 87 CPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSLDLFNC------EVTNLNDYRENVFKLL 139
Query: 211 PSLSVL 216
P L+ L
Sbjct: 140 PQLTYL 145
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 8e-08
Identities = 24/109 (22%), Positives = 45/109 (41%), Gaps = 8/109 (7%)
Query: 266 LQEISLSHNKI-VGPIPDELGKLSKLQKLDLSYNAIG--GSFPVTFTNITSLVSLNLENN 322
++E+ L +++ G + + +L+ L + + P + L L L +N
Sbjct: 19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSDN 74
Query: 323 RLGNKIPEGLERLQNLTVLNLKNNQFKG-HIPETIGNISGINQLDLSEN 370
R+ + E+ NLT LNL N+ K E + + + LDL
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 9e-07
Identities = 29/111 (26%), Positives = 45/111 (40%), Gaps = 9/111 (8%)
Query: 192 LNLSYNSL-LGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN 250
L L + G + L L+ + L+ S+ N L +L+ L L N
Sbjct: 22 LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN----LPKLN--KLKKLELSDN 74
Query: 251 LIAGTIPVSLGKLGLLQEISLSHNKIVGP-IPDELGKLSKLQKLDLSYNAI 300
++G + V K L ++LS NKI + L KL L+ LDL +
Sbjct: 75 RVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 22/92 (23%), Positives = 40/92 (43%), Gaps = 9/92 (9%)
Query: 310 NITSLVSLNLENNRLGN-KIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQL--- 365
+ + L L+N+R K+ + + L L+ N +I N+ +N+L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKL 69
Query: 366 DLSENDFTGEISPSLASLANLTSFNVSYNNLS 397
+LS+N +G + NLT N+S N +
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 45/222 (20%), Positives = 86/222 (38%), Gaps = 46/222 (20%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRL-REKTTK-----GQKEFEAEAAAIGKIH---- 589
++GK +GT + L D +VA+K + R + E A + K+
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 590 HPNLLAL-------RAYYL-----GPKGEKLLVFDF-MPKGSLASFLHARGPETIVNWAT 636
HP ++ L + L P + +FD+ KG L +R
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQD---LFDYITEKGPLGEGP-SR---------- 142
Query: 637 RMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNP-RIADFGLSRLMTAAANTNVI 695
+ + + H ++H ++ N+L+D + ++ DFG L+ +
Sbjct: 143 --CFFGQVVAAIQHCH-SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYT 196
Query: 696 ATAGTLGYRAPE-LSKLKNANTKTDVYSLGVIILELLTGKSP 736
GT Y PE +S+ + V+SLG+++ +++ G P
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-12
Identities = 36/143 (25%), Positives = 62/143 (43%), Gaps = 7/143 (4%)
Query: 234 LAGNKSYQLQFLNLD-HNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQK 292
L ++ L LD G I + L+ +SL + ++ + + L KL KL+K
Sbjct: 18 LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSN-LPKLPKLKK 75
Query: 293 LDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGN-KIPEGLERLQNLTVLNLKNN---QF 348
L+LS N I G + + +L LNL N+L + E L++L+ L L+L N
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNL 135
Query: 349 KGHIPETIGNISGINQLDLSEND 371
+ + + LD + +
Sbjct: 136 NDYRESVFKLLPQLTYLDGYDRE 158
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 28/117 (23%), Positives = 50/117 (42%), Gaps = 7/117 (5%)
Query: 138 LPNLRGVYLFNNRLS-GSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSY 196
+R + L N + + G I NL+ L L N + ++ L +L +L LS
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV-GLISVSN-LPKLPKLKKLELSE 80
Query: 197 NSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIA 253
N + G + + +LP+L+ L L N L + L + L+ L+L + +
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLEC--LKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-09
Identities = 33/126 (26%), Positives = 48/126 (38%), Gaps = 26/126 (20%)
Query: 105 GRISEKISQLHALRKLSLHDNLL---AGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGN 161
G+I ++ L LSL + L + L LP L+ + L NR+ G +
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLISVSN-----LPKLPKLKKLELSENRIFGGLDMLAEK 93
Query: 162 CPNLQTLDLSNNAL--IGAIPPSLANSTRLYRLNLSYNSLLGSIPLS---------LTRL 210
PNL L+LS N L I + P L L L+L ++ L
Sbjct: 94 LPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNC------EVTNLNDYRESVFKLL 146
Query: 211 PSLSVL 216
P L+ L
Sbjct: 147 PQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 25/92 (27%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 310 NITSLVSLNLENNRLGN-KIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISG---INQL 365
++ L L+N + + KI NL L+L N ++ N+ + +L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKKL 76
Query: 366 DLSENDFTGEISPSLASLANLTSFNVSYNNLS 397
+LSEN G + L NLT N+S N L
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 24/195 (12%), Positives = 52/195 (26%), Gaps = 45/195 (23%)
Query: 549 GTAYKATLED---GSEVAVKRLRE---KTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602
++A D +VA+ + +E + + +I P + + +
Sbjct: 45 LQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV--LDVV 100
Query: 603 PKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGN 661
+V +++ GSL P + +A + H +
Sbjct: 101 HTRAGGLVVAEWIRGGSLQEVA-DTSPSP----VGAIRAMQSLAAAADAAH-RAGVALSI 154
Query: 662 LTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVY 721
S V + + +A AN + D+
Sbjct: 155 DHPSRVRVSIDGDVVLAYPA---------------------TMPD-------ANPQDDIR 186
Query: 722 SLGVIILELLTGKSP 736
+G + LL + P
Sbjct: 187 GIGASLYALLVNRWP 201
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 48/247 (19%), Positives = 82/247 (33%), Gaps = 58/247 (23%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKR--------------LREKTTKGQKEFEAEAAAI 585
++G+ +YG Y A VA+K+ LRE
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE--ITILNRL------- 82
Query: 586 GKIHHPNLLALRAYYLGPKGEKL----LVFDFMPKGSLASFLHARGPETIVNWATRMSIA 641
++ L + K +V + L T + +I
Sbjct: 83 ---KSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEH---IKTIL 135
Query: 642 IGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTL 701
+ G N++H E +IH +L +N LL++ + ++ DFGL+R + + +TN++
Sbjct: 136 YNLLLGENFIH-ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 702 G---------------------YRAPE-LSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739
YRAPE + +N D++S G I ELL
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254
Query: 740 MNGMDLP 746
P
Sbjct: 255 DPTNRFP 261
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 544 GKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AE----AAAIGKIHHPNLLA 595
GK ++G + A + ++ A+K L++ + E E + A HP L
Sbjct: 26 GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW---EHPFLTH 82
Query: 596 LRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
+ + E L V +++ G L H + A I GL +LH
Sbjct: 83 MFCTFQTK--ENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAA-EIILGLQFLH-S 136
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLGYRAPELSKLKN 713
+ +++ +L N+LLD+ + +IADFG+ + M A TN GT Y APE+ +
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--CGTPDYIAPEILLGQK 194
Query: 714 ANTKTDVYSLGVIILELLTGKSP 736
N D +S GV++ E+L G+SP
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 45/220 (20%), Positives = 83/220 (37%), Gaps = 40/220 (18%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
+ +G G + A + VA+K++ + E I ++ H N++ +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFE 75
Query: 599 YYLGPKGEKL-------------LVFDFMP-------KGSLASFLHARGPETIVNWATRM 638
+ +V ++M + HAR
Sbjct: 76 ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHAR------------ 123
Query: 639 SIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT-NPRIADFGLSRLMTAAANTNVIAT 697
+ RGL Y+H N++H +L +N+ ++ + +I DFGL+R+M + +
Sbjct: 124 LFMYQLLRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 698 A--GTLGYRAPE-LSKLKNANTKTDVYSLGVIILELLTGK 734
T YR+P L N D+++ G I E+LTGK
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 544 GKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEAAAIGKI-HHPNLLALRA 598
GK ++G + + E+ AVK L++ + E E + P L L +
Sbjct: 29 GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHS 88
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
+ ++L V +++ G L H + A IA GL +L + +
Sbjct: 89 CFQTM--DRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQ-SKGI 142
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLGYRAPELSKLKNANT 716
I+ +L NV+LD + + +IADFG+ + + T GT Y APE+ +
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF--CGTPDYIAPEIIAYQPYGK 200
Query: 717 KTDVYSLGVIILELLTGKSP 736
D ++ GV++ E+L G++P
Sbjct: 201 SVDWWAFGVLLYEMLAGQAP 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 52/238 (21%), Positives = 84/238 (35%), Gaps = 68/238 (28%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKR--------------LREKTTKGQKEFEAEAAAI 585
+ +GK YG +K+ G VAVK+ RE E
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE--IMILTELS------ 66
Query: 586 GKIHHPNLLALRAYYLGPKGEKL-LVFDFMP-------KGSLASFLHARGPETIVNWATR 637
H N++ L + LVFD+M + ++ +H +
Sbjct: 67 ---GHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQ----------- 112
Query: 638 MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697
+ + + + YLH ++H ++ SN+LL+ + + ++ADFGLSR
Sbjct: 113 -YVVYQLIKVIKYLH-SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 698 AGTLG--------------------YRAPE-LSKLKNANTKTDVYSLGVIILELLTGK 734
YRAPE L D++SLG I+ E+L GK
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 544 GKSTYGT---AYKATLEDGSEV-AVKRLREKT-TKGQKEFE---AEAAAIGKIHHPNLLA 595
GK YG K T + ++ A+K L++ + K+ AE + ++ HP ++
Sbjct: 26 GKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVD 85
Query: 596 LRAYYLGPKGEKL-LVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLH 652
L Y G KL L+ +++ G L L G E +A I+ L +LH
Sbjct: 86 L--IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED----TACFYLA-EISMALGHLH 138
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLGYRAPELSKL 711
++ +I+ +L N++L+ + + ++ DFGL + + T+ GT+ Y APE+
Sbjct: 139 -QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF--CGTIEYMAPEILMR 195
Query: 712 KNANTKTDVYSLGVIILELLTGKSP 736
N D +SLG ++ ++LTG P
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 544 GKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEAAAIGKI-HHPNLLALRA 598
GK ++G A +++ ++ AVK L++ + E E + +HP L L
Sbjct: 32 GKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFC 91
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
+ P ++L V +F+ G L H + R A I L +LH ++ +
Sbjct: 92 CFQTP--DRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAA-EIISALMFLH-DKGI 145
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIATAGTLGYRAPELSKLKNANT 716
I+ +L NVLLD + + ++ADFG+ + + T GT Y APE+ +
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF--CGTPDYIAPEILQEMLYGP 203
Query: 717 KTDVYSLGVIILELLTGKSP 736
D +++GV++ E+L G +P
Sbjct: 204 AVDWWAMGVLLYEMLCGHAP 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 5/102 (4%)
Query: 638 MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697
+ + +A+G+ +L IH +L + N+LL EK +I DFGL+R + V
Sbjct: 196 ICYSFQVAKGMEFL-ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY-KDPDYVRKG 253
Query: 698 AGTLGYR--APELSKLKNANTKTDVYSLGVIILELLT-GKSP 736
L + APE + ++DV+S GV++ E+ + G SP
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 24/108 (22%), Positives = 44/108 (40%), Gaps = 8/108 (7%)
Query: 544 GKSTYGTAYKATL------EDGSEVAVKRLREKTTKG-QKEFEAEAAAIGKI-HHPNLLA 595
G+ +G +A VAVK L+E T + +E + I HH N++
Sbjct: 31 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIG 643
L P G +++ +F G+L+++L ++ E + G
Sbjct: 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQG 138
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 37/164 (22%), Positives = 61/164 (37%), Gaps = 34/164 (20%)
Query: 191 RLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN 250
L+ + + +L+ L + LAL NN+ + + L+G + L+ L+L N
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KISS----LSGME--NLRILSLGRN 80
Query: 251 LIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTN 310
LI I L+E+ +S+N+I + KL L+ L +S N
Sbjct: 81 LIK-KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNN-----------K 126
Query: 311 ITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPE 354
IT+ + + L L L L L N E
Sbjct: 127 ITNWGEI------------DKLAALDKLEDLLLAGNPLYNDYKE 158
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-10
Identities = 30/121 (24%), Positives = 47/121 (38%), Gaps = 14/121 (11%)
Query: 106 RISEKISQLHALRKLSLHDNL---LAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNC 162
++ +S L A + L+L N ++ L + NLR + L N + I
Sbjct: 39 KMDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRNLIK-KIENLDAVA 92
Query: 163 PNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSL--LGSIPLSLTRLPSLSVLALQH 220
L+ L +S N I ++ + L L +S N + G I L L L L L
Sbjct: 93 DTLEELWISYNQ-IASLSG-IEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAG 149
Query: 221 N 221
N
Sbjct: 150 N 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 28/130 (21%), Positives = 43/130 (33%), Gaps = 30/130 (23%)
Query: 268 EISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNK 327
E+ I + L L + L LS N I K
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-------------------------K 62
Query: 328 IPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLT 387
I L ++NL +L+L N K I + +L +S N +S + L NL
Sbjct: 63 I-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLR 118
Query: 388 SFNVSYNNLS 397
+S N ++
Sbjct: 119 VLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 31/161 (19%), Positives = 61/161 (37%), Gaps = 22/161 (13%)
Query: 145 YLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIP 204
+ + + ++ + L LS N I I L+ L L+L N L+ I
Sbjct: 31 HGMIPPIEK-MDATLSTLKACKHLALSTN-NIEKISS-LSGMENLRILSLGRN-LIKKIE 86
Query: 205 LSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVS-LGKL 263
+L L + +N ++ S+ + + L+ L + +N I + L L
Sbjct: 87 NLDAVADTLEELWISYNQIA-SLSG----IEKLVN--LRVLYMSNNKITNWGEIDKLAAL 139
Query: 264 GLLQEISLSHNKIVGPIPDE----------LGKLSKLQKLD 294
L+++ L+ N + + + +L L+KLD
Sbjct: 140 DKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 7e-11
Identities = 24/95 (25%), Positives = 40/95 (42%), Gaps = 4/95 (4%)
Query: 131 VPWSLGFLPNLRGVYLFNNRLSGSIPP-SIGNCPNLQTLDLSNNALIGAIPP-SLANSTR 188
L NL +Y+ N + + + L+ L + + + + P + + R
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG-LRFVAPDAFHFTPR 81
Query: 189 LYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNL 223
L RLNLS+N+L S+ + SL L L N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 7e-10
Identities = 24/104 (23%), Positives = 34/104 (32%), Gaps = 7/104 (6%)
Query: 148 NNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPP-SLANSTRLYRLNLSYNSLLGSIPLS 206
+ + NL L + N + + L L L + + L P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 207 LTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN 250
P LS L L N L S+ W + G LQ L L N
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLS--WKTVQGLS---LQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 23/128 (17%), Positives = 40/128 (31%), Gaps = 29/128 (22%)
Query: 197 NSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTI 256
L +L+ L +++ + L G
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLE--LRDLRG-------------------- 54
Query: 257 PVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVS 316
LG L+ +++ + + PD +L +L+LS+NA+ T SL
Sbjct: 55 ------LGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG-LSLQE 107
Query: 317 LNLENNRL 324
L L N L
Sbjct: 108 LVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 18/95 (18%), Positives = 32/95 (33%), Gaps = 2/95 (2%)
Query: 280 IPDELGKLSKLQKLDLSYNAIGGSFP-VTFTNITSLVSLNLENNRLGNKIPEGLERLQNL 338
L L +L + + L +L + + L P+ L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 339 TVLNLKNNQFKGHIPETIGNISGINQLDLSENDFT 373
+ LNL N + +T+ +S + +L LS N
Sbjct: 83 SRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 18/95 (18%), Positives = 33/95 (34%), Gaps = 2/95 (2%)
Query: 303 SFPVTFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQFKGHIPETIGNISG 361
+L L +EN + + L L L L + + + P+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 362 INQLDLSENDFTGEISPSLASLANLTSFNVSYNNL 396
+++L+LS N +S +L +S N L
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 5e-05
Identities = 16/84 (19%), Positives = 33/84 (39%), Gaps = 4/84 (4%)
Query: 321 NNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIP-ETIGNISGINQLDLSENDFTGEISP- 378
L +NLT L ++N Q H+ + + + L + ++ ++P
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 379 SLASLANLTSFNVSYNNLSGSVPP 402
+ L+ N+S+N L S+
Sbjct: 75 AFHFTPRLSRLNLSFNALE-SLSW 97
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 8e-05
Identities = 20/68 (29%), Positives = 28/68 (41%), Gaps = 1/68 (1%)
Query: 108 SEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQT 167
+ L LR L++ + L P + F P L + L N L S+ +LQ
Sbjct: 49 LRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQE 107
Query: 168 LDLSNNAL 175
L LS N L
Sbjct: 108 LVLSGNPL 115
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 7e-11
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 544 GKSTYGTAYKATLEDGSEV-AVKRLREKTTKGQKEFE---AEAAAIGK-IHHPNLLALRA 598
GK ++G A + AVK L++K +KE + +E + K + HP L+ L
Sbjct: 47 GKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHF 106
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
+ +KL V D++ G L F H + + R A IA L YLH N+
Sbjct: 107 SFQTA--DKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAA-EIASALGYLH-SLNI 160
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRL-MTAAANTNVIAT-AGTLGYRAPELSKLKNAN 715
++ +L N+LLD + + + DFGL + + + T+ T GT Y APE+ + +
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS---TFCGTPEYLAPEVLHKQPYD 217
Query: 716 TKTDVYSLGVIILELLTGKSP 736
D + LG ++ E+L G P
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPP 238
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 267 QEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGN 326
E+ L N+ +P EL L +DLS N I +F+N+T L++L L NRL
Sbjct: 34 TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92
Query: 327 KIPEGL-ERLQNLTVLNLKNNQFKGHIPE 354
IP + L++L +L+L N +PE
Sbjct: 93 -IPPRTFDGLKSLRLLSLHGNDISV-VPE 119
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 32/87 (36%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 145 YLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSL-ANSTRLYRLNLSYNSLLGSI 203
YL N+ + +P + N +L +DLSNN I + +N T+L L LSYN L I
Sbjct: 37 YLDGNQFT-LVPKELSNYKHLTLIDLSNNR-ISTLSNQSFSNMTQLLTLILSYNR-LRCI 93
Query: 204 PLSLT-RLPSLSVLALQHNNLSGSVPN 229
P L SL +L+L N++S VP
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVPE 119
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 28/210 (13%)
Query: 544 GKSTYGT---AYKATLEDGSEV-AVKRLREKT----------TKGQKEFEAEAAAIGKIH 589
G YG K + D ++ A+K L++ T T+ +++
Sbjct: 63 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-----Q 117
Query: 590 HPNLLALRAYYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGL 648
P L+ L +Y KL L+ D++ G L F H E ++ + I L
Sbjct: 118 SPFLVTL--HYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVG-EIVLAL 172
Query: 649 NYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE- 707
+LH + +I+ ++ N+LLD + + DFGLS+ A GT+ Y AP+
Sbjct: 173 EHLH-KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 708 LSKLKNANTKT-DVYSLGVIILELLTGKSP 736
+ + + K D +SLGV++ ELLTG SP
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 60.4 bits (145), Expect = 7e-10
Identities = 24/199 (12%), Positives = 63/199 (31%), Gaps = 21/199 (10%)
Query: 123 HDNLLAGPVPWSLGFLPNLRGVYLFNNRLS---------GSIPPSIGNCPNLQTLDLSNN 173
+ +A + + + G++ + + P + P L L +
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT 182
Query: 174 ALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLAL----QHNNLSGSVPN 229
+ N L + + + LP+L L L + G +
Sbjct: 183 NNLSIGKKPRPNLKSL-EIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNV 241
Query: 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGK---LGLLQEISLSHNKI----VGPIPD 282
+ + ++ L++L + + + L L+ + +S + + D
Sbjct: 242 FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLD 301
Query: 283 ELGKLSKLQKLDLSYNAIG 301
+ K+ L+ +++ YN +
Sbjct: 302 HVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 58.0 bits (139), Expect = 5e-09
Identities = 28/245 (11%), Positives = 65/245 (26%), Gaps = 31/245 (12%)
Query: 2 ENTYRYLYPFHNYKHFFLYTHLFLCLVLAFTSQFVAGHSWDGVIVTQAD----YQSLRAI 57
+ + L + G + + + +
Sbjct: 85 LSYDEAEEGVNLMDKILKDKKLPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGL 144
Query: 58 KHDLIDPHGFLRSWNDSGVGACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHAL 117
ID SW + + + +++ + +S L
Sbjct: 145 FWGDIDFEEQEISWI------EQVDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPNL 195
Query: 118 RKLSLHDNLLAGPVPWSLG--FLPNLRGVYLF---NNRLSGSIPPSI------GNCPNLQ 166
+ L + L V + LPNL + L+ + PNL+
Sbjct: 196 KSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLK 255
Query: 167 TLDLSNNALIGAIPPSLANS---TRLYRLNLSYNSL----LGSIPLSLTRLPSLSVLALQ 219
L + + + S +L +++S L + + ++ L + ++
Sbjct: 256 WLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMK 315
Query: 220 HNNLS 224
+N LS
Sbjct: 316 YNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 55.0 bits (131), Expect = 4e-08
Identities = 30/183 (16%), Positives = 61/183 (33%), Gaps = 21/183 (11%)
Query: 254 GTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFP--VTFTNI 311
+ L + LL + + + L+ L++ + S + +++
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 312 TSLVSLNL---ENNRLGNKIPEGL------ERLQNLTVLNLKNNQFKGHIPETIGNISGI 362
+L L L + + +R NL L + + + + + E +
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 363 NQL---DLSENDFTGE----ISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVG 415
QL D+S T E + + + +L N+ YN LS + L K V
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338
Query: 416 NLQ 418
+ Q
Sbjct: 339 DSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 2e-07
Identities = 34/269 (12%), Positives = 85/269 (31%), Gaps = 40/269 (14%)
Query: 121 SLHDNLLAGPVPWSLGFLPNLRGVYLFNN--RLSGSIPPSIGNCPNLQTLDLSNNAL--- 175
+L D +L SL + Y + ++ I + + + L +
Sbjct: 95 NLMDKILKDKKLPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQ 154
Query: 176 ------IGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229
+ P L L L + + L + P+L L + L SV
Sbjct: 155 EISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS---IGKKPRPNLKSLEIISGGLPDSVVE 211
Query: 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSK 289
+ + G+ L+ L L + + L +
Sbjct: 212 D---ILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS---------------KDRFPN 253
Query: 290 LQKLDLSYNAIGGSFP---VTFTNITSLVSLNLENNRLGNK----IPEGLERLQNLTVLN 342
L+ L + + + L ++++ L ++ + + ++++++L +N
Sbjct: 254 LKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFIN 313
Query: 343 LKNNQFKGHIPETIGNISGINQLDLSEND 371
+K N + + + + +D+S++
Sbjct: 314 MKYNYLSDEMKKELQKSLPMK-IDVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 41.9 bits (97), Expect = 6e-04
Identities = 13/82 (15%), Positives = 27/82 (32%), Gaps = 7/82 (8%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLG---FLPNLRGVYLFNNRLSGS----IPPSIGNCPN 164
+ L+ L + D V LP L + + L+ + + +
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308
Query: 165 LQTLDLSNNALIGAIPPSLANS 186
L+ +++ N L + L S
Sbjct: 309 LKFINMKYNYLSDEMKKELQKS 330
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 7e-10
Identities = 33/109 (30%), Positives = 52/109 (47%), Gaps = 5/109 (4%)
Query: 243 QFLNLDHNLIAGTIPVSL-GKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIG 301
L L+ N + L G+L L ++ L N++ G P+ S +Q+L L N I
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 302 GSFPV-TFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQF 348
F + L +LNL +N++ + + G E L +LT LNL +N F
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-09
Identities = 26/90 (28%), Positives = 40/90 (44%), Gaps = 4/90 (4%)
Query: 267 QEISLSHNKIVGPIPDEL-GKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLG 325
E+ L+ N++ D L G+L L KL+L N + G P F + + L L N++
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 326 NKIPEGL-ERLQNLTVLNLKNNQFKGHIPE 354
I + L L LNL +NQ +
Sbjct: 92 E-ISNKMFLGLHQLKTLNLYDNQISC-VMP 119
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 31/110 (28%), Positives = 40/110 (36%), Gaps = 12/110 (10%)
Query: 145 YLFNNRLSGSIPPS--IGNCPNLQTLDLSNNALIGAIPPSLANS-TRLYRLNLSYNSLLG 201
L +N L I G P+L L+L N L I P+ + + L L N +
Sbjct: 35 LLNDNELG-RISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKI-K 91
Query: 202 SIPLSL-TRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN 250
I + L L L L N +S V G S L LNL N
Sbjct: 92 EISNKMFLGLHQLKTLNLYDNQIS-CVMP--GSFEHLNS--LTSLNLASN 136
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 47/225 (20%), Positives = 87/225 (38%), Gaps = 23/225 (10%)
Query: 87 KCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSL-HDNLLAGPVPWSLGFLPNLRGVY 145
+ + VIA + P + ++E S ++ + L + + + L L+ +
Sbjct: 66 RLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124
Query: 146 LFNNRLSGSIPPSIGNCPNLQTLDLSN-----NALIGAIPPSLANSTRLYRLNLSYNSLL 200
L RLS I ++ NL L+LS + + L++ +RL LNLS+
Sbjct: 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL---LSSCSRLDELNLSWCFDF 181
Query: 201 GSIPLSL---TRLPSLSVLALQHNNLSGSVPN--NWGVLA-GNKSYQLQFLNLDH-NLIA 253
+ + +++ L NLSG N + + L L+L ++
Sbjct: 182 TEKHVQVAVAHVSETITQL-----NLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLK 236
Query: 254 GTIPVSLGKLGLLQEISLSHNKIVGPI-PDELGKLSKLQKLDLSY 297
+L LQ +SLS + P ELG++ L+ L +
Sbjct: 237 NDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 42/207 (20%), Positives = 75/207 (36%), Gaps = 44/207 (21%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+++G G + + A+K L + K ++E E A P+++ +
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREVELHWRASQ---CPHIVRIVDV 79
Query: 600 Y---LGPKGEKLLVFDFMPKGSLASFLHARGP----ETIVNWATRMSIAIGIARGLNYLH 652
Y + L+V + + G L S + RG E + + I + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS-----IGEAIQYLH 134
Query: 653 VEENMIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELS 709
N+ H ++ N+L ++ DFG A E +
Sbjct: 135 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------------AKETT 171
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSP 736
+ + D++SLGVI+ LL G P
Sbjct: 172 G-EKYDKSCDMWSLGVIMYILLCGYPP 197
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 43/287 (14%), Positives = 86/287 (29%), Gaps = 62/287 (21%)
Query: 164 NLQTLDLSNNAL--IGAIPPSLA-----NSTRLYRLNLSYNSL--LGSIPLSLTRLPSLS 214
+L+ L+L+ + + +A L +NL+ L G L L
Sbjct: 73 SLRQLNLAGVRMTPVKCT--VVAAVLGSGRHALDEVNLASCQLDPAGLRTL-LPVFLRAR 129
Query: 215 VLALQHNNLSGSVPNNWGV------LAGNKSYQLQFLNLDHNLI----AGTIPVSLGKLG 264
L LQ N+L L ++ Q+ L L +N + + L
Sbjct: 130 KLGLQLNSLGPE-----ACKDLRDLLLHDQC-QITTLRLSNNPLTAAGVAVLMEGLAGNT 183
Query: 265 LLQEISLSHNKI----VGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNI----TSLVS 316
+ +SL H + + + +L + +LQ+L+++YN G + + SL
Sbjct: 184 SVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLEL 243
Query: 317 LNLENNRLGN-------KIPEGLERLQNLTVLNLKNNQF---------------KGHIPE 354
L+L N L + + E + V +
Sbjct: 244 LHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRA 303
Query: 355 TIGNISGINQLDLSENDFTGE----ISPSLASLANLTSFNVSYNNLS 397
+ + DL ++ + L + + +
Sbjct: 304 RVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 47/272 (17%), Positives = 86/272 (31%), Gaps = 52/272 (19%)
Query: 148 NNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSL-LGSIPLS 206
N + + I N L+ L L S L + + + S
Sbjct: 11 NRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELL---DHLFFHYEFQNQRFS 67
Query: 207 LTRLPSLSVLALQHNNLSGSVPNNWGVLA---GNKSYQLQFLNLDHNLIAGTIPVSLGKL 263
L SL L L ++ P V+A G+ + L +NL L
Sbjct: 68 AEVLSSLRQLNLAGVRMT---PVKCTVVAAVLGSGRHALDEVNLASC--------QLDPA 116
Query: 264 GLLQEISLSHNKIVGPIPDELGK-LSKLQKLDLSYNAIGGS-----FPVTFTNITSLVSL 317
GL L + +KL L N++G + + + +L
Sbjct: 117 GLRT----------------LLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTL 160
Query: 318 NLENNRLGNK----IPEGLERLQNLTVLNLKNNQFK----GHIPETIGNISGINQLDLSE 369
L NN L + EGL ++T L+L + + + + +L+++
Sbjct: 161 RLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAY 220
Query: 370 NDFTGE----ISPSLASLANLTSFNVSYNNLS 397
N ++ + +L ++ +N LS
Sbjct: 221 NGAGDTAALALARAAREHPSLELLHLYFNELS 252
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 47/258 (18%), Positives = 86/258 (33%), Gaps = 33/258 (12%)
Query: 115 HALRKLSLHDNLLAGPVPWS--LGFLPNLRGVYLFNNRLSGSIPPSIG-----NCPNLQT 167
HAL +++L L P L R + L N L + + + T
Sbjct: 101 HALDEVNLASCQL-DPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITT 159
Query: 168 LDLSNNAL----IGAIPPSLANSTRLYRLNLSYNSL----LGSIPLSLTRLPSLSVLALQ 219
L LSNN L + + LA +T + L+L + L L + L R L L +
Sbjct: 160 LRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVA 219
Query: 220 HNNLSGS-VPNNWGVLAGNKSYQLQFLNLDHNLI----AGTIPVSLGKLGLLQEISLSHN 274
+N + + S L+ L+L N + + G + +S
Sbjct: 220 YNGAGDTAALALARAAREHPS--LELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLT 277
Query: 275 KIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGN----KIPE 330
+ LS++Q+ S++ + L+ +LE++R + +
Sbjct: 278 EGTAVSEYWSVILSEVQRNLNSWDRARVQRHLE------LLLRDLEDSRGATLNPWRKAQ 331
Query: 331 GLERLQNLTVLNLKNNQF 348
L + L +
Sbjct: 332 LLRVEGEVRALLEQLGSS 349
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 8e-06
Identities = 41/263 (15%), Positives = 80/263 (30%), Gaps = 46/263 (17%)
Query: 111 ISQLHALRKLSLHDNLLAGPVPWSLGFL-----PNLRGVYLFNNRLSGS----IPPSIGN 161
+ RKL L N L L L + + L NN L+ + + +
Sbjct: 122 LPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG 181
Query: 162 CPNLQTLDLSNNAL----IGAIPPSLANSTRLYRLNLSYNSL--LGSIPLS--LTRLPSL 213
++ L L + L + + L + +L LN++YN ++ L+ PSL
Sbjct: 182 NTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSL 241
Query: 214 SVLALQHNNLSGSVPNNWGV------LAGNKSY-QLQFLNLDHNLIAGTIPVSLGKLGLL 266
+L L N LS + G + ++ + + S +L
Sbjct: 242 ELLHLYFNELS-----SEGRQVLRDLGGAAEGGARVVVSLTEGTAV------SEYWSVIL 290
Query: 267 QEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNI----TSLVSLNLENN 322
E+ + + + +L DL + P + + +L +
Sbjct: 291 SEV-QRNLNSWDR--ARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLG 347
Query: 323 RLGNK----IPEGLERLQNLTVL 341
G+ E+
Sbjct: 348 SSGSPSGSWSHPQFEKGAGHHHH 370
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 35/149 (23%), Positives = 58/149 (38%), Gaps = 15/149 (10%)
Query: 206 SLTRLPS-----LSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSL 260
+P+ +L L N ++ P + L+ L L N + +PV +
Sbjct: 30 RHASVPAGIPTNAQILYLHDNQITKLEPG-----VFDSLINLKELYLGSNQLG-ALPVGV 83
Query: 261 -GKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNL 319
L L + L N++ +L L++L + N + P +T L L L
Sbjct: 84 FDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142
Query: 320 ENNRLGNKIPEG-LERLQNLTVLNLKNNQ 347
+ N+L IP G +RL +LT L N
Sbjct: 143 DQNQL-KSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 36/114 (31%), Positives = 56/114 (49%), Gaps = 6/114 (5%)
Query: 118 RKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNALI 176
+ L LHDN + P L NL+ +YL +N+L ++P + + L LDL N L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL- 100
Query: 177 GAIPPSLANS-TRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229
+P ++ + L L + N L +P + RL L+ LAL N L S+P+
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNK-LTELPRGIERLTHLTHLALDQNQLK-SIPH 152
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 34/113 (30%), Positives = 54/113 (47%), Gaps = 6/113 (5%)
Query: 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGL-ERLQNLTVLNLKNNQFK 349
Q L L N I P F ++ +L L L +N+L +P G+ + L LTVL+L NQ
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 350 GHIPETI-GNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVP 401
+P + + + +L + N T E+ + L +LT + N L S+P
Sbjct: 102 V-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIP 151
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 44/171 (25%), Positives = 68/171 (39%), Gaps = 36/171 (21%)
Query: 154 SIPPSIGNCP-NLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSL-TRLP 211
S+P I P N Q L L +N + P + L L L N LG++P+ + L
Sbjct: 33 SVPAGI---PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ-LGALPVGVFDSLT 88
Query: 212 SLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISL 271
L+VL L N L+ +P+ V F D +L L+E+ +
Sbjct: 89 QLTVLDLGTNQLT-VLPS--AV----------F---D-------------RLVHLKELFM 119
Query: 272 SHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENN 322
NK+ +P + +L+ L L L N + F ++SL L N
Sbjct: 120 CCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 47/261 (18%), Positives = 86/261 (32%), Gaps = 68/261 (26%)
Query: 543 MGKSTYGTAYKA-TLEDGSEVAVK---RLREKTTKGQKEFEA-EAAAIGKIHHPNLLALR 597
+G + T + + ++ VA+K T E ++ + PN +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 598 A-----YYLGPKGEKL-LVFDFMPKG-SLASFLHARGPETIVNWATRMSIAIGIARGLNY 650
G G + +VF+ + G L ++ + + + I + +GL+Y
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVK-KIIQQVLQGLDY 161
Query: 651 LHVEENMIHGNLTSSNVLL----------------------------------------- 669
LH + +IH ++ N+LL
Sbjct: 162 LHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221
Query: 670 --------DEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVY 721
EK +IAD G + + ++ T YR+ E+ NT D++
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNACWVHKHFTEDI----QTRQYRSLEVLIGSGYNTPADIW 277
Query: 722 SLGVIILELLTGKSPGEPMNG 742
S + EL TG EP +G
Sbjct: 278 STACMAFELATGDYLFEPHSG 298
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 34/219 (15%), Positives = 73/219 (33%), Gaps = 14/219 (6%)
Query: 138 LPNLRGVYLFNNRLSGSIPPSIG-NCPNLQTLDLSNNALIG--AIPPSLANSTRLYRLNL 194
L + L ++ I + N + L LS+ + A L L+L
Sbjct: 104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDL 163
Query: 195 SYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN--NWGVLA-GNKSYQLQFLNLDHNL 251
+ + L+ P +L N+S + + L+ L L+ +
Sbjct: 164 RESDVDDVSGHWLSHFPDTY-TSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAV 222
Query: 252 IAGTIPVSLGKLGLLQEISLS------HNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFP 305
+ L + L+E+ + + L +L+ L ++A+ P
Sbjct: 223 PLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLP 282
Query: 306 VTFTNITSLVSLNLENNRLGNK-IPEGLERLQNLTVLNL 343
++ + L +LNL + + + + L + L L +
Sbjct: 283 AVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWV 321
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 44/286 (15%), Positives = 89/286 (31%), Gaps = 52/286 (18%)
Query: 111 ISQLHALRKLSLH------DNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPN 164
+ + L +L + + +L LR + F + + +P C
Sbjct: 231 LQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSR 290
Query: 165 LQTLDLSNNALIG-AIPPSLANSTRLYRLNLSYN---SLLGSIPLSLTRLPSLSVLALQH 220
L TL+LS + + L +L RL + + L + + L L V +
Sbjct: 291 LTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEP 350
Query: 221 NNLSGSVP-NNWGVLA-GNKSYQLQFLNLDHNLI--AGTIPVSLGKLGLLQEISLSHNKI 276
+ +V G+++ +L+ + + A I ++ + L +
Sbjct: 351 FVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARN-RPNMTRFRLCIIEP 409
Query: 277 VGP------IPDE-----LGKLSKLQKLDLSY-------NAIGGSFP------VTFTNIT 312
P D + L++L LS IG V F +
Sbjct: 410 KAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDS 469
Query: 313 ------------SLVSLNLENNRLGNK-IPEGLERLQNLTVLNLKN 345
SL L + + G+K + +L+ + L + +
Sbjct: 470 DLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSS 515
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 36/255 (14%), Positives = 80/255 (31%), Gaps = 41/255 (16%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFL----PNLRGVYLFNNRLS---GSIPPSIGNCPN 164
+ L++L L ++ + L +L + + ++ + CPN
Sbjct: 153 ATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPN 212
Query: 165 LQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLS 224
L++L L+ + + L + +L L + + R S L++ +
Sbjct: 213 LKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYT-------AEVRPDVYSGLSVALSGCK 265
Query: 225 GSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGP-IPDE 283
+L+ L+ + + +P L ++LS+ + +
Sbjct: 266 ----------------ELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKL 309
Query: 284 LGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIP------EGLERL-- 335
L + KLQ+L + V + L L + + P +GL +
Sbjct: 310 LCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSM 369
Query: 336 --QNLTVLNLKNNQF 348
L + Q
Sbjct: 370 GCPKLESVLYFCRQM 384
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 51/317 (16%), Positives = 100/317 (31%), Gaps = 48/317 (15%)
Query: 112 SQLHALRKLSLHDNLL--AGPVPWSLGFLPNLRGVYLFN-NRLSGSIPPSIG-NCPNLQT 167
+ L L+ + ++ + +L + L + + SI +C ++T
Sbjct: 109 NNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKT 168
Query: 168 LDLSNNALIGAIPPSLA----NSTRLYRLNLSYNSLLGSIPLSLTRL----PSLSVLALQ 219
L + ++ L ++T L LN P L + SL + +
Sbjct: 169 LLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVG 228
Query: 220 HNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGP 279
+ G L+ +P L +++ +GP
Sbjct: 229 DFEIL----ELVGFFKAAA--NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP 282
Query: 280 --IPDELGKLSKLQKLDLSY-NAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERL- 335
+P ++++KLDL Y +L L N +G+ GLE L
Sbjct: 283 NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNV-IGD---RGLEVLA 338
Query: 336 ---QNLTVLNLKNNQFKGHIPETIGNIS------------GINQLDLSENDFTGEISPSL 380
+ L L ++ + + + G +S + + + +D T E SL
Sbjct: 339 QYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNE---SL 395
Query: 381 ASLA----NLTSFNVSY 393
S+ NL F +
Sbjct: 396 ESIGTYLKNLCDFRLVL 412
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 46/269 (17%), Positives = 85/269 (31%), Gaps = 31/269 (11%)
Query: 107 ISEKISQLHALRKLSLHDNLLAGP--VPWSLGFLPNLRGVYL-FNNRLSGSIPPSIGNCP 163
+ EK L RKL GP +P F +R + L + + I CP
Sbjct: 259 MPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCP 318
Query: 164 NLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLA------ 217
NL+ L+ N + +L RL + + + + ++A
Sbjct: 319 NLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQ 378
Query: 218 -LQHNNLSGSVPNNWGVLA-GNKSYQLQFLNL----------DHNLIAGTIPVSLGKLGL 265
L++ + S N + + G L L D L G + L
Sbjct: 379 ELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNG-VRSLLIGCKK 437
Query: 266 LQEISLSHNKIVGPIPDE----LGKLSK-LQKLDLSYNAIG-GSFPVTFTNITSLVSLNL 319
L+ + G + D +G+ S ++ + L Y +L L +
Sbjct: 438 LRRFAFYLR--QGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEM 495
Query: 320 ENNRLGNK-IPEGLERLQNLTVLNLKNNQ 347
+ I + +L +L L ++ +
Sbjct: 496 RGCCFSERAIAAAVTKLPSLRYLWVQGYR 524
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 36/234 (15%), Positives = 78/234 (33%), Gaps = 22/234 (9%)
Query: 182 SLANSTRLY-RLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLA----- 235
+ + TR + + L Y + + L SL + + +P NWG
Sbjct: 46 KIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVT 105
Query: 236 --GNKSYQLQFLNLDHNLI--AGTIPVSLGKLGLLQEISLSHNKIVGP--IPDELGKLSK 289
N QL+ ++ ++ ++ + L+ + L + + K
Sbjct: 106 EISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRK 165
Query: 290 LQKLDLSYNAI---GGSFPVTF-TNITSLVSLNLENNRLGNKIPEGLERL----QNLTVL 341
++ L + ++ G + + TSL LN P+ LE + ++L +
Sbjct: 166 IKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSV 225
Query: 342 NLKNNQFKGH--IPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSY 393
+ + + + N+ L+E+ E +L L +SY
Sbjct: 226 KVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSY 279
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 51/349 (14%), Positives = 109/349 (31%), Gaps = 38/349 (10%)
Query: 147 FNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLS 206
+ + PNL++L L R NL + G +
Sbjct: 57 MALCYTATPDRLSRRFPNLRSLKLK-------------GKPRAAMFNLIPENWGGYVTPW 103
Query: 207 LTRLPSLSVLALQHNNLSGSVPNNWGV--LAGNKSYQLQFLNLDH--NLIAGTIPVSLGK 262
+T + S ++ L+ + + ++ + LA ++ L+ L LD + +
Sbjct: 104 VTEI-SNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTH 162
Query: 263 LGLLQEISLSHNKIVGPIPDELGKLSK----LQKLDLSYNAIGG----SFPVTFTNITSL 314
++ + + + L +L++ L+ L+ N SL
Sbjct: 163 CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSL 222
Query: 315 VSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQL-DLSENDFT 373
VS+ + + + + + NL + +PE N+ +L L +
Sbjct: 223 VSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG 281
Query: 374 GEISPSLASLA-NLTSFNVSYNNLSG-SVPPLLSK-----KFNSSSFVGNLQLCGYSPST 426
P L A + ++ Y L L+ K + + +G+ L +
Sbjct: 282 PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQY- 340
Query: 427 ACPSLAPLSLPPPPVEAPKHHHHRKLSTKDIILIGVGA-LLAVLLILCC 474
C L L + E +S + +I + G L + +
Sbjct: 341 -CKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVS 388
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.7 bits (128), Expect = 9e-08
Identities = 29/187 (15%), Positives = 52/187 (27%), Gaps = 43/187 (22%)
Query: 543 MGKSTYGTAYKATLEDGSEVAVKRLR--------EKTTKGQKEFEAEAA---------AI 585
+G+ +G ++ D + VA+K + K +E E
Sbjct: 28 IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 586 GKIHHPNLLALRAYYL--GPKGEKLL-VFDFMP--KGSLASFLHARGPETI--------- 631
+ L + + G LL +D KGS + +
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 632 -----------VNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADF 680
+ AT SI + L H +L NVLL + + ++
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYT 206
Query: 681 GLSRLMT 687
+ T
Sbjct: 207 LNGKSST 213
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 5e-07
Identities = 35/118 (29%), Positives = 52/118 (44%), Gaps = 15/118 (12%)
Query: 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGL-ERLQNLTVLNLKNNQFK 349
LDL N++ F +TSL L L N+L +P G+ +L +LT LNL NQ +
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 350 GHIPETI-GNISGINQLDLSENDFTGEISPSL-----ASLANLTSFNVSYNNLSGSVP 401
+P + ++ + +L L+ N SL L L + N L SVP
Sbjct: 90 S-LPNGVFDKLTQLKELALNTNQLQ-----SLPDGVFDKLTQLKDLRLYQNQLK-SVP 140
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 29/96 (30%), Positives = 41/96 (42%), Gaps = 10/96 (10%)
Query: 256 IPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPV-TFTNITSL 314
IP L L N + +L+ L +L L N + S P F +TSL
Sbjct: 26 IPAQTTYL------DLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSL 78
Query: 315 VSLNLENNRLGNKIPEGL-ERLQNLTVLNLKNNQFK 349
LNL N+L +P G+ ++L L L L NQ +
Sbjct: 79 TYLNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQ 113
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 46/197 (23%), Positives = 69/197 (35%), Gaps = 59/197 (29%)
Query: 154 SIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSL 213
S+P I LDL N+L T L +L L N L LP+
Sbjct: 21 SVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGN--------KLQSLPN- 69
Query: 214 SVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSH 273
GV KL L ++LS
Sbjct: 70 ------------------GVFN--------------------------KLTSLTYLNLST 85
Query: 274 NKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPV-TFTNITSLVSLNLENNRLGNKIPEG- 331
N++ KL++L++L L+ N + S P F +T L L L N+L +P+G
Sbjct: 86 NQLQSLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQL-KSVPDGV 143
Query: 332 LERLQNLTVLNLKNNQF 348
+RL +L + L +N +
Sbjct: 144 FDRLTSLQYIWLHDNPW 160
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 34/107 (31%), Positives = 49/107 (45%), Gaps = 4/107 (3%)
Query: 243 QFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGG 302
L L+ N + KL L ++SLS N+I KL+KL L L N +
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKL-Q 89
Query: 303 SFPV-TFTNITSLVSLNLENNRLGNKIPEG-LERLQNLTVLNLKNNQ 347
S P F +T L L L+ N+L +P+G +RL +L + L N
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 4/82 (4%)
Query: 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGL-ERLQNLTVLNLKNNQFK 349
+L+L N + F +T L L+L N++ +P+G+ ++L LT+L L N+ +
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKLQ 89
Query: 350 GHIPETI-GNISGINQLDLSEN 370
+P + ++ + +L L N
Sbjct: 90 S-LPNGVFDKLTQLKELALDTN 110
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 57/237 (24%), Positives = 89/237 (37%), Gaps = 41/237 (17%)
Query: 525 DGPFLFTADDLLCATAEI---MGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFE 579
G ++ D + E+ +GK ++G KA + VA+K +R EK Q E
Sbjct: 84 QGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE 143
Query: 580 AEAAAIGKIHHPNLLALRAYYLGPKGEKLLV-----FDF---------MPKGSLASFLHA 625
L LR ++ F F + +L +
Sbjct: 144 IRI----------LEHLRKQ--DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKK 191
Query: 626 RGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNP--RIADFGLS 683
+ R A I + L+ LH + +IH +L N+LL ++ ++ DFG S
Sbjct: 192 NKFQGFSLPLVR-KFAHSILQCLDALH-KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
Query: 684 RLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKS--PGE 738
+ V + YRAPE+ D++SLG I+ ELLTG PGE
Sbjct: 250 CY----EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 21/142 (14%), Positives = 46/142 (32%), Gaps = 21/142 (14%)
Query: 266 LQEISLSHNKIVGP-----IPDELGKLSKLQKLDLSYNAIGGSFPVTF-----TNITSLV 315
L+E++L++ + + L + ++K + N +L
Sbjct: 38 LEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVN-NTLK 96
Query: 316 SLNLENNRLGNK----IPEGLERLQNLTVLNLKNNQFK------GHIPETIGNISGINQL 365
SLN+E+N + + E L+ +L L + N I + + + +
Sbjct: 97 SLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKF 156
Query: 366 DLSENDFTGEISPSLASLANLT 387
+ S A + N
Sbjct: 157 GYHFTQQGPRLRASNAMMNNND 178
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 4e-06
Identities = 27/71 (38%), Positives = 38/71 (53%), Gaps = 3/71 (4%)
Query: 285 GKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGL-ERLQNLTVLNL 343
G + Q L L N I P F +T L L+L+NN+L +P G+ ++L LT L+L
Sbjct: 27 GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQL-TVLPAGVFDKLTQLTQLSL 85
Query: 344 KNNQFKGHIPE 354
+NQ K IP
Sbjct: 86 NDNQLKS-IPR 95
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 8e-06
Identities = 23/65 (35%), Positives = 35/65 (53%), Gaps = 3/65 (4%)
Query: 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGL-ERLQNLTVLNLKNNQFK 349
Q+L L+ N I P F ++ +L L +N+L IP G+ ++L LT L+L +N K
Sbjct: 36 QRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKL-TAIPTGVFDKLTQLTQLDLNDNHLK 94
Query: 350 GHIPE 354
IP
Sbjct: 95 S-IPR 98
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 27/100 (27%), Positives = 49/100 (49%), Gaps = 9/100 (9%)
Query: 639 SIAIGIARGLNYLHVEE-NMIHGNLTSSNVLL--DEKTNPRIADFGLSRLMTAAANTNVI 695
A + L +L E ++IH +L N+LL +++ +I DFG ++ I
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-----SSCQLGQRI 215
Query: 696 AT-AGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGK 734
+ YR+PE+ + D++SLG I++E+ TG+
Sbjct: 216 YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1qzv_F Plant photosystem I: subunit PSAF; photosynthesis,plant photosynthetic reaction center, peripheral antenna; HET: CL1 PQN; 4.44A {Pisum sativum} SCOP: i.5.1.1 Length = 154 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 1e-04
Identities = 10/27 (37%), Positives = 15/27 (55%), Gaps = 8/27 (29%)
Query: 406 KKFNSSSFVGNLQLCGYSPSTACPSLA 432
KK +S L+L Y+ +A P+LA
Sbjct: 23 KKLQAS-----LKL--YADDSA-PALA 41
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 35/154 (22%), Positives = 67/154 (43%), Gaps = 26/154 (16%)
Query: 544 GKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEA--AAIGKIHHPNLLALRAYY 600
G+ ++G ++ T L + +VA+K ++ Q E G PN+ YY
Sbjct: 19 GEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV-----YY 73
Query: 601 LGPKGE-KLLVFDFMPKGSLASFLHARG----PETIVNWATRMSIAIGIARGLNYLHVEE 655
G +G +LV D + SL L G +T+ A +M +AR + +H E+
Sbjct: 74 FGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQM-----LAR-VQSIH-EK 125
Query: 656 NMIHGNLTSSNVLLDEKTNPR-----IADFGLSR 684
++++ ++ N L+ + + DFG+ +
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 | Back alignment and structure |
|---|
Score = 40.2 bits (94), Expect = 8e-04
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 13/95 (13%)
Query: 266 LQEISLSHNKIVGP-----IPDELGKLSKLQKLDLSYNAIGGSFPVTFTNI----TSLVS 316
L+E+++++ K V + + ++K L+ AI S + SL
Sbjct: 43 LKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRV 102
Query: 317 LNLENNRLGNK----IPEGLERLQNLTVLNLKNNQ 347
LN+E+N L + + Q++ N +
Sbjct: 103 LNVESNFLTPELLARLLRSTLVTQSIVEFKADNQR 137
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 9e-04
Identities = 23/107 (21%), Positives = 43/107 (40%), Gaps = 10/107 (9%)
Query: 245 LNLDHNLIAGTIPVSLGKLGLLQEISLSHNKI--VGPIPDELGKLSKLQKLDLSYNAIGG 302
LN + A T+ + + L ++LS+N++ + + + K L+ L+LS N +
Sbjct: 152 LNRRSCMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS 210
Query: 303 SFPVTFTNITSLVSLNLENNRLGNKIPEG-------LERLQNLTVLN 342
+ L L L+ N L + + ER L L+
Sbjct: 211 ERELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 773 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.98 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.98 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.98 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.98 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.98 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.98 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.98 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.98 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.98 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.98 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.98 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.98 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.98 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.98 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.98 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.97 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.84 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.82 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.81 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.68 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.62 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.6 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.6 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.58 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.49 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.39 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.38 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.36 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.32 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.25 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.17 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.15 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.14 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.08 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.05 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.79 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.76 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.75 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.6 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.58 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.56 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.53 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.43 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.15 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.1 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.06 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.01 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.98 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.77 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.77 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.63 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.6 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.58 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.53 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.33 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.95 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.86 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.68 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.67 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.62 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.6 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.57 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.4 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.31 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.08 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.23 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.14 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.42 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 90.04 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 84.83 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 82.34 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 80.37 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-47 Score=449.80 Aligned_cols=344 Identities=30% Similarity=0.444 Sum_probs=214.2
Q ss_pred cCHHHHHHHHHHHHhCCCCCCCcCCCCCCCCCCCCCCCcceEeeCCCEEEEEcCCCCcccc---cCcc------------
Q 041878 46 VTQADYQSLRAIKHDLIDPHGFLRSWNDSGVGACSGGWAGIKCVKGQVIAIQLPWRRLGGR---ISEK------------ 110 (773)
Q Consensus 46 ~~~~~~~~L~~~k~~~~~~~~~l~sW~~~~~~~c~~~w~gv~c~~~~v~~l~l~~~~l~~~---i~~~------------ 110 (773)
+.++|++||++||+++.||. .+++|+. +.+||. |.||+|+.++|+.|+|++++++|. +++.
T Consensus 9 ~~~~~~~all~~k~~~~~~~-~l~~W~~-~~~~C~--w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~ 84 (768)
T 3rgz_A 9 SLYREIHQLISFKDVLPDKN-LLPDWSS-NKNPCT--FDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFL 84 (768)
T ss_dssp CHHHHHHHHHHHHTTCSCTT-SSTTCCT-TSCGGG--STTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEEC
T ss_pred CCHHHHHHHHHHHhhCCCcc-cccCCCC-CCCCcC--CcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccccCC
Confidence 46889999999999999998 8999964 566665 999999999999999999999987 6654
Q ss_pred -----------ccCCCCCcEEEccCCcccccCCC--CCCCCCCCceEEcccCccCCCCCCCC-CCCCCCCEEEccCCCCC
Q 041878 111 -----------ISQLHALRKLSLHDNLLAGPVPW--SLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNALI 176 (773)
Q Consensus 111 -----------l~~l~~L~~L~L~~n~l~~~~~~--~l~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~Ls~N~l~ 176 (773)
++++++|++|+|++|.++|.+|. .++.+++|++|+|++|.+++.+|..+ .++++|++|+|++|.++
T Consensus 85 ~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~ 164 (768)
T 3rgz_A 85 SNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS 164 (768)
T ss_dssp TTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCE
T ss_pred cCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccC
Confidence 45555666666666666655555 55666666666666666655555544 55566666666666665
Q ss_pred CCCccc---cccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccc
Q 041878 177 GAIPPS---LANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIA 253 (773)
Q Consensus 177 ~~~~~~---l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~ 253 (773)
+..|.. +.++++|++|+|++|.+++..+. ..+++|++|+|++|++++.+|. ++.+. +|++|+|++|.++
T Consensus 165 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~l~-----~L~~L~Ls~n~l~ 236 (768)
T 3rgz_A 165 GANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGDCS-----ALQHLDISGNKLS 236 (768)
T ss_dssp EETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTTCC-----SCCEEECCSSCCC
T ss_pred CcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-cccCC-----CCCEEECcCCcCC
Confidence 555444 44555555555555555544332 4555555556666655554443 33332 5666666666666
Q ss_pred cccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCccccccc-ccCceEEccCCCCCCCcchhh
Q 041878 254 GTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNI-TSLVSLNLENNRLGNKIPEGL 332 (773)
Q Consensus 254 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~l 332 (773)
+.+|..++.+++|++|+|++|++++.+|.. .+++|++|++++|++++.+|..+... ++|++|+|++|++++.+|..+
T Consensus 237 ~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~ 314 (768)
T 3rgz_A 237 GDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314 (768)
T ss_dssp SCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGG
T ss_pred CcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHH
Confidence 656666666666666666666665554443 45555555555555555555555443 556666666666655555556
Q ss_pred ccccccccccccCcccccccccc-cCCCCcCceeecCCccCccCCCchhhccC-ccCEEEeecccCCCCCchh
Q 041878 333 ERLQNLTVLNLKNNQFKGHIPET-IGNISGINQLDLSENDFTGEISPSLASLA-NLTSFNVSYNNLSGSVPPL 403 (773)
Q Consensus 333 ~~l~~L~~L~ls~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~ls~N~l~g~~p~~ 403 (773)
+.+++|++|++++|+++|.+|.. ++++++|++|+|++|++++.+|..+..++ +|+.|++++|+++|.+|..
T Consensus 315 ~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~ 387 (768)
T 3rgz_A 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387 (768)
T ss_dssp GGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTT
T ss_pred hcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChh
Confidence 66666666666666665555544 55566666666666666555555555554 5555555555555544443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=392.72 Aligned_cols=203 Identities=29% Similarity=0.491 Sum_probs=175.8
Q ss_pred HhhcccccccceEEEEEEeC------CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+| ..++..++||
T Consensus 16 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-~~~~~~~lV~ 94 (299)
T 4asz_A 16 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVC-VEGDPLIMVF 94 (299)
T ss_dssp EEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSSEEEEE
T ss_pred EEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEE-eeCCEEEEEE
Confidence 45688999999999999863 4678999999877666778899999999999999999999999 4556899999
Q ss_pred eecCCCCHHHHHhhcC----------CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecC
Q 041878 612 DFMPKGSLASFLHARG----------PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFG 681 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG 681 (773)
|||++|+|.++++..+ ....++|.+++.++.||++||+||| +++||||||||+|||+++++.+||+|||
T Consensus 95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH-~~~iiHRDlKp~NILl~~~~~~Ki~DFG 173 (299)
T 4asz_A 95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA-SQHFVHRDLATRNCLVGENLLVKIGDFG 173 (299)
T ss_dssp ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGGCEEECCCS
T ss_pred EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCccCHhhEEECCCCcEEECCcc
Confidence 9999999999998643 2346899999999999999999999 8999999999999999999999999999
Q ss_pred Cccccccccccce-eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 682 LSRLMTAAANTNV-IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 682 ~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
+|+.......... ....||++|||||++.+..|+.++|||||||++|||+| |+.||...+.
T Consensus 174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~ 236 (299)
T 4asz_A 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 236 (299)
T ss_dssp CHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9987654433222 22458999999999999999999999999999999999 8999987543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=395.62 Aligned_cols=203 Identities=26% Similarity=0.446 Sum_probs=170.3
Q ss_pred HhhcccccccceEEEEEEeC------CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+| ...+..++||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-~~~~~~~lV~ 122 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVC-TEGRPLLMVF 122 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSSEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-EECCEEEEEE
Confidence 45688999999999999864 4778999999877666678899999999999999999999999 4556899999
Q ss_pred eecCCCCHHHHHhhcCC------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEee
Q 041878 612 DFMPKGSLASFLHARGP------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIAD 679 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~D 679 (773)
|||++|+|.++++.... ...++|.+++.++.|||+||+||| +++||||||||+|||+++++.+||+|
T Consensus 123 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH-~~~iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp ECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEETTTEEEECC
T ss_pred EcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh-cCCeecccccHhhEEECCCCcEEEcc
Confidence 99999999999987532 235899999999999999999999 89999999999999999999999999
Q ss_pred cCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 680 FGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 680 fG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||...+.
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~ 266 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence 9999876544322 2234579999999999999999999999999999999999 8999987543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=439.44 Aligned_cols=334 Identities=35% Similarity=0.615 Sum_probs=271.4
Q ss_pred EEEEEcCCCCcccccCccccCCC-CCcEEEccCCcccccCCCCCCC--CCCCceEEcccCccCCCCCCCCCCCCCCCEEE
Q 041878 93 VIAIQLPWRRLGGRISEKISQLH-ALRKLSLHDNLLAGPVPWSLGF--LPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLD 169 (773)
Q Consensus 93 v~~l~l~~~~l~~~i~~~l~~l~-~L~~L~L~~n~l~~~~~~~l~~--l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 169 (773)
++.|+|++|.++|.+|..+.+++ +|++|+|++|.+++.+|..+.. +++|++|+|++|++++.+|..++++++|++|+
T Consensus 345 L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 424 (768)
T 3rgz_A 345 LKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH 424 (768)
T ss_dssp CCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEE
T ss_pred CCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEE
Confidence 33444444444444444444443 4444444444444444444444 56677777777777777777788888888888
Q ss_pred ccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccc
Q 041878 170 LSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDH 249 (773)
Q Consensus 170 Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~ 249 (773)
|++|.+++.+|..+..+++|++|+|++|++++.+|..+..+++|++|++++|++++.+|..+..+. +|++|+|++
T Consensus 425 Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-----~L~~L~L~~ 499 (768)
T 3rgz_A 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT-----NLNWISLSN 499 (768)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT-----TCCEEECCS
T ss_pred CcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCC-----CCCEEEccC
Confidence 888888888888888888888888888888888888888888888888888888888887776654 788999999
Q ss_pred cccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccc---------------------
Q 041878 250 NLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTF--------------------- 308 (773)
Q Consensus 250 n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~--------------------- 308 (773)
|.+++.+|..++.+++|+.|+|++|++++.+|..+..+++|++|++++|.++|.+|..+
T Consensus 500 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~ 579 (768)
T 3rgz_A 500 NRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIK 579 (768)
T ss_dssp SCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEE
T ss_pred CccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccc
Confidence 99988888888889999999999999988888889999999999999998887776543
Q ss_pred -------------------------------------------------cccccCceEEccCCCCCCCcchhhccccccc
Q 041878 309 -------------------------------------------------TNITSLVSLNLENNRLGNKIPEGLERLQNLT 339 (773)
Q Consensus 309 -------------------------------------------------~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 339 (773)
..+++|+.|+|++|++++.+|..++.+++|+
T Consensus 580 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~ 659 (768)
T 3rgz_A 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLF 659 (768)
T ss_dssp CCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCC
T ss_pred cccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCC
Confidence 3357899999999999999999999999999
Q ss_pred cccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCchh-hhccCCCCCCCCCCC
Q 041878 340 VLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPL-LSKKFNSSSFVGNLQ 418 (773)
Q Consensus 340 ~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~~~~~~~~~~n~~ 418 (773)
.|+|++|+++|.+|..++++++|+.|||++|+++|.+|..+..+++|+.|||++|+|+|.||.. ....+...+|.||+.
T Consensus 660 ~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~ 739 (768)
T 3rgz_A 660 ILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPG 739 (768)
T ss_dssp EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTE
T ss_pred EEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCch
Confidence 9999999999999999999999999999999999999999999999999999999999999975 336778888999999
Q ss_pred CCCCCCCCCCCCCC
Q 041878 419 LCGYSPSTACPSLA 432 (773)
Q Consensus 419 ~c~~~~~~~c~s~~ 432 (773)
+||.|++ .|....
T Consensus 740 Lcg~~l~-~C~~~~ 752 (768)
T 3rgz_A 740 LCGYPLP-RCDPSN 752 (768)
T ss_dssp EESTTSC-CCCSCC
T ss_pred hcCCCCc-CCCCCc
Confidence 9999877 786543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=388.86 Aligned_cols=202 Identities=27% Similarity=0.450 Sum_probs=173.8
Q ss_pred hhcccccccceEEEEEEeC------CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 539 TAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
+.+.||+|+||+||+|.+. +++.||||+++... ....++|.+|+.++++++|||||+++|+| ...+..++||
T Consensus 30 ~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~-~~~~~~~lV~ 108 (308)
T 4gt4_A 30 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV-TKDQPLSMIF 108 (308)
T ss_dssp EEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSCEEEE
T ss_pred EeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEE-EECCEEEEEE
Confidence 4678999999999999863 46789999997543 33467899999999999999999999999 4556899999
Q ss_pred eecCCCCHHHHHhhcCC-------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEe
Q 041878 612 DFMPKGSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIA 678 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~ 678 (773)
|||++|+|.++++...+ ...++|.++++++.|||+||+||| +++||||||||+|||+++++.+||+
T Consensus 109 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH-~~~iiHRDLK~~NILl~~~~~~Ki~ 187 (308)
T 4gt4_A 109 SYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS-SHHVVHKDLATRNVLVYDKLNVKIS 187 (308)
T ss_dssp ECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH-hCCCCCCCccccceEECCCCCEEEC
Confidence 99999999999976432 235899999999999999999999 9999999999999999999999999
Q ss_pred ecCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 679 DFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 679 DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
|||+|+........ ......||++|||||++.++.|+.++|||||||++|||+| |+.||.+.+.
T Consensus 188 DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~ 253 (308)
T 4gt4_A 188 DLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 253 (308)
T ss_dssp CSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred CcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence 99999876544322 2334579999999999999999999999999999999999 8999987543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=429.89 Aligned_cols=351 Identities=23% Similarity=0.349 Sum_probs=261.4
Q ss_pred cccCHHHHHHHHHHHHhCCCCCCCcCCCCCCC----CCCCCCCC------------cceEee-CCCEEEEEcCCCCcccc
Q 041878 44 VIVTQADYQSLRAIKHDLIDPHGFLRSWNDSG----VGACSGGW------------AGIKCV-KGQVIAIQLPWRRLGGR 106 (773)
Q Consensus 44 ~~~~~~~~~~L~~~k~~~~~~~~~l~sW~~~~----~~~c~~~w------------~gv~c~-~~~v~~l~l~~~~l~~~ 106 (773)
..+..+|++||++||+++.|| +|+..+ .+||+|.| .||+|+ .++|+.|+|++++++|.
T Consensus 264 ~~~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ 338 (876)
T 4ecn_A 264 TAEYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338 (876)
T ss_dssp CCHHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEE
T ss_pred cccchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCc
Confidence 345678999999999999887 786543 45644459 999997 58999999999999999
Q ss_pred cCccccCCCCCcEEEc-cCCccccc-------------------------------------------------------
Q 041878 107 ISEKISQLHALRKLSL-HDNLLAGP------------------------------------------------------- 130 (773)
Q Consensus 107 i~~~l~~l~~L~~L~L-~~n~l~~~------------------------------------------------------- 130 (773)
+|+.+++|++|++|+| ++|.++|.
T Consensus 339 ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~ 418 (876)
T 4ecn_A 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418 (876)
T ss_dssp ECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCC
T ss_pred CchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccc
Confidence 9999999999999999 77766554
Q ss_pred ---------------------CCCCCCCCCCCceEEcccCccCC-----------------CCCCCCC--CCCCCCEEEc
Q 041878 131 ---------------------VPWSLGFLPNLRGVYLFNNRLSG-----------------SIPPSIG--NCPNLQTLDL 170 (773)
Q Consensus 131 ---------------------~~~~l~~l~~L~~L~L~~n~l~~-----------------~~p~~l~--~l~~L~~L~L 170 (773)
+|..++++++|++|+|++|+|++ .+|..++ ++++|++|+|
T Consensus 419 ~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~L 498 (876)
T 4ecn_A 419 KDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498 (876)
T ss_dssp CCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred cccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEEC
Confidence 78889999999999999999998 3999988 9999999999
Q ss_pred cCCCCCCCCccccccccccceeeccccc-ccc-cCCccccCCC-------ccceeeccccccccccCC--cccccc----
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNS-LLG-SIPLSLTRLP-------SLSVLALQHNNLSGSVPN--NWGVLA---- 235 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~-l~~-~~~~~l~~l~-------~L~~L~L~~N~l~~~~p~--~~~~l~---- 235 (773)
++|.+.+.+|..++++++|++|+|++|+ +++ .+|..+.+++ +|++|+|++|+++ .+|. .++.+.
T Consensus 499 s~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~ 577 (876)
T 4ecn_A 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGL 577 (876)
T ss_dssp ESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCE
T ss_pred cCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCE
Confidence 9999999999999999999999999998 887 6666554443 7777777777777 6665 444433
Q ss_pred -------------cCcccccceeeccccccccccCccCCCCCC-ccEEECCCCcccCCCCCCcCcccc--cceecccccc
Q 041878 236 -------------GNKSYQLQFLNLDHNLIAGTIPVSLGKLGL-LQEISLSHNKIVGPIPDELGKLSK--LQKLDLSYNA 299 (773)
Q Consensus 236 -------------~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~Ls~N~ 299 (773)
...+++|+.|+|++|.++ .+|..+..+++ |+.|+|++|+++ .+|..+..++. |+.|+|++|+
T Consensus 578 L~Ls~N~l~~lp~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~ 655 (876)
T 4ecn_A 578 LDCVHNKVRHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNK 655 (876)
T ss_dssp EECTTSCCCBCCCCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSC
T ss_pred EECCCCCcccchhhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCc
Confidence 011224555555555555 44444555555 555555555555 34444433321 4444444444
Q ss_pred ccccCc----------------------------cc-ccccccCceEEccCCCCCCCcchhhcc--------cccccccc
Q 041878 300 IGGSFP----------------------------VT-FTNITSLVSLNLENNRLGNKIPEGLER--------LQNLTVLN 342 (773)
Q Consensus 300 l~~~~~----------------------------~~-~~~l~~L~~L~Ls~N~l~~~~~~~l~~--------l~~L~~L~ 342 (773)
+++.+| .. +..+++|+.|+|++|+++ .+|..+.. +++|+.|+
T Consensus 656 l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~ 734 (876)
T 4ecn_A 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTID 734 (876)
T ss_dssp TTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEE
T ss_pred CCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEE
Confidence 433222 11 224566777777777776 44443322 33899999
Q ss_pred ccCcccccccccccC--CCCcCceeecCCccCccCCCchhhccCccCEEEeec------ccCCCCCchhhh
Q 041878 343 LKNNQFKGHIPETIG--NISGINQLDLSENDFTGEISPSLASLANLTSFNVSY------NNLSGSVPPLLS 405 (773)
Q Consensus 343 ls~N~l~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~------N~l~g~~p~~~~ 405 (773)
|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++ |++.+.+|..+.
T Consensus 735 Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~ 803 (876)
T 4ecn_A 735 LRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGIT 803 (876)
T ss_dssp CCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGG
T ss_pred CCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHh
Confidence 9999999 7888887 99999999999999997 899999999999999976 888999998763
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=389.39 Aligned_cols=197 Identities=22% Similarity=0.394 Sum_probs=175.7
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
...+.||+|+||+||+|... +|+.||||++........+.+.+|+++|++++|||||++++++. .++..|+|||||++
T Consensus 77 ~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-~~~~~~ivmEy~~g 155 (346)
T 4fih_A 77 DNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-VGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEECCCTT
T ss_pred EEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEEEEEEeCCCC
Confidence 34578999999999999864 79999999997665556677899999999999999999999995 45589999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
|+|.+++.+. .+++.++..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+....... ....
T Consensus 156 g~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~ 229 (346)
T 4fih_A 156 GALTDIVTHT----RMNEEQIAAVCLAVLQALSVLH-AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 229 (346)
T ss_dssp EEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCC
T ss_pred CcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cccc
Confidence 9999999763 3899999999999999999999 99999999999999999999999999999987654332 2334
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 579999999999999999999999999999999999999997654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=383.39 Aligned_cols=213 Identities=24% Similarity=0.406 Sum_probs=184.1
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.++||+|+||+||+|.. .+|+.||||++... .....+.+.+|++++++++|||||++++++. .++..|+|||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~yivmE 112 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-DDEKLYFGLS 112 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-eCCEEEEEEe
Confidence 45678999999999999986 47899999999753 2334678999999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc-
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN- 691 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~- 691 (773)
|++||+|.+++++.+ .+++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+.......
T Consensus 113 y~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH-~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 113 YAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred cCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 999999999998764 3889999999999999999999 99999999999999999999999999999998754332
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhhh
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEW 757 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 757 (773)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+ ..+...++.+.++
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~ 251 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGLIFAKIIKLEY 251 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCC
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCC
Confidence 23345679999999999999999999999999999999999999997644 4455556665544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=385.48 Aligned_cols=293 Identities=30% Similarity=0.498 Sum_probs=224.3
Q ss_pred ccCHHHHHHHHHHHHhCCCCCCCcCCCCCCCCCCCCCCCcceEeeC----CCEEEEEcCCCCccc--ccCccccCCCCCc
Q 041878 45 IVTQADYQSLRAIKHDLIDPHGFLRSWNDSGVGACSGGWAGIKCVK----GQVIAIQLPWRRLGG--RISEKISQLHALR 118 (773)
Q Consensus 45 ~~~~~~~~~L~~~k~~~~~~~~~l~sW~~~~~~~c~~~w~gv~c~~----~~v~~l~l~~~~l~~--~i~~~l~~l~~L~ 118 (773)
.|.++|++||++||+++.||. .+++|+. +.++|.+.|.||+|.. ++|+.|+|++++++| .+|+.++++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 489999999999999999886 7899965 5677766799999964 799999999999999 8999999999999
Q ss_pred EEEccC-CcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccc
Q 041878 119 KLSLHD-NLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197 (773)
Q Consensus 119 ~L~L~~-n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N 197 (773)
+|+|++ |++.+.+|..++.+++|++|+|++|++++.+|..|+++++|++|+|++|.+++.+|..+..+++|++|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 8999999999999999999999999999899999999999999999999999888999999999999999999
Q ss_pred cccccCCccccCCC-ccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcc
Q 041878 198 SLLGSIPLSLTRLP-SLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKI 276 (773)
Q Consensus 198 ~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l 276 (773)
++++.+|..+..++ +|++|++++|++++.+|..+..+ +|++|++++|.+++..|..+..+++|+.|+|++|
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-- 231 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL------NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN-- 231 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC------CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSS--
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCC------cccEEECcCCcccCcCCHHHhcCCCCCEEECCCC--
Confidence 99888888888887 88888888888887777655433 1555555555555544444555555555555554
Q ss_pred cCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCccccccccccc
Q 041878 277 VGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETI 356 (773)
Q Consensus 277 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~ 356 (773)
.+++.+|. +..+++|++|+|++|++++.+|..+..+++|++|++++|+++|.+|..
T Consensus 232 ----------------------~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~- 287 (313)
T 1ogq_A 232 ----------------------SLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG- 287 (313)
T ss_dssp ----------------------EECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-
T ss_pred ----------------------ceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-
Confidence 44433333 444555555555555555555555555666666666666666655554
Q ss_pred CCCCcCceeecCCcc
Q 041878 357 GNISGINQLDLSEND 371 (773)
Q Consensus 357 ~~l~~L~~L~L~~N~ 371 (773)
+.+++|+.|++++|+
T Consensus 288 ~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 288 GNLQRFDVSAYANNK 302 (313)
T ss_dssp TTGGGSCGGGTCSSS
T ss_pred ccccccChHHhcCCC
Confidence 556666666666665
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=384.36 Aligned_cols=197 Identities=30% Similarity=0.504 Sum_probs=165.4
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.++||+|+||+||+|++.+ .||||+++... ....++|.+|++++++++|||||+++|++. . +..++|||||+
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~-~~~~iVmEy~~ 114 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-K-DNLAIVTQWCE 114 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S-SSCEEEEECCS
T ss_pred EEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-C-CeEEEEEEcCC
Confidence 457889999999999998753 69999997543 334578999999999999999999999983 3 46899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc-cce
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN-TNV 694 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 694 (773)
+|+|.++++... ..+++.++..++.|||+||+||| +++||||||||+|||+++++.+||+|||+|+....... ...
T Consensus 115 gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH-~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 115 GSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLH-AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp SCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred CCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 999999998653 34899999999999999999999 89999999999999999999999999999987654322 233
Q ss_pred eeccCccccccccccCC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKL---KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....||+.|||||++.. ..|+.++|||||||++|||+||+.||...+
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC
Confidence 45579999999998853 458999999999999999999999997654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=386.17 Aligned_cols=214 Identities=24% Similarity=0.437 Sum_probs=176.7
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|.+.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|++++++++|||||++++++. .++..|+||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-~~~~~yiVmEy 104 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-ENGSLYIVMDY 104 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEEEC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-ECCEEEEEEeC
Confidence 45678999999999999986 479999999997542 334567999999999999999999999995 45689999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
++||+|.+++.... ...+++.+++.++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+....... .
T Consensus 105 ~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 181 (350)
T 4b9d_A 105 CEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVH-DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-L 181 (350)
T ss_dssp CTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH-HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH-H
T ss_pred CCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc-c
Confidence 99999999997653 334788899999999999999999 99999999999999999999999999999987654321 1
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhhh
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEW 757 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 757 (773)
....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+ ..+.+.++....+
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~ 242 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS---MKNLVLKIISGSF 242 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCC
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCC
Confidence 223469999999999999999999999999999999999999997644 4555566665554
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=380.90 Aligned_cols=200 Identities=22% Similarity=0.306 Sum_probs=171.2
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
...++||+|+||+||+|... +|+.||||+++..... .+|+.++++++|||||++++++. .++..|+||||++|
T Consensus 61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~-~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVR-EGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEE-ETTEEEEEECCCTT
T ss_pred EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEE-ECCEEEEEEeccCC
Confidence 45678999999999999864 6899999999754332 46999999999999999999995 45589999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC-CeEEeecCCccccccccccc--
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT-NPRIADFGLSRLMTAAANTN-- 693 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~~~~~-- 693 (773)
|+|.+++++.+ .+++..+..++.||+.||+||| +++||||||||+|||++.++ .+||+|||+|+.........
T Consensus 135 g~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 135 GSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLH-TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 99999998764 3899999999999999999999 99999999999999999987 59999999998775443221
Q ss_pred --eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHH
Q 041878 694 --VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQ 747 (773)
Q Consensus 694 --~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~ 747 (773)
....+||+.|||||++.+..|+.++||||+||++|||+||+.||...+..++..
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 266 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 266 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH
Confidence 123469999999999999999999999999999999999999998876665544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=390.91 Aligned_cols=198 Identities=22% Similarity=0.387 Sum_probs=176.3
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|...+.||+|+||.||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.. .+..|+|||||+
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~iVmEy~~ 231 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLE 231 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-CCEEEEEEeCCC
Confidence 345688999999999999864 799999999987666667789999999999999999999999954 558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
||+|.++++.. .+++.++..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+....... ...
T Consensus 232 gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH-~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~ 305 (423)
T 4fie_A 232 GGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLH-AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRK 305 (423)
T ss_dssp TEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBC
T ss_pred CCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHH-HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-ccc
Confidence 99999999764 2789999999999999999999 99999999999999999999999999999987654332 233
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
..+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 4579999999999999999999999999999999999999997654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=368.10 Aligned_cols=194 Identities=27% Similarity=0.444 Sum_probs=166.9
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECC---CCeEEEEEe
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP---KGEKLLVFD 612 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~~~lV~e 612 (773)
..++||+|+||+||+|.+. ++..||+|++... .....+.|.+|++++++++|||||++++++... +...|+|||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE 109 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence 3467999999999999864 6889999999654 233456799999999999999999999998542 345799999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCC--ceecCCCCCCEEeCC-CCCeEEeecCCccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN--MIHGNLTSSNVLLDE-KTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~--iiH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~~ 689 (773)
||++|+|.+++++.. .+++..+..++.||+.||+||| +++ ||||||||+|||++. ++.+||+|||+|+.....
T Consensus 110 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH-~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 110 LMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred CCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 999999999998764 3889999999999999999999 777 999999999999984 789999999999854322
Q ss_pred cccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
.....+||+.|||||++.+ .|+.++|||||||++|||+||+.||...
T Consensus 186 ---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 186 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 2335679999999998864 6999999999999999999999999653
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=416.92 Aligned_cols=315 Identities=22% Similarity=0.324 Sum_probs=215.7
Q ss_pred cCHHHHHHHHHHHHhCCCCCCC--------cCCCCCCCCCCCCCCC---cceEee-CCCEEEEEcCCCCcccccCccccC
Q 041878 46 VTQADYQSLRAIKHDLIDPHGF--------LRSWNDSGVGACSGGW---AGIKCV-KGQVIAIQLPWRRLGGRISEKISQ 113 (773)
Q Consensus 46 ~~~~~~~~L~~~k~~~~~~~~~--------l~sW~~~~~~~c~~~w---~gv~c~-~~~v~~l~l~~~~l~~~i~~~l~~ 113 (773)
....|++||.+++.++.++... ..+|+. +.++|. | .||+|+ .++|+.|+|++++++|.+|+.+++
T Consensus 27 ~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~--w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~ 103 (636)
T 4eco_A 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDM--WGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103 (636)
T ss_dssp HHHHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGG--TTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGG
T ss_pred hHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCccc--ccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhc
Confidence 3457999999999998755321 347964 566666 9 999995 479999999999999999999999
Q ss_pred CCCCcEEEccCCc-------------------------------------------------------------------
Q 041878 114 LHALRKLSLHDNL------------------------------------------------------------------- 126 (773)
Q Consensus 114 l~~L~~L~L~~n~------------------------------------------------------------------- 126 (773)
|++|++|+|++|.
T Consensus 104 L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l 183 (636)
T 4eco_A 104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183 (636)
T ss_dssp CTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCC
T ss_pred CccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccch
Confidence 9999999999884
Q ss_pred -----------ccccCCCCCCCCCCCceEEcccCccCCC-----------------CCCCCC--CCCCCCEEEccCCCCC
Q 041878 127 -----------LAGPVPWSLGFLPNLRGVYLFNNRLSGS-----------------IPPSIG--NCPNLQTLDLSNNALI 176 (773)
Q Consensus 127 -----------l~~~~~~~l~~l~~L~~L~L~~n~l~~~-----------------~p~~l~--~l~~L~~L~Ls~N~l~ 176 (773)
++| +|..++++++|++|+|++|++++. +|..++ ++++|++|+|++|.+.
T Consensus 184 ~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~ 262 (636)
T 4eco_A 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNL 262 (636)
T ss_dssp CTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTC
T ss_pred hhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCC
Confidence 445 788888888999999999888875 888888 8888999999888888
Q ss_pred CCCccccccccccceeeccccc-ccc-cCCccccCC------CccceeeccccccccccCC--cccccccCcccccceee
Q 041878 177 GAIPPSLANSTRLYRLNLSYNS-LLG-SIPLSLTRL------PSLSVLALQHNNLSGSVPN--NWGVLAGNKSYQLQFLN 246 (773)
Q Consensus 177 ~~~~~~l~~l~~L~~L~Ls~N~-l~~-~~~~~l~~l------~~L~~L~L~~N~l~~~~p~--~~~~l~~~~~~~L~~L~ 246 (773)
+.+|..++++++|++|+|++|+ +++ .+|..+..+ ++|++|+|++|+++ .+|. .++.+. +|++|+
T Consensus 263 ~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~-----~L~~L~ 336 (636)
T 4eco_A 263 TKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMK-----KLGMLE 336 (636)
T ss_dssp SSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCT-----TCCEEE
T ss_pred ccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCC-----CCCEEe
Confidence 8888888888888888888887 877 667666554 66777777777766 5665 554443 566666
Q ss_pred ccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccc-cceeccccccccccCcccccccc--cCceEEccCCC
Q 041878 247 LDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSK-LQKLDLSYNAIGGSFPVTFTNIT--SLVSLNLENNR 323 (773)
Q Consensus 247 L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~Ls~N~ 323 (773)
+++|.++|.+| .++.+++|++|+|++|+++ .+|..+..+++ |++|++++|.++ .+|..+..++ +|+.|++++|+
T Consensus 337 L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~ 413 (636)
T 4eco_A 337 CLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNE 413 (636)
T ss_dssp CCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSC
T ss_pred CcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCc
Confidence 66666665555 5555555555555555555 45555555555 555555555555 4444444332 45555555555
Q ss_pred CCCCcchhhc-------cccccccccccCcccccccccccCCCCcCceeecCCccCc
Q 041878 324 LGNKIPEGLE-------RLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFT 373 (773)
Q Consensus 324 l~~~~~~~l~-------~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 373 (773)
+++.+|..+. .+++|++|++++|++++..+..+..+++|++|+|++|+++
T Consensus 414 l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~ 470 (636)
T 4eco_A 414 IGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470 (636)
T ss_dssp TTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS
T ss_pred CCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC
Confidence 5555554444 4444555555555544221122223444444444444444
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=364.19 Aligned_cols=210 Identities=26% Similarity=0.429 Sum_probs=166.5
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||+||+|.. .+|+.||||+++... ......+.+|++++++++|||||++++++. .++..|+|||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~~~~~ivmE 93 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-SKDEIIMVIE 93 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-ECCEEEEEEe
Confidence 35678999999999999986 479999999997542 234567999999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+ +|+|.+++.+.+ .++...+..++.||+.||+||| ++||+||||||+|||+++++.+||+|||+|+.......
T Consensus 94 y~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH-~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~- 167 (275)
T 3hyh_A 94 YA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCH-RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF- 167 (275)
T ss_dssp CC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred CC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc-
Confidence 99 689999998754 3899999999999999999999 99999999999999999999999999999987643322
Q ss_pred ceeeccCccccccccccCCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhhh
Q 041878 693 NVIATAGTLGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEW 757 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 757 (773)
.....||+.|||||++.+..| ++++||||+||++|||+||+.||.+.+ ..+..+++....+
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~~~~~~i~~~~~ 229 (275)
T 3hyh_A 168 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IPVLFKNISNGVY 229 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCC
T ss_pred -cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCC
Confidence 234579999999999988776 589999999999999999999997543 4555556655544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=377.98 Aligned_cols=211 Identities=24% Similarity=0.395 Sum_probs=172.1
Q ss_pred HHhhcccccccceEEEEEEeC----CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE----DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
|.+.+.||+|+||+||+|+.. +++.||||+++... ......+.+|++++++++|||||++++++. .++..|+|
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~iv 104 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-TEGKLYLI 104 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-ETTEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-ECCEEEEE
Confidence 466789999999999999752 47889999997542 223457889999999999999999999995 45689999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||++||+|.+++++.+ .+++.++..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+......
T Consensus 105 mEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp ECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 99999999999998764 3899999999999999999999 9999999999999999999999999999998654332
Q ss_pred ccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhh
Q 041878 691 NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 756 (773)
. ......||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+ ..+.+.++.+..
T Consensus 181 ~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~ 242 (304)
T 3ubd_A 181 K-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD---RKETMTMILKAK 242 (304)
T ss_dssp C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCC
T ss_pred c-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC---HHHHHHHHHcCC
Confidence 2 2234579999999999999999999999999999999999999997654 344445555443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=377.33 Aligned_cols=205 Identities=25% Similarity=0.412 Sum_probs=175.8
Q ss_pred HHHhhcccccccceEEEEEEeCC------CCEEEEEEecccCc-ccHHHHHHHHHHHHccCC-CceEEeEEEEECCCCeE
Q 041878 536 LCATAEIMGKSTYGTAYKATLED------GSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHH-PNLLALRAYYLGPKGEK 607 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~ 607 (773)
.+.+.+.||+|+||+||+|.+.. ++.||||+++.... ...++|.+|+++|++++| ||||+++|+|..+.+..
T Consensus 65 ~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~ 144 (353)
T 4ase_A 65 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 144 (353)
T ss_dssp GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEE
Confidence 34678899999999999998532 35799999976543 345679999999999976 89999999996666678
Q ss_pred EEEEeecCCCCHHHHHhhcCC-------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC
Q 041878 608 LLVFDFMPKGSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN 674 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~ 674 (773)
++|||||++|+|.++++.... ...+++.++..++.|||+||+||| +++||||||||+|||+++++.
T Consensus 145 ~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH-~~~iiHRDLK~~NILl~~~~~ 223 (353)
T 4ase_A 145 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNV 223 (353)
T ss_dssp EEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh-hCCeecCccCccceeeCCCCC
Confidence 999999999999999986421 345899999999999999999999 999999999999999999999
Q ss_pred eEEeecCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 675 PRIADFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 675 ~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+
T Consensus 224 vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 224 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 999999999876544332 2234468999999999999999999999999999999998 999998754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=368.22 Aligned_cols=195 Identities=29% Similarity=0.398 Sum_probs=160.0
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCC---eEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG---EKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~lV~e~~ 614 (773)
.+.++||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||++++++..... ..++|||||
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 3468899999999999998 489999999965432 22334556777778999999999999965432 579999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCC--------CceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE--------NMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~--------~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
++|+|.+++++.. ++|..+.+++.|+++||+||| +. +||||||||+|||++.++.+||+|||+|+..
T Consensus 84 ~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH-~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 84 EHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLH-MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp TTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHH-CCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHH-HhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 9999999998743 799999999999999999999 54 8999999999999999999999999999876
Q ss_pred cccccc---ceeeccCccccccccccCCC------CCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 687 TAAANT---NVIATAGTLGYRAPELSKLK------NANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 687 ~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
...... ......||+.|||||++.+. .++.++|||||||++|||+||+.||..
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 544322 12235799999999988654 467899999999999999999876643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=361.88 Aligned_cols=199 Identities=23% Similarity=0.414 Sum_probs=161.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCC---------
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG--------- 605 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------- 605 (773)
|.+.+.||+|+||+||+|... +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.....
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 456789999999999999864 789999999975443 345678999999999999999999999854332
Q ss_pred --eEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCc
Q 041878 606 --EKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS 683 (773)
Q Consensus 606 --~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a 683 (773)
..|+||||+++|+|.++++........++..++.++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH-~~~IiHRDlKp~NILl~~~~~vKl~DFGla 165 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 165 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH-HCcCccccCcHHHeEECCCCcEEEccCccc
Confidence 36899999999999999988765555677788999999999999999 999999999999999999999999999999
Q ss_pred ccccccccc-----------ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 684 RLMTAAANT-----------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 684 ~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
+........ .....+||+.|||||++.+..|+.++||||+||++|||++ ||..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp --------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred eecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 877543221 1223469999999999999999999999999999999996 7754
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=369.83 Aligned_cols=325 Identities=21% Similarity=0.234 Sum_probs=258.5
Q ss_pred CCCCCCCcceEeeC----------CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccC-CCCCCCCCCCceEE
Q 041878 77 GACSGGWAGIKCVK----------GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPV-PWSLGFLPNLRGVY 145 (773)
Q Consensus 77 ~~c~~~w~gv~c~~----------~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~ 145 (773)
..|.+.+..|.|.. .+++.|+|++|.+++..+..++++++|++|+|++|.+.+.+ +..|..+++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 34542233477843 46899999999999988999999999999999999998655 66799999999999
Q ss_pred cccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccc--cccccccceeecccccccccCCcc-ccCCCccceeeccccc
Q 041878 146 LFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPS--LANSTRLYRLNLSYNSLLGSIPLS-LTRLPSLSVLALQHNN 222 (773)
Q Consensus 146 L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~--l~~l~~L~~L~Ls~N~l~~~~~~~-l~~l~~L~~L~L~~N~ 222 (773)
|++|++++..|..|+++++|++|+|++|.+++.++.. +..+++|++|+|++|++++..|.. +.++++|++|++++|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999889999999999999999999999766555 899999999999999999887876 8899999999999999
Q ss_pred cccccCCccccccc-----------------------------CcccccceeeccccccccccCccCCC-----------
Q 041878 223 LSGSVPNNWGVLAG-----------------------------NKSYQLQFLNLDHNLIAGTIPVSLGK----------- 262 (773)
Q Consensus 223 l~~~~p~~~~~l~~-----------------------------~~~~~L~~L~L~~n~l~~~~~~~l~~----------- 262 (773)
+++..+..+..+.. ...++|++|++++|.+++..|..+..
T Consensus 166 l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~ 245 (455)
T 3v47_A 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245 (455)
T ss_dssp BSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEE
T ss_pred ccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEe
Confidence 99888877765421 12246777777777776544433211
Q ss_pred ----------------------------CCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccC
Q 041878 263 ----------------------------LGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSL 314 (773)
Q Consensus 263 ----------------------------l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 314 (773)
.++|+.|++++|++++..|..+..+++|++|+|++|++++..|..|..+++|
T Consensus 246 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 325 (455)
T 3v47_A 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHL 325 (455)
T ss_dssp CTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred eccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccC
Confidence 1467777777777777777777777778888888887777777777777778
Q ss_pred ceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecc
Q 041878 315 VSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYN 394 (773)
Q Consensus 315 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N 394 (773)
++|+|++|++++..|..+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..+..+..+++|+.|++++|
T Consensus 326 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 405 (455)
T 3v47_A 326 LKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405 (455)
T ss_dssp CEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCC
Confidence 88888888777777777777777888888888777777777777777888888888777665566677777788888888
Q ss_pred cCCCCCc
Q 041878 395 NLSGSVP 401 (773)
Q Consensus 395 ~l~g~~p 401 (773)
+++|.+|
T Consensus 406 ~l~~~~~ 412 (455)
T 3v47_A 406 PWDCSCP 412 (455)
T ss_dssp CBCCCTT
T ss_pred CcccCCC
Confidence 8877777
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=361.14 Aligned_cols=210 Identities=24% Similarity=0.358 Sum_probs=173.7
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECC-----CCeEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-----KGEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~~ 608 (773)
|.+.+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++... .+..|
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 35678999999999999986 479999999997543 23356788999999999999999999987532 35789
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+|||||+ |+|.+++.... .+++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+....
T Consensus 136 ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH-~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 136 VVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMH-SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 9999995 78999998653 4899999999999999999999 99999999999999999999999999999987643
Q ss_pred cc---ccceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHH
Q 041878 689 AA---NTNVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK 754 (773)
Q Consensus 689 ~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 754 (773)
.. .......+||+.|||||++.+. .|+.++||||+||++|||++|+.||.+.+. .+.+..++.
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~---~~~l~~I~~ 277 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY---VHQLQLIMM 277 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHH
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH---HHHHHHHHH
Confidence 32 1223345799999999987764 579999999999999999999999976553 344444443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=369.77 Aligned_cols=212 Identities=25% Similarity=0.356 Sum_probs=176.8
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHH---HHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEA---EAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
|.+.++||+|+||.||+|+.. +|+.||||++.... ......+.+ ++.+++.++|||||++++++. ..+..|+
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~-~~~~lyl 269 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-TPDKLSF 269 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-CSSEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE-ECCEEEE
Confidence 345789999999999999864 69999999996432 222333333 466677789999999999995 4559999
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||++||+|.+++.+.+. ++...+..++.||+.||+||| ++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 270 VmEy~~GGdL~~~l~~~~~---l~E~~a~~y~~qIl~aL~yLH-~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~ 345 (689)
T 3v5w_A 270 ILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMH-NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345 (689)
T ss_dssp EECCCCSCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH-TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred EEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH-HCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence 9999999999999988643 899999999999999999999 999999999999999999999999999999876543
Q ss_pred cccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhh
Q 041878 690 ANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 756 (773)
. ....+||+.|||||++.. ..|+.++|+||+||++|||++|+.||.+.+..+..+..+.+....
T Consensus 346 ~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~ 410 (689)
T 3v5w_A 346 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 410 (689)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC
T ss_pred C---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC
Confidence 2 234579999999999864 579999999999999999999999998876666655555554443
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=363.82 Aligned_cols=339 Identities=20% Similarity=0.195 Sum_probs=303.2
Q ss_pred CCcceEeeC-----------CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCc
Q 041878 82 GWAGIKCVK-----------GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNR 150 (773)
Q Consensus 82 ~w~gv~c~~-----------~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~ 150 (773)
.|..|.|.. ..++.|+|++|.+++..+..+.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 467888853 367899999999999889999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCc
Q 041878 151 LSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNN 230 (773)
Q Consensus 151 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~ 230 (773)
+++..+..|+++++|++|+|++|.+++..+..+.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 171 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEA 171 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHH
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhH
Confidence 99777778899999999999999999888999999999999999999999988999999999999999999999655555
Q ss_pred ccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccc
Q 041878 231 WGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTN 310 (773)
Q Consensus 231 ~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 310 (773)
+..+. +|+.|+|++|.+++..+..|..+++|+.|++++|.+.+.+|..+....+|++|+|++|++++..+..+..
T Consensus 172 l~~l~-----~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 246 (477)
T 2id5_A 172 LSHLH-----GLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRH 246 (477)
T ss_dssp HTTCT-----TCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTT
T ss_pred hcccC-----CCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcC
Confidence 55444 8999999999999999999999999999999999988888887777789999999999999766678999
Q ss_pred cccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEE
Q 041878 311 ITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFN 390 (773)
Q Consensus 311 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 390 (773)
+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+
T Consensus 247 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 326 (477)
T 2id5_A 247 LVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLI 326 (477)
T ss_dssp CTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEE
T ss_pred ccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEE
Confidence 99999999999999988888999999999999999999999999999999999999999999988888889999999999
Q ss_pred eecccCCCCCchh-hhccCCCCCCCCCCCCCCCCCC
Q 041878 391 VSYNNLSGSVPPL-LSKKFNSSSFVGNLQLCGYSPS 425 (773)
Q Consensus 391 ls~N~l~g~~p~~-~~~~~~~~~~~~n~~~c~~~~~ 425 (773)
|++|+|+|.++.. +........+.++...|+.|..
T Consensus 327 l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~ 362 (477)
T 2id5_A 327 LDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEF 362 (477)
T ss_dssp CCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESGG
T ss_pred ccCCCccCccchHhHHhhhhccccCccCceeCCchH
Confidence 9999999887643 2233333456677777776643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.31 Aligned_cols=194 Identities=23% Similarity=0.406 Sum_probs=163.9
Q ss_pred HHhhcccccccceEEEEEEeC----CCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE----DGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
|.+.++||+|+||+||+|+.+ +++.||||++.... ...++.+|+++++++ +||||+++++++. ..+..|+||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-~~~~~~lvm 99 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR-KNDHVVIAM 99 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE-ETTEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE-ECCEEEEEE
Confidence 456789999999999999753 46789999986543 456788999999998 6999999999995 456999999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC-CCeEEeecCCcccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK-TNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~~~~~ 690 (773)
||+++|+|.++++. +++.++..++.||+.||+||| ++|||||||||+|||++.+ +.+||+|||+|+......
T Consensus 100 E~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH-~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 100 PYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIH-QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp ECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred eCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHH-HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999999853 788999999999999999999 9999999999999999877 789999999997653221
Q ss_pred c---------------------------cceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 691 N---------------------------TNVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 691 ~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
. ......+||+.|||||++.+. .|+.++||||+||++|||+||+.||...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 1 112234699999999988764 5899999999999999999999999653
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=382.45 Aligned_cols=143 Identities=21% Similarity=0.171 Sum_probs=79.6
Q ss_pred CcceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccC-CCCCCCCCCCceEEcccCccCCCCCCCCCC
Q 041878 83 WAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPV-PWSLGFLPNLRGVYLFNNRLSGSIPPSIGN 161 (773)
Q Consensus 83 w~gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~ 161 (773)
|..|.+...+++.|+|++|.+++..+..+.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|++++..|..|++
T Consensus 16 L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~ 95 (844)
T 3j0a_A 16 LTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQG 95 (844)
T ss_dssp SSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCS
T ss_pred CCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccC
Confidence 5555554456667777777666665555666666666666655443333 455555555555555555555555555555
Q ss_pred CCCCCEEEccCCCCCCCCccc--cccccccceeecccccccccCC-ccccCCCccceeecccccccc
Q 041878 162 CPNLQTLDLSNNALIGAIPPS--LANSTRLYRLNLSYNSLLGSIP-LSLTRLPSLSVLALQHNNLSG 225 (773)
Q Consensus 162 l~~L~~L~Ls~N~l~~~~~~~--l~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~ 225 (773)
+++|++|+|++|.+++.+|.. +.++++|++|+|++|.+++..+ ..+.++++|++|+|++|.+++
T Consensus 96 l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~ 162 (844)
T 3j0a_A 96 LFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162 (844)
T ss_dssp CSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred CcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence 555555555555555444433 5555555555555555554332 345555555555555554443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=366.59 Aligned_cols=211 Identities=23% Similarity=0.396 Sum_probs=181.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.+.||+|+||+||+|... +|+.||+|++......+.+.+.+|+++|++++|||||++++++. ..+..++|||||+
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~iv~E~~~ 237 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-DDNEMVMIYEFMS 237 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-CSSEEEEEEECCC
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE-ECCEEEEEEeecC
Confidence 456789999999999999864 79999999998766666778999999999999999999999995 5569999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC--CCeEEeecCCccccccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK--TNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~--~~~kl~DfG~a~~~~~~~~~~ 693 (773)
||+|.+++.... ..+++.++..++.||+.||+||| +++|+||||||+|||++.+ +.+||+|||+|+.+.... .
T Consensus 238 gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH-~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~ 312 (573)
T 3uto_A 238 GGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S 312 (573)
T ss_dssp CCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--E
T ss_pred CCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--c
Confidence 999999997542 34889999999999999999999 9999999999999999864 789999999998775433 2
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhh
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 756 (773)
.....||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+. .+.+.++....
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---~~~~~~i~~~~ 372 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKSCD 372 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHTTC
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHHHHHHHhCC
Confidence 3345799999999999999999999999999999999999999976543 34444554443
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=359.86 Aligned_cols=139 Identities=19% Similarity=0.168 Sum_probs=121.0
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
.+++.|+|+++.+++..+..+.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 46888999999998888888999999999999999999888888999999999999999999888889999999999999
Q ss_pred cCCCCCCCCccccccccccceeecccccccc-cCCccccCCCccceeeccccccccccCC
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLG-SIPLSLTRLPSLSVLALQHNNLSGSVPN 229 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~p~ 229 (773)
++|.+++..+..++++++|++|+|++|.+++ .+|..+.++++|++|++++|++++..+.
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 9999987776788889999999999998876 5688888888888888888888765554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=346.80 Aligned_cols=332 Identities=20% Similarity=0.199 Sum_probs=271.6
Q ss_pred CCCCCCCcceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCC-
Q 041878 77 GACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSI- 155 (773)
Q Consensus 77 ~~c~~~w~gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~- 155 (773)
++|. .+..|... .++.++++++ .+|. +. ++|++|+|++|.+++..|..|+.+++|++|+|++|.+.+.+
T Consensus 2 ~p~~---~~c~~~~~---~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~ 71 (455)
T 3v47_A 2 DPGT---SECSVIGY---NAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIR 71 (455)
T ss_dssp --------CCEEETT---EEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEEC
T ss_pred CCcc---ceeEEEcc---ccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceEC
Confidence 4565 35556432 3677777776 4554 32 78999999999999999999999999999999999998666
Q ss_pred CCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCcc--ccCCCccceeeccccccccccCCc-cc
Q 041878 156 PPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLS--LTRLPSLSVLALQHNNLSGSVPNN-WG 232 (773)
Q Consensus 156 p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~--l~~l~~L~~L~L~~N~l~~~~p~~-~~ 232 (773)
+..|.++++|++|+|++|.+++..|..+.++++|++|+|++|++++..+.. +.++++|++|+|++|++++..|.. +.
T Consensus 72 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 151 (455)
T 3v47_A 72 NNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151 (455)
T ss_dssp TTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGG
T ss_pred cccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccC
Confidence 567999999999999999999888999999999999999999999865554 899999999999999999887765 55
Q ss_pred ccccCcccccceeeccccccccccCccCCCC----------------------------------CCccEEECCCCcccC
Q 041878 233 VLAGNKSYQLQFLNLDHNLIAGTIPVSLGKL----------------------------------GLLQEISLSHNKIVG 278 (773)
Q Consensus 233 ~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l----------------------------------~~L~~L~L~~N~l~~ 278 (773)
.+. +|++|++++|.+++..+..+..+ ++|++|++++|++++
T Consensus 152 ~l~-----~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~ 226 (455)
T 3v47_A 152 NMR-----RFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE 226 (455)
T ss_dssp GCT-----TCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCH
T ss_pred CCC-----cccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccc
Confidence 544 89999999999998888776554 578888888887765
Q ss_pred CCCCCcCc---------------------------------------ccccceeccccccccccCcccccccccCceEEc
Q 041878 279 PIPDELGK---------------------------------------LSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNL 319 (773)
Q Consensus 279 ~~p~~l~~---------------------------------------l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 319 (773)
..|..+.. .++|++|++++|.+++..|..+..+++|++|+|
T Consensus 227 ~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 306 (455)
T 3v47_A 227 SMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTL 306 (455)
T ss_dssp HHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEEC
Confidence 33322211 157888888899998888888999999999999
Q ss_pred cCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCC
Q 041878 320 ENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGS 399 (773)
Q Consensus 320 s~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~ 399 (773)
++|++++..|..+..+++|++|+|++|++++..|..++++++|++|+|++|++++..|..+..+++|+.|+|++|++++.
T Consensus 307 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 386 (455)
T 3v47_A 307 AQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSV 386 (455)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccC
Confidence 99999988888999999999999999999988888999999999999999999988899999999999999999999975
Q ss_pred Cchhhh--ccCCCCCCCCCCCCCCCC
Q 041878 400 VPPLLS--KKFNSSSFVGNLQLCGYS 423 (773)
Q Consensus 400 ~p~~~~--~~~~~~~~~~n~~~c~~~ 423 (773)
.+..+. ..+....+.+|+..|.++
T Consensus 387 ~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 387 PDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CHhHhccCCcccEEEccCCCcccCCC
Confidence 544331 233344567777776554
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=363.09 Aligned_cols=302 Identities=22% Similarity=0.299 Sum_probs=258.2
Q ss_pred CCEEEEEcCCCCcccc-----------------cCcccc--CCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCc-
Q 041878 91 GQVIAIQLPWRRLGGR-----------------ISEKIS--QLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNR- 150 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~-----------------i~~~l~--~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~- 150 (773)
.+++.|+|++|.++|. +|+.++ ++++|++|+|++|.+.+.+|..++++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~ 285 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence 5788999999999996 999999 99999999999999999999999999999999999998
Q ss_pred cCC-CCCCCCCCC------CCCCEEEccCCCCCCCCcc--ccccccccceeecccccccccCCccccCCCccceeecccc
Q 041878 151 LSG-SIPPSIGNC------PNLQTLDLSNNALIGAIPP--SLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHN 221 (773)
Q Consensus 151 l~~-~~p~~l~~l------~~L~~L~Ls~N~l~~~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N 221 (773)
++| .+|..++.+ ++|++|+|++|.++ .+|. .++++++|++|+|++|+++|.+| .+..+++|++|+|++|
T Consensus 286 l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N 363 (636)
T 4eco_A 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYN 363 (636)
T ss_dssp SCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSS
T ss_pred CccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCC
Confidence 998 899988876 99999999999999 8888 89999999999999999999999 8899999999999999
Q ss_pred ccccccCCcccccccCcccc-cceeeccccccccccCccCCCCC--CccEEECCCCcccCCCCCCcC-------cccccc
Q 041878 222 NLSGSVPNNWGVLAGNKSYQ-LQFLNLDHNLIAGTIPVSLGKLG--LLQEISLSHNKIVGPIPDELG-------KLSKLQ 291 (773)
Q Consensus 222 ~l~~~~p~~~~~l~~~~~~~-L~~L~L~~n~l~~~~~~~l~~l~--~L~~L~L~~N~l~~~~p~~l~-------~l~~L~ 291 (773)
+++ .+|..+..+. + |++|++++|.++ .+|..+..++ +|+.|++++|++++.+|..+. .+++|+
T Consensus 364 ~l~-~lp~~l~~l~-----~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~ 436 (636)
T 4eco_A 364 QIT-EIPANFCGFT-----EQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436 (636)
T ss_dssp EEE-ECCTTSEEEC-----TTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEE
T ss_pred ccc-cccHhhhhhc-----ccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCC
Confidence 999 7888777665 6 999999999998 6777777655 899999999999888888887 778888
Q ss_pred eeccccccccccCcccccccccCceEEccCCCCCCCcchh-hccc-------cccccccccCcccccccccccC--CCCc
Q 041878 292 KLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG-LERL-------QNLTVLNLKNNQFKGHIPETIG--NISG 361 (773)
Q Consensus 292 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-l~~l-------~~L~~L~ls~N~l~~~~~~~~~--~l~~ 361 (773)
+|+|++|+++...+..+..+++|++|+|++|+++ .+|.. +... ++|+.|+|++|+++ .+|..+. .+++
T Consensus 437 ~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~ 514 (636)
T 4eco_A 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPY 514 (636)
T ss_dssp EEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTT
T ss_pred EEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCC
Confidence 9999999888544444566888888888888887 44443 3322 38888888888888 6777776 8888
Q ss_pred CceeecCCccCccCCCchhhccCccCEEEe------ecccCCCCCchhh
Q 041878 362 INQLDLSENDFTGEISPSLASLANLTSFNV------SYNNLSGSVPPLL 404 (773)
Q Consensus 362 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l------s~N~l~g~~p~~~ 404 (773)
|+.|+|++|++++ +|..+..+++|+.|+| ++|++.+.+|..+
T Consensus 515 L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l 562 (636)
T 4eco_A 515 LVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGI 562 (636)
T ss_dssp CCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTG
T ss_pred cCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHH
Confidence 8888888888887 7888888888888888 4577788888765
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=341.05 Aligned_cols=330 Identities=20% Similarity=0.183 Sum_probs=294.5
Q ss_pred ceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCC
Q 041878 85 GIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPN 164 (773)
Q Consensus 85 gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 164 (773)
+..|... ...++.++++++ .+|..+. ++|+.|+|++|++++..+..|..+++|++|+|++|.+++..|..|+++++
T Consensus 6 ~C~C~~~-~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~ 81 (477)
T 2id5_A 6 RCECSAQ-DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFN 81 (477)
T ss_dssp TCEEETT-TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred CCeECCC-CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCcc
Confidence 5568542 235778888877 5666553 68999999999999998999999999999999999999988999999999
Q ss_pred CCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccce
Q 041878 165 LQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQF 244 (773)
Q Consensus 165 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~ 244 (773)
|++|+|++|.+++..+..|.++++|++|+|++|++++..+..+.++++|++|+|++|++++..+..|..+. +|+.
T Consensus 82 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-----~L~~ 156 (477)
T 2id5_A 82 LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLN-----SLEQ 156 (477)
T ss_dssp CCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCT-----TCCE
T ss_pred CCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCC-----CCCE
Confidence 99999999999976666789999999999999999999999999999999999999999988887777655 8999
Q ss_pred eeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCC
Q 041878 245 LNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRL 324 (773)
Q Consensus 245 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 324 (773)
|+|++|.+++..+..+..+++|+.|+|++|++.+..+..|..+++|++|++++|.+.+.+|.......+|++|+|++|++
T Consensus 157 L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l 236 (477)
T 2id5_A 157 LTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL 236 (477)
T ss_dssp EEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCC
T ss_pred EECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcc
Confidence 99999999988888899999999999999999998888999999999999999998888888777778999999999999
Q ss_pred CCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCchhh
Q 041878 325 GNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLL 404 (773)
Q Consensus 325 ~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~~ 404 (773)
+...+..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..+..+++|+.|+|++|++++..+..+
T Consensus 237 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 316 (477)
T 2id5_A 237 TAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVF 316 (477)
T ss_dssp CSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGB
T ss_pred cccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHc
Confidence 97777889999999999999999998888899999999999999999999999999999999999999999998665544
Q ss_pred h--ccCCCCCCCCCCCCCCCC
Q 041878 405 S--KKFNSSSFVGNLQLCGYS 423 (773)
Q Consensus 405 ~--~~~~~~~~~~n~~~c~~~ 423 (773)
. ..+....+.+|+..|.+.
T Consensus 317 ~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 317 HSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp SCGGGCCEEECCSSCEECSGG
T ss_pred CCCcccCEEEccCCCccCccc
Confidence 2 344555678898888654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=352.17 Aligned_cols=313 Identities=20% Similarity=0.210 Sum_probs=222.7
Q ss_pred CEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEcc
Q 041878 92 QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171 (773)
Q Consensus 92 ~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 171 (773)
.+..++++++.++...+..+.++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|+
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 131 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence 45677888888876656668899999999999999999888999999999999999999999888899999999999999
Q ss_pred CCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccc
Q 041878 172 NNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNL 251 (773)
Q Consensus 172 ~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~ 251 (773)
+|.+++..+..|+++++|++|+|++|.+++..|..+.++++|++|+|++|.+++..+..+ ++|+.|++++|.
T Consensus 132 ~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l--------~~L~~L~l~~n~ 203 (597)
T 3oja_B 132 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLI--------PSLFHANVSYNL 203 (597)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGC--------TTCSEEECCSSC
T ss_pred CCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhh--------hhhhhhhcccCc
Confidence 999996656667999999999999999999999999999999999999999986532222 245555555555
Q ss_pred ccc-------------------ccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccc
Q 041878 252 IAG-------------------TIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNIT 312 (773)
Q Consensus 252 l~~-------------------~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 312 (773)
+++ ..+.. .++|+.|+|++|.+++ +..+..+++|++|+|++|.+++..|..|..++
T Consensus 204 l~~l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 278 (597)
T 3oja_B 204 LSTLAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 278 (597)
T ss_dssp CSEEECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCS
T ss_pred cccccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCcc
Confidence 443 22211 1356666666666654 24556666666666666666666666666666
Q ss_pred cCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEee
Q 041878 313 SLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVS 392 (773)
Q Consensus 313 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls 392 (773)
+|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+++. + +..+++|+.|+|+
T Consensus 279 ~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~ 353 (597)
T 3oja_B 279 RLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLS 353 (597)
T ss_dssp SCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECC
T ss_pred CCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEee
Confidence 66666666666654 3445555666666666666666 4555556666666666666666543 2 4445566666666
Q ss_pred cccCCCCCchhhhccCCCCCCCCCCCCCCC
Q 041878 393 YNNLSGSVPPLLSKKFNSSSFVGNLQLCGY 422 (773)
Q Consensus 393 ~N~l~g~~p~~~~~~~~~~~~~~n~~~c~~ 422 (773)
+|+|+|.....+...+....+.++...|+.
T Consensus 354 ~N~~~~~~~~~~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 354 HNDWDCNSLRALFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp SSCEEHHHHHHHTTTCCTTTBCCCCCCCCT
T ss_pred CCCCCChhHHHHHHHHhhhccccccccCCc
Confidence 666665544444344444455555555654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=332.72 Aligned_cols=286 Identities=20% Similarity=0.211 Sum_probs=190.1
Q ss_pred CEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEcc
Q 041878 92 QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171 (773)
Q Consensus 92 ~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 171 (773)
.++.++++++.++...+..+..+++|++|+|++|.+++..+..+..+++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 46 ~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 125 (390)
T 3o6n_A 46 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125 (390)
T ss_dssp CCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECC
Confidence 46678888888775444557899999999999999998888899999999999999999998888999999999999999
Q ss_pred CCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccc
Q 041878 172 NNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNL 251 (773)
Q Consensus 172 ~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~ 251 (773)
+|.++...+..+.++++|++|+|++|++++..+..+..+++|++|++++|++++... .. .++|+.|++++|.
T Consensus 126 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~---~~-----l~~L~~L~l~~n~ 197 (390)
T 3o6n_A 126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDL---SL-----IPSLFHANVSYNL 197 (390)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCG---GG-----CTTCSEEECCSSC
T ss_pred CCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcccc---cc-----ccccceeeccccc
Confidence 999995444557899999999999999998888899999999999999999986422 22 2256666666666
Q ss_pred cccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchh
Q 041878 252 IAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEG 331 (773)
Q Consensus 252 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 331 (773)
+++. ...++|++|++++|++... |.. ..++|++|++++|.+++. ..+..+++|++|+|++|++++..|..
T Consensus 198 l~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~ 267 (390)
T 3o6n_A 198 LSTL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHP 267 (390)
T ss_dssp CSEE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGG
T ss_pred cccc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhH
Confidence 5532 1223455555555554432 111 123455555555554432 23444455555555555554444444
Q ss_pred hccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCC
Q 041878 332 LERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLS 397 (773)
Q Consensus 332 l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~ 397 (773)
+..+++|+.|++++|++++ +|..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+++
T Consensus 268 ~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~ 331 (390)
T 3o6n_A 268 FVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331 (390)
T ss_dssp GTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCC
T ss_pred ccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccc
Confidence 5555555555555555442 3333444455555555555544 33444444445555555555544
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=348.62 Aligned_cols=163 Identities=17% Similarity=0.190 Sum_probs=139.4
Q ss_pred CEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEcc
Q 041878 92 QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171 (773)
Q Consensus 92 ~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 171 (773)
.++.|+|++|.+++..+..+.++++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 27 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 106 (549)
T 2z81_A 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLM 106 (549)
T ss_dssp TCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECT
T ss_pred CccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECC
Confidence 78999999999999889999999999999999999999989999999999999999999998888889999999999999
Q ss_pred CCCCCC-CCccccccccccceeecccccccccCC-ccccCCCccceeeccccccccccCCccccccc-------------
Q 041878 172 NNALIG-AIPPSLANSTRLYRLNLSYNSLLGSIP-LSLTRLPSLSVLALQHNNLSGSVPNNWGVLAG------------- 236 (773)
Q Consensus 172 ~N~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~------------- 236 (773)
+|.+++ ..|..+.++++|++|+|++|++.+.+| ..+.++++|++|++++|++++..|..++.+..
T Consensus 107 ~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~ 186 (549)
T 2z81_A 107 GNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186 (549)
T ss_dssp TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTT
T ss_pred CCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccc
Confidence 999986 457789999999999999998544554 67889999999999999999887776654321
Q ss_pred ------Ccccccceeecccccccc
Q 041878 237 ------NKSYQLQFLNLDHNLIAG 254 (773)
Q Consensus 237 ------~~~~~L~~L~L~~n~l~~ 254 (773)
..+++|++|++++|.+++
T Consensus 187 ~~~~~~~~l~~L~~L~L~~n~l~~ 210 (549)
T 2z81_A 187 LLEIFADILSSVRYLELRDTNLAR 210 (549)
T ss_dssp HHHHHHHSTTTBSEEEEESCBCTT
T ss_pred cchhhHhhcccccEEEccCCcccc
Confidence 123467777777776665
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.37 Aligned_cols=198 Identities=28% Similarity=0.432 Sum_probs=172.5
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++. ..+..++||||
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~e~ 95 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-TEKTLYLIMEY 95 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEECC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-ECCEEEEEEEC
Confidence 34578999999999999986 57999999999754 2334567889999999999999999999994 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++|+|.+++.+... ++...+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 96 ~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-- 169 (328)
T 3fe3_A 96 ASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCH-QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-- 169 (328)
T ss_dssp CTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG--
T ss_pred CCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH-HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc--
Confidence 999999999987643 789999999999999999999 99999999999999999999999999999986643322
Q ss_pred eeeccCccccccccccCCCCCC-cchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNAN-TKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~-~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||++.+..++ +++||||+||++|||++|+.||.+.+
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 2345699999999999877765 79999999999999999999997654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.14 Aligned_cols=198 Identities=24% Similarity=0.424 Sum_probs=175.6
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|...+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++. ..+..++||||++
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-VGDELWVVMEYLA 100 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEEECCT
T ss_pred eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE-ECCEEEEEEECCC
Confidence 34568899999999999985 578999999998766666788999999999999999999999995 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.+. .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++........ ...
T Consensus 101 ~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 174 (297)
T 3fxz_A 101 GGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 174 (297)
T ss_dssp TCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred CCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-ccC
Confidence 99999999875 2788999999999999999999 89999999999999999999999999999887654332 223
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4569999999999999999999999999999999999999997643
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=345.67 Aligned_cols=304 Identities=23% Similarity=0.245 Sum_probs=257.2
Q ss_pred CEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEcc
Q 041878 92 QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171 (773)
Q Consensus 92 ~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 171 (773)
.++.++++++.+++..+..+.++++|++|+|++|.++ .+|..+..+++|++|+|++|++++..|..++.+++|++|+++
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 333 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECC
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECC
Confidence 6888888888888877777888899999999998888 678888888899999999998887778888888999999999
Q ss_pred CCCCCCCCccc-cccccccceeecccccccccC--CccccCCCccceeeccccccccccCCcccccccCcccccceeecc
Q 041878 172 NNALIGAIPPS-LANSTRLYRLNLSYNSLLGSI--PLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLD 248 (773)
Q Consensus 172 ~N~l~~~~~~~-l~~l~~L~~L~Ls~N~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~ 248 (773)
+|.+.+.+|.. +..+++|++|++++|++++.. +..+..+++|++|++++|++++..|..+..+. +|++|+++
T Consensus 334 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-----~L~~L~l~ 408 (606)
T 3t6q_A 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECP-----QLELLDLA 408 (606)
T ss_dssp SCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCT-----TCSEEECT
T ss_pred CCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCc-----cCCeEECC
Confidence 98888666554 888888999999999888665 77788888999999999988877777766554 78899999
Q ss_pred ccccccccCcc-CCCCCCccEEECCCCcccCCCCCCcCcccccceecccccccccc---CcccccccccCceEEccCCCC
Q 041878 249 HNLIAGTIPVS-LGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGS---FPVTFTNITSLVSLNLENNRL 324 (773)
Q Consensus 249 ~n~l~~~~~~~-l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l 324 (773)
+|.+++..+.. +..+++|++|++++|.+++..|..+..+++|++|++++|.+++. .+..+..+++|+.|++++|++
T Consensus 409 ~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l 488 (606)
T 3t6q_A 409 FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488 (606)
T ss_dssp TCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCC
T ss_pred CCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCcc
Confidence 99888776544 88888899999999988888888888888999999999988762 235688888899999999998
Q ss_pred CCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCch
Q 041878 325 GNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402 (773)
Q Consensus 325 ~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~ 402 (773)
++..|..+..+++|+.|++++|++++..|..+.++++| .|+|++|++++..|..+..+++|+.|++++|+++|.++.
T Consensus 489 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred CccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 88888888888999999999999888888888888888 899999999888888888888899999999998887773
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=345.79 Aligned_cols=311 Identities=19% Similarity=0.176 Sum_probs=232.5
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
..++.|+|++|.+++..|..++++++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 46889999999999888889999999999999999999988999999999999999999999888999999999999999
Q ss_pred cCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCc------------
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNK------------ 238 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~------------ 238 (773)
++|.+++..+..+.++++|++|+|++|++++.....+..+++|++|++++|++++..|..++.+....
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~ 192 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccC
Confidence 99999876677888899999999999988875444444588888888888887765554444332100
Q ss_pred ------------------------------------------------------------ccccceeeccccccccccCc
Q 041878 239 ------------------------------------------------------------SYQLQFLNLDHNLIAGTIPV 258 (773)
Q Consensus 239 ------------------------------------------------------------~~~L~~L~L~~n~l~~~~~~ 258 (773)
..+|+.|++++|.+++..+.
T Consensus 193 ~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~ 272 (606)
T 3t6q_A 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272 (606)
T ss_dssp EECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTT
T ss_pred ccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHH
Confidence 00455566666666666666
Q ss_pred cCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcch-hhccccc
Q 041878 259 SLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPE-GLERLQN 337 (773)
Q Consensus 259 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~l~~l~~ 337 (773)
.|+.+++|++|++++|+++ .+|..+..+++|++|++++|.+++..|..+..+++|++|++++|.+.+.+|. .+..+++
T Consensus 273 ~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~ 351 (606)
T 3t6q_A 273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351 (606)
T ss_dssp TTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTT
T ss_pred HhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCc
Confidence 6666777777777777776 5666677777777777777777766666677777777777777776655544 3666777
Q ss_pred cccccccCccccccc--ccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCch
Q 041878 338 LTVLNLKNNQFKGHI--PETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402 (773)
Q Consensus 338 L~~L~ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~ 402 (773)
|++|++++|.+++.. +..++.+++|++|++++|++.+..|..+..+++|+.|++++|++++..|.
T Consensus 352 L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 418 (606)
T 3t6q_A 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ 418 (606)
T ss_dssp CCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTC
T ss_pred CCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccc
Confidence 777777777776554 56667777777777777777766666777777777777777777665554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=338.39 Aligned_cols=201 Identities=20% Similarity=0.299 Sum_probs=172.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.++||+|+||+||+|+.. +++.||+|+++... ......+.+|+.+++.++||||+++++++. ..+..++|||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-~~~~~~lV~E 154 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ-DDNNLYLVMD 154 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-CSSEEEEEEC
T ss_pred eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-eCCEEEEEEe
Confidence 345689999999999999976 57889999996532 122334888999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++++. ...+++..+..++.||+.||+||| +.|||||||||+|||++.++.+||+|||+|+........
T Consensus 155 y~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH-~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 231 (437)
T 4aw2_A 155 YYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVH-QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231 (437)
T ss_dssp CCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred cCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHH-hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence 99999999999874 234899999999999999999999 999999999999999999999999999999876554443
Q ss_pred ceeeccCccccccccccC-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSK-----LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~ 285 (437)
T 4aw2_A 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 285 (437)
T ss_dssp ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence 334457999999999886 5678999999999999999999999997654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=322.28 Aligned_cols=198 Identities=23% Similarity=0.366 Sum_probs=172.7
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+.++||+|+||.||+|... +|+.||+|+++.. .......+.+|+.++++++||||+++++++. ..+..++||||
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~~lv~E~ 86 (337)
T 1o6l_A 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-THDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-CSSEEEEEEEC
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-eCCEEEEEEeC
Confidence 45688999999999999865 6899999999754 2334667889999999999999999999995 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++|+|.+++.+.. .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 87 ~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-~ 161 (337)
T 1o6l_A 87 ANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 161 (337)
T ss_dssp CTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-C
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-c
Confidence 99999999998754 3789999999999999999999 99999999999999999999999999999986433221 2
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 234568999999999999999999999999999999999999997644
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=316.07 Aligned_cols=200 Identities=23% Similarity=0.403 Sum_probs=168.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++. ..+..++|||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e 91 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-EDDCYYLVME 91 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-CSSEEEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-eCCeEEEEEe
Confidence 456789999999999999864 689999999864432 23467899999999999999999999994 5558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++++|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++........
T Consensus 92 ~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 92 YIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAH-DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred CCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 999999999998764 3789999999999999999999 999999999999999999999999999999876544433
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......||+.|+|||.+.+..++.++||||+|+++|||+||+.||...+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3444569999999999999999999999999999999999999997643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=335.07 Aligned_cols=198 Identities=21% Similarity=0.318 Sum_probs=171.1
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+.++||+|+||.||+|... +++.||+|+++... ......+.+|+.+++.++||||+++++++. ..+..++||||
T Consensus 72 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~~~lV~E~ 150 (410)
T 3v8s_A 72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-DDRYLYMVMEY 150 (410)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEECC
T ss_pred EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-ECCEEEEEEeC
Confidence 45689999999999999875 68899999996531 223445788999999999999999999995 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++|+|.+++++. .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++.........
T Consensus 151 ~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH-~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 225 (410)
T 3v8s_A 151 MPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225 (410)
T ss_dssp CTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred CCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence 9999999999764 2788999999999999999999 9999999999999999999999999999998765544333
Q ss_pred eeeccCccccccccccCCCC----CCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKN----ANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~----~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||++.... ++.++||||+||++|||++|+.||...+
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 277 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence 34567999999999987655 7899999999999999999999997654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=339.68 Aligned_cols=321 Identities=21% Similarity=0.246 Sum_probs=213.7
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
.+++.|+|++|.+++..+..+.++++|++|+|++|++++..|..|+.+++|++|+|++|+++ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 46788888888888877778888888888888888888888888888888888888888888 56666 7888888888
Q ss_pred cCCCCCC-CCccccccccccceeecccccccccCCccccCCCcc--ceeecccccc--ccccCCccccccc---------
Q 041878 171 SNNALIG-AIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSL--SVLALQHNNL--SGSVPNNWGVLAG--------- 236 (773)
Q Consensus 171 s~N~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L--~~L~L~~N~l--~~~~p~~~~~l~~--------- 236 (773)
++|.+++ .+|..++++++|++|+|++|++++ ..+..+++| ++|++++|++ .+..|..+..+..
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 174 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence 8888886 467888888888888888888875 344555555 7777777776 5555544443210
Q ss_pred ------------C---------------------------------------------------------cccccceeec
Q 041878 237 ------------N---------------------------------------------------------KSYQLQFLNL 247 (773)
Q Consensus 237 ------------~---------------------------------------------------------~~~~L~~L~L 247 (773)
. ..++|++|++
T Consensus 175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l 254 (520)
T 2z7x_B 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254 (520)
T ss_dssp SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEE
T ss_pred CcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEe
Confidence 0 0115666677
Q ss_pred cccccccccCccC-----------------------------------------------------CCCCCccEEECCCC
Q 041878 248 DHNLIAGTIPVSL-----------------------------------------------------GKLGLLQEISLSHN 274 (773)
Q Consensus 248 ~~n~l~~~~~~~l-----------------------------------------------------~~l~~L~~L~L~~N 274 (773)
++|.+++.+|..+ ..+++|++|++++|
T Consensus 255 ~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n 334 (520)
T 2z7x_B 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334 (520)
T ss_dssp EEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSS
T ss_pred ecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECC
Confidence 7777766666555 44556666666666
Q ss_pred cccCCCCCCcCcccccceeccccccccc--cCcccccccccCceEEccCCCCCCCcch-hhccccccccccccCcccccc
Q 041878 275 KIVGPIPDELGKLSKLQKLDLSYNAIGG--SFPVTFTNITSLVSLNLENNRLGNKIPE-GLERLQNLTVLNLKNNQFKGH 351 (773)
Q Consensus 275 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~l~~l~~L~~L~ls~N~l~~~ 351 (773)
++++.+|..+..+++|++|+|++|++++ .+|..+..+++|++|++++|++++.+|. .+..+++|+.|++++|++++.
T Consensus 335 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~ 414 (520)
T 2z7x_B 335 LLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT 414 (520)
T ss_dssp CCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGG
T ss_pred ccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcc
Confidence 6666566666666666666666666664 3445566666666666666666654443 355566666666666666655
Q ss_pred cccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCchh-hh--ccCCCCCCCCCCCCCC
Q 041878 352 IPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPL-LS--KKFNSSSFVGNLQLCG 421 (773)
Q Consensus 352 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~-~~--~~~~~~~~~~n~~~c~ 421 (773)
+|..+. ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|.. +. ..+....+.+|+..|.
T Consensus 415 ~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 415 IFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp GGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred hhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCccc
Confidence 555543 56666666666666 56665556666667777766666 34443 21 1122234455555553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=343.80 Aligned_cols=163 Identities=19% Similarity=0.269 Sum_probs=115.6
Q ss_pred cCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCc-ccccccccCceEEccCCCCCCCcchhhccccc
Q 041878 259 SLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFP-VTFTNITSLVSLNLENNRLGNKIPEGLERLQN 337 (773)
Q Consensus 259 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 337 (773)
.+..+++|++|++++|++++..+ .+..+++|++|++++|.+++..+ ..+..+++|++|++++|++++..|..+..+++
T Consensus 368 ~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 446 (570)
T 2z63_A 368 SDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446 (570)
T ss_dssp HHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTT
T ss_pred cccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCc
Confidence 34444555555555555553322 26667777777777777776555 46777788888888888887777888888888
Q ss_pred cccccccCcccc-cccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCchhhh--ccCCCCCCC
Q 041878 338 LTVLNLKNNQFK-GHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLS--KKFNSSSFV 414 (773)
Q Consensus 338 L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~~~--~~~~~~~~~ 414 (773)
|++|++++|.++ +.+|..+..+++|++|+|++|++++..|..+..+++|+.|++++|++++..|..+. ..+....+.
T Consensus 447 L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 526 (570)
T 2z63_A 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLH 526 (570)
T ss_dssp CCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred CcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEec
Confidence 888888888887 56788888888888888888888887788888888888888888888876665442 223334556
Q ss_pred CCCCCCCC
Q 041878 415 GNLQLCGY 422 (773)
Q Consensus 415 ~n~~~c~~ 422 (773)
+|+..|.+
T Consensus 527 ~N~~~~~~ 534 (570)
T 2z63_A 527 TNPWDCSC 534 (570)
T ss_dssp SSCBCCCT
T ss_pred CCcccCCC
Confidence 67666644
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.39 Aligned_cols=201 Identities=36% Similarity=0.571 Sum_probs=165.9
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.+.||+|+||+||+|.. +|+.||||++..... ...+++.+|++++++++||||+++++++ ...+..++||||+
T Consensus 39 y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~lv~e~~ 116 (309)
T 3p86_A 39 LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-TQPPNLSIVTEYL 116 (309)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSTTCCEEEEECC
T ss_pred ceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-EECCceEEEEecC
Confidence 45678999999999999987 588999999975532 3346789999999999999999999999 5555899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCC--ceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN--MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~--iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
++|+|.+++........+++..+..++.||+.||+||| +.| |+||||||+||+++.++.+||+|||+++...... .
T Consensus 117 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~-~ 194 (309)
T 3p86_A 117 SRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-L 194 (309)
T ss_dssp TTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH-TSSSCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred CCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc-c
Confidence 99999999987543345899999999999999999999 888 9999999999999999999999999997654332 1
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp -------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2234568999999999999999999999999999999999999997654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.09 Aligned_cols=203 Identities=35% Similarity=0.617 Sum_probs=177.3
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
...+.||+|+||.||+|.+.+|+.||||++........+.+.+|++++++++||||+++++++ ...+..++||||+++|
T Consensus 42 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-DERNEMILIYKYMENG 120 (321)
T ss_dssp SCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-CCTTCCEEEEECCTTC
T ss_pred CccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-cCCCeEEEEEEcCCCC
Confidence 456789999999999999888999999999877666678899999999999999999999998 5556899999999999
Q ss_pred CHHHHHhhcCC-CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc-cee
Q 041878 618 SLASFLHARGP-ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT-NVI 695 (773)
Q Consensus 618 ~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~ 695 (773)
+|.+++..... ...+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++........ ...
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 199 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBC
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc-CCCeecCCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 99999876532 235899999999999999999999 899999999999999999999999999999865432221 222
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp CCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred ccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 34589999999999888999999999999999999999999986543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=338.80 Aligned_cols=325 Identities=23% Similarity=0.244 Sum_probs=258.4
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
.+++.|+|++|.+++..+..+.++++|++|+|++|.+++..|..|..+++|++|+|++|+++ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 57889999999999888889999999999999999999998999999999999999999999 67766 8999999999
Q ss_pred cCCCCCC-CCccccccccccceeecccccccccCCccccCCCccceeecccccc--ccccCCcccccc------------
Q 041878 171 SNNALIG-AIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNL--SGSVPNNWGVLA------------ 235 (773)
Q Consensus 171 s~N~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l--~~~~p~~~~~l~------------ 235 (773)
++|.+++ .+|..++++++|++|+|++|++++.....+.++ +|++|++++|++ ++..|..+..+.
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L-~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~ 207 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL-HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNS 207 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTS-CEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSS
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhc-eeeEEEeecccccccccCcccccccCcceEEEEecCcc
Confidence 9999986 456899999999999999999986433333333 448899998888 666666554432
Q ss_pred ---------cC-------------------------------------------------------cccccceeeccccc
Q 041878 236 ---------GN-------------------------------------------------------KSYQLQFLNLDHNL 251 (773)
Q Consensus 236 ---------~~-------------------------------------------------------~~~~L~~L~L~~n~ 251 (773)
.. ...+|++|++++|.
T Consensus 208 ~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~ 287 (562)
T 3a79_B 208 LFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLT 287 (562)
T ss_dssp CCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEE
T ss_pred chhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccE
Confidence 00 00167777788888
Q ss_pred cccccCccC-----------------------------------------------------CCCCCccEEECCCCcccC
Q 041878 252 IAGTIPVSL-----------------------------------------------------GKLGLLQEISLSHNKIVG 278 (773)
Q Consensus 252 l~~~~~~~l-----------------------------------------------------~~l~~L~~L~L~~N~l~~ 278 (773)
+++.+|..+ ..+++|++|++++|++++
T Consensus 288 l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~ 367 (562)
T 3a79_B 288 ITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTD 367 (562)
T ss_dssp ECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCT
T ss_pred eeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCcccc
Confidence 877766655 567888899999999988
Q ss_pred CCCCCcCcccccceeccccccccc--cCcccccccccCceEEccCCCCCCCcch-hhccccccccccccCcccccccccc
Q 041878 279 PIPDELGKLSKLQKLDLSYNAIGG--SFPVTFTNITSLVSLNLENNRLGNKIPE-GLERLQNLTVLNLKNNQFKGHIPET 355 (773)
Q Consensus 279 ~~p~~l~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~l~~l~~L~~L~ls~N~l~~~~~~~ 355 (773)
.+|..+..+++|++|+|++|++++ .+|..+..+++|++|++++|++++.+|. .+..+++|++|++++|++++.+|..
T Consensus 368 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 447 (562)
T 3a79_B 368 SVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRC 447 (562)
T ss_dssp TTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSS
T ss_pred chhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhh
Confidence 888888888999999999998886 3356788888999999999998875554 5778888888999988888777766
Q ss_pred cCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCchh-hh--ccCCCCCCCCCCCCCCCC
Q 041878 356 IGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPL-LS--KKFNSSSFVGNLQLCGYS 423 (773)
Q Consensus 356 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~-~~--~~~~~~~~~~n~~~c~~~ 423 (773)
+. ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ .+|.. +. ..+....+.+|+..|.++
T Consensus 448 l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 448 LP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp CC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred hc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 54 68888999999888 67777778888999999999988 46654 31 223334566777776543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=325.95 Aligned_cols=198 Identities=25% Similarity=0.385 Sum_probs=168.6
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEe
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
.+.++||+|+||.||+|... +|+.||||+++.. .......+.+|+.+++.+ +||||+++++++. ..+..++|||
T Consensus 26 ~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-~~~~~~lv~E 104 (353)
T 3txo_A 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ-TPDRLFFVME 104 (353)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE-CSSEEEEEEE
T ss_pred EEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE-eCCEEEEEEe
Confidence 45689999999999999865 6899999999754 233456788899999988 6999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++++.. .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++...... .
T Consensus 105 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~-~ 179 (353)
T 3txo_A 105 FVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLH-DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-V 179 (353)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCHHHEEECCCCCEEEccccceeecccCC-c
Confidence 999999999998764 3889999999999999999999 9999999999999999999999999999997543222 2
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 2334569999999999998899999999999999999999999997654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=315.60 Aligned_cols=200 Identities=28% Similarity=0.486 Sum_probs=174.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|...++||+|+||+||+|... +++.||+|++........+.+.+|++++++++||||+++++++. ..+..++||||++
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~~ 90 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-KDKRLNFITEYIK 90 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTEEEEEEECCT
T ss_pred eeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-cCCeeEEEEEecC
Confidence 345789999999999999874 68999999997766667788999999999999999999999995 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc--
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN-- 693 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~-- 693 (773)
+|+|.++++... ..+++.++..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.........
T Consensus 91 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 91 GGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLH-SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp TCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred CCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 999999998753 34899999999999999999999 9999999999999999999999999999998764332211
Q ss_pred -----------eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 694 -----------VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 694 -----------~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
.....||+.|+|||++.+..++.++||||||+++|||++|..||...
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 11346999999999999999999999999999999999999998763
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=332.16 Aligned_cols=200 Identities=19% Similarity=0.302 Sum_probs=172.4
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+.++||+|+||.||+|... +|+.||||+++... ......+.+|+.++.+++||||+++++++.. .+..|+||||
T Consensus 64 ~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~-~~~~~lVmE~ 142 (412)
T 2vd5_A 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-ENYLYLVMEY 142 (412)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-SSEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEEEEEEcC
Confidence 45688999999999999874 78999999996532 2223457889999999999999999999954 5589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++|+|.+++.+.+ ..+++..+..++.||+.||+||| +.||+||||||+|||++.++++||+|||+++.........
T Consensus 143 ~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH-~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~ 219 (412)
T 2vd5_A 143 YVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVH-RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219 (412)
T ss_dssp CCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred CCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCeeecccCHHHeeecCCCCEEEeechhheeccCCCccc
Confidence 99999999998753 24889999999999999999999 9999999999999999999999999999998765444333
Q ss_pred eeeccCccccccccccC-------CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSK-------LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~-------~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 33457999999999886 4578999999999999999999999997654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=317.06 Aligned_cols=195 Identities=24% Similarity=0.414 Sum_probs=172.0
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+.++||+|+||.||+|... +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++. ..+..++||||
T Consensus 9 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~~lv~e~ 87 (318)
T 1fot_A 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-DAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-CSSEEEEEECC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-eCCEEEEEEeC
Confidence 45689999999999999865 78999999997542 234567889999999999999999999995 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++|+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---- 159 (318)
T 1fot_A 88 IEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLH-SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 159 (318)
T ss_dssp CCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred CCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCChheEEEcCCCCEEEeecCcceecCCc----
Confidence 99999999998753 3789999999999999999999 999999999999999999999999999999865432
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 223469999999999999999999999999999999999999997644
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=325.34 Aligned_cols=207 Identities=28% Similarity=0.439 Sum_probs=175.0
Q ss_pred HHHhhcccccccceEEEEEEeC--------CCCEEEEEEecccCc-ccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCC
Q 041878 536 LCATAEIMGKSTYGTAYKATLE--------DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKG 605 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 605 (773)
.|.+.+.||+|+||.||+|.+. ++..||||+++.... ...+++.+|+++++++ +||||+++++++ ...+
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-~~~~ 160 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-TQDG 160 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE-CSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-ccCC
Confidence 3466789999999999999852 345799999976533 3456799999999999 899999999999 4556
Q ss_pred eEEEEEeecCCCCHHHHHhhcCC-------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC
Q 041878 606 EKLLVFDFMPKGSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK 672 (773)
Q Consensus 606 ~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~ 672 (773)
..++||||+++|+|.++++.... ...+++..++.++.||+.||+||| +.||+||||||+|||++.+
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA-SQKCIHRDLAARNVLVTEN 239 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTT
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-hCCeeccccchhhEEECCC
Confidence 89999999999999999987542 235789999999999999999999 9999999999999999999
Q ss_pred CCeEEeecCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCC
Q 041878 673 TNPRIADFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMD 744 (773)
Q Consensus 673 ~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~ 744 (773)
+.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999866543221 2223457889999999998999999999999999999999 999998755433
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=317.08 Aligned_cols=197 Identities=22% Similarity=0.376 Sum_probs=174.5
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
...++||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++.. .+..++||||+++
T Consensus 48 ~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~ 126 (321)
T 2c30_A 48 DSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-GEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEECCCCS
T ss_pred hccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEecCCC
Confidence 34568999999999999876 799999999987766677889999999999999999999999954 4589999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.+++... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++........ ....
T Consensus 127 ~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 200 (321)
T 2c30_A 127 GALTDIVSQV----RLNEEQIATVCEAVLQALAYLH-AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 200 (321)
T ss_dssp CBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCC
T ss_pred CCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-cccc
Confidence 9999998753 3899999999999999999999 89999999999999999999999999999887654322 2234
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 569999999999999999999999999999999999999997643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=322.68 Aligned_cols=209 Identities=22% Similarity=0.355 Sum_probs=178.1
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.++||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++. ..+..++|||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~~~lv~e 95 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-DEEDMFMVVD 95 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEEC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-eCCEEEEEEe
Confidence 356789999999999999865 68899999996432 334577889999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.... .+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-- 169 (384)
T 4fr4_A 96 LLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQ-NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-- 169 (384)
T ss_dssp CCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC--
Confidence 999999999998753 3889999999999999999999 9999999999999999999999999999998764332
Q ss_pred ceeeccCccccccccccCC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 041878 693 NVIATAGTLGYRAPELSKL---KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASI 752 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~ 752 (773)
......||+.|+|||++.. ..++.++||||+||++|||++|+.||.........+.+..+
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~ 232 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH
Confidence 2334569999999999863 45899999999999999999999999876666555544443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=321.93 Aligned_cols=198 Identities=26% Similarity=0.452 Sum_probs=173.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc------cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK------GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
|.+.+.||+|+||.||+|... +|+.||+|.++..... ..+.+.+|+.++++++||||+++++++. ..+..++
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~l 92 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE-NRTDVVL 92 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE-eCCEEEE
Confidence 356789999999999999865 6899999999754322 3578999999999999999999999994 4558999
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC----CeEEeecCCccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT----NPRIADFGLSRL 685 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~----~~kl~DfG~a~~ 685 (773)
||||+++|+|.+++.... .+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++..
T Consensus 93 v~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH-~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 93 ILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 999999999999997643 4899999999999999999999 99999999999999998877 799999999987
Q ss_pred cccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 686 MTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+
T Consensus 169 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~ 222 (361)
T 2yab_A 169 IEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (361)
T ss_dssp CCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred cCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 654322 234569999999999998999999999999999999999999997654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=321.05 Aligned_cols=198 Identities=24% Similarity=0.397 Sum_probs=171.7
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEe
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
.+.++||+|+||.||+|... +|+.||||+++... ......+..|..+++++ +||||+++++++.. .+..++|||
T Consensus 20 ~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~-~~~~~lv~E 98 (345)
T 1xjd_A 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENLFFVME 98 (345)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-CCEEEEEEe
Confidence 45689999999999999875 68899999997542 33456788899999887 89999999999954 558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.++++... .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++...... .
T Consensus 99 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 173 (345)
T 1xjd_A 99 YLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLH-SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 173 (345)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred CCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-C
Confidence 999999999998754 3789999999999999999999 9999999999999999999999999999997643222 1
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 2334579999999999999999999999999999999999999997654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=342.57 Aligned_cols=328 Identities=21% Similarity=0.224 Sum_probs=248.0
Q ss_pred CEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCC-----CCCC----CCCCC
Q 041878 92 QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSG-----SIPP----SIGNC 162 (773)
Q Consensus 92 ~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~-----~~p~----~l~~l 162 (773)
.++.|+|++|.+++..+..++++++|++|+|++|.+++..|..+..+++|++|+|++|...+ .+|. .|+.+
T Consensus 249 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l 328 (680)
T 1ziw_A 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL 328 (680)
T ss_dssp CCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTC
T ss_pred CCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccC
Confidence 46777777777777777777777777777777777777666666666666666555544332 1221 45555
Q ss_pred CCCCEEEccCCCCCCCCccccccccccce----------------------------eecccccccccCCccccCCCccc
Q 041878 163 PNLQTLDLSNNALIGAIPPSLANSTRLYR----------------------------LNLSYNSLLGSIPLSLTRLPSLS 214 (773)
Q Consensus 163 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~----------------------------L~Ls~N~l~~~~~~~l~~l~~L~ 214 (773)
++|++|+|++|.+++..+..+.++++|++ |+|++|++++..|..+..+++|+
T Consensus 329 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 408 (680)
T 1ziw_A 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLE 408 (680)
T ss_dssp TTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred CCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCC
Confidence 66666666666666555555555544444 44455556666677777888888
Q ss_pred eeeccccccccccC-CcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCccc--CCCCCCcCcccccc
Q 041878 215 VLALQHNNLSGSVP-NNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIV--GPIPDELGKLSKLQ 291 (773)
Q Consensus 215 ~L~L~~N~l~~~~p-~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~ 291 (773)
.|+|++|++++.+| ..+..+ ++|++|++++|.+++..+..|..+++|+.|++++|.+. +.+|..|..+++|+
T Consensus 409 ~L~L~~N~l~~~~~~~~~~~l-----~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~ 483 (680)
T 1ziw_A 409 VLDLGLNEIGQELTGQEWRGL-----ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483 (680)
T ss_dssp EEECCSSCCEEECCSGGGTTC-----TTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred EEeCCCCcCccccCcccccCc-----ccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence 88888888877665 344433 37888888888888888888888888888888888886 56788899999999
Q ss_pred eeccccccccccCcccccccccCceEEccCCCCCCCcc--------hhhccccccccccccCcccccccccccCCCCcCc
Q 041878 292 KLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIP--------EGLERLQNLTVLNLKNNQFKGHIPETIGNISGIN 363 (773)
Q Consensus 292 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--------~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~ 363 (773)
+|+|++|++++..+..|..+++|++|+|++|++++..+ ..+..+++|++|+|++|+++...+..|.++++|+
T Consensus 484 ~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 563 (680)
T 1ziw_A 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcc
Confidence 99999999998888889999999999999999976422 2478899999999999999955556789999999
Q ss_pred eeecCCccCccCCCchhhccCccCEEEeecccCCCCCchhhh---ccCCCCCCCCCCCCCCCCC
Q 041878 364 QLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLS---KKFNSSSFVGNLQLCGYSP 424 (773)
Q Consensus 364 ~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~~~---~~~~~~~~~~n~~~c~~~~ 424 (773)
.|+|++|++++..+..|..+++|+.|+|++|++++..|..+. ..+....+.+|++.|+++.
T Consensus 564 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred eeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 999999999977777789999999999999999998776543 3455567889999997753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=311.36 Aligned_cols=200 Identities=27% Similarity=0.485 Sum_probs=175.6
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
|.+.+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++ ...+..++||||+++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVC-LEQAPICLVFEFMEH 89 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSSEEEEEECCTT
T ss_pred ceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEE-ecCCceEEEEEeCCC
Confidence 456789999999999999988889999999975443 457899999999999999999999999 455689999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.............
T Consensus 90 ~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 90 GCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE-EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp CBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHH-hCCeecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence 99999997643 34789999999999999999999 9999999999999999999999999999998765443333334
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
..+|+.|+|||.+....++.++||||+|+++|||++ |+.||...+
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 457889999999988899999999999999999999 999997654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=337.45 Aligned_cols=327 Identities=23% Similarity=0.270 Sum_probs=260.2
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
.+++.|+|++|.+++..|..+.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..++++++|++|+|
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence 36777888888888777777888888888888888888777888888888888888888887766677888888888888
Q ss_pred cCCCCCC-CCccccccccccceeecccccccccCCccccC----------------------------------------
Q 041878 171 SNNALIG-AIPPSLANSTRLYRLNLSYNSLLGSIPLSLTR---------------------------------------- 209 (773)
Q Consensus 171 s~N~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~---------------------------------------- 209 (773)
++|.+++ .+|..++++++|++|+|++|++++..+..+..
T Consensus 136 ~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n~ 215 (606)
T 3vq2_A 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNF 215 (606)
T ss_dssp CSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCC
T ss_pred CCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCCc
Confidence 8888775 45777888888888887777776544332211
Q ss_pred --------------------------------------------------------------------------------
Q 041878 210 -------------------------------------------------------------------------------- 209 (773)
Q Consensus 210 -------------------------------------------------------------------------------- 209 (773)
T Consensus 216 ~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~ 295 (606)
T 3vq2_A 216 NSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295 (606)
T ss_dssp SCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESC
T ss_pred cchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCc
Confidence
Q ss_pred -----------------------------------------------------CCccceeecccccccccc--CCccccc
Q 041878 210 -----------------------------------------------------LPSLSVLALQHNNLSGSV--PNNWGVL 234 (773)
Q Consensus 210 -----------------------------------------------------l~~L~~L~L~~N~l~~~~--p~~~~~l 234 (773)
+++|++|++++|++++.. |..+.
T Consensus 296 ~~~~l~~l~~~~~L~~L~l~~n~l~~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~-- 373 (606)
T 3vq2_A 296 SIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDL-- 373 (606)
T ss_dssp CCCCCCCCCTTCCCSEEEEESCCCSSCCCCCCSSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHH--
T ss_pred cchhhhhccccccCCEEEcccccCcccccCCCCccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhc--
Confidence 112222222222222111 11111
Q ss_pred ccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCC-CCcCcccccceeccccccccccCccccccccc
Q 041878 235 AGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIP-DELGKLSKLQKLDLSYNAIGGSFPVTFTNITS 313 (773)
Q Consensus 235 ~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 313 (773)
.+++|++|++++|.+++ +|..+..+++|+.|++++|++.+..| ..+..+++|++|++++|.+++..|..+..+++
T Consensus 374 ---~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 449 (606)
T 3vq2_A 374 ---GTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS 449 (606)
T ss_dssp ---CCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTT
T ss_pred ---cCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCC
Confidence 23489999999999986 55889999999999999999998877 68999999999999999999999999999999
Q ss_pred CceEEccCCCCCC-CcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEee
Q 041878 314 LVSLNLENNRLGN-KIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVS 392 (773)
Q Consensus 314 L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls 392 (773)
|++|++++|++++ .+|..+..+++|++|++++|++++..|..++++++|++|+|++|++++.+|..+..+++|+.|+|+
T Consensus 450 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 529 (606)
T 3vq2_A 450 LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529 (606)
T ss_dssp CCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECT
T ss_pred CCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECC
Confidence 9999999999988 478899999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCchhhhc---cCCCCCCCCCCCCCCCCC
Q 041878 393 YNNLSGSVPPLLSK---KFNSSSFVGNLQLCGYSP 424 (773)
Q Consensus 393 ~N~l~g~~p~~~~~---~~~~~~~~~n~~~c~~~~ 424 (773)
+|+++ .+|..+.. .+....+.+|+..|+++.
T Consensus 530 ~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 530 FNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp TSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 99999 57765422 234456789999998775
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=321.75 Aligned_cols=200 Identities=40% Similarity=0.691 Sum_probs=173.9
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|...++||+|+||.||+|...+|+.||||++..... .....+.+|++++++++||||+++++++ ...+..++||||++
T Consensus 32 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~ 110 (326)
T 3uim_A 32 FSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC-MTPTERLLVYPYMA 110 (326)
T ss_dssp SCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE-CCSSCCEEEEECCT
T ss_pred cccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE-ecCCceEEEEEecc
Confidence 345688999999999999988899999999975432 2344789999999999999999999999 45558899999999
Q ss_pred CCCHHHHHhhcCC-CCccCHHHHHHHHHHHHHHHHHhccCC---CceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 616 KGSLASFLHARGP-ETIVNWATRMSIAIGIARGLNYLHVEE---NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 616 ~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~yLH~~~---~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
+|+|.++++.... ...+++..+..++.|++.||+||| +. ||+||||||+||+++.++.+||+|||+++.......
T Consensus 111 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 189 (326)
T 3uim_A 111 NGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189 (326)
T ss_dssp TCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH-HSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS
T ss_pred CCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc
Confidence 9999999987642 345899999999999999999999 77 999999999999999999999999999987755444
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGE 738 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~ 738 (773)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||.
T Consensus 190 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 44445569999999999988889999999999999999999999996
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=323.51 Aligned_cols=198 Identities=21% Similarity=0.392 Sum_probs=170.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
|.+.++||+|+||.||+|+.. +++.||+|+++.... .....+..|..+++++ +||||+++++++. ..+..++||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-~~~~~~lV~ 132 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-TESRLFFVI 132 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-CSSEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-ECCEEEEEE
Confidence 356789999999999999875 578899999975432 2334678899999887 8999999999995 455899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++|+|.+++.+.. .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++......
T Consensus 133 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH-~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~- 207 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG- 207 (396)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred EcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC-
Confidence 9999999999998754 3899999999999999999999 9999999999999999999999999999998633222
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 2233457999999999999999999999999999999999999999753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.10 Aligned_cols=195 Identities=23% Similarity=0.350 Sum_probs=172.2
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++. ..+..++||||
T Consensus 44 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~ 122 (350)
T 1rdq_E 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-DNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEEC
T ss_pred EEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-cCCEEEEEEcC
Confidence 45688999999999999865 68999999996532 234567889999999999999999999995 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++|+|.+++.+... ++...+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++......
T Consensus 123 ~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~--- 195 (350)
T 1rdq_E 123 VAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT--- 195 (350)
T ss_dssp CTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB---
T ss_pred CCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHH-HCCcccccCccceEEECCCCCEEEcccccceeccCCc---
Confidence 999999999987643 789999999999999999999 9999999999999999999999999999998764332
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 196 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 196 -WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp -CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 23468999999999999999999999999999999999999997644
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=311.25 Aligned_cols=210 Identities=29% Similarity=0.402 Sum_probs=175.8
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.++||+|+||+||+|...+|+.||+|++..... .....+.+|++++++++||||+++++++ ...+..++||||++
T Consensus 24 ~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 24 QKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-HSERCLTLVFEFME 102 (311)
T ss_dssp EEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-CCSSCEEEEEECCS
T ss_pred HhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-ccCCEEEEEEcCCC
Confidence 45689999999999999998899999999975432 2346788999999999999999999999 55568999999997
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
|+|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....... ...
T Consensus 103 -~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 177 (311)
T 3niz_A 103 -KDLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCH-QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYT 177 (311)
T ss_dssp -EEHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC----
T ss_pred -CCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-ccc
Confidence 58888887653 34789999999999999999999 99999999999999999999999999999987643322 223
Q ss_pred eccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHH
Q 041878 696 ATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIV 753 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~ 753 (773)
...+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+.+..
T Consensus 178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 236 (311)
T 3niz_A 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236 (311)
T ss_dssp CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHH
T ss_pred CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Confidence 4468999999998865 568999999999999999999999999877776666555543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.25 Aligned_cols=198 Identities=23% Similarity=0.353 Sum_probs=171.8
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEe
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
.+.++||+|+||.||+|... +|+.||||+++.. .......+..|..+++.+ +||+|+++++++. ..+..++|||
T Consensus 23 ~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-~~~~~~lv~E 101 (353)
T 2i0e_A 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-TMDRLYFVME 101 (353)
T ss_dssp EEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE-CSSEEEEEEE
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE-cCCEEEEEEe
Confidence 45689999999999999875 4788999999754 223456788999999988 7999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++++.. .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++...... .
T Consensus 102 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 176 (353)
T 2i0e_A 102 YVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQ-SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-V 176 (353)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-c
Confidence 999999999998754 3889999999999999999999 9999999999999999999999999999998643222 1
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 2334569999999999999999999999999999999999999997654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=314.04 Aligned_cols=217 Identities=21% Similarity=0.354 Sum_probs=182.1
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCC-CeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-GEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~lV~e~~ 614 (773)
.+.++||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.... ...++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 91 (319)
T 4euu_A 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91 (319)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred EEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCC
Confidence 45689999999999999875 58999999997543 334677889999999999999999999986544 3679999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe----CCCCCeEEeecCCcccccccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL----DEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll----~~~~~~kl~DfG~a~~~~~~~ 690 (773)
++++|.+++........+++..++.++.||+.||+||| +.||+||||||+||++ +.++.+||+|||+++......
T Consensus 92 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~ 170 (319)
T 4euu_A 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170 (319)
T ss_dssp TTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC
T ss_pred CCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC
Confidence 99999999987654445899999999999999999999 9999999999999999 778889999999998765443
Q ss_pred ccceeeccCccccccccccC--------CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC-CChHHHHHHHHHhhh
Q 041878 691 NTNVIATAGTLGYRAPELSK--------LKNANTKTDVYSLGVIILELLTGKSPGEPMNG-MDLPQWVASIVKEEW 757 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~-~~~~~~~~~~~~~~~ 757 (773)
. .....||+.|+|||++. ...++.++|||||||++|||++|+.||..... ....+.+.+++...+
T Consensus 171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 171 Q--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp C--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred c--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 2 22346899999999875 57889999999999999999999999987543 345566666665543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=319.31 Aligned_cols=199 Identities=28% Similarity=0.406 Sum_probs=172.4
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
.|.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++. ..+..++|||
T Consensus 30 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~~~lv~e 108 (362)
T 2bdw_A 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-EESFHYLVFD 108 (362)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEEC
T ss_pred CeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-eCCEEEEEEe
Confidence 3567789999999999999864 68999999997543 234567889999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC---CeEEeecCCccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT---NPRIADFGLSRLMTAA 689 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~---~~kl~DfG~a~~~~~~ 689 (773)
|+++|+|.+++.... .+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++......
T Consensus 109 ~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH-~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 109 LVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred cCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 999999999997643 4789999999999999999999 99999999999999998654 5999999999876533
Q ss_pred cccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 185 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 185 EA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234 (362)
T ss_dssp CS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 22 234569999999999998899999999999999999999999997654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=318.30 Aligned_cols=204 Identities=25% Similarity=0.473 Sum_probs=171.3
Q ss_pred HHHHhhcccccccceEEEEEEeC----CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 535 LLCATAEIMGKSTYGTAYKATLE----DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
-+|.+.++||+|+||.||+|.+. .+..||||+++... ....+.+.+|+.++++++||||+++++++ ...+..++
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~l 127 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-TRGRLAMI 127 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CGGGCCEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-EeCCccEE
Confidence 34567789999999999999874 34469999997653 33456799999999999999999999999 45558899
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||+++|+|.++++... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLS-DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 999999999999997652 34899999999999999999999 999999999999999999999999999999876544
Q ss_pred cccc--eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 690 ANTN--VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 690 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
.... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 260 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence 3222 122346778999999988899999999999999999999 9999976543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-35 Score=339.74 Aligned_cols=333 Identities=21% Similarity=0.206 Sum_probs=264.0
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
..++.|||++|.+++..+..|.++++|++|+|++|+|++..+.+|.++++|++|+|++|+|++..+..|+++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 36899999999999877889999999999999999999888889999999999999999999777788999999999999
Q ss_pred cCCCCCCCCccccccccccceeecccccccc-cCCccccCCCccceeeccccccccccCCccccccc-------------
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLG-SIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAG------------- 236 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~------------- 236 (773)
++|++++..+..|+++++|++|+|++|.+++ ..|..+..+++|++|+|++|++++..+..+..+..
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 9999997777789999999999999999986 46888999999999999999987655443321100
Q ss_pred --------------------------------------------------------------------------------
Q 041878 237 -------------------------------------------------------------------------------- 236 (773)
Q Consensus 237 -------------------------------------------------------------------------------- 236 (773)
T Consensus 212 ~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~ 291 (635)
T 4g8a_A 212 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 291 (635)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECC
T ss_pred cccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhh
Confidence
Q ss_pred ---------------------------------CcccccceeeccccccccccCc-------------------cCCCCC
Q 041878 237 ---------------------------------NKSYQLQFLNLDHNLIAGTIPV-------------------SLGKLG 264 (773)
Q Consensus 237 ---------------------------------~~~~~L~~L~L~~n~l~~~~~~-------------------~l~~l~ 264 (773)
....+|+.|++.+|.+.+..+. ....++
T Consensus 292 ~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~ 371 (635)
T 4g8a_A 292 DYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP 371 (635)
T ss_dssp CSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCT
T ss_pred cccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCccccccc
Confidence 0001233344444433322111 112345
Q ss_pred CccEEECCCCccc-------------------------------------------------CCC-CCCcCcccccceec
Q 041878 265 LLQEISLSHNKIV-------------------------------------------------GPI-PDELGKLSKLQKLD 294 (773)
Q Consensus 265 ~L~~L~L~~N~l~-------------------------------------------------~~~-p~~l~~l~~L~~L~ 294 (773)
+|+.|++++|.+. ... +..+..+++++.++
T Consensus 372 ~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ 451 (635)
T 4g8a_A 372 SLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 451 (635)
T ss_dssp TCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEE
T ss_pred ccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccccccccc
Confidence 5666666666542 111 13355667778888
Q ss_pred cccccccccCcccccccccCceEEccCCCC-CCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCc
Q 041878 295 LSYNAIGGSFPVTFTNITSLVSLNLENNRL-GNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFT 373 (773)
Q Consensus 295 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 373 (773)
++.|.+.+..+..+..+++|+.|+|++|++ .+..|..+..+++|++|+|++|++++..|..|.++++|++|+|++|+|+
T Consensus 452 ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~ 531 (635)
T 4g8a_A 452 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 531 (635)
T ss_dssp CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred ccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCC
Confidence 888888888888888899999999999974 4457788999999999999999999989999999999999999999999
Q ss_pred cCCCchhhccCccCEEEeecccCCCCCchhhhc---cCCCCCCCCCCCCCCCC
Q 041878 374 GEISPSLASLANLTSFNVSYNNLSGSVPPLLSK---KFNSSSFVGNLQLCGYS 423 (773)
Q Consensus 374 ~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~~~~---~~~~~~~~~n~~~c~~~ 423 (773)
+..|..+..+++|+.|+|++|+|++..|..+.. .+....+.+|+..|+|.
T Consensus 532 ~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 532 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp BCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 988899999999999999999999988876632 23344677898888664
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=313.74 Aligned_cols=199 Identities=26% Similarity=0.435 Sum_probs=173.7
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc------ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT------KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
.|.+.+.||+|+||.||+|... +|+.||+|.+..... ...+++.+|+.++++++||||+++++++. ..+..+
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~ 90 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-NKTDVI 90 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-eCCEEE
Confidence 3567789999999999999865 689999999975432 24678999999999999999999999995 455899
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC----CeEEeecCCcc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT----NPRIADFGLSR 684 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~----~~kl~DfG~a~ 684 (773)
+||||+++|+|.+++.... .+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+++
T Consensus 91 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHH-HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 9999999999999997643 4889999999999999999999 99999999999999999887 79999999998
Q ss_pred ccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 685 LMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....... .....||+.|+|||++....++.++||||+||++|||++|+.||....
T Consensus 167 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 221 (326)
T 2y0a_A 167 KIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 221 (326)
T ss_dssp ECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence 7653322 233469999999999998999999999999999999999999997644
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.16 Aligned_cols=199 Identities=25% Similarity=0.423 Sum_probs=162.9
Q ss_pred HHhhcccccccceEEEEEEe----CCCCEEEEEEecccC----cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 537 CATAEIMGKSTYGTAYKATL----EDGSEVAVKRLREKT----TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
|.+.++||+|+||.||+|.. .+|+.||+|+++... ......+.+|+.++++++||||+++++++. ..+..+
T Consensus 19 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~ 97 (327)
T 3a62_A 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ-TGGKLY 97 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE-CSSCEE
T ss_pred eEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE-cCCEEE
Confidence 45678999999999999986 478999999997542 233456788999999999999999999995 455899
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||+++|+|.+++.... .++...+..++.||+.||.||| +.||+||||||+|||++.++.+||+|||+++....
T Consensus 98 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH-~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 173 (327)
T 3a62_A 98 LILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLH-QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173 (327)
T ss_dssp EEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred EEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHH-hCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence 9999999999999998754 3788899999999999999999 89999999999999999999999999999875433
Q ss_pred ccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 174 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 174 DGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 221 2233468999999999998999999999999999999999999997644
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=316.10 Aligned_cols=279 Identities=17% Similarity=0.238 Sum_probs=179.6
Q ss_pred cccCHHHHHHHHHHHHhCC-CCCCCcCCCC---CCCCCCCCCCCcceEeeC----------CCEEEEEcCCCCcccccCc
Q 041878 44 VIVTQADYQSLRAIKHDLI-DPHGFLRSWN---DSGVGACSGGWAGIKCVK----------GQVIAIQLPWRRLGGRISE 109 (773)
Q Consensus 44 ~~~~~~~~~~L~~~k~~~~-~~~~~l~sW~---~~~~~~c~~~w~gv~c~~----------~~v~~l~l~~~~l~~~i~~ 109 (773)
..+..+|++||++||.++. ||.+++.+|. ....++|. |.|+.|.. .+|+.|+|++++++ .+|+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~--~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~ 98 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIET--RTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD 98 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCC--SHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccc--cCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh
Confidence 3456789999999999984 8888899994 33455565 99999941 45666666666665 5566
Q ss_pred cccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCcccccccccc
Q 041878 110 KISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRL 189 (773)
Q Consensus 110 ~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 189 (773)
.+.++++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..++++++|++|+|++|++.+.+|..+...
T Consensus 99 ~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~--- 173 (328)
T 4fcg_A 99 QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST--- 173 (328)
T ss_dssp CGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE---
T ss_pred hhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc---
Confidence 6666666666666666666 55666666666666666666666 556666666666666666666555555554430
Q ss_pred ceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEE
Q 041878 190 YRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEI 269 (773)
Q Consensus 190 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 269 (773)
..+..+.++++|++|+|++|+++ .+|..++.+. +|++|+|++|.+++ +|..++.+++|++|
T Consensus 174 ------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~-----~L~~L~L~~N~l~~-l~~~l~~l~~L~~L 234 (328)
T 4fcg_A 174 ------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQ-----NLKSLKIRNSPLSA-LGPAIHHLPKLEEL 234 (328)
T ss_dssp ------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCT-----TCCEEEEESSCCCC-CCGGGGGCTTCCEE
T ss_pred ------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCC-----CCCEEEccCCCCCc-CchhhccCCCCCEE
Confidence 00001122445555555555554 4444443332 45555555555553 34456666777777
Q ss_pred ECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccc
Q 041878 270 SLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFK 349 (773)
Q Consensus 270 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~ 349 (773)
+|++|++.+.+|..+..+++|++|+|++|.+.+.+|..+..+++|++|+|++|++.+.+|..++.+++|+.+++..|.+.
T Consensus 235 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp ECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred ECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 77777777777777777777777777777777777777777777777777777777777777777777777777766554
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.60 Aligned_cols=208 Identities=21% Similarity=0.333 Sum_probs=176.4
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
.+.+.||+|+||+||+|... +++.||+|.+.... .....+.+|+.++++++||||+++++++. ..+..++||||+++
T Consensus 8 ~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~e~~~g 85 (321)
T 1tki_A 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE-SMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE-ETTEEEEEECCCCC
T ss_pred EeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEe-cCCEEEEEEEeCCC
Confidence 45688999999999999865 67889999987443 34567899999999999999999999994 45589999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC--CCCeEEeecCCccccccccccce
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE--KTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~--~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
|+|.+++.... ..+++..+..++.||+.||.||| +.||+||||||+||+++. ++.+||+|||++....... ..
T Consensus 86 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH-~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~~ 160 (321)
T 1tki_A 86 LDIFERINTSA--FELNEREIVSYVHQVCEALQFLH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NF 160 (321)
T ss_dssp CBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--EE
T ss_pred CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--cc
Confidence 99999997642 34889999999999999999999 999999999999999997 7899999999998765432 22
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHh
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKE 755 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 755 (773)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...+. .+.+..+...
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~ 218 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMNA 218 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHHT
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHcC
Confidence 345689999999999988899999999999999999999999976543 3444444443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=323.03 Aligned_cols=199 Identities=19% Similarity=0.285 Sum_probs=169.6
Q ss_pred HHHhhcccccccceEEEEEE------eCCCCEEEEEEecccCcccHHHHHHHHHHHHccC---CCceEEeEEEEECCCCe
Q 041878 536 LCATAEIMGKSTYGTAYKAT------LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH---HPNLLALRAYYLGPKGE 606 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~------~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~ 606 (773)
.|.+.++||+|+||+||+|. ..+++.||||+++.. ...++..|++++++++ |+|++++++++.. .+.
T Consensus 66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~-~~~ 141 (365)
T 3e7e_A 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF-QNG 141 (365)
T ss_dssp EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-SSC
T ss_pred EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec-CCC
Confidence 34567899999999999994 456889999999654 3567788888888887 9999999999954 458
Q ss_pred EEEEEeecCCCCHHHHHhhcC--CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-----------CC
Q 041878 607 KLLVFDFMPKGSLASFLHARG--PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE-----------KT 673 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~-----------~~ 673 (773)
.++||||+++|+|.+++.... ....+++..++.++.||+.||+||| +.|||||||||+|||++. ++
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH-~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH-DCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh-hCCeecCCCCHHHEEecccccCccccccccC
Confidence 899999999999999997532 2345899999999999999999999 899999999999999998 89
Q ss_pred CeEEeecCCcccccccc-ccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 674 NPRIADFGLSRLMTAAA-NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 674 ~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
.+||+|||+|+...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 99999999997654222 2233455799999999999999999999999999999999999999865
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.98 Aligned_cols=200 Identities=22% Similarity=0.443 Sum_probs=175.8
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
|.+.+.||+|+||.||+|...++..||+|+++.... ..+++.+|++++++++||||+++++++ ...+..++||||+++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~ 87 (268)
T 3sxs_A 10 ITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVC-SKEYPIYIVTEYISN 87 (268)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSEEEEEECCTT
T ss_pred eeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEE-ccCCceEEEEEccCC
Confidence 456789999999999999998888999999975443 457799999999999999999999999 556689999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+.............
T Consensus 88 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 164 (268)
T 3sxs_A 88 GCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLE-SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164 (268)
T ss_dssp CBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH-HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred CcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence 99999998753 34889999999999999999999 9999999999999999999999999999998765544333344
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
..+|+.|+|||.+.+..++.++||||+|+++|||+| |+.||...+
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 457788999999988889999999999999999999 999997644
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=315.51 Aligned_cols=197 Identities=22% Similarity=0.395 Sum_probs=171.1
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
|.+.++||+|+||.||+|+.. +++.||+|+++... ......+.+|+.+++++ +||||+++++++. ..+..++||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-~~~~~~lv~ 89 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-TESRLFFVI 89 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-CSSEEEEEE
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-eCCEEEEEE
Confidence 345689999999999999875 68899999997543 22345688899999988 8999999999995 455899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++|+|.+++.+.. .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++.......
T Consensus 90 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp CCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 9999999999998754 3889999999999999999999 99999999999999999999999999999986432221
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 166 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 166 -TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 23345799999999999999999999999999999999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=320.03 Aligned_cols=199 Identities=23% Similarity=0.382 Sum_probs=174.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.+.||+|+||.||+|... +|+.||+|.+..........+.+|++++++++||||+++++++. .....++||||++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~~~lv~E~~~ 131 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-DKYEMVLILEFLS 131 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-CSSEEEEEEECCC
T ss_pred eEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-eCCEEEEEEEcCC
Confidence 456789999999999999865 68999999998766556678999999999999999999999995 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC--CCCeEEeecCCccccccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE--KTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~--~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+|+|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+|||++. ++.+||+|||+++.......
T Consensus 132 gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-- 206 (387)
T 1kob_A 132 GGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH-EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-- 206 (387)
T ss_dssp CCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--
T ss_pred CCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc--
Confidence 999999987642 34899999999999999999999 999999999999999974 46799999999987654322
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 254 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC
Confidence 234469999999999999999999999999999999999999997654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=314.04 Aligned_cols=210 Identities=18% Similarity=0.238 Sum_probs=179.1
Q ss_pred HhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.+.||+|+||.||+|.. .+|+.||||.+..... ..++.+|+++++++ +||||+++++++.. .+..++||||+
T Consensus 12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~e~~- 87 (330)
T 2izr_A 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC-GKYNAMVLELL- 87 (330)
T ss_dssp EEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-TTEEEEEEECC-
T ss_pred EEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec-CCccEEEEEeC-
Confidence 4568999999999999986 5789999999865432 34688999999999 89999999999854 55889999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC-----eEEeecCCcccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN-----PRIADFGLSRLMTAAA 690 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~-----~kl~DfG~a~~~~~~~ 690 (773)
+++|.+++... ...+++..+..++.||+.||+||| +.||+||||||+|||++.++. +||+|||+++......
T Consensus 88 ~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH-~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 88 GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVH-SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99999999875 235899999999999999999999 999999999999999999887 9999999998764433
Q ss_pred cc------ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHH
Q 041878 691 NT------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK 754 (773)
Q Consensus 691 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 754 (773)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+..+.+.++..
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 21 12345699999999999999999999999999999999999999998877777666665543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=326.79 Aligned_cols=202 Identities=27% Similarity=0.511 Sum_probs=174.6
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.+.+.||+|+||.||+|.+. |+.||||+++... ..++|.+|++++++++||||+++++++....+..++||||+++
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~ 271 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 271 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred eEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence 356789999999999999886 7899999997543 4678999999999999999999999987666689999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
|+|.++++... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 272 g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~~ 345 (450)
T 1k9a_A 272 GSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DT 345 (450)
T ss_dssp CBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc----cC
Confidence 99999998764 234688999999999999999999 9999999999999999999999999999998543221 12
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCChHH
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQ 747 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~~~ 747 (773)
..+++.|+|||.+.+..++.++|||||||++|||+| |+.||...+..+..+
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~ 397 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 397 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH
T ss_pred CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 257889999999999999999999999999999998 999998766555443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=332.74 Aligned_cols=200 Identities=28% Similarity=0.476 Sum_probs=173.8
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.+.+.||+|+||.||+|.+.++..||||+++... ...++|.+|++++++++||||+++++++. .+..++||||+++
T Consensus 190 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~lv~e~~~~ 266 (454)
T 1qcf_A 190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT--KEPIYIITEFMAK 266 (454)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEECCCTT
T ss_pred eEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CCccEEEEeecCC
Confidence 35678999999999999999888999999997644 35788999999999999999999999984 4478999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
|+|.++++... ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++............
T Consensus 267 g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 344 (454)
T 1qcf_A 267 GSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344 (454)
T ss_dssp CBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred CcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence 99999998542 123688899999999999999999 8999999999999999999999999999998765433222233
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
..+|+.|+|||++....++.++|||||||++|||+| |+.||...+
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~ 390 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 390 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC
Confidence 456789999999988899999999999999999999 999997654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=309.57 Aligned_cols=201 Identities=20% Similarity=0.414 Sum_probs=173.1
Q ss_pred HHHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 536 LCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.|.+.+.||+|+||+||+|.+.++..||+|+++.... ..+++.+|++++++++||||+++++++ ...+..++||||++
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~ 102 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC-TKQRPIFIITEYMA 102 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSSEEEEECCCT
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEE-ecCCCeEEEEeccC
Confidence 3466789999999999999998888999999975543 457899999999999999999999999 55568999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+............
T Consensus 103 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (283)
T 3gen_A 103 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179 (283)
T ss_dssp TCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH-HCCccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence 999999998642 23899999999999999999999 999999999999999999999999999999876544333333
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
...+|+.|+|||.+....++.++||||+|+++|||+| |+.||...+
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~ 226 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226 (283)
T ss_dssp STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC
Confidence 4457889999999988899999999999999999998 999997654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=330.09 Aligned_cols=208 Identities=26% Similarity=0.391 Sum_probs=178.0
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
...++||+|+||.||+|... +|+.||||++... .......+.+|++++++++||||+++++++. ..+..++||||
T Consensus 187 ~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-~~~~l~lVmEy 265 (576)
T 2acx_A 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-TKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEECC
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-eCCEEEEEEEc
Confidence 45688999999999999875 7999999999653 2234567889999999999999999999995 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++|+|.+++.... ...+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++...... .
T Consensus 266 ~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH-~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~--~ 341 (576)
T 2acx_A 266 MNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLH-RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--T 341 (576)
T ss_dssp CCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--C
T ss_pred CCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH-HCCEeccCCchheEEEeCCCCeEEEecccceecccCc--c
Confidence 99999999998754 234899999999999999999999 8999999999999999999999999999998764332 2
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHH
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVA 750 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 750 (773)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.....+.+.
T Consensus 342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~ 398 (576)
T 2acx_A 342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398 (576)
T ss_dssp EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH
T ss_pred ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH
Confidence 234579999999999998899999999999999999999999998765544333333
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=313.54 Aligned_cols=196 Identities=24% Similarity=0.422 Sum_probs=169.8
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++. ..+..++|||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~E 89 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-TPTDIVMVIE 89 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-eCCEEEEEEE
Confidence 34578999999999999986 578999999996432 223467899999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+ +|+|.+++.... .+++..+..++.||+.||.||| +.||+||||||+||++++++.+||+|||++........
T Consensus 90 ~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH-~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~- 163 (336)
T 3h4j_B 90 YA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCH-RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF- 163 (336)
T ss_dssp CC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH-HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT-
T ss_pred CC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc-
Confidence 99 789999987754 3889999999999999999999 89999999999999999999999999999987654332
Q ss_pred ceeeccCccccccccccCCCCC-CcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
.....||+.|+|||++.+..+ ++++||||+||++|||++|+.||...
T Consensus 164 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 164 -LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp -TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred -cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 233469999999999987776 78999999999999999999999764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=313.21 Aligned_cols=200 Identities=25% Similarity=0.411 Sum_probs=170.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCC---------
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG--------- 605 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--------- 605 (773)
|.+.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++.....
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~ 87 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDE 87 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC
T ss_pred CceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhh
Confidence 456789999999999999975 79999999997543 3346789999999999999999999999854321
Q ss_pred -----------------------------------------------eEEEEEeecCCCCHHHHHhhcCCCCccCHHHHH
Q 041878 606 -----------------------------------------------EKLLVFDFMPKGSLASFLHARGPETIVNWATRM 638 (773)
Q Consensus 606 -----------------------------------------------~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 638 (773)
..++||||+++|+|.+++.+.......++..++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 167 (332)
T 3qd2_B 88 IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL 167 (332)
T ss_dssp --------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHH
T ss_pred hhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHH
Confidence 379999999999999999987665667788889
Q ss_pred HHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc-----------cceeeccCcccccccc
Q 041878 639 SIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN-----------TNVIATAGTLGYRAPE 707 (773)
Q Consensus 639 ~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-----------~~~~~~~gt~~y~aPE 707 (773)
.++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....... .......||+.|+|||
T Consensus 168 ~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 246 (332)
T 3qd2_B 168 HIFIQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246 (332)
T ss_dssp HHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred HHHHHHHHHHHHHH-hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence 99999999999999 99999999999999999999999999999987654421 1122346999999999
Q ss_pred ccCCCCCCcchhhHHHHHHHHHHHcCCCCC
Q 041878 708 LSKLKNANTKTDVYSLGVIILELLTGKSPG 737 (773)
Q Consensus 708 ~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~ 737 (773)
.+.+..++.++||||+||++|||++|..|+
T Consensus 247 ~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 247 QIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp HHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred HhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 999899999999999999999999998775
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.80 Aligned_cols=199 Identities=31% Similarity=0.441 Sum_probs=168.6
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCC---CeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK---GEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~lV~e~ 613 (773)
|.+.++||+|+||+||+|++. ++.||||++.... .....+..|+.++++++||||+++++++.... ...++||||
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~ 103 (322)
T 3soc_A 26 LQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103 (322)
T ss_dssp EEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred chhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence 456789999999999999876 7899999996543 23455677999999999999999999996543 247999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCC----------CceecCCCCCCEEeCCCCCeEEeecCCc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE----------NMIHGNLTSSNVLLDEKTNPRIADFGLS 683 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~----------~iiH~Dik~~NIll~~~~~~kl~DfG~a 683 (773)
+++|+|.++++... +++..+..++.||+.||+||| +. +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH-~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 104 HEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLH-EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp CTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHT-CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHH-hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 99999999998643 899999999999999999999 87 9999999999999999999999999999
Q ss_pred ccccccccc-ceeeccCccccccccccCC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 684 RLMTAAANT-NVIATAGTLGYRAPELSKL-----KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 684 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+...
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 876543322 2223468999999999876 3556789999999999999999999987543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=324.13 Aligned_cols=200 Identities=26% Similarity=0.361 Sum_probs=171.5
Q ss_pred HHHhhcccccccceEEEEEEe-CCCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 536 LCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
.|.+.+.||+|+||+||+|.. .+|+.||+|++..... ...+.+.+|++++++++||||+++++++. ..+..++|||
T Consensus 12 ~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~lv~E 90 (444)
T 3soa_A 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-EEGHHYLIFD 90 (444)
T ss_dssp HEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-CSSEEEEEEC
T ss_pred CeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-ECCEEEEEEE
Confidence 355678999999999999986 4788999999975432 34567899999999999999999999994 5568999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeC---CCCCeEEeecCCccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLD---EKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~---~~~~~kl~DfG~a~~~~~~ 689 (773)
|+++|+|.+++.... .+++..+..++.||+.||.||| +.||+||||||+|||++ .++.+||+|||++......
T Consensus 91 ~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH-~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 91 LVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred eCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 999999999998753 3889999999999999999999 99999999999999998 4578999999999876543
Q ss_pred cccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 167 ~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~ 217 (444)
T 3soa_A 167 QQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED 217 (444)
T ss_dssp CC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred Cc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc
Confidence 32 2234569999999999999999999999999999999999999997654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.59 Aligned_cols=208 Identities=25% Similarity=0.386 Sum_probs=172.8
Q ss_pred hcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCC
Q 041878 540 AEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
.++||+|+||.||+|.. .+|+.||+|+++.......+++.+|++++++++||||+++++++. ..+..++||||+++|+
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-SKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-ECCEEEEEEeCCCCCc
Confidence 46799999999999986 468999999998776666788999999999999999999999995 4558999999999999
Q ss_pred HHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe--CCCCCeEEeecCCccccccccccceee
Q 041878 619 LASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL--DEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 619 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll--~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+|||+ +.++.+||+|||+++....... ...
T Consensus 173 L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~ 247 (373)
T 2x4f_A 173 LFDRIIDES--YNLTELDTILFMKQICEGIRHMH-QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247 (373)
T ss_dssp EHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence 999987642 34789999999999999999999 9999999999999999 5677899999999987654332 223
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhh
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 756 (773)
..||+.|+|||++....++.++|||||||++|||++|+.||...+ ..+.+.++....
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~ 304 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETLNNILACR 304 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTC
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhcc
Confidence 469999999999998899999999999999999999999997654 334444555443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=315.02 Aligned_cols=256 Identities=33% Similarity=0.547 Sum_probs=150.4
Q ss_pred CCCcEEEccCCcccc--cCCCCCCCCCCCceEEccc-CccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccce
Q 041878 115 HALRKLSLHDNLLAG--PVPWSLGFLPNLRGVYLFN-NRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYR 191 (773)
Q Consensus 115 ~~L~~L~L~~n~l~~--~~~~~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 191 (773)
.+++.|+|++|.+++ .+|..++.+++|++|+|++ |++.+.+|..|+++++|++|+|++|.+++.+|..+.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 456677777777766 6666666666666666663 6666666666666666666666666666666666666666666
Q ss_pred eecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCC-CccEEE
Q 041878 192 LNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLG-LLQEIS 270 (773)
Q Consensus 192 L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~ 270 (773)
|+|++|++++.+|..+..+++|++|+|++|++++.+| ..++.++ +|++|+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-----------------------------~~l~~l~~~L~~L~ 180 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP-----------------------------DSYGSFSKLFTSMT 180 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECC-----------------------------GGGGCCCTTCCEEE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCC-----------------------------HHHhhhhhcCcEEE
Confidence 6666666665555555555555555555555544333 3344444 566666
Q ss_pred CCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCccccc
Q 041878 271 LSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKG 350 (773)
Q Consensus 271 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~ 350 (773)
+++|++++.+|..+..++ |++|++++|.+++..|..+..+++|+.|+|++|++++.+|. +.
T Consensus 181 L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~----------------- 241 (313)
T 1ogq_A 181 ISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VG----------------- 241 (313)
T ss_dssp CCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CC-----------------
T ss_pred CcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-cc-----------------
Confidence 666666666666666554 66666666666666666666666666666666665544333 44
Q ss_pred ccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCchhh-hccCCCCCCCCCCCCCCCCCC
Q 041878 351 HIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLL-SKKFNSSSFVGNLQLCGYSPS 425 (773)
Q Consensus 351 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~~-~~~~~~~~~~~n~~~c~~~~~ 425 (773)
.+++|++|+|++|++++.+|..+..+++|+.|+|++|+++|.+|... ...+....+.+|+++||.|++
T Consensus 242 -------~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 242 -------LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp -------CCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred -------ccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC
Confidence 44455555555555555555555555555555555555555554431 123334455566667776554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=339.73 Aligned_cols=306 Identities=23% Similarity=0.272 Sum_probs=256.0
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
.+++.|+|+++.+++..+..++++++|++|+|++|.+++..|..++++++|++|+|++|++++..+..|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 47899999999999888888999999999999999999999999999999999999999999666667999999999999
Q ss_pred cCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecccc
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN 250 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n 250 (773)
++|.+++..|..++++++|++|+|++|.+++..+..+.++++|++|++++|++++..+..+... ..++|++|++++|
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~---~~~~L~~L~L~~n 181 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF---ANSSLKKLELSSN 181 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGG---TTCEESEEECTTC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhcc---ccccccEEECCCC
Confidence 9999997777889999999999999999999889999999999999999999987766555432 1347999999999
Q ss_pred ccccccCccCCCC---------------------------CCccEEECCCCcccCCCCCCcCcccc--cceecccccccc
Q 041878 251 LIAGTIPVSLGKL---------------------------GLLQEISLSHNKIVGPIPDELGKLSK--LQKLDLSYNAIG 301 (773)
Q Consensus 251 ~l~~~~~~~l~~l---------------------------~~L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~Ls~N~l~ 301 (773)
.+++..|..+..+ ++|+.|++++|++++..|..|..++. |++|++++|+++
T Consensus 182 ~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~ 261 (680)
T 1ziw_A 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN 261 (680)
T ss_dssp CCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCC
T ss_pred cccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcC
Confidence 9998888776654 45677777788888777778877755 888888888888
Q ss_pred ccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCccccc-----cccc----ccCCCCcCceeecCCccC
Q 041878 302 GSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKG-----HIPE----TIGNISGINQLDLSENDF 372 (773)
Q Consensus 302 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~-----~~~~----~~~~l~~L~~L~L~~N~l 372 (773)
+..|..|..+++|++|++++|++++..|..+..+++|+.|++++|...+ .+|. .+..+++|++|++++|.+
T Consensus 262 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l 341 (680)
T 1ziw_A 262 VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDI 341 (680)
T ss_dssp EECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCB
T ss_pred ccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCcc
Confidence 7777888888888888888888888788888888888888888776553 2232 677788888888888888
Q ss_pred ccCCCchhhccCccCEEEeecccCCCC
Q 041878 373 TGEISPSLASLANLTSFNVSYNNLSGS 399 (773)
Q Consensus 373 ~~~~~~~~~~l~~L~~L~ls~N~l~g~ 399 (773)
++..+..+..+++|+.|++++|.+++.
T Consensus 342 ~~~~~~~~~~l~~L~~L~Ls~n~~~~~ 368 (680)
T 1ziw_A 342 PGIKSNMFTGLINLKYLSLSNSFTSLR 368 (680)
T ss_dssp CCCCTTTTTTCTTCCEEECTTCBSCCC
T ss_pred CCCChhHhccccCCcEEECCCCchhhh
Confidence 887777788888888888888876543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=313.97 Aligned_cols=202 Identities=25% Similarity=0.375 Sum_probs=172.7
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEeccc-----CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK-----TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
.|.+.+.||+|+||+||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++. ..+..++
T Consensus 25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~l 103 (351)
T 3c0i_A 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-SDGMLYM 103 (351)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEE
T ss_pred ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-eCCEEEE
Confidence 4667899999999999999864 6899999998642 1224678999999999999999999999995 4558999
Q ss_pred EEeecCCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC---eEEeecCCccc
Q 041878 610 VFDFMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN---PRIADFGLSRL 685 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~---~kl~DfG~a~~ 685 (773)
||||+++|+|.+++.... ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++. +||+|||++..
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998886542 2334789999999999999999999 999999999999999987655 99999999987
Q ss_pred cccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 686 MTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 183 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 183 LGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 654322 223456999999999999899999999999999999999999999763
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.86 Aligned_cols=202 Identities=24% Similarity=0.484 Sum_probs=161.3
Q ss_pred HHHhhcccccccceEEEEEEeC----CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE----DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
.+.+.++||+|+||.||+|.+. ++..||||+++... ....++|.+|+.++++++||||+++++++ ...+..++|
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv 124 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-TKSKPVMIV 124 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSSCEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-eeCCceEEE
Confidence 3456789999999999999864 57789999997653 33456799999999999999999999999 455689999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||+++|+|.++++... ..+++.++..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 99999999999998653 34899999999999999999999 9999999999999999999999999999998765432
Q ss_pred ccc--eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 691 NTN--VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 691 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
... .....+++.|+|||++....++.++|||||||++|||++ |+.||...+
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC
Confidence 211 112235778999999998999999999999999999998 999997654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.08 Aligned_cols=199 Identities=26% Similarity=0.382 Sum_probs=163.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHH-HHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAA-IGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
|.+.++||+|+||.||+|+.. +++.||||+++.... .....+..|..+ ++.++||||+++++++.. .+..|+||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-~~~~~lv~ 118 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVL 118 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-CCEEEEEE
Confidence 356789999999999999875 588999999976432 234456667776 577899999999999954 55899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++|+|.+++++.. .++...+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++......
T Consensus 119 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~- 193 (373)
T 2r5t_A 119 DYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLH-SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN- 193 (373)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC-
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCHHHEEECCCCCEEEeeCccccccccCC-
Confidence 9999999999998754 3788899999999999999999 9999999999999999999999999999998643222
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 22334579999999999999999999999999999999999999997644
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.74 Aligned_cols=206 Identities=25% Similarity=0.409 Sum_probs=163.3
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.+.||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++||||+++++++ ...+..++||||+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-HTENKLTLVFEFM 85 (317)
T ss_dssp ------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-CCTTEEEEEEECC
T ss_pred eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-EECCeEEEEEEec
Confidence 566789999999999999864 689999999975433 3456788999999999999999999999 5566899999999
Q ss_pred CCCCHHHHHhhcC---CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 615 PKGSLASFLHARG---PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 615 ~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
+ |+|.+++.... ....+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH-~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 163 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH-ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc
Confidence 7 69999987642 1234889999999999999999999 99999999999999999999999999999987643322
Q ss_pred cceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChH
Q 041878 692 TNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLP 746 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~ 746 (773)
......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...+..+..
T Consensus 164 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 218 (317)
T 2pmi_A 164 -TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL 218 (317)
T ss_dssp -CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred -cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 1223468999999998865 46899999999999999999999999876544333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=325.23 Aligned_cols=201 Identities=26% Similarity=0.442 Sum_probs=171.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
+.+.+.||+|+||.||+|.+. +++.||||.++.... ....+|.+|++++++++||||+++++++ ...+..++||||+
T Consensus 116 ~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~~~~~~lv~e~~ 194 (377)
T 3cbl_A 116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC-TQKQPIYIVMELV 194 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-CSSSSCEEEEECC
T ss_pred eEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-ecCCCcEEEEEcC
Confidence 456789999999999999976 789999999975433 2345788999999999999999999999 5556899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++|+|.++++... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus 195 ~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH-~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~ 271 (377)
T 3cbl_A 195 QGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLE-SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS 271 (377)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence 9999999998653 34789999999999999999999 99999999999999999999999999999986543221111
Q ss_pred -eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 695 -IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 695 -~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
....+++.|+|||.+....++.++|||||||++|||+| |+.||...+
T Consensus 272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 12235678999999988889999999999999999998 999997654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=326.14 Aligned_cols=201 Identities=26% Similarity=0.409 Sum_probs=174.5
Q ss_pred hhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 539 TAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
..++||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++||||+++++++. ..+..++||||+
T Consensus 189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-~~~~l~lVmE~~ 267 (543)
T 3c4z_A 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-TKTDLCLVMTIM 267 (543)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEECCC
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-eCCEEEEEEEec
Confidence 4578999999999999875 69999999996542 234567889999999999999999999985 455899999999
Q ss_pred CCCCHHHHHhhcCC-CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 615 PKGSLASFLHARGP-ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 615 ~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
++|+|.+++..... ...+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 268 ~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH-~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~-~ 345 (543)
T 3c4z_A 268 NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT-K 345 (543)
T ss_dssp TTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC-C
T ss_pred cCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH-HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc-c
Confidence 99999999986532 335899999999999999999999 99999999999999999999999999999987654322 2
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~ 394 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc
Confidence 2334799999999999999999999999999999999999999987644
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=332.99 Aligned_cols=205 Identities=31% Similarity=0.478 Sum_probs=176.8
Q ss_pred HHhhcccccccceEEEEEEeCC-CCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLED-GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
+.+.++||+|+||.||+|.+.. +..||||.++... ...++|.+|+.++++++||||+++++++ ...+..++||||++
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lv~E~~~ 299 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFYIITEFMT 299 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSCEEEEECCT
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEE-ecCCcEEEEEEccC
Confidence 4567899999999999999764 7899999997543 3467899999999999999999999999 45568999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.++++... ...+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++...........
T Consensus 300 ~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 377 (495)
T 1opk_A 300 YGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE-KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377 (495)
T ss_dssp TCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence 999999998754 344889999999999999999999 999999999999999999999999999999876543332223
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCh
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDL 745 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~ 745 (773)
...+++.|+|||++....++.++|||||||++|||+| |+.||...+..++
T Consensus 378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~ 428 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 428 (495)
T ss_dssp TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 3446789999999988899999999999999999999 9999987654433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=329.36 Aligned_cols=302 Identities=22% Similarity=0.273 Sum_probs=255.4
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCC-CCCCCCCCCCCCCEEE
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSG-SIPPSIGNCPNLQTLD 169 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~ 169 (773)
.+++.|+|++|.+++..|..++++++|++|+|++|.|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+
T Consensus 45 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~ 121 (520)
T 2z7x_B 45 SKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLG 121 (520)
T ss_dssp TTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEE
T ss_pred ccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEE
Confidence 57889999999999988999999999999999999999 46655 89999999999999997 5789999999999999
Q ss_pred ccCCCCCCCCcccccccccc--ceeecccccc--cccCCccccCCC----------------------------------
Q 041878 170 LSNNALIGAIPPSLANSTRL--YRLNLSYNSL--LGSIPLSLTRLP---------------------------------- 211 (773)
Q Consensus 170 Ls~N~l~~~~~~~l~~l~~L--~~L~Ls~N~l--~~~~~~~l~~l~---------------------------------- 211 (773)
|++|.+++ ..+..+++| ++|+|++|.+ .+..|..+..+.
T Consensus 122 L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 198 (520)
T 2z7x_B 122 LSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198 (520)
T ss_dssp EEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEE
T ss_pred ecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeecccc
Confidence 99999875 345666666 7777777777 555555544422
Q ss_pred -------------------------------------------------ccceeeccccccccccCCcc-----cccc--
Q 041878 212 -------------------------------------------------SLSVLALQHNNLSGSVPNNW-----GVLA-- 235 (773)
Q Consensus 212 -------------------------------------------------~L~~L~L~~N~l~~~~p~~~-----~~l~-- 235 (773)
+|++|++++|+++|.+|..+ +.+.
T Consensus 199 ~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L 278 (520)
T 2z7x_B 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKAL 278 (520)
T ss_dssp ECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEE
T ss_pred ccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCcee
Confidence 56666666677766666554 1100
Q ss_pred -----------------------------------------cCcccccceeeccccccccccCccCCCCCCccEEECCCC
Q 041878 236 -----------------------------------------GNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHN 274 (773)
Q Consensus 236 -----------------------------------------~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N 274 (773)
...+++|++|++++|.+++..|..++.+++|++|+|++|
T Consensus 279 ~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N 358 (520)
T 2z7x_B 279 SIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN 358 (520)
T ss_dssp EEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSS
T ss_pred EeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCC
Confidence 035568999999999999999999999999999999999
Q ss_pred cccC--CCCCCcCcccccceeccccccccccCcc-cccccccCceEEccCCCCCCCcchhhccccccccccccCcccccc
Q 041878 275 KIVG--PIPDELGKLSKLQKLDLSYNAIGGSFPV-TFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGH 351 (773)
Q Consensus 275 ~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~ 351 (773)
++++ .+|..+..+++|++|++++|.+++.+|. .+..+++|++|++++|++++..|..+. ++|+.|++++|+++ .
T Consensus 359 ~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ 435 (520)
T 2z7x_B 359 QLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-S 435 (520)
T ss_dssp CCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-C
T ss_pred ccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-c
Confidence 9997 5667899999999999999999985665 488899999999999999988887665 79999999999999 8
Q ss_pred cccccCCCCcCceeecCCccCccCCCch-hhccCccCEEEeecccCCCCCch
Q 041878 352 IPETIGNISGINQLDLSENDFTGEISPS-LASLANLTSFNVSYNNLSGSVPP 402 (773)
Q Consensus 352 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~ls~N~l~g~~p~ 402 (773)
+|..+..+++|++|+|++|+++ .+|.. +..+++|+.|++++|+++|.++.
T Consensus 436 ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 436 IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp CCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred cchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCCc
Confidence 8888889999999999999999 46655 89999999999999999998874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.14 Aligned_cols=198 Identities=20% Similarity=0.326 Sum_probs=173.6
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
+|.+.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++. ..+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~ 88 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-DNTDIYLVMELC 88 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEEECC
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCeEEEEEecc
Confidence 3566789999999999999865 57789999998776667888999999999999999999999995 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe---CCCCCeEEeecCCccccccccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll---~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
++++|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||++ +.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 89 TGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCH-KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp CSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 9999999998754 3789999999999999999999 9999999999999999 7888999999999987654332
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||.+.+ .++.++||||+|+++|||++|+.||...+
T Consensus 165 --~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 211 (277)
T 3f3z_A 165 --MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT 211 (277)
T ss_dssp --BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence 233468999999998865 48999999999999999999999997644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=347.86 Aligned_cols=325 Identities=24% Similarity=0.253 Sum_probs=202.6
Q ss_pred CEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCC--CCCCCCCceEEcccCccCCCCC-CCCCCCCCCCEE
Q 041878 92 QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWS--LGFLPNLRGVYLFNNRLSGSIP-PSIGNCPNLQTL 168 (773)
Q Consensus 92 ~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~--l~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L 168 (773)
+++.|+|++|.+++..|..++++++|++|+|++|.+++.+|.. ++.+++|++|+|++|.+++..+ ..|+++++|++|
T Consensus 74 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L 153 (844)
T 3j0a_A 74 NLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSI 153 (844)
T ss_dssp TCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEE
T ss_pred CCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEE
Confidence 4556666666666655666666666666666666666544443 5666666666666666655443 345666666666
Q ss_pred EccCCCCCCCCccccccc--cc------------------------------cceeecccc-------------------
Q 041878 169 DLSNNALIGAIPPSLANS--TR------------------------------LYRLNLSYN------------------- 197 (773)
Q Consensus 169 ~Ls~N~l~~~~~~~l~~l--~~------------------------------L~~L~Ls~N------------------- 197 (773)
+|++|.+++..+..+..+ ++ |++|+|++|
T Consensus 154 ~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l 233 (844)
T 3j0a_A 154 DFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQA 233 (844)
T ss_dssp EEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCB
T ss_pred ECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccc
Confidence 666666554444333322 11 222222222
Q ss_pred -------------------------------------------cccccCCccccCCCccceeeccccccccccCCccccc
Q 041878 198 -------------------------------------------SLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVL 234 (773)
Q Consensus 198 -------------------------------------------~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 234 (773)
.+.+..+..+..+++|+.|+|++|++++..|..|..+
T Consensus 234 ~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l 313 (844)
T 3j0a_A 234 FSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGL 313 (844)
T ss_dssp SEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTC
T ss_pred cceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCC
Confidence 2222223333344444444444444444444444333
Q ss_pred ccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccC----------
Q 041878 235 AGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSF---------- 304 (773)
Q Consensus 235 ~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~---------- 304 (773)
. +|++|+|++|.+++..+..|..+++|+.|++++|++.+..+..|..+++|++|+|++|.+++..
T Consensus 314 ~-----~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l 388 (844)
T 3j0a_A 314 D-----NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFL 388 (844)
T ss_dssp S-----SCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEE
T ss_pred C-----CCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhcc
Confidence 2 5666666666666666666666666666666666666555555666666666666666654311
Q ss_pred --------c----------------------ccccccccCceEEccCCCCCCC---------------------------
Q 041878 305 --------P----------------------VTFTNITSLVSLNLENNRLGNK--------------------------- 327 (773)
Q Consensus 305 --------~----------------------~~~~~l~~L~~L~Ls~N~l~~~--------------------------- 327 (773)
| ..+..+++|+.|+|++|++++.
T Consensus 389 ~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~ 468 (844)
T 3j0a_A 389 SGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWE 468 (844)
T ss_dssp ESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCC
T ss_pred CCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccc
Confidence 0 0012345555555555555422
Q ss_pred ---cchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCchhh
Q 041878 328 ---IPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLL 404 (773)
Q Consensus 328 ---~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~~ 404 (773)
.+..+..+++|+.|+|++|++++..|..+.++++|+.|+|++|++++..+..+. ++|+.|+|++|+|++.+|..+
T Consensus 469 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~ 546 (844)
T 3j0a_A 469 TELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF 546 (844)
T ss_dssp SCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC
T ss_pred cccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh
Confidence 223467789999999999999999999999999999999999999987777665 899999999999999998766
Q ss_pred hccCCCCCCCCCCCCCCCCC
Q 041878 405 SKKFNSSSFVGNLQLCGYSP 424 (773)
Q Consensus 405 ~~~~~~~~~~~n~~~c~~~~ 424 (773)
..+....+.+|+..|+++.
T Consensus 547 -~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 547 -VSLSVLDITHNKFICECEL 565 (844)
T ss_dssp -SSCCEEEEEEECCCCSSSC
T ss_pred -CCcCEEEecCCCccccccc
Confidence 4556667889999997764
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=330.87 Aligned_cols=162 Identities=22% Similarity=0.321 Sum_probs=146.4
Q ss_pred ccceeeccccccccccCccCCCCCCccEEECCCCcccCCCC-CCcCcccccceeccccccccccCcccccccccCceEEc
Q 041878 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIP-DELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNL 319 (773)
Q Consensus 241 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 319 (773)
+|++|++++|.+++..+. +..+++|+.|++++|++.+..+ ..+..+++|++|++++|.+++..|..+..+++|++|++
T Consensus 374 ~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 452 (570)
T 2z63_A 374 SLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452 (570)
T ss_dssp CCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEEC
T ss_pred ccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEEC
Confidence 555666666666654444 8899999999999999998766 57899999999999999999999999999999999999
Q ss_pred cCCCCC-CCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCC
Q 041878 320 ENNRLG-NKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSG 398 (773)
Q Consensus 320 s~N~l~-~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g 398 (773)
++|+++ +.+|..+..+++|++|++++|++++..|..+..+++|++|+|++|++++..|..+..+++|+.|++++|+++|
T Consensus 453 ~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 532 (570)
T 2z63_A 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 532 (570)
T ss_dssp TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccC
Confidence 999997 5789999999999999999999999989999999999999999999999888889999999999999999999
Q ss_pred CCchh
Q 041878 399 SVPPL 403 (773)
Q Consensus 399 ~~p~~ 403 (773)
.+|..
T Consensus 533 ~~~~~ 537 (570)
T 2z63_A 533 SCPRI 537 (570)
T ss_dssp CTTTT
T ss_pred CCcch
Confidence 99853
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.53 Aligned_cols=205 Identities=25% Similarity=0.433 Sum_probs=173.7
Q ss_pred HHHhhcccccccceEEEEEEe------CCCCEEEEEEecccCc-ccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeE
Q 041878 536 LCATAEIMGKSTYGTAYKATL------EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEK 607 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 607 (773)
.|.+.+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++.......
T Consensus 23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 102 (359)
T 3vhe_A 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 102 (359)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCce
Confidence 345678999999999999973 2457899999976533 3346799999999999 7899999999996666668
Q ss_pred EEEEeecCCCCHHHHHhhcCC-----------------------------------------------------------
Q 041878 608 LLVFDFMPKGSLASFLHARGP----------------------------------------------------------- 628 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~----------------------------------------------------------- 628 (773)
++||||+++|+|.++++....
T Consensus 103 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (359)
T 3vhe_A 103 MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182 (359)
T ss_dssp EEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------------
T ss_pred EEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccc
Confidence 999999999999999987532
Q ss_pred ----CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc-cceeeccCcccc
Q 041878 629 ----ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN-TNVIATAGTLGY 703 (773)
Q Consensus 629 ----~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y 703 (773)
...+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....... .......||+.|
T Consensus 183 ~~~~~~~l~~~~~~~~~~ql~~aL~~LH-~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 261 (359)
T 3vhe_A 183 EDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261 (359)
T ss_dssp -CTTTTCBCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred cchhccccCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence 122889999999999999999999 99999999999999999999999999999986644332 222345688999
Q ss_pred ccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 704 RAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 704 ~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 262 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 300 (359)
T 3vhe_A 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300 (359)
T ss_dssp CCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred EChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence 99999988999999999999999999998 999997654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.52 Aligned_cols=285 Identities=24% Similarity=0.308 Sum_probs=246.1
Q ss_pred EEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCC
Q 041878 95 AIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNA 174 (773)
Q Consensus 95 ~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 174 (773)
.+++++++++ .+|..+. ++|++|+|++|.+++..|..+..+++|++|+|++|++++..|..|+++++|++|+|++|.
T Consensus 37 ~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 113 (332)
T 2ft3_A 37 VVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113 (332)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSC
T ss_pred EEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCc
Confidence 3555666665 5666553 689999999999998888899999999999999999998889999999999999999999
Q ss_pred CCCCCccccccccccceeecccccccccCCccccCCCccceeecccccccc--ccCCcccccccCcccccceeecccccc
Q 041878 175 LIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSG--SVPNNWGVLAGNKSYQLQFLNLDHNLI 252 (773)
Q Consensus 175 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~~~~~~L~~L~L~~n~l 252 (773)
++ .+|..+. ++|++|++++|++++..+..+.++++|++|++++|+++. ..+..+..+ +|++|++++|.+
T Consensus 114 l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l------~L~~L~l~~n~l 184 (332)
T 2ft3_A 114 LV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL------KLNYLRISEAKL 184 (332)
T ss_dssp CC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC------CCSCCBCCSSBC
T ss_pred CC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC------ccCEEECcCCCC
Confidence 98 6676665 799999999999998777889999999999999999963 555555433 699999999999
Q ss_pred ccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhh
Q 041878 253 AGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGL 332 (773)
Q Consensus 253 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l 332 (773)
++ +|..+. ++|++|++++|++++..+..|..+++|++|+|++|++++..+..+..+++|++|+|++|+++ .+|..+
T Consensus 185 ~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l 260 (332)
T 2ft3_A 185 TG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260 (332)
T ss_dssp SS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTG
T ss_pred Cc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhh
Confidence 96 454443 78999999999999888889999999999999999999888889999999999999999997 788889
Q ss_pred ccccccccccccCcccccccccccCC------CCcCceeecCCccCc--cCCCchhhccCccCEEEeeccc
Q 041878 333 ERLQNLTVLNLKNNQFKGHIPETIGN------ISGINQLDLSENDFT--GEISPSLASLANLTSFNVSYNN 395 (773)
Q Consensus 333 ~~l~~L~~L~ls~N~l~~~~~~~~~~------l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~ls~N~ 395 (773)
..+++|+.|++++|++++..+..+.. .++|+.|++++|++. +..|..+..+++|+.+++++|+
T Consensus 261 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 261 PDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp GGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred hcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 99999999999999999877777765 367999999999998 6788889999999999999885
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=312.29 Aligned_cols=200 Identities=24% Similarity=0.361 Sum_probs=169.3
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++||||+++++++. ..+..++||||++
T Consensus 10 ~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~e~~~ 88 (323)
T 3tki_A 10 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-EGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEEECCT
T ss_pred eeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCCeEEEEEEcCC
Confidence 45789999999999999865 789999999965432 23467889999999999999999999995 4558899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc-cce
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN-TNV 694 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 694 (773)
+|+|.+++... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++........ ...
T Consensus 89 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH-~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 89 GGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp TEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH-HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 99999998764 34899999999999999999999 99999999999999999999999999999986643322 222
Q ss_pred eeccCccccccccccCCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.....
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 34569999999999877665 7789999999999999999999986543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=317.93 Aligned_cols=206 Identities=28% Similarity=0.419 Sum_probs=175.1
Q ss_pred HHHHHhhcccccccceEEEEEEeC--------CCCEEEEEEecccCc-ccHHHHHHHHHHHHcc-CCCceEEeEEEEECC
Q 041878 534 DLLCATAEIMGKSTYGTAYKATLE--------DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGP 603 (773)
Q Consensus 534 ~l~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 603 (773)
.-++.+.++||+|+||.||+|... .+..||||+++.... ....++.+|+++++++ +||||+++++++ ..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-TQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee-cc
Confidence 334567899999999999999852 235799999976533 3457789999999999 899999999999 55
Q ss_pred CCeEEEEEeecCCCCHHHHHhhcCC-------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeC
Q 041878 604 KGEKLLVFDFMPKGSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLD 670 (773)
Q Consensus 604 ~~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~ 670 (773)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+||| +.||+||||||+|||++
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVT 225 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEC
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCcceEEEc
Confidence 6689999999999999999987642 235899999999999999999999 99999999999999999
Q ss_pred CCCCeEEeecCCccccccccc-cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 671 EKTNPRIADFGLSRLMTAAAN-TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 671 ~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999987654332 22223457889999999999999999999999999999999 999997654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=306.93 Aligned_cols=193 Identities=22% Similarity=0.404 Sum_probs=150.2
Q ss_pred hcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 540 AEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
.++||+|+||.||+|... +++.||||++... ....+.+|+.+++++. ||||+++++++. .....++||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~-~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFH-DQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEE-CSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEE-cCCEEEEEEEccCCC
Confidence 478999999999999875 6899999999643 4567788999999997 999999999995 455899999999999
Q ss_pred CHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC---CeEEeecCCccccccccccce
Q 041878 618 SLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT---NPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 618 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~---~~kl~DfG~a~~~~~~~~~~~ 694 (773)
+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++ .+||+|||+++....... ..
T Consensus 92 ~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~ 166 (325)
T 3kn6_A 92 ELFERIKKKK---HFSETEASYIMRKLVSAVSHMH-DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PL 166 (325)
T ss_dssp BHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cc
Confidence 9999998753 4899999999999999999999 99999999999999998766 799999999986543322 22
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 34468999999999999999999999999999999999999998644
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=305.17 Aligned_cols=199 Identities=26% Similarity=0.411 Sum_probs=167.1
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.+.||+|+||+||+|...+|+.||+|++..... .....+.+|++++++++||||+++++++. ..+..++||||++
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-TKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-CSSCEEEEEECCS
T ss_pred hhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-cCCeEEEEEEecC
Confidence 45688999999999999988899999999965432 23467889999999999999999999995 4558999999997
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+ +|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....... ...
T Consensus 84 ~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 158 (288)
T 1ob3_A 84 Q-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYT 158 (288)
T ss_dssp E-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred C-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-ccc
Confidence 5 9999987642 34788999999999999999999 99999999999999999999999999999976543221 222
Q ss_pred eccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
...+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 3468999999998865 4589999999999999999999999976553
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=316.62 Aligned_cols=208 Identities=21% Similarity=0.306 Sum_probs=175.9
Q ss_pred HHHHHhhcccccc--cceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 534 DLLCATAEIMGKS--TYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 534 ~l~~~~~~~lG~G--~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
.-+|.+.++||+| +||.||+|... +|+.||||+++... ....+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-ADNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-ECCEEE
Confidence 3345678999999 99999999975 78999999997543 233467888999999999999999999995 455899
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||+++|+|.+++.... ...+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||.+.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIH-HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 9999999999999998753 234899999999999999999999 99999999999999999999999999998875533
Q ss_pred cccc------ceeeccCccccccccccCC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 041878 689 AANT------NVIATAGTLGYRAPELSKL--KNANTKTDVYSLGVIILELLTGKSPGEPMNGMD 744 (773)
Q Consensus 689 ~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~ 744 (773)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 244 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 244 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 2111 1112368999999999877 679999999999999999999999998765544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=329.29 Aligned_cols=200 Identities=29% Similarity=0.455 Sum_probs=167.6
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.+.+.||+|+||.||+|.+.++..||||+++... ...++|.+|++++++++||||+++++++. . +..++||||+++
T Consensus 186 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~-~~~~iv~e~~~~ 262 (452)
T 1fmk_A 186 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E-EPIYIVTEYMSK 262 (452)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S-SSCEEEECCCTT
T ss_pred ceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEc-C-CceEEEehhhcC
Confidence 45678999999999999999888889999997654 34678999999999999999999999984 3 578999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
|+|.++++... ...+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++............
T Consensus 263 gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 340 (452)
T 1fmk_A 263 GSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340 (452)
T ss_dssp CBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred CCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence 99999997542 234789999999999999999999 9999999999999999999999999999998765443333334
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
..+++.|+|||.+....++.++|||||||++|||+| |+.||.+..
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~ 386 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 386 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC
Confidence 457889999999988899999999999999999999 999997654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=312.25 Aligned_cols=201 Identities=25% Similarity=0.426 Sum_probs=165.0
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcc---cHHHHHHHHHHHHccCCCceEEeEEEEECCCC---eEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTK---GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG---EKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~l 609 (773)
|.+.+.||+|+||.||+|.. .+++.||||+++..... ....+.+|++++++++||||+++++++..... ..++
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l 93 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 93 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence 34578999999999999986 57889999999765332 24578899999999999999999999854332 3489
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||+++++|.++++... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 v~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 94 VMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 999999999999998754 3789999999999999999999 999999999999999999999999999999876543
Q ss_pred cc--cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 690 AN--TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 690 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 223 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 12233468999999999998999999999999999999999999997644
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=327.65 Aligned_cols=199 Identities=23% Similarity=0.359 Sum_probs=163.0
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.++||+|+||.||+|.. .+|+.||||+++.. .......+.+|+.++++++||||+++++++. ..+..++|||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-~~~~~~lv~e 228 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-THDRLCFVME 228 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-ETTEEEEEEC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-eCCEEEEEEe
Confidence 45678999999999999986 46899999999753 2334466788999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccC-CCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE-ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~-~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
|+++|+|.+++.... .+++..+..++.||+.||+||| + .||+||||||+|||++.++.+||+|||+++.......
T Consensus 229 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH-~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 229 YANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp CCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH-HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred eCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHh-hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 999999999998754 3789999999999999999999 6 9999999999999999999999999999976433222
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 305 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 353 (446)
T 4ejn_A 305 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 2234579999999999999999999999999999999999999997654
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=327.94 Aligned_cols=303 Identities=20% Similarity=0.245 Sum_probs=260.5
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCC-CCCCCCCCCCCCCEEE
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSG-SIPPSIGNCPNLQTLD 169 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~ 169 (773)
.+++.|+|++|.+++..|..+.++++|++|+|++|.|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+
T Consensus 76 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~ 152 (562)
T 3a79_B 76 SELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLG 152 (562)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEE
T ss_pred CCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEe
Confidence 57899999999999988999999999999999999999 56666 89999999999999997 4578999999999999
Q ss_pred ccCCCCCCCCcccccccccc--ceeecccccc--cccCCccccCCC----------------------------------
Q 041878 170 LSNNALIGAIPPSLANSTRL--YRLNLSYNSL--LGSIPLSLTRLP---------------------------------- 211 (773)
Q Consensus 170 Ls~N~l~~~~~~~l~~l~~L--~~L~Ls~N~l--~~~~~~~l~~l~---------------------------------- 211 (773)
|++|.+++. .+..+++| ++|+|++|++ ++..|..+..+.
T Consensus 153 L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 229 (562)
T 3a79_B 153 LSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229 (562)
T ss_dssp EECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEE
T ss_pred cCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEeccc
Confidence 999999863 45555555 9999999998 666666655433
Q ss_pred -----------------------------------------------ccceeeccccccccccCCccc-----ccc----
Q 041878 212 -----------------------------------------------SLSVLALQHNNLSGSVPNNWG-----VLA---- 235 (773)
Q Consensus 212 -----------------------------------------------~L~~L~L~~N~l~~~~p~~~~-----~l~---- 235 (773)
+|++|++++|+++|.+|..+. .+.
T Consensus 230 ~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~ 309 (562)
T 3a79_B 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMI 309 (562)
T ss_dssp CCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEE
T ss_pred ccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheeh
Confidence 678888888888888877551 000
Q ss_pred ---------------------------------------cCcccccceeeccccccccccCccCCCCCCccEEECCCCcc
Q 041878 236 ---------------------------------------GNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKI 276 (773)
Q Consensus 236 ---------------------------------------~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l 276 (773)
....++|++|++++|.+++..|..++.+++|++|+|++|++
T Consensus 310 ~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l 389 (562)
T 3a79_B 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389 (562)
T ss_dssp EEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCC
T ss_pred hhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCc
Confidence 03456899999999999999999999999999999999999
Q ss_pred cCC--CCCCcCcccccceeccccccccccCc-ccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccc
Q 041878 277 VGP--IPDELGKLSKLQKLDLSYNAIGGSFP-VTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIP 353 (773)
Q Consensus 277 ~~~--~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~ 353 (773)
++. +|..+..+++|++|++++|++++.+| ..+..+++|++|++++|++++..|..+. ++|++|++++|+++ .+|
T Consensus 390 ~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip 466 (562)
T 3a79_B 390 KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIP 466 (562)
T ss_dssp CBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCC
T ss_pred CCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccC
Confidence 973 35678999999999999999998555 4588999999999999999987777655 79999999999999 788
Q ss_pred cccCCCCcCceeecCCccCccCCCch-hhccCccCEEEeecccCCCCCchh
Q 041878 354 ETIGNISGINQLDLSENDFTGEISPS-LASLANLTSFNVSYNNLSGSVPPL 403 (773)
Q Consensus 354 ~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~ls~N~l~g~~p~~ 403 (773)
..+..+++|++|+|++|+++ .+|.. +..+++|+.|++++|+|+|.+|..
T Consensus 467 ~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~ 516 (562)
T 3a79_B 467 KDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPGI 516 (562)
T ss_dssp TTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHHHH
T ss_pred hhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcchH
Confidence 88889999999999999999 56665 999999999999999999998853
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=318.51 Aligned_cols=203 Identities=26% Similarity=0.393 Sum_probs=171.7
Q ss_pred HHhhcccccccceEEEEEEeC------CCCEEEEEEeccc-CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREK-TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
+.+.++||+|+||.||+|.+. +++.||||+++.. ......++.+|+.++++++||||+++++++ ......++
T Consensus 73 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-~~~~~~~l 151 (367)
T 3l9p_A 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-LQSLPRFI 151 (367)
T ss_dssp EEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSCEE
T ss_pred eEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-ecCCCCEE
Confidence 456789999999999999853 4568999999754 334456789999999999999999999999 45558899
Q ss_pred EEeecCCCCHHHHHhhcCC----CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC---CeEEeecCC
Q 041878 610 VFDFMPKGSLASFLHARGP----ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT---NPRIADFGL 682 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~---~~kl~DfG~ 682 (773)
||||+++|+|.++++.... ...+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+
T Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~ 230 (367)
T 3l9p_A 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 230 (367)
T ss_dssp EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence 9999999999999987632 245899999999999999999999 99999999999999999555 499999999
Q ss_pred ccccccccc-cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 683 SRLMTAAAN-TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 683 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+
T Consensus 231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~ 291 (367)
T 3l9p_A 231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 291 (367)
T ss_dssp HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 986543322 22234457899999999988999999999999999999998 999997654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.14 Aligned_cols=205 Identities=22% Similarity=0.403 Sum_probs=162.5
Q ss_pred HHHhhcccccccceEEEEEEeCC----CCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLED----GSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
+|.+.+.||+|+||.||+|.+.. +..||+|..+.... ...+.+.+|+.++++++||||+++++++ . .+..++|
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~-~~~~~lv 93 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-T-ENPVWII 93 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-C-SSSCEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-c-cCccEEE
Confidence 45667899999999999998643 45699999875433 3456789999999999999999999998 3 3478999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||+++++|.+++.... ..+++..+..++.|++.||.||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-hCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 99999999999998653 34789999999999999999999 9999999999999999999999999999998765443
Q ss_pred ccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCh
Q 041878 691 NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDL 745 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~ 745 (773)
........+|+.|+|||.+....++.++||||+|+++|||++ |..||......+.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~ 226 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH
Confidence 333334457889999999988899999999999999999997 9999987654443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=339.72 Aligned_cols=315 Identities=20% Similarity=0.287 Sum_probs=270.4
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCc-ccc-cCCCCCCCC-------CCCceEEcccCccCCCCCC--CC
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNL-LAG-PVPWSLGFL-------PNLRGVYLFNNRLSGSIPP--SI 159 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~-l~~-~~~~~l~~l-------~~L~~L~L~~n~l~~~~p~--~l 159 (773)
.+++.|+|++|++.|.+|+.++++++|++|+|++|+ ++| .+|..++.+ ++|++|+|++|+++ .+|. .|
T Consensus 491 ~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l 569 (876)
T 4ecn_A 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASL 569 (876)
T ss_dssp TTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHH
T ss_pred CCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhh
Confidence 468899999999999999999999999999999998 998 788755544 59999999999999 8999 99
Q ss_pred CCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCc-cceeeccccccccccCCcccccccCc
Q 041878 160 GNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPS-LSVLALQHNNLSGSVPNNWGVLAGNK 238 (773)
Q Consensus 160 ~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~~~ 238 (773)
+++++|++|+|++|.++ .+| .++.+++|++|+|++|+++ .+|..+.++++ |++|+|++|+++ .+|..+....
T Consensus 570 ~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~--- 642 (876)
T 4ecn_A 570 QKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS--- 642 (876)
T ss_dssp TTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTC---
T ss_pred hcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccc---
Confidence 99999999999999999 888 8999999999999999999 89999999999 999999999999 7887665443
Q ss_pred ccccceeeccccccccccCcc---CC--CCCCccEEECCCCcccCCCCCCc-CcccccceeccccccccccCcccccc--
Q 041878 239 SYQLQFLNLDHNLIAGTIPVS---LG--KLGLLQEISLSHNKIVGPIPDEL-GKLSKLQKLDLSYNAIGGSFPVTFTN-- 310 (773)
Q Consensus 239 ~~~L~~L~L~~n~l~~~~~~~---l~--~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~~~~~~~-- 310 (773)
.++|+.|+|++|.+++.+|.. +. .+++|+.|+|++|+++ .+|..+ ..+++|+.|+|++|+|+ .+|..+..
T Consensus 643 ~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~ 720 (876)
T 4ecn_A 643 VYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPK 720 (876)
T ss_dssp SSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCT
T ss_pred cCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccc
Confidence 235999999999999876643 23 3458999999999999 566554 47899999999999999 55554332
Q ss_pred ------cccCceEEccCCCCCCCcchhhc--cccccccccccCcccccccccccCCCCcCceeecCC------ccCccCC
Q 041878 311 ------ITSLVSLNLENNRLGNKIPEGLE--RLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSE------NDFTGEI 376 (773)
Q Consensus 311 ------l~~L~~L~Ls~N~l~~~~~~~l~--~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~------N~l~~~~ 376 (773)
+++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..++.+++|+.|+|++ |++.+.+
T Consensus 721 ~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~i 798 (876)
T 4ecn_A 721 DGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQW 798 (876)
T ss_dssp TSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCC
T ss_pred cccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccC
Confidence 349999999999998 6788887 89999999999999997 798999999999999976 8889999
Q ss_pred CchhhccCccCEEEeecccCCCCCchhhhccCCCCCCCCCCC
Q 041878 377 SPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQ 418 (773)
Q Consensus 377 ~~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~~~n~~ 418 (773)
|..+..+++|+.|+|++|++ +.+|..+...+....+.+|+.
T Consensus 799 p~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l 839 (876)
T 4ecn_A 799 PTGITTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPN 839 (876)
T ss_dssp CTTGGGCSSCCEEECCSSCC-CBCCSCCCSSSCEEECCSCTT
T ss_pred hHHHhcCCCCCEEECCCCCC-CccCHhhcCCCCEEECCCCCC
Confidence 99999999999999999999 888887655454455566653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=302.02 Aligned_cols=200 Identities=26% Similarity=0.470 Sum_probs=174.6
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
|...+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++ ...+..++||||+++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVC-LEQAPICLVTEFMEH 87 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSSCEEEECCCTT
T ss_pred eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEE-ccCCCeEEEEeCCCC
Confidence 456789999999999999988888999999976543 457899999999999999999999999 455689999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.+++.... ..+++..+..++.|++.||+||| +.|++||||||+||+++.++.+||+|||.+.............
T Consensus 88 ~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 88 GCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE-EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 99999998753 34789999999999999999999 9999999999999999999999999999998765433222334
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
..+++.|+|||.+....++.++||||+|+++|||++ |+.||...+
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 457889999999988899999999999999999999 899997644
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.04 Aligned_cols=210 Identities=23% Similarity=0.325 Sum_probs=166.1
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.+.||+|+||+||++... +++.||||++..... ..+.+.+|+.++++++||||+++++++. ..+..++||||++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIIMEYAS 99 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEEECCC
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEe-eCCEEEEEEEeCC
Confidence 456789999999999999875 789999999975433 3467889999999999999999999995 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC--eEEeecCCccccccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN--PRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~--~kl~DfG~a~~~~~~~~~~ 693 (773)
+|+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++. +||+|||+++...... .
T Consensus 100 ~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH-~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~ 173 (361)
T 3uc3_A 100 GGELYERICNAG---RFSEDEARFFFQQLLSGVSYCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q 173 (361)
T ss_dssp SCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--C
Confidence 999999998754 3889999999999999999999 999999999999999987775 9999999987543222 1
Q ss_pred eeeccCccccccccccCCCCCCcc-hhhHHHHHHHHHHHcCCCCCCCCCC-CChHHHHHHHHH
Q 041878 694 VIATAGTLGYRAPELSKLKNANTK-TDVYSLGVIILELLTGKSPGEPMNG-MDLPQWVASIVK 754 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~-~Dvws~Gv~l~el~tg~~P~~~~~~-~~~~~~~~~~~~ 754 (773)
.....||+.|+|||++.+..++.+ +||||+||++|||++|+.||..... .+..+.+.++..
T Consensus 174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 236 (361)
T 3uc3_A 174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS 236 (361)
T ss_dssp -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT
T ss_pred CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc
Confidence 223469999999999887777655 8999999999999999999987544 344444444443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=314.02 Aligned_cols=203 Identities=29% Similarity=0.463 Sum_probs=172.7
Q ss_pred HHhhcccccccceEEEEEEeC------CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
|.+.+.||+|+||.||+|... +++.||||+++.... ...+.+.+|+.++++++||||+++++++ ...+..++
T Consensus 49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~l 127 (343)
T 1luf_A 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-AVGKPMCL 127 (343)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSSCEE
T ss_pred CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-ccCCceEE
Confidence 456789999999999999864 347899999976533 3456799999999999999999999999 45568999
Q ss_pred EEeecCCCCHHHHHhhcCC---------------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEE
Q 041878 610 VFDFMPKGSLASFLHARGP---------------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVL 668 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIl 668 (773)
||||+++|+|.+++..... ...+++..++.++.||++||.||| +.||+||||||+||+
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp~NIl 206 (343)
T 1luf_A 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS-ERKFVHRDLATRNCL 206 (343)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEE
T ss_pred EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCcceEE
Confidence 9999999999999987532 145899999999999999999999 999999999999999
Q ss_pred eCCCCCeEEeecCCccccccccc-cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 669 LDEKTNPRIADFGLSRLMTAAAN-TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 669 l~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...+
T Consensus 207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 99999999999999987644332 22234467899999999988899999999999999999999 999997654
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=300.89 Aligned_cols=285 Identities=23% Similarity=0.278 Sum_probs=238.4
Q ss_pred EEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCC
Q 041878 96 IQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNAL 175 (773)
Q Consensus 96 l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 175 (773)
+++++++++ .+|..+. +.|++|+|++|++++..+..|+.+++|++|+|++|++++..|..|+++++|++|+|++|.+
T Consensus 36 l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (330)
T 1xku_A 36 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112 (330)
T ss_dssp EECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcC
Confidence 444555555 4555443 6899999999999988888999999999999999999988899999999999999999999
Q ss_pred CCCCccccccccccceeecccccccccCCccccCCCccceeecccccccc--ccCCcccccccCcccccceeeccccccc
Q 041878 176 IGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSG--SVPNNWGVLAGNKSYQLQFLNLDHNLIA 253 (773)
Q Consensus 176 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~~~~~~L~~L~L~~n~l~ 253 (773)
+ .+|..+. ++|++|++++|++++..+..+.++++|++|++++|+++. ..+..+..+. +|++|++++|.++
T Consensus 113 ~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~-----~L~~L~l~~n~l~ 184 (330)
T 1xku_A 113 K-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK-----KLSYIRIADTNIT 184 (330)
T ss_dssp S-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCT-----TCCEEECCSSCCC
T ss_pred C-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCC-----CcCEEECCCCccc
Confidence 8 5666654 789999999999998888889999999999999999963 5555555544 8999999999998
Q ss_pred cccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhc
Q 041878 254 GTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLE 333 (773)
Q Consensus 254 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 333 (773)
. +|..+. ++|++|++++|++++..|..|..+++|++|+|++|.+++..+..+..+++|++|+|++|+++ .+|..+.
T Consensus 185 ~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~ 260 (330)
T 1xku_A 185 T-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260 (330)
T ss_dssp S-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTT
T ss_pred c-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhc
Confidence 5 444443 78999999999999888888999999999999999999888888999999999999999997 7788889
Q ss_pred cccccccccccCcccccccccccCC------CCcCceeecCCccCcc--CCCchhhccCccCEEEeeccc
Q 041878 334 RLQNLTVLNLKNNQFKGHIPETIGN------ISGINQLDLSENDFTG--EISPSLASLANLTSFNVSYNN 395 (773)
Q Consensus 334 ~l~~L~~L~ls~N~l~~~~~~~~~~------l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~ls~N~ 395 (773)
.+++|++|++++|++++..+..|.. .+.|+.|++++|++.. ..|..|..+.+++.++|++|+
T Consensus 261 ~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp TCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred cCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 9999999999999999777776654 3788899999999864 566788888999999999885
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-35 Score=313.33 Aligned_cols=202 Identities=26% Similarity=0.392 Sum_probs=170.9
Q ss_pred HHhhcccccccceEEEEEEe----CCCCEEEEEEecccC----cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeE
Q 041878 537 CATAEIMGKSTYGTAYKATL----EDGSEVAVKRLREKT----TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEK 607 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 607 (773)
|.+.++||+|+||.||+|.. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++. ..+..
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-~~~~~ 134 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-TETKL 134 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE-ETTEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe-eCceE
Confidence 45678999999999999986 368999999997532 22345677899999999 5999999999984 45589
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccc
Q 041878 608 LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMT 687 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 687 (773)
++||||+++|+|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 135 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLH-KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp EEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred EEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999998754 3789999999999999999999 9999999999999999999999999999998765
Q ss_pred cccccceeeccCccccccccccCC--CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 688 AAANTNVIATAGTLGYRAPELSKL--KNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 688 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 268 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc
Confidence 444433444579999999999875 45789999999999999999999999865443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-35 Score=306.14 Aligned_cols=199 Identities=25% Similarity=0.383 Sum_probs=164.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc--------------------------cHHHHHHHHHHHHccC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK--------------------------GQKEFEAEAAAIGKIH 589 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--------------------------~~~~~~~E~~~l~~l~ 589 (773)
|.+.+.||+|+||.||+|... +++.||||++...... ..+++.+|++++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 345788999999999999864 6889999999654211 1356889999999999
Q ss_pred CCceEEeEEEEECC-CCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEE
Q 041878 590 HPNLLALRAYYLGP-KGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVL 668 (773)
Q Consensus 590 h~niv~l~~~~~~~-~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIl 668 (773)
||||+++++++... .+..++||||+++++|.+++.. ..+++..+..++.||+.||+||| +.||+||||||+||+
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLH-YQKIIHRDIKPSNLL 169 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEE
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEE
Confidence 99999999999653 4578999999999999876543 34899999999999999999999 899999999999999
Q ss_pred eCCCCCeEEeecCCccccccccccceeeccCccccccccccCCCC---CCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 669 LDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKN---ANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 669 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++||||+||++|||++|+.||...+
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999987653322 223456999999999987655 4788999999999999999999997543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=300.43 Aligned_cols=201 Identities=34% Similarity=0.569 Sum_probs=172.2
Q ss_pred hcccccccceEEEEEEeCCCCEEEEEEecccC----cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 540 AEIMGKSTYGTAYKATLEDGSEVAVKRLREKT----TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
++.||+|+||.||+|.. +++.||||++.... ....+.+.+|++++++++||||+++++++ ...+..++||||++
T Consensus 36 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~ 113 (307)
T 2nru_A 36 GNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-SDGDDLCLVYVYMP 113 (307)
T ss_dssp CCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSCEEEEECCT
T ss_pred CCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE-ecCCceEEEEEecC
Confidence 37899999999999987 58899999986532 23357799999999999999999999999 45568999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc-e
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN-V 694 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~-~ 694 (773)
+++|.+++........+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||++.......... .
T Consensus 114 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp TCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred CCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh-cCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence 9999999986544456899999999999999999999 9999999999999999999999999999998665432222 2
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMD 744 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~ 744 (773)
....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+
T Consensus 193 ~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp SSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred cccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 23468999999998764 58899999999999999999999998765444
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.30 Aligned_cols=196 Identities=24% Similarity=0.408 Sum_probs=155.9
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.+.||+|+||.||+|... +++.||||+++... ..+.+.+|++++++++||||+++++++. ..+..++||||++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE-TPTEISLVLELVT 131 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-CSSEEEEEECCCC
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe-cCCeEEEEEEeCC
Confidence 345688999999999999975 57899999997543 3567889999999999999999999995 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC---CCCeEEeecCCcccccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE---KTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~---~~~~kl~DfG~a~~~~~~~~~ 692 (773)
+|+|.+++.... .+++..+..++.||+.||.||| +.||+||||||+||+++. ++.+||+|||+++.......
T Consensus 132 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 206 (349)
T 2w4o_A 132 GGELFDRIVEKG---YYSERDAADAVKQILEAVAYLH-ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL- 206 (349)
T ss_dssp SCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc-
Confidence 999999998643 3789999999999999999999 999999999999999975 88999999999986543321
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 254 (349)
T 2w4o_A 207 -MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254 (349)
T ss_dssp -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred -cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence 223468999999999998899999999999999999999999997654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=306.05 Aligned_cols=199 Identities=25% Similarity=0.441 Sum_probs=173.7
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc------cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK------GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
.|.+.+.||+|+||.||+|... +|+.||+|.+...... ..+++.+|+.++++++||||+++++++. ..+..+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (321)
T 2a2a_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE-NRTDVV 91 (321)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEE
T ss_pred cEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCEEE
Confidence 3567889999999999999865 6899999999754322 3678999999999999999999999995 455899
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC----CeEEeecCCcc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT----NPRIADFGLSR 684 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~----~~kl~DfG~a~ 684 (773)
+||||+++++|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++ .+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH-~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 9999999999999998643 4789999999999999999999 99999999999999999888 79999999998
Q ss_pred ccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 685 LMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....... .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||...+
T Consensus 168 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 222 (321)
T 2a2a_A 168 EIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222 (321)
T ss_dssp ECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC
Confidence 7654322 233468999999999998999999999999999999999999997644
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.87 Aligned_cols=200 Identities=26% Similarity=0.413 Sum_probs=160.3
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc--CcccHHHHHHHHHHHHccC-CCceEEeEEEEECCC-CeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPK-GEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~~lV~ 611 (773)
|.+.+.||+|+||.||+|.+ .+|+.||||++... .......+.+|+.+++++. ||||+++++++.... ...++||
T Consensus 11 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~ 90 (388)
T 3oz6_A 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF 90 (388)
T ss_dssp EEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEE
T ss_pred eEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEe
Confidence 34578999999999999986 47899999998643 2334567889999999997 999999999996543 3689999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc-
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA- 690 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~- 690 (773)
||++ ++|.++++.. .++...+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+|+......
T Consensus 91 e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 91 DYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLH-SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp ECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred cccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 9997 6999998764 3788999999999999999999 9999999999999999999999999999998653211
Q ss_pred -------------------ccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 691 -------------------NTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 691 -------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 111233569999999998876 6789999999999999999999999976543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=319.77 Aligned_cols=218 Identities=21% Similarity=0.350 Sum_probs=181.7
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCC-CeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-GEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~lV~e~ 613 (773)
|.+.++||+|+||.||+|.+. +|+.||||++.... ....+.+.+|++++++++||||+++++++.... ...++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 345789999999999999875 58999999997543 334577889999999999999999999986544 367999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe----CCCCCeEEeecCCccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL----DEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll----~~~~~~kl~DfG~a~~~~~~ 689 (773)
+++|+|.++++.......+++..++.++.||+.||+||| +.||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~ 169 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH-HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence 999999999987654445899999999999999999999 9999999999999999 77778999999999876543
Q ss_pred cccceeeccCccccccccccCC--------CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC-CChHHHHHHHHHhhh
Q 041878 690 ANTNVIATAGTLGYRAPELSKL--------KNANTKTDVYSLGVIILELLTGKSPGEPMNG-MDLPQWVASIVKEEW 757 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~-~~~~~~~~~~~~~~~ 757 (773)
.. .....||+.|+|||++.. ..++.++|||||||++|||++|+.||.+... ....+.+.+++.+.+
T Consensus 170 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 170 EQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp GG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred Cc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 32 223468999999998764 5678899999999999999999999987543 445566666665543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=322.06 Aligned_cols=198 Identities=26% Similarity=0.450 Sum_probs=171.9
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.+++.++||||+++++++. ..+..++|||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-~~~~~~lv~E 96 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-TPSDIFMVME 96 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEEEEEEe
Confidence 345789999999999999875 79999999996532 223567899999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.+.. .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 97 ~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH-~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~- 171 (476)
T 2y94_A 97 YVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCH-RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 171 (476)
T ss_dssp CCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHH-TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC-
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc-
Confidence 999999999997643 4899999999999999999999 99999999999999999999999999999987654322
Q ss_pred ceeeccCccccccccccCCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||++.+..+ +.++||||+||++|||++|+.||...+
T Consensus 172 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 172 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp -BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 234469999999999887766 689999999999999999999997644
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=307.45 Aligned_cols=201 Identities=23% Similarity=0.441 Sum_probs=169.2
Q ss_pred HHHhhcccccccceEEEEEEe-----CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECC-CCeEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATL-----EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-KGEKLL 609 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~l 609 (773)
+|.+.+.||+|+||+||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++... ....++
T Consensus 11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 90 (295)
T 3ugc_A 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 90 (295)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence 345678999999999999984 36789999999876666677899999999999999999999998543 245899
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.....
T Consensus 91 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 91 IMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp EEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred EEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHh-cCCcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 999999999999998753 34889999999999999999999 999999999999999999999999999999876543
Q ss_pred ccc--ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 690 ANT--NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 690 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
... ......+++.|+|||.+.+..++.++||||||+++|||+||..||..
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 321 12233477789999999989999999999999999999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=316.63 Aligned_cols=208 Identities=30% Similarity=0.510 Sum_probs=164.9
Q ss_pred HHHhhcccccccceEEEEEEeC--CC--CEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE--DG--SEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~--~g--~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
.+...++||+|+||.||+|.+. ++ ..||||.++... ....+++.+|+.++++++||||+++++++....+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3455689999999999999863 22 358999987543 344578999999999999999999999986666688999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||+++|+|.++++... ..+++..+..++.||++||+||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHH-HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 99999999999997643 34788999999999999999999 9999999999999999999999999999998664332
Q ss_pred cc---ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCChH
Q 041878 691 NT---NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLP 746 (773)
Q Consensus 691 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~~ 746 (773)
.. ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||...+..+..
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~ 306 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 306 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH
Confidence 21 1223457889999999998999999999999999999999 67788776555443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.88 Aligned_cols=205 Identities=27% Similarity=0.483 Sum_probs=167.1
Q ss_pred HHhhcccccccceEEEEEEeC-CCCE----EEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSE----VAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~----vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
|...++||+|+||+||+|.+. +++. ||+|.++... ....+++.+|+.++++++||||+++++++... ..++|
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~v 94 (327)
T 3poz_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQLI 94 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--SEEEE
T ss_pred cccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEE
Confidence 456789999999999999864 4443 6888886443 34567899999999999999999999999643 57899
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
+||+++|+|.+++.... ..+++..++.++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHh-hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 99999999999998753 34889999999999999999999 8999999999999999999999999999998765443
Q ss_pred cc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCChH
Q 041878 691 NT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLP 746 (773)
Q Consensus 691 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~~ 746 (773)
.. ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...+..++.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 229 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229 (327)
T ss_dssp C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH
Confidence 22 2223457889999999999999999999999999999999 99999876554443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=307.86 Aligned_cols=208 Identities=27% Similarity=0.413 Sum_probs=175.6
Q ss_pred HHHhhcccccccceEEEEEEe------CCCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 536 LCATAEIMGKSTYGTAYKATL------EDGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
.|.+.+.||+|+||.||+|.. .+++.||||+++... ....+++.+|++++++++||||+++++++ ...+..+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~~~~~~ 102 (314)
T 2ivs_A 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-SQDGPLL 102 (314)
T ss_dssp GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSSCE
T ss_pred heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-ecCCceE
Confidence 356778999999999999985 245789999997543 33457789999999999999999999999 5556899
Q ss_pred EEEeecCCCCHHHHHhhcCC---------------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCE
Q 041878 609 LVFDFMPKGSLASFLHARGP---------------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNV 667 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NI 667 (773)
+||||+++|+|.+++..... ...+++..+..++.||+.||+||| +.||+||||||+||
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dikp~NI 181 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA-EMKLVHRDLAARNI 181 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGE
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH-HCCCcccccchheE
Confidence 99999999999999987532 234889999999999999999999 99999999999999
Q ss_pred EeCCCCCeEEeecCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCh
Q 041878 668 LLDEKTNPRIADFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDL 745 (773)
Q Consensus 668 ll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~ 745 (773)
+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||+||++|||++ |+.||...+..++
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999876443221 1223457889999999988889999999999999999999 9999987654433
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=322.42 Aligned_cols=196 Identities=22% Similarity=0.300 Sum_probs=163.0
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCC-----CeEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-----GEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~~ 608 (773)
|.+.++||+|+||+||+|... +|+.||||++... .....+++.+|+.+++.++||||+++++++.... ...+
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 143 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence 456789999999999999864 6889999999754 3334567889999999999999999999995432 3579
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||+++ ++.+.+.. .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++....
T Consensus 144 lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH-~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 144 LVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred EEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 99999975 57666653 2788999999999999999999 89999999999999999999999999999987643
Q ss_pred ccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+
T Consensus 217 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 217 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 32 2234568999999999999999999999999999999999999997654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=299.29 Aligned_cols=208 Identities=25% Similarity=0.378 Sum_probs=170.4
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.+.++||+|+||+||+|... +++.||||++..... .....+.+|+.++++++||||+++++++. ..+..++||||+
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~ 83 (292)
T 3o0g_A 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-SDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTEEEEEEECC
T ss_pred eeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-eCCEEEEEEecC
Confidence 45688999999999999875 689999999975432 23467889999999999999999999995 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++ ++.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....... ..
T Consensus 84 ~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH-~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 158 (292)
T 3o0g_A 84 DQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CY 158 (292)
T ss_dssp SE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-CC
T ss_pred CC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-cc
Confidence 75 6666665532 34899999999999999999999 89999999999999999999999999999987643322 22
Q ss_pred eeccCccccccccccCCCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHH
Q 041878 695 IATAGTLGYRAPELSKLKN-ANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIV 753 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~ 753 (773)
....||+.|+|||++.+.. ++.++||||+||++|||++|+.||... .+..+.+.++.
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~--~~~~~~~~~i~ 216 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG--NDVDDQLKRIF 216 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC--SSHHHHHHHHH
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC--CCHHHHHHHHH
Confidence 3446899999999887655 899999999999999999999886432 33444444443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.45 Aligned_cols=204 Identities=25% Similarity=0.352 Sum_probs=167.1
Q ss_pred HHHhhcccccccceEEEEEEe-CCCCEEEEEEeccc-----CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK-----TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
+|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++. ..+..++
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~l 105 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-DEQYICL 105 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEE
T ss_pred heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-cCCeEEE
Confidence 356788999999999999986 46889999998643 2345678999999999999999999999995 4558999
Q ss_pred EEeecCCCCHHHHHhhcC-------------------------------------CCCccCHHHHHHHHHHHHHHHHHhc
Q 041878 610 VFDFMPKGSLASFLHARG-------------------------------------PETIVNWATRMSIAIGIARGLNYLH 652 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~-------------------------------------~~~~~~~~~~~~i~~~i~~al~yLH 652 (773)
||||+++|+|.+++.... ....+++..+..++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 999999999999986311 0112356778889999999999999
Q ss_pred cCCCceecCCCCCCEEeCCCC--CeEEeecCCccccccccc---cceeeccCccccccccccCC--CCCCcchhhHHHHH
Q 041878 653 VEENMIHGNLTSSNVLLDEKT--NPRIADFGLSRLMTAAAN---TNVIATAGTLGYRAPELSKL--KNANTKTDVYSLGV 725 (773)
Q Consensus 653 ~~~~iiH~Dik~~NIll~~~~--~~kl~DfG~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv 725 (773)
+.+|+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||.+.. ..++.++|||||||
T Consensus 186 -~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 186 -NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp -HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred -HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 89999999999999998777 899999999986643221 12334569999999998865 67899999999999
Q ss_pred HHHHHHcCCCCCCCCC
Q 041878 726 IILELLTGKSPGEPMN 741 (773)
Q Consensus 726 ~l~el~tg~~P~~~~~ 741 (773)
++|||++|+.||...+
T Consensus 265 il~el~~g~~pf~~~~ 280 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVN 280 (345)
T ss_dssp HHHHHHHSSCSSCCSS
T ss_pred HHHHHHHCCCCCCCCC
Confidence 9999999999997654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.76 Aligned_cols=206 Identities=31% Similarity=0.461 Sum_probs=177.8
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.|.+.+.||+|+||.||+|.+. ++..||+|.+.... ...+++.+|++++++++||||+++++++ ...+..++||||+
T Consensus 14 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~~v~e~~ 91 (288)
T 3kfa_A 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFYIITEFM 91 (288)
T ss_dssp GEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSEEEEEECC
T ss_pred ceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEE-ccCCCEEEEEEcC
Confidence 3456789999999999999876 47889999997543 3467899999999999999999999999 5556899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++++|.+++.... ...+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+...........
T Consensus 92 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 169 (288)
T 3kfa_A 92 TYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169 (288)
T ss_dssp TTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHH-HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE
T ss_pred CCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHH-HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc
Confidence 9999999998754 345899999999999999999999 99999999999999999999999999999987765443333
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCh
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDL 745 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~ 745 (773)
....+|+.|+|||.+.+..++.++||||+|+++|||++ |..||...+..+.
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~ 221 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV 221 (288)
T ss_dssp TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 34457889999999988899999999999999999999 9999987554443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=302.43 Aligned_cols=203 Identities=27% Similarity=0.394 Sum_probs=170.2
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC-----cccHHHHHHHHHHHHccC---CCceEEeEEEEECCCC--
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT-----TKGQKEFEAEAAAIGKIH---HPNLLALRAYYLGPKG-- 605 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~-- 605 (773)
|.+.++||+|+||+||+|.. .+++.||||++.... ......+.+|++++++++ ||||+++++++.....
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~ 90 (308)
T 3g33_A 11 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR 90 (308)
T ss_dssp CEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSS
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCC
Confidence 45678999999999999986 578999999986432 122356777888877775 9999999999965443
Q ss_pred --eEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCc
Q 041878 606 --EKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS 683 (773)
Q Consensus 606 --~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a 683 (773)
..++||||++ ++|.+++..... ..+++..+..++.||+.||+||| +.+|+||||||+||+++.++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 91 EIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp EEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred ceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 4789999996 699999987643 34899999999999999999999 999999999999999999999999999999
Q ss_pred cccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 041878 684 RLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMD 744 (773)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~ 744 (773)
+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+
T Consensus 168 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 226 (308)
T 3g33_A 168 RIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226 (308)
T ss_dssp TTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH
T ss_pred cccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 86643322 234568999999999988999999999999999999999999997765433
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.62 Aligned_cols=207 Identities=28% Similarity=0.434 Sum_probs=161.4
Q ss_pred HHHhhcccccccceEEEEEEeCCC----CEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCe---
Q 041878 536 LCATAEIMGKSTYGTAYKATLEDG----SEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGE--- 606 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~g----~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~--- 606 (773)
.|.+.+.||+|+||.||+|.+... ..||||+++.. .....+++.+|++++++++||||+++++++......
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence 456778999999999999986533 27999999754 334567899999999999999999999999654321
Q ss_pred --EEEEEeecCCCCHHHHHhhcCC---CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecC
Q 041878 607 --KLLVFDFMPKGSLASFLHARGP---ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFG 681 (773)
Q Consensus 607 --~~lV~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG 681 (773)
.++||||+++|+|.+++..... ...+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS-SRNFIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH-cCCcccCCCCcceEEEcCCCCEEEeecc
Confidence 3899999999999999976431 224899999999999999999999 9999999999999999999999999999
Q ss_pred Ccccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 041878 682 LSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGM 743 (773)
Q Consensus 682 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~ 743 (773)
+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...+..
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 246 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246 (323)
T ss_dssp C-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred ccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH
Confidence 99876543322 2223457889999999998999999999999999999999 99999875543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.41 Aligned_cols=204 Identities=22% Similarity=0.417 Sum_probs=169.4
Q ss_pred HHhhcccccccceEEEEEEeCC----CCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLED----GSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
|.+.+.||+|+||.||+|.+.+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++. . +..++||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~-~~~~~v~ 91 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-E-EPTWIIM 91 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-S-SSCEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-C-CCCEEEE
Confidence 4567899999999999998542 2359999997653 334678999999999999999999999984 3 3578999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++++|.+++.... ..+++..+..++.|++.||.||| +.||+||||||+||+++.++.+||+|||.+........
T Consensus 92 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 168 (281)
T 3cc6_A 92 ELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLE-SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY 168 (281)
T ss_dssp ECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred ecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence 9999999999998753 34789999999999999999999 99999999999999999999999999999987655443
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCh
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDL 745 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~ 745 (773)
.......+|+.|+|||.+....++.++||||||+++|||+| |+.||......+.
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~ 223 (281)
T 3cc6_A 169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223 (281)
T ss_dssp ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH
T ss_pred cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH
Confidence 33344557889999999988899999999999999999998 9999976554433
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=312.64 Aligned_cols=195 Identities=23% Similarity=0.355 Sum_probs=160.0
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHc-cCCCceEEeEEEEEC---CCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGK-IHHPNLLALRAYYLG---PKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~---~~~~~~lV~e~~~ 615 (773)
++||+|+||+||+|... +|+.||||+++. ...+.+|+.++.+ .+||||+++++++.. .....++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 68999999999999865 689999999953 3456778888754 579999999998843 2446899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC---CCCeEEeecCCcccccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE---KTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~---~~~~kl~DfG~a~~~~~~~~~ 692 (773)
+|+|.+++.... ...+++..+..++.||+.||.||| +.||+||||||+|||++. ++.+||+|||+++......
T Consensus 143 gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~-- 218 (400)
T 1nxk_A 143 GGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-- 218 (400)
T ss_dssp SEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred CCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC--
Confidence 999999998753 235899999999999999999999 899999999999999998 7889999999998654322
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMD 744 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~ 744 (773)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...
T Consensus 219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 270 (400)
T 1nxk_A 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270 (400)
T ss_dssp --------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCS
T ss_pred ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 2234568999999999999999999999999999999999999998765443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.56 Aligned_cols=200 Identities=19% Similarity=0.277 Sum_probs=164.4
Q ss_pred HHhhcccccccceEEEEEEeCC------CCEEEEEEecccCccc-----------HHHHHHHHHHHHccCCCceEEeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLED------GSEVAVKRLREKTTKG-----------QKEFEAEAAAIGKIHHPNLLALRAY 599 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~------g~~vAvK~l~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~~ 599 (773)
|.+.++||+|+||.||+|.+.. ++.||||++....... ...+..|+..++.++|+||++++++
T Consensus 37 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 116 (364)
T 3op5_A 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGS 116 (364)
T ss_dssp EEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEE
T ss_pred EEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEee
Confidence 3567899999999999998754 4789999987543211 1123345666778889999999999
Q ss_pred EECCC---CeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeC--CCCC
Q 041878 600 YLGPK---GEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLD--EKTN 674 (773)
Q Consensus 600 ~~~~~---~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~--~~~~ 674 (773)
+.... ...++||||+ +++|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+|||++ .++.
T Consensus 117 ~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH-~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 117 GLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIH-EHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEESSCTTC
T ss_pred eeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH-HCCeEEecCCHHHEEEecCCCCe
Confidence 86532 3579999999 999999998752 34899999999999999999999 89999999999999999 8899
Q ss_pred eEEeecCCccccccccccc------eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 675 PRIADFGLSRLMTAAANTN------VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 675 ~kl~DfG~a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 9999999998765432211 12335999999999999999999999999999999999999999863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=307.56 Aligned_cols=210 Identities=22% Similarity=0.361 Sum_probs=174.3
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.+.||+|+||.||+|... +|+.||||++...... ..+|++++.++ +||||+++++++. ..+..++||||+
T Consensus 24 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~-~~~~~~lv~E~~ 98 (342)
T 2qr7_A 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYD-DGKYVYVVTELM 98 (342)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEE-CSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEE-cCCEEEEEEeCC
Confidence 456789999999999999875 6889999999754332 34688888887 7999999999994 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC-C---CeEEeecCCcccccccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK-T---NPRIADFGLSRLMTAAA 690 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~-~---~~kl~DfG~a~~~~~~~ 690 (773)
++|+|.+++.+.. .+++..+..++.||+.||+||| +.||+||||||+||++.++ + .+||+|||+++......
T Consensus 99 ~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH-~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 99 KGGELLDKILRQK---FFSEREASAVLFTITKTVEYLH-AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 9999999998753 4899999999999999999999 9999999999999998543 3 49999999998764432
Q ss_pred ccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhh
Q 041878 691 NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 756 (773)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.........+...++....
T Consensus 175 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~ 239 (342)
T 2qr7_A 175 G-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239 (342)
T ss_dssp C-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC
T ss_pred C-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC
Confidence 2 2234568999999999988889999999999999999999999998765555555555555443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-34 Score=298.21 Aligned_cols=209 Identities=16% Similarity=0.255 Sum_probs=176.5
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.+++++ +|+|++++++++. .....++||||+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-~~~~~~lv~e~~ 88 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-EGLHNVLVIDLL 88 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-ETTEEEEEEECC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC-CCceeEEEEEec
Confidence 34568899999999999985 578999999986443 334678899999999 7999999999984 555899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC-----eEEeecCCccccccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN-----PRIADFGLSRLMTAA 689 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~-----~kl~DfG~a~~~~~~ 689 (773)
+++|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++. +||+|||+++.....
T Consensus 89 -~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 89 -GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIH-EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp -CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 999999998753 34899999999999999999999 999999999999999988776 999999999876544
Q ss_pred ccc------ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 041878 690 ANT------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASI 752 (773)
Q Consensus 690 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~ 752 (773)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+..+....+
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 233 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH
Confidence 321 123456999999999999999999999999999999999999999987665555544444
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=334.16 Aligned_cols=199 Identities=23% Similarity=0.348 Sum_probs=172.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
|.+.++||+|+||.||+|... +++.||||+++.. .......+..|..++..+ +|++|+++++++ ...+..|+||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-~~~~~~~lV~ 421 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-QTMDRLYFVM 421 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-BCSSEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-EeCCEEEEEE
Confidence 345689999999999999865 6889999999753 233456788899999987 699999999988 4556899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++|+|.++++... .+++..+..++.||+.||+||| +.|||||||||+|||++.++.+||+|||+++.......
T Consensus 422 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH-~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 497 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQ-SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497 (674)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred eCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence 9999999999998764 3889999999999999999999 99999999999999999999999999999986433222
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+
T Consensus 498 -~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 498 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp -CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 2334579999999999999999999999999999999999999997654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=332.90 Aligned_cols=200 Identities=29% Similarity=0.455 Sum_probs=173.5
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.+.++||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++|+||+++++++.. +..++||||+++
T Consensus 269 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~e~~~~ 345 (535)
T 2h8h_A 269 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSK 345 (535)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTT
T ss_pred hhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEeeehhcC
Confidence 45678999999999999999888889999997654 346789999999999999999999999843 578999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
|+|.++++... ...+++..++.++.||+.||+||| +++|+||||||+|||++.++.+||+|||+++............
T Consensus 346 gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 423 (535)
T 2h8h_A 346 GSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423 (535)
T ss_dssp EEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCS
T ss_pred CcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccC
Confidence 99999997542 133789999999999999999999 9999999999999999999999999999998765433222233
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
..++..|+|||++....++.++|||||||++|||+| |+.||....
T Consensus 424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~ 469 (535)
T 2h8h_A 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 469 (535)
T ss_dssp TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC
T ss_pred CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 456789999999988899999999999999999999 999997654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=301.57 Aligned_cols=207 Identities=30% Similarity=0.505 Sum_probs=171.8
Q ss_pred HHHhhcccccccceEEEEEEeCC----CCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLED----GSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
.|.+.++||+|+||.||+|.+.+ ...||+|.+..... ...+.+.+|+.++++++||||+++++++....+..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 34567899999999999998642 22589999875433 34567899999999999999999999986677788999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||+++|+|.++++... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 106 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH-~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 99999999999997643 34788999999999999999999 9999999999999999999999999999998765433
Q ss_pred cc---ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCCh
Q 041878 691 NT---NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDL 745 (773)
Q Consensus 691 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~ 745 (773)
.. ......+|+.|+|||.+.+..++.++||||+|+++|||++ |..||...+..+.
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~ 241 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 241 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH
T ss_pred hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH
Confidence 21 2234457889999999988999999999999999999999 5666766554443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=301.76 Aligned_cols=198 Identities=24% Similarity=0.391 Sum_probs=165.9
Q ss_pred hcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 540 AEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
.++||+|+||.||+|.. .+++.||||++..........+.+|++++.++ +||||+++++++. ..+..++||||+++|
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-~~~~~~lv~e~~~~~ 96 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-EEDRFYLVFEKMRGG 96 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-ETTEEEEEEECCTTC
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-eCCEEEEEEEcCCCC
Confidence 36799999999999985 47899999999876666678899999999985 7999999999995 455899999999999
Q ss_pred CHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC---eEEeecCCccccccccc---
Q 041878 618 SLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN---PRIADFGLSRLMTAAAN--- 691 (773)
Q Consensus 618 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~---~kl~DfG~a~~~~~~~~--- 691 (773)
+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+||+++.++. +||+|||++........
T Consensus 97 ~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (316)
T 2ac3_A 97 SILSHIHKRR---HFNELEASVVVQDVASALDFLH-NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172 (316)
T ss_dssp BHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----------
T ss_pred cHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccc
Confidence 9999998753 3789999999999999999999 899999999999999998876 99999999876542211
Q ss_pred ---cceeeccCccccccccccCC-----CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 692 ---TNVIATAGTLGYRAPELSKL-----KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 692 ---~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.......||+.|+|||++.. ..++.++||||+||++|||++|+.||.....
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 231 (316)
T 2ac3_A 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231 (316)
T ss_dssp ---------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccc
Confidence 11223458999999998864 5688999999999999999999999987543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.96 Aligned_cols=205 Identities=28% Similarity=0.443 Sum_probs=172.7
Q ss_pred HHHHhhcccccccceEEEEEEeC--------CCCEEEEEEecccCc-ccHHHHHHHHHHHHcc-CCCceEEeEEEEECCC
Q 041878 535 LLCATAEIMGKSTYGTAYKATLE--------DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPK 604 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 604 (773)
-.|.+.+.||+|+||.||+|.+. ++..||||+++.... ....++.+|+++++++ +||||+++++++ ...
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-~~~ 113 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-TQD 113 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE-ccC
Confidence 34567899999999999999863 467899999975533 3456789999999999 899999999999 455
Q ss_pred CeEEEEEeecCCCCHHHHHhhcCC-------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC
Q 041878 605 GEKLLVFDFMPKGSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE 671 (773)
Q Consensus 605 ~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~ 671 (773)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||.||| +.||+||||||+||+++.
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA-SQKCIHRDLAARNVLVTE 192 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECT
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCccceEEEcC
Confidence 689999999999999999987542 234789999999999999999999 999999999999999999
Q ss_pred CCCeEEeecCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 672 KTNPRIADFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 672 ~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...+
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999999999999876543221 1223357889999999988889999999999999999999 999997654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-34 Score=297.48 Aligned_cols=197 Identities=28% Similarity=0.418 Sum_probs=170.7
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++||||+++++++. ..+..++||||+
T Consensus 9 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~ 87 (284)
T 3kk8_A 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-EESFHYLVFDLV 87 (284)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEECCC
T ss_pred hhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-cCCEEEEEEecC
Confidence 45688999999999999865 68999999997543 234567889999999999999999999994 555889999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC---eEEeecCCccccccccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN---PRIADFGLSRLMTAAAN 691 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~---~kl~DfG~a~~~~~~~~ 691 (773)
++++|.+++.... .+++..+..++.|++.||.||| +.||+||||||+||+++.++. +||+|||.+........
T Consensus 88 ~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 88 TGGELFEDIVARE---FYSEADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp CSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 9999999988753 3789999999999999999999 999999999999999987665 99999999976654332
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||.+.+..++.++||||+|+++|||++|+.||...+
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 164 --WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211 (284)
T ss_dssp --CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence 223568999999999999999999999999999999999999997644
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=308.48 Aligned_cols=206 Identities=23% Similarity=0.394 Sum_probs=172.1
Q ss_pred HHHHhhcccccccceEEEEEEe------CCCCEEEEEEecccC-cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCe
Q 041878 535 LLCATAEIMGKSTYGTAYKATL------EDGSEVAVKRLREKT-TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGE 606 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 606 (773)
-.|.+.+.||+|+||.||+|.. .++..||||.+.... ....+.+.+|+.+++++ +||||+++++++ ...+.
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-~~~~~ 123 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-TLSGP 123 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSS
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-eeCCc
Confidence 3456788999999999999985 235679999997543 33457899999999999 899999999999 45568
Q ss_pred EEEEEeecCCCCHHHHHhhcCCC--------------------CccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCC
Q 041878 607 KLLVFDFMPKGSLASFLHARGPE--------------------TIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSN 666 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~N 666 (773)
.++||||+++|+|.+++...... ..+++..++.++.||+.||+||| +.||+||||||+|
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~N 202 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHRDLAARN 202 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH-HTTEEETTCSGGG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChhh
Confidence 99999999999999999875321 23789999999999999999999 8999999999999
Q ss_pred EEeCCCCCeEEeecCCccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 667 VLLDEKTNPRIADFGLSRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 667 Ill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
|+++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999998765443322 223357889999999988899999999999999999998 9999977543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=302.59 Aligned_cols=194 Identities=28% Similarity=0.501 Sum_probs=163.0
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.+.+.||+|+||.||+|... ++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||+++
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---~~~~lv~e~~~~ 83 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL---NPVCLVMEYAEG 83 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT---TTTEEEEECCTT
T ss_pred eeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc---CCcEEEEEcCCC
Confidence 346789999999999999875 788999999643 34678999999999999999999999873 357999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccC---CCceecCCCCCCEEeCCCCC-eEEeecCCcccccccccc
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE---ENMIHGNLTSSNVLLDEKTN-PRIADFGLSRLMTAAANT 692 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~---~~iiH~Dik~~NIll~~~~~-~kl~DfG~a~~~~~~~~~ 692 (773)
|+|.+++........+++..++.++.||++||+||| + +||+||||||+||+++.++. +||+|||++.......
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-- 160 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH-SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-- 160 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHH-TCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHH-hCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence 999999987654445788999999999999999999 6 79999999999999998887 7999999987654321
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 161 --~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 161 --TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred --ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 23358999999999998999999999999999999999999997643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=302.19 Aligned_cols=200 Identities=28% Similarity=0.474 Sum_probs=172.6
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
|.+.+.||+|+||.||+|...++..||||.++... ...+.+.+|++++++++||||+++++++. .+..++||||+++
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~~~~ 91 (279)
T 1qpc_A 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMEN 91 (279)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSCEEEEECCTT
T ss_pred hhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc--CCCcEEEEecCCC
Confidence 45678999999999999998888899999997543 34678999999999999999999999984 3368999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.+++.... ...+++..+..++.|++.||+||| +.||+||||||+||++++++.+||+|||.+.............
T Consensus 92 ~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 169 (279)
T 1qpc_A 92 GSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (279)
T ss_dssp CBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred CCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence 99999997542 123789999999999999999999 9999999999999999999999999999998765443322233
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
..+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 215 (279)
T 1qpc_A 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215 (279)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC
Confidence 456789999999988889999999999999999999 999997644
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=299.45 Aligned_cols=197 Identities=25% Similarity=0.310 Sum_probs=163.0
Q ss_pred HHHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc--ccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEE
Q 041878 535 LLCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT--KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV 610 (773)
-.|...++||+|+||+||+|.+. +|+.||||++..... ....++..|+..+.++ +|+||+++++++. ..+..++|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-EGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-eCCEEEEE
Confidence 45667889999999999999875 799999999865432 2334555666666655 8999999999994 55689999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||+ +++|.+++.... ..+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||++.......
T Consensus 136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLH-SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999 779999988763 34899999999999999999999 8999999999999999999999999999987664332
Q ss_pred ccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 691 NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
. .....||+.|+|||++.+ .++.++|||||||++|||++|..|+..
T Consensus 212 ~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 212 A--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred C--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2 233458999999998875 789999999999999999999776644
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=306.58 Aligned_cols=197 Identities=21% Similarity=0.337 Sum_probs=169.9
Q ss_pred HHHhhcccccccceEEEEEEe-CCCCEEEEEEecccCc--------ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCe
Q 041878 536 LCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTT--------KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGE 606 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 606 (773)
+|.+.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++++++||||+++++++. ..+.
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-~~~~ 103 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-NQGF 103 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE-CSSE
T ss_pred ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-eCCE
Confidence 455678999999999999985 4688999999975431 12346778999999999999999999994 5558
Q ss_pred EEEEEeecCCC-CHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccc
Q 041878 607 KLLVFDFMPKG-SLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL 685 (773)
Q Consensus 607 ~~lV~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~ 685 (773)
.++||||+.+| +|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++..
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLR-LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 99999999777 9999998754 3899999999999999999999 99999999999999999999999999999987
Q ss_pred cccccccceeeccCccccccccccCCCCC-CcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 686 MTAAANTNVIATAGTLGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
....... ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 180 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 180 LERGKLF--YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp CCTTCCB--CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred CCCCCce--eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 6544322 23468999999999887776 7899999999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=298.43 Aligned_cols=201 Identities=23% Similarity=0.379 Sum_probs=167.5
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.|.+.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++++++. ..+..++||||
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~ 101 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-DYHNMYIVMET 101 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEECC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-cCCeEEEEEEe
Confidence 3566799999999999999864 68899999997653 345688999999999999999999999995 45589999999
Q ss_pred cCCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe---CCCCCeEEeecCCccccccc
Q 041878 614 MPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 614 ~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll---~~~~~~kl~DfG~a~~~~~~ 689 (773)
+++|+|.+++.... ....+++..+..++.|++.||+||| +.||+||||||+||++ +.++.+||+|||++......
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH-SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH-hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 99999999986541 1344899999999999999999999 9999999999999999 45678999999999865443
Q ss_pred cccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. .....||+.|+|||.+. ..++.++||||+|+++|||++|+.||...+
T Consensus 181 ~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~ 229 (285)
T 3is5_A 181 EH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS 229 (285)
T ss_dssp --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence 22 23446899999999876 578999999999999999999999997654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=295.93 Aligned_cols=199 Identities=25% Similarity=0.438 Sum_probs=170.7
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc------ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT------KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
.|.+.+.||+|+||.||+|... +|+.||+|.++.... ...+.+.+|+.++++++||||+++++++. ..+..+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (283)
T 3bhy_A 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-NKTDVV 84 (283)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEE
T ss_pred hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-CCCeEE
Confidence 3556789999999999999875 689999999875422 23678999999999999999999999995 455899
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC----CeEEeecCCcc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT----NPRIADFGLSR 684 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~----~~kl~DfG~a~ 684 (773)
+||||+++++|.+++.... .+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||.+.
T Consensus 85 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLH-SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 9999999999999998753 3789999999999999999999 99999999999999999887 79999999998
Q ss_pred ccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 685 LMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....... .....+|+.|+|||.+....++.++||||||+++|||++|+.||...+
T Consensus 161 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 215 (283)
T 3bhy_A 161 KIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET 215 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred eccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc
Confidence 6643322 223458999999999998999999999999999999999999997654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=299.31 Aligned_cols=196 Identities=26% Similarity=0.439 Sum_probs=162.8
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHc--cCCCceEEeEEEEECC---CCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGK--IHHPNLLALRAYYLGP---KGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~---~~~~~lV~ 611 (773)
|.+.+.||+|+||+||+|.. +++.||||++... ....+..|.+++.. ++||||+++++++... ....++||
T Consensus 10 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 85 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLIT 85 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEeh
Confidence 34578999999999999987 5899999998643 34555666666666 7899999999987542 34678999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhcc-------CCCceecCCCCCCEEeCCCCCeEEeecCCcc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV-------EENMIHGNLTSSNVLLDEKTNPRIADFGLSR 684 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~-------~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~ 684 (773)
||+++|+|.++++.. .+++..+..++.||+.||+|||. +.+|+||||||+|||++.++.+||+|||+++
T Consensus 86 e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 86 HYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp CCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred hhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 999999999999653 48999999999999999999994 6789999999999999999999999999997
Q ss_pred ccccccccc---eeeccCccccccccccCCC------CCCcchhhHHHHHHHHHHHcC----------CCCCCCC
Q 041878 685 LMTAAANTN---VIATAGTLGYRAPELSKLK------NANTKTDVYSLGVIILELLTG----------KSPGEPM 740 (773)
Q Consensus 685 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~el~tg----------~~P~~~~ 740 (773)
......... .....||+.|+|||++.+. .+++++|||||||++|||+|| +.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 665433221 1234699999999998766 455799999999999999999 8888764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=303.03 Aligned_cols=199 Identities=23% Similarity=0.358 Sum_probs=161.8
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc---cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK---GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+.++++++||||+++++++.. .+..++|||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e 114 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-DGQLYVDMR 114 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-CCeEEEEEE
Confidence 345789999999999999865 6889999999755332 24678999999999999999999999954 558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++++|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++.........
T Consensus 115 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 115 LINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAH-AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp CCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred ecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 999999999998754 3789999999999999999999 999999999999999999999999999999876544333
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 334456899999999999899999999999999999999999999764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-34 Score=301.10 Aligned_cols=198 Identities=26% Similarity=0.432 Sum_probs=169.4
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.|.+.+.||+|+||.||+|... +|+.||+|.++.........+.+|+.++++++||||+++++++. ..+..++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~ 88 (304)
T 2jam_A 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-STTHYYLVMQLV 88 (304)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEECCC
T ss_pred cceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-cCCEEEEEEEcC
Confidence 3456789999999999999865 78999999998665555677899999999999999999999995 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe---CCCCCeEEeecCCccccccccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll---~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
++++|.+++.... .+++..+..++.|++.||.||| +.||+||||||+||++ +.++.+||+|||++.......
T Consensus 89 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~- 163 (304)
T 2jam_A 89 SGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLH-ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI- 163 (304)
T ss_dssp CSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH-HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT-
T ss_pred CCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc-
Confidence 9999999997754 3789999999999999999999 9999999999999999 788899999999987543321
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||.+.+..++.++||||+|+++|||++|+.||...+
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 211 (304)
T 2jam_A 164 --MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211 (304)
T ss_dssp --THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred --cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 123358999999999998999999999999999999999999997643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=303.16 Aligned_cols=206 Identities=25% Similarity=0.374 Sum_probs=175.1
Q ss_pred HHHHhhcccccccceEEEEEEe------CCCCEEEEEEecccCc-ccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCe
Q 041878 535 LLCATAEIMGKSTYGTAYKATL------EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGE 606 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 606 (773)
-+|.+.+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++ ...+.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-~~~~~ 101 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC-TIGGP 101 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSS
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE-ecCCC
Confidence 3456778999999999999984 3467899999975543 3457789999999999 899999999999 45568
Q ss_pred EEEEEeecCCCCHHHHHhhcCC---------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC
Q 041878 607 KLLVFDFMPKGSLASFLHARGP---------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE 671 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~ 671 (773)
.++||||+++|+|.+++..... ...+++..+..++.||+.||.||| +.||+||||||+||+++.
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNILLTH 180 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEET
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCccceEEEcC
Confidence 8999999999999999987542 124899999999999999999999 999999999999999999
Q ss_pred CCCeEEeecCCccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 672 KTNPRIADFGLSRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 672 ~~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999999999998765443322 223346789999999988899999999999999999999 9999977543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=308.10 Aligned_cols=202 Identities=24% Similarity=0.324 Sum_probs=172.4
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccC-----CCceEEeEEEEECCCCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-----HPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~~lV 610 (773)
|.+.++||+|+||+||+|.. .+++.||||+++.. ......+..|+.++++++ ||||+++++++.. .+..++|
T Consensus 37 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~-~~~~~lv 114 (360)
T 3llt_A 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY-YDHMCLI 114 (360)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE-TTEEEEE
T ss_pred EEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE-CCeeEEE
Confidence 45678999999999999987 47899999999642 334566788999999987 9999999999954 4589999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-------------------
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE------------------- 671 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~------------------- 671 (773)
|||+ +++|.+++..... ..+++..+..++.||+.||+||| +.||+||||||+|||++.
T Consensus 115 ~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 191 (360)
T 3llt_A 115 FEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLR-KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191 (360)
T ss_dssp ECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEE
T ss_pred EcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCcccEEEccccccccccchhcccccccc
Confidence 9999 9999999987642 34789999999999999999999 999999999999999976
Q ss_pred ------CCCeEEeecCCccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCCh
Q 041878 672 ------KTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745 (773)
Q Consensus 672 ------~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~ 745 (773)
++.+||+|||++....... ....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+.
T Consensus 192 ~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 267 (360)
T 3llt_A 192 QIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH 267 (360)
T ss_dssp EEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHH
Confidence 7889999999997644322 234689999999999999999999999999999999999999987654433
Q ss_pred HH
Q 041878 746 PQ 747 (773)
Q Consensus 746 ~~ 747 (773)
..
T Consensus 268 ~~ 269 (360)
T 3llt_A 268 LA 269 (360)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=306.87 Aligned_cols=195 Identities=29% Similarity=0.452 Sum_probs=167.6
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCc---ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|...+.||+|+||+||+|.. .+|+.||||++..... ...+++.+|++++++++||||+++++++.. .+..++|||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e 134 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLVME 134 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCeEEEEEe
Confidence 45678899999999999986 5789999999975432 234578899999999999999999999954 558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|++ |+|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 135 ~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 135 YCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH-SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp CCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred cCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 997 68888886543 34889999999999999999999 899999999999999999999999999999765432
Q ss_pred ceeeccCccccccccccC---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSK---LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2346899999999873 5778999999999999999999999987543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=296.79 Aligned_cols=197 Identities=26% Similarity=0.432 Sum_probs=168.4
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++. ..+..++|||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e 89 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-DATRVYLILE 89 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-cCCEEEEEEe
Confidence 345789999999999999865 57799999986432 223567899999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.... .+++..+..++.||+.|++||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH-~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~-- 163 (279)
T 3fdn_A 90 YAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 163 (279)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-TTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCEecccCChHhEEEcCCCCEEEEeccccccCCccc--
Confidence 999999999998754 3789999999999999999999 9999999999999999999999999999886543322
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||.+.+..++.++||||+|+++|||++|+.||...+
T Consensus 164 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 164 -RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 223468999999999998999999999999999999999999997644
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=297.74 Aligned_cols=206 Identities=19% Similarity=0.264 Sum_probs=173.2
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.+.||+|+||.||+|.. .+++.||||++..... ..++.+|++++++++|++++..++++....+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 4hgt_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-
Confidence 45678999999999999986 5788999998754432 3457889999999999998888888866777889999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe---CCCCCeEEeecCCcccccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll---~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
+++|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||++ +.++.+||+|||+++........
T Consensus 88 ~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 164 (296)
T 4hgt_A 88 GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence 999999998643 34899999999999999999999 9999999999999999 78899999999999876544321
Q ss_pred ------ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHH
Q 041878 693 ------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQW 748 (773)
Q Consensus 693 ------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~ 748 (773)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+..+.
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 226 (296)
T 4hgt_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226 (296)
T ss_dssp CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh
Confidence 12244689999999999999999999999999999999999999988655443333
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.70 Aligned_cols=206 Identities=25% Similarity=0.438 Sum_probs=170.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCE----EEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSE----VAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~----vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
|...++||+|+||+||+|.+. +++. ||+|.+.... ......+.+|+.++++++||||+++++++. .+..++|
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v 92 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP--GSSLQLV 92 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC--BSSEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCccEEE
Confidence 356789999999999999864 4554 7888875433 233456788999999999999999999883 3478999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||+++|+|.+++... ...+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLE-EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHH-HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHH-hCCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999999999764 234788899999999999999999 9999999999999999999999999999998775443
Q ss_pred cc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCChHH
Q 041878 691 NT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQ 747 (773)
Q Consensus 691 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~~~ 747 (773)
.. ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+..+
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 228 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD 228 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH
Confidence 22 2234457889999999998899999999999999999999 999998766554443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=295.75 Aligned_cols=200 Identities=27% Similarity=0.467 Sum_probs=152.7
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|.. .+|+.||||.+.... ......+.+|+.++++++||||+++++++. ..+..++|||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e 91 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-DSNYVYLVLE 91 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-CSSEEEEEEE
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-cCCeEEEEEe
Confidence 34578899999999999986 578999999996432 223477899999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++++|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+........
T Consensus 92 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 167 (278)
T 3cok_A 92 MCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLH-SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE- 167 (278)
T ss_dssp CCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHH-HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred cCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-
Confidence 999999999998652 34789999999999999999999 99999999999999999999999999999987643322
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......||+.|+|||.+.+..++.++||||+|+++|||++|+.||....
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 1223458999999999998889999999999999999999999998644
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=301.23 Aligned_cols=204 Identities=25% Similarity=0.367 Sum_probs=167.4
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc--cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK--GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++++++||||+++++++. ..+..++||||+
T Consensus 6 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~ 84 (311)
T 4agu_A 6 EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-RKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEEECC
T ss_pred eEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-cCCeEEEEEEeC
Confidence 45688999999999999875 5899999998654332 2466889999999999999999999995 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++++|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+......... .
T Consensus 85 ~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~ 159 (311)
T 4agu_A 85 DHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCH-KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-Y 159 (311)
T ss_dssp SEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHH-HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc-c
Confidence 9999999887643 3789999999999999999999 999999999999999999999999999999876533221 2
Q ss_pred eeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHH
Q 041878 695 IATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQ 747 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~ 747 (773)
....+|+.|+|||.+.+ ..++.++||||+|+++|||++|+.||...+..+...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 213 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY 213 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 23468999999998865 678999999999999999999999998765444333
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=296.10 Aligned_cols=195 Identities=34% Similarity=0.543 Sum_probs=158.4
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCc----ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTT----KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|...++||+|+||.||+|.+. ++.||||+++.... ...+.+.+|++++++++||||+++++++ ...+..++|||
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e 86 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-LKEPNLCLVME 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-CCC--CEEEEE
T ss_pred eeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-ecCCceEEEEE
Confidence 345689999999999999975 88999999875432 2356789999999999999999999999 45558899999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCC---ceecCCCCCCEEeCC--------CCCeEEeecC
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN---MIHGNLTSSNVLLDE--------KTNPRIADFG 681 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~---iiH~Dik~~NIll~~--------~~~~kl~DfG 681 (773)
|+++++|.+++... .+++..+..++.|++.||+||| +.+ |+||||||+||+++. ++.+||+|||
T Consensus 87 ~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH-~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 87 FARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLH-DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp CCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHH-HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred cCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH-hCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 99999999998643 4789999999999999999999 777 999999999999986 6779999999
Q ss_pred CccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 682 LSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 682 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.+........ ....||+.|+|||.+.+..+++++||||+|+++|||++|+.||...+
T Consensus 162 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (271)
T 3dtc_A 162 LAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID 218 (271)
T ss_dssp C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred cccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9986543322 23458999999999988899999999999999999999999997643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=296.71 Aligned_cols=202 Identities=19% Similarity=0.276 Sum_probs=172.3
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.+.||+|+||.||+|.. .+|+.||||++..... ..++.+|+.++++++|++++..+.++....+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 34568899999999999986 5789999999865433 3468899999999999988877777766677889999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe---CCCCCeEEeecCCcccccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll---~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
+++|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||++ +.++.+||+|||++.........
T Consensus 88 ~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 88 GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 999999998543 34899999999999999999999 9999999999999999 48889999999999876544321
Q ss_pred ------ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 041878 693 ------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMD 744 (773)
Q Consensus 693 ------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~ 744 (773)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchh
Confidence 1234468999999999999999999999999999999999999998755443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=299.08 Aligned_cols=205 Identities=27% Similarity=0.462 Sum_probs=170.1
Q ss_pred HHHHHhhcccccccceEEEEEEeC-CC---CEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 534 DLLCATAEIMGKSTYGTAYKATLE-DG---SEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 534 ~l~~~~~~~lG~G~fg~Vy~~~~~-~g---~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
...+...++||+|+||+||+|.+. ++ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.......+
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 334456789999999999999853 23 3699999975433 345778999999999999999999999966555569
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||+.+|+|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLA-EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp EEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999999998642 34788999999999999999999 89999999999999999999999999999986644
Q ss_pred ccc---cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCC-CCCCC
Q 041878 689 AAN---TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP-GEPMN 741 (773)
Q Consensus 689 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P-~~~~~ 741 (773)
... .......+|+.|+|||.+.+..++.++||||+|+++|||++|+.| |...+
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~ 233 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC
Confidence 321 122234578899999999999999999999999999999996555 44433
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.22 Aligned_cols=197 Identities=28% Similarity=0.518 Sum_probs=166.6
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCccc-------HHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKG-------QKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
|.+.+.||+|+||+||+|.+ .+++.||+|++....... .+.+.+|++++++++||||+++++++. .. .+
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~--~~ 97 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH-NP--PR 97 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET-TT--TE
T ss_pred ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec-CC--Ce
Confidence 45678999999999999986 478999999996543221 167899999999999999999999983 32 37
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCC--ceecCCCCCCEEeCCCCC-----eEEeecC
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN--MIHGNLTSSNVLLDEKTN-----PRIADFG 681 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~--iiH~Dik~~NIll~~~~~-----~kl~DfG 681 (773)
+||||+++|+|.+++.... ..+++..+..++.|++.|++||| +.+ |+||||||+||+++.++. +||+|||
T Consensus 98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH-~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp EEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH-TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred EEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHH-hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 9999999999999887653 35899999999999999999999 888 999999999999988876 9999999
Q ss_pred CccccccccccceeeccCcccccccccc--CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 682 LSRLMTAAANTNVIATAGTLGYRAPELS--KLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 682 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
+++.... ......||+.|+|||.+ ....+++++||||+||++|||++|+.||......
T Consensus 175 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 234 (287)
T 4f0f_A 175 LSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234 (287)
T ss_dssp TCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred ccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc
Confidence 9875432 23345689999999998 4456789999999999999999999999865543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=317.98 Aligned_cols=199 Identities=21% Similarity=0.356 Sum_probs=154.9
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCC----CeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK----GEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~l 609 (773)
|.+.++||+|+||+||+|... +++.||||++... .....+++.+|++++++++||||+++++++.... ...|+
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence 456789999999999999864 7899999999653 2334577899999999999999999999985432 46899
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||+ +++|.+++... ..+++..+..++.||+.||+||| +.|||||||||+|||++.++.+||+|||+++.....
T Consensus 135 v~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH-~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 135 VLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVH-SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred EEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHH-hCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 99998 57999999764 34899999999999999999999 999999999999999999999999999999876432
Q ss_pred cc--------------------------cceeeccCcccccccccc-CCCCCCcchhhHHHHHHHHHHHc----------
Q 041878 690 AN--------------------------TNVIATAGTLGYRAPELS-KLKNANTKTDVYSLGVIILELLT---------- 732 (773)
Q Consensus 690 ~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~el~t---------- 732 (773)
.. .......||+.|+|||++ ....++.++||||+||++|||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 21 112344689999999976 56679999999999999999999
Q ss_pred -CCCCCCCC
Q 041878 733 -GKSPGEPM 740 (773)
Q Consensus 733 -g~~P~~~~ 740 (773)
|+.||.+.
T Consensus 290 ~~~p~f~g~ 298 (458)
T 3rp9_A 290 DRGPLFPGS 298 (458)
T ss_dssp GCCCSCC--
T ss_pred cccccCCCC
Confidence 66666553
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=306.00 Aligned_cols=196 Identities=20% Similarity=0.335 Sum_probs=162.3
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccC--cccHHHHHHHHHHHHccCC--CceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHH--PNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++++++| +||+++++++. ..+..++|||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-~~~~~~lv~e 89 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-TDQYIYMVME 89 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-CSSEEEEEEC
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-eCCEEEEEEe
Confidence 35678999999999999998889999999997543 2334678999999999987 99999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
+ .+++|.+++.... .+++..+..++.||+.||+||| +.||+||||||+|||++ ++.+||+|||+++........
T Consensus 90 ~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH-~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 90 C-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp C-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred C-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 5 5889999998753 3789999999999999999999 99999999999999997 577999999999876544322
Q ss_pred -ceeeccCccccccccccCC-----------CCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 693 -NVIATAGTLGYRAPELSKL-----------KNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 693 -~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 2234569999999998754 6789999999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=295.93 Aligned_cols=198 Identities=22% Similarity=0.363 Sum_probs=172.1
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++. ..+..++||||
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~ 96 (294)
T 2rku_A 18 VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-DNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEEEC
T ss_pred EEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-cCCEEEEEEec
Confidence 45789999999999999875 57899999986542 234567889999999999999999999995 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++++|.+++.... .+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+........ .
T Consensus 97 ~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 171 (294)
T 2rku_A 97 CRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH-RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-R 171 (294)
T ss_dssp CTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-c
Confidence 99999999988753 3789999999999999999999 99999999999999999999999999999987643322 2
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||.+.+..++.++||||+|+++|||++|+.||....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 233468999999999998899999999999999999999999997643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.42 Aligned_cols=198 Identities=17% Similarity=0.262 Sum_probs=160.3
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc---CcccHHHHHHHH---HHHHccCCCceEEeE-------EEEEC
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK---TTKGQKEFEAEA---AAIGKIHHPNLLALR-------AYYLG 602 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~~~ 602 (773)
|.+.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+ +.+++++||||++++ +++..
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 34568999999999999996 56999999999743 334467889999 555566899999998 66643
Q ss_pred CCC----------------eEEEEEeecCCCCHHHHHhhcCC----CCccCHHHHHHHHHHHHHHHHHhccCCCceecCC
Q 041878 603 PKG----------------EKLLVFDFMPKGSLASFLHARGP----ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNL 662 (773)
Q Consensus 603 ~~~----------------~~~lV~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Di 662 (773)
... ..++||||+ +|+|.+++..... ...+++..++.++.||+.||+||| +.||+||||
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDi 232 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-HYGLVHTYL 232 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH-HTTEECSCC
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH-hCCeecCCC
Confidence 321 378999999 6899999986421 123446888899999999999999 899999999
Q ss_pred CCCCEEeCCCCCeEEeecCCccccccccccceeeccCccccccccccCCC-----------CCCcchhhHHHHHHHHHHH
Q 041878 663 TSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLK-----------NANTKTDVYSLGVIILELL 731 (773)
Q Consensus 663 k~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dvws~Gv~l~el~ 731 (773)
||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++|||+
T Consensus 233 kp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ell 307 (377)
T 3byv_A 233 RPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307 (377)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHH
Confidence 99999999999999999999985332 2234457 999999998877 8999999999999999999
Q ss_pred cCCCCCCCCC
Q 041878 732 TGKSPGEPMN 741 (773)
Q Consensus 732 tg~~P~~~~~ 741 (773)
+|+.||...+
T Consensus 308 tg~~Pf~~~~ 317 (377)
T 3byv_A 308 CADLPITKDA 317 (377)
T ss_dssp HSSCCC----
T ss_pred HCCCCCcccc
Confidence 9999997744
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.11 Aligned_cols=199 Identities=22% Similarity=0.360 Sum_probs=172.6
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++. ..+..++|||
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e 121 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-DNDFVFVVLE 121 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEEC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCCeEEEEEe
Confidence 345789999999999999875 57899999987542 234567889999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++++|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 122 ~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 122 LCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH-RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp CCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred cCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH-HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 999999999988753 3789999999999999999999 99999999999999999999999999999987643322
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 2234568999999999998899999999999999999999999997643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-34 Score=328.41 Aligned_cols=198 Identities=27% Similarity=0.456 Sum_probs=166.6
Q ss_pred ccccccceEEEEEEeC---CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 542 IMGKSTYGTAYKATLE---DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 542 ~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
.||+|+||.||+|.+. ++..||||+++... ....+++.+|++++++++||||+++++++.. +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEEEEeCCCC
Confidence 7999999999999864 45679999998653 3356889999999999999999999999954 4689999999999
Q ss_pred CHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc--ee
Q 041878 618 SLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN--VI 695 (773)
Q Consensus 618 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~--~~ 695 (773)
+|.+++... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+++......... ..
T Consensus 421 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH-~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 421 PLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLE-EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp BHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred cHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH-HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 999999764 345899999999999999999999 9999999999999999999999999999998765432211 12
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMD 744 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~ 744 (773)
...+++.|+|||++....++.++|||||||++|||+| |+.||...+..+
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~ 547 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Confidence 2345689999999998999999999999999999998 999998765433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=319.03 Aligned_cols=199 Identities=29% Similarity=0.452 Sum_probs=167.4
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
.|.+.++||+|+||+||+|... ++..||+|++.... ......+.+|+.++++++||||+++++++. ..+..++|||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e 116 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-DKRNYYLVME 116 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEE
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-eCCEEEEEEe
Confidence 4567889999999999999875 68899999997543 334678899999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC---CCeEEeecCCccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK---TNPRIADFGLSRLMTAA 689 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~---~~~kl~DfG~a~~~~~~ 689 (773)
|+++|+|.+++.... .+++..+..++.||+.||.||| +.||+||||||+|||++.. +.+||+|||++......
T Consensus 117 ~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 117 CYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLH-KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 999999999988754 3789999999999999999999 9999999999999999764 45999999999876543
Q ss_pred cccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.. .....||+.|+|||++. ..++.++||||+||++|||++|+.||...+.
T Consensus 193 ~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 242 (494)
T 3lij_A 193 KK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD 242 (494)
T ss_dssp BC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 22 23456999999999876 5699999999999999999999999976543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=305.90 Aligned_cols=208 Identities=24% Similarity=0.415 Sum_probs=165.8
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc-cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.+.||+|+||+||+|... +++.||||+++..... ....+.+|++++++++||||+++++++. ..+..++||||++
T Consensus 5 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 5 IKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-TEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-CSSCEEEEEECCS
T ss_pred EEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-eCCEEEEEecccc
Confidence 45688999999999999875 7899999999654322 1224567999999999999999999995 4558999999997
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
|+|.+++.... ..+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||+++....... ...
T Consensus 84 -~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 158 (324)
T 3mtl_A 84 -KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCH-RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYD 158 (324)
T ss_dssp -EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH-HTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred -cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-ccc
Confidence 59999988753 34789999999999999999999 99999999999999999999999999999976543322 222
Q ss_pred eccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHH
Q 041878 696 ATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVAS 751 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~ 751 (773)
...+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+....+.+
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 215 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR 215 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 3468999999998865 6789999999999999999999999987665444444433
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=318.68 Aligned_cols=198 Identities=27% Similarity=0.397 Sum_probs=169.9
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+|.+.++||+|+||+||+|... +++.||||++... .......+.+|++++++++||||+++++++. ..+..++|||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e 101 (486)
T 3mwu_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-DSSSFYIVGE 101 (486)
T ss_dssp HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEEC
T ss_pred ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-cCCEEEEEEE
Confidence 3566789999999999999875 7899999999643 2345678999999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeC---CCCCeEEeecCCccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLD---EKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~---~~~~~kl~DfG~a~~~~~~ 689 (773)
|+++|+|.+++.... .+++..+..++.||+.||.||| +.||+||||||+|||++ .++.+||+|||+++.....
T Consensus 102 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 102 LYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 999999999987754 3889999999999999999999 99999999999999995 4567999999999866433
Q ss_pred cccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
. ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.+.+
T Consensus 178 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 226 (486)
T 3mwu_A 178 T--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred C--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 2234569999999999875 59999999999999999999999997654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.34 Aligned_cols=198 Identities=26% Similarity=0.464 Sum_probs=169.6
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc--------cHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK--------GQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGE 606 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 606 (773)
|.+.++||+|+||.||+|.+. +|+.||||++...... ..+.+.+|+.+++++ +||||+++++++. ..+.
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-~~~~ 174 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE-SSSF 174 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-BSSE
T ss_pred cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe-eCCE
Confidence 445689999999999999975 7999999998754311 135678899999999 7999999999984 4568
Q ss_pred EEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 607 KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
.++||||+++++|.+++.... .+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||++...
T Consensus 175 ~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH-~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLH-ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 999999999999999998653 3889999999999999999999 899999999999999999999999999999876
Q ss_pred ccccccceeeccCccccccccccC------CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 687 TAAANTNVIATAGTLGYRAPELSK------LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
..... .....||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 251 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 251 EPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 54322 23456999999999875 3468899999999999999999999997643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.57 Aligned_cols=210 Identities=24% Similarity=0.352 Sum_probs=173.0
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECC-------CCe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-------KGE 606 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------~~~ 606 (773)
|.+.++||+|+||.||+|.. .+|+.||||++..... .....+.+|++++++++||||+++++++... .+.
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (351)
T 3mi9_A 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 98 (351)
T ss_dssp EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CE
T ss_pred eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCce
Confidence 45678999999999999987 5789999999865432 2356788999999999999999999998653 346
Q ss_pred EEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 607 KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
.++||||+++ +|.+.+.... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++..
T Consensus 99 ~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 99 IYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIH-RNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp EEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 8999999974 8888776543 34899999999999999999999 999999999999999999999999999999876
Q ss_pred ccccc---cceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHH
Q 041878 687 TAAAN---TNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVA 750 (773)
Q Consensus 687 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 750 (773)
..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+....+.
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 242 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 43221 22234568999999998865 568999999999999999999999998765444433333
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=320.13 Aligned_cols=199 Identities=28% Similarity=0.443 Sum_probs=172.2
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
+|.+.++||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++. ..+..++||
T Consensus 27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~ 105 (484)
T 3nyv_A 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-DKGYFYLVG 105 (484)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEE
T ss_pred ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-eCCEEEEEE
Confidence 4566789999999999999875 78999999996542 345678999999999999999999999995 455899999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe---CCCCCeEEeecCCcccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll---~~~~~~kl~DfG~a~~~~~ 688 (773)
||+++|+|.+++.... .+++..+..++.||+.||.||| +.||+||||||+|||+ +.++.+||+|||+++....
T Consensus 106 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 106 EVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMH-KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999998653 3889999999999999999999 9999999999999999 5678899999999986654
Q ss_pred ccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||...+.
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 232 (484)
T 3nyv_A 182 SKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 232 (484)
T ss_dssp CCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH
Confidence 322 223469999999998865 699999999999999999999999976543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-34 Score=293.89 Aligned_cols=196 Identities=24% Similarity=0.420 Sum_probs=167.3
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECC-CCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-KGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV~e~ 613 (773)
|.+.+.||+|+||.||+|.+. ++.||||+++... ....+.+.+|+.++++++||||+++++++... .+..++||||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred hHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence 356789999999999999985 8899999997543 33456799999999999999999999999554 2578999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCC--ceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN--MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~--iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
+++|+|.+++.... ...+++..+..++.||+.||+||| +.+ |+||||||+||+++.++.++++|||++......
T Consensus 91 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH-~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~-- 166 (271)
T 3kmu_A 91 MPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-- 166 (271)
T ss_dssp CTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHT-TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT--
T ss_pred cCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHh-cCCCceecCCCccceEEEcCCcceeEEeccceeeeccc--
Confidence 99999999998753 235899999999999999999999 888 999999999999999999999999887543222
Q ss_pred cceeeccCccccccccccCCCCCCc---chhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANT---KTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...+|+.|+|||.+.+..++. ++|||||||++|||++|+.||...+
T Consensus 167 ----~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 215 (271)
T 3kmu_A 167 ----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215 (271)
T ss_dssp ----TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred ----CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 235899999999987655544 7999999999999999999997643
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-34 Score=307.26 Aligned_cols=195 Identities=25% Similarity=0.380 Sum_probs=162.2
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCC-----CeEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-----GEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~~ 608 (773)
|...+.||+|+||.||+|.. .+|+.||||++.... ....+++.+|++++++++||||+++++++.... ...+
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 34568899999999999986 478999999996532 233567889999999999999999999995432 3569
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||+ +++|.++++.. .++...+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 107 lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp EEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH-HCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 999999 88999999863 3788999999999999999999 99999999999999999999999999999986543
Q ss_pred ccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
. .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+
T Consensus 181 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 230 (367)
T 1cm8_A 181 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 230 (367)
T ss_dssp S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred c----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 223468999999998876 789999999999999999999999997654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.03 Aligned_cols=197 Identities=20% Similarity=0.330 Sum_probs=163.8
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccC--cccHHHHHHHHHHHHccC--CCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIH--HPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++ |+||+++++++.. .+..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv~E 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMVME 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-CCEEEEEEe
Confidence 45678999999999999998889999999996543 334577899999999997 5999999999954 458999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
+.+++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+|||++ ++.+||+|||+++........
T Consensus 137 -~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH-~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 137 -CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp -CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHH-TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred -cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 56889999998754 4788899999999999999999 99999999999999995 578999999999876543322
Q ss_pred -ceeeccCccccccccccCC-----------CCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 693 -NVIATAGTLGYRAPELSKL-----------KNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 693 -~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 1234569999999998754 46889999999999999999999999753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=303.18 Aligned_cols=205 Identities=25% Similarity=0.430 Sum_probs=174.0
Q ss_pred HHHhhcccccccceEEEEEEe------CCCCEEEEEEecccCc-ccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeE
Q 041878 536 LCATAEIMGKSTYGTAYKATL------EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEK 607 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 607 (773)
.|.+.+.||+|+||.||+|.+ .+++.||||+++.... .....+.+|+.+++++ +||||+++++++.......
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 107 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence 356778999999999999974 3467899999976543 3356789999999999 6999999999996666678
Q ss_pred EEEEeecCCCCHHHHHhhcCC-------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC
Q 041878 608 LLVFDFMPKGSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN 674 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~ 674 (773)
++||||+++|+|.+++..... ...+++..+..++.||+.||.||| +.||+||||||+||+++.++.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dikp~Nil~~~~~~ 186 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNV 186 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGGC
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH-hCCcccccCccceEEECCCCC
Confidence 999999999999999987542 123789999999999999999999 999999999999999999999
Q ss_pred eEEeecCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 675 PRIADFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 675 ~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
+||+|||+++........ ......+|+.|+|||++.+..++.++||||+|+++|||+| |+.||....
T Consensus 187 ~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 187 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999876543322 2223457889999999988899999999999999999998 999997654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.27 Aligned_cols=196 Identities=23% Similarity=0.394 Sum_probs=162.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCC----CeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK----GEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~l 609 (773)
|.+.++||+|+||.||+|... +++.||||++... .....+++.+|++++++++|+||+++++++.... ...|+
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 345789999999999999864 6788999999754 2334578899999999999999999999985543 47899
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||++ |+|.++++.. ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|||+++.....
T Consensus 108 v~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH-~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 108 VLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIH-ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 999996 6999999864 34899999999999999999999 999999999999999999999999999999876543
Q ss_pred ccc---------------------ceeeccCcccccccccc-CCCCCCcchhhHHHHHHHHHHHcCCCCC
Q 041878 690 ANT---------------------NVIATAGTLGYRAPELS-KLKNANTKTDVYSLGVIILELLTGKSPG 737 (773)
Q Consensus 690 ~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dvws~Gv~l~el~tg~~P~ 737 (773)
... ......||+.|+|||++ ....++.++||||+||++|||++|..||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 221 12455789999999985 5667999999999999999999854444
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=296.46 Aligned_cols=197 Identities=26% Similarity=0.451 Sum_probs=169.2
Q ss_pred cccccccceEEEEEEeC---CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 541 EIMGKSTYGTAYKATLE---DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.||+|+||.||+|.+. ++..||||+++... ....+++.+|++++++++||||+++++++. .+..++||||+++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~ 93 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--AEALMLVMEMAGG 93 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEEEEEECCTT
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec--CCCcEEEEEeCCC
Confidence 48999999999999853 57789999997653 334677999999999999999999999993 3468999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc--ce
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT--NV 694 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~~ 694 (773)
++|.+++... ...+++..+..++.|++.||.||| +.||+||||||+||+++.++.+||+|||++......... ..
T Consensus 94 ~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 170 (287)
T 1u59_A 94 GPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170 (287)
T ss_dssp EEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCC
T ss_pred CCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHH-HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecc
Confidence 9999999754 234899999999999999999999 999999999999999999999999999999876543321 12
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
....+|+.|+|||.+.+..++.++||||+|+++|||+| |+.||...+.
T Consensus 171 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp CSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred ccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 23346889999999988889999999999999999998 9999977554
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=299.08 Aligned_cols=192 Identities=25% Similarity=0.398 Sum_probs=165.7
Q ss_pred HHhhcccccccceEEEEEEeCC-C-------CEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 537 CATAEIMGKSTYGTAYKATLED-G-------SEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~-g-------~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
|.+.+.||+|+||+||+|.... + ..||+|.+........+.+.+|++++++++||||+++++++ ...+..+
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~ 88 (289)
T 4fvq_A 10 LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVC-VCGDENI 88 (289)
T ss_dssp EEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEE-CCTTCCE
T ss_pred eeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-EeCCCCE
Confidence 4567899999999999998642 3 46999999877666778899999999999999999999999 4555889
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC--------eEEeec
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN--------PRIADF 680 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~--------~kl~Df 680 (773)
+||||+++|+|.+++.... ..+++..+..++.||+.||.||| +.||+||||||+||+++.++. +||+||
T Consensus 89 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 89 LVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLE-ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp EEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred EEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHh-hCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 9999999999999998753 34789999999999999999999 999999999999999998887 999999
Q ss_pred CCccccccccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCC
Q 041878 681 GLSRLMTAAANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPG 737 (773)
Q Consensus 681 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~ 737 (773)
|.+....... ...+|+.|+|||.+.+ ..++.++|||||||++|||++|..|+
T Consensus 166 g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 166 GISITVLPKD-----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp CSCTTTSCHH-----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cccccccCcc-----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 9987553322 2347889999999877 77899999999999999999965544
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=301.97 Aligned_cols=205 Identities=27% Similarity=0.481 Sum_probs=165.9
Q ss_pred HHhhcccccccceEEEEEEeC-CCCE----EEEEEeccc-CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSE----VAVKRLREK-TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~----vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
|.+.++||+|+||.||+|.+. +++. ||+|.+... .....+++.+|+.++++++||||+++++++... ..++|
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~v 94 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQLI 94 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--SEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--CceEE
Confidence 456789999999999999864 4554 577777543 344578899999999999999999999999643 48899
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
+||+++|+|.+++.... ..+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 95 ~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp ECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHh-hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 99999999999998753 34889999999999999999999 9999999999999999999999999999998765433
Q ss_pred cc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCChH
Q 041878 691 NT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLP 746 (773)
Q Consensus 691 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~~ 746 (773)
.. ......+|+.|+|||.+.+..++.++||||+||++|||++ |+.||...+..++.
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~ 229 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229 (327)
T ss_dssp --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 22 2223456889999999999999999999999999999999 99999876554433
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=328.68 Aligned_cols=196 Identities=27% Similarity=0.440 Sum_probs=165.4
Q ss_pred cccccccceEEEEEEeC---CCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLE---DGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
+.||+|+||.||+|.+. .++.||||+++.... ...+++.+|++++++++||||+++++++. . +..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-A-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-S-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c-CCEEEEEEccC
Confidence 57999999999999653 467899999976432 34678999999999999999999999994 3 36889999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc--c
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT--N 693 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~--~ 693 (773)
+|+|.++++... .+++..+..++.||+.||+||| +.+||||||||+|||++.++.+||+|||+++........ .
T Consensus 453 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH-~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 453 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHH-HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 999999998643 4789999999999999999999 999999999999999999999999999999876543321 2
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
.....+|+.|+|||++....++.++|||||||++|||++ |+.||...+.
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 578 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 223346789999999998999999999999999999998 9999987554
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-34 Score=297.35 Aligned_cols=198 Identities=27% Similarity=0.524 Sum_probs=164.2
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
|.+.+.||+|+||.||+|... |+.||||.++... ..+.+.+|++++++++||||+++++++....+..++||||+++
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 99 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 99 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred ceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCC
Confidence 456789999999999999875 8899999997543 4678899999999999999999999986666678999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
++|.+++.... ...+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||++........ .
T Consensus 100 ~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~----~ 173 (278)
T 1byg_A 100 GSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----T 173 (278)
T ss_dssp EEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCcceEEEeCCCcEEEeecccccccccccc----C
Confidence 99999998653 223688899999999999999999 99999999999999999999999999999876543221 2
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGM 743 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~ 743 (773)
..+++.|+|||.+.+..++.++||||+|+++|||+| |+.||...+..
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 221 (278)
T 1byg_A 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 221 (278)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 347889999999988899999999999999999998 99999765443
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-34 Score=304.15 Aligned_cols=203 Identities=23% Similarity=0.354 Sum_probs=158.3
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccC-CCceEEeEEEEE-------CCCCe
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPNLLALRAYYL-------GPKGE 606 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-------~~~~~ 606 (773)
+|.+.++||+|+||.||+|... +++.||||++..........+.+|+.+++++. ||||+++++++. .....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 4567789999999999999864 78999999997766666778999999999996 999999999984 22335
Q ss_pred EEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCC--ceecCCCCCCEEeCCCCCeEEeecCCcc
Q 041878 607 KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN--MIHGNLTSSNVLLDEKTNPRIADFGLSR 684 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~--iiH~Dik~~NIll~~~~~~kl~DfG~a~ 684 (773)
.++||||++ |+|.+++........+++..++.++.||+.||+||| +.+ |+||||||+||+++.++.+||+|||+++
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH-TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCEEEccCCcccEEECCCCCEEEecCccce
Confidence 789999995 799999876444455899999999999999999999 888 9999999999999999999999999998
Q ss_pred cccccccc-----------ceeeccCcccccccccc---CCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 685 LMTAAANT-----------NVIATAGTLGYRAPELS---KLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 685 ~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
........ ......+|+.|+|||++ .+..++.++|||||||++|||++|+.||...
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 76543221 11134589999999988 5677899999999999999999999999763
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.19 Aligned_cols=198 Identities=26% Similarity=0.437 Sum_probs=163.6
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|+.++++++||||+++++++. ..+..++|||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e 91 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-TPTDFFMVME 91 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEEE
T ss_pred EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-cCCeEEEEEe
Confidence 345789999999999999875 78999999996532 234568899999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++++|.+++.... .+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||.+........
T Consensus 92 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 166 (276)
T 2h6d_A 92 YVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCH-RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF- 166 (276)
T ss_dssp CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH-HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred ccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCChhhEEECCCCCEEEeecccccccCCCcc-
Confidence 999999999998754 3789999999999999999999 89999999999999999999999999999987644322
Q ss_pred ceeeccCccccccccccCCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....+|+.|+|||.+.+..+ +.++||||+|+++|||++|+.||...+
T Consensus 167 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 167 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 223458999999999887765 689999999999999999999997643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=292.33 Aligned_cols=201 Identities=23% Similarity=0.357 Sum_probs=172.3
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++||||+++++++. ..+..++||||+
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~ 87 (276)
T 2yex_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-EGNIQYLFLEYC 87 (276)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-ETTEEEEEEECC
T ss_pred eEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-cCCEEEEEEEec
Confidence 456789999999999999875 78999999997543 334578899999999999999999999995 455889999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc-cc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN-TN 693 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 693 (773)
++++|.+++... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+........ ..
T Consensus 88 ~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 88 SGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp TTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 999999988753 34889999999999999999999 99999999999999999999999999999986643322 11
Q ss_pred eeeccCccccccccccCCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.....||+.|+|||.+.+..+ +.++||||+|+++|||++|+.||.....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 234568999999999887665 7799999999999999999999987543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=293.29 Aligned_cols=197 Identities=26% Similarity=0.442 Sum_probs=171.4
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++. ..+..++|||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e 94 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-DRKRIYLMLE 94 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEEC
T ss_pred ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-cCCEEEEEEE
Confidence 456789999999999999875 57789999996432 223567899999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.... .+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||.+.......
T Consensus 95 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 168 (284)
T 2vgo_A 95 FAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCH-ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-- 168 (284)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred eCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence 999999999998764 3789999999999999999999 9999999999999999999999999999987554322
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....|++.|+|||.+.+..++.++||||+|+++|||++|+.||...+
T Consensus 169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 169 -RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp -BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 223468999999999998999999999999999999999999997643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.61 Aligned_cols=201 Identities=25% Similarity=0.500 Sum_probs=164.1
Q ss_pred HHhhcccccccceEEEEEEeCC-----CCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLED-----GSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~-----g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
+...++||+|+||.||+|.... +..||||.++.... ....++.+|++++++++||||+++++++ ...+..++|
T Consensus 46 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv 124 (333)
T 1mqb_A 46 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-SKYKPMMII 124 (333)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSSEEEE
T ss_pred hhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-ecCCCcEEE
Confidence 3456889999999999998642 23599999975533 3456789999999999999999999999 555689999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||+++|+|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++......
T Consensus 125 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 125 TEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLA-NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp EECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred EeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 99999999999998752 34889999999999999999999 8999999999999999999999999999998765432
Q ss_pred cc--ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 691 NT--NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 691 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
.. ......+|+.|+|||.+....++.++|||||||++|||++ |+.||...+
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 255 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence 21 1222346789999999988899999999999999999999 999997643
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=311.69 Aligned_cols=198 Identities=24% Similarity=0.382 Sum_probs=159.7
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--------cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--------TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEK 607 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 607 (773)
|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++. . +..
T Consensus 137 y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~-~~~ 214 (419)
T 3i6u_A 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A-EDY 214 (419)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S-SEE
T ss_pred EEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c-Cce
Confidence 456789999999999999864 68999999996532 112235889999999999999999999984 3 368
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC---CeEEeecCCcc
Q 041878 608 LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT---NPRIADFGLSR 684 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~---~~kl~DfG~a~ 684 (773)
++||||+++|+|.+++.... .+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+||+|||+++
T Consensus 215 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH-~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 215 YIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred EEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 99999999999999887643 4899999999999999999999 99999999999999997554 59999999998
Q ss_pred ccccccccceeeccCccccccccccC---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 685 LMTAAANTNVIATAGTLGYRAPELSK---LKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 685 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
...... ......||+.|+|||++. ...++.++||||+||++|||++|+.||.....
T Consensus 291 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 291 ILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred ecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 765332 223456899999999875 36788899999999999999999999986443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.72 Aligned_cols=208 Identities=24% Similarity=0.373 Sum_probs=174.0
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCC----CeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK----GEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~~lV 610 (773)
|.+.++||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++.... ...++|
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 456789999999999999865 678899999975432 33467899999999999999999999995432 468999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||++ |+|.+++... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 109 ~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 109 QDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 99996 5999998764 3789999999999999999999 9999999999999999999999999999998765443
Q ss_pred ccc--eeeccCccccccccccC-CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHH
Q 041878 691 NTN--VIATAGTLGYRAPELSK-LKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVA 750 (773)
Q Consensus 691 ~~~--~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~ 750 (773)
... .....||+.|+|||++. ...++.++||||+||++|||++|+.||...+..+..+.+.
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~ 245 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 221 23346899999999764 4558999999999999999999999998776555544443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=316.90 Aligned_cols=198 Identities=31% Similarity=0.440 Sum_probs=168.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-------------ccHHHHHHHHHHHHccCCCceEEeEEEEEC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-------------KGQKEFEAEAAAIGKIHHPNLLALRAYYLG 602 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 602 (773)
|.+.++||+|+||+||+|... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~- 116 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE- 116 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE-
T ss_pred eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-
Confidence 456789999999999999865 678999999975421 23567899999999999999999999995
Q ss_pred CCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC---CeEEee
Q 041878 603 PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT---NPRIAD 679 (773)
Q Consensus 603 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~---~~kl~D 679 (773)
..+..++||||+++|+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++ .+||+|
T Consensus 117 ~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 117 DKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLH-KHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 5558999999999999999998754 3899999999999999999999 99999999999999999876 599999
Q ss_pred cCCccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 680 FGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 680 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
||++....... ......||+.|+|||++. ..++.++||||+||++|||++|+.||...+.
T Consensus 193 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 252 (504)
T 3q5i_A 193 FGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND 252 (504)
T ss_dssp CTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99998765432 223456999999999887 5699999999999999999999999976543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=303.69 Aligned_cols=201 Identities=24% Similarity=0.415 Sum_probs=174.3
Q ss_pred HHHhhcccccccceEEEEEEe-----CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEEC-CCCeEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATL-----EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG-PKGEKLL 609 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~~l 609 (773)
.|.+.+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++|+||+++++++.. .....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 345678999999999999984 3678899999987766667789999999999999999999999864 3456889
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||+++++|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 999999999999998753 24899999999999999999999 999999999999999999999999999999876543
Q ss_pred ccc--ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 690 ANT--NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 690 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
... ......+|+.|+|||++.+..++.++||||+|+++|||++|+.||..
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 322 12234578889999999888899999999999999999999999854
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=304.26 Aligned_cols=204 Identities=22% Similarity=0.380 Sum_probs=172.0
Q ss_pred HHHhhcccccccceEEEEEEeC------CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 608 (773)
+|.+.+.||+|+||.||+|... +++.||||.+..... ....++.+|+.++++++||||+++++++ ...+..+
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~ 104 (322)
T 1p4o_A 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-SQGQPTL 104 (322)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-CSSSSCE
T ss_pred heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE-ccCCccE
Confidence 3566789999999999999754 367899999975433 3455789999999999999999999999 5556889
Q ss_pred EEEeecCCCCHHHHHhhcC-------CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecC
Q 041878 609 LVFDFMPKGSLASFLHARG-------PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFG 681 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG 681 (773)
+||||+++|+|.++++... ....+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH-HCCCccCCCccceEEEcCCCeEEECcCc
Confidence 9999999999999997642 1234688999999999999999999 8999999999999999999999999999
Q ss_pred Ccccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 682 LSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 682 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
+++........ ......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||...+
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 245 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 245 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence 99866443221 1122346889999999988899999999999999999999 899987643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=299.91 Aligned_cols=199 Identities=23% Similarity=0.366 Sum_probs=165.4
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc--cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK--GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|...++||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++++++||||+++++++. ..+..++||||
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~ 105 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-KKKRWYLVFEF 105 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEEEC
T ss_pred heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-cCCEEEEEEec
Confidence 456789999999999999875 5899999998654332 3456789999999999999999999995 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+++++|.++..... .+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||.+........ .
T Consensus 106 ~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 180 (331)
T 4aaa_A 106 VDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCH-SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-V 180 (331)
T ss_dssp CSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred CCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH-HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-c
Confidence 99999988876543 3889999999999999999999 99999999999999999999999999999976644322 2
Q ss_pred eeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...+
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS 229 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 2234689999999988765 78999999999999999999999997654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=294.63 Aligned_cols=198 Identities=25% Similarity=0.439 Sum_probs=173.0
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.. .+..++||||+
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 102 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIMEYL 102 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECC
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEEeC
Confidence 45578899999999999986 468999999997553 3446789999999999999999999999954 55899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++++|.+++... .+++..+..++.|++.||.||| +.||+||||||+||+++.++.+||+|||.+........ ..
T Consensus 103 ~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 176 (303)
T 3a7i_A 103 GGGSALDLLEPG----PLDETQIATILREILKGLDYLH-SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KR 176 (303)
T ss_dssp TTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CB
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCChheEEECCCCCEEEeecccceecCcccc-cc
Confidence 999999998753 3789999999999999999999 99999999999999999999999999999987654322 22
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 34468999999999998999999999999999999999999997643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=307.57 Aligned_cols=198 Identities=21% Similarity=0.408 Sum_probs=171.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++. ..+..++||||+
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~ 113 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-SDGEISICMEHM 113 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-ETTEEEEEECCC
T ss_pred ceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-ECCEEEEEEECC
Confidence 455789999999999999875 78999999997653 334567899999999999999999999995 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCC-CceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE-NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~-~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
++++|.+++.... .+++..+..++.|++.||.||| +. ||+||||||+||+++.++.+||+|||++.......
T Consensus 114 ~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh-~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 186 (360)
T 3eqc_A 114 DGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 186 (360)
T ss_dssp TTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred CCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH-HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc---
Confidence 9999999998764 3789999999999999999999 64 99999999999999999999999999987654322
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+.
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 187 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp ----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2234689999999999999999999999999999999999999986553
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.98 Aligned_cols=199 Identities=23% Similarity=0.408 Sum_probs=168.9
Q ss_pred HHhhcccccccceEEEEEEe-----CCCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCC-CeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-----EDGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-GEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~l 609 (773)
+...+.||+|+||.||+|.+ .+++.||||+++... ......+.+|++++++++||||+++++++.... ...++
T Consensus 23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 45678999999999999983 368899999997543 334578999999999999999999999996543 46889
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||.+......
T Consensus 103 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhh-cCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 999999999999997653 34889999999999999999999 999999999999999999999999999999876544
Q ss_pred ccc--ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 041878 690 ANT--NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGE 738 (773)
Q Consensus 690 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~ 738 (773)
... ......+|..|+|||.+.+..++.++||||+|+++|||+||+.|+.
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 321 2223457888999999988889999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-33 Score=289.58 Aligned_cols=195 Identities=26% Similarity=0.444 Sum_probs=166.8
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECC---CCeEEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP---KGEKLLVF 611 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~~~lV~ 611 (773)
.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++... ....++||
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence 45678999999999999864 67899999987542 33456789999999999999999999988542 34689999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCC--ceecCCCCCCEEeC-CCCCeEEeecCCcccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN--MIHGNLTSSNVLLD-EKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~--iiH~Dik~~NIll~-~~~~~kl~DfG~a~~~~~ 688 (773)
||+++++|.+++.... .+++..+..++.||+.||.||| +.+ |+||||||+||+++ .++.+||+|||++.....
T Consensus 109 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH-cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 9999999999998753 3789999999999999999999 888 99999999999998 788999999999975433
Q ss_pred ccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
. ......||+.|+|||.+. ..++.++||||+|+++|||++|+.||...
T Consensus 185 ~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 185 S---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred c---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 2 223456899999999876 55899999999999999999999999763
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.10 Aligned_cols=199 Identities=23% Similarity=0.401 Sum_probs=162.3
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCC-----eEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG-----EKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~~lV~ 611 (773)
|...++||+|+||+||+|....+..||+|++...... ..+|++++++++||||+++++++..... ..++||
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~ 117 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL 117 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence 4567899999999999999877777999988643322 2369999999999999999999854332 378999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeC-CCCCeEEeecCCcccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLD-EKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~-~~~~~kl~DfG~a~~~~~~~ 690 (773)
||++++.+............+++..+..++.||++||+||| +.||+||||||+|||++ .++.+||+|||+++......
T Consensus 118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 99987544443332223445899999999999999999999 99999999999999999 78999999999998764333
Q ss_pred ccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 691 NTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
. .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.
T Consensus 197 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 247 (394)
T 4e7w_A 197 P--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247 (394)
T ss_dssp C--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred C--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2 223468999999998865 4589999999999999999999999977653
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=294.71 Aligned_cols=198 Identities=29% Similarity=0.498 Sum_probs=158.2
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.++||+|+||+||+|... ..||||+++... ....+.+.+|++++++++||||+++++++ . .+..++||||+
T Consensus 26 y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~-~~~~~lv~e~~ 101 (289)
T 3og7_A 26 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T-APQLAIVTQWC 101 (289)
T ss_dssp CEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C-SSSCEEEEECC
T ss_pred eeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c-CCccEEEEEec
Confidence 456789999999999999864 369999997543 23456789999999999999999999976 3 34689999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc-ccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA-NTN 693 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 693 (773)
++++|.+++.... ..+++..+..++.|++.||.||| +.||+||||||+||+++.++.+||+|||++....... ...
T Consensus 102 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH-~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 102 EGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLH-AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp CEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred CCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 9999999997653 34899999999999999999999 9999999999999999999999999999997654322 222
Q ss_pred eeeccCccccccccccC---CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSK---LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||.+. ...++.++||||+|+++|||++|+.||....
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 23446899999999886 5678889999999999999999999997643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=297.39 Aligned_cols=209 Identities=24% Similarity=0.413 Sum_probs=163.8
Q ss_pred HHHHhhcccccccceEEEEEEeC----CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCC---
Q 041878 535 LLCATAEIMGKSTYGTAYKATLE----DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG--- 605 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--- 605 (773)
-.|.+.+.||+|+||.||+|... .+..||+|.++... ....+.+.+|+.++++++||||+++++++.....
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 34567889999999999999754 34479999997543 3335678999999999999999999999965432
Q ss_pred -eEEEEEeecCCCCHHHHHhhcC---CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecC
Q 041878 606 -EKLLVFDFMPKGSLASFLHARG---PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFG 681 (773)
Q Consensus 606 -~~~lV~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG 681 (773)
..++||||+++|+|.+++.... ....+++..++.++.||+.||.||| +.||+||||||+||+++.++.+||+|||
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS-NRNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH-TTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCcceEEEcCCCcEEEeecC
Confidence 3599999999999999986432 2345899999999999999999999 9999999999999999999999999999
Q ss_pred Ccccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCC
Q 041878 682 LSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMD 744 (773)
Q Consensus 682 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~ 744 (773)
++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 257 (313)
T 3brb_A 193 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257 (313)
T ss_dssp CC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred cceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 99876543322 2223457889999999998999999999999999999999 889997755443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-34 Score=302.44 Aligned_cols=199 Identities=24% Similarity=0.362 Sum_probs=160.3
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc--cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK--GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|.+.++||+|+||+||+|... +++.||||+++..... ....+.+|++++++++||||+++++++. ..+..++||||
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~ 114 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-HNHRLHLIFEY 114 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-ETTEEEEEEEC
T ss_pred EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-cCCEEEEEEec
Confidence 456789999999999999854 7889999999754332 2456789999999999999999999995 45589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeC-----CCCCeEEeecCCcccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLD-----EKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~-----~~~~~kl~DfG~a~~~~~ 688 (773)
++ |+|.+++.... .+++..+..++.||+.||+||| +.||+||||||+|||++ .++.+||+|||+++....
T Consensus 115 ~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH-~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 115 AE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCH-SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp CS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred CC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 97 59999998754 3789999999999999999999 89999999999999994 445599999999987643
Q ss_pred ccccceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
... ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...+.
T Consensus 190 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 190 PIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 322 22334689999999998764 589999999999999999999999976543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=297.99 Aligned_cols=196 Identities=26% Similarity=0.425 Sum_probs=166.6
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.||+|+||.||+|... +++.||+|+++... ......+.+|+.+++++. ||||+++++++. ..+..++||||+++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~-~~~~~~lv~e~~~~ 113 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE-NTSEIILILEYAAG 113 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE-CSSEEEEEEECCTT
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE-eCCeEEEEEEecCC
Confidence 78999999999999865 68999999997542 334678999999999995 699999999994 55589999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC---CCCeEEeecCCccccccccccc
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE---KTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~---~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
|+|.+++.... ...+++..+..++.|++.||+||| +.||+||||||+||+++. ++.+||+|||+++.......
T Consensus 114 ~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH-~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~-- 189 (327)
T 3lm5_A 114 GEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLH-QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-- 189 (327)
T ss_dssp EEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-------
T ss_pred CcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH-HCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc--
Confidence 99999986542 345899999999999999999999 999999999999999998 78999999999987643322
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....||+.|+|||++....++.++||||+||++|||++|+.||...+
T Consensus 190 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 190 LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp ----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 233468999999999999999999999999999999999999997644
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=310.20 Aligned_cols=197 Identities=23% Similarity=0.380 Sum_probs=161.0
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECC---CC--eEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP---KG--EKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~--~~~lV 610 (773)
|...++||+|+||.||+|.+. +|+.||||++..... ...+|++++++++|+||+++++++... .+ ..++|
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 456789999999999999975 689999999864322 234699999999999999999988532 12 36799
Q ss_pred EeecCCCCHHHHHhhc-CCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC-CCeEEeecCCcccccc
Q 041878 611 FDFMPKGSLASFLHAR-GPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK-TNPRIADFGLSRLMTA 688 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~~~~ 688 (773)
|||+++ ++.+.+... .....+++..+..++.||++||+||| +.||+||||||+|||++.+ +.+||+|||+++....
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 999975 676665432 22345899999999999999999999 9999999999999999965 5689999999987643
Q ss_pred ccccceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+
T Consensus 210 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~ 261 (420)
T 1j1b_A 210 GEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 261 (420)
T ss_dssp TCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 322 2234689999999988654 78999999999999999999999997754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=307.58 Aligned_cols=196 Identities=12% Similarity=0.107 Sum_probs=150.1
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc---ccHHHHHHHHHHHHcc--CCCceEEeE-------EEEECC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT---KGQKEFEAEAAAIGKI--HHPNLLALR-------AYYLGP 603 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~~~ 603 (773)
|...+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++.+ +|||+++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 346789999999999999865 789999999986543 2345677885555444 699988754 444222
Q ss_pred C----------------CeEEEEEeecCCCCHHHHHhhcCCCCccCHHHH------HHHHHHHHHHHHHhccCCCceecC
Q 041878 604 K----------------GEKLLVFDFMPKGSLASFLHARGPETIVNWATR------MSIAIGIARGLNYLHVEENMIHGN 661 (773)
Q Consensus 604 ~----------------~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~------~~i~~~i~~al~yLH~~~~iiH~D 661 (773)
. ...++||||++ |+|.+++..... .+++..+ ..++.||+.||+||| +.||+|||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH-~~~ivHrD 219 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQ-SKGLVHGH 219 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHH-HTTEEETT
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHH-HCCCccCc
Confidence 1 24799999998 899999987522 1344444 677899999999999 99999999
Q ss_pred CCCCCEEeCCCCCeEEeecCCccccccccccceeeccCccccccccccCC--CCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 662 LTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKL--KNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 662 ik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
|||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998654221 13457799999999987 7799999999999999999999999987
Q ss_pred C
Q 041878 740 M 740 (773)
Q Consensus 740 ~ 740 (773)
.
T Consensus 296 ~ 296 (371)
T 3q60_A 296 V 296 (371)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=306.05 Aligned_cols=198 Identities=18% Similarity=0.326 Sum_probs=162.8
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCC-----------
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK----------- 604 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----------- 604 (773)
|.+.++||+|+||+||+|.. .+|+.||||++...... ..+|++++++++||||+++++++....
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred EEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 45678999999999999986 57899999998654322 246999999999999999999985422
Q ss_pred --------------------------CeEEEEEeecCCCCHHHHHhhc-CCCCccCHHHHHHHHHHHHHHHHHhccCCCc
Q 041878 605 --------------------------GEKLLVFDFMPKGSLASFLHAR-GPETIVNWATRMSIAIGIARGLNYLHVEENM 657 (773)
Q Consensus 605 --------------------------~~~~lV~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~al~yLH~~~~i 657 (773)
...++||||++ |+|.+.+... .....+++..+..++.||++||+||| +.||
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~gi 162 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGI 162 (383)
T ss_dssp -------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-TTTE
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCcC
Confidence 23789999997 5888777642 12345899999999999999999999 9999
Q ss_pred eecCCCCCCEEeC-CCCCeEEeecCCccccccccccceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCC
Q 041878 658 IHGNLTSSNVLLD-EKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKS 735 (773)
Q Consensus 658 iH~Dik~~NIll~-~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~ 735 (773)
+||||||+||+++ .++.+||+|||+++....... .....+|+.|+|||++.+. .++.++||||+||++|||++|+.
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 9999999999998 678899999999987644332 2334689999999987764 58999999999999999999999
Q ss_pred CCCCCCC
Q 041878 736 PGEPMNG 742 (773)
Q Consensus 736 P~~~~~~ 742 (773)
||.+.+.
T Consensus 241 pf~~~~~ 247 (383)
T 3eb0_A 241 LFSGETS 247 (383)
T ss_dssp SSCCSSH
T ss_pred CCCCCCh
Confidence 9977553
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=293.13 Aligned_cols=198 Identities=27% Similarity=0.436 Sum_probs=168.0
Q ss_pred hcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCCC
Q 041878 540 AEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
..+||+|+||.||+|.. .+++.||||.+........+.+.+|+.++++++||||+++++++. ..+..++||||+++++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~ 105 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-ENGFIKIFMEQVPGGS 105 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-ETTEEEEEEECCSEEE
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-eCCcEEEEEEeCCCCC
Confidence 35899999999999986 468899999998776666788999999999999999999999995 4558999999999999
Q ss_pred HHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-CCCeEEeecCCccccccccccceeec
Q 041878 619 LASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE-KTNPRIADFGLSRLMTAAANTNVIAT 697 (773)
Q Consensus 619 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~ 697 (773)
|.+++........+++..+..++.||+.||+||| +.||+||||||+||+++. ++.+||+|||.+........ .....
T Consensus 106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 183 (295)
T 2clq_A 106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH-DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETF 183 (295)
T ss_dssp HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCC
T ss_pred HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH-hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-ccccc
Confidence 9999987654445678889999999999999999 899999999999999987 88999999999986643221 12234
Q ss_pred cCccccccccccCCC--CCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 698 AGTLGYRAPELSKLK--NANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 698 ~gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
.||+.|+|||++... .++.++||||||+++|||++|+.||...
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 689999999988654 3789999999999999999999999653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=298.22 Aligned_cols=197 Identities=25% Similarity=0.410 Sum_probs=170.0
Q ss_pred HhhcccccccceEEEEEEeC-----CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECC-CCeEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATLE-----DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-KGEKLLV 610 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-----~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV 610 (773)
.+.+.||+|+||+||++.+. +++.||||+++.... ...+.+.+|++++++++||||+++++++... ....++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 56789999999999998653 578899999976533 3456789999999999999999999999654 3578999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||+++|+|.+++.+.. +++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 114 ~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH-~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 188 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLH-AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188 (318)
T ss_dssp ECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTC
T ss_pred EecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHH-hCCccCCCCchheEEEcCCCCEEECCccccccccccc
Confidence 99999999999998653 789999999999999999999 9999999999999999999999999999998765433
Q ss_pred cc--ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 691 NT--NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 691 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
.. ......+|+.|+|||.+.+..++.++||||+|+++|||+||+.||..
T Consensus 189 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 239 (318)
T 3lxp_A 189 EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239 (318)
T ss_dssp SEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence 21 12234578889999999888899999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-33 Score=309.02 Aligned_cols=211 Identities=18% Similarity=0.268 Sum_probs=174.6
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.++||+|+||.||+|.. .+++.||||++..... ..++..|+++++.++|++.+..+.++....+..++||||+
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~- 85 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence 34568999999999999986 5789999998865433 3457889999999998655555555545666889999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe---CCCCCeEEeecCCcccccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll---~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
+++|.+++.... ..+++..++.++.||+.||+||| +.+||||||||+|||+ +.++.+||+|||+++........
T Consensus 86 g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH-~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 86 GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 999999998643 34899999999999999999999 9999999999999999 68899999999999876544321
Q ss_pred ------ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHH
Q 041878 693 ------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIV 753 (773)
Q Consensus 693 ------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~ 753 (773)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+..+.+.++.
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH
T ss_pred cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh
Confidence 1124569999999999999999999999999999999999999999877666555554443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=304.30 Aligned_cols=196 Identities=21% Similarity=0.304 Sum_probs=159.6
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCC-----CeEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-----GEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~~ 608 (773)
|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++.... ...+
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence 456789999999999999864 68899999997532 234567889999999999999999999995443 2689
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||++ |+|.+++.. .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 107 lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 107 IVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred EEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHH-HCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 9999996 578888863 2788999999999999999999 99999999999999999999999999999986543
Q ss_pred ccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+
T Consensus 180 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 180 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 2233468999999999998999999999999999999999999997654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=296.43 Aligned_cols=202 Identities=26% Similarity=0.426 Sum_probs=169.4
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEEC---CCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG---PKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|.. .+++.||||++........+.+.+|++++++++||||+++++++.. .....++|||
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 110 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence 45678999999999999986 5789999999977666667789999999999999999999999863 2347889999
Q ss_pred ecCCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 613 FMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
|+++|+|.+++.... ....+++..++.++.||+.||.||| +.+|+||||||+||+++.++.+||+|||.+........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~ 189 (317)
T 2buj_A 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH-AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189 (317)
T ss_dssp CCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEE
T ss_pred eCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccc
Confidence 999999999998642 2345899999999999999999999 89999999999999999999999999999876532211
Q ss_pred c--------ceeeccCccccccccccCCCC---CCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 692 T--------NVIATAGTLGYRAPELSKLKN---ANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 692 ~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
. ......||+.|+|||.+.... +++++||||||+++|||++|+.||..
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 190 GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp SHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred cccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 1 112234799999999887544 68899999999999999999999854
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=302.73 Aligned_cols=199 Identities=27% Similarity=0.385 Sum_probs=161.7
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccCcc-----------cHHHHHHHHHHHHccCCCceEEeEEEEECCC--
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTK-----------GQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-- 604 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 604 (773)
.+.+.||+|+||.||+|...+|+.||||++...... ..+.+.+|++++++++||||+++++++....
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (362)
T 3pg1_A 25 TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP 104 (362)
T ss_dssp EEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTT
T ss_pred EEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCC
Confidence 456899999999999999888999999999653221 1378899999999999999999999985422
Q ss_pred --CeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCC
Q 041878 605 --GEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGL 682 (773)
Q Consensus 605 --~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~ 682 (773)
...++||||++ |+|.+++... ...+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 180 (362)
T 3pg1_A 105 AMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLH-EAGVVHRDLHPGNILLADNNDITICDFNL 180 (362)
T ss_dssp TCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTCCEEECCTTC
T ss_pred CcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH-HCcCEecCCChHHEEEcCCCCEEEEecCc
Confidence 36799999997 6898888754 335899999999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 683 SRLMTAAANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 683 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
++....... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.
T Consensus 181 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 181 AREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp -----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 975443322 233468999999998876 6789999999999999999999999976553
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=295.62 Aligned_cols=203 Identities=23% Similarity=0.380 Sum_probs=169.9
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEEC-CCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLG-PKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.. .....++|||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence 345688999999999999875 78999999997543 3345678999999999999999999998754 3457899999
Q ss_pred ecCCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCC-----ceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 613 FMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEEN-----MIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~-----iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
|+++++|.+++.... ....+++..+..++.|++.||+||| +.+ |+||||||+||+++.++.+||+|||.+...
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~ 166 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH-RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166 (279)
T ss_dssp CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh-cccCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence 999999999997643 2344899999999999999999999 777 999999999999999999999999998766
Q ss_pred ccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 687 TAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 167 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 220 (279)
T 2w5a_A 167 NHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220 (279)
T ss_dssp ---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence 433211 123358999999999988899999999999999999999999997654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.25 Aligned_cols=198 Identities=21% Similarity=0.297 Sum_probs=162.2
Q ss_pred HHhhcccccccceEEEEEEeC----CCCEEEEEEecccCcc-----------cHHHHHHHHHHHHccCCCceEEeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE----DGSEVAVKRLREKTTK-----------GQKEFEAEAAAIGKIHHPNLLALRAYYL 601 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~----~g~~vAvK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~~~~ 601 (773)
|.+.+.||+|+||.||+|... ++..||||+....... ....+.+|+..++.++||||+++++++.
T Consensus 39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~ 118 (345)
T 2v62_A 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL 118 (345)
T ss_dssp EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence 456789999999999999875 5788999998754322 1234667888999999999999999986
Q ss_pred CC---CCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC--CeE
Q 041878 602 GP---KGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT--NPR 676 (773)
Q Consensus 602 ~~---~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~--~~k 676 (773)
.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+||| +.||+||||||+||+++.++ .+|
T Consensus 119 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 119 TEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIH-ENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCcCHHHEEEccCCCCcEE
Confidence 52 45789999999 999999998754 4899999999999999999999 89999999999999999887 999
Q ss_pred EeecCCcccccccccc------ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 677 IADFGLSRLMTAAANT------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 677 l~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
|+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999999876543221 11334689999999999988999999999999999999999999965
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=301.32 Aligned_cols=200 Identities=26% Similarity=0.395 Sum_probs=165.5
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc-----cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK-----GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
+|.+.+.||+|+||.||+|... +|+.||||++...... ....+.+|++++++++||||+++++++ ...+..++
T Consensus 11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~l 89 (346)
T 1ua2_A 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-GHKSNISL 89 (346)
T ss_dssp --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-CCTTCCEE
T ss_pred ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-eeCCceEE
Confidence 3567789999999999999875 6899999999753221 124678999999999999999999999 55668999
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||+++ +|.+++.... ..+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||+|||+++.....
T Consensus 90 v~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLH-QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHH-HCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999975 8998887643 34778889999999999999999 999999999999999999999999999999876433
Q ss_pred cccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. ......+|+.|+|||++.+ ..++.++||||+||++|||++|..||.+.+
T Consensus 166 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~ 217 (346)
T 1ua2_A 166 NR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 217 (346)
T ss_dssp CC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 22 2234568999999998865 458999999999999999999999987654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=305.55 Aligned_cols=196 Identities=27% Similarity=0.391 Sum_probs=151.6
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECC-----CCeEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-----KGEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~~ 608 (773)
|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++... ....+
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~ 110 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110 (367)
T ss_dssp EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence 45678999999999999985 468899999996532 23456788999999999999999999998543 14679
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+|+||+ +++|.++++.. .+++..+..++.||++||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 111 lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH-~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp EEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred EEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 999999 78999988752 3889999999999999999999 99999999999999999999999999999986543
Q ss_pred ccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
. .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.
T Consensus 185 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 235 (367)
T 2fst_X 185 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred c----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2 223468999999998876 6789999999999999999999999976553
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=296.56 Aligned_cols=199 Identities=27% Similarity=0.434 Sum_probs=166.5
Q ss_pred Hhhc-ccccccceEEEEEEe---CCCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 538 ATAE-IMGKSTYGTAYKATL---EDGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 538 ~~~~-~lG~G~fg~Vy~~~~---~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
.+.+ .||+|+||.||+|.+ .+++.||||+++.... ...+++.+|++++++++||||+++++++ . .+..++||
T Consensus 19 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~-~~~~~lv~ 96 (291)
T 1xbb_A 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-E-AESWMLVM 96 (291)
T ss_dssp EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-E-SSSEEEEE
T ss_pred hhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-C-CCCcEEEE
Confidence 4445 899999999999964 2467899999975432 2356799999999999999999999998 3 34789999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++++|.+++.... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++........
T Consensus 97 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 97 EMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp ECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHH-hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 9999999999998753 3789999999999999999999 99999999999999999999999999999987654432
Q ss_pred cc--eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 692 TN--VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 692 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
.. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+.
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 226 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 21 122346789999999988889999999999999999999 9999976543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=300.74 Aligned_cols=324 Identities=17% Similarity=0.151 Sum_probs=253.5
Q ss_pred cCCCCCCCCCCCCCCCcceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcc
Q 041878 68 LRSWNDSGVGACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLF 147 (773)
Q Consensus 68 l~sW~~~~~~~c~~~w~gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 147 (773)
+++|.. +.+ |++.|.+..|....+. +............-..++++++|++++|.++...+..+..+++|++|+|+
T Consensus 3 ~~~~~~-~~~-C~~~~~~~~c~~~~~~---i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~ 77 (390)
T 3o6n_A 3 VKPRQP-EYK-CIDSNLQYDCVFYDVH---IDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN 77 (390)
T ss_dssp ----CC-EEC-BCC------EEEESCE---ECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECT
T ss_pred cCCCCC-ccc-eehhhhhhccceeeee---eecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECC
Confidence 577854 334 4445777777422222 22222222222223457899999999999996555557899999999999
Q ss_pred cCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeecccccccccc
Q 041878 148 NNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSV 227 (773)
Q Consensus 148 ~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 227 (773)
+|++++..+..|+.+++|++|+|++|.+++..|..+.++++|++|+|++|+++...+..+.++++|++|++++|++++..
T Consensus 78 ~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~ 157 (390)
T 3o6n_A 78 DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIE 157 (390)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCC
T ss_pred CCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccC
Confidence 99999888889999999999999999999888888999999999999999999666666799999999999999999877
Q ss_pred CCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCccc
Q 041878 228 PNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVT 307 (773)
Q Consensus 228 p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~ 307 (773)
+..+..+. +|++|++++|.+++. .+..+++|+.|++++|.+++. ...++|++|++++|.++.. |..
T Consensus 158 ~~~~~~l~-----~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L~l~~n~l~~~-~~~ 223 (390)
T 3o6n_A 158 DDTFQATT-----SLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVV-RGP 223 (390)
T ss_dssp TTTTSSCT-----TCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-----ECCSSCSEEECCSSCCCEE-ECC
T ss_pred hhhccCCC-----CCCEEECCCCcCCcc---ccccccccceeeccccccccc-----CCCCcceEEECCCCeeeec-ccc
Confidence 77776554 899999999999975 366788999999999999852 3446899999999999855 332
Q ss_pred ccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccC
Q 041878 308 FTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLT 387 (773)
Q Consensus 308 ~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 387 (773)
..++|+.|++++|++++. ..+..+++|++|++++|.+++..|..+..+++|++|+|++|++++ +|..+..+++|+
T Consensus 224 --~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~ 298 (390)
T 3o6n_A 224 --VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLK 298 (390)
T ss_dssp --CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCC
T ss_pred --ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCC
Confidence 247999999999999875 578999999999999999999999999999999999999999995 566778899999
Q ss_pred EEEeecccCCCCCchhhh--ccCCCCCCCCC
Q 041878 388 SFNVSYNNLSGSVPPLLS--KKFNSSSFVGN 416 (773)
Q Consensus 388 ~L~ls~N~l~g~~p~~~~--~~~~~~~~~~n 416 (773)
.|+|++|++++ +|..+. ..+....+.+|
T Consensus 299 ~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N 328 (390)
T 3o6n_A 299 VLDLSHNHLLH-VERNQPQFDRLENLYLDHN 328 (390)
T ss_dssp EEECCSSCCCC-CGGGHHHHTTCSEEECCSS
T ss_pred EEECCCCccee-cCccccccCcCCEEECCCC
Confidence 99999999984 555432 23333344454
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=305.95 Aligned_cols=197 Identities=19% Similarity=0.281 Sum_probs=167.9
Q ss_pred HHhhcccccccceEEEEEEeCC---------CCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEE------------
Q 041878 537 CATAEIMGKSTYGTAYKATLED---------GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLA------------ 595 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~---------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~------------ 595 (773)
|.+.+.||+|+||.||+|.... ++.||||.+... ..+.+|++++++++||||++
T Consensus 44 y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred EEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 4567899999999999998753 789999998643 46788999999999999887
Q ss_pred ---eEEEEECCCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC
Q 041878 596 ---LRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK 672 (773)
Q Consensus 596 ---l~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~ 672 (773)
+++++....+..++||||+ +++|.+++.... ...+++..+..++.||+.||+||| +.||+||||||+||+++.+
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLH-ENEYVHGNVTAENIFVDPE 195 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCCGGGEEEETT
T ss_pred ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCCHHHEEEcCC
Confidence 6777765567899999999 999999998752 234899999999999999999999 8999999999999999999
Q ss_pred C--CeEEeecCCcccccccccc------ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 673 T--NPRIADFGLSRLMTAAANT------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 673 ~--~~kl~DfG~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
+ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 8 8999999999876543321 1123468999999999999899999999999999999999999998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-32 Score=292.93 Aligned_cols=196 Identities=25% Similarity=0.387 Sum_probs=161.0
Q ss_pred HHHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHcc--CCCceEEeEEEEECCC---CeEEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI--HHPNLLALRAYYLGPK---GEKLLV 610 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~---~~~~lV 610 (773)
.|.+.+.||+|+||.||+|... ++.||||++... ....+..|.+++... +||||+++++++.... ...++|
T Consensus 38 ~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 113 (337)
T 3mdy_A 38 QIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113 (337)
T ss_dssp HCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred ceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence 4567899999999999999876 899999998543 234445566665554 8999999999986543 578999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCC--------CceecCCCCCCEEeCCCCCeEEeecCC
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE--------NMIHGNLTSSNVLLDEKTNPRIADFGL 682 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~--------~iiH~Dik~~NIll~~~~~~kl~DfG~ 682 (773)
|||+++|+|.++++.. .+++..++.++.|++.||+||| +. ||+||||||+||+++.++.+||+|||+
T Consensus 114 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH-~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 114 TDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLH-TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp ECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHH-SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHH-HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 9999999999999764 3889999999999999999999 77 999999999999999999999999999
Q ss_pred ccccccccccc---eeeccCccccccccccCCCCCCcc------hhhHHHHHHHHHHHcC----------CCCCCCC
Q 041878 683 SRLMTAAANTN---VIATAGTLGYRAPELSKLKNANTK------TDVYSLGVIILELLTG----------KSPGEPM 740 (773)
Q Consensus 683 a~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dvws~Gv~l~el~tg----------~~P~~~~ 740 (773)
+.......... .....||+.|+|||++.+..++.+ +|||||||++|||+|| +.||...
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 97664433221 123469999999999887766655 9999999999999999 7777653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=293.70 Aligned_cols=192 Identities=19% Similarity=0.343 Sum_probs=166.9
Q ss_pred HHHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccC-CCceEEeEEEEECC-CCeEEEEEe
Q 041878 536 LCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGP-KGEKLLVFD 612 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~~~lV~e 612 (773)
.|.+.+.||+|+||.||+|.. .+++.||||+++.. ..+.+.+|++++++++ ||||+++++++... ....++|||
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred ceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 356678999999999999985 57899999999643 3577899999999997 99999999999654 447899999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC-CeEEeecCCccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT-NPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~~~ 691 (773)
|+++++|.++++. ++...+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++.......
T Consensus 114 ~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 114 HVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp CCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC
T ss_pred ccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc
Confidence 9999999998864 688899999999999999999 99999999999999999777 799999999986654332
Q ss_pred cceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
.....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 187 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 187 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred --cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 233468999999998876 6789999999999999999999999954
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=296.04 Aligned_cols=200 Identities=24% Similarity=0.414 Sum_probs=167.7
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.+.||+|+||.||+|... +++.||+|++........+++.+|++++++++||||+++++++.. .+..++||||++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 99 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-DGKLWIMIEFCP 99 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-C-CEEEEEECCT
T ss_pred eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-CCeEEEEEEeCC
Confidence 456788999999999999875 589999999987766677889999999999999999999999954 458999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|.+++.... ..+++..+..++.||+.||.||| +.|++||||||+||+++.++.+||+|||++........ ...
T Consensus 100 ~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 175 (302)
T 2j7t_A 100 GGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLH-SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ-KRD 175 (302)
T ss_dssp TEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-C--
T ss_pred CCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh-cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-ccc
Confidence 999999987643 34889999999999999999999 89999999999999999999999999998764332211 122
Q ss_pred eccCcccccccccc-----CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELS-----KLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~-----~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...||+.|+|||.+ ....++.++||||||+++|||++|+.||...+
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 34589999999987 46778999999999999999999999997654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-32 Score=291.08 Aligned_cols=285 Identities=26% Similarity=0.416 Sum_probs=242.9
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
..++.|+++++.++. ++ .+..+++|++|+|++|.+++..+ +..+++|++|+|++|+++. +| .+..+++|++|+|
T Consensus 44 ~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l 117 (347)
T 4fmz_A 44 ESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYL 117 (347)
T ss_dssp TTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEEC
T ss_pred ccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEEC
Confidence 467889999988874 33 48889999999999999986443 8999999999999999985 33 6899999999999
Q ss_pred cCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecccc
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN 250 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n 250 (773)
++|.+++. +. +..+++|++|++++|.....++ .+..+++|++|++++|.+++..+ +.. +++|++|++++|
T Consensus 118 ~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~-----l~~L~~L~l~~n 187 (347)
T 4fmz_A 118 NEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IAN-----LTDLYSLSLNYN 187 (347)
T ss_dssp TTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGG-----CTTCSEEECTTS
T ss_pred cCCcccCc-hh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hcc-----CCCCCEEEccCC
Confidence 99999854 44 8899999999999997664444 48899999999999999885543 333 348999999999
Q ss_pred ccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcch
Q 041878 251 LIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPE 330 (773)
Q Consensus 251 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 330 (773)
.+++..+ +..+++|+.|++++|++++..+ +..+++|++|++++|++++..+ +..+++|++|++++|++++. .
T Consensus 188 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~ 259 (347)
T 4fmz_A 188 QIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--N 259 (347)
T ss_dssp CCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--G
T ss_pred ccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--h
Confidence 9986654 8889999999999999986544 8889999999999999986554 88899999999999999774 5
Q ss_pred hhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCc
Q 041878 331 GLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVP 401 (773)
Q Consensus 331 ~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p 401 (773)
.+..+++|++|++++|++++. +.+..+++|+.|+|++|++++..|..+..+++|+.|++++|++++..|
T Consensus 260 ~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 260 AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG
T ss_pred hHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC
Confidence 688899999999999999864 458899999999999999999889999999999999999999998766
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=306.64 Aligned_cols=199 Identities=26% Similarity=0.426 Sum_probs=153.9
Q ss_pred hcccccccceEEEEEEeC---CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEEC-CCCeEEEEEeecC
Q 041878 540 AEIMGKSTYGTAYKATLE---DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG-PKGEKLLVFDFMP 615 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~~lV~e~~~ 615 (773)
+++||+|+||+||+|... +++.||||++.... ....+.+|+.++++++||||+++++++.. .....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 568999999999999865 57889999996543 34578899999999999999999999864 3557899999996
Q ss_pred CCCHHHHHhhcC------CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe----CCCCCeEEeecCCccc
Q 041878 616 KGSLASFLHARG------PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL----DEKTNPRIADFGLSRL 685 (773)
Q Consensus 616 ~g~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll----~~~~~~kl~DfG~a~~ 685 (773)
|+|.+++.... ....+++..++.++.||+.||+||| +.||+||||||+|||+ +.++.+||+|||+++.
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 181 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH-hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence 58888876431 1224889999999999999999999 9999999999999999 6778999999999987
Q ss_pred cccccc--cceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 686 MTAAAN--TNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 686 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
...... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred cCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 654322 22234568999999998876 4589999999999999999999999976543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=318.05 Aligned_cols=178 Identities=19% Similarity=0.178 Sum_probs=150.2
Q ss_pred CCcceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCC
Q 041878 82 GWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGN 161 (773)
Q Consensus 82 ~w~gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~ 161 (773)
.|.|+ |+ +++++++ .+|+.+. ++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|++
T Consensus 5 ~~~~~-c~--------~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~ 72 (549)
T 2z81_A 5 DASGV-CD--------GRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYS 72 (549)
T ss_dssp CTTSE-EE--------CTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTT
T ss_pred CCCce-EE--------CCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccc
Confidence 39888 83 4556666 5666554 79999999999999999999999999999999999999988899999
Q ss_pred CCCCCEEEccCCCCCCCCccccccccccceeecccccccc-cCCccccCCCccceeeccccccccccC-CcccccccCcc
Q 041878 162 CPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLG-SIPLSLTRLPSLSVLALQHNNLSGSVP-NNWGVLAGNKS 239 (773)
Q Consensus 162 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~~~~ 239 (773)
+++|++|+|++|.+++..|..++++++|++|+|++|++++ ..|..+.++++|++|++++|++.+.+| ..+..+.
T Consensus 73 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~---- 148 (549)
T 2z81_A 73 LGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT---- 148 (549)
T ss_dssp CTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC----
T ss_pred cccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccc----
Confidence 9999999999999998877789999999999999999987 467889999999999999999555555 4565544
Q ss_pred cccceeeccccccccccCccCCCCCCccEEECCCCcc
Q 041878 240 YQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKI 276 (773)
Q Consensus 240 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l 276 (773)
+|++|++++|.+++..|..++.+++|++|++++|.+
T Consensus 149 -~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~ 184 (549)
T 2z81_A 149 -SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184 (549)
T ss_dssp -EEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBS
T ss_pred -ccCeeeccCCcccccChhhhhccccCceEecccCcc
Confidence 899999999999998888887655555444444443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=308.62 Aligned_cols=198 Identities=22% Similarity=0.302 Sum_probs=168.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHcc------CCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKI------HHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~~l 609 (773)
|.+.++||+|+||.||+|... +++.||||+++.. .....++.+|+++++.+ +|+||+++++++. ..+..++
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~-~~~~~~l 176 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT-FRNHICM 176 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE-ETTEEEE
T ss_pred EEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc-cCCeEEE
Confidence 456789999999999999865 5889999999753 23356778888888887 4679999999994 4558999
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC--eEEeecCCccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN--PRIADFGLSRLMT 687 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~--~kl~DfG~a~~~~ 687 (773)
||||++ ++|.+++.... ...+++..+..++.||+.||+||| +.+|+||||||+|||++.++. +||+|||++....
T Consensus 177 v~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~ 253 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALH-KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH 253 (429)
T ss_dssp EECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH-HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT
T ss_pred EEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEEccCCCcceEEeecccceecC
Confidence 999995 69999998754 234899999999999999999999 899999999999999999987 9999999997543
Q ss_pred cccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 688 AAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 688 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
.. .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+..
T Consensus 254 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 254 QR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp CC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred Cc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 32 22346899999999999999999999999999999999999999776543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-33 Score=292.43 Aligned_cols=201 Identities=21% Similarity=0.381 Sum_probs=160.4
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|.. .+|+.||||++.... .....++.+|+.++++++||||+++++++.. .+..++|||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 112 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIVLE 112 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCcEEEEEe
Confidence 45678999999999999986 578999999997532 3345678899999999999999999999954 558999999
Q ss_pred ecCCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 613 FMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
|+++++|.+++.... ....++...+..++.||+.||.||| +.|++||||||+||+++.++.+||+|||++........
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH-SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh-hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence 999999999997532 2345789999999999999999999 99999999999999999999999999999876543322
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 192 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 192 -AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred -cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 122345899999999999899999999999999999999999999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-33 Score=291.10 Aligned_cols=198 Identities=27% Similarity=0.411 Sum_probs=169.4
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---------cccHHHHHHHHHHHHccC-CCceEEeEEEEECCCC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---------TKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKG 605 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 605 (773)
|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++++. ||||+++++++. ..+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-~~~ 97 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-TNT 97 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-CSS
T ss_pred cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec-cCC
Confidence 345688999999999999875 68899999996543 122456789999999996 999999999994 456
Q ss_pred eEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccc
Q 041878 606 EKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL 685 (773)
Q Consensus 606 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~ 685 (773)
..++||||+++++|.+++.... .+++..+..++.||+.||.||| +.|++||||||+||+++.++.+||+|||.+..
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 8999999999999999998753 3789999999999999999999 99999999999999999999999999999987
Q ss_pred cccccccceeeccCccccccccccC------CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 686 MTAAANTNVIATAGTLGYRAPELSK------LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...... .....+|+.|+|||++. ...++.++||||+|+++|||++|+.||...+
T Consensus 174 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 174 LDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp CCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 654322 23346899999999874 4578899999999999999999999997643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=300.83 Aligned_cols=203 Identities=23% Similarity=0.371 Sum_probs=171.5
Q ss_pred HHhhcccccccceEEEEEEeCC-C-----CEEEEEEecccCc-ccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEE
Q 041878 537 CATAEIMGKSTYGTAYKATLED-G-----SEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~-g-----~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 608 (773)
|.+.+.||+|+||.||+|.... + ..||+|.+..... ...+.+.+|+.+++++ +||||+++++++ ...+..+
T Consensus 48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-~~~~~~~ 126 (333)
T 2i1m_A 48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC-THGGPVL 126 (333)
T ss_dssp EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSCE
T ss_pred ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE-ecCCceE
Confidence 4567899999999999998642 2 4799999976533 3456789999999999 899999999999 5556899
Q ss_pred EEEeecCCCCHHHHHhhcCC-----------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEE
Q 041878 609 LVFDFMPKGSLASFLHARGP-----------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRI 677 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl 677 (773)
+||||+++|+|.+++..... ...+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||
T Consensus 127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~NIl~~~~~~~kl 205 (333)
T 2i1m_A 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLTNGHVAKI 205 (333)
T ss_dssp EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGCEEEGGGEEEB
T ss_pred EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh-cCCcccCCcccceEEECCCCeEEE
Confidence 99999999999999976421 234789999999999999999999 899999999999999999999999
Q ss_pred eecCCccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 678 ADFGLSRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 678 ~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
+|||++.......... .....+|+.|+|||.+.+..++.++|||||||++|||+| |..||....
T Consensus 206 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 206 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp CCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred CccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 9999998665433222 223346789999999988899999999999999999999 999997654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.10 Aligned_cols=203 Identities=26% Similarity=0.388 Sum_probs=166.9
Q ss_pred HHhhcccccccceEEEEEEe------CCCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL------EDGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
|.+.+.||+|+||.||+|.+ .++..||||.+.... .....++.+|+.++++++||||+++++++ ...+..++
T Consensus 32 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~l 110 (327)
T 2yfx_A 32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS-LQSLPRFI 110 (327)
T ss_dssp CEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSCEE
T ss_pred eEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE-cCCCCcEE
Confidence 45678999999999999984 256789999997543 34456789999999999999999999999 45558899
Q ss_pred EEeecCCCCHHHHHhhcCC----CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC---CCeEEeecCC
Q 041878 610 VFDFMPKGSLASFLHARGP----ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK---TNPRIADFGL 682 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~---~~~kl~DfG~ 682 (773)
||||+++++|.+++..... ...+++..++.++.||+.||.||| +.||+||||||+||+++.+ ..+||+|||+
T Consensus 111 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~ 189 (327)
T 2yfx_A 111 LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGM 189 (327)
T ss_dssp EEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred EEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh-hCCeecCcCCHhHEEEecCCCcceEEECcccc
Confidence 9999999999999987642 244889999999999999999999 9999999999999999944 4599999999
Q ss_pred cccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 683 SRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 683 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
+......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 250 (327)
T 2yfx_A 190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS 250 (327)
T ss_dssp HHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC
Confidence 8765433221 2223457889999999988899999999999999999998 999997644
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=290.29 Aligned_cols=197 Identities=18% Similarity=0.305 Sum_probs=166.1
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
.|.+.+.||+|+||+||+|... +++.||+|+++.. ......++.+|+..+.++ +||||+++++++. ..+..++||
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-~~~~~~lv~ 90 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-EDDHMLIQN 90 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-ETTEEEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-cCCeEEEEE
Confidence 3556789999999999999875 7899999999754 233456788999999999 8999999999994 455899999
Q ss_pred eecCCCCHHHHHhhcCC-CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC------------------
Q 041878 612 DFMPKGSLASFLHARGP-ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK------------------ 672 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~------------------ 672 (773)
||+++++|.+++..... ...+++..+..++.||+.||+||| +.||+||||||+||+++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEC--------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH-hCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 99999999999986521 234789999999999999999999 9999999999999999844
Q ss_pred -CCeEEeecCCccccccccccceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 673 -TNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 673 -~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
..+||+|||.+....... ...||+.|+|||.+.+. .+++++|||||||++|||++|..|+..
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred ceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 479999999988765432 23489999999998765 567899999999999999999987643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-33 Score=294.90 Aligned_cols=199 Identities=25% Similarity=0.383 Sum_probs=165.1
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc--------ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCe
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT--------KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGE 606 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 606 (773)
.|.+.+.||+|+||.||+|... +++.||||.+..... .....+.+|++++++++||||+++++++.. . .
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-~ 88 (322)
T 2ycf_A 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E-D 88 (322)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-S-S
T ss_pred ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-C-c
Confidence 3566789999999999999865 578999999864321 123458899999999999999999999853 3 4
Q ss_pred EEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC---eEEeecCCc
Q 041878 607 KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN---PRIADFGLS 683 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~---~kl~DfG~a 683 (773)
.++||||+++++|.+++.... .+++..+..++.||+.||.||| +.||+||||||+||+++.++. +||+|||++
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 899999999999999987643 4789999999999999999999 999999999999999987665 999999999
Q ss_pred cccccccccceeeccCcccccccccc---CCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 684 RLMTAAANTNVIATAGTLGYRAPELS---KLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
+....... .....||+.|+|||++ ....++.++|||||||++|||++|+.||.....
T Consensus 165 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 165 KILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp EECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred eecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 87643321 1234589999999986 356789999999999999999999999986543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-33 Score=291.45 Aligned_cols=195 Identities=25% Similarity=0.471 Sum_probs=168.2
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEEC------------
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG------------ 602 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------------ 602 (773)
.|...+.||+|+||.||+|... +++.||+|++.... ..+.+|++++++++||||+++++++..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence 3456789999999999999875 78999999997543 356789999999999999999998743
Q ss_pred ---CCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEee
Q 041878 603 ---PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIAD 679 (773)
Q Consensus 603 ---~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~D 679 (773)
.....++||||+++++|.+++.... ...+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIH-SKKLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETTEEEECC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCHHHEEEcCCCCEEECc
Confidence 1235789999999999999997653 234889999999999999999999 89999999999999999999999999
Q ss_pred cCCccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 041878 680 FGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGE 738 (773)
Q Consensus 680 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~ 738 (773)
||++........ .....+|+.|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 166 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 166 FGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp CTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred chhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 999987654322 223458999999999998899999999999999999999998864
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=315.67 Aligned_cols=296 Identities=18% Similarity=0.166 Sum_probs=249.5
Q ss_pred cCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccce
Q 041878 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYR 191 (773)
Q Consensus 112 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 191 (773)
..+++++.|++++|.++...+..+..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++
T Consensus 48 l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 127 (597)
T 3oja_B 48 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 127 (597)
T ss_dssp GGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCE
Confidence 35789999999999999776667899999999999999999888889999999999999999999888888999999999
Q ss_pred eecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEEC
Q 041878 192 LNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISL 271 (773)
Q Consensus 192 L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 271 (773)
|+|++|.+++..+..|.++++|++|+|++|.+++..|..++.+. +|++|+|++|.+++.... .+++|+.|++
T Consensus 128 L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-----~L~~L~L~~N~l~~~~~~---~l~~L~~L~l 199 (597)
T 3oja_B 128 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT-----SLQNLQLSSNRLTHVDLS---LIPSLFHANV 199 (597)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCT-----TCCEEECTTSCCSBCCGG---GCTTCSEEEC
T ss_pred EEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCC-----cCcEEECcCCCCCCcChh---hhhhhhhhhc
Confidence 99999999977777789999999999999999988887777655 899999999999976433 3445555555
Q ss_pred CCCcccCC------------------CCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhc
Q 041878 272 SHNKIVGP------------------IPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLE 333 (773)
Q Consensus 272 ~~N~l~~~------------------~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~ 333 (773)
++|.+++. ++..+ .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..+.
T Consensus 200 ~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 275 (597)
T 3oja_B 200 SYNLLSTLAIPIAVEELDASHNSINVVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFV 275 (597)
T ss_dssp CSSCCSEEECCTTCSEEECCSSCCCEEECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred ccCccccccCCchhheeeccCCccccccccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhc
Confidence 55544431 11111 2578999999999986 46788999999999999999999999999
Q ss_pred cccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCchhhhccCCCCCC
Q 041878 334 RLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSF 413 (773)
Q Consensus 334 ~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~~~~~~~~~~~ 413 (773)
.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|++++..+..+ ..+....+
T Consensus 276 ~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~L~~L~l 352 (597)
T 3oja_B 276 KMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTH-HTLKNLTL 352 (597)
T ss_dssp TCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTT-CCCSEEEC
T ss_pred CccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcChhhc-CCCCEEEe
Confidence 99999999999999996 5777888999999999999999 688889999999999999999987543333 44555567
Q ss_pred CCCCCCCCC
Q 041878 414 VGNLQLCGY 422 (773)
Q Consensus 414 ~~n~~~c~~ 422 (773)
.+|+..|.+
T Consensus 353 ~~N~~~~~~ 361 (597)
T 3oja_B 353 SHNDWDCNS 361 (597)
T ss_dssp CSSCEEHHH
T ss_pred eCCCCCChh
Confidence 788777654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.20 Aligned_cols=201 Identities=28% Similarity=0.511 Sum_probs=166.4
Q ss_pred HHhhcccccccceEEEEEEeC-CCCE--EEEEEecccC-cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSE--VAVKRLREKT-TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~--vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
|.+.+.||+|+||.||+|... ++.. ||+|.++... ....+.+.+|+++++++ +||||+++++++. ..+..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-~~~~~~lv~ 105 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-HRGYLYLAI 105 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-ETTEEEEEE
T ss_pred ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-eCCceEEEE
Confidence 456789999999999999864 5554 4999987542 33456789999999999 8999999999994 455899999
Q ss_pred eecCCCCHHHHHhhcC-------------CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEe
Q 041878 612 DFMPKGSLASFLHARG-------------PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIA 678 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~ 678 (773)
||+++|+|.+++.... ....+++..++.++.||+.||+||| +.||+||||||+||+++.++.+||+
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIl~~~~~~~kL~ 184 (327)
T 1fvr_A 106 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIA 184 (327)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECGGGCEEEC
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCccceEEEcCCCeEEEc
Confidence 9999999999998653 1235899999999999999999999 9999999999999999999999999
Q ss_pred ecCCccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 679 DFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 679 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
|||+++...... ......+++.|+|||.+....++.++||||+||++|||+| |+.||...+
T Consensus 185 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 185 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp CTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 999987543222 1223347889999999988889999999999999999998 999997644
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=300.16 Aligned_cols=199 Identities=19% Similarity=0.343 Sum_probs=170.6
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCccc-----------------HHHHHHHHHHHHccCCCceEEeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKG-----------------QKEFEAEAAAIGKIHHPNLLALRAY 599 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l~~~ 599 (773)
|.+.+.||+|+||.||+|.. +|+.||||.+....... .+.+.+|++++++++||||++++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 111 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEE
T ss_pred eEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 45678999999999999998 89999999996432211 1789999999999999999999999
Q ss_pred EECCCCeEEEEEeecCCCCHHHH------HhhcCCCCccCHHHHHHHHHHHHHHHHHhccC-CCceecCCCCCCEEeCCC
Q 041878 600 YLGPKGEKLLVFDFMPKGSLASF------LHARGPETIVNWATRMSIAIGIARGLNYLHVE-ENMIHGNLTSSNVLLDEK 672 (773)
Q Consensus 600 ~~~~~~~~~lV~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~-~~iiH~Dik~~NIll~~~ 672 (773)
+.. .+..++||||+++|+|.++ +.... ...+++..+..++.||+.||.||| + .||+||||||+||+++.+
T Consensus 112 ~~~-~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH-~~~~i~H~dl~p~Nil~~~~ 188 (348)
T 2pml_X 112 ITN-YDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIH-NEKNICHRDVKPSNILMDKN 188 (348)
T ss_dssp EES-SSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHH-HTSCEECCCCCGGGEEECTT
T ss_pred Eee-CCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHh-ccCCEeecCCChHhEEEcCC
Confidence 954 4589999999999999998 54421 345899999999999999999999 7 999999999999999999
Q ss_pred CCeEEeecCCccccccccccceeeccCccccccccccCCC-CCCc-chhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 673 TNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLK-NANT-KTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 673 ~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
+.+||+|||.+...... ......||+.|+|||.+.+. .++. ++||||+|+++|||++|+.||.....
T Consensus 189 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 189 GRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp SCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred CcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999875433 23345689999999998877 6666 99999999999999999999986543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=299.68 Aligned_cols=193 Identities=32% Similarity=0.516 Sum_probs=156.3
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHH--HHHccCCCceEEeEEEEEC----CCCeEEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAA--AIGKIHHPNLLALRAYYLG----PKGEKLLVF 611 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~--~l~~l~h~niv~l~~~~~~----~~~~~~lV~ 611 (773)
.+.+.||+|+||.||+|+. +++.||||++.... ...+..|.+ .+..++|+||+++++.+.. .....++||
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 16 KLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred heeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 4568999999999999987 58999999996432 333444444 4556899999999976532 223568999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCC---------CceecCCCCCCEEeCCCCCeEEeecCC
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE---------NMIHGNLTSSNVLLDEKTNPRIADFGL 682 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~---------~iiH~Dik~~NIll~~~~~~kl~DfG~ 682 (773)
||+++|+|.++++... .++..+..++.||+.||+||| +. ||+||||||+|||++.++.+||+|||+
T Consensus 92 e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH-~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~ 166 (336)
T 3g2f_A 92 EYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLH-TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166 (336)
T ss_dssp CCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHH-CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred ecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHH-hhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence 9999999999998753 488899999999999999999 77 999999999999999999999999999
Q ss_pred ccccccccc-------cceeeccCccccccccccCC-------CCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 683 SRLMTAAAN-------TNVIATAGTLGYRAPELSKL-------KNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 683 a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 987653221 11223469999999999876 4567789999999999999999887654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-32 Score=291.01 Aligned_cols=198 Identities=25% Similarity=0.444 Sum_probs=168.3
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.+.||+|+||.||+|... +|+.||+|.+.... ...++.+|+.++++++||||+++++++.. .+..++||||++
T Consensus 31 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~ 107 (314)
T 3com_A 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK-NTDLWIVMEYCG 107 (314)
T ss_dssp EEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCT
T ss_pred hhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEeecCC
Confidence 345788999999999999875 58999999997543 45678999999999999999999999954 558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+++|.+++.... ..+++..+..++.||+.||.||| +.|++||||||+||+++.++.+||+|||.+........ ...
T Consensus 108 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~ 183 (314)
T 3com_A 108 AGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLH-FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRN 183 (314)
T ss_dssp TEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CBC
T ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-ccC
Confidence 999999997542 34789999999999999999999 99999999999999999999999999999976643322 223
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||...+
T Consensus 184 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 3468999999999998899999999999999999999999997643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=298.37 Aligned_cols=200 Identities=23% Similarity=0.442 Sum_probs=171.6
Q ss_pred HHhhcccccccceEEEEEEe-----CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCC-CeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-----EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-GEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-----~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~~lV 610 (773)
+.+.+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++.... ...++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 45678999999999999984 368899999998766666778999999999999999999999985433 367999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||+++++|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++.......
T Consensus 123 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp ECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred EECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH-hCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 99999999999998753 34789999999999999999999 9999999999999999999999999999998765433
Q ss_pred ccc--eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 691 NTN--VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 691 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
... .....++..|+|||.+.+..++.++||||||+++|||+||+.||..
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 211 1223467789999999888899999999999999999999998763
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6e-33 Score=295.06 Aligned_cols=200 Identities=24% Similarity=0.330 Sum_probs=162.1
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEEC-------------
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG------------- 602 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------------- 602 (773)
|.+.+.||+|+||.||+|... +++.||+|++........+++.+|++++++++||||+++++++..
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 92 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92 (320)
T ss_dssp EEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence 345688999999999999876 588999999987666667789999999999999999999998742
Q ss_pred CCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeC-CCCCeEEeecC
Q 041878 603 PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLD-EKTNPRIADFG 681 (773)
Q Consensus 603 ~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~-~~~~~kl~DfG 681 (773)
.....++||||++ |+|.++++.. .++...+..++.||+.||+||| +.||+||||||+||+++ +++.+||+|||
T Consensus 93 ~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 93 ELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp SCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred ccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence 2347799999997 6999998753 3788999999999999999999 99999999999999997 56789999999
Q ss_pred Cccccccccc--cceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 682 LSRLMTAAAN--TNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 682 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
+++....... .......+|+.|+|||.+.. ..++.++|||||||++|||++|+.||...+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 9987643221 11223457899999998754 6789999999999999999999999986553
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=290.22 Aligned_cols=201 Identities=21% Similarity=0.388 Sum_probs=167.9
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccC----cccHHHHHHHHHHHHccCCCceEEeEEEEECC-CCeEEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT----TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-KGEKLLVF 611 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV~ 611 (773)
.+.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++... ....++||
T Consensus 8 ~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (305)
T 2wtk_C 8 LMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVM 87 (305)
T ss_dssp CCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEE
T ss_pred eEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEe
Confidence 45688999999999999864 68899999997542 23467899999999999999999999998543 44789999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||++++ |.+++.... ...+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||.+........
T Consensus 88 e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH-~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~ 164 (305)
T 2wtk_C 88 EYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLH-SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164 (305)
T ss_dssp ECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCS
T ss_pred hhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCcccEEEcCCCcEEeeccccccccCcccc
Confidence 999876 878777643 345899999999999999999999 99999999999999999999999999999987653322
Q ss_pred -cceeeccCccccccccccCCCC--CCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 -TNVIATAGTLGYRAPELSKLKN--ANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 -~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.......||+.|+|||++.+.. ++.++||||+|+++|||++|+.||...+
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 2223456899999999887644 3789999999999999999999997643
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=294.09 Aligned_cols=201 Identities=26% Similarity=0.425 Sum_probs=164.5
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEECC-----CCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGP-----KGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-----~~~~~l 609 (773)
|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.+++++ +||||+++++++... .+..++
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 34578999999999999986 478999999996543 3457889999999999 799999999999653 457899
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||+++|+|.+++.... ...++...+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLH-QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp EEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred EEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 999999999999998753 234788999999999999999999 899999999999999999999999999998765432
Q ss_pred cccceeeccCccccccccccC-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSK-----LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. ......||+.|+|||++. ...++.++|||||||++|||++|+.||...+
T Consensus 183 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 183 VG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 21 122346899999999886 5678999999999999999999999997643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=287.24 Aligned_cols=198 Identities=27% Similarity=0.403 Sum_probs=169.3
Q ss_pred HHHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 536 LCATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
+|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++. ..+..++|||
T Consensus 23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e 101 (287)
T 2wei_A 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-DSSSFYIVGE 101 (287)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEEC
T ss_pred cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-CCCeEEEEEE
Confidence 3556789999999999999875 78999999986542 345678999999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC---CCeEEeecCCccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK---TNPRIADFGLSRLMTAA 689 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~---~~~kl~DfG~a~~~~~~ 689 (773)
|+++++|.+++.... .+++..+..++.||+.||.||| +.||+||||||+||+++.+ +.+||+|||++......
T Consensus 102 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 102 LYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 999999999987653 3789999999999999999999 9999999999999999764 46999999998865433
Q ss_pred cccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. .....+|+.|+|||.+.+ .++.++||||+|+++|||++|+.||...+
T Consensus 178 ~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 178 TK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp SS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred Cc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 22 223347899999998875 48999999999999999999999997654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-33 Score=296.46 Aligned_cols=203 Identities=26% Similarity=0.440 Sum_probs=153.0
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.+.||+|+||.||+|... +++.||||++.... ....+++.+|+.++++++||||+++++++.. .+..++||||+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~ 95 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-KDELWLVMKLL 95 (303)
T ss_dssp CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-SSCEEEEEECC
T ss_pred hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-cCCcEEEehhc
Confidence 346789999999999999864 68999999986543 3345678899999999999999999999954 45899999999
Q ss_pred CCCCHHHHHhhc-----CCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 615 PKGSLASFLHAR-----GPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 615 ~~g~L~~~l~~~-----~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
++++|.+++... .....+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||.+......
T Consensus 96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 174 (303)
T 2vwi_A 96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG 174 (303)
T ss_dssp TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence 999999998752 12345899999999999999999999 899999999999999999999999999998765433
Q ss_pred cc----cceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 690 AN----TNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 690 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. .......||+.|+|||.+.. ..++.++||||+|+++|||++|+.||...+
T Consensus 175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 231 (303)
T 2vwi_A 175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYP 231 (303)
T ss_dssp -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCc
Confidence 21 11223468999999998865 568999999999999999999999997644
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.2e-32 Score=289.94 Aligned_cols=281 Identities=26% Similarity=0.365 Sum_probs=245.1
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
.+++.|+|+++.+++. ++ +.++++|++|+|++|.+++. +.+..+++|++|+|++|++++..+ +..+++|++|++
T Consensus 66 ~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l 139 (347)
T 4fmz_A 66 TNLEYLNLNGNQITDI-SP-LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNL 139 (347)
T ss_dssp TTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEEC
T ss_pred CCccEEEccCCccccc-hh-hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEECcCCcccCchh--hccCCceeEEEC
Confidence 4789999999999864 33 99999999999999999863 469999999999999999996543 899999999999
Q ss_pred cCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecccc
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN 250 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n 250 (773)
++|.....+ ..+..+++|++|++++|.+.+..+ +..+++|++|++++|++++..+ +.. +++|+.|++++|
T Consensus 140 ~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~-----l~~L~~L~l~~n 209 (347)
T 4fmz_A 140 GANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LAS-----LTSLHYFTAYVN 209 (347)
T ss_dssp TTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGG-----CTTCCEEECCSS
T ss_pred CCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccC-----CCccceeecccC
Confidence 999776554 448999999999999999986544 8899999999999999985433 333 348999999999
Q ss_pred ccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcch
Q 041878 251 LIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPE 330 (773)
Q Consensus 251 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 330 (773)
.+++..+ +..+++|++|++++|++++..+ +..+++|++|++++|.+++. ..+..+++|++|++++|++++. .
T Consensus 210 ~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~ 281 (347)
T 4fmz_A 210 QITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--S 281 (347)
T ss_dssp CCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--G
T ss_pred CCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--h
Confidence 9997665 8899999999999999996544 89999999999999999864 4688999999999999999875 4
Q ss_pred hhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCC
Q 041878 331 GLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLS 397 (773)
Q Consensus 331 ~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~ 397 (773)
.+..+++|+.|++++|++++..+..++.+++|++|+|++|++++..| +..+++|+.|++++|+++
T Consensus 282 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 282 VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 68899999999999999999999999999999999999999997666 889999999999999985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=293.49 Aligned_cols=201 Identities=27% Similarity=0.406 Sum_probs=168.4
Q ss_pred HHhhcccccccceEEEEEEe--CCCCEEEEEEecccCc--ccHHHHHHHHHHHHcc---CCCceEEeEEEEEC----CCC
Q 041878 537 CATAEIMGKSTYGTAYKATL--EDGSEVAVKRLREKTT--KGQKEFEAEAAAIGKI---HHPNLLALRAYYLG----PKG 605 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~--~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----~~~ 605 (773)
|.+.+.||+|+||.||+|.. .+|+.||+|+++.... .....+.+|+.+++++ +||||+++++++.. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 45678999999999999987 4678899999865322 2234566777777766 89999999999852 344
Q ss_pred eEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccc
Q 041878 606 EKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL 685 (773)
Q Consensus 606 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~ 685 (773)
..++||||++ |+|.+++.... ...+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH-~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred eEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 7899999997 69999998754 234789999999999999999999 99999999999999999999999999999986
Q ss_pred cccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 686 MTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
..... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 170 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 170 YSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp CCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 64332 22334689999999999988999999999999999999999999976554
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.98 E-value=9.6e-33 Score=299.79 Aligned_cols=195 Identities=26% Similarity=0.388 Sum_probs=162.7
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCC-----eEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG-----EKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~~ 608 (773)
|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++||||+++++++..... ..+
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 123 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence 456788999999999999864 688999999975432 235678899999999999999999999954332 239
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||++ ++|.+++.. .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 124 lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIH-SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp EEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred EEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH-HCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 9999997 688887743 2789999999999999999999 89999999999999999999999999999976543
Q ss_pred ccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
. .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.
T Consensus 197 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 247 (371)
T 4exu_A 197 E----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 247 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred C----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 2 233468999999998876 7889999999999999999999999976553
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-33 Score=322.08 Aligned_cols=202 Identities=22% Similarity=0.395 Sum_probs=168.4
Q ss_pred HHHHhhcccccccceEEEEEEeCC----CCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 535 LLCATAEIMGKSTYGTAYKATLED----GSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
-.+.+.+.||+|+||.||+|.+.. +..||||.++.... ...+.+.+|+.++++++||||+++++++ .. +..++
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~-~~~~l 467 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE-NPVWI 467 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CS-SSCEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-ec-CceEE
Confidence 345677899999999999998642 45799999875433 3346799999999999999999999998 33 46899
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||+++|+|.++++... ..+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH-hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 999999999999998653 34789999999999999999999 899999999999999999999999999999876544
Q ss_pred cccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
.........+|+.|+|||.+....++.++|||||||++|||++ |..||.+.+
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 597 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597 (656)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 4333334457889999999988899999999999999999997 999997654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=294.86 Aligned_cols=206 Identities=19% Similarity=0.328 Sum_probs=172.1
Q ss_pred HHhhcccccccceEEEEEEe--CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCc------eEEeEEEEECCCCeEE
Q 041878 537 CATAEIMGKSTYGTAYKATL--EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPN------LLALRAYYLGPKGEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~--~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~~ 608 (773)
|.+.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+++++.++|++ ++++++++. ..+..+
T Consensus 16 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~-~~~~~~ 93 (339)
T 1z57_A 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE-HHGHIC 93 (339)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE-ETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc-cCCcEE
Confidence 45678999999999999986 36789999999643 234567889999999987664 999999984 455899
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-----------------
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE----------------- 671 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~----------------- 671 (773)
+||||+ +++|.+++.... ...+++..+..++.||+.||+||| +.||+||||||+||+++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLH-SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHH-HCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 999999 899999998764 234789999999999999999999 999999999999999987
Q ss_pred --CCCeEEeecCCccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHH
Q 041878 672 --KTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWV 749 (773)
Q Consensus 672 --~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~ 749 (773)
++.+||+|||+++...... ....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 246 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMM 246 (339)
T ss_dssp ESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHH
T ss_pred ccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 6689999999997643322 2346899999999999899999999999999999999999999876654444433
Q ss_pred HH
Q 041878 750 AS 751 (773)
Q Consensus 750 ~~ 751 (773)
.+
T Consensus 247 ~~ 248 (339)
T 1z57_A 247 ER 248 (339)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=300.85 Aligned_cols=201 Identities=20% Similarity=0.257 Sum_probs=169.2
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccC--------CCceEEeEEEEEC---CC
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH--------HPNLLALRAYYLG---PK 604 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~---~~ 604 (773)
|.+.++||+|+||+||+|.. .+++.||||+++.. ....+.+.+|++++++++ |+||+++++++.. ..
T Consensus 39 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~ 117 (397)
T 1wak_A 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNG 117 (397)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTE
T ss_pred EEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCC
Confidence 56678999999999999986 46889999999643 334567889999999996 7889999999852 34
Q ss_pred CeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCC-CceecCCCCCCEEeCCCC----------
Q 041878 605 GEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE-NMIHGNLTSSNVLLDEKT---------- 673 (773)
Q Consensus 605 ~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~-~iiH~Dik~~NIll~~~~---------- 673 (773)
...++||||+ ++++.+++.... ...+++..++.++.||+.||+||| ++ ||+||||||+|||++.++
T Consensus 118 ~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH-~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 118 THICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLH-TKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHH-HTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred ceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH-HhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 4789999999 667777766543 244899999999999999999999 77 999999999999999775
Q ss_pred ---------------------------------------CeEEeecCCccccccccccceeeccCccccccccccCCCCC
Q 041878 674 ---------------------------------------NPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNA 714 (773)
Q Consensus 674 ---------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 714 (773)
.+||+|||.+...... .....||+.|+|||++.+..+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTSCC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCCCC
Confidence 7999999999876433 223468999999999998899
Q ss_pred CcchhhHHHHHHHHHHHcCCCCCCCCCCCCh
Q 041878 715 NTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745 (773)
Q Consensus 715 ~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~ 745 (773)
+.++|||||||++|||+||+.||...+..+.
T Consensus 271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~ 301 (397)
T 1wak_A 271 NTPADIWSTACMAFELATGDYLFEPHSGEEY 301 (397)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSS
T ss_pred CcHHHHHHHHHHHHHHhhCCCCCCCCccccc
Confidence 9999999999999999999999988765543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.5e-32 Score=292.19 Aligned_cols=198 Identities=27% Similarity=0.407 Sum_probs=166.9
Q ss_pred HHHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHc--cCCCceEEeEEEEECCC---CeEEEE
Q 041878 536 LCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGK--IHHPNLLALRAYYLGPK---GEKLLV 610 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---~~~~lV 610 (773)
.|.+.+.||+|+||.||+|... |+.||||++... ....+.+|+++++. ++||||+++++++.... ...++|
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 118 (342)
T 1b6c_B 43 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118 (342)
T ss_dssp HCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred cEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence 4556789999999999999874 899999999643 35677888888887 78999999999996554 278999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhcc-------CCCceecCCCCCCEEeCCCCCeEEeecCCc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV-------EENMIHGNLTSSNVLLDEKTNPRIADFGLS 683 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~-------~~~iiH~Dik~~NIll~~~~~~kl~DfG~a 683 (773)
|||+++|+|.+++.+. .+++..++.++.|++.||+|||. +.+|+||||||+||+++.++.+||+|||++
T Consensus 119 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp ECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 9999999999999864 37899999999999999999994 578999999999999999999999999999
Q ss_pred ccccccccc---ceeeccCccccccccccCCC------CCCcchhhHHHHHHHHHHHcC----------CCCCCCCC
Q 041878 684 RLMTAAANT---NVIATAGTLGYRAPELSKLK------NANTKTDVYSLGVIILELLTG----------KSPGEPMN 741 (773)
Q Consensus 684 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dvws~Gv~l~el~tg----------~~P~~~~~ 741 (773)
......... ......||+.|+|||++.+. .++.++|||||||++|||+|| ..||....
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 876544322 12334689999999988765 234689999999999999999 78887643
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-31 Score=300.50 Aligned_cols=282 Identities=30% Similarity=0.454 Sum_probs=153.4
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
.+++.|+|++|.+++..+ +.++++|++|+|++|.+++..+ ++.+++|++|+|++|++++..+ +.++++|++|+|
T Consensus 68 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l 141 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLEL 141 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEE
T ss_pred cCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEEC
Confidence 357777888777775443 7777888888888887775544 7777888888888887775433 777777888888
Q ss_pred cCCCCCCCCccccccccc---------------------cceeecccccccccCCccccCCCccceeeccccccccccCC
Q 041878 171 SNNALIGAIPPSLANSTR---------------------LYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~---------------------L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~ 229 (773)
++|.+++ ++ .+..+++ |++|++++|.+++. ..+..+++|++|++++|++++..|
T Consensus 142 ~~n~l~~-~~-~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~- 216 (466)
T 1o6v_A 142 SSNTISD-IS-ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP- 216 (466)
T ss_dssp EEEEECC-CG-GGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-
T ss_pred CCCccCC-Ch-hhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc-
Confidence 7777764 22 2444444 44444444444321 123344444444444444443322
Q ss_pred cccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCccccc
Q 041878 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFT 309 (773)
Q Consensus 230 ~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 309 (773)
++. +++|+.|++++|.+++. ..+..+++|+.|++++|++++..+ +..+++|++|++++|.+++..+ +.
T Consensus 217 -~~~-----l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~ 284 (466)
T 1o6v_A 217 -LGI-----LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LA 284 (466)
T ss_dssp -GGG-----CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GT
T ss_pred -ccc-----cCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--cc
Confidence 111 12444555555544432 234444555555555555544322 4455555555555555553332 44
Q ss_pred ccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEE
Q 041878 310 NITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSF 389 (773)
Q Consensus 310 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 389 (773)
.+++|+.|++++|++++..+ +..+++|+.|++++|++++..| +..+++|+.|++++|++++. ..+..+++|+.|
T Consensus 285 ~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 358 (466)
T 1o6v_A 285 GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWL 358 (466)
T ss_dssp TCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEE
T ss_pred CCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEE
Confidence 55555555555555544333 4455555555555555554433 44555555555555555543 345555555555
Q ss_pred EeecccCCCCCc
Q 041878 390 NVSYNNLSGSVP 401 (773)
Q Consensus 390 ~ls~N~l~g~~p 401 (773)
++++|++++..|
T Consensus 359 ~l~~n~l~~~~~ 370 (466)
T 1o6v_A 359 SAGHNQISDLTP 370 (466)
T ss_dssp ECCSSCCCBCGG
T ss_pred eCCCCccCccch
Confidence 555555555444
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=296.18 Aligned_cols=198 Identities=22% Similarity=0.339 Sum_probs=166.2
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECC----CCeEEEEE
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGP----KGEKLLVF 611 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~~lV~ 611 (773)
.+.+.||+|+||.||+|... +|+.||||++..... ....++.+|++++++++||||+++++++... ....++||
T Consensus 14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 93 (353)
T 2b9h_A 14 QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ 93 (353)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred EEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence 45688999999999999865 688999999975432 3356788999999999999999999988543 25789999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||++ ++|.+++... .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++.......
T Consensus 94 e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH-~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 94 ELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLH-GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp CCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred eccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 9996 6999998763 3789999999999999999999 99999999999999999999999999999987653221
Q ss_pred c---------ceeeccCccccccccccC-CCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 692 T---------NVIATAGTLGYRAPELSK-LKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 692 ~---------~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
. ......||+.|+|||++. ...++.++||||+||++|||++|+.||.+.+
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 112346899999999765 4778999999999999999999999997655
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.98 E-value=9.7e-33 Score=289.18 Aligned_cols=198 Identities=24% Similarity=0.386 Sum_probs=152.6
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcc-cH-HHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTK-GQ-KEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~-~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|.+.+.||+|+||.||+|.. .+|+.||||+++..... .. ..+.++...++.++||||+++++++. ..+..++||||
T Consensus 9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-~~~~~~lv~e~ 87 (290)
T 3fme_A 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-REGDVWICMEL 87 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSSEEEEEEC
T ss_pred hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-ccCCEEEEEeh
Confidence 45678999999999999986 47889999999754322 22 33445555688889999999999995 45589999999
Q ss_pred cCCCCHHHHHhhc-CCCCccCHHHHHHHHHHHHHHHHHhccCC-CceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 614 MPKGSLASFLHAR-GPETIVNWATRMSIAIGIARGLNYLHVEE-NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 614 ~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~al~yLH~~~-~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
++ |+|.+++... .....+++..+..++.|++.||+||| +. ||+||||||+||+++.++.+||+|||++........
T Consensus 88 ~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 88 MD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165 (290)
T ss_dssp CS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HHSCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred hc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh-hcCCeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence 97 5888887652 12345899999999999999999999 76 999999999999999999999999999987654322
Q ss_pred cceeeccCcccccccccc----CCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELS----KLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
. ....||+.|+|||.+ ....++.++||||+||++|||++|+.||..
T Consensus 166 ~--~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 166 K--DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred c--cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 2 233589999999985 566789999999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.6e-33 Score=291.79 Aligned_cols=200 Identities=27% Similarity=0.419 Sum_probs=160.5
Q ss_pred HHhhcccccccceEEEEEEeC--CCC--EEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE--DGS--EVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~--~g~--~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
|.+.+.||+|+||+||+|.+. +++ .||||+++... ....+++.+|++++++++||||+++++++.. . ..++
T Consensus 20 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-~~~~ 97 (291)
T 1u46_A 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P-PMKM 97 (291)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-SCEE
T ss_pred eeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc-C-Ccee
Confidence 456789999999999999853 333 68999987542 3345788999999999999999999999853 3 4889
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
|+||+++++|.+++.... ..+++..+..++.||+.||.||| +.||+||||||+||+++.++.+||+|||++......
T Consensus 98 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLE-SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHH-hCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 999999999999998752 34789999999999999999999 999999999999999999999999999999876543
Q ss_pred cccc--eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 690 ANTN--VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 690 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
.... .....+|+.|+|||.+....++.++||||||+++|||++ |+.||...+
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 229 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC
Confidence 3221 223457889999999988889999999999999999999 999997654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=296.20 Aligned_cols=199 Identities=23% Similarity=0.325 Sum_probs=166.7
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccC-CC-----ceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HP-----NLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~~l 609 (773)
|.+.++||+|+||+||+|... +++.||||+++.. .....++..|+.+++.++ |+ +++++++++.. .+..++
T Consensus 56 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-~~~~~l 133 (382)
T 2vx3_A 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-RNHLCL 133 (382)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-TTEEEE
T ss_pred EEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-CCceEE
Confidence 456789999999999999865 6788999999743 233567788999998885 55 49999999854 458999
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCceecCCCCCCEEeC--CCCCeEEeecCCcccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV-EENMIHGNLTSSNVLLD--EKTNPRIADFGLSRLM 686 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~-~~~iiH~Dik~~NIll~--~~~~~kl~DfG~a~~~ 686 (773)
||||++ |+|.+++..... ..+++..+..++.||+.||.|||. +.||+||||||+|||++ .++.+||+|||+++..
T Consensus 134 v~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 999996 599999987542 348999999999999999999994 47999999999999995 4778999999999876
Q ss_pred ccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 687 TAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+..
T Consensus 212 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 212 GQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp TCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 432 22346899999999999999999999999999999999999999876543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=295.47 Aligned_cols=202 Identities=22% Similarity=0.346 Sum_probs=153.7
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCC------eEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG------EKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~~l 609 (773)
|.+.+.||+|+||.||+|... +|+.||||++..... ....+.+|++.++.++||||+++++++..... ..++
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l 103 (360)
T 3e3p_A 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV 103 (360)
T ss_dssp EEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence 445788999999999999874 689999999865432 23456778888999999999999999854321 2789
Q ss_pred EEeecCCCCHHHHHhh-cCCCCccCHHHHHHHHHHHHHHHHHhcc-CCCceecCCCCCCEEeCC-CCCeEEeecCCcccc
Q 041878 610 VFDFMPKGSLASFLHA-RGPETIVNWATRMSIAIGIARGLNYLHV-EENMIHGNLTSSNVLLDE-KTNPRIADFGLSRLM 686 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~al~yLH~-~~~iiH~Dik~~NIll~~-~~~~kl~DfG~a~~~ 686 (773)
||||+++ +|.+.+.. ......+++..+..++.|++.|+.|||. +.||+||||||+|||++. ++.+||+|||+++..
T Consensus 104 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~ 182 (360)
T 3e3p_A 104 VMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182 (360)
T ss_dssp EEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred Eeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence 9999976 55544443 2234457889999999999999999994 689999999999999997 889999999999876
Q ss_pred ccccccceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 687 TAAANTNVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.
T Consensus 183 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 237 (360)
T 3e3p_A 183 SPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS 237 (360)
T ss_dssp CTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence 54332 2344689999999988654 489999999999999999999999987554
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=307.48 Aligned_cols=312 Identities=21% Similarity=0.224 Sum_probs=253.2
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
.+++.|+|++|.+++..+..|.+|++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|+++++|++|+|
T Consensus 76 ~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~L 155 (635)
T 4g8a_A 76 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 155 (635)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeecc
Confidence 36889999999999877888999999999999999999887888999999999999999999887788999999999999
Q ss_pred cCCCCCC-CCccccccccccceeecccccccccCCccccCCC--------------------------------------
Q 041878 171 SNNALIG-AIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLP-------------------------------------- 211 (773)
Q Consensus 171 s~N~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~-------------------------------------- 211 (773)
++|.+++ .+|..++.+++|++|+|++|++++..+..+..+.
T Consensus 156 s~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~ 235 (635)
T 4g8a_A 156 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF 235 (635)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCC
T ss_pred ccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhccc
Confidence 9999985 4678889999999999999988765444332211
Q ss_pred --------------------------------------------------------------------------------
Q 041878 212 -------------------------------------------------------------------------------- 211 (773)
Q Consensus 212 -------------------------------------------------------------------------------- 211 (773)
T Consensus 236 ~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~ 315 (635)
T 4g8a_A 236 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVS 315 (635)
T ss_dssp SSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEES
T ss_pred ccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccc
Confidence
Q ss_pred -------------ccceeeccccccccccCCccccc--------------ccCcccccceeecccccccc----------
Q 041878 212 -------------SLSVLALQHNNLSGSVPNNWGVL--------------AGNKSYQLQFLNLDHNLIAG---------- 254 (773)
Q Consensus 212 -------------~L~~L~L~~N~l~~~~p~~~~~l--------------~~~~~~~L~~L~L~~n~l~~---------- 254 (773)
+|+.|++.+|.+.+..+..+..+ ....+++|+.|++++|.+..
T Consensus 316 ~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~ 395 (635)
T 4g8a_A 316 VTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 395 (635)
T ss_dssp CEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHS
T ss_pred cccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhh
Confidence 12222222222221111100000 00123456666666655431
Q ss_pred ---------------------------------------c-cCccCCCCCCccEEECCCCcccCCCCCCcCcccccceec
Q 041878 255 ---------------------------------------T-IPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLD 294 (773)
Q Consensus 255 ---------------------------------------~-~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 294 (773)
. .+..+..+++++.++++.|++.+..+..+..+++|++|+
T Consensus 396 ~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~ 475 (635)
T 4g8a_A 396 TISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 475 (635)
T ss_dssp CSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred hhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhh
Confidence 1 123456778899999999999999999999999999999
Q ss_pred ccccccc-ccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCc
Q 041878 295 LSYNAIG-GSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFT 373 (773)
Q Consensus 295 Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 373 (773)
|++|.+. +..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+
T Consensus 476 Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~ 555 (635)
T 4g8a_A 476 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 555 (635)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCC
T ss_pred hhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCC
Confidence 9999854 467889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCchhhcc-CccCEEEeecccCCCCCch
Q 041878 374 GEISPSLASL-ANLTSFNVSYNNLSGSVPP 402 (773)
Q Consensus 374 ~~~~~~~~~l-~~L~~L~ls~N~l~g~~p~ 402 (773)
+..|..+..+ ++|+.|+|++|+|+|.+.-
T Consensus 556 ~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 556 TSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp BCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 9999999988 6899999999999998863
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=282.15 Aligned_cols=291 Identities=19% Similarity=0.226 Sum_probs=252.0
Q ss_pred CCCCCCCCCCCCCCCcceEeeC-----------CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCC
Q 041878 69 RSWNDSGVGACSGGWAGIKCVK-----------GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGF 137 (773)
Q Consensus 69 ~sW~~~~~~~c~~~w~gv~c~~-----------~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~ 137 (773)
..|.......|.|.|+.+.|.. ..++.|+|+++.+++..+..+.++++|++|+|++|.+++..|..++.
T Consensus 19 ~~~~~~cp~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (330)
T 1xku_A 19 EPMGPVCPFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP 98 (330)
T ss_dssp ---CCCCCTTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTT
T ss_pred ccccCCCCCCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcC
Confidence 4453323344555689999942 36788999999999888889999999999999999999988999999
Q ss_pred CCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccc--cCCccccCCCccce
Q 041878 138 LPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLG--SIPLSLTRLPSLSV 215 (773)
Q Consensus 138 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~--~~~~~l~~l~~L~~ 215 (773)
+++|++|+|++|+++ .+|..+. ++|++|++++|.+++..+..+.++++|++|+|++|.+.. ..+..+.++++|++
T Consensus 99 l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~ 175 (330)
T 1xku_A 99 LVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 175 (330)
T ss_dssp CTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCE
T ss_pred CCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCE
Confidence 999999999999999 6676665 899999999999998888889999999999999999964 77888999999999
Q ss_pred eeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceecc
Q 041878 216 LALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDL 295 (773)
Q Consensus 216 L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 295 (773)
|++++|+++. +|..+. ++|++|++++|.+++..+..+..+++|+.|+|++|++++..+..+..+++|++|+|
T Consensus 176 L~l~~n~l~~-l~~~~~-------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 247 (330)
T 1xku_A 176 IRIADTNITT-IPQGLP-------PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 247 (330)
T ss_dssp EECCSSCCCS-CCSSCC-------TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred EECCCCcccc-CCcccc-------ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEEC
Confidence 9999999984 555432 48999999999999999999999999999999999999888889999999999999
Q ss_pred ccccccccCcccccccccCceEEccCCCCCCCcchhhcc------ccccccccccCccccc--ccccccCCCCcCceeec
Q 041878 296 SYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLER------LQNLTVLNLKNNQFKG--HIPETIGNISGINQLDL 367 (773)
Q Consensus 296 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~------l~~L~~L~ls~N~l~~--~~~~~~~~l~~L~~L~L 367 (773)
++|+++ .+|..+..+++|++|++++|++++..+..+.. .+.|+.|++++|.+.. ..|..+..+.+|+.++|
T Consensus 248 ~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L 326 (330)
T 1xku_A 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 326 (330)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC
T ss_pred CCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEe
Confidence 999999 78888999999999999999999888777754 3789999999999864 56788999999999999
Q ss_pred CCcc
Q 041878 368 SEND 371 (773)
Q Consensus 368 ~~N~ 371 (773)
++|+
T Consensus 327 ~~N~ 330 (330)
T 1xku_A 327 GNYK 330 (330)
T ss_dssp ----
T ss_pred cccC
Confidence 9985
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=288.68 Aligned_cols=285 Identities=22% Similarity=0.249 Sum_probs=183.1
Q ss_pred CCCCCCCcceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCC--C
Q 041878 77 GACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSG--S 154 (773)
Q Consensus 77 ~~c~~~w~gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~--~ 154 (773)
+.|.|.|.+|.|.... ++ .+|..+. ++|++|+|++|+++...+..|..+++|++|+|++|+++. .
T Consensus 3 ~~C~C~~~~l~c~~~~----------l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~ 69 (306)
T 2z66_A 3 SRCSCSGTEIRCNSKG----------LT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGC 69 (306)
T ss_dssp TTCEEETTEEECCSSC----------CS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEE
T ss_pred CCCeeCCCEEEcCCCC----------cc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccC
Confidence 3565668888885433 22 2333222 567777777777775444456777777777777777762 2
Q ss_pred CCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCC-ccccCCCccceeeccccccccccCCcccc
Q 041878 155 IPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIP-LSLTRLPSLSVLALQHNNLSGSVPNNWGV 233 (773)
Q Consensus 155 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 233 (773)
.|..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|++|++++|++++
T Consensus 70 ~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~-------- 140 (306)
T 2z66_A 70 CSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-------- 140 (306)
T ss_dssp EEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEE--------
T ss_pred cccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCc--------
Confidence 3455566777777777777776 455566667777777777776664433 345555555555555555554
Q ss_pred cccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccC-CCCCCcCcccccceeccccccccccCcccccccc
Q 041878 234 LAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVG-PIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNIT 312 (773)
Q Consensus 234 l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 312 (773)
..+..+..+++|++|++++|++++ .+|..+..+++|++|+|++|++++..|..+..++
T Consensus 141 ---------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 199 (306)
T 2z66_A 141 ---------------------AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 199 (306)
T ss_dssp ---------------------CSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred ---------------------cchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCC
Confidence 444555566666666666666665 4566666666777777777777666666666677
Q ss_pred cCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCC-cCceeecCCccCccCCC--chhhccCccCEE
Q 041878 313 SLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNIS-GINQLDLSENDFTGEIS--PSLASLANLTSF 389 (773)
Q Consensus 313 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L 389 (773)
+|++|+|++|++++..+..+..+++|++|++++|++++..|..+..++ +|++|+|++|++++... .....+...+.+
T Consensus 200 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~ 279 (306)
T 2z66_A 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQL 279 (306)
T ss_dssp TCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGG
T ss_pred CCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhh
Confidence 777777777777666666677777777777777777777777777774 77888888887776432 112223444555
Q ss_pred EeecccCCCCCchhh
Q 041878 390 NVSYNNLSGSVPPLL 404 (773)
Q Consensus 390 ~ls~N~l~g~~p~~~ 404 (773)
.+..|.+.|..|..+
T Consensus 280 ~~~~~~~~C~~p~~~ 294 (306)
T 2z66_A 280 LVEVERMECATPSDK 294 (306)
T ss_dssp BSCGGGCBEEESGGG
T ss_pred hccccccccCCchhh
Confidence 666777777777655
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=283.03 Aligned_cols=283 Identities=20% Similarity=0.264 Sum_probs=250.1
Q ss_pred CCCCCCCCcceEeeC-----------CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceE
Q 041878 76 VGACSGGWAGIKCVK-----------GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGV 144 (773)
Q Consensus 76 ~~~c~~~w~gv~c~~-----------~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 144 (773)
...|.|.|+.+.|.. ..++.|+|+++.+++..+..+.++++|++|+|++|.+++..|..++.+++|++|
T Consensus 28 p~~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 107 (332)
T 2ft3_A 28 PFGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKL 107 (332)
T ss_dssp CSSCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEE
T ss_pred CCCCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEE
Confidence 344555699999952 368899999999998888899999999999999999999889999999999999
Q ss_pred EcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeeccccccc--ccCCccccCCCccceeeccccc
Q 041878 145 YLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLL--GSIPLSLTRLPSLSVLALQHNN 222 (773)
Q Consensus 145 ~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~--~~~~~~l~~l~~L~~L~L~~N~ 222 (773)
+|++|+++ .+|..+. ++|++|+|++|.+++..+..+.++++|++|++++|.++ +..+..+..+ +|++|++++|+
T Consensus 108 ~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~ 183 (332)
T 2ft3_A 108 YISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAK 183 (332)
T ss_dssp ECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSB
T ss_pred ECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCC
Confidence 99999999 6776665 89999999999999776777999999999999999996 4778888888 99999999999
Q ss_pred cccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccc
Q 041878 223 LSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGG 302 (773)
Q Consensus 223 l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 302 (773)
+++ +|..+. ++|++|++++|.+++..+..+..+++|+.|+|++|++++..+..+..+++|++|+|++|+++
T Consensus 184 l~~-l~~~~~-------~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~- 254 (332)
T 2ft3_A 184 LTG-IPKDLP-------ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS- 254 (332)
T ss_dssp CSS-CCSSSC-------SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-
T ss_pred CCc-cCcccc-------CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-
Confidence 995 555443 38999999999999999999999999999999999999888889999999999999999999
Q ss_pred cCcccccccccCceEEccCCCCCCCcchhhcc------ccccccccccCcccc--cccccccCCCCcCceeecCCcc
Q 041878 303 SFPVTFTNITSLVSLNLENNRLGNKIPEGLER------LQNLTVLNLKNNQFK--GHIPETIGNISGINQLDLSEND 371 (773)
Q Consensus 303 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~------l~~L~~L~ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~ 371 (773)
.+|..+..+++|+.|++++|++++..+..+.. ..+|+.|++++|.+. +..|..+..+++|+.|+|++|+
T Consensus 255 ~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 255 RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 78888999999999999999999888777765 367999999999988 6778889999999999999985
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-31 Score=292.19 Aligned_cols=253 Identities=21% Similarity=0.182 Sum_probs=157.7
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
.+++.|+|+++.+++. | .++.+++|++|+|++|.+++. | ++.+++|++|+|++|++++. | ++++++|++|+|
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEEC
Confidence 4567777777777763 3 577777888888888877763 3 77777788888888777764 3 777777888888
Q ss_pred cCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecccc
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN 250 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n 250 (773)
++|.+++ +| ++.+++|++|++++|++++. .+.++++|++|++++|+..+.++ ++. +++|++|++++|
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~~--~~~-----l~~L~~L~ls~n 180 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTP-----QTQLTTLDCSFN 180 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCCC--CTT-----CTTCCEEECCSS
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCcccccc--ccc-----CCcCCEEECCCC
Confidence 8777775 33 67777777777777777753 26667777777777775443431 222 236666666666
Q ss_pred ccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcch
Q 041878 251 LIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPE 330 (773)
Q Consensus 251 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 330 (773)
.+++. | ++.+++|+.|++++|++++. .+..+++|++|++++|++++ +| +..+++|+.|++++|++++..+.
T Consensus 181 ~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~ 251 (457)
T 3bz5_A 181 KITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS 251 (457)
T ss_dssp CCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT
T ss_pred cccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHH
Confidence 66653 2 55666666666666666653 25666666666666666665 33 55666666666666666655444
Q ss_pred hhcccc-------ccccccccCcccccccccccCCCCcCceeecCCccCccC
Q 041878 331 GLERLQ-------NLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGE 375 (773)
Q Consensus 331 ~l~~l~-------~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 375 (773)
.+..+. +|+.|++++|.+.+.+| ++.+++|+.|+|++|.+.+.
T Consensus 252 ~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~ 301 (457)
T 3bz5_A 252 TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYL 301 (457)
T ss_dssp TCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCE
T ss_pred HCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccce
Confidence 444333 34444555554444443 23444444444444444333
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=294.75 Aligned_cols=195 Identities=26% Similarity=0.388 Sum_probs=162.6
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCC-----eEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG-----EKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~~ 608 (773)
|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++||||+++++++..... ..+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 345688999999999999864 689999999975432 235678899999999999999999999954432 359
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||++ ++|.+++.. .+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||+++....
T Consensus 106 lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH-~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIH-SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp EEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred EEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 9999997 688877643 2789999999999999999999 99999999999999999999999999999976543
Q ss_pred ccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
. .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.
T Consensus 179 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 229 (353)
T 3coi_A 179 E----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 229 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH
T ss_pred C----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2 223468999999998876 6789999999999999999999999976553
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-32 Score=284.10 Aligned_cols=192 Identities=24% Similarity=0.445 Sum_probs=158.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECC------------
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP------------ 603 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------------ 603 (773)
|.+.+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.++++++||||+++++++...
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK 86 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------C
T ss_pred chhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccccc
Confidence 456789999999999999864 7899999999643 23456789999999999999999999988542
Q ss_pred CCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCc
Q 041878 604 KGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLS 683 (773)
Q Consensus 604 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a 683 (773)
.+..++||||+++|+|.++++... ..+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||.+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 87 KSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIH-SQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred CCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHH-hCCeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 346789999999999999998643 34788899999999999999999 899999999999999999999999999999
Q ss_pred ccccccc-------------ccceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHc
Q 041878 684 RLMTAAA-------------NTNVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLT 732 (773)
Q Consensus 684 ~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~t 732 (773)
....... ........||+.|+|||.+.+. .++.++||||+||++|||++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 8654321 1112334689999999998754 78999999999999999998
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-32 Score=289.27 Aligned_cols=195 Identities=24% Similarity=0.358 Sum_probs=141.7
Q ss_pred hcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECC---CCeEEEEEeecC
Q 041878 540 AEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP---KGEKLLVFDFMP 615 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~~~lV~e~~~ 615 (773)
.++||+|+||.||+|... +|+.||||++... .....+....++.++||||+++++++... ....++||||++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 457999999999999875 6899999999642 22223333445677899999999998542 335789999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC---CCeEEeecCCcccccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK---TNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~---~~~kl~DfG~a~~~~~~~~~ 692 (773)
+|+|.+++.+.. ...+++.++..++.||+.||.||| +.||+||||||+||+++.+ +.+||+|||++.......
T Consensus 110 gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH-~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-- 185 (336)
T 3fhr_A 110 GGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLH-SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-- 185 (336)
T ss_dssp TEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------
T ss_pred CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc--
Confidence 999999998754 245899999999999999999999 8999999999999999864 459999999997654322
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
.....+|+.|+|||++....++.++||||+||++|||++|+.||......
T Consensus 186 -~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 186 -LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp -------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred -cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 22345899999999998888999999999999999999999999775543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=289.96 Aligned_cols=206 Identities=21% Similarity=0.325 Sum_probs=169.9
Q ss_pred HHhhcccccccceEEEEEEeC-CC-CEEEEEEecccCcccHHHHHHHHHHHHccCCCc------eEEeEEEEECCCCeEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DG-SEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPN------LLALRAYYLGPKGEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g-~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~~~ 608 (773)
|.+.+.||+|+||+||+|... ++ +.||+|+++.. ......+.+|+.++++++|++ ++.+++++. ..+..+
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~-~~~~~~ 98 (355)
T 2eu9_A 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN-FHGHMC 98 (355)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE-ETTEEE
T ss_pred EEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee-eCCeEE
Confidence 456789999999999999864 44 68999999643 234567888999999998765 888888884 455899
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEe-------------------
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLL------------------- 669 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll------------------- 669 (773)
+||||+ ++++.+++.... ...+++..+..++.||+.||+||| +.||+||||||+|||+
T Consensus 99 lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH-~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLH-ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 999999 678888777653 234899999999999999999999 9999999999999999
Q ss_pred CCCCCeEEeecCCccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHH
Q 041878 670 DEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWV 749 (773)
Q Consensus 670 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~ 749 (773)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM 251 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 567889999999997643322 2346899999999999999999999999999999999999999876654443433
Q ss_pred HH
Q 041878 750 AS 751 (773)
Q Consensus 750 ~~ 751 (773)
.+
T Consensus 252 ~~ 253 (355)
T 2eu9_A 252 EK 253 (355)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=292.84 Aligned_cols=279 Identities=31% Similarity=0.421 Sum_probs=172.3
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
.+++.|++.++++.. ++ .+..+++|++|+|++|.+++..+ +..+++|++|+|++|++++..+ ++++++|++|+|
T Consensus 46 ~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 119 (466)
T 1o6v_A 46 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119 (466)
T ss_dssp HTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred ccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEEC
Confidence 467889999998874 44 48899999999999999997654 9999999999999999997665 999999999999
Q ss_pred cCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeec---------------------cccccccccCC
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLAL---------------------QHNNLSGSVPN 229 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L---------------------~~N~l~~~~p~ 229 (773)
++|.+++. +. +.++++|++|+|++|.+++. + .+..+++|++|++ ++|++++. +
T Consensus 120 ~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~- 193 (466)
T 1o6v_A 120 FNNQITDI-DP-LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI-S- 193 (466)
T ss_dssp CSSCCCCC-GG-GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC-G-
T ss_pred CCCCCCCC-hH-HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC-h-
Confidence 99999864 43 89999999999999999853 2 3555555555555 44444321 1
Q ss_pred cccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCccccc
Q 041878 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFT 309 (773)
Q Consensus 230 ~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 309 (773)
.+.. +++|++|++++|.+++..+ ++.+++|+.|++++|++++. ..+..+++|++|++++|.+++..+ +.
T Consensus 194 ~l~~-----l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~ 262 (466)
T 1o6v_A 194 VLAK-----LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LS 262 (466)
T ss_dssp GGGG-----CTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred hhcc-----CCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hh
Confidence 1111 2244444444444444333 34444455555555544432 234444555555555555543332 44
Q ss_pred ccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEE
Q 041878 310 NITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSF 389 (773)
Q Consensus 310 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 389 (773)
.+++|++|++++|++++..+ +..+++|+.|++++|++++..+ +..+++|+.|+|++|++++..| +..+++|+.|
T Consensus 263 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 336 (466)
T 1o6v_A 263 GLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRL 336 (466)
T ss_dssp TCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEE
T ss_pred cCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEe
Confidence 45555555555555544333 4445555555555555544322 4445555555555555554333 4445555555
Q ss_pred EeecccCCC
Q 041878 390 NVSYNNLSG 398 (773)
Q Consensus 390 ~ls~N~l~g 398 (773)
++++|++++
T Consensus 337 ~l~~n~l~~ 345 (466)
T 1o6v_A 337 FFYNNKVSD 345 (466)
T ss_dssp ECCSSCCCC
T ss_pred ECCCCccCC
Confidence 555555544
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=289.96 Aligned_cols=275 Identities=19% Similarity=0.200 Sum_probs=238.1
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
.+++.|+|++|.+++. + ++.+++|++|+|++|.+++. + ++.+++|++|+|++|++++ +| ++.+++|++|+|
T Consensus 64 ~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l 134 (457)
T 3bz5_A 64 TGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNC 134 (457)
T ss_dssp TTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEEC
Confidence 5788999999999984 3 89999999999999999975 3 8999999999999999997 44 899999999999
Q ss_pred cCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecccc
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN 250 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n 250 (773)
++|.+++. + ++.+++|++|++++|+..+.+ .+..+++|++|++++|++++ +| +.. +++|+.|++++|
T Consensus 135 ~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~-----l~~L~~L~l~~N 201 (457)
T 3bz5_A 135 ARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQ-----NKLLNRLNCDTN 201 (457)
T ss_dssp TTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTT-----CTTCCEEECCSS
T ss_pred CCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--ccc-----CCCCCEEECcCC
Confidence 99999974 3 889999999999999766565 48899999999999999996 34 333 448999999999
Q ss_pred ccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccc-------cCceEEccCCC
Q 041878 251 LIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNIT-------SLVSLNLENNR 323 (773)
Q Consensus 251 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-------~L~~L~Ls~N~ 323 (773)
.+++. .++.+++|+.|++++|++++ +| +..+++|++|++++|++++..+..+.+++ +|+.|++++|+
T Consensus 202 ~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~ 275 (457)
T 3bz5_A 202 NITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNT 275 (457)
T ss_dssp CCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCT
T ss_pred cCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCc
Confidence 99976 48899999999999999997 56 88999999999999999987666665554 56777777777
Q ss_pred CCCCcchhhccccccccccccCccccccccc--------ccCCCCcCceeecCCccCccCCCchhhccCccCEEEeeccc
Q 041878 324 LGNKIPEGLERLQNLTVLNLKNNQFKGHIPE--------TIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNN 395 (773)
Q Consensus 324 l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~--------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~ 395 (773)
+.+.+| ++.+++|+.|++++|.+.+.+|. .+.++++|+.|+|++|++++. + +..+++|+.|++++|+
T Consensus 276 ~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~ 350 (457)
T 3bz5_A 276 QLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAH 350 (457)
T ss_dssp TCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSC
T ss_pred cCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCC
Confidence 777666 56789999999999998877765 356778999999999999984 3 8899999999999999
Q ss_pred CCC
Q 041878 396 LSG 398 (773)
Q Consensus 396 l~g 398 (773)
++|
T Consensus 351 l~~ 353 (457)
T 3bz5_A 351 IQD 353 (457)
T ss_dssp CCB
T ss_pred CCC
Confidence 998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=310.01 Aligned_cols=201 Identities=26% Similarity=0.440 Sum_probs=172.6
Q ss_pred HHHhhcccccccceEEEEEEe-CCCCEEEEEEeccc-CcccHHHHHHHHHHHHccCCCceEEeEEEEEC-----CCCeEE
Q 041878 536 LCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK-TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLG-----PKGEKL 608 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~~~ 608 (773)
.|.+.++||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|++++++++||||+++++++.. ..+..+
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~ 94 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 94 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence 356789999999999999986 46899999998754 33345678999999999999999999998733 145779
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC---eEEeecCCccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN---PRIADFGLSRL 685 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~---~kl~DfG~a~~ 685 (773)
+||||+++|+|.+++........+++..+..++.|++.||+||| +.||+||||||+||+++.++. +||+|||.+..
T Consensus 95 LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH-s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~ 173 (676)
T 3qa8_A 95 LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH-ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE 173 (676)
T ss_dssp CEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH-HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred EEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence 99999999999999987654455888899999999999999999 899999999999999997765 89999999987
Q ss_pred cccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 686 MTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
...... .....||+.|+|||.+.+..++.++||||+||++|||++|+.||.+
T Consensus 174 ~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~ 225 (676)
T 3qa8_A 174 LDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225 (676)
T ss_dssp TTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 654332 2335689999999999999999999999999999999999999964
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.5e-32 Score=285.04 Aligned_cols=197 Identities=20% Similarity=0.337 Sum_probs=161.7
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccC--cccHHHHHHHHHHHHccC--CCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIH--HPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++ |+||+++++++.. .+..++|||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv~e 108 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMVME 108 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-CCEEEEEEe
Confidence 45678999999999999998889999999997543 334567899999999997 5999999999954 558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
+.+++|.+++.... .+++..+..++.||+.||.||| +.+|+||||||+||++++ +.+||+|||++.........
T Consensus 109 -~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~ 182 (313)
T 3cek_A 109 -CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS 182 (313)
T ss_dssp -CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred -cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence 55889999998753 4788999999999999999999 899999999999999965 78999999999876543321
Q ss_pred -ceeeccCccccccccccCC-----------CCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 693 -NVIATAGTLGYRAPELSKL-----------KNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 693 -~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
......||+.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 1223468999999998765 47888999999999999999999999753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-32 Score=299.17 Aligned_cols=196 Identities=24% Similarity=0.346 Sum_probs=153.6
Q ss_pred hhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 539 TAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
..++||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++. ..+..++||||++ |
T Consensus 19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSET-TDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEE-CSSEEEEEECCCS-E
T ss_pred ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEe-cCCeEEEEEecCC-C
Confidence 35789999999998777678999999998643 245678899999986 8999999999984 4558999999995 6
Q ss_pred CHHHHHhhcCCCCc----cCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC-------------CCeEEeec
Q 041878 618 SLASFLHARGPETI----VNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK-------------TNPRIADF 680 (773)
Q Consensus 618 ~L~~~l~~~~~~~~----~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~-------------~~~kl~Df 680 (773)
+|.+++........ .++..++.++.||+.||+||| +.||+||||||+|||++.+ +.+||+||
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH-HCCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 99999987542111 123345789999999999999 9999999999999999754 47999999
Q ss_pred CCcccccccccc---ceeeccCccccccccccCC-------CCCCcchhhHHHHHHHHHHHc-CCCCCCCC
Q 041878 681 GLSRLMTAAANT---NVIATAGTLGYRAPELSKL-------KNANTKTDVYSLGVIILELLT-GKSPGEPM 740 (773)
Q Consensus 681 G~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~ 740 (773)
|+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||...
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 243 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence 999877543321 1223469999999998865 678999999999999999999 99999653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=288.44 Aligned_cols=195 Identities=19% Similarity=0.375 Sum_probs=165.6
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcc------cHHHHHHHHHHHHccC--CCceEEeEEEEECCCCeE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTK------GQKEFEAEAAAIGKIH--HPNLLALRAYYLGPKGEK 607 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~ 607 (773)
|.+.+.||+|+||.||+|.. .+++.||||.+...... ....+.+|+.++++++ |+||+++++++. ..+..
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~-~~~~~ 123 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE-RPDSF 123 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-CSSEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe-cCCcE
Confidence 34678999999999999985 46889999999754322 2345678999999996 599999999995 45589
Q ss_pred EEEEeecCC-CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeC-CCCCeEEeecCCccc
Q 041878 608 LLVFDFMPK-GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLD-EKTNPRIADFGLSRL 685 (773)
Q Consensus 608 ~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~-~~~~~kl~DfG~a~~ 685 (773)
++|+||+.+ ++|.+++.+.. .+++..+..++.||+.||+||| +.||+||||||+||+++ +++.+||+|||+++.
T Consensus 124 ~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 124 VLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp EEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH-HCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 999999976 89999998754 3789999999999999999999 99999999999999999 778999999999987
Q ss_pred cccccccceeeccCccccccccccCCCCC-CcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 686 MTAAANTNVIATAGTLGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
..... .....||+.|+|||++....+ +.++||||||+++|||++|+.||..
T Consensus 200 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 200 LKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp CCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 65332 223458999999998876665 6789999999999999999999975
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=289.52 Aligned_cols=280 Identities=19% Similarity=0.220 Sum_probs=203.2
Q ss_pred CCCcceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCC
Q 041878 81 GGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIG 160 (773)
Q Consensus 81 ~~w~gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~ 160 (773)
|.|.|+ | ++++++++ .+|..+. ++|++|+|++|++++..+..+..+++|++|+|++|++++..|..|+
T Consensus 30 C~~~~~-c--------~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (353)
T 2z80_A 30 CDRNGI-C--------KGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFS 97 (353)
T ss_dssp ECTTSE-E--------ECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred CCCCeE-e--------eCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcC
Confidence 348876 6 34556665 4565554 4899999999999987777899999999999999999988888899
Q ss_pred CCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCC-ccccCCCccceeeccccc-cccccCCcccccccCc
Q 041878 161 NCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIP-LSLTRLPSLSVLALQHNN-LSGSVPNNWGVLAGNK 238 (773)
Q Consensus 161 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~~~ 238 (773)
++++|++|+|++|.+++..+..+.++++|++|+|++|+++...+ ..+.++++|++|++++|+ +++..
T Consensus 98 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~----------- 166 (353)
T 2z80_A 98 SLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQ----------- 166 (353)
T ss_dssp TCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEEC-----------
T ss_pred CCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccC-----------
Confidence 99999999999999986555558889999999999998885433 467778888888888774 44332
Q ss_pred ccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEE
Q 041878 239 SYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLN 318 (773)
Q Consensus 239 ~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 318 (773)
+..+..+++|++|++++|++++..|..+..+++|++|++++|.++...+..+..+++|+.|+
T Consensus 167 ------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~ 228 (353)
T 2z80_A 167 ------------------RKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLE 228 (353)
T ss_dssp ------------------TTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEE
T ss_pred ------------------HHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEE
Confidence 33455555666666666666655566666666666666666666533333344466666666
Q ss_pred ccCCCCCCCcchhhc---cccccccccccCccccc----ccccccCCCCcCceeecCCccCccCCCch-hhccCccCEEE
Q 041878 319 LENNRLGNKIPEGLE---RLQNLTVLNLKNNQFKG----HIPETIGNISGINQLDLSENDFTGEISPS-LASLANLTSFN 390 (773)
Q Consensus 319 Ls~N~l~~~~~~~l~---~l~~L~~L~ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~ 390 (773)
+++|++++..+..+. ....++.+++++|.+++ .+|..+..+++|++|+|++|+++ .+|.. +..+++|+.|+
T Consensus 229 L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~ 307 (353)
T 2z80_A 229 LRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIW 307 (353)
T ss_dssp EESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred CCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEE
Confidence 666666655444332 24556666666666665 47788899999999999999999 55655 58999999999
Q ss_pred eecccCCCCCch
Q 041878 391 VSYNNLSGSVPP 402 (773)
Q Consensus 391 ls~N~l~g~~p~ 402 (773)
|++|+++|.+|.
T Consensus 308 L~~N~~~~~~~~ 319 (353)
T 2z80_A 308 LHTNPWDCSCPR 319 (353)
T ss_dssp CCSSCBCCCHHH
T ss_pred eeCCCccCcCCC
Confidence 999999999874
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-32 Score=287.12 Aligned_cols=198 Identities=26% Similarity=0.428 Sum_probs=146.4
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHH-HHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAA-AIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|...+.||+|+||.||+|... +|+.||||+++.... ....++..|+. +++.++||||+++++++.. .+..++||||
T Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-~~~~~lv~e~ 102 (327)
T 3aln_A 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-EGDCWICMEL 102 (327)
T ss_dssp EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-SSEEEEEECC
T ss_pred hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-CCceEEEEee
Confidence 345688999999999999874 788999999976532 33445666666 7777899999999999954 4589999999
Q ss_pred cCCCCHHHHHhhc--CCCCccCHHHHHHHHHHHHHHHHHhccCC-CceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 614 MPKGSLASFLHAR--GPETIVNWATRMSIAIGIARGLNYLHVEE-NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 614 ~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~al~yLH~~~-~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
+++ +|.+++... .....+++..+..++.|++.||.||| +. ||+||||||+||+++.++.+||+|||+++......
T Consensus 103 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 180 (327)
T 3aln_A 103 MST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK-ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180 (327)
T ss_dssp CSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH-HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred cCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh-ccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence 975 888877642 12345889999999999999999999 77 99999999999999999999999999998664332
Q ss_pred ccceeeccCcccccccccc----CCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 691 NTNVIATAGTLGYRAPELS----KLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
. .....||+.|+|||++ .+..++.++|||||||++|||++|+.||..
T Consensus 181 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 181 A--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred c--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 2 2233589999999998 566789999999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=292.65 Aligned_cols=198 Identities=24% Similarity=0.375 Sum_probs=161.3
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.+.||+|+||.||+|.... .||+|+++... ....+.+.+|+.++++++|+||+++++++.. .+..++||||+
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~iv~e~~ 111 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-PPHLAIITSLC 111 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-SSCEEEECBCC
T ss_pred eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CCceEEEeecc
Confidence 3467899999999999998753 59999987542 2234567889999999999999999999954 45799999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc----
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA---- 690 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~---- 690 (773)
++++|.+++.... ..+++..+..++.||+.||+||| +.||+||||||+||+++ ++.+||+|||++.......
T Consensus 112 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH-~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 112 KGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLH-AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp CSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHH-HTTCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred cCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 9999999997653 34788999999999999999999 99999999999999998 6799999999987653211
Q ss_pred ccceeeccCccccccccccCC---------CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 691 NTNVIATAGTLGYRAPELSKL---------KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
........||+.|+|||.+.. ..++.++||||||+++|||++|+.||....
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 247 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC
T ss_pred ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 112223458999999998764 457889999999999999999999997644
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-32 Score=292.73 Aligned_cols=200 Identities=22% Similarity=0.305 Sum_probs=164.6
Q ss_pred HHHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccC-----------CCceEEeEEEEECC
Q 041878 536 LCATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-----------HPNLLALRAYYLGP 603 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~ 603 (773)
+|.+.+.||+|+||+||+|.. .+++.||||++... ......+.+|+.++++++ |+||+++++++...
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred eEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 345678999999999999986 57889999999643 234567889999999887 88999999998543
Q ss_pred C---CeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCC-CceecCCCCCCEEeC------CCC
Q 041878 604 K---GEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE-NMIHGNLTSSNVLLD------EKT 673 (773)
Q Consensus 604 ~---~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~-~iiH~Dik~~NIll~------~~~ 673 (773)
. ...++||||+ +++|.+++.... ...+++..+..++.||+.||+||| +. ||+||||||+|||++ ..+
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH-~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHH-HTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHH-hcCCEEecCCChHHeEEeccCCCcCcc
Confidence 2 2678999999 899999998753 234889999999999999999999 76 999999999999994 444
Q ss_pred CeEEeecCCccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 674 NPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 674 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||+||+.||...+..
T Consensus 176 ~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 241 (373)
T 1q8y_A 176 QIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 241 (373)
T ss_dssp EEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred eEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence 79999999998664322 2346899999999999889999999999999999999999999876543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-32 Score=285.05 Aligned_cols=195 Identities=21% Similarity=0.392 Sum_probs=162.4
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcc------cHHHHHHHHHHHHcc----CCCceEEeEEEEECCCC
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTK------GQKEFEAEAAAIGKI----HHPNLLALRAYYLGPKG 605 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~~~~~~~ 605 (773)
|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.+++++ +|+||+++++++. ..+
T Consensus 33 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~-~~~ 111 (312)
T 2iwi_A 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE-TQE 111 (312)
T ss_dssp CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----
T ss_pred eEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe-cCC
Confidence 45678999999999999986 46889999999654322 223456799999998 8999999999984 455
Q ss_pred eEEEEEee-cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeC-CCCCeEEeecCCc
Q 041878 606 EKLLVFDF-MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLD-EKTNPRIADFGLS 683 (773)
Q Consensus 606 ~~~lV~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~-~~~~~kl~DfG~a 683 (773)
..++|+|| +++++|.+++.+.. .+++..+..++.||+.||+||| +.||+||||||+||+++ .++.+||+|||++
T Consensus 112 ~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 112 GFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCH-SRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH-HHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred eEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 78999999 78999999998754 3789999999999999999999 89999999999999999 7889999999999
Q ss_pred cccccccccceeeccCccccccccccCCCCCC-cchhhHHHHHHHHHHHcCCCCCCC
Q 041878 684 RLMTAAANTNVIATAGTLGYRAPELSKLKNAN-TKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 684 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
....... .....||+.|+|||++.+..+. .++||||+|+++|||++|+.||..
T Consensus 188 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 188 ALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp EECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred hhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 8765432 2234589999999988766664 589999999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=287.76 Aligned_cols=192 Identities=19% Similarity=0.179 Sum_probs=161.0
Q ss_pred HHHHhhcccccccceEEEEEEeCCCCEEEEEEecccC--------cccHHHHHHHHHHHHccC---------CCceEEeE
Q 041878 535 LLCATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKT--------TKGQKEFEAEAAAIGKIH---------HPNLLALR 597 (773)
Q Consensus 535 l~~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l~ 597 (773)
-.|.+.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.++++++ ||||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4578889999999999999988 68999999997542 223478899999999886 88888887
Q ss_pred EEEEC-----------------------------CCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHH
Q 041878 598 AYYLG-----------------------------PKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGL 648 (773)
Q Consensus 598 ~~~~~-----------------------------~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al 648 (773)
+++.. ..+..++||||+++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence 76531 25689999999999977766643 3378999999999999999
Q ss_pred HHhccCCCceecCCCCCCEEeCCCC--------------------CeEEeecCCccccccccccceeeccCccccccccc
Q 041878 649 NYLHVEENMIHGNLTSSNVLLDEKT--------------------NPRIADFGLSRLMTAAANTNVIATAGTLGYRAPEL 708 (773)
Q Consensus 649 ~yLH~~~~iiH~Dik~~NIll~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~ 708 (773)
+|||++.||+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|||+
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhh
Confidence 9999558999999999999999887 8999999999866432 2358999999999
Q ss_pred cCCCCCCcchhhHHHHHH-HHHHHcCCCCCC
Q 041878 709 SKLKNANTKTDVYSLGVI-ILELLTGKSPGE 738 (773)
Q Consensus 709 ~~~~~~~~~~Dvws~Gv~-l~el~tg~~P~~ 738 (773)
+.+.. +.++||||+|++ .+++++|..||.
T Consensus 249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred hcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 98666 889999998777 778999999984
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=294.71 Aligned_cols=195 Identities=21% Similarity=0.358 Sum_probs=153.1
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|...++||+|+||+||.....+|+.||||++...... .+.+|+++++++ +||||+++++++. .....++||||++
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~-~~~~~~lv~E~~~ 101 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEK-DRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEE-ETTEEEEEEECCS
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEe-cCCEEEEEEECCC
Confidence 3456899999999976555667999999999654332 356799999999 7999999999984 4558899999996
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-----CCCeEEeecCCcccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE-----KTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~-----~~~~kl~DfG~a~~~~~~~ 690 (773)
|+|.+++..... ......+..++.||+.||+||| +.||+||||||+||+++. ...+||+|||+++......
T Consensus 102 -g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 102 -ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLH-SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp -EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHH-HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred -CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHH-HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 699999987542 1333455789999999999999 999999999999999953 2358899999998765432
Q ss_pred c--cceeeccCccccccccccC---CCCCCcchhhHHHHHHHHHHHc-CCCCCCC
Q 041878 691 N--TNVIATAGTLGYRAPELSK---LKNANTKTDVYSLGVIILELLT-GKSPGEP 739 (773)
Q Consensus 691 ~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~ 739 (773)
. .......||+.|+|||++. ...++.++||||+||++|||+| |..||..
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~ 232 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence 2 2223456999999999987 4667889999999999999999 9999864
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=286.46 Aligned_cols=274 Identities=19% Similarity=0.203 Sum_probs=219.0
Q ss_pred CcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeeccc
Q 041878 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSY 196 (773)
Q Consensus 117 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~ 196 (773)
....++++|+++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|.+++..|..+.++++|++|+|++
T Consensus 33 ~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (353)
T 2z80_A 33 NGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109 (353)
T ss_dssp TSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCC
Confidence 345788888888 5666554 5889999999999876666888899999999999998877777888888888888888
Q ss_pred ccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccC-ccCCCCCCccEEECCCC-
Q 041878 197 NSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIP-VSLGKLGLLQEISLSHN- 274 (773)
Q Consensus 197 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N- 274 (773)
|++++..+..+.++++|++|+|++|++++ ..+ ..+..+++|++|++++|
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-----------------------------l~~~~~~~~l~~L~~L~l~~n~ 160 (353)
T 2z80_A 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYKT-----------------------------LGETSLFSHLTKLQILRVGNMD 160 (353)
T ss_dssp SCCSSCCHHHHTTCTTCSEEECTTCCCSS-----------------------------SCSSCSCTTCTTCCEEEEEESS
T ss_pred CcCCcCCHhHhCCCccCCEEECCCCCCcc-----------------------------cCchhhhccCCCCcEEECCCCc
Confidence 88886555557777777777777777662 112 35778889999999999
Q ss_pred cccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCccccccccc
Q 041878 275 KIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPE 354 (773)
Q Consensus 275 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~ 354 (773)
.+.+..+..|.++++|++|++++|++++..|..+..+++|++|++++|+++...+..+..+++|+.|++++|++++..+.
T Consensus 161 ~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~ 240 (353)
T 2z80_A 161 TFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFS 240 (353)
T ss_dssp SCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC
T ss_pred cccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccc
Confidence 47766778899999999999999999999999999999999999999999655555566799999999999999986655
Q ss_pred ccC---CCCcCceeecCCccCcc----CCCchhhccCccCEEEeecccCCCCCchhhhc---cCCCCCCCCCCCCCCCC
Q 041878 355 TIG---NISGINQLDLSENDFTG----EISPSLASLANLTSFNVSYNNLSGSVPPLLSK---KFNSSSFVGNLQLCGYS 423 (773)
Q Consensus 355 ~~~---~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~ls~N~l~g~~p~~~~~---~~~~~~~~~n~~~c~~~ 423 (773)
.+. ....++.++|++|.+++ .+|..+..+++|+.|++++|+++ .+|..... .+....+.+|+..|.++
T Consensus 241 ~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 241 ELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp ------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 443 46678899999999887 47788899999999999999999 57765323 33344677888877554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=289.62 Aligned_cols=240 Identities=20% Similarity=0.199 Sum_probs=155.6
Q ss_pred ccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCcccccc
Q 041878 106 RISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLAN 185 (773)
Q Consensus 106 ~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~ 185 (773)
.+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|.+++..+..+..
T Consensus 68 ~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 145 (452)
T 3zyi_A 68 EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEY 145 (452)
T ss_dssp SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSS
T ss_pred ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcc
Confidence 3454443 57888888888888888888888888888888888888777788888888888888888888666666788
Q ss_pred ccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCC
Q 041878 186 STRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGL 265 (773)
Q Consensus 186 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~ 265 (773)
+++|++|+|++|+++...+..+.++++|++|+|++|+..+.+ .+..|..+++
T Consensus 146 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i----------------------------~~~~~~~l~~ 197 (452)
T 3zyi_A 146 LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYI----------------------------SEGAFEGLFN 197 (452)
T ss_dssp CTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEE----------------------------CTTTTTTCTT
T ss_pred cCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCcccc----------------------------ChhhccCCCC
Confidence 888888888888887666666777777777777764322222 2234556666
Q ss_pred ccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccC
Q 041878 266 LQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKN 345 (773)
Q Consensus 266 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~ 345 (773)
|+.|+|++|++++. | .+..+++|++|+|++|.+++..|..|..+++|+.|+|++|+++
T Consensus 198 L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-------------------- 255 (452)
T 3zyi_A 198 LKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-------------------- 255 (452)
T ss_dssp CCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCC--------------------
T ss_pred CCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCc--------------------
Confidence 77777777766642 3 3455555555555555555554555555555555555554444
Q ss_pred cccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCc
Q 041878 346 NQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVP 401 (773)
Q Consensus 346 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p 401 (773)
+..+..|.++++|+.|+|++|++++..+..+..+++|+.|+|++|+|.+.+.
T Consensus 256 ----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 256 ----LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCD 307 (452)
T ss_dssp ----EECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred ----eECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCC
Confidence 4444444555555555555555554444445555555555555555555443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=278.59 Aligned_cols=251 Identities=23% Similarity=0.280 Sum_probs=208.3
Q ss_pred cEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCC--Cccccccccccceeecc
Q 041878 118 RKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGA--IPPSLANSTRLYRLNLS 195 (773)
Q Consensus 118 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~~~~l~~l~~L~~L~Ls 195 (773)
+.++++++.++ .+|..+. ++|++|+|++|+++...+..|+++++|++|+|++|.++.. .+..+..+++|++|+|+
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 46778888877 4565443 6788888888888855445578888888888888888732 35566667777777777
Q ss_pred cccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccC-ccCCCCCCccEEECCCC
Q 041878 196 YNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIP-VSLGKLGLLQEISLSHN 274 (773)
Q Consensus 196 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N 274 (773)
+|.++ .+|..+..+++|++|++++|+++ +..+ ..+..+++|++|++++|
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~-----------------------------~~~~~~~~~~l~~L~~L~l~~n 136 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLK-----------------------------QMSEFSVFLSLRNLIYLDISHT 136 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEE-----------------------------SSTTTTTTTTCTTCCEEECTTS
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCccc-----------------------------ccccchhhhhccCCCEEECCCC
Confidence 77776 34555666666666666666655 3322 46788899999999999
Q ss_pred cccCCCCCCcCcccccceeccccccccc-cCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccc
Q 041878 275 KIVGPIPDELGKLSKLQKLDLSYNAIGG-SFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIP 353 (773)
Q Consensus 275 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~ 353 (773)
++.+..+..+..+++|++|++++|.+++ ..|..+..+++|++|++++|++++..|..+..+++|+.|++++|++++..+
T Consensus 137 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 216 (306)
T 2z66_A 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 216 (306)
T ss_dssp CCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCS
T ss_pred cCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccCh
Confidence 9999899999999999999999999987 688999999999999999999999889999999999999999999998888
Q ss_pred cccCCCCcCceeecCCccCccCCCchhhccC-ccCEEEeecccCCCCCc
Q 041878 354 ETIGNISGINQLDLSENDFTGEISPSLASLA-NLTSFNVSYNNLSGSVP 401 (773)
Q Consensus 354 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~ls~N~l~g~~p 401 (773)
..+..+++|+.|+|++|++++..|..+..++ +|+.|+|++|+++|.++
T Consensus 217 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 217 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp GGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGG
T ss_pred hhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccC
Confidence 8899999999999999999999999999984 99999999999998765
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=312.76 Aligned_cols=190 Identities=20% Similarity=0.313 Sum_probs=160.7
Q ss_pred HHhhcccccccceEEEEEEeC--CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCe----EEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE--DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGE----KLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~--~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~~l 609 (773)
|.+.++||+|+||.||+|.+. +|+.||||++.... ......+.+|++++++++||||+++++++...... .|+
T Consensus 82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 456789999999999999875 68899999986543 33456788999999999999999999999654321 699
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||+++++|.+++.. .+++.+++.++.||+.||.||| +.|||||||||+|||++.+ .+||+|||+++.....
T Consensus 162 v~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH-~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH-SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred EEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH-HCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 9999999999987754 3899999999999999999999 9999999999999999886 8999999999865433
Q ss_pred cccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
....||+.|+|||++.+. ++.++|||||||++|||++|..||..
T Consensus 235 -----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred -----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcc
Confidence 234689999999988654 48899999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-31 Score=279.06 Aligned_cols=196 Identities=23% Similarity=0.395 Sum_probs=146.5
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc-cH-HHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK-GQ-KEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|...+.||+|+||.||+|... +|+.||||++...... .. +.+.++..+++.++||||+++++++.. .+..++||||
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~~lv~e~ 105 (318)
T 2dyl_A 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-NTDVFIAMEL 105 (318)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECC
T ss_pred ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCcEEEEEec
Confidence 456789999999999999875 7899999999755332 22 334455567888899999999999954 4589999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCC-CceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE-NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~-~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
+ ++.+..+.... ...+++..+..++.||+.||.||| ++ ||+||||||+||+++.++.+||+|||++........
T Consensus 106 ~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH-~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (318)
T 2dyl_A 106 M-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLK-EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA- 180 (318)
T ss_dssp C-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH-HHHCCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred c-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH-hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc-
Confidence 9 55666655543 234789999999999999999999 74 999999999999999999999999999876543322
Q ss_pred ceeeccCccccccccccC-----CCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSK-----LKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
.....+|+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 181 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 181 -KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 22345899999999884 56788999999999999999999999975
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-30 Score=266.89 Aligned_cols=263 Identities=22% Similarity=0.230 Sum_probs=187.5
Q ss_pred ceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCC
Q 041878 85 GIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPN 164 (773)
Q Consensus 85 gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 164 (773)
+..|.....+.++.++++++ .+|..+ .++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..|+.+++
T Consensus 5 ~C~C~~~~~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~ 81 (285)
T 1ozn_A 5 ACVCYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81 (285)
T ss_dssp TCEEECSSSCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred CceECCCCCeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccC
Confidence 34465444456777777776 345433 468999999999999888888999999999999999999888889999999
Q ss_pred CCEEEccCCC-CCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccc
Q 041878 165 LQTLDLSNNA-LIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQ 243 (773)
Q Consensus 165 L~~L~Ls~N~-l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~ 243 (773)
|++|+|++|. ++...|..+..+++|++|+|++|++++..+..+.++++|++|++++|++++..+..+..+. +|+
T Consensus 82 L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-----~L~ 156 (285)
T 1ozn_A 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG-----NLT 156 (285)
T ss_dssp CCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-----TCC
T ss_pred CCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCC-----Ccc
Confidence 9999999997 7766688889999999999999999988888888888999999988888855544444333 667
Q ss_pred eeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCC
Q 041878 244 FLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNR 323 (773)
Q Consensus 244 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 323 (773)
+|+|++|.+++..+..+..+++|+.|+|++|++++..|..|..+++|++|++++|++++..+..+..+++|+.|++++|+
T Consensus 157 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~ 236 (285)
T 1ozn_A 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236 (285)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSC
T ss_pred EEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCC
Confidence 77777777666655566666667777777776666666666666666666666666665555556666666666666666
Q ss_pred CCCCcchhhccccccccccccCccccccccccc
Q 041878 324 LGNKIPEGLERLQNLTVLNLKNNQFKGHIPETI 356 (773)
Q Consensus 324 l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~ 356 (773)
+....+.. .-...|+.+..+.+.+....|..+
T Consensus 237 ~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 237 WVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp EECSGGGH-HHHHHHHHCCSEECCCBEEESGGG
T ss_pred ccCCCCcH-HHHHHHHhcccccCccccCCchHh
Confidence 65433221 111234444455555555555544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=271.55 Aligned_cols=171 Identities=14% Similarity=0.106 Sum_probs=146.8
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcc---cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK---GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+..+++++||||+++++++. ..+..|+|||
T Consensus 33 y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e 111 (286)
T 3uqc_A 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-TRAGGLVVAE 111 (286)
T ss_dssp EEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-ETTEEEEEEE
T ss_pred EEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-ECCcEEEEEE
Confidence 455689999999999999875 5899999999765432 2467899999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++++|.+++++. ....++.+++.|++.||+||| +.||+||||||+|||++.++.+||+++|
T Consensus 112 ~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH-~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 112 WIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH-RAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred ecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHH-HCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999643 245567889999999999999 9999999999999999999999998443
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
|++ .++.++|||||||++|||+||+.||...+.
T Consensus 175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 333 378899999999999999999999987543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-30 Score=273.56 Aligned_cols=286 Identities=19% Similarity=0.221 Sum_probs=182.3
Q ss_pred HHhCCCCCCCcCCCCCC-CCCCCCCCCcceEeeCCCEEEEEcCCCCcccc----cCccc--cCCCCCcEEEccCCccccc
Q 041878 58 KHDLIDPHGFLRSWNDS-GVGACSGGWAGIKCVKGQVIAIQLPWRRLGGR----ISEKI--SQLHALRKLSLHDNLLAGP 130 (773)
Q Consensus 58 k~~~~~~~~~l~sW~~~-~~~~c~~~w~gv~c~~~~v~~l~l~~~~l~~~----i~~~l--~~l~~L~~L~L~~n~l~~~ 130 (773)
+.++.|+...+.+|... ..++|. |.+.-|....- .-.-+...|. ++..+ ...++++.|+|++|.++ .
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~--~~~~w~~~~~~---~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~ 95 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNR--WHSAWRQANSN---NPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-Q 95 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTT--HHHHHHHHTTT---CTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-S
T ss_pred cccCchHHHHHHHHHHhccCCchh--hhhhhcccccc---cccccccCCcchhhhHHHHhcccccceeEEEccCCCch-h
Confidence 44555666678888532 235555 87776621100 0001111111 11111 12355666666666665 4
Q ss_pred CCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCC
Q 041878 131 VPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRL 210 (773)
Q Consensus 131 ~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l 210 (773)
+|..+..+++|++|+|++|+++ .+|..++++++|++|+|++|.++ .+|..+.++++|++|+|++|++.+
T Consensus 96 lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~--------- 164 (328)
T 4fcg_A 96 FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT--------- 164 (328)
T ss_dssp CCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCC---------
T ss_pred cChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCcc---------
Confidence 5555555566666666666555 55555555555555555555555 445555555555555555554444
Q ss_pred CccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCccccc
Q 041878 211 PSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKL 290 (773)
Q Consensus 211 ~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 290 (773)
.+|..++.. ..+..+..+++|++|+|++|+++ .+|..+..+++|
T Consensus 165 ---------------~~p~~~~~~--------------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L 208 (328)
T 4fcg_A 165 ---------------ELPEPLAST--------------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL 208 (328)
T ss_dssp ---------------CCCSCSEEE--------------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTC
T ss_pred ---------------ccChhHhhc--------------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCC
Confidence 444333211 01223555667777777777777 667777777888
Q ss_pred ceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCc
Q 041878 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSEN 370 (773)
Q Consensus 291 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N 370 (773)
++|+|++|++++ +|..+..+++|++|+|++|++.+.+|..+..+++|++|++++|++.+.+|..++++++|++|+|++|
T Consensus 209 ~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n 287 (328)
T 4fcg_A 209 KSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC 287 (328)
T ss_dssp CEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTC
T ss_pred CEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCC
Confidence 888888888874 5556778888888888888888888888888888888888888888888888888888888888888
Q ss_pred cCccCCCchhhccCccCEEEeecccCC
Q 041878 371 DFTGEISPSLASLANLTSFNVSYNNLS 397 (773)
Q Consensus 371 ~l~~~~~~~~~~l~~L~~L~ls~N~l~ 397 (773)
++.+.+|..+..+++|+.+++..|.+.
T Consensus 288 ~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 288 VNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CchhhccHHHhhccCceEEeCCHHHHH
Confidence 888888888888888888888877654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=285.87 Aligned_cols=195 Identities=17% Similarity=0.234 Sum_probs=151.9
Q ss_pred hhcccccccceEEEEEEe-CCCCEEEEEEecccCc---ccHHHHHHHHHHHHccCC-Cce----------E-----Ee--
Q 041878 539 TAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHH-PNL----------L-----AL-- 596 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h-~ni----------v-----~l-- 596 (773)
..++||+|+||+||+|.+ .+|+.||||+++.... ...+.+.+|+.+++.++| +|. + .+
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 467899999999999985 5799999999974322 336789999999999987 221 1 11
Q ss_pred ----EEEEECC----CCeEEEEEeecCCCCHHHHHhhc----CCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCC
Q 041878 597 ----RAYYLGP----KGEKLLVFDFMPKGSLASFLHAR----GPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTS 664 (773)
Q Consensus 597 ----~~~~~~~----~~~~~lV~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~ 664 (773)
..+.... ....+++|+++ +++|.++++.. .....+++..++.++.||++||+||| +.||+||||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~iiHrDiKp 239 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-HYGLVHTYLRP 239 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH-HTTEECSCCCG
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCccc
Confidence 1111111 12356777766 78999988522 22345788899999999999999999 99999999999
Q ss_pred CCEEeCCCCCeEEeecCCccccccccccceeeccCcccccccccc----------CCCCCCcchhhHHHHHHHHHHHcCC
Q 041878 665 SNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELS----------KLKNANTKTDVYSLGVIILELLTGK 734 (773)
Q Consensus 665 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dvws~Gv~l~el~tg~ 734 (773)
+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||+||+
T Consensus 240 ~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~ 314 (413)
T 3dzo_A 240 VDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314 (413)
T ss_dssp GGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred ceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence 9999999999999999998765433 233457 999999988 6667889999999999999999999
Q ss_pred CCCCCC
Q 041878 735 SPGEPM 740 (773)
Q Consensus 735 ~P~~~~ 740 (773)
.||...
T Consensus 315 ~Pf~~~ 320 (413)
T 3dzo_A 315 LPNTDD 320 (413)
T ss_dssp CCCCTT
T ss_pred CCCCCc
Confidence 999874
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=276.89 Aligned_cols=271 Identities=25% Similarity=0.366 Sum_probs=171.7
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
..++.|++++|.+++ +|+. +++|++|++++|.+++ +|.. .++|++|+|++|++++ +| .|+++++|++|++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l 160 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDV 160 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEEC
Confidence 467778888887776 5543 3677777777777774 2221 1577888888887775 66 4777788888888
Q ss_pred cCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecccc
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN 250 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n 250 (773)
++|.+++ +|..+ ++|++|++++|++++ +| .+.++++|++|++++|++++ +|... .+|++|++++|
T Consensus 161 ~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~--------~~L~~L~l~~n 225 (454)
T 1jl5_A 161 DNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP--------LSLESIVAGNN 225 (454)
T ss_dssp CSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC--------TTCCEEECCSS
T ss_pred CCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc--------CcccEEECcCC
Confidence 8887774 55433 477777888777775 45 47777777777777777774 33321 25777777777
Q ss_pred ccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCC--Cc
Q 041878 251 LIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGN--KI 328 (773)
Q Consensus 251 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~ 328 (773)
.++ .+| .++.+++|++|++++|++++ +|.. +++|++|++++|++++ +|.. +++|+.|++++|++++ ..
T Consensus 226 ~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~~ 295 (454)
T 1jl5_A 226 ILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSEL 295 (454)
T ss_dssp CCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESCC
T ss_pred cCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccCc
Confidence 776 444 36677777777777777764 3432 2456666666666654 3322 2445555555555544 22
Q ss_pred chhhc-------------cc-cccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecc
Q 041878 329 PEGLE-------------RL-QNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYN 394 (773)
Q Consensus 329 ~~~l~-------------~l-~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N 394 (773)
|..+. .+ ++|+.|++++|++++ +|.. +++|+.|++++|+++ .+|. .+++|+.|++++|
T Consensus 296 ~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N 367 (454)
T 1jl5_A 296 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYN 367 (454)
T ss_dssp CTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSS
T ss_pred CCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCC
Confidence 22111 22 467777777777774 4443 467777777777777 3554 3567777777777
Q ss_pred cCCC--CCchhh
Q 041878 395 NLSG--SVPPLL 404 (773)
Q Consensus 395 ~l~g--~~p~~~ 404 (773)
++++ .+|..+
T Consensus 368 ~l~~l~~ip~~l 379 (454)
T 1jl5_A 368 PLREFPDIPESV 379 (454)
T ss_dssp CCSSCCCCCTTC
T ss_pred CCCcCCCChHHH
Confidence 7777 566544
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-30 Score=291.89 Aligned_cols=287 Identities=26% Similarity=0.351 Sum_probs=237.1
Q ss_pred CcCCCCCCCCCCCCCCCcce--------EeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCC
Q 041878 67 FLRSWNDSGVGACSGGWAGI--------KCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFL 138 (773)
Q Consensus 67 ~l~sW~~~~~~~c~~~w~gv--------~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l 138 (773)
..++|.. +.++|. |.|. .|....++.|++++++++ .+|..+. ++|++|+|++|+|+ .+|. .+
T Consensus 11 ~w~~W~~-~~~~~~--~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l 80 (622)
T 3g06_A 11 VWSAWRR-AAPAEE--SRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LP 80 (622)
T ss_dssp HHHHHHH-TCCGGG--HHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CC
T ss_pred HHHHHHh-cCCcch--hccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cC
Confidence 3466743 334444 8653 334456899999999998 7887776 89999999999999 4665 67
Q ss_pred CCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeec
Q 041878 139 PNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLAL 218 (773)
Q Consensus 139 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 218 (773)
++|++|+|++|+|+ .+|. .+++|++|+|++|.+++ +|. .+++|++|+|++|++++ +|.. +++|++|+|
T Consensus 81 ~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~L 148 (622)
T 3g06_A 81 PELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSV 148 (622)
T ss_dssp TTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEEC
T ss_pred CCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEEC
Confidence 99999999999999 5665 78999999999999985 555 57889999999999985 5543 489999999
Q ss_pred cccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccc
Q 041878 219 QHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYN 298 (773)
Q Consensus 219 ~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 298 (773)
++|++++ +|.. ..+|+.|++++|.+++. | ..+++|+.|++++|++++ +|.. +++|+.|++++|
T Consensus 149 s~N~l~~-l~~~--------~~~L~~L~L~~N~l~~l-~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N 211 (622)
T 3g06_A 149 SDNQLAS-LPAL--------PSELCKLWAYNNQLTSL-P---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNN 211 (622)
T ss_dssp CSSCCSC-CCCC--------CTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSS
T ss_pred cCCcCCC-cCCc--------cCCCCEEECCCCCCCCC-c---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCC
Confidence 9999985 4432 23799999999999964 4 457899999999999996 5543 478999999999
Q ss_pred cccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCc
Q 041878 299 AIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISP 378 (773)
Q Consensus 299 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 378 (773)
.++ .+|.. +++|+.|+|++|++++ +| ..+++|+.|++++|+|+ .+|. .+++|+.|+|++|+|+ .+|.
T Consensus 212 ~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~ 278 (622)
T 3g06_A 212 RLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPE 278 (622)
T ss_dssp CCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCG
T ss_pred ccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCH
Confidence 999 45543 4899999999999987 44 56689999999999999 5665 6789999999999999 7899
Q ss_pred hhhccCccCEEEeecccCCCCCchhhh
Q 041878 379 SLASLANLTSFNVSYNNLSGSVPPLLS 405 (773)
Q Consensus 379 ~~~~l~~L~~L~ls~N~l~g~~p~~~~ 405 (773)
.+..+++|+.|+|++|++++.+|..+.
T Consensus 279 ~l~~l~~L~~L~L~~N~l~~~~~~~l~ 305 (622)
T 3g06_A 279 SLIHLSSETTVNLEGNPLSERTLQALR 305 (622)
T ss_dssp GGGGSCTTCEEECCSCCCCHHHHHHHH
T ss_pred HHhhccccCEEEecCCCCCCcCHHHHH
Confidence 999999999999999999998887663
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-30 Score=283.71 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=130.0
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCC-------------ceEEcccCccCCCCCC
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNL-------------RGVYLFNNRLSGSIPP 157 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L-------------~~L~L~~n~l~~~~p~ 157 (773)
.+++.++++++++ |.+|+.++++++|++|++++|.+.|.+|..++.+++| ++|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 4577788888888 7888888888888888888888888888888877653 677777777664 332
Q ss_pred CCCCCCCCCEEEccCCCCCCCCccccc----------------cc-cccceeecccccccccCCccccCCCccceeeccc
Q 041878 158 SIGNCPNLQTLDLSNNALIGAIPPSLA----------------NS-TRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQH 220 (773)
Q Consensus 158 ~l~~l~~L~~L~Ls~N~l~~~~~~~l~----------------~l-~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 220 (773)
. .++|++|+|++|.+++ +|..+. .+ ++|++|+|++|++++ +| .+.++++|++|++++
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~ 162 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDN 162 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred C---cCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCC
Confidence 1 2455555665555553 333210 11 355666666666654 44 356666666666666
Q ss_pred cccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccc
Q 041878 221 NNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAI 300 (773)
Q Consensus 221 N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 300 (773)
|++++ +|..+ .+|++|++++|.+++ +| .++.+++|+.|++++|++++ +|... ++|++|++++|.+
T Consensus 163 N~l~~-lp~~~--------~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l 227 (454)
T 1jl5_A 163 NSLKK-LPDLP--------PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNIL 227 (454)
T ss_dssp SCCSC-CCCCC--------TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCC
T ss_pred CcCcc-cCCCc--------ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcC
Confidence 66653 33321 156666666666665 33 45666666666666666654 33322 3566666666666
Q ss_pred cccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCcc
Q 041878 301 GGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTG 374 (773)
Q Consensus 301 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (773)
+ .+| .+..+++|++|++++|++++ +|.. +++|+.|++++|++++ +|.. +++|+.|++++|++++
T Consensus 228 ~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~ 291 (454)
T 1jl5_A 228 E-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG 291 (454)
T ss_dssp S-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE
T ss_pred C-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCc
Confidence 5 444 25566666666666666654 2221 2455555555555553 3332 2455555555555554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=278.68 Aligned_cols=251 Identities=21% Similarity=0.218 Sum_probs=178.0
Q ss_pred CcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeeccc
Q 041878 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSY 196 (773)
Q Consensus 117 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~ 196 (773)
.+.++.++++++ .+|..+. ++|++|+|++|+|++..|..|+++++|++|+|++|.+++..+..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 456788888887 4665553 6788888888888877778888888888888888888877677777777777777777
Q ss_pred ccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcc
Q 041878 197 NSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKI 276 (773)
Q Consensus 197 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l 276 (773)
|+++...+..+.++++|++|+|++|+++. ..+..|..+++|+.|++++|+.
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-----------------------------~~~~~~~~l~~L~~L~l~~~~~ 183 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIES-----------------------------IPSYAFNRVPSLMRLDLGELKK 183 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCCE-----------------------------ECTTTTTTCTTCCEEECCCCTT
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcce-----------------------------eCHhHHhcCCcccEEeCCCCCC
Confidence 77775555556666666666665555542 2233455566666666666322
Q ss_pred cCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCccccccccccc
Q 041878 277 VGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETI 356 (773)
Q Consensus 277 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~ 356 (773)
.+.+ .+..|..+++|++|+|++|++++. | .+..+++|+.|+|++|++++..|..|
T Consensus 184 l~~i-----------------------~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~ 238 (452)
T 3zyi_A 184 LEYI-----------------------SEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSF 238 (452)
T ss_dssp CCEE-----------------------CTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGG
T ss_pred cccc-----------------------ChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccc
Confidence 2222 222344445555555555555432 2 35667778888888888888888999
Q ss_pred CCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCchhhh--ccCCCCCCCCCCCCCCCCC
Q 041878 357 GNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLS--KKFNSSSFVGNLQLCGYSP 424 (773)
Q Consensus 357 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~~~--~~~~~~~~~~n~~~c~~~~ 424 (773)
.++++|+.|+|++|++++..+..+..+++|+.|+|++|+|++..+..+. ..+....+.+|+..|++..
T Consensus 239 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 239 HGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred cCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 9999999999999999999999999999999999999999976554432 2344456789999888764
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-29 Score=276.96 Aligned_cols=252 Identities=20% Similarity=0.219 Sum_probs=188.3
Q ss_pred CCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecc
Q 041878 116 ALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLS 195 (773)
Q Consensus 116 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls 195 (773)
..+.++.++++++ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 4678888888888 5676554 688889999999988888888889999999999998887777888888888888888
Q ss_pred cccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCC-
Q 041878 196 YNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHN- 274 (773)
Q Consensus 196 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N- 274 (773)
+|+++...+..|..+++|++|+|++|+++... +..|..+++|++|+|++|
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~-----------------------------~~~~~~l~~L~~L~l~~~~ 171 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIP-----------------------------SYAFNRIPSLRRLDLGELK 171 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEEC-----------------------------TTTTTTCTTCCEEECCCCT
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccC-----------------------------HHHhhhCcccCEeCCCCCC
Confidence 88888666667778888888888777776433 334455555666666653
Q ss_pred cccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCccccccccc
Q 041878 275 KIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPE 354 (773)
Q Consensus 275 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~ 354 (773)
.+....+..|.++++|++|+|++|+++ .+| .+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+.
T Consensus 172 ~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 249 (440)
T 3zyj_A 172 RLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERN 249 (440)
T ss_dssp TCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTT
T ss_pred CcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChh
Confidence 333233335666666666666666666 333 356667777777777777777777777777778888888888877777
Q ss_pred ccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCc
Q 041878 355 TIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVP 401 (773)
Q Consensus 355 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p 401 (773)
.|.++++|+.|+|++|++++..+..+..+++|+.|+|++|+|.+.+.
T Consensus 250 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 250 AFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp SSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred hhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCC
Confidence 88888888888888888887777777888888888888888877665
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=264.15 Aligned_cols=254 Identities=26% Similarity=0.287 Sum_probs=163.1
Q ss_pred cEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccc
Q 041878 118 RKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197 (773)
Q Consensus 118 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N 197 (773)
+.++.+++.++ .+|..+ .++|++|+|++|++++..+..|+.+++|++|+|++|.+++..|..+..+++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 57788888877 445433 467888888888888766677888888888888888888776777888888888888888
Q ss_pred c-ccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcc
Q 041878 198 S-LLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKI 276 (773)
Q Consensus 198 ~-l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l 276 (773)
. ++...+..+..+++|++|++++|++++..| ..+..+++|++|++++|++
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-----------------------------~~~~~l~~L~~L~l~~n~l 141 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGP-----------------------------GLFRGLAALQYLYLQDNAL 141 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCT-----------------------------TTTTTCTTCCEEECCSSCC
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECH-----------------------------hHhhCCcCCCEEECCCCcc
Confidence 6 665556777777777777777777664444 3444555555555555555
Q ss_pred cCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCccccccccccc
Q 041878 277 VGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETI 356 (773)
Q Consensus 277 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~ 356 (773)
++..+..|..+++|++|+|++|++++..+..+..+++|++|++++|++++..|..+..+++|+.|++++|++++..+..+
T Consensus 142 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 221 (285)
T 1ozn_A 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221 (285)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHH
T ss_pred cccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHc
Confidence 54444445555555555555555554444455555666666666666655555666666666666666666665555556
Q ss_pred CCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCchhh
Q 041878 357 GNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLL 404 (773)
Q Consensus 357 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~~ 404 (773)
..+++|+.|+|++|++....+.. .....++.+..+.|.+.|..|..+
T Consensus 222 ~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 222 APLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp TTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGG
T ss_pred ccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHh
Confidence 66666666666666666433321 112234445566677777777654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-31 Score=280.82 Aligned_cols=253 Identities=19% Similarity=0.195 Sum_probs=182.8
Q ss_pred CCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCC-CCCccccc-------cccccceeecccccccccCCccc-
Q 041878 137 FLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALI-GAIPPSLA-------NSTRLYRLNLSYNSLLGSIPLSL- 207 (773)
Q Consensus 137 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~~~~l~-------~l~~L~~L~Ls~N~l~~~~~~~l- 207 (773)
..++|++|++++|.+ .+|..+... |++|+|++|.+. ..+|..+. ++++|++|+|++|++++.+|..+
T Consensus 41 ~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 116 (312)
T 1wwl_A 41 GGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116 (312)
T ss_dssp EEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSS
T ss_pred cCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHH
Confidence 344555555555555 444444333 555666666652 33444443 56666666666666666666654
Q ss_pred -cCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCC--CCCCc
Q 041878 208 -TRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGP--IPDEL 284 (773)
Q Consensus 208 -~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~p~~l 284 (773)
..+++|++|+|++|++++. |..++.+.....++|++|+|++|.+++..+..|+.+++|++|+|++|++.+. .+..+
T Consensus 117 ~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 195 (312)
T 1wwl_A 117 EATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195 (312)
T ss_dssp SCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHS
T ss_pred HhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHH
Confidence 6666777777777777655 5555554222224788888888888888888888999999999999988764 23333
Q ss_pred --Ccccccceeccccccccc---cCcccccccccCceEEccCCCCCCCcc-hhhccccccccccccCcccccccccccCC
Q 041878 285 --GKLSKLQKLDLSYNAIGG---SFPVTFTNITSLVSLNLENNRLGNKIP-EGLERLQNLTVLNLKNNQFKGHIPETIGN 358 (773)
Q Consensus 285 --~~l~~L~~L~Ls~N~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~L~ls~N~l~~~~~~~~~~ 358 (773)
..+++|++|+|++|++++ .....+..+++|++|+|++|++++..| ..+..+++|++|+|++|+++ .+|..+.
T Consensus 196 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~- 273 (312)
T 1wwl_A 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP- 273 (312)
T ss_dssp CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC-
T ss_pred HhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc-
Confidence 788899999999999983 222345677899999999999988775 45667899999999999998 7788776
Q ss_pred CCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCC
Q 041878 359 ISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGS 399 (773)
Q Consensus 359 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~ 399 (773)
++|++|+|++|++++. |. +..+++|+.|+|++|+|++.
T Consensus 274 -~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 274 -AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp -SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred -CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 8999999999999976 55 88999999999999999863
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-29 Score=274.93 Aligned_cols=243 Identities=23% Similarity=0.265 Sum_probs=186.3
Q ss_pred CCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCC
Q 041878 99 PWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGA 178 (773)
Q Consensus 99 ~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 178 (773)
.+.+++ .+|..+. +.++.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|.++..
T Consensus 51 ~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~ 127 (440)
T 3zyj_A 51 VRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTI 127 (440)
T ss_dssp CSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSC
T ss_pred CCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCee
Confidence 334444 4565554 6899999999999999999999999999999999999988889999999999999999999977
Q ss_pred CccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCc
Q 041878 179 IPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPV 258 (773)
Q Consensus 179 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~ 258 (773)
.+..|..+++|++|+|++|+++...+..|.++++|++|+|++|+..+.++ +.
T Consensus 128 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~----------------------------~~ 179 (440)
T 3zyj_A 128 PNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYIS----------------------------EG 179 (440)
T ss_dssp CTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEEC----------------------------TT
T ss_pred CHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeC----------------------------cc
Confidence 67789999999999999999998888889999999999999855433333 23
Q ss_pred cCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhcccccc
Q 041878 259 SLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNL 338 (773)
Q Consensus 259 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 338 (773)
.|..+++|++|+|++|+++. +| .+..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|
T Consensus 180 ~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 257 (440)
T 3zyj_A 180 AFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSL 257 (440)
T ss_dssp TTTTCSSCCEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTC
T ss_pred hhhcccccCeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCC
Confidence 45555666666666666663 33 35666666666666666666666666666777777777777766666666677777
Q ss_pred ccccccCcccccccccccCCCCcCceeecCCccCcc
Q 041878 339 TVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTG 374 (773)
Q Consensus 339 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (773)
+.|+|++|++++..+..+..+++|+.|+|++|++..
T Consensus 258 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 258 VEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp CEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred CEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 777777777776666666777777777777777663
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=262.50 Aligned_cols=171 Identities=22% Similarity=0.355 Sum_probs=146.5
Q ss_pred hcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHH-HccCCCceEEeEEEEEC---CCCeEEEEEeec
Q 041878 540 AEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAI-GKIHHPNLLALRAYYLG---PKGEKLLVFDFM 614 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~---~~~~~~lV~e~~ 614 (773)
.++||+|+||.||+|.. .+++.||+|+++. ...+.+|+.++ +..+||||+++++++.. .....++||||+
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred CcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 37799999999999986 4789999999953 34567888888 55689999999999854 244689999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC---CCCeEEeecCCccccccccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE---KTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~---~~~~kl~DfG~a~~~~~~~~ 691 (773)
++|+|.+++.... ...+++..+..++.|++.||+||| +.||+||||||+||+++. ++.+||+|||++....
T Consensus 98 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---- 171 (299)
T 3m2w_A 98 DGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---- 171 (299)
T ss_dssp CSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc----
Confidence 9999999998754 235899999999999999999999 999999999999999998 7889999999886432
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
+..++.++||||+||++|||++|+.||...
T Consensus 172 -------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~ 201 (299)
T 3m2w_A 172 -------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSN 201 (299)
T ss_dssp -------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred -------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 234678999999999999999999999754
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-31 Score=277.05 Aligned_cols=267 Identities=23% Similarity=0.281 Sum_probs=180.5
Q ss_pred cCCCCCCCCCCCCCCCcc--eEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCccc-ccCCCCCC-------C
Q 041878 68 LRSWNDSGVGACSGGWAG--IKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLA-GPVPWSLG-------F 137 (773)
Q Consensus 68 l~sW~~~~~~~c~~~w~g--v~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~-~~~~~~l~-------~ 137 (773)
..+|.. ...|.. +.. +.|...+++.++++++.+ .+|..+... |+.|+|++|.++ +.+|..+. +
T Consensus 21 ~~~~~~--~~~c~~-~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~ 93 (312)
T 1wwl_A 21 KPDWSS--AFNCLG-AADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLG 93 (312)
T ss_dssp SCCGGG--GGGSSS-CSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHT
T ss_pred ccchHH--Hhhhhc-cccEEEEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcC
Confidence 456743 223332 444 455556677788888888 778777655 899999999984 56676665 7
Q ss_pred CCCCceEEcccCccCCCCCCCC--CCCCCCCEEEccCCCCCCCCccccccc-----cccceeecccccccccCCccccCC
Q 041878 138 LPNLRGVYLFNNRLSGSIPPSI--GNCPNLQTLDLSNNALIGAIPPSLANS-----TRLYRLNLSYNSLLGSIPLSLTRL 210 (773)
Q Consensus 138 l~~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~~~~~l~~l-----~~L~~L~Ls~N~l~~~~~~~l~~l 210 (773)
+++|++|+|++|++++.+|..+ +.+++|++|+|++|.+++. |..+..+ ++|++|+|++|++++..+..+.++
T Consensus 94 l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l 172 (312)
T 1wwl_A 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF 172 (312)
T ss_dssp TSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCC
T ss_pred cCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccC
Confidence 8999999999999998888876 8999999999999999876 8888877 889999999999998888889999
Q ss_pred Cccceeecccccccccc--CCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCC--CC-CCcC
Q 041878 211 PSLSVLALQHNNLSGSV--PNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGP--IP-DELG 285 (773)
Q Consensus 211 ~~L~~L~L~~N~l~~~~--p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~p-~~l~ 285 (773)
++|++|+|++|++.+.+ +..+ .+..+++|++|+|++|++++. ++ ..+.
T Consensus 173 ~~L~~L~Ls~N~l~~~~~~~~~~---------------------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 225 (312)
T 1wwl_A 173 PALSTLDLSDNPELGERGLISAL---------------------------CPLKFPTLQVLALRNAGMETPSGVCSALAA 225 (312)
T ss_dssp SSCCEEECCSCTTCHHHHHHHHS---------------------------CTTSCTTCCEEECTTSCCCCHHHHHHHHHH
T ss_pred CCCCEEECCCCCcCcchHHHHHH---------------------------HhccCCCCCEEECCCCcCcchHHHHHHHHh
Confidence 99999999999877542 2111 113344455555555544421 11 1223
Q ss_pred cccccceeccccccccccCc-ccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCce
Q 041878 286 KLSKLQKLDLSYNAIGGSFP-VTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQ 364 (773)
Q Consensus 286 ~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~ 364 (773)
.+++|++|+|++|++++..| ..+..+++|++|+|++|+++ .+|..+. ++|++|++++|++++. |. +..+++|++
T Consensus 226 ~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~ 300 (312)
T 1wwl_A 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGN 300 (312)
T ss_dssp TTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEE
T ss_pred cCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCE
Confidence 34455555555555554443 33444556666666666665 4444444 5666666666666654 44 667777777
Q ss_pred eecCCccCcc
Q 041878 365 LDLSENDFTG 374 (773)
Q Consensus 365 L~L~~N~l~~ 374 (773)
|+|++|++++
T Consensus 301 L~L~~N~l~~ 310 (312)
T 1wwl_A 301 LSLKGNPFLD 310 (312)
T ss_dssp EECTTCTTTC
T ss_pred EeccCCCCCC
Confidence 7777777764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-31 Score=278.93 Aligned_cols=264 Identities=22% Similarity=0.230 Sum_probs=169.9
Q ss_pred cEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccc
Q 041878 118 RKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197 (773)
Q Consensus 118 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N 197 (773)
+.++++.+.+.......+..+++|++|+|++|++++..|..|+.+++|++|+|++|.+++..+ +..+++|++|+|++|
T Consensus 13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 344444555443333334445555666666666555555555566666666666666554332 555666666666666
Q ss_pred cccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCccc
Q 041878 198 SLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIV 277 (773)
Q Consensus 198 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~ 277 (773)
++++.. ..++|++|++++|++++..+.. .++|++|++++|.+++..+..++.+++|++|+|++|+++
T Consensus 91 ~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~--------~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 157 (317)
T 3o53_A 91 YVQELL-----VGPSIETLHAANNNISRVSCSR--------GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157 (317)
T ss_dssp EEEEEE-----ECTTCCEEECCSSCCSEEEECC--------CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCC
T ss_pred cccccc-----CCCCcCEEECCCCccCCcCccc--------cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCC
Confidence 655321 2256666666666666444332 125777777777777666667777777777888877777
Q ss_pred CCCCCCcC-cccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCccccccccccc
Q 041878 278 GPIPDELG-KLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETI 356 (773)
Q Consensus 278 ~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~ 356 (773)
+..+..+. .+++|++|+|++|.+++. + ....+++|++|+|++|++++.. ..+..+++|+.|++++|+++ .+|..+
T Consensus 158 ~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~-~~~~~l~~L~~L~L~~N~l~-~l~~~~ 233 (317)
T 3o53_A 158 TVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLV-LIEKAL 233 (317)
T ss_dssp EEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCC-EECTTC
T ss_pred cccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcch-hhhcccCcccEEECcCCccc-chhhHh
Confidence 66555553 567788888888877754 2 2234778888888888886543 34777888888888888887 467778
Q ss_pred CCCCcCceeecCCccCc-cCCCchhhccCccCEEEee-cccCCCCC
Q 041878 357 GNISGINQLDLSENDFT-GEISPSLASLANLTSFNVS-YNNLSGSV 400 (773)
Q Consensus 357 ~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~ls-~N~l~g~~ 400 (773)
..+++|+.|+|++|++. +.+|..+..+++|+.|+++ .+.++|..
T Consensus 234 ~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~ 279 (317)
T 3o53_A 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279 (317)
T ss_dssp CCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSS
T ss_pred hcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCc
Confidence 88888888888888887 6677777788888888877 33444433
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-30 Score=271.80 Aligned_cols=272 Identities=21% Similarity=0.203 Sum_probs=231.4
Q ss_pred eCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEE
Q 041878 89 VKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTL 168 (773)
Q Consensus 89 ~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 168 (773)
+..+....+++.+.+...+...+..+++|++|+|++|.+++..|..+..+++|++|+|++|++++..+ +..+++|++|
T Consensus 8 ~g~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L 85 (317)
T 3o53_A 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTL 85 (317)
T ss_dssp ETTEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEE
T ss_pred CcCceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEE
Confidence 34456667788888876666666778899999999999998888899999999999999999997665 9999999999
Q ss_pred EccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecc
Q 041878 169 DLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLD 248 (773)
Q Consensus 169 ~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~ 248 (773)
+|++|.+++. ...++|++|++++|++++..+. .+++|++|++++|++++..+..++.+. +|++|+|+
T Consensus 86 ~Ls~n~l~~l-----~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~-----~L~~L~Ls 152 (317)
T 3o53_A 86 DLNNNYVQEL-----LVGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRS-----RVQYLDLK 152 (317)
T ss_dssp ECCSSEEEEE-----EECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGS-----SEEEEECT
T ss_pred ECcCCccccc-----cCCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccC-----CCCEEECC
Confidence 9999999843 2448999999999999876544 367899999999999987776776554 89999999
Q ss_pred ccccccccCccCC-CCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCC
Q 041878 249 HNLIAGTIPVSLG-KLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNK 327 (773)
Q Consensus 249 ~n~l~~~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 327 (773)
+|.+++..+..+. .+++|++|+|++|++++. + ....+++|++|+|++|++++. |..+..+++|+.|+|++|+++ .
T Consensus 153 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~ 228 (317)
T 3o53_A 153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-L 228 (317)
T ss_dssp TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-E
T ss_pred CCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-c
Confidence 9999998887774 789999999999999865 3 234589999999999999955 455999999999999999997 5
Q ss_pred cchhhccccccccccccCcccc-cccccccCCCCcCceeecCCc-cCccCCCch
Q 041878 328 IPEGLERLQNLTVLNLKNNQFK-GHIPETIGNISGINQLDLSEN-DFTGEISPS 379 (773)
Q Consensus 328 ~~~~l~~l~~L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~ 379 (773)
+|..+..+++|+.|++++|++. +.+|..+..+++|+.|++++| .+.|..|..
T Consensus 229 l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence 7888999999999999999999 888999999999999999944 577665544
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=284.42 Aligned_cols=235 Identities=23% Similarity=0.247 Sum_probs=123.8
Q ss_pred CCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeec
Q 041878 139 PNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLAL 218 (773)
Q Consensus 139 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 218 (773)
++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| +..+++|++|+|++|.+++..+ .++|++|++
T Consensus 34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L 106 (487)
T 3oja_A 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA 106 (487)
T ss_dssp GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence 345555555555554444455555555555555555543332 4455555555555555442211 145555555
Q ss_pred cccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcC-cccccceecccc
Q 041878 219 QHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELG-KLSKLQKLDLSY 297 (773)
Q Consensus 219 ~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~ 297 (773)
++|.+++..+..+ ++|+.|+|++|.+++..|..++.+++|+.|+|++|.+++..|..+. .+++|++|+|++
T Consensus 107 ~~N~l~~~~~~~l--------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~ 178 (487)
T 3oja_A 107 ANNNISRVSCSRG--------QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178 (487)
T ss_dssp CSSCCCCEEECCC--------SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTT
T ss_pred cCCcCCCCCcccc--------CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCC
Confidence 5555554333211 2455555555555555555555556666666666666655555554 455666666666
Q ss_pred ccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCc-cCC
Q 041878 298 NAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFT-GEI 376 (773)
Q Consensus 298 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~ 376 (773)
|.|++..+ +..+++|+.|+|++|++++..| .+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|++. +.+
T Consensus 179 N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~ 254 (487)
T 3oja_A 179 NFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTL 254 (487)
T ss_dssp SCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHH
T ss_pred Cccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcch
Confidence 66654422 2235566666666666654333 35556666666666666663 4555666666666666666665 444
Q ss_pred CchhhccCccCEEEee
Q 041878 377 SPSLASLANLTSFNVS 392 (773)
Q Consensus 377 ~~~~~~l~~L~~L~ls 392 (773)
|..+..++.|+.++++
T Consensus 255 ~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 255 RDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHHHTTCHHHHHHHHH
T ss_pred HHHHHhCCCCcEEecc
Confidence 5555555555555443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-31 Score=296.76 Aligned_cols=307 Identities=23% Similarity=0.211 Sum_probs=141.8
Q ss_pred CEEEEEcCCCCccc----ccCccccCCCCCcEEEccCCcccccCCCCC-CCCC----CCceEEcccCccCC----CCCCC
Q 041878 92 QVIAIQLPWRRLGG----RISEKISQLHALRKLSLHDNLLAGPVPWSL-GFLP----NLRGVYLFNNRLSG----SIPPS 158 (773)
Q Consensus 92 ~v~~l~l~~~~l~~----~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l-~~l~----~L~~L~L~~n~l~~----~~p~~ 158 (773)
+++.|+|++|++++ .++..+..+++|++|+|++|.+++..+..+ ..++ +|++|+|++|+++. .++..
T Consensus 29 ~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 108 (461)
T 1z7x_W 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 108 (461)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHH
Confidence 34445555555543 234445555555555555555543222111 1122 45555555555552 33455
Q ss_pred CCCCCCCCEEEccCCCCCCCCcccccc-----ccccceeecccccccccC----CccccCCCccceeeccccccccccCC
Q 041878 159 IGNCPNLQTLDLSNNALIGAIPPSLAN-----STRLYRLNLSYNSLLGSI----PLSLTRLPSLSVLALQHNNLSGSVPN 229 (773)
Q Consensus 159 l~~l~~L~~L~Ls~N~l~~~~~~~l~~-----l~~L~~L~Ls~N~l~~~~----~~~l~~l~~L~~L~L~~N~l~~~~p~ 229 (773)
+..+++|++|+|++|.+++..+..+.. .++|++|+|++|++++.. +..+..+++|++|++++|.+++..+.
T Consensus 109 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 188 (461)
T 1z7x_W 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVR 188 (461)
T ss_dssp TTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHH
Confidence 555555555555555554332222221 334555555555555422 33344455555555555555433322
Q ss_pred cccccccCcccccceeeccccccccc----cCccCCCCCCccEEECCCCcccCCC-----CCCcCcccccceeccccccc
Q 041878 230 NWGVLAGNKSYQLQFLNLDHNLIAGT----IPVSLGKLGLLQEISLSHNKIVGPI-----PDELGKLSKLQKLDLSYNAI 300 (773)
Q Consensus 230 ~~~~l~~~~~~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~-----p~~l~~l~~L~~L~Ls~N~l 300 (773)
.+........++|++|++++|.+++. ++..+..+++|++|++++|++++.. +..+..+++|++|++++|.+
T Consensus 189 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l 268 (461)
T 1z7x_W 189 VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 268 (461)
T ss_dssp HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCC
Confidence 22211101112455555555555542 2344444555555555555554321 11122344555555555555
Q ss_pred ccc----CcccccccccCceEEccCCCCCCCcchhhccc-----cccccccccCcccccc----cccccCCCCcCceeec
Q 041878 301 GGS----FPVTFTNITSLVSLNLENNRLGNKIPEGLERL-----QNLTVLNLKNNQFKGH----IPETIGNISGINQLDL 367 (773)
Q Consensus 301 ~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l-----~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~L 367 (773)
++. ++..+..+++|++|++++|++++..+..+... ++|+.|++++|.+++. ++..+..+++|++|+|
T Consensus 269 ~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L 348 (461)
T 1z7x_W 269 TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 348 (461)
T ss_dssp CHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEEC
T ss_pred CHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEc
Confidence 532 34444445555555555555544333333322 3555555555555443 3334444455555555
Q ss_pred CCccCccCCCchhhc-----cCccCEEEeecccCCC
Q 041878 368 SENDFTGEISPSLAS-----LANLTSFNVSYNNLSG 398 (773)
Q Consensus 368 ~~N~l~~~~~~~~~~-----l~~L~~L~ls~N~l~g 398 (773)
++|++++..+..+.. .++|+.|+|++|++++
T Consensus 349 s~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~ 384 (461)
T 1z7x_W 349 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384 (461)
T ss_dssp CSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred cCCccccccHHHHHHHHcCCCCceEEEECCCCCCCh
Confidence 555555443333332 3455555555555543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=275.71 Aligned_cols=251 Identities=22% Similarity=0.217 Sum_probs=212.9
Q ss_pred CCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCC
Q 041878 100 WRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAI 179 (773)
Q Consensus 100 ~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 179 (773)
..++...+......+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| ++.+++|++|+|++|.+++.
T Consensus 19 ~~~l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l- 95 (487)
T 3oja_A 19 DSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL- 95 (487)
T ss_dssp TTTHHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEE-
T ss_pred hhhhHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCC-
Confidence 333333333333445589999999999998888899999999999999999997766 99999999999999999843
Q ss_pred ccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCcc
Q 041878 180 PPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVS 259 (773)
Q Consensus 180 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~ 259 (773)
| ..++|++|+|++|.+++..+. .+++|+.|+|++|++++..|..++.+. +|++|+|++|.+++..|..
T Consensus 96 ~----~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~-----~L~~L~Ls~N~l~~~~~~~ 163 (487)
T 3oja_A 96 L----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRS-----RVQYLDLKLNEIDTVNFAE 163 (487)
T ss_dssp E----ECTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGS-----SEEEEECTTSCCCEEEGGG
T ss_pred C----CCCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCC-----CCCEEECCCCCCCCcChHH
Confidence 2 338999999999999976554 468899999999999988887777655 8999999999999988888
Q ss_pred CC-CCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhcccccc
Q 041878 260 LG-KLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNL 338 (773)
Q Consensus 260 l~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 338 (773)
+. .+++|+.|+|++|.+++..+ +..+++|++|+|++|.|++..| .+..+++|+.|+|++|++++ +|..+..+++|
T Consensus 164 l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L 239 (487)
T 3oja_A 164 LAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNL 239 (487)
T ss_dssp GGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTC
T ss_pred HhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCC
Confidence 86 79999999999999997632 4468999999999999997544 58999999999999999985 77789999999
Q ss_pred ccccccCcccc-cccccccCCCCcCceeecCC
Q 041878 339 TVLNLKNNQFK-GHIPETIGNISGINQLDLSE 369 (773)
Q Consensus 339 ~~L~ls~N~l~-~~~~~~~~~l~~L~~L~L~~ 369 (773)
+.|++++|.+. +.+|..+..++.|+.|+++.
T Consensus 240 ~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~ 271 (487)
T 3oja_A 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271 (487)
T ss_dssp CEEECTTCCBCHHHHHHHHTTCHHHHHHHHHH
T ss_pred CEEEcCCCCCcCcchHHHHHhCCCCcEEeccc
Confidence 99999999998 78888899999999998863
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-30 Score=291.31 Aligned_cols=304 Identities=20% Similarity=0.184 Sum_probs=244.2
Q ss_pred CCEEEEEcCCCCcccccCcccc-CCC----CCcEEEccCCcccc----cCCCCCCCCCCCceEEcccCccCCCCCCCC--
Q 041878 91 GQVIAIQLPWRRLGGRISEKIS-QLH----ALRKLSLHDNLLAG----PVPWSLGFLPNLRGVYLFNNRLSGSIPPSI-- 159 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~-~l~----~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l-- 159 (773)
.+++.|+|++|.+++..+..+. .++ +|++|+|++|.++. .++..+..+++|++|+|++|.+++..+..+
T Consensus 56 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 135 (461)
T 1z7x_W 56 PALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE 135 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH
T ss_pred CCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHH
Confidence 4688999999999876554443 355 69999999999984 568889999999999999999885444333
Q ss_pred ---CCCCCCCEEEccCCCCCCCC----ccccccccccceeecccccccccCCcccc-----CCCccceeeccccccccc-
Q 041878 160 ---GNCPNLQTLDLSNNALIGAI----PPSLANSTRLYRLNLSYNSLLGSIPLSLT-----RLPSLSVLALQHNNLSGS- 226 (773)
Q Consensus 160 ---~~l~~L~~L~Ls~N~l~~~~----~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~-----~l~~L~~L~L~~N~l~~~- 226 (773)
...++|++|+|++|.+++.. +..+..+++|++|+|++|.++...+..+. ..++|++|++++|++++.
T Consensus 136 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 215 (461)
T 1z7x_W 136 GLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDN 215 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTH
T ss_pred HHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHH
Confidence 23678999999999998643 55667789999999999999865444443 367999999999999864
Q ss_pred ---cCCcccccccCcccccceeecccccccccc-----CccCCCCCCccEEECCCCcccCC----CCCCcCcccccceec
Q 041878 227 ---VPNNWGVLAGNKSYQLQFLNLDHNLIAGTI-----PVSLGKLGLLQEISLSHNKIVGP----IPDELGKLSKLQKLD 294 (773)
Q Consensus 227 ---~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~-----~~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~ 294 (773)
++..+.. +++|++|++++|.+++.. +..+..+++|++|++++|++++. ++..+..+++|++|+
T Consensus 216 ~~~l~~~l~~-----~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~ 290 (461)
T 1z7x_W 216 CRDLCGIVAS-----KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELS 290 (461)
T ss_dssp HHHHHHHHHH-----CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEE
T ss_pred HHHHHHHHHh-----CCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEE
Confidence 3444433 348999999999988643 33344688999999999999864 566777889999999
Q ss_pred cccccccccCccccccc-----ccCceEEccCCCCCCC----cchhhccccccccccccCcccccccccccCC-----CC
Q 041878 295 LSYNAIGGSFPVTFTNI-----TSLVSLNLENNRLGNK----IPEGLERLQNLTVLNLKNNQFKGHIPETIGN-----IS 360 (773)
Q Consensus 295 Ls~N~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~-----l~ 360 (773)
|++|.+++..+..+... ++|++|++++|.+++. ++..+..+++|++|++++|++++..+..+.. .+
T Consensus 291 Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~ 370 (461)
T 1z7x_W 291 LAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGS 370 (461)
T ss_dssp CTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred CCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCC
Confidence 99999987655555443 6999999999999876 4666778899999999999998766655543 78
Q ss_pred cCceeecCCccCcc----CCCchhhccCccCEEEeecccCCCC
Q 041878 361 GINQLDLSENDFTG----EISPSLASLANLTSFNVSYNNLSGS 399 (773)
Q Consensus 361 ~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~ls~N~l~g~ 399 (773)
+|++|+|++|.+++ .+|..+..+++|+.|++++|++++.
T Consensus 371 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 371 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp CCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred ceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence 99999999999997 7888889999999999999999864
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-28 Score=280.69 Aligned_cols=185 Identities=17% Similarity=0.081 Sum_probs=128.3
Q ss_pred ccccccceEEEEEE-eCCCCEEEEEEecccC----------cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEE
Q 041878 542 IMGKSTYGTAYKAT-LEDGSEVAVKRLREKT----------TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 542 ~lG~G~fg~Vy~~~-~~~g~~vAvK~l~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~l 609 (773)
-.+.|++|.+..+. ..-|+.+|||.+.... ....++|.+|+++|+++ .|+||+++++++ +..+..||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-ed~~~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-ENAQSGWL 319 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-ECSSEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-EECCEEEE
Confidence 35667777666654 3458899999997542 12245799999999999 699999999999 55669999
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||++|++|.+++.+.++ ++.. +|+.||+.||+|+| ++|||||||||+|||+++++.+||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH-~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALE-KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHH-HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHH-HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999999987653 4443 58999999999999 999999999999999999999999999999876543
Q ss_pred cccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P 736 (773)
.. .....+||+.|||||++.+ .+..++|+||+|++++++.++..|
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Cc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 32 2234569999999999874 467789999999998887665444
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-26 Score=234.56 Aligned_cols=217 Identities=24% Similarity=0.279 Sum_probs=150.3
Q ss_pred CCCCCCCcceEee-CCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCC
Q 041878 77 GACSGGWAGIKCV-KGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSI 155 (773)
Q Consensus 77 ~~c~~~w~gv~c~-~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 155 (773)
+.|. |.|+.|. .+.++.+++++++++ .+|..+. +.|++|+|++|++++..+..|..+++|++|+|++|+++...
T Consensus 3 ~~C~--~~~~~C~c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 3 ALCK--KDGGVCSCNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCBG--GGTCSBEEETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred ccCC--CCCCCCEeCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 4565 9998884 344566777777777 3555443 56777777777777666667777777777777777777555
Q ss_pred CCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccc
Q 041878 156 PPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLA 235 (773)
Q Consensus 156 p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 235 (773)
+..|.++++|++|+|++|.+++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|+++
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~----------- 146 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ----------- 146 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-----------
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC-----------
Confidence 555677777777777777777555555666777777777777776655555666666666666666555
Q ss_pred cCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCc
Q 041878 236 GNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLV 315 (773)
Q Consensus 236 ~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 315 (773)
+..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|+
T Consensus 147 ------------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 208 (270)
T 2o6q_A 147 ------------------SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLK 208 (270)
T ss_dssp ------------------CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred ------------------ccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCC
Confidence 33344566677777777777777766666677777888888888887766666677788888
Q ss_pred eEEccCCCCCCC
Q 041878 316 SLNLENNRLGNK 327 (773)
Q Consensus 316 ~L~Ls~N~l~~~ 327 (773)
.|+|++|++...
T Consensus 209 ~L~l~~N~~~c~ 220 (270)
T 2o6q_A 209 MLQLQENPWDCT 220 (270)
T ss_dssp EEECCSSCBCCS
T ss_pred EEEecCCCeeCC
Confidence 888888887543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-26 Score=235.60 Aligned_cols=227 Identities=22% Similarity=0.231 Sum_probs=166.1
Q ss_pred eEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccc
Q 041878 143 GVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNN 222 (773)
Q Consensus 143 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~ 222 (773)
.++..+.+++ .+|..+. ++|++|+|++|.+++..+..+.++++|++|+|++|++++..+..+.++++|++|+|++|+
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 4555666665 5565543 467777777777776655577777777777777777776555566666666666666666
Q ss_pred cccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccc
Q 041878 223 LSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGG 302 (773)
Q Consensus 223 l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 302 (773)
+++ ..+..|..+++|++|++++|++++..+..+..+++|++|++++|.+++
T Consensus 88 l~~-----------------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 138 (276)
T 2z62_A 88 IQS-----------------------------LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138 (276)
T ss_dssp CCE-----------------------------ECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCC
T ss_pred cCc-----------------------------cChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccce
Confidence 653 334556666777777777777776655567777777777777777775
Q ss_pred c-CcccccccccCceEEccCCCCCCCcchhhccccccc----cccccCcccccccccccCCCCcCceeecCCccCccCCC
Q 041878 303 S-FPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLT----VLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEIS 377 (773)
Q Consensus 303 ~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~----~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 377 (773)
. +|..+..+++|++|++++|++++..+..+..+++|+ .|++++|++++..+..+ ...+|+.|+|++|++++..+
T Consensus 139 ~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~-~~~~L~~L~L~~n~l~~~~~ 217 (276)
T 2z62_A 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLKELALDTNQLKSVPD 217 (276)
T ss_dssp CCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSS-CSCCEEEEECCSSCCSCCCT
T ss_pred ecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCcccc-CCCcccEEECCCCceeecCH
Confidence 3 577777788888888888888777777777777777 78889999886555444 44589999999999997777
Q ss_pred chhhccCccCEEEeecccCCCCCch
Q 041878 378 PSLASLANLTSFNVSYNNLSGSVPP 402 (773)
Q Consensus 378 ~~~~~l~~L~~L~ls~N~l~g~~p~ 402 (773)
..+..+++|+.|+|++|+++|.+|.
T Consensus 218 ~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 218 GIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp TTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred hHhcccccccEEEccCCcccccCCc
Confidence 7788999999999999999998873
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=233.97 Aligned_cols=225 Identities=23% Similarity=0.251 Sum_probs=183.2
Q ss_pred EEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeeccccc
Q 041878 119 KLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNS 198 (773)
Q Consensus 119 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~ 198 (773)
.++..+.+++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|.+++..+..+.++++|++|+|++|+
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 4666666776 5676553 689999999999998877899999999999999999997777889999999999999999
Q ss_pred ccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccC
Q 041878 199 LLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVG 278 (773)
Q Consensus 199 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 278 (773)
+++..+..+.++++|++|++++|++++.. +..++.+++|++|++++|++++
T Consensus 88 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-----------------------------~~~~~~l~~L~~L~l~~n~l~~ 138 (276)
T 2z62_A 88 IQSLALGAFSGLSSLQKLVAVETNLASLE-----------------------------NFPIGHLKTLKELNVAHNLIQS 138 (276)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCCCST-----------------------------TCCCTTCTTCCEEECCSSCCCC
T ss_pred cCccChhhhcCCccccEEECCCCCccccC-----------------------------chhcccCCCCCEEECcCCccce
Confidence 99888888999999999988888877432 2345666777777787777776
Q ss_pred C-CCCCcCcccccceeccccccccccCcccccccccCc----eEEccCCCCCCCcchhhccccccccccccCcccccccc
Q 041878 279 P-IPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLV----SLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIP 353 (773)
Q Consensus 279 ~-~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~ 353 (773)
. +|..+..+++|++|+|++|++++..+..+..+++|+ +|++++|++++..+..+. ..+|+.|++++|++++..+
T Consensus 139 ~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~ 217 (276)
T 2z62_A 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPD 217 (276)
T ss_dssp CCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCT
T ss_pred ecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCH
Confidence 3 577788888888888888888877777777777777 888899988765555444 3489999999999997767
Q ss_pred cccCCCCcCceeecCCccCccCC
Q 041878 354 ETIGNISGINQLDLSENDFTGEI 376 (773)
Q Consensus 354 ~~~~~l~~L~~L~L~~N~l~~~~ 376 (773)
..+..+++|+.|+|++|++++..
T Consensus 218 ~~~~~l~~L~~L~l~~N~~~c~c 240 (276)
T 2z62_A 218 GIFDRLTSLQKIWLHTNPWDCSC 240 (276)
T ss_dssp TTTTTCCSCCEEECCSSCBCCCT
T ss_pred hHhcccccccEEEccCCcccccC
Confidence 77889999999999999998654
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-25 Score=252.78 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=209.6
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
.+++.|+|++|.++ .+|. .+++|++|+|++|.|++ +|. .+++|++|+|++|++++ +|. .+++|++|+|
T Consensus 61 ~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L 128 (622)
T 3g06_A 61 AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWI 128 (622)
T ss_dssp TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEEC
T ss_pred CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEEC
Confidence 47889999999998 5665 67999999999999984 665 78999999999999995 554 6789999999
Q ss_pred cCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecccc
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN 250 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n 250 (773)
++|.+++ +|.. +++|++|+|++|++++ +|. .+++|+.|++++|++++ +|. ..++|+.|++++|
T Consensus 129 ~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~~--------~~~~L~~L~Ls~N 191 (622)
T 3g06_A 129 FGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LPM--------LPSGLQELSVSDN 191 (622)
T ss_dssp CSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC--------CCTTCCEEECCSS
T ss_pred CCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Ccc--------cCCCCcEEECCCC
Confidence 9999984 6654 4899999999999985 443 35789999999999995 552 2348999999999
Q ss_pred ccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcch
Q 041878 251 LIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPE 330 (773)
Q Consensus 251 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 330 (773)
.+++. |. .+++|+.|++++|.++. +|.. +++|++|+|++|+|++ +| ..+++|+.|+|++|+|+. +|.
T Consensus 192 ~l~~l-~~---~~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~ 258 (622)
T 3g06_A 192 QLASL-PT---LPSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM 258 (622)
T ss_dssp CCSCC-CC---CCTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC
T ss_pred CCCCC-CC---ccchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc
Confidence 99963 33 24789999999999994 5543 4789999999999996 55 456899999999999985 444
Q ss_pred hhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccC
Q 041878 331 GLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLA 384 (773)
Q Consensus 331 ~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 384 (773)
.+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|++++.+|..+..++
T Consensus 259 ---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 259 ---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp ---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred ---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 6789999999999999 7899999999999999999999999998888765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.4e-26 Score=234.84 Aligned_cols=224 Identities=25% Similarity=0.271 Sum_probs=112.9
Q ss_pred CCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecc
Q 041878 116 ALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLS 195 (773)
Q Consensus 116 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls 195 (773)
.+..+++.++.+.... .+..+++|+.|++++|.++. + +.++.+++|++|+|++|.+++. ..+..+++|++|+|+
T Consensus 20 ~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~ 93 (272)
T 3rfs_A 20 ETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILT 93 (272)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECT
T ss_pred HHHHHHhcCccccccc--ccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECC
Confidence 3444555555554332 24455666666666666652 2 2356666666666666666542 355666666666666
Q ss_pred cccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCc
Q 041878 196 YNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNK 275 (773)
Q Consensus 196 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~ 275 (773)
+|++++..+..+.++++|++|+|++|++++..+..++.+. +|++|++++|.+++..+..+..+++|+.|++++|+
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-----~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 168 (272)
T 3rfs_A 94 GNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLT-----NLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQ 168 (272)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCT-----TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCC-----CCCEEECCCCccCccCHHHhccCccCCEEECCCCC
Confidence 6666655555556666666666666655533332222222 34444444444443334444455555555555555
Q ss_pred ccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccc
Q 041878 276 IVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPET 355 (773)
Q Consensus 276 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~ 355 (773)
+++..+..+..+++|++|+|++|++++..+..+..+++|+.|++++|.+.+. +++|+.|+++.|.++|.+|..
T Consensus 169 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~ 241 (272)
T 3rfs_A 169 LQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNS 241 (272)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCT
T ss_pred cCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCc
Confidence 5544444445555555555555555544444444455555555555544322 223444444444444444444
Q ss_pred cC
Q 041878 356 IG 357 (773)
Q Consensus 356 ~~ 357 (773)
++
T Consensus 242 ~~ 243 (272)
T 3rfs_A 242 AG 243 (272)
T ss_dssp TS
T ss_pred cc
Confidence 43
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-27 Score=256.07 Aligned_cols=261 Identities=22% Similarity=0.231 Sum_probs=153.6
Q ss_pred EEcCCCCcccccCccccCCCCCcEEEccCCcccccCC----CCCCCCC-CCceEEcccCccCCCCCCCCCCC-----CCC
Q 041878 96 IQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVP----WSLGFLP-NLRGVYLFNNRLSGSIPPSIGNC-----PNL 165 (773)
Q Consensus 96 l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~----~~l~~l~-~L~~L~L~~n~l~~~~p~~l~~l-----~~L 165 (773)
.+|++++++|.+|..+...++|++|+|++|.+++..+ ..+..++ +|++|+|++|++++..+..++.+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 3556666666666655555556666666666665444 4455555 56666666666655544444443 556
Q ss_pred CEEEccCCCCCCCCccccccc-----cccceeecccccccccCCcccc----C-CCccceeeccccccccccCCcccccc
Q 041878 166 QTLDLSNNALIGAIPPSLANS-----TRLYRLNLSYNSLLGSIPLSLT----R-LPSLSVLALQHNNLSGSVPNNWGVLA 235 (773)
Q Consensus 166 ~~L~Ls~N~l~~~~~~~l~~l-----~~L~~L~Ls~N~l~~~~~~~l~----~-l~~L~~L~L~~N~l~~~~p~~~~~l~ 235 (773)
++|+|++|.+++..+..+... ++|++|+|++|++++..+..+. . .++|++|+|++|++++..+.
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~------ 156 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSD------ 156 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHH------
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHH------
Confidence 666666666554444433322 4555555555555543333221 2 13444444444444422211
Q ss_pred cCcccccceeeccccccccccCccCCCCC-CccEEECCCCcccCCCCCCcCc----c-cccceecccccccccc----Cc
Q 041878 236 GNKSYQLQFLNLDHNLIAGTIPVSLGKLG-LLQEISLSHNKIVGPIPDELGK----L-SKLQKLDLSYNAIGGS----FP 305 (773)
Q Consensus 236 ~~~~~~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~l~~----l-~~L~~L~Ls~N~l~~~----~~ 305 (773)
.++..+..++ +|++|+|++|++++..+..+.. + ++|++|+|++|.|++. ++
T Consensus 157 -------------------~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~ 217 (362)
T 3goz_A 157 -------------------ELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELA 217 (362)
T ss_dssp -------------------HHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred -------------------HHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHH
Confidence 1222333343 6777777777777655543333 3 5788888888887753 34
Q ss_pred ccccc-cccCceEEccCCCCCCCcch----hhccccccccccccCccccc-------ccccccCCCCcCceeecCCccCc
Q 041878 306 VTFTN-ITSLVSLNLENNRLGNKIPE----GLERLQNLTVLNLKNNQFKG-------HIPETIGNISGINQLDLSENDFT 373 (773)
Q Consensus 306 ~~~~~-l~~L~~L~Ls~N~l~~~~~~----~l~~l~~L~~L~ls~N~l~~-------~~~~~~~~l~~L~~L~L~~N~l~ 373 (773)
..+.. .++|++|+|++|++++..+. .+..+++|+.|++++|.+.+ .++..+..+++|+.|||++|++.
T Consensus 218 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~ 297 (362)
T 3goz_A 218 YIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297 (362)
T ss_dssp HHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCC
T ss_pred HHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCC
Confidence 44544 35888888888888776653 34566888888888888443 23456778888888999999888
Q ss_pred cCCCchhh
Q 041878 374 GEISPSLA 381 (773)
Q Consensus 374 ~~~~~~~~ 381 (773)
+..+..+.
T Consensus 298 ~~~~~~~~ 305 (362)
T 3goz_A 298 PSHSIPIS 305 (362)
T ss_dssp GGGCHHHH
T ss_pred CcchHHHH
Confidence 76555444
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-24 Score=222.61 Aligned_cols=206 Identities=24% Similarity=0.301 Sum_probs=153.2
Q ss_pred CCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccc
Q 041878 164 NLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQ 243 (773)
Q Consensus 164 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~ 243 (773)
+++++++++|.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|+++
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~------------------- 74 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ------------------- 74 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-------------------
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-------------------
Confidence 5677888888777 4665544 46777777777777655566666666666666666665
Q ss_pred eeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCC
Q 041878 244 FLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNR 323 (773)
Q Consensus 244 ~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 323 (773)
...+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+
T Consensus 75 ----------~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 144 (270)
T 2o6q_A 75 ----------TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNE 144 (270)
T ss_dssp ----------CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ----------eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCc
Confidence 2333445666777777777777776656666777777777777777777666777777788888888888
Q ss_pred CCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCc
Q 041878 324 LGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVP 401 (773)
Q Consensus 324 l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p 401 (773)
+++..+..+..+++|+.|++++|++++..+..+..+++|++|+|++|++++..+..+..+++|+.|+|++|++.+.++
T Consensus 145 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 145 LQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred CCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 777666667788888888888888887666778888888899999998887666678888899999999999988765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=230.93 Aligned_cols=223 Identities=20% Similarity=0.230 Sum_probs=155.8
Q ss_pred CCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeecc
Q 041878 140 NLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQ 219 (773)
Q Consensus 140 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~ 219 (773)
++..+++..+.+.... .+..+++|+.|++++|.++. + ..+..+++|++|+|++|++++. ..+..+++|++|+|+
T Consensus 20 ~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~ 93 (272)
T 3rfs_A 20 ETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILT 93 (272)
T ss_dssp HHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECT
T ss_pred HHHHHHhcCccccccc--ccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECC
Confidence 4445555555555332 34566777777777777652 2 3466666777777777766542 244555555555555
Q ss_pred ccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceecccccc
Q 041878 220 HNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNA 299 (773)
Q Consensus 220 ~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 299 (773)
+|++ ++..+..+..+++|++|+|++|++++..+..|..+++|++|++++|+
T Consensus 94 ~n~l-----------------------------~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 144 (272)
T 3rfs_A 94 GNQL-----------------------------QSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQ 144 (272)
T ss_dssp TSCC-----------------------------CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CCcc-----------------------------CccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCc
Confidence 5554 44445556677777777777777776666667777777778887777
Q ss_pred ccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCch
Q 041878 300 IGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPS 379 (773)
Q Consensus 300 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 379 (773)
+++..+..+..+++|+.|++++|++++..+..+..+++|++|++++|++++..+..+..+++|+.|+|++|++.+.
T Consensus 145 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~---- 220 (272)
T 3rfs_A 145 LQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT---- 220 (272)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC----
T ss_pred cCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc----
Confidence 7766666677778888888888888777777777888888888888888877777778888888888888888754
Q ss_pred hhccCccCEEEeecccCCCCCchhh
Q 041878 380 LASLANLTSFNVSYNNLSGSVPPLL 404 (773)
Q Consensus 380 ~~~l~~L~~L~ls~N~l~g~~p~~~ 404 (773)
+++|+.|+++.|.++|.+|..+
T Consensus 221 ---~~~l~~l~~~~n~~~g~ip~~~ 242 (272)
T 3rfs_A 221 ---CPGIRYLSEWINKHSGVVRNSA 242 (272)
T ss_dssp ---TTTTHHHHHHHHHTGGGBBCTT
T ss_pred ---CcHHHHHHHHHHhCCCcccCcc
Confidence 4467888888888888888765
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=226.01 Aligned_cols=136 Identities=24% Similarity=0.242 Sum_probs=85.7
Q ss_pred CCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhcccccccccc
Q 041878 263 LGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLN 342 (773)
Q Consensus 263 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 342 (773)
+++|++|+|++|+++ .+|..+..+++|++|+|++|+|++..+..|..+++|++|+|++|++++..+..+..+++|+.|+
T Consensus 76 l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 154 (290)
T 1p9a_G 76 LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (290)
T ss_dssp CTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEE
Confidence 344455555555554 3444455555555555555555555455555666666666666666655555566666666666
Q ss_pred ccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCC
Q 041878 343 LKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSV 400 (773)
Q Consensus 343 ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~ 400 (773)
|++|++++..+..+..+++|+.|+|++|+++ .+|..+..+.+|+.|+|++|+|.+.+
T Consensus 155 L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 6666666554555666777777777777777 56666667777888888888887765
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=234.73 Aligned_cols=226 Identities=20% Similarity=0.257 Sum_probs=137.8
Q ss_pred CCcEEEccCCcccccCCC---CCCCCCCCceEEcccCccCCCCCCCC--CCCCCCCEEEccCCCCCCCCc----cccccc
Q 041878 116 ALRKLSLHDNLLAGPVPW---SLGFLPNLRGVYLFNNRLSGSIPPSI--GNCPNLQTLDLSNNALIGAIP----PSLANS 186 (773)
Q Consensus 116 ~L~~L~L~~n~l~~~~~~---~l~~l~~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~~~----~~l~~l 186 (773)
.++.|.+.++.++...-. .+..+++|++|+|++|++++..|..+ +.+++|++|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 467777777766531100 11234668888888888888888877 788888888888888886544 334567
Q ss_pred cccceeecccccccccCCccccCCCccceeeccccccccc--cCCcccccccCcccccceeeccccccccccCccCCCCC
Q 041878 187 TRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGS--VPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLG 264 (773)
Q Consensus 187 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~ 264 (773)
++|++|+|++|++++..+..+..+++|++|+|++|++.+. ++. +..+..++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---------------------------~~~~~~l~ 197 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMA---------------------------ALCPHKFP 197 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHT---------------------------TSCTTSSC
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhH---------------------------HHhhhcCC
Confidence 8888888888888877777888888888888888887542 111 11123344
Q ss_pred CccEEECCCCcccCCCCC----CcCcccccceeccccccccccCccccccc---ccCceEEccCCCCCCCcchhhccccc
Q 041878 265 LLQEISLSHNKIVGPIPD----ELGKLSKLQKLDLSYNAIGGSFPVTFTNI---TSLVSLNLENNRLGNKIPEGLERLQN 337 (773)
Q Consensus 265 ~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~l~~l~~ 337 (773)
+|++|+|++|+++. ++. .+..+++|++|+|++|++++..|..+..+ ++|++|+|++|+++ .+|..+. ++
T Consensus 198 ~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~ 273 (310)
T 4glp_A 198 AIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AK 273 (310)
T ss_dssp CCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SC
T ss_pred CCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CC
Confidence 44444444444431 111 12344455555555555554444444443 45566666666655 3444442 56
Q ss_pred cccccccCcccccccccccCCCCcCceeecCCccCcc
Q 041878 338 LTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTG 374 (773)
Q Consensus 338 L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (773)
|+.|+|++|++++. |. +..+++|+.|+|++|+++.
T Consensus 274 L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 274 LRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 66666666666643 22 4566777777777777763
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-24 Score=224.73 Aligned_cols=116 Identities=26% Similarity=0.209 Sum_probs=75.9
Q ss_pred ccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccc
Q 041878 258 VSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQN 337 (773)
Q Consensus 258 ~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 337 (773)
..+..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+++...+..+..+++
T Consensus 94 ~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~ 173 (290)
T 1p9a_G 94 LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173 (290)
T ss_dssp CCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTT
T ss_pred hhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCC
Confidence 34445555566666666665554555666666666666666666555555666666666666666666555555666777
Q ss_pred cccccccCcccccccccccCCCCcCceeecCCccCcc
Q 041878 338 LTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTG 374 (773)
Q Consensus 338 L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (773)
|+.|+|++|+++ .+|..+..+++|+.|+|++|++..
T Consensus 174 L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 777777777776 667777777788888888888764
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.5e-26 Score=255.18 Aligned_cols=184 Identities=16% Similarity=0.230 Sum_probs=143.9
Q ss_pred hhcccccccceEEEEEEeCCCCEEEEEEecccCcc--------cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 539 TAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTK--------GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
..++||+|+||.||+|.. .++.+|+|+....... ..+++.+|++++++++||||+++..++. ..+..++|
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-DLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-ETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-eCCccEEE
Confidence 357899999999999954 4788999987543211 1345899999999999999995555553 33467999
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
|||+++++|.++++. +..++.|+++||+||| +++|+||||||+|||++. .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH-~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLH-KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHH-HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHH-HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999875 4578999999999999 999999999999999999 99999999999875543
Q ss_pred ccc------eeeccCccccccccccCC--CCCCcchhhHHHHHHHHHHHcCCCCCC
Q 041878 691 NTN------VIATAGTLGYRAPELSKL--KNANTKTDVYSLGVIILELLTGKSPGE 738 (773)
Q Consensus 691 ~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dvws~Gv~l~el~tg~~P~~ 738 (773)
... .....||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 221 124469999999999876 667888999999999999888887764
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4e-27 Score=257.12 Aligned_cols=257 Identities=19% Similarity=0.255 Sum_probs=122.7
Q ss_pred cCccccCCCCCcEEEccCCccccc----CCCCCCCCCCCceEEcccC---ccCCCCCCCC-------CCCCCCCEEEccC
Q 041878 107 ISEKISQLHALRKLSLHDNLLAGP----VPWSLGFLPNLRGVYLFNN---RLSGSIPPSI-------GNCPNLQTLDLSN 172 (773)
Q Consensus 107 i~~~l~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n---~l~~~~p~~l-------~~l~~L~~L~Ls~ 172 (773)
++..+..+++|++|+|++|.+++. ++..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 445555666666666666666543 2333555666666666654 3333444333 4555555555555
Q ss_pred CCCCC----CCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecc
Q 041878 173 NALIG----AIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLD 248 (773)
Q Consensus 173 N~l~~----~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~ 248 (773)
|.+++ .+|..+..+++|++|+|++|.+++..+..+... |.. +..|++++.. ++|++|+|+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~--l~~--l~~~~~~~~~------------~~L~~L~L~ 167 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA--LQE--LAVNKKAKNA------------PPLRSIICG 167 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH--HHH--HHHHHHHHTC------------CCCCEEECC
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH--HHH--HhhhhhcccC------------CCCcEEECC
Confidence 55554 234444455555555555555442222211110 000 0000000000 133333333
Q ss_pred ccccc-cccC---ccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccc---cCcccccccccCceEEccC
Q 041878 249 HNLIA-GTIP---VSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGG---SFPVTFTNITSLVSLNLEN 321 (773)
Q Consensus 249 ~n~l~-~~~~---~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~---~~~~~~~~l~~L~~L~Ls~ 321 (773)
+|.++ +..+ ..+..+++|++|+|++|+++.. | ..+..+..+++|+.|+|++
T Consensus 168 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~----------------------g~~~l~~~~l~~~~~L~~L~Ls~ 225 (386)
T 2ca6_A 168 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE----------------------GIEHLLLEGLAYCQELKVLDLQD 225 (386)
T ss_dssp SSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH----------------------HHHHHHHTTGGGCTTCCEEECCS
T ss_pred CCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHh----------------------HHHHHHHHHhhcCCCccEEECcC
Confidence 33333 1111 2333344455555555544410 1 1222444445555555555
Q ss_pred CCCC----CCcchhhccccccccccccCcccccc----ccccc--CCCCcCceeecCCccCcc----CCCchh-hccCcc
Q 041878 322 NRLG----NKIPEGLERLQNLTVLNLKNNQFKGH----IPETI--GNISGINQLDLSENDFTG----EISPSL-ASLANL 386 (773)
Q Consensus 322 N~l~----~~~~~~l~~l~~L~~L~ls~N~l~~~----~~~~~--~~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L 386 (773)
|.++ ..+|..+..+++|+.|+|++|.+++. ++..+ +.+++|+.|+|++|.+++ .+|..+ .++++|
T Consensus 226 n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L 305 (386)
T 2ca6_A 226 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 305 (386)
T ss_dssp SCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTC
T ss_pred CCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCc
Confidence 5543 33444455555555555555555543 34444 336666667777766665 355555 446777
Q ss_pred CEEEeecccCCCCCc
Q 041878 387 TSFNVSYNNLSGSVP 401 (773)
Q Consensus 387 ~~L~ls~N~l~g~~p 401 (773)
+.|+|++|++++..|
T Consensus 306 ~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 306 LFLELNGNRFSEEDD 320 (386)
T ss_dssp CEEECTTSBSCTTSH
T ss_pred eEEEccCCcCCcchh
Confidence 777777777776664
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-26 Score=248.04 Aligned_cols=232 Identities=19% Similarity=0.186 Sum_probs=149.0
Q ss_pred CCcceEeeCCCEEEEEcCCCCcccccCccccCC--CCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCC-CCCC
Q 041878 82 GWAGIKCVKGQVIAIQLPWRRLGGRISEKISQL--HALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGS-IPPS 158 (773)
Q Consensus 82 ~w~gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l--~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~p~~ 158 (773)
.|.++.|+...++.++++++.+. +..+..+ +.++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..
T Consensus 38 ~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~ 113 (336)
T 2ast_B 38 RWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGI 113 (336)
T ss_dssp HHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHH
T ss_pred HHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHH
Confidence 39888887666788999988776 4556666 8899999999998877665 55788899999998888765 7777
Q ss_pred CCCCCCCCEEEccCCCCCCCCccccccccccceeecccc-ccccc-CCccccCCCccceeecccc-ccccc-cCCccccc
Q 041878 159 IGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN-SLLGS-IPLSLTRLPSLSVLALQHN-NLSGS-VPNNWGVL 234 (773)
Q Consensus 159 l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N-~l~~~-~~~~l~~l~~L~~L~L~~N-~l~~~-~p~~~~~l 234 (773)
+..+++|++|+|++|.+++..+..++.+++|++|+|++| .+++. ++..+.++++|++|++++| .+++. ++..+..
T Consensus 114 ~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~- 192 (336)
T 2ast_B 114 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAH- 192 (336)
T ss_dssp HTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHH-
T ss_pred HhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHh-
Confidence 888888888888888888777778888888888888888 57652 5666777788888888888 77643 2222221
Q ss_pred ccCccc-ccceeecccc--ccc-cccCccCCCCCCccEEECCCCc-ccCCCCCCcCcccccceecccccc-ccccCcccc
Q 041878 235 AGNKSY-QLQFLNLDHN--LIA-GTIPVSLGKLGLLQEISLSHNK-IVGPIPDELGKLSKLQKLDLSYNA-IGGSFPVTF 308 (773)
Q Consensus 235 ~~~~~~-~L~~L~L~~n--~l~-~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~~~~~ 308 (773)
++ +|++|++++| .++ +.++..+..+++|+.|++++|. +++..+..+..+++|++|++++|. ++......+
T Consensus 193 ----l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l 268 (336)
T 2ast_B 193 ----VSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLEL 268 (336)
T ss_dssp ----SCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGG
T ss_pred ----cccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHH
Confidence 22 4555555555 233 2333344444555555555554 333334444444444444444442 221111233
Q ss_pred cccccCceEEccCC
Q 041878 309 TNITSLVSLNLENN 322 (773)
Q Consensus 309 ~~l~~L~~L~Ls~N 322 (773)
..+++|+.|++++|
T Consensus 269 ~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 269 GEIPTLKTLQVFGI 282 (336)
T ss_dssp GGCTTCCEEECTTS
T ss_pred hcCCCCCEEeccCc
Confidence 44444444444444
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-26 Score=248.07 Aligned_cols=261 Identities=18% Similarity=0.152 Sum_probs=170.8
Q ss_pred EEccCCcccccCCCCCCCCCCCceEEcccCccCCCCC----CCCCCCC-CCCEEEccCCCCCCCCccccccc-----ccc
Q 041878 120 LSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIP----PSIGNCP-NLQTLDLSNNALIGAIPPSLANS-----TRL 189 (773)
Q Consensus 120 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p----~~l~~l~-~L~~L~Ls~N~l~~~~~~~l~~l-----~~L 189 (773)
+.|+.|+++|.+|..+...++|++|+|++|++++..+ ..+.+++ +|++|+|++|.+++..+..+..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4556666666666555555556666666666664444 4455555 56666666666655555555443 555
Q ss_pred ceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCcc----CCC-CC
Q 041878 190 YRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVS----LGK-LG 264 (773)
Q Consensus 190 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~----l~~-l~ 264 (773)
++|+|++|++++..+..+. .......++|++|+|++|.+++..+.. +.. .+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~------------------------~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 138 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELV------------------------KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPA 138 (362)
T ss_dssp CEEECCSSCGGGSCHHHHH------------------------HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCT
T ss_pred cEEECcCCcCChHHHHHHH------------------------HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCC
Confidence 5555555555544433222 211000024445555555544433332 333 25
Q ss_pred CccEEECCCCcccCCCCC----CcCccc-ccceeccccccccccCcccccc----c-ccCceEEccCCCCCCCc----ch
Q 041878 265 LLQEISLSHNKIVGPIPD----ELGKLS-KLQKLDLSYNAIGGSFPVTFTN----I-TSLVSLNLENNRLGNKI----PE 330 (773)
Q Consensus 265 ~L~~L~L~~N~l~~~~p~----~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~----l-~~L~~L~Ls~N~l~~~~----~~ 330 (773)
+|++|+|++|++++..+. .+..++ +|++|+|++|++++..+..+.. + ++|++|+|++|++++.. +.
T Consensus 139 ~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~ 218 (362)
T 3goz_A 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAY 218 (362)
T ss_dssp TCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred ceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHH
Confidence 899999999998864433 334454 9999999999999877765554 4 69999999999998753 44
Q ss_pred hhcc-ccccccccccCcccccccc----cccCCCCcCceeecCCccCccCCCc-------hhhccCccCEEEeecccCCC
Q 041878 331 GLER-LQNLTVLNLKNNQFKGHIP----ETIGNISGINQLDLSENDFTGEISP-------SLASLANLTSFNVSYNNLSG 398 (773)
Q Consensus 331 ~l~~-l~~L~~L~ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~~~-------~~~~l~~L~~L~ls~N~l~g 398 (773)
.+.. .++|++|+|++|.+++..+ ..+..+++|+.|+|++|.+.+..+. .+..+++|+.||+++|++.+
T Consensus 219 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp HHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 5555 4599999999999997554 4467889999999999996654433 45677889999999999987
Q ss_pred CCchhh
Q 041878 399 SVPPLL 404 (773)
Q Consensus 399 ~~p~~~ 404 (773)
..+..+
T Consensus 299 ~~~~~~ 304 (362)
T 3goz_A 299 SHSIPI 304 (362)
T ss_dssp GGCHHH
T ss_pred cchHHH
Confidence 755443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-26 Score=252.25 Aligned_cols=239 Identities=20% Similarity=0.279 Sum_probs=154.4
Q ss_pred cCCCCCCCCCCCceEEcccCccCCC----CCCCCCCCCCCCEEEccCCC---CCCCCcccc-------ccccccceeecc
Q 041878 130 PVPWSLGFLPNLRGVYLFNNRLSGS----IPPSIGNCPNLQTLDLSNNA---LIGAIPPSL-------ANSTRLYRLNLS 195 (773)
Q Consensus 130 ~~~~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~---l~~~~~~~l-------~~l~~L~~L~Ls 195 (773)
.++..+..+++|++|+|++|++++. ++..+..+++|++|+|++|. +++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 3455566667777777777776654 23335566777777776643 333444433 344555555555
Q ss_pred cccccc----cCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEEC
Q 041878 196 YNSLLG----SIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISL 271 (773)
Q Consensus 196 ~N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 271 (773)
+|.+++ .++..+..+++|++|+|++|.+++..+..+.
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~--------------------------------------- 143 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA--------------------------------------- 143 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHH---------------------------------------
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHH---------------------------------------
Confidence 555543 2333444444444444444444322221111
Q ss_pred CCCcccCCCCCCcCcc---------cccceecccccccc-ccCc---ccccccccCceEEccCCCCCC-----Ccchhhc
Q 041878 272 SHNKIVGPIPDELGKL---------SKLQKLDLSYNAIG-GSFP---VTFTNITSLVSLNLENNRLGN-----KIPEGLE 333 (773)
Q Consensus 272 ~~N~l~~~~p~~l~~l---------~~L~~L~Ls~N~l~-~~~~---~~~~~l~~L~~L~Ls~N~l~~-----~~~~~l~ 333 (773)
..+..+ ++|++|+|++|+++ +.++ ..+..+++|++|+|++|+++. ..+..+.
T Consensus 144 ----------~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~ 213 (386)
T 2ca6_A 144 ----------RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLA 213 (386)
T ss_dssp ----------HHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGG
T ss_pred ----------HHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhh
Confidence 111111 56777777777776 3334 467788999999999999973 3444888
Q ss_pred cccccccccccCcccc----cccccccCCCCcCceeecCCccCccC----CCchhhc--cCccCEEEeecccCCC----C
Q 041878 334 RLQNLTVLNLKNNQFK----GHIPETIGNISGINQLDLSENDFTGE----ISPSLAS--LANLTSFNVSYNNLSG----S 399 (773)
Q Consensus 334 ~l~~L~~L~ls~N~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~--l~~L~~L~ls~N~l~g----~ 399 (773)
.+++|+.|+|++|.++ +.+|..+..+++|+.|+|++|.+++. ++..+.. +++|+.|+|++|++++ .
T Consensus 214 ~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~ 293 (386)
T 2ca6_A 214 YCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRT 293 (386)
T ss_dssp GCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHH
T ss_pred cCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHH
Confidence 9999999999999997 67888999999999999999999976 5566643 8999999999999998 4
Q ss_pred Cchhhhcc---CCCCCCCCCC
Q 041878 400 VPPLLSKK---FNSSSFVGNL 417 (773)
Q Consensus 400 ~p~~~~~~---~~~~~~~~n~ 417 (773)
+|..+... +....+.+|.
T Consensus 294 l~~~l~~~l~~L~~L~l~~N~ 314 (386)
T 2ca6_A 294 LKTVIDEKMPDLLFLELNGNR 314 (386)
T ss_dssp HHHHHHHHCTTCCEEECTTSB
T ss_pred HHHHHHhcCCCceEEEccCCc
Confidence 77765333 3333444553
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=213.34 Aligned_cols=182 Identities=21% Similarity=0.238 Sum_probs=156.0
Q ss_pred ccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccc
Q 041878 212 SLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQ 291 (773)
Q Consensus 212 ~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 291 (773)
+.++++++++.++ .+|..+. .+|+.|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~-------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 86 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP-------ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG 86 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC-------TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred CCeEEecCCCCcc-ccCCCCC-------CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCC
Confidence 4556666666666 4454332 2678888888888888888888999999999999999988888889999999
Q ss_pred eeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCcc
Q 041878 292 KLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSEND 371 (773)
Q Consensus 292 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 371 (773)
+|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|+
T Consensus 87 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 166 (251)
T 3m19_A 87 TLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQ 166 (251)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCc
Confidence 99999999998888888999999999999999988888888999999999999999997777789999999999999999
Q ss_pred CccCCCchhhccCccCEEEeecccCCCCCc
Q 041878 372 FTGEISPSLASLANLTSFNVSYNNLSGSVP 401 (773)
Q Consensus 372 l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p 401 (773)
+++..+..+..+++|+.|+|++|+|+|..+
T Consensus 167 l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 167 LQSVPHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred CCccCHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 998888889999999999999999998743
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=212.32 Aligned_cols=196 Identities=18% Similarity=0.175 Sum_probs=129.4
Q ss_pred CCcEEEccCCcccccCCCCCCCCCCCceEEcccCc-cCCCCCCCCCCCCCCCEEEccC-CCCCCCCccccccccccceee
Q 041878 116 ALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNR-LSGSIPPSIGNCPNLQTLDLSN-NALIGAIPPSLANSTRLYRLN 193 (773)
Q Consensus 116 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~~l~~l~~L~~L~ 193 (773)
+|++|+|++|++++..+..|..+++|++|+|++|+ ++...+..|.++++|++|+|++ |.+++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 78888888888887777778888888888888886 7755556778888888888887 788766666777778888888
Q ss_pred cccccccccCCccccCCCccc---eeecccc-ccccccCCcccccccCcccccceeeccccccccccCccCCCCCCcc-E
Q 041878 194 LSYNSLLGSIPLSLTRLPSLS---VLALQHN-NLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQ-E 268 (773)
Q Consensus 194 Ls~N~l~~~~~~~l~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~-~ 268 (773)
|++|++++ +|. +..+++|+ +|++++| +++ +..+..|..+++|+ .
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~-----------------------------~i~~~~~~~l~~L~~~ 160 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMT-----------------------------SIPVNAFQGLCNETLT 160 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCC-----------------------------EECTTTTTTTBSSEEE
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchh-----------------------------hcCcccccchhcceeE
Confidence 88887775 444 55555555 5555555 554 34444555566666 6
Q ss_pred EECCCCcccCCCCCCcCcccccceecccccc-ccccCccccccc-ccCceEEccCCCCCCCcchhhccccccccccccCc
Q 041878 269 ISLSHNKIVGPIPDELGKLSKLQKLDLSYNA-IGGSFPVTFTNI-TSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNN 346 (773)
Q Consensus 269 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N 346 (773)
|++++|+++. +|......++|++|+|++|+ +++..+..|..+ ++|+.|++++|++++..+. .+++|+.|+++++
T Consensus 161 L~l~~n~l~~-i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 161 LKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp EECCSCCCCE-ECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred EEcCCCCCcc-cCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 6666666663 33322222566666666663 665555566666 6666666666666543333 4556666666654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.6e-24 Score=224.18 Aligned_cols=205 Identities=20% Similarity=0.179 Sum_probs=154.2
Q ss_pred cccceeecccccccccCCccc--cCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCC
Q 041878 187 TRLYRLNLSYNSLLGSIPLSL--TRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLG 264 (773)
Q Consensus 187 ~~L~~L~Ls~N~l~~~~~~~l--~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~ 264 (773)
++|++|+|++|.+++..|..+ ..+++|++|+|++|++++..+. +.......+++|++|+|++|.+++..+..++.++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~-~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 169 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSW-LAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP 169 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSS-HHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhh-hHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence 445555555555555555554 5555555556665555543331 1111111234788888888888878888899999
Q ss_pred CccEEECCCCcccCC----CCCCcCcccccceeccccccccccCcc----cccccccCceEEccCCCCCCCcchhhccc-
Q 041878 265 LLQEISLSHNKIVGP----IPDELGKLSKLQKLDLSYNAIGGSFPV----TFTNITSLVSLNLENNRLGNKIPEGLERL- 335 (773)
Q Consensus 265 ~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l- 335 (773)
+|++|+|++|++.+. .+..+..+++|++|+|++|+++. ++. .+..+++|++|+|++|++++..|..+..+
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~ 248 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM 248 (310)
T ss_dssp TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC
T ss_pred CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc
Confidence 999999999998652 23445789999999999999973 333 35788999999999999999988888777
Q ss_pred --cccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCC
Q 041878 336 --QNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSG 398 (773)
Q Consensus 336 --~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g 398 (773)
++|++|+|++|+++ .+|..+. ++|++|+|++|++++. |. +..+++|+.|+|++|+|+.
T Consensus 249 ~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 249 WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 69999999999999 7787775 8999999999999964 33 6788999999999999974
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-25 Score=238.80 Aligned_cols=253 Identities=19% Similarity=0.210 Sum_probs=177.4
Q ss_pred CCcEEEccCCcccccCCCCCCCC--CCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCC-Ccccccccccccee
Q 041878 116 ALRKLSLHDNLLAGPVPWSLGFL--PNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGA-IPPSLANSTRLYRL 192 (773)
Q Consensus 116 ~L~~L~L~~n~l~~~~~~~l~~l--~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L 192 (773)
.++.|++++|.+. +..+..+ ++++.|++++|.+++..+. +.++++|++|+|++|.+++. ++..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4678888887776 3445555 7788888888888766554 55678888888888877654 66667777788888
Q ss_pred ecccccccccCCccccCCCccceeecccc-ccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEEC
Q 041878 193 NLSYNSLLGSIPLSLTRLPSLSVLALQHN-NLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISL 271 (773)
Q Consensus 193 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 271 (773)
+|++|++++..+..+..+++|++|+|++| .+++. .++..+..+++|++|++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~----------------------------~l~~~~~~~~~L~~L~l 175 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF----------------------------ALQTLLSSCSRLDELNL 175 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHH----------------------------HHHHHHHHCTTCCEEEC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHH----------------------------HHHHHHhcCCCCCEEcC
Confidence 88887777666777777777777777777 45532 12233445566677777
Q ss_pred CCC-cccCC-CCCCcCccc-ccceeccccc--ccc-ccCcccccccccCceEEccCCC-CCCCcchhhcccccccccccc
Q 041878 272 SHN-KIVGP-IPDELGKLS-KLQKLDLSYN--AIG-GSFPVTFTNITSLVSLNLENNR-LGNKIPEGLERLQNLTVLNLK 344 (773)
Q Consensus 272 ~~N-~l~~~-~p~~l~~l~-~L~~L~Ls~N--~l~-~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~l~~l~~L~~L~ls 344 (773)
++| .+++. ++..+..++ +|++|++++| .++ +.++..+..+++|++|++++|. +++..+..+..+++|+.|+++
T Consensus 176 ~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~ 255 (336)
T 2ast_B 176 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS 255 (336)
T ss_dssp CCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred CCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCC
Confidence 776 66543 445566666 7777777777 444 3556667778888888888888 777777788888888888888
Q ss_pred Ccc-cccccccccCCCCcCceeecCCccCccCCCchhhcc-CccCEEEeecccCCCCCchhh
Q 041878 345 NNQ-FKGHIPETIGNISGINQLDLSENDFTGEISPSLASL-ANLTSFNVSYNNLSGSVPPLL 404 (773)
Q Consensus 345 ~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~ls~N~l~g~~p~~~ 404 (773)
+|. +.......++++++|+.|+|++| ++.. .+..+ ..|..|++++|++++..|+..
T Consensus 256 ~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~~ 313 (336)
T 2ast_B 256 RCYDIIPETLLELGEIPTLKTLQVFGI-VPDG---TLQLLKEALPHLQINCSHFTTIARPTI 313 (336)
T ss_dssp TCTTCCGGGGGGGGGCTTCCEEECTTS-SCTT---CHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred CCCCCCHHHHHHHhcCCCCCEEeccCc-cCHH---HHHHHHhhCcceEEecccCccccCCcc
Confidence 884 33333346778899999999988 4432 33333 347777899999999888765
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=212.45 Aligned_cols=198 Identities=18% Similarity=0.230 Sum_probs=165.6
Q ss_pred CCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCC-CCCCCccccccccccceeeccc-ccccccCCccccCCCcccee
Q 041878 139 PNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNA-LIGAIPPSLANSTRLYRLNLSY-NSLLGSIPLSLTRLPSLSVL 216 (773)
Q Consensus 139 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~~~~l~~l~~L~~L~Ls~-N~l~~~~~~~l~~l~~L~~L 216 (773)
++|++|+|++|++++..+..|+++++|++|+|++|. ++...+..|.++++|++|+|++ |++++..+..|.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 489999999999997777789999999999999997 8766666888999999999998 89987777788888888888
Q ss_pred eccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCcc---EEECCCC-cccCCCCCCcCcccccc-
Q 041878 217 ALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQ---EISLSHN-KIVGPIPDELGKLSKLQ- 291 (773)
Q Consensus 217 ~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~---~L~L~~N-~l~~~~p~~l~~l~~L~- 291 (773)
++++|++++ +| . +..+++|+ +|++++| ++++..+..|..+++|+
T Consensus 111 ~l~~n~l~~-lp-----------------------------~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~ 159 (239)
T 2xwt_C 111 GIFNTGLKM-FP-----------------------------D-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETL 159 (239)
T ss_dssp EEEEECCCS-CC-----------------------------C-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEE
T ss_pred eCCCCCCcc-cc-----------------------------c-cccccccccccEEECCCCcchhhcCcccccchhccee
Confidence 888888763 33 2 44555565 9999999 99987778899999999
Q ss_pred eeccccccccccCcccccccccCceEEccCCC-CCCCcchhhccc-cccccccccCcccccccccccCCCCcCceeecCC
Q 041878 292 KLDLSYNAIGGSFPVTFTNITSLVSLNLENNR-LGNKIPEGLERL-QNLTVLNLKNNQFKGHIPETIGNISGINQLDLSE 369 (773)
Q Consensus 292 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~l~~l-~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~ 369 (773)
+|++++|+++...+..+.. ++|+.|++++|+ +++..+..+..+ ++|+.|++++|++++ +|.. .+++|+.|++++
T Consensus 160 ~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~ 235 (239)
T 2xwt_C 160 TLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARN 235 (239)
T ss_dssp EEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTT
T ss_pred EEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccC
Confidence 9999999999444445555 899999999995 987778889999 999999999999995 4544 678999999988
Q ss_pred cc
Q 041878 370 ND 371 (773)
Q Consensus 370 N~ 371 (773)
+.
T Consensus 236 ~~ 237 (239)
T 2xwt_C 236 TW 237 (239)
T ss_dssp C-
T ss_pred cc
Confidence 74
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.6e-23 Score=210.66 Aligned_cols=188 Identities=24% Similarity=0.246 Sum_probs=90.1
Q ss_pred CcceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCC
Q 041878 83 WAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNC 162 (773)
Q Consensus 83 w~gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l 162 (773)
|.|++|..+ .+.+++++++++ .+|..+. +.|+.|+|++|.+++..+..+..+++|++|+|++|++++..|..|..+
T Consensus 7 ~~gC~C~~~-~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 82 (251)
T 3m19_A 7 VTGCTCNEG-KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDL 82 (251)
T ss_dssp HHSSEEEGG-GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTC
T ss_pred CCceEcCCC-CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccC
Confidence 899999521 123555555554 3333332 344455555555544444444444444444444444444444444444
Q ss_pred CCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCccccc
Q 041878 163 PNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQL 242 (773)
Q Consensus 163 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L 242 (773)
++|++|+|++| ++++..+..+..+++|++|+|++|++++..
T Consensus 83 ~~L~~L~L~~n------------------------~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--------------- 123 (251)
T 3m19_A 83 TELGTLGLANN------------------------QLASLPLGVFDHLTQLDKLYLGGNQLKSLP--------------- 123 (251)
T ss_dssp TTCCEEECTTS------------------------CCCCCCTTTTTTCTTCCEEECCSSCCCCCC---------------
T ss_pred CcCCEEECCCC------------------------cccccChhHhcccCCCCEEEcCCCcCCCcC---------------
Confidence 44444444444 444333344444444444444444443221
Q ss_pred ceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCC
Q 041878 243 QFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENN 322 (773)
Q Consensus 243 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 322 (773)
+..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+..+++|+.|+|++|
T Consensus 124 --------------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 189 (251)
T 3m19_A 124 --------------SGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189 (251)
T ss_dssp --------------TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSC
T ss_pred --------------hhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCC
Confidence 222333444444444444444433334455555555555555555444445555555555555555
Q ss_pred CCCCC
Q 041878 323 RLGNK 327 (773)
Q Consensus 323 ~l~~~ 327 (773)
+++..
T Consensus 190 ~~~c~ 194 (251)
T 3m19_A 190 QFDCS 194 (251)
T ss_dssp CBCTT
T ss_pred ceeCC
Confidence 55443
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=237.16 Aligned_cols=211 Identities=24% Similarity=0.354 Sum_probs=130.0
Q ss_pred cCCCCCCCCCCCCC---CCcce-EeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCce
Q 041878 68 LRSWNDSGVGACSG---GWAGI-KCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRG 143 (773)
Q Consensus 68 l~sW~~~~~~~c~~---~w~gv-~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 143 (773)
+.+|.. +.++|.. .|.|+ .|..++++.|+|+++++++ +|+.+. ++|++|+|++|+|+ .+| ..+++|++
T Consensus 33 l~~W~~-~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~ 104 (571)
T 3cvr_A 33 WDKWEK-QALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEY 104 (571)
T ss_dssp HHHHHT-TCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred HHHHhc-cCCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCE
Confidence 456744 4566743 38898 7876677777777777776 666553 67777777777777 455 44667777
Q ss_pred EEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeecccccc
Q 041878 144 VYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNL 223 (773)
Q Consensus 144 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l 223 (773)
|+|++|+|++ +|. +.+ +|++|+|++|.|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|++
T Consensus 105 L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 105 LDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQL 172 (571)
T ss_dssp EECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCC
T ss_pred EEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCC
Confidence 7777777775 555 544 67777777777764 444 45666666666666664 333 344555555555555
Q ss_pred ccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCccccc-------ceeccc
Q 041878 224 SGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKL-------QKLDLS 296 (773)
Q Consensus 224 ~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L-------~~L~Ls 296 (773)
++ +| . |. ++|+.|+|++|+|+ .+|. |.. +| +.|+|+
T Consensus 173 ~~-lp-----------------------------~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls 215 (571)
T 3cvr_A 173 TF-LP-----------------------------E-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCR 215 (571)
T ss_dssp SC-CC-----------------------------C-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECC
T ss_pred CC-cc-----------------------------h-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecC
Confidence 43 33 2 33 55666666666665 3444 433 44 667777
Q ss_pred cccccccCcccccccccCceEEccCCCCCCCcchhhcccc
Q 041878 297 YNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQ 336 (773)
Q Consensus 297 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 336 (773)
+|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+.
T Consensus 216 ~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 216 ENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp SSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred CCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 77666 4566666667777777777777666666665543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-22 Score=218.20 Aligned_cols=247 Identities=19% Similarity=0.137 Sum_probs=159.9
Q ss_pred CCCCCcceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCC-
Q 041878 79 CSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPP- 157 (773)
Q Consensus 79 c~~~w~gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~- 157 (773)
|.|.|..|.|+.. +++ .||..+ .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|.
T Consensus 7 C~C~~~~v~C~~~----------~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~ 73 (350)
T 4ay9_X 7 CHCSNRVFLCQES----------KVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73 (350)
T ss_dssp SEEETTEEEEEST----------TCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTT
T ss_pred cEeeCCEEEecCC----------CCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChh
Confidence 5555777888643 344 455544 25789999999999976667889999999999999998766654
Q ss_pred CCCCCCCCCE-EEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccc-cccccccCCcccccc
Q 041878 158 SIGNCPNLQT-LDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQH-NNLSGSVPNNWGVLA 235 (773)
Q Consensus 158 ~l~~l~~L~~-L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~ 235 (773)
.|.++++|++ +++++|+++...|..|..+++|++|++++|+++...+..+....++..|++.+ |++....+..|..+.
T Consensus 74 ~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~ 153 (350)
T 4ay9_X 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 153 (350)
T ss_dssp SBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred HhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc
Confidence 5788888775 66677888877788888899999999999998876666677777777888765 455543333333322
Q ss_pred cCcccccceeeccccccccccCccCCCCCCccEEECCC-CcccCCCCCCcCcccccceeccccccccccCcccccccccC
Q 041878 236 GNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSH-NKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSL 314 (773)
Q Consensus 236 ~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 314 (773)
..++.|+|++|+|+.+.+.. ....+|++|++++ |.++...++.|..+++|++|||++|+|+...+..+. +|
T Consensus 154 ----~~l~~L~L~~N~i~~i~~~~-f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~---~L 225 (350)
T 4ay9_X 154 ----FESVILWLNKNGIQEIHNSA-FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE---NL 225 (350)
T ss_dssp ----SSCEEEECCSSCCCEECTTS-STTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT---TC
T ss_pred ----hhhhhhccccccccCCChhh-ccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc---cc
Confidence 24666777777776443333 3445666666664 444433334566666677777777666644333333 34
Q ss_pred ceEEccCCCCCCCcchhhccccccccccccCcc
Q 041878 315 VSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQ 347 (773)
Q Consensus 315 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~ 347 (773)
+.|.+.++.--..+| .+..+++|+.++++++.
T Consensus 226 ~~L~~l~~~~l~~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 226 KKLRARSTYNLKKLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp CEEECTTCTTCCCCC-CTTTCCSCCEEECSCHH
T ss_pred hHhhhccCCCcCcCC-CchhCcChhhCcCCCCc
Confidence 444433333223334 25556666666665544
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=8.4e-23 Score=215.24 Aligned_cols=195 Identities=26% Similarity=0.410 Sum_probs=126.3
Q ss_pred ccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccc
Q 041878 111 ISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLY 190 (773)
Q Consensus 111 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 190 (773)
+.++++|++|++++|.++. ++ .+..+++|++|+|++|++++..+ +..+++|++|+|++|.+++ + +.+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~-~~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-c-hhhcCCCCCC
Confidence 3467778888888888774 34 57778888888888888875444 7888888888888888774 3 3577788888
Q ss_pred eeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEE
Q 041878 191 RLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEIS 270 (773)
Q Consensus 191 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 270 (773)
+|+|++|++++. + .+..+++|++|++++|++++..+ +.. +++|++|+|++|.+++..+ +..+++|+.|+
T Consensus 111 ~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~-----l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~ 179 (308)
T 1h6u_A 111 TLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAG-----LTNLQYLSIGNAQVSDLTP--LANLSKLTTLK 179 (308)
T ss_dssp EEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGG-----CTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred EEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccC-----CCCccEEEccCCcCCCChh--hcCCCCCCEEE
Confidence 888888887753 3 26777777777777777764322 222 2256666666666654333 55666666666
Q ss_pred CCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCC
Q 041878 271 LSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGN 326 (773)
Q Consensus 271 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 326 (773)
+++|++++..+ +..+++|++|+|++|++++..+ +..+++|+.|++++|++++
T Consensus 180 l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 180 ADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred CCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 66666654322 5555566666666666654332 5555556666666655543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.7e-22 Score=215.51 Aligned_cols=216 Identities=20% Similarity=0.186 Sum_probs=149.4
Q ss_pred cEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCc-cccccccccce-eecc
Q 041878 118 RKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIP-PSLANSTRLYR-LNLS 195 (773)
Q Consensus 118 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~-L~Ls 195 (773)
+.++.++++++ .+|..+ .+++++|+|++|+|+...+..|+++++|++|+|++|.+.+.+| ..|.++++|++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 46788888888 677766 4689999999999996555679999999999999999876655 46788888775 5677
Q ss_pred cccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccc-cccccccCccCCCCC-CccEEECCC
Q 041878 196 YNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDH-NLIAGTIPVSLGKLG-LLQEISLSH 273 (773)
Q Consensus 196 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~-n~l~~~~~~~l~~l~-~L~~L~L~~ 273 (773)
+|+++...|..|.++++|++|++++|+++...+..+.. ..++..|++.+ |.++...+..|..+. .++.|+|++
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~-----~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~ 163 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH-----SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCC-----BSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCS
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcc-----cchhhhhhhccccccccccccchhhcchhhhhhcccc
Confidence 89999888889999999999999999998554433322 22566777754 456655555666654 567777777
Q ss_pred CcccCCCCCCcCcccccceecccc-ccccccCcccccccccCceEEccCCCCCCCcchhhcccccccccc
Q 041878 274 NKIVGPIPDELGKLSKLQKLDLSY-NAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLN 342 (773)
Q Consensus 274 N~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 342 (773)
|+|+. +|.......+|++|++++ |.++...+..|..+++|+.|+|++|+|+...+..+.++++|+.++
T Consensus 164 N~i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~ 232 (350)
T 4ay9_X 164 NGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS 232 (350)
T ss_dssp SCCCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTT
T ss_pred ccccC-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhcc
Confidence 77764 333334445677777654 455533334566666666666666666554444444444444433
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-22 Score=214.64 Aligned_cols=208 Identities=24% Similarity=0.360 Sum_probs=106.0
Q ss_pred EEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccc
Q 041878 120 LSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSL 199 (773)
Q Consensus 120 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l 199 (773)
+.+..+.+++.+ .+..+++|++|++++|.++. +| .+..+++|++|+|++|.+++. +. +..+++|++|+|++|++
T Consensus 24 ~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l 97 (308)
T 1h6u_A 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPL 97 (308)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCcee--cHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcC
Confidence 344444444322 23345666666666666663 33 456666666666666666532 22 55556666666665555
Q ss_pred cccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCC
Q 041878 200 LGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGP 279 (773)
Q Consensus 200 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 279 (773)
++. ..+..+++|++|+|++|+++ +.. .+..+++|++|++++|++++.
T Consensus 98 ~~~--~~~~~l~~L~~L~l~~n~l~-----------------------------~~~--~l~~l~~L~~L~l~~n~l~~~ 144 (308)
T 1h6u_A 98 KNV--SAIAGLQSIKTLDLTSTQIT-----------------------------DVT--PLAGLSNLQVLYLDLNQITNI 144 (308)
T ss_dssp SCC--GGGTTCTTCCEEECTTSCCC-----------------------------CCG--GGTTCTTCCEEECCSSCCCCC
T ss_pred CCc--hhhcCCCCCCEEECCCCCCC-----------------------------Cch--hhcCCCCCCEEECCCCccCcC
Confidence 431 12334444444444444333 211 144555666666666665543
Q ss_pred CCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCC
Q 041878 280 IPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNI 359 (773)
Q Consensus 280 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l 359 (773)
.+ +..+++|++|+|++|+++ +..+ +..+++|+.|++++|++++..+ +..+
T Consensus 145 ~~--l~~l~~L~~L~l~~n~l~------------------------~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l 194 (308)
T 1h6u_A 145 SP--LAGLTNLQYLSIGNAQVS------------------------DLTP--LANLSKLTTLKADDNKISDISP--LASL 194 (308)
T ss_dssp GG--GGGCTTCCEEECCSSCCC------------------------CCGG--GTTCTTCCEEECCSSCCCCCGG--GGGC
T ss_pred cc--ccCCCCccEEEccCCcCC------------------------CChh--hcCCCCCCEEECCCCccCcChh--hcCC
Confidence 22 445555555555555554 3222 4444445555555555443322 4555
Q ss_pred CcCceeecCCccCccCCCchhhccCccCEEEeecccCCC
Q 041878 360 SGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSG 398 (773)
Q Consensus 360 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g 398 (773)
++|++|+|++|++++..+ +..+++|+.|++++|++++
T Consensus 195 ~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 195 PNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp TTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred CCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 566666666666654332 5556666666666666654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.4e-24 Score=247.73 Aligned_cols=305 Identities=14% Similarity=0.085 Sum_probs=194.3
Q ss_pred CCEEEEEcCCCCcccc----cCccccCCCCCcEEEccCCccc----ccCCCCCCCCCCCceEEcccCccCC---------
Q 041878 91 GQVIAIQLPWRRLGGR----ISEKISQLHALRKLSLHDNLLA----GPVPWSLGFLPNLRGVYLFNNRLSG--------- 153 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~----i~~~l~~l~~L~~L~L~~n~l~----~~~~~~l~~l~~L~~L~L~~n~l~~--------- 153 (773)
..++.|+|++|.+++. ++..+..+++|++|+|++|.++ +.++..+..+++|++|+|++|.+.+
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~~~~~~~~ 243 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAA 243 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGHHHHHHCT
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHHHHHhhhh
Confidence 3566677777766544 3334455666667777666665 2333344556666666666666553
Q ss_pred -----------------CCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCC-ccccCCCccce
Q 041878 154 -----------------SIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIP-LSLTRLPSLSV 215 (773)
Q Consensus 154 -----------------~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~l~~l~~L~~ 215 (773)
..+..+..+++|+.|+++++.. +.+|..+..+++|++|+|++|.+++... ..+..+++|++
T Consensus 244 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~ 322 (592)
T 3ogk_B 244 NLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEV 322 (592)
T ss_dssp TCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCE
T ss_pred HHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCE
Confidence 2223344455555555555432 2455666667777777777777654333 33567777777
Q ss_pred eeccccccccccCCcccccccCcccccceeecc-----------ccccccccCcc-CCCCCCccEEECCCCcccCCCCCC
Q 041878 216 LALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLD-----------HNLIAGTIPVS-LGKLGLLQEISLSHNKIVGPIPDE 283 (773)
Q Consensus 216 L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~-----------~n~l~~~~~~~-l~~l~~L~~L~L~~N~l~~~~p~~ 283 (773)
|+++ |.+.......+. ..+++|++|+++ .|.+++..... ...+++|++|+++.|++++..+..
T Consensus 323 L~L~-~~~~~~~l~~~~----~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~ 397 (592)
T 3ogk_B 323 LETR-NVIGDRGLEVLA----QYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLES 397 (592)
T ss_dssp EEEE-GGGHHHHHHHHH----HHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHH
T ss_pred Eecc-CccCHHHHHHHH----HhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHH
Confidence 7777 333322211111 123368888888 35665432222 345778888888888887665555
Q ss_pred cCc-ccccceeccc----ccccccc-----CcccccccccCceEEccCC--CCCCCcchhhcc-ccccccccccCccccc
Q 041878 284 LGK-LSKLQKLDLS----YNAIGGS-----FPVTFTNITSLVSLNLENN--RLGNKIPEGLER-LQNLTVLNLKNNQFKG 350 (773)
Q Consensus 284 l~~-l~~L~~L~Ls----~N~l~~~-----~~~~~~~l~~L~~L~Ls~N--~l~~~~~~~l~~-l~~L~~L~ls~N~l~~ 350 (773)
+.. +++|+.|+++ .|.+++. ++..+..+++|+.|++++| .+++..+..+.. +++|++|++++|++++
T Consensus 398 l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~ 477 (592)
T 3ogk_B 398 IGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESD 477 (592)
T ss_dssp HHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSH
T ss_pred HHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCH
Confidence 554 7788888886 6677753 3444667888888888754 366666666554 7889999999998886
Q ss_pred -ccccccCCCCcCceeecCCccCccCC-CchhhccCccCEEEeecccCCCCCc
Q 041878 351 -HIPETIGNISGINQLDLSENDFTGEI-SPSLASLANLTSFNVSYNNLSGSVP 401 (773)
Q Consensus 351 -~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~ls~N~l~g~~p 401 (773)
.++..+..+++|++|+|++|.+++.. +..+..+++|+.|+|++|++++.-.
T Consensus 478 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~ 530 (592)
T 3ogk_B 478 EGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQ 530 (592)
T ss_dssp HHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCT
T ss_pred HHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHH
Confidence 34555678888999999999887553 3444568889999999999876533
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.5e-22 Score=197.10 Aligned_cols=201 Identities=22% Similarity=0.187 Sum_probs=157.6
Q ss_pred CCCCCCCcceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCC
Q 041878 77 GACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIP 156 (773)
Q Consensus 77 ~~c~~~w~gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p 156 (773)
+.|.|.|.+|.|.... ++ .+|..+ .++|++|+|++|.+++..+..+..+++|++|+|++|++++..+
T Consensus 3 ~~C~C~~~~v~c~~~~----------l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQG----------RT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPN 69 (208)
T ss_dssp TTCEEETTEEECCSSC----------CS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred CCCEECCCEEEecCCC----------cc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccCh
Confidence 3566669999996432 22 233333 3588999999999997777778899999999999999997767
Q ss_pred CCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCccccccc
Q 041878 157 PSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAG 236 (773)
Q Consensus 157 ~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 236 (773)
..|..+++|++|+|++|.+++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|++++..+..+..+.
T Consensus 70 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~- 148 (208)
T 2o6s_A 70 GVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLT- 148 (208)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT-
T ss_pred hhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCC-
Confidence 7788999999999999999876666788899999999999999977777788999999999999999866555555444
Q ss_pred CcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcc
Q 041878 237 NKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPV 306 (773)
Q Consensus 237 ~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~ 306 (773)
+|++|++++|.+.+ .+++|+.|+++.|+++|.+|..++.++. ++..|...+..+.
T Consensus 149 ----~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~~----~~~~C~~~~~~~~ 203 (208)
T 2o6s_A 149 ----SLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP----DSAKCSGSGKPVR 203 (208)
T ss_dssp ----TCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBCT----TCSBBTTTCCBGG
T ss_pred ----CccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCccccC----CccccccCCCcce
Confidence 89999999997764 4567899999999999999988887755 5555555444443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=6.3e-23 Score=212.66 Aligned_cols=141 Identities=18% Similarity=0.202 Sum_probs=113.7
Q ss_pred hhcccccccceEEEEEEeCCCCEEEEEEecccCc------------------ccHHHHHHHHHHHHccCCCceEEeEEEE
Q 041878 539 TAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTT------------------KGQKEFEAEAAAIGKIHHPNLLALRAYY 600 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~~ 600 (773)
+.+.||+|+||.||+|...+|+.||||.++.... .....+.+|++++++++ | +++.+++
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~ 170 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY 170 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE
Confidence 4589999999999999987799999999964321 12456899999999999 4 5555555
Q ss_pred ECCCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeec
Q 041878 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADF 680 (773)
Q Consensus 601 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~Df 680 (773)
.. +..++||||+++|+|.+ +.. .....++.||+.|+.||| +.||+||||||+|||++ ++.+||+||
T Consensus 171 ~~--~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH-~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 171 AW--EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFY-HRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp EE--ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred ec--cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHH-HCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 22 35699999999999988 422 123469999999999999 99999999999999999 999999999
Q ss_pred CCccccccccccceeeccCccccccccccC
Q 041878 681 GLSRLMTAAANTNVIATAGTLGYRAPELSK 710 (773)
Q Consensus 681 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~ 710 (773)
|+|+. +..++|||.+.
T Consensus 237 G~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TTCEE--------------TTSTTHHHHHH
T ss_pred CCCeE--------------CCCCCHHHHHH
Confidence 99863 34578899764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.7e-24 Score=247.48 Aligned_cols=306 Identities=10% Similarity=0.077 Sum_probs=207.4
Q ss_pred CEEEEEcCCCC-ccc-ccCccccCCCCCcEEEccCCccccc----CCCCCCCCCCCceEEcccCccCC----CCCCCCCC
Q 041878 92 QVIAIQLPWRR-LGG-RISEKISQLHALRKLSLHDNLLAGP----VPWSLGFLPNLRGVYLFNNRLSG----SIPPSIGN 161 (773)
Q Consensus 92 ~v~~l~l~~~~-l~~-~i~~~l~~l~~L~~L~L~~n~l~~~----~~~~l~~l~~L~~L~L~~n~l~~----~~p~~l~~ 161 (773)
+++.|+|+++. ++. .++....++++|++|+|++|.+++. ++..+..+++|++|+|++|.+++ .++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 48899998876 221 2334445889999999999998765 33445678999999999999983 34455678
Q ss_pred CCCCCEEEccCCCCCCCCccccccccccceeeccccccc--------------------------ccCCccccCCCccce
Q 041878 162 CPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLL--------------------------GSIPLSLTRLPSLSV 215 (773)
Q Consensus 162 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~--------------------------~~~~~~l~~l~~L~~ 215 (773)
+++|++|+|++|.+.+ +|..+.++++|++|+++.+... ..+|..+..+++|++
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~ 297 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRK 297 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCE
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcE
Confidence 9999999999999874 6677777788888887643221 233444555666666
Q ss_pred eeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCC-----------CcccCC-CCCC
Q 041878 216 LALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSH-----------NKIVGP-IPDE 283 (773)
Q Consensus 216 L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~-----------N~l~~~-~p~~ 283 (773)
|+|++|.+++.....+ ...+++|++|+++++-..+.++..+..+++|++|+|++ |.+++. ++..
T Consensus 298 L~Ls~~~l~~~~~~~~----~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l 373 (592)
T 3ogk_B 298 LDLLYALLETEDHCTL----IQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL 373 (592)
T ss_dssp EEETTCCCCHHHHHHH----HTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHH
T ss_pred EecCCCcCCHHHHHHH----HHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHH
Confidence 6666666543322110 01233666666663322223333334567777777773 455432 1222
Q ss_pred cCcccccceeccccccccccCcccccc-cccCceEEcc----CCCCCCC-----cchhhccccccccccccCcc--cccc
Q 041878 284 LGKLSKLQKLDLSYNAIGGSFPVTFTN-ITSLVSLNLE----NNRLGNK-----IPEGLERLQNLTVLNLKNNQ--FKGH 351 (773)
Q Consensus 284 l~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls----~N~l~~~-----~~~~l~~l~~L~~L~ls~N~--l~~~ 351 (773)
+..+++|++|+++.|++++..+..+.. +++|+.|+++ .|.+++. ++..+..+++|+.|++++|. +++.
T Consensus 374 ~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~ 453 (592)
T 3ogk_B 374 AQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDL 453 (592)
T ss_dssp HHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHH
T ss_pred HhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHH
Confidence 344678888888888888766666665 7888888886 6777764 44456678889999987543 6666
Q ss_pred cccccC-CCCcCceeecCCccCccC-CCchhhccCccCEEEeecccCCCCCch
Q 041878 352 IPETIG-NISGINQLDLSENDFTGE-ISPSLASLANLTSFNVSYNNLSGSVPP 402 (773)
Q Consensus 352 ~~~~~~-~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~ls~N~l~g~~p~ 402 (773)
.+..++ .+++|+.|+|++|.+++. ++..+..+++|+.|+|++|++++....
T Consensus 454 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~ 506 (592)
T 3ogk_B 454 GLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIA 506 (592)
T ss_dssp HHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHH
T ss_pred HHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHH
Confidence 555554 378899999999998863 445567789999999999998755333
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.5e-21 Score=220.75 Aligned_cols=95 Identities=24% Similarity=0.357 Sum_probs=47.4
Q ss_pred CCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhcccccccccc
Q 041878 263 LGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLN 342 (773)
Q Consensus 263 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 342 (773)
+++|+.|+|++|++++ +|. |. ++|++|+|++|+|+ .+|. +.. +| ....+.|+.|+
T Consensus 159 l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L-----------------~~~~~~L~~L~ 213 (571)
T 3cvr_A 159 PTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RN-----------------HHSEETEIFFR 213 (571)
T ss_dssp CTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC---------------------------CCEEEE
T ss_pred CCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hh-----------------hcccccceEEe
Confidence 4556666666666664 444 43 55666666666665 3333 322 33 00011125555
Q ss_pred ccCcccccccccccCCCCcCceeecCCccCccCCCchhhcc
Q 041878 343 LKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASL 383 (773)
Q Consensus 343 ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 383 (773)
|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+
T Consensus 214 Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp CCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred cCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 5555555 345555555556666666666655555555544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=9.1e-21 Score=187.65 Aligned_cols=179 Identities=22% Similarity=0.137 Sum_probs=125.2
Q ss_pred cEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccc
Q 041878 118 RKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197 (773)
Q Consensus 118 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N 197 (773)
+.++++++.++ .+|..+ .++|++|+|++|++++..+..|+.+++|++|+|++|.+++..+..+..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 46778888877 455444 468999999999999777777889999999999999998666666788999999999999
Q ss_pred cccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCccc
Q 041878 198 SLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIV 277 (773)
Q Consensus 198 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~ 277 (773)
++++..+..+.++++|++|+|++|++++..+..+..+. +|++|+|++|.+++..+..+..+++|+.|++++|.+.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-----~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLT-----QLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-----TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCC-----cCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 99877677778888888888888888755444343332 5666666666666555555555666666666666554
Q ss_pred CCCCCCcCcccccceeccccccccccCccccccc
Q 041878 278 GPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNI 311 (773)
Q Consensus 278 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l 311 (773)
+. +++|++|+++.|+++|.+|..++.+
T Consensus 162 ~~-------~~~l~~L~~~~n~~~g~ip~~~~~l 188 (208)
T 2o6s_A 162 CT-------CPGIRYLSEWINKHSGVVRNSAGSV 188 (208)
T ss_dssp CC-------TTTTHHHHHHHHHCTTTBBCTTSSB
T ss_pred cC-------CCCHHHHHHHHHhCCceeeccCccc
Confidence 32 2345555555555555555554443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.84 E-value=4.9e-22 Score=233.04 Aligned_cols=229 Identities=22% Similarity=0.206 Sum_probs=99.2
Q ss_pred cCHHHHHHHHHHHHhCCC-CCCCcCCCCCCCCCCCCCCCcceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccC
Q 041878 46 VTQADYQSLRAIKHDLID-PHGFLRSWNDSGVGACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHD 124 (773)
Q Consensus 46 ~~~~~~~~L~~~k~~~~~-~~~~l~sW~~~~~~~c~~~w~gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~ 124 (773)
....++++|.++..+... ......+|.......+. |.++.++.++++.++|.++.+... +. ..|+.++|+.
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~~l~L~~n~~~~~-~~-----~~l~~l~Ls~ 200 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGT--ATNSAVSTPLTPKIELFANGKDEA-NQ-----ALLQHKKLSQ 200 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCcccc--CCCceecCCccceEEeeCCCCCcc-hh-----hHhhcCccCc
Confidence 456788999999887642 22334566442233333 999999888999999988887752 32 2345566666
Q ss_pred CcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCC
Q 041878 125 NLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIP 204 (773)
Q Consensus 125 n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~ 204 (773)
|.|.+ ++++.|++. ..|..+..+++|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|
T Consensus 201 ~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp 263 (727)
T 4b8c_D 201 YSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELP 263 (727)
T ss_dssp ------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCC
T ss_pred ccccC--------------cccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccC
Confidence 65552 344455555 55666667777777777777766 56666666777777777777776 666
Q ss_pred ccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCc
Q 041878 205 LSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDEL 284 (773)
Q Consensus 205 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l 284 (773)
..+.++++|++|+|++|+|+ .+|..++.+. +|++|+|++|.|+ .+|..|+.+++|+.|+|++|+|++.+|..+
T Consensus 264 ~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~-----~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~ 336 (727)
T 4b8c_D 264 AEIKNLSNLRVLDLSHNRLT-SLPAELGSCF-----QLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKIL 336 (727)
T ss_dssp GGGGGGTTCCEEECTTSCCS-SCCSSGGGGT-----TCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHH
T ss_pred hhhhCCCCCCEEeCcCCcCC-ccChhhcCCC-----CCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHH
Confidence 66666777777777777766 5555554433 4555555555554 445556666667777777777766666555
Q ss_pred Ccccc-cceeccccccccccCcc
Q 041878 285 GKLSK-LQKLDLSYNAIGGSFPV 306 (773)
Q Consensus 285 ~~l~~-L~~L~Ls~N~l~~~~~~ 306 (773)
..+.. +..|+|++|.+++.+|.
T Consensus 337 ~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 337 TEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp HHHHHHHHHHHHHHCCCCCCCCC
T ss_pred hhcchhhhHHhhccCcccCcCcc
Confidence 44322 23456666666666554
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=7.1e-23 Score=232.81 Aligned_cols=204 Identities=20% Similarity=0.216 Sum_probs=165.5
Q ss_pred CCCCCCCEEEccCCCCCCCCccccccccccceeeccccc-------------ccccCCccccCCCccceee-cccccccc
Q 041878 160 GNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNS-------------LLGSIPLSLTRLPSLSVLA-LQHNNLSG 225 (773)
Q Consensus 160 ~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~-------------l~~~~~~~l~~l~~L~~L~-L~~N~l~~ 225 (773)
..+++|+.|+|++|.++ .+|..++++++|+.|++++|. +.+..|..+.++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 56777888888888876 677788888888888876664 5566777888888888888 7777664
Q ss_pred ccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCc
Q 041878 226 SVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFP 305 (773)
Q Consensus 226 ~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 305 (773)
.|..+.+.+|.++...+. .|+.|+|++|++++ +|. |+.+++|+.|+|++|+|+ .+|
T Consensus 424 ---------------~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp 479 (567)
T 1dce_A 424 ---------------DLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALP 479 (567)
T ss_dssp ---------------HHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCC
T ss_pred ---------------hhhhhhhhcccccccCcc------CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccc
Confidence 577788888888765432 48899999999986 676 899999999999999998 778
Q ss_pred ccccccccCceEEccCCCCCCCcchhhccccccccccccCccccccc-ccccCCCCcCceeecCCccCccCCCch---hh
Q 041878 306 VTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHI-PETIGNISGINQLDLSENDFTGEISPS---LA 381 (773)
Q Consensus 306 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~---~~ 381 (773)
..++.+++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..++.+++|+.|+|++|++++..|.. +.
T Consensus 480 ~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~ 557 (567)
T 1dce_A 480 PALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 557 (567)
T ss_dssp GGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHH
T ss_pred hhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHH
Confidence 899999999999999999987 56 7889999999999999999876 889999999999999999998765532 34
Q ss_pred ccCccCEEEe
Q 041878 382 SLANLTSFNV 391 (773)
Q Consensus 382 ~l~~L~~L~l 391 (773)
.+++|+.|++
T Consensus 558 ~lp~L~~L~l 567 (567)
T 1dce_A 558 MLPSVSSILT 567 (567)
T ss_dssp HCTTCSEEEC
T ss_pred HCcccCccCC
Confidence 4788888864
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.3e-20 Score=186.31 Aligned_cols=157 Identities=20% Similarity=0.259 Sum_probs=127.9
Q ss_pred ceeeccccccccccCccCCCCCCccEEECCCCcccCCCC-CCcCcccccceeccccccccccCcccccccccCceEEccC
Q 041878 243 QFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIP-DELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLEN 321 (773)
Q Consensus 243 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 321 (773)
+.+++++|.++. +|..+. ..+++|+|++|++++..+ ..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 456666666653 344332 345788888888876644 4577888888888888888877777888888888888888
Q ss_pred CCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCc
Q 041878 322 NRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVP 401 (773)
Q Consensus 322 N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p 401 (773)
|++++..+..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..+..+++|+.|+|++|+|+|.++
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 88888888888888899999999999998888889999999999999999998889999999999999999999998887
Q ss_pred h
Q 041878 402 P 402 (773)
Q Consensus 402 ~ 402 (773)
-
T Consensus 171 l 171 (220)
T 2v70_A 171 L 171 (220)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.6e-20 Score=184.82 Aligned_cols=156 Identities=23% Similarity=0.312 Sum_probs=110.4
Q ss_pred ceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCC
Q 041878 243 QFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENN 322 (773)
Q Consensus 243 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 322 (773)
+.+++++|+++. +|..+. ++|+.|+|++|++++..+..|..+++|++|+|++|+|++..|..|..+++|++|+|++|
T Consensus 14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 344555555552 233332 45667777777776655556667777777777777777666777777777777777777
Q ss_pred CCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCc
Q 041878 323 RLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVP 401 (773)
Q Consensus 323 ~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p 401 (773)
+|+...+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+|.+.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 7766656666777777777777777777777778888888888888888887777778888888888888888877665
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.2e-22 Score=231.00 Aligned_cols=204 Identities=22% Similarity=0.222 Sum_probs=175.7
Q ss_pred CCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCC-------------CCCCCccccccccccceee-cccccccc
Q 041878 136 GFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNA-------------LIGAIPPSLANSTRLYRLN-LSYNSLLG 201 (773)
Q Consensus 136 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~-------------l~~~~~~~l~~l~~L~~L~-Ls~N~l~~ 201 (773)
..+++|+.|+|++|+++ .+|..++++++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 56788888888888887 788888888888888887765 5667788899999999999 7887653
Q ss_pred cCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCC
Q 041878 202 SIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIP 281 (773)
Q Consensus 202 ~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p 281 (773)
+|+.+.+++|.++...+. .|+.|+|++|.|++ +|. ++.+++|+.|+|++|+|+ .+|
T Consensus 424 ----------~L~~l~l~~n~i~~l~~~-----------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp 479 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEYA-----------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALP 479 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHHT-----------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCC
T ss_pred ----------hhhhhhhhcccccccCcc-----------CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccc
Confidence 677888999998843321 58999999999997 465 999999999999999999 789
Q ss_pred CCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCc-chhhccccccccccccCcccccccccc---cC
Q 041878 282 DELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKI-PEGLERLQNLTVLNLKNNQFKGHIPET---IG 357 (773)
Q Consensus 282 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~ls~N~l~~~~~~~---~~ 357 (773)
..|+.+++|++|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..++.+++|+.|+|++|++++..|.. +.
T Consensus 480 ~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~ 557 (567)
T 1dce_A 480 PALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 557 (567)
T ss_dssp GGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHH
T ss_pred hhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHH
Confidence 999999999999999999996 66 8999999999999999999987 999999999999999999999765532 23
Q ss_pred CCCcCceeec
Q 041878 358 NISGINQLDL 367 (773)
Q Consensus 358 ~l~~L~~L~L 367 (773)
.+++|+.|++
T Consensus 558 ~lp~L~~L~l 567 (567)
T 1dce_A 558 MLPSVSSILT 567 (567)
T ss_dssp HCTTCSEEEC
T ss_pred HCcccCccCC
Confidence 4889999875
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-20 Score=215.04 Aligned_cols=172 Identities=29% Similarity=0.419 Sum_probs=81.2
Q ss_pred cCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccce
Q 041878 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYR 191 (773)
Q Consensus 112 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 191 (773)
.+|++|+.|+|++|.+.. ++ .+..+++|++|+|++|+|++..| +..+++|++|+|++|.+++ + +.+..+++|++
T Consensus 40 ~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~ 113 (605)
T 1m9s_A 40 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-L-SSLKDLKKLKS 113 (605)
T ss_dssp HHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-TTSTTCTTCCE
T ss_pred hcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-C-hhhccCCCCCE
Confidence 445555555555555542 22 35555555555555555554333 5555555555555555543 2 24455555555
Q ss_pred eecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEEC
Q 041878 192 LNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISL 271 (773)
Q Consensus 192 L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 271 (773)
|+|++|++++. ..+..+++|+.|+|++|+++ +. ..+..+++|+.|+|
T Consensus 114 L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~-----------------------------~l--~~l~~l~~L~~L~L 160 (605)
T 1m9s_A 114 LSLEHNGISDI--NGLVHLPQLESLYLGNNKIT-----------------------------DI--TVLSRLTKLDTLSL 160 (605)
T ss_dssp EECTTSCCCCC--GGGGGCTTCSEEECCSSCCC-----------------------------CC--GGGGSCTTCSEEEC
T ss_pred EEecCCCCCCC--ccccCCCccCEEECCCCccC-----------------------------Cc--hhhcccCCCCEEEC
Confidence 55555555431 23444444444444444444 22 23444444444444
Q ss_pred CCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCC
Q 041878 272 SHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGN 326 (773)
Q Consensus 272 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 326 (773)
++|++++..| +..+++|+.|+|++|.|++. ..+..+++|+.|+|++|++++
T Consensus 161 s~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 161 EDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred cCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 4444443333 44444444444444444432 134444444444444444443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=9.8e-20 Score=208.22 Aligned_cols=169 Identities=27% Similarity=0.333 Sum_probs=129.4
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
.+++.|+|+++.+.. ++ .+..+++|+.|+|++|.|++..+ +..+++|++|+|++|+|++ +| .+..+++|++|+|
T Consensus 43 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~L 116 (605)
T 1m9s_A 43 NSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSL 116 (605)
T ss_dssp TTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEe
Confidence 467789999998875 33 68999999999999999997655 9999999999999999995 33 7999999999999
Q ss_pred cCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeecccc
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN 250 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n 250 (773)
++|.+++ + +.+..+++|+.|+|++|++++. ..+..+++|+.|+|++|++++..| +.. +++|+.|+|++|
T Consensus 117 s~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~-----l~~L~~L~Ls~N 185 (605)
T 1m9s_A 117 EHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAG-----LTKLQNLYLSKN 185 (605)
T ss_dssp TTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTT-----CTTCCEEECCSS
T ss_pred cCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hcc-----CCCCCEEECcCC
Confidence 9999985 3 5689999999999999999865 677888888888888888875443 222 224555555555
Q ss_pred ccccccCccCCCCCCccEEECCCCcccC
Q 041878 251 LIAGTIPVSLGKLGLLQEISLSHNKIVG 278 (773)
Q Consensus 251 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 278 (773)
.|++. ..+..+++|+.|+|++|++.+
T Consensus 186 ~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 186 HISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred CCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 55543 234445555555555555543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=4.9e-20 Score=198.68 Aligned_cols=180 Identities=24% Similarity=0.255 Sum_probs=135.9
Q ss_pred ceeeccccccccccCCcccccccCcccccceeeccccccccccCccCC-CCCCccEEECCCCcccCCCCCCcCcccccce
Q 041878 214 SVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLG-KLGLLQEISLSHNKIVGPIPDELGKLSKLQK 292 (773)
Q Consensus 214 ~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 292 (773)
+.+++++|+++ .+|..+. ..++.|+|++|.|++..+..+. .+++|+.|+|++|+|++..+..|..+++|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~-------~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~ 92 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP-------SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRY 92 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC-------TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred CEEEeCCCCcC-ccCccCC-------CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCE
Confidence 34555555555 3443322 1466677777777766666676 7788888888888888777777888888888
Q ss_pred eccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCccccccccccc---CCCCcCceeecCC
Q 041878 293 LDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETI---GNISGINQLDLSE 369 (773)
Q Consensus 293 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~---~~l~~L~~L~L~~ 369 (773)
|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+ ..+++|+.|+|++
T Consensus 93 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~ 172 (361)
T 2xot_A 93 LDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSS 172 (361)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCS
T ss_pred EECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCC
Confidence 8888888887777778888888888888888887778888888888888888888886544444 5789999999999
Q ss_pred ccCccCCCchhhccCc--cCEEEeecccCCCCCc
Q 041878 370 NDFTGEISPSLASLAN--LTSFNVSYNNLSGSVP 401 (773)
Q Consensus 370 N~l~~~~~~~~~~l~~--L~~L~ls~N~l~g~~p 401 (773)
|+|++..+..+..++. |+.|+|++|+|.+.+.
T Consensus 173 N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 173 NKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp SCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred CCCCccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 9999766677888877 4889999999988764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.81 E-value=2e-22 Score=233.01 Aligned_cols=303 Identities=16% Similarity=0.118 Sum_probs=166.3
Q ss_pred CCEEEEEcCCCCcccccCcccc-CCCCCcEEEccCC-ccccc-CCCCCCCCCCCceEEcccCccCCCCCCCC----CCCC
Q 041878 91 GQVIAIQLPWRRLGGRISEKIS-QLHALRKLSLHDN-LLAGP-VPWSLGFLPNLRGVYLFNNRLSGSIPPSI----GNCP 163 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~-~l~~L~~L~L~~n-~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~p~~l----~~l~ 163 (773)
.+++.|+|+++.+++..+..+. .+++|++|+|++| .++.. ++..+..+++|++|+|++|.+++..+..+ ..++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 5788999999998887777776 6899999999998 56543 44445578999999999999886554444 3677
Q ss_pred CCCEEEccCCC--CCCC-Cccccccccccceeecccc-cccccCCccccCCCccceeeccccc-------cc--------
Q 041878 164 NLQTLDLSNNA--LIGA-IPPSLANSTRLYRLNLSYN-SLLGSIPLSLTRLPSLSVLALQHNN-------LS-------- 224 (773)
Q Consensus 164 ~L~~L~Ls~N~--l~~~-~~~~l~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~L~~N~-------l~-------- 224 (773)
+|++|+|++|. +... ++..+..+++|++|+|++| .+. .++..+..+++|++|+++.+. +.
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~ 263 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSG 263 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHT
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhc
Confidence 99999999887 2211 1112245688999999888 333 255555556666666544331 00
Q ss_pred -----------cccCCcccccccCcccccceeeccccccccccC-ccCCCCCCccEEECCCCcccCC-CCCCcCc-----
Q 041878 225 -----------GSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIP-VSLGKLGLLQEISLSHNKIVGP-IPDELGK----- 286 (773)
Q Consensus 225 -----------~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~-~p~~l~~----- 286 (773)
......+.... ..+++|++|+|++|.+++... ..+..+++|+.|++++| +.+. ++.....
T Consensus 264 ~~~L~~Ls~~~~~~~~~l~~~~-~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~ 341 (594)
T 2p1m_B 264 CKELRCLSGFWDAVPAYLPAVY-SVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLR 341 (594)
T ss_dssp CTTCCEEECCBTCCGGGGGGGH-HHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCC
T ss_pred CCCcccccCCcccchhhHHHHH-HhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCC
Confidence 00000010000 023366666666666554322 22345556666666655 2211 1111112
Q ss_pred -----------------------------ccccceeccccccccccCccccc-ccccCceEEcc--C----CCCCCCc--
Q 041878 287 -----------------------------LSKLQKLDLSYNAIGGSFPVTFT-NITSLVSLNLE--N----NRLGNKI-- 328 (773)
Q Consensus 287 -----------------------------l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls--~----N~l~~~~-- 328 (773)
+++|++|+++.|.+++..+..+. .+++|+.|+++ + |.+++..
T Consensus 342 ~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~ 421 (594)
T 2p1m_B 342 ELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLD 421 (594)
T ss_dssp EEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTH
T ss_pred EEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchh
Confidence 34444444444444443333332 34555555555 2 3333211
Q ss_pred ---chhhccccccccccccCcccccccccccCC-CCcCceeecCCccCccCCCchh-hccCccCEEEeecccCC
Q 041878 329 ---PEGLERLQNLTVLNLKNNQFKGHIPETIGN-ISGINQLDLSENDFTGEISPSL-ASLANLTSFNVSYNNLS 397 (773)
Q Consensus 329 ---~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~ls~N~l~ 397 (773)
+..+..+++|+.|++++ .+++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|+++
T Consensus 422 ~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 422 IGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp HHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred hHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence 11234445555555544 444433333433 5556666666666654444333 44566666666666653
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.81 E-value=4e-22 Score=230.43 Aligned_cols=302 Identities=15% Similarity=0.147 Sum_probs=196.5
Q ss_pred CCEEEEEcCCC-Ccccc-cCccccCCCCCcEEEccCCcccccCCCC----CCCCCCCceEEcccCc--cCCC-CCCCCCC
Q 041878 91 GQVIAIQLPWR-RLGGR-ISEKISQLHALRKLSLHDNLLAGPVPWS----LGFLPNLRGVYLFNNR--LSGS-IPPSIGN 161 (773)
Q Consensus 91 ~~v~~l~l~~~-~l~~~-i~~~l~~l~~L~~L~L~~n~l~~~~~~~----l~~l~~L~~L~L~~n~--l~~~-~p~~l~~ 161 (773)
.+++.|+|+++ .++.. ++..+.++++|++|+|++|.+++..+.. ...+++|++|+|++|. ++.. ++..+.+
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~ 209 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTR 209 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHh
Confidence 46788888887 55543 4444557889999999998877644333 3467788888888886 2211 1112244
Q ss_pred CCCCCEEEccCCCCCCCCccccc------------------------------------------------------ccc
Q 041878 162 CPNLQTLDLSNNALIGAIPPSLA------------------------------------------------------NST 187 (773)
Q Consensus 162 l~~L~~L~Ls~N~l~~~~~~~l~------------------------------------------------------~l~ 187 (773)
+++|++|+|++|...+.++..+. .++
T Consensus 210 ~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~ 289 (594)
T 2p1m_B 210 CPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCS 289 (594)
T ss_dssp CTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHHT
T ss_pred CCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhhC
Confidence 67888888887721111222222 345
Q ss_pred ccceeecccccccccC-CccccCCCccceeeccccccccccCCcccccccCcccccceeecc---------ccccccccC
Q 041878 188 RLYRLNLSYNSLLGSI-PLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLD---------HNLIAGTIP 257 (773)
Q Consensus 188 ~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~---------~n~l~~~~~ 257 (773)
+|++|+|++|.+++.. ...+..+++|++|++++| ++......+. ..+++|++|++. .+.+++...
T Consensus 290 ~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~----~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l 364 (594)
T 2p1m_B 290 RLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLA----STCKDLRELRVFPSEPFVMEPNVALTEQGL 364 (594)
T ss_dssp TCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHH----HHCTTCCEEEEECSCTTCSSCSSCCCHHHH
T ss_pred CCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHH----HhCCCCCEEEEecCcccccccCCCCCHHHH
Confidence 5666666666654322 222345566666666655 3211111111 113367777773 344544333
Q ss_pred ccCC-CCCCccEEECCCCcccCCCCCCcC-cccccceeccc--c----cccccc-----CcccccccccCceEEccCCCC
Q 041878 258 VSLG-KLGLLQEISLSHNKIVGPIPDELG-KLSKLQKLDLS--Y----NAIGGS-----FPVTFTNITSLVSLNLENNRL 324 (773)
Q Consensus 258 ~~l~-~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls--~----N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l 324 (773)
..+. .+++|+.|+++.|++++.....+. .+++|+.|+++ + |.+++. ++..+..+++|+.|+|++ .+
T Consensus 365 ~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l 443 (594)
T 2p1m_B 365 VSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LL 443 (594)
T ss_dssp HHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SC
T ss_pred HHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cc
Confidence 3333 367888888888888765444444 47899999999 4 566632 223367789999999987 77
Q ss_pred CCCcchhhcc-ccccccccccCccccccccccc-CCCCcCceeecCCccCccCCCc-hhhccCccCEEEeecccCCC
Q 041878 325 GNKIPEGLER-LQNLTVLNLKNNQFKGHIPETI-GNISGINQLDLSENDFTGEISP-SLASLANLTSFNVSYNNLSG 398 (773)
Q Consensus 325 ~~~~~~~l~~-l~~L~~L~ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~ls~N~l~g 398 (773)
++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|++++.... .+..+++|+.|++++|+++.
T Consensus 444 ~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 444 TDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp CHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred cHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 7777777776 8999999999999987666655 6789999999999999765554 34458999999999999843
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.8e-20 Score=195.54 Aligned_cols=82 Identities=24% Similarity=0.415 Sum_probs=36.5
Q ss_pred CCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCcccccccccccee
Q 041878 113 QLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRL 192 (773)
Q Consensus 113 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 192 (773)
++++|++|++++|.++.. + .+..+++|++|+|++|++++..+ ++++++|++|+|++|.+++ + +.+..+++|++|
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-L-SSLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-G-GGGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-C-hhhccCCCCCEE
Confidence 444455555555544422 2 24444445555555544443322 4444444444444444442 1 124444444444
Q ss_pred eccccccc
Q 041878 193 NLSYNSLL 200 (773)
Q Consensus 193 ~Ls~N~l~ 200 (773)
+|++|+++
T Consensus 118 ~L~~n~i~ 125 (291)
T 1h6t_A 118 SLEHNGIS 125 (291)
T ss_dssp ECTTSCCC
T ss_pred ECCCCcCC
Confidence 44444443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=189.77 Aligned_cols=190 Identities=31% Similarity=0.331 Sum_probs=111.5
Q ss_pred cEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccc
Q 041878 118 RKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197 (773)
Q Consensus 118 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N 197 (773)
..+.+..+.+++.. .+..+++|++|++++|.++.. + .++.+++|++|+|++|.+++.. . +..+++|++|+|++|
T Consensus 27 ~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~-~-l~~l~~L~~L~l~~n 100 (291)
T 1h6t_A 27 IKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK-P-LANLKNLGWLFLDEN 100 (291)
T ss_dssp HHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG-G-GTTCTTCCEEECCSS
T ss_pred HHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCc-c-cccCCCCCEEECCCC
Confidence 33444444444322 234566666666666666633 2 3666666666666666666432 2 666666666666666
Q ss_pred cccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCccc
Q 041878 198 SLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIV 277 (773)
Q Consensus 198 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~ 277 (773)
++++ + ..+..+++|++|+|++|++++. +.+.. +++|++|++++|.+++. ..+..+++|+.|++++|+++
T Consensus 101 ~l~~-~-~~l~~l~~L~~L~L~~n~i~~~--~~l~~-----l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~ 169 (291)
T 1h6t_A 101 KVKD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVH-----LPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 169 (291)
T ss_dssp CCCC-G-GGGTTCTTCCEEECTTSCCCCC--GGGGG-----CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred cCCC-C-hhhccCCCCCEEECCCCcCCCC--hhhcC-----CCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccc
Confidence 6654 2 2366666666666666666642 22322 23566666666666654 45666666666666666666
Q ss_pred CCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCc
Q 041878 278 GPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKI 328 (773)
Q Consensus 278 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 328 (773)
+..+ +..+++|++|+|++|.+++. + .+..+++|+.|++++|+++...
T Consensus 170 ~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 170 DIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECCC
T ss_pred cchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCCc
Confidence 5433 66666677777777766643 3 3666667777777777665543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.3e-19 Score=179.09 Aligned_cols=160 Identities=25% Similarity=0.290 Sum_probs=112.3
Q ss_pred CCCCCCCCCcceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCC
Q 041878 75 GVGACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGS 154 (773)
Q Consensus 75 ~~~~c~~~w~gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 154 (773)
+.+.|. |.+|.|...+ ++ .+|..+. ++|++|+|++|.|++..|..|..+++|++|+|++|+|+..
T Consensus 15 ~~~~Cs--~~~v~c~~~~----------l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i 79 (229)
T 3e6j_A 15 SQCSCS--GTTVDCRSKR----------HA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL 79 (229)
T ss_dssp TTCEEE--TTEEECTTSC----------CS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCEEe--CCEeEccCCC----------cC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCc
Confidence 345555 9999996433 22 4444333 7788888888888877777788888888888888888765
Q ss_pred CCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCccccc
Q 041878 155 IPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVL 234 (773)
Q Consensus 155 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 234 (773)
.+..|..+++|++|+|++|.|++..+..+..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+++
T Consensus 80 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~---------- 148 (229)
T 3e6j_A 80 PVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK---------- 148 (229)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCC----------
T ss_pred ChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCC----------
Confidence 5566778888888888888887665566677777777777777777 55666666666666666666555
Q ss_pred ccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCC
Q 041878 235 AGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGP 279 (773)
Q Consensus 235 ~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 279 (773)
+..+..|..+++|+.|+|++|.+...
T Consensus 149 -------------------~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 149 -------------------SIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp -------------------CCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred -------------------ccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 33344566777788888888887743
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.4e-19 Score=178.17 Aligned_cols=157 Identities=22% Similarity=0.252 Sum_probs=126.3
Q ss_pred ccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEcc
Q 041878 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLE 320 (773)
Q Consensus 241 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 320 (773)
+.+.+++++++++. +|..+. ++|+.|+|++|++++..|..|..+++|++|+|++|+|+...+..|..+++|+.|+|+
T Consensus 20 s~~~v~c~~~~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 20 SGTTVDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp ETTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred eCCEeEccCCCcCc-cCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence 35566666666663 343332 678888888888887777788888888888888888876666677888888888888
Q ss_pred CCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCC
Q 041878 321 NNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSV 400 (773)
Q Consensus 321 ~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~ 400 (773)
+|++++..+..+..+++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+++|.+
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 88888777777888888888888888888 77888888999999999999999777777888999999999999999887
Q ss_pred c
Q 041878 401 P 401 (773)
Q Consensus 401 p 401 (773)
+
T Consensus 176 ~ 176 (229)
T 3e6j_A 176 R 176 (229)
T ss_dssp G
T ss_pred c
Confidence 6
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.8e-19 Score=178.31 Aligned_cols=155 Identities=21% Similarity=0.260 Sum_probs=123.2
Q ss_pred eeeccccccccccCCcccccccCcccccceeeccccccccccC-ccCCCCCCccEEECCCCcccCCCCCCcCccccccee
Q 041878 215 VLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIP-VSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKL 293 (773)
Q Consensus 215 ~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~-~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 293 (773)
.+++++|.++ .+|..+. ..+++|+|++|.+++..+ ..|..+++|+.|+|++|++++..+..|..+++|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~-------~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 86 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP-------QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI 86 (220)
T ss_dssp EEECCSSCCS-SCCSCCC-------TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred EeEeCCCCcc-cCccCCC-------CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEE
Confidence 4555555555 3443332 145667777777766644 457788888888888888887777788888889999
Q ss_pred ccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCc
Q 041878 294 DLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFT 373 (773)
Q Consensus 294 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 373 (773)
+|++|+|++..+..|..+++|++|+|++|++++..|..+..+++|++|+|++|++++..|..|..+++|+.|+|++|++.
T Consensus 87 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 87 LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 99999988888888888899999999999998888888889999999999999999888889999999999999999998
Q ss_pred cCCC
Q 041878 374 GEIS 377 (773)
Q Consensus 374 ~~~~ 377 (773)
+..+
T Consensus 167 c~c~ 170 (220)
T 2v70_A 167 CNCY 170 (220)
T ss_dssp CSGG
T ss_pred CCCc
Confidence 7544
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.8e-19 Score=190.96 Aligned_cols=176 Identities=27% Similarity=0.247 Sum_probs=107.6
Q ss_pred ceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccc-cccccceeecccccccccCCccccCCCccceeeccc
Q 041878 142 RGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLA-NSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQH 220 (773)
Q Consensus 142 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~-~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~ 220 (773)
+.+++++|+++ .+|..+. +.+++|+|++|.|++..+..+. ++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 57788888877 4665543 3577788888877766666665 777777777777777766666666666666666666
Q ss_pred cccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccc
Q 041878 221 NNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAI 300 (773)
Q Consensus 221 N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 300 (773)
|++++.. +..|..+++|+.|+|++|++++..|..|..+++|++|+|++|+|
T Consensus 98 N~l~~~~-----------------------------~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 148 (361)
T 2xot_A 98 NHLHTLD-----------------------------EFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQI 148 (361)
T ss_dssp SCCCEEC-----------------------------TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcCCcCC-----------------------------HHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcC
Confidence 6665333 33445555555566666655555555555556666666666666
Q ss_pred cccCcccc---cccccCceEEccCCCCCCCcchhhccccc--cccccccCcccc
Q 041878 301 GGSFPVTF---TNITSLVSLNLENNRLGNKIPEGLERLQN--LTVLNLKNNQFK 349 (773)
Q Consensus 301 ~~~~~~~~---~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~--L~~L~ls~N~l~ 349 (773)
++..+..| ..+++|+.|+|++|+|+...+..+..++. |+.|+|++|.+.
T Consensus 149 ~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 149 SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred CeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 54333333 44566666666666666555555555554 255555555554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.3e-18 Score=173.58 Aligned_cols=124 Identities=21% Similarity=0.212 Sum_probs=74.2
Q ss_pred cCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCC
Q 041878 98 LPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIG 177 (773)
Q Consensus 98 l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 177 (773)
+++++++ .+|..+. +.|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|.|+.
T Consensus 18 c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~ 94 (220)
T 2v9t_B 18 CRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE 94 (220)
T ss_dssp CTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCC
T ss_pred cCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCc
Confidence 3444444 3444333 567777777777776666666777777777777777766666666666777777777766664
Q ss_pred CCccccccccccceeecccccccccCCccccCCCccceeeccccccc
Q 041878 178 AIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLS 224 (773)
Q Consensus 178 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~ 224 (773)
..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|+++
T Consensus 95 l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 141 (220)
T 2v9t_B 95 LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141 (220)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred cCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCC
Confidence 44444555666666666666665555555555555555444444444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.5e-19 Score=182.82 Aligned_cols=170 Identities=25% Similarity=0.267 Sum_probs=92.2
Q ss_pred CCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCcccccccccccee
Q 041878 113 QLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRL 192 (773)
Q Consensus 113 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 192 (773)
++.++..+++++|.+++.. .+..+++|++|++++|+++ .+| .++.+++|++|+|++|.+++. +. +..+++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~-~~-l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDL-SP-LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCC-hh-hccCCCCCEE
Confidence 3455666666666666432 4566667777777777666 344 566667777777777776643 33 6666666666
Q ss_pred ecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECC
Q 041878 193 NLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLS 272 (773)
Q Consensus 193 ~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~ 272 (773)
+|++|++++ ++.. .. ++|++|+|++|++++. + .+.. +++|++|+|++|.+++. + .+..+++|+.|+|+
T Consensus 91 ~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~~-~-~l~~-----l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~ 158 (263)
T 1xeu_A 91 SVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRDT-D-SLIH-----LKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLH 158 (263)
T ss_dssp ECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSBS-G-GGTT-----CTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECT
T ss_pred ECCCCccCC-cCcc-cc-CcccEEEccCCccCCC-h-hhcC-----cccccEEECCCCcCCCC-h-HHccCCCCCEEECC
Confidence 666666664 2221 11 5555555555555532 1 1221 22444444444444433 1 34445555555555
Q ss_pred CCcccCCCCCCcCcccccceeccccccccc
Q 041878 273 HNKIVGPIPDELGKLSKLQKLDLSYNAIGG 302 (773)
Q Consensus 273 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 302 (773)
+|++++. ..+..+++|+.|++++|.+++
T Consensus 159 ~N~i~~~--~~l~~l~~L~~L~l~~N~~~~ 186 (263)
T 1xeu_A 159 GNEITNT--GGLTRLKKVNWIDLTGQKCVN 186 (263)
T ss_dssp TSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred CCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence 5555543 345555555555555555543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.9e-19 Score=183.47 Aligned_cols=171 Identities=27% Similarity=0.249 Sum_probs=119.1
Q ss_pred CCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCcccee
Q 041878 137 FLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVL 216 (773)
Q Consensus 137 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 216 (773)
.+.++..+++++|.+++. + .+..+++|++|++++|.++ .++ .+..+++|++|+|++|++++..+ +.++++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 567788889999999854 3 6888999999999999998 455 78899999999999999986554 8889999999
Q ss_pred eccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccc
Q 041878 217 ALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLS 296 (773)
Q Consensus 217 ~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 296 (773)
+|++|++++ +|.... .+|++|+|++|.+++. ..+..+++|+.|+|++|++++. + .+..+++|++|+|+
T Consensus 91 ~L~~N~l~~-l~~~~~-------~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~ 158 (263)
T 1xeu_A 91 SVNRNRLKN-LNGIPS-------ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLH 158 (263)
T ss_dssp ECCSSCCSC-CTTCCC-------SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECT
T ss_pred ECCCCccCC-cCcccc-------CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECC
Confidence 999999885 332111 3566666666666653 2466666666666666666643 2 45555666666666
Q ss_pred cccccccCcccccccccCceEEccCCCCCCC
Q 041878 297 YNAIGGSFPVTFTNITSLVSLNLENNRLGNK 327 (773)
Q Consensus 297 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 327 (773)
+|++++. ..+..+++|+.|++++|+++..
T Consensus 159 ~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 159 GNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp TSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred CCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 6666544 4455555555555555555443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.4e-19 Score=208.01 Aligned_cols=223 Identities=22% Similarity=0.244 Sum_probs=103.8
Q ss_pred CCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeec
Q 041878 139 PNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLAL 218 (773)
Q Consensus 139 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 218 (773)
++++.|+|.+|.+.. ++.. .|+.++|+.|.|.+ ++++.|++. ..+..+..+++|+.|+|
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~-----~l~~l~Ls~~~i~~--------------~~~~~n~~~-~~~~~~~~l~~L~~L~L 231 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQA-----LLQHKKLSQYSIDE--------------DDDIENRMV-MPKDSKYDDQLWHALDL 231 (727)
T ss_dssp ----------------------------------------------------------------------CCCCCCEEEC
T ss_pred CccceEEeeCCCCCc-chhh-----HhhcCccCcccccC--------------cccccccee-cChhhhccCCCCcEEEC
Confidence 456777777777774 2322 24444555544432 233334433 34555566666666666
Q ss_pred cccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccc
Q 041878 219 QHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYN 298 (773)
Q Consensus 219 ~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 298 (773)
++|++. .+|..+..+. +|++|+|++|.|+ .+|..|+.+++|+.|+|++|+|+ .+|..|+.+++|++|+|++|
T Consensus 232 s~n~l~-~l~~~~~~l~-----~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N 303 (727)
T 4b8c_D 232 SNLQIF-NISANIFKYD-----FLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDN 303 (727)
T ss_dssp TTSCCS-CCCGGGGGCC-----SCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSS
T ss_pred CCCCCC-CCChhhcCCC-----CCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCC
Confidence 666665 4444443332 5666666666666 56677778888888888888888 67888888888888888888
Q ss_pred cccccCcccccccccCceEEccCCCCCCCcchhhcccc-ccccccccCcccccccccccCCCCcCceeecCCc-------
Q 041878 299 AIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQ-NLTVLNLKNNQFKGHIPETIGNISGINQLDLSEN------- 370 (773)
Q Consensus 299 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~-~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N------- 370 (773)
.|+ .+|..|..+++|+.|+|++|+|++.+|..+..+. .+..|+|++|.+++.+|.. |+.|++++|
T Consensus 304 ~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~~~~~ 376 (727)
T 4b8c_D 304 MVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEPQREY 376 (727)
T ss_dssp CCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----------------------
T ss_pred CCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeeccccccccc
Confidence 887 6677788888888888888888888888776653 2345788888888887764 455666666
Q ss_pred -cCccCCCchhhccCccCEEEeecccCC
Q 041878 371 -DFTGEISPSLASLANLTSFNVSYNNLS 397 (773)
Q Consensus 371 -~l~~~~~~~~~~l~~L~~L~ls~N~l~ 397 (773)
.+.+..+..+..+..+....+++|-+.
T Consensus 377 ~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 377 DSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp -------------------------CCC
T ss_pred CCccccccchhhcccccceeeeeccccc
Confidence 333333444445555556666666554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.75 E-value=2.5e-18 Score=167.59 Aligned_cols=155 Identities=21% Similarity=0.318 Sum_probs=111.3
Q ss_pred cEEECCCCcccCCCCCCcCcccccceeccccccccccCcc-cccccccCceEEccCCCCCCCcchhhccccccccccccC
Q 041878 267 QEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPV-TFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKN 345 (773)
Q Consensus 267 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~ 345 (773)
+.|++++|+++ .+|..+.. +|++|++++|+|++..+. .|..+++|++|+|++|++++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56666666665 45554443 677777777777755553 477777888888888888777777788888888888888
Q ss_pred cccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCchh-hhccCCCCCCCCCCCCCCCCC
Q 041878 346 NQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPL-LSKKFNSSSFVGNLQLCGYSP 424 (773)
Q Consensus 346 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~~-~~~~~~~~~~~~n~~~c~~~~ 424 (773)
|++++..+..|.++++|++|+|++|++++..|..+..+++|+.|+|++|+|+|.++.. +...+....+.++...|+.|.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P~ 167 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCCh
Confidence 8888777777888888888888888888888888888888888888888888887743 222222223445555565554
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.2e-18 Score=168.81 Aligned_cols=151 Identities=12% Similarity=0.256 Sum_probs=108.2
Q ss_pred ccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEcc
Q 041878 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLE 320 (773)
Q Consensus 241 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 320 (773)
+|+.|++++|.++ .++ .+..+++|++|++++|.++. +..+..+++|++|++++|++++..+..+..+++|++|+++
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls 120 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS 120 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence 4556666666555 223 46667777777777776652 3467777788888888888877677777788888888888
Q ss_pred CCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCC
Q 041878 321 NNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSG 398 (773)
Q Consensus 321 ~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g 398 (773)
+|++++..+..+..+++|++|++++|++.+.+| .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|++.+
T Consensus 121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp SSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 888877777778888888888888887333445 57888888888888888885 33 67788888888888888754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-18 Score=178.55 Aligned_cols=135 Identities=16% Similarity=0.210 Sum_probs=104.3
Q ss_pred hhcccccccceEEEEEEe-CCCCE--EEEEEecccCcc------------------------cHHHHHHHHHHHHccCCC
Q 041878 539 TAEIMGKSTYGTAYKATL-EDGSE--VAVKRLREKTTK------------------------GQKEFEAEAAAIGKIHHP 591 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~-~~g~~--vAvK~l~~~~~~------------------------~~~~~~~E~~~l~~l~h~ 591 (773)
+.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+..+++++|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 457899999999999987 67888 999987543111 113678899999999887
Q ss_pred ce--EEeEEEEECCCCeEEEEEeecCC-C----CHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCC
Q 041878 592 NL--LALRAYYLGPKGEKLLVFDFMPK-G----SLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTS 664 (773)
Q Consensus 592 ni--v~l~~~~~~~~~~~~lV~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~ 664 (773)
++ ...+.. ...++||||+.+ | +|.++.... ++..+..++.|++.|+.|||.+.||+||||||
T Consensus 131 ~i~~p~~~~~-----~~~~lVmE~~g~~g~~~~~L~~~~~~~------~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 131 GVSVPQPYTY-----MKNVLLMEFIGEDELPAPTLVELGREL------KELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp TCCCCCEEEE-----ETTEEEEECCEETTEECCBHHHHGGGG------GGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred CCCCCeEEEc-----CCCEEEEEecCCCCCccccHHHHhhcc------ChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 54 333332 256899999942 4 677664431 23346789999999999999678999999999
Q ss_pred CCEEeCCCCCeEEeecCCcccc
Q 041878 665 SNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 665 ~NIll~~~~~~kl~DfG~a~~~ 686 (773)
+|||++. .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 8999999999754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.6e-18 Score=167.26 Aligned_cols=153 Identities=19% Similarity=0.298 Sum_probs=97.7
Q ss_pred cCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccce
Q 041878 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYR 191 (773)
Q Consensus 112 ~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 191 (773)
+++++|++|++++|.++ .+| .+..+++|++|++++|.++. +..+..+++|++|+|++|.+++..+..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 45667777777777776 444 56677777777777775542 235666777777777777776656666777777777
Q ss_pred eecccccccccCCccccCCCccceeeccccc-cccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEE
Q 041878 192 LNLSYNSLLGSIPLSLTRLPSLSVLALQHNN-LSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEIS 270 (773)
Q Consensus 192 L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 270 (773)
|+|++|++++..+..+..+++|++|++++|+ ++ .+ + .+..+++|+.|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~-----------------------------~-~l~~l~~L~~L~ 165 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DI-----------------------------M-PLKTLPELKSLN 165 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CC-----------------------------G-GGGGCSSCCEEE
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-cc-----------------------------H-hhcCCCCCCEEE
Confidence 7777777766666666666666666666665 33 22 2 345556666666
Q ss_pred CCCCcccCCCCCCcCcccccceecccccccc
Q 041878 271 LSHNKIVGPIPDELGKLSKLQKLDLSYNAIG 301 (773)
Q Consensus 271 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 301 (773)
+++|++++ ++ .+..+++|++|++++|++.
T Consensus 166 l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 166 IQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred CCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 66666664 22 5666667777777777665
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=4.9e-18 Score=165.47 Aligned_cols=157 Identities=22% Similarity=0.310 Sum_probs=110.4
Q ss_pred ceeeccccccccccCccCCCCCCccEEECCCCcccCCCCC-CcCcccccceeccccccccccCcccccccccCceEEccC
Q 041878 243 QFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPD-ELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLEN 321 (773)
Q Consensus 243 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 321 (773)
+++++++|+++ .+|..+.. +|++|++++|++++..+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 45566666664 33443332 677777777777765554 477777888888888888877777788888888888888
Q ss_pred CCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCch-hhccCccCEEEeecccCCCCC
Q 041878 322 NRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPS-LASLANLTSFNVSYNNLSGSV 400 (773)
Q Consensus 322 N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~ls~N~l~g~~ 400 (773)
|+|++..+..+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..+.. +. ..++...+..+...+..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~--~~l~~~~~~~~~~~C~~ 165 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--HHHHHHCCSGGGCBBCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHH--HHHHHcCCCCCCCCCCC
Confidence 8887777777888888888888888888888888888888888888888888765522 11 11222344556666666
Q ss_pred chhh
Q 041878 401 PPLL 404 (773)
Q Consensus 401 p~~~ 404 (773)
|..+
T Consensus 166 P~~l 169 (192)
T 1w8a_A 166 PSKV 169 (192)
T ss_dssp STTT
T ss_pred ChHH
Confidence 6554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=7.4e-18 Score=179.23 Aligned_cols=103 Identities=14% Similarity=0.057 Sum_probs=82.6
Q ss_pred ccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccc-cccccCcccccccccccCCCCcCcee
Q 041878 287 LSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLT-VLNLKNNQFKGHIPETIGNISGINQL 365 (773)
Q Consensus 287 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~-~L~ls~N~l~~~~~~~~~~l~~L~~L 365 (773)
+++|+.|+|++|+++...+..|.++++|++|+|.+| ++...+..|.++.+|+ .+++.+ .++...+..|.++++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 577888888888888666677888888888888887 6666677788888888 888887 6776667888888888888
Q ss_pred ecCCccCccCCCchhhccCccCEEEe
Q 041878 366 DLSENDFTGEISPSLASLANLTSFNV 391 (773)
Q Consensus 366 ~L~~N~l~~~~~~~~~~l~~L~~L~l 391 (773)
++++|.++...+..|.++++|+.++.
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EeCCCccCccchhhhcCCcchhhhcc
Confidence 88888888777778888888888763
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=1e-16 Score=153.96 Aligned_cols=139 Identities=24% Similarity=0.223 Sum_probs=116.4
Q ss_pred CCCCCCCcceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCC
Q 041878 77 GACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIP 156 (773)
Q Consensus 77 ~~c~~~w~gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p 156 (773)
+.|.|.|.++.|... +++ .+|..+ .++|++|+|++|.+++..+..+..+++|++|+|++|++++..+
T Consensus 3 ~~C~C~~~~l~~~~~----------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (177)
T 2o6r_A 3 SRCSCSGTEIRCNSK----------GLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPD 69 (177)
T ss_dssp TTCEEETTEEECCSS----------CCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred CCCEeCCCEEEecCC----------CCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeCh
Confidence 346556888888543 333 234333 3689999999999998777788999999999999999997777
Q ss_pred CCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccC
Q 041878 157 PSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVP 228 (773)
Q Consensus 157 ~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p 228 (773)
..|+.+++|++|+|++|.+++..+..+..+++|++|+|++|++++..+..+..+++|++|+|++|++++..|
T Consensus 70 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 70 GVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 778999999999999999997777778999999999999999997777778899999999999999986654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.3e-16 Score=155.43 Aligned_cols=132 Identities=20% Similarity=0.292 Sum_probs=107.2
Q ss_pred cEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCc
Q 041878 267 QEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNN 346 (773)
Q Consensus 267 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N 346 (773)
+.+++++|+++ .+|..+. ++|++|+|++|+|+ .+|..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 46677777776 4555443 47788888888887 66677888888888888888888877788888888888888888
Q ss_pred ccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCch
Q 041878 347 QFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402 (773)
Q Consensus 347 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~ 402 (773)
++++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.|.+.-
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l 144 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNM 144 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGG
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcC
Confidence 88888788888999999999999999976667788899999999999999887653
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.5e-16 Score=151.38 Aligned_cols=132 Identities=23% Similarity=0.252 Sum_probs=93.0
Q ss_pred CCccEEECCCCccc-CCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhcccccccccc
Q 041878 264 GLLQEISLSHNKIV-GPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLN 342 (773)
Q Consensus 264 ~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 342 (773)
++|+.|++++|+++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 55667777777766 55666666777777777777777654 5666677777777777777666666666677777777
Q ss_pred ccCccccccc-ccccCCCCcCceeecCCccCccCCC---chhhccCccCEEEeecccCC
Q 041878 343 LKNNQFKGHI-PETIGNISGINQLDLSENDFTGEIS---PSLASLANLTSFNVSYNNLS 397 (773)
Q Consensus 343 ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~ls~N~l~ 397 (773)
+++|++++.. +..+..+++|+.|++++|++++..+ ..+..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 7777777532 2667777778888888888775554 46777788888888887765
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=9.6e-17 Score=152.72 Aligned_cols=135 Identities=27% Similarity=0.285 Sum_probs=107.9
Q ss_pred ccceeeccccccc-cccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEc
Q 041878 241 QLQFLNLDHNLIA-GTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNL 319 (773)
Q Consensus 241 ~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 319 (773)
+|+.|++++|.++ +.+|..+..+++|+.|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+|
T Consensus 25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 5777777777776 56677777788888888888888865 67888888888888888888777877778888999999
Q ss_pred cCCCCCCCc-chhhccccccccccccCcccccccc---cccCCCCcCceeecCCccCccCCCc
Q 041878 320 ENNRLGNKI-PEGLERLQNLTVLNLKNNQFKGHIP---ETIGNISGINQLDLSENDFTGEISP 378 (773)
Q Consensus 320 s~N~l~~~~-~~~l~~l~~L~~L~ls~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~~ 378 (773)
++|++++.. +..+..+++|++|++++|.+++..+ ..+..+++|+.|++++|.+. .+|.
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 999887753 3778888899999999999886554 47888999999999999887 3443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.4e-16 Score=148.21 Aligned_cols=127 Identities=21% Similarity=0.276 Sum_probs=72.3
Q ss_pred CCccEEECCCCccc-CCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhcccccccccc
Q 041878 264 GLLQEISLSHNKIV-GPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLN 342 (773)
Q Consensus 264 ~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 342 (773)
++|+.|++++|+++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|++++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34455555555554 44444445555555555555555533 4455555555555555555555555555566666666
Q ss_pred ccCcccccc-cccccCCCCcCceeecCCccCccCCC---chhhccCccCEEEee
Q 041878 343 LKNNQFKGH-IPETIGNISGINQLDLSENDFTGEIS---PSLASLANLTSFNVS 392 (773)
Q Consensus 343 ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~ls 392 (773)
+++|++++. .+..++.+++|++|++++|++++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 666666542 33556666666666776666665544 456666777776665
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=6.1e-16 Score=148.54 Aligned_cols=134 Identities=20% Similarity=0.298 Sum_probs=96.2
Q ss_pred ccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccC
Q 041878 266 LQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKN 345 (773)
Q Consensus 266 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~ 345 (773)
.+.+++++|+++. +|..+. ++|++|++++|++++..+..|..+++|++|++++|++++..+..+..+++|++|++++
T Consensus 9 ~~~l~~~~~~l~~-~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSS-CCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCcc-CCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 3455666666653 343332 4666777777777655555666777777777777777766666677777778888888
Q ss_pred cccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCch
Q 041878 346 NQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPP 402 (773)
Q Consensus 346 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p~ 402 (773)
|++++..+..+..+++|++|+|++|++++..+..+..+++|+.|++++|+++|.+|.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 887766666778888888888888888866666677888899999999999888773
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=7e-16 Score=150.14 Aligned_cols=127 Identities=28% Similarity=0.238 Sum_probs=109.9
Q ss_pred EEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCC
Q 041878 95 AIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNA 174 (773)
Q Consensus 95 ~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 174 (773)
.+++++++++ .+|..+. +.|++|+|++|.|+ .+|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|.
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 3556666666 5565543 58999999999998 678899999999999999999998888889999999999999999
Q ss_pred CCCCCccccccccccceeecccccccccCCccccCCCccceeecccccccc
Q 041878 175 LIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSG 225 (773)
Q Consensus 175 l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~ 225 (773)
|++..+..|..+++|++|+|++|+|+...+..|..+++|+.|+|++|.+..
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 998888889999999999999999997777788899999999999999874
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.6e-16 Score=146.43 Aligned_cols=128 Identities=26% Similarity=0.303 Sum_probs=111.4
Q ss_pred cccceeeccccccc-cccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEE
Q 041878 240 YQLQFLNLDHNLIA-GTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLN 318 (773)
Q Consensus 240 ~~L~~L~L~~n~l~-~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 318 (773)
++|+.|++++|.++ +.+|..+..+++|+.|++++|++++. ..+..+++|++|++++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 36888888888887 67788888999999999999999865 7788999999999999999987888888899999999
Q ss_pred ccCCCCCCC-cchhhccccccccccccCcccccccc---cccCCCCcCceeecCC
Q 041878 319 LENNRLGNK-IPEGLERLQNLTVLNLKNNQFKGHIP---ETIGNISGINQLDLSE 369 (773)
Q Consensus 319 Ls~N~l~~~-~~~~l~~l~~L~~L~ls~N~l~~~~~---~~~~~l~~L~~L~L~~ 369 (773)
+++|++++. .+..+..+++|++|++++|++++..+ ..+..+++|+.||+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999874 45889999999999999999997665 5788999999999874
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.62 E-value=5.1e-16 Score=165.03 Aligned_cols=243 Identities=14% Similarity=0.099 Sum_probs=155.6
Q ss_pred CCCCcEEEccCCccc--ccCCCCCCCCCCCceEEcccCccCCCCCCCCCC--------CCCCCEEEccCCCCCCCCcccc
Q 041878 114 LHALRKLSLHDNLLA--GPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGN--------CPNLQTLDLSNNALIGAIPPSL 183 (773)
Q Consensus 114 l~~L~~L~L~~n~l~--~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~--------l~~L~~L~Ls~N~l~~~~~~~l 183 (773)
+++|+.|||++|+|. ......+ +.++.+.+..|.|. +..|.+ +++|+.|+|.+ .++...+.+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I~---~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFVP---AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEEC---TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCccccc---cccccccccccccC---HHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 788999999999887 2222122 22344444444332 233444 66666666666 5554445556
Q ss_pred ccccccceeecccccccccCCccccCCCccceeeccccccc----c----------------------ccCCcccccccC
Q 041878 184 ANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLS----G----------------------SVPNNWGVLAGN 237 (773)
Q Consensus 184 ~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~----~----------------------~~p~~~~~l~~~ 237 (773)
.++++|+.|++++|.+....+..|.++.++..+.+..+... . .++..+... ..
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~-~~ 199 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKA-GL 199 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHT-TC
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhc-cc
Confidence 66666666666666665555555555555555554442210 0 001000000 00
Q ss_pred cccccceeeccccccccccCccC-CCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCc-
Q 041878 238 KSYQLQFLNLDHNLIAGTIPVSL-GKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLV- 315 (773)
Q Consensus 238 ~~~~L~~L~L~~n~l~~~~~~~l-~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~- 315 (773)
...++..+.+.++-.. .....+ ..+++|+.|+|++|+++...+.+|.++++|+.|+|++| ++...+.+|.++++|+
T Consensus 200 ~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~ 277 (329)
T 3sb4_A 200 QPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAG 277 (329)
T ss_dssp CGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCE
T ss_pred CccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccE
Confidence 1224455555544221 111111 23688999999999998777778999999999999988 7767778899999999
Q ss_pred eEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeec
Q 041878 316 SLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDL 367 (773)
Q Consensus 316 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L 367 (773)
.|++.+ .++...+..|.++++|+.|++++|+++...+..|.++++|+.++.
T Consensus 278 ~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 278 TLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 999988 777777889999999999999999999777889999999998864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=8.4e-17 Score=170.59 Aligned_cols=137 Identities=15% Similarity=0.157 Sum_probs=99.5
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCc--------------ccHH--------HHHHHHHHHHccCCCceE
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTT--------------KGQK--------EFEAEAAAIGKIHHPNLL 594 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~--------------~~~~--------~~~~E~~~l~~l~h~niv 594 (773)
|++.+.||+|+||.||+|...+|+.||||+++.... .... ....|...|.++.+..+.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 345788999999999999998999999998753210 0001 123466777777554432
Q ss_pred --EeEEEEECCCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC
Q 041878 595 --ALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK 672 (773)
Q Consensus 595 --~l~~~~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~ 672 (773)
..++.. ..++||||++|++|.++... .....++.||+.++.||| +.|||||||||.|||++++
T Consensus 177 vp~p~~~~-----~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH-~~gIVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 177 VPEPIAQS-----RHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLA-KHGLIHGDFNEFNILIREE 241 (397)
T ss_dssp CCCEEEEE-----TTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEEEEEE
T ss_pred CCeeeecc-----CceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHH-HCCCcCCCCCHHHEEEeCC
Confidence 222221 34799999999888654321 123467899999999999 8999999999999999887
Q ss_pred CC----------eEEeecCCcccccc
Q 041878 673 TN----------PRIADFGLSRLMTA 688 (773)
Q Consensus 673 ~~----------~kl~DfG~a~~~~~ 688 (773)
+. +.|+||+.+.....
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred CCcccccccccceEEEEeCCcccCCC
Confidence 73 89999998765543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2e-14 Score=156.14 Aligned_cols=263 Identities=11% Similarity=0.081 Sum_probs=136.6
Q ss_pred CCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeec
Q 041878 115 HALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNL 194 (773)
Q Consensus 115 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 194 (773)
..++.+.+.+ .++..-..+|.++ +|+.++|..| ++..-..+|.++ +|+.++|.+ .++...+.+|.++++|+.++|
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 4555555543 3443445555554 5666666554 443444445553 466666654 444444455666666666666
Q ss_pred ccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCC
Q 041878 195 SYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHN 274 (773)
Q Consensus 195 s~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N 274 (773)
++|+++......|. ..+|+.+.|..+ ++..-...|. .+.+|+.+++..| ++.+...+|.+ .+|+.+.+ .|
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~-----~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~ 257 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFL-----KTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PN 257 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTT-----TCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ET
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhh-----CCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CC
Confidence 66666543333333 455666655533 3322222222 2225555555543 44444444554 45555555 33
Q ss_pred cccCCCCCCcCcccccceecccccccc-----ccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccc
Q 041878 275 KIVGPIPDELGKLSKLQKLDLSYNAIG-----GSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFK 349 (773)
Q Consensus 275 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~ 349 (773)
.++.....+|.++++|+.+++.+|.+. ...+..|.++++|+.+.|. |.++......|.++++|+.++|..| ++
T Consensus 258 ~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~ 335 (401)
T 4fdw_A 258 GVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT 335 (401)
T ss_dssp TCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC
T ss_pred CccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc
Confidence 344344455555666666666555443 2334455666666666665 3354444555666666666666433 44
Q ss_pred cccccccCCCCcCceeecCCccCccCCCchhhccC-ccCEEEeeccc
Q 041878 350 GHIPETIGNISGINQLDLSENDFTGEISPSLASLA-NLTSFNVSYNN 395 (773)
Q Consensus 350 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~ls~N~ 395 (773)
......|.++ +|+.|++++|.+....+..|.+++ +++.|++..|.
T Consensus 336 ~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~ 381 (401)
T 4fdw_A 336 QINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES 381 (401)
T ss_dssp EECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred EEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence 4445556666 666666666665544445555553 45566555443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.9e-14 Score=156.25 Aligned_cols=248 Identities=11% Similarity=0.079 Sum_probs=204.5
Q ss_pred ccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccc
Q 041878 109 EKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTR 188 (773)
Q Consensus 109 ~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 188 (773)
.++.+. +|+.+.|.++ ++.....+|.++ +|+.+.|.+ .++..-+..|.+|++|+.++|++|.++.....+|. ..+
T Consensus 130 ~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~ 204 (401)
T 4fdw_A 130 DAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAG 204 (401)
T ss_dssp TTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCC
T ss_pred hhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecc
Confidence 456664 7999999876 776777888885 799999986 77766778899999999999999999965555666 689
Q ss_pred cceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccE
Q 041878 189 LYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQE 268 (773)
Q Consensus 189 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 268 (773)
|+.+.|..+ ++......|.++++|+.+++..| ++..-...|.. .+|+.+.+ .+.++.+...+|.++++|+.
T Consensus 205 L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~------~~L~~i~l-p~~i~~I~~~aF~~c~~L~~ 275 (401)
T 4fdw_A 205 IEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE------SGITTVKL-PNGVTNIASRAFYYCPELAE 275 (401)
T ss_dssp CSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT------CCCSEEEE-ETTCCEECTTTTTTCTTCCE
T ss_pred cCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc------CCccEEEe-CCCccEEChhHhhCCCCCCE
Confidence 999999855 77677888999999999999875 55344444433 37999999 56678788899999999999
Q ss_pred EECCCCccc-----CCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccc
Q 041878 269 ISLSHNKIV-----GPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNL 343 (773)
Q Consensus 269 L~L~~N~l~-----~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l 343 (773)
+++.+|.+. ...+.+|.++++|+.++|. +.++......|.++++|+.|.|.+| ++......|.++ +|+.|++
T Consensus 276 l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l 352 (401)
T 4fdw_A 276 VTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKV 352 (401)
T ss_dssp EEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEE
T ss_pred EEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEE
Confidence 999998875 3556789999999999999 5588777889999999999999665 777777889999 9999999
Q ss_pred cCcccccccccccCCCC-cCceeecCCccCc
Q 041878 344 KNNQFKGHIPETIGNIS-GINQLDLSENDFT 373 (773)
Q Consensus 344 s~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~ 373 (773)
++|.+....+..|.+++ +++.|++..+.+.
T Consensus 353 ~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 353 EGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred cCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 99999877777788885 7889999887654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.58 E-value=4.9e-17 Score=159.27 Aligned_cols=150 Identities=23% Similarity=0.323 Sum_probs=117.8
Q ss_pred cceeeccccccccccCc------cCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCc
Q 041878 242 LQFLNLDHNLIAGTIPV------SLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLV 315 (773)
Q Consensus 242 L~~L~L~~n~l~~~~~~------~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 315 (773)
++.++++.+.+++..|. .+..+++|++|+|++|++++ +| .+..+++|++|++++|.++ .+|..+..+++|+
T Consensus 20 l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~ 96 (198)
T 1ds9_A 20 VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCS
T ss_pred ccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCC
Confidence 34444444444444333 77788889999999999886 66 8888899999999999998 6777788889999
Q ss_pred eEEccCCCCCCCcchhhccccccccccccCcccccccc-cccCCCCcCceeecCCccCccCCCch----------hhccC
Q 041878 316 SLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIP-ETIGNISGINQLDLSENDFTGEISPS----------LASLA 384 (773)
Q Consensus 316 ~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~----------~~~l~ 384 (773)
.|++++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|++|++++|++++.+|.. +..++
T Consensus 97 ~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~ 174 (198)
T 1ds9_A 97 ELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP 174 (198)
T ss_dssp EEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCS
T ss_pred EEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCC
Confidence 99999999976 44 68889999999999999985433 57888999999999999998776653 77889
Q ss_pred ccCEEEeecccCCC
Q 041878 385 NLTSFNVSYNNLSG 398 (773)
Q Consensus 385 ~L~~L~ls~N~l~g 398 (773)
+|+.|| +|.++.
T Consensus 175 ~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 175 NLKKLD--GMPVDV 186 (198)
T ss_dssp SCSEEC--CGGGTT
T ss_pred CcEEEC--CcccCH
Confidence 999886 777654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=6.9e-15 Score=140.95 Aligned_cols=132 Identities=21% Similarity=0.224 Sum_probs=94.1
Q ss_pred CCCCCCccEEECCCCcccCCCCCCcCccc-ccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhcccccc
Q 041878 260 LGKLGLLQEISLSHNKIVGPIPDELGKLS-KLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNL 338 (773)
Q Consensus 260 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 338 (773)
+.++.+|+.|++++|+++. +|. +..+. +|++|++++|.|++. ..+..+++|+.|+|++|++++..+..+..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 4456667777777777773 343 44444 777777777777754 567777777777777777776554555777788
Q ss_pred ccccccCccccccccc--ccCCCCcCceeecCCccCccCCCch----hhccCccCEEEeecccCC
Q 041878 339 TVLNLKNNQFKGHIPE--TIGNISGINQLDLSENDFTGEISPS----LASLANLTSFNVSYNNLS 397 (773)
Q Consensus 339 ~~L~ls~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~ls~N~l~ 397 (773)
++|++++|+++ .+|. .+..+++|+.|++++|+++ .+|.. +..+++|+.||+++|...
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 88888888875 4454 6778888888888888887 44553 788888888888888754
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.4e-16 Score=155.96 Aligned_cols=127 Identities=26% Similarity=0.310 Sum_probs=96.6
Q ss_pred ccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEcc
Q 041878 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLE 320 (773)
Q Consensus 241 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 320 (773)
+|++|+|++|.+++ +| .+..+++|+.|++++|+++ .+|..+..+++|++|++++|++++ +| .+..+++|+.|+++
T Consensus 49 ~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~ 123 (198)
T 1ds9_A 49 ACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMS 123 (198)
T ss_dssp TCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEES
T ss_pred CCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECC
Confidence 44555555555544 33 5666777888888888887 567777777889999999998885 44 68888999999999
Q ss_pred CCCCCCCcc-hhhccccccccccccCcccccccccc----------cCCCCcCceeecCCccCcc
Q 041878 321 NNRLGNKIP-EGLERLQNLTVLNLKNNQFKGHIPET----------IGNISGINQLDLSENDFTG 374 (773)
Q Consensus 321 ~N~l~~~~~-~~l~~l~~L~~L~ls~N~l~~~~~~~----------~~~l~~L~~L~L~~N~l~~ 374 (773)
+|++++..+ ..+..+++|++|++++|.+.+.+|.. +..+++|+.|| +|.++.
T Consensus 124 ~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~ 186 (198)
T 1ds9_A 124 NNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV 186 (198)
T ss_dssp EEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred CCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence 999976543 57888999999999999998776653 78899999887 777764
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=1.5e-14 Score=138.52 Aligned_cols=110 Identities=21% Similarity=0.185 Sum_probs=71.2
Q ss_pred cccCCCCCcEEEccCCcccccCCCCCCCC-CCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccc
Q 041878 110 KISQLHALRKLSLHDNLLAGPVPWSLGFL-PNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTR 188 (773)
Q Consensus 110 ~l~~l~~L~~L~L~~n~l~~~~~~~l~~l-~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 188 (773)
.+.++++|+.|+|++|.++. +|. +..+ ++|++|+|++|+|++. +.++.+++|++|+|++|.+++..+..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 34566677777777777773 343 3333 3777777777777754 56677777777777777777443344467777
Q ss_pred cceeecccccccccCCc--cccCCCccceeeccccccc
Q 041878 189 LYRLNLSYNSLLGSIPL--SLTRLPSLSVLALQHNNLS 224 (773)
Q Consensus 189 L~~L~Ls~N~l~~~~~~--~l~~l~~L~~L~L~~N~l~ 224 (773)
|++|+|++|+++ .+|. .+..+++|+.|++++|+++
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 777777777775 3443 5666666666666666665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.49 E-value=6.2e-14 Score=133.34 Aligned_cols=108 Identities=24% Similarity=0.311 Sum_probs=71.2
Q ss_pred ceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCc
Q 041878 291 QKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSEN 370 (773)
Q Consensus 291 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N 370 (773)
+.|++++|.|+ .+|..+. ++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 44455555544 2333332 45666666666666666666666666666666667666555556677777777777777
Q ss_pred cCccCCCchhhccCccCEEEeecccCCCCCc
Q 041878 371 DFTGEISPSLASLANLTSFNVSYNNLSGSVP 401 (773)
Q Consensus 371 ~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p 401 (773)
+|++..+..+..+++|+.|+|++|+|++.++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 7776666667778888888888888887765
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=1.9e-13 Score=129.92 Aligned_cols=102 Identities=22% Similarity=0.184 Sum_probs=60.6
Q ss_pred EEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCC
Q 041878 96 IQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNAL 175 (773)
Q Consensus 96 l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l 175 (773)
+++++++++. +|..+. +.|++|+|++|.|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|
T Consensus 14 l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l 90 (170)
T 3g39_A 14 VDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL 90 (170)
T ss_dssp EECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCcc
Confidence 4455555553 444442 5666666666666666566666666666666666666655555556666666666666666
Q ss_pred CCCCccccccccccceeeccccccc
Q 041878 176 IGAIPPSLANSTRLYRLNLSYNSLL 200 (773)
Q Consensus 176 ~~~~~~~l~~l~~L~~L~Ls~N~l~ 200 (773)
++..+..|..+++|++|+|++|.+.
T Consensus 91 ~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 91 KSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 6444445556666666666666554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.3e-13 Score=128.75 Aligned_cols=103 Identities=22% Similarity=0.260 Sum_probs=59.3
Q ss_pred EEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCC
Q 041878 95 AIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNA 174 (773)
Q Consensus 95 ~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~ 174 (773)
.+++++++++ .+|..+. ++|++|+|++|.|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 4566666653 4454443 566666666666665556566666666666666666665444445566666666666666
Q ss_pred CCCCCccccccccccceeeccccccc
Q 041878 175 LIGAIPPSLANSTRLYRLNLSYNSLL 200 (773)
Q Consensus 175 l~~~~~~~l~~l~~L~~L~Ls~N~l~ 200 (773)
|++..+..|..+++|++|+|++|.+.
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred cceeCHHHhccccCCCEEEeCCCCcc
Confidence 65443334555555555555555554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=2e-13 Score=130.20 Aligned_cols=90 Identities=22% Similarity=0.288 Sum_probs=52.0
Q ss_pred ccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEe
Q 041878 312 TSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNV 391 (773)
Q Consensus 312 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 391 (773)
++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..+..+++|+.|+|
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 34445555555554444555555555555555555555444444566666666666666666544445666667777777
Q ss_pred ecccCCCCCc
Q 041878 392 SYNNLSGSVP 401 (773)
Q Consensus 392 s~N~l~g~~p 401 (773)
++|+|.+..+
T Consensus 113 ~~N~~~c~~~ 122 (174)
T 2r9u_A 113 YNNPWDCECR 122 (174)
T ss_dssp CSSCBCTTBG
T ss_pred CCCCcccccc
Confidence 7777766544
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.39 E-value=4.6e-15 Score=159.57 Aligned_cols=66 Identities=15% Similarity=0.231 Sum_probs=27.9
Q ss_pred ccccccCceEEccCCCCCCCc----chhhccccccccccccCcccccccccccCCC---C--cCceee--cCCccCc
Q 041878 308 FTNITSLVSLNLENNRLGNKI----PEGLERLQNLTVLNLKNNQFKGHIPETIGNI---S--GINQLD--LSENDFT 373 (773)
Q Consensus 308 ~~~l~~L~~L~Ls~N~l~~~~----~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l---~--~L~~L~--L~~N~l~ 373 (773)
+..+++|++|+|++|.|++.. +..+...++|++|+|++|.|++.....+..+ . .|+.+. +..|.++
T Consensus 207 L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 207 LDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp GGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred HhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 334445555555555554322 2223334555555555555554333333221 1 155565 5566655
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=6.9e-15 Score=158.22 Aligned_cols=65 Identities=14% Similarity=0.215 Sum_probs=28.7
Q ss_pred ccccccccccccCcccccc----cccccCCCCcCceeecCCccCccCC----CchhhccCccCEEEeecccCC
Q 041878 333 ERLQNLTVLNLKNNQFKGH----IPETIGNISGINQLDLSENDFTGEI----SPSLASLANLTSFNVSYNNLS 397 (773)
Q Consensus 333 ~~l~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~ls~N~l~ 397 (773)
..+++|++|+|++|.+++. ++..+...++|+.|+|++|.|+... +..+...++|+.|+|++|.|+
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence 3344444444444444431 1333344445555555555554321 122223345555555555554
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.7e-11 Score=131.89 Aligned_cols=284 Identities=12% Similarity=0.059 Sum_probs=184.7
Q ss_pred CEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCcc--------------------
Q 041878 92 QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRL-------------------- 151 (773)
Q Consensus 92 ~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l-------------------- 151 (773)
.++.+.|+. +++..-..++.++++|+.++|.++ ++.....+|.++.+|+.+.+..+--
T Consensus 72 ~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~~~~~~~~ 149 (394)
T 4fs7_A 72 KVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFKEITIPEG 149 (394)
T ss_dssp TEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCSEEECCTT
T ss_pred CceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeecccccccccCcc
Confidence 466666653 344333455677777777777644 4444455666666666665543310
Q ss_pred -CCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCc
Q 041878 152 -SGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNN 230 (773)
Q Consensus 152 -~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~ 230 (773)
...-...|.++++|+.+.+.++. .......|.++++|+.+.+..| ++......+.++..|+.+.+..+... +.+.
T Consensus 150 ~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~ 225 (394)
T 4fs7_A 150 VTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDF 225 (394)
T ss_dssp CCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTT
T ss_pred ccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehh
Confidence 00112345566666666665443 2234455666666666666554 33344455666666666666554432 1111
Q ss_pred ccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccc
Q 041878 231 WGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTN 310 (773)
Q Consensus 231 ~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 310 (773)
. ....+|+.+.+..+ ++......+..+..|+.+.+..+... .....|..+..++.+.+..+.+. ...|..
T Consensus 226 ~-----~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~ 295 (394)
T 4fs7_A 226 A-----LSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYG 295 (394)
T ss_dssp T-----TTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTT
T ss_pred h-----cccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccc
Confidence 1 11235777776543 34455667788888888888877554 45667888888888887766543 346788
Q ss_pred cccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEE
Q 041878 311 ITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFN 390 (773)
Q Consensus 311 l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 390 (773)
+.+|+.+.+.++ ++......|.++.+|+.++|.++ ++......|.++.+|+.+++..| ++.....+|.++.+|+.++
T Consensus 296 ~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ 372 (394)
T 4fs7_A 296 CSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVE 372 (394)
T ss_dssp CTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEE
T ss_pred cccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEE
Confidence 899999999765 65566778999999999999754 66566788999999999999877 7766778899999999999
Q ss_pred eecc
Q 041878 391 VSYN 394 (773)
Q Consensus 391 ls~N 394 (773)
+..|
T Consensus 373 lp~~ 376 (394)
T 4fs7_A 373 LPKR 376 (394)
T ss_dssp EEGG
T ss_pred ECCC
Confidence 8755
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.32 E-value=3e-12 Score=136.90 Aligned_cols=108 Identities=25% Similarity=0.280 Sum_probs=82.8
Q ss_pred CCCCcceEeeCCCEEEEEcCCC-CcccccCccccCCCCCcEEEccC-CcccccCCCCCCCCCCCceEEcccCccCCCCCC
Q 041878 80 SGGWAGIKCVKGQVIAIQLPWR-RLGGRISEKISQLHALRKLSLHD-NLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPP 157 (773)
Q Consensus 80 ~~~w~gv~c~~~~v~~l~l~~~-~l~~~i~~~l~~l~~L~~L~L~~-n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~ 157 (773)
.|.|.+|.|. ++ ++++ +|. |..+++|++|+|++ |.|++..+..|+.|++|++|+|++|+|++..|.
T Consensus 7 ~C~~~~v~~~----------~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 7 PHGSSGLRCT----------RDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp CSSSSCEECC----------SSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred cccCCEEEcC----------CCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 4447777774 33 5553 777 88888888888886 888887778888888888888888888888888
Q ss_pred CCCCCCCCCEEEccCCCCCCCCccccccccccceeeccccccc
Q 041878 158 SIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLL 200 (773)
Q Consensus 158 ~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 200 (773)
.|+++++|++|+|++|+|++..+..+..++ |++|+|.+|.+.
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 888888888888888888855555555554 788888777776
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.25 E-value=8.1e-12 Score=133.52 Aligned_cols=93 Identities=22% Similarity=0.243 Sum_probs=49.0
Q ss_pred ccccccCceEEccC-CCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCcc
Q 041878 308 FTNITSLVSLNLEN-NRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANL 386 (773)
Q Consensus 308 ~~~l~~L~~L~Ls~-N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 386 (773)
+..+++|+.|+|++ |+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+..++ |
T Consensus 27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L 105 (347)
T 2ifg_A 27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-L 105 (347)
T ss_dssp SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-C
T ss_pred CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-c
Confidence 44444444444443 444444444455555555555555555555555555555555555555555544444444443 6
Q ss_pred CEEEeecccCCCCCc
Q 041878 387 TSFNVSYNNLSGSVP 401 (773)
Q Consensus 387 ~~L~ls~N~l~g~~p 401 (773)
+.|+|.+|+|.+.+.
T Consensus 106 ~~l~l~~N~~~c~c~ 120 (347)
T 2ifg_A 106 QELVLSGNPLHCSCA 120 (347)
T ss_dssp CEEECCSSCCCCCGG
T ss_pred eEEEeeCCCccCCCc
Confidence 666666666665544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.17 E-value=5e-10 Score=121.74 Aligned_cols=272 Identities=8% Similarity=0.114 Sum_probs=145.3
Q ss_pred ccccCCC-CCcEEEccCCcccccCCCCCCCCCCCceEEcccCc---cCCCCCCCCCCCCCCCEEEccCCCCCCCCccccc
Q 041878 109 EKISQLH-ALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNR---LSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLA 184 (773)
Q Consensus 109 ~~l~~l~-~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~---l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~ 184 (773)
.++.++. .|+.+.+.++ ++.+-..+|.++++|+.+.+..|. ++..-..+|..+.+|+.+.+..+ ++.....++.
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~ 134 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFH 134 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhh
Confidence 3455553 4666666543 554556666667777777666553 44333455666666666666543 3333344556
Q ss_pred cccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCC
Q 041878 185 NSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLG 264 (773)
Q Consensus 185 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~ 264 (773)
.+.+|+.+.+..+ +.......|..+.+|+.+.+..+ ++..-...|. ..+|+.+.+..+-. .....+|..+.
T Consensus 135 ~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~------~~~l~~i~ip~~~~-~i~~~af~~c~ 205 (394)
T 4gt6_A 135 HCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT------GTALTQIHIPAKVT-RIGTNAFSECF 205 (394)
T ss_dssp TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT------TCCCSEEEECTTCC-EECTTTTTTCT
T ss_pred hhcccccccccce-eeeecccceecccccccccccce-eeEecccccc------ccceeEEEECCccc-ccccchhhhcc
Confidence 6666666666533 22233445555666666655443 2211111111 11344444433221 12223333333
Q ss_pred CccEEECCCC------------------------------------cccCCCCCCcCcccccceeccccccccccCcccc
Q 041878 265 LLQEISLSHN------------------------------------KIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTF 308 (773)
Q Consensus 265 ~L~~L~L~~N------------------------------------~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~ 308 (773)
+|+......+ .++..-..+|.++.+|+.+.+..+..+ .....|
T Consensus 206 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF 284 (394)
T 4gt6_A 206 ALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAF 284 (394)
T ss_dssp TCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTT
T ss_pred ccceecccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccce-ecCccc
Confidence 3333322211 111122345666677777777654332 445566
Q ss_pred cccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCE
Q 041878 309 TNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTS 388 (773)
Q Consensus 309 ~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 388 (773)
.++++|+.+.+. +.++......|.++.+|+.++|..+ ++......|.++.+|+.+.|..+ ++.....+|.++.+|+.
T Consensus 285 ~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~ 361 (394)
T 4gt6_A 285 MNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNN 361 (394)
T ss_dssp TTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCE
T ss_pred ccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCE
Confidence 777777777775 4454455556777777777777654 55445566777777777777544 55455567777777777
Q ss_pred EEeeccc
Q 041878 389 FNVSYNN 395 (773)
Q Consensus 389 L~ls~N~ 395 (773)
+++.+|.
T Consensus 362 i~~~~~~ 368 (394)
T 4gt6_A 362 IEYSGSR 368 (394)
T ss_dssp EEESSCH
T ss_pred EEECCce
Confidence 7777654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.15 E-value=5.4e-10 Score=121.53 Aligned_cols=269 Identities=10% Similarity=0.019 Sum_probs=153.4
Q ss_pred CccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCcccccccc
Q 041878 108 SEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANST 187 (773)
Q Consensus 108 ~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 187 (773)
..++.++++|+.+.|.. .++..-..+|.++++|+.++|.++ ++..-...|.++.+|+.+.+..+ +......+|.+..
T Consensus 64 ~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~ 140 (394)
T 4fs7_A 64 YAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCD 140 (394)
T ss_dssp TTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCC
T ss_pred HHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccc
Confidence 45688899999999975 477667788999999999999765 55455567888888888877654 2223333343333
Q ss_pred ccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCcc
Q 041878 188 RLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQ 267 (773)
Q Consensus 188 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~ 267 (773)
.+........ .......|.++++|+.+.+.++-.+ .....| ..+.+|+.+.+..| ++.+....|.++..|+
T Consensus 141 ~~~~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F-----~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~ 211 (394)
T 4fs7_A 141 FKEITIPEGV--TVIGDEAFATCESLEYVSLPDSMET-LHNGLF-----SGCGKLKSIKLPRN-LKIIRDYCFAECILLE 211 (394)
T ss_dssp CSEEECCTTC--CEECTTTTTTCTTCCEEECCTTCCE-ECTTTT-----TTCTTCCBCCCCTT-CCEECTTTTTTCTTCC
T ss_pred ccccccCccc--cccchhhhcccCCCcEEecCCccce-eccccc-----cCCCCceEEEcCCC-ceEeCchhhccccccc
Confidence 2222221111 1122334555555555555433211 111111 12224555555443 3333344444444444
Q ss_pred EEECCCCcc---------------------cCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCC
Q 041878 268 EISLSHNKI---------------------VGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGN 326 (773)
Q Consensus 268 ~L~L~~N~l---------------------~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 326 (773)
.+.+..+.. +......+..+..|+.+.+..+... .....|..+..++.+.+..+.+
T Consensus 212 ~i~~~~~~~~i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i-- 288 (394)
T 4fs7_A 212 NMEFPNSLYYLGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV-- 288 (394)
T ss_dssp BCCCCTTCCEECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE--
T ss_pred eeecCCCceEeehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee--
Confidence 444443322 2122334555566666666555333 4445566666666666655433
Q ss_pred CcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecc
Q 041878 327 KIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYN 394 (773)
Q Consensus 327 ~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N 394 (773)
....+..+.+|+.+.+.++ ++......|.++.+|+.++|.++ ++.....+|.++.+|+.+++..|
T Consensus 289 -~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 289 -PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp -CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred -ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 2235666777787777654 55455667778888888888644 66555677888888888877654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.6e-09 Score=117.77 Aligned_cols=286 Identities=12% Similarity=0.187 Sum_probs=185.8
Q ss_pred EEEEEcCCCCcccccCccccCCCCCcEEEccCCc---ccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEE
Q 041878 93 VIAIQLPWRRLGGRISEKISQLHALRKLSLHDNL---LAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLD 169 (773)
Q Consensus 93 v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~---l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 169 (773)
++++.++. .++..-..++.++++|+.+.+.+|. ++.....+|.++.+|+.+.+..+ ++..-...|..+.+|+.+.
T Consensus 66 L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~ 143 (394)
T 4gt6_A 66 LTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVT 143 (394)
T ss_dssp CCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEE
T ss_pred CEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccc
Confidence 44555543 2333335567888999999988764 66566778888999998887654 4435556788899999999
Q ss_pred ccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccc
Q 041878 170 LSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDH 249 (773)
Q Consensus 170 Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~ 249 (773)
+..+ +.......+..+.+|+.+.+..+ ++......|. ..+|+.+.+..+-.. .....|.. +.++.......
T Consensus 144 lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~l~~i~ip~~~~~-i~~~af~~-----c~~l~~~~~~~ 214 (394)
T 4gt6_A 144 IPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTALTQIHIPAKVTR-IGTNAFSE-----CFALSTITSDS 214 (394)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TCCCSEEEECTTCCE-ECTTTTTT-----CTTCCEEEECC
T ss_pred ccce-eeeecccceecccccccccccce-eeEecccccc-ccceeEEEECCcccc-cccchhhh-----ccccceecccc
Confidence 9754 34355667888888999888765 4433344444 356888877654322 11222211 11222221111
Q ss_pred ------------------------------------cccccccCccCCCCCCccEEECCCCcccCCCCCCcCccccccee
Q 041878 250 ------------------------------------NLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKL 293 (773)
Q Consensus 250 ------------------------------------n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 293 (773)
+.++.+...+|.++..|+.+.+.++..+ ....+|.++++|+.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i 293 (394)
T 4gt6_A 215 ESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDI 293 (394)
T ss_dssp SSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEE
T ss_pred cccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccce-ecCcccccccccccc
Confidence 2233344557788888999988766544 556678888899999
Q ss_pred ccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCc
Q 041878 294 DLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFT 373 (773)
Q Consensus 294 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 373 (773)
.+. +.++......|.++.+|+.+.|..+ ++......|.++.+|+.+.+..+ ++......|.++.+|+.+++.+|...
T Consensus 294 ~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 294 EFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp ECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred cCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence 886 5566566678888999999999765 65566678889999999999654 66566778889999999999888654
Q ss_pred cCCCchhhccCccCEEEeecccC
Q 041878 374 GEISPSLASLANLTSFNVSYNNL 396 (773)
Q Consensus 374 ~~~~~~~~~l~~L~~L~ls~N~l 396 (773)
. ..+....+|+.+.+..|.+
T Consensus 371 ~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 371 W---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp H---HTCBCCCCC----------
T ss_pred h---hhhhccCCCCEEEeCCCCE
Confidence 2 3556677788887766654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.12 E-value=6.1e-11 Score=121.26 Aligned_cols=135 Identities=14% Similarity=0.074 Sum_probs=103.1
Q ss_pred hcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEEeecCCCC
Q 041878 540 AEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
...++.|+.+.||++... ++.+++|............+.+|+++++.+. +..+.++++++. ..+..|+||||++|.+
T Consensus 19 ~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-~~~~~~lv~e~i~G~~ 96 (263)
T 3tm0_A 19 VKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-HDGWSNLLMSEADGVL 96 (263)
T ss_dssp EECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-ETTEEEEEEECCSSEE
T ss_pred EeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-cCCceEEEEEecCCee
Confidence 456777888999999754 6899999987532233456889999999885 566778888874 4568899999999999
Q ss_pred HHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccC--------------------------------------------
Q 041878 619 LASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE-------------------------------------------- 654 (773)
Q Consensus 619 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~-------------------------------------------- 654 (773)
|.+.... ......++.++++++..||.-
T Consensus 97 l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 97 CSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred hhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 9875321 112246788899999999940
Q ss_pred --------------CCceecCCCCCCEEeCCCCCeEEeecCCcc
Q 041878 655 --------------ENMIHGNLTSSNVLLDEKTNPRIADFGLSR 684 (773)
Q Consensus 655 --------------~~iiH~Dik~~NIll~~~~~~kl~DfG~a~ 684 (773)
..++|+|++|.||+++++..+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348999999999999876556799999774
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.08 E-value=1.6e-11 Score=130.78 Aligned_cols=59 Identities=20% Similarity=0.380 Sum_probs=31.0
Q ss_pred ccccceecccccccccc----CcccccccccCceEEccCCCCCCCcchhhcc-ccccccccccCcc
Q 041878 287 LSKLQKLDLSYNAIGGS----FPVTFTNITSLVSLNLENNRLGNKIPEGLER-LQNLTVLNLKNNQ 347 (773)
Q Consensus 287 l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~-l~~L~~L~ls~N~ 347 (773)
+++|++|+|+.|.|++. ++..+..+++|+.|+|++|.+++.....+.. + ...+++++|+
T Consensus 278 ~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp GGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred CCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 45566666666655542 2233344566666666666665444333333 2 2445666665
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.8e-11 Score=130.39 Aligned_cols=206 Identities=15% Similarity=0.178 Sum_probs=109.8
Q ss_pred CCEEEEEcCCCCccc-c-------cCccccCCCCCcEEEccCCccc---------ccCCCCCCCCCCCceEEcccCccCC
Q 041878 91 GQVIAIQLPWRRLGG-R-------ISEKISQLHALRKLSLHDNLLA---------GPVPWSLGFLPNLRGVYLFNNRLSG 153 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~-~-------i~~~l~~l~~L~~L~L~~n~l~---------~~~~~~l~~l~~L~~L~L~~n~l~~ 153 (773)
.+|+.|.+....+.| . +.+++.++++|+.|.+.++... +.+...+..+|+|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 457777777555543 2 2344567788888888664321 112233445566777776665211
Q ss_pred CCCCCCCCCCCCCEEEccCCCCCCCCccccc--cccccceeeccc--ccccccCCccccCCCccceeeccccccccccCC
Q 041878 154 SIPPSIGNCPNLQTLDLSNNALIGAIPPSLA--NSTRLYRLNLSY--NSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229 (773)
Q Consensus 154 ~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~--~l~~L~~L~Ls~--N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~ 229 (773)
.++. +. +++|++|+|..|.+.......+. .+++|++|+|+. |...+... ..
T Consensus 186 ~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~-----------------------~~ 240 (362)
T 2ra8_A 186 SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGD-----------------------MN 240 (362)
T ss_dssp BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSC-----------------------GG
T ss_pred eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchh-----------------------HH
Confidence 1222 22 56666666666665433222333 456666666542 11111000 00
Q ss_pred cccc-cccCcccccceeeccccccccccCccC---CCCCCccEEECCCCcccCC----CCCCcCcccccceecccccccc
Q 041878 230 NWGV-LAGNKSYQLQFLNLDHNLIAGTIPVSL---GKLGLLQEISLSHNKIVGP----IPDELGKLSKLQKLDLSYNAIG 301 (773)
Q Consensus 230 ~~~~-l~~~~~~~L~~L~L~~n~l~~~~~~~l---~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 301 (773)
.+.. +....+++|++|+|.+|.+++..+..+ ..+++|++|+|+.|.+.+. ++..+..+++|+.|+|++|.++
T Consensus 241 ~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 241 VFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp GTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred HHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 0000 000122356666666665553222222 2467888888888888753 3444566788999999999887
Q ss_pred ccCcccccccccCceEEccCCC
Q 041878 302 GSFPVTFTNITSLVSLNLENNR 323 (773)
Q Consensus 302 ~~~~~~~~~l~~L~~L~Ls~N~ 323 (773)
......+...- ...+++++|+
T Consensus 321 d~~~~~l~~al-g~~~~~~~~~ 341 (362)
T 2ra8_A 321 DEMKKELQKSL-PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHHHHC-CSEEECCSBC
T ss_pred HHHHHHHHHHc-CCEEEecCCc
Confidence 65444444311 4668888887
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.01 E-value=4.4e-10 Score=114.60 Aligned_cols=126 Identities=15% Similarity=0.164 Sum_probs=93.5
Q ss_pred ccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCc--eEEeEEEEECCCCeEEEEEeecCCCCHHH
Q 041878 544 GKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPN--LLALRAYYLGPKGEKLLVFDFMPKGSLAS 621 (773)
Q Consensus 544 G~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~~lV~e~~~~g~L~~ 621 (773)
+.|..+.||++...+|+.+++|..... ....+..|+++++.+.+.+ +.+++++.. ..+..++||||++|.++.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-~~~~~~~v~e~i~G~~l~- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-EAGRDWLLLGEVPGQDLL- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-CSSCEEEEEECCSSEETT-
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc-CCCCCEEEEEecCCcccC-
Confidence 355669999998777889999997643 2345788999999886544 455777764 445789999999998883
Q ss_pred HHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCC----------------------------------------------
Q 041878 622 FLHARGPETIVNWATRMSIAIGIARGLNYLHVEE---------------------------------------------- 655 (773)
Q Consensus 622 ~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~---------------------------------------------- 655 (773)
... .+ ...++.++++.+..|| ..
T Consensus 104 -~~~------~~---~~~~~~~l~~~l~~lh-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 104 -SSH------LA---PAEKVSIMADAMRRLH-TLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp -TSC------CC---HHHHHHHHHHHHHHHT-TSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred -cCc------CC---HhHHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 211 11 1256677788888888 32
Q ss_pred ------------CceecCCCCCCEEeCCCCCeEEeecCCccc
Q 041878 656 ------------NMIHGNLTSSNVLLDEKTNPRIADFGLSRL 685 (773)
Q Consensus 656 ------------~iiH~Dik~~NIll~~~~~~kl~DfG~a~~ 685 (773)
+++|+|++|.||++++++.+.|+|||.+..
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 299999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=2.7e-09 Score=114.46 Aligned_cols=140 Identities=15% Similarity=0.198 Sum_probs=102.8
Q ss_pred cccccccceEEEEEEeCCCCEEEEEEec--ccC-cccHHHHHHHHHHHHccCC--CceEEeEEEEECCC--CeEEEEEee
Q 041878 541 EIMGKSTYGTAYKATLEDGSEVAVKRLR--EKT-TKGQKEFEAEAAAIGKIHH--PNLLALRAYYLGPK--GEKLLVFDF 613 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~--~~~-~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~~lV~e~ 613 (773)
+.++.|.++.||+.... +..+++|+.. ... .....++.+|+.+++.+.+ ..+.+++.++.... +..|+||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 56899999999999876 4678888875 322 1234578889999999974 45778888874332 458999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhcc----------------------------------------
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV---------------------------------------- 653 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~---------------------------------------- 653 (773)
++|..+.+.. ...++..++..++.+++++|..||.
T Consensus 123 v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 123 VSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred cCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 9988774311 1225677788899999999999993
Q ss_pred -----------------CCCceecCCCCCCEEeCCCCC--eEEeecCCcccc
Q 041878 654 -----------------EENMIHGNLTSSNVLLDEKTN--PRIADFGLSRLM 686 (773)
Q Consensus 654 -----------------~~~iiH~Dik~~NIll~~~~~--~kl~DfG~a~~~ 686 (773)
...++|||+++.||+++.++. +.|+||+.+..-
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 146899999999999998764 689999988753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.79 E-value=1.3e-09 Score=114.02 Aligned_cols=184 Identities=20% Similarity=0.190 Sum_probs=115.3
Q ss_pred cccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccC-CCc--eEEeEEEEECCC--CeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPN--LLALRAYYLGPK--GEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~--~~~~lV~e~~~ 615 (773)
+.++.|....||+.. ..+++|..... .....+.+|+++++.+. +.. +.+.+....... ...|+|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 458899999999873 56888986432 34567899999998884 322 334444331111 13588999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhcc------------------------------------------
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV------------------------------------------ 653 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~------------------------------------------ 653 (773)
|.++.+.... .++..++..++.++++.+..||.
T Consensus 100 G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9888653322 14555666667777777776662
Q ss_pred ---------------CCCceecCCCCCCEEeCC--CCCeEEeecCCccccccccccceeeccCccccccccccCC-----
Q 041878 654 ---------------EENMIHGNLTSSNVLLDE--KTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKL----- 711 (773)
Q Consensus 654 ---------------~~~iiH~Dik~~NIll~~--~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----- 711 (773)
...++|+|++|.||++++ ...+.++||+.+........-.... ....-..|+....
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~--~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLM--EDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTC--CTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHH--hhccccCHHHHHHHHHHc
Confidence 024799999999999998 4557899999886543211100000 0000012221100
Q ss_pred CCC---------CcchhhHHHHHHHHHHHcCCCCC
Q 041878 712 KNA---------NTKTDVYSLGVIILELLTGKSPG 737 (773)
Q Consensus 712 ~~~---------~~~~Dvws~Gv~l~el~tg~~P~ 737 (773)
+.. ....+.|+++.++|++.+|..+|
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 12368999999999999998775
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.76 E-value=2.6e-07 Score=99.65 Aligned_cols=274 Identities=9% Similarity=0.031 Sum_probs=158.3
Q ss_pred CccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCcccccccc
Q 041878 108 SEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANST 187 (773)
Q Consensus 108 ~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 187 (773)
..++.++.+|+.++|..+ ++..-..+|.++ +|+.+.+..+ ++..-...|.. .+|+.+++..+- +......+.+.
T Consensus 62 ~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp~~~-~~i~~~~F~~~- 135 (379)
T 4h09_A 62 EANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFPGAT-TEIGNYIFYNS- 135 (379)
T ss_dssp TTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECCTTC-CEECTTTTTTC-
T ss_pred HHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCCCcc-ccccccccccc-
Confidence 345666666666666543 444445556655 4555555432 33222233433 356666665442 21222333332
Q ss_pred ccceeecccccccccCCccccCCCccceeeccccccccccCCccc-------ccccCcccccceeeccccccccccCccC
Q 041878 188 RLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWG-------VLAGNKSYQLQFLNLDHNLIAGTIPVSL 260 (773)
Q Consensus 188 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~-------~l~~~~~~~L~~L~L~~n~l~~~~~~~l 260 (773)
+|+.+.+..+ ++......+..+.+++.+.+..+........... .........+..+.+..+. .......+
T Consensus 136 ~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~i~~~~f 213 (379)
T 4h09_A 136 SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTV-KTVTAYGF 213 (379)
T ss_dssp CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTC-CEECTTTT
T ss_pred eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccce-eEEeeccc
Confidence 4444444332 3323445566666777666655443211110000 0000111133333333222 22444566
Q ss_pred CCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhcccccccc
Q 041878 261 GKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTV 340 (773)
Q Consensus 261 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 340 (773)
....+|+.+.+..+ +.......|..+..|+.+.+..+ ++......|.++.+|+.+.+..+ +.......|..+.+|+.
T Consensus 214 ~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~ 290 (379)
T 4h09_A 214 SYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTK 290 (379)
T ss_dssp TTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCE
T ss_pred ccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccccc
Confidence 67778888887655 33344567778888888888765 55555677888888888888654 54555567888888888
Q ss_pred ccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeec
Q 041878 341 LNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSY 393 (773)
Q Consensus 341 L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~ 393 (773)
+.+.++.++......|.++.+|+.+.|..+ ++.....+|.++.+|+.+.+..
T Consensus 291 i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 291 VVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp EEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred ccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 888888887666778888888988888755 6655567788888888876643
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.75 E-value=2.5e-10 Score=115.29 Aligned_cols=66 Identities=33% Similarity=0.409 Sum_probs=28.6
Q ss_pred CCCCCCEEEccCCCCCC--CCccccccccccceeecccccccccCCccccCCC--ccceeeccccccccccC
Q 041878 161 NCPNLQTLDLSNNALIG--AIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLP--SLSVLALQHNNLSGSVP 228 (773)
Q Consensus 161 ~l~~L~~L~Ls~N~l~~--~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~--~L~~L~L~~N~l~~~~p 228 (773)
++++|++|+|++|.|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 34444444444444443 2233334444455555555544432 1112222 45555555555544333
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.60 E-value=1.7e-06 Score=93.23 Aligned_cols=275 Identities=9% Similarity=0.034 Sum_probs=175.7
Q ss_pred CEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEcc
Q 041878 92 QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171 (773)
Q Consensus 92 ~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 171 (773)
.++.+.|+.+ ++..-..++.++ .|+.+.+..+ ++.....+|... +|+.+.+..+- +..-...|.+. +|+.+.+.
T Consensus 70 ~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~~i~lp~~~-~~i~~~~F~~~-~l~~~~~~ 143 (379)
T 4h09_A 70 NMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLDDFEFPGAT-TEIGNYIFYNS-SVKRIVIP 143 (379)
T ss_dssp TCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCSEEECCTTC-CEECTTTTTTC-CCCEEEEC
T ss_pred CCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-CcccccCCCcc-ccccccccccc-eeeeeecc
Confidence 4666777543 443334556665 6778777653 554445566654 79999997653 32333344444 57776665
Q ss_pred CCCCCCCCccccccccccceeecccccccc------------cCCccccCCCccceeeccccccccccCCcccccccCcc
Q 041878 172 NNALIGAIPPSLANSTRLYRLNLSYNSLLG------------SIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKS 239 (773)
Q Consensus 172 ~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~------------~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~ 239 (773)
.+ ++......+....+++.+.+..+.... .....+.....+..+.+..+.-. ..... ....
T Consensus 144 ~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~-----f~~~ 216 (379)
T 4h09_A 144 KS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKT-VTAYG-----FSYG 216 (379)
T ss_dssp TT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCE-ECTTT-----TTTC
T ss_pred ce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeE-Eeecc-----cccc
Confidence 43 343445667777777777766543321 11222333444444443332211 11111 1223
Q ss_pred cccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEc
Q 041878 240 YQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNL 319 (773)
Q Consensus 240 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 319 (773)
.+|+.+.+..+ ++......+.++..|+.+.+..+ ++..-..+|.++.+|+.+.+..+ ++......|.++++|+.+.+
T Consensus 217 ~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l 293 (379)
T 4h09_A 217 KNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVM 293 (379)
T ss_dssp SSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEE
T ss_pred cccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccc
Confidence 46777777654 45566777888899999998776 55455677888889999988654 55455677888999999999
Q ss_pred cCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccC
Q 041878 320 ENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLA 384 (773)
Q Consensus 320 s~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 384 (773)
.++.++......|.++.+|+.++|..+ ++.....+|.++.+|+.+.+..+ ++.....+|.++.
T Consensus 294 ~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 294 DNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp CCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred cccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 988887777788999999999999755 66556678889999999988655 5544455665553
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.58 E-value=7.7e-09 Score=99.32 Aligned_cols=120 Identities=15% Similarity=0.178 Sum_probs=59.0
Q ss_pred ccCCCCCCccEEECCCC-cccCC----CCCCcCcccccceecccccccccc----CcccccccccCceEEccCCCCCCCc
Q 041878 258 VSLGKLGLLQEISLSHN-KIVGP----IPDELGKLSKLQKLDLSYNAIGGS----FPVTFTNITSLVSLNLENNRLGNKI 328 (773)
Q Consensus 258 ~~l~~l~~L~~L~L~~N-~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~ 328 (773)
..+...++|++|+|++| .+... +...+...++|++|+|++|.|+.. +...+...++|++|+|++|.|++..
T Consensus 30 ~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g 109 (185)
T 1io0_A 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 109 (185)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHH
Confidence 34555666777777766 66532 222333344555555555555432 1222333344555555555444321
Q ss_pred chhhccccccccccccCcccccccccccCCCCcCceeec--CCccCccCCC----chhhccCccCEEEeecccCC
Q 041878 329 PEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDL--SENDFTGEIS----PSLASLANLTSFNVSYNNLS 397 (773)
Q Consensus 329 ~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L--~~N~l~~~~~----~~~~~l~~L~~L~ls~N~l~ 397 (773)
.. .+...+...++|++|+| ++|.+..... ..+...++|+.|+|++|.+.
T Consensus 110 ~~--------------------~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 110 IL--------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HH--------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HH--------------------HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 11 12344445556666666 5566654322 23333466777777776653
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.56 E-value=1.6e-08 Score=101.99 Aligned_cols=105 Identities=26% Similarity=0.379 Sum_probs=64.1
Q ss_pred cCcccccce--ecccccccc---ccCcccccccccCceEEccCCCCCC--CcchhhccccccccccccCccccccccccc
Q 041878 284 LGKLSKLQK--LDLSYNAIG---GSFPVTFTNITSLVSLNLENNRLGN--KIPEGLERLQNLTVLNLKNNQFKGHIPETI 356 (773)
Q Consensus 284 l~~l~~L~~--L~Ls~N~l~---~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~ 356 (773)
|...+.|.. ++++.|... +.+.....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 333344554 556666432 1222222456778888888888776 3456666777777777777777754 223
Q ss_pred CCCC--cCceeecCCccCccCCCc-------hhhccCccCEEE
Q 041878 357 GNIS--GINQLDLSENDFTGEISP-------SLASLANLTSFN 390 (773)
Q Consensus 357 ~~l~--~L~~L~L~~N~l~~~~~~-------~~~~l~~L~~L~ 390 (773)
..+. +|++|+|++|++.+.+|. .+..+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 3333 778888888888776652 255667777664
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.53 E-value=7.7e-09 Score=99.30 Aligned_cols=111 Identities=23% Similarity=0.276 Sum_probs=82.6
Q ss_pred ccccceeecccc-ccccc----cCccCCCCCCccEEECCCCcccCC----CCCCcCcccccceecccccccccc----Cc
Q 041878 239 SYQLQFLNLDHN-LIAGT----IPVSLGKLGLLQEISLSHNKIVGP----IPDELGKLSKLQKLDLSYNAIGGS----FP 305 (773)
Q Consensus 239 ~~~L~~L~L~~n-~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~~ 305 (773)
.++|++|+|++| .+... +...+...++|++|+|++|++... +...+...++|++|+|++|.|++. +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 458999999999 88753 445567788999999999999753 334455668999999999999864 45
Q ss_pred ccccccccCceEEc--cCCCCCCCcch----hhccccccccccccCcccc
Q 041878 306 VTFTNITSLVSLNL--ENNRLGNKIPE----GLERLQNLTVLNLKNNQFK 349 (773)
Q Consensus 306 ~~~~~l~~L~~L~L--s~N~l~~~~~~----~l~~l~~L~~L~ls~N~l~ 349 (773)
..+...++|++|+| ++|.++..... .+...++|+.|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 56677788999999 78888765433 3334466666666666654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=1.8e-06 Score=89.92 Aligned_cols=136 Identities=18% Similarity=0.185 Sum_probs=89.8
Q ss_pred cccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCC---ceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHP---NLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
+.++.|....||+. |..+++|.-. .......+..|+++++.+.+. .+.+.+.+.....+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888999988 5778888853 223456789999999999753 25566666644455688999999998
Q ss_pred CHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 041878 618 SLASFLHARGPETIVNWATRMSIAIGIARGLNYLH--------------------------------------------- 652 (773)
Q Consensus 618 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH--------------------------------------------- 652 (773)
++.+..-.. ++...+..++.++++.|..||
T Consensus 99 ~l~~~~~~~-----l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMAV-----LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHTT-----SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhhh-----CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 876531110 122222223333333333332
Q ss_pred --------------cCCCceecCCCCCCEEeCC---CCCe-EEeecCCccccc
Q 041878 653 --------------VEENMIHGNLTSSNVLLDE---KTNP-RIADFGLSRLMT 687 (773)
Q Consensus 653 --------------~~~~iiH~Dik~~NIll~~---~~~~-kl~DfG~a~~~~ 687 (773)
....++|+|+++.||+++. ++.+ .|+||+.+..-.
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 1345799999999999987 4554 899999876543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.15 E-value=9.7e-06 Score=82.69 Aligned_cols=133 Identities=17% Similarity=0.204 Sum_probs=90.1
Q ss_pred ccccccce-EEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEEeecCCCC
Q 041878 542 IMGKSTYG-TAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 542 ~lG~G~fg-~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
.+..|..| .||+.... ++..+++|+-... ...++.+|...++.+. +--+.++++++. ..+..++|||+++|.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIR-TPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEE-ETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEE-ECCeEEEEEEeeCCcc
Confidence 35556665 69998765 4667899986432 3567888999998885 223566777774 4458899999999988
Q ss_pred HHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhcc---------------------------------------------
Q 041878 619 LASFLHARGPETIVNWATRMSIAIGIARGLNYLHV--------------------------------------------- 653 (773)
Q Consensus 619 L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~--------------------------------------------- 653 (773)
+.+...... .....+..+++..+..||.
T Consensus 107 ~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 776544321 1112334444444444441
Q ss_pred ------------CCCceecCCCCCCEEeCCCCCeEEeecCCccc
Q 041878 654 ------------EENMIHGNLTSSNVLLDEKTNPRIADFGLSRL 685 (773)
Q Consensus 654 ------------~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~ 685 (773)
...++|+|+.+.||++++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01278999999999999877677999998754
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.06 E-value=1.3e-06 Score=81.58 Aligned_cols=83 Identities=13% Similarity=0.109 Sum_probs=47.8
Q ss_pred ccceeccccccccccCcccccccccCceEEccCCC-CCCCcchhhccc----cccccccccCcc-cccccccccCCCCcC
Q 041878 289 KLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNR-LGNKIPEGLERL----QNLTVLNLKNNQ-FKGHIPETIGNISGI 362 (773)
Q Consensus 289 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~l~~l----~~L~~L~ls~N~-l~~~~~~~~~~l~~L 362 (773)
+|+.||++++.++..--..+..+++|++|+|++|. +++..-..++.+ ++|++|+|++|. +++..-..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 56666666666655444555666666666666664 555444445543 356666666653 555444445556666
Q ss_pred ceeecCCcc
Q 041878 363 NQLDLSEND 371 (773)
Q Consensus 363 ~~L~L~~N~ 371 (773)
+.|+|+++.
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666554
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=4.8e-06 Score=88.81 Aligned_cols=80 Identities=6% Similarity=0.002 Sum_probs=54.2
Q ss_pred ccc-ccccceEEEEEEeC-------CCCEEEEEEecccC---cccHHHHHHHHHHHHccCC---CceEEeEEEEECCC--
Q 041878 541 EIM-GKSTYGTAYKATLE-------DGSEVAVKRLREKT---TKGQKEFEAEAAAIGKIHH---PNLLALRAYYLGPK-- 604 (773)
Q Consensus 541 ~~l-G~G~fg~Vy~~~~~-------~g~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~-- 604 (773)
+.| +.|....+|+.... ++..+++|...... ......+.+|+.+++.+.. -.+.+++.++....
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 557 88889999998754 26678888865432 1112457788888888753 24667777763332
Q ss_pred CeEEEEEeecCCCCHH
Q 041878 605 GEKLLVFDFMPKGSLA 620 (773)
Q Consensus 605 ~~~~lV~e~~~~g~L~ 620 (773)
+..++||||++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3568999999986654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.98 E-value=1.8e-06 Score=80.63 Aligned_cols=91 Identities=12% Similarity=0.112 Sum_probs=76.3
Q ss_pred cccccccccCceEEccCCCCCCCcchhhccccccccccccCcc-cccccccccCCC----CcCceeecCCcc-CccCCCc
Q 041878 305 PVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQ-FKGHIPETIGNI----SGINQLDLSEND-FTGEISP 378 (773)
Q Consensus 305 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~-l~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~~~ 378 (773)
|.....-.+|++||++++.+++..-..+..+++|+.|+|++|. +++..-..+..+ ++|++|+|++|. ++...-.
T Consensus 54 P~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~ 133 (176)
T 3e4g_A 54 PTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGII 133 (176)
T ss_dssp CCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHH
T ss_pred CcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHH
Confidence 4333333589999999999998888889999999999999995 887766777765 489999999985 8877677
Q ss_pred hhhccCccCEEEeeccc
Q 041878 379 SLASLANLTSFNVSYNN 395 (773)
Q Consensus 379 ~~~~l~~L~~L~ls~N~ 395 (773)
.+..+++|+.|+|+++.
T Consensus 134 ~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 134 ALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HGGGCTTCCEEEEESCT
T ss_pred HHhcCCCCCEEECCCCC
Confidence 78899999999999986
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.77 E-value=6.3e-05 Score=81.32 Aligned_cols=74 Identities=8% Similarity=0.036 Sum_probs=48.6
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccCc-------ccHHHHHHHHHHHHccCC--C-ceEEeEEEEECCCCeEEE
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-------KGQKEFEAEAAAIGKIHH--P-NLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~~l 609 (773)
+.+|.|.++.||++... +++.++||....... .....+..|+++++.+.. + .+.+++.+. .+..++
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d---~~~~~l 112 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD---TEMAVT 112 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE---TTTTEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc---CCccEE
Confidence 56899999999999764 468899998653221 123456778888887743 3 344555432 234689
Q ss_pred EEeecCCC
Q 041878 610 VFDFMPKG 617 (773)
Q Consensus 610 V~e~~~~g 617 (773)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.77 E-value=4e-05 Score=80.95 Aligned_cols=140 Identities=16% Similarity=0.258 Sum_probs=78.8
Q ss_pred cccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCC--CceEEeEEE-----EECCCCeEEEEEee
Q 041878 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHH--PNLLALRAY-----YLGPKGEKLLVFDF 613 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~-----~~~~~~~~~lV~e~ 613 (773)
+.|+.|..+.||+....+| .+++|+.... ..++..|+.+++.+.. -.+.+++.. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677889999987654 5889988642 2344455555555531 122333321 11124467899999
Q ss_pred cCCCCHH--------------HHHhhcC-----CC------CccCHHHH-------------------------------
Q 041878 614 MPKGSLA--------------SFLHARG-----PE------TIVNWATR------------------------------- 637 (773)
Q Consensus 614 ~~~g~L~--------------~~l~~~~-----~~------~~~~~~~~------------------------------- 637 (773)
++|.++. ..++... +. ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986432 1122111 10 01123211
Q ss_pred HHHHHHHHHHHHHhc------------cCCCceecCCCCCCEEeCCCCCeEEeecCCccc
Q 041878 638 MSIAIGIARGLNYLH------------VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL 685 (773)
Q Consensus 638 ~~i~~~i~~al~yLH------------~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~ 685 (773)
..+..++..++++|+ ....++|+|+++.||+++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 011122334566664 147799999999999998888899999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00015 Score=74.48 Aligned_cols=75 Identities=19% Similarity=0.280 Sum_probs=56.3
Q ss_pred hcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCC---ceEEeEEEEECCCCeEEEEEeecCC
Q 041878 540 AEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHP---NLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
.+.+|.|..+.||+.+..||+.|++|+-..........|..|++.|+.+.-. -+.+++++. ..++||||+++
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-----~~~lv~e~l~~ 94 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-----DRTLAMEWVDE 94 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-----TTEEEEECCCC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-----CceEEEEeecc
Confidence 3568999999999999999999999987655444456788999999988522 244444432 34789999987
Q ss_pred CCH
Q 041878 617 GSL 619 (773)
Q Consensus 617 g~L 619 (773)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 643
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.60 E-value=7.4e-06 Score=78.01 Aligned_cols=64 Identities=22% Similarity=0.253 Sum_probs=28.7
Q ss_pred CCCccEEECCCC-cccCC----CCCCcCcccccceecccccccccc----CcccccccccCceEEccCCCCCC
Q 041878 263 LGLLQEISLSHN-KIVGP----IPDELGKLSKLQKLDLSYNAIGGS----FPVTFTNITSLVSLNLENNRLGN 326 (773)
Q Consensus 263 l~~L~~L~L~~N-~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~ 326 (773)
-+.|++|+|++| ++... +.+.+...+.|+.|+|++|+|++. +...+...+.|++|+|++|.|++
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 344555555553 44321 222333344555555555555432 22223334455555555555543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.58 E-value=1.5e-05 Score=75.82 Aligned_cols=112 Identities=13% Similarity=0.183 Sum_probs=75.5
Q ss_pred cCcccccceeccccc-cccc----cCcccccccccCceEEccCCCCCCCcch----hhccccccccccccCcccccc---
Q 041878 284 LGKLSKLQKLDLSYN-AIGG----SFPVTFTNITSLVSLNLENNRLGNKIPE----GLERLQNLTVLNLKNNQFKGH--- 351 (773)
Q Consensus 284 l~~l~~L~~L~Ls~N-~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~----~l~~l~~L~~L~ls~N~l~~~--- 351 (773)
+.+-+.|+.|+|++| +|.. .+...+...+.|+.|+|++|+|++.... .+..-+.|+.|+|++|.|.+.
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 344568888999885 7764 2344566678899999999998765443 444567888888888888753
Q ss_pred -cccccCCCCcCceeecCCc---cCccC----CCchhhccCccCEEEeeccc
Q 041878 352 -IPETIGNISGINQLDLSEN---DFTGE----ISPSLASLANLTSFNVSYNN 395 (773)
Q Consensus 352 -~~~~~~~l~~L~~L~L~~N---~l~~~----~~~~~~~l~~L~~L~ls~N~ 395 (773)
+.+.+..-+.|++|+|++| .+... +...+..-+.|+.|+++.|.
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 4445666677888888765 33322 22334445678888887664
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00011 Score=79.92 Aligned_cols=80 Identities=14% Similarity=0.162 Sum_probs=50.2
Q ss_pred CCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeeccCccccccccccCCC---CCCcchhhHHHHHHHHHH
Q 041878 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLK---NANTKTDVYSLGVIILEL 730 (773)
Q Consensus 654 ~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dvws~Gv~l~el 730 (773)
...++|+|+++.|||++.++ ++++||+.+..-.....-......-...|++|+..... ......++.+....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 67899999999999998876 99999998875432211100000011346666654321 112245666888888888
Q ss_pred HcCC
Q 041878 731 LTGK 734 (773)
Q Consensus 731 ~tg~ 734 (773)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0013 Score=67.98 Aligned_cols=135 Identities=18% Similarity=0.171 Sum_probs=88.8
Q ss_pred cccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccC---CCceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH---HPNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
+.|+.|.+..+|+... ++..+++|+.... ....+..|++.|+.+. ...+.+++++.. ..+..++||||+++.
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGN-SQGHSFLLLEALNKS 116 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-CSSEEEEEEECCCCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEee-cCCceEEEEEeccCC
Confidence 5688999999999986 4678889987532 3567889999998885 245777777774 346899999999987
Q ss_pred CHH--------H---HHhhcCC-C------------------CccCHHHHH---HHHH----------------HHHHH-
Q 041878 618 SLA--------S---FLHARGP-E------------------TIVNWATRM---SIAI----------------GIARG- 647 (773)
Q Consensus 618 ~L~--------~---~l~~~~~-~------------------~~~~~~~~~---~i~~----------------~i~~a- 647 (773)
.+. . .++.... . -.-+|.... ++.. .++..
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 542 1 1232221 0 012454321 1111 11111
Q ss_pred HHHhc---cCCCceecCCCCCCEEeCCCCCeEEeecC
Q 041878 648 LNYLH---VEENMIHGNLTSSNVLLDEKTNPRIADFG 681 (773)
Q Consensus 648 l~yLH---~~~~iiH~Dik~~NIll~~~~~~kl~DfG 681 (773)
...|. ....+||+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 12332 135699999999999999887 8999984
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0036 Score=65.52 Aligned_cols=140 Identities=9% Similarity=0.082 Sum_probs=72.6
Q ss_pred cccccccceE-EEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCC--CceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 541 EIMGKSTYGT-AYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHH--PNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 541 ~~lG~G~fg~-Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
+.|+.|+... +|+....+|..+++|....... .++..|+.+++.+.. -.+.+++.+. ...+ ++|||++++.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d-~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEE-HARG--LLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEE-TTTT--EEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeec-CCCC--EEEEeeCCCc
Confidence 3455555554 6677654477787776543221 233456666666542 2244555554 3333 7899999877
Q ss_pred CHHHHHhhcC---------------------CC--CccCHHHHH--------------------HHHHHHHHHHHHh---
Q 041878 618 SLASFLHARG---------------------PE--TIVNWATRM--------------------SIAIGIARGLNYL--- 651 (773)
Q Consensus 618 ~L~~~l~~~~---------------------~~--~~~~~~~~~--------------------~i~~~i~~al~yL--- 651 (773)
.+.+++.... .. ..++..... .....+...++.+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 7665443210 00 011111000 0001111222222
Q ss_pred --ccCCCceecCCCCCCEEeCCC----CCeEEeecCCcccc
Q 041878 652 --HVEENMIHGNLTSSNVLLDEK----TNPRIADFGLSRLM 686 (773)
Q Consensus 652 --H~~~~iiH~Dik~~NIll~~~----~~~kl~DfG~a~~~ 686 (773)
.....++|||+.+.|||++.+ +.+.|+||+.+..-
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 114579999999999999875 67899999988654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0032 Score=65.70 Aligned_cols=140 Identities=16% Similarity=0.188 Sum_probs=80.5
Q ss_pred ccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCc--eEEeEEE----EECCCCeEEEEEeecC
Q 041878 542 IMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPN--LLALRAY----YLGPKGEKLLVFDFMP 615 (773)
Q Consensus 542 ~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~----~~~~~~~~~lV~e~~~ 615 (773)
.++ |....||+....+|+.+++|...... ....++..|..+++.+.... +.+++.. .....+..++||||++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 456 77788999887778889999986332 23556777888887775222 3334332 0011346688999998
Q ss_pred CCCHH-----HH---------HhhcC---C---CCccCHHHH----------------------HHHHHHHHHHHHHhc-
Q 041878 616 KGSLA-----SF---------LHARG---P---ETIVNWATR----------------------MSIAIGIARGLNYLH- 652 (773)
Q Consensus 616 ~g~L~-----~~---------l~~~~---~---~~~~~~~~~----------------------~~i~~~i~~al~yLH- 652 (773)
|..+. .+ ++... . ....++... ...+.+++..+.-+-
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75321 11 11110 0 111222111 011112222222221
Q ss_pred --cCCCceecCCCCCCEEeCCCCCeEEeecCCccc
Q 041878 653 --VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL 685 (773)
Q Consensus 653 --~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~ 685 (773)
....++|+|+++.||+++ + .+.++||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 135689999999999999 4 899999988754
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.003 Score=55.98 Aligned_cols=38 Identities=24% Similarity=0.274 Sum_probs=27.0
Q ss_pred CCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCC
Q 041878 139 PNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALI 176 (773)
Q Consensus 139 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 176 (773)
++|++|+|++|+|+..-+..|..+++|++|+|++|.+.
T Consensus 31 ~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 31 VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 35677777777777555566677777777777777764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0011 Score=68.40 Aligned_cols=136 Identities=14% Similarity=0.101 Sum_probs=73.4
Q ss_pred cccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCce-EEeEEEEECCCCeEEEEEeec-CCCC
Q 041878 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNL-LALRAYYLGPKGEKLLVFDFM-PKGS 618 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~lV~e~~-~~g~ 618 (773)
+.|+.|....+|+. ..+++|+....... ..+...|+.+++.+....+ .+++++. .+.-++|+||+ ++.+
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~---~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD---PATGVMVTRYIAGAQT 94 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC---TTTCCEEEECCTTCEE
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE---CCCCEEEEeecCCCcc
Confidence 56888999999999 56888887643221 1223557777777643222 3444433 22357899999 6544
Q ss_pred HHH------------------HHhhcCCC--CccCHHH-H---------------------HHHHHHHHHHHHHhccCCC
Q 041878 619 LAS------------------FLHARGPE--TIVNWAT-R---------------------MSIAIGIARGLNYLHVEEN 656 (773)
Q Consensus 619 L~~------------------~l~~~~~~--~~~~~~~-~---------------------~~i~~~i~~al~yLH~~~~ 656 (773)
+.. -++..... ...+... . ...+..+...+.-......
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 421 01111110 0011111 1 1111111111111111345
Q ss_pred ceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 657 iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
++|+|+.+.||+ ..++.+.++||..+..-
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 56677899999987643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0046 Score=67.16 Aligned_cols=71 Identities=10% Similarity=0.159 Sum_probs=48.2
Q ss_pred cccccccceEEEEEEeCC--------CCEEEEEEecccCcccHHHHHHHHHHHHccCCCce-EEeEEEEECCCCeEEEEE
Q 041878 541 EIMGKSTYGTAYKATLED--------GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNL-LALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~lV~ 611 (773)
+.|+.|....||++...+ +..+++|+.... .....+..|..+++.+...++ .++++.+ . . .+|+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~-~-~---g~v~ 151 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIF-S-G---GRLE 151 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEE-T-T---EEEE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEe-C-C---CEEE
Confidence 567888889999998653 478999988432 112455678888888753333 5666655 2 2 3899
Q ss_pred eecCCCC
Q 041878 612 DFMPKGS 618 (773)
Q Consensus 612 e~~~~g~ 618 (773)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998633
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0022 Score=56.77 Aligned_cols=60 Identities=15% Similarity=0.201 Sum_probs=44.3
Q ss_pred cccccCcccc-cccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCc
Q 041878 340 VLNLKNNQFK-GHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVP 401 (773)
Q Consensus 340 ~L~ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p 401 (773)
.++.+++.++ ..+|..+ -++|+.|+|++|+|+...+..|..+++|+.|+|++|+|.+..-
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~ 72 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCR 72 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGG
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCc
Confidence 5666666665 2445432 2368889999999987667778889999999999999987654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.57 E-value=0.002 Score=67.03 Aligned_cols=142 Identities=11% Similarity=0.144 Sum_probs=77.6
Q ss_pred cccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCc--eEEeEEEE-----ECCCCeEEEEEee
Q 041878 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPN--LLALRAYY-----LGPKGEKLLVFDF 613 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~-----~~~~~~~~lV~e~ 613 (773)
+.|+.|....+|+....+| .+++|...... ...++..|+.+++.+.... +.+++... ....+..++|+||
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4577888899999987655 68889886531 2234566777777664222 22332110 0112467899999
Q ss_pred cCCCCHHH--------------HHhhcC----CC-----CccCHHHHHH------------HHHHHHHHHHHhc------
Q 041878 614 MPKGSLAS--------------FLHARG----PE-----TIVNWATRMS------------IAIGIARGLNYLH------ 652 (773)
Q Consensus 614 ~~~g~L~~--------------~l~~~~----~~-----~~~~~~~~~~------------i~~~i~~al~yLH------ 652 (773)
++|..+.. .++... .. ....|..... +...+.+.+++++
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99864311 112111 00 0011222110 0011333444443
Q ss_pred cCCCceecCCCCCCEEeCCCCCeEEeecCCccc
Q 041878 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL 685 (773)
Q Consensus 653 ~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~ 685 (773)
...+++|+|+.+.||+++++..+.++||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 124699999999999998876568999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0094 Score=63.27 Aligned_cols=140 Identities=14% Similarity=0.152 Sum_probs=81.5
Q ss_pred cccccccceEEEEEEeC--------CCCEEEEEEecccCcccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEE
Q 041878 541 EIMGKSTYGTAYKATLE--------DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~--------~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~ 611 (773)
+.+..|-...+|+.... +++.+++|+.... ......+.+|.++++.+. +.-..++++++ . . .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-~-~---g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVF-P-E---GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-T-T---EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEc-C-C---ccEE
Confidence 45777888889999864 2478999986432 234566778999998885 32235566655 2 2 3899
Q ss_pred eecCCCCHHH--------------H---HhhcCC--CCccC--HHHHHHHHHHHHH-------------------HHHHh
Q 041878 612 DFMPKGSLAS--------------F---LHARGP--ETIVN--WATRMSIAIGIAR-------------------GLNYL 651 (773)
Q Consensus 612 e~~~~g~L~~--------------~---l~~~~~--~~~~~--~~~~~~i~~~i~~-------------------al~yL 651 (773)
||++|.++.. . ++.... ..... +.+..++..++.. .+.+|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9999754421 0 111110 11122 3444444433321 12222
Q ss_pred ----c---cCCCceecCCCCCCEEeCCC----CCeEEeecCCcccc
Q 041878 652 ----H---VEENMIHGNLTSSNVLLDEK----TNPRIADFGLSRLM 686 (773)
Q Consensus 652 ----H---~~~~iiH~Dik~~NIll~~~----~~~kl~DfG~a~~~ 686 (773)
. ....++|+|+.+.||+++.+ +.+.++||..+..-
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 2 12358999999999999876 68999999988643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0039 Score=66.37 Aligned_cols=72 Identities=6% Similarity=0.018 Sum_probs=43.3
Q ss_pred cccccccceEEEEEEeCC---------CCEEEEEEecccCcccHHHHHHHHHHHHccCCCc-eEEeEEEEECCCCeEEEE
Q 041878 541 EIMGKSTYGTAYKATLED---------GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPN-LLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~---------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~~lV 610 (773)
+.++.|....+|+....+ +..+++|+....... ..+...|.++++.+.... +.++++.. . -++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~---~~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N---GGRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T---TEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C---CcEE
Confidence 457788888999998654 268888887543221 123466888887775333 34555443 1 3789
Q ss_pred EeecCCCC
Q 041878 611 FDFMPKGS 618 (773)
Q Consensus 611 ~e~~~~g~ 618 (773)
|||++|.+
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.08 E-value=0.023 Score=62.04 Aligned_cols=73 Identities=14% Similarity=0.113 Sum_probs=46.8
Q ss_pred cccccccceEEEEEEeCC-CCEEEEEEecccCcccHHHHHHHHHHHHccCCCce-EEeEEEEECCCCeEEEEEeecCCCC
Q 041878 541 EIMGKSTYGTAYKATLED-GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNL-LALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
+.|+.|-...+|+....+ +..+++|+....... .-+..+|..+++.+...++ .++++.+ . . .+||||++|.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~-~-~---G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF-T-N---GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE-T-T---EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe-C-C---eEEEEeeCCcc
Confidence 568888889999998765 477888887543221 1122578888888865444 4666665 2 2 35999998744
Q ss_pred H
Q 041878 619 L 619 (773)
Q Consensus 619 L 619 (773)
+
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.23 E-value=0.051 Score=56.80 Aligned_cols=32 Identities=22% Similarity=0.333 Sum_probs=28.1
Q ss_pred CCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 655 ~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
..++|+|+.+.||++++++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 56999999999999998888999999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.71 E-value=0.08 Score=56.95 Aligned_cols=72 Identities=6% Similarity=0.037 Sum_probs=47.1
Q ss_pred cccccccceEEEEEEeCC--------CCEEEEEEecccCcccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEE
Q 041878 541 EIMGKSTYGTAYKATLED--------GSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~ 611 (773)
+.+..|-...+|+....+ ++.+++|+...... ..-+..+|..+++.+. +.-..++++.+ . -++|+
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~---~~~I~ 149 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P---EGRIE 149 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T---TEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C---CCEEE
Confidence 457778888999998653 57889988754322 2223456888888775 32234555543 2 37899
Q ss_pred eecCCCC
Q 041878 612 DFMPKGS 618 (773)
Q Consensus 612 e~~~~g~ 618 (773)
||++|.+
T Consensus 150 efI~G~~ 156 (424)
T 3mes_A 150 EFIDGEP 156 (424)
T ss_dssp ECCCSEE
T ss_pred EEeCCcc
Confidence 9999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.42 E-value=0.84 Score=48.69 Aligned_cols=30 Identities=30% Similarity=0.444 Sum_probs=25.5
Q ss_pred ceecCCCCCCEEe------CCCCCeEEeecCCcccc
Q 041878 657 MIHGNLTSSNVLL------DEKTNPRIADFGLSRLM 686 (773)
Q Consensus 657 iiH~Dik~~NIll------~~~~~~kl~DfG~a~~~ 686 (773)
++|+|+.+.||++ +++..++++||..|..-
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 6799999999999 45667999999988653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=90.04 E-value=1.1 Score=42.74 Aligned_cols=102 Identities=17% Similarity=0.098 Sum_probs=68.4
Q ss_pred CHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeec
Q 041878 618 SLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697 (773)
Q Consensus 618 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 697 (773)
+|.+.|+..+ ..++..+++.++.|.+.+|.-.-..+.-..+=+.|..|++..+|.+...+ ..+.
T Consensus 34 SL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------- 97 (229)
T 2yle_A 34 SLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------- 97 (229)
T ss_dssp EHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence 8999998874 56999999999999999987762011112344567899999999988764 2111
Q ss_pred cCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCC
Q 041878 698 AGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSP 736 (773)
Q Consensus 698 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P 736 (773)
.....+.|||... ...+.+.=|||+|+++|..+-=..|
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122466888653 3456788899999999999986665
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.83 E-value=0.75 Score=31.31 Aligned_cols=6 Identities=17% Similarity=0.213 Sum_probs=2.5
Q ss_pred ehhhHH
Q 041878 461 GVGALL 466 (773)
Q Consensus 461 ~~~~~~ 466 (773)
+.+++.
T Consensus 14 A~gVVg 19 (44)
T 2ks1_B 14 ATGMVG 19 (44)
T ss_dssp THHHHH
T ss_pred EeehhH
Confidence 344443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.34 E-value=0.94 Score=30.76 Aligned_cols=11 Identities=18% Similarity=0.392 Sum_probs=4.4
Q ss_pred HHHhhhhcccc
Q 041878 477 LFCLMRKRSAS 487 (773)
Q Consensus 477 ~~~~~rrr~~~ 487 (773)
+|+++|||+++
T Consensus 30 ~~~~~RRRr~~ 40 (44)
T 2l2t_A 30 FAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHTTCSS
T ss_pred HHHHhhhhhhh
Confidence 33444444333
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=80.37 E-value=1.1 Score=30.29 Aligned_cols=7 Identities=29% Similarity=0.748 Sum_probs=2.7
Q ss_pred Hhhhhcc
Q 041878 479 CLMRKRS 485 (773)
Q Consensus 479 ~~~rrr~ 485 (773)
.+.|||+
T Consensus 33 ~~~RRR~ 39 (44)
T 2jwa_A 33 ILIKRRQ 39 (44)
T ss_dssp HHHHHHC
T ss_pred hheehhh
Confidence 3334433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 773 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-50 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-49 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-45 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-44 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-44 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-38 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-37 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-31 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-24 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 7e-06 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-24 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-24 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-16 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-15 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-13 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-10 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 4e-08 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 8e-08 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-07 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 5e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 2e-50
Identities = 56/221 (25%), Positives = 110/221 (49%), Gaps = 12/221 (5%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
+ +G ++GT YK V + + T + + F+ E + K H N+L Y
Sbjct: 14 QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHG 660
P+ +V + SL LH ET + IA A+G++YLH +++IH
Sbjct: 74 TAPQ--LAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLH-AKSIIHR 128
Query: 661 NLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELSKLKNAN---T 716
+L S+N+ L E +I DFGL+ + + + ++ +G++ + APE+ ++++ N
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 717 KTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEW 757
++DVY+ G+++ EL+TG+ P + ++ + +V +
Sbjct: 189 QSDVYAFGIVLYELMTGQL---PYSNINNRDQIIFMVGRGY 226
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-49
Identities = 58/231 (25%), Positives = 108/231 (46%), Gaps = 14/231 (6%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
E +G +G + ++VAVK L+ + + F AEA + ++ H L+ L A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHG 660
+ ++ ++M GSL FL + + +A IA G+ ++ E N IH
Sbjct: 78 T--QEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIE-ERNYIHR 133
Query: 661 NLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDV 720
+L ++N+L+ + + +IADFGL+RL+ T + + APE K+DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 721 YSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK-------EEWTNEVFDL 764
+S G+++ E++T P GM P+ + ++ + + E++ L
Sbjct: 194 WSFGILLTEIVTHGRI--PYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 8e-49
Identities = 44/222 (19%), Positives = 98/222 (44%), Gaps = 9/222 (4%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
+G G +K + G +A K + E + + E + + + P ++
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
+ GE + + M GSL L G + ++I + +GL YL + ++
Sbjct: 72 AFYS-DGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHKIM 127
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKT 718
H ++ SN+L++ + ++ DFG+S + ++ + GT Y +PE + + + ++
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 719 DVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNE 760
D++S+G+ ++E+ G+ P P + +L V+ +
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 2e-47
Identities = 57/231 (24%), Positives = 111/231 (48%), Gaps = 18/231 (7%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
+ +GK +G G++VAVK ++ + F AEA+ + ++ H NL+ L
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHG 660
+ KG +V ++M KGSL +L +RG + + ++ + + YL N +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGDCLLKFSLDVCEAMEYLE-GNNFVHR 127
Query: 661 NLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDV 720
+L + NVL+ E +++DFGL++ ++ +T + + APE + K +TK+DV
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFSTKSDV 183
Query: 721 YSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK-------EEWTNEVFDL 764
+S G+++ E+ + P + L V + K + V+++
Sbjct: 184 WSFGILLWEIYSFGRV--PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 232
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-46
Identities = 54/229 (23%), Positives = 114/229 (49%), Gaps = 10/229 (4%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
+ +G +G + + +VA+K +R + +++F EA + K+ HP L+ L
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHG 660
L + LVF+FM G L+ +L + + T + + + + G+ YL E +IH
Sbjct: 70 LE-QAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE-EACVIHR 125
Query: 661 NLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDV 720
+L + N L+ E +++DFG++R + T+ T + + +PE+ ++K+DV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 721 YSLGVIILELLT-GKSPGEPMNGMDLPQWVASIVK----EEWTNEVFDL 764
+S GV++ E+ + GK P E + ++ + +++ + + V+ +
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI 234
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 4e-46
Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 14/231 (6%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
+G+ +G + T + VA+K L+ T + F EA + K+ H L+ L A
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHG 660
+ +V ++M KGSL FL + + + +A IA G+ Y+ N +H
Sbjct: 82 --SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE-RMNYVHR 137
Query: 661 NLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDV 720
+L ++N+L+ E ++ADFGL+RL+ T + + APE + K+DV
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197
Query: 721 YSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK-------EEWTNEVFDL 764
+S G+++ EL T P GM + + + + E + DL
Sbjct: 198 WSFGILLTELTTKGRV--PYPGMVNREVLDQVERGYRMPCPPECPESLHDL 246
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 7e-46
Identities = 42/229 (18%), Positives = 102/229 (44%), Gaps = 10/229 (4%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
+ +G +G +VA+K ++ + + + EF EA + + H L+ L
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 601 LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHG 660
++ ++M G L ++L + + + + YL + +H
Sbjct: 69 TKQ-RPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLE-SKQFLHR 124
Query: 661 NLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDV 720
+L + N L++++ +++DFGLSR + T+ + + + + PE+ ++K+D+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 721 YSLGVIILELLT-GKSPGEPMNGMDLPQWVASIVK----EEWTNEVFDL 764
++ GV++ E+ + GK P E + + +A ++ + +V+ +
Sbjct: 185 WAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI 233
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 9e-45
Identities = 61/241 (25%), Positives = 114/241 (47%), Gaps = 13/241 (5%)
Query: 528 FLFTADDLLCATAEIMGKSTYGTAYKATL---EDGSEVAVKRLREKTTKGQ-KEFEAEAA 583
D+LL A E+ G +G+ + + +VA+K L++ T K +E EA
Sbjct: 3 LFLKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 584 AIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIG 643
+ ++ +P ++ L +LV + G L FL + E + + +
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQ 117
Query: 644 IARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA--GTL 701
++ G+ YL E+N +H +L + NVLL + +I+DFGLS+ + A + +A L
Sbjct: 118 VSMGMKYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 702 GYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWVASIVKEEWTNE 760
+ APE + ++++DV+S GV + E L+ G+ P + M G ++ ++ + E E
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE 236
Query: 761 V 761
Sbjct: 237 C 237
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-44
Identities = 52/237 (21%), Positives = 100/237 (42%), Gaps = 14/237 (5%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALR 597
+G +YG K DG + K L T ++ +E + ++ HPN++
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 598 AYYLGPKGEKL-LVFDFMPKGSLASFLHARGPET-IVNWATRMSIAIGIARGLNYLH--- 652
+ L +V ++ G LAS + E ++ + + + L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 653 -VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKL 711
++H +L +NV LD K N ++ DFGL+R++ + A GT Y +PE
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMNR 188
Query: 712 KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASI----VKEEWTNEVFDL 764
+ N K+D++SLG ++ EL P + +L + + +++E+ ++
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEI 245
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-44
Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 16/235 (6%)
Query: 541 EIMGKSTYGTAYKATL-EDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALR 597
+G+ ++ T YK E EVA L+++ T ++ F+ EA + + HPN++
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 598 AYYLGP---KGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
+ K +LV + M G+L ++L + S I +GL +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTR 131
Query: 655 -ENMIHGNLTSSNVLLDEKTN-PRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLK 712
+IH +L N+ + T +I D GL+ L A+ VI GT + APE+ + +
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI---GTPEFMAPEMYE-E 187
Query: 713 NANTKTDVYSLGVIILELLTGKSP-GEPMNGMDLPQWVASIVKEEWTNEVFDLEL 766
+ DVY+ G+ +LE+ T + P E N + + V S VK ++V E+
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 242
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (404), Expect = 3e-44
Identities = 59/236 (25%), Positives = 104/236 (44%), Gaps = 22/236 (9%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR---EKTTKGQKEFEAEAAAIGKIHHPNLLAL 596
+G ++G Y A + + VA+K++ +++ + ++ E + K+ HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 597 RAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
R YL LV ++ + + P + ++ G +GL YLH N
Sbjct: 81 RGCYLRE-HTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLH-SHN 135
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPEL---SKLKN 713
MIH ++ + N+LL E ++ DFG + +M AN+ V GT + APE+
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-PANSFV----GTPYWMAPEVILAMDEGQ 190
Query: 714 ANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVA-----SIVKEEWTNEVFDL 764
+ K DV+SLG+ +EL K P MN M +A ++ W+ +
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 7e-44
Identities = 61/239 (25%), Positives = 110/239 (46%), Gaps = 20/239 (8%)
Query: 541 EIMGKSTYGTAYKATLEDGS----EVAVKRLREKTTKGQ-KEFEAEAAAIGKIHHPNLLA 595
E++G+ +G Y TL D AVK L T G+ +F E + HPN+L+
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
L L +G L+V +M G L +F+ + + +A+G+ +L +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFLA-SK 149
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMT---AAANTNVIATAGTLGYRAPELSKLK 712
+H +L + N +LDEK ++ADFGL+R M + N + + A E + +
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209
Query: 713 NANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK-------EEWTNEVFDL 764
TK+DV+S GV++ EL+T +P P ++ +++ E + ++++
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 61/252 (24%), Positives = 101/252 (40%), Gaps = 32/252 (12%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYY 600
E +GK +G ++ G EVAVK + + EAE + H N+L A
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAAD 66
Query: 601 L---GPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE-- 655
G + LV D+ GSL +L+ V + +A+ A GL +LH+E
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 656 -----NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT---AGTLGYRAPE 707
+ H +L S N+L+ + IAD GL+ +A +T IA GT Y APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 708 L------SKLKNANTKTDVYSLGVIILELLTGKSPGE-------PMNGMDLPQWVASIVK 754
+ K + + D+Y++G++ E+ S G P + ++
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 755 EEWTNEVFDLEL 766
+ + +
Sbjct: 243 KVVCEQKLRPNI 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (394), Expect = 4e-43
Identities = 64/260 (24%), Positives = 113/260 (43%), Gaps = 40/260 (15%)
Query: 541 EIMGKSTYGTAYKATL------EDGSEVAVKRLREKTTKG-QKEFEAEAAAIGKIHHPNL 593
+G+ +G ++A E + VAVK L+E+ + Q +F+ EAA + + +PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIV--------------------- 632
+ L L+F++M G L FL + P T+
Sbjct: 79 VKLLGVCAVG-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137
Query: 633 NWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692
+ A ++ IA +A G+ YL E +H +L + N L+ E +IADFGLSR + +A
Sbjct: 138 SCAEQLCIARQVAAGMAYLS-ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196
Query: 693 NVIAT-AGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVAS 751
A + + PE T++DV++ GV++ E+ + P GM + +
Sbjct: 197 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ--PYYGMAHEEVIYY 254
Query: 752 IVK-------EEWTNEVFDL 764
+ E E+++L
Sbjct: 255 VRDGNILACPENCPLELYNL 274
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 11/211 (5%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+G +G YKA E A K + K+ + +++ E + HPN++ L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIH 659
+ ++ +F G++ + + E + + + LNYLH + +IH
Sbjct: 78 FYYE-NNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLH-DNKIIH 133
Query: 660 GNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPEL-----SKLKNA 714
+L + N+L + ++ADFG+S T + GT + APE+ SK +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 192
Query: 715 NTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745
+ K DV+SLG+ ++E+ + P +N M +
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRV 223
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-42
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 22/235 (9%)
Query: 544 GKSTYGTAYKATLED---GSEVAVKRLREKTTKGQ--KEFEAEAAAIGKIHHPNLLALRA 598
G +GT K + VAVK L+ + E AEA + ++ +P ++ +
Sbjct: 16 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM-- 73
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
+ +LV + G L +L V + + ++ G+ YL E N +
Sbjct: 74 IGICEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE-ESNFV 129
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT--AGTLGYRAPELSKLKNANT 716
H +L + NVLL + +I+DFGLS+ + A N T + + APE ++
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 717 KTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK-------EEWTNEVFDL 764
K+DV+S GV++ E + P GM + A + K E++DL
Sbjct: 190 KSDVWSFGVLMWEAFSYGQK--PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL 242
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 8e-42
Identities = 55/231 (23%), Positives = 96/231 (41%), Gaps = 15/231 (6%)
Query: 541 EIMGKSTYGTAYKATL-EDGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLAL 596
+GK +G Y A + +A+K L + + + E + HPN+L L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 597 RAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
Y+ L+ ++ P G++ L + + +A L+Y H +
Sbjct: 72 YGYFHDA-TRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCH-SKR 126
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANT 716
+IH ++ N+LL +IADFG S ++ GTL Y PE+ + + +
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGRMHDE 183
Query: 717 KTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASI---VKEEWTNEVFDL 764
K D++SLGV+ E L GK P E + + ++ + + T DL
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDL 234
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (380), Expect = 2e-41
Identities = 68/232 (29%), Positives = 110/232 (47%), Gaps = 14/232 (6%)
Query: 541 EIMGKSTYGTAYKATLED-GSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+G YG Y+ + VAVK L+E T + +EF EAA + +I HPNL+ L
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIH 659
++ +FM G+L +L + + + + +A I+ + YL ++N IH
Sbjct: 82 CTRE-PPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLE-KKNFIH 138
Query: 660 GNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTD 719
+L + N L+ E ++ADFGLSRLMT T + + APE + K+D
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 720 VYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK-------EEWTNEVFDL 764
V++ GV++ E+ T P G+DL Q + K E +V++L
Sbjct: 199 VWAFGVLLWEIATYGMS--PYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 248
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (380), Expect = 3e-41
Identities = 60/263 (22%), Positives = 119/263 (45%), Gaps = 32/263 (12%)
Query: 530 FTADDLLCATA--------------EIMGKSTYGTAYKATL----EDGSEVAVKRLREKT 571
FT +D A +++G +G L + VA+K L+
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 572 TKGQ-KEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPET 630
T+ Q ++F +EA+ +G+ HPN++ L +++ +FM GSL SFL +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-KSTPVMIITEFMENGSLDSFLRQNDGQF 125
Query: 631 IVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690
+ + GIA G+ YL + N +H +L + N+L++ +++DFGLSR +
Sbjct: 126 --TVIQLVGMLRGIAAGMKYLA-DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 691 N----TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDL 745
+ T+ + + + APE + + + +DV+S G+++ E+++ G+ P M D+
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV 242
Query: 746 PQWVASIVK----EEWTNEVFDL 764
+ + + + + L
Sbjct: 243 INAIEQDYRLPPPMDCPSALHQL 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 152 bits (384), Expect = 3e-41
Identities = 50/221 (22%), Positives = 98/221 (44%), Gaps = 12/221 (5%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
E +G +G ++ T G+ A K + ++ E + + HP L+ L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIH 659
+ E +++++FM G L + ++ + + +GL ++H E N +H
Sbjct: 92 FEDD-NEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMH-ENNYVH 147
Query: 660 GNLTSSNVLLDEKTNPRI--ADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTK 717
+L N++ K + + DFGL+ + +V T GT + APE+++ K
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPEVAEGKPVGYY 205
Query: 718 TDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWT 758
TD++S+GV+ LL+G SP N + + ++ +W
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDET---LRNVKSCDWN 243
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-41
Identities = 45/209 (21%), Positives = 86/209 (41%), Gaps = 9/209 (4%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR-EKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
+ +G+ YG A VAVK + ++ + + E ++H N++
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
+ + L ++ G L + + + G+ YLH +
Sbjct: 71 HRREG-NIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLH-GIGIT 125
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPE-LSKLKNANT 716
H ++ N+LLDE+ N +I+DFGL+ + ++ GTL Y APE L + +
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 717 KTDVYSLGVIILELLTGKSPGEPMNGMDL 745
DV+S G+++ +L G+ P + +
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 7e-41
Identities = 48/206 (23%), Positives = 93/206 (45%), Gaps = 8/206 (3%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
E +G+ GT Y A + G EVA++++ + ++ E + + +PN++
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIH 659
YL E +V +++ GSL + + ++ + L +LH +IH
Sbjct: 86 YLVG-DELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLH-SNQVIH 139
Query: 660 GNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTD 719
++ S N+LL + ++ DFG +T + GT + APE+ K K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 720 VYSLGVIILELLTGKSPGEPMNGMDL 745
++SLG++ +E++ G+ P N +
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRA 224
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 151 bits (382), Expect = 7e-41
Identities = 48/221 (21%), Positives = 100/221 (45%), Gaps = 12/221 (5%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
E +G +G ++ G K + + + E + + ++HHP L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIH 659
+ K E +L+ +F+ G L + A + ++ A ++ GL ++H E +++H
Sbjct: 95 FED-KYEMVLILEFLSGGELFDRIAAEDYK--MSEAEVINYMRQACEGLKHMH-EHSIVH 150
Query: 660 GNLTSSNVLLDEKTNPRI--ADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTK 717
++ N++ + K + DFGL+ + + V T T + APE+ +
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVDREPVGFY 208
Query: 718 TDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWT 758
TD++++GV+ LL+G S P G D + + ++ + +W
Sbjct: 209 TDMWAIGVLGYVLLSGLS---PFAGEDDLETLQNVKRCDWE 246
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-40
Identities = 52/249 (20%), Positives = 108/249 (43%), Gaps = 33/249 (13%)
Query: 541 EIMGKSTYGTAYKATLEDGSE------VAVKRLREKTTKGQKE-FEAEAAAIGKI-HHPN 592
+++G +G AT S+ VAVK L+EK ++E +E + ++ H N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 593 LLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGP--------------------ETIV 632
++ L G L+F++ G L ++L ++ ++
Sbjct: 103 IVNLLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161
Query: 633 NWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692
+ + A +A+G+ +L ++ +H +L + NVL+ +I DFGL+R + + +N
Sbjct: 162 TFEDLLCFAYQVAKGMEFLE-FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 693 NVIATA-GTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVAS 751
V A + + APE K+DV+S G+++ E+ + P G+ +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN--PYPGIPVDANFYK 278
Query: 752 IVKEEWTNE 760
+++ + +
Sbjct: 279 LIQNGFKMD 287
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-40
Identities = 61/249 (24%), Positives = 112/249 (44%), Gaps = 31/249 (12%)
Query: 541 EIMGKSTYGTAYKATLEDGS---EVAVKRLREKTTK-GQKEFEAEAAAIGKI-HHPNLLA 595
+++G+ +G KA ++ + A+KR++E +K ++F E + K+ HHPN++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLH-------------ARGPETIVNWATRMSIAI 642
L +G L ++ P G+L FL A + ++ + A
Sbjct: 76 LLGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134
Query: 643 GIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLG 702
+ARG++YL ++ IH +L + N+L+ E +IADFGLSR + +
Sbjct: 135 DVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM--GRLPVR 191
Query: 703 YRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK-------E 755
+ A E T +DV+S GV++ E+++ P GM + + +
Sbjct: 192 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKLPQGYRLEKPL 249
Query: 756 EWTNEVFDL 764
+EV+DL
Sbjct: 250 NCDDEVYDL 258
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-38
Identities = 56/225 (24%), Positives = 94/225 (41%), Gaps = 16/225 (7%)
Query: 541 EIMGKSTYGTAYKATLE----DGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNL 593
E +G ++G + + VAVK L+ + +F E A+ + H NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
+ L L +V + P GSL L ++ +R A+ +A G+ YL
Sbjct: 74 IRLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE- 128
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT--AGTLGYRAPELSKL 711
+ IH +L + N+LL + +I DFGL R + + V+ + APE K
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 712 KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756
+ + +D + GV + E+ T P G++ Q + I KE
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE--PWIGLNGSQILHKIDKEG 231
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-38
Identities = 48/221 (21%), Positives = 91/221 (41%), Gaps = 12/221 (5%)
Query: 541 EIMGKSTYGTAYKATL----EDGSEVAVKRLREKTTKGQKE-FEAEAAAIGKIHHPNLLA 595
+G+ +G ++ VA+K + T+ +E F EA + + HP+++
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
L + ++ + G L SFL R ++ A+ + A ++ L YL +
Sbjct: 73 LIGVIT--ENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLE-SK 127
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNAN 715
+H ++ + NVL+ ++ DFGLSR M + + + APE +
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 716 TKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756
+ +DV+ GV + E+L P G+ + I E
Sbjct: 188 SASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRIENGE 226
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 3e-38
Identities = 46/221 (20%), Positives = 95/221 (42%), Gaps = 13/221 (5%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
E +G+ +G ++ K ++ K T Q + E + + H N+L L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHES 69
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIH 659
+ E +++F+F+ + ++ E +N +S + L +LH N+ H
Sbjct: 70 FESM-EELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLH-SHNIGH 125
Query: 660 GNLTSSNVLLDEKTNPR--IADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTK 717
++ N++ + + I +FG +R + N + Y APE+ + +T
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQHDVVSTA 183
Query: 718 TDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWT 758
TD++SLG ++ LL+G +P + + +I+ E+T
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQI---IENIMNAEYT 221
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (356), Expect = 8e-38
Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 15/223 (6%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKG-QKEFEAEAAAIGKIHHPNLLALRA 598
+++G + A VA+K + +K +G + E E A + KI HPN++AL
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
Y G L+ + G L + +G + + + YLH + ++
Sbjct: 75 IYE-SGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH-DLGIV 129
Query: 659 HGNLTSSNVLL---DEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNAN 715
H +L N+L DE + I+DFGLS++ + + GT GY APE+ K +
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC--GTPGYVAPEVLAQKPYS 187
Query: 716 TKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWT 758
D +S+GVI LL G P + + I+K E+
Sbjct: 188 KAVDCWSIGVIAYILLCGYP---PFYDENDAKLFEQILKAEYE 227
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 9e-38
Identities = 60/238 (25%), Positives = 107/238 (44%), Gaps = 21/238 (8%)
Query: 541 EIMGKSTYGTAYKATLEDGSE-----VAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLL 594
+++G +GT YK E VA+K LRE T+ K KE EA + + +P++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 595 ALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
L L L+ MP G L ++ ++ + IA+G+NYL +
Sbjct: 75 RLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNYLE-D 129
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKN 713
++H +L + NVL+ + +I DFGL++L+ A + + + A E +
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 714 ANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK-------EEWTNEVFDL 764
++DV+S GV + EL+T S P +G+ + + + K T +V+ +
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISSILEKGERLPQPPICTIDVYMI 245
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 3e-37
Identities = 56/241 (23%), Positives = 104/241 (43%), Gaps = 28/241 (11%)
Query: 541 EIMGKSTYGTAYKATL------EDGSEVAVKRLREKTTKGQKE-FEAEAAAIGKI-HHPN 592
+ +G +G +AT + VAVK L+ ++E +E + + +H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 593 LLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETI---------------VNWATR 637
++ L G L++ ++ G L +FL + I ++
Sbjct: 89 IVNLLGACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 638 MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697
+S + +A+G+ +L +N IH +L + N+LL +I DFGL+R + +N V
Sbjct: 148 LSFSYQVAKGMAFLA-SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 698 A-GTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756
A + + APE ++DV+S G+ + EL + S P GM + ++KE
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP--GMPVDSKFYKMIKEG 264
Query: 757 W 757
+
Sbjct: 265 F 265
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 6e-37
Identities = 53/232 (22%), Positives = 99/232 (42%), Gaps = 13/232 (5%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLAL 596
+I+G+ ++ T A L E A+K L ++ E + ++ HP + L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 597 RAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
+ + + G L ++ G + I L YLH +
Sbjct: 74 YFTFQ-DDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLH-GKG 128
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT-AGTLGYRAPELSKLKNAN 715
+IH +L N+LL+E + +I DFG +++++ + + GT Y +PEL K+A
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 716 TKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASI---VKEEWTNEVFDL 764
+D+++LG II +L+ G P N + Q + + E++ + DL
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 240
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-36
Identities = 52/239 (21%), Positives = 107/239 (44%), Gaps = 21/239 (8%)
Query: 541 EIMGKSTYGTAYKATLEDGSE-----VAVKRLREKTTKGQK-EFEAEAAAIGKIHHPNLL 594
+++G +G YK L+ S VA+K L+ T+ Q+ +F EA +G+ H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 595 ALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
L +++ ++M G+ R + + + + GIA G+ YL
Sbjct: 73 RLEGVISKY-KPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA-N 128
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM--TAAANTNVIATAGTLGYRAPELSKLK 712
N +H +L + N+L++ +++DFGLSR++ A + + APE +
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188
Query: 713 NANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK-------EEWTNEVFDL 764
+ +DV+S G+++ E++T P + + + +I + + ++ L
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYGER--PYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 135 bits (340), Expect = 5e-36
Identities = 53/227 (23%), Positives = 101/227 (44%), Gaps = 16/227 (7%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQ---KEFEAEAAAIGKIHHPNLLAL 596
EI+G + A L +VAVK LR + F EA ++HP ++A+
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 597 RAYYLGPKGEKL---LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
+V +++ +L +H GP + + + + LN+ H
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH- 128
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA--GTLGYRAPELSKL 711
+ +IH ++ +N+++ ++ DFG++R + + N+ A GT Y +PE ++
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 712 KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWT 758
+ + ++DVYSLG ++ E+LTG+ P G V+E+
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEP---PFTGDSPVSVAYQHVREDPI 232
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 6e-36
Identities = 56/245 (22%), Positives = 106/245 (43%), Gaps = 25/245 (10%)
Query: 541 EIMGKSTYGTAYKAT------LEDGSEVAVKRLREKTTKG-QKEFEAEAAAIGKI-HHPN 592
+ +G+ +G +A VAVK L+E T + +E + I HH N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 593 LLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETI-------------VNWATRMS 639
++ L P G +++ +F G+L+++L ++ E + + +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 640 IAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA- 698
+ +A+G+ +L IH +L + N+LL EK +I DFGL+R + + A
Sbjct: 139 YSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197
Query: 699 GTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWT 758
L + APE + ++DV+S GV++ E+ + + P G+ + + +KE
Sbjct: 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS--PYPGVKIDEEFCRRLKEGTR 255
Query: 759 NEVFD 763
D
Sbjct: 256 MRAPD 260
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 7e-36
Identities = 52/246 (21%), Positives = 107/246 (43%), Gaps = 26/246 (10%)
Query: 541 EIMGKSTYGTAYKATL------EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNL 593
+G+ ++G Y+ E + VA+K + E + + + EF EA+ + + + ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVN-------WATRMSIAIGIAR 646
+ L L++ + M +G L S+L + P N + + +A IA
Sbjct: 86 VRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144
Query: 647 GLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATA-GTLGYRA 705
G+ YL+ +H +L + N ++ E +I DFG++R + + + +
Sbjct: 145 GMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203
Query: 706 PELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK-------EEWT 758
PE K T +DV+S GV++ E+ T P G+ Q + +++ +
Sbjct: 204 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLSNEQVLRFVMEGGLLDKPDNCP 261
Query: 759 NEVFDL 764
+ +F+L
Sbjct: 262 DMLFEL 267
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 132 bits (334), Expect = 3e-35
Identities = 56/228 (24%), Positives = 93/228 (40%), Gaps = 24/228 (10%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR---------EKTTKGQKEFEAEAAAIGKIH- 589
EI+G+ + E AVK + E+ + ++ E + K+
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 590 HPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLN 649
HPN++ L+ Y LVFD M KG L +L + ++ I + +
Sbjct: 69 HPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVIC 124
Query: 650 YLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPEL- 708
LH + N++H +L N+LLD+ N ++ DFG S + + GT Y APE+
Sbjct: 125 ALH-KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSYLAPEII 181
Query: 709 -----SKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVAS 751
+ D++S GVI+ LL G P M + + + S
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 134 bits (338), Expect = 6e-35
Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 16/215 (7%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQ------KEFEAEAAAIGKIHHPNL 593
I+G+ +G Y + G A+K L +K K + + + P +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
+ + + P + + D M G L L G + A A I GL ++H
Sbjct: 70 VCMSYAFHTP-DKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGLEHMH- 124
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKLK 712
+++ +L +N+LLDE + RI+D GL+ + A+ GT GY APE L K
Sbjct: 125 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYMAPEVLQKGV 181
Query: 713 NANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQ 747
++ D +SLG ++ +LL G SP D +
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 216
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-34
Identities = 48/214 (22%), Positives = 92/214 (42%), Gaps = 11/214 (5%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEA----EAAAIGKIHHPNLLA 595
+++GK ++G + A + A+K L++ + E + HP L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 596 LRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
+ + K V +++ G L + + + + A I GL +LH +
Sbjct: 68 MFCTFQT-KENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLH-SK 122
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNAN 715
+++ +L N+LLD+ + +IADFG+ + + GT Y APE+ + N
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 716 TKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWV 749
D +S GV++ E+L G+SP + +L +
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 215
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-34
Identities = 49/224 (21%), Positives = 95/224 (42%), Gaps = 15/224 (6%)
Query: 539 TAEIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
T++++G G + + A+K L+ K ++E E A P+++ +
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRAS---QCPHIVRIV 71
Query: 598 AYYLGPKGEK---LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
Y + L+V + + G L S + RG + I I + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLH-S 129
Query: 655 ENMIHGNLTSSNVLLDEKTNP---RIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKL 711
N+ H ++ N+L K ++ DFG ++ T+ + ++ T Y APE+
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--HNSLTTPCYTPYYVAPEVLGP 187
Query: 712 KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKE 755
+ + D++SLGVI+ LL G P +G+ + + + ++
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 231
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 6e-34
Identities = 60/255 (23%), Positives = 108/255 (42%), Gaps = 35/255 (13%)
Query: 541 EIMGKSTYGTAYKATL--------EDGSEVAVKRLR-EKTTKGQKEFEAEAAAIGKI-HH 590
+ +G+ +G A ++VAVK L+ + T K + +E + I H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 591 PNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGP-------------ETIVNWATR 637
N++ L G ++ ++ KG+L +L AR P E ++
Sbjct: 79 KNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 638 MSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA-ANTNVIA 696
+S A +ARG+ YL + IH +L + NVL+ E +IADFGL+R +
Sbjct: 138 VSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK-- 754
+ + APE + ++DV+S GV++ E+ T P G+ + + + +
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPVEELFKLLKEGH 254
Query: 755 -----EEWTNEVFDL 764
TNE++ +
Sbjct: 255 RMDKPSNCTNELYMM 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 1e-32
Identities = 48/213 (22%), Positives = 96/213 (45%), Gaps = 15/213 (7%)
Query: 541 EIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+++G ++G Y+A L + G VA+K++ + ++ E + K+ H N++ LR +
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 600 YLGPKGEK-----LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
+ +K LV D++P+ H + + + R L Y+H
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-S 140
Query: 655 ENMIHGNLTSSNVLLDEKTN-PRIADFGLSRLMTAAANTNVIATAGTLGYRAP-ELSKLK 712
+ H ++ N+LLD T ++ DFG ++ + ++ + YRAP +
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGAT 198
Query: 713 NANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745
+ + DV+S G ++ ELL G+ +G+D
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 5e-32
Identities = 48/220 (21%), Positives = 91/220 (41%), Gaps = 13/220 (5%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQ-KEFEAEAAAIGKIHHPNLLALRA 598
+G+ YG A + VA+K++ + + E + + H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 599 YYLGP---KGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEE 655
P + + + + + L L + ++ I RGL Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQILRGLKYIH-SA 128
Query: 656 NMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT--AGTLGYRAPELSKLKN 713
N++H +L SN+LL+ + +I DFGL+R+ + T T YRAPE+
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 714 ANT-KTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASI 752
T D++S+G I+ E+L+ + + +D + I
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 228
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 6e-32
Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 18/226 (7%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKG------QKEFEAEAAAIGKIHHPNL 593
E +G + K G + A K ++++ TK +++ E E + + +I HPN+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 594 LALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
+ L Y K + +L+ + + G L FL + + I G+ YLH
Sbjct: 76 ITLHEVYEN-KTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLH- 130
Query: 654 EENMIHGNLTSSNVLLDEKTNPR----IADFGLSRLMTAAANTNVIATAGTLGYRAPELS 709
+ H +L N++L ++ P+ I DFGL+ + GT + APE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTPEFVAPEIV 188
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKE 755
+ + D++S+GVI LL+G SP + V+++ E
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 124 bits (311), Expect = 1e-31
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 13/209 (6%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLAL 596
+G ++G + +G A+K L+++ K + E + + HP ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 597 RAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
+ + ++ D++ G L S L A + L YLH ++
Sbjct: 70 WGTFQDA-QQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCLALEYLH-SKD 124
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANT 716
+I+ +L N+LLD+ + +I DFG ++ + T GT Y APE+ K N
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEVVSTKPYNK 180
Query: 717 KTDVYSLGVIILELLTGKSPGEPMNGMDL 745
D +S G++I E+L G +P N M
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKT 209
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (307), Expect = 2e-31
Identities = 39/219 (17%), Positives = 74/219 (33%), Gaps = 16/219 (7%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+G ++G Y T + G EVA+K K + E+ + + +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIH 659
++V + + F + T + +A + + Y+H +N IH
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIH-SKNFIH 126
Query: 660 GNLTSSNVL---LDEKTNPRIADFGLSRLMTAAANTNVIAT------AGTLGYRAPELSK 710
++ N L + I DFGL++ A I GT Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 711 LKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWV 749
+ + D+ SLG +++ G P + + Q
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-31
Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 13/212 (6%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR-----EKTTKGQKEFEAEAAAIGKIHHPNLL 594
+ +G+ + T YKA VA+K+++ E + E + ++ HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 595 ALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVE 654
L + G K LVFDFM + + + + +GL YLH +
Sbjct: 64 GLLDAF-GHKSNISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLH-Q 118
Query: 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKLKN 713
++H +L +N+LLDE ++ADFGL++ + T YRAPE L +
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH-QVVTRWYRAPELLFGARM 177
Query: 714 ANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745
D++++G I+ ELL + +D
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ 209
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 121 bits (305), Expect = 3e-31
Identities = 47/207 (22%), Positives = 86/207 (41%), Gaps = 7/207 (3%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLR--EKTTKGQKEFEAEAAAIGKIHHPNLLALRA 598
E +G+ TYG YKA G A+K++R ++ E + + ++ H N++ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 599 YYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMI 658
K +LVF+ + + G + T S + + G+ Y H + ++
Sbjct: 68 VIHTKK-RLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCH-DRRVL 122
Query: 659 HGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKT 718
H +L N+L++ + +IADFGL+R L K +T
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 719 DVYSLGVIILELLTGKSPGEPMNGMDL 745
D++S+G I E++ G ++ D
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQ 209
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-31
Identities = 51/219 (23%), Positives = 90/219 (41%), Gaps = 18/219 (8%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKG--QKEFEAEAAAIGKIHHPNLLAL- 596
+G+ T+G +KA + G +VA+K++ + K E + + H N++ L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 597 ------RAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNY 650
+ Y KG LVFDF + T + + + GL Y
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT---LSEIKRVMQMLLNGLYY 132
Query: 651 LHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT---NVIATAGTLGYRAPE 707
+H ++H ++ ++NVL+ ++ADFGL+R + A N+ TL YR PE
Sbjct: 133 IH-RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 708 -LSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745
L ++ D++ G I+ E+ T +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 230
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 121 bits (304), Expect = 4e-31
Identities = 37/224 (16%), Positives = 81/224 (36%), Gaps = 18/224 (8%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAY 599
+G+ ++G ++ T L + +VA+K + + E + + Y
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIP-NVY 67
Query: 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIH 659
Y G +G ++ + SL L G + T A + + +H E+++++
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIH-EKSLVY 124
Query: 660 GNLTSSNVLLDEKTNP-----RIADFGLSRLMTAAANTNVI------ATAGTLGYRAPEL 708
++ N L+ + + DFG+ + I +GT Y +
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 709 SKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASI 752
+ + + D+ +LG + + L G P + + Q I
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 7e-31
Identities = 43/235 (18%), Positives = 88/235 (37%), Gaps = 21/235 (8%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR------EKTTKGQKEFEAEAAAIGKIH--HP 591
++G +G+ Y + D VA+K + E + K+
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 592 NLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYL 651
++ L ++ P L++ P L F+ RG + S + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHC 126
Query: 652 HVEENMIHGNLTSSNVLLD-EKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LS 709
H ++H ++ N+L+D + ++ DFG L+ T+ GT Y PE +
Sbjct: 127 H-NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWIR 182
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEVFDL 764
+ V+SLG+++ +++ G P E + Q ++ ++E L
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV---FFRQRVSSECQHL 234
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 3e-30
Identities = 53/224 (23%), Positives = 96/224 (42%), Gaps = 16/224 (7%)
Query: 541 EIMGKSTYGTAYKAT--LEDGSEVAVKRLREKTTKGQKEFE-----AEAAAIGKIHHPNL 593
+G+ YG +KA G VA+KR+R +T + A + HPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 594 LALRAYYLGPKGEK----LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLN 649
+ L + ++ LVF+ + + P V T + + RGL+
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGLD 130
Query: 650 YLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELS 709
+LH ++H +L N+L+ ++ADFGL+R+ + + + TL YRAPE+
Sbjct: 131 FLH-SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVL 187
Query: 710 KLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIV 753
+ T D++S+G I E+ K + +D + ++
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-29
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 9/209 (4%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR--EKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
E +G+ TYG YKA G VA+K++R +T E + + +++HPN++ L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
KL + L F+ A I S + +GL + H +
Sbjct: 68 DVIH--TENKLYLVFEFLHQDLKKFMDASALTGI-PLPLIKSYLFQLLQGLAFCH-SHRV 123
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKLKNANT 716
+H +L N+L++ + ++ADFGL+R TL YRAPE L K +T
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 717 KTDVYSLGVIILELLTGKSPGEPMNGMDL 745
D++SLG I E++T ++ + +D
Sbjct: 183 AVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-29
Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 13/220 (5%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKE---FEAEAAAIGKIHHPNLLAL 596
+++GK T+G G A+K LR++ + E E+ + HP L AL
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 597 RAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
+ + V ++ G L L T I L YLH +
Sbjct: 71 KYAFQTH-DRLCFVMEYANGGELFFHLSRERVFT---EERARFYGAEIVSALEYLH-SRD 125
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANT 716
+++ ++ N++LD+ + +I DFGL + + + GT Y APE+ + +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 717 KTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756
D + LGV++ E++ G+ P D + I+ EE
Sbjct: 185 AVDWWGLGVVMYEMMCGRL---PFYNQDHERLFELILMEE 221
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 5e-29
Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 19/221 (8%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALR 597
+ +G YG A G++VA+K+L + K E + + H N++ L
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 598 AYY-----LGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLH 652
+ L + LV FM G+ L + + + +GL Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK---LGEDRIQFLVYQMLKGLRYIH 138
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKL 711
+IH +L N+ ++E +I DFGL+R + V T YRAPE +
Sbjct: 139 -AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV----VTRWYRAPEVILNW 193
Query: 712 KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASI 752
D++S+G I+ E++TGK+ + + +D + + +
Sbjct: 194 MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 234
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 115 bits (289), Expect = 1e-28
Identities = 46/213 (21%), Positives = 88/213 (41%), Gaps = 13/213 (6%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKE---FEAEAAAIGKIHHPNLLAL 596
+ +G ++G E G+ A+K L ++ K+ E + ++ P L+ L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 597 RAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN 656
+ +V +++ G + S L G + A I YLH +
Sbjct: 107 EFSFKDNS-NLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLH-SLD 161
Query: 657 MIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANT 716
+I+ +L N+L+D++ ++ DFG ++ + T GT APE+ K N
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEIILSKGYNK 217
Query: 717 KTDVYSLGVIILELLTGKSPGEPMNGMDLPQWV 749
D ++LGV+I E+ G P + + + +
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI 250
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 1e-27
Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 10/221 (4%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR--EKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
E +G+ TYGT +KA E VA+KR+R + E + ++ H N++ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 598 AYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
K + LVF+F + F G + S + +GL + H N+
Sbjct: 68 DVLHSDK-KLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH-SRNV 122
Query: 658 IHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTK 717
+H +L N+L++ ++A+FGL+R L K +T
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 718 TDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWT 758
D++S G I EL P G D+ + I + T
Sbjct: 183 IDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLLGT 221
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 7e-27
Identities = 51/226 (22%), Positives = 92/226 (40%), Gaps = 14/226 (6%)
Query: 541 EIMGKSTYGTAYKATL----EDGSEVAVKRLREKT----TKGQKEFEAEAAAIGKIHHPN 592
+++G YG + + G A+K L++ T K + E + I
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 593 LLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLH 652
L Y + + L+ D++ G L + L R I L +LH
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLH 146
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLK 712
+ +I+ ++ N+LLD + + DFGLS+ A GT+ Y AP++ +
Sbjct: 147 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 713 NA--NTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756
++ + D +SLGV++ ELLTG SP + ++ + +
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 108 bits (271), Expect = 2e-26
Identities = 44/228 (19%), Positives = 89/228 (39%), Gaps = 19/228 (8%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRA 598
+G+ Y ++A + + +V VK L+ +K+ + E + + PN++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 97
Query: 599 YYLGPKGEKL-LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENM 657
P LVF+ + I I + L+Y H +
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF------YMYEILKALDYCH-SMGI 150
Query: 658 IHGNLTSSNVLLDEKTNP-RIADFGLSRLMTAAANTNVIATAGTLGYRAPEL-SKLKNAN 715
+H ++ NV++D + R+ D+GL+ + ++ PEL + +
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH--PGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 716 TKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEVFD 763
D++SLG ++ ++ K P +G D + I K T +++D
Sbjct: 209 YSLDMWSLGCMLASMIFRKEP--FFHGHDNYDQLVRIAKVLGTEDLYD 254
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 104 bits (260), Expect = 1e-24
Identities = 55/211 (26%), Positives = 86/211 (40%), Gaps = 21/211 (9%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171
++L L L +N ++ P L NL + L N+L ++ + NL LDL+
Sbjct: 194 AKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 172 NNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNW 231
NN + P L+ T+L L L N + PL L +L+ L L N L P +
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPL--AGLTALTNLELNENQLEDISPISN 305
Query: 232 GVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQ 291
L +L L N I+ P + L LQ + ++NK+ L L+ +
Sbjct: 306 -------LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV--SSLANLTNIN 354
Query: 292 KLDLSYNAIGGSFPVTFTNITSLVSLNLENN 322
L +N I P N+T + L L +
Sbjct: 355 WLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.9 bits (232), Expect = 4e-21
Identities = 58/238 (24%), Positives = 85/238 (35%), Gaps = 45/238 (18%)
Query: 133 WSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRL 192
L L NL + NN++S P I NL L L+ N L +LA+ T L L
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDL 246
Query: 193 NLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLI 252
+L+ N + PLS L L+ L L N +S P N L +
Sbjct: 247 DLANNQISNLAPLS--GLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS 304
Query: 253 AGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNIT 312
L L ++L N I P + L+KLQ+L + N +
Sbjct: 305 ---------NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD---------- 343
Query: 313 SLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSEN 370
L L N+ L+ +NQ P + N++ I QL L++
Sbjct: 344 ----------------VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 86.2 bits (212), Expect = 1e-18
Identities = 63/362 (17%), Positives = 121/362 (33%), Gaps = 68/362 (18%)
Query: 92 QVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRL 151
+ + L + +S+ + L + L + + +L NL + NN+L
Sbjct: 23 EKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQL 78
Query: 152 SGSIPPSIGNCPNLQTLDLSNNALIG------------------------------AIPP 181
+ P + N L + ++NN + +
Sbjct: 79 TDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 136
Query: 182 SLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQ 241
+S + ++ ++ L LA + +N +
Sbjct: 137 LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196
Query: 242 LQFLNLD--HNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNA 299
+L +N I+ P+ + L E+SL+ N++ L L+ L LDL+ N
Sbjct: 197 TNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 252
Query: 300 IGGSFPVTFTNITSLVSLNLENNRLGNKIP--------------------EGLERLQNLT 339
I P + +T L L L N++ N P + L+NLT
Sbjct: 253 ISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLT 310
Query: 340 VLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGS 399
L L N P + +++ + +L + N + SLA+L N+ + +N +S
Sbjct: 311 YLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDL 366
Query: 400 VP 401
P
Sbjct: 367 TP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 85.8 bits (211), Expect = 2e-18
Identities = 46/206 (22%), Positives = 78/206 (37%), Gaps = 37/206 (17%)
Query: 209 RLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQE 268
+L +L L +N +S P L L+L+ N + +L L L +
Sbjct: 195 KLTNLESLIATNNQISDITPLGI-------LTNLDELSLNGNQLKD--IGTLASLTNLTD 245
Query: 269 ISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVT--------------------F 308
+ L++N+I P L L+KL +L L N I P+
Sbjct: 246 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPI 303
Query: 309 TNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLS 368
+N+ +L L L N + + P + L L L NN+ ++ N++ IN L
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 369 ENDFTGEISPSLASLANLTSFNVSYN 394
N + LA+L +T ++
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.3 bits (176), Expect = 4e-14
Identities = 31/131 (23%), Positives = 50/131 (38%), Gaps = 26/131 (19%)
Query: 111 ISQLHALRKLSLHDNLLAGPVP--------------------WSLGFLPNLRGVYLFNNR 150
+S L L +L L N ++ P + L NL + L+ N
Sbjct: 259 LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318
Query: 151 LSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRL 210
+S P + + LQ L +NN + SLAN T + L+ +N + PL+ L
Sbjct: 319 ISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA--NL 372
Query: 211 PSLSVLALQHN 221
++ L L
Sbjct: 373 TRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.5 bits (153), Expect = 3e-11
Identities = 22/122 (18%), Positives = 45/122 (36%), Gaps = 6/122 (4%)
Query: 53 SLRAIKHDLIDPHGFLRSWNDSGVGACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKIS 112
L A + I P L + + + + + L + + +S
Sbjct: 269 KLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VS 326
Query: 113 QLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSN 172
L L++L +N ++ SL L N+ + +N++S P + N + L L++
Sbjct: 327 SLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382
Query: 173 NA 174
A
Sbjct: 383 QA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.5 bits (153), Expect = 4e-11
Identities = 75/335 (22%), Positives = 118/335 (35%), Gaps = 27/335 (8%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171
+ L K L + V S L + + + SI + NL ++ S
Sbjct: 19 TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFS 74
Query: 172 NNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNW 231
NN L P L N T+L + ++ N + PL+ + L + N
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 232 GVLAG----------NKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIP 281
+ + L L T L L L+ + +S NK+
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 282 DELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVL 341
KL+ L+ L + N I P +T+L L+L N+L K L L NLT L
Sbjct: 193 L--AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQL--KDIGTLASLTNLTDL 246
Query: 342 NLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVP 401
+L NNQ P + ++ + +L L N + LA L LT+ ++ N L P
Sbjct: 247 DLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP 302
Query: 402 PLLSKKFNSSSFVGNLQLCGYSPSTACPSLAPLSL 436
K + N + SP ++ L L
Sbjct: 303 ISNLKNLTYLTLYFN-NISDISPVSSLTKLQRLFF 336
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 51.9 bits (123), Expect = 2e-07
Identities = 21/93 (22%), Positives = 41/93 (44%), Gaps = 8/93 (8%)
Query: 280 IPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLT 339
D L++ K L + V+ T++ + +L + + I +G+E L NLT
Sbjct: 16 FTDT--ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI-KSI-DGVEYLNNLT 69
Query: 340 VLNLKNNQFKGHIPETIGNISGINQLDLSENDF 372
+N NNQ P + N++ + + ++ N
Sbjct: 70 QINFSNNQLTDITP--LKNLTKLVDILMNNNQI 100
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 102 bits (255), Expect = 1e-24
Identities = 55/261 (21%), Positives = 85/261 (32%), Gaps = 17/261 (6%)
Query: 140 NLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSL 199
+LR V + L +P + P+ LDL NN + N L+ L L N +
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 200 LGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVS 259
P + L L L L N L LQ L + N I
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMP--------KTLQELRVHENEITKVRKSV 119
Query: 260 LGKLGLLQEISLSH--NKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSL 317
L + + L K G + KL + ++ I + L L
Sbjct: 120 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS---LTEL 176
Query: 318 NLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEIS 377
+L+ N++ L+ L NL L L N ++ N + +L L+ N
Sbjct: 177 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP- 235
Query: 378 PSLASLANLTSFNVSYNNLSG 398
LA + + NN+S
Sbjct: 236 GGLADHKYIQVVYLHNNNISA 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 99.7 bits (247), Expect = 1e-23
Identities = 66/270 (24%), Positives = 98/270 (36%), Gaps = 17/270 (6%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALI 176
L L +N + L NL + L NN++S P + L+ L LS N L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 177 GAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAG 236
L + S+ L ++ + L SG + +
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGM-- 149
Query: 237 NKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLS 296
+L ++ + I TIP L L E+ L NKI L L+ L KL LS
Sbjct: 150 ---KKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203
Query: 297 YNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKG------ 350
+N+I + N L L+L NN+L K+P GL + + V+ L NN
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDF 262
Query: 351 HIPETIGNISGINQLDLSENDFT-GEISPS 379
P + + + L N EI PS
Sbjct: 263 CPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 98.2 bits (243), Expect = 4e-23
Identities = 55/268 (20%), Positives = 91/268 (33%), Gaps = 16/268 (5%)
Query: 136 GFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLS 195
P+ + L NN+++ N NL TL L NN + P + A +L RL LS
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 196 YNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGT 255
N L L L V + + V G + L + +G
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKV------RKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 256 IPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLV 315
+ + L I ++ I IP L L +L L N I + + +L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 316 SLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTG- 374
L L N + L +L L+L NN+ +P + + I + L N+ +
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257
Query: 375 -----EISPSLASLANLTSFNVSYNNLS 397
A+ + ++ N +
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.5 bits (210), Expect = 1e-18
Identities = 51/276 (18%), Positives = 94/276 (34%), Gaps = 22/276 (7%)
Query: 102 RLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGN 161
++ L L L L +N ++ P + L L +YL N+L +P +
Sbjct: 42 KITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK 100
Query: 162 CPNLQTLDLSNNALIGAIPPSLANSTRLYRLNL--SYNSLLGSIPLSLTRLPSLSVLALQ 219
Q L + N + ++ + L + G + + LS + +
Sbjct: 101 TL--QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 158
Query: 220 HNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGP 279
N++ + L L+LD N I SL L L ++ LS N I
Sbjct: 159 DTNIT--------TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 210
Query: 280 IPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGN------KIPEGLE 333
L L++L L+ N + P + + + L NN + P
Sbjct: 211 DNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNT 269
Query: 334 RLQNLTVLNLKNN--QFKGHIPETIGNISGINQLDL 367
+ + + ++L +N Q+ P T + + L
Sbjct: 270 KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (258), Expect = 2e-24
Identities = 44/244 (18%), Positives = 89/244 (36%), Gaps = 16/244 (6%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRA- 598
+G + T + A + + + VA+K +R + E E + +++ + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 599 -----------YYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARG 647
+ +V F G L + + I+ + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 648 LNYLHVEENMIHGNLTSSNVLLDEKTNPR-IADFGLSRLMTAAA-NTNVIATAGTLGYRA 705
L+Y+H +IH ++ NVL++ +P + ++ L A + + + T YR+
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 706 PELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEWTNEVFDLE 765
PE+ D++S +I EL+TG EP G + I +
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257
Query: 766 LMRD 769
L+R+
Sbjct: 258 LLRN 261
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 102 bits (254), Expect = 2e-24
Identities = 72/300 (24%), Positives = 111/300 (37%), Gaps = 28/300 (9%)
Query: 50 DYQSLRAIKHDLIDPHGFLRSWNDSGVGACSGGWAGIKC----VKGQVIAIQLPWRRLGG 105
D Q+L IK DL +P L SW + C+ W G+ C +V + L L
Sbjct: 7 DKQALLQIKKDLGNPT-TLSSWLPTT-DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 106 R--ISEKISQLHALRKLSLHDNL-LAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNC 162
I ++ L L L + L GP+P ++ L L +Y+ + +SG+IP +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 163 PNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNN 222
L TLD S NAL G +PPS+++ L + N + G+IP S L N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 223 ------------------LSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLG 264
S + +G
Sbjct: 185 RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSK 244
Query: 265 LLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRL 324
L + L +N+I G +P L +L L L++S+N + G P N+ NN+
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 71.3 bits (173), Expect = 6e-14
Identities = 20/62 (32%), Positives = 28/62 (45%), Gaps = 1/62 (1%)
Query: 145 YLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIP 204
L NNR+ G++P + L +L++S N L G I P N R + N L P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308
Query: 205 LS 206
L
Sbjct: 309 LP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 65.9 bits (159), Expect = 3e-12
Identities = 24/68 (35%), Positives = 31/68 (45%), Gaps = 1/68 (1%)
Query: 161 NCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQH 220
NL LDL NN + G +P L L+ LN+S+N+L G IP L V A +
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYAN 300
Query: 221 NNLSGSVP 228
N P
Sbjct: 301 NKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.9 bits (146), Expect = 1e-10
Identities = 17/59 (28%), Positives = 24/59 (40%), Gaps = 1/59 (1%)
Query: 122 LHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIP 180
L +N + G +P L L L + + N L G I P GN +NN + P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 46.3 bits (108), Expect = 7e-06
Identities = 19/63 (30%), Positives = 29/63 (46%), Gaps = 2/63 (3%)
Query: 97 QLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNR-LSGSI 155
L R+ G + + ++QL L L++ N L G +P G L NN+ L GS
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
Query: 156 PPS 158
P+
Sbjct: 309 LPA 311
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 2e-24
Identities = 44/213 (20%), Positives = 80/213 (37%), Gaps = 17/213 (7%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR--EKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
+ +G G A VA+K+L + K E + ++H N+++L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 598 AYYLGPK-----GEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLH 652
+ K + LV + M E + + + G+ +LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY------LLYQMLCGIKHLH 136
Query: 653 VEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLK 712
+IH +L SN+++ +I DFGL+R + T YRAPE+
Sbjct: 137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP--YVVTRYYRAPEVILGM 193
Query: 713 NANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745
D++S+G I+ E++ K + +D
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 8e-24
Identities = 52/213 (24%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 541 EIMGKSTYGTAYKAT-LEDGSEVAVKRLR--EKTTKGQKEFEAEAAAIGKIHHPNLLALR 597
+G YG+ A + G VAVK+L ++ K E + + H N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 598 AYYLGPK----GEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV 653
+ + + + + L + + + + I RGL Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL----TDDHVQFLIYQILRGLKYIH- 138
Query: 654 EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIATAGTLGYRAPE-LSKLK 712
++IH +L SN+ ++E +I DFGL+R V T YRAPE +
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNWM 194
Query: 713 NANTKTDVYSLGVIILELLTGKSPGEPMNGMDL 745
+ N D++S+G I+ ELLTG++ + +D
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 227
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (225), Expect = 7e-21
Identities = 56/259 (21%), Positives = 96/259 (37%), Gaps = 10/259 (3%)
Query: 117 LRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALI 176
+++ LH N ++ S NL ++L +N L+ + L+ LDLS+NA +
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 177 GAI-PPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLA 235
++ P + RL+ L+L L P L +L L LQ N L + +
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF---- 149
Query: 236 GNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDL 295
L L L N I+ + L L + L N++ P L +L L L
Sbjct: 150 -RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 296 SYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPET 355
N + + +L L L +N L +++ +P+
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPW-VCDCRARPLWAWLQKFRGSSSEVPCSLPQ- 266
Query: 356 IGNISGINQLDLSENDFTG 374
++G + L+ ND G
Sbjct: 267 --RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (222), Expect = 2e-20
Identities = 63/264 (23%), Positives = 98/264 (37%), Gaps = 10/264 (3%)
Query: 136 GFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLS 195
G + ++L NR+S S C NL L L +N L + L +L+LS
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 196 YNSLLGSI-PLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAG 254
N+ L S+ P + L L L L L P + LQ+L L N +
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF-----RGLAALQYLYLQDNALQA 143
Query: 255 TIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSL 314
+ LG L + L N+I L L +L L N + P F ++ L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 315 VSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTG 374
++L L N L E L L+ L L L +N + + + + S ++
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPC 262
Query: 375 EISPSLASLANLTSFNVSYNNLSG 398
+ LA ++ N+L G
Sbjct: 263 SLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (206), Expect = 2e-18
Identities = 53/271 (19%), Positives = 93/271 (34%), Gaps = 9/271 (3%)
Query: 157 PSIGNCPNLQ--TLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLS 214
P C N T L A+P + +++ R+ L N + S +L+
Sbjct: 3 PGACVCYNEPKVTTSCPQQGLQ-AVPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLT 59
Query: 215 VLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHN 274
+L L N L+ + + Q D+ + P + LG L + L
Sbjct: 60 ILWLHSNVLARIDAAAFT----GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC 115
Query: 275 KIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLER 334
+ P L+ LQ L L NA+ TF ++ +L L L NR+ +
Sbjct: 116 GLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175
Query: 335 LQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYN 394
L +L L L N+ P ++ + L L N+ + + +LA L L ++ N
Sbjct: 176 LHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
Query: 395 NLSGSVPPLLSKKFNSSSFVGNLQLCGYSPS 425
+ + ++ P
Sbjct: 236 PWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ 266
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (191), Expect = 2e-16
Identities = 48/249 (19%), Positives = 70/249 (28%), Gaps = 8/249 (3%)
Query: 50 DYQSLRAIKHDLIDPHGFLRSWNDSGVGACSGGWAGIKCVKGQVIAIQLPWRRLGGRISE 109
+ + L A + +L
Sbjct: 40 HGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPA 99
Query: 110 KISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLD 169
L L L L L P L L+ +YL +N L + + NL L
Sbjct: 100 TFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159
Query: 170 LSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229
L N + + L RL L N + P + L L L L NNLS
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219
Query: 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELG--KL 287
LQ+L L+ N + LQ+ S +++ +P L L
Sbjct: 220 AL-----APLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAGRDL 273
Query: 288 SKLQKLDLS 296
+L DL
Sbjct: 274 KRLAANDLQ 282
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 75.6 bits (185), Expect = 3e-16
Identities = 26/154 (16%), Positives = 47/154 (30%), Gaps = 19/154 (12%)
Query: 541 EIMGKSTYGTAYKATLEDGSEVAVKRLREKTT----------KGQKEFEAEAAAIGKIHH 590
++MG+ + E E VK + T G F A +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 591 PNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNY 650
L L+ + + + ++ L V + I +
Sbjct: 66 RALQKLQGLAVPKV------YAWE-GNAVLMELIDAKELYRVRVENPDEVLDMILEEVAK 118
Query: 651 LHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSR 684
+ ++HG+L+ NVL+ E+ I DF S
Sbjct: 119 FY-HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSV 150
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.0 bits (180), Expect = 5e-15
Identities = 53/211 (25%), Positives = 79/211 (37%), Gaps = 12/211 (5%)
Query: 138 LPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197
+ + V L+ ++PP + + L LS N L +L TRL +LNL
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 198 SLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIP 257
+ LP L L L HN L L L++ N +
Sbjct: 66 E--LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQ------TLPALTVLDVSFNRLTSLPL 117
Query: 258 VSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSL 317
+L LG LQE+ L N++ P L KL+KL L+ N + + +L +L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 318 NLENNRLGNKIPEGLERLQNLTVLNLKNNQF 348
L+ N IP+G L L N +
Sbjct: 178 LLQENS-LYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.0 bits (162), Expect = 9e-13
Identities = 53/276 (19%), Positives = 86/276 (31%), Gaps = 17/276 (6%)
Query: 158 SIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLA 217
+ + ++ L A+PP L T L+LS N L +L L+ L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 218 LQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIV 277
L L+ + + G L L + + +S N++
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL--------TVLDVSFNRLT 113
Query: 278 GPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQN 337
L L +LQ+L L N + P T L L+L NN L L L+N
Sbjct: 114 SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173
Query: 338 LTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLS 397
L L L+ N IP+ + L N + + + N +
Sbjct: 174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL--CNCEILYFRRWLQDNAENVYVW 230
Query: 398 GSVPPLLSKKFNSSSFV---GNLQLCGYSPSTACPS 430
+ + N +S + P CP+
Sbjct: 231 KQGVDVKAMTSNVASVQCDNSDKFPVYKYPGKGCPT 266
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (145), Expect = 1e-10
Identities = 38/215 (17%), Positives = 70/215 (32%), Gaps = 12/215 (5%)
Query: 110 KISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLD 169
++S++ + +++ L +P L + ++L N L ++ L L+
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 170 LSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPN 229
L L L+ + L + +L L L V + +L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 230 NWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSK 289
G L + L L+ T L+++SL++N + L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTP--------KLEKLSLANNNLTELPAGLLNGLEN 173
Query: 290 LQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRL 324
L L L N++ + P F L L N
Sbjct: 174 LDTLLLQENSL-YTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 14/54 (25%), Positives = 18/54 (33%), Gaps = 1/54 (1%)
Query: 123 HDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALI 176
+N L L L NL + L N L +IP L L N +
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.7 bits (143), Expect = 3e-10
Identities = 44/262 (16%), Positives = 87/262 (33%), Gaps = 10/262 (3%)
Query: 89 VKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDN-LLAGPVPWSLGFLPNLRGVYLF 147
+ VIA + P + ++E S ++ + L ++ + + L L+ + L
Sbjct: 21 LSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79
Query: 148 NNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSL 207
RLS I ++ NL L+LS + S+ L+ + +
Sbjct: 80 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHV 139
Query: 208 TRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN----LIAGTIPVSLGKL 263
+ + NLSG N + L ++ +L
Sbjct: 140 QVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL 199
Query: 264 GLLQEISLSH-NKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENN 322
LQ +SLS I+ ELG++ L+ L + G+ + +L L + +
Sbjct: 200 NYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL---KEALPHLQINCS 256
Query: 323 RLGNKIPEGLERLQNLTVLNLK 344
+ +N + +K
Sbjct: 257 HFTTIARPTIGNKKNQEIWGIK 278
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 8e-08
Identities = 40/250 (16%), Positives = 84/250 (33%), Gaps = 16/250 (6%)
Query: 166 QTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSG 225
QTLDL+ L + L + + + + + + + + L ++ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEV 60
Query: 226 SVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLS--HNKIVGPIPDE 283
S + ++ +LQ L+L+ ++ I +L K L ++LS +
Sbjct: 61 STLHGI----LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL 116
Query: 284 LGKLSKLQKLDLSYNAIGGSFPVTF-------TNITSLVSLNLENNRLGNKIPEGLERLQ 336
L S+L +L+LS+ V T +S +N + +
Sbjct: 117 LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN 176
Query: 337 NLTVLNLKNNQFKGHIPETIGNISGINQLDLSE-NDFTGEISPSLASLANLTSFNVSYNN 395
+ + + K + ++ + L LS D E L + L + V
Sbjct: 177 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIV 236
Query: 396 LSGSVPPLLS 405
G++ L
Sbjct: 237 PDGTLQLLKE 246
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 58.5 bits (140), Expect = 4e-10
Identities = 36/218 (16%), Positives = 67/218 (30%), Gaps = 17/218 (7%)
Query: 113 QLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSN 172
L K++ + + V + L + + F ++ +I + NL L+L +
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 173 NALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWG 232
N + P L+ + + +I + + + +N
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 233 VLAGNKSYQLQFLNL---------DHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDE 283
VL + + L + L L L + NKI P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 284 LGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLEN 321
L L L ++ L N I P N ++L + L N
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 49.3 bits (116), Expect = 4e-07
Identities = 22/64 (34%), Positives = 32/64 (50%), Gaps = 4/64 (6%)
Query: 109 EKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTL 168
++ L L L DN ++ P L LPNL V+L NN++S P + N NL +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 169 DLSN 172
L+N
Sbjct: 223 TLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 3e-06
Identities = 35/231 (15%), Positives = 75/231 (32%), Gaps = 23/231 (9%)
Query: 138 LPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197
L N + + ++ ++ + + + TL + + L L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 198 SLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIP 257
+ PL +L+ + + + + + ++
Sbjct: 74 QITDLAPLK-----NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128
Query: 258 VSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSL 317
+L L L + + + G + S S N++ L +L
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTNLQYL----------SIGNAQVSDLTPLANLSKLTTL 178
Query: 318 NLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLS 368
++N++ + P L L NL ++LKNNQ P + N S + + L+
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 9e-06
Identities = 19/83 (22%), Positives = 34/83 (40%), Gaps = 7/83 (8%)
Query: 270 SLSHNK-IVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKI 328
S++ I PD L+ K+ + + VT ++ + +L+ +
Sbjct: 2 SITQPTAINVIFPDP--ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT-- 55
Query: 329 PEGLERLQNLTVLNLKNNQFKGH 351
EG++ L NL L LK+NQ
Sbjct: 56 IEGVQYLNNLIGLELKDNQITDL 78
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 58.3 bits (139), Expect = 1e-09
Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 10/91 (10%)
Query: 122 LHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPP 181
+ N + + P+L + + NN+L +P P L+ L S N L +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHL-AEVPE 321
Query: 182 SLANSTRLYRLNLSYNSL--LGSIPLSLTRL 210
N L +L++ YN L IP S+ L
Sbjct: 322 LPQN---LKQLHVEYNPLREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 5e-08
Identities = 25/85 (29%), Positives = 38/85 (44%), Gaps = 9/85 (10%)
Query: 145 YLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIP 204
+ N S I P+L+ L++SNN LI +P RL RL S+N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNH-LAEVP 320
Query: 205 LSLTRLPSLSVLALQHNNLSGSVPN 229
+L L +++N L P+
Sbjct: 321 EL---PQNLKQLHVEYNPLR-EFPD 341
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 7e-08
Identities = 18/99 (18%), Positives = 34/99 (34%), Gaps = 14/99 (14%)
Query: 193 NLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLI 252
N+ I PSL L + +N L +P +L+ L N +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP--------RLERLIASFNHL 316
Query: 253 AGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQ 291
+P L +++ + +N + PD + L+
Sbjct: 317 -AEVPELPQNL---KQLHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 22/102 (21%), Positives = 36/102 (35%), Gaps = 16/102 (15%)
Query: 318 NLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEIS 377
N N+I + +L LN+ NN+ +P + +L S N E+
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVP 320
Query: 378 PSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQL 419
NL +V YN L P + V +L++
Sbjct: 321 E---LPQNLKQLHVEYNPLR-EFPDIPES-------VEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 3e-07
Identities = 19/90 (21%), Positives = 33/90 (36%), Gaps = 9/90 (10%)
Query: 271 LSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPE 330
N I L++L++S N + P L L N L ++PE
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHL-AEVPE 321
Query: 331 GLERLQNLTVLNLKNNQFKGHIPETIGNIS 360
QNL L+++ N + P+ ++
Sbjct: 322 LP---QNLKQLHVEYNPLRE-FPDIPESVE 347
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 2e-06
Identities = 18/96 (18%), Positives = 38/96 (39%), Gaps = 9/96 (9%)
Query: 219 QHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVG 278
N + +N + L+ LN+ +N + +P + L+ + S N +
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE 318
Query: 279 PIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSL 314
+P+ L++L + YN + FP ++ L
Sbjct: 319 -VPELPQ---NLKQLHVEYNPL-REFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.5 bits (98), Expect = 1e-04
Identities = 19/70 (27%), Positives = 25/70 (35%), Gaps = 5/70 (7%)
Query: 162 CPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHN 221
L+L+N L ++P + L L S NS L +P L SL V
Sbjct: 37 DRQAHELELNNLGL-SSLPELPPH---LESLVASCNS-LTELPELPQSLKSLLVDNNNLK 91
Query: 222 NLSGSVPNNW 231
LS P
Sbjct: 92 ALSDLPPLLE 101
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 5e-04
Identities = 18/66 (27%), Positives = 28/66 (42%), Gaps = 5/66 (7%)
Query: 140 NLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSL 199
+ L N LS S+P P+L++L S N+L +P + L N + +L
Sbjct: 39 QAHELELNNLGLS-SLPELP---PHLESLVASCNSL-TELPELPQSLKSLLVDNNNLKAL 93
Query: 200 LGSIPL 205
PL
Sbjct: 94 SDLPPL 99
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.9 bits (86), Expect = 0.003
Identities = 16/66 (24%), Positives = 26/66 (39%), Gaps = 5/66 (7%)
Query: 288 SKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQ 347
+ +L+L+ + S P L SL N L ++PE + L++L V N
Sbjct: 38 RQAHELELNNLGL-SSLP---ELPPHLESLVASCNSL-TELPELPQSLKSLLVDNNNLKA 92
Query: 348 FKGHIP 353
P
Sbjct: 93 LSDLPP 98
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.1 bits (138), Expect = 2e-09
Identities = 20/92 (21%), Positives = 35/92 (38%), Gaps = 5/92 (5%)
Query: 164 NLQTLDLSNNALIGAIPPSLANS-TRLYRLNLSYNSL----LGSIPLSLTRLPSLSVLAL 218
++Q+LD+ L A L + + L L I +L P+L+ L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 219 QHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHN 250
+ N L + S ++Q L+L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.7 bits (137), Expect = 3e-09
Identities = 23/142 (16%), Positives = 41/142 (28%), Gaps = 5/142 (3%)
Query: 313 SLVSLNLENNRLGNK-IPEGLERLQNLTVLNLKNNQFKG----HIPETIGNISGINQLDL 367
+ SL+++ L + E L LQ V+ L + I + + +L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 368 SENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQLCGYSPSTA 427
N+ + S + +L SS+ L S
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 428 CPSLAPLSLPPPPVEAPKHHHH 449
A L L + P+
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLE 144
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.3 bits (136), Expect = 4e-09
Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 10/91 (10%)
Query: 117 LRKLSLHDN-LLAGPVPWSLGFLPNLRGVYLFNNRLSG----SIPPSIGNCPNLQTLDLS 171
++ L + L L L + V L + L+ I ++ P L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 172 NNALIGAIPPSLA-----NSTRLYRLNLSYN 197
+N L + S ++ +L+L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.3 bits (136), Expect = 4e-09
Identities = 15/97 (15%), Positives = 30/97 (30%), Gaps = 5/97 (5%)
Query: 140 NLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNAL----IGAIPPSLANSTRLYRLNL 194
+++ + + LS + + Q + L + L I +L + L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 195 SYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNW 231
N L + + +Q +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (131), Expect = 1e-08
Identities = 15/85 (17%), Positives = 29/85 (34%), Gaps = 9/85 (10%)
Query: 308 FTNITSLVSLNLENNRLGNK----IPEGLERLQNLTVLNLKNNQFKGHIPETIG-----N 358
+ L L L + + + + L +L L+L NN +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 359 ISGINQLDLSENDFTGEISPSLASL 383
+ QL L + ++ E+ L +L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.4 bits (131), Expect = 2e-08
Identities = 17/89 (19%), Positives = 35/89 (39%), Gaps = 13/89 (14%)
Query: 266 LQEISLSHNKI----VGPIPDELGKLSKLQKLDLSYNAIGGSFPVTF-----TNITSLVS 316
L+ + L+ + + L L++LDLS N +G + + L
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 317 LNLENNRLGNKIPEGLERLQ----NLTVL 341
L L + ++ + L+ L+ +L V+
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.0 bits (130), Expect = 2e-08
Identities = 24/91 (26%), Positives = 36/91 (39%), Gaps = 13/91 (14%)
Query: 139 PNLRGVYLFNNRLSG----SIPPSIGNCPNLQTLDLSNNALIGAIPPSLA-----NSTRL 189
LR ++L + +S S+ ++ +L+ LDLSNN L A L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 190 YRLNLSYNSLLGSIPLSLTRL----PSLSVL 216
+L L + L L PSL V+
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 4e-08
Identities = 16/99 (16%), Positives = 33/99 (33%), Gaps = 10/99 (10%)
Query: 266 LQEISLSHNKIV-GPIPDELGKLSKLQKLDLSYNAIGG----SFPVTFTNITSLVSLNLE 320
+Q + + ++ + L L + Q + L + +L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 321 NNRLGNKIPEGLERL-----QNLTVLNLKNNQFKGHIPE 354
+N LG+ + + + L+L+N G
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 102
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 2e-07
Identities = 17/93 (18%), Positives = 29/93 (31%), Gaps = 5/93 (5%)
Query: 239 SYQLQFLNLDHNLIAGTIPVSL-GKLGLLQEISLSHNKI----VGPIPDELGKLSKLQKL 293
S +Q L++ ++ L L Q + L + I L L +L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 294 DLSYNAIGGSFPVTFTNITSLVSLNLENNRLGN 326
+L N +G S ++ L N
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 8e-07
Identities = 19/81 (23%), Positives = 32/81 (39%), Gaps = 9/81 (11%)
Query: 288 SKLQKLDLSYNAIGG----SFPVTFTNITSLVSLNLENNRLGNKIPEGL-ERLQN----L 338
S L+ L L+ + S T SL L+L NN LG+ L E ++ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 339 TVLNLKNNQFKGHIPETIGNI 359
L L + + + + + +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 2e-06
Identities = 16/83 (19%), Positives = 26/83 (31%), Gaps = 4/83 (4%)
Query: 185 NSTRLYRLNLSYNSL----LGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSY 240
+ L L L+ + S+ +L SL L L +N L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 241 QLQFLNLDHNLIAGTIPVSLGKL 263
L+ L L + + L L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 5e-05
Identities = 14/80 (17%), Positives = 21/80 (26%), Gaps = 9/80 (11%)
Query: 336 QNLTVLNLKNNQFKG----HIPETIGNISGINQLDLSENDFTGEISPSLAS-----LANL 386
L VL L + + T+ + +LDLS N L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 387 TSFNVSYNNLSGSVPPLLSK 406
+ S + L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 6e-05
Identities = 16/79 (20%), Positives = 26/79 (32%), Gaps = 9/79 (11%)
Query: 115 HALRKLSLHDNLL----AGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIG-----NCPNL 165
LR L L D + + +L +LR + L NN L + + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 166 QTLDLSNNALIGAIPPSLA 184
+ L L + + L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQ 447
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 1e-04
Identities = 21/85 (24%), Positives = 35/85 (41%), Gaps = 8/85 (9%)
Query: 211 PSLSVLALQHNNLSGSVPNNWG-VLAGNKSYQLQFLNLDHNLIAGTIPVSLGK-----LG 264
L VL L ++S S ++ L N S L+ L+L +N + + L +
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHS--LRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 265 LLQEISLSHNKIVGPIPDELGKLSK 289
LL+++ L + D L L K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.0 bits (124), Expect = 9e-09
Identities = 32/109 (29%), Positives = 46/109 (42%), Gaps = 6/109 (5%)
Query: 243 QFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGG 302
+ L+L H + T+ L +L L+ + LSHN++ P L L L+ L S NA+
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 303 SFPVTFTNITSLVSLNLENNRLGN-KIPEGLERLQNLTVLNLKNNQFKG 350
V L L NNRL + L L +LNL+ N
Sbjct: 58 VDGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 9e-07
Identities = 21/104 (20%), Positives = 38/104 (36%), Gaps = 24/104 (23%)
Query: 317 LNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIP---------------------ET 355
L+L + L + LE+L +T L+L +N+ + P +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 356 IGNISGINQLDLSENDFTGEISP-SLASLANLTSFNVSYNNLSG 398
+ N+ + +L L N + L S L N+ N+L
Sbjct: 61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 26/106 (24%), Positives = 38/106 (35%), Gaps = 24/106 (22%)
Query: 142 RGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIP--------------------- 180
R ++L + L+ + + + LDLS+N L P
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 181 PSLANSTRLYRLNLSYNSLLG-SIPLSLTRLPSLSVLALQHNNLSG 225
+AN RL L L N L + L P L +L LQ N+L
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.2 bits (101), Expect = 1e-05
Identities = 33/131 (25%), Positives = 54/131 (41%), Gaps = 14/131 (10%)
Query: 215 VLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHN 274
VL L H +L+ V + L + L+L HN + P +L L L+ + S N
Sbjct: 2 VLHLAHKDLT--VLCHLEQLL-----LVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN 53
Query: 275 KIVGPIPDELGKLSKLQKLDLSYNAI-GGSFPVTFTNITSLVSLNLENNRL---GNKIPE 330
+ D + L +LQ+L L N + + + LV LNL+ N L
Sbjct: 54 AL--ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 111
Query: 331 GLERLQNLTVL 341
E L +++ +
Sbjct: 112 LAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 4e-05
Identities = 22/92 (23%), Positives = 31/92 (33%), Gaps = 24/92 (26%)
Query: 109 EKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRG----------------------VYL 146
+ QL + L L N L P +L L L + L
Sbjct: 14 CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANLPRLQELLL 72
Query: 147 FNNRL-SGSIPPSIGNCPNLQTLDLSNNALIG 177
NNRL + + +CP L L+L N+L
Sbjct: 73 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.0 bits (121), Expect = 4e-08
Identities = 30/159 (18%), Positives = 56/159 (35%), Gaps = 18/159 (11%)
Query: 193 NLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLI 252
L + + L +++ S AL L + L LN ++
Sbjct: 3 ELKPEQV-EQLKLIMSKRYDGSQQALDLKGL-----RSDPDLVAQN--IDVVLNRRSSMA 54
Query: 253 AGTIPVSLGKLGLLQEISLSHNKIVG--PIPDELGKLSKLQKLDLSYNAIGGSFPVTFTN 310
A T+ + + L ++LS+N++ + + K L+ L+LS N + +
Sbjct: 55 A-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIK 113
Query: 311 ITSLVSLNLENNRLGNKIPEG-------LERLQNLTVLN 342
L L L+ N L + + ER L L+
Sbjct: 114 GLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.8 bits (118), Expect = 1e-07
Identities = 32/158 (20%), Positives = 62/158 (39%), Gaps = 15/158 (9%)
Query: 106 RISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFN-----NRLSGSIPPSIG 160
++ +S+ + + +L L P+L + + ++ ++
Sbjct: 11 QLKLIMSKRYDGSQQALDLK--------GLRSDPDLVAQNIDVVLNRRSSMAATLRIIEE 62
Query: 161 NCPNLQTLDLSNNAL--IGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLAL 218
N P L +L+LSNN L + + + + L LNLS N L L + L L L
Sbjct: 63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 122
Query: 219 QHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTI 256
N+LS + + ++ + + L LD + + I
Sbjct: 123 DGNSLSDTFRDQSTYISAIRERFPKLLRLDGHELPPPI 160
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.9 bits (113), Expect = 5e-07
Identities = 25/124 (20%), Positives = 47/124 (37%), Gaps = 5/124 (4%)
Query: 256 IPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLV 315
+ + + K + +L + +L + L+ + + + NI L+
Sbjct: 12 LKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELL 68
Query: 316 SLNLENNRLGNK--IPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFT 373
SLNL NNRL + +++ NL +LNL N+ K + +L L N +
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 374 GEIS 377
Sbjct: 129 DTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (110), Expect = 1e-06
Identities = 24/131 (18%), Positives = 40/131 (30%), Gaps = 5/131 (3%)
Query: 234 LAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKL 293
L +K Y LD + L + ++ + + + +L L
Sbjct: 14 LIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSL 70
Query: 294 DLSYNAIGG--SFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGH 351
+LS N + +L LNL N L ++ + L L L N
Sbjct: 71 NLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT 130
Query: 352 IPETIGNISGI 362
+ IS I
Sbjct: 131 FRDQSTYISAI 141
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (100), Expect = 3e-05
Identities = 22/133 (16%), Positives = 41/133 (30%), Gaps = 6/133 (4%)
Query: 271 LSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPE 330
L ++ + + K + L + V LN ++ +
Sbjct: 4 LKPEQV-EQLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMA-ATLRI 59
Query: 331 GLERLQNLTVLNLKNNQFKGH--IPETIGNISGINQLDLSENDFTGEISPSLASLANLTS 388
E + L LNL NN+ + + + L+LS N+ E L
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119
Query: 389 FNVSYNNLSGSVP 401
+ N+LS +
Sbjct: 120 LWLDGNSLSDTFR 132
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 51.0 bits (120), Expect = 8e-08
Identities = 44/218 (20%), Positives = 70/218 (32%), Gaps = 40/218 (18%)
Query: 161 NCP-----NLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSV 215
+CP T+D + L IP + T L L+ N
Sbjct: 1 DCPAMCHCEGTTVDCTGRGLK-EIPRDIPLHTT--ELLLNDNE----------------- 40
Query: 216 LALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNK 275
S + L + + Q ++ N G + QE+ L NK
Sbjct: 41 ---LGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI--------QELQLGENK 89
Query: 276 IVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERL 335
I L +L+ L+L N I P +F ++ SL SLNL +N N
Sbjct: 90 IKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNP-FNCNCHLAWFA 148
Query: 336 QNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFT 373
+ L +L + P + + DL ++F
Sbjct: 149 EWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.4 bits (103), Expect = 1e-05
Identities = 36/216 (16%), Positives = 65/216 (30%), Gaps = 35/216 (16%)
Query: 142 RGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLG 201
V L IP I + L L++N L L
Sbjct: 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLP------------- 54
Query: 202 SIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLG 261
L L + A + +Q L L N I
Sbjct: 55 ---------------HLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFL 99
Query: 262 KLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLEN 321
L L+ ++L N+I +P L+ L L+L+ N + + + L +L
Sbjct: 100 GLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNG 158
Query: 322 NRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIG 357
P +++++ + +L +++FK + G
Sbjct: 159 GAARCGAP---SKVRDVQIKDLPHSEFKCSSENSEG 191
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (116), Expect = 2e-07
Identities = 24/140 (17%), Positives = 39/140 (27%), Gaps = 4/140 (2%)
Query: 157 PSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVL 216
N + LDL I I A + ++ S N + L L L
Sbjct: 12 AQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 68
Query: 217 ALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKI 276
+ +N + L L +L L SL L L +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSL-VELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 277 VGPIPDELGKLSKLQKLDLS 296
+ K+ +++ LD
Sbjct: 128 KHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (100), Expect = 2e-05
Identities = 14/87 (16%), Positives = 32/87 (36%), Gaps = 3/87 (3%)
Query: 287 LSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNN 346
+ ++LDL I + +++ +N + + +G L+ L L + NN
Sbjct: 17 AVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNN 73
Query: 347 QFKGHIPETIGNISGINQLDLSENDFT 373
+ + + +L L+ N
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (100), Expect = 3e-05
Identities = 20/132 (15%), Positives = 41/132 (31%), Gaps = 4/132 (3%)
Query: 138 LPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197
R + L ++ I +D S+N + RL L ++ N
Sbjct: 17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNNN 73
Query: 198 SLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIP 257
+ LP L+ L L +N+L + + + + L L
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 258 VSLGKLGLLQEI 269
+ K+ ++ +
Sbjct: 133 YVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 0.001
Identities = 17/131 (12%), Positives = 39/131 (29%), Gaps = 4/131 (3%)
Query: 307 TFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLD 366
+TN L+L ++ I L ++ +N+ + + + L
Sbjct: 13 QYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLL 69
Query: 367 LSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFVGNLQLCGYSPST 426
++ N +L +LT ++ N+L + L S + +
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 427 ACPSLAPLSLP 437
+P
Sbjct: 129 HYRLYVIYKVP 139
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.001
Identities = 10/35 (28%), Positives = 15/35 (42%), Gaps = 1/35 (2%)
Query: 266 LQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAI 300
+E+ L KI I + L + +D S N I
Sbjct: 20 DRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI 53
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 49.2 bits (116), Expect = 4e-07
Identities = 36/194 (18%), Positives = 59/194 (30%), Gaps = 15/194 (7%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171
K +L + V + L ++ + N+ + I PN+ L L+
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76
Query: 172 NNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLT---------RLPSLSVLALQHNN 222
N L P + + L+ + L S+ + ++ L
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 223 LSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPD 282
S + NN S + L + V L L LQ + LS N I
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LR 194
Query: 283 ELGKLSKLQKLDLS 296
L L L L+L
Sbjct: 195 ALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 9e-06
Identities = 28/208 (13%), Positives = 60/208 (28%), Gaps = 23/208 (11%)
Query: 154 SIPPSIG------NCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSL 207
++P I +L ++ A+ + NS + ++ + + + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNS--IDQIIANNSDIKSVQGIQ- 65
Query: 208 TRLPSLSVLALQHNNLSGS----------VPNNWGVLAGNKSYQLQFLNLDHNLIAGTIP 257
LP+++ L L N L+ + S L +
Sbjct: 66 -YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 258 VSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSL 317
+ L L ++ + + + +T L +L
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNL 183
Query: 318 NLENNRLGNKIPEGLERLQNLTVLNLKN 345
L N + + L L+NL VL L +
Sbjct: 184 YLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 2e-05
Identities = 14/72 (19%), Positives = 31/72 (43%), Gaps = 6/72 (8%)
Query: 280 IPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLT 339
D+ ++ K +L ++ VT + S+ + N+ + + +G++ L N+T
Sbjct: 18 FSDD--AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKS--VQGIQYLPNVT 71
Query: 340 VLNLKNNQFKGH 351
L L N+
Sbjct: 72 KLFLNGNKLTDI 83
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 11/41 (26%), Positives = 18/41 (43%), Gaps = 2/41 (4%)
Query: 132 PWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSN 172
L L L+ +YL N +S ++ NL L+L +
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 28/178 (15%), Positives = 57/178 (32%), Gaps = 21/178 (11%)
Query: 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAI 300
+ NL + V+ +L + +I +++ I + L + KL L+ N +
Sbjct: 25 ETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKL 80
Query: 301 GG---------------SFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKN 345
+ L++ L + + L +L L
Sbjct: 81 TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLY 140
Query: 346 NQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVPPL 403
T+ + E++ +I P LA L L + +S N++S + L
Sbjct: 141 LGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHIS-DLRAL 196
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.8 bits (109), Expect = 3e-06
Identities = 25/212 (11%), Positives = 60/212 (28%), Gaps = 1/212 (0%)
Query: 136 GFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLS 195
N + +L + +L+ +++S N ++ I + ++
Sbjct: 26 DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85
Query: 196 YNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGT 255
+ ++ L +N + + + L + N+
Sbjct: 86 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI-QDNINIHTIE 144
Query: 256 IPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLV 315
+G + L+ N I + N + F + V
Sbjct: 145 RNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 204
Query: 316 SLNLENNRLGNKIPEGLERLQNLTVLNLKNNQ 347
L++ R+ + GLE L+ L + N +
Sbjct: 205 ILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 5e-06
Identities = 32/231 (13%), Positives = 65/231 (28%), Gaps = 8/231 (3%)
Query: 140 NLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSL 199
+ R ++++ IP + N L L + + L ++ +S N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 200 LGSI--PLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIP 257
L I + + + NNL P + L + + + H I
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 258 VSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSL 317
L +I + N +G + L L+ N I F
Sbjct: 126 SLQKV---LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELN 182
Query: 318 NLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLS 368
+NN L + +L++ + + N+ +
Sbjct: 183 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (103), Expect = 2e-05
Identities = 16/94 (17%), Positives = 26/94 (27%), Gaps = 10/94 (10%)
Query: 120 LSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAI 179
L L+ N + + NN L LD+S +
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 180 PPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSL 213
L N +L + +L +LP+L
Sbjct: 218 SYGLENLKKLRARSTY----------NLKKLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 5e-05
Identities = 36/248 (14%), Positives = 66/248 (26%), Gaps = 8/248 (3%)
Query: 156 PPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSV 215
I +C + + + + IP L + L L + + L
Sbjct: 2 HHRICHC-SNRVFLCQESKVT-EIPSDLPRNAI--ELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 216 LALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNK 275
+ + N++ + + + I +L IS + K
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPN-LQYLLISNTGIK 116
Query: 276 IVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERL 335
+ + L + + N V L L N +
Sbjct: 117 HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGT 176
Query: 336 QNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNN 395
Q + NN + + SG LD+S S L +L L + + N
Sbjct: 177 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YN 234
Query: 396 LSGSVPPL 403
L +P L
Sbjct: 235 LK-KLPTL 241
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 2e-05
Identities = 18/72 (25%), Positives = 31/72 (43%), Gaps = 6/72 (8%)
Query: 280 IPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLT 339
D L++ K L + V+ T++ + +L + + K +G+E L NLT
Sbjct: 12 FTDT--ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLT 65
Query: 340 VLNLKNNQFKGH 351
+N NNQ
Sbjct: 66 QINFSNNQLTDI 77
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 5e-05
Identities = 32/191 (16%), Positives = 54/191 (28%), Gaps = 15/191 (7%)
Query: 112 SQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS 171
+ L K L + V S L + + + SI + NL ++ S
Sbjct: 15 TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFS 70
Query: 172 NNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNW 231
NN L P +N + + + + + N
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130
Query: 232 GVLA---------GNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPD 282
L S L+ + T L L L+ + +S NK+
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--IS 188
Query: 283 ELGKLSKLQKL 293
L KL+ L+ L
Sbjct: 189 VLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 37/204 (18%), Positives = 68/204 (33%), Gaps = 21/204 (10%)
Query: 138 LPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197
L L ++ ++ + + + TL I +I + L ++N S N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLG-IKSIDG-VEYLNNLTQINFSNN 72
Query: 198 SLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIP 257
L PL +L+ L N + N + F N ++
Sbjct: 73 QLTDITPLK-----NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 127
Query: 258 VSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSL 317
+L +L L + + G + S Q DL N+T+L L
Sbjct: 128 TNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLK----------PLANLTTLERL 177
Query: 318 NLENNRLGNKIPEGLERLQNLTVL 341
++ +N++ + L +L NL L
Sbjct: 178 DISSNKVSD--ISVLAKLTNLESL 199
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.9 bits (104), Expect = 2e-05
Identities = 17/90 (18%), Positives = 30/90 (33%), Gaps = 8/90 (8%)
Query: 266 LQEISLSHNKI----VGPIPDELGKLSKLQKLDLSYNAIGG----SFPVTFTNITSLVSL 317
++ SL + I + L + ++++ LS N IG + L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 318 NLENNRLGNKIPEGLERLQNLTVLNLKNNQ 347
+ G E E L+ L LK +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPK 94
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.5 bits (103), Expect = 3e-05
Identities = 14/87 (16%), Positives = 28/87 (32%), Gaps = 12/87 (13%)
Query: 271 LSHNKIVGPIPDELG------KLSKLQKLDLSYNAIGGS-----FPVTFTNITSLVSLNL 319
L+ + + + LQ L L YN I V + L+ L L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 320 ENNRLGNKIPEGLERLQNLTVLNLKNN 346
NR + + ++ ++ + +
Sbjct: 310 NGNRFS-EEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.7 bits (101), Expect = 5e-05
Identities = 15/91 (16%), Positives = 25/91 (27%), Gaps = 13/91 (14%)
Query: 145 YLFNNRLSGSIPPSIGNC------PNLQTLDLSNNALIGAIPPSLA-----NSTRLYRLN 193
L + LS ++ + LQTL L N + +L L L
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 194 LSYNSLLGSIPLSLTRLPSLSVLALQHNNLS 224
L+ N + + + L
Sbjct: 309 LNGNR-FSEEDDVVDEIREV-FSTRGRGELD 337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.8 bits (96), Expect = 2e-04
Identities = 9/68 (13%), Positives = 25/68 (36%), Gaps = 8/68 (11%)
Query: 140 NLRGVYLFNNRLSG----SIPPSIGNCPNLQTLDLSNNAL----IGAIPPSLANSTRLYR 191
++ G L + ++ S+ + +++ + LS N + + ++A+ L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 192 LNLSYNSL 199
S
Sbjct: 64 AEFSDIFT 71
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 5e-04
Identities = 14/90 (15%), Positives = 30/90 (33%), Gaps = 5/90 (5%)
Query: 242 LQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKI----VGPIPDELGKLSKLQKLDLSY 297
L+ + ++ L + ++EI LS N I + + + L+ + S
Sbjct: 10 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 298 NAIGGSFPVTFTNITSLVSLNLENNRLGNK 327
G + L+ L+ +L
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTV 98
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 7e-04
Identities = 16/76 (21%), Positives = 30/76 (39%), Gaps = 11/76 (14%)
Query: 307 TFTNITSLVSLNLENNRLGNKIPEGL-----ERLQNLTVLNLKNNQFK--GHIPETIGNI 359
+ L +L L+ N + L E++ +L L L N+F + + I +
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327
Query: 360 ---SGINQLD-LSEND 371
G +LD L + +
Sbjct: 328 FSTRGRGELDELDDME 343
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 0.001
Identities = 16/85 (18%), Positives = 30/85 (35%), Gaps = 8/85 (9%)
Query: 218 LQHNNLSGSVPNNWG-VLAGNKSYQLQFLNLDHNLIAGTIPVSL-----GKLGLLQEISL 271
L LS + ++ LQ L L +N I +L K+ L + L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 272 SHNKI--VGPIPDELGKLSKLQKLD 294
+ N+ + DE+ ++ +
Sbjct: 310 NGNRFSEEDDVVDEIREVFSTRGRG 334
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 9/69 (13%), Positives = 20/69 (28%), Gaps = 7/69 (10%)
Query: 132 PWSLGFLPNLRGVYLFNNRLSGSIPPSI-----GNCPNLQTLDLSNNAL--IGAIPPSLA 184
+S L+ + L N + ++ P+L L+L+ N + +
Sbjct: 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIR 325
Query: 185 NSTRLYRLN 193
Sbjct: 326 EVFSTRGRG 334
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 2e-04
Identities = 13/76 (17%), Positives = 23/76 (30%), Gaps = 2/76 (2%)
Query: 157 PSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTR-LPSLSV 215
P L + + + L + L L + L + L R L L
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 216 LALQHNNLSGSVPNNW 231
L + + L P+ +
Sbjct: 61 LTIVKSGLRFVAPDAF 76
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 2e-04
Identities = 21/115 (18%), Positives = 33/115 (28%), Gaps = 5/115 (4%)
Query: 140 NLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPP-SLANSTRLYRLNLSYNS 198
G+ + + NL L + N + + L L L + +
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 199 LLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQ--FLNLDHNL 251
L P + P LS L L N L S+ + L L+ L
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCAL 121
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.001
Identities = 27/102 (26%), Positives = 40/102 (39%), Gaps = 2/102 (1%)
Query: 131 VPWSLGFLPNLRGVYLFNNRLSGSIPPSI-GNCPNLQTLDLSNNALIGAIPPSLANSTRL 189
L NL +Y+ N + + L+ L + + L P + + RL
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 190 YRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNW 231
RLNLS+N+L S+ + SL L L N L S W
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRW 123
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (83), Expect = 0.003
Identities = 18/114 (15%), Positives = 37/114 (32%), Gaps = 3/114 (2%)
Query: 312 TSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIP-ETIGNISGINQLDLSEN 370
L + + L +NLT L ++N Q H+ + + + L + ++
Sbjct: 8 HGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 371 DFTGEISPSLASLANLTSFNVSYNNLSGSVPPLLSKKFNSSSFV-GNLQLCGYS 423
+ L+ N+S+N L + + GN C +
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 773 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.71 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.68 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.61 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.6 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.57 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.56 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.48 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.47 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.28 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.26 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.22 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.61 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.46 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.96 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.83 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.82 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.57 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.36 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.35 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.26 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.75 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.18 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.19 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.2e-43 Score=374.15 Aligned_cols=293 Identities=31% Similarity=0.510 Sum_probs=217.0
Q ss_pred ccCHHHHHHHHHHHHhCCCCCCCcCCCCCCCCCCCCCCCcceEeeC----CCEEEEEcCCCCccc--ccCccccCCCCCc
Q 041878 45 IVTQADYQSLRAIKHDLIDPHGFLRSWNDSGVGACSGGWAGIKCVK----GQVIAIQLPWRRLGG--RISEKISQLHALR 118 (773)
Q Consensus 45 ~~~~~~~~~L~~~k~~~~~~~~~l~sW~~~~~~~c~~~w~gv~c~~----~~v~~l~l~~~~l~~--~i~~~l~~l~~L~ 118 (773)
-|.++|++||++||+++.|| ..+++|.. +.|||.+.|.||+|+. +||+.|+|++++++| .+|+.+++|++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~-~~l~sW~~-~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNP-TTLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCC-GGGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHHCCCC-CcCCCCCC-CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 49999999999999999988 46899965 6788865699999953 379999999999988 5789999999999
Q ss_pred EEEccC-CcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccc
Q 041878 119 KLSLHD-NLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197 (773)
Q Consensus 119 ~L~L~~-n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N 197 (773)
+|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+++++++|.+.+.+|..+.++++|+++++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 999986 7899999999999999999999999999888888899999999999999988888889999999999999999
Q ss_pred cccccCCccccCCCcc-ceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcc
Q 041878 198 SLLGSIPLSLTRLPSL-SVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKI 276 (773)
Q Consensus 198 ~l~~~~~~~l~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l 276 (773)
.+.+.+|..+..+.++ +.+++++|++++..|..+..+. +..+++.+|.+.+.+|..+..+++|+.+++++|.+
T Consensus 160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~------~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l 233 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN------LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC------CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEE
T ss_pred ccccccccccccccccccccccccccccccccccccccc------ccccccccccccccccccccccccccccccccccc
Confidence 9888888888887765 7788888888877766554432 34455555555555555555555555555555555
Q ss_pred cCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCccccccccccc
Q 041878 277 VGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETI 356 (773)
Q Consensus 277 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~ 356 (773)
.+.+| .+..++ +|+.|+|++|++++.+|..++.+++|++|+|++|+|+|.+|+ +
T Consensus 234 ~~~~~-~~~~~~------------------------~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~ 287 (313)
T d1ogqa_ 234 AFDLG-KVGLSK------------------------NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-G 287 (313)
T ss_dssp CCBGG-GCCCCT------------------------TCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-S
T ss_pred ccccc-cccccc------------------------ccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-c
Confidence 54332 344444 444555555555444555555555555555555555555543 3
Q ss_pred CCCCcCceeecCCcc
Q 041878 357 GNISGINQLDLSEND 371 (773)
Q Consensus 357 ~~l~~L~~L~L~~N~ 371 (773)
+++++|+.+++++|+
T Consensus 288 ~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 288 GNLQRFDVSAYANNK 302 (313)
T ss_dssp TTGGGSCGGGTCSSS
T ss_pred ccCCCCCHHHhCCCc
Confidence 455555555555554
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=359.94 Aligned_cols=210 Identities=26% Similarity=0.420 Sum_probs=180.1
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||+||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++. .++..++|||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~~~ivmE 86 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-DATRVYLILE 86 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEEE
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-ECCEEEEEEe
Confidence 456789999999999999875 6899999998643 2334678899999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.+.. .+++..+..++.||++||+||| ++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 87 y~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH-~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--- 159 (263)
T d2j4za1 87 YAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--- 159 (263)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---
T ss_pred ecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH-HCCeeeeeeccccceecCCCCEeecccceeeecCCC---
Confidence 999999999998754 3899999999999999999999 999999999999999999999999999999765432
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhhh
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEW 757 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 757 (773)
......||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+ ..+..+++.+..+
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~ 221 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISRVEF 221 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCC
T ss_pred cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCC
Confidence 2234579999999999999999999999999999999999999997644 3444445544443
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=366.33 Aligned_cols=198 Identities=24% Similarity=0.421 Sum_probs=175.8
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|...+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|++++++++||||+++++++.. .+..|+||||++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmEy~~ 100 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLA 100 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEECCT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-CCEEEEEEEecC
Confidence 34568899999999999986 4799999999986666667889999999999999999999999954 558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.+. .++..++..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+....... ...
T Consensus 101 gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH-~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~ 174 (293)
T d1yhwa1 101 GGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRS 174 (293)
T ss_dssp TCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBC
T ss_pred CCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-ccc
Confidence 99999988764 3789999999999999999999 99999999999999999999999999999987654332 233
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+
T Consensus 175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 4569999999999999999999999999999999999999997644
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=362.92 Aligned_cols=197 Identities=26% Similarity=0.482 Sum_probs=162.0
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
...+.||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++||||++++|++ ..++..++||||+++|
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~-~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC-LEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSCEEEEECCTTC
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCccccccee-ccCCceEEEEEecCCC
Confidence 3467899999999999999888899999997543 3467899999999999999999999999 4556899999999999
Q ss_pred CHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeec
Q 041878 618 SLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697 (773)
Q Consensus 618 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 697 (773)
+|.+++.... ..+++..+..++.|||.||+||| +++|+||||||+|||+++++.+||+|||+++.............
T Consensus 86 ~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH-~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 162 (263)
T d1sm2a_ 86 CLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE-EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162 (263)
T ss_dssp BHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH-HTTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred cHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhh-ccceeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence 9999987653 44789999999999999999999 99999999999999999999999999999987765544444455
Q ss_pred cCccccccccccCCCCCCcchhhHHHHHHHHHHHcC-CCCCCC
Q 041878 698 AGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTG-KSPGEP 739 (773)
Q Consensus 698 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg-~~P~~~ 739 (773)
.||+.|||||++.+..|+.++|||||||++|||+|+ +.||..
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~ 205 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence 789999999999999999999999999999999995 555544
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=361.23 Aligned_cols=201 Identities=23% Similarity=0.357 Sum_probs=171.0
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.+.||+|+||+||+|... +|+.||||++..... ...+.+.+|++++++++||||+++++++.. ++..|+||||+
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-~~~~~ivmEy~ 85 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CceeEEEEecc
Confidence 345689999999999999864 789999999975432 334678999999999999999999999954 55899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc-cc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN-TN 693 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 693 (773)
++|+|.++++.. ..+++..+..++.||+.||+||| ++||+||||||+|||+++++.+||+|||+|+....... ..
T Consensus 86 ~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH-~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 86 SGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp TTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred CCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH-HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 999999999764 34899999999999999999999 99999999999999999999999999999987654332 22
Q ss_pred eeeccCccccccccccCCCCC-CcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.....||+.|||||++.+..+ +.++||||+||++|||+||+.||.....
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence 334579999999999987776 5789999999999999999999976543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-43 Score=363.83 Aligned_cols=203 Identities=23% Similarity=0.376 Sum_probs=175.6
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.+.||+|+||+||+|... +|+.||||+++.......+.+.+|++++++++|||||++++++. .++..++||||++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~lvmEy~~ 92 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-YENNLWILIEFCA 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEEECCT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-eCCeEEEEEecCC
Confidence 345688999999999999864 68999999998776667788999999999999999999999995 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.+.. ..+++.++..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+....... ...
T Consensus 93 ~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH-~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~~ 168 (288)
T d2jfla1 93 GGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLH-DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD 168 (288)
T ss_dssp TEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HHT
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-ccc
Confidence 999999987653 34899999999999999999999 99999999999999999999999999999976543321 222
Q ss_pred eccCccccccccccC-----CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSK-----LKNANTKTDVYSLGVIILELLTGKSPGEPMNGMD 744 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~-----~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~ 744 (773)
...||+.|||||++. ...|+.++||||+||++|||+||+.||.+.+..+
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~ 222 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR 222 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH
Confidence 456999999999873 4568999999999999999999999998765433
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=362.80 Aligned_cols=197 Identities=29% Similarity=0.503 Sum_probs=164.9
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.+.||+|+||+||+|+.+ ..||||+++.. .....++|.+|++++++++|||||++++++. . +..++||||++
T Consensus 11 ~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~-~~~~lv~Ey~~ 86 (276)
T d1uwha_ 11 TVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-A-PQLAIVTQWCE 86 (276)
T ss_dssp CCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S-SSCEEEEECCC
T ss_pred EEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-c-cEEEEEEecCC
Confidence 45689999999999999865 36999999754 3344678999999999999999999999883 3 36899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc-cce
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN-TNV 694 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 694 (773)
+|+|.+++.... ..+++..+..++.||++||+||| +++||||||||+|||++.++.+||+|||+|+....... ...
T Consensus 87 ~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH-~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 87 GSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLH-AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp EEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred CCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHh-cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 999999997653 34899999999999999999999 89999999999999999999999999999987654332 223
Q ss_pred eeccCccccccccccCC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKL---KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....||+.|||||++.. ..|+.++|||||||++|||+||+.||.+.+
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence 34579999999998854 358899999999999999999999997654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=363.34 Aligned_cols=197 Identities=26% Similarity=0.438 Sum_probs=171.5
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.+.+.||+|+||+||+|.+++++.||||+++... ...++|.+|++++++++|||||+++|++. . +..++||||+++
T Consensus 15 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q-EPIYIITEYMEN 91 (272)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S-SSCEEEEECCTT
T ss_pred eEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-c-CCeEEEEEeCCC
Confidence 45678999999999999999888899999997543 34678999999999999999999999883 3 367999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
|+|.+++.... ...+++..+++++.||++||+||| +++|+||||||+|||+++++.+||+|||+|+............
T Consensus 92 g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH-~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (272)
T d1qpca_ 92 GSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (272)
T ss_dssp CBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred CcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCccchhheeeecccceeeccccceEEccCCccccccc
Confidence 99999876543 223899999999999999999999 8999999999999999999999999999999876544333344
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGE 738 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~ 738 (773)
..||+.|||||++.+..++.++|||||||++|||+||+.|+.
T Consensus 170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 568999999999998899999999999999999999766543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-43 Score=362.31 Aligned_cols=213 Identities=24% Similarity=0.400 Sum_probs=178.6
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++. .++..|+|||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~ivmE 88 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-DDEKLYFGLS 88 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-CSSEEEEEEC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-ECCEEEEEEE
Confidence 45678999999999999987 47899999999643 2334577999999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc-
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN- 691 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~- 691 (773)
|+++|+|.+++...+ .+++..+..++.|++.||+||| +.+||||||||+|||+++++.+||+|||+|+.......
T Consensus 89 y~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH-~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred ccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhc-cccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 999999999988764 3889999999999999999999 99999999999999999999999999999987754332
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhhh
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEW 757 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 757 (773)
.......||+.|||||++.+..|+.++||||+||++|||+||+.||...+ ..+...++.+..+
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~~~ 227 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EYLIFQKIIKLEY 227 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHTTCC
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HHHHHHHHHcCCC
Confidence 22334579999999999999999999999999999999999999997654 3344445554443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=360.59 Aligned_cols=214 Identities=22% Similarity=0.363 Sum_probs=167.6
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECC-CCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-KGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~~lV~e 612 (773)
|.+.+.||+|+||+||+|.. .+|+.||||.+.... ....+.+.+|++++++++||||+++++++.+. .+..|+|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 34568999999999999986 478999999997543 23346789999999999999999999998654 346799999
Q ss_pred ecCCCCHHHHHhhcC-CCCccCHHHHHHHHHHHHHHHHHhccCCC-----ceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 613 FMPKGSLASFLHARG-PETIVNWATRMSIAIGIARGLNYLHVEEN-----MIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~al~yLH~~~~-----iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
|+++|+|.+++.+.. ....+++..++.++.||+.||+||| +++ ||||||||+|||++.++.+||+|||+|+..
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH-~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH-RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH-HHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH-HhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 999999999987542 2345899999999999999999999 644 999999999999999999999999999876
Q ss_pred ccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHh
Q 041878 687 TAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKE 755 (773)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 755 (773)
..... ......||+.|||||++.+..|++++|||||||++|||+||+.||...+. .+...++...
T Consensus 165 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~~~i~~~ 229 (269)
T d2java1 165 NHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIREG 229 (269)
T ss_dssp ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHT
T ss_pred ccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---HHHHHHHHcC
Confidence 54332 22345699999999999999999999999999999999999999976543 3334444443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=353.61 Aligned_cols=201 Identities=20% Similarity=0.421 Sum_probs=177.8
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
...++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++|++. .++..++||||+++|
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-~~~~~~iv~Ey~~~g 84 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT-KQRPIFIITEYMANG 84 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-CSSSEEEEEECCTTE
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEe-eCCceEEEEEccCCC
Confidence 35688999999999999998888999999986543 4678999999999999999999999994 556899999999999
Q ss_pred CHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeec
Q 041878 618 SLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697 (773)
Q Consensus 618 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 697 (773)
+|.+++.... ..+++..+++++.||++||+||| ++||+||||||+||++++++.+||+|||+++.............
T Consensus 85 ~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH-~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 161 (258)
T d1k2pa_ 85 CLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS 161 (258)
T ss_dssp EHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHH-HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred cHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHh-hcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence 9999977653 34788999999999999999999 89999999999999999999999999999987765554444456
Q ss_pred cCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 041878 698 AGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGM 743 (773)
Q Consensus 698 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~ 743 (773)
.||+.|+|||.+....++.++|||||||++|||+| |+.||...+..
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH
Confidence 78999999999999999999999999999999998 89999876543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.6e-43 Score=360.18 Aligned_cols=199 Identities=31% Similarity=0.462 Sum_probs=174.6
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
+.+.+.||+|+||+||+|.+. +|+.||||+++... ...++|.+|++++++++|||||++++++ ...+..++||||++
T Consensus 19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~-~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFYIITEFMT 96 (287)
T ss_dssp EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSCEEEEECCT
T ss_pred eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccE-eeCCeeEEEeeccc
Confidence 456789999999999999875 58899999997543 3467899999999999999999999999 45568999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
+|+|.+++.+.. ...+++..+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+|+...........
T Consensus 97 ~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~ 174 (287)
T d1opja_ 97 YGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174 (287)
T ss_dssp TCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred CcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHH-HCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence 999999998754 345899999999999999999999 899999999999999999999999999999877655444444
Q ss_pred eccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
...||+.|||||++.+..|+.++|||||||++|||++|+.||..
T Consensus 175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 45588999999999999999999999999999999998777643
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-42 Score=362.15 Aligned_cols=201 Identities=26% Similarity=0.519 Sum_probs=161.1
Q ss_pred HhhcccccccceEEEEEEeC-CCC---EEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGS---EVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~---~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
.+.++||+|+||+||+|.++ +++ .||||++.... ....++|.+|++++++++|||||+++|++ ...+..++|||
T Consensus 29 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-~~~~~~~iv~E 107 (299)
T d1jpaa_ 29 KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVV-TKSTPVMIITE 107 (299)
T ss_dssp EEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSSCEEEEE
T ss_pred EEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEE-eeCCEEEEEEE
Confidence 45689999999999999874 332 58999987543 33456899999999999999999999999 55568999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.... ..+++.++..++.||++||+||| +++|+||||||+|||++.++.+||+|||+|+........
T Consensus 108 y~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH-~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 108 FMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLA-DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp CCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred ecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHh-hCCCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 999999999888653 34899999999999999999999 899999999999999999999999999999876543322
Q ss_pred c----eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 693 N----VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 693 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
. .....||+.|||||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence 1 223457899999999999999999999999999999998 8999976543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-43 Score=368.65 Aligned_cols=200 Identities=21% Similarity=0.390 Sum_probs=173.8
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.++||+|+||+||+|.. .+|+.||+|+++... .....++.+|++++++++|||||++++++. .++..++||||+
T Consensus 8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~iVmEy~ 86 (322)
T d1s9ja_ 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-SDGEISICMEHM 86 (322)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-CSSEEEEEEECC
T ss_pred CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEEEEEEEcC
Confidence 45668999999999999986 478999999997553 333567899999999999999999999995 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
++|+|.+++.+.+ .+++..+..++.||+.||.|||+..||+||||||+|||+++++.+||+|||+|+...... .
T Consensus 87 ~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~ 160 (322)
T d1s9ja_ 87 DGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---A 160 (322)
T ss_dssp TTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---C
T ss_pred CCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---c
Confidence 9999999998764 389999999999999999999933599999999999999999999999999998764332 2
Q ss_pred eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
....||+.|||||++.+..|++++||||+||++|||++|+.||.+.+..
T Consensus 161 ~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp ---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 2357999999999999999999999999999999999999999876544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-42 Score=350.32 Aligned_cols=193 Identities=27% Similarity=0.451 Sum_probs=165.9
Q ss_pred hcccccccceEEEEEEeC-CCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECC---CCeEEEEEee
Q 041878 540 AEIMGKSTYGTAYKATLE-DGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP---KGEKLLVFDF 613 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---~~~~~lV~e~ 613 (773)
.++||+|+||+||+|.+. +++.||+|++... .....+.|.+|++++++++|||||++++++... ....++||||
T Consensus 14 ~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence 467999999999999865 6889999998754 233456789999999999999999999998542 3457899999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCC--ceecCCCCCCEEeC-CCCCeEEeecCCcccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEEN--MIHGNLTSSNVLLD-EKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~--iiH~Dik~~NIll~-~~~~~kl~DfG~a~~~~~~~ 690 (773)
+++|+|.+++.+.. .+++..+..++.||+.||+||| +++ |+||||||+|||++ +++.+||+|||+|+.....
T Consensus 94 ~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH-~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 94 MTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred CCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHH-HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 99999999998754 3789999999999999999999 777 99999999999996 5789999999999764332
Q ss_pred ccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCC
Q 041878 691 NTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPM 740 (773)
Q Consensus 691 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~ 740 (773)
......||+.|||||++.+ .++.++||||+||++|||++|+.||...
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 2234579999999998864 6999999999999999999999999754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-42 Score=354.97 Aligned_cols=199 Identities=27% Similarity=0.454 Sum_probs=170.5
Q ss_pred hc-ccccccceEEEEEEeC---CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 540 AE-IMGKSTYGTAYKATLE---DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 540 ~~-~lG~G~fg~Vy~~~~~---~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.+ +||+|+||+||+|.+. ++..||||+++.... ...++|.+|++++++++|||||+++|++.. +..++||||+
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~lvmE~~ 90 (285)
T d1u59a_ 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMA 90 (285)
T ss_dssp EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECC
T ss_pred CCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CeEEEEEEeC
Confidence 34 4999999999999764 345799999976543 345789999999999999999999999853 3689999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc--
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT-- 692 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~-- 692 (773)
++|+|.+++.... ..+++..+..++.||++||+||| +++|+||||||+|||++.++.+||+|||+|+........
T Consensus 91 ~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH-~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (285)
T d1u59a_ 91 GGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167 (285)
T ss_dssp TTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred CCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHH-hCCeecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence 9999999986542 35899999999999999999999 899999999999999999999999999999877543322
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGM 743 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~ 743 (773)
......||+.|||||++....++.++|||||||++|||+| |+.||...+..
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219 (285)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 2223458999999999998999999999999999999998 99999876543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.1e-42 Score=358.19 Aligned_cols=208 Identities=24% Similarity=0.397 Sum_probs=178.7
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.++++++||||+++++++. ..+..|+|||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~ivmE 84 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-DAQQIFMIMD 84 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-CSSEEEEEEC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-eCCeeeeEee
Confidence 45678999999999999986 46999999999643 2334678999999999999999999999995 4559999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|..++..... ++...+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH-~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-- 158 (316)
T d1fota_ 85 YIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLH-SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 158 (316)
T ss_dssp CCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB--
T ss_pred ecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhc-cCcEEccccCchheeEcCCCCEEEecCccceEecccc--
Confidence 9999999999887543 678888899999999999999 9999999999999999999999999999998764332
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhh
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 756 (773)
....||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+ ..+...++....
T Consensus 159 --~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i~~~~ 217 (316)
T d1fota_ 159 --YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYEKILNAE 217 (316)
T ss_dssp --CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHCC
T ss_pred --ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC---HHHHHHHHHcCC
Confidence 23569999999999999999999999999999999999999997644 344444555444
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=355.09 Aligned_cols=196 Identities=27% Similarity=0.437 Sum_probs=166.6
Q ss_pred cccccccceEEEEEEeCC---CCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 541 EIMGKSTYGTAYKATLED---GSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~---g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
++||+|+||+||+|.+++ ++.||||+++... ....++|.+|++++++++|||||+++|++.. +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~--~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc--CCEEEEEEcCC
Confidence 579999999999998643 4679999997543 2335679999999999999999999999843 35789999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc--
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN-- 693 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~-- 693 (773)
+|+|.+++++.. .+++..++.++.||+.||+||| +++||||||||+|||++.++.+||+|||+++.........
T Consensus 91 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH-~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 91 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHH-hCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999999998754 3899999999999999999999 8999999999999999999999999999998765443322
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
.....||+.|||||.+....++.++|||||||++|||+| |+.||.+.+.
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~ 216 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH
Confidence 223468999999999998999999999999999999998 8999987543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-42 Score=359.73 Aligned_cols=210 Identities=27% Similarity=0.434 Sum_probs=161.9
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.+.||+|+||+||+|... +|+.||||++.... ......+.+|++++++++||||+++++++. .++..|+||||+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lvmE~~ 89 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE-SGGHLYLIMQLV 89 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEECCC
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEEEEEEecc
Confidence 456789999999999999865 68999999997543 233567889999999999999999999995 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeC---CCCCeEEeecCCccccccccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLD---EKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~---~~~~~kl~DfG~a~~~~~~~~ 691 (773)
++|+|.+++.+.. .+++..+..++.||+.||+||| ++||+||||||+||++. +++.+||+|||+|+.......
T Consensus 90 ~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH-~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 90 SGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp CSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred CCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhh-hceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 9999999998753 4899999999999999999999 99999999999999995 578899999999986543322
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhh
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 756 (773)
.....||+.|||||++.+..|++++||||+||++|||++|+.||.+.+. .+...++.+..
T Consensus 166 --~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~~~~ 225 (307)
T d1a06a_ 166 --LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLFEQILKAE 225 (307)
T ss_dssp ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHTTC
T ss_pred --eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---HHHHHHHhccC
Confidence 2345699999999999999999999999999999999999999976442 33334444433
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=359.33 Aligned_cols=199 Identities=23% Similarity=0.353 Sum_probs=175.2
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.++||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|+.++++++||||+++++++. ..+..|+|||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~~~iv~e 85 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-THDRLCFVME 85 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-CSSEEEEEEE
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec-ccccccccee
Confidence 34578999999999999986 57999999999753 2334678899999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.+... ++...+..++.||+.||+||| ++|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 86 y~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH-~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~- 160 (337)
T d1o6la_ 86 YANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp CCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred ccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhh-hcCccccccCHHHeEecCCCCEEEeecccccccccCCc-
Confidence 9999999999988643 788899999999999999999 99999999999999999999999999999986543322
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 2334569999999999999999999999999999999999999997755
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.4e-42 Score=363.78 Aligned_cols=212 Identities=23% Similarity=0.404 Sum_probs=182.1
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.+.||+|+||+||+|.. .+|+.||||++........+.+.+|++++++++|||||++++++. ..+..++||||++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~ivmE~~~ 106 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-DDNEMVMIYEFMS 106 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-ETTEEEEEECCCC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEEEEEEEcCC
Confidence 45678999999999999986 478999999998766666778999999999999999999999995 4568999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC--CCCeEEeecCCccccccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE--KTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~--~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+|+|.+++.+.. ..+++..+..++.||+.||+||| +.|||||||||+|||++. ++.+||+|||+|+.......
T Consensus 107 gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH-~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-- 181 (350)
T d1koaa2 107 GGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-- 181 (350)
T ss_dssp SCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC--
T ss_pred CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH-hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc--
Confidence 999999996542 34899999999999999999999 999999999999999964 57899999999987654332
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhhh
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEW 757 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 757 (773)
.....||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+ ..+.++++....+
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~ 242 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVKSCDW 242 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCC
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC
Confidence 334569999999999999999999999999999999999999997554 4455555555444
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-41 Score=361.57 Aligned_cols=211 Identities=21% Similarity=0.364 Sum_probs=181.0
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.+.||+|+||.||+|.. .+|+.||||+++.....+...+.+|+.++++++|||||++++++. .++..|+||||++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~~~~~ivmE~~~ 109 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-DKYEMVLILEFLS 109 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-CSSEEEEEEECCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEEEEEEEcCC
Confidence 45678999999999999986 479999999998766666778899999999999999999999995 5568999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeC--CCCCeEEeecCCccccccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLD--EKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~--~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+|+|.+++.... ..+++..+..++.||+.||+||| +.|||||||||+|||++ .++.+||+|||+|+.......
T Consensus 110 gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH-~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~-- 184 (352)
T d1koba_ 110 GGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH-EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-- 184 (352)
T ss_dssp CCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC--
T ss_pred CChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HCCeeecccccccccccccCCCeEEEeecccceecCCCCc--
Confidence 999998876542 34899999999999999999999 99999999999999998 568899999999987754432
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhh
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 756 (773)
.....||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+. .+.+.++....
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~ 244 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVKRCD 244 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHHHCC
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC
Confidence 3345699999999999999999999999999999999999999976543 34444444443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=351.53 Aligned_cols=198 Identities=25% Similarity=0.429 Sum_probs=173.6
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC------cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT------TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
|.+.+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++|||||++++++. ..+..++
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~i 90 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-NKTDVIL 90 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEE
T ss_pred EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEEEE
Confidence 45678999999999999987 478999999986432 223578999999999999999999999995 5558999
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC----CeEEeecCCccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT----NPRIADFGLSRL 685 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~----~~kl~DfG~a~~ 685 (773)
||||+++|+|.+++.+.. .+++..+..++.||+.||+||| +.+|+||||||+|||++.++ .+|++|||+|..
T Consensus 91 v~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH-~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhh-hcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 999999999999998764 3899999999999999999999 99999999999999999877 499999999987
Q ss_pred cccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 686 MTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
...... .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+
T Consensus 167 ~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 167 IDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp CTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence 654332 233468999999999999999999999999999999999999997654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-41 Score=354.57 Aligned_cols=195 Identities=27% Similarity=0.419 Sum_probs=168.6
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCc---ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTT---KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|...+.||+|+||+||+|.. .+|+.||||++..... ...+++.+|++++++++|||||++++++.. ++..|+|||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv~E 95 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLVME 95 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-CCEEEEEEE
Confidence 55678899999999999986 4688999999975433 234578899999999999999999999954 558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|++..++.... .+++..+..++.||+.||.||| ++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH-~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLH-SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp CCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHH-hCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 999999987766543 4899999999999999999999 999999999999999999999999999999865432
Q ss_pred ceeeccCccccccccccCC---CCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKL---KNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||...+
T Consensus 169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC
Confidence 23469999999998753 468999999999999999999999997643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=351.07 Aligned_cols=198 Identities=28% Similarity=0.438 Sum_probs=166.2
Q ss_pred HHhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCC
Q 041878 537 CATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPK 616 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~ 616 (773)
+.+.+.||+|+||.||+|.+++++.||||+++... ...++|.+|+.++++++|||||++++++. . +..++||||+++
T Consensus 19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-E-EPIYIVTEYMSK 95 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S-SSCEEEECCCTT
T ss_pred EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-c-CCeEEEEEecCC
Confidence 56788999999999999999888899999997543 35678999999999999999999999983 3 368999999999
Q ss_pred CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceee
Q 041878 617 GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIA 696 (773)
Q Consensus 617 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 696 (773)
|+|.+++.... ...+++.+++.++.||+.||+||| +.+|+||||||+|||++.++.+||+|||+|+............
T Consensus 96 g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH-~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 173 (285)
T d1fmka3 96 GSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173 (285)
T ss_dssp CBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred Cchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHh-hhheecccccceEEEECCCCcEEEcccchhhhccCCCceeecc
Confidence 99999987643 234899999999999999999999 8999999999999999999999999999998765544444445
Q ss_pred ccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 697 TAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 697 ~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
..||+.|+|||++..+.++.++|||||||++|||+||+.|+..
T Consensus 174 ~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 5689999999999999999999999999999999997666543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-41 Score=346.71 Aligned_cols=196 Identities=25% Similarity=0.479 Sum_probs=160.7
Q ss_pred hhcccccccceEEEEEEeCCC-----CEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 539 TAEIMGKSTYGTAYKATLEDG-----SEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~~g-----~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
..++||+|+||+||+|.++.. ..||||+++.... ....+|.+|++++++++|||||+++|++ ...+..++|||
T Consensus 11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-~~~~~~~~v~e 89 (283)
T d1mqba_ 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-SKYKPMMIITE 89 (283)
T ss_dssp EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSSEEEEEE
T ss_pred eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEE-ecCCceEEEEE
Confidence 468899999999999986532 3699999975433 3456799999999999999999999999 45558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|++.+++.... ..+++.++..++.||+.|++||| +++|+||||||+|||++.++.+||+|||+|+........
T Consensus 90 ~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH-~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 90 YMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLA-NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp CCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred ecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcc-ccccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 999999999887653 34899999999999999999999 999999999999999999999999999999876543221
Q ss_pred --ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCC
Q 041878 693 --NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGE 738 (773)
Q Consensus 693 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~ 738 (773)
......||+.|||||++.+..++.++|||||||++|||++|+.|+.
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 2233468999999999999999999999999999999999766654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-41 Score=355.76 Aligned_cols=204 Identities=24% Similarity=0.411 Sum_probs=170.5
Q ss_pred HHhhcccccccceEEEEEEeCC-C-----CEEEEEEeccc-CcccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEE
Q 041878 537 CATAEIMGKSTYGTAYKATLED-G-----SEVAVKRLREK-TTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~-g-----~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 608 (773)
+.+.++||+|+||+||+|++.. + ..||||.+... .......+.+|+.+++++ +|||||++++++ ...+..+
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~-~~~~~~~ 117 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC-TLSGPIY 117 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSCE
T ss_pred eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-eeCCeEE
Confidence 4567899999999999998642 2 26999998654 334456789999999998 899999999999 4555899
Q ss_pred EEEeecCCCCHHHHHhhcCC--------------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEE
Q 041878 609 LVFDFMPKGSLASFLHARGP--------------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVL 668 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIl 668 (773)
+||||+++|+|.++++.... ...+++..++.++.||+.||+||| +++||||||||+||+
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH-~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH-HTTEEETTCSGGGEE
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCchhccc
Confidence 99999999999999976532 134789999999999999999999 899999999999999
Q ss_pred eCCCCCeEEeecCCccccccccccce-eeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 669 LDEKTNPRIADFGLSRLMTAAANTNV-IATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 669 l~~~~~~kl~DfG~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
++.++.+||+|||+|+.......... ....||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+.
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999987655443322 23457999999999999999999999999999999998 8999987554
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.2e-41 Score=355.90 Aligned_cols=207 Identities=23% Similarity=0.329 Sum_probs=178.1
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|++++++++||||+++++++. .....++|||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~~~~v~e 121 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-DNSNLYMVME 121 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEE
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-cccccccccc
Confidence 456789999999999999864 7999999998643 2234567899999999999999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.+++.+.. .++...+..++.||+.||.||| +.+||||||||+|||++.++.+||+|||+|+......
T Consensus 122 ~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH-~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-- 195 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-- 195 (350)
T ss_dssp CCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB--
T ss_pred cccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHH-hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc--
Confidence 999999999998764 3889999999999999999999 9999999999999999999999999999998765432
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHh
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKE 755 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 755 (773)
....||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+ ..+...++...
T Consensus 196 --~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~~~~~~i~~~ 253 (350)
T d1rdqe_ 196 --WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQIYEKIVSG 253 (350)
T ss_dssp --CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHC
T ss_pred --ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC---HHHHHHHHhcC
Confidence 23469999999999999999999999999999999999999997643 33444444443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=342.56 Aligned_cols=203 Identities=27% Similarity=0.522 Sum_probs=167.7
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecCCC
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~~g 617 (773)
++.++||+|+||.||+|.++ |+.||||+++.. ...++|.+|++++++++||||++++|++....+..++||||+++|
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 45788999999999999985 789999999653 345789999999999999999999999966666789999999999
Q ss_pred CHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccceeec
Q 041878 618 SLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVIAT 697 (773)
Q Consensus 618 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 697 (773)
+|.+++.... ...+++..+++++.||+.||.||| +.+|+||||||+||+++.++.+|++|||+++....... ..
T Consensus 87 ~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH-~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~----~~ 160 (262)
T d1byga_ 87 SLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----TG 160 (262)
T ss_dssp EHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTSCEEECCCCC---------------
T ss_pred CHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccc-cCceeccccchHhheecCCCCEeecccccceecCCCCc----cc
Confidence 9999997642 234799999999999999999999 89999999999999999999999999999986543322 23
Q ss_pred cCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCChHHHH
Q 041878 698 AGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQWV 749 (773)
Q Consensus 698 ~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~~~~~ 749 (773)
.+|+.|+|||++.+..+++++|||||||++|||+| |+.||...+..++.+++
T Consensus 161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i 213 (262)
T d1byga_ 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 213 (262)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH
T ss_pred cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 57889999999988999999999999999999998 78888776655555443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-41 Score=344.65 Aligned_cols=206 Identities=22% Similarity=0.399 Sum_probs=163.8
Q ss_pred HHhhcccccccceEEEEEEeCC----CCEEEEEEecccCcc-cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLED----GSEVAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~~----g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~ 611 (773)
|.+.+.||+|+||+||+|.+.. +..||||.++..... ..+.|.+|++++++++||||+++++++. .+..++||
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~iv~ 86 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWIIM 86 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCEEEE
T ss_pred eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCeEEEEE
Confidence 4567899999999999998642 346899998754433 3567999999999999999999999983 34789999
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
||+++|+|.+++.... ..+++..++.++.||++||+||| +++|+||||||+||+++.++.+||+|||+|+.......
T Consensus 87 E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH-~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp ECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhc-ccCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 9999999999887653 34899999999999999999999 99999999999999999999999999999987665444
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCChHH
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQ 747 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~~~ 747 (773)
.......||+.|+|||++.+..++.++|||||||++|||+| |..||...+..++.+
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~ 220 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 220 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 44445568999999999999999999999999999999998 899998766554443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-40 Score=353.39 Aligned_cols=207 Identities=25% Similarity=0.365 Sum_probs=172.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC---cccHHHHHH---HHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT---TKGQKEFEA---EAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
|.+.++||+|+||.||+|+.. +|+.||||++.... ......+.+ |+++++.++|||||++++++. ..+..|+
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~-~~~~~~i 84 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-TPDKLSF 84 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-CSSEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-ECCEEEE
Confidence 345689999999999999864 69999999986432 122333444 466777778999999999995 4558999
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||+++|+|.+++.+... +++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|+.....
T Consensus 85 vmE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH-~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMH-NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEecCCCcHHHHHHhccc---ccHHHHHHHHHHHHHHHHHHH-HCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999999987643 788999999999999999999 999999999999999999999999999999876543
Q ss_pred cccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHH
Q 041878 690 ANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVAS 751 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~ 751 (773)
. .....||+.|||||++.. ..|++++||||+||++|||+||+.||...+..+..+..+.
T Consensus 161 ~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 220 (364)
T d1omwa3 161 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220 (364)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH
T ss_pred c---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 2 234569999999999864 5689999999999999999999999988766655444333
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=346.67 Aligned_cols=198 Identities=24% Similarity=0.400 Sum_probs=170.4
Q ss_pred HhhcccccccceEEEEEEeC-CCCEEEEEEeccc---CcccHHHHHHHHHHHH-ccCCCceEEeEEEEECCCCeEEEEEe
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREK---TTKGQKEFEAEAAAIG-KIHHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
.+.++||+|+||+||+|... +|+.||||+++.. .....+.+..|+.++. .++||||+++++++. .++..|+|||
T Consensus 5 ~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-~~~~~yivmE 83 (320)
T d1xjda_ 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-TKENLFFVME 83 (320)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-CSSEEEEEEE
T ss_pred EEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-cCCceeEEEe
Confidence 45689999999999999864 6899999999643 2233456667777665 689999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc
Q 041878 613 FMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 613 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~ 692 (773)
|+++|+|.++++.... ++...+..++.||+.||+||| +++|+||||||+|||+++++.+||+|||+++.......
T Consensus 84 y~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH-~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~- 158 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLH-SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA- 158 (320)
T ss_dssp CCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred ecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHH-hCCeeeccCcccceeecCCCceeccccchhhhcccccc-
Confidence 9999999999987643 788999999999999999999 99999999999999999999999999999986544332
Q ss_pred ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
......||+.|+|||++.+..|++++||||+||++|||+||+.||.+.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence 2334569999999999999999999999999999999999999997654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=344.10 Aligned_cols=198 Identities=29% Similarity=0.497 Sum_probs=170.0
Q ss_pred hhcccccccceEEEEEEeCCC----CEEEEEEeccc-CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 539 TAEIMGKSTYGTAYKATLEDG----SEVAVKRLREK-TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~~g----~~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
..++||+|+||+||+|.+.++ ..||||+++.. .....++|.+|++++++++||||++++|++...++..++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 357899999999999987532 25899999753 3445578999999999999999999999987667789999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccc-
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANT- 692 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~- 692 (773)
+++|+|.++++... ...++..+++++.|+++||.||| +.+|+||||||+|||+++++.+||+|||+++........
T Consensus 111 ~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH-~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 111 MKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred eecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhc-ccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999999988653 34678889999999999999999 999999999999999999999999999999876543221
Q ss_pred --ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 693 --NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 693 --~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
......||+.|+|||.+....++.++||||||+++|||+||+.||..
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 22234689999999999999999999999999999999998888764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7e-40 Score=337.94 Aligned_cols=213 Identities=24% Similarity=0.407 Sum_probs=171.3
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcc---cHHHHHHHHHHHHccCCCceEEeEEEEECCC---CeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTK---GQKEFEAEAAAIGKIHHPNLLALRAYYLGPK---GEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~l 609 (773)
|.+.+.||+|+||+||+|.. .+|+.||||+++..... ....+.+|++++++++||||+++++++.... ...|+
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 34678999999999999986 57899999999754332 3457899999999999999999999986543 24789
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||+++|+|.+++...+. +++.++..++.||+.||+||| +.|||||||||+|||++.++..+++|||.+......
T Consensus 89 vmE~~~g~~L~~~~~~~~~---l~~~~~~~i~~qi~~al~~lH-~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEECCCCCEehhhhcccCC---CCHHHHHHHHHHHHHHHHHHH-hCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 9999999999999887643 899999999999999999999 999999999999999999999999999998765433
Q ss_pred cc--cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhh
Q 041878 690 AN--TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756 (773)
Q Consensus 690 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 756 (773)
.. .......||+.|||||++.+..+++++||||+||++|||+||+.||...+ ..+...+++.+.
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~~~~~~ 230 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSVAYQHVRED 230 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCC
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC---HHHHHHHHHhcC
Confidence 22 22334569999999999999999999999999999999999999997643 334444444443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-40 Score=345.44 Aligned_cols=206 Identities=27% Similarity=0.476 Sum_probs=169.8
Q ss_pred HHhhcccccccceEEEEEEeC-CCC----EEEEEEeccc-CcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGS----EVAVKRLREK-TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~----~vAvK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV 610 (773)
|...++||+|+||+||+|.+. +|+ .||+|+++.. ..+..++|.+|++++++++|||||+++|++.. +..+++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~v 88 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQLI 88 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeeEE
Confidence 456789999999999999864 444 5899988654 34457789999999999999999999999964 367889
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAA 690 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~ 690 (773)
+||+.+|+|.+++... ...+++..+++++.||+.||+||| +++||||||||+|||++.++.+||+|||+|+......
T Consensus 89 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH-~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHH-HcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 9999999999988875 345899999999999999999999 8999999999999999999999999999998775443
Q ss_pred ccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCCCChHH
Q 041878 691 NTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNGMDLPQ 747 (773)
Q Consensus 691 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~~~~~~ 747 (773)
... .....||+.|||||++.++.++.++|||||||++|||+| |+.||...+..++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~ 224 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 224 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 322 233468999999999999999999999999999999999 889988765544433
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-40 Score=344.67 Aligned_cols=211 Identities=22% Similarity=0.342 Sum_probs=178.2
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.+.||+|+||+||+|... +|+.||||.++.... +...+.+|+++|++++||||+++++++. ..+..|+||||++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFE-SMEELVMIFEFIS 84 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEE-ETTEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEE-ECCEEEEEEecCC
Confidence 456789999999999999875 688999999976543 3566889999999999999999999995 4558999999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC--CCeEEeecCCccccccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK--TNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~--~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+|+|.+++.+.. ..+++.++..++.||+.||+||| +.||+||||||+|||++.+ ..+||+|||+++...... .
T Consensus 85 gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH-~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--~ 159 (321)
T d1tkia_ 85 GLDIFERINTSA--FELNEREIVSYVHQVCEALQFLH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N 159 (321)
T ss_dssp CCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--E
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH-HcCCCcccccccceeecCCCceEEEEcccchhhccccCC--c
Confidence 999999997653 24899999999999999999999 9999999999999999854 479999999998764332 2
Q ss_pred eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhhh
Q 041878 694 VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEEW 757 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 757 (773)
.....+|+.|+|||...+..|+.++||||+||++|||++|+.||...+ ..+.+.++++..+
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~---~~~~~~~i~~~~~ 220 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEY 220 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCC
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCC
Confidence 334468999999999999999999999999999999999999997654 3444555555443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.2e-40 Score=335.36 Aligned_cols=209 Identities=26% Similarity=0.382 Sum_probs=175.4
Q ss_pred HhhcccccccceEEEEEEe-CCCCEEEEEEecccCcc---------cHHHHHHHHHHHHccC-CCceEEeEEEEECCCCe
Q 041878 538 ATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTK---------GQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGE 606 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 606 (773)
.+.+.||+|+||+||+|+. .+|+.||||+++..... ..+++.+|+.++++++ ||||+++++++. .++.
T Consensus 6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-~~~~ 84 (277)
T d1phka_ 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-TNTF 84 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-CSSE
T ss_pred EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc-cCcc
Confidence 4578999999999999986 47899999999654221 1246889999999997 999999999995 5569
Q ss_pred EEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 607 KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
.|+||||+++|+|.++++..+ .+++.++..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-HcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 999999999999999998764 3899999999999999999999 999999999999999999999999999999876
Q ss_pred ccccccceeeccCccccccccccC------CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHHhh
Q 041878 687 TAAANTNVIATAGTLGYRAPELSK------LKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVKEE 756 (773)
Q Consensus 687 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 756 (773)
..... .....||+.|+|||.+. ...++.++||||+||++|||+||+.||.+.+. ......++.+.
T Consensus 161 ~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~~~~~~i~~~~ 231 (277)
T d1phka_ 161 DPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---MLMLRMIMSGN 231 (277)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTC
T ss_pred cCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---HHHHHHHHhCC
Confidence 54322 23456999999999764 34578899999999999999999999976543 33334455443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-40 Score=343.07 Aligned_cols=205 Identities=28% Similarity=0.433 Sum_probs=172.7
Q ss_pred HHhhcccccccceEEEEEEeC------CCCEEEEEEecccCcc-cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTTK-GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
+.+.+.||+|+||+||+|++. +++.||||+++..... ..++|.+|++++++++||||+++++++ ...+..++
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-~~~~~~~~ 93 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC-AVGKPMCL 93 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSSCEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee-ccCCceEE
Confidence 356788999999999999863 3578999999765443 356799999999999999999999999 45668999
Q ss_pred EEeecCCCCHHHHHhhcCC---------------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEE
Q 041878 610 VFDFMPKGSLASFLHARGP---------------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVL 668 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIl 668 (773)
||||+++|+|.++++.... ...+++..+..++.||+.||+||| +++||||||||+|||
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH-~~~ivHrDlKp~NIL 172 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS-ERKFVHRDLATRNCL 172 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEE
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc-cCCeEeeEEcccceE
Confidence 9999999999999975421 234789999999999999999999 999999999999999
Q ss_pred eCCCCCeEEeecCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCC-CCCCCCCCC
Q 041878 669 LDEKTNPRIADFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGK-SPGEPMNGM 743 (773)
Q Consensus 669 l~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~-~P~~~~~~~ 743 (773)
+|.++.+||+|||+|+........ ......+|+.|+|||.+.+..|+.++|||||||++|||++|. .||...+..
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~ 249 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence 999999999999999876544332 233456889999999999999999999999999999999986 567665443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-39 Score=344.63 Aligned_cols=196 Identities=22% Similarity=0.355 Sum_probs=167.3
Q ss_pred hcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHcc-CCCceEEeEEEEEC---CCCeEEEEEeec
Q 041878 540 AEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKI-HHPNLLALRAYYLG---PKGEKLLVFDFM 614 (773)
Q Consensus 540 ~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---~~~~~~lV~e~~ 614 (773)
.++||+|+||+||+|.. .+|+.||||+++. ...+.+|+.++.++ +|||||++++++.. .....|+|||||
T Consensus 17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 35799999999999986 5789999999853 35677899987655 79999999999853 234689999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC---CCCeEEeecCCccccccccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE---KTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~---~~~~kl~DfG~a~~~~~~~~ 691 (773)
+||+|.+++.+.+ ...+++.++..++.||+.||+||| +.||+||||||+|||++. ++.+||+|||+|+.......
T Consensus 92 ~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH-~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~ 169 (335)
T d2ozaa1 92 DGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169 (335)
T ss_dssp CSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC
T ss_pred CCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHH-HcCCccccccccccccccccccccccccccceeeeccCCCc
Confidence 9999999998753 245899999999999999999999 999999999999999986 45699999999987654332
Q ss_pred cceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCC
Q 041878 692 TNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMD 744 (773)
Q Consensus 692 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~ 744 (773)
.....||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+..+
T Consensus 170 --~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~ 220 (335)
T d2ozaa1 170 --LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220 (335)
T ss_dssp --CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-
T ss_pred --cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH
Confidence 234569999999999999999999999999999999999999998765443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=340.18 Aligned_cols=197 Identities=26% Similarity=0.386 Sum_probs=163.7
Q ss_pred cccccccceEEEEEEeC-CCCEEEEEEecccCcc-----cHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 541 EIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTK-----GQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
++||+|+||+||+|... +|+.||||+++..... ..+.+.+|++++++++|||||++++++ ..++..++||||+
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-GHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-CCTTCCEEEEECC
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-ccCCceeehhhhh
Confidence 68999999999999964 6899999999654322 134688999999999999999999999 5566899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
+++++..+.... ..+++..+..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+|+........ .
T Consensus 83 ~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH-~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~ 157 (299)
T d1ua2a_ 83 ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH-QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-Y 157 (299)
T ss_dssp SEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-C
T ss_pred cchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhh-ccceecccCCcceEEecCCCccccccCccccccCCCccc-c
Confidence 888777665433 34778889999999999999999 999999999999999999999999999999876543322 2
Q ss_pred eeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
....||+.|+|||++.. ..|+.++||||+||++|||+||+.||...+..
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~ 207 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 207 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH
Confidence 23568999999998764 56899999999999999999999999766543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-40 Score=336.28 Aligned_cols=201 Identities=27% Similarity=0.426 Sum_probs=161.3
Q ss_pred HHhhcccccccceEEEEEEeC--CC--CEEEEEEecccC---cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE--DG--SEVAVKRLREKT---TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~--~g--~~vAvK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
|.+.+.||+|+||.||+|++. ++ ..||||+++... .+..++|.+|+.++++++||||++++|++.. + ..++
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~-~~~l 87 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P-PMKM 87 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-SCEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c-chhe
Confidence 355688999999999999853 23 368999987542 2335689999999999999999999999943 3 6789
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
||||+++|++.+++.... ..+++..+..++.||+.||+||| +++|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH-~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLE-SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp EEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhh-hCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 999999999999887653 34899999999999999999999 899999999999999999999999999999987544
Q ss_pred cccc--eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCCC
Q 041878 690 ANTN--VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMNG 742 (773)
Q Consensus 690 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~~ 742 (773)
.... .....|++.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~ 220 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH
Confidence 3322 223357889999999999999999999999999999998 8999976543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-39 Score=338.21 Aligned_cols=204 Identities=25% Similarity=0.410 Sum_probs=162.7
Q ss_pred HHhhcccccccceEEEEEEeC------CCCEEEEEEecccCc-ccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 608 (773)
|.+.++||+|+||.||+|.+. +++.||||+++.... ...+.+.+|+..+.++ +|+||+.+++++.......+
T Consensus 15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~ 94 (299)
T d1ywna1 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 94 (299)
T ss_dssp EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence 456789999999999999853 346799999975433 3456788888888877 58899999999866666789
Q ss_pred EEEeecCCCCHHHHHhhcCC-------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCe
Q 041878 609 LVFDFMPKGSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNP 675 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~ 675 (773)
+||||+++|+|.++++.... ...+++.+++.++.||++||+||| +++||||||||+|||+++++.+
T Consensus 95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH-~~~ivHrDlKp~NILl~~~~~~ 173 (299)
T d1ywna1 95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVV 173 (299)
T ss_dssp EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECGGGCE
T ss_pred EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH-hCCCcCCcCCccceeECCCCcE
Confidence 99999999999999976421 234889999999999999999999 9999999999999999999999
Q ss_pred EEeecCCcccccccccc-ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCC-CCCCCCC
Q 041878 676 RIADFGLSRLMTAAANT-NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGK-SPGEPMN 741 (773)
Q Consensus 676 kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~-~P~~~~~ 741 (773)
||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+||. .||...+
T Consensus 174 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 174 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp EECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999876543322 223456999999999999999999999999999999999975 5776544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-39 Score=334.16 Aligned_cols=195 Identities=29% Similarity=0.394 Sum_probs=159.5
Q ss_pred hhcccccccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCC---eEEEEEeecC
Q 041878 539 TAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKG---EKLLVFDFMP 615 (773)
Q Consensus 539 ~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~lV~e~~~ 615 (773)
..+.||+|+||.||+|++ +|+.||||+++.... ....++.|+..+++++||||+++++++..... ..++||||++
T Consensus 7 l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~ 84 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 84 (303)
T ss_dssp EEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEeccc
Confidence 457899999999999987 488999999964422 12223445556667899999999999965432 5789999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhcc-------CCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHV-------EENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~-------~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+|+|.+++++. .++|..+.+++.|+|.||+|+|+ ++|||||||||+|||++.++.+||+|||+++....
T Consensus 85 ~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 85 HGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp TCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 99999999875 38999999999999999999993 36999999999999999999999999999987754
Q ss_pred cccc---ceeeccCccccccccccCCCC------CCcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 689 AANT---NVIATAGTLGYRAPELSKLKN------ANTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 689 ~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
.... ......||+.|||||++.... ++.++|||||||++|||+||..||..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~ 220 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence 4322 223457999999999876543 57789999999999999999988754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-39 Score=335.35 Aligned_cols=204 Identities=28% Similarity=0.427 Sum_probs=169.0
Q ss_pred HHHhhcccccccceEEEEEEeCC--------CCEEEEEEecccCc-ccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCC
Q 041878 536 LCATAEIMGKSTYGTAYKATLED--------GSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKG 605 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~~~--------g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 605 (773)
+|.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||++++++. .++
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~-~~~ 92 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-QDG 92 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc-cCC
Confidence 34567899999999999998532 24799999976544 3457888999999988 7999999999994 556
Q ss_pred eEEEEEeecCCCCHHHHHhhcCC-------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC
Q 041878 606 EKLLVFDFMPKGSLASFLHARGP-------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK 672 (773)
Q Consensus 606 ~~~lV~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~ 672 (773)
..++||||+++|+|.+++..... ...+++.+++.++.||+.||+||| +.+||||||||+|||++.+
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH-~~~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTED 171 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTT
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh-hCCEEeeeecccceeecCC
Confidence 89999999999999999976532 345899999999999999999999 9999999999999999999
Q ss_pred CCeEEeecCCccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 673 TNPRIADFGLSRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 673 ~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
+.+||+|||.++......... .....+|+.|+|||.+.++.|++++|||||||++|||++ |..||...+
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999999999998776543322 234568999999999999999999999999999999998 688887654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-39 Score=334.21 Aligned_cols=202 Identities=22% Similarity=0.374 Sum_probs=171.3
Q ss_pred HHhhcccccccceEEEEEEeC------CCCEEEEEEecccCc-ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE------DGSEVAVKRLREKTT-KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~------~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~l 609 (773)
+...+.||+|+||+||+|.+. +++.||||+++.... .....|.+|++++++++||||+++++++ ..++..++
T Consensus 22 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-~~~~~~~l 100 (308)
T d1p4oa_ 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-SQGQPTLV 100 (308)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-CSSSSCEE
T ss_pred eEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE-ecCCceeE
Confidence 356789999999999999863 357899999975433 3445789999999999999999999999 55568999
Q ss_pred EEeecCCCCHHHHHhhcC-------CCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCC
Q 041878 610 VFDFMPKGSLASFLHARG-------PETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGL 682 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~-------~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~ 682 (773)
||||+++|+|.+++.... ....+++..+.+++.|+++||.||| +++|+||||||+|||+++++.+||+|||+
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH-~~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh-hCCeeeceEcCCceeecCCceEEEeeccc
Confidence 999999999999987541 2234689999999999999999999 89999999999999999999999999999
Q ss_pred ccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCC-CCCCCC
Q 041878 683 SRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGK-SPGEPM 740 (773)
Q Consensus 683 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~-~P~~~~ 740 (773)
|+......... .....+|+.|+|||.+.+..++.++|||||||++|||+||+ .||...
T Consensus 180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~ 239 (308)
T d1p4oa_ 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239 (308)
T ss_dssp CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC
Confidence 98765443322 22335899999999999999999999999999999999985 677554
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-39 Score=335.08 Aligned_cols=200 Identities=28% Similarity=0.505 Sum_probs=165.6
Q ss_pred HhhcccccccceEEEEEEeC-CCC--EEEEEEecccC-cccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeEEEEEe
Q 041878 538 ATAEIMGKSTYGTAYKATLE-DGS--EVAVKRLREKT-TKGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEKLLVFD 612 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~-~g~--~vAvK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~lV~e 612 (773)
.+.++||+|+||+||+|.+. +|. .||||+++... ....++|.+|+++++++ +||||++++|++. .++..++|||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-~~~~~~iV~e 91 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-HRGYLYLAIE 91 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-ETTEEEEEEC
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-cCCeeEEEEE
Confidence 45689999999999999875 343 47888886543 33456899999999998 7999999999995 4558999999
Q ss_pred ecCCCCHHHHHhhc-------------CCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEee
Q 041878 613 FMPKGSLASFLHAR-------------GPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIAD 679 (773)
Q Consensus 613 ~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~D 679 (773)
|+++|+|.++++.. .....+++..+..++.||++||.||| +++|+||||||+|||++.++.+||+|
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH-~~~iiHrDlkp~NIL~~~~~~~kl~D 170 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIAD 170 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECGGGCEEECC
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh-cCCccccccccceEEEcCCCceEEcc
Confidence 99999999999764 12356899999999999999999999 99999999999999999999999999
Q ss_pred cCCccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCC-CCCCCC
Q 041878 680 FGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKS-PGEPMN 741 (773)
Q Consensus 680 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~-P~~~~~ 741 (773)
||+|+........ ....||+.|+|||.+....++.++|||||||++|||++|.. ||...+
T Consensus 171 fG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~ 231 (309)
T d1fvra_ 171 FGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231 (309)
T ss_dssp TTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence 9999765433222 23458999999999999999999999999999999999764 675544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-38 Score=329.05 Aligned_cols=199 Identities=25% Similarity=0.382 Sum_probs=166.9
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
.+.++||+|+||+||+|.+++|+.||||+++... ....+++.+|+.++++++||||+++++++. ..+..++|+||+.
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-TKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-CSSCEEEEEECCS
T ss_pred eeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-cCCceeEEEEeeh
Confidence 4568899999999999999999999999996543 233578999999999999999999999995 5558999999998
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccccccccee
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNVI 695 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 695 (773)
++.+..+.+.. ..++...+..++.||+.||+||| +.+||||||||+|||++.++.+|++|||.|........ ...
T Consensus 84 ~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH-~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 158 (286)
T d1ob3a_ 84 QDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYT 158 (286)
T ss_dssp EEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred hhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhc-cCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-ccc
Confidence 77666665543 34899999999999999999999 89999999999999999999999999999987654332 223
Q ss_pred eccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 696 ATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 696 ~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
...+++.|+|||.+.. ..++.++||||+||++|||++|+.||.+.+.
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~ 206 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH
Confidence 4468999999998765 4568999999999999999999999976553
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=330.30 Aligned_cols=199 Identities=28% Similarity=0.426 Sum_probs=165.1
Q ss_pred HhhcccccccceEEEEEEe-CCCCEEEEEEecccCc--ccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeec
Q 041878 538 ATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTT--KGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
.+.+.||+|+||+||+|.. .+|+.||||+++.... ...+++.+|++++++++||||+++++++. .++..++||||+
T Consensus 5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-TENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTEEEEEEECC
T ss_pred EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-cccceeEEEeec
Confidence 4568899999999999986 5799999999965432 23578899999999999999999999995 455899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccce
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTNV 694 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 694 (773)
.+ ++.+++.... ...+++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||.|+....... ..
T Consensus 84 ~~-~~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH-~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-~~ 159 (298)
T d1gz8a_ 84 HQ-DLKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCH-SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY 159 (298)
T ss_dssp SE-EHHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-CT
T ss_pred CC-chhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhh-cCCEEccccCchheeecccCcceeccCCcceeccCCcc-cc
Confidence 65 5555554432 344899999999999999999999 99999999999999999999999999999987654332 22
Q ss_pred eeccCccccccccccCCCC-CCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 695 IATAGTLGYRAPELSKLKN-ANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 695 ~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
....||+.|+|||.+.... ++.++||||+||++|||++|+.||.+.+
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 3446999999999876655 5789999999999999999999997654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-38 Score=331.24 Aligned_cols=204 Identities=25% Similarity=0.388 Sum_probs=172.0
Q ss_pred HHHhhcccccccceEEEEEEe------CCCCEEEEEEecccCc-ccHHHHHHHHHHHHcc-CCCceEEeEEEEECCCCeE
Q 041878 536 LCATAEIMGKSTYGTAYKATL------EDGSEVAVKRLREKTT-KGQKEFEAEAAAIGKI-HHPNLLALRAYYLGPKGEK 607 (773)
Q Consensus 536 ~~~~~~~lG~G~fg~Vy~~~~------~~g~~vAvK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 607 (773)
.+.+.++||+|+||.||+|++ .+++.||||+++.... ....+|.+|+.+++++ +|||||++++++ ..+...
T Consensus 24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~-~~~~~~ 102 (311)
T d1t46a_ 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC-TIGGPT 102 (311)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSSC
T ss_pred HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE-eeCCEE
Confidence 345678999999999999985 2456899999976543 3456789999999999 699999999999 455589
Q ss_pred EEEEeecCCCCHHHHHhhcCC---------------CCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC
Q 041878 608 LLVFDFMPKGSLASFLHARGP---------------ETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK 672 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~ 672 (773)
++||||+++|+|.+++++... ...+++..+..++.||++|++||| ++++|||||||+||+++.+
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH-~~~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNILLTHG 181 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEETT
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccccccccccccc
Confidence 999999999999999987531 234889999999999999999999 9999999999999999999
Q ss_pred CCeEEeecCCccccccccccc-eeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHc-CCCCCCCCC
Q 041878 673 TNPRIADFGLSRLMTAAANTN-VIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLT-GKSPGEPMN 741 (773)
Q Consensus 673 ~~~kl~DfG~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~t-g~~P~~~~~ 741 (773)
+.+|++|||.++......... .....||+.|+|||.+.+..++.++|||||||++|||+| |.+||...+
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 999999999998775443322 234568999999999999999999999999999999999 555555444
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-39 Score=328.37 Aligned_cols=195 Identities=19% Similarity=0.366 Sum_probs=164.4
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcc------cHHHHHHHHHHHHccC--CCceEEeEEEEECCCCeE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTK------GQKEFEAEAAAIGKIH--HPNLLALRAYYLGPKGEK 607 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~ 607 (773)
|.+.++||+|+||+||+|.. .+|+.||||+++..... ...++.+|+.++++++ ||||+++++++. .++..
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~-~~~~~ 84 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE-RPDSF 84 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-CSSEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe-eCCeE
Confidence 45678999999999999986 47899999998653211 1234678999999997 899999999995 45589
Q ss_pred EEEEeecCC-CCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCC-CCeEEeecCCccc
Q 041878 608 LLVFDFMPK-GSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEK-TNPRIADFGLSRL 685 (773)
Q Consensus 608 ~lV~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~-~~~kl~DfG~a~~ 685 (773)
++||||+.+ +++.+++.... .+++..+..++.||+.||+||| ++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH-~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH-HCCCccccCcccceEEecCCCeEEECcccccee
Confidence 999999976 68888887754 3889999999999999999999 9999999999999999855 7899999999986
Q ss_pred cccccccceeeccCccccccccccCCCCC-CcchhhHHHHHHHHHHHcCCCCCCC
Q 041878 686 MTAAANTNVIATAGTLGYRAPELSKLKNA-NTKTDVYSLGVIILELLTGKSPGEP 739 (773)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dvws~Gv~l~el~tg~~P~~~ 739 (773)
..... .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||..
T Consensus 161 ~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 161 LKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp CCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred ccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 54332 234569999999999876665 5779999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-38 Score=329.84 Aligned_cols=201 Identities=26% Similarity=0.382 Sum_probs=164.9
Q ss_pred HHhhcccccccceEEEEEEe-CC-CCEEEEEEecccCc--ccHHHHHHHHHHHHcc---CCCceEEeEEEEEC----CCC
Q 041878 537 CATAEIMGKSTYGTAYKATL-ED-GSEVAVKRLREKTT--KGQKEFEAEAAAIGKI---HHPNLLALRAYYLG----PKG 605 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~-g~~vAvK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----~~~ 605 (773)
|.+.+.||+|+||+||+|.+ ++ ++.||||+++.... .....+.+|+.+++.+ +||||+++++++.. ...
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence 45678999999999999986 34 56799999865422 2234566777777666 79999999999853 234
Q ss_pred eEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccc
Q 041878 606 EKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRL 685 (773)
Q Consensus 606 ~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~ 685 (773)
..+++|||++++.+....... ...+++..+..++.||+.||+||| +++||||||||+|||+++++.+||+|||.++.
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH-~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred eEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHH-hCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 678999999887765444433 344789999999999999999999 99999999999999999999999999999886
Q ss_pred cccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 686 MTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 686 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
..... ......||+.|+|||++.+..|+.++||||+||++|||+||+.||.+.+.
T Consensus 166 ~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~ 220 (305)
T d1blxa_ 166 YSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220 (305)
T ss_dssp CCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH
Confidence 54333 23345699999999999999999999999999999999999999976653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.7e-37 Score=319.63 Aligned_cols=209 Identities=16% Similarity=0.252 Sum_probs=173.4
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCC-CceEEeEEEEECCCCeEEEEEeec
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHH-PNLLALRAYYLGPKGEKLLVFDFM 614 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~~lV~e~~ 614 (773)
|.+.++||+|+||+||+|++. +|+.||||++.... ....+.+|++.++.++| +|++.+++++ ......++||||+
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~-~~~~~~~~vme~~ 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG-QEGLHNVLVIDLL 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEE-EETTEEEEEEECC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEe-ecCCccEEEEEec
Confidence 456789999999999999864 68899999986543 23456788999999976 8999998888 4556899999999
Q ss_pred CCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC-----CCCeEEeecCCccccccc
Q 041878 615 PKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE-----KTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 615 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~-----~~~~kl~DfG~a~~~~~~ 689 (773)
+++|.++++... ..++..++..++.|++.||+||| +.||+||||||+|||++. ++.+||+|||+|+.....
T Consensus 84 -~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH-~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 -GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIH-EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp -CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHH-HCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 789999987653 34889999999999999999999 999999999999999974 567999999999876533
Q ss_pred ccc------ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 041878 690 ANT------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASI 752 (773)
Q Consensus 690 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~ 752 (773)
... ......||+.|||||++.+..+++++|||||||++|||+||+.||.........+...++
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i 228 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH
Confidence 211 122446999999999999999999999999999999999999999887766555544433
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=331.22 Aligned_cols=199 Identities=24% Similarity=0.383 Sum_probs=163.3
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECC-----CCeEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-----KGEKLLV 610 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~~lV 610 (773)
|...++||+|+||+||+|++. +|+.||||+++.... .+.+|++++++++||||+++++++... ....++|
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 445689999999999999974 689999999975432 234699999999999999999998542 2357899
Q ss_pred EeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC-CeEEeecCCccccccc
Q 041878 611 FDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT-NPRIADFGLSRLMTAA 689 (773)
Q Consensus 611 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~ 689 (773)
|||++++.+..+.+.......+++.+++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH-~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH-hcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 999987654444433333456899999999999999999999 99999999999999999775 7999999999876543
Q ss_pred cccceeeccCccccccccccC-CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSK-LKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.. .....||+.|+|||.+. ...++.++||||+||++|||++|+.||...+.
T Consensus 177 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 177 EP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp SC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred cc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 32 22346899999999765 45789999999999999999999999976553
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=326.14 Aligned_cols=211 Identities=25% Similarity=0.372 Sum_probs=177.7
Q ss_pred HHhhcccccccceEEEEEEe----CCCCEEEEEEecccC----cccHHHHHHHHHHHHccCC-CceEEeEEEEECCCCeE
Q 041878 537 CATAEIMGKSTYGTAYKATL----EDGSEVAVKRLREKT----TKGQKEFEAEAAAIGKIHH-PNLLALRAYYLGPKGEK 607 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~----~~g~~vAvK~l~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~ 607 (773)
|.+.++||+|+||+||+|.. .+|+.||||.++... ....+.+.+|++++++++| |||+++++++. .....
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~-~~~~~ 104 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-TETKL 104 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE-ETTEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec-cCCce
Confidence 46678999999999999974 257899999986432 2345678899999999987 79999999984 45589
Q ss_pred EEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccc
Q 041878 608 LLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMT 687 (773)
Q Consensus 608 ~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~ 687 (773)
++||||+++|+|.++++.... ++......++.||+.|++|+| +.+|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH-~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 105 HLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLH-KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp EEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhh-cCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 999999999999999988653 577888899999999999999 9999999999999999999999999999998776
Q ss_pred cccccceeeccCccccccccccCCC--CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHH
Q 041878 688 AAANTNVIATAGTLGYRAPELSKLK--NANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASI 752 (773)
Q Consensus 688 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~ 752 (773)
...........|++.|+|||.+... .++.++||||+||++|||+||+.||...+..+....+.+.
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~ 247 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 247 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 5555545556799999999988654 4688999999999999999999999887766665555443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-37 Score=320.07 Aligned_cols=206 Identities=19% Similarity=0.257 Sum_probs=166.5
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEeecC
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDFMP 615 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~~~ 615 (773)
|.+.+.||+|+||+||+|.+ .+|+.||||++..... ..++..|++++++++|++++..+..+....+..++||||+
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 45678999999999999986 4688999999875432 3457889999999998887777777766777899999999
Q ss_pred CCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCC---CCCeEEeecCCcccccccccc
Q 041878 616 KGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDE---KTNPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 616 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~---~~~~kl~DfG~a~~~~~~~~~ 692 (773)
++++.+.+.... ..+++..+..++.|++.||+||| ++|||||||||+|||++. +..+|++|||+|+........
T Consensus 86 ~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH-~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 86 GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHH-HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 567777665542 34899999999999999999999 999999999999999864 457999999999977543221
Q ss_pred ------ceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHH
Q 041878 693 ------NVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQW 748 (773)
Q Consensus 693 ------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~ 748 (773)
......||+.|||||.+.+..+++++|||||||++|||+||+.||......+....
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~ 224 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH
Confidence 12344699999999999999999999999999999999999999987665544333
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-37 Score=324.17 Aligned_cols=208 Identities=23% Similarity=0.327 Sum_probs=166.8
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEeccc--CcccHHHHHHHHHHHHccCCCceEEeEEEEECC-------CCe
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREK--TTKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-------KGE 606 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------~~~ 606 (773)
|.+.+.||+|+||+||+|.+ .+|+.||||++... ......++.+|++++++++|||++++++++... ++.
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~ 91 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred EEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCce
Confidence 45678999999999999986 57999999998644 333457789999999999999999999998543 235
Q ss_pred EEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccc
Q 041878 607 KLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLM 686 (773)
Q Consensus 607 ~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~ 686 (773)
.++||||++++.+..+... ...++...++.++.||+.||.||| +.||+||||||+|||++.++.+|++|||+++..
T Consensus 92 ~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH-~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIH-RNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp EEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhc-cCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 7899999987766654433 234788889999999999999999 999999999999999999999999999999766
Q ss_pred cccccc---ceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHH
Q 041878 687 TAAANT---NVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQW 748 (773)
Q Consensus 687 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~ 748 (773)
...... ......||+.|+|||++.+. .+++++||||+||++|||++|+.||.+.+..+..+.
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~ 233 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL 233 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHH
Confidence 533221 22234699999999987654 689999999999999999999999987654433333
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-37 Score=325.13 Aligned_cols=201 Identities=22% Similarity=0.348 Sum_probs=165.3
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC-cccHHHHHHHHHHHHccCCCceEEeEEEEECCC---CeEEEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT-TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK---GEKLLVF 611 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~~~lV~ 611 (773)
|.+.++||+|+||+||+|.. .+|+.||||+++... ....+++.+|+++|++++||||+++++++.... ...++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 45678999999999999985 589999999997543 334567899999999999999999999995432 1334555
Q ss_pred eecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccc
Q 041878 612 DFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAAN 691 (773)
Q Consensus 612 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~ 691 (773)
+|+.+|+|.+++... .+++..+..++.||+.||+||| ++|||||||||+|||++.++.+||+|||+|........
T Consensus 90 ~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH-~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 90 THLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHH-HCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 677799999999764 3899999999999999999999 99999999999999999999999999999987654432
Q ss_pred c--ceeeccCccccccccccC-CCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 692 T--NVIATAGTLGYRAPELSK-LKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 692 ~--~~~~~~gt~~y~aPE~~~-~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
. ......||+.|+|||++. ...++.++||||+||++|||++|+.||...+.
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 2 223456899999999874 45678999999999999999999999976543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-37 Score=325.14 Aligned_cols=196 Identities=24% Similarity=0.371 Sum_probs=161.5
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCC-----CeEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPK-----GEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~~ 608 (773)
|.+.++||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.... ...+
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence 45678999999999999986 469999999997542 233567889999999999999999999995433 2579
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||+ +.+|..+.+.. .+++..++.++.||+.||+||| +.|||||||||+|||++.++.+|++|||.|+....
T Consensus 100 lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH-~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp EEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHH-hCCCcccccCcchhhcccccccccccccceeccCC
Confidence 999999 66788777653 3899999999999999999999 99999999999999999999999999999987643
Q ss_pred ccccceeeccCccccccccccCC-CCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKL-KNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
.. ....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.
T Consensus 174 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~ 224 (346)
T d1cm8a_ 174 EM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224 (346)
T ss_dssp SC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh
Confidence 32 34568999999998765 5678999999999999999999999977653
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-35 Score=309.64 Aligned_cols=210 Identities=27% Similarity=0.392 Sum_probs=174.7
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECCCCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGPKGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~lV~e~ 613 (773)
|.+.+.||+|+||+||+|++ .+|+.||||+++... .....++.+|+.+++.++||||+++++++. .....++|+|+
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-~~~~~~iv~~~ 82 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-SDKKLTLVFEF 82 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEEC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-cccceeEEeee
Confidence 34568999999999999986 478999999996543 234678999999999999999999999995 45588999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAAANTN 693 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 693 (773)
+.++++..+++... .+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+|||.|+........
T Consensus 83 ~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH-~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~- 157 (292)
T d1unla_ 83 CDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC- 157 (292)
T ss_dssp CSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC-
T ss_pred cccccccccccccc---ccchhHHHHHHHHHHHHHHHhh-cCCEeeecccCcccccccCCceeeeecchhhcccCCCcc-
Confidence 99999888877643 4788999999999999999999 999999999999999999999999999999876543322
Q ss_pred eeeccCccccccccccCCCC-CCcchhhHHHHHHHHHHHcCCCCCCCCCCCChHHHHHHHHH
Q 041878 694 VIATAGTLGYRAPELSKLKN-ANTKTDVYSLGVIILELLTGKSPGEPMNGMDLPQWVASIVK 754 (773)
Q Consensus 694 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 754 (773)
.....+++.|+|||.+.... ++.++||||+||++|||++|+.||.. +.+..+++.++..
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~--~~~~~~~~~~~~~ 217 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFR 217 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHH
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC--CCCHHHHHHHHHh
Confidence 22345788999999876554 68999999999999999999999753 3445555555443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-35 Score=314.42 Aligned_cols=193 Identities=19% Similarity=0.336 Sum_probs=165.0
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccC-CCceEEeEEEEECC-CCeEEEEEee
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGP-KGEKLLVFDF 613 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~-~~~~~lV~e~ 613 (773)
|.+.++||+|+||+||+|+. .+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++... ....++||||
T Consensus 37 y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 56778999999999999986 57899999999643 3567899999999996 99999999998654 3468999999
Q ss_pred cCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCC-CeEEeecCCcccccccccc
Q 041878 614 MPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKT-NPRIADFGLSRLMTAAANT 692 (773)
Q Consensus 614 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~-~~kl~DfG~a~~~~~~~~~ 692 (773)
+++++|.++.+ .++...+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+|+.......
T Consensus 114 ~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH-~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~- 185 (328)
T d3bqca1 114 VNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 185 (328)
T ss_dssp CCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC-
T ss_pred cCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHh-hcccccccccccceEEcCCCCeeeecccccceeccCCCc-
Confidence 99999976543 3788999999999999999999 99999999999999998765 589999999987654332
Q ss_pred ceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 693 NVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 693 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....
T Consensus 186 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 186 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred -ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 2344689999999987654 57999999999999999999999997644
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-35 Score=315.59 Aligned_cols=196 Identities=21% Similarity=0.284 Sum_probs=157.3
Q ss_pred HHhhcccccccceEEEEEEeC-CCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECC-----CCeEE
Q 041878 537 CATAEIMGKSTYGTAYKATLE-DGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP-----KGEKL 608 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~~ 608 (773)
|.+.++||+|+||+||+|.+. +|+.||||++.... .....++.+|+.++++++||||+++++++... ....|
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 456789999999999999875 69999999997543 23345788999999999999999999999543 35789
Q ss_pred EEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCcccccc
Q 041878 609 LVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTA 688 (773)
Q Consensus 609 lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~ 688 (773)
+||||+.++ +.+.+.. .+++..+..++.||+.||+||| +.||+||||||+|||++.++.+|++|||+++....
T Consensus 99 iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~LH-~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 99 LVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp EEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHHhh-hcccccccCCccccccccccceeeechhhhhcccc
Confidence 999999654 5554433 3788999999999999999999 99999999999999999999999999999876543
Q ss_pred ccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCC
Q 041878 689 AANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMN 741 (773)
Q Consensus 689 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~ 741 (773)
.. ......+|+.|+|||++.+..+++++||||+||++|||++|+.||.+.+
T Consensus 172 ~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 172 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp -----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 32 2234468999999999999999999999999999999999999997654
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-35 Score=316.32 Aligned_cols=198 Identities=25% Similarity=0.369 Sum_probs=163.9
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccC--cccHHHHHHHHHHHHccCCCceEEeEEEEECC----CCeEEE
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKT--TKGQKEFEAEAAAIGKIHHPNLLALRAYYLGP----KGEKLL 609 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~~~~~l 609 (773)
|.+.++||+|+||+||+|.. .+|+.||||+++... ....+++.+|++++++++|||++++++++... ....++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 45678999999999999986 579999999997543 23456788999999999999999999998532 224566
Q ss_pred EEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEeecCCccccccc
Q 041878 610 VFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIADFGLSRLMTAA 689 (773)
Q Consensus 610 V~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~~~~~ 689 (773)
|+||+.+|+|.++++.. .++...+..++.||+.||+||| ++||+||||||+|||++.++.+|++|||.+......
T Consensus 100 i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH-~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp EEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred EEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHH-hCCCcccccCCccccccccccccccccchhcccCcc
Confidence 77888899999999653 3899999999999999999999 999999999999999999999999999998765433
Q ss_pred cccceeeccCccccccccccCCC-CCCcchhhHHHHHHHHHHHcCCCCCCCCCCC
Q 041878 690 ANTNVIATAGTLGYRAPELSKLK-NANTKTDVYSLGVIILELLTGKSPGEPMNGM 743 (773)
Q Consensus 690 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~~ 743 (773)
. ....||+.|+|||...+. .++.++||||+||++|||++|+.||.+.+..
T Consensus 175 ~----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~ 225 (348)
T d2gfsa1 175 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225 (348)
T ss_dssp G----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred c----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH
Confidence 2 234589999999986654 5689999999999999999999999766543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.2e-32 Score=289.31 Aligned_cols=255 Identities=31% Similarity=0.520 Sum_probs=210.4
Q ss_pred CCCcEEEccCCcccc--cCCCCCCCCCCCceEEccc-CccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccce
Q 041878 115 HALRKLSLHDNLLAG--PVPWSLGFLPNLRGVYLFN-NRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYR 191 (773)
Q Consensus 115 ~~L~~L~L~~n~l~~--~~~~~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~ 191 (773)
.+++.|+|++|+++| .+|+.+++|++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+++|++
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 467888999988887 5788888888888888886 7888888888888888888888888888877877888888888
Q ss_pred eecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCC-ccEEE
Q 041878 192 LNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGL-LQEIS 270 (773)
Q Consensus 192 L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~-L~~L~ 270 (773)
+++++|.+.+.+|..+.+++.|+.+++++|.+++.+|..+. .+.. ++.++
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~-----------------------------~l~~l~~~l~ 180 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG-----------------------------SFSKLFTSMT 180 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGG-----------------------------CCCTTCCEEE
T ss_pred cccccccccccCchhhccCcccceeeccccccccccccccc-----------------------------cccccccccc
Confidence 88888888888888888888888888887777776665443 3333 36677
Q ss_pred CCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCccccc
Q 041878 271 LSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKG 350 (773)
Q Consensus 271 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~ 350 (773)
+++|++++..|..+..+..+ .++++.|.+.+.+|..+..+++|+.|++++|.+++.+| .+..+++|+.|+|++|+++|
T Consensus 181 ~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g 258 (313)
T d1ogqa_ 181 ISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYG 258 (313)
T ss_dssp CCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEE
T ss_pred cccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecc
Confidence 77777777777776666444 68888888888888888888899999999999877655 58889999999999999999
Q ss_pred ccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeeccc-CCCC-Cc
Q 041878 351 HIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNN-LSGS-VP 401 (773)
Q Consensus 351 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~-l~g~-~p 401 (773)
.+|+.++++++|++|+|++|+|+|.+|. +.++++|+.+++++|+ ++|. +|
T Consensus 259 ~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp CCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEESTTSS
T ss_pred cCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCCCCC
Confidence 9999999999999999999999999984 6789999999999998 6764 44
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.9e-31 Score=286.11 Aligned_cols=201 Identities=22% Similarity=0.261 Sum_probs=160.3
Q ss_pred HHhhcccccccceEEEEEEe-CCCCEEEEEEecccCcccHHHHHHHHHHHHccC-----------CCceEEeEEEEEC-C
Q 041878 537 CATAEIMGKSTYGTAYKATL-EDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-----------HPNLLALRAYYLG-P 603 (773)
Q Consensus 537 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~-~ 603 (773)
|.+.++||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|++++++++ |+||+++++++.. .
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 46679999999999999986 5799999999975432 3457788999888875 5789999988743 3
Q ss_pred CCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCC------eEE
Q 041878 604 KGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTN------PRI 677 (773)
Q Consensus 604 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~------~kl 677 (773)
....+++++++..+..............++...+..++.||+.|++|||+..||+||||||+|||++.++. +++
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl 173 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 173 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeE
Confidence 34667777777666555444444445668889999999999999999995599999999999999987654 899
Q ss_pred eecCCccccccccccceeeccCccccccccccCCCCCCcchhhHHHHHHHHHHHcCCCCCCCCCC
Q 041878 678 ADFGLSRLMTAAANTNVIATAGTLGYRAPELSKLKNANTKTDVYSLGVIILELLTGKSPGEPMNG 742 (773)
Q Consensus 678 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws~Gv~l~el~tg~~P~~~~~~ 742 (773)
+|||.+....... ....||+.|+|||++....++.++||||+||+++||++|+.||.+.+.
T Consensus 174 ~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 174 ADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp CCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 9999987654322 335699999999999989999999999999999999999999987554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=7.9e-27 Score=243.61 Aligned_cols=279 Identities=22% Similarity=0.276 Sum_probs=191.1
Q ss_pred CCCCCCcceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCC
Q 041878 78 ACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPP 157 (773)
Q Consensus 78 ~c~~~w~gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~ 157 (773)
.|.|.|.+|.|+. .+++ .+|+.+. +.+++|+|++|+|+...+..|.++++|++|++++|.+....|.
T Consensus 7 ~c~c~~~~~~C~~----------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~ 73 (305)
T d1xkua_ 7 RCQCHLRVVQCSD----------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73 (305)
T ss_dssp TCEEETTEEECTT----------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTT
T ss_pred CCEecCCEEEecC----------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchh
Confidence 4555578888853 3344 4565553 5789999999999866666789999999999999999977788
Q ss_pred CCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccC
Q 041878 158 SIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGN 237 (773)
Q Consensus 158 ~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~ 237 (773)
.|.++++|++|++++|+++ .+|..+ ...|+.|+++.|.+.+..+..+.....+..++...|.....
T Consensus 74 ~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~----------- 139 (305)
T d1xkua_ 74 AFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS----------- 139 (305)
T ss_dssp TTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGG-----------
T ss_pred hhhCCCccCEecccCCccC-cCccch--hhhhhhhhccccchhhhhhhhhhcccccccccccccccccc-----------
Confidence 8999999999999999988 455543 34688888888888866666666666777777766654311
Q ss_pred cccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceE
Q 041878 238 KSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSL 317 (773)
Q Consensus 238 ~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 317 (773)
...+..+..+++|+.+++++|+++. +|..+ +++|++|++++|.+++..+..|..++.++.|
T Consensus 140 ----------------~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L 200 (305)
T d1xkua_ 140 ----------------GIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKL 200 (305)
T ss_dssp ----------------GBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred ----------------CCCccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhcccccccc
Confidence 1223344455566666666666652 33332 3566666666666666666666666677777
Q ss_pred EccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCch------hhccCccCEEEe
Q 041878 318 NLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPS------LASLANLTSFNV 391 (773)
Q Consensus 318 ~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~------~~~l~~L~~L~l 391 (773)
++++|.+++..+..+..+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|+...... ...+.+|+.|+|
T Consensus 201 ~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L 279 (305)
T d1xkua_ 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 279 (305)
T ss_dssp ECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEEC
T ss_pred ccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEEC
Confidence 77777776666666667777777777777776 45667777777777777777776432222 234567888888
Q ss_pred ecccCC-CCCchh
Q 041878 392 SYNNLS-GSVPPL 403 (773)
Q Consensus 392 s~N~l~-g~~p~~ 403 (773)
++|+++ ..+++.
T Consensus 280 ~~N~~~~~~~~~~ 292 (305)
T d1xkua_ 280 FSNPVQYWEIQPS 292 (305)
T ss_dssp CSSSSCGGGSCGG
T ss_pred CCCcCccCcCCHh
Confidence 888875 455544
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=1.4e-26 Score=249.86 Aligned_cols=284 Identities=28% Similarity=0.374 Sum_probs=199.3
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
..+++|++++++++. + +.+..|++|++|+|++|+|++.. .++++++|++|+|++|++++.. .++.+++|+.|++
T Consensus 44 ~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~ 117 (384)
T d2omza2 44 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTL 117 (384)
T ss_dssp TTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc--ccccccccccccc
Confidence 468899999998874 3 46888999999999999999653 3999999999999999999653 3899999999999
Q ss_pred cCCCCCCCCccccccccccceeeccccccc-----------------------------------------ccCCccccC
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLL-----------------------------------------GSIPLSLTR 209 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~-----------------------------------------~~~~~~l~~ 209 (773)
++|.+++..+. .....+..+....|.+. ......+..
T Consensus 118 ~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (384)
T d2omza2 118 FNNQITDIDPL--KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195 (384)
T ss_dssp CSSCCCCCGGG--TTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGG
T ss_pred ccccccccccc--cccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccccccccc
Confidence 99998753221 22223333333332221 012234556
Q ss_pred CCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccc
Q 041878 210 LPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSK 289 (773)
Q Consensus 210 l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 289 (773)
+++++.+++++|.+++..|. . ...+|++|++++|.++.. ..+..+++|+.|++++|++++.. .+..+++
T Consensus 196 l~~~~~l~l~~n~i~~~~~~--~-----~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~ 264 (384)
T d2omza2 196 LTNLESLIATNNQISDITPL--G-----ILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTK 264 (384)
T ss_dssp CTTCSEEECCSSCCCCCGGG--G-----GCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTT
T ss_pred ccccceeeccCCccCCCCcc--c-----ccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--ccccccc
Confidence 67778888888877754432 1 123678888888877753 35667778888888888877543 3667778
Q ss_pred cceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCC
Q 041878 290 LQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSE 369 (773)
Q Consensus 290 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~ 369 (773)
|++|++++|++++.. .+..++.++.++++.|++++. ..+..+++++.|++++|++++.. .+..+++|++|+|++
T Consensus 265 L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~ 338 (384)
T d2omza2 265 LTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFAN 338 (384)
T ss_dssp CSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCS
T ss_pred CCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCC
Confidence 888888888777543 256677777777777777652 34667777777788887777543 266777788888888
Q ss_pred ccCccCCCchhhccCccCEEEeecccCCCCCc
Q 041878 370 NDFTGEISPSLASLANLTSFNVSYNNLSGSVP 401 (773)
Q Consensus 370 N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p 401 (773)
|++++ ++ .+..+++|+.|++++|++++..|
T Consensus 339 n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 339 NKVSD-VS-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp SCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred CCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence 87774 33 57777778888888887776544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=4e-26 Score=238.20 Aligned_cols=244 Identities=26% Similarity=0.305 Sum_probs=187.0
Q ss_pred CCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecc
Q 041878 116 ALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLS 195 (773)
Q Consensus 116 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls 195 (773)
.++.++-++++++ .+|..+. ++|++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 3456777777777 5565553 567777777777775444567777777777777777776656667777777777777
Q ss_pred cccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCc
Q 041878 196 YNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNK 275 (773)
Q Consensus 196 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~ 275 (773)
+|+++. +|..+ .+. ++.|.+.+|.+.+..+..+.....+..++...|.
T Consensus 88 ~n~l~~-l~~~~--~~~-----------------------------l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~ 135 (305)
T d1xkua_ 88 KNQLKE-LPEKM--PKT-----------------------------LQELRVHENEITKVRKSVFNGLNQMIVVELGTNP 135 (305)
T ss_dssp SSCCSB-CCSSC--CTT-----------------------------CCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSC
T ss_pred CCccCc-Cccch--hhh-----------------------------hhhhhccccchhhhhhhhhhcccccccccccccc
Confidence 776662 33211 123 4455555555554445556666777888888875
Q ss_pred cc--CCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccc
Q 041878 276 IV--GPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIP 353 (773)
Q Consensus 276 l~--~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~ 353 (773)
.. ...+..+..+++|+.+++++|.++. +|..+ +++|+.|++++|.++...+..+..++.+++|++++|.+.+..+
T Consensus 136 ~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~ 212 (305)
T d1xkua_ 136 LKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN 212 (305)
T ss_dssp CCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECT
T ss_pred ccccCCCccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccc
Confidence 53 3456678889999999999999984 45443 5799999999999999999999999999999999999999889
Q ss_pred cccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCC
Q 041878 354 ETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSG 398 (773)
Q Consensus 354 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g 398 (773)
..+.++++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+.
T Consensus 213 ~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 213 GSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp TTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred ccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCc
Confidence 99999999999999999998 678899999999999999999985
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.5e-26 Score=238.70 Aligned_cols=222 Identities=24% Similarity=0.253 Sum_probs=132.5
Q ss_pred EEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEcc-CC
Q 041878 95 AIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLS-NN 173 (773)
Q Consensus 95 ~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls-~N 173 (773)
.++.++++++ .+|..+. +.+++|+|++|+|+...+..|.++++|++|++++|++....+..+..+..++.++.+ .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 3445555665 5555443 467788888888876666678888888888888888887777777777778777664 45
Q ss_pred CCCCCCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccc
Q 041878 174 ALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIA 253 (773)
Q Consensus 174 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~ 253 (773)
.++...+..+.++++|++|++++|.+....+..+...++|+.+++++|++++..+..|.... +|+.|++++|+++
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~-----~L~~L~l~~N~l~ 166 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG-----NLTHLFLHGNRIS 166 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT-----TCCEEECCSSCCC
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhcccc-----chhhcccccCccc
Confidence 55555566677777777777777777655566666666666677666666643333332222 4444555555444
Q ss_pred cccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCC
Q 041878 254 GTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRL 324 (773)
Q Consensus 254 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 324 (773)
+..+..|..+++|+.+++++|++++..|..|..+++|++|++++|++++..+..|..+++|+.|+|++|++
T Consensus 167 ~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l 237 (284)
T d1ozna_ 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237 (284)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCE
T ss_pred ccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCC
Confidence 44444444444444444444444444444444444444444444444444444444444444444444444
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.93 E-value=1e-25 Score=243.04 Aligned_cols=278 Identities=28% Similarity=0.362 Sum_probs=216.8
Q ss_pred CCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCc
Q 041878 101 RRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIP 180 (773)
Q Consensus 101 ~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~ 180 (773)
.++++.+. ..++.+|++|++++|+|+. + +.+..+++|++|+|++|+|++.. .++++++|++|+|++|++.+. +
T Consensus 32 ~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i-~ 104 (384)
T d2omza2 32 TNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADI-T 104 (384)
T ss_dssp SSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G
T ss_pred CCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccccc-c
Confidence 34444443 3577899999999999985 3 46889999999999999999653 399999999999999999854 3
Q ss_pred cccccccccceeecccccccccCCccccCCCccceeeccccccccccCCc-------------------c----------
Q 041878 181 PSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNN-------------------W---------- 231 (773)
Q Consensus 181 ~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-------------------~---------- 231 (773)
.++++++|+.|++++|.+++..+. .....+..+....|.+....+.. +
T Consensus 105 -~l~~l~~L~~L~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (384)
T d2omza2 105 -PLANLTNLTGLTLFNNQITDIDPL--KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLD 181 (384)
T ss_dssp -GGTTCTTCCEEECCSSCCCCCGGG--TTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEE
T ss_pred -cccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccchhhhhcccccccccc
Confidence 488999999999999999864432 23344444444444432110000 0
Q ss_pred -------cccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccC
Q 041878 232 -------GVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSF 304 (773)
Q Consensus 232 -------~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 304 (773)
.......+++++.+++++|.+++..| +..+++|++|++++|++++. ..+..+++|+.|++++|.+++..
T Consensus 182 ~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~ 257 (384)
T d2omza2 182 ISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA 257 (384)
T ss_dssp CCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG
T ss_pred ccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC
Confidence 00111234589999999999997655 45678999999999999853 46888999999999999999654
Q ss_pred cccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCCCchhhccC
Q 041878 305 PVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLA 384 (773)
Q Consensus 305 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 384 (773)
+ +..+++|++|++++|++++..+ +..++.++.+++++|.+.+. ..+..+++++.|++++|++++.. .+..++
T Consensus 258 ~--~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~ 329 (384)
T d2omza2 258 P--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLT 329 (384)
T ss_dssp G--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCT
T ss_pred c--ccccccCCEeeccCcccCCCCc--cccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCC
Confidence 4 7889999999999999986543 77889999999999999863 45788999999999999999753 388899
Q ss_pred ccCEEEeecccCCCCCc
Q 041878 385 NLTSFNVSYNNLSGSVP 401 (773)
Q Consensus 385 ~L~~L~ls~N~l~g~~p 401 (773)
+|+.|++++|++++ +|
T Consensus 330 ~L~~L~L~~n~l~~-l~ 345 (384)
T d2omza2 330 KLQRLFFANNKVSD-VS 345 (384)
T ss_dssp TCCEEECCSSCCCC-CG
T ss_pred CCCEEECCCCCCCC-Ch
Confidence 99999999999986 44
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.7e-26 Score=238.41 Aligned_cols=269 Identities=25% Similarity=0.281 Sum_probs=189.3
Q ss_pred cEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecc-c
Q 041878 118 RKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLS-Y 196 (773)
Q Consensus 118 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls-~ 196 (773)
..++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|++++|.+....+..+..++.++.++.. .
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 34677787887 6676553 678999999999997666789999999999999999998888888888889888764 6
Q ss_pred ccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcc
Q 041878 197 NSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKI 276 (773)
Q Consensus 197 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l 276 (773)
|.++...+..+.++++|++|++++|.+....+..+.... +|+.+++++|.++++.+..|..+++|+.|++++|++
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-----~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l 165 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLA-----ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCT-----TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhc-----ccchhhhccccccccChhHhccccchhhcccccCcc
Confidence 677777788889999999999999988755444443333 677777777777766667777777777777777777
Q ss_pred cCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCccccccccccc
Q 041878 277 VGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETI 356 (773)
Q Consensus 277 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~ 356 (773)
++..+..|.++++|+++++++|++++..|..|..+++|++|++++|++++..+..+..+++|++|++++|.+...-+. .
T Consensus 166 ~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~ 244 (284)
T d1ozna_ 166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-R 244 (284)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-H
T ss_pred cccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-h
Confidence 766666777777777777777777776677777777777777777777766666677777777777777766643221 1
Q ss_pred CCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCC
Q 041878 357 GNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSG 398 (773)
Q Consensus 357 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g 398 (773)
.-...++.+....+++....|..+.+ +..++++.+.|+|
T Consensus 245 ~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 245 PLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp HHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred HHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 11123444555555555555554432 2333445555544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=1.3e-23 Score=214.05 Aligned_cols=138 Identities=23% Similarity=0.237 Sum_probs=93.9
Q ss_pred CCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccc
Q 041878 262 KLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVL 341 (773)
Q Consensus 262 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 341 (773)
.+++|++|+|++|++++ .+..+..+++|++|++++|.+.+..+..+..+.+++.|++++|.++...+..+..+++|+.|
T Consensus 75 ~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l 153 (266)
T d1p9ag_ 75 TLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153 (266)
T ss_dssp CCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred ccccccccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhc
Confidence 34455555555555552 34455555666666666666665555556666666667777776666666666667777777
Q ss_pred cccCcccccccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCCc
Q 041878 342 NLKNNQFKGHIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSVP 401 (773)
Q Consensus 342 ~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~p 401 (773)
++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|.|.+.
T Consensus 154 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp ECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred ccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 77777777666677777888888888888887 677777778888888888888877653
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3.4e-23 Score=210.95 Aligned_cols=114 Identities=26% Similarity=0.213 Sum_probs=73.1
Q ss_pred CCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccc
Q 041878 260 LGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLT 339 (773)
Q Consensus 260 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 339 (773)
+..+++|+.|++++|.+.+..+..+..+.++++|++++|.++...+..+..+++|+.|++++|++++..+..+..+++|+
T Consensus 96 ~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~ 175 (266)
T d1p9ag_ 96 GQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175 (266)
T ss_dssp TTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCC
T ss_pred cccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccc
Confidence 44444555555555555544445555555666666666666655555556666666666666666666666666677777
Q ss_pred cccccCcccccccccccCCCCcCceeecCCccCcc
Q 041878 340 VLNLKNNQFKGHIPETIGNISGINQLDLSENDFTG 374 (773)
Q Consensus 340 ~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (773)
+|+|++|+|+ .+|+.+..+++|+.|+|++|++..
T Consensus 176 ~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 176 TLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp EEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred eeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 7777777776 667777777778888888887763
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=2.9e-23 Score=200.13 Aligned_cols=164 Identities=18% Similarity=0.168 Sum_probs=120.4
Q ss_pred HhhcccccccceEEEEEEeCCCCEEEEEEecccCc------------------ccHHHHHHHHHHHHccCCCceEEeEEE
Q 041878 538 ATAEIMGKSTYGTAYKATLEDGSEVAVKRLREKTT------------------KGQKEFEAEAAAIGKIHHPNLLALRAY 599 (773)
Q Consensus 538 ~~~~~lG~G~fg~Vy~~~~~~g~~vAvK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 599 (773)
+++++||+|+||+||+|...+|+.||||+++.... ........|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35789999999999999988999999998753211 012335568889999999999888765
Q ss_pred EECCCCeEEEEEeecCCCCHHHHHhhcCCCCccCHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCEEeCCCCCeEEee
Q 041878 600 YLGPKGEKLLVFDFMPKGSLASFLHARGPETIVNWATRMSIAIGIARGLNYLHVEENMIHGNLTSSNVLLDEKTNPRIAD 679 (773)
Q Consensus 600 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~al~yLH~~~~iiH~Dik~~NIll~~~~~~kl~D 679 (773)
. ..++||||+++..+.+ ++......++.|+++|++||| +.||+||||||+|||+++++ ++++|
T Consensus 83 ~-----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH-~~giiHrDiKP~NILv~~~~-~~liD 145 (191)
T d1zara2 83 E-----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFY-HRGIVHGDLSQYNVLVSEEG-IWIID 145 (191)
T ss_dssp E-----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEEEETTE-EEECC
T ss_pred c-----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHh-hCCEEEccCChhheeeeCCC-EEEEE
Confidence 4 2479999998765432 223334678999999999999 99999999999999999765 89999
Q ss_pred cCCccccccccccceeeccCcccccccc-----ccCCCCCCcchhhHHHHHHH
Q 041878 680 FGLSRLMTAAANTNVIATAGTLGYRAPE-----LSKLKNANTKTDVYSLGVII 727 (773)
Q Consensus 680 fG~a~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~Dvws~Gv~l 727 (773)
||.|.....+.... |.... .+....|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~~---------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWRE---------ILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHHH---------HHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcHH---------HHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99987654332211 11110 01235678899999975443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=3.1e-19 Score=178.64 Aligned_cols=225 Identities=16% Similarity=0.122 Sum_probs=140.0
Q ss_pred CCCCCCcceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCC-C
Q 041878 78 ACSGGWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSI-P 156 (773)
Q Consensus 78 ~c~~~w~gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~-p 156 (773)
.|.|..+.|.|. +.+++ .+|+.+. +.+++|+|++|.|+...+..|.++++|++|+|++|.+...+ +
T Consensus 5 ~C~C~~~~i~c~----------~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~ 71 (242)
T d1xwdc1 5 ICHCSNRVFLCQ----------ESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 71 (242)
T ss_dssp SEEECSSEEEEE----------SCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECS
T ss_pred cCCCcCCEEEEe----------CCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeec
Confidence 354445556664 33444 4554442 46788888888887655667788888888888888776544 3
Q ss_pred CCCCCCCCCCEEEccC-CCCCCCCccccccccccceeecccccccccCCc-cccCCCccceeeccccccccccCCccccc
Q 041878 157 PSIGNCPNLQTLDLSN-NALIGAIPPSLANSTRLYRLNLSYNSLLGSIPL-SLTRLPSLSVLALQHNNLSGSVPNNWGVL 234 (773)
Q Consensus 157 ~~l~~l~~L~~L~Ls~-N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 234 (773)
..|.+++++++|++.. |.+....+..|.++++|++|++++|++....+. .+..+..+..+...++++.
T Consensus 72 ~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~---------- 141 (242)
T d1xwdc1 72 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH---------- 141 (242)
T ss_dssp SSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC----------
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccccccc----------
Confidence 4567778888877653 566666666777777777777777777632221 2223344444444444443
Q ss_pred ccCcccccceeeccccccccccCccCCCCC-CccEEECCCCcccCCCCCCcCccccc-ceeccccccccccCcccccccc
Q 041878 235 AGNKSYQLQFLNLDHNLIAGTIPVSLGKLG-LLQEISLSHNKIVGPIPDELGKLSKL-QKLDLSYNAIGGSFPVTFTNIT 312 (773)
Q Consensus 235 ~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~ 312 (773)
...+..+..++ .++.|++++|+++...+..+. ..++ +.+++++|+++...+..|.+++
T Consensus 142 -------------------~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~ 201 (242)
T d1xwdc1 142 -------------------TIERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGAS 201 (242)
T ss_dssp -------------------EECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSC
T ss_pred -------------------cccccccccccccceeeeccccccccccccccc-chhhhccccccccccccccHHHhcCCC
Confidence 33334444433 566677777777644333333 3343 3445667777755555677788
Q ss_pred cCceEEccCCCCCCCcchhhccccccccccccC
Q 041878 313 SLVSLNLENNRLGNKIPEGLERLQNLTVLNLKN 345 (773)
Q Consensus 313 ~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~ 345 (773)
+|++|+|++|+++...+..+.++++|+.|++.+
T Consensus 202 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 202 GPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred CCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 888888888888766566677788888877654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=9.1e-19 Score=175.18 Aligned_cols=221 Identities=17% Similarity=0.182 Sum_probs=166.0
Q ss_pred cEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCC-ccccccccccceeecc-
Q 041878 118 RKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAI-PPSLANSTRLYRLNLS- 195 (773)
Q Consensus 118 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~Ls- 195 (773)
+.++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 56788888887 6676553 57899999999998555567888999999999999887544 4467788888888775
Q ss_pred cccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCc
Q 041878 196 YNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNK 275 (773)
Q Consensus 196 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~ 275 (773)
.|++....+..|.++++|++|++++|+++.. +. ...+..+..+..+...+++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~-~~---------------------------~~~~~~l~~l~~~~~~n~~ 139 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHL-PD---------------------------VHKIHSLQKVLLDIQDNIN 139 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSC-CC---------------------------CTTTCBSSCEEEEEESCTT
T ss_pred cccccccccccccccccccccccchhhhccc-cc---------------------------ccccccccccccccccccc
Confidence 4677767777778888888888888777521 11 1123445667777778888
Q ss_pred ccCCCCCCcCccc-ccceeccccccccccCcccccccccCceE-EccCCCCCCCcchhhccccccccccccCcccccccc
Q 041878 276 IVGPIPDELGKLS-KLQKLDLSYNAIGGSFPVTFTNITSLVSL-NLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIP 353 (773)
Q Consensus 276 l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~ 353 (773)
+....+..|..++ .++.|++++|+++...+..+ ..+++.++ ++++|+++...+..|.++++|++|++++|+++...+
T Consensus 140 l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~ 218 (242)
T d1xwdc1 140 IHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218 (242)
T ss_dssp CCEECTTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCS
T ss_pred cccccccccccccccceeeecccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCH
Confidence 8866667777664 78999999999996555544 44555555 678889987667779999999999999999996666
Q ss_pred cccCCCCcCceeecCCc
Q 041878 354 ETIGNISGINQLDLSEN 370 (773)
Q Consensus 354 ~~~~~l~~L~~L~L~~N 370 (773)
..|.++++|+.|++.+.
T Consensus 219 ~~~~~l~~L~~l~~~~l 235 (242)
T d1xwdc1 219 YGLENLKKLRARSTYNL 235 (242)
T ss_dssp SSCTTCCEEESSSEESS
T ss_pred HHHcCCcccccCcCCCC
Confidence 67889999988887543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.78 E-value=4.5e-18 Score=179.91 Aligned_cols=269 Identities=26% Similarity=0.307 Sum_probs=164.3
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEc
Q 041878 91 GQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDL 170 (773)
Q Consensus 91 ~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 170 (773)
.+++.|||++++++ .+|+. +++|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++.. .+.|++|+|
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 45778999999997 47753 468999999999998 66765 458899999999988 33321 146999999
Q ss_pred cCCCCCCCCccccccccccceeecccccccccCC------------------ccccCCCccceeeccccccccccCCccc
Q 041878 171 SNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIP------------------LSLTRLPSLSVLALQHNNLSGSVPNNWG 232 (773)
Q Consensus 171 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~------------------~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 232 (773)
++|.+. .+|. ++.+++|++|++++|.+..... ..+..++.++.|++++|..... +...
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~-~~~~- 181 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKL-PDLP- 181 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSC-CCCC-
T ss_pred cccccc-cccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceeccccccccccc-cccc-
Confidence 999998 5564 6789999999999998863221 1122333444444444443311 1100
Q ss_pred ccccCcccccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccc
Q 041878 233 VLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNIT 312 (773)
Q Consensus 233 ~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 312 (773)
...+.+...++.+. . ...+..++.|+.+++++|.... ++.. ..++..+.+..|.+... +.. ..
T Consensus 182 -------~~~~~l~~~~~~~~-~-~~~~~~l~~L~~l~l~~n~~~~-~~~~---~~~l~~~~~~~~~~~~~-~~~---~~ 244 (353)
T d1jl5a_ 182 -------LSLESIVAGNNILE-E-LPELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDL-PEL---PQ 244 (353)
T ss_dssp -------TTCCEEECCSSCCS-S-CCCCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCC-CCC---CT
T ss_pred -------cccccccccccccc-c-cccccccccccccccccccccc-cccc---ccccccccccccccccc-ccc---cc
Confidence 01223333333332 1 1234556777777777776653 3332 23455566666655422 111 12
Q ss_pred cCceEEccCCCCCC----------------CcchhhccccccccccccCcccccccccccCCCCcCceeecCCccCccCC
Q 041878 313 SLVSLNLENNRLGN----------------KIPEGLERLQNLTVLNLKNNQFKGHIPETIGNISGINQLDLSENDFTGEI 376 (773)
Q Consensus 313 ~L~~L~Ls~N~l~~----------------~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 376 (773)
++..+++..|.+.+ .++.....+++|++|+|++|+++ .+|.. +++|+.|+|++|+|+ .+
T Consensus 245 ~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l 319 (353)
T d1jl5a_ 245 SLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EV 319 (353)
T ss_dssp TCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CC
T ss_pred cccccccccccccccccccchhcccccccCccccccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-cc
Confidence 23333333322211 01111223568888899888888 56643 577888889888888 56
Q ss_pred CchhhccCccCEEEeecccCCCCCc
Q 041878 377 SPSLASLANLTSFNVSYNNLSGSVP 401 (773)
Q Consensus 377 ~~~~~~l~~L~~L~ls~N~l~g~~p 401 (773)
|.. +++|+.|+|++|+|+ .+|
T Consensus 320 ~~~---~~~L~~L~L~~N~L~-~lp 340 (353)
T d1jl5a_ 320 PEL---PQNLKQLHVEYNPLR-EFP 340 (353)
T ss_dssp CCC---CTTCCEEECCSSCCS-SCC
T ss_pred ccc---cCCCCEEECcCCcCC-CCC
Confidence 643 457888899988887 455
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=1.4e-19 Score=179.32 Aligned_cols=204 Identities=25% Similarity=0.343 Sum_probs=98.1
Q ss_pred cEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccc
Q 041878 118 RKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197 (773)
Q Consensus 118 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N 197 (773)
..++++.+.+++.+ .+..+.+|++|++++|+|+. + +.+.++++|++|+|++|.+++.. .+..+++|++|++++|
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGN 95 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeeccc--cccccccccccccccc
Confidence 33445555555432 23445556666666666653 3 24566666666666666665332 2555666666666666
Q ss_pred cccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCCccc
Q 041878 198 SLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIV 277 (773)
Q Consensus 198 ~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~ 277 (773)
.++. + ..+.++++|+.+++++|...+.. .+...+.++.+.++.+.+.
T Consensus 96 ~~~~-i-~~l~~l~~L~~l~l~~~~~~~~~-------------------------------~~~~~~~~~~l~~~~~~~~ 142 (227)
T d1h6ua2 96 PLKN-V-SAIAGLQSIKTLDLTSTQITDVT-------------------------------PLAGLSNLQVLYLDLNQIT 142 (227)
T ss_dssp CCSC-C-GGGTTCTTCCEEECTTSCCCCCG-------------------------------GGTTCTTCCEEECCSSCCC
T ss_pred cccc-c-ccccccccccccccccccccccc-------------------------------hhccccchhhhhchhhhhc
Confidence 5542 2 23455555666666555544221 1122233333334333333
Q ss_pred CCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcccccccccccC
Q 041878 278 GPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPETIG 357 (773)
Q Consensus 278 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~~~~ 357 (773)
.. ..+...++|++|++++|.+++.. .+.++++|++|+|++|++++.. .++.+++|++|+|++|++++. + .++
T Consensus 143 ~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i-~-~l~ 214 (227)
T d1h6ua2 143 NI--SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDV-S-PLA 214 (227)
T ss_dssp CC--GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBC-G-GGT
T ss_pred hh--hhhccccccccccccccccccch--hhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCC-c-ccc
Confidence 21 11333344444444444443221 1444455555555555554321 245555555555555555532 2 255
Q ss_pred CCCcCceeecC
Q 041878 358 NISGINQLDLS 368 (773)
Q Consensus 358 ~l~~L~~L~L~ 368 (773)
++++|+.|+|+
T Consensus 215 ~l~~L~~L~ls 225 (227)
T d1h6ua2 215 NTSNLFIVTLT 225 (227)
T ss_dssp TCTTCCEEEEE
T ss_pred cCCCCCEEEee
Confidence 56666666654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=9e-19 Score=173.34 Aligned_cols=200 Identities=25% Similarity=0.383 Sum_probs=132.1
Q ss_pred cCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCC
Q 041878 98 LPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIG 177 (773)
Q Consensus 98 l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 177 (773)
+..+.+++.+ .++++.+|+.|++.+|+|+. + +.+..+++|++|+|++|++++..| +..+++|++|++++|.++.
T Consensus 26 l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~ 99 (227)
T d1h6ua2 26 AGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN 99 (227)
T ss_dssp TTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC
T ss_pred hCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc
Confidence 3344444432 45678899999999999985 4 368999999999999999986544 8999999999999999873
Q ss_pred CCccccccccccceeecccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccC
Q 041878 178 AIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIP 257 (773)
Q Consensus 178 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~ 257 (773)
+ ..+.++++|+++++++|...+. ..+...+.++.+.++.+.+....+
T Consensus 100 -i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~----------------------------- 146 (227)
T d1h6ua2 100 -V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP----------------------------- 146 (227)
T ss_dssp -C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG-----------------------------
T ss_pred -c-cccccccccccccccccccccc--chhccccchhhhhchhhhhchhhh-----------------------------
Confidence 3 4688999999999999987643 335667778888887777653221
Q ss_pred ccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccc
Q 041878 258 VSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQN 337 (773)
Q Consensus 258 ~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 337 (773)
+..+++|+.|++++|.+.+. ..+..+++|++|+|++|++++. + .+.++++|++|+|++|++++..| +..+++
T Consensus 147 --~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~ 218 (227)
T d1h6ua2 147 --LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSN 218 (227)
T ss_dssp --GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTT
T ss_pred --hccccccccccccccccccc--hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCC
Confidence 22334444445544444422 1244455555555555555432 2 24555566666666666554322 555666
Q ss_pred ccccccc
Q 041878 338 LTVLNLK 344 (773)
Q Consensus 338 L~~L~ls 344 (773)
|++|+++
T Consensus 219 L~~L~ls 225 (227)
T d1h6ua2 219 LFIVTLT 225 (227)
T ss_dssp CCEEEEE
T ss_pred CCEEEee
Confidence 6666654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=5.4e-19 Score=169.90 Aligned_cols=130 Identities=27% Similarity=0.304 Sum_probs=113.3
Q ss_pred EEEcCCCCcccccCccccCCCCCcEEEccCCccccc-CCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCC
Q 041878 95 AIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGP-VPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNN 173 (773)
Q Consensus 95 ~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~-~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N 173 (773)
.++.++++++ .+|+.+. +++++|+|++|.|++. .+..|..+++|++|+|++|++.+..+..+..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 3455666776 5676553 6899999999999864 4667899999999999999999999999999999999999999
Q ss_pred CCCCCCccccccccccceeecccccccccCCccccCCCccceeecccccccccc
Q 041878 174 ALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSV 227 (773)
Q Consensus 174 ~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 227 (773)
+|+...+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+....
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence 999888888999999999999999999888899999999999999999987543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.73 E-value=1.9e-16 Score=167.08 Aligned_cols=264 Identities=25% Similarity=0.296 Sum_probs=174.8
Q ss_pred CCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeec
Q 041878 115 HALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNL 194 (773)
Q Consensus 115 ~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L 194 (773)
.++++|||++|+++ .+|+. +++|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++. + .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h--ccccccccc
Confidence 46899999999998 57753 578999999999999 77865 468999999999998 4442 1 146999999
Q ss_pred ccccccccCCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCC
Q 041878 195 SYNSLLGSIPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHN 274 (773)
Q Consensus 195 s~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N 274 (773)
++|.+. .+|. +..+++|++|++++|.++... ... ..+..+.+..+... ....+..++.++.|++++|
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~-~~~--------~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n 172 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLP-DLP--------PSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNN 172 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCC-CCC--------TTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSS
T ss_pred cccccc-cccc-hhhhccceeeccccccccccc-ccc--------ccccchhhcccccc--ccccccccccceecccccc
Confidence 999998 4554 578999999999999987432 221 14556666555443 2344566677777777777
Q ss_pred cccCCC------------------CCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhcccc
Q 041878 275 KIVGPI------------------PDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQ 336 (773)
Q Consensus 275 ~l~~~~------------------p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 336 (773)
.+.... ...+..++.|+.+++++|.... .+. ...++..+.+.+|++.... ... .
T Consensus 173 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~~-~~~---~ 244 (353)
T d1jl5a_ 173 SLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDLP-ELP---Q 244 (353)
T ss_dssp CCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCCC-CCC---T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc-ccc---ccccccccccccccccccc-ccc---c
Confidence 654311 1224556777888888777653 332 2356777777777775432 111 1
Q ss_pred ccccccccCccccc----------------ccccccCCCCcCceeecCCccCccCCCchhhccCccCEEEeecccCCCCC
Q 041878 337 NLTVLNLKNNQFKG----------------HIPETIGNISGINQLDLSENDFTGEISPSLASLANLTSFNVSYNNLSGSV 400 (773)
Q Consensus 337 ~L~~L~ls~N~l~~----------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ls~N~l~g~~ 400 (773)
.+..+++..|.+.+ .++.....+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+
T Consensus 245 ~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l 319 (353)
T d1jl5a_ 245 SLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EV 319 (353)
T ss_dssp TCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CC
T ss_pred cccccccccccccccccccchhcccccccCccccccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-cc
Confidence 22222222222211 11122234689999999999999 56754 578999999999998 56
Q ss_pred chhhhccCCCCCCCCCC
Q 041878 401 PPLLSKKFNSSSFVGNL 417 (773)
Q Consensus 401 p~~~~~~~~~~~~~~n~ 417 (773)
|... ..+....+.+|+
T Consensus 320 ~~~~-~~L~~L~L~~N~ 335 (353)
T d1jl5a_ 320 PELP-QNLKQLHVEYNP 335 (353)
T ss_dssp CCCC-TTCCEEECCSSC
T ss_pred cccc-CCCCEEECcCCc
Confidence 6543 334444455553
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=3.5e-18 Score=164.12 Aligned_cols=109 Identities=26% Similarity=0.402 Sum_probs=47.1
Q ss_pred CccEEECCCCcccCCC-CCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccc
Q 041878 265 LLQEISLSHNKIVGPI-PDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNL 343 (773)
Q Consensus 265 ~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~l 343 (773)
++++|+|++|+|++.+ +..|.++++|++|+|++|.+....+..|..+++|++|+|++|+|+...+..|.++++|++|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence 3444444444443321 233344444444444444444444444444444444444444444433444444444444444
Q ss_pred cCcccccccccccCCCCcCceeecCCccCc
Q 041878 344 KNNQFKGHIPETIGNISGINQLDLSENDFT 373 (773)
Q Consensus 344 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 373 (773)
++|+|++..+..|..+++|++|+|++|++.
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCccccccCHHHhcCCcccccccccccccc
Confidence 444444444444444444444444444444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=1e-17 Score=163.18 Aligned_cols=80 Identities=24% Similarity=0.397 Sum_probs=35.3
Q ss_pred CCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceee
Q 041878 114 LHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLN 193 (773)
Q Consensus 114 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 193 (773)
+..|++|++++|.++.. + .+..+++|++|+|++|+|++.. .++.+++|++|++++|++++ +| .+..+++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccc
Confidence 34455555555554422 1 2444445555555555444321 23444445555554444442 22 244444444444
Q ss_pred cccccc
Q 041878 194 LSYNSL 199 (773)
Q Consensus 194 Ls~N~l 199 (773)
+++|.+
T Consensus 119 l~~~~~ 124 (210)
T d1h6ta2 119 LEHNGI 124 (210)
T ss_dssp CTTSCC
T ss_pred cccccc
Confidence 444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=8.7e-18 Score=163.76 Aligned_cols=99 Identities=28% Similarity=0.309 Sum_probs=61.3
Q ss_pred cEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccc
Q 041878 118 RKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197 (773)
Q Consensus 118 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N 197 (773)
....+..+.+++.++. ..+.+|++|++++|.++.. + .+..+++|++|+|++|.+++. + .++.+++|++|++++|
T Consensus 27 i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n 100 (210)
T d1h6ta2 27 IKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDEN 100 (210)
T ss_dssp HHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSS
T ss_pred HHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccc
Confidence 3345666666654432 3456777778877777743 2 367777777777777777643 3 3566777777777777
Q ss_pred cccccCCccccCCCccceeeccccccc
Q 041878 198 SLLGSIPLSLTRLPSLSVLALQHNNLS 224 (773)
Q Consensus 198 ~l~~~~~~~l~~l~~L~~L~L~~N~l~ 224 (773)
++++ ++ .+.++++|+.|++++|.+.
T Consensus 101 ~i~~-l~-~l~~l~~L~~L~l~~~~~~ 125 (210)
T d1h6ta2 101 KVKD-LS-SLKDLKKLKSLSLEHNGIS 125 (210)
T ss_dssp CCCC-GG-GGTTCTTCCEEECTTSCCC
T ss_pred cccc-cc-ccccccccccccccccccc
Confidence 7663 22 3555666666666655543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=3.4e-17 Score=158.13 Aligned_cols=81 Identities=25% Similarity=0.338 Sum_probs=36.1
Q ss_pred CCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccccccccCCccccCCCccceee
Q 041878 138 LPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLLGSIPLSLTRLPSLSVLA 217 (773)
Q Consensus 138 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ 217 (773)
+++|++|++++|.++. + +.++.+++|++|+|++|.+++. + .+.++++|++|++++|.+.. ++ .+.++++|+.|+
T Consensus 39 l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~-~-~l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCc-c-cccCCccccccccccccccc-cc-cccccccccccc
Confidence 3444444444444442 1 2244445555555555554432 1 14445555555555554432 11 244445555555
Q ss_pred ccccccc
Q 041878 218 LQHNNLS 224 (773)
Q Consensus 218 L~~N~l~ 224 (773)
+++|.+.
T Consensus 113 l~~~~~~ 119 (199)
T d2omxa2 113 LFNNQIT 119 (199)
T ss_dssp CCSSCCC
T ss_pred ccccccc
Confidence 5544443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=2.8e-20 Score=204.58 Aligned_cols=309 Identities=20% Similarity=0.207 Sum_probs=193.9
Q ss_pred CEEEEEcCCCCccccc-CccccCCCCCcEEEccCCcccc----cCCCCCCCCCCCceEEcccCccCCC----CCCCCC-C
Q 041878 92 QVIAIQLPWRRLGGRI-SEKISQLHALRKLSLHDNLLAG----PVPWSLGFLPNLRGVYLFNNRLSGS----IPPSIG-N 161 (773)
Q Consensus 92 ~v~~l~l~~~~l~~~i-~~~l~~l~~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~----~p~~l~-~ 161 (773)
++..||++++++++.. ...+..+++++.|+|++|+|+. .+...+..+++|++|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5778888888888643 4456677888889999888873 3455667888899999988888621 222332 2
Q ss_pred CCCCCEEEccCCCCCCC----CccccccccccceeecccccccccCCc--------------------------------
Q 041878 162 CPNLQTLDLSNNALIGA----IPPSLANSTRLYRLNLSYNSLLGSIPL-------------------------------- 205 (773)
Q Consensus 162 l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~~~~-------------------------------- 205 (773)
..+|++|+|++|.++.. ++..+..+++|++|+|++|.++.....
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 35788999998888743 345567788889999988877531000
Q ss_pred -cccCCCccceeecccccccccc-----------CCc----------ccc-------cccCcccccceeecccccccc--
Q 041878 206 -SLTRLPSLSVLALQHNNLSGSV-----------PNN----------WGV-------LAGNKSYQLQFLNLDHNLIAG-- 254 (773)
Q Consensus 206 -~l~~l~~L~~L~L~~N~l~~~~-----------p~~----------~~~-------l~~~~~~~L~~L~L~~n~l~~-- 254 (773)
.+.....++.++++++...... +.. +.. ........++.+++..|.+..
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 0112234555555555432100 000 000 000123468888888887643
Q ss_pred ---ccCccCCCCCCccEEECCCCcccCC----CCCCcCcccccceeccccccccccCcccc-----cccccCceEEccCC
Q 041878 255 ---TIPVSLGKLGLLQEISLSHNKIVGP----IPDELGKLSKLQKLDLSYNAIGGSFPVTF-----TNITSLVSLNLENN 322 (773)
Q Consensus 255 ---~~~~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~Ls~N 322 (773)
...........|+.|++++|.+... ....+...+.++.+++++|.+++.....+ .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 2333445567788888888877642 22234556778888888888764332222 12357888888888
Q ss_pred CCCCCcchhh----ccccccccccccCcccccc----cccccC-CCCcCceeecCCccCccC----CCchhhccCccCEE
Q 041878 323 RLGNKIPEGL----ERLQNLTVLNLKNNQFKGH----IPETIG-NISGINQLDLSENDFTGE----ISPSLASLANLTSF 389 (773)
Q Consensus 323 ~l~~~~~~~l----~~l~~L~~L~ls~N~l~~~----~~~~~~-~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L 389 (773)
.++......+ ...++|++|+|++|++++. +++.+. ..+.|++|+|++|.|+.. ++..+..+++|++|
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence 8776544443 3445788888888887653 333333 456688888888888743 33445566788888
Q ss_pred EeecccCCCCC
Q 041878 390 NVSYNNLSGSV 400 (773)
Q Consensus 390 ~ls~N~l~g~~ 400 (773)
+|++|+++...
T Consensus 403 ~Ls~N~i~~~g 413 (460)
T d1z7xw1 403 DLSNNCLGDAG 413 (460)
T ss_dssp ECCSSSCCHHH
T ss_pred ECCCCcCCHHH
Confidence 88888887543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=3.4e-17 Score=158.08 Aligned_cols=82 Identities=27% Similarity=0.351 Sum_probs=39.2
Q ss_pred CCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCcccccccccccee
Q 041878 113 QLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRL 192 (773)
Q Consensus 113 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L 192 (773)
++++|++|++++|.++. + +.+..+++|++|+|++|++++..| ++++++|++|++++|.+.. ++ .+.++++|+.|
T Consensus 38 ~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L 111 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL 111 (199)
T ss_dssp HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEE
T ss_pred HhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccc
Confidence 34455555555555542 1 234445555555555555553322 4555555555555555442 22 24455555555
Q ss_pred eccccccc
Q 041878 193 NLSYNSLL 200 (773)
Q Consensus 193 ~Ls~N~l~ 200 (773)
++++|.+.
T Consensus 112 ~l~~~~~~ 119 (199)
T d2omxa2 112 TLFNNQIT 119 (199)
T ss_dssp ECCSSCCC
T ss_pred cccccccc
Confidence 55555443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=1.6e-19 Score=198.45 Aligned_cols=284 Identities=21% Similarity=0.176 Sum_probs=195.5
Q ss_pred CCcEEEccCCcccccC-CCCCCCCCCCceEEcccCccCC----CCCCCCCCCCCCCEEEccCCCCCCCC----ccccc-c
Q 041878 116 ALRKLSLHDNLLAGPV-PWSLGFLPNLRGVYLFNNRLSG----SIPPSIGNCPNLQTLDLSNNALIGAI----PPSLA-N 185 (773)
Q Consensus 116 ~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~----~~~l~-~ 185 (773)
.|+.||+++|++++.. ...+..++++++|+|++|.|+. .++..+..+++|++|||++|.|+... ...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5899999999998632 3345678999999999999883 34556788999999999999986322 22232 2
Q ss_pred ccccceeeccccccccc----CCccccCCCccceeeccccccccccCCcccccc--------------------------
Q 041878 186 STRLYRLNLSYNSLLGS----IPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLA-------------------------- 235 (773)
Q Consensus 186 l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-------------------------- 235 (773)
..+|++|+|++|+++.. ++..+..+++|++|+|++|+++......+....
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 35799999999999854 456678899999999999997642111100000
Q ss_pred --cCcccccceeeccccccc-----------------------------cc----cCccCCCCCCccEEECCCCcccCC-
Q 041878 236 --GNKSYQLQFLNLDHNLIA-----------------------------GT----IPVSLGKLGLLQEISLSHNKIVGP- 279 (773)
Q Consensus 236 --~~~~~~L~~L~L~~n~l~-----------------------------~~----~~~~l~~l~~L~~L~L~~N~l~~~- 279 (773)
......++.++++.+.+. .. ....+...+.++.+++++|++...
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 001123444554444332 10 001122346789999999987431
Q ss_pred ----CCCCcCcccccceeccccccccccC----cccccccccCceEEccCCCCCCCcchhhc-----cccccccccccCc
Q 041878 280 ----IPDELGKLSKLQKLDLSYNAIGGSF----PVTFTNITSLVSLNLENNRLGNKIPEGLE-----RLQNLTVLNLKNN 346 (773)
Q Consensus 280 ----~p~~l~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-----~l~~L~~L~ls~N 346 (773)
.+........++.|++++|.+.... ...+...+.++.+++++|.+++.....+. ....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 2233445678999999999987532 33456678999999999999765444332 3468999999999
Q ss_pred ccccccccc----cCCCCcCceeecCCccCccCCCch----hh-ccCccCEEEeecccCCCC
Q 041878 347 QFKGHIPET----IGNISGINQLDLSENDFTGEISPS----LA-SLANLTSFNVSYNNLSGS 399 (773)
Q Consensus 347 ~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~~~~----~~-~l~~L~~L~ls~N~l~g~ 399 (773)
.++...... +...++|++|+|++|++++..... +. ..+.|+.|+|++|+++..
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~ 384 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 384 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChH
Confidence 998654333 345678999999999998643333 32 356799999999999753
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.61 E-value=3.8e-17 Score=167.09 Aligned_cols=222 Identities=20% Similarity=0.200 Sum_probs=128.2
Q ss_pred EEEcCCCCcccccCccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCC-CCCCCCCCCCCCEEEccCC
Q 041878 95 AIQLPWRRLGGRISEKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGS-IPPSIGNCPNLQTLDLSNN 173 (773)
Q Consensus 95 ~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~Ls~N 173 (773)
.+||+++.+.......+.. ..+..+.++...+..... ......+|++|||+++.++.. ++..+.++++|++|+|++|
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 5788887775433332222 234566666665553333 334556888899988887743 3445678888999999888
Q ss_pred CCCCCCccccccccccceeecccc-ccccc-CCccccCCCccceeecccc-ccccc-cCCcccccccCcccccceeeccc
Q 041878 174 ALIGAIPPSLANSTRLYRLNLSYN-SLLGS-IPLSLTRLPSLSVLALQHN-NLSGS-VPNNWGVLAGNKSYQLQFLNLDH 249 (773)
Q Consensus 174 ~l~~~~~~~l~~l~~L~~L~Ls~N-~l~~~-~~~~l~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~~~~~~L~~L~L~~ 249 (773)
.+++..+..++.+++|++|+|+++ .++.. +.....++++|++|+++++ .++.. +...+. ...++|+.|++++
T Consensus 82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~----~~~~~L~~L~l~~ 157 (284)
T d2astb2 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVA----HVSETITQLNLSG 157 (284)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHH----HSCTTCCEEECCS
T ss_pred CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhc----ccccccchhhhcc
Confidence 888777777888888888888885 55532 2223456788888888875 34321 111111 1123566666665
Q ss_pred c--ccccc-cCccCCCCCCccEEECCCC-cccCCCCCCcCcccccceeccccc-cccccCcccccccccCceEEccCC
Q 041878 250 N--LIAGT-IPVSLGKLGLLQEISLSHN-KIVGPIPDELGKLSKLQKLDLSYN-AIGGSFPVTFTNITSLVSLNLENN 322 (773)
Q Consensus 250 n--~l~~~-~~~~l~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N 322 (773)
+ .++.. +...+.++++|++|++++| .+++.....+.++++|++|+|++| .+++.....++++++|+.|+++++
T Consensus 158 ~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 158 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 3 23321 1122234556666666654 344444445555555666666553 455444444555555555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.60 E-value=2.4e-17 Score=173.98 Aligned_cols=95 Identities=19% Similarity=0.185 Sum_probs=55.9
Q ss_pred ccCccccCCCCCcEEEccCCcccc----cCCCCCCCCCCCceEEcccCccCCC----------CCCCCCCCCCCCEEEcc
Q 041878 106 RISEKISQLHALRKLSLHDNLLAG----PVPWSLGFLPNLRGVYLFNNRLSGS----------IPPSIGNCPNLQTLDLS 171 (773)
Q Consensus 106 ~i~~~l~~l~~L~~L~L~~n~l~~----~~~~~l~~l~~L~~L~L~~n~l~~~----------~p~~l~~l~~L~~L~Ls 171 (773)
.+...+.+...|+.|+|++|.|.. .+...+...++|+.|+++++.+... +...+..+++|++|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 344556677788888888887753 2344566677777777776654311 11224456667777777
Q ss_pred CCCCCCCCc----cccccccccceeeccccccc
Q 041878 172 NNALIGAIP----PSLANSTRLYRLNLSYNSLL 200 (773)
Q Consensus 172 ~N~l~~~~~----~~l~~l~~L~~L~Ls~N~l~ 200 (773)
+|.++.... ..+...++|++|++++|.++
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~ 134 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 134 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred ccccccccccchhhhhcccccchheeccccccc
Confidence 776654322 22334556666666666554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.57 E-value=3.1e-17 Score=173.11 Aligned_cols=254 Identities=18% Similarity=0.194 Sum_probs=149.4
Q ss_pred cCCCCCCCCCCCceEEcccCccCCC----CCCCCCCCCCCCEEEccCCCCCCC---Cc-------cccccccccceeecc
Q 041878 130 PVPWSLGFLPNLRGVYLFNNRLSGS----IPPSIGNCPNLQTLDLSNNALIGA---IP-------PSLANSTRLYRLNLS 195 (773)
Q Consensus 130 ~~~~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~---~~-------~~l~~l~~L~~L~Ls 195 (773)
.+...+.....|++|+|++|.|+.. +...+...++|+.|+++++..... .+ ..+...++|++|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 3445566788999999999988632 344577889999999998765421 11 223456778888888
Q ss_pred ccccccc----CCccccCCCccceeeccccccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEEC
Q 041878 196 YNSLLGS----IPLSLTRLPSLSVLALQHNNLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISL 271 (773)
Q Consensus 196 ~N~l~~~----~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L 271 (773)
+|.++.. +...+..+++|++|++++|.++......++. .|..+... ......+.|+.|++
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~-------~l~~~~~~---------~~~~~~~~L~~l~l 165 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR-------ALQELAVN---------KKAKNAPPLRSIIC 165 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH-------HHHHHHHH---------HHHHTCCCCCEEEC
T ss_pred ccccccccccchhhhhcccccchheecccccccccccccccc-------cccccccc---------cccccCcccceeec
Confidence 8888754 2334456678888888888765321111110 00000000 00112334556666
Q ss_pred CCCcccCC----CCCCcCcccccceecccccccccc-----CcccccccccCceEEccCCCCCCC----cchhhcccccc
Q 041878 272 SHNKIVGP----IPDELGKLSKLQKLDLSYNAIGGS-----FPVTFTNITSLVSLNLENNRLGNK----IPEGLERLQNL 338 (773)
Q Consensus 272 ~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~l~~l~~L 338 (773)
++|+++.. +...+...+.|+.|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|
T Consensus 166 ~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L 245 (344)
T d2ca6a1 166 GRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 245 (344)
T ss_dssp CSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTC
T ss_pred ccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccc
Confidence 66655422 122233445666666666666531 223455566777777777776543 23345566777
Q ss_pred ccccccCccccccccccc----C--CCCcCceeecCCccCccCCC----chhh-ccCccCEEEeecccCCCC
Q 041878 339 TVLNLKNNQFKGHIPETI----G--NISGINQLDLSENDFTGEIS----PSLA-SLANLTSFNVSYNNLSGS 399 (773)
Q Consensus 339 ~~L~ls~N~l~~~~~~~~----~--~l~~L~~L~L~~N~l~~~~~----~~~~-~l~~L~~L~ls~N~l~g~ 399 (773)
++|+|++|.+++.....+ . ..+.|++|+|++|+++.... ..+. ++++|+.|+|++|++...
T Consensus 246 ~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp CEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred hhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence 777777777765422222 2 24568888888888775332 2232 467888999999888654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=1.6e-16 Score=162.27 Aligned_cols=253 Identities=18% Similarity=0.172 Sum_probs=153.9
Q ss_pred cEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCC-Cccccccccccceeeccc
Q 041878 118 RKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGA-IPPSLANSTRLYRLNLSY 196 (773)
Q Consensus 118 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~~~~l~~l~~L~~L~Ls~ 196 (773)
++|||+++.+.......+.. ..+..+.++.+.+...+. ......+|++|||++|.++.. +...+..+++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 47888888775322211111 234566676666653333 334556888888888887643 334456778888888888
Q ss_pred ccccccCCccccCCCccceeecccc-ccccccCCcccccccCcccccceeeccccccccccCccCCCCCCccEEECCCC-
Q 041878 197 NSLLGSIPLSLTRLPSLSVLALQHN-NLSGSVPNNWGVLAGNKSYQLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHN- 274 (773)
Q Consensus 197 N~l~~~~~~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~~~~~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N- 274 (773)
|.+++..+..+..+++|++|+++++ .++... + ...+..+++|++|+++++
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~---l-------------------------~~l~~~~~~L~~L~ls~c~ 132 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA---L-------------------------QTLLSSCSRLDELNLSWCF 132 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHH---H-------------------------HHHHHHCTTCCEEECCCCT
T ss_pred cCCCcHHHHHHhcCCCCcCccccccccccccc---c-------------------------chhhHHHHhcccccccccc
Confidence 8887777777777888888888774 343211 0 001123455666666554
Q ss_pred cccCC-CCCCcCc-ccccceeccccc--ccccc-CcccccccccCceEEccCC-CCCCCcchhhccccccccccccCc-c
Q 041878 275 KIVGP-IPDELGK-LSKLQKLDLSYN--AIGGS-FPVTFTNITSLVSLNLENN-RLGNKIPEGLERLQNLTVLNLKNN-Q 347 (773)
Q Consensus 275 ~l~~~-~p~~l~~-l~~L~~L~Ls~N--~l~~~-~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~l~~l~~L~~L~ls~N-~ 347 (773)
.+++. +...+.. .++|+.|+++++ .++.. +...+..+++|++|++++| .+++.....+..+++|++|++++| .
T Consensus 133 ~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~ 212 (284)
T d2astb2 133 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD 212 (284)
T ss_dssp TCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTT
T ss_pred ccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCC
Confidence 23211 1111222 246677777654 33332 2233456788888888876 477777778888888888888884 5
Q ss_pred cccccccccCCCCcCceeecCCccCccCC-CchhhccCccCEEEeecccCCCCCchhh
Q 041878 348 FKGHIPETIGNISGINQLDLSENDFTGEI-SPSLASLANLTSFNVSYNNLSGSVPPLL 404 (773)
Q Consensus 348 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~ls~N~l~g~~p~~~ 404 (773)
+++.....++++++|+.|+++++ ++... ......+++ |.+..++++...++.+
T Consensus 213 i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~---L~i~~~~ls~~~~~~~ 266 (284)
T d2astb2 213 IIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPH---LQINCSHFTTIARPTI 266 (284)
T ss_dssp CCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTT---SEESCCCSCCTTCSSC
T ss_pred CChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCcc---ccccCccCCCCCCCcc
Confidence 77777777888899999999887 33222 222233444 4567788887655544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=7.5e-15 Score=135.78 Aligned_cols=128 Identities=20% Similarity=0.170 Sum_probs=79.6
Q ss_pred CCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccc
Q 041878 260 LGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLT 339 (773)
Q Consensus 260 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~ 339 (773)
+.++..|++|+|++|+|+. ++..+..+++|+.|+|++|+|+.. ..|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 3445556666666666663 344455566666666666666632 2356666677777777776655555555666777
Q ss_pred cccccCccccccc-ccccCCCCcCceeecCCccCccCC---CchhhccCccCEEE
Q 041878 340 VLNLKNNQFKGHI-PETIGNISGINQLDLSENDFTGEI---SPSLASLANLTSFN 390 (773)
Q Consensus 340 ~L~ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L~ 390 (773)
.|++++|+++... ...+..+++|++|++++|+++... +..+..+++|+.||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 7777777766432 145667777777777777776432 12466778888776
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=4.6e-14 Score=123.95 Aligned_cols=101 Identities=25% Similarity=0.358 Sum_probs=52.5
Q ss_pred EEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhccccccccccccCcc
Q 041878 268 EISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQ 347 (773)
Q Consensus 268 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~ 347 (773)
.|+|++|+++ .++ .+..+++|++|++++|+|+ .+|..+..+++|+.|++++|+|++. | .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence 4555555555 222 2555555555555555555 3444555555555555555555432 2 25555555555555555
Q ss_pred ccccc-ccccCCCCcCceeecCCccCc
Q 041878 348 FKGHI-PETIGNISGINQLDLSENDFT 373 (773)
Q Consensus 348 l~~~~-~~~~~~l~~L~~L~L~~N~l~ 373 (773)
++... ...++.+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 55322 134455555555555555554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=2.5e-14 Score=132.18 Aligned_cols=113 Identities=19% Similarity=0.133 Sum_probs=83.2
Q ss_pred ccccCCCCCcEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccc
Q 041878 109 EKISQLHALRKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTR 188 (773)
Q Consensus 109 ~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~ 188 (773)
+.+.+...|++|+|++|+|+. ++..+..+++|++|+|++|+|+ .+ +.|..+++|++|+|++|.++...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-cc-CCcccCcchhhhhcccccccCCCccccccccc
Confidence 345677788888888888874 4666677888888888888887 34 35778888888888888887554445567888
Q ss_pred cceeecccccccccC-CccccCCCccceeeccccccc
Q 041878 189 LYRLNLSYNSLLGSI-PLSLTRLPSLSVLALQHNNLS 224 (773)
Q Consensus 189 L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~ 224 (773)
|++|+|++|+++... ...+..+++|++|++++|+++
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cccceeccccccccccccccccccccchhhcCCCccc
Confidence 888888888887432 145667777777777777775
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.47 E-value=5.5e-14 Score=123.41 Aligned_cols=102 Identities=34% Similarity=0.384 Sum_probs=65.9
Q ss_pred cEEEccCCcccccCCCCCCCCCCCceEEcccCccCCCCCCCCCCCCCCCEEEccCCCCCCCCccccccccccceeecccc
Q 041878 118 RKLSLHDNLLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIGNCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYN 197 (773)
Q Consensus 118 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N 197 (773)
|.|+|++|+|+ .++ .++.+++|++|+|++|+|+ .+|+.++.+++|++|++++|.+++ +| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 45677777776 333 3666777777777777776 456666777777777777777763 33 4666777777777777
Q ss_pred cccccC-CccccCCCccceeeccccccc
Q 041878 198 SLLGSI-PLSLTRLPSLSVLALQHNNLS 224 (773)
Q Consensus 198 ~l~~~~-~~~l~~l~~L~~L~L~~N~l~ 224 (773)
+++... ...+..+++|++|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 776432 245666667777777777665
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=1.3e-14 Score=139.11 Aligned_cols=129 Identities=24% Similarity=0.349 Sum_probs=100.3
Q ss_pred CccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEccCCCCCCCcchhhcccc
Q 041878 257 PVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKIPEGLERLQ 336 (773)
Q Consensus 257 ~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~ 336 (773)
+..++.+++|++|+|++|+|+. ++ .+..+++|++|+|++|.|+ .+|..+..+++|+.|++++|+++.. ..+..++
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred hhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccc
Confidence 4567778889999999998884 43 5888889999999999987 5566666677899999999998753 4578888
Q ss_pred ccccccccCcccccccc-cccCCCCcCceeecCCccCccCCCch----------hhccCccCEEE
Q 041878 337 NLTVLNLKNNQFKGHIP-ETIGNISGINQLDLSENDFTGEISPS----------LASLANLTSFN 390 (773)
Q Consensus 337 ~L~~L~ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~----------~~~l~~L~~L~ 390 (773)
+|+.|++++|+++.... ..+..+++|+.|+|++|++....+.. +..+++|+.||
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 99999999999885422 56788999999999999887544432 56788888875
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.28 E-value=6.6e-14 Score=134.01 Aligned_cols=126 Identities=25% Similarity=0.295 Sum_probs=89.7
Q ss_pred ccceeeccccccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEcc
Q 041878 241 QLQFLNLDHNLIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLE 320 (773)
Q Consensus 241 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 320 (773)
+|++|+|++|.|+.. + .+..+++|+.|+|++|+++ .+|..+..+++|++|++++|+++.. ..+..+++|+.|+++
T Consensus 49 ~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L~ 123 (198)
T d1m9la_ 49 ACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMS 123 (198)
T ss_dssp TCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSSEEEES
T ss_pred ccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccccccccccccc
Confidence 455555555555533 2 3667778888888888887 4555555567788888888888743 347788889999999
Q ss_pred CCCCCCCcc-hhhccccccccccccCcccccccccc----------cCCCCcCceeecCCccCc
Q 041878 321 NNRLGNKIP-EGLERLQNLTVLNLKNNQFKGHIPET----------IGNISGINQLDLSENDFT 373 (773)
Q Consensus 321 ~N~l~~~~~-~~l~~l~~L~~L~ls~N~l~~~~~~~----------~~~l~~L~~L~L~~N~l~ 373 (773)
+|+++.... ..+..+++|+.|++++|++....+.. +..+|+|+.|| +..++
T Consensus 124 ~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD--~~~I~ 185 (198)
T d1m9la_ 124 NNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp EEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES--SGGGT
T ss_pred cchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC--CccCC
Confidence 998876432 56888899999999999887554432 56788999887 44444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=1e-11 Score=113.46 Aligned_cols=107 Identities=24% Similarity=0.256 Sum_probs=70.3
Q ss_pred CCcceEeeCCCEEEEEcCCCCcccccCccccCCCCCcEEEccCC-cccccCCCCCCCCCCCceEEcccCccCCCCCCCCC
Q 041878 82 GWAGIKCVKGQVIAIQLPWRRLGGRISEKISQLHALRKLSLHDN-LLAGPVPWSLGFLPNLRGVYLFNNRLSGSIPPSIG 160 (773)
Q Consensus 82 ~w~gv~c~~~~v~~l~l~~~~l~~~i~~~l~~l~~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~ 160 (773)
.+.+|+|.. ++++ .+|..+..+++|++|++++| .|+..-+.+|.++++|+.|+|++|+|+...|..|.
T Consensus 9 ~~~~l~c~~----------~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~ 77 (156)
T d2ifga3 9 GSSGLRCTR----------DGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFH 77 (156)
T ss_dssp SSSCEECCS----------SCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGG
T ss_pred CCCeEEecC----------CCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccc
Confidence 466777742 2332 34566677777788887655 47766566677777777777777777766667777
Q ss_pred CCCCCCEEEccCCCCCCCCccccccccccceeeccccccc
Q 041878 161 NCPNLQTLDLSNNALIGAIPPSLANSTRLYRLNLSYNSLL 200 (773)
Q Consensus 161 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 200 (773)
.+++|++|+|++|+|+ .+|.......+|++|+|++|.+.
T Consensus 78 ~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 78 FTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred ccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 7777777777777777 34443333345777777776663
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=2e-11 Score=111.52 Aligned_cols=84 Identities=25% Similarity=0.276 Sum_probs=50.3
Q ss_pred ccceeecccc-ccccccCccCCCCCCccEEECCCCcccCCCCCCcCcccccceeccccccccccCcccccccccCceEEc
Q 041878 241 QLQFLNLDHN-LIAGTIPVSLGKLGLLQEISLSHNKIVGPIPDELGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNL 319 (773)
Q Consensus 241 ~L~~L~L~~n-~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 319 (773)
+|++|++++| .++.+.+..|.++++|+.|+|++|+|+...+.+|..+++|++|+|++|+|+...+..|.. .+|+.|+|
T Consensus 32 ~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~-~~l~~L~L 110 (156)
T d2ifga3 32 NLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG-LSLQELVL 110 (156)
T ss_dssp CCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS-CCCCEEEC
T ss_pred ccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhcc-cccccccc
Confidence 3444444333 244444555666666777777777776655666666777777777777776443344433 35777777
Q ss_pred cCCCCC
Q 041878 320 ENNRLG 325 (773)
Q Consensus 320 s~N~l~ 325 (773)
++|.+.
T Consensus 111 ~~Np~~ 116 (156)
T d2ifga3 111 SGNPLH 116 (156)
T ss_dssp CSSCCC
T ss_pred CCCccc
Confidence 777664
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=4e-09 Score=96.56 Aligned_cols=110 Identities=23% Similarity=0.214 Sum_probs=72.1
Q ss_pred cCcccccceeccccccccccCcccccccccCceEEccCCCCCCCc--chhhccccccccccccCcccccccccccCCCCc
Q 041878 284 LGKLSKLQKLDLSYNAIGGSFPVTFTNITSLVSLNLENNRLGNKI--PEGLERLQNLTVLNLKNNQFKGHIPETIGNISG 361 (773)
Q Consensus 284 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~l~~l~~L~~L~ls~N~l~~~~~~~~~~l~~ 361 (773)
+..+..+..++..+|... .++..+..+++|++|+|++|+|+... +..+..+++|+.|+|++|.++...+-.+....+
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 333444455555555443 44455567788888888888887653 455777888888888888888543333344557
Q ss_pred CceeecCCccCccCCCch-------hhccCccCEEEeecccC
Q 041878 362 INQLDLSENDFTGEISPS-------LASLANLTSFNVSYNNL 396 (773)
Q Consensus 362 L~~L~L~~N~l~~~~~~~-------~~~l~~L~~L~ls~N~l 396 (773)
|+.|++++|++....... +..+++|+.|| ++.+
T Consensus 117 L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp CSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred cceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence 888888888887655432 45578888764 4444
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.46 E-value=6.4e-09 Score=95.16 Aligned_cols=82 Identities=21% Similarity=0.182 Sum_probs=47.1
Q ss_pred CcccccceeccccccccccC--cccccccccCceEEccCCCCCCCcchhhccccccccccccCccccccccc-------c
Q 041878 285 GKLSKLQKLDLSYNAIGGSF--PVTFTNITSLVSLNLENNRLGNKIPEGLERLQNLTVLNLKNNQFKGHIPE-------T 355 (773)
Q Consensus 285 ~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~ls~N~l~~~~~~-------~ 355 (773)
..+++|++|+|++|+|+... +..+..+++|+.|+|++|+++...+-......+|+.|++++|+++..... .
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i 141 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence 34555666666666665432 23455566666666666666554443333444667777777777644332 2
Q ss_pred cCCCCcCceee
Q 041878 356 IGNISGINQLD 366 (773)
Q Consensus 356 ~~~l~~L~~L~ 366 (773)
+..+|+|+.||
T Consensus 142 ~~~~P~L~~LD 152 (162)
T d1koha1 142 RERFPKLLRLD 152 (162)
T ss_dssp HTTSTTCCEET
T ss_pred HHHCCCCCEEC
Confidence 45677777776
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.96 E-value=1.2e-05 Score=78.99 Aligned_cols=130 Identities=15% Similarity=0.109 Sum_probs=84.1
Q ss_pred ccceEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEEeecCCCCHHHHHh
Q 041878 546 STYGTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVFDFMPKGSLASFLH 624 (773)
Q Consensus 546 G~fg~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~e~~~~g~L~~~l~ 624 (773)
++.+.||+... +++.+++|+...........+.+|...++.+. +--+.+++.+. ...+..++||++++|.++.+...
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-~~~~~~~lv~~~l~G~~~~~~~~ 102 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-RHDGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-EETTEEEEEEECCSSEEHHHHTT
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-ecCCceEEEEEeccccccccccc
Confidence 33468998864 46678888886555445556788888887764 32345666666 34568899999999987755432
Q ss_pred hcCCCCccCHHHHHHHHHHHHHHHHHhcc---------------------------------------------------
Q 041878 625 ARGPETIVNWATRMSIAIGIARGLNYLHV--------------------------------------------------- 653 (773)
Q Consensus 625 ~~~~~~~~~~~~~~~i~~~i~~al~yLH~--------------------------------------------------- 653 (773)
... . ...++.++++.+..||.
T Consensus 103 ~~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (263)
T d1j7la_ 103 DEQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL 174 (263)
T ss_dssp TCS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred ccc-----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence 110 1 11123333333333331
Q ss_pred -------CCCceecCCCCCCEEeCCCCCeEEeecCCccc
Q 041878 654 -------EENMIHGNLTSSNVLLDEKTNPRIADFGLSRL 685 (773)
Q Consensus 654 -------~~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~ 685 (773)
...++|+|+.|.||++++++.+-|+||+.+..
T Consensus 175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11278999999999999876677999998753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.83 E-value=4.1e-06 Score=76.28 Aligned_cols=60 Identities=13% Similarity=0.174 Sum_probs=29.4
Q ss_pred cccccccccCcccccc----cccccCCCCcCceeecCCccCccC-------CCchhhccCccCEEEeeccc
Q 041878 336 QNLTVLNLKNNQFKGH----IPETIGNISGINQLDLSENDFTGE-------ISPSLASLANLTSFNVSYNN 395 (773)
Q Consensus 336 ~~L~~L~ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~ls~N~ 395 (773)
+.|+.|+|++|.++.. +-..+...++|++|+|++|.+... +...+..-++|+.|+++.+.
T Consensus 72 ~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 72 PSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp SSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred ccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 4444444444444431 223344555666666666654421 22233345667777766553
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.82 E-value=1.4e-06 Score=79.42 Aligned_cols=63 Identities=17% Similarity=0.149 Sum_probs=30.7
Q ss_pred ccccCceEEccCCCCCCCcc----hhhccccccccccccCccccc-------ccccccCCCCcCceeecCCccC
Q 041878 310 NITSLVSLNLENNRLGNKIP----EGLERLQNLTVLNLKNNQFKG-------HIPETIGNISGINQLDLSENDF 372 (773)
Q Consensus 310 ~l~~L~~L~Ls~N~l~~~~~----~~l~~l~~L~~L~ls~N~l~~-------~~~~~~~~l~~L~~L~L~~N~l 372 (773)
..++|++|+|++|.++.... ..+...+.|++|++++|.+.. .+...+...++|+.|+++.+..
T Consensus 70 ~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 70 TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred hcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 34455555555555543322 223334455555555554331 1333444556677777766543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.57 E-value=0.00011 Score=71.34 Aligned_cols=74 Identities=15% Similarity=0.139 Sum_probs=51.3
Q ss_pred ccccccc-eEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCC--ceEEeEEEEECCCCeEEEEEeecCCCC
Q 041878 542 IMGKSTY-GTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHP--NLLALRAYYLGPKGEKLLVFDFMPKGS 618 (773)
Q Consensus 542 ~lG~G~f-g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~~lV~e~~~~g~ 618 (773)
.+..|.. +.||+....++..+++|...... ..++..|+..++.+... .+.+++++. ...+..++|||+++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~-~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVV-TEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEE-ECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeec-ccccceEEEEEeeeccc
Confidence 3455554 57999998888889999875443 33467788888777533 345666666 34557899999998765
Q ss_pred H
Q 041878 619 L 619 (773)
Q Consensus 619 L 619 (773)
+
T Consensus 93 ~ 93 (255)
T d1nd4a_ 93 L 93 (255)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.36 E-value=6.3e-06 Score=74.97 Aligned_cols=64 Identities=20% Similarity=0.222 Sum_probs=27.5
Q ss_pred CCCCccEEECCC-CcccCC----CCCCcCcccccceeccccccccccC----cccccccccCceEEccCCCCC
Q 041878 262 KLGLLQEISLSH-NKIVGP----IPDELGKLSKLQKLDLSYNAIGGSF----PVTFTNITSLVSLNLENNRLG 325 (773)
Q Consensus 262 ~l~~L~~L~L~~-N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~ 325 (773)
+.++|++|+|++ +.++.. +...+...+.|++|+|++|.++... ...+...++++.|++++|.++
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 344555555554 233321 1122333444555555555444321 122333445555555555554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.35 E-value=2.2e-05 Score=71.20 Aligned_cols=112 Identities=16% Similarity=0.222 Sum_probs=82.1
Q ss_pred Ccccccceecccc-cccccc----CcccccccccCceEEccCCCCCCCcch----hhccccccccccccCcccccc----
Q 041878 285 GKLSKLQKLDLSY-NAIGGS----FPVTFTNITSLVSLNLENNRLGNKIPE----GLERLQNLTVLNLKNNQFKGH---- 351 (773)
Q Consensus 285 ~~l~~L~~L~Ls~-N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~----~l~~l~~L~~L~ls~N~l~~~---- 351 (773)
.+.++|++|+|++ +.++.. +...+...++|++|+|++|.++..... .+...+.|+.+++++|.+...
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 4567999999997 567642 334456788999999999999765433 455678999999999998753
Q ss_pred cccccCCCCcCcee--ecCCccCccC----CCchhhccCccCEEEeecccC
Q 041878 352 IPETIGNISGINQL--DLSENDFTGE----ISPSLASLANLTSFNVSYNNL 396 (773)
Q Consensus 352 ~~~~~~~l~~L~~L--~L~~N~l~~~----~~~~~~~l~~L~~L~ls~N~l 396 (773)
+...+...++|+.+ ++++|.+... +...+...++|+.|+++.|..
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 34566778889875 4467777652 444455778999999987754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.26 E-value=0.00032 Score=72.89 Aligned_cols=75 Identities=8% Similarity=0.032 Sum_probs=47.8
Q ss_pred cccccccceEEEEEEeCC-CCEEEEEEecccC-------cccHHHHHHHHHHHHccC-C--CceEEeEEEEECCCCeEEE
Q 041878 541 EIMGKSTYGTAYKATLED-GSEVAVKRLREKT-------TKGQKEFEAEAAAIGKIH-H--PNLLALRAYYLGPKGEKLL 609 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~-g~~vAvK~l~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~~l 609 (773)
+.||.|....||+.+..+ ++.|+||.-.... .....+...|.+.++.+. + ..+.+++.+. ++..++
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d---~~~~~l 108 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD---TEMAVT 108 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE---TTTTEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc---CCCCEE
Confidence 468999999999998754 6789999754311 112334566888777663 2 3455565543 235578
Q ss_pred EEeecCCCC
Q 041878 610 VFDFMPKGS 618 (773)
Q Consensus 610 V~e~~~~g~ 618 (773)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.75 E-value=0.0023 Score=64.26 Aligned_cols=68 Identities=19% Similarity=0.150 Sum_probs=45.2
Q ss_pred eEEEEEEeCCCCEEEEEEecccCcccHHHHHHHHHHHHccCCCceE--EeEEE----EECCCCeEEEEEeecCCC
Q 041878 549 GTAYKATLEDGSEVAVKRLREKTTKGQKEFEAEAAAIGKIHHPNLL--ALRAY----YLGPKGEKLLVFDFMPKG 617 (773)
Q Consensus 549 g~Vy~~~~~~g~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~~~----~~~~~~~~~lV~e~~~~g 617 (773)
-.||+++.++|+.+++|..+.. ....+++..|...+..+....+. ..+.. .....+..+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 4799999999999999998654 23467788899888887532221 11110 011234678899999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.18 E-value=0.0069 Score=62.46 Aligned_cols=71 Identities=8% Similarity=0.095 Sum_probs=48.2
Q ss_pred cccccccceEEEEEEeCCC--------CEEEEEEecccCcccHHHHHHHHHHHHccC-CCceEEeEEEEECCCCeEEEEE
Q 041878 541 EIMGKSTYGTAYKATLEDG--------SEVAVKRLREKTTKGQKEFEAEAAAIGKIH-HPNLLALRAYYLGPKGEKLLVF 611 (773)
Q Consensus 541 ~~lG~G~fg~Vy~~~~~~g--------~~vAvK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~lV~ 611 (773)
+.|+.|-.-.+|++...++ +.|.+++.. . .....+..+|..+++.+. +.-..++++++ . -++|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-~----~g~I~ 120 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIF-S----GGRLE 120 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-T----TEEEE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEc-C----CceEE
Confidence 5688888899999986543 456666654 2 233456678998888885 43344677766 2 26899
Q ss_pred eecCCCC
Q 041878 612 DFMPKGS 618 (773)
Q Consensus 612 e~~~~g~ 618 (773)
||++|.+
T Consensus 121 efi~g~~ 127 (395)
T d1nw1a_ 121 EYIPSRP 127 (395)
T ss_dssp CCCCEEE
T ss_pred EEecccc
Confidence 9998753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.19 E-value=0.047 Score=53.90 Aligned_cols=31 Identities=23% Similarity=0.303 Sum_probs=27.8
Q ss_pred CCceecCCCCCCEEeCCCCCeEEeecCCccc
Q 041878 655 ENMIHGNLTSSNVLLDEKTNPRIADFGLSRL 685 (773)
Q Consensus 655 ~~iiH~Dik~~NIll~~~~~~kl~DfG~a~~ 685 (773)
.|+||+|+.++||+++.+...-|.||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 6799999999999999887778999998764
|